1	Involvement	Involvement	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	adenylate	adenylate	B-NP	B-NP	-	4	NMOD	-	-
4	cyclase	cyclase	I-NP	I-NP	-	6	NMOD	-	-
5	and	and	O	O	-	6	NMOD	-	-
6	p70	p70	B-NP	B-NP	-	10	NMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	S6	S6	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	-kinase	-kinase	B-NP	B-NP	-	11	NMOD	-	-
11	activation	activation	I-NP	I-NP	-	2	PMOD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	IL-10	IL-10	B-NP	B-NP	-	14	NMOD	-	-
14	up-regulation	up-regulation	I-NP	I-NP	-	12	PMOD	-	-
15	in	in	B-PP	B-PP	-	11	NMOD	-	-
16	human	human	B-NP	B-NP	-	17	NMOD	-	-
17	monocytes	monocytes	I-NP	I-NP	-	15	PMOD	-	-
18	by	by	B-PP	B-PP	-	1	NMOD	-	-
19	gp41	gp41	B-NP	B-NP	-	21	NMOD	-	-
20	envelope	envelope	I-NP	I-NP	-	21	NMOD	-	-
21	protein	protein	I-NP	I-NP	-	18	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	human	human	B-NP	B-NP	-	26	NMOD	-	-
24	immunodeficiency	immunodeficiency	I-NP	I-NP	-	26	NMOD	-	-
25	virus	virus	I-NP	I-NP	-	26	NMOD	-	-
26	type	type	I-NP	I-NP	-	22	PMOD	-	-
27	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
28	.	.	O	O	-	1	P	-	-

1	Our	Our	B-NP	B-NP	-	3	NMOD	-	-
2	previous	previous	I-NP	I-NP	-	3	NMOD	-	-
3	results	results	I-NP	I-NP	-	4	SUB	-	-
4	show	show	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	recombinant	recombinant	B-NP	B-NP	-	14	NMOD	-	-
7	gp41	gp41	I-NP	I-NP	-	14	NMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	aa565-647	aa565-647	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	,	,	O	O	-	14	P	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	extracellular	extracellular	I-NP	I-NP	-	14	NMOD	-	-
14	domain	domain	I-NP	I-NP	-	20	SUB	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	HIV-1	HIV-1	B-NP	B-NP	-	18	NMOD	-	-
17	transmembrane	transmembrane	I-NP	I-NP	-	18	NMOD	-	-
18	glycoprotein	glycoprotein	I-NP	I-NP	-	15	PMOD	-	-
19	,	,	O	O	-	14	P	-	-
20	stimulates	stimulates	B-VP	B-VP	-	5	SBAR	-	-
21	interleukin-10	interleukin-10	B-NP	B-NP	-	25	NMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	IL-10	IL-10	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	production	production	B-NP	B-NP	-	20	OBJ	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	human	human	B-NP	B-NP	-	28	NMOD	-	-
28	monocytes	monocytes	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	signal	signal	I-NP	I-NP	-	3	NMOD	-	-
3	cascade	cascade	I-NP	I-NP	-	7	SUB	-	-
4	transducing	transducing	B-VP	B-VP	-	3	NMOD	-	-
5	this	this	B-NP	B-NP	-	6	NMOD	-	-
6	effect	effect	I-NP	I-NP	-	4	OBJ	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	not	not	O	O	-	7	VMOD	-	-
9	yet	yet	B-ADJP	B-ADJP	-	10	AMOD	-	-
10	clear	clear	I-ADJP	I-ADJP	-	7	PRD	-	-
11	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
7	whether	whether	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	gp41-induced	gp41-induced	B-NP	B-NP	-	10	NMOD	-	-
9	IL-10	IL-10	I-NP	I-NP	-	10	NMOD	-	-
10	up-regulation	up-regulation	I-NP	I-NP	-	11	SUB	-	-
11	is	is	B-VP	B-VP	-	7	SBAR	-	-
12	mediated	mediated	I-VP	I-VP	-	11	VC	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	previously	previously	I-NP	I-NP	-	16	AMOD	-	-
16	described	described	I-NP	I-NP	-	18	NMOD	-	-
17	synergistic	synergistic	I-NP	I-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	13	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	cAMP	cAMP	B-NP	B-NP	-	23	NMOD	-	-
21	and	and	I-NP	I-NP	-	23	NMOD	-	-
22	NF-kappaB	NF-kappaB	I-NP	I-NP	-	23	NMOD	-	-
23	pathways	pathways	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	6	P	-	-

1	gp41	gp41	B-NP	B-NP	-	2	SUB	-	-
2	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
3	cAMP	cAMP	B-NP	B-NP	-	4	NMOD	-	-
4	accumulation	accumulation	I-NP	I-NP	-	2	OBJ	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	monocytes	monocytes	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	2	VMOD	-	-
8	a	a	B-NP	B-NP	-	9	NMOD	-	-
9	time-	time-	I-NP	I-NP	-	7	PMOD	-	-
10	and	and	O	O	-	23	NMOD	-	-
11	concentration-dependent	concentration-dependent	B-NP	B-NP	-	12	NMOD	-	-
12	manner	manner	I-NP	I-NP	-	18	NMOD	-	-
13	and	and	O	O	-	18	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	adenylate	adenylate	I-NP	I-NP	-	18	NMOD	-	-
16	cyclase	cyclase	I-NP	I-NP	-	18	NMOD	-	-
17	inhibitor	inhibitor	I-NP	I-NP	-	18	NMOD	-	-
18	SQ	SQ	I-NP	I-NP	-	23	NMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	18	NMOD	-	-
20	suppressed	suppressed	B-VP	B-VP	-	19	NMOD	-	-
21	gp41-induced	gp41-induced	B-NP	B-NP	-	23	NMOD	-	-
22	IL-10	IL-10	I-NP	I-NP	-	23	NMOD	-	-
23	production	production	I-NP	I-NP	-	2	OBJ	-	-
24	in	in	B-PP	B-PP	-	23	NMOD	-	-
25	monocytes	monocytes	B-NP	B-NP	-	24	PMOD	-	-
26	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	gp41	gp41	B-NP	B-NP	-	5	SUB	-	-
5	failed	failed	B-VP	B-VP	-	17	VMOD	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	stimulate	stimulate	I-VP	I-VP	-	5	VMOD	-	-
8	NF-kappaB	NF-kappaB	B-NP	B-NP	-	10	NMOD	-	-
9	binding	binding	I-NP	I-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	7	OBJ	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	as	as	B-NP	B-NP	-	13	AMOD	-	-
13	much	much	I-NP	I-NP	-	11	PMOD	-	-
14	as	as	B-PP	B-PP	-	7	VMOD	-	-
15	no	no	B-NP	B-NP	-	16	NMOD	-	-
16	NF-kappaB	NF-kappaB	I-NP	I-NP	-	14	PMOD	-	-
17	bound	bound	B-VP	B-VP	-	0	ROOT	-	-
18	to	to	B-PP	B-PP	-	17	VMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	main	main	I-NP	I-NP	-	22	NMOD	-	-
21	NF-kappaB-binding	NF-kappaB-binding	I-NP	I-NP	-	22	NMOD	-	-
22	site	site	I-NP	I-NP	-	18	PMOD	-	-
23	<num>	<num>	I-NP	I-NP	-	22	NMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	IL-10	IL-10	I-NP	I-NP	-	27	NMOD	-	-
27	promoter	promoter	I-NP	I-NP	-	24	PMOD	-	-
28	after	after	B-PP	B-PP	-	23	NMOD	-	-
29	addition	addition	B-NP	B-NP	-	28	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	gp41	gp41	B-NP	B-NP	-	30	PMOD	-	-
32	.	.	O	O	-	17	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	involvement	involvement	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	other	other	B-NP	B-NP	-	10	NMOD	-	-
8	signal	signal	I-NP	I-NP	-	10	NMOD	-	-
9	transduction	transduction	I-NP	I-NP	-	10	NMOD	-	-
10	pathways	pathways	I-NP	I-NP	-	6	PMOD	-	-
11	.	.	O	O	-	3	P	-	-

1	Specific	Specific	B-NP	B-NP	-	2	NMOD	-	-
2	inhibitors	inhibitors	I-NP	I-NP	-	21	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	p70	p70	B-NP	B-NP	-	8	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	S6	S6	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	-kinase	-kinase	B-NP	B-NP	-	3	PMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	rapamycin	rapamycin	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	,	,	O	O	-	21	P	-	-
13	and	and	O	O	-	21	VMOD	-	-
14	Gi	Gi	B-NP	B-NP	-	15	NMOD	-	-
15	protein	protein	I-NP	I-NP	-	21	SUB	-	-
16	(	(	O	O	-	18	P	-	-
17	pertussis	pertussis	B-NP	B-NP	-	18	NMOD	-	-
18	toxin	toxin	I-NP	I-NP	-	15	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	,	,	O	O	-	21	P	-	-
21	prevented	prevented	B-VP	B-VP	-	0	ROOT	-	-
22	induction	induction	B-NP	B-NP	-	21	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	IL-10	IL-10	B-NP	B-NP	-	25	NMOD	-	-
25	production	production	I-NP	I-NP	-	23	PMOD	-	-
26	by	by	B-PP	B-PP	-	22	NMOD	-	-
27	gp41	gp41	B-NP	B-NP	-	26	PMOD	-	-
28	in	in	B-PP	B-PP	-	22	NMOD	-	-
29	monocytes	monocytes	B-NP	B-NP	-	28	PMOD	-	-
30	,	,	O	O	-	21	P	-	-
31	while	while	B-SBAR	B-SBAR	-	21	VMOD	-	-
32	inhibitors	inhibitors	B-NP	B-NP	-	56	SUB	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	the	the	B-NP	B-NP	-	36	NMOD	-	-
35	phosphatidylinositol	phosphatidylinositol	I-NP	I-NP	-	36	NMOD	-	-
36	3-kinase	3-kinase	I-NP	I-NP	-	51	NMOD	-	-
37	(	(	O	O	-	39	P	-	-
38	PI	PI	B-NP	B-NP	-	39	NMOD	-	-
39	3-kinase	3-kinase	I-NP	I-NP	-	36	NMOD	-	-
40	)	)	O	O	-	39	P	-	-
41	(	(	O	O	-	42	P	-	-
42	wortmannin	wortmannin	B-NP	B-NP	-	36	NMOD	-	-
43	)	)	O	O	-	42	P	-	-
44	and	and	O	O	-	47	NMOD	-	-
45	mitogen-activated	mitogen-activated	B-NP	B-NP	-	47	NMOD	-	-
46	protein	protein	I-NP	I-NP	-	47	NMOD	-	-
47	kinase	kinase	I-NP	I-NP	-	51	NMOD	-	-
48	(	(	O	O	-	49	P	-	-
49	MAPK	MAPK	B-NP	B-NP	-	47	NMOD	-	-
50	)	)	O	O	-	49	P	-	-
51	pathway	pathway	B-NP	B-NP	-	33	PMOD	-	-
52	(	(	O	O	-	53	P	-	-
53	PD	PD	B-NP	B-NP	-	51	NMOD	-	-
54	<num>	<num>	I-NP	I-NP	-	53	NMOD	-	-
55	)	)	O	O	-	53	P	-	-
56	did	did	B-VP	B-VP	-	31	SBAR	-	-
57	not	not	O	O	-	56	VMOD	-	-
58	.	.	O	O	-	21	P	-	-

1	Thus	Thus	B-NP	B-NP	-	5	NMOD	-	-
2	HIV-1	HIV-1	I-NP	I-NP	-	5	NMOD	-	-
3	gp41-induced	gp41-induced	I-NP	I-NP	-	5	NMOD	-	-
4	IL-10	IL-10	I-NP	I-NP	-	5	NMOD	-	-
5	up-regulation	up-regulation	I-NP	I-NP	-	8	SUB	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	monocytes	monocytes	B-NP	B-NP	-	6	PMOD	-	-
8	may	may	B-VP	B-VP	-	0	ROOT	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	involve	involve	I-VP	I-VP	-	8	VC	-	-
11	NF-kappaB	NF-kappaB	B-NP	B-NP	-	10	OBJ	-	-
12	,	,	O	O	-	18	P	-	-
13	MAPK	MAPK	B-NP	B-NP	-	18	NMOD	-	-
14	,	,	O	O	-	18	P	-	-
15	or	or	O	O	-	18	NMOD	-	-
16	PI	PI	B-NP	B-NP	-	18	NMOD	-	-
17	3-kinase	3-kinase	I-NP	I-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	10	OBJ	-	-
19	,	,	O	O	-	10	P	-	-
20	but	but	O	O	-	10	VMOD	-	-
21	rather	rather	B-VP	B-VP	-	22	VMOD	-	-
22	may	may	I-VP	I-VP	-	10	VMOD	-	-
23	operate	operate	I-VP	I-VP	-	22	VC	-	-
24	through	through	B-PP	B-PP	-	23	VMOD	-	-
25	activation	activation	B-NP	B-NP	-	24	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	adenylate	adenylate	B-NP	B-NP	-	28	NMOD	-	-
28	cyclase	cyclase	I-NP	I-NP	-	32	NMOD	-	-
29	and	and	O	O	-	32	NMOD	-	-
30	pertussis-toxin-sensitive	pertussis-toxin-sensitive	B-NP	B-NP	-	32	NMOD	-	-
31	Gi/Go	Gi/Go	I-NP	I-NP	-	32	NMOD	-	-
32	protein	protein	I-NP	I-NP	-	26	PMOD	-	-
33	to	to	B-PP	B-PP	-	25	NMOD	-	-
34	effect	effect	B-NP	B-NP	-	35	NMOD	-	-
35	p70	p70	I-NP	I-NP	-	40	NMOD	-	-
36	(	(	O	O	-	37	P	-	-
37	S6	S6	B-NP	B-NP	-	35	NMOD	-	-
38	)	)	O	O	-	37	P	-	-
39	-kinase	-kinase	B-NP	B-NP	-	40	NMOD	-	-
40	activation	activation	I-NP	I-NP	-	33	PMOD	-	-
41	.	.	O	O	-	8	P	-	-

1	Constitutive	Constitutive	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NF-kappaB	NF-kappaB	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	primary	primary	B-NP	B-NP	-	10	NMOD	-	-
7	adult	adult	I-NP	I-NP	-	10	NMOD	-	-
8	T-cell	T-cell	I-NP	I-NP	-	10	NMOD	-	-
9	leukemia	leukemia	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	Human	Human	B-NP	B-NP	-	5	NMOD	-	-
2	T-cell	T-cell	I-NP	I-NP	-	5	NMOD	-	-
3	leukemia	leukemia	I-NP	I-NP	-	5	NMOD	-	-
4	virus	virus	I-NP	I-NP	-	5	NMOD	-	-
5	type	type	I-NP	I-NP	-	10	SUB	-	-
6	I	I	I-NP	I-NP	-	5	NMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	HTLV-I	HTLV-I	B-NP	B-NP	-	5	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	an	an	B-NP	B-NP	-	13	NMOD	-	-
12	etiologic	etiologic	I-NP	I-NP	-	13	NMOD	-	-
13	agent	agent	I-NP	I-NP	-	10	PRD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	adult	adult	B-NP	B-NP	-	17	NMOD	-	-
16	T-cell	T-cell	I-NP	I-NP	-	17	NMOD	-	-
17	leukemia	leukemia	I-NP	I-NP	-	14	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	ATL	ATL	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	viral	viral	I-NP	I-NP	-	4	NMOD	-	-
3	protein	protein	I-NP	I-NP	-	4	NMOD	-	-
4	Tax	Tax	I-NP	I-NP	-	5	SUB	-	-
5	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	10	NMOD	-	-
8	and	and	O	O	-	10	NMOD	-	-
9	nuclear	nuclear	B-NP	B-NP	-	10	NMOD	-	-
10	translocalization	translocalization	I-NP	I-NP	-	5	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	transcription	transcription	B-NP	B-NP	-	14	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	14	NMOD	-	-
14	NF-kappaB	NF-kappaB	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	which	which	B-NP	B-NP	-	14	NMOD	-	-
17	is	is	B-VP	B-VP	-	16	SBAR	-	-
18	proposed	proposed	I-VP	I-VP	-	17	VC	-	-
19	to	to	I-VP	I-VP	-	20	VMOD	-	-
20	play	play	I-VP	I-VP	-	18	VMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	crucial	crucial	I-NP	I-NP	-	23	NMOD	-	-
23	role	role	I-NP	I-NP	-	20	OBJ	-	-
24	in	in	B-PP	B-PP	-	20	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	transformation	transformation	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	T	T	B-NP	B-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	27	PMOD	-	-
30	by	by	B-PP	B-PP	-	26	NMOD	-	-
31	HTLV-I	HTLV-I	B-NP	B-NP	-	30	PMOD	-	-
32	.	.	O	O	-	5	P	-	-

1	However	However	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	HTLV-I	HTLV-I	I-NP	I-NP	-	5	NMOD	-	-
5	genes	genes	I-NP	I-NP	-	8	SUB	-	-
6	including	including	B-PP	B-PP	-	5	NMOD	-	-
7	Tax	Tax	B-NP	B-NP	-	6	PMOD	-	-
8	are	are	B-VP	B-VP	-	0	ROOT	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	expressed	expressed	I-VP	I-VP	-	8	VC	-	-
11	significantly	significantly	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	in	in	B-PP	B-PP	-	10	VMOD	-	-
13	primary	primary	B-NP	B-NP	-	15	NMOD	-	-
14	leukemic	leukemic	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
16	from	from	B-PP	B-PP	-	15	NMOD	-	-
17	ATL	ATL	B-NP	B-NP	-	18	NMOD	-	-
18	patients	patients	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	8	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	basis	basis	I-NP	I-NP	-	6	OBJ	-	-
9	for	for	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappaB	NF-kappaB	B-NP	B-NP	-	11	NMOD	-	-
11	activation	activation	I-NP	I-NP	-	9	PMOD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	freshly	freshly	B-NP	B-NP	-	16	NMOD	-	-
14	isolated	isolated	I-NP	I-NP	-	16	NMOD	-	-
15	leukemic	leukemic	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
17	from	from	B-PP	B-PP	-	11	NMOD	-	-
18	ATL	ATL	B-NP	B-NP	-	19	NMOD	-	-
19	patients	patients	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	found	found	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	leukemic	leukemic	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	15	SUB	-	-
6	from	from	B-PP	B-PP	-	5	NMOD	-	-
7	ATL	ATL	B-NP	B-NP	-	8	NMOD	-	-
8	patients	patients	I-NP	I-NP	-	6	PMOD	-	-
9	,	,	O	O	-	8	P	-	-
10	like	like	B-PP	B-PP	-	8	NMOD	-	-
11	HTLV-I-infected	HTLV-I-infected	B-NP	B-NP	-	13	NMOD	-	-
12	T-cell	T-cell	I-NP	I-NP	-	13	NMOD	-	-
13	lines	lines	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	8	P	-	-
15	display	display	B-VP	B-VP	-	3	SBAR	-	-
16	constitutive	constitutive	B-NP	B-NP	-	20	NMOD	-	-
17	NF-kappaB	NF-kappaB	I-NP	I-NP	-	20	NMOD	-	-
18	DNA	DNA	I-NP	I-NP	-	20	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	increased	increased	B-NP	B-NP	-	23	NMOD	-	-
23	degradation	degradation	I-NP	I-NP	-	15	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	28	NMOD	-	-
26	(	(	O	O	-	28	P	-	-
27	an	an	B-NP	B-NP	-	28	NMOD	-	-
28	inhibitor	inhibitor	I-NP	I-NP	-	24	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	NF-kappaB	NF-kappaB	B-NP	B-NP	-	29	PMOD	-	-
31	)	)	O	O	-	28	P	-	-
32	.	.	O	O	-	2	P	-	-

1	Whereas	Whereas	B-SBAR	B-SBAR	-	18	VMOD	-	-
2	the	the	B-NP	B-NP	-	5	NMOD	-	-
3	NF-kappaB	NF-kappaB	I-NP	I-NP	-	5	NMOD	-	-
4	binding	binding	I-NP	I-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	10	SUB	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	Tax-expressing	Tax-expressing	B-NP	B-NP	-	9	NMOD	-	-
8	T-cell	T-cell	I-NP	I-NP	-	9	NMOD	-	-
9	lines	lines	I-NP	I-NP	-	6	PMOD	-	-
10	consisted	consisted	B-VP	B-VP	-	1	SBAR	-	-
11	mostly	mostly	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	of	of	B-PP	B-PP	-	10	VMOD	-	-
13	p50/c-Rel	p50/c-Rel	B-NP	B-NP	-	12	PMOD	-	-
14	,	,	O	O	-	18	P	-	-
15	fresh	fresh	B-NP	B-NP	-	17	NMOD	-	-
16	ATL	ATL	I-NP	I-NP	-	17	NMOD	-	-
17	samples	samples	I-NP	I-NP	-	18	SUB	-	-
18	contained	contained	B-VP	B-VP	-	0	ROOT	-	-
19	p50/p50	p50/p50	B-NP	B-NP	-	22	NMOD	-	-
20	and	and	I-NP	I-NP	-	22	NMOD	-	-
21	p50/p65	p50/p65	I-NP	I-NP	-	22	NMOD	-	-
22	heterodimers	heterodimers	I-NP	I-NP	-	18	OBJ	-	-
23	.	.	O	O	-	18	P	-	-

1	One	One	B-NP	B-NP	-	3	NMOD	-	-
2	T-cell	T-cell	I-NP	I-NP	-	3	NMOD	-	-
3	line	line	I-NP	I-NP	-	12	SUB	-	-
4	derived	derived	B-VP	B-VP	-	3	NMOD	-	-
5	from	from	B-PP	B-PP	-	4	VMOD	-	-
6	ATL	ATL	B-NP	B-NP	-	8	NMOD	-	-
7	leukemic	leukemic	I-NP	I-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
9	,	,	O	O	-	12	P	-	-
10	TL-Om1	TL-Om1	B-NP	B-NP	-	12	SUB	-	-
11	,	,	O	O	-	10	P	-	-
12	displayed	displayed	B-VP	B-VP	-	0	ROOT	-	-
13	constitutive	constitutive	B-NP	B-NP	-	15	NMOD	-	-
14	NF-kappaB	NF-kappaB	I-NP	I-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	12	OBJ	-	-
16	,	,	O	O	-	12	P	-	-
17	as	as	B-CONJP	B-CONJP	-	21	NMOD	-	-
18	well	well	I-CONJP	I-CONJP	-	17	DEP	-	-
19	as	as	I-CONJP	I-CONJP	-	17	DEP	-	-
20	enhanced	enhanced	B-NP	B-NP	-	21	NMOD	-	-
21	degradation	degradation	I-NP	I-NP	-	12	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	22	PMOD	-	-
24	,	,	O	O	-	12	P	-	-
25	despite	despite	B-PP	B-PP	-	12	VMOD	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	lack	lack	I-NP	I-NP	-	25	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	detectable	detectable	B-NP	B-NP	-	31	NMOD	-	-
30	Tax	Tax	I-NP	I-NP	-	31	NMOD	-	-
31	expression	expression	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	12	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	NF-kappaB	NF-kappaB	I-NP	I-NP	-	7	SUB	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	TL-Om1	TL-Om1	B-NP	B-NP	-	5	PMOD	-	-
7	consists	consists	B-VP	B-VP	-	0	ROOT	-	-
8	of	of	B-PP	B-PP	-	7	VMOD	-	-
9	p50/p50	p50/p50	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	O	O	-	11	NMOD	-	-
11	p50/p65	p50/p65	B-NP	B-NP	-	8	PMOD	-	-
12	like	like	B-PP	B-PP	-	7	VMOD	-	-
13	that	that	B-NP	B-NP	-	12	PMOD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	fresh	fresh	B-NP	B-NP	-	18	NMOD	-	-
16	primary	primary	I-NP	I-NP	-	18	NMOD	-	-
17	leukemic	leukemic	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
19	.	.	O	O	-	7	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	activation	activation	B-NP	B-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	NF-kappaB	NF-kappaB	B-NP	B-NP	-	6	PMOD	-	-
8	occurs	occurs	B-VP	B-VP	-	4	SBAR	-	-
9	through	through	B-PP	B-PP	-	8	VMOD	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	Tax-independent	Tax-independent	I-NP	I-NP	-	12	NMOD	-	-
12	mechanism	mechanism	I-NP	I-NP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	leukemic	leukemic	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	ATL	ATL	B-NP	B-NP	-	18	NMOD	-	-
18	patients	patients	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	15	P	-	-
20	possibly	possibly	B-ADVP	B-ADVP	-	22	PMOD	-	-
21	due	due	B-PP	B-PP	-	22	PMOD	-	-
22	to	to	B-PP	B-PP	-	13	PMOD	-	-
23	differential	differential	B-NP	B-NP	-	26	NMOD	-	-
24	NF-kappaB	NF-kappaB	I-NP	I-NP	-	26	NMOD	-	-
25	subunit	subunit	I-NP	I-NP	-	26	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	Apoptosis-resistant	Apoptosis-resistant	B-NP	B-NP	-	3	NMOD	-	-
2	T	T	I-NP	I-NP	-	3	NMOD	-	-
3	cells	cells	I-NP	I-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	deficiency	deficiency	I-NP	I-NP	-	4	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappaB-mediated	NF-kappaB-mediated	B-NP	B-NP	-	9	NMOD	-	-
9	induction	induction	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	Fas	Fas	B-NP	B-NP	-	13	NMOD	-	-
12	ligand	ligand	I-NP	I-NP	-	13	NMOD	-	-
13	transcription	transcription	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	4	P	-	-

1	Apoptosis	Apoptosis	B-NP	B-NP	-	10	SUB	-	-
2	induced	induced	B-VP	B-VP	-	1	NMOD	-	-
3	through	through	B-PP	B-PP	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	TCR	TCR	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	VMOD	-	-
7	CD4+	CD4+	B-NP	B-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	mostly	mostly	I-VP	I-VP	-	10	VMOD	-	-
12	mediated	mediated	I-VP	I-VP	-	10	VC	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	inducible	inducible	I-NP	I-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	13	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	Fas	Fas	B-NP	B-NP	-	19	NMOD	-	-
19	ligand	ligand	I-NP	I-NP	-	17	PMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	FasL	FasL	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	as	as	B-PP	B-PP	-	12	VMOD	-	-
24	a	a	B-NP	B-NP	-	26	NMOD	-	-
25	primary	primary	I-NP	I-NP	-	26	NMOD	-	-
26	event	event	I-NP	I-NP	-	23	PMOD	-	-
27	leading	leading	B-VP	B-VP	-	26	NMOD	-	-
28	to	to	B-PP	B-PP	-	27	VMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	commitment	commitment	I-NP	I-NP	-	28	PMOD	-	-
31	to	to	B-PP	B-PP	-	30	NMOD	-	-
32	death	death	B-NP	B-NP	-	31	PMOD	-	-
33	.	.	O	O	-	10	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	gain	gain	I-VP	I-VP	-	16	VMOD	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	better	better	I-NP	I-NP	-	5	NMOD	-	-
5	understanding	understanding	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	transcriptional	transcriptional	I-NP	I-NP	-	9	NMOD	-	-
9	events	events	I-NP	I-NP	-	6	PMOD	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	regulate	regulate	B-VP	B-VP	-	10	SBAR	-	-
12	this	this	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	OBJ	-	-
14	,	,	O	O	-	16	P	-	-
15	we	we	B-NP	B-NP	-	16	SUB	-	-
16	took	took	B-VP	B-VP	-	0	ROOT	-	-
17	advantage	advantage	B-NP	B-NP	-	16	OBJ	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	our	our	B-NP	B-NP	-	24	NMOD	-	-
20	previously	previously	I-NP	I-NP	-	21	AMOD	-	-
21	described	described	I-NP	I-NP	-	24	NMOD	-	-
22	mutant	mutant	I-NP	I-NP	-	24	NMOD	-	-
23	Jurkat	Jurkat	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
25	.	.	O	O	-	16	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	deficient	deficient	B-ADJP	B-ADJP	-	3	PRD	-	-
5	in	in	B-PP	B-PP	-	4	AMOD	-	-
6	FasL	FasL	B-NP	B-NP	-	7	NMOD	-	-
7	expression	expression	B-NP	B-NP	-	9	NMOD	-	-
8	and	and	O	O	-	9	NMOD	-	-
9	apoptosis	apoptosis	B-NP	B-NP	-	5	PMOD	-	-
10	induced	induced	B-VP	B-VP	-	9	NMOD	-	-
11	upon	upon	B-PP	B-PP	-	10	VMOD	-	-
12	TCR	TCR	B-NP	B-NP	-	13	NMOD	-	-
13	triggering	triggering	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	3	P	-	-
15	although	although	B-SBAR	B-SBAR	-	3	VMOD	-	-
16	their	their	B-NP	B-NP	-	17	NMOD	-	-
17	cytokine	cytokine	I-NP	I-NP	-	23	NMOD	-	-
18	(	(	O	O	-	21	P	-	-
19	IL-2	IL-2	B-NP	B-NP	-	21	NMOD	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	IFN-gamma	IFN-gamma	B-NP	B-NP	-	17	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	production	production	B-NP	B-NP	-	24	SUB	-	-
24	is	is	B-VP	B-VP	-	15	SBAR	-	-
25	normal	normal	B-ADJP	B-ADJP	-	24	PRD	-	-
26	.	.	O	O	-	3	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	both	both	O	O	-	13	NMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	FasL-	FasL-	I-NP	I-NP	-	13	NMOD	-	-
8	and	and	O	O	-	13	NMOD	-	-
9	a	a	B-NP	B-NP	-	13	NMOD	-	-
10	consensus	consensus	I-NP	I-NP	-	13	NMOD	-	-
11	NF-kappaB-	NF-kappaB-	I-NP	I-NP	-	13	NMOD	-	-
12	reporter	reporter	I-NP	I-NP	-	13	NMOD	-	-
13	construct	construct	I-NP	I-NP	-	14	SUB	-	-
14	are	are	B-VP	B-VP	-	4	SBAR	-	-
15	inefficiently	inefficiently	I-VP	I-VP	-	14	VMOD	-	-
16	induced	induced	I-VP	I-VP	-	14	VC	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	these	these	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	compared	compared	B-VP	B-VP	-	19	NMOD	-	-
21	to	to	B-PP	B-PP	-	20	PMOD	-	-
22	wild-type	wild-type	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	we	we	B-NP	B-NP	-	5	SUB	-	-
5	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	inducible	inducible	I-NP	I-NP	-	10	NMOD	-	-
9	transcriptional	transcriptional	I-NP	I-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	15	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	FasL	FasL	I-NP	I-NP	-	14	NMOD	-	-
14	reporter	reporter	I-NP	I-NP	-	11	PMOD	-	-
15	is	is	B-VP	B-VP	-	6	SBAR	-	-
16	abolished	abolished	I-VP	I-VP	-	15	VC	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	specific	specific	B-NP	B-NP	-	19	NMOD	-	-
19	inhibitors	inhibitors	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	NF-kappaB	NF-kappaB	B-NP	B-NP	-	22	NMOD	-	-
22	activation	activation	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	could	could	B-VP	B-VP	-	0	ROOT	-	-
5	trace	trace	I-VP	I-VP	-	4	VC	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	deficit	deficit	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	mutant	mutant	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
12	to	to	B-PP	B-PP	-	7	NMOD	-	-
13	an	an	B-NP	B-NP	-	16	NMOD	-	-
14	inefficient	inefficient	I-NP	I-NP	-	16	NMOD	-	-
15	NF-kappaB	NF-kappaB	I-NP	I-NP	-	16	NMOD	-	-
16	activation	activation	I-NP	I-NP	-	12	PMOD	-	-
17	,	,	O	O	-	5	P	-	-
18	evidencing	evidencing	B-VP	B-VP	-	5	VMOD	-	-
19	a	a	B-NP	B-NP	-	21	NMOD	-	-
20	relevant	relevant	I-NP	I-NP	-	21	NMOD	-	-
21	role	role	I-NP	I-NP	-	18	OBJ	-	-
22	for	for	B-PP	B-PP	-	21	NMOD	-	-
23	NF-kappaB	NF-kappaB	B-NP	B-NP	-	22	PMOD	-	-
24	in	in	B-PP	B-PP	-	21	NMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	regulation	regulation	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	FasL	FasL	B-NP	B-NP	-	29	NMOD	-	-
29	expression	expression	I-NP	I-NP	-	27	PMOD	-	-
30	in	in	B-PP	B-PP	-	26	NMOD	-	-
31	activated	activated	B-NP	B-NP	-	33	NMOD	-	-
32	T	T	I-NP	I-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	30	PMOD	-	-
34	.	.	O	O	-	4	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	our	our	B-NP	B-NP	-	4	NMOD	-	-
4	results	results	I-NP	I-NP	-	5	SUB	-	-
5	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	induction	induction	I-NP	I-NP	-	15	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	FasL	FasL	B-NP	B-NP	-	14	NMOD	-	-
11	versus	versus	I-NP	I-NP	-	14	NMOD	-	-
12	cytokine	cytokine	I-NP	I-NP	-	14	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	9	PMOD	-	-
15	is	is	B-VP	B-VP	-	6	SBAR	-	-
16	differentially	differentially	B-ADJP	B-ADJP	-	17	AMOD	-	-
17	sensitive	sensitive	I-ADJP	I-ADJP	-	15	PRD	-	-
18	to	to	B-PP	B-PP	-	17	AMOD	-	-
19	NF-kappaB	NF-kappaB	B-NP	B-NP	-	20	NMOD	-	-
20	deprivation	deprivation	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	5	P	-	-

1	NF-kappaB	NF-kappaB	B-NP	B-NP	-	2	SUB	-	-
2	regulates	regulates	B-VP	B-VP	-	0	ROOT	-	-
3	Fas/APO-1/CD95-	Fas/APO-1/CD95-	B-NP	B-NP	-	5	NMOD	-	-
4	and	and	I-NP	I-NP	-	5	NMOD	-	-
5	TCR-	TCR-	I-NP	I-NP	-	7	NMOD	-	-
6	mediated	mediated	I-NP	I-NP	-	7	NMOD	-	-
7	apoptosis	apoptosis	I-NP	I-NP	-	2	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	T	T	B-NP	B-NP	-	10	NMOD	-	-
10	lymphocytes	lymphocytes	I-NP	I-NP	-	8	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	maintenance	maintenance	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	lymphocyte	lymphocyte	B-NP	B-NP	-	5	NMOD	-	-
5	homeostasis	homeostasis	I-NP	I-NP	-	3	PMOD	-	-
6	by	by	B-PP	B-PP	-	2	NMOD	-	-
7	apoptosis	apoptosis	B-NP	B-NP	-	6	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	12	NMOD	-	-
10	critical	critical	I-NP	I-NP	-	12	NMOD	-	-
11	regulatory	regulatory	I-NP	I-NP	-	12	NMOD	-	-
12	mechanism	mechanism	I-NP	I-NP	-	8	PRD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	17	NMOD	-	-
15	normal	normal	I-NP	I-NP	-	17	NMOD	-	-
16	immune	immune	I-NP	I-NP	-	17	NMOD	-	-
17	system	system	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	8	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	transcription	transcription	I-NP	I-NP	-	4	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	4	NMOD	-	-
4	NF-kappaB	NF-kappaB	I-NP	I-NP	-	5	SUB	-	-
5	has	has	B-VP	B-VP	-	21	VMOD	-	-
6	been	been	I-VP	I-VP	-	5	VC	-	-
7	shown	shown	I-VP	I-VP	-	6	VC	-	-
8	to	to	I-VP	I-VP	-	9	VMOD	-	-
9	play	play	I-VP	I-VP	-	7	VMOD	-	-
10	a	a	B-NP	B-NP	-	11	NMOD	-	-
11	role	role	I-NP	I-NP	-	9	OBJ	-	-
12	in	in	B-PP	B-PP	-	9	VMOD	-	-
13	protecting	protecting	B-VP	B-VP	-	14	NMOD	-	-
14	cells	cells	B-NP	B-NP	-	12	PMOD	-	-
15	against	against	B-PP	B-PP	-	14	NMOD	-	-
16	death	death	B-NP	B-NP	-	15	PMOD	-	-
17	mediated	mediated	B-VP	B-VP	-	16	NMOD	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	TNF	TNF	B-NP	B-NP	-	18	PMOD	-	-
20	We	We	B-NP	B-NP	-	21	SUB	-	-
21	show	show	B-VP	B-VP	-	0	ROOT	-	-
22	here	here	B-ADVP	B-ADVP	-	21	VMOD	-	-
23	that	that	B-SBAR	B-SBAR	-	21	VMOD	-	-
24	NF-kappaB	NF-kappaB	B-NP	B-NP	-	26	SUB	-	-
25	also	also	B-ADVP	B-ADVP	-	26	VMOD	-	-
26	has	has	B-VP	B-VP	-	23	SBAR	-	-
27	a	a	B-NP	B-NP	-	28	NMOD	-	-
28	role	role	I-NP	I-NP	-	26	OBJ	-	-
29	in	in	B-PP	B-PP	-	26	VMOD	-	-
30	regulating	regulating	B-VP	B-VP	-	29	PMOD	-	-
31	Fas/APO-1/CD95-mediated	Fas/APO-1/CD95-mediated	B-NP	B-NP	-	32	NMOD	-	-
32	death	death	I-NP	I-NP	-	30	OBJ	-	-
33	,	,	O	O	-	26	P	-	-
34	a	a	B-NP	B-NP	-	36	NMOD	-	-
35	major	major	I-NP	I-NP	-	36	NMOD	-	-
36	pathway	pathway	I-NP	I-NP	-	26	OBJ	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	peripheral	peripheral	B-NP	B-NP	-	41	NMOD	-	-
39	T	T	I-NP	I-NP	-	41	NMOD	-	-
40	cell	cell	I-NP	I-NP	-	41	NMOD	-	-
41	death	death	I-NP	I-NP	-	37	PMOD	-	-
42	.	.	O	O	-	21	P	-	-

1	Transfection	Transfection	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Jurkat	Jurkat	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	with	with	B-PP	B-PP	-	1	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	NF-kappaB	NF-kappaB	I-NP	I-NP	-	8	NMOD	-	-
8	subunits	subunits	I-NP	I-NP	-	11	NMOD	-	-
9	p50	p50	I-NP	I-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	p65	p65	I-NP	I-NP	-	5	PMOD	-	-
12	confers	confers	B-VP	B-VP	-	0	ROOT	-	-
13	resistance	resistance	B-NP	B-NP	-	12	OBJ	-	-
14	against	against	B-PP	B-PP	-	13	NMOD	-	-
15	Fas-mediated	Fas-mediated	B-NP	B-NP	-	16	NMOD	-	-
16	apoptosis	apoptosis	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	12	P	-	-

1	Reciprocally	Reciprocally	B-ADVP	B-ADVP	-	23	VMOD	-	-
2	,	,	O	O	-	23	P	-	-
3	inhibition	inhibition	B-NP	B-NP	-	15	NMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	NF-kappaB	NF-kappaB	B-NP	B-NP	-	6	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	4	PMOD	-	-
7	by	by	B-PP	B-PP	-	3	NMOD	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	soluble	soluble	I-NP	I-NP	-	11	NMOD	-	-
10	peptide	peptide	I-NP	I-NP	-	11	NMOD	-	-
11	inhibitor	inhibitor	I-NP	I-NP	-	15	NMOD	-	-
12	or	or	O	O	-	15	NMOD	-	-
13	a	a	B-NP	B-NP	-	15	NMOD	-	-
14	dominant	dominant	I-NP	I-NP	-	15	NMOD	-	-
15	form	form	I-NP	I-NP	-	23	SUB	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	NF-kappaB	NF-kappaB	I-NP	I-NP	-	19	NMOD	-	-
19	inhibitor	inhibitor	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	21	P	-	-
21	IkappaB	IkappaB	B-NP	B-NP	-	16	PMOD	-	-
22	,	,	O	O	-	15	P	-	-
23	makes	makes	B-VP	B-VP	-	0	ROOT	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	23	OBJ	-	-
26	more	more	B-ADJP	B-ADJP	-	27	AMOD	-	-
27	susceptible	susceptible	I-ADJP	I-ADJP	-	25	NMOD	-	-
28	to	to	B-PP	B-PP	-	27	AMOD	-	-
29	Fas-mediated	Fas-mediated	B-NP	B-NP	-	30	NMOD	-	-
30	apoptosis	apoptosis	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	23	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	12	VMOD	-	-
2	,	,	O	O	-	12	P	-	-
3	inhibition	inhibition	B-NP	B-NP	-	12	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	NF-kappaB	NF-kappaB	B-NP	B-NP	-	6	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	4	PMOD	-	-
7	by	by	B-PP	B-PP	-	3	NMOD	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	soluble	soluble	I-NP	I-NP	-	11	NMOD	-	-
10	peptide	peptide	I-NP	I-NP	-	11	NMOD	-	-
11	inhibitor	inhibitor	I-NP	I-NP	-	7	PMOD	-	-
12	rendered	rendered	B-VP	B-VP	-	0	ROOT	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	T	T	I-NP	I-NP	-	16	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	16	NMOD	-	-
16	hybridoma	hybridoma	I-NP	I-NP	-	12	OBJ	-	-
17	more	more	B-ADJP	B-ADJP	-	18	AMOD	-	-
18	susceptible	susceptible	I-ADJP	I-ADJP	-	16	NMOD	-	-
19	to	to	B-PP	B-PP	-	18	AMOD	-	-
20	TCR-mediated	TCR-mediated	B-NP	B-NP	-	21	NMOD	-	-
21	apoptosis	apoptosis	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	12	P	-	-

1	Correspondingly	Correspondingly	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	transfection	transfection	B-NP	B-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	p50	p50	B-NP	B-NP	-	7	NMOD	-	-
6	and	and	O	O	-	7	NMOD	-	-
7	p65	p65	B-NP	B-NP	-	4	PMOD	-	-
8	provided	provided	B-VP	B-VP	-	0	ROOT	-	-
9	considerable	considerable	B-NP	B-NP	-	10	NMOD	-	-
10	protection	protection	I-NP	I-NP	-	8	OBJ	-	-
11	from	from	B-PP	B-PP	-	10	NMOD	-	-
12	TCR-mediated	TCR-mediated	B-NP	B-NP	-	13	NMOD	-	-
13	apoptosis	apoptosis	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	observations	observations	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	corroborated	corroborated	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	studies	studies	B-NP	B-NP	-	5	PMOD	-	-
7	on	on	B-PP	B-PP	-	6	NMOD	-	-
8	Fas-mediated	Fas-mediated	B-NP	B-NP	-	9	NMOD	-	-
9	death	death	I-NP	I-NP	-	7	PMOD	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	primary	primary	B-NP	B-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	Concanavalin	Concanavalin	B-NP	B-NP	-	6	NMOD	-	-
2	A-activated	A-activated	I-NP	I-NP	-	6	NMOD	-	-
3	cycling	cycling	I-NP	I-NP	-	6	NMOD	-	-
4	T	T	I-NP	I-NP	-	6	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
6	blasts	blasts	I-NP	I-NP	-	17	SUB	-	-
7	from	from	B-PP	B-PP	-	6	NMOD	-	-
8	mice	mice	B-NP	B-NP	-	7	PMOD	-	-
9	that	that	B-NP	B-NP	-	8	NMOD	-	-
10	are	are	B-VP	B-VP	-	9	SBAR	-	-
11	transgenic	transgenic	B-ADJP	B-ADJP	-	10	PRD	-	-
12	for	for	B-PP	B-PP	-	11	AMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	dominant	dominant	I-NP	I-NP	-	16	NMOD	-	-
15	IkappaB	IkappaB	I-NP	I-NP	-	16	NMOD	-	-
16	molecule	molecule	I-NP	I-NP	-	12	PMOD	-	-
17	have	have	B-VP	B-VP	-	0	ROOT	-	-
18	increased	increased	I-VP	I-VP	-	17	VC	-	-
19	sensitivity	sensitivity	B-NP	B-NP	-	18	OBJ	-	-
20	to	to	B-PP	B-PP	-	19	NMOD	-	-
21	Fas-mediated	Fas-mediated	B-NP	B-NP	-	22	NMOD	-	-
22	apoptosis	apoptosis	I-NP	I-NP	-	20	PMOD	-	-
23	,	,	O	O	-	19	P	-	-
24	associated	associated	B-VP	B-VP	-	19	NMOD	-	-
25	with	with	B-PP	B-PP	-	24	VMOD	-	-
26	a	a	B-NP	B-NP	-	27	NMOD	-	-
27	down-regulation	down-regulation	I-NP	I-NP	-	25	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	NF-kappaB	NF-kappaB	B-NP	B-NP	-	30	NMOD	-	-
30	complexes	complexes	I-NP	I-NP	-	28	PMOD	-	-
31	in	in	B-PP	B-PP	-	27	NMOD	-	-
32	the	the	B-NP	B-NP	-	33	NMOD	-	-
33	nucleus	nucleus	I-NP	I-NP	-	31	PMOD	-	-
34	.	.	O	O	-	17	P	-	-

1	In	In	B-PP	B-PP	-	17	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	17	P	-	-
4	blocking	blocking	B-VP	B-VP	-	10	NMOD	-	-
5	TNF	TNF	B-NP	B-NP	-	10	NMOD	-	-
6	,	,	O	O	-	10	P	-	-
7	itself	itself	B-NP	B-NP	-	10	NMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	positive	positive	I-NP	I-NP	-	10	NMOD	-	-
10	regulator	regulator	I-NP	I-NP	-	17	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	NF-kappaB	NF-kappaB	B-NP	B-NP	-	11	PMOD	-	-
13	,	,	O	O	-	10	P	-	-
14	with	with	B-PP	B-PP	-	10	NMOD	-	-
15	neutralizing	neutralizing	B-NP	B-NP	-	16	NMOD	-	-
16	antibodies	antibodies	I-NP	I-NP	-	14	PMOD	-	-
17	renders	renders	B-VP	B-VP	-	0	ROOT	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	OBJ	-	-
20	more	more	B-ADJP	B-ADJP	-	21	AMOD	-	-
21	susceptible	susceptible	I-ADJP	I-ADJP	-	19	NMOD	-	-
22	to	to	B-PP	B-PP	-	21	AMOD	-	-
23	anti-Fas-mediated	anti-Fas-mediated	B-NP	B-NP	-	24	NMOD	-	-
24	apoptosis	apoptosis	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	17	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	summary	summary	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	our	our	B-NP	B-NP	-	5	NMOD	-	-
5	results	results	I-NP	I-NP	-	6	SUB	-	-
6	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
7	compelling	compelling	B-NP	B-NP	-	8	NMOD	-	-
8	evidence	evidence	I-NP	I-NP	-	6	OBJ	-	-
9	that	that	B-SBAR	B-SBAR	-	8	NMOD	-	-
10	NF-kappaB	NF-kappaB	B-NP	B-NP	-	11	SUB	-	-
11	protects	protects	B-VP	B-VP	-	9	SBAR	-	-
12	against	against	B-PP	B-PP	-	11	VMOD	-	-
13	Fas-mediated	Fas-mediated	B-NP	B-NP	-	14	NMOD	-	-
14	death	death	I-NP	I-NP	-	12	PMOD	-	-
15	and	and	O	O	-	11	VMOD	-	-
16	is	is	B-VP	B-VP	-	11	VMOD	-	-
17	likely	likely	B-ADJP	B-ADJP	-	16	PRD	-	-
18	to	to	B-VP	B-VP	-	19	VMOD	-	-
19	be	be	I-VP	I-VP	-	17	AMOD	-	-
20	an	an	B-NP	B-NP	-	22	NMOD	-	-
21	important	important	I-NP	I-NP	-	22	NMOD	-	-
22	regulator	regulator	I-NP	I-NP	-	19	PRD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	T	T	B-NP	B-NP	-	26	NMOD	-	-
25	cell	cell	I-NP	I-NP	-	26	NMOD	-	-
26	homeostasis	homeostasis	I-NP	I-NP	-	28	NMOD	-	-
27	and	and	I-NP	I-NP	-	28	NMOD	-	-
28	tolerance	tolerance	I-NP	I-NP	-	23	PMOD	-	-
29	.	.	O	O	-	6	P	-	-

1	Evidence	Evidence	B-NP	B-NP	-	0	ROOT	-	-
2	for	for	B-PP	B-PP	-	1	NMOD	-	-
3	distinct	distinct	B-NP	B-NP	-	6	NMOD	-	-
4	intracellular	intracellular	I-NP	I-NP	-	6	NMOD	-	-
5	signaling	signaling	I-NP	I-NP	-	6	NMOD	-	-
6	pathways	pathways	I-NP	I-NP	-	2	PMOD	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	CD34+	CD34+	B-NP	B-NP	-	9	NMOD	-	-
9	progenitor	progenitor	I-NP	I-NP	-	7	PMOD	-	-
10	to	to	B-PP	B-PP	-	1	NMOD	-	-
11	dendritic	dendritic	B-NP	B-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	differentiation	differentiation	I-NP	I-NP	-	10	PMOD	-	-
14	from	from	B-PP	B-PP	-	13	NMOD	-	-
15	a	a	B-NP	B-NP	-	19	NMOD	-	-
16	human	human	I-NP	I-NP	-	19	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
18	line	line	I-NP	I-NP	-	19	NMOD	-	-
19	model	model	I-NP	I-NP	-	14	PMOD	-	-
20	.	.	O	O	-	1	P	-	-

1	Intracellular	Intracellular	B-NP	B-NP	-	2	NMOD	-	-
2	signals	signals	I-NP	I-NP	-	16	SUB	-	-
3	that	that	B-NP	B-NP	-	2	NMOD	-	-
4	mediate	mediate	B-VP	B-VP	-	3	SBAR	-	-
5	differentiation	differentiation	B-NP	B-NP	-	4	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	pluripotent	pluripotent	B-NP	B-NP	-	9	NMOD	-	-
8	hemopoietic	hemopoietic	I-NP	I-NP	-	9	NMOD	-	-
9	progenitors	progenitors	I-NP	I-NP	-	6	PMOD	-	-
10	to	to	B-PP	B-PP	-	5	NMOD	-	-
11	dendritic	dendritic	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	DC	DC	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	are	are	B-VP	B-VP	-	0	ROOT	-	-
17	largely	largely	B-ADJP	B-ADJP	-	18	AMOD	-	-
18	undefined	undefined	I-ADJP	I-ADJP	-	16	PRD	-	-
19	.	.	O	O	-	16	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	previously	previously	I-VP	I-VP	-	2	VMOD	-	-
4	shown	shown	I-VP	I-VP	-	2	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	protein	protein	B-NP	B-NP	-	8	NMOD	-	-
7	kinase	kinase	I-NP	I-NP	-	8	NMOD	-	-
8	C	C	I-NP	I-NP	-	12	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	PKC	PKC	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	activation	activation	B-NP	B-NP	-	23	SUB	-	-
13	(	(	O	O	-	12	P	-	-
14	with	with	B-PP	B-PP	-	12	NMOD	-	-
15	phorbol	phorbol	B-NP	B-NP	-	16	NMOD	-	-
16	ester	ester	I-NP	I-NP	-	14	PMOD	-	-
17	(	(	O	O	-	18	P	-	-
18	PMA	PMA	B-NP	B-NP	-	16	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	alone	alone	B-ADVP	B-ADVP	-	16	NMOD	-	-
21	)	)	O	O	-	16	P	-	-
22	specifically	specifically	B-ADVP	B-ADVP	-	23	VMOD	-	-
23	induces	induces	B-VP	B-VP	-	5	SBAR	-	-
24	differentiation	differentiation	B-NP	B-NP	-	23	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	primary	primary	B-NP	B-NP	-	31	NMOD	-	-
27	human	human	I-NP	I-NP	-	31	NMOD	-	-
28	CD34+	CD34+	I-NP	I-NP	-	31	NMOD	-	-
29	hemopoietic	hemopoietic	I-NP	I-NP	-	31	NMOD	-	-
30	progenitor	progenitor	I-NP	I-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	HPC	HPC	B-NP	B-NP	-	31	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	to	to	B-PP	B-PP	-	24	NMOD	-	-
36	mature	mature	B-NP	B-NP	-	37	NMOD	-	-
37	DC	DC	I-NP	I-NP	-	35	PMOD	-	-
38	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	now	now	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	find	find	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	cytokine-driven	cytokine-driven	O	O	-	10	NMOD	-	-
6	(	(	O	O	-	10	P	-	-
7	granulocyte-macrophage	granulocyte-macrophage	B-NP	B-NP	-	8	NMOD	-	-
8	CSF	CSF	I-NP	I-NP	-	10	NMOD	-	-
9	and	and	I-NP	I-NP	-	10	NMOD	-	-
10	TNF-alpha	TNF-alpha	I-NP	I-NP	-	12	AMOD	-	-
11	)	)	I-NP	I-NP	-	10	P	-	-
12	CD34+	CD34+	I-NP	I-NP	-	17	NMOD	-	-
13	HPC	HPC	I-NP	I-NP	-	17	NMOD	-	-
14	--	--	O	O	-	17	NMOD	-	-
15	>	>	O	O	-	17	NMOD	-	-
16	DC	DC	B-NP	B-NP	-	17	NMOD	-	-
17	differentiation	differentiation	I-NP	I-NP	-	18	SUB	-	-
18	is	is	B-VP	B-VP	-	4	SBAR	-	-
19	preferentially	preferentially	I-VP	I-VP	-	18	VMOD	-	-
20	blocked	blocked	I-VP	I-VP	-	18	VC	-	-
21	by	by	B-PP	B-PP	-	20	VMOD	-	-
22	inhibitors	inhibitors	B-NP	B-NP	-	21	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	PKC	PKC	B-NP	B-NP	-	25	NMOD	-	-
25	activation	activation	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	3	P	-	-

1	To	To	B-VP	B-VP	-	3	VMOD	-	-
2	further	further	I-VP	I-VP	-	3	VMOD	-	-
3	identify	identify	I-VP	I-VP	-	5	NMOD	-	-
4	intracellular	intracellular	B-NP	B-NP	-	5	NMOD	-	-
5	signals	signals	I-NP	I-NP	-	8	NMOD	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	downstream	downstream	B-NP	B-NP	-	8	NMOD	-	-
8	events	events	I-NP	I-NP	-	18	SUB	-	-
9	important	important	B-ADJP	B-ADJP	-	8	NMOD	-	-
10	in	in	B-PP	B-PP	-	9	AMOD	-	-
11	CD34+	CD34+	B-NP	B-NP	-	12	NMOD	-	-
12	HPC	HPC	I-NP	I-NP	-	10	PMOD	-	-
13	--	--	O	O	-	18	P	-	-
14	>	>	B-NP	B-NP	-	16	NMOD	-	-
15	DC	DC	I-NP	I-NP	-	16	NMOD	-	-
16	differentiation	differentiation	I-NP	I-NP	-	17	NMOD	-	-
17	we	we	B-NP	B-NP	-	18	SUB	-	-
18	have	have	B-VP	B-VP	-	0	ROOT	-	-
19	characterized	characterized	I-VP	I-VP	-	18	VC	-	-
20	a	a	B-NP	B-NP	-	25	NMOD	-	-
21	human	human	I-NP	I-NP	-	24	NMOD	-	-
22	leukemic	leukemic	I-NP	I-NP	-	24	NMOD	-	-
23	cell	cell	I-NP	I-NP	-	24	NMOD	-	-
24	line	line	I-NP	I-NP	-	25	NMOD	-	-
25	model	model	I-NP	I-NP	-	19	OBJ	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	this	this	B-NP	B-NP	-	28	NMOD	-	-
28	process	process	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	18	P	-	-

1	The	The	B-NP	B-NP	-	6	NMOD	-	-
2	CD34+	CD34+	I-NP	I-NP	-	6	NMOD	-	-
3	myelomonocytic	myelomonocytic	I-NP	I-NP	-	6	NMOD	-	-
4	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
5	line	line	I-NP	I-NP	-	6	NMOD	-	-
6	KG1	KG1	I-NP	I-NP	-	7	SUB	-	-
7	differentiates	differentiates	B-VP	B-VP	-	0	ROOT	-	-
8	into	into	B-PP	B-PP	-	7	VMOD	-	-
9	dendritic-like	dendritic-like	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	in	in	B-PP	B-PP	-	7	VMOD	-	-
12	response	response	B-NP	B-NP	-	11	PMOD	-	-
13	to	to	B-PP	B-PP	-	12	NMOD	-	-
14	granulocyte-macrophage	granulocyte-macrophage	B-NP	B-NP	-	15	NMOD	-	-
15	CSF	CSF	I-NP	I-NP	-	17	NMOD	-	-
16	plus	plus	I-NP	I-NP	-	17	NMOD	-	-
17	TNF-alpha	TNF-alpha	I-NP	I-NP	-	13	PMOD	-	-
18	,	,	O	O	-	31	P	-	-
19	or	or	O	O	-	20	NMOD	-	-
20	PMA	PMA	B-NP	B-NP	-	31	NMOD	-	-
21	(	(	O	O	-	31	P	-	-
22	with	with	B-PP	B-PP	-	28	NMOD	-	-
23	or	or	I-PP	I-PP	-	22	PMOD	-	-
24	without	without	I-PP	I-PP	-	22	PMOD	-	-
25	the	the	B-NP	B-NP	-	28	NMOD	-	-
26	calcium	calcium	I-NP	I-NP	-	28	NMOD	-	-
27	ionophore	ionophore	I-NP	I-NP	-	28	NMOD	-	-
28	ionomycin	ionomycin	I-NP	I-NP	-	31	NMOD	-	-
29	,	,	O	O	-	31	P	-	-
30	or	or	O	O	-	31	NMOD	-	-
31	TNF-alpha	TNF-alpha	B-NP	B-NP	-	17	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	,	,	O	O	-	7	P	-	-
34	with	with	B-PP	B-PP	-	7	VMOD	-	-
35	different	different	B-NP	B-NP	-	36	NMOD	-	-
36	stimuli	stimuli	I-NP	I-NP	-	34	PMOD	-	-
37	mediating	mediating	B-VP	B-VP	-	36	NMOD	-	-
38	different	different	B-NP	B-NP	-	39	NMOD	-	-
39	aspects	aspects	I-NP	I-NP	-	37	OBJ	-	-
40	of	of	B-PP	B-PP	-	39	NMOD	-	-
41	the	the	B-NP	B-NP	-	42	NMOD	-	-
42	process	process	I-NP	I-NP	-	40	PMOD	-	-
43	.	.	O	O	-	7	P	-	-

1	Phenotypic	Phenotypic	B-NP	B-NP	-	3	NMOD	-	-
2	DC	DC	I-NP	I-NP	-	3	NMOD	-	-
3	characteristics	characteristics	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	KG1	KG1	B-NP	B-NP	-	7	NMOD	-	-
6	dendritic-like	dendritic-like	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
8	include	include	B-VP	B-VP	-	0	ROOT	-	-
9	morphology	morphology	B-NP	B-NP	-	13	NMOD	-	-
10	(	(	O	O	-	13	P	-	-
11	loosely	loosely	B-NP	B-NP	-	12	AMOD	-	-
12	adherent	adherent	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	8	OBJ	-	-
14	with	with	B-PP	B-PP	-	13	NMOD	-	-
15	long	long	B-NP	B-NP	-	17	NMOD	-	-
16	neurite	neurite	I-NP	I-NP	-	17	NMOD	-	-
17	processes	processes	I-NP	I-NP	-	14	PMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	,	,	O	O	-	32	P	-	-
20	MHC	MHC	B-NP	B-NP	-	25	NMOD	-	-
21	I+/MHC	I+/MHC	I-NP	I-NP	-	25	NMOD	-	-
22	IIbright/CD83+/CD86+/CD14-	IIbright/CD83+/CD86+/CD14-	I-NP	I-NP	-	25	NMOD	-	-
23	surface	surface	I-NP	I-NP	-	25	NMOD	-	-
24	Ag	Ag	I-NP	I-NP	-	25	NMOD	-	-
25	expression	expression	I-NP	I-NP	-	32	NMOD	-	-
26	,	,	O	O	-	32	P	-	-
27	and	and	O	O	-	32	NMOD	-	-
28	RelB	RelB	B-NP	B-NP	-	32	NMOD	-	-
29	and	and	I-NP	I-NP	-	32	NMOD	-	-
30	DC-CK1	DC-CK1	I-NP	I-NP	-	32	NMOD	-	-
31	gene	gene	I-NP	I-NP	-	32	NMOD	-	-
32	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
33	.	.	O	O	-	8	P	-	-

1	Functional	Functional	B-NP	B-NP	-	3	NMOD	-	-
2	DC	DC	I-NP	I-NP	-	3	NMOD	-	-
3	characteristics	characteristics	I-NP	I-NP	-	4	SUB	-	-
4	include	include	B-VP	B-VP	-	0	ROOT	-	-
5	fluid	fluid	B-NP	B-NP	-	8	NMOD	-	-
6	phase	phase	I-NP	I-NP	-	8	NMOD	-	-
7	macromolecule	macromolecule	I-NP	I-NP	-	8	NMOD	-	-
8	uptake	uptake	I-NP	I-NP	-	13	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	FITC-dextran	FITC-dextran	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	activation	activation	B-NP	B-NP	-	4	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	resting	resting	B-NP	B-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	Comparison	Comparison	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	KG1	KG1	B-NP	B-NP	-	2	PMOD	-	-
4	to	to	B-PP	B-PP	-	1	NMOD	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	PMA-unresponsive	PMA-unresponsive	I-NP	I-NP	-	8	NMOD	-	-
7	subline	subline	I-NP	I-NP	-	8	NMOD	-	-
8	KG1a	KG1a	I-NP	I-NP	-	4	PMOD	-	-
9	reveals	reveals	B-VP	B-VP	-	0	ROOT	-	-
10	differences	differences	B-NP	B-NP	-	9	OBJ	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	expression	expression	B-NP	B-NP	-	11	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	TNF	TNF	B-NP	B-NP	-	15	NMOD	-	-
15	receptors	receptors	I-NP	I-NP	-	13	PMOD	-	-
16	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
17	and	and	I-NP	I-NP	-	18	NMOD	-	-
18	<num>	<num>	I-NP	I-NP	-	15	NMOD	-	-
19	;	;	O	O	-	31	P	-	-
20	PKC	PKC	B-NP	B-NP	-	21	NMOD	-	-
21	isoforms	isoforms	I-NP	I-NP	-	31	NMOD	-	-
22	alpha	alpha	I-NP	I-NP	-	31	NMOD	-	-
23	,	,	O	O	-	31	P	-	-
24	beta	beta	B-NP	B-NP	-	31	NMOD	-	-
25	I	I	I-NP	I-NP	-	24	NMOD	-	-
26	,	,	O	O	-	31	P	-	-
27	beta	beta	B-NP	B-NP	-	31	NMOD	-	-
28	II	II	I-NP	I-NP	-	27	NMOD	-	-
29	,	,	O	O	-	31	P	-	-
30	and	and	O	O	-	31	NMOD	-	-
31	mu	mu	B-NP	B-NP	-	15	NMOD	-	-
32	;	;	O	O	-	31	P	-	-
33	and	and	O	O	-	34	NMOD	-	-
34	RelB	RelB	B-NP	B-NP	-	31	NMOD	-	-
35	,	,	O	O	-	34	P	-	-
36	suggesting	suggesting	B-VP	B-VP	-	31	NMOD	-	-
37	that	that	B-SBAR	B-SBAR	-	36	VMOD	-	-
38	these	these	B-NP	B-NP	-	39	NMOD	-	-
39	components/pathways	components/pathways	I-NP	I-NP	-	40	SUB	-	-
40	are	are	B-VP	B-VP	-	37	SBAR	-	-
41	important	important	B-ADJP	B-ADJP	-	40	PRD	-	-
42	for	for	B-PP	B-PP	-	41	AMOD	-	-
43	DC	DC	B-NP	B-NP	-	44	NMOD	-	-
44	differentiation	differentiation	I-NP	I-NP	-	42	PMOD	-	-
45	.	.	O	O	-	9	P	-	-

1	Together	Together	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	findings	findings	I-NP	I-NP	-	5	SUB	-	-
5	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	cytokine	cytokine	B-NP	B-NP	-	11	NMOD	-	-
8	or	or	O	O	-	11	NMOD	-	-
9	phorbol	phorbol	B-NP	B-NP	-	11	NMOD	-	-
10	ester	ester	I-NP	I-NP	-	11	NMOD	-	-
11	stimulation	stimulation	I-NP	I-NP	-	14	SUB	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	KG1	KG1	B-NP	B-NP	-	12	PMOD	-	-
14	is	is	B-VP	B-VP	-	6	SBAR	-	-
15	a	a	B-NP	B-NP	-	16	NMOD	-	-
16	model	model	I-NP	I-NP	-	14	PRD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	human	human	B-NP	B-NP	-	20	NMOD	-	-
19	CD34+	CD34+	I-NP	I-NP	-	20	NMOD	-	-
20	HPC	HPC	I-NP	I-NP	-	17	PMOD	-	-
21	to	to	B-PP	B-PP	-	16	NMOD	-	-
22	DC	DC	B-NP	B-NP	-	23	NMOD	-	-
23	differentiation	differentiation	I-NP	I-NP	-	21	PMOD	-	-
24	and	and	O	O	-	5	VMOD	-	-
25	suggest	suggest	B-VP	B-VP	-	5	VMOD	-	-
26	that	that	B-SBAR	B-SBAR	-	25	VMOD	-	-
27	specific	specific	B-NP	B-NP	-	30	NMOD	-	-
28	intracellular	intracellular	I-NP	I-NP	-	30	NMOD	-	-
29	signaling	signaling	I-NP	I-NP	-	30	NMOD	-	-
30	pathways	pathways	I-NP	I-NP	-	31	SUB	-	-
31	mediate	mediate	B-VP	B-VP	-	26	SBAR	-	-
32	specific	specific	B-NP	B-NP	-	33	NMOD	-	-
33	events	events	I-NP	I-NP	-	31	OBJ	-	-
34	in	in	B-PP	B-PP	-	31	VMOD	-	-
35	DC	DC	B-NP	B-NP	-	37	NMOD	-	-
36	lineage	lineage	I-NP	I-NP	-	37	NMOD	-	-
37	commitment	commitment	I-NP	I-NP	-	34	PMOD	-	-
38	.	.	O	O	-	5	P	-	-

1	IL-2-mediated	IL-2-mediated	B-NP	B-NP	-	4	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
3	cycle	cycle	I-NP	I-NP	-	4	NMOD	-	-
4	progression	progression	I-NP	I-NP	-	6	NMOD	-	-
5	and	and	I-NP	I-NP	-	6	NMOD	-	-
6	inhibition	inhibition	I-NP	I-NP	-	9	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	apoptosis	apoptosis	B-NP	B-NP	-	7	PMOD	-	-
9	does	does	B-VP	B-VP	-	0	ROOT	-	-
10	not	not	I-VP	I-VP	-	9	VMOD	-	-
11	require	require	I-VP	I-VP	-	9	VC	-	-
12	NF-kappa	NF-kappa	B-NP	B-NP	-	13	NMOD	-	-
13	B	B	I-NP	I-NP	-	11	OBJ	-	-
14	or	or	O	O	-	11	VMOD	-	-
15	activating	activating	B-VP	B-VP	-	9	VMOD	-	-
16	protein-1	protein-1	B-NP	B-NP	-	17	NMOD	-	-
17	activation	activation	I-NP	I-NP	-	15	OBJ	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	primary	primary	B-NP	B-NP	-	22	NMOD	-	-
20	human	human	I-NP	I-NP	-	22	NMOD	-	-
21	T	T	I-NP	I-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
23	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	IL-2	IL-2	I-NP	I-NP	-	4	NMOD	-	-
3	growth	growth	I-NP	I-NP	-	4	NMOD	-	-
4	hormone	hormone	I-NP	I-NP	-	5	SUB	-	-
5	is	is	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	major	major	I-NP	I-NP	-	9	NMOD	-	-
8	growth	growth	I-NP	I-NP	-	9	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	5	PRD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	activated	activated	B-NP	B-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	lymphocytes	lymphocytes	I-NP	I-NP	-	10	PMOD	-	-
14	during	during	B-PP	B-PP	-	5	VMOD	-	-
15	a	a	B-NP	B-NP	-	18	NMOD	-	-
16	developing	developing	I-NP	I-NP	-	18	NMOD	-	-
17	immune	immune	I-NP	I-NP	-	18	NMOD	-	-
18	response	response	I-NP	I-NP	-	14	PMOD	-	-
19	.	.	O	O	-	5	P	-	-

1	IL-2	IL-2	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	required	required	I-VP	I-VP	-	2	VC	-	-
4	not	not	B-CONJP	B-CONJP	-	2	VMOD	-	-
5	only	only	I-CONJP	I-CONJP	-	4	DEP	-	-
6	for	for	B-PP	B-PP	-	4	PMOD	-	-
7	cell	cell	B-NP	B-NP	-	9	NMOD	-	-
8	cycle	cycle	I-NP	I-NP	-	9	NMOD	-	-
9	progression	progression	I-NP	I-NP	-	6	PMOD	-	-
10	but	but	B-CONJP	B-CONJP	-	4	PMOD	-	-
11	also	also	I-CONJP	I-CONJP	-	10	DEP	-	-
12	to	to	B-VP	B-VP	-	13	VMOD	-	-
13	protect	protect	I-VP	I-VP	-	2	VMOD	-	-
14	Ag-activated	Ag-activated	B-NP	B-NP	-	16	NMOD	-	-
15	T	T	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	13	OBJ	-	-
17	from	from	B-PP	B-PP	-	16	NMOD	-	-
18	programmed	programmed	B-NP	B-NP	-	20	NMOD	-	-
19	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
20	death	death	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	16	VMOD	-	-
2	several	several	B-NP	B-NP	-	4	NMOD	-	-
3	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
4	types	types	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	16	P	-	-
6	activation	activation	B-NP	B-NP	-	16	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappa	NF-kappa	B-NP	B-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	7	PMOD	-	-
10	and/or	and/or	O	O	-	12	NMOD	-	-
11	activating	activating	B-VP	B-VP	-	12	NMOD	-	-
12	protein-1	protein-1	B-NP	B-NP	-	16	SUB	-	-
13	(	(	O	O	-	14	P	-	-
14	AP-1	AP-1	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	has	has	B-VP	B-VP	-	0	ROOT	-	-
17	been	been	I-VP	I-VP	-	16	VC	-	-
18	demonstrated	demonstrated	I-VP	I-VP	-	17	VC	-	-
19	to	to	I-VP	I-VP	-	20	VMOD	-	-
20	be	be	I-VP	I-VP	-	18	VMOD	-	-
21	extremely	extremely	B-ADJP	B-ADJP	-	22	AMOD	-	-
22	important	important	I-ADJP	I-ADJP	-	20	PRD	-	-
23	in	in	B-PP	B-PP	-	22	AMOD	-	-
24	blocking	blocking	B-VP	B-VP	-	23	PMOD	-	-
25	apoptosis	apoptosis	B-NP	B-NP	-	24	OBJ	-	-
26	.	.	O	O	-	16	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	determine	determine	I-VP	I-VP	-	34	VMOD	-	-
3	whether	whether	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	either	either	B-NP	B-NP	-	6	NMOD	-	-
5	or	or	I-NP	I-NP	-	6	NMOD	-	-
6	both	both	I-NP	I-NP	-	11	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	these	these	B-NP	B-NP	-	10	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	10	NMOD	-	-
10	factors	factors	I-NP	I-NP	-	7	PMOD	-	-
11	are	are	B-VP	B-VP	-	3	SBAR	-	-
12	involved	involved	I-VP	I-VP	-	11	VC	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	cell	cell	B-NP	B-NP	-	15	NMOD	-	-
15	survival	survival	I-NP	I-NP	-	19	NMOD	-	-
16	or	or	O	O	-	19	NMOD	-	-
17	cell	cell	B-NP	B-NP	-	19	NMOD	-	-
18	cycle	cycle	I-NP	I-NP	-	19	NMOD	-	-
19	progression	progression	I-NP	I-NP	-	13	PMOD	-	-
20	in	in	B-PP	B-PP	-	12	VMOD	-	-
21	response	response	I-PP	I-PP	-	20	PMOD	-	-
22	to	to	I-PP	I-PP	-	20	PMOD	-	-
23	IL-2	IL-2	B-NP	B-NP	-	20	PMOD	-	-
24	,	,	O	O	-	34	P	-	-
25	primary	primary	B-NP	B-NP	-	28	NMOD	-	-
26	human	human	I-NP	I-NP	-	28	NMOD	-	-
27	T	T	I-NP	I-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	34	SUB	-	-
29	responsive	responsive	B-ADJP	B-ADJP	-	28	NMOD	-	-
30	to	to	B-PP	B-PP	-	29	AMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	growth	growth	I-NP	I-NP	-	33	NMOD	-	-
33	factor	factor	I-NP	I-NP	-	30	PMOD	-	-
34	were	were	B-VP	B-VP	-	0	ROOT	-	-
35	analyzed	analyzed	I-VP	I-VP	-	34	VC	-	-
36	for	for	B-PP	B-PP	-	35	VMOD	-	-
37	NF-kappa	NF-kappa	B-NP	B-NP	-	38	NMOD	-	-
38	B	B	I-NP	I-NP	-	41	NMOD	-	-
39	and	and	O	O	-	40	NMOD	-	-
40	AP-1	AP-1	B-NP	B-NP	-	41	NMOD	-	-
41	activation	activation	B-NP	B-NP	-	36	PMOD	-	-
42	.	.	O	O	-	34	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	current	current	I-NP	I-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	5	SUB	-	-
4	clearly	clearly	B-ADVP	B-ADVP	-	5	VMOD	-	-
5	demonstrates	demonstrates	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	IL-2	IL-2	B-NP	B-NP	-	8	SUB	-	-
8	does	does	B-VP	B-VP	-	6	SBAR	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	induce	induce	I-VP	I-VP	-	8	VC	-	-
11	I	I	B-NP	B-NP	-	15	NMOD	-	-
12	kappa	kappa	I-NP	I-NP	-	15	NMOD	-	-
13	B	B	I-NP	I-NP	-	15	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	15	NMOD	-	-
15	degradation	degradation	I-NP	I-NP	-	19	NMOD	-	-
16	or	or	O	O	-	19	NMOD	-	-
17	NF-kappa	NF-kappa	B-NP	B-NP	-	19	NMOD	-	-
18	B	B	I-NP	I-NP	-	19	NMOD	-	-
19	activation	activation	I-NP	I-NP	-	10	OBJ	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	primary	primary	B-NP	B-NP	-	24	NMOD	-	-
22	human	human	I-NP	I-NP	-	24	NMOD	-	-
23	T	T	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
25	that	that	B-NP	B-NP	-	24	NMOD	-	-
26	respond	respond	B-VP	B-VP	-	25	SBAR	-	-
27	to	to	B-PP	B-PP	-	26	VMOD	-	-
28	IL-2	IL-2	B-NP	B-NP	-	27	PMOD	-	-
29	by	by	B-PP	B-PP	-	26	VMOD	-	-
30	entering	entering	B-VP	B-VP	-	29	PMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	cell	cell	I-NP	I-NP	-	33	NMOD	-	-
33	cycle	cycle	I-NP	I-NP	-	30	OBJ	-	-
34	and	and	O	O	-	26	VMOD	-	-
35	avoiding	avoiding	B-VP	B-VP	-	26	VMOD	-	-
36	apoptosis	apoptosis	B-NP	B-NP	-	35	OBJ	-	-
37	.	.	O	O	-	5	P	-	-

1	Similarly	Similarly	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	IL-2	IL-2	B-NP	B-NP	-	5	SUB	-	-
4	neither	neither	O	O	-	5	VMOD	-	-
5	activates	activates	B-VP	B-VP	-	8	VMOD	-	-
6	JNK	JNK	B-NP	B-NP	-	5	OBJ	-	-
7	nor	nor	O	O	-	5	VMOD	-	-
8	increases	increases	B-VP	B-VP	-	0	ROOT	-	-
9	AP-1	AP-1	B-NP	B-NP	-	11	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	8	OBJ	-	-
12	to	to	B-PP	B-PP	-	11	NMOD	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	consensus	consensus	I-NP	I-NP	-	16	NMOD	-	-
15	o-tetradecanoylphorbol	o-tetradecanoylphorbol	I-NP	I-NP	-	16	NMOD	-	-
16	13-acetate	13-acetate	I-NP	I-NP	-	21	NMOD	-	-
17	(	(	O	O	-	18	P	-	-
18	TPA	TPA	B-NP	B-NP	-	16	NMOD	-	-
19	)	)	O	O	-	21	P	-	-
20	response	response	B-NP	B-NP	-	21	NMOD	-	-
21	element	element	I-NP	I-NP	-	12	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	On	On	B-PP	B-PP	-	9	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	other	other	I-NP	I-NP	-	4	NMOD	-	-
4	hand	hand	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	9	P	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	growth	growth	I-NP	I-NP	-	8	NMOD	-	-
8	factor	factor	I-NP	I-NP	-	9	SUB	-	-
9	does	does	B-VP	B-VP	-	0	ROOT	-	-
10	induce	induce	I-VP	I-VP	-	9	VC	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	STAT3	STAT3	B-NP	B-NP	-	16	NMOD	-	-
15	and	and	I-NP	I-NP	-	16	NMOD	-	-
16	STAT5	STAT5	I-NP	I-NP	-	13	PMOD	-	-
17	in	in	B-PP	B-PP	-	12	NMOD	-	-
18	these	these	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	9	P	-	-
21	as	as	B-SBAR	B-SBAR	-	9	VMOD	-	-
22	has	has	B-VP	B-VP	-	21	SBAR	-	-
23	been	been	I-VP	I-VP	-	22	VC	-	-
24	previously	previously	I-VP	I-VP	-	23	VMOD	-	-
25	demonstrated	demonstrated	I-VP	I-VP	-	23	VC	-	-
26	.	.	O	O	-	9	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	neither	neither	O	O	-	10	NMOD	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	7	NMOD	-	-
7	B	B	I-NP	I-NP	-	10	NMOD	-	-
8	nor	nor	O	O	-	10	NMOD	-	-
9	AP-1	AP-1	B-NP	B-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	11	SUB	-	-
11	is	is	B-VP	B-VP	-	4	SBAR	-	-
12	required	required	I-VP	I-VP	-	11	VC	-	-
13	for	for	B-PP	B-PP	-	12	VMOD	-	-
14	IL-2-mediated	IL-2-mediated	B-NP	B-NP	-	15	NMOD	-	-
15	survival	survival	I-NP	I-NP	-	19	NMOD	-	-
16	or	or	O	O	-	19	NMOD	-	-
17	cell	cell	B-NP	B-NP	-	19	NMOD	-	-
18	cycle	cycle	I-NP	I-NP	-	19	NMOD	-	-
19	progression	progression	I-NP	I-NP	-	13	PMOD	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	activated	activated	B-NP	B-NP	-	25	NMOD	-	-
22	primary	primary	I-NP	I-NP	-	25	NMOD	-	-
23	human	human	I-NP	I-NP	-	25	NMOD	-	-
24	T	T	I-NP	I-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
26	.	.	O	O	-	3	P	-	-

1	Impaired	Impaired	B-NP	B-NP	-	4	NMOD	-	-
2	fetal	fetal	I-NP	I-NP	-	4	NMOD	-	-
3	thymocyte	thymocyte	I-NP	I-NP	-	4	NMOD	-	-
4	development	development	I-NP	I-NP	-	0	ROOT	-	-
5	after	after	B-PP	B-PP	-	4	NMOD	-	-
6	efficient	efficient	B-NP	B-NP	-	8	NMOD	-	-
7	adenovirus-mediated	adenovirus-mediated	I-NP	I-NP	-	8	NMOD	-	-
8	inhibition	inhibition	I-NP	I-NP	-	5	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	introduce	introduce	B-VP	B-VP	-	0	ROOT	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	new	new	I-NP	I-NP	-	6	NMOD	-	-
5	experimental	experimental	I-NP	I-NP	-	6	NMOD	-	-
6	system	system	I-NP	I-NP	-	2	OBJ	-	-
7	combining	combining	B-VP	B-VP	-	6	NMOD	-	-
8	adenovirus-mediated	adenovirus-mediated	B-NP	B-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	transfer	transfer	I-NP	I-NP	-	15	NMOD	-	-
11	and	and	O	O	-	15	NMOD	-	-
12	fetal	fetal	B-NP	B-NP	-	15	NMOD	-	-
13	thymic	thymic	I-NP	I-NP	-	15	NMOD	-	-
14	organ	organ	I-NP	I-NP	-	15	NMOD	-	-
15	culture	culture	I-NP	I-NP	-	7	OBJ	-	-
16	(	(	O	O	-	17	P	-	-
17	FTOC	FTOC	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	.	.	O	O	-	2	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	system	system	I-NP	I-NP	-	3	SUB	-	-
3	allowed	allowed	B-VP	B-VP	-	0	ROOT	-	-
4	us	us	B-NP	B-NP	-	7	SUB	-	-
5	to	to	B-VP	B-VP	-	7	VMOD	-	-
6	efficiently	efficiently	I-VP	I-VP	-	7	VMOD	-	-
7	express	express	I-VP	I-VP	-	3	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	developing	developing	B-VP	B-VP	-	8	PMOD	-	-
10	thymocytes	thymocytes	B-NP	B-NP	-	9	OBJ	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	mutant	mutant	I-NP	I-NP	-	13	NMOD	-	-
13	form	form	I-NP	I-NP	-	9	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	22	NMOD	-	-
16	NF-kappa	NF-kappa	I-NP	I-NP	-	22	NMOD	-	-
17	B	B	I-NP	I-NP	-	22	NMOD	-	-
18	inhibitor	inhibitor	I-NP	I-NP	-	22	NMOD	-	-
19	I	I	I-NP	I-NP	-	22	NMOD	-	-
20	kappa	kappa	I-NP	I-NP	-	22	NMOD	-	-
21	B	B	I-NP	I-NP	-	22	NMOD	-	-
22	alpha	alpha	I-NP	I-NP	-	14	PMOD	-	-
23	(	(	O	O	-	26	P	-	-
24	mut-I	mut-I	B-NP	B-NP	-	26	NMOD	-	-
25	kappa	kappa	I-NP	I-NP	-	26	NMOD	-	-
26	B	B	I-NP	I-NP	-	22	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	and	and	O	O	-	3	VMOD	-	-
29	to	to	B-VP	B-VP	-	30	VMOD	-	-
30	study	study	I-VP	I-VP	-	3	VMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	maturation	maturation	I-NP	I-NP	-	33	NMOD	-	-
33	defects	defects	I-NP	I-NP	-	30	OBJ	-	-
34	occurring	occurring	B-VP	B-VP	-	33	NMOD	-	-
35	when	when	B-ADVP	B-ADVP	-	34	VMOD	-	-
36	NF-kappa	NF-kappa	B-NP	B-NP	-	38	NMOD	-	-
37	B	B	I-NP	I-NP	-	38	NMOD	-	-
38	activation	activation	I-NP	I-NP	-	39	SUB	-	-
39	is	is	B-VP	B-VP	-	35	SBAR	-	-
40	inhibited	inhibited	I-VP	I-VP	-	39	VC	-	-
41	during	during	B-PP	B-PP	-	40	VMOD	-	-
42	fetal	fetal	B-NP	B-NP	-	43	NMOD	-	-
43	development	development	I-NP	I-NP	-	41	PMOD	-	-
44	.	.	O	O	-	3	P	-	-

1	Fetal	Fetal	B-NP	B-NP	-	2	NMOD	-	-
2	thymocytes	thymocytes	I-NP	I-NP	-	10	SUB	-	-
3	infected	infected	B-VP	B-VP	-	2	NMOD	-	-
4	with	with	B-PP	B-PP	-	3	VMOD	-	-
5	adenovirus	adenovirus	B-NP	B-NP	-	4	PMOD	-	-
6	containing	containing	B-VP	B-VP	-	5	NMOD	-	-
7	mut-I	mut-I	B-NP	B-NP	-	9	NMOD	-	-
8	kappa	kappa	I-NP	I-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	6	OBJ	-	-
10	were	were	B-VP	B-VP	-	0	ROOT	-	-
11	found	found	I-VP	I-VP	-	10	VC	-	-
12	to	to	I-VP	I-VP	-	13	VMOD	-	-
13	develop	develop	I-VP	I-VP	-	11	VMOD	-	-
14	normally	normally	B-ADVP	B-ADVP	-	13	VMOD	-	-
15	until	until	B-SBAR	B-SBAR	-	13	VMOD	-	-
16	the	the	B-NP	B-NP	-	21	NMOD	-	-
17	CD44-CD25+	CD44-CD25+	I-NP	I-NP	-	21	NMOD	-	-
18	,	,	I-NP	I-NP	-	21	P	-	-
19	CD4-CD8-	CD4-CD8-	I-NP	I-NP	-	21	NMOD	-	-
20	double-negative	double-negative	I-NP	I-NP	-	21	NMOD	-	-
21	stage	stage	I-NP	I-NP	-	13	OBJ	-	-
22	,	,	O	O	-	10	P	-	-
23	while	while	B-SBAR	B-SBAR	-	10	VMOD	-	-
24	production	production	B-NP	B-NP	-	32	SUB	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	more	more	B-NP	B-NP	-	27	AMOD	-	-
27	mature	mature	I-NP	I-NP	-	31	NMOD	-	-
28	double-positive	double-positive	I-NP	I-NP	-	31	NMOD	-	-
29	and	and	I-NP	I-NP	-	31	NMOD	-	-
30	single-positive	single-positive	I-NP	I-NP	-	31	NMOD	-	-
31	populations	populations	I-NP	I-NP	-	25	PMOD	-	-
32	was	was	B-VP	B-VP	-	23	SBAR	-	-
33	strongly	strongly	I-VP	I-VP	-	32	VMOD	-	-
34	decreased	decreased	I-VP	I-VP	-	32	VC	-	-
35	.	.	O	O	-	10	P	-	-

1	Proliferation	Proliferation	B-NP	B-NP	-	12	SUB	-	-
2	,	,	O	O	-	12	P	-	-
3	as	as	B-SBAR	B-SBAR	-	12	VMOD	-	-
4	measured	measured	B-VP	B-VP	-	3	SBAR	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	percentage	percentage	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	cells	cells	B-NP	B-NP	-	8	PMOD	-	-
10	in	in	B-PP	B-PP	-	7	NMOD	-	-
11	cycle	cycle	B-NP	B-NP	-	10	PMOD	-	-
12	appeared	appeared	B-VP	B-VP	-	0	ROOT	-	-
13	normal	normal	B-ADJP	B-ADJP	-	12	PRD	-	-
14	,	,	O	O	-	12	P	-	-
15	as	as	B-SBAR	B-SBAR	-	12	VMOD	-	-
16	did	did	O	O	-	15	DEP	-	-
17	rearrangement	rearrangement	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	O	O	-	19	NMOD	-	-
19	expression	expression	B-NP	B-NP	-	16	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	23	NMOD	-	-
22	TCR	TCR	I-NP	I-NP	-	23	NMOD	-	-
23	beta-chain	beta-chain	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	12	P	-	-

1	However	However	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	apoptosis	apoptosis	B-NP	B-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	much	much	B-ADJP	B-ADJP	-	6	AMOD	-	-
6	higher	higher	I-ADJP	I-ADJP	-	4	PRD	-	-
7	in	in	B-PP	B-PP	-	4	VMOD	-	-
8	FTOC	FTOC	B-NP	B-NP	-	7	PMOD	-	-
9	infected	infected	B-VP	B-VP	-	8	NMOD	-	-
10	with	with	B-PP	B-PP	-	9	VMOD	-	-
11	adenovirus	adenovirus	B-NP	B-NP	-	10	PMOD	-	-
12	containing	containing	B-VP	B-VP	-	11	NMOD	-	-
13	mut-I	mut-I	B-NP	B-NP	-	15	NMOD	-	-
14	kappa	kappa	I-NP	I-NP	-	15	NMOD	-	-
15	B	B	I-NP	I-NP	-	12	OBJ	-	-
16	than	than	B-PP	B-PP	-	9	VMOD	-	-
17	in	in	B-PP	B-PP	-	16	PMOD	-	-
18	FTOC	FTOC	B-NP	B-NP	-	17	PMOD	-	-
19	infected	infected	B-VP	B-VP	-	18	NMOD	-	-
20	with	with	B-PP	B-PP	-	19	VMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	control	control	I-NP	I-NP	-	23	NMOD	-	-
23	virus	virus	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	4	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	results	results	I-NP	I-NP	-	6	SUB	-	-
6	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	NF-kappa	NF-kappa	B-NP	B-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	10	SUB	-	-
10	plays	plays	B-VP	B-VP	-	7	SBAR	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	crucial	crucial	I-NP	I-NP	-	13	NMOD	-	-
13	role	role	I-NP	I-NP	-	10	OBJ	-	-
14	in	in	B-PP	B-PP	-	10	VMOD	-	-
15	ensuring	ensuring	B-VP	B-VP	-	14	PMOD	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	differentiation	differentiation	I-NP	I-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	survival	survival	I-NP	I-NP	-	15	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	thymocytes	thymocytes	B-NP	B-NP	-	20	PMOD	-	-
22	in	in	B-PP	B-PP	-	15	VMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	early	early	I-NP	I-NP	-	25	NMOD	-	-
25	stages	stages	I-NP	I-NP	-	22	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	their	their	B-NP	B-NP	-	28	NMOD	-	-
28	development	development	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	6	P	-	-

1	Differential	Differential	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	4E-BP1	4E-BP1	B-NP	B-NP	-	6	NMOD	-	-
5	and	and	I-NP	I-NP	-	6	NMOD	-	-
6	4E-BP2	4E-BP2	I-NP	I-NP	-	3	PMOD	-	-
7	,	,	O	O	-	9	P	-	-
8	two	two	B-NP	B-NP	-	9	NMOD	-	-
9	repressors	repressors	I-NP	I-NP	-	3	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	translation	translation	B-NP	B-NP	-	12	NMOD	-	-
12	initiation	initiation	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	9	P	-	-
14	during	during	B-PP	B-PP	-	2	NMOD	-	-
15	human	human	B-NP	B-NP	-	18	NMOD	-	-
16	myeloid	myeloid	I-NP	I-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	differentiation	differentiation	I-NP	I-NP	-	14	PMOD	-	-
19	.	.	O	O	-	2	P	-	-

1	Human	Human	B-NP	B-NP	-	3	NMOD	-	-
2	myeloid	myeloid	I-NP	I-NP	-	3	NMOD	-	-
3	differentiation	differentiation	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	accompanied	accompanied	I-VP	I-VP	-	4	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	decrease	decrease	I-NP	I-NP	-	6	PMOD	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	cell	cell	B-NP	B-NP	-	11	NMOD	-	-
11	proliferation	proliferation	I-NP	I-NP	-	9	PMOD	-	-
12	.	.	O	O	-	4	P	-	-

1	Because	Because	B-SBAR	B-SBAR	-	14	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	translation	translation	I-NP	I-NP	-	4	NMOD	-	-
4	rate	rate	I-NP	I-NP	-	5	SUB	-	-
5	is	is	B-VP	B-VP	-	1	SBAR	-	-
6	an	an	B-NP	B-NP	-	8	NMOD	-	-
7	important	important	I-NP	I-NP	-	8	NMOD	-	-
8	determinant	determinant	I-NP	I-NP	-	5	PRD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	cell	cell	B-NP	B-NP	-	11	NMOD	-	-
11	proliferation	proliferation	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	we	we	B-NP	B-NP	-	14	SUB	-	-
14	have	have	B-VP	B-VP	-	0	ROOT	-	-
15	investigated	investigated	I-VP	I-VP	-	14	VC	-	-
16	translation	translation	B-NP	B-NP	-	17	NMOD	-	-
17	initiation	initiation	I-NP	I-NP	-	15	OBJ	-	-
18	during	during	B-PP	B-PP	-	15	VMOD	-	-
19	human	human	B-NP	B-NP	-	22	NMOD	-	-
20	myeloid	myeloid	I-NP	I-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	differentiation	differentiation	I-NP	I-NP	-	18	PMOD	-	-
23	using	using	B-VP	B-VP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	29	NMOD	-	-
25	HL-60	HL-60	I-NP	I-NP	-	29	NMOD	-	-
26	promyelocytic	promyelocytic	I-NP	I-NP	-	29	NMOD	-	-
27	leukemia	leukemia	I-NP	I-NP	-	29	NMOD	-	-
28	cell	cell	I-NP	I-NP	-	29	NMOD	-	-
29	line	line	I-NP	I-NP	-	35	NMOD	-	-
30	and	and	O	O	-	35	NMOD	-	-
31	the	the	B-NP	B-NP	-	35	NMOD	-	-
32	U-937	U-937	I-NP	I-NP	-	35	NMOD	-	-
33	monoblastic	monoblastic	I-NP	I-NP	-	35	NMOD	-	-
34	cell	cell	I-NP	I-NP	-	35	NMOD	-	-
35	line	line	I-NP	I-NP	-	23	OBJ	-	-
36	.	.	O	O	-	14	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	decrease	decrease	I-NP	I-NP	-	7	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	translation	translation	I-NP	I-NP	-	6	NMOD	-	-
6	rate	rate	I-NP	I-NP	-	3	PMOD	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	observed	observed	I-VP	I-VP	-	7	VC	-	-
9	when	when	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	12	SUB	-	-
12	are	are	B-VP	B-VP	-	9	SBAR	-	-
13	induced	induced	I-VP	I-VP	-	12	VC	-	-
14	to	to	I-VP	I-VP	-	15	VMOD	-	-
15	differentiate	differentiate	I-VP	I-VP	-	13	VMOD	-	-
16	along	along	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	monocytic/macrophage	monocytic/macrophage	I-NP	I-NP	-	19	NMOD	-	-
19	pathway	pathway	I-NP	I-NP	-	16	PMOD	-	-
20	or	or	B-PP	B-PP	-	16	PMOD	-	-
21	along	along	B-PP	B-PP	-	16	PMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	granulocytic	granulocytic	I-NP	I-NP	-	24	NMOD	-	-
24	pathway	pathway	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	inhibition	inhibition	I-NP	I-NP	-	6	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	protein	protein	B-NP	B-NP	-	5	NMOD	-	-
5	synthesis	synthesis	I-NP	I-NP	-	3	PMOD	-	-
6	correlates	correlates	B-VP	B-VP	-	0	ROOT	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	specific	specific	B-NP	B-NP	-	9	NMOD	-	-
9	regulation	regulation	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	two	two	B-NP	B-NP	-	12	NMOD	-	-
12	repressors	repressors	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	translation	translation	B-NP	B-NP	-	15	NMOD	-	-
15	initiation	initiation	I-NP	I-NP	-	19	NMOD	-	-
16	,	,	O	O	-	19	P	-	-
17	4E-BP1	4E-BP1	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	4E-BP2	4E-BP2	I-NP	I-NP	-	13	PMOD	-	-
20	.	.	O	O	-	6	P	-	-

1	Induction	Induction	B-NP	B-NP	-	14	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	HL-60	HL-60	B-NP	B-NP	-	7	NMOD	-	-
4	and	and	I-NP	I-NP	-	7	NMOD	-	-
5	U-937	U-937	I-NP	I-NP	-	7	NMOD	-	-
6	cell	cell	I-NP	I-NP	-	7	NMOD	-	-
7	differentiation	differentiation	I-NP	I-NP	-	2	PMOD	-	-
8	into	into	B-PP	B-PP	-	1	NMOD	-	-
9	monocytes/macrophages	monocytes/macrophages	B-NP	B-NP	-	8	PMOD	-	-
10	by	by	B-PP	B-PP	-	1	NMOD	-	-
11	IFN-gamma	IFN-gamma	B-NP	B-NP	-	13	NMOD	-	-
12	or	or	I-NP	I-NP	-	13	NMOD	-	-
13	PMA	PMA	I-NP	I-NP	-	10	PMOD	-	-
14	results	results	B-VP	B-VP	-	0	ROOT	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	a	a	B-NP	B-NP	-	20	NMOD	-	-
17	dephosphorylation	dephosphorylation	I-NP	I-NP	-	20	NMOD	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	consequent	consequent	B-NP	B-NP	-	20	NMOD	-	-
20	activation	activation	I-NP	I-NP	-	15	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	4E-BP1	4E-BP1	B-NP	B-NP	-	21	PMOD	-	-
23	.	.	O	O	-	14	P	-	-

1	Dephosphorylation	Dephosphorylation	B-NP	B-NP	-	4	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	4E-BP1	4E-BP1	B-NP	B-NP	-	2	PMOD	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	also	also	I-VP	I-VP	-	4	VMOD	-	-
6	observed	observed	I-VP	I-VP	-	4	VC	-	-
7	when	when	B-ADVP	B-ADVP	-	6	VMOD	-	-
8	U-937	U-937	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	10	SUB	-	-
10	were	were	B-VP	B-VP	-	7	SBAR	-	-
11	induced	induced	I-VP	I-VP	-	10	VC	-	-
12	to	to	I-VP	I-VP	-	13	VMOD	-	-
13	differentiate	differentiate	I-VP	I-VP	-	11	VMOD	-	-
14	into	into	B-PP	B-PP	-	13	VMOD	-	-
15	monocytes/macrophages	monocytes/macrophages	B-NP	B-NP	-	14	PMOD	-	-
16	following	following	B-PP	B-PP	-	15	NMOD	-	-
17	treatment	treatment	B-NP	B-NP	-	16	PMOD	-	-
18	with	with	B-PP	B-PP	-	17	NMOD	-	-
19	retinoic	retinoic	B-NP	B-NP	-	20	NMOD	-	-
20	acid	acid	I-NP	I-NP	-	22	NMOD	-	-
21	or	or	I-NP	I-NP	-	22	NMOD	-	-
22	DMSO	DMSO	I-NP	I-NP	-	18	PMOD	-	-
23	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	24	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	24	P	-	-
4	treatment	treatment	B-NP	B-NP	-	24	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	HL-60	HL-60	B-NP	B-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
8	with	with	B-PP	B-PP	-	4	NMOD	-	-
9	retinoic	retinoic	B-NP	B-NP	-	10	NMOD	-	-
10	acid	acid	I-NP	I-NP	-	12	NMOD	-	-
11	or	or	O	O	-	12	NMOD	-	-
12	DMSO	DMSO	B-NP	B-NP	-	8	PMOD	-	-
13	,	,	O	O	-	12	P	-	-
14	which	which	B-NP	B-NP	-	12	NMOD	-	-
15	results	results	B-VP	B-VP	-	14	SBAR	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	a	a	B-NP	B-NP	-	19	NMOD	-	-
18	granulocytic	granulocytic	I-NP	I-NP	-	19	NMOD	-	-
19	differentiation	differentiation	I-NP	I-NP	-	16	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	these	these	B-NP	B-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
23	,	,	O	O	-	4	P	-	-
24	decreases	decreases	B-VP	B-VP	-	0	ROOT	-	-
25	4E-BP1	4E-BP1	B-NP	B-NP	-	26	NMOD	-	-
26	amount	amount	I-NP	I-NP	-	24	OBJ	-	-
27	without	without	B-PP	B-PP	-	24	VMOD	-	-
28	affecting	affecting	B-VP	B-VP	-	27	PMOD	-	-
29	its	its	B-NP	B-NP	-	30	NMOD	-	-
30	phosphorylation	phosphorylation	I-NP	I-NP	-	28	OBJ	-	-
31	and	and	O	O	-	28	VMOD	-	-
32	strongly	strongly	B-VP	B-VP	-	33	VMOD	-	-
33	increases	increases	I-VP	I-VP	-	24	VMOD	-	-
34	4E-BP2	4E-BP2	B-NP	B-NP	-	35	NMOD	-	-
35	amount	amount	I-NP	I-NP	-	33	OBJ	-	-
36	.	.	O	O	-	24	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	data	data	I-NP	I-NP	-	6	SUB	-	-
6	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
7	evidence	evidence	B-NP	B-NP	-	6	OBJ	-	-
8	for	for	B-PP	B-PP	-	7	NMOD	-	-
9	differential	differential	B-NP	B-NP	-	10	NMOD	-	-
10	regulation	regulation	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	translational	translational	I-NP	I-NP	-	14	NMOD	-	-
14	machinery	machinery	I-NP	I-NP	-	11	PMOD	-	-
15	during	during	B-PP	B-PP	-	10	NMOD	-	-
16	human	human	B-NP	B-NP	-	18	NMOD	-	-
17	myeloid	myeloid	I-NP	I-NP	-	18	NMOD	-	-
18	differentiation	differentiation	I-NP	I-NP	-	15	PMOD	-	-
19	,	,	O	O	-	6	P	-	-
20	specific	specific	B-ADJP	B-ADJP	-	6	VMOD	-	-
21	to	to	B-PP	B-PP	-	20	AMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	monocytic/macrophage	monocytic/macrophage	I-NP	I-NP	-	24	NMOD	-	-
24	pathway	pathway	I-NP	I-NP	-	21	PMOD	-	-
25	or	or	B-PP	B-PP	-	21	PMOD	-	-
26	to	to	B-PP	B-PP	-	21	PMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	granulocytic	granulocytic	I-NP	I-NP	-	29	NMOD	-	-
29	pathway	pathway	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	6	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	CD40	CD40	B-NP	B-NP	-	2	PMOD	-	-
4	on	on	B-PP	B-PP	-	1	NMOD	-	-
5	immunogenic	immunogenic	B-NP	B-NP	-	8	NMOD	-	-
6	human	human	I-NP	I-NP	-	8	NMOD	-	-
7	malignant	malignant	I-NP	I-NP	-	8	NMOD	-	-
8	melanomas	melanomas	I-NP	I-NP	-	4	PMOD	-	-
9	augments	augments	B-VP	B-VP	-	0	ROOT	-	-
10	their	their	B-NP	B-NP	-	14	NMOD	-	-
11	cytotoxic	cytotoxic	I-NP	I-NP	-	14	NMOD	-	-
12	T	T	I-NP	I-NP	-	14	NMOD	-	-
13	lymphocyte-mediated	lymphocyte-mediated	I-NP	I-NP	-	14	NMOD	-	-
14	lysis	lysis	I-NP	I-NP	-	9	OBJ	-	-
15	and	and	O	O	-	9	VMOD	-	-
16	induces	induces	B-VP	B-VP	-	9	VMOD	-	-
17	apoptosis	apoptosis	B-NP	B-NP	-	16	OBJ	-	-
18	.	.	O	O	-	9	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	report	report	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	functional	functional	I-NP	I-NP	-	7	NMOD	-	-
7	expression	expression	I-NP	I-NP	-	4	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	CD40	CD40	B-NP	B-NP	-	8	PMOD	-	-
10	on	on	B-PP	B-PP	-	7	NMOD	-	-
11	human	human	B-NP	B-NP	-	13	NMOD	-	-
12	malignant	malignant	I-NP	I-NP	-	13	NMOD	-	-
13	melanomas	melanomas	I-NP	I-NP	-	10	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	MMs	MMs	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	.	.	O	O	-	4	P	-	-

1	Comparison	Comparison	B-NP	B-NP	-	15	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	tumor	tumor	B-NP	B-NP	-	4	NMOD	-	-
4	specimen	specimen	I-NP	I-NP	-	2	PMOD	-	-
5	from	from	B-PP	B-PP	-	4	NMOD	-	-
6	MM	MM	B-NP	B-NP	-	8	NMOD	-	-
7	precursor	precursor	I-NP	I-NP	-	8	NMOD	-	-
8	lesions	lesions	I-NP	I-NP	-	5	PMOD	-	-
9	,	,	O	O	-	15	P	-	-
10	primary	primary	B-NP	B-NP	-	11	NMOD	-	-
11	tumors	tumors	I-NP	I-NP	-	15	SUB	-	-
12	,	,	O	O	-	15	P	-	-
13	and	and	O	O	-	15	VMOD	-	-
14	metastases	metastases	B-NP	B-NP	-	15	SUB	-	-
15	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	CD40	CD40	B-NP	B-NP	-	19	NMOD	-	-
18	surface	surface	I-NP	I-NP	-	19	NMOD	-	-
19	expression	expression	I-NP	I-NP	-	20	SUB	-	-
20	is	is	B-VP	B-VP	-	16	SBAR	-	-
21	down-regulated	down-regulated	I-VP	I-VP	-	20	VC	-	-
22	during	during	B-PP	B-PP	-	21	VMOD	-	-
23	tumor	tumor	B-NP	B-NP	-	24	NMOD	-	-
24	progression	progression	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	15	P	-	-

1	CD40	CD40	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	19	VMOD	-	-
4	confirmed	confirmed	I-VP	I-VP	-	3	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	<num>	<num>	B-NP	B-NP	-	10	NMOD	-	-
7	human	human	I-NP	I-NP	-	10	NMOD	-	-
8	MM	MM	I-NP	I-NP	-	10	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	10	NMOD	-	-
10	lines	lines	I-NP	I-NP	-	5	PMOD	-	-
11	established	established	B-VP	B-VP	-	10	NMOD	-	-
12	from	from	B-PP	B-PP	-	11	VMOD	-	-
13	immunogenic	immunogenic	B-NP	B-NP	-	15	NMOD	-	-
14	primary	primary	I-NP	I-NP	-	15	NMOD	-	-
15	tumors	tumors	I-NP	I-NP	-	17	NMOD	-	-
16	or	or	I-NP	I-NP	-	17	NMOD	-	-
17	metastases	metastases	I-NP	I-NP	-	12	PMOD	-	-
18	,	,	O	O	-	3	P	-	-
19	whereas	whereas	O	O	-	0	ROOT	-	-
20	<num>	<num>	B-NP	B-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	lines	lines	I-NP	I-NP	-	27	SUB	-	-
23	established	established	B-VP	B-VP	-	22	NMOD	-	-
24	from	from	B-PP	B-PP	-	23	VMOD	-	-
25	advanced	advanced	B-NP	B-NP	-	26	NMOD	-	-
26	stages	stages	I-NP	I-NP	-	24	PMOD	-	-
27	were	were	B-VP	B-VP	-	19	VMOD	-	-
28	CD40	CD40	B-ADJP	B-ADJP	-	29	AMOD	-	-
29	negative	negative	I-ADJP	I-ADJP	-	27	PRD	-	-
30	.	.	O	O	-	19	P	-	-

1	CD40	CD40	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	3	SUB	-	-
3	could	could	B-VP	B-VP	-	0	ROOT	-	-
4	be	be	I-VP	I-VP	-	3	VC	-	-
5	enhanced	enhanced	I-VP	I-VP	-	4	VC	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	CD40-positive	CD40-positive	B-NP	B-NP	-	8	NMOD	-	-
8	MM	MM	I-NP	I-NP	-	6	PMOD	-	-
9	by	by	B-PP	B-PP	-	8	NMOD	-	-
10	stimulation	stimulation	B-NP	B-NP	-	9	PMOD	-	-
11	with	with	B-PP	B-PP	-	10	NMOD	-	-
12	IFN-gamma	IFN-gamma	B-NP	B-NP	-	16	NMOD	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	tumor	tumor	B-NP	B-NP	-	16	NMOD	-	-
15	necrosis	necrosis	I-NP	I-NP	-	16	NMOD	-	-
16	factor-alpha	factor-alpha	I-NP	I-NP	-	11	PMOD	-	-
17	but	but	B-PP	B-PP	-	9	PMOD	-	-
18	not	not	B-PP	B-PP	-	19	PMOD	-	-
19	by	by	I-PP	I-PP	-	9	PMOD	-	-
20	interleukin	interleukin	B-NP	B-NP	-	22	NMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	IL	IL	B-NP	B-NP	-	27	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	-1beta	-1beta	B-NP	B-NP	-	27	NMOD	-	-
25	or	or	O	O	-	27	NMOD	-	-
26	CD40	CD40	B-NP	B-NP	-	27	NMOD	-	-
27	triggering	triggering	I-NP	I-NP	-	19	PMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	CD40	CD40	B-NP	B-NP	-	2	NMOD	-	-
2	ligation	ligation	I-NP	I-NP	-	16	SUB	-	-
3	on	on	B-PP	B-PP	-	2	NMOD	-	-
4	MM	MM	B-NP	B-NP	-	3	PMOD	-	-
5	by	by	B-PP	B-PP	-	4	NMOD	-	-
6	CD40L-transfected	CD40L-transfected	B-NP	B-NP	-	8	NMOD	-	-
7	murine	murine	I-NP	I-NP	-	8	NMOD	-	-
8	L-cells	L-cells	I-NP	I-NP	-	5	PMOD	-	-
9	or	or	B-PP	B-PP	-	3	PMOD	-	-
10	by	by	B-PP	B-PP	-	3	PMOD	-	-
11	a	a	B-NP	B-NP	-	15	NMOD	-	-
12	soluble	soluble	I-NP	I-NP	-	15	NMOD	-	-
13	CD40L	CD40L	I-NP	I-NP	-	15	NMOD	-	-
14	fusion	fusion	I-NP	I-NP	-	15	NMOD	-	-
15	protein	protein	I-NP	I-NP	-	10	PMOD	-	-
16	up-regulated	up-regulated	B-VP	B-VP	-	0	ROOT	-	-
17	their	their	B-NP	B-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	33	NMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	intercellular	intercellular	B-NP	B-NP	-	22	NMOD	-	-
21	adhesion	adhesion	I-NP	I-NP	-	22	NMOD	-	-
22	molecule-1	molecule-1	I-NP	I-NP	-	30	NMOD	-	-
23	and	and	I-NP	I-NP	-	30	NMOD	-	-
24	MHC	MHC	I-NP	I-NP	-	30	NMOD	-	-
25	class	class	I-NP	I-NP	-	30	NMOD	-	-
26	I	I	I-NP	I-NP	-	25	NMOD	-	-
27	and	and	O	O	-	28	NMOD	-	-
28	class	class	B-NP	B-NP	-	30	NMOD	-	-
29	II	II	B-NP	B-NP	-	30	NMOD	-	-
30	molecules	molecules	I-NP	I-NP	-	33	NMOD	-	-
31	and	and	O	O	-	33	NMOD	-	-
32	their	their	B-NP	B-NP	-	33	NMOD	-	-
33	secretion	secretion	I-NP	I-NP	-	16	OBJ	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	IL-6	IL-6	B-NP	B-NP	-	34	PMOD	-	-
36	,	,	O	O	-	47	P	-	-
37	IL-8	IL-8	B-NP	B-NP	-	47	NMOD	-	-
38	,	,	O	O	-	47	P	-	-
39	tumor	tumor	B-NP	B-NP	-	41	NMOD	-	-
40	necrosis	necrosis	I-NP	I-NP	-	41	NMOD	-	-
41	factor-a	factor-a	I-NP	I-NP	-	47	NMOD	-	-
42	,	,	O	O	-	47	P	-	-
43	and	and	O	O	-	44	NMOD	-	-
44	granulocyte	granulocyte	B-NP	B-NP	-	47	NMOD	-	-
45	macrophage	macrophage	B-NP	B-NP	-	47	NMOD	-	-
46	colony-stimulating	colony-stimulating	I-NP	I-NP	-	47	NMOD	-	-
47	factor	factor	I-NP	I-NP	-	34	PMOD	-	-
48	and	and	O	O	-	16	VMOD	-	-
49	also	also	B-VP	B-VP	-	50	VMOD	-	-
50	induced	induced	I-VP	I-VP	-	16	VMOD	-	-
51	a	a	B-NP	B-NP	-	53	NMOD	-	-
52	rapid	rapid	I-NP	I-NP	-	53	NMOD	-	-
53	activation	activation	I-NP	I-NP	-	50	OBJ	-	-
54	of	of	B-PP	B-PP	-	53	NMOD	-	-
55	the	the	B-NP	B-NP	-	60	NMOD	-	-
56	transcription	transcription	I-NP	I-NP	-	57	NMOD	-	-
57	factor	factor	I-NP	I-NP	-	60	NMOD	-	-
58	nuclear	nuclear	B-NP	B-NP	-	60	NMOD	-	-
59	factor	factor	I-NP	I-NP	-	60	NMOD	-	-
60	kappaB	kappaB	I-NP	I-NP	-	54	PMOD	-	-
61	.	.	O	O	-	16	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	13	VMOD	-	-
2	,	,	O	O	-	13	P	-	-
3	CD40	CD40	B-NP	B-NP	-	4	NMOD	-	-
4	ligation	ligation	I-NP	I-NP	-	13	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	a	a	B-NP	B-NP	-	12	NMOD	-	-
7	HLA-A2+	HLA-A2+	I-NP	I-NP	-	12	NMOD	-	-
8	,	,	I-NP	I-NP	-	12	P	-	-
9	MelanA/MART1+	MelanA/MART1+	I-NP	I-NP	-	12	NMOD	-	-
10	MM	MM	I-NP	I-NP	-	12	NMOD	-	-
11	cell	cell	I-NP	I-NP	-	12	NMOD	-	-
12	line	line	I-NP	I-NP	-	5	PMOD	-	-
13	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
14	its	its	B-NP	B-NP	-	15	NMOD	-	-
15	susceptibility	susceptibility	I-NP	I-NP	-	13	OBJ	-	-
16	to	to	B-PP	B-PP	-	15	NMOD	-	-
17	specific	specific	B-NP	B-NP	-	18	NMOD	-	-
18	lysis	lysis	I-NP	I-NP	-	16	PMOD	-	-
19	by	by	B-PP	B-PP	-	13	VMOD	-	-
20	a	a	B-NP	B-NP	-	25	NMOD	-	-
21	HLA-A2-restricted	HLA-A2-restricted	I-NP	I-NP	-	25	NMOD	-	-
22	,	,	I-NP	I-NP	-	25	P	-	-
23	MelanA/MART-1-specific	MelanA/MART-1-specific	I-NP	I-NP	-	25	NMOD	-	-
24	CTL	CTL	I-NP	I-NP	-	25	NMOD	-	-
25	clone	clone	I-NP	I-NP	-	19	PMOD	-	-
26	.	.	O	O	-	13	P	-	-

1	Finally	Finally	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	CD40	CD40	B-NP	B-NP	-	4	NMOD	-	-
4	ligation	ligation	I-NP	I-NP	-	5	SUB	-	-
5	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
6	growth	growth	B-NP	B-NP	-	7	NMOD	-	-
7	inhibition	inhibition	I-NP	I-NP	-	9	NMOD	-	-
8	and	and	I-NP	I-NP	-	9	NMOD	-	-
9	apoptosis	apoptosis	I-NP	I-NP	-	5	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	MM	MM	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	CD40-CD40L	CD40-CD40L	B-NP	B-NP	-	6	NMOD	-	-
6	interactions	interactions	I-NP	I-NP	-	7	SUB	-	-
7	may	may	B-VP	B-VP	-	4	SBAR	-	-
8	play	play	I-VP	I-VP	-	7	VC	-	-
9	an	an	B-NP	B-NP	-	11	NMOD	-	-
10	important	important	I-NP	I-NP	-	11	NMOD	-	-
11	role	role	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	8	VMOD	-	-
13	augmenting	augmenting	B-VP	B-VP	-	12	PMOD	-	-
14	antitumor	antitumor	B-NP	B-NP	-	15	NMOD	-	-
15	immunity	immunity	I-NP	I-NP	-	13	OBJ	-	-
16	and	and	O	O	-	3	VMOD	-	-
17	inducing	inducing	B-VP	B-VP	-	3	VMOD	-	-
18	apoptosis	apoptosis	B-NP	B-NP	-	17	OBJ	-	-
19	in	in	B-PP	B-PP	-	17	VMOD	-	-
20	some	some	B-NP	B-NP	-	24	NMOD	-	-
21	CD40-positive	CD40-positive	I-NP	I-NP	-	24	NMOD	-	-
22	immunogenic	immunogenic	I-NP	I-NP	-	24	NMOD	-	-
23	human	human	I-NP	I-NP	-	24	NMOD	-	-
24	MMs	MMs	I-NP	I-NP	-	19	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Essential	Essential	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	alveolar	alveolar	B-NP	B-NP	-	5	NMOD	-	-
5	macrophages	macrophages	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	NMOD	-	-
7	intrapulmonary	intrapulmonary	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappaB	NF-kappaB	B-NP	B-NP	-	9	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	Acute	Acute	B-NP	B-NP	-	3	NMOD	-	-
2	inflammatory	inflammatory	I-NP	I-NP	-	3	NMOD	-	-
3	injury	injury	I-NP	I-NP	-	15	SUB	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	rat	rat	B-NP	B-NP	-	6	NMOD	-	-
6	lung	lung	I-NP	I-NP	-	4	PMOD	-	-
7	induced	induced	B-VP	B-VP	-	6	NMOD	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	deposition	deposition	B-NP	B-NP	-	8	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	immunoglobulin	immunoglobulin	B-NP	B-NP	-	14	NMOD	-	-
12	G	G	I-NP	I-NP	-	14	NMOD	-	-
13	immune	immune	I-NP	I-NP	-	14	NMOD	-	-
14	complexes	complexes	I-NP	I-NP	-	10	PMOD	-	-
15	requires	requires	B-VP	B-VP	-	0	ROOT	-	-
16	expression	expression	B-NP	B-NP	-	15	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	cytokines	cytokines	B-NP	B-NP	-	20	NMOD	-	-
19	and	and	I-NP	I-NP	-	20	NMOD	-	-
20	chemokines	chemokines	I-NP	I-NP	-	17	PMOD	-	-
21	as	as	B-CONJP	B-CONJP	-	24	NMOD	-	-
22	well	well	I-CONJP	I-CONJP	-	21	DEP	-	-
23	as	as	I-CONJP	I-CONJP	-	21	DEP	-	-
24	activation	activation	B-NP	B-NP	-	15	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	34	NMOD	-	-
27	transcription	transcription	I-NP	I-NP	-	28	NMOD	-	-
28	factor	factor	I-NP	I-NP	-	34	NMOD	-	-
29	nuclear	nuclear	B-NP	B-NP	-	34	NMOD	-	-
30	factor	factor	I-NP	I-NP	-	34	NMOD	-	-
31	(	(	O	O	-	34	P	-	-
32	NF	NF	B-NP	B-NP	-	34	NMOD	-	-
33	)	)	O	O	-	34	P	-	-
34	-kappaB	-kappaB	B-NP	B-NP	-	25	PMOD	-	-
35	.	.	O	O	-	15	P	-	-

1	There	There	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	little	little	B-NP	B-NP	-	5	NMOD	-	-
4	direct	direct	I-NP	I-NP	-	5	NMOD	-	-
5	evidence	evidence	I-NP	I-NP	-	2	PRD	-	-
6	regarding	regarding	B-VP	B-VP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	role	role	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	alveolar	alveolar	B-NP	B-NP	-	11	NMOD	-	-
11	macrophages	macrophages	I-NP	I-NP	-	9	PMOD	-	-
12	in	in	B-PP	B-PP	-	8	NMOD	-	-
13	these	these	B-NP	B-NP	-	15	NMOD	-	-
14	activation	activation	I-NP	I-NP	-	15	NMOD	-	-
15	events	events	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	8	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	present	present	I-NP	I-NP	-	4	NMOD	-	-
4	studies	studies	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	8	P	-	-
6	rat	rat	B-NP	B-NP	-	7	NMOD	-	-
7	lungs	lungs	I-NP	I-NP	-	8	SUB	-	-
8	were	were	B-VP	B-VP	-	0	ROOT	-	-
9	depleted	depleted	I-VP	I-VP	-	8	VC	-	-
10	of	of	B-PP	B-PP	-	9	VMOD	-	-
11	alveolar	alveolar	B-NP	B-NP	-	12	NMOD	-	-
12	macrophages	macrophages	I-NP	I-NP	-	10	PMOD	-	-
13	by	by	B-PP	B-PP	-	9	VMOD	-	-
14	airway	airway	B-NP	B-NP	-	15	NMOD	-	-
15	instillation	instillation	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	liposome-encapsulated	liposome-encapsulated	B-NP	B-NP	-	19	NMOD	-	-
18	dichloromethylene	dichloromethylene	I-NP	I-NP	-	19	NMOD	-	-
19	diphosphonate	diphosphonate	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	procedures	procedures	I-NP	I-NP	-	14	SUB	-	-
3	,	,	O	O	-	2	P	-	-
4	which	which	B-NP	B-NP	-	2	NMOD	-	-
5	greatly	greatly	B-VP	B-VP	-	6	VMOD	-	-
6	reduced	reduced	I-VP	I-VP	-	4	SBAR	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	number	number	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	retrievable	retrievable	B-NP	B-NP	-	12	NMOD	-	-
11	alveolar	alveolar	I-NP	I-NP	-	12	NMOD	-	-
12	macrophages	macrophages	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	2	P	-	-
14	suppressed	suppressed	B-VP	B-VP	-	0	ROOT	-	-
15	activation	activation	B-NP	B-NP	-	14	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	lung	lung	B-NP	B-NP	-	18	NMOD	-	-
18	NF-kappaB	NF-kappaB	I-NP	I-NP	-	16	PMOD	-	-
19	in	in	B-PP	B-PP	-	15	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	inflammatory	inflammatory	I-NP	I-NP	-	22	NMOD	-	-
22	model	model	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	14	P	-	-

1	In	In	B-PP	B-PP	-	23	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	23	P	-	-
4	bronchoalveolar	bronchoalveolar	B-NP	B-NP	-	6	NMOD	-	-
5	lavage	lavage	I-NP	I-NP	-	6	NMOD	-	-
6	levels	levels	I-NP	I-NP	-	23	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	tumor	tumor	B-NP	B-NP	-	10	NMOD	-	-
9	necrosis	necrosis	I-NP	I-NP	-	10	NMOD	-	-
10	factor-alpha	factor-alpha	I-NP	I-NP	-	17	NMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	TNF-alpha	TNF-alpha	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	and	and	O	O	-	17	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	CXC	CXC	I-NP	I-NP	-	17	NMOD	-	-
17	chemokine	chemokine	I-NP	I-NP	-	21	NMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	macrophage	macrophage	B-NP	B-NP	-	21	NMOD	-	-
20	inflammatory	inflammatory	I-NP	I-NP	-	21	NMOD	-	-
21	protein-2	protein-2	I-NP	I-NP	-	7	PMOD	-	-
22	,	,	O	O	-	6	P	-	-
23	were	were	B-VP	B-VP	-	0	ROOT	-	-
24	substantially	substantially	I-VP	I-VP	-	23	VMOD	-	-
25	reduced	reduced	I-VP	I-VP	-	23	VC	-	-
26	.	.	O	O	-	23	P	-	-

1	In	In	B-PP	B-PP	-	16	VMOD	-	-
2	parallel	parallel	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	16	P	-	-
4	upregulation	upregulation	B-NP	B-NP	-	16	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	lung	lung	I-NP	I-NP	-	10	NMOD	-	-
8	vascular	vascular	I-NP	I-NP	-	10	NMOD	-	-
9	adhesion	adhesion	I-NP	I-NP	-	10	NMOD	-	-
10	molecule	molecule	I-NP	I-NP	-	14	NMOD	-	-
11	,	,	O	O	-	14	P	-	-
12	intercellular	intercellular	B-NP	B-NP	-	14	NMOD	-	-
13	adhesion	adhesion	I-NP	I-NP	-	14	NMOD	-	-
14	molecule-1	molecule-1	I-NP	I-NP	-	5	PMOD	-	-
15	,	,	O	O	-	4	P	-	-
16	was	was	B-VP	B-VP	-	0	ROOT	-	-
17	greatly	greatly	I-VP	I-VP	-	16	VMOD	-	-
18	reduced	reduced	I-VP	I-VP	-	16	VC	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	intrapulmonary	intrapulmonary	B-NP	B-NP	-	21	NMOD	-	-
21	instillation	instillation	I-NP	I-NP	-	19	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	phosphonate-containing	phosphonate-containing	B-NP	B-NP	-	24	NMOD	-	-
24	liposomes	liposomes	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	16	P	-	-

1	Neutrophil	Neutrophil	B-NP	B-NP	-	2	NMOD	-	-
2	accumulation	accumulation	I-NP	I-NP	-	4	NMOD	-	-
3	and	and	I-NP	I-NP	-	4	NMOD	-	-
4	development	development	I-NP	I-NP	-	8	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	lung	lung	B-NP	B-NP	-	7	NMOD	-	-
7	injury	injury	I-NP	I-NP	-	5	PMOD	-	-
8	were	were	B-VP	B-VP	-	0	ROOT	-	-
9	also	also	I-VP	I-VP	-	8	VMOD	-	-
10	substantially	substantially	I-VP	I-VP	-	8	VMOD	-	-
11	diminished	diminished	I-VP	I-VP	-	8	VC	-	-
12	.	.	O	O	-	8	P	-	-

1	Lung	Lung	B-NP	B-NP	-	2	NMOD	-	-
2	instillation	instillation	I-NP	I-NP	-	9	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	TNF-alpha	TNF-alpha	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	alveolar	alveolar	B-NP	B-NP	-	8	NMOD	-	-
7	macrophage-depleted	macrophage-depleted	I-NP	I-NP	-	8	NMOD	-	-
8	rats	rats	I-NP	I-NP	-	5	PMOD	-	-
9	restored	restored	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	NF-kappaB	NF-kappaB	I-NP	I-NP	-	13	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	13	NMOD	-	-
13	response	response	I-NP	I-NP	-	9	OBJ	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	whole	whole	B-NP	B-NP	-	16	NMOD	-	-
16	lung	lung	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	9	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	,	,	O	O	-	15	P	-	-
6	in	in	B-PP	B-PP	-	15	VMOD	-	-
7	this	this	B-NP	B-NP	-	9	NMOD	-	-
8	inflammatory	inflammatory	I-NP	I-NP	-	9	NMOD	-	-
9	model	model	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	15	P	-	-
11	initial	initial	B-NP	B-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	15	SUB	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	NF-kappaB	NF-kappaB	B-NP	B-NP	-	13	PMOD	-	-
15	occurs	occurs	B-VP	B-VP	-	4	SBAR	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	alveolar	alveolar	B-NP	B-NP	-	18	NMOD	-	-
18	macrophages	macrophages	I-NP	I-NP	-	22	NMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	ensuing	ensuing	I-NP	I-NP	-	22	NMOD	-	-
22	production	production	I-NP	I-NP	-	16	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	TNF-alpha	TNF-alpha	B-NP	B-NP	-	23	PMOD	-	-
25	may	may	B-VP	B-VP	-	4	SBAR	-	-
26	propagate	propagate	I-VP	I-VP	-	25	VC	-	-
27	NF-kappaB	NF-kappaB	B-NP	B-NP	-	28	NMOD	-	-
28	activation	activation	I-NP	I-NP	-	26	OBJ	-	-
29	to	to	B-PP	B-PP	-	28	NMOD	-	-
30	other	other	B-NP	B-NP	-	32	NMOD	-	-
31	cell	cell	I-NP	I-NP	-	32	NMOD	-	-
32	types	types	I-NP	I-NP	-	29	PMOD	-	-
33	in	in	B-PP	B-PP	-	26	VMOD	-	-
34	the	the	B-NP	B-NP	-	35	NMOD	-	-
35	lung	lung	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	3	P	-	-

1	Role	Role	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	cellular	cellular	B-NP	B-NP	-	8	NMOD	-	-
4	tumor	tumor	I-NP	I-NP	-	8	NMOD	-	-
5	necrosis	necrosis	I-NP	I-NP	-	8	NMOD	-	-
6	factor	factor	I-NP	I-NP	-	8	NMOD	-	-
7	receptor-associated	receptor-associated	I-NP	I-NP	-	8	NMOD	-	-
8	factors	factors	I-NP	I-NP	-	2	PMOD	-	-
9	in	in	B-PP	B-PP	-	1	NMOD	-	-
10	NF-kappaB	NF-kappaB	B-NP	B-NP	-	11	NMOD	-	-
11	activation	activation	B-NP	B-NP	-	14	NMOD	-	-
12	and	and	O	O	-	14	NMOD	-	-
13	lymphocyte	lymphocyte	B-NP	B-NP	-	14	NMOD	-	-
14	transformation	transformation	I-NP	I-NP	-	9	PMOD	-	-
15	by	by	B-PP	B-PP	-	1	NMOD	-	-
16	herpesvirus	herpesvirus	B-NP	B-NP	-	18	NMOD	-	-
17	Saimiri	Saimiri	I-NP	I-NP	-	18	NMOD	-	-
18	STP	STP	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	STP	STP	I-NP	I-NP	-	3	NMOD	-	-
3	oncoproteins	oncoproteins	I-NP	I-NP	-	20	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	herpesvirus	herpesvirus	I-NP	I-NP	-	7	NMOD	-	-
7	saimiri	saimiri	I-NP	I-NP	-	13	NMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	HVS	HVS	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	subgroup	subgroup	B-NP	B-NP	-	13	NMOD	-	-
12	A	A	I-NP	I-NP	-	13	NMOD	-	-
13	strain	strain	I-NP	I-NP	-	18	NMOD	-	-
14	<num>	<num>	I-NP	I-NP	-	13	NMOD	-	-
15	and	and	O	O	-	18	NMOD	-	-
16	subgroup	subgroup	B-NP	B-NP	-	18	NMOD	-	-
17	C	C	I-NP	I-NP	-	18	NMOD	-	-
18	strain	strain	I-NP	I-NP	-	4	PMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	18	NMOD	-	-
20	are	are	B-VP	B-VP	-	0	ROOT	-	-
21	now	now	I-VP	I-VP	-	20	VMOD	-	-
22	found	found	I-VP	I-VP	-	20	VC	-	-
23	to	to	I-VP	I-VP	-	24	VMOD	-	-
24	be	be	I-VP	I-VP	-	22	VMOD	-	-
25	stably	stably	I-VP	I-VP	-	24	VMOD	-	-
26	associated	associated	I-VP	I-VP	-	24	VC	-	-
27	with	with	B-PP	B-PP	-	26	VMOD	-	-
28	tumor	tumor	B-NP	B-NP	-	32	NMOD	-	-
29	necrosis	necrosis	I-NP	I-NP	-	32	NMOD	-	-
30	factor	factor	I-NP	I-NP	-	32	NMOD	-	-
31	receptor-associated	receptor-associated	I-NP	I-NP	-	32	NMOD	-	-
32	factor	factor	I-NP	I-NP	-	27	PMOD	-	-
33	(	(	O	O	-	34	P	-	-
34	TRAF	TRAF	B-NP	B-NP	-	32	NMOD	-	-
35	)	)	O	O	-	34	P	-	-
36	<num>	<num>	B-NP	B-NP	-	41	NMOD	-	-
37	,	,	I-NP	I-NP	-	41	P	-	-
38	<num>	<num>	I-NP	I-NP	-	41	NMOD	-	-
39	,	,	O	O	-	41	P	-	-
40	or	or	O	O	-	41	NMOD	-	-
41	<num>	<num>	B-NP	B-NP	-	32	NMOD	-	-
42	.	.	O	O	-	20	P	-	-

1	Mutational	Mutational	B-NP	B-NP	-	2	NMOD	-	-
2	analyses	analyses	I-NP	I-NP	-	3	SUB	-	-
3	identified	identified	B-VP	B-VP	-	0	ROOT	-	-
4	residues	residues	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	PXQXT/S	PXQXT/S	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	4	NMOD	-	-
8	STP-A11	STP-A11	B-NP	B-NP	-	7	PMOD	-	-
9	as	as	B-PP	B-PP	-	3	VMOD	-	-
10	critical	critical	B-ADJP	B-ADJP	-	9	PMOD	-	-
11	for	for	B-PP	B-PP	-	10	AMOD	-	-
12	TRAF	TRAF	B-NP	B-NP	-	13	NMOD	-	-
13	association	association	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	10	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	10	P	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	somewhat	somewhat	I-NP	I-NP	-	6	AMOD	-	-
6	divergent	divergent	I-NP	I-NP	-	7	NMOD	-	-
7	region	region	I-NP	I-NP	-	10	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	STP-C488	STP-C488	B-NP	B-NP	-	8	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	critical	critical	B-ADJP	B-ADJP	-	10	PRD	-	-
12	for	for	B-PP	B-PP	-	11	AMOD	-	-
13	TRAF	TRAF	B-NP	B-NP	-	14	NMOD	-	-
14	association	association	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	10	P	-	-

1	Mutational	Mutational	B-NP	B-NP	-	2	NMOD	-	-
2	analysis	analysis	I-NP	I-NP	-	4	SUB	-	-
3	also	also	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	STP-C488	STP-C488	B-NP	B-NP	-	7	SUB	-	-
7	induced	induced	B-VP	B-VP	-	5	SBAR	-	-
8	NF-kappaB	NF-kappaB	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	7	OBJ	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	was	was	B-VP	B-VP	-	10	SBAR	-	-
12	correlated	correlated	I-VP	I-VP	-	11	VC	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	its	its	B-NP	B-NP	-	15	NMOD	-	-
15	ability	ability	I-NP	I-NP	-	13	PMOD	-	-
16	to	to	B-VP	B-VP	-	17	VMOD	-	-
17	associate	associate	I-VP	I-VP	-	15	NMOD	-	-
18	with	with	B-PP	B-PP	-	17	VMOD	-	-
19	TRAFs	TRAFs	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	HVS	HVS	I-NP	I-NP	-	4	NMOD	-	-
3	STP-C488	STP-C488	I-NP	I-NP	-	4	NMOD	-	-
4	P10	P10	I-NP	I-NP	-	8	NMOD	-	-
5	--	--	O	O	-	8	P	-	-
6	>	>	O	O	-	8	NMOD	-	-
7	R	R	B-NP	B-NP	-	8	NMOD	-	-
8	mutant	mutant	I-NP	I-NP	-	9	SUB	-	-
9	was	was	B-VP	B-VP	-	0	ROOT	-	-
10	deficient	deficient	B-ADJP	B-ADJP	-	9	PRD	-	-
11	in	in	B-PP	B-PP	-	10	AMOD	-	-
12	human	human	B-NP	B-NP	-	14	NMOD	-	-
13	T-lymphocyte	T-lymphocyte	I-NP	I-NP	-	14	NMOD	-	-
14	transformation	transformation	I-NP	I-NP	-	11	PMOD	-	-
15	to	to	B-PP	B-PP	-	14	NMOD	-	-
16	interleukin-2-independent	interleukin-2-independent	B-NP	B-NP	-	17	NMOD	-	-
17	growth	growth	I-NP	I-NP	-	15	PMOD	-	-
18	but	but	O	O	-	9	VMOD	-	-
19	showed	showed	B-VP	B-VP	-	9	VMOD	-	-
20	wild-type	wild-type	B-NP	B-NP	-	21	NMOD	-	-
21	phenotype	phenotype	I-NP	I-NP	-	19	OBJ	-	-
22	for	for	B-PP	B-PP	-	21	NMOD	-	-
23	marmoset	marmoset	B-NP	B-NP	-	25	NMOD	-	-
24	T-lymphocyte	T-lymphocyte	I-NP	I-NP	-	25	NMOD	-	-
25	transformation	transformation	I-NP	I-NP	-	22	PMOD	-	-
26	in	in	B-ADVP	B-ADVP	-	19	VMOD	-	-
27	vitro	vitro	I-ADVP	I-ADVP	-	26	AMOD	-	-
28	and	and	O	O	-	26	AMOD	-	-
29	in	in	B-ADVP	B-ADVP	-	26	AMOD	-	-
30	vivo	vivo	I-ADVP	I-ADVP	-	29	AMOD	-	-
31	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	STP-C488	STP-C488	I-NP	I-NP	-	3	NMOD	-	-
3	P10	P10	I-NP	I-NP	-	7	NMOD	-	-
4	--	--	O	O	-	7	P	-	-
5	>	>	O	O	-	7	NMOD	-	-
6	R	R	B-NP	B-NP	-	7	NMOD	-	-
7	mutant	mutant	I-NP	I-NP	-	8	SUB	-	-
8	was	was	B-VP	B-VP	-	20	VMOD	-	-
9	also	also	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	defective	defective	B-ADJP	B-ADJP	-	8	PRD	-	-
11	in	in	B-PP	B-PP	-	10	AMOD	-	-
12	Rat-1	Rat-1	B-NP	B-NP	-	14	NMOD	-	-
13	fibroblast	fibroblast	I-NP	I-NP	-	14	NMOD	-	-
14	transformation	transformation	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	20	P	-	-
16	and	and	O	O	-	20	VMOD	-	-
17	fibroblast	fibroblast	B-NP	B-NP	-	19	NMOD	-	-
18	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
19	transformation	transformation	I-NP	I-NP	-	20	SUB	-	-
20	was	was	B-VP	B-VP	-	0	ROOT	-	-
21	blocked	blocked	I-VP	I-VP	-	20	VC	-	-
22	by	by	B-PP	B-PP	-	21	VMOD	-	-
23	a	a	B-NP	B-NP	-	26	NMOD	-	-
24	TRAF2	TRAF2	I-NP	I-NP	-	26	NMOD	-	-
25	dominant-negative	dominant-negative	I-NP	I-NP	-	26	NMOD	-	-
26	mutant	mutant	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	20	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	implicate	implicate	B-VP	B-VP	-	0	ROOT	-	-
4	TRAFs	TRAFs	B-NP	B-NP	-	3	OBJ	-	-
5	in	in	B-PP	B-PP	-	3	VMOD	-	-
6	STP-C488-mediated	STP-C488-mediated	B-NP	B-NP	-	7	NMOD	-	-
7	transformation	transformation	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	human	human	B-NP	B-NP	-	10	NMOD	-	-
10	lymphocytes	lymphocytes	I-NP	I-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	rodent	rodent	B-NP	B-NP	-	13	NMOD	-	-
13	fibroblasts	fibroblasts	I-NP	I-NP	-	8	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	Other	Other	B-NP	B-NP	-	2	NMOD	-	-
2	factors	factors	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	implicated	implicated	I-VP	I-VP	-	3	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	immortalization	immortalization	B-NP	B-NP	-	5	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	common	common	B-NP	B-NP	-	11	NMOD	-	-
9	marmoset	marmoset	I-NP	I-NP	-	11	NMOD	-	-
10	T	T	I-NP	I-NP	-	11	NMOD	-	-
11	lymphocytes	lymphocytes	I-NP	I-NP	-	7	PMOD	-	-
12	and	and	O	O	-	3	VMOD	-	-
13	may	may	B-VP	B-VP	-	3	VMOD	-	-
14	also	also	I-VP	I-VP	-	13	VMOD	-	-
15	be	be	I-VP	I-VP	-	13	VC	-	-
16	critical	critical	B-ADJP	B-ADJP	-	15	PRD	-	-
17	in	in	B-PP	B-PP	-	15	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	transformation	transformation	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	human	human	B-NP	B-NP	-	22	NMOD	-	-
22	lymphocytes	lymphocytes	I-NP	I-NP	-	25	NMOD	-	-
23	and	and	O	O	-	25	NMOD	-	-
24	rodent	rodent	B-NP	B-NP	-	25	NMOD	-	-
25	fibroblasts	fibroblasts	I-NP	I-NP	-	20	PMOD	-	-
26	.	.	O	O	-	3	P	-	-

1	Regulation	Regulation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Fas	Fas	B-NP	B-NP	-	5	NMOD	-	-
4	ligand	ligand	I-NP	I-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	cell	cell	B-NP	B-NP	-	8	NMOD	-	-
8	death	death	I-NP	I-NP	-	2	PMOD	-	-
9	by	by	B-PP	B-PP	-	1	NMOD	-	-
10	apoptosis-linked	apoptosis-linked	B-NP	B-NP	-	11	NMOD	-	-
11	gene	gene	I-NP	I-NP	-	9	PMOD	-	-
12	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
13	.	.	O	O	-	1	P	-	-

1	Programmed	Programmed	B-NP	B-NP	-	3	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	3	NMOD	-	-
3	death	death	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	process	process	I-NP	I-NP	-	4	PRD	-	-
7	required	required	B-VP	B-VP	-	6	NMOD	-	-
8	for	for	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	normal	normal	I-NP	I-NP	-	11	NMOD	-	-
11	development	development	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	an	an	B-NP	B-NP	-	14	NMOD	-	-
14	organism	organism	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	One	One	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	best	best	I-NP	I-NP	-	7	NMOD	-	-
5	understood	understood	I-NP	I-NP	-	7	NMOD	-	-
6	apoptotic	apoptotic	I-NP	I-NP	-	7	NMOD	-	-
7	pathways	pathways	I-NP	I-NP	-	2	PMOD	-	-
8	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	T	T	B-NP	B-NP	-	11	NMOD	-	-
11	lymphocytes	lymphocytes	I-NP	I-NP	-	9	PMOD	-	-
12	and	and	O	O	-	8	VMOD	-	-
13	is	is	B-VP	B-VP	-	8	VMOD	-	-
14	mediated	mediated	I-VP	I-VP	-	13	VC	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	Fas/Fas	Fas/Fas	B-NP	B-NP	-	17	NMOD	-	-
17	ligand	ligand	I-NP	I-NP	-	21	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	FasL	FasL	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	interaction	interaction	B-NP	B-NP	-	15	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	During	During	B-PP	B-PP	-	12	VMOD	-	-
2	studies	studies	B-NP	B-NP	-	1	PMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	apoptosis	apoptosis	B-NP	B-NP	-	3	PMOD	-	-
5	induced	induced	B-VP	B-VP	-	4	NMOD	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	T	T	B-NP	B-NP	-	9	NMOD	-	-
8	cell-receptor	cell-receptor	I-NP	I-NP	-	9	NMOD	-	-
9	engagement	engagement	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	12	P	-	-
11	we	we	B-NP	B-NP	-	12	SUB	-	-
12	identified	identified	B-VP	B-VP	-	0	ROOT	-	-
13	ALG-4F	ALG-4F	B-NP	B-NP	-	17	NMOD	-	-
14	,	,	O	O	-	17	P	-	-
15	a	a	B-NP	B-NP	-	17	NMOD	-	-
16	truncated	truncated	I-NP	I-NP	-	17	NMOD	-	-
17	transcript	transcript	I-NP	I-NP	-	12	OBJ	-	-
18	that	that	B-NP	B-NP	-	17	NMOD	-	-
19	prevents	prevents	B-VP	B-VP	-	18	SBAR	-	-
20	T	T	B-NP	B-NP	-	23	NMOD	-	-
21	cell-receptor-induced	cell-receptor-induced	I-NP	I-NP	-	23	NMOD	-	-
22	FasL	FasL	I-NP	I-NP	-	23	NMOD	-	-
23	upregulation	upregulation	I-NP	I-NP	-	26	NMOD	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	cell	cell	B-NP	B-NP	-	26	NMOD	-	-
26	death	death	I-NP	I-NP	-	19	OBJ	-	-
27	.	.	O	O	-	12	P	-	-

1	Overexpression	Overexpression	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	full-length	full-length	B-NP	B-NP	-	4	NMOD	-	-
4	ALG-4	ALG-4	I-NP	I-NP	-	2	PMOD	-	-
5	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
6	transcription	transcription	B-NP	B-NP	-	5	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	FasL	FasL	B-NP	B-NP	-	7	PMOD	-	-
9	and	and	O	O	-	5	VMOD	-	-
10	,	,	O	O	-	5	P	-	-
11	consequently	consequently	B-ADVP	B-ADVP	-	5	VMOD	-	-
12	,	,	O	O	-	5	P	-	-
13	apoptosis	apoptosis	B-NP	B-NP	-	5	OBJ	-	-
14	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	ALG-4	ALG-4	B-NP	B-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	4	SBAR	-	-
7	necessary	necessary	B-ADJP	B-ADJP	-	9	AMOD	-	-
8	and	and	I-ADJP	I-ADJP	-	9	AMOD	-	-
9	sufficient	sufficient	I-ADJP	I-ADJP	-	6	PRD	-	-
10	for	for	B-PP	B-PP	-	9	AMOD	-	-
11	FasL	FasL	B-NP	B-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	3	P	-	-

1	Fas/FasL	Fas/FasL	B-NP	B-NP	-	2	NMOD	-	-
2	interaction	interaction	I-NP	I-NP	-	3	SUB	-	-
3	initiates	initiates	B-VP	B-VP	-	14	VMOD	-	-
4	cell	cell	B-NP	B-NP	-	5	NMOD	-	-
5	death	death	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	many	many	B-NP	B-NP	-	9	NMOD	-	-
8	other	other	I-NP	I-NP	-	9	NMOD	-	-
9	systems	systems	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	14	P	-	-
11	and	and	O	O	-	14	VMOD	-	-
12	its	its	B-NP	B-NP	-	13	NMOD	-	-
13	dysregulation	dysregulation	I-NP	I-NP	-	14	SUB	-	-
14	is	is	B-VP	B-VP	-	0	ROOT	-	-
15	a	a	B-NP	B-NP	-	16	NMOD	-	-
16	mechanism	mechanism	I-NP	I-NP	-	14	PRD	-	-
17	by	by	B-PP	B-PP	-	16	NMOD	-	-
18	which	which	B-NP	B-NP	-	17	PMOD	-	-
19	several	several	B-NP	B-NP	-	21	NMOD	-	-
20	pathologic	pathologic	I-NP	I-NP	-	21	NMOD	-	-
21	conditions	conditions	I-NP	I-NP	-	17	PMOD	-	-
22	arise	arise	B-VP	B-VP	-	17	SBAR	-	-
23	.	.	O	O	-	14	P	-	-

1	Understanding	Understanding	B-VP	B-VP	-	8	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	molecular	molecular	I-NP	I-NP	-	4	NMOD	-	-
4	mechanisms	mechanisms	I-NP	I-NP	-	1	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	FasL	FasL	B-NP	B-NP	-	7	NMOD	-	-
7	regulation	regulation	I-NP	I-NP	-	5	PMOD	-	-
8	could	could	B-VP	B-VP	-	0	ROOT	-	-
9	be	be	I-VP	I-VP	-	8	VC	-	-
10	very	very	B-ADJP	B-ADJP	-	11	AMOD	-	-
11	useful	useful	I-ADJP	I-ADJP	-	9	PRD	-	-
12	in	in	B-PP	B-PP	-	11	AMOD	-	-
13	elucidating	elucidating	B-VP	B-VP	-	12	PMOD	-	-
14	how	how	B-ADVP	B-ADVP	-	13	VMOD	-	-
15	these	these	B-NP	B-NP	-	16	NMOD	-	-
16	diseases	diseases	I-NP	I-NP	-	17	SUB	-	-
17	develop	develop	B-VP	B-VP	-	14	SBAR	-	-
18	and	and	O	O	-	17	VMOD	-	-
19	in	in	B-PP	B-PP	-	17	VMOD	-	-
20	identifying	identifying	B-VP	B-VP	-	19	PMOD	-	-
21	potential	potential	B-NP	B-NP	-	23	NMOD	-	-
22	therapeutic	therapeutic	I-NP	I-NP	-	23	NMOD	-	-
23	targets	targets	I-NP	I-NP	-	20	OBJ	-	-
24	.	.	O	O	-	8	P	-	-

1	High	High	B-NP	B-NP	-	5	NMOD	-	-
2	molecular	molecular	I-NP	I-NP	-	5	NMOD	-	-
3	weight	weight	I-NP	I-NP	-	5	NMOD	-	-
4	dextran	dextran	I-NP	I-NP	-	5	NMOD	-	-
5	sulfate	sulfate	I-NP	I-NP	-	6	SUB	-	-
6	increases	increases	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	activity	activity	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappaB-regulated	NF-kappaB-regulated	B-NP	B-NP	-	11	NMOD	-	-
11	promoter	promoter	I-NP	I-NP	-	9	PMOD	-	-
12	in	in	B-PP	B-PP	-	6	VMOD	-	-
13	monocyte-derived	monocyte-derived	B-NP	B-NP	-	14	NMOD	-	-
14	macrophages	macrophages	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	6	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	known	known	I-VP	I-VP	-	2	VC	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	sulfated	sulfated	B-NP	B-NP	-	6	NMOD	-	-
6	polysaccharides	polysaccharides	I-NP	I-NP	-	7	SUB	-	-
7	can	can	B-VP	B-VP	-	4	SBAR	-	-
8	mimic	mimic	I-VP	I-VP	-	7	VC	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	action	action	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	common	common	B-NP	B-NP	-	14	NMOD	-	-
13	T-cell	T-cell	I-NP	I-NP	-	14	NMOD	-	-
14	mitogens	mitogens	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	investigate	investigate	I-VP	I-VP	-	22	VMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	molecular	molecular	I-NP	I-NP	-	5	NMOD	-	-
5	basis	basis	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	mitogenic	mitogenic	I-NP	I-NP	-	9	NMOD	-	-
9	effect	effect	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	high	high	B-NP	B-NP	-	15	NMOD	-	-
12	molecular	molecular	I-NP	I-NP	-	15	NMOD	-	-
13	weight	weight	I-NP	I-NP	-	15	NMOD	-	-
14	dextran	dextran	I-NP	I-NP	-	15	NMOD	-	-
15	sulfate	sulfate	I-NP	I-NP	-	10	PMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	HMDS	HMDS	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	,	,	O	O	-	22	P	-	-
20	monocyte-derived	monocyte-derived	B-NP	B-NP	-	21	NMOD	-	-
21	macrophages	macrophages	I-NP	I-NP	-	22	SUB	-	-
22	were	were	B-VP	B-VP	-	0	ROOT	-	-
23	transfected	transfected	I-VP	I-VP	-	22	VC	-	-
24	with	with	B-PP	B-PP	-	23	VMOD	-	-
25	recombinant	recombinant	B-NP	B-NP	-	26	NMOD	-	-
26	plasmid	plasmid	I-NP	I-NP	-	24	PMOD	-	-
27	containing	containing	B-VP	B-VP	-	26	NMOD	-	-
28	chloramphenicol	chloramphenicol	B-NP	B-NP	-	35	NMOD	-	-
29	acetyl	acetyl	I-NP	I-NP	-	35	NMOD	-	-
30	transferase	transferase	I-NP	I-NP	-	35	NMOD	-	-
31	(	(	O	O	-	35	P	-	-
32	CAT	CAT	B-NP	B-NP	-	35	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	reporter	reporter	B-NP	B-NP	-	35	NMOD	-	-
35	gene	gene	I-NP	I-NP	-	27	OBJ	-	-
36	under	under	B-PP	B-PP	-	27	VMOD	-	-
37	the	the	B-NP	B-NP	-	38	NMOD	-	-
38	control	control	I-NP	I-NP	-	36	PMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	the	the	B-NP	B-NP	-	48	NMOD	-	-
41	HIV-1	HIV-1	I-NP	I-NP	-	48	NMOD	-	-
42	long	long	I-NP	I-NP	-	48	NMOD	-	-
43	terminal	terminal	I-NP	I-NP	-	48	NMOD	-	-
44	repeat	repeat	I-NP	I-NP	-	48	NMOD	-	-
45	(	(	O	O	-	46	P	-	-
46	LTR	LTR	B-NP	B-NP	-	44	NMOD	-	-
47	)	)	O	O	-	46	P	-	-
48	promoter	promoter	B-NP	B-NP	-	39	PMOD	-	-
49	,	,	O	O	-	48	P	-	-
50	which	which	B-NP	B-NP	-	48	NMOD	-	-
51	is	is	B-VP	B-VP	-	50	SBAR	-	-
52	regulated	regulated	I-VP	I-VP	-	51	VC	-	-
53	by	by	B-PP	B-PP	-	52	VMOD	-	-
54	transcription	transcription	B-NP	B-NP	-	56	NMOD	-	-
55	factor	factor	I-NP	I-NP	-	56	NMOD	-	-
56	NF-kappaB	NF-kappaB	I-NP	I-NP	-	53	PMOD	-	-
57	.	.	O	O	-	22	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	observed	observed	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	HMDS	HMDS	B-NP	B-NP	-	14	SUB	-	-
5	,	,	O	O	-	14	P	-	-
6	similar	similar	B-ADJP	B-ADJP	-	14	SUB	-	-
7	to	to	B-PP	B-PP	-	6	AMOD	-	-
8	bacterial	bacterial	B-NP	B-NP	-	7	PMOD	-	-
9	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	8	NMOD	-	-
10	(	(	O	O	-	11	P	-	-
11	LPS	LPS	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	,	,	O	O	-	9	P	-	-
14	increases	increases	B-VP	B-VP	-	3	SBAR	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	14	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	CAT	CAT	B-NP	B-NP	-	20	NMOD	-	-
19	reporter	reporter	I-NP	I-NP	-	20	NMOD	-	-
20	gene	gene	I-NP	I-NP	-	17	PMOD	-	-
21	suggesting	suggesting	B-VP	B-VP	-	20	NMOD	-	-
22	increased	increased	B-NP	B-NP	-	23	NMOD	-	-
23	activity	activity	I-NP	I-NP	-	21	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	NF-kappaB	NF-kappaB	B-NP	B-NP	-	24	PMOD	-	-
26	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NF-kappaB	NF-kappaB	B-NP	B-NP	-	3	PMOD	-	-
5	correlated	correlated	B-VP	B-VP	-	0	ROOT	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	increased	increased	I-NP	I-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	B7.1	B7.1	B-NP	B-NP	-	12	NMOD	-	-
12	molecules	molecules	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	5	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	postulated	postulated	I-VP	I-VP	-	2	VC	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	this	this	B-NP	B-NP	-	7	NMOD	-	-
6	NF-kappaB-regulated	NF-kappaB-regulated	I-NP	I-NP	-	7	NMOD	-	-
7	promoter	promoter	I-NP	I-NP	-	8	SUB	-	-
8	might	might	B-VP	B-VP	-	4	SBAR	-	-
9	play	play	I-VP	I-VP	-	8	VC	-	-
10	a	a	B-NP	B-NP	-	11	NMOD	-	-
11	role	role	I-NP	I-NP	-	9	OBJ	-	-
12	in	in	B-PP	B-PP	-	9	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	activation	activation	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	accessory	accessory	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
19	as	as	B-CONJP	B-CONJP	-	12	PMOD	-	-
20	well	well	I-CONJP	I-CONJP	-	19	DEP	-	-
21	as	as	I-CONJP	I-CONJP	-	19	DEP	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	rate	rate	I-NP	I-NP	-	21	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	replication	replication	B-NP	B-NP	-	24	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	HIV-1	HIV-1	B-NP	B-NP	-	26	PMOD	-	-
28	in	in	B-PP	B-PP	-	25	NMOD	-	-
29	monocyte-derived	monocyte-derived	B-NP	B-NP	-	30	NMOD	-	-
30	macrophages	macrophages	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	2	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
4	B	B	I-NP	I-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	2	PMOD	-	-
6	in	in	B-PP	B-PP	-	1	NMOD	-	-
7	human	human	B-NP	B-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	lymphocytes	lymphocytes	I-NP	I-NP	-	6	PMOD	-	-
10	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
11	caspase-dependent	caspase-dependent	B-NP	B-NP	-	12	NMOD	-	-
12	apoptosis	apoptosis	I-NP	I-NP	-	10	OBJ	-	-
13	without	without	B-PP	B-PP	-	10	VMOD	-	-
14	detectable	detectable	B-NP	B-NP	-	15	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	caspase-1	caspase-1	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	O	O	-	19	NMOD	-	-
19	-3	-3	B-NP	B-NP	-	16	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	NF-kappa	NF-kappa	B-NP	B-NP	-	2	NMOD	-	-
2	B	B	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	involved	involved	I-VP	I-VP	-	3	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	transcriptional	transcriptional	I-NP	I-NP	-	8	NMOD	-	-
8	control	control	I-NP	I-NP	-	5	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	various	various	B-NP	B-NP	-	11	NMOD	-	-
11	genes	genes	I-NP	I-NP	-	9	PMOD	-	-
12	that	that	B-NP	B-NP	-	11	NMOD	-	-
13	act	act	B-VP	B-VP	-	12	SBAR	-	-
14	as	as	B-PP	B-PP	-	13	VMOD	-	-
15	extrinsic	extrinsic	B-NP	B-NP	-	19	NMOD	-	-
16	and	and	I-NP	I-NP	-	19	NMOD	-	-
17	intrinsic	intrinsic	I-NP	I-NP	-	19	NMOD	-	-
18	survival	survival	I-NP	I-NP	-	19	NMOD	-	-
19	factors	factors	I-NP	I-NP	-	14	PMOD	-	-
20	for	for	B-PP	B-PP	-	19	NMOD	-	-
21	T	T	B-NP	B-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	suppression	suppression	B-NP	B-NP	-	31	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	NF-kappa	NF-kappa	B-NP	B-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	activity	activity	I-NP	I-NP	-	6	PMOD	-	-
10	with	with	B-PP	B-PP	-	5	NMOD	-	-
11	cell-permeable	cell-permeable	B-NP	B-NP	-	13	NMOD	-	-
12	SN50	SN50	I-NP	I-NP	-	13	NMOD	-	-
13	peptide	peptide	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	which	which	B-NP	B-NP	-	13	NMOD	-	-
16	masks	masks	B-VP	B-VP	-	15	SBAR	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	nuclear	nuclear	I-NP	I-NP	-	20	NMOD	-	-
19	localization	localization	I-NP	I-NP	-	20	NMOD	-	-
20	sequence	sequence	I-NP	I-NP	-	16	OBJ	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	NF-kappa	NF-kappa	B-NP	B-NP	-	24	NMOD	-	-
23	B1	B1	I-NP	I-NP	-	24	NMOD	-	-
24	dimers	dimers	I-NP	I-NP	-	21	PMOD	-	-
25	and	and	O	O	-	16	VMOD	-	-
26	prevents	prevents	B-VP	B-VP	-	16	VMOD	-	-
27	their	their	B-NP	B-NP	-	29	NMOD	-	-
28	nuclear	nuclear	I-NP	I-NP	-	29	NMOD	-	-
29	localization	localization	I-NP	I-NP	-	26	OBJ	-	-
30	,	,	O	O	-	13	P	-	-
31	induces	induces	B-VP	B-VP	-	4	SBAR	-	-
32	apoptosis	apoptosis	B-NP	B-NP	-	31	OBJ	-	-
33	in	in	B-PP	B-PP	-	31	VMOD	-	-
34	resting	resting	B-NP	B-NP	-	37	NMOD	-	-
35	normal	normal	I-NP	I-NP	-	37	NMOD	-	-
36	human	human	I-NP	I-NP	-	37	NMOD	-	-
37	PBL	PBL	I-NP	I-NP	-	33	PMOD	-	-
38	.	.	O	O	-	3	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
4	B	B	I-NP	I-NP	-	2	PMOD	-	-
5	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	externalization	externalization	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	phosphatidylserine	phosphatidylserine	B-NP	B-NP	-	9	PMOD	-	-
11	,	,	O	O	-	19	P	-	-
12	induction	induction	B-NP	B-NP	-	19	NMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	DNA	DNA	B-NP	B-NP	-	15	NMOD	-	-
15	breaks	breaks	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	19	P	-	-
17	and	and	O	O	-	19	NMOD	-	-
18	morphological	morphological	B-NP	B-NP	-	19	NMOD	-	-
19	changes	changes	I-NP	I-NP	-	6	PMOD	-	-
20	consistent	consistent	B-ADJP	B-ADJP	-	19	NMOD	-	-
21	with	with	B-PP	B-PP	-	20	AMOD	-	-
22	apoptosis	apoptosis	B-NP	B-NP	-	21	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	DNA	DNA	B-NP	B-NP	-	2	NMOD	-	-
2	fragmentation	fragmentation	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	efficiently	efficiently	I-VP	I-VP	-	3	VMOD	-	-
5	blocked	blocked	I-VP	I-VP	-	3	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	caspase	caspase	I-NP	I-NP	-	10	NMOD	-	-
9	inhibitor	inhibitor	I-NP	I-NP	-	10	NMOD	-	-
10	Z-VAD-fmk	Z-VAD-fmk	I-NP	I-NP	-	6	PMOD	-	-
11	and	and	O	O	-	5	VMOD	-	-
12	partially	partially	B-VP	B-VP	-	13	VMOD	-	-
13	blocked	blocked	I-VP	I-VP	-	5	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	Ac-DEVD-fmk	Ac-DEVD-fmk	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	5	P	-	-
17	suggesting	suggesting	B-VP	B-VP	-	5	VMOD	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	SN50-mediated	SN50-mediated	B-NP	B-NP	-	20	NMOD	-	-
20	apoptosis	apoptosis	I-NP	I-NP	-	21	SUB	-	-
21	is	is	B-VP	B-VP	-	18	SBAR	-	-
22	caspase-dependent	caspase-dependent	B-ADJP	B-ADJP	-	21	PRD	-	-
23	.	.	O	O	-	3	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	39	VMOD	-	-
2	,	,	O	O	-	39	P	-	-
3	apoptosis	apoptosis	B-NP	B-NP	-	8	NMOD	-	-
4	induced	induced	B-VP	B-VP	-	3	NMOD	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	8	NMOD	-	-
7	B	B	I-NP	I-NP	-	8	NMOD	-	-
8	suppression	suppression	I-NP	I-NP	-	39	SUB	-	-
9	,	,	O	O	-	8	P	-	-
10	in	in	B-PP	B-PP	-	8	NMOD	-	-
11	contrast	contrast	B-NP	B-NP	-	10	PMOD	-	-
12	to	to	B-PP	B-PP	-	10	PMOD	-	-
13	that	that	B-NP	B-NP	-	10	PMOD	-	-
14	induced	induced	B-VP	B-VP	-	13	NMOD	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	TPEN	TPEN	B-NP	B-NP	-	15	PMOD	-	-
17	(	(	O	O	-	29	P	-	-
18	N	N	B-NP	B-NP	-	29	NMOD	-	-
19	,	,	O	O	-	29	P	-	-
20	N	N	B-NP	B-NP	-	25	NMOD	-	-
21	,	,	O	O	-	25	P	-	-
22	N	N	B-NP	B-NP	-	25	NMOD	-	-
23	'	'	O	O	-	22	P	-	-
24	,	,	O	O	-	25	P	-	-
25	N'-tetrakis	N'-tetrakis	B-NP	B-NP	-	29	NMOD	-	-
26	[	[	O	O	-	29	P	-	-
27	2-pyridylmethyl	2-pyridylmethyl	B-NP	B-NP	-	29	NMOD	-	-
28	]	]	I-NP	I-NP	-	29	P	-	-
29	ethylenediamine	ethylenediamine	I-NP	I-NP	-	34	NMOD	-	-
30	)	)	O	O	-	29	P	-	-
31	or	or	O	O	-	34	NMOD	-	-
32	soluble	soluble	B-NP	B-NP	-	34	NMOD	-	-
33	Fas	Fas	I-NP	I-NP	-	34	NMOD	-	-
34	ligand	ligand	I-NP	I-NP	-	15	PMOD	-	-
35	(	(	O	O	-	36	P	-	-
36	CD95	CD95	B-NP	B-NP	-	34	NMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	,	,	O	O	-	8	P	-	-
39	was	was	B-VP	B-VP	-	0	ROOT	-	-
40	observed	observed	I-VP	I-VP	-	39	VC	-	-
41	in	in	B-PP	B-PP	-	40	VMOD	-	-
42	the	the	B-NP	B-NP	-	43	NMOD	-	-
43	absence	absence	I-NP	I-NP	-	41	PMOD	-	-
44	of	of	B-PP	B-PP	-	43	NMOD	-	-
45	active	active	B-NP	B-NP	-	48	NMOD	-	-
46	death	death	I-NP	I-NP	-	48	NMOD	-	-
47	effector	effector	I-NP	I-NP	-	48	NMOD	-	-
48	proteases	proteases	I-NP	I-NP	-	44	PMOD	-	-
49	caspase-1-like	caspase-1-like	B-ADJP	B-ADJP	-	48	NMOD	-	-
50	(	(	O	O	-	53	P	-	-
51	IL-1	IL-1	B-NP	B-NP	-	53	NMOD	-	-
52	converting	converting	B-VP	B-VP	-	51	NMOD	-	-
53	enzyme	enzyme	B-NP	B-NP	-	48	NMOD	-	-
54	)	)	O	O	-	53	P	-	-
55	,	,	O	O	-	48	P	-	-
56	caspase-3-like	caspase-3-like	B-ADJP	B-ADJP	-	48	NMOD	-	-
57	(	(	O	O	-	58	P	-	-
58	CPP32/Yama/apopain	CPP32/Yama/apopain	B-NP	B-NP	-	56	NMOD	-	-
59	)	)	O	O	-	58	P	-	-
60	,	,	O	O	-	48	P	-	-
61	and	and	O	O	-	48	NMOD	-	-
62	caspase-6-like	caspase-6-like	B-ADJP	B-ADJP	-	48	NMOD	-	-
63	and	and	O	O	-	41	PMOD	-	-
64	without	without	B-PP	B-PP	-	41	PMOD	-	-
65	cleavage	cleavage	B-NP	B-NP	-	64	PMOD	-	-
66	of	of	B-PP	B-PP	-	65	NMOD	-	-
67	caspase-3	caspase-3	B-NP	B-NP	-	68	NMOD	-	-
68	substrates	substrates	I-NP	I-NP	-	77	NMOD	-	-
69	poly	poly	I-NP	I-NP	-	77	NMOD	-	-
70	(	(	O	O	-	71	P	-	-
71	ADP-ribose	ADP-ribose	B-NP	B-NP	-	69	NMOD	-	-
72	)	)	O	O	-	77	P	-	-
73	polymerase	polymerase	B-NP	B-NP	-	77	NMOD	-	-
74	and	and	I-NP	I-NP	-	77	NMOD	-	-
75	DNA	DNA	I-NP	I-NP	-	77	NMOD	-	-
76	fragmentation	fragmentation	I-NP	I-NP	-	77	NMOD	-	-
77	factor-45	factor-45	I-NP	I-NP	-	66	PMOD	-	-
78	.	.	O	O	-	39	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	either	either	B-NP	B-NP	-	6	NMOD	-	-
5	low	low	I-NP	I-NP	-	6	NMOD	-	-
6	level	level	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	activation	activation	B-NP	B-NP	-	7	PMOD	-	-
9	is	is	B-VP	B-VP	-	7	SBAR	-	-
10	required	required	I-VP	I-VP	-	9	VC	-	-
11	or	or	O	O	-	12	DEP	-	-
12	that	that	B-SBAR	B-SBAR	-	10	VMOD	-	-
13	different	different	B-NP	B-NP	-	14	NMOD	-	-
14	caspases	caspases	I-NP	I-NP	-	15	SUB	-	-
15	are	are	B-VP	B-VP	-	12	SBAR	-	-
16	involved	involved	I-VP	I-VP	-	15	VC	-	-
17	.	.	O	O	-	3	P	-	-

1	Preactivation	Preactivation	B-NP	B-NP	-	11	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	resulting	resulting	B-VP	B-VP	-	4	NMOD	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	NF-kappa	NF-kappa	B-NP	B-NP	-	8	NMOD	-	-
8	B	B	I-NP	I-NP	-	10	NMOD	-	-
9	nuclear	nuclear	I-NP	I-NP	-	10	NMOD	-	-
10	translocation	translocation	I-NP	I-NP	-	6	PMOD	-	-
11	protected	protected	B-VP	B-VP	-	0	ROOT	-	-
12	cells	cells	B-NP	B-NP	-	11	OBJ	-	-
13	from	from	B-PP	B-PP	-	12	NMOD	-	-
14	SN50-induced	SN50-induced	B-NP	B-NP	-	15	NMOD	-	-
15	apoptosis	apoptosis	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	11	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	an	an	B-NP	B-NP	-	6	NMOD	-	-
5	essential	essential	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappa	NF-kappa	B-NP	B-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	7	PMOD	-	-
10	in	in	B-PP	B-PP	-	6	NMOD	-	-
11	survival	survival	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	naive	naive	B-NP	B-NP	-	14	NMOD	-	-
14	PBL	PBL	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	3	P	-	-

1	Signaling	Signaling	B-NP	B-NP	-	2	NMOD	-	-
2	events	events	I-NP	I-NP	-	0	ROOT	-	-
3	induced	induced	B-VP	B-VP	-	2	NMOD	-	-
4	by	by	B-PP	B-PP	-	3	VMOD	-	-
5	lipopolysaccharide-activated	lipopolysaccharide-activated	B-NP	B-NP	-	7	NMOD	-	-
6	toll-like	toll-like	I-NP	I-NP	-	7	NMOD	-	-
7	receptor	receptor	I-NP	I-NP	-	4	PMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	7	NMOD	-	-
9	.	.	O	O	-	2	P	-	-

1	Human	Human	B-NP	B-NP	-	3	NMOD	-	-
2	Toll-like	Toll-like	I-NP	I-NP	-	3	NMOD	-	-
3	receptor	receptor	I-NP	I-NP	-	8	SUB	-	-
4	<num>	<num>	I-NP	I-NP	-	3	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	TLR2	TLR2	B-NP	B-NP	-	3	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	signaling	signaling	I-NP	I-NP	-	11	NMOD	-	-
11	receptor	receptor	I-NP	I-NP	-	8	PRD	-	-
12	that	that	B-NP	B-NP	-	11	NMOD	-	-
13	responds	responds	B-VP	B-VP	-	12	SBAR	-	-
14	to	to	B-PP	B-PP	-	13	VMOD	-	-
15	LPS	LPS	B-NP	B-NP	-	14	PMOD	-	-
16	and	and	O	O	-	13	VMOD	-	-
17	activates	activates	B-VP	B-VP	-	13	VMOD	-	-
18	NF-kappaB	NF-kappaB	B-NP	B-NP	-	17	OBJ	-	-
19	.	.	O	O	-	8	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	investigate	investigate	B-VP	B-VP	-	0	ROOT	-	-
5	further	further	B-ADVP	B-ADVP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	events	events	I-NP	I-NP	-	4	OBJ	-	-
8	triggered	triggered	B-VP	B-VP	-	7	NMOD	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	TLR2	TLR2	B-NP	B-NP	-	9	PMOD	-	-
11	in	in	B-PP	B-PP	-	8	VMOD	-	-
12	response	response	B-NP	B-NP	-	11	PMOD	-	-
13	to	to	B-PP	B-PP	-	12	NMOD	-	-
14	LPS	LPS	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	23	DEP	-	-
4	TLR2	TLR2	B-NP	B-NP	-	5	SUB	-	-
5	associates	associates	B-VP	B-VP	-	3	SBAR	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	13	NMOD	-	-
8	high-affinity	high-affinity	I-NP	I-NP	-	13	NMOD	-	-
9	LPS	LPS	I-NP	I-NP	-	13	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	13	NMOD	-	-
11	protein	protein	I-NP	I-NP	-	13	NMOD	-	-
12	membrane	membrane	I-NP	I-NP	-	13	NMOD	-	-
13	CD14	CD14	I-NP	I-NP	-	6	PMOD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	serve	serve	I-VP	I-VP	-	5	VMOD	-	-
16	as	as	B-PP	B-PP	-	15	VMOD	-	-
17	an	an	B-NP	B-NP	-	20	NMOD	-	-
18	LPS	LPS	I-NP	I-NP	-	20	NMOD	-	-
19	receptor	receptor	I-NP	I-NP	-	20	NMOD	-	-
20	complex	complex	I-NP	I-NP	-	16	PMOD	-	-
21	,	,	O	O	-	23	P	-	-
22	and	and	O	O	-	23	DEP	-	-
23	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
24	LPS	LPS	B-NP	B-NP	-	25	NMOD	-	-
25	treatment	treatment	I-NP	I-NP	-	26	SUB	-	-
26	enhances	enhances	B-VP	B-VP	-	23	SBAR	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	oligomerization	oligomerization	I-NP	I-NP	-	26	OBJ	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	TLR2	TLR2	B-NP	B-NP	-	29	PMOD	-	-
31	.	.	O	O	-	2	P	-	-

1	Concomitant	Concomitant	B-ADJP	B-ADJP	-	12	SUB	-	-
2	with	with	B-PP	B-PP	-	1	AMOD	-	-
3	receptor	receptor	B-NP	B-NP	-	4	NMOD	-	-
4	oligomerization	oligomerization	I-NP	I-NP	-	2	PMOD	-	-
5	,	,	O	O	-	12	P	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	IL-1R-associated	IL-1R-associated	I-NP	I-NP	-	8	NMOD	-	-
8	kinase	kinase	I-NP	I-NP	-	12	SUB	-	-
9	(	(	O	O	-	10	P	-	-
10	IRAK	IRAK	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	recruited	recruited	I-VP	I-VP	-	12	VC	-	-
14	to	to	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	TLR2	TLR2	I-NP	I-NP	-	17	NMOD	-	-
17	complex	complex	I-NP	I-NP	-	14	PMOD	-	-
18	.	.	O	O	-	12	P	-	-

1	Intracellular	Intracellular	B-NP	B-NP	-	3	NMOD	-	-
2	deletion	deletion	I-NP	I-NP	-	3	NMOD	-	-
3	variants	variants	I-NP	I-NP	-	12	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	TLR2	TLR2	B-NP	B-NP	-	4	PMOD	-	-
6	lacking	lacking	B-VP	B-VP	-	5	NMOD	-	-
7	C-terminal	C-terminal	B-NP	B-NP	-	11	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	10	AMOD	-	-
9	or	or	I-NP	I-NP	-	10	AMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
11	aa	aa	I-NP	I-NP	-	6	OBJ	-	-
12	fail	fail	B-VP	B-VP	-	0	ROOT	-	-
13	to	to	I-VP	I-VP	-	14	VMOD	-	-
14	recruit	recruit	I-VP	I-VP	-	12	VMOD	-	-
15	IRAK	IRAK	B-NP	B-NP	-	14	OBJ	-	-
16	,	,	O	O	-	15	P	-	-
17	which	which	B-NP	B-NP	-	15	NMOD	-	-
18	is	is	B-VP	B-VP	-	17	SBAR	-	-
19	consistent	consistent	B-ADJP	B-ADJP	-	18	PRD	-	-
20	with	with	B-PP	B-PP	-	19	AMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	inability	inability	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	these	these	B-NP	B-NP	-	25	NMOD	-	-
25	mutants	mutants	I-NP	I-NP	-	23	PMOD	-	-
26	to	to	B-VP	B-VP	-	27	VMOD	-	-
27	transmit	transmit	I-VP	I-VP	-	22	NMOD	-	-
28	LPS	LPS	B-NP	B-NP	-	30	NMOD	-	-
29	cellular	cellular	I-NP	I-NP	-	30	NMOD	-	-
30	signaling	signaling	I-NP	I-NP	-	27	OBJ	-	-
31	.	.	O	O	-	12	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	both	both	B-NP	B-NP	-	5	NMOD	-	-
4	deletion	deletion	I-NP	I-NP	-	5	NMOD	-	-
5	mutants	mutants	I-NP	I-NP	-	6	SUB	-	-
6	could	could	B-VP	B-VP	-	0	ROOT	-	-
7	still	still	I-VP	I-VP	-	6	VMOD	-	-
8	form	form	I-VP	I-VP	-	6	VC	-	-
9	complexes	complexes	B-NP	B-NP	-	8	OBJ	-	-
10	with	with	B-PP	B-PP	-	8	VMOD	-	-
11	wild-type	wild-type	B-NP	B-NP	-	12	NMOD	-	-
12	TLR2	TLR2	I-NP	I-NP	-	10	PMOD	-	-
13	and	and	O	O	-	8	VMOD	-	-
14	act	act	B-VP	B-VP	-	8	VMOD	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	a	a	O	O	-	21	NMOD	-	-
17	dominant-negative	dominant-negative	O	O	-	21	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	DN	DN	B-ADJP	B-ADJP	-	17	AMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	fashion	fashion	B-NP	B-NP	-	15	PMOD	-	-
22	to	to	B-VP	B-VP	-	23	VMOD	-	-
23	block	block	I-VP	I-VP	-	14	VMOD	-	-
24	TLR2-mediated	TLR2-mediated	B-NP	B-NP	-	26	NMOD	-	-
25	signal	signal	I-NP	I-NP	-	26	NMOD	-	-
26	transduction	transduction	I-NP	I-NP	-	23	OBJ	-	-
27	.	.	O	O	-	6	P	-	-

1	DN	DN	B-NP	B-NP	-	2	NMOD	-	-
2	constructs	constructs	I-NP	I-NP	-	24	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	myeloid	myeloid	B-NP	B-NP	-	6	NMOD	-	-
5	differentiation	differentiation	I-NP	I-NP	-	6	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	17	NMOD	-	-
7	,	,	O	O	-	17	P	-	-
8	IRAK	IRAK	B-NP	B-NP	-	17	NMOD	-	-
9	,	,	O	O	-	17	P	-	-
10	TNF	TNF	B-NP	B-NP	-	12	NMOD	-	-
11	receptor-associated	receptor-associated	I-NP	I-NP	-	12	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	17	NMOD	-	-
13	<num>	<num>	I-NP	I-NP	-	12	NMOD	-	-
14	,	,	O	O	-	17	P	-	-
15	and	and	O	O	-	17	NMOD	-	-
16	NF-kappaB-inducing	NF-kappaB-inducing	B-NP	B-NP	-	17	NMOD	-	-
17	kinase	kinase	I-NP	I-NP	-	3	PMOD	-	-
18	,	,	O	O	-	17	P	-	-
19	when	when	B-ADVP	B-ADVP	-	17	NMOD	-	-
20	coexpressed	coexpressed	B-VP	B-VP	-	19	SBAR	-	-
21	with	with	B-PP	B-PP	-	20	VMOD	-	-
22	TLR2	TLR2	B-NP	B-NP	-	21	PMOD	-	-
23	,	,	O	O	-	17	P	-	-
24	abrogate	abrogate	B-VP	B-VP	-	0	ROOT	-	-
25	TLR2-mediated	TLR2-mediated	B-NP	B-NP	-	27	NMOD	-	-
26	NF-kappaB	NF-kappaB	I-NP	I-NP	-	27	NMOD	-	-
27	activation	activation	I-NP	I-NP	-	24	OBJ	-	-
28	.	.	O	O	-	24	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	reveal	reveal	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	conserved	conserved	I-NP	I-NP	-	7	NMOD	-	-
6	signaling	signaling	I-NP	I-NP	-	7	NMOD	-	-
7	pathway	pathway	I-NP	I-NP	-	3	OBJ	-	-
8	for	for	B-PP	B-PP	-	7	NMOD	-	-
9	TLR2	TLR2	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	IL-1Rs	IL-1Rs	I-NP	I-NP	-	8	PMOD	-	-
12	and	and	O	O	-	3	VMOD	-	-
13	suggest	suggest	B-VP	B-VP	-	3	VMOD	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	molecular	molecular	I-NP	I-NP	-	16	NMOD	-	-
16	mechanism	mechanism	I-NP	I-NP	-	13	OBJ	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	inhibition	inhibition	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	TLR2	TLR2	B-NP	B-NP	-	20	PMOD	-	-
22	by	by	B-PP	B-PP	-	19	NMOD	-	-
23	DN	DN	B-NP	B-NP	-	24	NMOD	-	-
24	variants	variants	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Activation	Activation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	Janus	Janus	I-NP	I-NP	-	7	NMOD	-	-
5	kinase	kinase	I-NP	I-NP	-	7	NMOD	-	-
6	3-STAT5a	3-STAT5a	I-NP	I-NP	-	7	NMOD	-	-
7	pathway	pathway	I-NP	I-NP	-	2	PMOD	-	-
8	after	after	B-PP	B-PP	-	1	NMOD	-	-
9	CD40	CD40	B-NP	B-NP	-	10	NMOD	-	-
10	triggering	triggering	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	human	human	B-NP	B-NP	-	13	NMOD	-	-
13	monocytes	monocytes	I-NP	I-NP	-	11	PMOD	-	-
14	but	but	B-PP	B-PP	-	11	PMOD	-	-
15	not	not	B-PP	B-PP	-	16	PMOD	-	-
16	of	of	I-PP	I-PP	-	11	PMOD	-	-
17	resting	resting	B-NP	B-NP	-	19	NMOD	-	-
18	B	B	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	1	P	-	-

1	CD40/CD40	CD40/CD40	B-NP	B-NP	-	3	NMOD	-	-
2	ligand	ligand	I-NP	I-NP	-	3	NMOD	-	-
3	interactions	interactions	I-NP	I-NP	-	4	SUB	-	-
4	play	play	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	key	key	I-NP	I-NP	-	7	NMOD	-	-
7	role	role	I-NP	I-NP	-	4	OBJ	-	-
8	in	in	B-PP	B-PP	-	4	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	immune	immune	I-NP	I-NP	-	11	NMOD	-	-
11	responses	responses	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	B	B	B-NP	B-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	20	NMOD	-	-
15	,	,	O	O	-	20	P	-	-
16	monocytes	monocytes	B-NP	B-NP	-	20	NMOD	-	-
17	,	,	O	O	-	20	P	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	dendritic	dendritic	B-NP	B-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
21	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	signal	signal	I-NP	I-NP	-	4	NMOD	-	-
3	transduction	transduction	I-NP	I-NP	-	4	NMOD	-	-
4	events	events	I-NP	I-NP	-	12	SUB	-	-
5	triggered	triggered	B-VP	B-VP	-	4	NMOD	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	cross-linking	cross-linking	B-NP	B-NP	-	6	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	CD40	CD40	I-NP	I-NP	-	11	NMOD	-	-
11	receptor	receptor	I-NP	I-NP	-	8	PMOD	-	-
12	have	have	B-VP	B-VP	-	23	VMOD	-	-
13	been	been	I-VP	I-VP	-	12	VC	-	-
14	widely	widely	I-VP	I-VP	-	13	VMOD	-	-
15	studied	studied	I-VP	I-VP	-	13	VC	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	B	B	B-NP	B-NP	-	19	NMOD	-	-
18	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
19	lines	lines	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	23	P	-	-
21	but	but	O	O	-	23	VMOD	-	-
22	little	little	B-NP	B-NP	-	23	SUB	-	-
23	is	is	B-VP	B-VP	-	0	ROOT	-	-
24	known	known	I-VP	I-VP	-	23	VC	-	-
25	about	about	B-PP	B-PP	-	24	VMOD	-	-
26	signaling	signaling	B-NP	B-NP	-	25	PMOD	-	-
27	following	following	B-PP	B-PP	-	26	NMOD	-	-
28	CD40	CD40	B-NP	B-NP	-	29	NMOD	-	-
29	stimulation	stimulation	I-NP	I-NP	-	27	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	monocytes	monocytes	B-NP	B-NP	-	36	NMOD	-	-
32	and	and	O	O	-	36	NMOD	-	-
33	resting	resting	B-NP	B-NP	-	36	NMOD	-	-
34	tonsillar	tonsillar	I-NP	I-NP	-	36	NMOD	-	-
35	B	B	I-NP	I-NP	-	36	NMOD	-	-
36	cells	cells	I-NP	I-NP	-	30	PMOD	-	-
37	.	.	O	O	-	23	P	-	-

1	Therefore	Therefore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	studied	studied	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	CD40	CD40	I-NP	I-NP	-	7	NMOD	-	-
7	pathway	pathway	I-NP	I-NP	-	4	OBJ	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	highly	highly	B-NP	B-NP	-	10	AMOD	-	-
10	purified	purified	I-NP	I-NP	-	12	NMOD	-	-
11	human	human	I-NP	I-NP	-	12	NMOD	-	-
12	monocytes	monocytes	I-NP	I-NP	-	16	NMOD	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	resting	resting	B-NP	B-NP	-	16	NMOD	-	-
15	B	B	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
17	.	.	O	O	-	4	P	-	-

1	After	After	B-PP	B-PP	-	21	VMOD	-	-
2	CD40	CD40	B-NP	B-NP	-	3	NMOD	-	-
3	triggering	triggering	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	7	P	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	similar	similar	I-NP	I-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	1	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	NF-kappaB	NF-kappaB	I-NP	I-NP	-	8	PMOD	-	-
11	(	(	O	O	-	21	P	-	-
12	but	but	O	O	-	21	VMOD	-	-
13	not	not	O	O	-	12	DEP	-	-
14	of	of	B-PP	B-PP	-	12	PMOD	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	AP-1	AP-1	I-NP	I-NP	-	20	NMOD	-	-
17	)	)	O	O	-	20	P	-	-
18	transcription	transcription	B-NP	B-NP	-	20	NMOD	-	-
19	factor	factor	I-NP	I-NP	-	20	NMOD	-	-
20	complex	complex	I-NP	I-NP	-	14	PMOD	-	-
21	occurred	occurred	B-VP	B-VP	-	0	ROOT	-	-
22	in	in	B-PP	B-PP	-	21	VMOD	-	-
23	both	both	B-NP	B-NP	-	25	NMOD	-	-
24	cell	cell	I-NP	I-NP	-	25	NMOD	-	-
25	preparations	preparations	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	21	P	-	-

1	However	However	B-ADVP	B-ADVP	-	9	VMOD	-	-
2	,	,	O	O	-	9	P	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	components	components	I-NP	I-NP	-	9	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	NF-kappaB	NF-kappaB	I-NP	I-NP	-	8	NMOD	-	-
8	complexes	complexes	I-NP	I-NP	-	5	PMOD	-	-
9	were	were	B-VP	B-VP	-	0	ROOT	-	-
10	different	different	B-ADJP	B-ADJP	-	9	PRD	-	-
11	in	in	B-PP	B-PP	-	10	AMOD	-	-
12	monocytes	monocytes	B-NP	B-NP	-	15	NMOD	-	-
13	and	and	O	O	-	15	NMOD	-	-
14	B	B	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
16	,	,	O	O	-	9	P	-	-
17	because	because	B-SBAR	B-SBAR	-	9	VMOD	-	-
18	p50	p50	B-NP	B-NP	-	19	SUB	-	-
19	is	is	B-VP	B-VP	-	17	SBAR	-	-
20	part	part	B-NP	B-NP	-	19	PRD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	NF-kappaB	NF-kappaB	I-NP	I-NP	-	24	NMOD	-	-
24	complex	complex	I-NP	I-NP	-	21	PMOD	-	-
25	induced	induced	B-VP	B-VP	-	24	NMOD	-	-
26	by	by	B-PP	B-PP	-	25	VMOD	-	-
27	CD40	CD40	B-NP	B-NP	-	28	NMOD	-	-
28	triggering	triggering	I-NP	I-NP	-	26	PMOD	-	-
29	in	in	B-PP	B-PP	-	28	NMOD	-	-
30	both	both	O	O	-	34	NMOD	-	-
31	monocytes	monocytes	B-NP	B-NP	-	34	NMOD	-	-
32	and	and	O	O	-	34	NMOD	-	-
33	B	B	B-NP	B-NP	-	34	NMOD	-	-
34	cells	cells	I-NP	I-NP	-	29	PMOD	-	-
35	,	,	O	O	-	9	P	-	-
36	whereas	whereas	O	O	-	9	VMOD	-	-
37	p65	p65	B-NP	B-NP	-	38	SUB	-	-
38	was	was	B-VP	B-VP	-	36	SBAR	-	-
39	only	only	I-VP	I-VP	-	38	VMOD	-	-
40	induced	induced	I-VP	I-VP	-	38	VC	-	-
41	in	in	B-PP	B-PP	-	40	VMOD	-	-
42	B	B	B-NP	B-NP	-	43	NMOD	-	-
43	cells	cells	I-NP	I-NP	-	41	PMOD	-	-
44	.	.	O	O	-	9	P	-	-

1	In	In	B-PP	B-PP	-	29	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	29	P	-	-
4	although	although	B-SBAR	B-SBAR	-	29	VMOD	-	-
5	the	the	B-NP	B-NP	-	10	NMOD	-	-
6	Janus	Janus	I-NP	I-NP	-	10	NMOD	-	-
7	kinase	kinase	I-NP	I-NP	-	10	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	10	NMOD	-	-
9	tyrosine	tyrosine	I-NP	I-NP	-	10	NMOD	-	-
10	kinase	kinase	I-NP	I-NP	-	11	SUB	-	-
11	was	was	B-VP	B-VP	-	4	SBAR	-	-
12	associated	associated	I-VP	I-VP	-	11	VC	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	CD40	CD40	B-NP	B-NP	-	15	NMOD	-	-
15	molecules	molecules	I-NP	I-NP	-	13	PMOD	-	-
16	in	in	B-PP	B-PP	-	15	NMOD	-	-
17	both	both	O	O	-	22	NMOD	-	-
18	monocytes	monocytes	B-NP	B-NP	-	22	NMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	resting	resting	B-NP	B-NP	-	22	NMOD	-	-
21	B	B	I-NP	I-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
23	,	,	O	O	-	29	P	-	-
24	Janus	Janus	B-NP	B-NP	-	25	NMOD	-	-
25	kinase	kinase	I-NP	I-NP	-	28	NMOD	-	-
26	<num>	<num>	I-NP	I-NP	-	28	NMOD	-	-
27	phosphorylation	phosphorylation	I-NP	I-NP	-	28	NMOD	-	-
28	induction	induction	I-NP	I-NP	-	29	SUB	-	-
29	was	was	B-VP	B-VP	-	0	ROOT	-	-
30	observed	observed	I-VP	I-VP	-	29	VC	-	-
31	only	only	B-ADVP	B-ADVP	-	32	PMOD	-	-
32	in	in	B-PP	B-PP	-	30	VMOD	-	-
33	CD40-activated	CD40-activated	B-NP	B-NP	-	34	NMOD	-	-
34	monocytes	monocytes	I-NP	I-NP	-	32	PMOD	-	-
35	,	,	O	O	-	30	P	-	-
36	with	with	B-PP	B-PP	-	30	VMOD	-	-
37	subsequent	subsequent	B-NP	B-NP	-	38	NMOD	-	-
38	induction	induction	I-NP	I-NP	-	36	PMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	STAT5a	STAT5a	B-NP	B-NP	-	43	NMOD	-	-
41	DNA	DNA	I-NP	I-NP	-	43	NMOD	-	-
42	binding	binding	I-NP	I-NP	-	43	NMOD	-	-
43	activity	activity	I-NP	I-NP	-	39	PMOD	-	-
44	in	in	B-PP	B-PP	-	38	NMOD	-	-
45	the	the	B-NP	B-NP	-	46	NMOD	-	-
46	nucleus	nucleus	I-NP	I-NP	-	44	PMOD	-	-
47	.	.	O	O	-	29	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	7	NMOD	-	-
7	signals	signals	I-NP	I-NP	-	14	SUB	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	human	human	B-NP	B-NP	-	11	NMOD	-	-
10	B	B	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	13	NMOD	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	monocytes	monocytes	B-NP	B-NP	-	8	PMOD	-	-
14	differ	differ	B-VP	B-VP	-	4	SBAR	-	-
15	following	following	I-VP	I-VP	-	14	VMOD	-	-
16	CD40	CD40	B-NP	B-NP	-	17	NMOD	-	-
17	stimulation	stimulation	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	3	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	observation	observation	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	consistent	consistent	B-ADJP	B-ADJP	-	3	PRD	-	-
5	with	with	B-PP	B-PP	-	4	AMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	detection	detection	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	normal	normal	B-NP	B-NP	-	12	NMOD	-	-
10	CD40-induced	CD40-induced	I-NP	I-NP	-	12	NMOD	-	-
11	monocyte	monocyte	I-NP	I-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	8	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	patients	patients	B-NP	B-NP	-	13	PMOD	-	-
15	with	with	B-PP	B-PP	-	14	NMOD	-	-
16	CD40	CD40	B-NP	B-NP	-	20	NMOD	-	-
17	ligand+	ligand+	I-NP	I-NP	-	20	NMOD	-	-
18	hyper	hyper	I-NP	I-NP	-	20	NMOD	-	-
19	IgM	IgM	I-NP	I-NP	-	20	NMOD	-	-
20	syndrome	syndrome	I-NP	I-NP	-	15	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	whom	whom	B-NP	B-NP	-	24	NMOD	-	-
23	a	a	B-NP	B-NP	-	24	NMOD	-	-
24	defect	defect	I-NP	I-NP	-	21	PMOD	-	-
25	in	in	B-PP	B-PP	-	24	NMOD	-	-
26	CD40-induced	CD40-induced	B-NP	B-NP	-	29	NMOD	-	-
27	B	B	I-NP	I-NP	-	29	NMOD	-	-
28	cell	cell	I-NP	I-NP	-	29	NMOD	-	-
29	activation	activation	I-NP	I-NP	-	25	PMOD	-	-
30	has	has	B-VP	B-VP	-	25	SBAR	-	-
31	been	been	I-VP	I-VP	-	30	VC	-	-
32	reported	reported	I-VP	I-VP	-	31	VC	-	-
33	.	.	O	O	-	3	P	-	-

1	Suppression	Suppression	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-kappaB	NF-kappaB	B-NP	B-NP	-	4	NMOD	-	-
4	activation	activation	I-NP	I-NP	-	2	PMOD	-	-
5	in	in	B-PP	B-PP	-	1	NMOD	-	-
6	normal	normal	B-NP	B-NP	-	8	NMOD	-	-
7	T	T	I-NP	I-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
9	by	by	B-PP	B-PP	-	1	NMOD	-	-
10	supernatant	supernatant	B-NP	B-NP	-	11	NMOD	-	-
11	fluid	fluid	I-NP	I-NP	-	9	PMOD	-	-
12	from	from	B-PP	B-PP	-	11	NMOD	-	-
13	human	human	B-NP	B-NP	-	16	NMOD	-	-
14	renal	renal	I-NP	I-NP	-	16	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	16	NMOD	-	-
16	carcinomas	carcinomas	I-NP	I-NP	-	12	PMOD	-	-
17	.	.	O	O	-	1	P	-	-

1	T	T	B-NP	B-NP	-	2	NMOD	-	-
2	lymphocytes	lymphocytes	I-NP	I-NP	-	12	SUB	-	-
3	from	from	B-PP	B-PP	-	2	NMOD	-	-
4	patients	patients	B-NP	B-NP	-	3	PMOD	-	-
5	with	with	B-PP	B-PP	-	4	NMOD	-	-
6	renal	renal	B-NP	B-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	carcinoma	carcinoma	I-NP	I-NP	-	5	PMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	RCC	RCC	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	show	show	B-VP	B-VP	-	0	ROOT	-	-
13	reduced	reduced	I-VP	I-VP	-	15	NMOD	-	-
14	immune	immune	B-NP	B-NP	-	15	NMOD	-	-
15	function	function	I-NP	I-NP	-	18	NMOD	-	-
16	and	and	O	O	-	18	NMOD	-	-
17	impaired	impaired	B-NP	B-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	12	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	transcription	transcription	I-NP	I-NP	-	22	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	24	NMOD	-	-
23	,	,	O	O	-	24	P	-	-
24	NF-kappaB	NF-kappaB	B-NP	B-NP	-	19	PMOD	-	-
25	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	determined	determined	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	mechanism	mechanism	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	NF-kappaB	NF-kappaB	B-NP	B-NP	-	7	NMOD	-	-
7	suppression	suppression	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	T	T	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	RCC	RCC	B-NP	B-NP	-	13	NMOD	-	-
13	patient	patient	I-NP	I-NP	-	11	PMOD	-	-
14	and	and	O	O	-	2	VMOD	-	-
15	determined	determined	B-VP	B-VP	-	2	VMOD	-	-
16	whether	whether	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	supernatant	supernatant	B-NP	B-NP	-	18	NMOD	-	-
18	fluid	fluid	I-NP	I-NP	-	25	SUB	-	-
19	from	from	B-PP	B-PP	-	18	NMOD	-	-
20	RCC	RCC	B-NP	B-NP	-	21	NMOD	-	-
21	explants	explants	I-NP	I-NP	-	19	PMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	RCC-S	RCC-S	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	induced	induced	B-VP	B-VP	-	16	SBAR	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	same	same	I-NP	I-NP	-	28	NMOD	-	-
28	phenotype	phenotype	I-NP	I-NP	-	25	OBJ	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	NF-kappaB	NF-kappaB	B-NP	B-NP	-	31	NMOD	-	-
31	suppression	suppression	I-NP	I-NP	-	29	PMOD	-	-
32	in	in	B-PP	B-PP	-	31	NMOD	-	-
33	normal	normal	B-NP	B-NP	-	35	NMOD	-	-
34	T	T	I-NP	I-NP	-	35	NMOD	-	-
35	cells	cells	I-NP	I-NP	-	32	PMOD	-	-
36	that	that	B-NP	B-NP	-	31	NMOD	-	-
37	is	is	B-VP	B-VP	-	36	SBAR	-	-
38	observed	observed	I-VP	I-VP	-	37	VC	-	-
39	in	in	B-PP	B-PP	-	38	VMOD	-	-
40	patient	patient	B-NP	B-NP	-	42	NMOD	-	-
41	T	T	I-NP	I-NP	-	42	NMOD	-	-
42	cells	cells	I-NP	I-NP	-	39	PMOD	-	-
43	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	pattern	pattern	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	kappaB-binding	kappaB-binding	B-NP	B-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	NMOD	-	-
7	T	T	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	RCC	RCC	B-NP	B-NP	-	11	NMOD	-	-
11	patient	patient	I-NP	I-NP	-	9	PMOD	-	-
12	was	was	B-VP	B-VP	-	0	ROOT	-	-
13	altered	altered	I-VP	I-VP	-	12	VC	-	-
14	as	as	B-SBAR	B-SBAR	-	13	VMOD	-	-
15	compared	compared	B-VP	B-VP	-	14	SBAR	-	-
16	to	to	B-PP	B-PP	-	15	VMOD	-	-
17	that	that	B-NP	B-NP	-	16	PMOD	-	-
18	seen	seen	B-VP	B-VP	-	17	NMOD	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	T	T	B-NP	B-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
22	obtained	obtained	B-VP	B-VP	-	21	NMOD	-	-
23	from	from	B-PP	B-PP	-	22	VMOD	-	-
24	normal	normal	B-NP	B-NP	-	25	NMOD	-	-
25	volunteers	volunteers	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	12	P	-	-

1	In	In	B-PP	B-PP	-	10	VMOD	-	-
2	some	some	B-NP	B-NP	-	3	NMOD	-	-
3	patients	patients	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	10	P	-	-
5	no	no	B-NP	B-NP	-	6	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	10	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	RelA/NFkappaB1-binding	RelA/NFkappaB1-binding	B-NP	B-NP	-	9	NMOD	-	-
9	activity	activity	I-NP	I-NP	-	7	PMOD	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	detectable	detectable	B-ADJP	B-ADJP	-	10	PRD	-	-
12	,	,	O	O	-	10	P	-	-
13	while	while	B-SBAR	B-SBAR	-	10	VMOD	-	-
14	in	in	B-PP	B-PP	-	18	VMOD	-	-
15	others	others	B-NP	B-NP	-	14	PMOD	-	-
16	kappaB-binding	kappaB-binding	B-NP	B-NP	-	17	NMOD	-	-
17	activity	activity	I-NP	I-NP	-	18	SUB	-	-
18	was	was	B-VP	B-VP	-	13	SBAR	-	-
19	modestly	modestly	I-VP	I-VP	-	18	VMOD	-	-
20	induced	induced	I-VP	I-VP	-	18	VC	-	-
21	but	but	O	O	-	24	VMOD	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	duration	duration	I-NP	I-NP	-	24	SUB	-	-
24	was	was	B-VP	B-VP	-	13	SBAR	-	-
25	reduced	reduced	I-VP	I-VP	-	24	VC	-	-
26	.	.	O	O	-	10	P	-	-

1	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	degraded	degraded	I-VP	I-VP	-	2	VC	-	-
4	normally	normally	B-ADVP	B-ADVP	-	3	VMOD	-	-
5	following	following	B-PP	B-PP	-	3	VMOD	-	-
6	stimulation	stimulation	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	both	both	B-NP	B-NP	-	10	NMOD	-	-
9	normal	normal	I-NP	I-NP	-	10	NMOD	-	-
10	controls	controls	I-NP	I-NP	-	7	PMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	T	T	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	B-NP	B-NP	-	7	PMOD	-	-
14	from	from	B-PP	B-PP	-	13	NMOD	-	-
15	RCC	RCC	B-NP	B-NP	-	16	NMOD	-	-
16	patients	patients	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	2	P	-	-

1	RCC-S	RCC-S	B-NP	B-NP	-	2	SUB	-	-
2	did	did	B-VP	B-VP	-	0	ROOT	-	-
3	not	not	I-VP	I-VP	-	2	VMOD	-	-
4	alter	alter	I-VP	I-VP	-	2	VC	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	cytoplasmic	cytoplasmic	I-NP	I-NP	-	7	NMOD	-	-
7	levels	levels	I-NP	I-NP	-	4	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	RelA	RelA	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	NF-kappaB1	NF-kappaB1	I-NP	I-NP	-	8	PMOD	-	-
12	but	but	O	O	-	2	VMOD	-	-
13	did	did	B-VP	B-VP	-	2	VMOD	-	-
14	suppress	suppress	I-VP	I-VP	-	13	VC	-	-
15	their	their	B-NP	B-NP	-	17	NMOD	-	-
16	nuclear	nuclear	I-NP	I-NP	-	17	NMOD	-	-
17	localization	localization	I-NP	I-NP	-	14	OBJ	-	-
18	and	and	O	O	-	14	VMOD	-	-
19	inhibited	inhibited	B-VP	B-VP	-	2	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	RelA/NF-kappaB1	RelA/NF-kappaB1	B-NP	B-NP	-	25	NMOD	-	-
24	binding	binding	I-NP	I-NP	-	25	NMOD	-	-
25	complexes	complexes	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	2	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	RCC-S	RCC-S	B-NP	B-NP	-	6	SUB	-	-
6	can	can	B-VP	B-VP	-	4	SBAR	-	-
7	induce	induce	I-VP	I-VP	-	6	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	normal	normal	B-NP	B-NP	-	11	NMOD	-	-
10	T	T	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	same	same	I-NP	I-NP	-	14	NMOD	-	-
14	phenotype	phenotype	I-NP	I-NP	-	8	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	impaired	impaired	B-NP	B-NP	-	18	NMOD	-	-
17	NF-kappaB	NF-kappaB	I-NP	I-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	15	PMOD	-	-
19	that	that	B-NP	B-NP	-	18	NMOD	-	-
20	is	is	B-VP	B-VP	-	19	SBAR	-	-
21	detected	detected	I-VP	I-VP	-	20	VC	-	-
22	in	in	B-PP	B-PP	-	21	VMOD	-	-
23	T	T	B-NP	B-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	RCC	RCC	B-NP	B-NP	-	27	NMOD	-	-
27	patient	patient	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	It	It	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	NF-kappaB	NF-kappaB	B-NP	B-NP	-	6	NMOD	-	-
6	suppression	suppression	I-NP	I-NP	-	9	SUB	-	-
7	by	by	B-PP	B-PP	-	6	NMOD	-	-
8	RCC-S	RCC-S	B-NP	B-NP	-	7	PMOD	-	-
9	may	may	B-VP	B-VP	-	4	SBAR	-	-
10	contribute	contribute	I-VP	I-VP	-	9	VC	-	-
11	to	to	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	immunosuppression	immunosuppression	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	host	host	B-NP	B-NP	-	16	NMOD	-	-
16	immunity	immunity	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	Monoclonal	Monoclonal	B-NP	B-NP	-	4	NMOD	-	-
2	anti-endothelial	anti-endothelial	I-NP	I-NP	-	4	NMOD	-	-
3	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
4	antibodies	antibodies	I-NP	I-NP	-	11	SUB	-	-
5	from	from	B-PP	B-PP	-	4	NMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	patient	patient	I-NP	I-NP	-	5	PMOD	-	-
8	with	with	B-PP	B-PP	-	7	NMOD	-	-
9	Takayasu	Takayasu	B-NP	B-NP	-	10	NMOD	-	-
10	arteritis	arteritis	I-NP	I-NP	-	8	PMOD	-	-
11	activate	activate	B-VP	B-VP	-	0	ROOT	-	-
12	endothelial	endothelial	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	OBJ	-	-
14	from	from	B-PP	B-PP	-	11	VMOD	-	-
15	large	large	B-NP	B-NP	-	16	NMOD	-	-
16	vessels	vessels	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	11	P	-	-

1	OBJECTIVE	OBJECTIVE	B-NP	B-NP	-	0	ROOT	-	-
2	:	:	O	O	-	1	P	-	-
3	To	To	B-VP	B-VP	-	4	VMOD	-	-
4	create	create	I-VP	I-VP	-	1	NMOD	-	-
5	monoclonal	monoclonal	B-NP	B-NP	-	8	NMOD	-	-
6	anti-endothelial	anti-endothelial	I-NP	I-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	antibodies	antibodies	I-NP	I-NP	-	4	OBJ	-	-
9	(	(	O	O	-	10	P	-	-
10	mAECA	mAECA	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	from	from	B-PP	B-PP	-	8	NMOD	-	-
13	a	a	B-NP	B-NP	-	14	NMOD	-	-
14	patient	patient	I-NP	I-NP	-	12	PMOD	-	-
15	with	with	B-PP	B-PP	-	14	NMOD	-	-
16	Takayasu	Takayasu	B-NP	B-NP	-	17	NMOD	-	-
17	arteritis	arteritis	I-NP	I-NP	-	15	PMOD	-	-
18	to	to	B-VP	B-VP	-	19	VMOD	-	-
19	evaluate	evaluate	I-VP	I-VP	-	17	NMOD	-	-
20	their	their	B-NP	B-NP	-	21	NMOD	-	-
21	ability	ability	I-NP	I-NP	-	19	OBJ	-	-
22	to	to	B-VP	B-VP	-	23	VMOD	-	-
23	activate	activate	I-VP	I-VP	-	21	NMOD	-	-
24	human	human	B-NP	B-NP	-	28	NMOD	-	-
25	umbilical	umbilical	I-NP	I-NP	-	28	NMOD	-	-
26	vein	vein	I-NP	I-NP	-	28	NMOD	-	-
27	endothelial	endothelial	I-NP	I-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	23	OBJ	-	-
29	(	(	O	O	-	30	P	-	-
30	HUVEC	HUVEC	B-NP	B-NP	-	28	NMOD	-	-
31	)	)	O	O	-	30	P	-	-
32	,	,	O	O	-	8	P	-	-
33	and	and	O	O	-	4	VMOD	-	-
34	to	to	B-VP	B-VP	-	35	VMOD	-	-
35	characterize	characterize	I-VP	I-VP	-	4	VMOD	-	-
36	the	the	B-NP	B-NP	-	37	NMOD	-	-
37	mechanism	mechanism	I-NP	I-NP	-	35	OBJ	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	EC	EC	B-NP	B-NP	-	40	NMOD	-	-
40	activation	activation	I-NP	I-NP	-	38	PMOD	-	-
41	.	.	O	O	-	1	P	-	-

1	METHODS	METHODS	B-NP	B-NP	-	4	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	A	A	B-NP	B-NP	-	4	NMOD	-	-
4	panel	panel	I-NP	I-NP	-	7	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	mAECA	mAECA	B-NP	B-NP	-	5	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	generated	generated	I-VP	I-VP	-	7	VC	-	-
9	from	from	B-PP	B-PP	-	8	VMOD	-	-
10	peripheral	peripheral	B-NP	B-NP	-	12	NMOD	-	-
11	blood	blood	I-NP	I-NP	-	12	NMOD	-	-
12	lymphocytes	lymphocytes	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	a	a	B-NP	B-NP	-	15	NMOD	-	-
15	patient	patient	I-NP	I-NP	-	13	PMOD	-	-
16	with	with	B-PP	B-PP	-	15	NMOD	-	-
17	Takayasu	Takayasu	B-NP	B-NP	-	18	NMOD	-	-
18	arteritis	arteritis	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	7	P	-	-
20	using	using	B-VP	B-VP	-	7	VMOD	-	-
21	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	23	NMOD	-	-
22	virus	virus	I-NP	I-NP	-	23	NMOD	-	-
23	transformation	transformation	I-NP	I-NP	-	20	OBJ	-	-
24	.	.	O	O	-	7	P	-	-

1	Activity	Activity	B-NP	B-NP	-	10	NMOD	-	-
2	against	against	B-PP	B-PP	-	1	NMOD	-	-
3	macrovascular	macrovascular	B-NP	B-NP	-	4	NMOD	-	-
4	EC	EC	I-NP	I-NP	-	10	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	HUVEC	HUVEC	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	and	and	O	O	-	10	NMOD	-	-
9	microvascular	microvascular	B-NP	B-NP	-	10	NMOD	-	-
10	EC	EC	I-NP	I-NP	-	15	NMOD	-	-
11	(	(	O	O	-	15	P	-	-
12	human	human	B-NP	B-NP	-	15	NMOD	-	-
13	bone	bone	I-NP	I-NP	-	15	NMOD	-	-
14	marrow	marrow	I-NP	I-NP	-	15	NMOD	-	-
15	EC	EC	I-NP	I-NP	-	20	NMOD	-	-
16	immortalized	immortalized	B-VP	B-VP	-	15	NMOD	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	SV40	SV40	B-NP	B-NP	-	17	PMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	antigens	antigens	B-NP	B-NP	-	21	SUB	-	-
21	was	was	B-VP	B-VP	-	0	ROOT	-	-
22	detected	detected	I-VP	I-VP	-	21	VC	-	-
23	by	by	B-PP	B-PP	-	22	VMOD	-	-
24	enzyme-linked	enzyme-linked	B-NP	B-NP	-	26	NMOD	-	-
25	immunosorbent	immunosorbent	I-NP	I-NP	-	26	NMOD	-	-
26	assay	assay	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	21	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	used	used	I-VP	I-VP	-	3	VC	-	-
5	to	to	B-VP	B-VP	-	6	VMOD	-	-
6	select	select	I-VP	I-VP	-	4	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	monoclonal	monoclonal	I-NP	I-NP	-	9	NMOD	-	-
9	antibodies	antibodies	I-NP	I-NP	-	6	OBJ	-	-
10	(	(	O	O	-	11	P	-	-
11	mAECA	mAECA	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	which	which	B-NP	B-NP	-	9	NMOD	-	-
14	share	share	B-VP	B-VP	-	13	SBAR	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	same	same	I-NP	I-NP	-	20	NMOD	-	-
17	EC	EC	I-NP	I-NP	-	20	NMOD	-	-
18	epitope	epitope	I-NP	I-NP	-	20	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	20	NMOD	-	-
20	specificity	specificity	I-NP	I-NP	-	14	OBJ	-	-
21	as	as	B-PP	B-PP	-	14	VMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	total	total	I-NP	I-NP	-	24	NMOD	-	-
24	IgG-AECA	IgG-AECA	I-NP	I-NP	-	21	PMOD	-	-
25	from	from	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	Takayasu	Takayasu	I-NP	I-NP	-	29	NMOD	-	-
28	arteritis	arteritis	I-NP	I-NP	-	29	NMOD	-	-
29	patient	patient	I-NP	I-NP	-	25	PMOD	-	-
30	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	binding	binding	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	mAECA	mAECA	I-NP	I-NP	-	3	PMOD	-	-
6	to	to	B-PP	B-PP	-	2	NMOD	-	-
7	human	human	B-NP	B-NP	-	9	NMOD	-	-
8	aortic	aortic	I-NP	I-NP	-	9	NMOD	-	-
9	EC	EC	I-NP	I-NP	-	6	PMOD	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	studied	studied	I-VP	I-VP	-	10	VC	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	immunohistochemistry	immunohistochemistry	B-NP	B-NP	-	12	PMOD	-	-
14	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	secretion	secretion	I-NP	I-NP	-	3	NMOD	-	-
3	levels	levels	I-NP	I-NP	-	16	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	interleukin-6	interleukin-6	B-NP	B-NP	-	12	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	IL-6	IL-6	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	and	and	O	O	-	12	NMOD	-	-
10	von	von	B-NP	B-NP	-	12	NMOD	-	-
11	Willebrand	Willebrand	I-NP	I-NP	-	12	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	4	PMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	vWF	vWF	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	were	were	B-VP	B-VP	-	0	ROOT	-	-
17	determined	determined	I-VP	I-VP	-	16	VC	-	-
18	,	,	O	O	-	17	P	-	-
19	to	to	B-VP	B-VP	-	20	VMOD	-	-
20	serve	serve	I-VP	I-VP	-	17	VMOD	-	-
21	as	as	B-PP	B-PP	-	20	VMOD	-	-
22	markers	markers	B-NP	B-NP	-	21	PMOD	-	-
23	for	for	B-PP	B-PP	-	22	NMOD	-	-
24	EC	EC	B-NP	B-NP	-	25	NMOD	-	-
25	activation	activation	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	16	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	activated	activated	I-NP	I-NP	-	3	NMOD	-	-
3	EC	EC	I-NP	I-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	0	ROOT	-	-
5	examined	examined	I-VP	I-VP	-	4	VC	-	-
6	for	for	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	adherence	adherence	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	a	a	B-NP	B-NP	-	13	NMOD	-	-
11	monocytic	monocytic	I-NP	I-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	line	line	I-NP	I-NP	-	9	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	U937	U937	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	,	,	O	O	-	6	P	-	-
18	as	as	B-CONJP	B-CONJP	-	6	PMOD	-	-
19	well	well	I-CONJP	I-CONJP	-	18	DEP	-	-
20	as	as	I-CONJP	I-CONJP	-	18	DEP	-	-
21	for	for	B-PP	B-PP	-	6	PMOD	-	-
22	expression	expression	B-NP	B-NP	-	21	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	vascular	vascular	B-NP	B-NP	-	27	NMOD	-	-
25	cell	cell	I-NP	I-NP	-	27	NMOD	-	-
26	adhesion	adhesion	I-NP	I-NP	-	27	NMOD	-	-
27	molecule	molecule	I-NP	I-NP	-	36	NMOD	-	-
28	<num>	<num>	I-NP	I-NP	-	27	NMOD	-	-
29	,	,	I-NP	I-NP	-	36	P	-	-
30	intercellular	intercellular	I-NP	I-NP	-	32	NMOD	-	-
31	adhesion	adhesion	I-NP	I-NP	-	32	NMOD	-	-
32	molecule	molecule	I-NP	I-NP	-	36	NMOD	-	-
33	<num>	<num>	I-NP	I-NP	-	32	NMOD	-	-
34	,	,	O	O	-	36	P	-	-
35	and	and	O	O	-	36	NMOD	-	-
36	E-selectin	E-selectin	B-NP	B-NP	-	23	PMOD	-	-
37	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	10	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	10	P	-	-
4	nuclear	nuclear	B-NP	B-NP	-	5	NMOD	-	-
5	extracts	extracts	I-NP	I-NP	-	10	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	mAECA-treated	mAECA-treated	I-NP	I-NP	-	9	NMOD	-	-
9	EC	EC	I-NP	I-NP	-	6	PMOD	-	-
10	were	were	B-VP	B-VP	-	0	ROOT	-	-
11	analyzed	analyzed	I-VP	I-VP	-	10	VC	-	-
12	for	for	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	induction	induction	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	translocation	translocation	B-NP	B-NP	-	15	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	nuclear	nuclear	B-NP	B-NP	-	20	NMOD	-	-
19	factor	factor	I-NP	I-NP	-	20	NMOD	-	-
20	kappaB	kappaB	I-NP	I-NP	-	17	PMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	NF-kappaB	NF-kappaB	B-NP	B-NP	-	20	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	,	,	O	O	-	10	P	-	-
25	using	using	B-VP	B-VP	-	10	VMOD	-	-
26	a	a	B-NP	B-NP	-	29	NMOD	-	-
27	specific	specific	I-NP	I-NP	-	29	NMOD	-	-
28	NF-kappaB	NF-kappaB	I-NP	I-NP	-	29	NMOD	-	-
29	oligoprobe	oligoprobe	I-NP	I-NP	-	25	OBJ	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	an	an	B-NP	B-NP	-	35	NMOD	-	-
32	electrophoretic	electrophoretic	I-NP	I-NP	-	35	NMOD	-	-
33	mobility	mobility	I-NP	I-NP	-	35	NMOD	-	-
34	shift	shift	I-NP	I-NP	-	35	NMOD	-	-
35	assay	assay	I-NP	I-NP	-	30	PMOD	-	-
36	.	.	O	O	-	10	P	-	-

1	RESULTS	RESULTS	B-NP	B-NP	-	0	ROOT	-	-
2	:	:	O	O	-	1	P	-	-
3	Six	Six	B-NP	B-NP	-	4	NMOD	-	-
4	mAECA	mAECA	I-NP	I-NP	-	5	SUB	-	-
5	were	were	B-VP	B-VP	-	1	NMOD	-	-
6	selected	selected	I-VP	I-VP	-	5	VC	-	-
7	,	,	O	O	-	12	P	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	mixture	mixture	I-NP	I-NP	-	12	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	which	which	B-NP	B-NP	-	10	PMOD	-	-
12	produced	produced	B-VP	B-VP	-	6	VMOD	-	-
13	<num>	<num>	B-NP	B-NP	-	14	AMOD	-	-
14	%	%	I-NP	I-NP	-	15	NMOD	-	-
15	inhibition	inhibition	I-NP	I-NP	-	12	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	binding	binding	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	original	original	I-NP	I-NP	-	21	NMOD	-	-
21	IgG	IgG	I-NP	I-NP	-	18	PMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	from	from	B-PP	B-PP	-	21	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	patient	patient	I-NP	I-NP	-	23	PMOD	-	-
26	with	with	B-PP	B-PP	-	25	NMOD	-	-
27	Takayasu	Takayasu	B-NP	B-NP	-	28	NMOD	-	-
28	arteritis	arteritis	I-NP	I-NP	-	26	PMOD	-	-
29	)	)	O	O	-	28	P	-	-
30	to	to	B-PP	B-PP	-	17	NMOD	-	-
31	HUVEC	HUVEC	B-NP	B-NP	-	30	PMOD	-	-
32	.	.	O	O	-	5	P	-	-

1	All	All	B-NP	B-NP	-	2	NMOD	-	-
2	mAECA	mAECA	I-NP	I-NP	-	3	SUB	-	-
3	possessed	possessed	B-VP	B-VP	-	12	VMOD	-	-
4	high	high	B-NP	B-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	3	OBJ	-	-
6	against	against	B-PP	B-PP	-	5	NMOD	-	-
7	macrovascular	macrovascular	B-NP	B-NP	-	8	NMOD	-	-
8	EC	EC	I-NP	I-NP	-	6	PMOD	-	-
9	,	,	O	O	-	12	P	-	-
10	but	but	O	O	-	12	VMOD	-	-
11	none	none	B-NP	B-NP	-	12	SUB	-	-
12	had	had	B-VP	B-VP	-	0	ROOT	-	-
13	significant	significant	B-NP	B-NP	-	16	NMOD	-	-
14	antimicrovascular	antimicrovascular	I-NP	I-NP	-	16	NMOD	-	-
15	EC	EC	I-NP	I-NP	-	16	NMOD	-	-
16	activity	activity	I-NP	I-NP	-	12	OBJ	-	-
17	.	.	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	mAECA	mAECA	I-NP	I-NP	-	10	SUB	-	-
3	,	,	O	O	-	10	P	-	-
4	but	but	O	O	-	10	VMOD	-	-
5	not	not	O	O	-	4	DEP	-	-
6	normal	normal	B-NP	B-NP	-	8	NMOD	-	-
7	human	human	I-NP	I-NP	-	8	NMOD	-	-
8	IgG	IgG	I-NP	I-NP	-	10	SUB	-	-
9	,	,	O	O	-	8	P	-	-
10	had	had	B-VP	B-VP	-	0	ROOT	-	-
11	anti-human	anti-human	B-NP	B-NP	-	14	NMOD	-	-
12	aortic	aortic	I-NP	I-NP	-	14	NMOD	-	-
13	EC	EC	I-NP	I-NP	-	14	NMOD	-	-
14	activity	activity	I-NP	I-NP	-	10	OBJ	-	-
15	.	.	O	O	-	10	P	-	-

1	Four	Four	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	<num>	<num>	I-NP	I-NP	-	5	NMOD	-	-
5	mAECA	mAECA	I-NP	I-NP	-	2	PMOD	-	-
6	activated	activated	B-VP	B-VP	-	0	ROOT	-	-
7	EC	EC	B-NP	B-NP	-	6	OBJ	-	-
8	,	,	O	O	-	6	P	-	-
9	manifested	manifested	B-VP	B-VP	-	6	VMOD	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	increased	increased	B-NP	B-NP	-	15	NMOD	-	-
12	IL-6	IL-6	I-NP	I-NP	-	15	NMOD	-	-
13	and	and	I-NP	I-NP	-	15	NMOD	-	-
14	vWF	vWF	I-NP	I-NP	-	15	NMOD	-	-
15	secretion	secretion	I-NP	I-NP	-	10	PMOD	-	-
16	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	<num>	<num>	I-NP	I-NP	-	3	NMOD	-	-
3	mAECA	mAECA	I-NP	I-NP	-	4	SUB	-	-
4	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
5	EC	EC	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	12	NMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	adhesion	adhesion	B-NP	B-NP	-	9	NMOD	-	-
9	molecules	molecules	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	increased	increased	B-NP	B-NP	-	12	NMOD	-	-
12	adhesion	adhesion	I-NP	I-NP	-	4	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	U937	U937	B-NP	B-NP	-	16	NMOD	-	-
15	monocytic	monocytic	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
17	to	to	B-PP	B-PP	-	12	NMOD	-	-
18	EC	EC	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	mAECA	mAECA	I-NP	I-NP	-	6	SUB	-	-
6	stimulated	stimulated	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	nuclear	nuclear	I-NP	I-NP	-	9	NMOD	-	-
9	translocation	translocation	I-NP	I-NP	-	6	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	NF-kappaB	NF-kappaB	I-NP	I-NP	-	14	NMOD	-	-
13	transcription	transcription	I-NP	I-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	10	PMOD	-	-
15	.	.	O	O	-	6	P	-	-

1	CONCLUSION	CONCLUSION	B-NP	B-NP	-	4	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	Our	Our	B-NP	B-NP	-	4	NMOD	-	-
4	findings	findings	I-NP	I-NP	-	5	SUB	-	-
5	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	AECA	AECA	B-NP	B-NP	-	8	SUB	-	-
8	may	may	B-VP	B-VP	-	6	SBAR	-	-
9	directly	directly	I-VP	I-VP	-	8	VMOD	-	-
10	stimulate	stimulate	I-VP	I-VP	-	8	VC	-	-
11	EC	EC	B-NP	B-NP	-	10	OBJ	-	-
12	in	in	B-PP	B-PP	-	10	VMOD	-	-
13	Takayasu	Takayasu	B-NP	B-NP	-	14	NMOD	-	-
14	arteritis	arteritis	I-NP	I-NP	-	12	PMOD	-	-
15	through	through	B-PP	B-PP	-	14	NMOD	-	-
16	elevation	elevation	B-NP	B-NP	-	15	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	adhesion	adhesion	B-NP	B-NP	-	20	NMOD	-	-
19	molecule	molecule	I-NP	I-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	17	PMOD	-	-
21	associated	associated	B-VP	B-VP	-	20	NMOD	-	-
22	with	with	B-PP	B-PP	-	21	VMOD	-	-
23	NF-kappaB	NF-kappaB	B-NP	B-NP	-	24	NMOD	-	-
24	activation	activation	I-NP	I-NP	-	26	NMOD	-	-
25	and	and	O	O	-	26	NMOD	-	-
26	adhesion	adhesion	B-NP	B-NP	-	22	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	monocytes	monocytes	B-NP	B-NP	-	27	PMOD	-	-
29	,	,	O	O	-	10	P	-	-
30	and	and	O	O	-	10	VMOD	-	-
31	may	may	B-VP	B-VP	-	8	VMOD	-	-
32	therefore	therefore	I-VP	I-VP	-	31	VMOD	-	-
33	play	play	I-VP	I-VP	-	31	VC	-	-
34	a	a	B-NP	B-NP	-	36	NMOD	-	-
35	pathogenic	pathogenic	I-NP	I-NP	-	36	NMOD	-	-
36	role	role	I-NP	I-NP	-	33	OBJ	-	-
37	in	in	B-PP	B-PP	-	33	VMOD	-	-
38	the	the	B-NP	B-NP	-	39	NMOD	-	-
39	development	development	I-NP	I-NP	-	37	PMOD	-	-
40	of	of	B-PP	B-PP	-	39	NMOD	-	-
41	the	the	B-NP	B-NP	-	42	NMOD	-	-
42	vasculopathy	vasculopathy	I-NP	I-NP	-	40	PMOD	-	-
43	in	in	B-PP	B-PP	-	42	NMOD	-	-
44	Takayasu	Takayasu	B-NP	B-NP	-	45	NMOD	-	-
45	arteritis	arteritis	I-NP	I-NP	-	43	PMOD	-	-
46	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	Epstein-Barr	Epstein-Barr	I-NP	I-NP	-	4	NMOD	-	-
3	virus	virus	I-NP	I-NP	-	4	NMOD	-	-
4	oncoprotein	oncoprotein	I-NP	I-NP	-	7	NMOD	-	-
5	latent	latent	I-NP	I-NP	-	7	NMOD	-	-
6	membrane	membrane	I-NP	I-NP	-	7	NMOD	-	-
7	protein	protein	I-NP	I-NP	-	9	SUB	-	-
8	<num>	<num>	I-NP	I-NP	-	7	NMOD	-	-
9	engages	engages	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	15	NMOD	-	-
11	tumor	tumor	I-NP	I-NP	-	15	NMOD	-	-
12	necrosis	necrosis	I-NP	I-NP	-	15	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	15	NMOD	-	-
14	receptor-associated	receptor-associated	I-NP	I-NP	-	15	NMOD	-	-
15	proteins	proteins	I-NP	I-NP	-	19	NMOD	-	-
16	TRADD	TRADD	I-NP	I-NP	-	19	NMOD	-	-
17	and	and	O	O	-	19	NMOD	-	-
18	receptor-interacting	receptor-interacting	B-NP	B-NP	-	19	NMOD	-	-
19	protein	protein	I-NP	I-NP	-	9	OBJ	-	-
20	(	(	O	O	-	21	P	-	-
21	RIP	RIP	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	but	but	O	O	-	9	VMOD	-	-
24	does	does	B-VP	B-VP	-	9	VMOD	-	-
25	not	not	I-VP	I-VP	-	24	VMOD	-	-
26	induce	induce	I-VP	I-VP	-	24	VC	-	-
27	apoptosis	apoptosis	B-NP	B-NP	-	26	OBJ	-	-
28	or	or	O	O	-	24	VMOD	-	-
29	require	require	B-VP	B-VP	-	24	VC	-	-
30	RIP	RIP	B-NP	B-NP	-	29	OBJ	-	-
31	for	for	B-PP	B-PP	-	29	VMOD	-	-
32	NF-kappaB	NF-kappaB	B-NP	B-NP	-	33	NMOD	-	-
33	activation	activation	I-NP	I-NP	-	31	PMOD	-	-
34	.	.	O	O	-	9	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	site	site	I-NP	I-NP	-	39	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	Epstein-Barr	Epstein-Barr	I-NP	I-NP	-	6	NMOD	-	-
6	virus	virus	I-NP	I-NP	-	3	PMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	EBV	EBV	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	transforming	transforming	B-VP	B-VP	-	2	NMOD	-	-
11	protein	protein	B-NP	B-NP	-	12	NMOD	-	-
12	LMP1	LMP1	I-NP	I-NP	-	10	OBJ	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	constitutively	constitutively	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	associates	associates	B-VP	B-VP	-	13	SBAR	-	-
16	with	with	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	tumor	tumor	I-NP	I-NP	-	21	NMOD	-	-
19	necrosis	necrosis	I-NP	I-NP	-	21	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	21	NMOD	-	-
21	receptor	receptor	I-NP	I-NP	-	30	NMOD	-	-
22	<num>	<num>	I-NP	I-NP	-	21	NMOD	-	-
23	(	(	I-NP	I-NP	-	24	P	-	-
24	TNFR1	TNFR1	I-NP	I-NP	-	21	NMOD	-	-
25	)	)	I-NP	I-NP	-	30	P	-	-
26	-associated	-associated	I-NP	I-NP	-	30	NMOD	-	-
27	death	death	I-NP	I-NP	-	30	NMOD	-	-
28	domain	domain	I-NP	I-NP	-	30	NMOD	-	-
29	protein	protein	I-NP	I-NP	-	30	NMOD	-	-
30	TRADD	TRADD	I-NP	I-NP	-	16	PMOD	-	-
31	to	to	B-VP	B-VP	-	32	VMOD	-	-
32	mediate	mediate	I-VP	I-VP	-	30	NMOD	-	-
33	NF-kappaB	NF-kappaB	B-NP	B-NP	-	35	NMOD	-	-
34	and	and	I-NP	I-NP	-	35	NMOD	-	-
35	c-Jun	c-Jun	I-NP	I-NP	-	38	NMOD	-	-
36	N-terminal	N-terminal	I-NP	I-NP	-	38	NMOD	-	-
37	kinase	kinase	I-NP	I-NP	-	38	NMOD	-	-
38	activation	activation	I-NP	I-NP	-	39	SUB	-	-
39	is	is	B-VP	B-VP	-	0	ROOT	-	-
40	critical	critical	B-ADJP	B-ADJP	-	39	PRD	-	-
41	for	for	B-PP	B-PP	-	40	AMOD	-	-
42	long-term	long-term	B-NP	B-NP	-	45	NMOD	-	-
43	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	45	NMOD	-	-
44	cell	cell	I-NP	I-NP	-	45	NMOD	-	-
45	proliferation	proliferation	I-NP	I-NP	-	41	PMOD	-	-
46	.	.	O	O	-	39	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	now	now	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	find	find	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	LMP1	LMP1	B-NP	B-NP	-	6	NMOD	-	-
6	signaling	signaling	I-NP	I-NP	-	9	SUB	-	-
7	through	through	B-PP	B-PP	-	6	NMOD	-	-
8	TRADD	TRADD	B-NP	B-NP	-	7	PMOD	-	-
9	differs	differs	B-VP	B-VP	-	4	SBAR	-	-
10	from	from	B-PP	B-PP	-	9	VMOD	-	-
11	TNFR1	TNFR1	B-NP	B-NP	-	12	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	10	PMOD	-	-
13	through	through	B-PP	B-PP	-	9	VMOD	-	-
14	TRADD	TRADD	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	3	P	-	-

1	LMP1	LMP1	B-NP	B-NP	-	2	SUB	-	-
2	needs	needs	B-VP	B-VP	-	0	ROOT	-	-
3	only	only	B-NP	B-NP	-	6	NMOD	-	-
4	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
5	amino	amino	I-NP	I-NP	-	6	NMOD	-	-
6	acids	acids	I-NP	I-NP	-	2	OBJ	-	-
7	to	to	B-VP	B-VP	-	8	VMOD	-	-
8	activate	activate	I-VP	I-VP	-	2	VMOD	-	-
9	NF-kappaB	NF-kappaB	B-NP	B-NP	-	8	OBJ	-	-
10	or	or	O	O	-	2	VMOD	-	-
11	synergize	synergize	B-VP	B-VP	-	2	VMOD	-	-
12	with	with	B-PP	B-PP	-	11	VMOD	-	-
13	TRADD	TRADD	B-NP	B-NP	-	12	PMOD	-	-
14	in	in	B-PP	B-PP	-	11	VMOD	-	-
15	NF-kappaB	NF-kappaB	B-NP	B-NP	-	16	NMOD	-	-
16	activation	activation	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	2	P	-	-
18	while	while	B-SBAR	B-SBAR	-	2	VMOD	-	-
19	TNFR1	TNFR1	B-NP	B-NP	-	20	SUB	-	-
20	requires	requires	B-VP	B-VP	-	18	SBAR	-	-
21	approximately	approximately	B-NP	B-NP	-	23	NMOD	-	-
22	<num>	<num>	I-NP	I-NP	-	21	AMOD	-	-
23	residues	residues	I-NP	I-NP	-	20	OBJ	-	-
24	.	.	O	O	-	2	P	-	-

1	Further	Further	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	LMP1	LMP1	B-NP	B-NP	-	4	SUB	-	-
4	does	does	B-VP	B-VP	-	0	ROOT	-	-
5	not	not	I-VP	I-VP	-	4	VMOD	-	-
6	require	require	I-VP	I-VP	-	4	VC	-	-
7	TRADD	TRADD	B-NP	B-NP	-	8	NMOD	-	-
8	residues	residues	I-NP	I-NP	-	6	OBJ	-	-
9	<num>	<num>	B-NP	B-NP	-	11	NMOD	-	-
10	to	to	B-PP	B-PP	-	11	NMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	8	NMOD	-	-
12	for	for	B-PP	B-PP	-	11	NMOD	-	-
13	NF-kappaB	NF-kappaB	B-NP	B-NP	-	14	NMOD	-	-
14	activation	activation	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	4	P	-	-
16	while	while	B-SBAR	B-SBAR	-	4	VMOD	-	-
17	TNFR1	TNFR1	B-NP	B-NP	-	18	SUB	-	-
18	requires	requires	B-VP	B-VP	-	16	SBAR	-	-
19	TRADD	TRADD	B-NP	B-NP	-	20	NMOD	-	-
20	residues	residues	I-NP	I-NP	-	18	OBJ	-	-
21	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
22	to	to	B-PP	B-PP	-	23	NMOD	-	-
23	<num>	<num>	B-NP	B-NP	-	20	NMOD	-	-
24	.	.	O	O	-	4	P	-	-

1	LMP1	LMP1	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	partially	partially	I-VP	I-VP	-	2	VMOD	-	-
4	blocked	blocked	I-VP	I-VP	-	2	VC	-	-
5	for	for	B-PP	B-PP	-	4	VMOD	-	-
6	NF-kappaB	NF-kappaB	B-NP	B-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	5	PMOD	-	-
8	by	by	B-PP	B-PP	-	4	VMOD	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	TRADD	TRADD	I-NP	I-NP	-	11	NMOD	-	-
11	mutant	mutant	I-NP	I-NP	-	8	PMOD	-	-
12	consisting	consisting	B-VP	B-VP	-	11	NMOD	-	-
13	of	of	B-PP	B-PP	-	12	VMOD	-	-
14	residues	residues	B-NP	B-NP	-	13	PMOD	-	-
15	<num>	<num>	B-NP	B-NP	-	17	NMOD	-	-
16	to	to	B-PP	B-PP	-	17	NMOD	-	-
17	<num>	<num>	B-NP	B-NP	-	14	NMOD	-	-
18	.	.	O	O	-	2	P	-	-

1	Unlike	Unlike	B-PP	B-PP	-	5	VMOD	-	-
2	TNFR1	TNFR1	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	LMP1	LMP1	B-NP	B-NP	-	5	SUB	-	-
5	can	can	B-VP	B-VP	-	0	ROOT	-	-
6	interact	interact	I-VP	I-VP	-	5	VC	-	-
7	directly	directly	B-ADVP	B-ADVP	-	6	VMOD	-	-
8	with	with	B-PP	B-PP	-	6	VMOD	-	-
9	receptor-interacting	receptor-interacting	B-NP	B-NP	-	10	NMOD	-	-
10	protein	protein	I-NP	I-NP	-	8	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	RIP	RIP	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	and	and	O	O	-	6	VMOD	-	-
15	stably	stably	B-VP	B-VP	-	16	VMOD	-	-
16	associates	associates	I-VP	I-VP	-	6	VMOD	-	-
17	with	with	B-PP	B-PP	-	16	VMOD	-	-
18	RIP	RIP	B-NP	B-NP	-	17	PMOD	-	-
19	in	in	B-PP	B-PP	-	6	VMOD	-	-
20	EBV-transformed	EBV-transformed	B-NP	B-NP	-	23	NMOD	-	-
21	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	23	NMOD	-	-
22	cell	cell	I-NP	I-NP	-	23	NMOD	-	-
23	lines	lines	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	Surprisingly	Surprisingly	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	LMP1	LMP1	B-NP	B-NP	-	4	SUB	-	-
4	does	does	B-VP	B-VP	-	0	ROOT	-	-
5	not	not	I-VP	I-VP	-	4	VMOD	-	-
6	require	require	I-VP	I-VP	-	4	VC	-	-
7	RIP	RIP	B-NP	B-NP	-	6	OBJ	-	-
8	for	for	B-PP	B-PP	-	6	VMOD	-	-
9	NF-kappaB	NF-kappaB	B-NP	B-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	8	PMOD	-	-
11	.	.	O	O	-	4	P	-	-

1	Despite	Despite	B-PP	B-PP	-	10	VMOD	-	-
2	constitutive	constitutive	B-NP	B-NP	-	3	NMOD	-	-
3	association	association	I-NP	I-NP	-	1	PMOD	-	-
4	with	with	B-PP	B-PP	-	3	NMOD	-	-
5	TRADD	TRADD	B-NP	B-NP	-	7	NMOD	-	-
6	or	or	I-NP	I-NP	-	7	NMOD	-	-
7	RIP	RIP	I-NP	I-NP	-	4	PMOD	-	-
8	,	,	O	O	-	10	P	-	-
9	LMP1	LMP1	B-NP	B-NP	-	10	SUB	-	-
10	does	does	B-VP	B-VP	-	0	ROOT	-	-
11	not	not	I-VP	I-VP	-	10	VMOD	-	-
12	induce	induce	I-VP	I-VP	-	10	VC	-	-
13	apoptosis	apoptosis	B-NP	B-NP	-	12	OBJ	-	-
14	in	in	B-PP	B-PP	-	12	VMOD	-	-
15	EBV-negative	EBV-negative	B-NP	B-NP	-	17	NMOD	-	-
16	Burkitt	Burkitt	I-NP	I-NP	-	17	NMOD	-	-
17	lymphoma	lymphoma	I-NP	I-NP	-	23	NMOD	-	-
18	or	or	O	O	-	23	NMOD	-	-
19	human	human	B-NP	B-NP	-	23	NMOD	-	-
20	embryonic	embryonic	I-NP	I-NP	-	23	NMOD	-	-
21	kidney	kidney	I-NP	I-NP	-	23	NMOD	-	-
22	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
24	.	.	O	O	-	10	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	add	add	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	different	different	I-NP	I-NP	-	6	NMOD	-	-
6	perspective	perspective	I-NP	I-NP	-	3	OBJ	-	-
7	to	to	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	molecular	molecular	I-NP	I-NP	-	10	NMOD	-	-
10	interactions	interactions	I-NP	I-NP	-	7	PMOD	-	-
11	through	through	B-PP	B-PP	-	10	NMOD	-	-
12	which	which	B-NP	B-NP	-	11	PMOD	-	-
13	LMP1	LMP1	B-NP	B-NP	-	18	NMOD	-	-
14	,	,	O	O	-	18	P	-	-
15	TRADD	TRADD	B-NP	B-NP	-	18	NMOD	-	-
16	,	,	O	O	-	18	P	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	RIP	RIP	B-NP	B-NP	-	11	PMOD	-	-
19	participate	participate	B-VP	B-VP	-	11	SBAR	-	-
20	in	in	B-PP	B-PP	-	19	VMOD	-	-
21	B-lymphocyte	B-lymphocyte	B-NP	B-NP	-	22	NMOD	-	-
22	activation	activation	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	growth	growth	B-NP	B-NP	-	20	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Regulatory	Regulatory	B-NP	B-NP	-	2	NMOD	-	-
2	effects	effects	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	interleukin-11	interleukin-11	B-NP	B-NP	-	3	PMOD	-	-
5	during	during	B-PP	B-PP	-	2	NMOD	-	-
6	acute	acute	B-NP	B-NP	-	9	NMOD	-	-
7	lung	lung	I-NP	I-NP	-	9	NMOD	-	-
8	inflammatory	inflammatory	I-NP	I-NP	-	9	NMOD	-	-
9	injury	injury	I-NP	I-NP	-	5	PMOD	-	-
10	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	interleukin-11	interleukin-11	B-NP	B-NP	-	3	PMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	IL-11	IL-11	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	evaluated	evaluated	I-VP	I-VP	-	8	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	IgG	IgG	I-NP	I-NP	-	15	NMOD	-	-
13	immune	immune	I-NP	I-NP	-	15	NMOD	-	-
14	complex	complex	I-NP	I-NP	-	15	NMOD	-	-
15	model	model	I-NP	I-NP	-	10	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	acute	acute	B-NP	B-NP	-	19	NMOD	-	-
18	lung	lung	I-NP	I-NP	-	19	NMOD	-	-
19	injury	injury	I-NP	I-NP	-	16	PMOD	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	rats	rats	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	IL-11	IL-11	B-NP	B-NP	-	2	NMOD	-	-
2	mRNA	mRNA	I-NP	I-NP	-	4	NMOD	-	-
3	and	and	I-NP	I-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	5	SUB	-	-
5	were	were	B-VP	B-VP	-	0	ROOT	-	-
6	both	both	O	O	-	5	PRD	-	-
7	up-regulated	up-regulated	B-VP	B-VP	-	5	VC	-	-
8	during	during	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	course	course	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	this	this	B-NP	B-NP	-	14	NMOD	-	-
13	inflammatory	inflammatory	I-NP	I-NP	-	14	NMOD	-	-
14	response	response	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	5	P	-	-

1	Exogenously	Exogenously	B-NP	B-NP	-	2	AMOD	-	-
2	administered	administered	I-NP	I-NP	-	3	NMOD	-	-
3	IL-11	IL-11	I-NP	I-NP	-	5	SUB	-	-
4	substantially	substantially	B-VP	B-VP	-	5	VMOD	-	-
5	reduced	reduced	I-VP	I-VP	-	0	ROOT	-	-
6	,	,	O	O	-	5	P	-	-
7	in	in	B-PP	B-PP	-	5	VMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	dose-dependent	dose-dependent	I-NP	I-NP	-	10	NMOD	-	-
10	manner	manner	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	5	P	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	intrapulmonary	intrapulmonary	I-NP	I-NP	-	14	NMOD	-	-
14	accumulation	accumulation	I-NP	I-NP	-	21	NMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	neutrophils	neutrophils	B-NP	B-NP	-	15	PMOD	-	-
17	and	and	O	O	-	21	NMOD	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	lung	lung	I-NP	I-NP	-	21	NMOD	-	-
20	vascular	vascular	I-NP	I-NP	-	21	NMOD	-	-
21	leak	leak	I-NP	I-NP	-	5	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	albumin	albumin	B-NP	B-NP	-	22	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	5	NMOD	-	-
2	in	in	I-NP	I-NP	-	3	AMOD	-	-
3	vivo	vivo	I-NP	I-NP	-	5	NMOD	-	-
4	anti-inflammatory	anti-inflammatory	I-NP	I-NP	-	5	NMOD	-	-
5	effects	effects	I-NP	I-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	IL-11	IL-11	B-NP	B-NP	-	6	PMOD	-	-
8	were	were	B-VP	B-VP	-	0	ROOT	-	-
9	associated	associated	I-VP	I-VP	-	8	VC	-	-
10	with	with	B-PP	B-PP	-	9	VMOD	-	-
11	reduced	reduced	B-NP	B-NP	-	13	NMOD	-	-
12	NF-kappaB	NF-kappaB	I-NP	I-NP	-	13	NMOD	-	-
13	activation	activation	I-NP	I-NP	-	10	PMOD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	lung	lung	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	8	P	-	-
17	reduced	reduced	B-VP	B-VP	-	8	VMOD	-	-
18	levels	levels	B-NP	B-NP	-	17	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	tumor	tumor	B-NP	B-NP	-	23	NMOD	-	-
21	necrosis	necrosis	I-NP	I-NP	-	23	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	23	NMOD	-	-
23	alpha	alpha	I-NP	I-NP	-	19	PMOD	-	-
24	(	(	O	O	-	25	P	-	-
25	TNF-alpha	TNF-alpha	B-NP	B-NP	-	23	NMOD	-	-
26	)	)	O	O	-	25	P	-	-
27	in	in	B-PP	B-PP	-	18	NMOD	-	-
28	bronchoalveolar	bronchoalveolar	B-NP	B-NP	-	33	NMOD	-	-
29	lavage	lavage	I-NP	I-NP	-	33	NMOD	-	-
30	(	(	O	O	-	31	P	-	-
31	BAL	BAL	B-NP	B-NP	-	29	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	fluids	fluids	B-NP	B-NP	-	27	PMOD	-	-
34	,	,	O	O	-	37	P	-	-
35	and	and	O	O	-	37	NMOD	-	-
36	diminished	diminished	B-VP	B-VP	-	37	NMOD	-	-
37	up-regulation	up-regulation	B-NP	B-NP	-	27	PMOD	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	lung	lung	B-NP	B-NP	-	41	NMOD	-	-
40	vascular	vascular	I-NP	I-NP	-	41	NMOD	-	-
41	ICAM-1	ICAM-1	I-NP	I-NP	-	38	PMOD	-	-
42	.	.	O	O	-	8	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	interesting	interesting	B-ADJP	B-ADJP	-	2	PRD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	IL-11	IL-11	B-NP	B-NP	-	6	SUB	-	-
6	did	did	B-VP	B-VP	-	4	SBAR	-	-
7	not	not	I-VP	I-VP	-	6	VMOD	-	-
8	affect	affect	I-VP	I-VP	-	6	VC	-	-
9	BAL	BAL	B-NP	B-NP	-	11	NMOD	-	-
10	fluid	fluid	I-NP	I-NP	-	11	NMOD	-	-
11	content	content	I-NP	I-NP	-	8	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	CXC	CXC	I-NP	I-NP	-	15	NMOD	-	-
15	chemokines	chemokines	I-NP	I-NP	-	12	PMOD	-	-
16	,	,	O	O	-	26	P	-	-
17	macrophage	macrophage	B-NP	B-NP	-	19	NMOD	-	-
18	inflammatory	inflammatory	I-NP	I-NP	-	19	NMOD	-	-
19	protein-2	protein-2	I-NP	I-NP	-	26	NMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	MIP-2	MIP-2	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	and	and	O	O	-	26	NMOD	-	-
24	cytokine-inducible	cytokine-inducible	B-NP	B-NP	-	26	NMOD	-	-
25	neutrophil	neutrophil	I-NP	I-NP	-	26	NMOD	-	-
26	chemoattractant	chemoattractant	I-NP	I-NP	-	12	PMOD	-	-
27	(	(	O	O	-	28	P	-	-
28	CINC	CINC	B-NP	B-NP	-	26	NMOD	-	-
29	)	)	O	O	-	28	P	-	-
30	;	;	O	O	-	35	P	-	-
31	the	the	B-NP	B-NP	-	32	NMOD	-	-
32	presence	presence	I-NP	I-NP	-	35	SUB	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	IL-11	IL-11	B-NP	B-NP	-	33	PMOD	-	-
35	did	did	B-VP	B-VP	-	4	SBAR	-	-
36	not	not	I-VP	I-VP	-	35	VMOD	-	-
37	affect	affect	I-VP	I-VP	-	35	VC	-	-
38	these	these	B-NP	B-NP	-	39	NMOD	-	-
39	chemokines	chemokines	I-NP	I-NP	-	37	OBJ	-	-
40	.	.	O	O	-	2	P	-	-

1	However	However	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	BAL	BAL	B-NP	B-NP	-	4	NMOD	-	-
4	content	content	I-NP	I-NP	-	7	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	C5a	C5a	B-NP	B-NP	-	5	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	reduced	reduced	I-VP	I-VP	-	7	VC	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	IL-11	IL-11	B-NP	B-NP	-	9	PMOD	-	-
11	.	.	O	O	-	7	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	14	DEP	-	-
5	IL-11	IL-11	B-NP	B-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	4	SBAR	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	regulatory	regulatory	I-NP	I-NP	-	9	NMOD	-	-
9	cytokine	cytokine	I-NP	I-NP	-	6	PRD	-	-
10	in	in	B-PP	B-PP	-	6	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	lung	lung	I-NP	I-NP	-	10	PMOD	-	-
13	and	and	O	O	-	14	DEP	-	-
14	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	like	like	B-PP	B-PP	-	26	VMOD	-	-
17	other	other	B-NP	B-NP	-	18	NMOD	-	-
18	members	members	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	this	this	B-NP	B-NP	-	21	NMOD	-	-
21	family	family	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	26	P	-	-
23	its	its	B-NP	B-NP	-	25	NMOD	-	-
24	anti-inflammatory	anti-inflammatory	I-NP	I-NP	-	25	NMOD	-	-
25	properties	properties	I-NP	I-NP	-	26	SUB	-	-
26	appear	appear	B-VP	B-VP	-	14	SBAR	-	-
27	to	to	I-VP	I-VP	-	28	VMOD	-	-
28	be	be	I-VP	I-VP	-	26	VMOD	-	-
29	linked	linked	I-VP	I-VP	-	28	VC	-	-
30	to	to	B-PP	B-PP	-	29	VMOD	-	-
31	its	its	B-NP	B-NP	-	32	NMOD	-	-
32	suppression	suppression	I-NP	I-NP	-	30	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	NF-kappaB	NF-kappaB	B-NP	B-NP	-	35	NMOD	-	-
35	activation	activation	I-NP	I-NP	-	33	PMOD	-	-
36	,	,	O	O	-	26	P	-	-
37	diminished	diminished	B-VP	B-VP	-	14	SBAR	-	-
38	production	production	B-NP	B-NP	-	37	OBJ	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	TNF-alpha	TNF-alpha	B-NP	B-NP	-	39	PMOD	-	-
41	,	,	O	O	-	44	P	-	-
42	and	and	O	O	-	44	NMOD	-	-
43	reduced	reduced	B-NP	B-NP	-	44	NMOD	-	-
44	up-regulation	up-regulation	I-NP	I-NP	-	39	PMOD	-	-
45	of	of	B-PP	B-PP	-	44	NMOD	-	-
46	lung	lung	B-NP	B-NP	-	48	NMOD	-	-
47	vascular	vascular	I-NP	I-NP	-	48	NMOD	-	-
48	ICAM-1	ICAM-1	I-NP	I-NP	-	45	PMOD	-	-
49	.	.	O	O	-	3	P	-	-

1	ETS	ETS	B-NP	B-NP	-	3	NMOD	-	-
2	transcription	transcription	I-NP	I-NP	-	3	NMOD	-	-
3	factors	factors	I-NP	I-NP	-	4	SUB	-	-
4	regulate	regulate	B-VP	B-VP	-	0	ROOT	-	-
5	an	an	B-NP	B-NP	-	7	NMOD	-	-
6	enhancer	enhancer	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	4	OBJ	-	-
8	in	in	B-PP	B-PP	-	4	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	third	third	I-NP	I-NP	-	11	NMOD	-	-
11	intron	intron	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	TNF-alpha	TNF-alpha	B-NP	B-NP	-	12	PMOD	-	-
14	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	describe	describe	B-VP	B-VP	-	0	ROOT	-	-
3	an	an	B-NP	B-NP	-	5	NMOD	-	-
4	enhancer	enhancer	I-NP	I-NP	-	5	NMOD	-	-
5	site	site	I-NP	I-NP	-	2	OBJ	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	third	third	I-NP	I-NP	-	9	NMOD	-	-
9	intron	intron	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	tumor	tumor	B-NP	B-NP	-	14	NMOD	-	-
12	necrosis	necrosis	I-NP	I-NP	-	14	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	14	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	10	PMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	TNF-alpha	TNF-alpha	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	.	.	O	O	-	2	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	reporter	reporter	I-NP	I-NP	-	3	NMOD	-	-
3	construct	construct	I-NP	I-NP	-	13	SUB	-	-
4	containing	containing	B-VP	B-VP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	5'-flanking	5'-flanking	I-NP	I-NP	-	7	NMOD	-	-
7	region	region	I-NP	I-NP	-	4	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	mouse	mouse	I-NP	I-NP	-	12	NMOD	-	-
11	TNF-alpha	TNF-alpha	I-NP	I-NP	-	12	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	8	PMOD	-	-
13	displayed	displayed	B-VP	B-VP	-	0	ROOT	-	-
14	weak	weak	B-NP	B-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	13	OBJ	-	-
16	when	when	B-ADVP	B-ADVP	-	13	VMOD	-	-
17	transfected	transfected	B-VP	B-VP	-	16	SBAR	-	-
18	into	into	B-PP	B-PP	-	17	VMOD	-	-
19	RAW264.7	RAW264.7	B-NP	B-NP	-	21	NMOD	-	-
20	macrophage-like	macrophage-like	I-NP	I-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
22	.	.	O	O	-	13	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	addition	addition	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	third	third	I-NP	I-NP	-	6	NMOD	-	-
6	intron	intron	I-NP	I-NP	-	3	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	TNF-alpha	TNF-alpha	B-NP	B-NP	-	7	PMOD	-	-
9	to	to	B-PP	B-PP	-	2	NMOD	-	-
10	this	this	B-NP	B-NP	-	11	NMOD	-	-
11	construct	construct	I-NP	I-NP	-	9	PMOD	-	-
12	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	an	an	B-NP	B-NP	-	15	NMOD	-	-
15	enhancement	enhancement	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	CAT	CAT	B-NP	B-NP	-	18	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	12	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	enhancement	enhancement	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	eliminated	eliminated	I-VP	I-VP	-	3	VC	-	-
5	if	if	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	9	NMOD	-	-
7	conserved	conserved	I-NP	I-NP	-	9	NMOD	-	-
8	20-bp	20-bp	I-NP	I-NP	-	9	NMOD	-	-
9	sequence	sequence	I-NP	I-NP	-	5	PMOD	-	-
10	was	was	B-VP	B-VP	-	5	SBAR	-	-
11	removed	removed	I-VP	I-VP	-	10	VC	-	-
12	from	from	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	intron	intron	I-NP	I-NP	-	12	PMOD	-	-
15	or	or	O	O	-	16	DEP	-	-
16	if	if	B-SBAR	B-SBAR	-	11	VMOD	-	-
17	a	a	B-NP	B-NP	-	20	NMOD	-	-
18	dominant-negative	dominant-negative	I-NP	I-NP	-	20	NMOD	-	-
19	ets-binding	ets-binding	I-NP	I-NP	-	20	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	21	SUB	-	-
21	was	was	B-VP	B-VP	-	16	SBAR	-	-
22	co-transfected	co-transfected	I-VP	I-VP	-	21	VC	-	-
23	with	with	B-PP	B-PP	-	22	VMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	reporter	reporter	I-NP	I-NP	-	26	NMOD	-	-
26	gene	gene	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	Mutations	Mutations	B-NP	B-NP	-	13	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	this	this	B-NP	B-NP	-	4	NMOD	-	-
4	site	site	I-NP	I-NP	-	2	PMOD	-	-
5	that	that	B-NP	B-NP	-	4	NMOD	-	-
6	destroyed	destroyed	B-VP	B-VP	-	5	SBAR	-	-
7	potential	potential	B-NP	B-NP	-	12	NMOD	-	-
8	ets	ets	I-NP	I-NP	-	12	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	12	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	12	NMOD	-	-
11	binding	binding	I-NP	I-NP	-	12	NMOD	-	-
12	sites	sites	I-NP	I-NP	-	2	PMOD	-	-
13	had	had	B-VP	B-VP	-	0	ROOT	-	-
14	reduced	reduced	I-VP	I-VP	-	16	NMOD	-	-
15	transcriptional	transcriptional	B-NP	B-NP	-	16	NMOD	-	-
16	activity	activity	I-NP	I-NP	-	13	OBJ	-	-
17	.	.	O	O	-	13	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	major	major	I-NP	I-NP	-	4	NMOD	-	-
3	transcription	transcription	I-NP	I-NP	-	4	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	10	SUB	-	-
5	that	that	B-NP	B-NP	-	4	NMOD	-	-
6	bound	bound	B-VP	B-VP	-	5	SBAR	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	oligonucleotide	oligonucleotide	I-NP	I-NP	-	7	PMOD	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	confirmed	confirmed	I-VP	I-VP	-	10	VC	-	-
12	to	to	I-VP	I-VP	-	13	VMOD	-	-
13	be	be	I-VP	I-VP	-	11	VMOD	-	-
14	GABP	GABP	B-NP	B-NP	-	13	PRD	-	-
15	by	by	B-PP	B-PP	-	13	VMOD	-	-
16	supershift	supershift	B-NP	B-NP	-	19	NMOD	-	-
17	and	and	I-NP	I-NP	-	19	NMOD	-	-
18	competition	competition	I-NP	I-NP	-	19	NMOD	-	-
19	analysis	analysis	I-NP	I-NP	-	15	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	RAW264.7	RAW264.7	B-NP	B-NP	-	3	NMOD	-	-
3	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	7	P	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	binding	binding	I-NP	I-NP	-	7	SUB	-	-
7	was	was	B-VP	B-VP	-	18	VMOD	-	-
8	constitutive	constitutive	B-ADJP	B-ADJP	-	7	PRD	-	-
9	,	,	O	O	-	18	P	-	-
10	however	however	B-ADVP	B-ADVP	-	18	VMOD	-	-
11	,	,	O	O	-	18	P	-	-
12	in	in	B-PP	B-PP	-	18	VMOD	-	-
13	bone	bone	B-NP	B-NP	-	15	NMOD	-	-
14	marrow-derived	marrow-derived	I-NP	I-NP	-	15	NMOD	-	-
15	macrophages	macrophages	I-NP	I-NP	-	12	PMOD	-	-
16	binding	binding	I-NP	I-NP	-	17	NMOD	-	-
17	activity	activity	I-NP	I-NP	-	18	SUB	-	-
18	was	was	B-VP	B-VP	-	0	ROOT	-	-
19	shown	shown	I-VP	I-VP	-	18	VC	-	-
20	to	to	I-VP	I-VP	-	21	VMOD	-	-
21	be	be	I-VP	I-VP	-	19	VMOD	-	-
22	interferon-gamma	interferon-gamma	B-NP	B-NP	-	21	PRD	-	-
23	inducible	inducible	B-ADJP	B-ADJP	-	22	AMOD	-	-
24	.	.	O	O	-	18	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	may	may	B-VP	B-VP	-	0	ROOT	-	-
3	imply	imply	I-VP	I-VP	-	2	VC	-	-
4	a	a	B-NP	B-NP	-	5	NMOD	-	-
5	role	role	I-NP	I-NP	-	3	OBJ	-	-
6	for	for	B-PP	B-PP	-	5	NMOD	-	-
7	ets	ets	B-NP	B-NP	-	9	NMOD	-	-
8	transcription	transcription	I-NP	I-NP	-	9	NMOD	-	-
9	factors	factors	I-NP	I-NP	-	6	PMOD	-	-
10	in	in	B-PP	B-PP	-	5	NMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	production	production	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	TNF-alpha	TNF-alpha	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	Abnormal	Abnormal	B-NP	B-NP	-	4	NMOD	-	-
2	NF-kappa	NF-kappa	I-NP	I-NP	-	4	NMOD	-	-
3	B	B	I-NP	I-NP	-	4	NMOD	-	-
4	activity	activity	I-NP	I-NP	-	14	SUB	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	T	T	B-NP	B-NP	-	7	NMOD	-	-
7	lymphocytes	lymphocytes	I-NP	I-NP	-	5	PMOD	-	-
8	from	from	B-PP	B-PP	-	7	NMOD	-	-
9	patients	patients	B-NP	B-NP	-	8	PMOD	-	-
10	with	with	B-PP	B-PP	-	9	NMOD	-	-
11	systemic	systemic	B-NP	B-NP	-	13	NMOD	-	-
12	lupus	lupus	I-NP	I-NP	-	13	NMOD	-	-
13	erythematosus	erythematosus	I-NP	I-NP	-	10	PMOD	-	-
14	is	is	B-VP	B-VP	-	0	ROOT	-	-
15	associated	associated	I-VP	I-VP	-	14	VC	-	-
16	with	with	B-PP	B-PP	-	15	VMOD	-	-
17	decreased	decreased	B-NP	B-NP	-	20	NMOD	-	-
18	p65-RelA	p65-RelA	I-NP	I-NP	-	20	NMOD	-	-
19	protein	protein	I-NP	I-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	14	P	-	-

1	Numerous	Numerous	B-NP	B-NP	-	5	NMOD	-	-
2	cellular	cellular	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	biochemical	biochemical	I-NP	I-NP	-	5	NMOD	-	-
5	abnormalities	abnormalities	I-NP	I-NP	-	9	SUB	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	immune	immune	B-NP	B-NP	-	8	NMOD	-	-
8	regulation	regulation	I-NP	I-NP	-	6	PMOD	-	-
9	have	have	B-VP	B-VP	-	0	ROOT	-	-
10	been	been	I-VP	I-VP	-	9	VC	-	-
11	described	described	I-VP	I-VP	-	10	VC	-	-
12	in	in	B-PP	B-PP	-	11	VMOD	-	-
13	patients	patients	B-NP	B-NP	-	12	PMOD	-	-
14	with	with	B-PP	B-PP	-	13	NMOD	-	-
15	systemic	systemic	B-NP	B-NP	-	17	NMOD	-	-
16	lupus	lupus	I-NP	I-NP	-	17	NMOD	-	-
17	erythematosus	erythematosus	I-NP	I-NP	-	27	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	SLE	SLE	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	27	P	-	-
22	including	including	B-PP	B-PP	-	27	NMOD	-	-
23	surface	surface	B-NP	B-NP	-	27	NMOD	-	-
24	Ag	Ag	I-NP	I-NP	-	27	NMOD	-	-
25	receptor-initiated	receptor-initiated	I-NP	I-NP	-	27	NMOD	-	-
26	signaling	signaling	I-NP	I-NP	-	27	NMOD	-	-
27	events	events	I-NP	I-NP	-	30	NMOD	-	-
28	and	and	O	O	-	30	NMOD	-	-
29	lymphokine	lymphokine	B-NP	B-NP	-	30	NMOD	-	-
30	production	production	I-NP	I-NP	-	14	PMOD	-	-
31	.	.	O	O	-	9	P	-	-

1	Because	Because	B-SBAR	B-SBAR	-	26	VMOD	-	-
2	NF-kappa	NF-kappa	B-NP	B-NP	-	3	NMOD	-	-
3	B	B	I-NP	I-NP	-	4	SUB	-	-
4	contributes	contributes	B-VP	B-VP	-	1	SBAR	-	-
5	to	to	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	transcription	transcription	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	numerous	numerous	B-NP	B-NP	-	11	NMOD	-	-
10	inflammatory	inflammatory	I-NP	I-NP	-	11	NMOD	-	-
11	genes	genes	I-NP	I-NP	-	8	PMOD	-	-
12	and	and	O	O	-	4	VMOD	-	-
13	has	has	B-VP	B-VP	-	4	VMOD	-	-
14	been	been	I-VP	I-VP	-	13	VC	-	-
15	shown	shown	I-VP	I-VP	-	14	VC	-	-
16	to	to	I-VP	I-VP	-	17	VMOD	-	-
17	be	be	I-VP	I-VP	-	15	VMOD	-	-
18	a	a	B-NP	B-NP	-	20	NMOD	-	-
19	molecular	molecular	I-NP	I-NP	-	20	NMOD	-	-
20	target	target	I-NP	I-NP	-	17	PRD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	antiinflammatory	antiinflammatory	B-NP	B-NP	-	23	NMOD	-	-
23	drugs	drugs	I-NP	I-NP	-	21	PMOD	-	-
24	,	,	O	O	-	26	P	-	-
25	we	we	B-NP	B-NP	-	26	SUB	-	-
26	sought	sought	B-VP	B-VP	-	0	ROOT	-	-
27	to	to	I-VP	I-VP	-	28	VMOD	-	-
28	characterize	characterize	I-VP	I-VP	-	26	VMOD	-	-
29	the	the	B-NP	B-NP	-	31	NMOD	-	-
30	functional	functional	I-NP	I-NP	-	31	NMOD	-	-
31	role	role	I-NP	I-NP	-	28	OBJ	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	37	NMOD	-	-
34	NF-kappa	NF-kappa	I-NP	I-NP	-	37	NMOD	-	-
35	B	B	I-NP	I-NP	-	37	NMOD	-	-
36	protein	protein	I-NP	I-NP	-	37	NMOD	-	-
37	complex	complex	I-NP	I-NP	-	32	PMOD	-	-
38	in	in	B-PP	B-PP	-	31	NMOD	-	-
39	lupus	lupus	B-NP	B-NP	-	41	NMOD	-	-
40	T	T	I-NP	I-NP	-	41	NMOD	-	-
41	cells	cells	I-NP	I-NP	-	38	PMOD	-	-
42	.	.	O	O	-	26	P	-	-

1	Freshly	Freshly	B-NP	B-NP	-	2	AMOD	-	-
2	isolated	isolated	I-NP	I-NP	-	4	NMOD	-	-
3	T	T	I-NP	I-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	19	SUB	-	-
5	from	from	B-PP	B-PP	-	4	NMOD	-	-
6	lupus	lupus	B-NP	B-NP	-	7	NMOD	-	-
7	patients	patients	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	19	P	-	-
9	rheumatoid	rheumatoid	B-NP	B-NP	-	10	NMOD	-	-
10	arthritis	arthritis	I-NP	I-NP	-	14	NMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	RA	RA	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	patients	patients	B-NP	B-NP	-	19	SUB	-	-
15	,	,	O	O	-	19	P	-	-
16	and	and	O	O	-	19	VMOD	-	-
17	normal	normal	B-NP	B-NP	-	18	NMOD	-	-
18	individuals	individuals	I-NP	I-NP	-	19	SUB	-	-
19	were	were	B-VP	B-VP	-	0	ROOT	-	-
20	activated	activated	I-VP	I-VP	-	19	VC	-	-
21	physiologically	physiologically	B-ADVP	B-ADVP	-	20	VMOD	-	-
22	via	via	B-PP	B-PP	-	20	VMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	TCR	TCR	I-NP	I-NP	-	22	PMOD	-	-
25	with	with	B-PP	B-PP	-	24	NMOD	-	-
26	anti-CD3	anti-CD3	B-NP	B-NP	-	29	NMOD	-	-
27	and	and	I-NP	I-NP	-	29	NMOD	-	-
28	anti-CD28	anti-CD28	I-NP	I-NP	-	29	NMOD	-	-
29	Abs	Abs	I-NP	I-NP	-	25	PMOD	-	-
30	to	to	B-VP	B-VP	-	31	VMOD	-	-
31	assess	assess	I-VP	I-VP	-	24	NMOD	-	-
32	proximal	proximal	B-NP	B-NP	-	34	NMOD	-	-
33	membrane	membrane	I-NP	I-NP	-	34	NMOD	-	-
34	signaling	signaling	I-NP	I-NP	-	31	OBJ	-	-
35	,	,	O	O	-	22	P	-	-
36	and	and	O	O	-	22	PMOD	-	-
37	with	with	B-PP	B-PP	-	22	PMOD	-	-
38	PMA	PMA	B-NP	B-NP	-	42	NMOD	-	-
39	and	and	O	O	-	42	NMOD	-	-
40	a	a	B-NP	B-NP	-	42	NMOD	-	-
41	calcium	calcium	I-NP	I-NP	-	42	NMOD	-	-
42	ionophore	ionophore	I-NP	I-NP	-	37	PMOD	-	-
43	(	(	O	O	-	44	P	-	-
44	A23187	A23187	B-NP	B-NP	-	42	NMOD	-	-
45	)	)	O	O	-	44	P	-	-
46	to	to	B-VP	B-VP	-	47	VMOD	-	-
47	bypass	bypass	I-VP	I-VP	-	42	NMOD	-	-
48	membrane-mediated	membrane-mediated	B-NP	B-NP	-	50	NMOD	-	-
49	signaling	signaling	I-NP	I-NP	-	50	NMOD	-	-
50	events	events	I-NP	I-NP	-	47	OBJ	-	-
51	.	.	O	O	-	19	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	measured	measured	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	NF-kappa	NF-kappa	I-NP	I-NP	-	7	NMOD	-	-
5	B	B	I-NP	I-NP	-	7	NMOD	-	-
6	binding	binding	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	2	OBJ	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	nuclear	nuclear	B-NP	B-NP	-	10	NMOD	-	-
10	extracts	extracts	I-NP	I-NP	-	8	PMOD	-	-
11	by	by	B-PP	B-PP	-	2	VMOD	-	-
12	gel	gel	B-NP	B-NP	-	14	NMOD	-	-
13	shift	shift	I-NP	I-NP	-	14	NMOD	-	-
14	analysis	analysis	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	When	When	B-ADVP	B-ADVP	-	16	VMOD	-	-
2	compared	compared	B-PP	B-PP	-	1	SBAR	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	normal	normal	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
6	,	,	O	O	-	16	P	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	16	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	8	NMOD	-	-
14	SLE	SLE	B-NP	B-NP	-	15	NMOD	-	-
15	patients	patients	I-NP	I-NP	-	13	PMOD	-	-
16	was	was	B-VP	B-VP	-	0	ROOT	-	-
17	significantly	significantly	I-VP	I-VP	-	16	VMOD	-	-
18	decreased	decreased	I-VP	I-VP	-	16	VC	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	SLE	SLE	B-NP	B-NP	-	19	PMOD	-	-
21	,	,	B-PP	B-PP	-	19	P	-	-
22	but	but	I-PP	I-PP	-	19	PMOD	-	-
23	not	not	B-PP	B-PP	-	24	PMOD	-	-
24	in	in	I-PP	I-PP	-	19	PMOD	-	-
25	RA	RA	B-NP	B-NP	-	27	NMOD	-	-
26	,	,	O	O	-	27	P	-	-
27	patients	patients	B-NP	B-NP	-	24	PMOD	-	-
28	.	.	O	O	-	16	P	-	-

1	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
2	B	B	I-NP	I-NP	-	4	NMOD	-	-
3	binding	binding	I-NP	I-NP	-	4	NMOD	-	-
4	activity	activity	I-NP	I-NP	-	5	SUB	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	absent	absent	B-ADJP	B-ADJP	-	5	PRD	-	-
7	in	in	B-PP	B-PP	-	6	AMOD	-	-
8	several	several	B-NP	B-NP	-	10	NMOD	-	-
9	SLE	SLE	I-NP	I-NP	-	10	NMOD	-	-
10	patients	patients	I-NP	I-NP	-	7	PMOD	-	-
11	who	who	B-NP	B-NP	-	10	NMOD	-	-
12	were	were	B-VP	B-VP	-	11	SBAR	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	receiving	receiving	I-VP	I-VP	-	12	VMOD	-	-
15	any	any	B-NP	B-NP	-	16	NMOD	-	-
16	medication	medication	I-NP	I-NP	-	14	OBJ	-	-
17	,	,	O	O	-	5	P	-	-
18	including	including	B-PP	B-PP	-	19	NMOD	-	-
19	corticosteroids	corticosteroids	B-NP	B-NP	-	5	PRD	-	-
20	.	.	O	O	-	5	P	-	-

1	Also	Also	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
4	B	B	I-NP	I-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	6	SUB	-	-
6	remained	remained	B-VP	B-VP	-	0	ROOT	-	-
7	absent	absent	B-ADJP	B-ADJP	-	6	PRD	-	-
8	in	in	B-PP	B-PP	-	7	AMOD	-	-
9	follow-up	follow-up	B-NP	B-NP	-	10	NMOD	-	-
10	studies	studies	I-NP	I-NP	-	8	PMOD	-	-
11	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	9	VMOD	-	-
2	supershift	supershift	B-NP	B-NP	-	3	NMOD	-	-
3	experiments	experiments	I-NP	I-NP	-	1	PMOD	-	-
4	using	using	B-VP	B-VP	-	3	NMOD	-	-
5	specific	specific	B-NP	B-NP	-	6	NMOD	-	-
6	Abs	Abs	I-NP	I-NP	-	4	OBJ	-	-
7	,	,	O	O	-	9	P	-	-
8	we	we	B-NP	B-NP	-	9	SUB	-	-
9	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
10	that	that	B-SBAR	B-SBAR	-	9	VMOD	-	-
11	,	,	O	O	-	19	P	-	-
12	in	in	B-PP	B-PP	-	19	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	group	group	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	SLE	SLE	B-NP	B-NP	-	17	NMOD	-	-
17	patients	patients	I-NP	I-NP	-	15	PMOD	-	-
18	who	who	B-NP	B-NP	-	17	NMOD	-	-
19	displayed	displayed	B-VP	B-VP	-	10	SBAR	-	-
20	undetectable	undetectable	B-NP	B-NP	-	23	NMOD	-	-
21	NF-kappa	NF-kappa	I-NP	I-NP	-	23	NMOD	-	-
22	B	B	I-NP	I-NP	-	23	NMOD	-	-
23	activity	activity	I-NP	I-NP	-	19	OBJ	-	-
24	,	,	O	O	-	27	P	-	-
25	p65	p65	B-NP	B-NP	-	26	NMOD	-	-
26	complexes	complexes	I-NP	I-NP	-	27	SUB	-	-
27	were	were	B-VP	B-VP	-	10	SBAR	-	-
28	not	not	I-VP	I-VP	-	27	VMOD	-	-
29	formed	formed	I-VP	I-VP	-	27	VC	-	-
30	.	.	O	O	-	9	P	-	-

1	Finally	Finally	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	immunoblot	immunoblot	B-NP	B-NP	-	4	NMOD	-	-
4	analysis	analysis	I-NP	I-NP	-	8	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	nuclear	nuclear	B-NP	B-NP	-	7	NMOD	-	-
7	extracts	extracts	I-NP	I-NP	-	5	PMOD	-	-
8	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
9	decreased	decreased	B-VP	B-VP	-	8	VC	-	-
10	or	or	O	O	-	14	NMOD	-	-
11	absent	absent	B-NP	B-NP	-	14	NMOD	-	-
12	p65	p65	I-NP	I-NP	-	14	NMOD	-	-
13	protein	protein	I-NP	I-NP	-	14	NMOD	-	-
14	levels	levels	I-NP	I-NP	-	9	OBJ	-	-
15	.	.	O	O	-	8	P	-	-

1	As	As	B-SBAR	B-SBAR	-	17	VMOD	-	-
2	p65	p65	B-NP	B-NP	-	3	NMOD	-	-
3	complexes	complexes	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	1	SBAR	-	-
5	transcriptionally	transcriptionally	B-ADJP	B-ADJP	-	6	AMOD	-	-
6	active	active	I-ADJP	I-ADJP	-	4	PRD	-	-
7	in	in	B-PP	B-PP	-	4	VMOD	-	-
8	comparison	comparison	B-NP	B-NP	-	7	PMOD	-	-
9	to	to	B-PP	B-PP	-	7	PMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	p50	p50	I-NP	I-NP	-	12	NMOD	-	-
12	homodimer	homodimer	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	17	P	-	-
14	this	this	B-NP	B-NP	-	16	NMOD	-	-
15	novel	novel	I-NP	I-NP	-	16	NMOD	-	-
16	finding	finding	I-NP	I-NP	-	17	SUB	-	-
17	may	may	B-VP	B-VP	-	0	ROOT	-	-
18	provide	provide	I-VP	I-VP	-	17	VC	-	-
19	insight	insight	B-NP	B-NP	-	18	OBJ	-	-
20	on	on	B-PP	B-PP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	origin	origin	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	abnormal	abnormal	B-NP	B-NP	-	25	NMOD	-	-
25	cytokine	cytokine	I-NP	I-NP	-	29	NMOD	-	-
26	or	or	O	O	-	29	NMOD	-	-
27	other	other	B-NP	B-NP	-	29	NMOD	-	-
28	gene	gene	I-NP	I-NP	-	29	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	23	PMOD	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	SLE	SLE	B-NP	B-NP	-	32	NMOD	-	-
32	patients	patients	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	17	P	-	-

1	Possible	Possible	B-NP	B-NP	-	2	NMOD	-	-
2	differences	differences	I-NP	I-NP	-	0	ROOT	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	mechanism	mechanism	I-NP	I-NP	-	7	NMOD	-	-
6	(	(	I-NP	I-NP	-	7	P	-	-
7	s	s	I-NP	I-NP	-	3	PMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	of	of	B-PP	B-PP	-	7	NMOD	-	-
10	action	action	B-NP	B-NP	-	9	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	different	different	B-NP	B-NP	-	15	NMOD	-	-
13	glucocorticoid	glucocorticoid	I-NP	I-NP	-	15	NMOD	-	-
14	hormone	hormone	I-NP	I-NP	-	15	NMOD	-	-
15	compounds	compounds	I-NP	I-NP	-	11	PMOD	-	-
16	.	.	O	O	-	7	P	-	-

1	Different	Different	B-NP	B-NP	-	3	NMOD	-	-
2	glucocorticoid	glucocorticoid	I-NP	I-NP	-	3	NMOD	-	-
3	hormones	hormones	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	GCH	GCH	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	show	show	B-VP	B-VP	-	0	ROOT	-	-
8	differences	differences	B-NP	B-NP	-	7	OBJ	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	intensity	intensity	I-NP	I-NP	-	9	PMOD	-	-
12	and	and	B-PP	B-PP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	9	PMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	kinetics	kinetics	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	their	their	B-NP	B-NP	-	19	NMOD	-	-
18	immunomodulating	immunomodulating	I-NP	I-NP	-	19	NMOD	-	-
19	activity	activity	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	mechanism	mechanism	I-NP	I-NP	-	4	NMOD	-	-
3	(	(	I-NP	I-NP	-	4	P	-	-
4	s	s	I-NP	I-NP	-	16	SUB	-	-
5	)	)	O	O	-	4	P	-	-
6	of	of	B-PP	B-PP	-	4	NMOD	-	-
7	action	action	B-NP	B-NP	-	6	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	GCH	GCH	B-NP	B-NP	-	8	PMOD	-	-
10	is	is	B-VP	B-VP	-	16	VMOD	-	-
11	under	under	B-PP	B-PP	-	10	PRD	-	-
12	investigation	investigation	B-NP	B-NP	-	11	PMOD	-	-
13	,	,	O	O	-	16	P	-	-
14	but	but	O	O	-	16	VMOD	-	-
15	is	is	B-NP	B-NP	-	16	VMOD	-	-
16	has	has	B-VP	B-VP	-	0	ROOT	-	-
17	been	been	I-VP	I-VP	-	16	VC	-	-
18	noted	noted	I-VP	I-VP	-	17	VC	-	-
19	that	that	B-SBAR	B-SBAR	-	18	VMOD	-	-
20	they	they	B-NP	B-NP	-	21	SUB	-	-
21	exert	exert	B-VP	B-VP	-	19	SBAR	-	-
22	immune	immune	B-NP	B-NP	-	23	NMOD	-	-
23	activity	activity	I-NP	I-NP	-	21	OBJ	-	-
24	via	via	B-PP	B-PP	-	21	VMOD	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	genomic	genomic	I-NP	I-NP	-	27	NMOD	-	-
27	pathway	pathway	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	16	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	studied	studied	I-VP	I-VP	-	2	VC	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	effects	effects	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	prednisone	prednisone	B-NP	B-NP	-	18	NMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	PDN	PDN	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	,	,	O	O	-	18	P	-	-
12	deflazacort	deflazacort	B-NP	B-NP	-	18	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	DFC	DFC	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	,	,	O	O	-	18	P	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	dexamethasone	dexamethasone	B-NP	B-NP	-	6	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	DXM	DXM	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	on	on	B-PP	B-PP	-	5	NMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	production	production	I-NP	I-NP	-	43	NMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	cytokines	cytokines	B-NP	B-NP	-	32	NMOD	-	-
27	(	(	O	O	-	32	P	-	-
28	IL-2	IL-2	B-NP	B-NP	-	32	NMOD	-	-
29	,	,	O	O	-	32	P	-	-
30	IL-6	IL-6	B-NP	B-NP	-	32	NMOD	-	-
31	,	,	O	O	-	32	P	-	-
32	TNF-alpha	TNF-alpha	B-NP	B-NP	-	25	PMOD	-	-
33	,	,	O	O	-	34	P	-	-
34	IL-10	IL-10	B-NP	B-NP	-	32	NMOD	-	-
35	)	)	O	O	-	34	P	-	-
36	by	by	B-PP	B-PP	-	24	NMOD	-	-
37	peripheral	peripheral	B-NP	B-NP	-	39	NMOD	-	-
38	T	T	I-NP	I-NP	-	39	NMOD	-	-
39	lymphocytes	lymphocytes	I-NP	I-NP	-	36	PMOD	-	-
40	,	,	O	O	-	43	P	-	-
41	and	and	O	O	-	43	NMOD	-	-
42	the	the	B-NP	B-NP	-	43	NMOD	-	-
43	effects	effects	I-NP	I-NP	-	22	PMOD	-	-
44	on	on	B-PP	B-PP	-	43	NMOD	-	-
45	the	the	B-NP	B-NP	-	46	NMOD	-	-
46	inhibition	inhibition	I-NP	I-NP	-	44	PMOD	-	-
47	of	of	B-PP	B-PP	-	46	NMOD	-	-
48	NF-kB	NF-kB	B-NP	B-NP	-	51	NMOD	-	-
49	DNA	DNA	I-NP	I-NP	-	51	NMOD	-	-
50	binding	binding	I-NP	I-NP	-	51	NMOD	-	-
51	activity	activity	I-NP	I-NP	-	47	PMOD	-	-
52	by	by	B-PP	B-PP	-	46	NMOD	-	-
53	activated	activated	B-NP	B-NP	-	56	NMOD	-	-
54	Jurkat	Jurkat	I-NP	I-NP	-	56	NMOD	-	-
55	cell	cell	I-NP	I-NP	-	56	NMOD	-	-
56	line	line	I-NP	I-NP	-	52	PMOD	-	-
57	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	4	SUB	-	-
3	obtained	obtained	B-VP	B-VP	-	2	NMOD	-	-
4	show	show	B-VP	B-VP	-	43	VMOD	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	three	three	I-NP	I-NP	-	9	NMOD	-	-
8	GCH	GCH	I-NP	I-NP	-	9	NMOD	-	-
9	molecules	molecules	I-NP	I-NP	-	10	SUB	-	-
10	exert	exert	B-VP	B-VP	-	5	SBAR	-	-
11	an	an	B-NP	B-NP	-	12	NMOD	-	-
12	immunosuppression	immunosuppression	I-NP	I-NP	-	10	OBJ	-	-
13	on	on	B-PP	B-PP	-	10	VMOD	-	-
14	cytokine	cytokine	B-NP	B-NP	-	15	NMOD	-	-
15	production	production	I-NP	I-NP	-	13	PMOD	-	-
16	by	by	B-PP	B-PP	-	10	VMOD	-	-
17	T	T	B-NP	B-NP	-	18	NMOD	-	-
18	lymphocytes	lymphocytes	I-NP	I-NP	-	16	PMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	strong	strong	I-NP	I-NP	-	22	NMOD	-	-
22	decrease	decrease	I-NP	I-NP	-	16	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	nuclear	nuclear	I-NP	I-NP	-	26	NMOD	-	-
26	translocation	translocation	I-NP	I-NP	-	23	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	NF-kB	NF-kB	B-NP	B-NP	-	27	PMOD	-	-
29	in	in	B-PP	B-PP	-	22	NMOD	-	-
30	Jurkat	Jurkat	B-NP	B-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	29	PMOD	-	-
32	;	;	O	O	-	4	P	-	-
33	moreover	moreover	B-ADVP	B-ADVP	-	43	VMOD	-	-
34	,	,	O	O	-	43	P	-	-
35	(	(	O	O	-	36	P	-	-
36	a	a	O	O	-	41	NMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	not	not	O	O	-	37	VMOD	-	-
39	all	all	B-NP	B-NP	-	41	NMOD	-	-
40	the	the	I-NP	I-NP	-	41	NMOD	-	-
41	cytokines	cytokines	I-NP	I-NP	-	43	SUB	-	-
42	investigated	investigated	B-VP	B-VP	-	41	NMOD	-	-
43	were	were	B-VP	B-VP	-	0	ROOT	-	-
44	affected	affected	I-VP	I-VP	-	43	VC	-	-
45	,	,	O	O	-	44	P	-	-
46	and	and	O	O	-	44	VMOD	-	-
47	not	not	B-PP	B-PP	-	48	PMOD	-	-
48	with	with	I-PP	I-PP	-	44	VMOD	-	-
49	the	the	B-NP	B-NP	-	51	NMOD	-	-
50	same	same	I-NP	I-NP	-	51	NMOD	-	-
51	intensity	intensity	I-NP	I-NP	-	48	PMOD	-	-
52	,	,	O	O	-	44	P	-	-
53	by	by	B-PP	B-PP	-	44	VMOD	-	-
54	the	the	B-NP	B-NP	-	56	NMOD	-	-
55	three	three	I-NP	I-NP	-	56	NMOD	-	-
56	GCH	GCH	I-NP	I-NP	-	61	NMOD	-	-
57	and	and	O	O	-	61	NMOD	-	-
58	(	(	B-LST	B-LST	-	59	P	-	-
59	b	b	I-LST	I-LST	-	61	NMOD	-	-
60	)	)	O	O	-	59	P	-	-
61	DXM	DXM	B-NP	B-NP	-	53	PMOD	-	-
62	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
63	the	the	B-NP	B-NP	-	65	NMOD	-	-
64	binding	binding	I-NP	I-NP	-	65	NMOD	-	-
65	activity	activity	I-NP	I-NP	-	62	OBJ	-	-
66	of	of	B-PP	B-PP	-	65	NMOD	-	-
67	NF-kB	NF-kB	B-NP	B-NP	-	66	PMOD	-	-
68	less	less	B-ADJP	B-ADJP	-	62	VMOD	-	-
69	than	than	B-PP	B-PP	-	68	AMOD	-	-
70	that	that	B-NP	B-NP	-	69	PMOD	-	-
71	of	of	B-PP	B-PP	-	70	NMOD	-	-
72	DFC	DFC	B-NP	B-NP	-	74	NMOD	-	-
73	and	and	I-NP	I-NP	-	74	NMOD	-	-
74	PDN	PDN	I-NP	I-NP	-	71	PMOD	-	-
75	.	.	O	O	-	62	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	in	in	B-PP	B-PP	-	3	VMOD	-	-
5	agreement	agreement	B-NP	B-NP	-	4	PMOD	-	-
6	with	with	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	concept	concept	I-NP	I-NP	-	6	PMOD	-	-
9	that	that	B-SBAR	B-SBAR	-	5	NMOD	-	-
10	different	different	B-NP	B-NP	-	12	NMOD	-	-
11	GCH	GCH	I-NP	I-NP	-	12	NMOD	-	-
12	compounds	compounds	I-NP	I-NP	-	13	SUB	-	-
13	might	might	B-VP	B-VP	-	9	SBAR	-	-
14	differ	differ	I-VP	I-VP	-	13	VC	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	their	their	B-NP	B-NP	-	20	NMOD	-	-
17	binding	binding	I-NP	I-NP	-	20	NMOD	-	-
18	and	and	I-NP	I-NP	-	20	NMOD	-	-
19	affinity	affinity	I-NP	I-NP	-	20	NMOD	-	-
20	properties	properties	I-NP	I-NP	-	26	NMOD	-	-
21	,	,	O	O	-	26	P	-	-
22	tissue-specific	tissue-specific	B-NP	B-NP	-	23	NMOD	-	-
23	metabolism	metabolism	I-NP	I-NP	-	26	NMOD	-	-
24	,	,	O	O	-	26	P	-	-
25	and	and	O	O	-	26	NMOD	-	-
26	interaction	interaction	B-NP	B-NP	-	15	PMOD	-	-
27	with	with	B-PP	B-PP	-	26	NMOD	-	-
28	transcription	transcription	B-NP	B-NP	-	29	NMOD	-	-
29	factor	factor	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	p53	p53	I-NP	I-NP	-	3	NMOD	-	-
3	paradox	paradox	I-NP	I-NP	-	0	ROOT	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	pathogenesis	pathogenesis	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	tumor	tumor	B-NP	B-NP	-	9	NMOD	-	-
9	progression	progression	I-NP	I-NP	-	7	PMOD	-	-
10	.	.	O	O	-	3	P	-	-

1	Recent	Recent	B-NP	B-NP	-	2	NMOD	-	-
2	evidence	evidence	I-NP	I-NP	-	3	SUB	-	-
3	suggests	suggests	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	p53	p53	I-NP	I-NP	-	7	NMOD	-	-
7	molecule	molecule	I-NP	I-NP	-	8	SUB	-	-
8	appears	appears	B-VP	B-VP	-	4	SBAR	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	two	two	B-NP	B-NP	-	12	NMOD	-	-
11	different	different	I-NP	I-NP	-	12	NMOD	-	-
12	forms	forms	I-NP	I-NP	-	9	PMOD	-	-
13	:	:	O	O	-	8	P	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	mutant	mutant	I-NP	I-NP	-	16	NMOD	-	-
16	p53	p53	I-NP	I-NP	-	8	OBJ	-	-
17	that	that	B-NP	B-NP	-	16	NMOD	-	-
18	stimulates	stimulates	B-VP	B-VP	-	17	SBAR	-	-
19	tumor	tumor	B-NP	B-NP	-	20	NMOD	-	-
20	progression	progression	I-NP	I-NP	-	18	OBJ	-	-
21	,	,	O	O	-	25	P	-	-
22	and	and	O	O	-	25	NMOD	-	-
23	wild	wild	B-NP	B-NP	-	25	NMOD	-	-
24	type	type	I-NP	I-NP	-	25	NMOD	-	-
25	p53	p53	I-NP	I-NP	-	18	OBJ	-	-
26	that	that	B-NP	B-NP	-	25	NMOD	-	-
27	inhibits	inhibits	B-VP	B-VP	-	26	SBAR	-	-
28	tumor	tumor	B-NP	B-NP	-	29	NMOD	-	-
29	progression	progression	I-NP	I-NP	-	27	OBJ	-	-
30	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	it	it	B-NP	B-NP	-	5	SUB	-	-
5	has	has	B-VP	B-VP	-	0	ROOT	-	-
6	been	been	I-VP	I-VP	-	5	VC	-	-
7	established	established	I-VP	I-VP	-	6	VC	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	tumor	tumor	B-NP	B-NP	-	11	NMOD	-	-
10	necrosis	necrosis	I-NP	I-NP	-	11	NMOD	-	-
11	factor-alpha	factor-alpha	I-NP	I-NP	-	15	SUB	-	-
12	(	(	O	O	-	13	P	-	-
13	TNF-alpha	TNF-alpha	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	can	can	B-VP	B-VP	-	8	SBAR	-	-
16	activate	activate	I-VP	I-VP	-	15	VC	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	16	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	wild	wild	B-NP	B-NP	-	22	NMOD	-	-
21	type	type	I-NP	I-NP	-	22	NMOD	-	-
22	p53	p53	I-NP	I-NP	-	19	PMOD	-	-
23	in	in	B-PP	B-PP	-	18	NMOD	-	-
24	concert	concert	B-NP	B-NP	-	23	PMOD	-	-
25	with	with	B-PP	B-PP	-	16	VMOD	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	nuclear	nuclear	I-NP	I-NP	-	29	NMOD	-	-
28	transcription	transcription	I-NP	I-NP	-	29	NMOD	-	-
29	factor	factor	I-NP	I-NP	-	32	NMOD	-	-
30	,	,	O	O	-	32	P	-	-
31	NF-kappa	NF-kappa	B-NP	B-NP	-	32	NMOD	-	-
32	B	B	I-NP	I-NP	-	25	PMOD	-	-
33	.	.	O	O	-	5	P	-	-

1	Both	Both	O	O	-	5	NMOD	-	-
2	TNF-alpha	TNF-alpha	B-NP	B-NP	-	5	NMOD	-	-
3	and	and	O	O	-	5	NMOD	-	-
4	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
5	B	B	I-NP	I-NP	-	6	SUB	-	-
6	are	are	B-VP	B-VP	-	0	ROOT	-	-
7	also	also	I-VP	I-VP	-	6	VMOD	-	-
8	involved	involved	I-VP	I-VP	-	6	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	stimulation	stimulation	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	pathway	pathway	I-NP	I-NP	-	12	PMOD	-	-
15	that	that	B-NP	B-NP	-	11	NMOD	-	-
16	leads	leads	B-VP	B-VP	-	15	SBAR	-	-
17	to	to	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	expression	expression	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	major	major	B-NP	B-NP	-	29	NMOD	-	-
22	histocompatibility	histocompatibility	I-NP	I-NP	-	29	NMOD	-	-
23	complex	complex	I-NP	I-NP	-	29	NMOD	-	-
24	(	(	O	O	-	27	P	-	-
25	MHC	MHC	B-NP	B-NP	-	27	NMOD	-	-
26	)	)	O	O	-	27	P	-	-
27	class	class	B-NP	B-NP	-	29	NMOD	-	-
28	I	I	B-NP	B-NP	-	29	NMOD	-	-
29	molecules	molecules	I-NP	I-NP	-	35	NMOD	-	-
30	and	and	O	O	-	35	NMOD	-	-
31	,	,	O	O	-	35	P	-	-
32	hence	hence	B-ADVP	B-ADVP	-	35	NMOD	-	-
33	,	,	O	O	-	35	P	-	-
34	antigen	antigen	B-NP	B-NP	-	35	NMOD	-	-
35	presentation	presentation	I-NP	I-NP	-	20	PMOD	-	-
36	to	to	B-PP	B-PP	-	35	NMOD	-	-
37	the	the	B-NP	B-NP	-	39	NMOD	-	-
38	T	T	I-NP	I-NP	-	39	NMOD	-	-
39	cells	cells	I-NP	I-NP	-	36	PMOD	-	-
40	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	paper	paper	I-NP	I-NP	-	1	PMOD	-	-
4	we	we	B-NP	B-NP	-	5	SUB	-	-
5	shall	shall	B-VP	B-VP	-	0	ROOT	-	-
6	advance	advance	I-VP	I-VP	-	5	VC	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	hypothesis	hypothesis	I-NP	I-NP	-	6	OBJ	-	-
9	that	that	B-NP	B-NP	-	8	NMOD	-	-
10	:	:	O	O	-	9	P	-	-
11	(	(	B-LST	B-LST	-	12	P	-	-
12	i	i	I-LST	I-LST	-	25	VMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	TNF-alpha	TNF-alpha	B-NP	B-NP	-	16	SUB	-	-
15	indirectly	indirectly	B-ADVP	B-ADVP	-	16	VMOD	-	-
16	controls	controls	B-VP	B-VP	-	25	VMOD	-	-
17	immune	immune	B-NP	B-NP	-	18	NMOD	-	-
18	surveillance	surveillance	I-NP	I-NP	-	16	OBJ	-	-
19	;	;	O	O	-	25	P	-	-
20	and	and	O	O	-	25	VMOD	-	-
21	(	(	B-LST	B-LST	-	22	P	-	-
22	ii	ii	I-LST	I-LST	-	25	VMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	TNF-alpha	TNF-alpha	B-NP	B-NP	-	25	SUB	-	-
25	controls	controls	B-VP	B-VP	-	9	SBAR	-	-
26	DNA	DNA	B-NP	B-NP	-	27	NMOD	-	-
27	repair	repair	I-NP	I-NP	-	30	NMOD	-	-
28	and	and	I-NP	I-NP	-	30	NMOD	-	-
29	tumor	tumor	I-NP	I-NP	-	30	NMOD	-	-
30	suppression	suppression	I-NP	I-NP	-	25	OBJ	-	-
31	through	through	B-PP	B-PP	-	25	VMOD	-	-
32	the	the	B-NP	B-NP	-	33	NMOD	-	-
33	regulation	regulation	I-NP	I-NP	-	31	PMOD	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	wild	wild	B-NP	B-NP	-	37	NMOD	-	-
36	type	type	I-NP	I-NP	-	37	NMOD	-	-
37	p53	p53	I-NP	I-NP	-	34	PMOD	-	-
38	.	.	O	O	-	5	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	it	it	B-NP	B-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	hypothesized	hypothesized	I-VP	I-VP	-	4	VC	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	elevated	elevated	B-NP	B-NP	-	8	NMOD	-	-
8	TNF-alpha	TNF-alpha	I-NP	I-NP	-	9	SUB	-	-
9	is	is	B-VP	B-VP	-	6	SBAR	-	-
10	primarily	primarily	B-ADJP	B-ADJP	-	11	AMOD	-	-
11	responsible	responsible	I-ADJP	I-ADJP	-	9	PRD	-	-
12	for	for	B-PP	B-PP	-	11	AMOD	-	-
13	promoting	promoting	B-VP	B-VP	-	12	PMOD	-	-
14	tumor	tumor	B-NP	B-NP	-	15	NMOD	-	-
15	progression	progression	I-NP	I-NP	-	13	OBJ	-	-
16	.	.	O	O	-	4	P	-	-

1	Differential	Differential	B-NP	B-NP	-	2	NMOD	-	-
2	effects	effects	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	lipopolysaccharide	lipopolysaccharide	B-NP	B-NP	-	8	NMOD	-	-
5	and	and	O	O	-	8	NMOD	-	-
6	tumor	tumor	B-NP	B-NP	-	8	NMOD	-	-
7	necrosis	necrosis	I-NP	I-NP	-	8	NMOD	-	-
8	factor	factor	I-NP	I-NP	-	3	PMOD	-	-
9	on	on	B-PP	B-PP	-	2	NMOD	-	-
10	monocytic	monocytic	B-NP	B-NP	-	12	NMOD	-	-
11	IkappaB	IkappaB	I-NP	I-NP	-	12	NMOD	-	-
12	kinase	kinase	I-NP	I-NP	-	17	NMOD	-	-
13	signalsome	signalsome	I-NP	I-NP	-	14	NMOD	-	-
14	activation	activation	I-NP	I-NP	-	17	NMOD	-	-
15	and	and	O	O	-	17	NMOD	-	-
16	IkappaB	IkappaB	B-NP	B-NP	-	17	NMOD	-	-
17	proteolysis	proteolysis	I-NP	I-NP	-	9	PMOD	-	-
18	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	inflammatory	inflammatory	I-NP	I-NP	-	3	NMOD	-	-
3	mediators	mediators	I-NP	I-NP	-	15	SUB	-	-
4	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	11	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	LPS	LPS	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	and	and	O	O	-	11	NMOD	-	-
9	tumor	tumor	B-NP	B-NP	-	11	NMOD	-	-
10	necrosis	necrosis	I-NP	I-NP	-	11	NMOD	-	-
11	factor	factor	I-NP	I-NP	-	3	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	TNF	TNF	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	are	are	B-VP	B-VP	-	0	ROOT	-	-
16	potent	potent	B-NP	B-NP	-	17	NMOD	-	-
17	activators	activators	I-NP	I-NP	-	15	PRD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	NF-kappaB	NF-kappaB	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	15	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	study	study	I-NP	I-NP	-	3	SUB	-	-
3	compared	compared	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	effect	effect	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	these	these	B-NP	B-NP	-	8	NMOD	-	-
8	stimuli	stimuli	I-NP	I-NP	-	6	PMOD	-	-
9	on	on	B-PP	B-PP	-	5	NMOD	-	-
10	endogenous	endogenous	B-NP	B-NP	-	12	NMOD	-	-
11	IkappaB	IkappaB	I-NP	I-NP	-	12	NMOD	-	-
12	kinase	kinase	I-NP	I-NP	-	20	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	IKK	IKK	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	signalsome	signalsome	B-ADJP	B-ADJP	-	17	NMOD	-	-
17	activation	activation	B-NP	B-NP	-	20	NMOD	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	IkappaB	IkappaB	B-NP	B-NP	-	20	NMOD	-	-
20	phosphorylation/proteolysis	phosphorylation/proteolysis	I-NP	I-NP	-	9	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	human	human	B-NP	B-NP	-	24	NMOD	-	-
23	monocytic	monocytic	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
25	and	and	O	O	-	3	VMOD	-	-
26	investigated	investigated	B-VP	B-VP	-	3	VMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	role	role	I-NP	I-NP	-	26	OBJ	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	the	the	B-NP	B-NP	-	32	NMOD	-	-
31	signalsome	signalsome	I-NP	I-NP	-	32	NMOD	-	-
32	proteins	proteins	I-NP	I-NP	-	38	NMOD	-	-
33	IKK-alpha	IKK-alpha	I-NP	I-NP	-	38	NMOD	-	-
34	,	,	O	O	-	38	P	-	-
35	IKK-beta	IKK-beta	B-NP	B-NP	-	38	NMOD	-	-
36	,	,	O	O	-	38	P	-	-
37	NF-kappaB-inducing	NF-kappaB-inducing	B-NP	B-NP	-	38	NMOD	-	-
38	kinase	kinase	I-NP	I-NP	-	53	NMOD	-	-
39	(	(	O	O	-	40	P	-	-
40	NIK	NIK	B-NP	B-NP	-	38	NMOD	-	-
41	)	)	O	O	-	40	P	-	-
42	,	,	O	O	-	53	P	-	-
43	IKK-gamma	IKK-gamma	B-NP	B-NP	-	53	NMOD	-	-
44	(	(	O	O	-	47	P	-	-
45	NF-kappaB	NF-kappaB	B-NP	B-NP	-	47	NMOD	-	-
46	essential	essential	I-NP	I-NP	-	47	NMOD	-	-
47	modulator	modulator	I-NP	I-NP	-	43	NMOD	-	-
48	)	)	O	O	-	47	P	-	-
49	,	,	O	O	-	53	P	-	-
50	and	and	O	O	-	53	NMOD	-	-
51	IKK	IKK	B-NP	B-NP	-	53	NMOD	-	-
52	complex-associated	complex-associated	I-NP	I-NP	-	53	NMOD	-	-
53	protein	protein	I-NP	I-NP	-	29	PMOD	-	-
54	.	.	O	O	-	3	P	-	-

1	Kinase	Kinase	B-NP	B-NP	-	2	NMOD	-	-
2	assays	assays	I-NP	I-NP	-	3	SUB	-	-
3	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	TNF	TNF	B-NP	B-NP	-	6	SUB	-	-
6	elicited	elicited	B-VP	B-VP	-	4	SBAR	-	-
7	a	a	B-NP	B-NP	-	11	NMOD	-	-
8	rapid	rapid	I-NP	I-NP	-	10	AMOD	-	-
9	but	but	I-NP	I-NP	-	10	AMOD	-	-
10	short-lived	short-lived	I-NP	I-NP	-	11	NMOD	-	-
11	induction	induction	I-NP	I-NP	-	6	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	IKK	IKK	B-NP	B-NP	-	14	NMOD	-	-
14	activity	activity	I-NP	I-NP	-	12	PMOD	-	-
15	with	with	B-PP	B-PP	-	11	NMOD	-	-
16	a	a	B-NP	B-NP	-	19	NMOD	-	-
17	3-fold	3-fold	I-NP	I-NP	-	19	NMOD	-	-
18	greater	greater	I-NP	I-NP	-	19	NMOD	-	-
19	effect	effect	I-NP	I-NP	-	15	PMOD	-	-
20	on	on	B-PP	B-PP	-	19	NMOD	-	-
21	IKK-alpha	IKK-alpha	B-NP	B-NP	-	20	PMOD	-	-
22	than	than	B-PP	B-PP	-	19	NMOD	-	-
23	on	on	B-PP	B-PP	-	22	PMOD	-	-
24	IKK-beta	IKK-beta	B-NP	B-NP	-	23	PMOD	-	-
25	,	,	O	O	-	6	P	-	-
26	peaking	peaking	B-VP	B-VP	-	6	VMOD	-	-
27	at	at	B-PP	B-PP	-	26	VMOD	-	-
28	<num>	<num>	B-NP	B-NP	-	29	NMOD	-	-
29	min	min	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	LPS	LPS	B-NP	B-NP	-	6	SUB	-	-
5	predominantly	predominantly	B-ADVP	B-ADVP	-	6	VMOD	-	-
6	stimulated	stimulated	B-VP	B-VP	-	0	ROOT	-	-
7	IKK-beta	IKK-beta	B-NP	B-NP	-	8	NMOD	-	-
8	activity	activity	I-NP	I-NP	-	6	OBJ	-	-
9	,	,	O	O	-	8	P	-	-
10	which	which	B-NP	B-NP	-	8	NMOD	-	-
11	slowly	slowly	B-ADVP	B-ADVP	-	12	VMOD	-	-
12	increased	increased	B-VP	B-VP	-	10	SBAR	-	-
13	,	,	O	O	-	12	P	-	-
14	peaking	peaking	B-VP	B-VP	-	12	VMOD	-	-
15	at	at	B-PP	B-PP	-	14	VMOD	-	-
16	<num>	<num>	B-NP	B-NP	-	17	NMOD	-	-
17	min	min	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	second	second	I-NP	I-NP	-	3	NMOD	-	-
3	peak	peak	I-NP	I-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	observed	observed	I-VP	I-VP	-	4	VC	-	-
6	at	at	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	10	NMOD	-	-
8	later	later	I-NP	I-NP	-	10	NMOD	-	-
9	time	time	I-NP	I-NP	-	10	NMOD	-	-
10	point	point	I-NP	I-NP	-	6	PMOD	-	-
11	following	following	B-PP	B-PP	-	5	VMOD	-	-
12	LPS	LPS	B-NP	B-NP	-	13	NMOD	-	-
13	stimulation	stimulation	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	which	which	B-NP	B-NP	-	13	NMOD	-	-
16	consisted	consisted	B-VP	B-VP	-	15	SBAR	-	-
17	of	of	B-PP	B-PP	-	16	VMOD	-	-
18	both	both	O	O	-	22	NMOD	-	-
19	IKK-alpha	IKK-alpha	B-NP	B-NP	-	22	NMOD	-	-
20	and	and	O	O	-	22	NMOD	-	-
21	-beta	-beta	B-NP	B-NP	-	22	NMOD	-	-
22	activity	activity	I-NP	I-NP	-	17	PMOD	-	-
23	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	endogenous	endogenous	I-NP	I-NP	-	3	NMOD	-	-
3	levels	levels	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	signalsome	signalsome	I-NP	I-NP	-	7	NMOD	-	-
7	components	components	I-NP	I-NP	-	4	PMOD	-	-
8	were	were	B-VP	B-VP	-	0	ROOT	-	-
9	unaffected	unaffected	B-ADJP	B-ADJP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	stimulation	stimulation	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	8	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	our	our	B-NP	B-NP	-	4	NMOD	-	-
4	studies	studies	I-NP	I-NP	-	5	SUB	-	-
5	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
6	association	association	B-NP	B-NP	-	5	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	IKK-alpha/beta	IKK-alpha/beta	I-NP	I-NP	-	10	NMOD	-	-
10	heterodimer	heterodimer	I-NP	I-NP	-	7	PMOD	-	-
11	with	with	B-PP	B-PP	-	6	NMOD	-	-
12	NIK	NIK	B-NP	B-NP	-	16	NMOD	-	-
13	,	,	I-NP	I-NP	-	16	P	-	-
14	IkappaB-alpha	IkappaB-alpha	I-NP	I-NP	-	16	NMOD	-	-
15	and	and	I-NP	I-NP	-	16	NMOD	-	-
16	-epsilon	-epsilon	I-NP	I-NP	-	11	PMOD	-	-
17	in	in	B-PP	B-PP	-	6	NMOD	-	-
18	unstimulated	unstimulated	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	5	P	-	-

1	Exposure	Exposure	B-NP	B-NP	-	6	SUB	-	-
2	to	to	B-PP	B-PP	-	1	NMOD	-	-
3	LPS	LPS	B-NP	B-NP	-	5	NMOD	-	-
4	or	or	I-NP	I-NP	-	5	NMOD	-	-
5	TNF	TNF	I-NP	I-NP	-	2	PMOD	-	-
6	led	led	B-VP	B-VP	-	22	VMOD	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	differential	differential	B-NP	B-NP	-	9	NMOD	-	-
9	patterns	patterns	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	IkappaB-alpha	IkappaB-alpha	B-NP	B-NP	-	14	NMOD	-	-
12	and	and	I-NP	I-NP	-	14	NMOD	-	-
13	IkappaB-epsilon	IkappaB-epsilon	I-NP	I-NP	-	14	NMOD	-	-
14	disappearance	disappearance	I-NP	I-NP	-	10	PMOD	-	-
15	from	from	B-PP	B-PP	-	14	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	reassembly	reassembly	B-NP	B-NP	-	15	PMOD	-	-
18	with	with	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	signalsome	signalsome	I-NP	I-NP	-	18	PMOD	-	-
21	,	,	O	O	-	6	P	-	-
22	whereas	whereas	O	O	-	0	ROOT	-	-
23	IKK-alpha	IKK-alpha	B-NP	B-NP	-	28	NMOD	-	-
24	,	,	O	O	-	28	P	-	-
25	IKK-beta	IKK-beta	B-NP	B-NP	-	28	NMOD	-	-
26	,	,	O	O	-	28	P	-	-
27	and	and	O	O	-	28	NMOD	-	-
28	NIK	NIK	B-NP	B-NP	-	29	SUB	-	-
29	remained	remained	B-VP	B-VP	-	22	VMOD	-	-
30	complex-associated	complex-associated	B-ADJP	B-ADJP	-	29	PRD	-	-
31	.	.	O	O	-	22	P	-	-

1	NIK	NIK	B-NP	B-NP	-	2	SUB	-	-
2	can	can	B-VP	B-VP	-	10	VMOD	-	-
3	not	not	I-VP	I-VP	-	2	VMOD	-	-
4	phosphorylate	phosphorylate	I-VP	I-VP	-	2	VC	-	-
5	IkappaB-alpha	IkappaB-alpha	B-NP	B-NP	-	4	OBJ	-	-
6	directly	directly	B-ADVP	B-ADVP	-	4	VMOD	-	-
7	,	,	O	O	-	10	P	-	-
8	but	but	O	O	-	10	VMOD	-	-
9	it	it	B-NP	B-NP	-	10	SUB	-	-
10	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
11	to	to	I-VP	I-VP	-	12	VMOD	-	-
12	be	be	I-VP	I-VP	-	10	VMOD	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	functionally	functionally	I-NP	I-NP	-	15	AMOD	-	-
15	important	important	I-NP	I-NP	-	16	NMOD	-	-
16	subunit	subunit	I-NP	I-NP	-	12	PRD	-	-
17	,	,	O	O	-	10	P	-	-
18	because	because	B-SBAR	B-SBAR	-	10	VMOD	-	-
19	mutated	mutated	B-NP	B-NP	-	20	NMOD	-	-
20	NIK	NIK	I-NP	I-NP	-	21	SUB	-	-
21	inhibited	inhibited	B-VP	B-VP	-	18	SBAR	-	-
22	stimulus-induced	stimulus-induced	B-NP	B-NP	-	24	NMOD	-	-
23	kappaB-dependent	kappaB-dependent	I-NP	I-NP	-	24	NMOD	-	-
24	transcription	transcription	I-NP	I-NP	-	21	OBJ	-	-
25	more	more	B-ADVP	B-ADVP	-	26	AMOD	-	-
26	effectively	effectively	I-ADVP	I-ADVP	-	21	VMOD	-	-
27	than	than	B-PP	B-PP	-	21	VMOD	-	-
28	mutated	mutated	B-NP	B-NP	-	31	NMOD	-	-
29	IKK-alpha	IKK-alpha	I-NP	I-NP	-	31	NMOD	-	-
30	or	or	I-NP	I-NP	-	31	NMOD	-	-
31	-beta	-beta	I-NP	I-NP	-	27	PMOD	-	-
32	.	.	O	O	-	10	P	-	-

1	Overexpression	Overexpression	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	IKK	IKK	B-NP	B-NP	-	5	NMOD	-	-
4	complex-associated	complex-associated	I-NP	I-NP	-	5	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	2	PMOD	-	-
6	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
7	stimulus-mediated	stimulus-mediated	B-NP	B-NP	-	8	NMOD	-	-
8	transcription	transcription	I-NP	I-NP	-	6	OBJ	-	-
9	,	,	O	O	-	10	P	-	-
10	whereas	whereas	O	O	-	6	VMOD	-	-
11	NF-kappaB	NF-kappaB	B-NP	B-NP	-	13	NMOD	-	-
12	essential	essential	I-NP	I-NP	-	13	NMOD	-	-
13	modulator	modulator	I-NP	I-NP	-	14	SUB	-	-
14	enhanced	enhanced	B-VP	B-VP	-	10	SBAR	-	-
15	it	it	B-NP	B-NP	-	14	OBJ	-	-
16	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	understanding	understanding	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	LPS-	LPS-	B-NP	B-NP	-	7	NMOD	-	-
5	and	and	O	O	-	7	NMOD	-	-
6	TNF-induced	TNF-induced	B-NP	B-NP	-	7	NMOD	-	-
7	signaling	signaling	I-NP	I-NP	-	3	PMOD	-	-
8	may	may	B-VP	B-VP	-	0	ROOT	-	-
9	allow	allow	I-VP	I-VP	-	8	VC	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	development	development	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	specific	specific	B-NP	B-NP	-	14	NMOD	-	-
14	strategies	strategies	I-NP	I-NP	-	12	PMOD	-	-
15	to	to	B-VP	B-VP	-	16	VMOD	-	-
16	treat	treat	I-VP	I-VP	-	11	NMOD	-	-
17	sepsis-associated	sepsis-associated	B-NP	B-NP	-	18	NMOD	-	-
18	disease	disease	I-NP	I-NP	-	16	OBJ	-	-
19	.	.	O	O	-	8	P	-	-

1	Activation	Activation	B-NP	B-NP	-	7	NMOD	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	protein	protein	B-NP	B-NP	-	5	NMOD	-	-
4	kinase	kinase	I-NP	I-NP	-	5	NMOD	-	-
5	C	C	I-NP	I-NP	-	2	PMOD	-	-
6	and	and	O	O	-	7	NMOD	-	-
7	elevation	elevation	B-NP	B-NP	-	10	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	cAMP	cAMP	B-NP	B-NP	-	8	PMOD	-	-
10	interact	interact	B-VP	B-VP	-	0	ROOT	-	-
11	synergistically	synergistically	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	to	to	B-VP	B-VP	-	13	VMOD	-	-
13	raise	raise	I-VP	I-VP	-	10	VMOD	-	-
14	c-Fos	c-Fos	B-NP	B-NP	-	17	NMOD	-	-
15	and	and	I-NP	I-NP	-	17	NMOD	-	-
16	AP-1	AP-1	I-NP	I-NP	-	17	NMOD	-	-
17	activity	activity	I-NP	I-NP	-	13	OBJ	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	Jurkat	Jurkat	B-NP	B-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	earlier	earlier	I-VP	I-VP	-	2	VMOD	-	-
4	found	found	I-VP	I-VP	-	2	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	in	in	B-PP	B-PP	-	17	VMOD	-	-
7	Jurkat	Jurkat	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	activation	activation	B-NP	B-NP	-	17	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	protein	protein	B-NP	B-NP	-	13	NMOD	-	-
12	kinase	kinase	I-NP	I-NP	-	13	NMOD	-	-
13	C	C	I-NP	I-NP	-	10	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	PKC	PKC	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	enhances	enhances	B-VP	B-VP	-	5	SBAR	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	cyclic	cyclic	I-NP	I-NP	-	21	NMOD	-	-
20	adenosine	adenosine	I-NP	I-NP	-	21	NMOD	-	-
21	monophosphate	monophosphate	I-NP	I-NP	-	25	NMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	cAMP	cAMP	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	accumulation	accumulation	B-NP	B-NP	-	17	OBJ	-	-
26	induced	induced	B-VP	B-VP	-	25	NMOD	-	-
27	by	by	B-PP	B-PP	-	26	VMOD	-	-
28	adenosine	adenosine	B-NP	B-NP	-	30	NMOD	-	-
29	receptor	receptor	I-NP	I-NP	-	30	NMOD	-	-
30	stimulation	stimulation	I-NP	I-NP	-	27	PMOD	-	-
31	or	or	O	O	-	32	NMOD	-	-
32	activation	activation	B-NP	B-NP	-	27	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	Gs	Gs	B-NP	B-NP	-	33	PMOD	-	-
35	.	.	O	O	-	2	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	have	have	B-VP	B-VP	-	0	ROOT	-	-
4	therefore	therefore	I-VP	I-VP	-	3	VMOD	-	-
5	examined	examined	I-VP	I-VP	-	3	VC	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	effect	effect	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	phorbol	phorbol	I-NP	I-NP	-	12	NMOD	-	-
11	ester	ester	I-NP	I-NP	-	12	NMOD	-	-
12	PMA	PMA	I-NP	I-NP	-	8	PMOD	-	-
13	(	(	O	O	-	16	P	-	-
14	phorbol	phorbol	B-NP	B-NP	-	16	NMOD	-	-
15	12-myristate	12-myristate	I-NP	I-NP	-	16	NMOD	-	-
16	13-acetate	13-acetate	I-NP	I-NP	-	12	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	which	which	B-NP	B-NP	-	12	NMOD	-	-
19	stimulates	stimulates	B-VP	B-VP	-	18	SBAR	-	-
20	PKC	PKC	B-NP	B-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	a	a	B-NP	B-NP	-	23	NMOD	-	-
23	combination	combination	I-NP	I-NP	-	19	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	29	NMOD	-	-
26	adenosine	adenosine	I-NP	I-NP	-	29	NMOD	-	-
27	receptor	receptor	I-NP	I-NP	-	29	NMOD	-	-
28	agonist	agonist	I-NP	I-NP	-	29	NMOD	-	-
29	NECA	NECA	I-NP	I-NP	-	24	PMOD	-	-
30	(	(	O	O	-	33	P	-	-
31	5'-	5'-	B-NP	B-NP	-	33	NMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	N-ethyl	N-ethyl	B-NP	B-NP	-	29	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	-carboxamido	-carboxamido	B-NP	B-NP	-	36	NMOD	-	-
36	adenosine	adenosine	I-NP	I-NP	-	29	NMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	and	and	O	O	-	39	NMOD	-	-
39	forskolin	forskolin	B-NP	B-NP	-	24	PMOD	-	-
40	to	to	B-VP	B-VP	-	41	VMOD	-	-
41	raise	raise	I-VP	I-VP	-	39	NMOD	-	-
42	cAMP	cAMP	B-NP	B-NP	-	41	OBJ	-	-
43	,	,	O	O	-	41	P	-	-
44	on	on	B-PP	B-PP	-	41	VMOD	-	-
45	the	the	B-NP	B-NP	-	46	NMOD	-	-
46	levels	levels	I-NP	I-NP	-	44	PMOD	-	-
47	of	of	B-PP	B-PP	-	46	NMOD	-	-
48	c-Fos	c-Fos	B-NP	B-NP	-	50	NMOD	-	-
49	and	and	I-NP	I-NP	-	50	NMOD	-	-
50	Jun	Jun	I-NP	I-NP	-	47	PMOD	-	-
51	and	and	B-PP	B-PP	-	44	PMOD	-	-
52	on	on	B-PP	B-PP	-	44	PMOD	-	-
53	the	the	B-NP	B-NP	-	57	NMOD	-	-
54	binding	binding	I-NP	I-NP	-	57	NMOD	-	-
55	and	and	O	O	-	57	NMOD	-	-
56	transcriptional	transcriptional	B-NP	B-NP	-	57	NMOD	-	-
57	activity	activity	I-NP	I-NP	-	52	PMOD	-	-
58	of	of	B-PP	B-PP	-	57	NMOD	-	-
59	the	the	B-NP	B-NP	-	61	NMOD	-	-
60	transcription	transcription	I-NP	I-NP	-	61	NMOD	-	-
61	factor	factor	I-NP	I-NP	-	64	NMOD	-	-
62	,	,	O	O	-	64	P	-	-
63	activator	activator	B-NP	B-NP	-	64	NMOD	-	-
64	protein-1	protein-1	I-NP	I-NP	-	58	PMOD	-	-
65	(	(	O	O	-	66	P	-	-
66	AP-1	AP-1	B-NP	B-NP	-	64	NMOD	-	-
67	)	)	O	O	-	66	P	-	-
68	.	.	O	O	-	3	P	-	-

1	PMA	PMA	B-NP	B-NP	-	2	NMOD	-	-
2	treatment	treatment	I-NP	I-NP	-	3	SUB	-	-
3	caused	caused	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	8	NMOD	-	-
5	concentration-	concentration-	I-NP	I-NP	-	8	NMOD	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	time-dependent	time-dependent	B-NP	B-NP	-	8	NMOD	-	-
8	increase	increase	I-NP	I-NP	-	3	OBJ	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	both	both	O	O	-	13	NMOD	-	-
11	c-Fos	c-Fos	B-NP	B-NP	-	13	NMOD	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	Jun	Jun	B-NP	B-NP	-	14	NMOD	-	-
14	immunoreactivity	immunoreactivity	I-NP	I-NP	-	9	PMOD	-	-
15	in	in	B-PP	B-PP	-	8	NMOD	-	-
16	contrast	contrast	B-NP	B-NP	-	15	PMOD	-	-
17	to	to	B-PP	B-PP	-	16	NMOD	-	-
18	cAMP	cAMP	B-NP	B-NP	-	19	NMOD	-	-
19	elevation	elevation	I-NP	I-NP	-	17	PMOD	-	-
20	that	that	B-NP	B-NP	-	19	NMOD	-	-
21	had	had	B-VP	B-VP	-	20	SBAR	-	-
22	only	only	B-NP	B-NP	-	25	NMOD	-	-
23	a	a	I-NP	I-NP	-	25	NMOD	-	-
24	slight	slight	I-NP	I-NP	-	25	NMOD	-	-
25	effect	effect	I-NP	I-NP	-	21	OBJ	-	-
26	.	.	O	O	-	3	P	-	-

1	Both	Both	O	O	-	5	NMOD	-	-
2	PMA	PMA	B-NP	B-NP	-	5	NMOD	-	-
3	and	and	O	O	-	5	NMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	combination	combination	I-NP	I-NP	-	10	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	NECA	NECA	B-NP	B-NP	-	9	NMOD	-	-
8	and	and	I-NP	I-NP	-	9	NMOD	-	-
9	forskolin	forskolin	I-NP	I-NP	-	6	PMOD	-	-
10	acted	acted	B-VP	B-VP	-	0	ROOT	-	-
11	together	together	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	either	either	O	O	-	10	VMOD	-	-
13	to	to	B-VP	B-VP	-	14	VMOD	-	-
14	increase	increase	I-VP	I-VP	-	10	VMOD	-	-
15	(	(	O	O	-	24	P	-	-
16	c-Fos	c-Fos	B-NP	B-NP	-	24	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	or	or	O	O	-	24	NMOD	-	-
19	decrease	decrease	B-NP	B-NP	-	24	NMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	Jun	Jun	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	protein	protein	B-NP	B-NP	-	24	NMOD	-	-
24	levels	levels	I-NP	I-NP	-	10	OBJ	-	-
25	as	as	B-CONJP	B-CONJP	-	28	VMOD	-	-
26	well	well	I-CONJP	I-CONJP	-	25	DEP	-	-
27	as	as	I-CONJP	I-CONJP	-	25	DEP	-	-
28	increasing	increasing	B-VP	B-VP	-	24	NMOD	-	-
29	AP-1	AP-1	B-NP	B-NP	-	30	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	28	OBJ	-	-
31	,	,	O	O	-	10	P	-	-
32	as	as	B-SBAR	B-SBAR	-	10	VMOD	-	-
33	judged	judged	B-VP	B-VP	-	32	SBAR	-	-
34	by	by	B-PP	B-PP	-	33	VMOD	-	-
35	gel-shift	gel-shift	B-NP	B-NP	-	36	NMOD	-	-
36	assay	assay	I-NP	I-NP	-	34	PMOD	-	-
37	,	,	O	O	-	41	P	-	-
38	and	and	O	O	-	41	NMOD	-	-
39	AP-1	AP-1	B-NP	B-NP	-	41	NMOD	-	-
40	transcriptional	transcriptional	I-NP	I-NP	-	41	NMOD	-	-
41	activity	activity	I-NP	I-NP	-	34	PMOD	-	-
42	.	.	O	O	-	10	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	there	there	B-NP	B-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	clear-cut	clear-cut	I-NP	I-NP	-	6	NMOD	-	-
6	synergy	synergy	I-NP	I-NP	-	3	PRD	-	-
7	between	between	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	PKC	PKC	I-NP	I-NP	-	10	NMOD	-	-
10	stimulator	stimulator	I-NP	I-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	cAMP	cAMP	I-NP	I-NP	-	7	PMOD	-	-
14	elevating	elevating	B-VP	B-VP	-	13	NMOD	-	-
15	agents	agents	B-NP	B-NP	-	14	OBJ	-	-
16	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	simultaneous	simultaneous	I-NP	I-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	14	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	PKC	PKC	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	elevation	elevation	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	cAMP	cAMP	B-NP	B-NP	-	12	PMOD	-	-
14	leads	leads	B-VP	B-VP	-	4	SBAR	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	an	an	B-NP	B-NP	-	20	NMOD	-	-
17	enhanced	enhanced	I-NP	I-NP	-	20	NMOD	-	-
18	AP-1	AP-1	I-NP	I-NP	-	20	NMOD	-	-
19	transcriptional	transcriptional	I-NP	I-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	15	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	a	a	B-NP	B-NP	-	25	NMOD	-	-
23	T-leukemia	T-leukemia	I-NP	I-NP	-	25	NMOD	-	-
24	cell	cell	I-NP	I-NP	-	25	NMOD	-	-
25	line	line	I-NP	I-NP	-	21	PMOD	-	-
26	,	,	O	O	-	14	P	-	-
27	suggesting	suggesting	B-VP	B-VP	-	14	VMOD	-	-
28	that	that	B-SBAR	B-SBAR	-	27	VMOD	-	-
29	the	the	B-NP	B-NP	-	32	NMOD	-	-
30	previously	previously	I-NP	I-NP	-	31	AMOD	-	-
31	observed	observed	I-NP	I-NP	-	32	NMOD	-	-
32	interaction	interaction	I-NP	I-NP	-	39	SUB	-	-
33	between	between	B-PP	B-PP	-	32	NMOD	-	-
34	the	the	B-NP	B-NP	-	38	NMOD	-	-
35	parallel	parallel	I-NP	I-NP	-	38	NMOD	-	-
36	signal	signal	I-NP	I-NP	-	38	NMOD	-	-
37	transduction	transduction	I-NP	I-NP	-	38	NMOD	-	-
38	pathways	pathways	I-NP	I-NP	-	33	PMOD	-	-
39	may	may	B-VP	B-VP	-	28	SBAR	-	-
40	have	have	I-VP	I-VP	-	39	VC	-	-
41	functional	functional	B-NP	B-NP	-	42	NMOD	-	-
42	consequences	consequences	I-NP	I-NP	-	40	OBJ	-	-
43	at	at	B-PP	B-PP	-	40	VMOD	-	-
44	the	the	B-NP	B-NP	-	45	NMOD	-	-
45	level	level	I-NP	I-NP	-	43	PMOD	-	-
46	of	of	B-PP	B-PP	-	45	NMOD	-	-
47	gene	gene	B-NP	B-NP	-	48	NMOD	-	-
48	transcription	transcription	I-NP	I-NP	-	46	PMOD	-	-
49	.	.	O	O	-	3	P	-	-

1	Functional	Functional	B-NP	B-NP	-	2	NMOD	-	-
2	interaction	interaction	I-NP	I-NP	-	0	ROOT	-	-
3	between	between	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	two	two	I-NP	I-NP	-	8	NMOD	-	-
6	zinc	zinc	I-NP	I-NP	-	8	NMOD	-	-
7	finger	finger	I-NP	I-NP	-	8	NMOD	-	-
8	domains	domains	I-NP	I-NP	-	3	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	v-erb	v-erb	I-NP	I-NP	-	13	NMOD	-	-
12	A	A	I-NP	I-NP	-	13	NMOD	-	-
13	oncoprotein	oncoprotein	I-NP	I-NP	-	9	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	v-erb	v-erb	I-NP	I-NP	-	4	NMOD	-	-
3	A	A	I-NP	I-NP	-	4	NMOD	-	-
4	oncogene	oncogene	I-NP	I-NP	-	9	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	avian	avian	B-NP	B-NP	-	8	NMOD	-	-
7	erythroblastosis	erythroblastosis	I-NP	I-NP	-	8	NMOD	-	-
8	virus	virus	I-NP	I-NP	-	5	PMOD	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	a	a	B-NP	B-NP	-	15	NMOD	-	-
11	mutated	mutated	I-NP	I-NP	-	15	NMOD	-	-
12	and	and	I-NP	I-NP	-	15	NMOD	-	-
13	virally	virally	I-NP	I-NP	-	14	AMOD	-	-
14	transduced	transduced	I-NP	I-NP	-	15	NMOD	-	-
15	copy	copy	I-NP	I-NP	-	9	PRD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	a	a	B-NP	B-NP	-	20	NMOD	-	-
18	host	host	I-NP	I-NP	-	20	NMOD	-	-
19	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
20	gene	gene	I-NP	I-NP	-	16	PMOD	-	-
21	encoding	encoding	B-VP	B-VP	-	20	NMOD	-	-
22	a	a	B-NP	B-NP	-	25	NMOD	-	-
23	thyroid	thyroid	I-NP	I-NP	-	25	NMOD	-	-
24	hormone	hormone	I-NP	I-NP	-	25	NMOD	-	-
25	receptor	receptor	I-NP	I-NP	-	21	OBJ	-	-
26	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	protein	protein	I-NP	I-NP	-	9	SUB	-	-
3	expressed	expressed	B-VP	B-VP	-	2	NMOD	-	-
4	by	by	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	v-erb	v-erb	I-NP	I-NP	-	8	NMOD	-	-
7	A	A	I-NP	I-NP	-	8	NMOD	-	-
8	oncogene	oncogene	I-NP	I-NP	-	4	PMOD	-	-
9	binds	binds	B-VP	B-VP	-	0	ROOT	-	-
10	to	to	B-PP	B-PP	-	9	VMOD	-	-
11	DNA	DNA	B-NP	B-NP	-	10	PMOD	-	-
12	and	and	O	O	-	9	VMOD	-	-
13	acts	acts	B-VP	B-VP	-	9	VMOD	-	-
14	as	as	B-PP	B-PP	-	13	VMOD	-	-
15	a	a	B-NP	B-NP	-	18	NMOD	-	-
16	dominant	dominant	I-NP	I-NP	-	18	NMOD	-	-
17	negative	negative	I-NP	I-NP	-	18	NMOD	-	-
18	inhibitor	inhibitor	I-NP	I-NP	-	14	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	both	both	O	O	-	31	NMOD	-	-
21	the	the	B-NP	B-NP	-	24	NMOD	-	-
22	thyroid	thyroid	I-NP	I-NP	-	24	NMOD	-	-
23	hormone	hormone	I-NP	I-NP	-	24	NMOD	-	-
24	receptor	receptor	I-NP	I-NP	-	31	NMOD	-	-
25	and	and	O	O	-	31	NMOD	-	-
26	the	the	B-NP	B-NP	-	31	NMOD	-	-
27	closely	closely	I-NP	I-NP	-	28	AMOD	-	-
28	related	related	I-NP	I-NP	-	31	NMOD	-	-
29	retinoic	retinoic	I-NP	I-NP	-	31	NMOD	-	-
30	acid	acid	I-NP	I-NP	-	31	NMOD	-	-
31	receptor	receptor	I-NP	I-NP	-	19	PMOD	-	-
32	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	v-erb	v-erb	I-NP	I-NP	-	4	NMOD	-	-
3	A	A	I-NP	I-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	5	SUB	-	-
5	has	has	B-VP	B-VP	-	0	ROOT	-	-
6	sustained	sustained	I-VP	I-VP	-	5	VC	-	-
7	two	two	B-NP	B-NP	-	10	NMOD	-	-
8	amino	amino	I-NP	I-NP	-	10	NMOD	-	-
9	acid	acid	I-NP	I-NP	-	10	NMOD	-	-
10	alterations	alterations	I-NP	I-NP	-	5	OBJ	-	-
11	within	within	B-PP	B-PP	-	10	NMOD	-	-
12	its	its	B-NP	B-NP	-	14	NMOD	-	-
13	DNA-binding	DNA-binding	I-NP	I-NP	-	14	NMOD	-	-
14	domain	domain	I-NP	I-NP	-	11	PMOD	-	-
15	relative	relative	B-ADVP	B-ADVP	-	14	NMOD	-	-
16	to	to	B-PP	B-PP	-	15	AMOD	-	-
17	that	that	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	c-erb	c-erb	B-NP	B-NP	-	20	NMOD	-	-
20	A	A	I-NP	I-NP	-	18	PMOD	-	-
21	,	,	O	O	-	20	P	-	-
22	one	one	B-NP	B-NP	-	23	NMOD	-	-
23	of	of	B-PP	B-PP	-	20	NMOD	-	-
24	which	which	B-NP	B-NP	-	23	PMOD	-	-
25	,	,	O	O	-	20	P	-	-
26	at	at	B-PP	B-PP	-	20	NMOD	-	-
27	serine	serine	B-NP	B-NP	-	26	PMOD	-	-
28	<num>	<num>	I-NP	I-NP	-	27	NMOD	-	-
29	,	,	O	O	-	20	P	-	-
30	is	is	B-VP	B-VP	-	18	SBAR	-	-
31	known	known	I-VP	I-VP	-	30	VC	-	-
32	to	to	I-VP	I-VP	-	33	VMOD	-	-
33	be	be	I-VP	I-VP	-	31	VMOD	-	-
34	important	important	B-ADJP	B-ADJP	-	33	PRD	-	-
35	for	for	B-PP	B-PP	-	34	AMOD	-	-
36	v-erb	v-erb	B-NP	B-NP	-	38	NMOD	-	-
37	A	A	I-NP	I-NP	-	38	NMOD	-	-
38	function	function	I-NP	I-NP	-	35	PMOD	-	-
39	in	in	B-PP	B-PP	-	38	NMOD	-	-
40	the	the	B-NP	B-NP	-	42	NMOD	-	-
41	neoplastic	neoplastic	I-NP	I-NP	-	42	NMOD	-	-
42	cell	cell	I-NP	I-NP	-	39	PMOD	-	-
43	.	.	O	O	-	5	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	report	report	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	second	second	I-NP	I-NP	-	7	NMOD	-	-
7	alteration	alteration	I-NP	I-NP	-	14	SUB	-	-
8	,	,	O	O	-	14	P	-	-
9	at	at	B-PP	B-PP	-	14	VMOD	-	-
10	threonine	threonine	B-NP	B-NP	-	9	PMOD	-	-
11	<num>	<num>	I-NP	I-NP	-	10	NMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	also	also	B-ADVP	B-ADVP	-	14	VMOD	-	-
14	plays	plays	B-VP	B-VP	-	4	SBAR	-	-
15	an	an	B-NP	B-NP	-	16	NMOD	-	-
16	important	important	I-NP	I-NP	-	14	OBJ	-	-
17	,	,	O	O	-	14	P	-	-
18	although	although	B-SBAR	B-SBAR	-	14	VMOD	-	-
19	more	more	B-ADJP	B-ADJP	-	20	AMOD	-	-
20	indirect	indirect	I-ADJP	I-ADJP	-	22	NMOD	-	-
21	,	,	O	O	-	20	P	-	-
22	role	role	B-NP	B-NP	-	14	OBJ	-	-
23	:	:	O	O	-	2	P	-	-
24	alteration	alteration	B-NP	B-NP	-	2	VMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	sequence	sequence	I-NP	I-NP	-	25	PMOD	-	-
28	at	at	B-PP	B-PP	-	24	NMOD	-	-
29	threonine	threonine	B-NP	B-NP	-	28	PMOD	-	-
30	<num>	<num>	I-NP	I-NP	-	29	NMOD	-	-
31	such	such	B-ADVP	B-ADVP	-	29	NMOD	-	-
32	that	that	B-SBAR	B-SBAR	-	29	NMOD	-	-
33	it	it	B-NP	B-NP	-	34	SUB	-	-
34	resembles	resembles	B-VP	B-VP	-	32	SBAR	-	-
35	that	that	B-NP	B-NP	-	34	OBJ	-	-
36	of	of	B-PP	B-PP	-	35	NMOD	-	-
37	c-erb	c-erb	B-NP	B-NP	-	38	NMOD	-	-
38	A	A	I-NP	I-NP	-	36	PMOD	-	-
39	can	can	B-VP	B-VP	-	34	VMOD	-	-
40	act	act	I-VP	I-VP	-	39	VC	-	-
41	as	as	B-PP	B-PP	-	40	VMOD	-	-
42	an	an	B-NP	B-NP	-	44	NMOD	-	-
43	intragenic	intragenic	I-NP	I-NP	-	44	NMOD	-	-
44	suppressor	suppressor	I-NP	I-NP	-	41	PMOD	-	-
45	and	and	O	O	-	34	VMOD	-	-
46	can	can	B-VP	B-VP	-	34	VMOD	-	-
47	partially	partially	I-VP	I-VP	-	46	VMOD	-	-
48	restore	restore	I-VP	I-VP	-	46	VC	-	-
49	function	function	B-NP	B-NP	-	48	OBJ	-	-
50	to	to	B-PP	B-PP	-	48	VMOD	-	-
51	a	a	B-NP	B-NP	-	54	NMOD	-	-
52	v-erb	v-erb	I-NP	I-NP	-	54	NMOD	-	-
53	A	A	I-NP	I-NP	-	54	NMOD	-	-
54	protein	protein	I-NP	I-NP	-	50	PMOD	-	-
55	rendered	rendered	B-VP	B-VP	-	48	VMOD	-	-
56	defective	defective	B-NP	B-NP	-	57	AMOD	-	-
57	due	due	I-NP	I-NP	-	58	PMOD	-	-
58	to	to	B-PP	B-PP	-	55	VMOD	-	-
59	a	a	B-NP	B-NP	-	60	NMOD	-	-
60	mutation	mutation	I-NP	I-NP	-	58	PMOD	-	-
61	at	at	B-PP	B-PP	-	60	NMOD	-	-
62	position	position	B-NP	B-NP	-	61	PMOD	-	-
63	<num>	<num>	I-NP	I-NP	-	62	NMOD	-	-
64	.	.	O	O	-	2	P	-	-

1	Threonine	Threonine	B-NP	B-NP	-	3	SUB	-	-
2	<num>	<num>	I-NP	I-NP	-	1	NMOD	-	-
3	lies	lies	B-VP	B-VP	-	0	ROOT	-	-
4	within	within	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	D-box	D-box	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	v-erb	v-erb	I-NP	I-NP	-	11	NMOD	-	-
10	A	A	I-NP	I-NP	-	11	NMOD	-	-
11	protein	protein	I-NP	I-NP	-	14	NMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	a	a	B-NP	B-NP	-	14	NMOD	-	-
14	region	region	I-NP	I-NP	-	7	PMOD	-	-
15	thought	thought	B-VP	B-VP	-	14	NMOD	-	-
16	to	to	I-VP	I-VP	-	17	VMOD	-	-
17	mediate	mediate	I-VP	I-VP	-	15	VMOD	-	-
18	receptor-receptor	receptor-receptor	B-NP	B-NP	-	19	NMOD	-	-
19	dimerizations	dimerizations	I-NP	I-NP	-	17	OBJ	-	-
20	,	,	O	O	-	3	P	-	-
21	and	and	O	O	-	3	VMOD	-	-
22	is	is	B-VP	B-VP	-	3	VMOD	-	-
23	not	not	O	O	-	22	VMOD	-	-
24	in	in	B-PP	B-PP	-	22	VMOD	-	-
25	physical	physical	B-NP	B-NP	-	26	NMOD	-	-
26	proximity	proximity	I-NP	I-NP	-	24	PMOD	-	-
27	to	to	B-PP	B-PP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	serine	serine	I-NP	I-NP	-	27	PMOD	-	-
30	at	at	B-PP	B-PP	-	29	NMOD	-	-
31	position	position	B-NP	B-NP	-	30	PMOD	-	-
32	<num>	<num>	I-NP	I-NP	-	31	NMOD	-	-
33	.	.	O	O	-	3	P	-	-

1	It	It	B-NP	B-NP	-	3	SUB	-	-
2	therefore	therefore	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	14	DEP	-	-
5	an	an	B-NP	B-NP	-	7	NMOD	-	-
6	indirect	indirect	I-NP	I-NP	-	7	NMOD	-	-
7	interaction	interaction	I-NP	I-NP	-	8	SUB	-	-
8	occurs	occurs	B-VP	B-VP	-	4	SBAR	-	-
9	between	between	B-PP	B-PP	-	8	VMOD	-	-
10	these	these	B-NP	B-NP	-	12	NMOD	-	-
11	two	two	I-NP	I-NP	-	12	NMOD	-	-
12	sites	sites	I-NP	I-NP	-	9	PMOD	-	-
13	and	and	O	O	-	14	DEP	-	-
14	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
15	this	this	B-NP	B-NP	-	16	NMOD	-	-
16	interaction	interaction	I-NP	I-NP	-	17	SUB	-	-
17	is	is	B-VP	B-VP	-	14	SBAR	-	-
18	crucial	crucial	B-ADJP	B-ADJP	-	17	PRD	-	-
19	for	for	B-PP	B-PP	-	18	AMOD	-	-
20	v-erb	v-erb	B-NP	B-NP	-	22	NMOD	-	-
21	A	A	I-NP	I-NP	-	22	NMOD	-	-
22	function	function	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	transcription	transcription	B-NP	B-NP	-	4	NMOD	-	-
4	factors	factors	I-NP	I-NP	-	2	PMOD	-	-
5	belonging	belonging	B-VP	B-VP	-	4	NMOD	-	-
6	to	to	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	rel/NF-kappa	rel/NF-kappa	I-NP	I-NP	-	10	NMOD	-	-
9	B	B	I-NP	I-NP	-	10	NMOD	-	-
10	family	family	I-NP	I-NP	-	6	PMOD	-	-
11	by	by	B-PP	B-PP	-	1	NMOD	-	-
12	a	a	B-NP	B-NP	-	15	NMOD	-	-
13	transdominant	transdominant	I-NP	I-NP	-	15	NMOD	-	-
14	negative	negative	I-NP	I-NP	-	15	NMOD	-	-
15	mutant	mutant	I-NP	I-NP	-	11	PMOD	-	-
16	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	KBF1	KBF1	I-NP	I-NP	-	3	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	24	SUB	-	-
4	,	,	O	O	-	3	P	-	-
5	which	which	B-NP	B-NP	-	3	NMOD	-	-
6	binds	binds	B-VP	B-VP	-	5	SBAR	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	enhancer	enhancer	I-NP	I-NP	-	10	NMOD	-	-
10	A	A	I-NP	I-NP	-	7	PMOD	-	-
11	located	located	B-ADJP	B-ADJP	-	10	NMOD	-	-
12	in	in	B-PP	B-PP	-	11	AMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	promoter	promoter	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	22	NMOD	-	-
17	mouse	mouse	I-NP	I-NP	-	22	NMOD	-	-
18	MHC	MHC	I-NP	I-NP	-	22	NMOD	-	-
19	class	class	I-NP	I-NP	-	21	NMOD	-	-
20	I	I	I-NP	I-NP	-	21	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	22	NMOD	-	-
22	H-2Kb	H-2Kb	I-NP	I-NP	-	15	PMOD	-	-
23	,	,	O	O	-	3	P	-	-
24	is	is	B-VP	B-VP	-	0	ROOT	-	-
25	indistinguishable	indistinguishable	B-ADJP	B-ADJP	-	24	PRD	-	-
26	from	from	B-PP	B-PP	-	25	AMOD	-	-
27	the	the	B-NP	B-NP	-	31	NMOD	-	-
28	p50	p50	I-NP	I-NP	-	31	NMOD	-	-
29	DNA	DNA	I-NP	I-NP	-	31	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	31	NMOD	-	-
31	subunit	subunit	I-NP	I-NP	-	26	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	37	NMOD	-	-
34	transcription	transcription	I-NP	I-NP	-	37	NMOD	-	-
35	factor	factor	I-NP	I-NP	-	37	NMOD	-	-
36	NF-kappa	NF-kappa	I-NP	I-NP	-	37	NMOD	-	-
37	B	B	I-NP	I-NP	-	32	PMOD	-	-
38	,	,	O	O	-	31	P	-	-
39	which	which	B-NP	B-NP	-	31	NMOD	-	-
40	regulates	regulates	B-VP	B-VP	-	39	SBAR	-	-
41	a	a	B-NP	B-NP	-	42	NMOD	-	-
42	series	series	I-NP	I-NP	-	40	OBJ	-	-
43	of	of	B-PP	B-PP	-	42	NMOD	-	-
44	genes	genes	B-NP	B-NP	-	43	PMOD	-	-
45	involved	involved	B-VP	B-VP	-	44	NMOD	-	-
46	in	in	B-PP	B-PP	-	45	VMOD	-	-
47	immune	immune	B-NP	B-NP	-	49	AMOD	-	-
48	and	and	I-NP	I-NP	-	49	AMOD	-	-
49	inflammatory	inflammatory	I-NP	I-NP	-	50	NMOD	-	-
50	responses	responses	I-NP	I-NP	-	46	PMOD	-	-
51	.	.	O	O	-	24	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	KBF1/p50	KBF1/p50	I-NP	I-NP	-	3	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	4	SUB	-	-
4	binds	binds	B-VP	B-VP	-	0	ROOT	-	-
5	as	as	B-PP	B-PP	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	homodimer	homodimer	I-NP	I-NP	-	5	PMOD	-	-
8	but	but	O	O	-	4	VMOD	-	-
9	can	can	B-VP	B-VP	-	4	VMOD	-	-
10	also	also	I-VP	I-VP	-	9	VMOD	-	-
11	form	form	I-VP	I-VP	-	9	VC	-	-
12	heterodimers	heterodimers	B-NP	B-NP	-	11	OBJ	-	-
13	with	with	B-PP	B-PP	-	11	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	products	products	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	other	other	B-NP	B-NP	-	18	NMOD	-	-
18	members	members	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	same	same	I-NP	I-NP	-	22	NMOD	-	-
22	family	family	I-NP	I-NP	-	19	PMOD	-	-
23	,	,	O	O	-	11	P	-	-
24	like	like	B-PP	B-PP	-	11	VMOD	-	-
25	the	the	B-NP	B-NP	-	28	NMOD	-	-
26	c-rel	c-rel	I-NP	I-NP	-	28	NMOD	-	-
27	and	and	O	O	-	28	NMOD	-	-
28	v-rel	v-rel	B-NP	B-NP	-	32	NMOD	-	-
29	(	(	B-NP	B-NP	-	30	P	-	-
30	proto	proto	I-NP	I-NP	-	28	NMOD	-	-
31	)	)	I-NP	I-NP	-	30	P	-	-
32	oncogenes	oncogenes	I-NP	I-NP	-	24	PMOD	-	-
33	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	dimerization	dimerization	I-NP	I-NP	-	3	NMOD	-	-
3	domain	domain	I-NP	I-NP	-	6	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	KBF1/p50	KBF1/p50	B-NP	B-NP	-	4	PMOD	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	contained	contained	I-VP	I-VP	-	6	VC	-	-
8	between	between	B-PP	B-PP	-	7	VMOD	-	-
9	amino	amino	B-NP	B-NP	-	10	NMOD	-	-
10	acids	acids	I-NP	I-NP	-	8	PMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	<num>	<num>	B-NP	B-NP	-	10	NMOD	-	-
14	.	.	O	O	-	6	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	mutant	mutant	I-NP	I-NP	-	23	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	KBF1/p50	KBF1/p50	B-NP	B-NP	-	3	PMOD	-	-
5	(	(	O	O	-	7	P	-	-
6	delta	delta	B-NP	B-NP	-	7	NMOD	-	-
7	SP	SP	I-NP	I-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	,	,	O	O	-	16	P	-	-
10	unable	unable	B-ADJP	B-ADJP	-	16	AMOD	-	-
11	to	to	B-VP	B-VP	-	12	VMOD	-	-
12	bind	bind	I-VP	I-VP	-	10	AMOD	-	-
13	to	to	B-PP	B-PP	-	12	VMOD	-	-
14	DNA	DNA	B-NP	B-NP	-	13	PMOD	-	-
15	but	but	O	O	-	16	AMOD	-	-
16	able	able	B-ADJP	B-ADJP	-	4	NMOD	-	-
17	to	to	B-VP	B-VP	-	18	VMOD	-	-
18	form	form	I-VP	I-VP	-	16	AMOD	-	-
19	homo-	homo-	B-NP	B-NP	-	18	OBJ	-	-
20	or	or	O	O	-	21	NMOD	-	-
21	heterodimers	heterodimers	B-NP	B-NP	-	19	NMOD	-	-
22	,	,	O	O	-	2	P	-	-
23	has	has	B-VP	B-VP	-	0	ROOT	-	-
24	been	been	I-VP	I-VP	-	23	VC	-	-
25	constructed	constructed	I-VP	I-VP	-	24	VC	-	-
26	.	.	O	O	-	23	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	protein	protein	I-NP	I-NP	-	3	SUB	-	-
3	reduces	reduces	B-VP	B-VP	-	0	ROOT	-	-
4	or	or	I-VP	I-VP	-	3	VMOD	-	-
5	abolishes	abolishes	I-VP	I-VP	-	3	VMOD	-	-
6	in	in	B-ADVP	B-ADVP	-	5	VMOD	-	-
7	vitro	vitro	I-ADVP	I-ADVP	-	6	AMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	DNA	DNA	I-NP	I-NP	-	11	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	5	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	wild-type	wild-type	B-NP	B-NP	-	14	NMOD	-	-
14	proteins	proteins	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	same	same	I-NP	I-NP	-	18	NMOD	-	-
18	family	family	I-NP	I-NP	-	15	PMOD	-	-
19	(	(	O	O	-	24	P	-	-
20	KBF1/p50	KBF1/p50	B-NP	B-NP	-	24	NMOD	-	-
21	,	,	O	O	-	24	P	-	-
22	c-	c-	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	v-rel	v-rel	B-NP	B-NP	-	18	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	.	.	O	O	-	3	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	mutant	mutant	I-NP	I-NP	-	4	SUB	-	-
3	also	also	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	functions	functions	B-VP	B-VP	-	0	ROOT	-	-
5	in	in	B-ADVP	B-ADVP	-	4	VMOD	-	-
6	vivo	vivo	I-ADVP	I-ADVP	-	5	AMOD	-	-
7	as	as	B-PP	B-PP	-	4	VMOD	-	-
8	a	a	B-NP	B-NP	-	12	NMOD	-	-
9	trans-acting	trans-acting	I-NP	I-NP	-	12	NMOD	-	-
10	dominant	dominant	I-NP	I-NP	-	12	NMOD	-	-
11	negative	negative	I-NP	I-NP	-	12	NMOD	-	-
12	regulator	regulator	I-NP	I-NP	-	7	PMOD	-	-
13	:	:	O	O	-	4	P	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	transcriptional	transcriptional	I-NP	I-NP	-	16	NMOD	-	-
16	inducibility	inducibility	I-NP	I-NP	-	4	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	22	NMOD	-	-
19	HIV	HIV	I-NP	I-NP	-	22	NMOD	-	-
20	long	long	I-NP	I-NP	-	22	NMOD	-	-
21	terminal	terminal	I-NP	I-NP	-	22	NMOD	-	-
22	repeat	repeat	I-NP	I-NP	-	17	PMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	which	which	B-NP	B-NP	-	22	NMOD	-	-
25	contains	contains	B-VP	B-VP	-	24	SBAR	-	-
26	two	two	B-NP	B-NP	-	25	OBJ	-	-
27	potential	potential	I-NP	I-NP	-	31	NMOD	-	-
28	NF-kappa	NF-kappa	I-NP	I-NP	-	31	NMOD	-	-
29	B	B	I-NP	I-NP	-	31	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	31	NMOD	-	-
31	sites	sites	I-NP	I-NP	-	26	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	by	by	B-PP	B-PP	-	26	NMOD	-	-
34	phorbol	phorbol	B-NP	B-NP	-	35	NMOD	-	-
35	ester	ester	I-NP	I-NP	-	33	PMOD	-	-
36	(	(	O	O	-	37	P	-	-
37	PMA	PMA	B-NP	B-NP	-	35	NMOD	-	-
38	)	)	O	O	-	37	P	-	-
39	is	is	B-VP	B-VP	-	33	SBAR	-	-
40	inhibited	inhibited	I-VP	I-VP	-	39	VC	-	-
41	when	when	B-ADVP	B-ADVP	-	40	VMOD	-	-
42	it	it	B-NP	B-NP	-	43	SUB	-	-
43	is	is	B-VP	B-VP	-	41	SBAR	-	-
44	co-transfected	co-transfected	I-VP	I-VP	-	43	VC	-	-
45	into	into	B-PP	B-PP	-	44	VMOD	-	-
46	CD4+	CD4+	B-NP	B-NP	-	48	NMOD	-	-
47	T	T	I-NP	I-NP	-	48	NMOD	-	-
48	cells	cells	I-NP	I-NP	-	45	PMOD	-	-
49	with	with	B-PP	B-PP	-	44	VMOD	-	-
50	the	the	B-NP	B-NP	-	53	NMOD	-	-
51	delta	delta	I-NP	I-NP	-	53	NMOD	-	-
52	SP	SP	I-NP	I-NP	-	53	NMOD	-	-
53	mutant	mutant	I-NP	I-NP	-	49	PMOD	-	-
54	.	.	O	O	-	4	P	-	-

1	Similarly	Similarly	B-ADVP	B-ADVP	-	18	VMOD	-	-
2	the	the	B-NP	B-NP	-	3	NMOD	-	-
3	basal	basal	I-NP	I-NP	-	10	NMOD	-	-
4	as	as	B-CONJP	B-CONJP	-	10	NMOD	-	-
5	well	well	I-CONJP	I-CONJP	-	4	DEP	-	-
6	as	as	I-CONJP	I-CONJP	-	4	DEP	-	-
7	TNF	TNF	B-NP	B-NP	-	10	NMOD	-	-
8	or	or	O	O	-	10	NMOD	-	-
9	IL1-induced	IL1-induced	B-NP	B-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	18	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	17	NMOD	-	-
13	MHC	MHC	I-NP	I-NP	-	17	NMOD	-	-
14	class	class	I-NP	I-NP	-	17	NMOD	-	-
15	I	I	I-NP	I-NP	-	17	NMOD	-	-
16	H-2Kb	H-2Kb	I-NP	I-NP	-	17	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	11	PMOD	-	-
18	can	can	B-VP	B-VP	-	0	ROOT	-	-
19	be	be	I-VP	I-VP	-	18	VC	-	-
20	inhibited	inhibited	I-VP	I-VP	-	19	VC	-	-
21	by	by	B-PP	B-PP	-	20	VMOD	-	-
22	this	this	B-NP	B-NP	-	23	NMOD	-	-
23	mutant	mutant	I-NP	I-NP	-	21	PMOD	-	-
24	in	in	B-PP	B-PP	-	23	NMOD	-	-
25	two	two	B-NP	B-NP	-	28	NMOD	-	-
26	different	different	I-NP	I-NP	-	28	NMOD	-	-
27	cell	cell	I-NP	I-NP	-	28	NMOD	-	-
28	lines	lines	I-NP	I-NP	-	24	PMOD	-	-
29	.	.	O	O	-	18	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	constitute	constitute	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	first	first	I-NP	I-NP	-	7	NMOD	-	-
6	formal	formal	I-NP	I-NP	-	7	NMOD	-	-
7	demonstration	demonstration	I-NP	I-NP	-	3	OBJ	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	these	these	B-NP	B-NP	-	10	NMOD	-	-
10	genes	genes	I-NP	I-NP	-	11	SUB	-	-
11	are	are	B-VP	B-VP	-	8	SBAR	-	-
12	regulated	regulated	I-VP	I-VP	-	11	VC	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	members	members	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	rel/NF-kappa	rel/NF-kappa	I-NP	I-NP	-	19	NMOD	-	-
18	B	B	I-NP	I-NP	-	19	NMOD	-	-
19	family	family	I-NP	I-NP	-	15	PMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	NF-kappa	NF-kappa	B-NP	B-NP	-	3	NMOD	-	-
2	B	B	I-NP	I-NP	-	3	NMOD	-	-
3	activity	activity	I-NP	I-NP	-	0	ROOT	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	T	T	B-NP	B-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
7	stably	stably	B-VP	B-VP	-	8	VMOD	-	-
8	expressing	expressing	I-VP	I-VP	-	6	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	Tax	Tax	I-NP	I-NP	-	11	NMOD	-	-
11	protein	protein	I-NP	I-NP	-	8	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	human	human	B-NP	B-NP	-	15	NMOD	-	-
14	T	T	I-NP	I-NP	-	15	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	12	PMOD	-	-
16	lymphotropic	lymphotropic	I-NP	I-NP	-	18	NMOD	-	-
17	virus	virus	I-NP	I-NP	-	18	NMOD	-	-
18	type	type	I-NP	I-NP	-	15	NMOD	-	-
19	I	I	I-NP	I-NP	-	18	NMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	23	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	constitutive	constitutive	B-NP	B-NP	-	6	NMOD	-	-
5	Tax	Tax	I-NP	I-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
7	on	on	B-PP	B-PP	-	2	NMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	interaction	interaction	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
12	B	B	I-NP	I-NP	-	10	PMOD	-	-
13	with	with	B-PP	B-PP	-	9	NMOD	-	-
14	its	its	B-NP	B-NP	-	16	NMOD	-	-
15	recognition	recognition	I-NP	I-NP	-	16	NMOD	-	-
16	sequence	sequence	I-NP	I-NP	-	13	PMOD	-	-
17	and	and	B-PP	B-PP	-	13	PMOD	-	-
18	on	on	B-PP	B-PP	-	13	PMOD	-	-
19	NF-kappa	NF-kappa	B-NP	B-NP	-	22	NMOD	-	-
20	B-dependent	B-dependent	I-NP	I-NP	-	19	AMOD	-	-
21	gene	gene	I-NP	I-NP	-	22	NMOD	-	-
22	expression	expression	I-NP	I-NP	-	18	PMOD	-	-
23	was	was	B-VP	B-VP	-	0	ROOT	-	-
24	examined	examined	I-VP	I-VP	-	23	VC	-	-
25	in	in	B-PP	B-PP	-	24	VMOD	-	-
26	T	T	B-NP	B-NP	-	30	NMOD	-	-
27	lymphoid	lymphoid	I-NP	I-NP	-	30	NMOD	-	-
28	Jurkat	Jurkat	I-NP	I-NP	-	30	NMOD	-	-
29	cell	cell	I-NP	I-NP	-	30	NMOD	-	-
30	lines	lines	I-NP	I-NP	-	25	PMOD	-	-
31	(	(	O	O	-	34	P	-	-
32	19D	19D	B-NP	B-NP	-	34	NMOD	-	-
33	and	and	O	O	-	34	NMOD	-	-
34	9J	9J	B-NP	B-NP	-	30	NMOD	-	-
35	)	)	O	O	-	34	P	-	-
36	stably	stably	B-VP	B-VP	-	37	VMOD	-	-
37	transformed	transformed	I-VP	I-VP	-	34	NMOD	-	-
38	with	with	B-PP	B-PP	-	37	VMOD	-	-
39	a	a	B-NP	B-NP	-	42	NMOD	-	-
40	Tax	Tax	I-NP	I-NP	-	42	NMOD	-	-
41	expression	expression	I-NP	I-NP	-	42	NMOD	-	-
42	vector	vector	I-NP	I-NP	-	38	PMOD	-	-
43	.	.	O	O	-	23	P	-	-

1	Tax	Tax	B-NP	B-NP	-	6	SUB	-	-
2	expressing	expressing	B-VP	B-VP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	5	NMOD	-	-
4	cell	cell	I-NP	I-NP	-	5	NMOD	-	-
5	lines	lines	I-NP	I-NP	-	2	OBJ	-	-
6	contained	contained	B-VP	B-VP	-	0	ROOT	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	constitutive	constitutive	I-NP	I-NP	-	9	NMOD	-	-
9	level	level	I-NP	I-NP	-	6	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-kappa	NF-kappa	B-NP	B-NP	-	14	NMOD	-	-
12	B	B	I-NP	I-NP	-	14	NMOD	-	-
13	binding	binding	I-NP	I-NP	-	14	NMOD	-	-
14	activity	activity	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	detectable	detectable	B-ADJP	B-ADJP	-	14	NMOD	-	-
17	by	by	B-PP	B-PP	-	16	AMOD	-	-
18	mobility	mobility	B-NP	B-NP	-	20	NMOD	-	-
19	shift	shift	I-NP	I-NP	-	20	NMOD	-	-
20	assay	assay	I-NP	I-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	uv	uv	B-NP	B-NP	-	23	NMOD	-	-
23	cross-linking	cross-linking	I-NP	I-NP	-	17	PMOD	-	-
24	using	using	B-VP	B-VP	-	23	NMOD	-	-
25	a	a	B-NP	B-NP	-	29	NMOD	-	-
26	palindromic	palindromic	I-NP	I-NP	-	29	NMOD	-	-
27	NF-kappa	NF-kappa	I-NP	I-NP	-	29	NMOD	-	-
28	B	B	I-NP	I-NP	-	29	NMOD	-	-
29	probe	probe	I-NP	I-NP	-	24	OBJ	-	-
30	homologous	homologous	B-ADJP	B-ADJP	-	29	NMOD	-	-
31	to	to	B-PP	B-PP	-	30	AMOD	-	-
32	the	the	B-NP	B-NP	-	36	NMOD	-	-
33	interferon	interferon	I-NP	I-NP	-	36	NMOD	-	-
34	beta	beta	I-NP	I-NP	-	36	NMOD	-	-
35	PRDII	PRDII	I-NP	I-NP	-	36	NMOD	-	-
36	site	site	I-NP	I-NP	-	31	PMOD	-	-
37	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	9	VMOD	-	-
2	Jurkat	Jurkat	B-NP	B-NP	-	4	NMOD	-	-
3	and	and	O	O	-	4	NMOD	-	-
4	NC2.10	NC2.10	B-NP	B-NP	-	5	NMOD	-	-
5	induction	induction	B-NP	B-NP	-	1	PMOD	-	-
6	with	with	B-PP	B-PP	-	5	NMOD	-	-
7	phorbol	phorbol	B-NP	B-NP	-	8	NMOD	-	-
8	esters	esters	I-NP	I-NP	-	6	PMOD	-	-
9	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	appearance	appearance	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	new	new	B-NP	B-NP	-	17	NMOD	-	-
15	DNA	DNA	I-NP	I-NP	-	17	NMOD	-	-
16	binding	binding	I-NP	I-NP	-	17	NMOD	-	-
17	proteins	proteins	I-NP	I-NP	-	13	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	<num>	<num>	B-NP	B-NP	-	25	NMOD	-	-
20	,	,	I-NP	I-NP	-	25	P	-	-
21	<num>	<num>	I-NP	I-NP	-	25	NMOD	-	-
22	,	,	O	O	-	25	P	-	-
23	and	and	O	O	-	25	NMOD	-	-
24	<num>	<num>	B-NP	B-NP	-	25	NMOD	-	-
25	kDa	kDa	I-NP	I-NP	-	18	PMOD	-	-
26	,	,	O	O	-	9	P	-	-
27	whereas	whereas	O	O	-	9	VMOD	-	-
28	in	in	B-PP	B-PP	-	41	VMOD	-	-
29	Tax	Tax	B-NP	B-NP	-	31	NMOD	-	-
30	expressing	expressing	I-NP	I-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	28	PMOD	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	85-kDa	85-kDa	I-NP	I-NP	-	34	NMOD	-	-
34	protein	protein	I-NP	I-NP	-	40	NMOD	-	-
35	and	and	O	O	-	40	NMOD	-	-
36	a	a	B-NP	B-NP	-	40	NMOD	-	-
37	92-kDa	92-kDa	I-NP	I-NP	-	40	NMOD	-	-
38	DNA	DNA	I-NP	I-NP	-	40	NMOD	-	-
39	binding	binding	I-NP	I-NP	-	40	NMOD	-	-
40	protein	protein	I-NP	I-NP	-	41	SUB	-	-
41	were	were	B-VP	B-VP	-	27	SBAR	-	-
42	constitutively	constitutively	I-VP	I-VP	-	41	VMOD	-	-
43	induced	induced	I-VP	I-VP	-	41	VC	-	-
44	.	.	O	O	-	9	P	-	-

1	Expression	Expression	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Tax	Tax	B-NP	B-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	2	PMOD	-	-
5	in	in	B-PP	B-PP	-	1	NMOD	-	-
6	19D	19D	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	O	O	-	8	NMOD	-	-
8	9J	9J	B-NP	B-NP	-	5	PMOD	-	-
9	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	transcription	transcription	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	21	NMOD	-	-
14	endogenous	endogenous	I-NP	I-NP	-	21	NMOD	-	-
15	NF-kappa	NF-kappa	I-NP	I-NP	-	21	NMOD	-	-
16	B-dependent	B-dependent	I-NP	I-NP	-	21	NMOD	-	-
17	granulocyte-macrophage	granulocyte-macrophage	I-NP	I-NP	-	21	NMOD	-	-
18	colony	colony	I-NP	I-NP	-	21	NMOD	-	-
19	stimulating	stimulating	I-NP	I-NP	-	21	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	21	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	12	PMOD	-	-
22	and	and	O	O	-	26	NMOD	-	-
23	increased	increased	B-NP	B-NP	-	26	NMOD	-	-
24	basal	basal	I-NP	I-NP	-	26	NMOD	-	-
25	level	level	I-NP	I-NP	-	26	NMOD	-	-
26	expression	expression	I-NP	I-NP	-	12	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	transfected	transfected	B-NP	B-NP	-	31	NMOD	-	-
29	NF-kappa	NF-kappa	I-NP	I-NP	-	31	NMOD	-	-
30	B-regulated	B-regulated	I-NP	I-NP	-	29	AMOD	-	-
31	promoters	promoters	I-NP	I-NP	-	27	PMOD	-	-
32	.	.	O	O	-	9	P	-	-

1	Nonetheless	Nonetheless	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	transcription	transcription	B-NP	B-NP	-	11	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	both	both	O	O	-	10	NMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	endogenous	endogenous	I-NP	I-NP	-	10	NMOD	-	-
7	and	and	O	O	-	10	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	transfected	transfected	I-NP	I-NP	-	10	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	3	PMOD	-	-
11	was	was	B-VP	B-VP	-	0	ROOT	-	-
12	inducible	inducible	B-ADJP	B-ADJP	-	11	PRD	-	-
13	by	by	B-PP	B-PP	-	12	AMOD	-	-
14	PMA	PMA	B-NP	B-NP	-	15	NMOD	-	-
15	treatment	treatment	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	11	P	-	-

1	Tax	Tax	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	7	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	Jurkat	Jurkat	B-NP	B-NP	-	6	NMOD	-	-
5	T	T	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
7	may	may	B-VP	B-VP	-	0	ROOT	-	-
8	alter	alter	I-VP	I-VP	-	7	VC	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	stoichiometry	stoichiometry	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	NF-kappa	NF-kappa	B-NP	B-NP	-	16	NMOD	-	-
13	B	B	I-NP	I-NP	-	16	NMOD	-	-
14	DNA	DNA	I-NP	I-NP	-	16	NMOD	-	-
15	binding	binding	I-NP	I-NP	-	16	NMOD	-	-
16	proteins	proteins	I-NP	I-NP	-	11	PMOD	-	-
17	and	and	O	O	-	7	VMOD	-	-
18	thus	thus	O	O	-	7	VMOD	-	-
19	change	change	B-VP	B-VP	-	7	VC	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	expression	expression	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	NF-kappa	NF-kappa	B-NP	B-NP	-	25	NMOD	-	-
24	B-regulated	B-regulated	I-NP	I-NP	-	23	AMOD	-	-
25	promoters	promoters	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	7	P	-	-

1	Anti-CD2	Anti-CD2	B-NP	B-NP	-	3	NMOD	-	-
2	receptor	receptor	I-NP	I-NP	-	3	NMOD	-	-
3	antibodies	antibodies	I-NP	I-NP	-	4	SUB	-	-
4	activate	activate	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	9	NMOD	-	-
6	HIV	HIV	I-NP	I-NP	-	9	NMOD	-	-
7	long	long	I-NP	I-NP	-	9	NMOD	-	-
8	terminal	terminal	I-NP	I-NP	-	9	NMOD	-	-
9	repeat	repeat	I-NP	I-NP	-	4	OBJ	-	-
10	in	in	B-PP	B-PP	-	4	VMOD	-	-
11	T	T	B-NP	B-NP	-	12	NMOD	-	-
12	lymphocytes	lymphocytes	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	7	NMOD	-	-
2	CD2	CD2	I-NP	I-NP	-	7	NMOD	-	-
3	T	T	I-NP	I-NP	-	7	NMOD	-	-
4	lymphocyte	lymphocyte	I-NP	I-NP	-	7	NMOD	-	-
5	glycoprotein	glycoprotein	I-NP	I-NP	-	7	NMOD	-	-
6	surface	surface	I-NP	I-NP	-	7	NMOD	-	-
7	molecule	molecule	I-NP	I-NP	-	8	SUB	-	-
8	mediates	mediates	B-VP	B-VP	-	0	ROOT	-	-
9	both	both	B-NP	B-NP	-	10	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	8	OBJ	-	-
11	to	to	B-PP	B-PP	-	10	NMOD	-	-
12	cell	cell	B-NP	B-NP	-	13	NMOD	-	-
13	adhesion	adhesion	I-NP	I-NP	-	17	NMOD	-	-
14	and	and	O	O	-	17	NMOD	-	-
15	T	T	B-NP	B-NP	-	17	NMOD	-	-
16	cell	cell	I-NP	I-NP	-	17	NMOD	-	-
17	activation	activation	I-NP	I-NP	-	20	NMOD	-	-
18	,	,	O	O	-	20	P	-	-
19	two	two	B-NP	B-NP	-	20	NMOD	-	-
20	processes	processes	I-NP	I-NP	-	11	PMOD	-	-
21	that	that	B-NP	B-NP	-	20	NMOD	-	-
22	are	are	B-VP	B-VP	-	21	SBAR	-	-
23	involved	involved	I-VP	I-VP	-	22	VC	-	-
24	in	in	B-PP	B-PP	-	23	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	spread	spread	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	HIV	HIV	B-NP	B-NP	-	29	NMOD	-	-
29	infection	infection	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	8	P	-	-

1	Treatment	Treatment	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	chronically	chronically	B-NP	B-NP	-	4	AMOD	-	-
4	HIV-infected	HIV-infected	I-NP	I-NP	-	5	NMOD	-	-
5	PBMC	PBMC	I-NP	I-NP	-	2	PMOD	-	-
6	with	with	B-PP	B-PP	-	1	NMOD	-	-
7	anti-CD2	anti-CD2	B-NP	B-NP	-	8	NMOD	-	-
8	mAb	mAb	I-NP	I-NP	-	6	PMOD	-	-
9	has	has	B-VP	B-VP	-	0	ROOT	-	-
10	been	been	I-VP	I-VP	-	9	VC	-	-
11	shown	shown	I-VP	I-VP	-	10	VC	-	-
12	to	to	I-VP	I-VP	-	13	VMOD	-	-
13	induce	induce	I-VP	I-VP	-	11	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	13	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	infectious	infectious	B-NP	B-NP	-	18	NMOD	-	-
18	virus	virus	I-NP	I-NP	-	16	PMOD	-	-
19	from	from	B-PP	B-PP	-	15	NMOD	-	-
20	these	these	B-NP	B-NP	-	21	NMOD	-	-
21	cultures	cultures	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	9	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	we	we	B-NP	B-NP	-	5	SUB	-	-
5	investigated	investigated	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	mechanisms	mechanisms	I-NP	I-NP	-	5	OBJ	-	-
8	whereby	whereby	B-ADVP	B-ADVP	-	7	NMOD	-	-
9	anti-CD2	anti-CD2	B-NP	B-NP	-	10	NMOD	-	-
10	antibodies	antibodies	I-NP	I-NP	-	11	SUB	-	-
11	stimulate	stimulate	B-VP	B-VP	-	8	SBAR	-	-
12	viral	viral	B-NP	B-NP	-	13	NMOD	-	-
13	production	production	I-NP	I-NP	-	11	OBJ	-	-
14	.	.	O	O	-	5	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	treatment	treatment	B-NP	B-NP	-	13	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	transiently	transiently	B-NP	B-NP	-	7	AMOD	-	-
7	transfected	transfected	I-NP	I-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	lymphocytes	lymphocytes	I-NP	I-NP	-	5	PMOD	-	-
10	with	with	B-PP	B-PP	-	4	NMOD	-	-
11	anti-CD2	anti-CD2	B-NP	B-NP	-	12	NMOD	-	-
12	antibodies	antibodies	I-NP	I-NP	-	10	PMOD	-	-
13	results	results	B-VP	B-VP	-	3	SBAR	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	activation	activation	B-NP	B-NP	-	14	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	HIV	HIV	I-NP	I-NP	-	21	NMOD	-	-
19	long	long	I-NP	I-NP	-	21	NMOD	-	-
20	terminal	terminal	I-NP	I-NP	-	21	NMOD	-	-
21	repeat	repeat	I-NP	I-NP	-	16	PMOD	-	-
22	.	.	O	O	-	2	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	16	VMOD	-	-
2	,	,	O	O	-	16	P	-	-
3	CAT	CAT	B-NP	B-NP	-	4	NMOD	-	-
4	assays	assays	I-NP	I-NP	-	15	NMOD	-	-
5	using	using	B-VP	B-VP	-	4	NMOD	-	-
6	mutated	mutated	B-NP	B-NP	-	11	NMOD	-	-
7	HIV	HIV	I-NP	I-NP	-	11	NMOD	-	-
8	long	long	I-NP	I-NP	-	11	NMOD	-	-
9	terminal	terminal	I-NP	I-NP	-	11	NMOD	-	-
10	repeat-CAT	repeat-CAT	I-NP	I-NP	-	11	NMOD	-	-
11	constructs	constructs	I-NP	I-NP	-	15	NMOD	-	-
12	and	and	O	O	-	15	NMOD	-	-
13	gel	gel	B-NP	B-NP	-	15	NMOD	-	-
14	shift	shift	I-NP	I-NP	-	15	NMOD	-	-
15	assays	assays	I-NP	I-NP	-	16	SUB	-	-
16	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
17	that	that	B-SBAR	B-SBAR	-	16	VMOD	-	-
18	this	this	B-NP	B-NP	-	19	NMOD	-	-
19	activation	activation	I-NP	I-NP	-	20	SUB	-	-
20	is	is	B-VP	B-VP	-	17	SBAR	-	-
21	dependent	dependent	B-ADJP	B-ADJP	-	20	PRD	-	-
22	on	on	B-PP	B-PP	-	21	AMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	NF-kappa	NF-kappa	I-NP	I-NP	-	26	NMOD	-	-
25	B	B	I-NP	I-NP	-	26	NMOD	-	-
26	enhancer	enhancer	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	16	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	interaction	interaction	B-NP	B-NP	-	15	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	CD2	CD2	B-NP	B-NP	-	6	PMOD	-	-
8	with	with	B-PP	B-PP	-	5	NMOD	-	-
9	its	its	B-NP	B-NP	-	11	NMOD	-	-
10	natural	natural	I-NP	I-NP	-	11	NMOD	-	-
11	ligand	ligand	I-NP	I-NP	-	13	NMOD	-	-
12	,	,	O	O	-	13	P	-	-
13	LFA-3	LFA-3	B-NP	B-NP	-	8	PMOD	-	-
14	,	,	O	O	-	5	P	-	-
15	may	may	B-VP	B-VP	-	4	SBAR	-	-
16	play	play	I-VP	I-VP	-	15	VC	-	-
17	a	a	B-NP	B-NP	-	18	NMOD	-	-
18	role	role	I-NP	I-NP	-	16	OBJ	-	-
19	in	in	B-PP	B-PP	-	16	VMOD	-	-
20	regulation	regulation	B-NP	B-NP	-	19	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	HIV	HIV	B-NP	B-NP	-	23	NMOD	-	-
23	expression	expression	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	3	P	-	-

1	v-erbA	v-erbA	B-NP	B-NP	-	2	NMOD	-	-
2	overexpression	overexpression	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	required	required	I-VP	I-VP	-	3	VC	-	-
5	to	to	I-VP	I-VP	-	6	VMOD	-	-
6	extinguish	extinguish	I-VP	I-VP	-	4	VMOD	-	-
7	c-erbA	c-erbA	B-NP	B-NP	-	8	NMOD	-	-
8	function	function	I-NP	I-NP	-	6	OBJ	-	-
9	in	in	B-PP	B-PP	-	6	VMOD	-	-
10	erythroid	erythroid	B-NP	B-NP	-	12	NMOD	-	-
11	cell	cell	I-NP	I-NP	-	12	NMOD	-	-
12	differentiation	differentiation	I-NP	I-NP	-	14	NMOD	-	-
13	and	and	O	O	-	14	NMOD	-	-
14	regulation	regulation	B-NP	B-NP	-	9	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	20	NMOD	-	-
17	erbA	erbA	I-NP	I-NP	-	20	NMOD	-	-
18	target	target	I-NP	I-NP	-	20	NMOD	-	-
19	gene	gene	I-NP	I-NP	-	20	NMOD	-	-
20	CAII	CAII	I-NP	I-NP	-	15	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	v-erbA	v-erbA	I-NP	I-NP	-	3	NMOD	-	-
3	oncoprotein	oncoprotein	I-NP	I-NP	-	4	SUB	-	-
4	represents	represents	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	8	NMOD	-	-
6	retrovirus-transduced	retrovirus-transduced	I-NP	I-NP	-	8	NMOD	-	-
7	oncogenic	oncogenic	I-NP	I-NP	-	8	NMOD	-	-
8	version	version	I-NP	I-NP	-	4	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	thyroid	thyroid	I-NP	I-NP	-	12	NMOD	-	-
12	hormone	hormone	I-NP	I-NP	-	9	PMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	T3/T4	T3/T4	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	20	P	-	-
16	receptor	receptor	B-NP	B-NP	-	20	NMOD	-	-
17	c-erbA	c-erbA	I-NP	I-NP	-	20	NMOD	-	-
18	(	(	I-NP	I-NP	-	20	P	-	-
19	type	type	I-NP	I-NP	-	20	NMOD	-	-
20	alpha	alpha	I-NP	I-NP	-	12	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	.	.	O	O	-	4	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	contributes	contributes	B-VP	B-VP	-	0	ROOT	-	-
3	to	to	B-PP	B-PP	-	2	VMOD	-	-
4	virus-induced	virus-induced	B-NP	B-NP	-	5	NMOD	-	-
5	erythroleukemia	erythroleukemia	I-NP	I-NP	-	3	PMOD	-	-
6	by	by	B-PP	B-PP	-	2	VMOD	-	-
7	efficiently	efficiently	B-ADVP	B-ADVP	-	8	VMOD	-	-
8	arresting	arresting	B-VP	B-VP	-	6	PMOD	-	-
9	differentiation	differentiation	B-NP	B-NP	-	8	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	red	red	B-NP	B-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	progenitors	progenitors	I-NP	I-NP	-	10	PMOD	-	-
14	and	and	B-PP	B-PP	-	8	VMOD	-	-
15	by	by	B-PP	B-PP	-	6	PMOD	-	-
16	suppressing	suppressing	B-VP	B-VP	-	15	PMOD	-	-
17	transcription	transcription	B-NP	B-NP	-	16	OBJ	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	erythrocyte-specific	erythrocyte-specific	B-NP	B-NP	-	20	NMOD	-	-
20	genes	genes	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	show	show	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	v-erbA	v-erbA	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	O	O	-	8	NMOD	-	-
8	c-erbA	c-erbA	B-NP	B-NP	-	9	SUB	-	-
9	bind	bind	B-VP	B-VP	-	5	SBAR	-	-
10	directly	directly	B-ADVP	B-ADVP	-	9	VMOD	-	-
11	to	to	B-PP	B-PP	-	9	VMOD	-	-
12	sequences	sequences	B-NP	B-NP	-	11	PMOD	-	-
13	within	within	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	promoter	promoter	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	erythrocyte-specific	erythrocyte-specific	I-NP	I-NP	-	20	NMOD	-	-
19	carbonic	carbonic	I-NP	I-NP	-	20	NMOD	-	-
20	anhydrase	anhydrase	I-NP	I-NP	-	16	PMOD	-	-
21	II	II	I-NP	I-NP	-	20	NMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	CAII	CAII	B-NP	B-NP	-	20	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	,	,	O	O	-	27	P	-	-
26	a	a	B-NP	B-NP	-	27	NMOD	-	-
27	gene	gene	I-NP	I-NP	-	16	PMOD	-	-
28	whose	whose	B-NP	B-NP	-	27	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	28	NMOD	-	-
30	is	is	B-VP	B-VP	-	28	SBAR	-	-
31	efficiently	efficiently	I-VP	I-VP	-	30	VMOD	-	-
32	suppressed	suppressed	I-VP	I-VP	-	30	VC	-	-
33	by	by	B-PP	B-PP	-	32	VMOD	-	-
34	v-erbA	v-erbA	B-NP	B-NP	-	33	PMOD	-	-
35	.	.	O	O	-	4	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	erbA-binding	erbA-binding	I-NP	I-NP	-	3	NMOD	-	-
3	site	site	I-NP	I-NP	-	4	SUB	-	-
4	confers	confers	B-VP	B-VP	-	0	ROOT	-	-
5	thyroid	thyroid	B-NP	B-NP	-	7	NMOD	-	-
6	hormone	hormone	I-NP	I-NP	-	7	NMOD	-	-
7	responsiveness	responsiveness	I-NP	I-NP	-	4	OBJ	-	-
8	to	to	B-PP	B-PP	-	7	NMOD	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	heterologous	heterologous	I-NP	I-NP	-	11	NMOD	-	-
11	promoter	promoter	I-NP	I-NP	-	8	PMOD	-	-
12	in	in	B-PP	B-PP	-	4	VMOD	-	-
13	transient	transient	B-NP	B-NP	-	15	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	15	NMOD	-	-
15	experiments	experiments	I-NP	I-NP	-	12	PMOD	-	-
16	and	and	O	O	-	4	VMOD	-	-
17	is	is	B-VP	B-VP	-	4	VMOD	-	-
18	a	a	B-NP	B-NP	-	19	NMOD	-	-
19	target	target	I-NP	I-NP	-	17	PRD	-	-
20	for	for	B-PP	B-PP	-	19	NMOD	-	-
21	efficient	efficient	B-NP	B-NP	-	22	NMOD	-	-
22	down-regulation	down-regulation	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	CAII	CAII	B-NP	B-NP	-	25	NMOD	-	-
25	transcription	transcription	I-NP	I-NP	-	23	PMOD	-	-
26	by	by	B-PP	B-PP	-	19	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	v-erbA	v-erbA	I-NP	I-NP	-	29	NMOD	-	-
29	oncoprotein	oncoprotein	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	21	VMOD	-	-
2	stably	stably	B-NP	B-NP	-	3	AMOD	-	-
3	transformed	transformed	I-NP	I-NP	-	4	NMOD	-	-
4	erythroblasts	erythroblasts	I-NP	I-NP	-	1	PMOD	-	-
5	coexpressing	coexpressing	B-VP	B-VP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	v-erbA	v-erbA	I-NP	I-NP	-	8	NMOD	-	-
8	oncoprotein	oncoprotein	I-NP	I-NP	-	12	NMOD	-	-
9	and	and	O	O	-	12	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	c-erbA/T3	c-erbA/T3	I-NP	I-NP	-	12	NMOD	-	-
12	receptor	receptor	I-NP	I-NP	-	5	OBJ	-	-
13	at	at	B-PP	B-PP	-	5	VMOD	-	-
14	an	an	B-NP	B-NP	-	17	NMOD	-	-
15	approximately	approximately	I-NP	I-NP	-	16	AMOD	-	-
16	equimolar	equimolar	I-NP	I-NP	-	17	NMOD	-	-
17	ratio	ratio	I-NP	I-NP	-	13	PMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	c-erbA	c-erbA	B-NP	B-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	21	SUB	-	-
21	is	is	B-VP	B-VP	-	0	ROOT	-	-
22	dominant	dominant	B-ADJP	B-ADJP	-	21	PRD	-	-
23	over	over	B-PP	B-PP	-	22	AMOD	-	-
24	v-erbA	v-erbA	B-NP	B-NP	-	23	PMOD	-	-
25	.	.	O	O	-	21	P	-	-

1	T3	T3	B-NP	B-NP	-	3	SUB	-	-
2	efficiently	efficiently	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
4	erythroid	erythroid	B-NP	B-NP	-	5	NMOD	-	-
5	differentiation	differentiation	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	3	VMOD	-	-
7	these	these	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	,	,	O	O	-	3	P	-	-
10	thus	thus	B-ADVP	B-ADVP	-	11	VMOD	-	-
11	overcoming	overcoming	B-VP	B-VP	-	3	VMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	v-erbA-mediated	v-erbA-mediated	I-NP	I-NP	-	15	NMOD	-	-
14	differentiation	differentiation	I-NP	I-NP	-	15	NMOD	-	-
15	arrest	arrest	I-NP	I-NP	-	11	OBJ	-	-
16	.	.	O	O	-	3	P	-	-

1	Likewise	Likewise	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	T3	T3	B-NP	B-NP	-	4	SUB	-	-
4	activated	activated	B-VP	B-VP	-	0	ROOT	-	-
5	CAII	CAII	B-NP	B-NP	-	6	NMOD	-	-
6	transcription	transcription	I-NP	I-NP	-	11	NMOD	-	-
7	as	as	B-CONJP	B-CONJP	-	11	NMOD	-	-
8	well	well	I-CONJP	I-CONJP	-	7	DEP	-	-
9	as	as	I-CONJP	I-CONJP	-	7	DEP	-	-
10	transient	transient	B-NP	B-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	4	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	T3-responsive	T3-responsive	I-NP	I-NP	-	16	NMOD	-	-
15	reporter	reporter	I-NP	I-NP	-	16	NMOD	-	-
16	gene	gene	I-NP	I-NP	-	12	PMOD	-	-
17	containing	containing	B-VP	B-VP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	CAII-specific	CAII-specific	I-NP	I-NP	-	21	NMOD	-	-
20	erbA-binding	erbA-binding	I-NP	I-NP	-	21	NMOD	-	-
21	site	site	I-NP	I-NP	-	17	OBJ	-	-
22	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	c-erbA-dependent	c-erbA-dependent	I-NP	I-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	9	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	this	this	B-NP	B-NP	-	8	NMOD	-	-
6	CAII	CAII	I-NP	I-NP	-	8	NMOD	-	-
7	reporter	reporter	I-NP	I-NP	-	8	NMOD	-	-
8	construct	construct	I-NP	I-NP	-	4	PMOD	-	-
9	could	could	B-VP	B-VP	-	0	ROOT	-	-
10	only	only	I-VP	I-VP	-	9	VMOD	-	-
11	be	be	I-VP	I-VP	-	9	VC	-	-
12	suppressed	suppressed	I-VP	I-VP	-	11	VC	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	very	very	B-NP	B-NP	-	15	AMOD	-	-
15	high	high	I-NP	I-NP	-	16	NMOD	-	-
16	amounts	amounts	I-NP	I-NP	-	13	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	v-erbA	v-erbA	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	9	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	overexpression	overexpression	B-NP	B-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	v-erbA	v-erbA	B-NP	B-NP	-	6	PMOD	-	-
8	is	is	B-VP	B-VP	-	4	SBAR	-	-
9	required	required	I-VP	I-VP	-	8	VC	-	-
10	for	for	B-PP	B-PP	-	9	VMOD	-	-
11	its	its	B-NP	B-NP	-	12	NMOD	-	-
12	function	function	I-NP	I-NP	-	10	PMOD	-	-
13	as	as	B-PP	B-PP	-	12	NMOD	-	-
14	an	an	B-NP	B-NP	-	15	NMOD	-	-
15	oncoprotein	oncoprotein	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	NF-X2	NF-X2	B-NP	B-NP	-	8	SUB	-	-
2	that	that	B-NP	B-NP	-	1	NMOD	-	-
3	binds	binds	B-VP	B-VP	-	2	SBAR	-	-
4	to	to	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	DRA	DRA	I-NP	I-NP	-	7	NMOD	-	-
7	X2-box	X2-box	I-NP	I-NP	-	4	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	activator	activator	B-NP	B-NP	-	8	PRD	-	-
10	protein	protein	I-NP	I-NP	-	9	NMOD	-	-
11	<num>	<num>	I-NP	I-NP	-	10	NMOD	-	-
12	.	.	O	O	-	8	P	-	-

1	Expression	Expression	B-NP	B-NP	-	2	NMOD	-	-
2	cloning	cloning	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	c-Jun	c-Jun	B-NP	B-NP	-	3	PMOD	-	-
5	.	.	O	O	-	2	P	-	-

1	Human	Human	B-NP	B-NP	-	5	NMOD	-	-
2	class	class	I-NP	I-NP	-	5	NMOD	-	-
3	II	II	I-NP	I-NP	-	5	NMOD	-	-
4	MHC	MHC	I-NP	I-NP	-	5	NMOD	-	-
5	Ag	Ag	I-NP	I-NP	-	6	SUB	-	-
6	are	are	B-VP	B-VP	-	0	ROOT	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	family	family	I-NP	I-NP	-	6	PRD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	cell	cell	B-NP	B-NP	-	12	NMOD	-	-
11	surface	surface	I-NP	I-NP	-	12	NMOD	-	-
12	glycoproteins	glycoproteins	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	6	P	-	-

1	Their	Their	B-NP	B-NP	-	3	NMOD	-	-
2	constitutive	constitutive	I-NP	I-NP	-	3	NMOD	-	-
3	expression	expression	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	limited	limited	I-VP	I-VP	-	4	VC	-	-
6	to	to	B-PP	B-PP	-	5	VMOD	-	-
7	B	B	B-NP	B-NP	-	8	NMOD	-	-
8	lymphocytes	lymphocytes	I-NP	I-NP	-	12	NMOD	-	-
9	and	and	O	O	-	12	NMOD	-	-
10	thymic	thymic	B-NP	B-NP	-	12	NMOD	-	-
11	epithelial	epithelial	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
13	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	many	many	B-NP	B-NP	-	4	NMOD	-	-
3	other	other	I-NP	I-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
5	their	their	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	7	SUB	-	-
7	can	can	B-VP	B-VP	-	0	ROOT	-	-
8	be	be	I-VP	I-VP	-	7	VC	-	-
9	induced	induced	I-VP	I-VP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	IFN-gamma	IFN-gamma	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	7	P	-	-

1	Conserved	Conserved	B-NP	B-NP	-	4	NMOD	-	-
2	upstream	upstream	I-NP	I-NP	-	4	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	4	NMOD	-	-
4	sequences	sequences	I-NP	I-NP	-	5	SUB	-	-
5	regulate	regulate	B-VP	B-VP	-	0	ROOT	-	-
6	this	this	B-NP	B-NP	-	8	NMOD	-	-
7	tissue-specific	tissue-specific	I-NP	I-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	class	class	B-NP	B-NP	-	12	NMOD	-	-
11	II	II	B-NP	B-NP	-	12	NMOD	-	-
12	genes	genes	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	5	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	DRA	DRA	I-NP	I-NP	-	4	NMOD	-	-
4	promoter	promoter	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	12	P	-	-
6	one	one	B-NP	B-NP	-	12	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	these	these	B-NP	B-NP	-	11	NMOD	-	-
9	cis-acting	cis-acting	I-NP	I-NP	-	11	NMOD	-	-
10	regulatory	regulatory	I-NP	I-NP	-	11	NMOD	-	-
11	motifs	motifs	I-NP	I-NP	-	7	PMOD	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	X2-box	X2-box	I-NP	I-NP	-	12	PRD	-	-
15	to	to	B-PP	B-PP	-	14	NMOD	-	-
16	which	which	B-NP	B-NP	-	15	PMOD	-	-
17	nuclear	nuclear	B-NP	B-NP	-	19	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	19	NMOD	-	-
19	X2	X2	I-NP	I-NP	-	15	PMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	NF-X2	NF-X2	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	binds	binds	B-VP	B-VP	-	19	NMOD	-	-
24	.	.	O	O	-	12	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	present	present	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	isolation	isolation	I-NP	I-NP	-	8	NMOD	-	-
7	and	and	I-NP	I-NP	-	8	NMOD	-	-
8	characterization	characterization	I-NP	I-NP	-	4	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	full-length	full-length	I-NP	I-NP	-	13	NMOD	-	-
12	cDNA	cDNA	I-NP	I-NP	-	13	NMOD	-	-
13	clone	clone	I-NP	I-NP	-	9	PMOD	-	-
14	encoding	encoding	B-VP	B-VP	-	13	NMOD	-	-
15	NF-X2	NF-X2	B-NP	B-NP	-	14	OBJ	-	-
16	.	.	O	O	-	4	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	cDNA	cDNA	I-NP	I-NP	-	3	NMOD	-	-
3	clone	clone	I-NP	I-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	isolated	isolated	I-VP	I-VP	-	4	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	expression	expression	B-NP	B-NP	-	9	NMOD	-	-
8	cDNA	cDNA	I-NP	I-NP	-	9	NMOD	-	-
9	cloning	cloning	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	4	P	-	-
11	and	and	O	O	-	4	VMOD	-	-
12	encodes	encodes	B-VP	B-VP	-	4	VMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	human	human	I-NP	I-NP	-	16	NMOD	-	-
15	c-Jun	c-Jun	I-NP	I-NP	-	16	NMOD	-	-
16	protein	protein	I-NP	I-NP	-	12	OBJ	-	-
17	,	,	O	O	-	16	P	-	-
18	which	which	B-NP	B-NP	-	16	NMOD	-	-
19	together	together	B-ADVP	B-ADVP	-	20	PMOD	-	-
20	with	with	B-PP	B-PP	-	18	SBAR	-	-
21	c-Fos	c-Fos	B-NP	B-NP	-	20	PMOD	-	-
22	forms	forms	B-VP	B-VP	-	20	SBAR	-	-
23	the	the	B-NP	B-NP	-	28	NMOD	-	-
24	heterodimeric	heterodimeric	I-NP	I-NP	-	28	NMOD	-	-
25	activator	activator	I-NP	I-NP	-	28	NMOD	-	-
26	protein-1	protein-1	I-NP	I-NP	-	28	NMOD	-	-
27	transcription	transcription	I-NP	I-NP	-	28	NMOD	-	-
28	complex	complex	I-NP	I-NP	-	20	PMOD	-	-
29	.	.	O	O	-	4	P	-	-

1	Whereas	Whereas	B-SBAR	B-SBAR	-	12	VMOD	-	-
2	c-Fos/c-Jun	c-Fos/c-Jun	B-NP	B-NP	-	3	NMOD	-	-
3	heterodimers	heterodimers	I-NP	I-NP	-	4	SUB	-	-
4	do	do	B-VP	B-VP	-	1	SBAR	-	-
5	not	not	I-VP	I-VP	-	4	VMOD	-	-
6	exist	exist	I-VP	I-VP	-	4	VC	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	B	B	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	,	,	O	O	-	12	P	-	-
11	they	they	B-NP	B-NP	-	12	SUB	-	-
12	form	form	B-VP	B-VP	-	0	ROOT	-	-
13	and	and	O	O	-	12	VMOD	-	-
14	bind	bind	B-VP	B-VP	-	12	VMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	X2-box	X2-box	I-NP	I-NP	-	15	PMOD	-	-
18	in	in	B-PP	B-PP	-	14	VMOD	-	-
19	class	class	B-NP	B-NP	-	22	NMOD	-	-
20	II	II	I-NP	I-NP	-	22	NMOD	-	-
21	nonexpressing	nonexpressing	I-NP	I-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
23	.	.	O	O	-	12	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	c-Fos/c-Jun	c-Fos/c-Jun	B-NP	B-NP	-	4	NMOD	-	-
4	heterodimers	heterodimers	I-NP	I-NP	-	5	SUB	-	-
5	might	might	B-VP	B-VP	-	0	ROOT	-	-
6	contribute	contribute	I-VP	I-VP	-	5	VC	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	repression	repression	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	DRA	DRA	B-NP	B-NP	-	13	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	5	P	-	-

1	Regulation	Regulation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	jun	jun	B-NP	B-NP	-	7	NMOD	-	-
4	and	and	I-NP	I-NP	-	7	NMOD	-	-
5	fos	fos	I-NP	I-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
8	in	in	B-PP	B-PP	-	1	NMOD	-	-
9	human	human	B-NP	B-NP	-	10	NMOD	-	-
10	monocytes	monocytes	I-NP	I-NP	-	8	PMOD	-	-
11	by	by	B-PP	B-PP	-	1	NMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	macrophage	macrophage	I-NP	I-NP	-	15	NMOD	-	-
14	colony-stimulating	colony-stimulating	I-NP	I-NP	-	15	NMOD	-	-
15	factor	factor	I-NP	I-NP	-	11	PMOD	-	-
16	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	macrophage	macrophage	I-NP	I-NP	-	4	NMOD	-	-
3	colony-stimulating	colony-stimulating	I-NP	I-NP	-	4	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	8	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	M-CSF	M-CSF	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	required	required	I-VP	I-VP	-	8	VC	-	-
10	for	for	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	growth	growth	B-NP	B-NP	-	14	NMOD	-	-
13	and	and	O	O	-	14	NMOD	-	-
14	differentiation	differentiation	B-NP	B-NP	-	10	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	mononuclear	mononuclear	B-NP	B-NP	-	17	NMOD	-	-
17	phagocytes	phagocytes	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	8	P	-	-

1	However	However	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	signaling	signaling	I-NP	I-NP	-	5	NMOD	-	-
5	events	events	I-NP	I-NP	-	10	SUB	-	-
6	responsible	responsible	B-ADJP	B-ADJP	-	5	NMOD	-	-
7	for	for	B-PP	B-PP	-	6	AMOD	-	-
8	these	these	B-NP	B-NP	-	9	NMOD	-	-
9	effects	effects	I-NP	I-NP	-	7	PMOD	-	-
10	remain	remain	B-VP	B-VP	-	0	ROOT	-	-
11	unclear	unclear	B-ADJP	B-ADJP	-	10	PRD	-	-
12	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	present	present	I-NP	I-NP	-	3	NMOD	-	-
3	studies	studies	I-NP	I-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	examined	examined	I-VP	I-VP	-	4	VC	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	effects	effects	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	M-CSF	M-CSF	B-NP	B-NP	-	8	PMOD	-	-
10	on	on	B-PP	B-PP	-	7	NMOD	-	-
11	potential	potential	B-NP	B-NP	-	13	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	13	NMOD	-	-
13	pathways	pathways	I-NP	I-NP	-	10	PMOD	-	-
14	involving	involving	B-VP	B-VP	-	13	NMOD	-	-
15	expression	expression	B-NP	B-NP	-	14	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	O	O	-	23	NMOD	-	-
18	jun	jun	B-NP	B-NP	-	23	NMOD	-	-
19	and	and	O	O	-	23	NMOD	-	-
20	fos	fos	B-NP	B-NP	-	23	NMOD	-	-
21	early	early	B-NP	B-NP	-	23	NMOD	-	-
22	response	response	I-NP	I-NP	-	23	NMOD	-	-
23	genes	genes	I-NP	I-NP	-	16	PMOD	-	-
24	.	.	O	O	-	4	P	-	-

1	Low	Low	B-NP	B-NP	-	2	NMOD	-	-
2	levels	levels	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	c-jun	c-jun	B-NP	B-NP	-	5	NMOD	-	-
5	transcripts	transcripts	I-NP	I-NP	-	3	PMOD	-	-
6	were	were	B-VP	B-VP	-	0	ROOT	-	-
7	detectable	detectable	B-ADJP	B-ADJP	-	6	PRD	-	-
8	in	in	B-PP	B-PP	-	6	VMOD	-	-
9	resting	resting	B-NP	B-NP	-	13	NMOD	-	-
10	human	human	I-NP	I-NP	-	13	NMOD	-	-
11	peripheral	peripheral	I-NP	I-NP	-	13	NMOD	-	-
12	blood	blood	I-NP	I-NP	-	13	NMOD	-	-
13	monocytes	monocytes	I-NP	I-NP	-	8	PMOD	-	-
14	.	.	O	O	-	6	P	-	-

1	Treatment	Treatment	B-NP	B-NP	-	14	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	with	with	B-PP	B-PP	-	1	NMOD	-	-
6	<num>	<num>	B-NP	B-NP	-	8	NMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	units/ml	units/ml	B-NP	B-NP	-	13	NMOD	-	-
11	human	human	I-NP	I-NP	-	13	NMOD	-	-
12	recombinant	recombinant	I-NP	I-NP	-	13	NMOD	-	-
13	M-CSF	M-CSF	I-NP	I-NP	-	5	PMOD	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	associated	associated	I-VP	I-VP	-	14	VC	-	-
16	with	with	B-PP	B-PP	-	15	VMOD	-	-
17	rapid	rapid	B-NP	B-NP	-	20	NMOD	-	-
18	and	and	I-NP	I-NP	-	20	NMOD	-	-
19	transient	transient	I-NP	I-NP	-	20	NMOD	-	-
20	increases	increases	I-NP	I-NP	-	16	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	c-jun	c-jun	B-NP	B-NP	-	24	NMOD	-	-
23	mRNA	mRNA	I-NP	I-NP	-	24	NMOD	-	-
24	levels	levels	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	14	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	3	NMOD	-	-
2	run-on	run-on	I-NP	I-NP	-	3	NMOD	-	-
3	assays	assays	I-NP	I-NP	-	7	NMOD	-	-
4	and	and	O	O	-	7	NMOD	-	-
5	mRNA	mRNA	B-NP	B-NP	-	7	NMOD	-	-
6	stability	stability	I-NP	I-NP	-	7	NMOD	-	-
7	studies	studies	I-NP	I-NP	-	8	SUB	-	-
8	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
9	that	that	B-SBAR	B-SBAR	-	8	VMOD	-	-
10	M-CSF	M-CSF	B-NP	B-NP	-	11	SUB	-	-
11	regulates	regulates	B-VP	B-VP	-	9	SBAR	-	-
12	c-jun	c-jun	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	OBJ	-	-
14	by	by	B-PP	B-PP	-	11	VMOD	-	-
15	both	both	O	O	-	23	NMOD	-	-
16	an	an	B-NP	B-NP	-	17	NMOD	-	-
17	increase	increase	I-NP	I-NP	-	23	NMOD	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	transcription	transcription	B-NP	B-NP	-	20	NMOD	-	-
20	rate	rate	I-NP	I-NP	-	18	PMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	a	a	B-NP	B-NP	-	23	NMOD	-	-
23	prolongation	prolongation	I-NP	I-NP	-	14	PMOD	-	-
24	in	in	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	half-life	half-life	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	c-jun	c-jun	B-NP	B-NP	-	29	NMOD	-	-
29	transcripts	transcripts	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	8	P	-	-

1	M-CSF	M-CSF	B-NP	B-NP	-	2	NMOD	-	-
2	treatment	treatment	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	also	also	I-VP	I-VP	-	3	VMOD	-	-
5	associated	associated	I-VP	I-VP	-	3	VC	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	rapid	rapid	I-NP	I-NP	-	9	NMOD	-	-
9	induction	induction	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	jun-B	jun-B	I-NP	I-NP	-	13	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	3	P	-	-
15	although	although	B-SBAR	B-SBAR	-	3	VMOD	-	-
16	expression	expression	B-NP	B-NP	-	20	SUB	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	this	this	B-NP	B-NP	-	19	NMOD	-	-
19	gene	gene	I-NP	I-NP	-	17	PMOD	-	-
20	was	was	B-VP	B-VP	-	15	SBAR	-	-
21	prolonged	prolonged	I-VP	I-VP	-	20	VC	-	-
22	compared	compared	B-VP	B-VP	-	21	VMOD	-	-
23	to	to	B-PP	B-PP	-	22	PMOD	-	-
24	that	that	B-NP	B-NP	-	23	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	c-jun	c-jun	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	further	further	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	M-CSF	M-CSF	B-NP	B-NP	-	6	SUB	-	-
6	increases	increases	B-VP	B-VP	-	4	SBAR	-	-
7	c-fos	c-fos	B-NP	B-NP	-	9	NMOD	-	-
8	mRNA	mRNA	I-NP	I-NP	-	9	NMOD	-	-
9	levels	levels	I-NP	I-NP	-	6	OBJ	-	-
10	in	in	B-PP	B-PP	-	6	VMOD	-	-
11	human	human	B-NP	B-NP	-	12	NMOD	-	-
12	monocytes	monocytes	I-NP	I-NP	-	10	PMOD	-	-
13	through	through	B-PP	B-PP	-	6	VMOD	-	-
14	control	control	B-NP	B-NP	-	13	PMOD	-	-
15	at	at	B-PP	B-PP	-	6	VMOD	-	-
16	both	both	B-NP	B-NP	-	21	NMOD	-	-
17	the	the	I-NP	I-NP	-	21	NMOD	-	-
18	transcriptional	transcriptional	I-NP	I-NP	-	20	AMOD	-	-
19	and	and	I-NP	I-NP	-	20	AMOD	-	-
20	posttranscriptional	posttranscriptional	I-NP	I-NP	-	21	NMOD	-	-
21	levels	levels	I-NP	I-NP	-	15	PMOD	-	-
22	.	.	O	O	-	3	P	-	-

1	Maximal	Maximal	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	7	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	c-fos	c-fos	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	3	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	followed	followed	I-VP	I-VP	-	7	VC	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	that	that	B-NP	B-NP	-	9	PMOD	-	-
11	for	for	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	fos-B	fos-B	I-NP	I-NP	-	14	NMOD	-	-
14	gene	gene	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	7	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	12	VMOD	-	-
2	,	,	O	O	-	12	P	-	-
3	M-CSF-induced	M-CSF-induced	B-NP	B-NP	-	4	NMOD	-	-
4	expression	expression	I-NP	I-NP	-	12	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	fos-related	fos-related	I-NP	I-NP	-	8	NMOD	-	-
8	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
9	,	,	O	O	-	10	P	-	-
10	fra-1	fra-1	B-NP	B-NP	-	5	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	was	was	B-VP	B-VP	-	0	ROOT	-	-
13	delayed	delayed	I-VP	I-VP	-	12	VC	-	-
14	compared	compared	B-VP	B-VP	-	13	VMOD	-	-
15	to	to	B-PP	B-PP	-	14	PMOD	-	-
16	that	that	B-NP	B-NP	-	15	PMOD	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	both	both	O	O	-	21	NMOD	-	-
19	c-fos	c-fos	B-NP	B-NP	-	21	NMOD	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	fos-B	fos-B	B-NP	B-NP	-	17	PMOD	-	-
22	.	.	O	O	-	12	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	results	results	I-NP	I-NP	-	6	SUB	-	-
6	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	23	DEP	-	-
8	M-CSF	M-CSF	B-NP	B-NP	-	9	NMOD	-	-
9	treatment	treatment	I-NP	I-NP	-	10	SUB	-	-
10	is	is	B-VP	B-VP	-	7	SBAR	-	-
11	associated	associated	I-VP	I-VP	-	10	VC	-	-
12	with	with	B-PP	B-PP	-	11	VMOD	-	-
13	differential	differential	B-NP	B-NP	-	14	NMOD	-	-
14	activation	activation	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	multiple	multiple	B-NP	B-NP	-	17	NMOD	-	-
17	members	members	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	jun/fos	jun/fos	I-NP	I-NP	-	21	NMOD	-	-
21	family	family	I-NP	I-NP	-	18	PMOD	-	-
22	and	and	O	O	-	23	DEP	-	-
23	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
24	expression	expression	B-NP	B-NP	-	28	SUB	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	these	these	B-NP	B-NP	-	27	NMOD	-	-
27	genes	genes	I-NP	I-NP	-	25	PMOD	-	-
28	could	could	B-VP	B-VP	-	23	SBAR	-	-
29	contribute	contribute	I-VP	I-VP	-	28	VC	-	-
30	to	to	B-PP	B-PP	-	29	VMOD	-	-
31	nuclear	nuclear	B-NP	B-NP	-	33	NMOD	-	-
32	signaling	signaling	I-NP	I-NP	-	33	NMOD	-	-
33	mechanisms	mechanisms	I-NP	I-NP	-	30	PMOD	-	-
34	that	that	B-NP	B-NP	-	33	NMOD	-	-
35	regulate	regulate	B-VP	B-VP	-	34	SBAR	-	-
36	a	a	B-NP	B-NP	-	38	NMOD	-	-
37	specific	specific	I-NP	I-NP	-	38	NMOD	-	-
38	program	program	I-NP	I-NP	-	35	OBJ	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	monocyte	monocyte	B-NP	B-NP	-	41	NMOD	-	-
41	differentiation	differentiation	I-NP	I-NP	-	39	PMOD	-	-
42	.	.	O	O	-	6	P	-	-

1	cAMP-dependent	cAMP-dependent	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	13	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	proenkephalin	proenkephalin	B-NP	B-NP	-	3	PMOD	-	-
5	by	by	B-PP	B-PP	-	2	NMOD	-	-
6	JunD	JunD	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	O	O	-	8	NMOD	-	-
8	JunB	JunB	B-NP	B-NP	-	5	PMOD	-	-
9	:	:	O	O	-	2	P	-	-
10	positive	positive	B-NP	B-NP	-	13	NMOD	-	-
11	and	and	I-NP	I-NP	-	13	NMOD	-	-
12	negative	negative	I-NP	I-NP	-	13	NMOD	-	-
13	effects	effects	I-NP	I-NP	-	0	ROOT	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	AP-1	AP-1	B-NP	B-NP	-	16	NMOD	-	-
16	proteins	proteins	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	13	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	JunD	JunD	B-NP	B-NP	-	7	NMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	component	component	I-NP	I-NP	-	15	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	13	NMOD	-	-
10	AP-1	AP-1	I-NP	I-NP	-	13	NMOD	-	-
11	transcription	transcription	I-NP	I-NP	-	13	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	13	NMOD	-	-
13	complex	complex	I-NP	I-NP	-	8	PMOD	-	-
14	,	,	O	O	-	7	P	-	-
15	activates	activates	B-VP	B-VP	-	3	SBAR	-	-
16	transcription	transcription	B-NP	B-NP	-	15	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	human	human	I-NP	I-NP	-	21	NMOD	-	-
20	proenkephalin	proenkephalin	I-NP	I-NP	-	21	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	17	PMOD	-	-
22	in	in	B-PP	B-PP	-	16	NMOD	-	-
23	a	a	B-NP	B-NP	-	24	NMOD	-	-
24	fashion	fashion	I-NP	I-NP	-	22	PMOD	-	-
25	that	that	B-NP	B-NP	-	24	NMOD	-	-
26	is	is	B-VP	B-VP	-	25	SBAR	-	-
27	completely	completely	B-ADJP	B-ADJP	-	28	AMOD	-	-
28	dependent	dependent	I-ADJP	I-ADJP	-	26	PRD	-	-
29	upon	upon	B-PP	B-PP	-	28	AMOD	-	-
30	the	the	B-NP	B-NP	-	33	NMOD	-	-
31	cAMP-dependent	cAMP-dependent	I-NP	I-NP	-	33	NMOD	-	-
32	protein	protein	I-NP	I-NP	-	33	NMOD	-	-
33	kinase	kinase	I-NP	I-NP	-	37	NMOD	-	-
34	,	,	O	O	-	37	P	-	-
35	protein	protein	B-NP	B-NP	-	37	NMOD	-	-
36	kinase	kinase	I-NP	I-NP	-	37	NMOD	-	-
37	A	A	I-NP	I-NP	-	29	PMOD	-	-
38	.	.	O	O	-	2	P	-	-

1	Activation	Activation	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	proenkephalin	proenkephalin	B-NP	B-NP	-	4	NMOD	-	-
4	transcription	transcription	I-NP	I-NP	-	2	PMOD	-	-
5	by	by	B-PP	B-PP	-	1	NMOD	-	-
6	JunD	JunD	B-NP	B-NP	-	5	PMOD	-	-
7	is	is	B-VP	B-VP	-	28	VMOD	-	-
8	dependent	dependent	B-ADJP	B-ADJP	-	7	PRD	-	-
9	upon	upon	B-PP	B-PP	-	8	AMOD	-	-
10	a	a	B-NP	B-NP	-	24	NMOD	-	-
11	previously	previously	I-NP	I-NP	-	12	AMOD	-	-
12	characterized	characterized	I-NP	I-NP	-	24	NMOD	-	-
13	cAMP-	cAMP-	B-NP	B-NP	-	24	NMOD	-	-
14	,	,	O	O	-	24	P	-	-
15	phorbol	phorbol	B-NP	B-NP	-	16	NMOD	-	-
16	ester-	ester-	I-NP	I-NP	-	24	NMOD	-	-
17	,	,	O	O	-	24	P	-	-
18	and	and	O	O	-	24	NMOD	-	-
19	Ca	Ca	B-NP	B-NP	-	24	NMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	2+	2+	B-ADJP	B-ADJP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	-inducible	-inducible	B-NP	B-NP	-	24	NMOD	-	-
24	enhancer	enhancer	I-NP	I-NP	-	9	PMOD	-	-
25	,	,	O	O	-	28	P	-	-
26	and	and	O	O	-	28	VMOD	-	-
27	JunD	JunD	B-NP	B-NP	-	28	SUB	-	-
28	is	is	B-VP	B-VP	-	0	ROOT	-	-
29	shown	shown	I-VP	I-VP	-	28	VC	-	-
30	to	to	I-VP	I-VP	-	31	VMOD	-	-
31	bind	bind	I-VP	I-VP	-	29	VMOD	-	-
32	the	the	B-NP	B-NP	-	33	NMOD	-	-
33	enhancer	enhancer	I-NP	I-NP	-	31	OBJ	-	-
34	as	as	B-PP	B-PP	-	31	VMOD	-	-
35	a	a	B-NP	B-NP	-	36	NMOD	-	-
36	homodimer	homodimer	I-NP	I-NP	-	34	PMOD	-	-
37	.	.	O	O	-	28	P	-	-

1	Another	Another	B-NP	B-NP	-	2	NMOD	-	-
2	component	component	I-NP	I-NP	-	11	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	AP-1	AP-1	I-NP	I-NP	-	7	NMOD	-	-
6	transcription	transcription	I-NP	I-NP	-	7	NMOD	-	-
7	complex	complex	I-NP	I-NP	-	3	PMOD	-	-
8	,	,	O	O	-	9	P	-	-
9	JunB	JunB	B-NP	B-NP	-	3	PMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	is	is	B-VP	B-VP	-	0	ROOT	-	-
12	shown	shown	I-VP	I-VP	-	11	VC	-	-
13	to	to	I-VP	I-VP	-	14	VMOD	-	-
14	inhibit	inhibit	I-VP	I-VP	-	12	VMOD	-	-
15	activation	activation	B-NP	B-NP	-	14	OBJ	-	-
16	mediated	mediated	B-VP	B-VP	-	15	NMOD	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	JunD	JunD	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	11	P	-	-

1	As	As	B-PP	B-PP	-	5	VMOD	-	-
2	a	a	B-NP	B-NP	-	4	NMOD	-	-
3	homodimer	homodimer	I-NP	I-NP	-	4	NMOD	-	-
4	JunB	JunB	B-NP	B-NP	-	5	SUB	-	-
5	is	is	B-VP	B-VP	-	0	ROOT	-	-
6	unable	unable	B-ADJP	B-ADJP	-	5	PRD	-	-
7	to	to	B-VP	B-VP	-	8	VMOD	-	-
8	bind	bind	I-VP	I-VP	-	6	AMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	enhancer	enhancer	I-NP	I-NP	-	8	OBJ	-	-
11	;	;	O	O	-	5	P	-	-
12	however	however	O	O	-	5	VMOD	-	-
13	in	in	B-PP	B-PP	-	5	VMOD	-	-
14	the	the	I-PP	I-PP	-	13	PMOD	-	-
15	presence	presence	I-PP	I-PP	-	13	PMOD	-	-
16	of	of	I-PP	I-PP	-	13	PMOD	-	-
17	c-Fos	c-Fos	B-NP	B-NP	-	13	PMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	high-affinity	high-affinity	B-NP	B-NP	-	20	NMOD	-	-
20	binding	binding	I-NP	I-NP	-	21	SUB	-	-
21	is	is	B-VP	B-VP	-	13	SBAR	-	-
22	observed	observed	I-VP	I-VP	-	21	VC	-	-
23	.	.	O	O	-	5	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	JunD	JunD	B-NP	B-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	shown	shown	I-VP	I-VP	-	4	VC	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	activate	activate	I-VP	I-VP	-	5	VMOD	-	-
8	transcription	transcription	B-NP	B-NP	-	7	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	genes	genes	B-NP	B-NP	-	9	PMOD	-	-
11	linked	linked	B-VP	B-VP	-	10	NMOD	-	-
12	to	to	B-PP	B-PP	-	11	VMOD	-	-
13	both	both	O	O	-	19	NMOD	-	-
14	cAMP	cAMP	B-NP	B-NP	-	19	NMOD	-	-
15	and	and	O	O	-	19	NMOD	-	-
16	phorbol	phorbol	B-NP	B-NP	-	19	NMOD	-	-
17	ester	ester	I-NP	I-NP	-	19	NMOD	-	-
18	response	response	I-NP	I-NP	-	19	NMOD	-	-
19	elements	elements	I-NP	I-NP	-	12	PMOD	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	a	a	B-NP	B-NP	-	25	NMOD	-	-
22	protein	protein	I-NP	I-NP	-	25	NMOD	-	-
23	kinase	kinase	I-NP	I-NP	-	25	NMOD	-	-
24	A-dependent	A-dependent	I-NP	I-NP	-	25	NMOD	-	-
25	fashion	fashion	I-NP	I-NP	-	20	PMOD	-	-
26	,	,	O	O	-	5	P	-	-
27	further	further	B-ADVP	B-ADVP	-	28	VMOD	-	-
28	blurring	blurring	B-VP	B-VP	-	5	VMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	distinction	distinction	I-NP	I-NP	-	28	OBJ	-	-
31	between	between	B-PP	B-PP	-	30	NMOD	-	-
32	these	these	B-NP	B-NP	-	34	NMOD	-	-
33	response	response	I-NP	I-NP	-	34	NMOD	-	-
34	elements	elements	I-NP	I-NP	-	31	PMOD	-	-
35	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	transcriptional	transcriptional	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	12	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	an	an	B-NP	B-NP	-	11	NMOD	-	-
10	AP-1-related	AP-1-related	I-NP	I-NP	-	11	NMOD	-	-
11	protein	protein	I-NP	I-NP	-	8	PMOD	-	-
12	is	is	B-VP	B-VP	-	4	SBAR	-	-
13	regulated	regulated	I-VP	I-VP	-	12	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	cAMP-dependent	cAMP-dependent	I-NP	I-NP	-	18	NMOD	-	-
17	second-messenger	second-messenger	I-NP	I-NP	-	18	NMOD	-	-
18	pathway	pathway	I-NP	I-NP	-	14	PMOD	-	-
19	and	and	O	O	-	3	VMOD	-	-
20	suggest	suggest	B-VP	B-VP	-	3	VMOD	-	-
21	that	that	B-SBAR	B-SBAR	-	20	VMOD	-	-
22	JunD	JunD	B-NP	B-NP	-	26	NMOD	-	-
23	and	and	O	O	-	26	NMOD	-	-
24	other	other	B-NP	B-NP	-	26	NMOD	-	-
25	AP-1-related	AP-1-related	I-NP	I-NP	-	26	NMOD	-	-
26	proteins	proteins	I-NP	I-NP	-	27	SUB	-	-
27	may	may	B-VP	B-VP	-	21	SBAR	-	-
28	play	play	I-VP	I-VP	-	27	VC	-	-
29	an	an	B-NP	B-NP	-	31	NMOD	-	-
30	important	important	I-NP	I-NP	-	31	NMOD	-	-
31	role	role	I-NP	I-NP	-	28	OBJ	-	-
32	in	in	B-PP	B-PP	-	28	VMOD	-	-
33	the	the	B-NP	B-NP	-	34	NMOD	-	-
34	regulation	regulation	I-NP	I-NP	-	32	PMOD	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	gene	gene	B-NP	B-NP	-	37	NMOD	-	-
37	expression	expression	I-NP	I-NP	-	35	PMOD	-	-
38	by	by	B-PP	B-PP	-	34	NMOD	-	-
39	cAMP-dependent	cAMP-dependent	B-NP	B-NP	-	42	NMOD	-	-
40	intracellular	intracellular	I-NP	I-NP	-	42	NMOD	-	-
41	signaling	signaling	I-NP	I-NP	-	42	NMOD	-	-
42	pathways	pathways	I-NP	I-NP	-	38	PMOD	-	-
43	.	.	O	O	-	3	P	-	-

1	Induction	Induction	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	monocytic	monocytic	B-NP	B-NP	-	4	NMOD	-	-
4	differentiation	differentiation	I-NP	I-NP	-	8	NMOD	-	-
5	and	and	O	O	-	8	NMOD	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	8	NMOD	-	-
7	B-like	B-like	I-NP	I-NP	-	8	NMOD	-	-
8	activities	activities	I-NP	I-NP	-	2	PMOD	-	-
9	by	by	B-PP	B-PP	-	1	NMOD	-	-
10	human	human	B-NP	B-NP	-	14	NMOD	-	-
11	immunodeficiency	immunodeficiency	I-NP	I-NP	-	14	NMOD	-	-
12	virus	virus	I-NP	I-NP	-	14	NMOD	-	-
13	<num>	<num>	I-NP	I-NP	-	14	NMOD	-	-
14	infection	infection	I-NP	I-NP	-	9	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	myelomonoblastic	myelomonoblastic	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effects	effects	I-NP	I-NP	-	21	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	human	human	B-NP	B-NP	-	6	NMOD	-	-
5	immunodeficiency	immunodeficiency	I-NP	I-NP	-	6	NMOD	-	-
6	virus	virus	I-NP	I-NP	-	11	NMOD	-	-
7	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	HIV-1	HIV-1	B-NP	B-NP	-	6	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	infection	infection	B-NP	B-NP	-	3	PMOD	-	-
12	on	on	B-PP	B-PP	-	2	NMOD	-	-
13	cellular	cellular	B-NP	B-NP	-	14	NMOD	-	-
14	differentiation	differentiation	I-NP	I-NP	-	20	NMOD	-	-
15	and	and	O	O	-	20	NMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	20	NMOD	-	-
17	B	B	I-NP	I-NP	-	20	NMOD	-	-
18	DNA	DNA	I-NP	I-NP	-	20	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	12	PMOD	-	-
21	have	have	B-VP	B-VP	-	0	ROOT	-	-
22	been	been	I-VP	I-VP	-	21	VC	-	-
23	investigated	investigated	I-VP	I-VP	-	22	VC	-	-
24	in	in	B-PP	B-PP	-	23	VMOD	-	-
25	a	a	B-NP	B-NP	-	27	NMOD	-	-
26	new	new	I-NP	I-NP	-	27	NMOD	-	-
27	model	model	I-NP	I-NP	-	24	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	myeloid	myeloid	B-NP	B-NP	-	30	NMOD	-	-
30	differentiation	differentiation	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	21	P	-	-

1	PLB-985	PLB-985	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	3	SUB	-	-
3	represent	represent	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	8	NMOD	-	-
5	bipotential	bipotential	I-NP	I-NP	-	8	NMOD	-	-
6	myelomonoblastic	myelomonoblastic	I-NP	I-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	population	population	I-NP	I-NP	-	3	OBJ	-	-
9	capable	capable	B-ADJP	B-ADJP	-	8	NMOD	-	-
10	of	of	B-PP	B-PP	-	9	AMOD	-	-
11	either	either	B-NP	B-NP	-	14	AMOD	-	-
12	granulocytic	granulocytic	I-NP	I-NP	-	14	AMOD	-	-
13	or	or	I-NP	I-NP	-	14	AMOD	-	-
14	monocytic	monocytic	I-NP	I-NP	-	15	NMOD	-	-
15	differentiation	differentiation	I-NP	I-NP	-	10	PMOD	-	-
16	after	after	B-PP	B-PP	-	15	NMOD	-	-
17	induction	induction	B-NP	B-NP	-	16	PMOD	-	-
18	with	with	B-PP	B-PP	-	17	NMOD	-	-
19	appropriate	appropriate	B-NP	B-NP	-	20	NMOD	-	-
20	inducers	inducers	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	By	By	B-PP	B-PP	-	15	VMOD	-	-
2	virtue	virtue	B-NP	B-NP	-	1	PMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	presence	presence	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	CD4	CD4	B-NP	B-NP	-	6	PMOD	-	-
8	on	on	B-PP	B-PP	-	5	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	surface	surface	I-NP	I-NP	-	8	PMOD	-	-
12	,	,	O	O	-	15	P	-	-
13	PLB-985	PLB-985	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	15	SUB	-	-
15	were	were	B-VP	B-VP	-	0	ROOT	-	-
16	chronically	chronically	I-VP	I-VP	-	15	VMOD	-	-
17	infected	infected	I-VP	I-VP	-	15	VC	-	-
18	with	with	B-PP	B-PP	-	17	VMOD	-	-
19	HIV-1	HIV-1	B-NP	B-NP	-	21	NMOD	-	-
20	strain	strain	I-NP	I-NP	-	21	NMOD	-	-
21	IIIB	IIIB	I-NP	I-NP	-	18	PMOD	-	-
22	.	.	O	O	-	15	P	-	-

1	PLB-IIIB	PLB-IIIB	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	4	SUB	-	-
3	clearly	clearly	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	possessed	possessed	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	8	NMOD	-	-
6	more	more	I-NP	I-NP	-	7	AMOD	-	-
7	monocytic	monocytic	I-NP	I-NP	-	8	NMOD	-	-
8	phenotype	phenotype	I-NP	I-NP	-	4	OBJ	-	-
9	than	than	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	parental	parental	I-NP	I-NP	-	12	NMOD	-	-
12	myeloblasts	myeloblasts	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	4	P	-	-
14	as	as	B-SBAR	B-SBAR	-	4	VMOD	-	-
15	determined	determined	B-VP	B-VP	-	14	SBAR	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	differential	differential	B-NP	B-NP	-	18	NMOD	-	-
18	staining	staining	I-NP	I-NP	-	29	NMOD	-	-
19	,	,	O	O	-	29	P	-	-
20	increased	increased	B-NP	B-NP	-	21	NMOD	-	-
21	expression	expression	I-NP	I-NP	-	29	NMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	myeloid-specific	myeloid-specific	I-NP	I-NP	-	26	NMOD	-	-
25	surface	surface	I-NP	I-NP	-	26	NMOD	-	-
26	markers	markers	I-NP	I-NP	-	22	PMOD	-	-
27	,	,	O	O	-	29	P	-	-
28	and	and	O	O	-	29	NMOD	-	-
29	transcription	transcription	B-NP	B-NP	-	16	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	c-fms	c-fms	I-NP	I-NP	-	33	NMOD	-	-
33	proto-oncogene	proto-oncogene	I-NP	I-NP	-	30	PMOD	-	-
34	.	.	O	O	-	4	P	-	-

1	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
2	B	B	I-NP	I-NP	-	4	NMOD	-	-
3	binding	binding	I-NP	I-NP	-	4	NMOD	-	-
4	activity	activity	I-NP	I-NP	-	5	SUB	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	inducible	inducible	B-ADJP	B-ADJP	-	5	PRD	-	-
7	by	by	B-PP	B-PP	-	6	AMOD	-	-
8	tumor	tumor	B-NP	B-NP	-	10	NMOD	-	-
9	necrosis	necrosis	I-NP	I-NP	-	10	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	14	NMOD	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	phorbol	phorbol	B-NP	B-NP	-	14	NMOD	-	-
13	myristate	myristate	I-NP	I-NP	-	14	NMOD	-	-
14	acetate	acetate	I-NP	I-NP	-	7	PMOD	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	PLB-985	PLB-985	B-NP	B-NP	-	15	PMOD	-	-
17	.	.	O	O	-	5	P	-	-

1	However	However	B-ADVP	B-ADVP	-	15	VMOD	-	-
2	,	,	O	O	-	15	P	-	-
3	in	in	B-PP	B-PP	-	15	VMOD	-	-
4	PLB-IIIB	PLB-IIIB	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
6	,	,	O	O	-	15	P	-	-
7	constitutive	constitutive	B-NP	B-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	15	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	a	a	B-NP	B-NP	-	14	NMOD	-	-
11	novel	novel	I-NP	I-NP	-	14	NMOD	-	-
12	NF-kappa	NF-kappa	I-NP	I-NP	-	14	NMOD	-	-
13	B	B	I-NP	I-NP	-	14	NMOD	-	-
14	complex	complex	I-NP	I-NP	-	9	PMOD	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	detected	detected	I-VP	I-VP	-	15	VC	-	-
17	,	,	O	O	-	16	P	-	-
18	composed	composed	B-VP	B-VP	-	16	VMOD	-	-
19	of	of	B-PP	B-PP	-	18	VMOD	-	-
20	proteins	proteins	B-NP	B-NP	-	19	PMOD	-	-
21	ranging	ranging	B-VP	B-VP	-	20	NMOD	-	-
22	between	between	B-PP	B-PP	-	21	VMOD	-	-
23	<num>	<num>	B-NP	B-NP	-	25	AMOD	-	-
24	and	and	O	O	-	25	AMOD	-	-
25	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
26	kD	kD	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	15	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	proteins	proteins	I-NP	I-NP	-	3	SUB	-	-
3	interacted	interacted	B-VP	B-VP	-	0	ROOT	-	-
4	specifically	specifically	B-ADVP	B-ADVP	-	3	VMOD	-	-
5	with	with	B-PP	B-PP	-	3	VMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	symmetric	symmetric	I-NP	I-NP	-	10	NMOD	-	-
8	NF-kappa	NF-kappa	I-NP	I-NP	-	10	NMOD	-	-
9	B	B	I-NP	I-NP	-	10	NMOD	-	-
10	site	site	I-NP	I-NP	-	5	PMOD	-	-
11	from	from	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	18	NMOD	-	-
13	interferon	interferon	I-NP	I-NP	-	14	NMOD	-	-
14	beta	beta	I-NP	I-NP	-	18	NMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	IFN-beta	IFN-beta	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	promoter	promoter	B-NP	B-NP	-	11	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	Mutations	Mutations	B-NP	B-NP	-	13	SUB	-	-
2	affecting	affecting	B-VP	B-VP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	<num>	<num>	I-NP	I-NP	-	7	NMOD	-	-
5	'	'	I-NP	I-NP	-	7	NMOD	-	-
6	guanine	guanine	I-NP	I-NP	-	7	NMOD	-	-
7	residues	residues	I-NP	I-NP	-	2	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	kappa	kappa	I-NP	I-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	site	site	I-NP	I-NP	-	8	PMOD	-	-
13	were	were	B-VP	B-VP	-	0	ROOT	-	-
14	unable	unable	B-ADJP	B-ADJP	-	13	PRD	-	-
15	to	to	B-VP	B-VP	-	16	VMOD	-	-
16	compete	compete	I-VP	I-VP	-	14	AMOD	-	-
17	for	for	B-PP	B-PP	-	16	VMOD	-	-
18	these	these	B-NP	B-NP	-	21	NMOD	-	-
19	NF-kappa	NF-kappa	I-NP	I-NP	-	21	NMOD	-	-
20	B-related	B-related	I-NP	I-NP	-	19	AMOD	-	-
21	proteins	proteins	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	13	P	-	-

1	Inducibility	Inducibility	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	endogenous	endogenous	B-NP	B-NP	-	7	NMOD	-	-
4	IFN-beta	IFN-beta	I-NP	I-NP	-	7	NMOD	-	-
5	and	and	I-NP	I-NP	-	7	NMOD	-	-
6	IFN-alpha	IFN-alpha	I-NP	I-NP	-	7	NMOD	-	-
7	RNA	RNA	I-NP	I-NP	-	2	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	also	also	I-VP	I-VP	-	8	VMOD	-	-
10	increased	increased	I-VP	I-VP	-	8	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	PLB-IIIB	PLB-IIIB	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	19	DEP	-	-
5	HIV-1	HIV-1	B-NP	B-NP	-	6	NMOD	-	-
6	infection	infection	I-NP	I-NP	-	10	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	myelomonoblastic	myelomonoblastic	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	may	may	B-VP	B-VP	-	4	SBAR	-	-
11	select	select	I-VP	I-VP	-	10	VC	-	-
12	for	for	B-PP	B-PP	-	11	VMOD	-	-
13	a	a	B-NP	B-NP	-	17	NMOD	-	-
14	more	more	I-NP	I-NP	-	15	AMOD	-	-
15	mature	mature	I-NP	I-NP	-	17	NMOD	-	-
16	monocytic	monocytic	I-NP	I-NP	-	17	NMOD	-	-
17	phenotype	phenotype	I-NP	I-NP	-	12	PMOD	-	-
18	and	and	O	O	-	19	DEP	-	-
19	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
20	unique	unique	B-NP	B-NP	-	22	NMOD	-	-
21	subunit	subunit	I-NP	I-NP	-	22	NMOD	-	-
22	associations	associations	I-NP	I-NP	-	29	SUB	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	NF-kappa	NF-kappa	B-NP	B-NP	-	28	NMOD	-	-
25	B	B	I-NP	I-NP	-	28	NMOD	-	-
26	DNA	DNA	I-NP	I-NP	-	28	NMOD	-	-
27	binding	binding	I-NP	I-NP	-	28	NMOD	-	-
28	proteins	proteins	I-NP	I-NP	-	23	PMOD	-	-
29	may	may	B-VP	B-VP	-	19	SBAR	-	-
30	contribute	contribute	I-VP	I-VP	-	29	VC	-	-
31	to	to	B-PP	B-PP	-	30	VMOD	-	-
32	differential	differential	B-NP	B-NP	-	36	NMOD	-	-
33	NF-kappa	NF-kappa	I-NP	I-NP	-	36	NMOD	-	-
34	B-mediated	B-mediated	I-NP	I-NP	-	33	AMOD	-	-
35	gene	gene	I-NP	I-NP	-	36	NMOD	-	-
36	expression	expression	I-NP	I-NP	-	31	PMOD	-	-
37	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	AP-1	AP-1	I-NP	I-NP	-	3	NMOD	-	-
3	site	site	I-NP	I-NP	-	15	SUB	-	-
4	at	at	B-PP	B-PP	-	3	NMOD	-	-
5	-150	-150	B-NP	B-NP	-	6	NMOD	-	-
6	bp	bp	I-NP	I-NP	-	4	PMOD	-	-
7	,	,	B-NP	B-NP	-	13	P	-	-
8	but	but	I-NP	I-NP	-	13	NMOD	-	-
9	not	not	I-NP	I-NP	-	8	DEP	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	NF-kappa	NF-kappa	I-NP	I-NP	-	13	NMOD	-	-
12	B	B	I-NP	I-NP	-	13	NMOD	-	-
13	site	site	I-NP	I-NP	-	4	PMOD	-	-
14	,	,	O	O	-	3	P	-	-
15	is	is	B-VP	B-VP	-	0	ROOT	-	-
16	likely	likely	B-ADJP	B-ADJP	-	15	PRD	-	-
17	to	to	B-VP	B-VP	-	18	VMOD	-	-
18	represent	represent	I-VP	I-VP	-	16	AMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	major	major	I-NP	I-NP	-	21	NMOD	-	-
21	target	target	I-NP	I-NP	-	18	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	protein	protein	B-NP	B-NP	-	25	NMOD	-	-
24	kinase	kinase	I-NP	I-NP	-	25	NMOD	-	-
25	C	C	I-NP	I-NP	-	22	PMOD	-	-
26	in	in	B-PP	B-PP	-	21	NMOD	-	-
27	the	the	B-NP	B-NP	-	30	NMOD	-	-
28	interleukin	interleukin	I-NP	I-NP	-	30	NMOD	-	-
29	<num>	<num>	I-NP	I-NP	-	30	NMOD	-	-
30	promoter	promoter	I-NP	I-NP	-	26	PMOD	-	-
31	.	.	O	O	-	15	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	with	with	B-PP	B-PP	-	1	NMOD	-	-
6	antigen	antigen	B-NP	B-NP	-	5	PMOD	-	-
7	results	results	B-VP	B-VP	-	0	ROOT	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	activation	activation	B-NP	B-NP	-	8	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	several	several	B-NP	B-NP	-	12	NMOD	-	-
12	kinases	kinases	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	12	P	-	-
14	including	including	B-PP	B-PP	-	12	NMOD	-	-
15	protein	protein	B-NP	B-NP	-	17	NMOD	-	-
16	kinase	kinase	I-NP	I-NP	-	17	NMOD	-	-
17	C	C	I-NP	I-NP	-	14	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	PKC	PKC	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	12	P	-	-
22	that	that	B-NP	B-NP	-	12	NMOD	-	-
23	may	may	B-VP	B-VP	-	22	SBAR	-	-
24	mediate	mediate	I-VP	I-VP	-	23	VC	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	later	later	I-NP	I-NP	-	27	NMOD	-	-
27	induction	induction	I-NP	I-NP	-	24	OBJ	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	activation-related	activation-related	B-NP	B-NP	-	30	NMOD	-	-
30	genes	genes	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	7	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	examined	examined	I-VP	I-VP	-	2	VC	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	potential	potential	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	PKC	PKC	B-NP	B-NP	-	7	PMOD	-	-
9	in	in	B-PP	B-PP	-	6	NMOD	-	-
10	induction	induction	B-NP	B-NP	-	9	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	18	NMOD	-	-
13	interleukin	interleukin	I-NP	I-NP	-	18	NMOD	-	-
14	<num>	<num>	I-NP	I-NP	-	13	NMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	IL-2	IL-2	B-NP	B-NP	-	13	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	gene	gene	B-NP	B-NP	-	11	PMOD	-	-
19	in	in	B-PP	B-PP	-	10	NMOD	-	-
20	T	T	B-NP	B-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
22	stimulated	stimulated	B-VP	B-VP	-	21	NMOD	-	-
23	through	through	B-PP	B-PP	-	22	VMOD	-	-
24	the	the	B-NP	B-NP	-	28	NMOD	-	-
25	T	T	I-NP	I-NP	-	28	NMOD	-	-
26	cell	cell	I-NP	I-NP	-	28	NMOD	-	-
27	receptor/CD3	receptor/CD3	I-NP	I-NP	-	28	NMOD	-	-
28	complex	complex	I-NP	I-NP	-	23	PMOD	-	-
29	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	previously	previously	I-VP	I-VP	-	2	VMOD	-	-
4	shown	shown	I-VP	I-VP	-	2	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	prolonged	prolonged	B-NP	B-NP	-	7	NMOD	-	-
7	treatment	treatment	I-NP	I-NP	-	18	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	14	NMOD	-	-
10	untransformed	untransformed	I-NP	I-NP	-	14	NMOD	-	-
11	T	T	I-NP	I-NP	-	14	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	14	NMOD	-	-
13	clone	clone	I-NP	I-NP	-	14	NMOD	-	-
14	Ar-5	Ar-5	I-NP	I-NP	-	8	PMOD	-	-
15	with	with	B-PP	B-PP	-	7	NMOD	-	-
16	phorbol	phorbol	B-NP	B-NP	-	17	NMOD	-	-
17	esters	esters	I-NP	I-NP	-	15	PMOD	-	-
18	results	results	B-VP	B-VP	-	5	SBAR	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	downmodulation	downmodulation	B-NP	B-NP	-	19	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	26	NMOD	-	-
23	alpha	alpha	I-NP	I-NP	-	25	NMOD	-	-
24	and	and	I-NP	I-NP	-	25	NMOD	-	-
25	beta	beta	I-NP	I-NP	-	26	NMOD	-	-
26	isozymes	isozymes	I-NP	I-NP	-	21	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	PKC	PKC	B-NP	B-NP	-	27	PMOD	-	-
29	,	,	O	O	-	18	P	-	-
30	and	and	O	O	-	18	VMOD	-	-
31	abrogates	abrogates	B-VP	B-VP	-	18	VMOD	-	-
32	induction	induction	B-NP	B-NP	-	31	OBJ	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	IL-2	IL-2	B-NP	B-NP	-	35	NMOD	-	-
35	mRNA	mRNA	I-NP	I-NP	-	37	NMOD	-	-
36	and	and	I-NP	I-NP	-	37	NMOD	-	-
37	protein	protein	I-NP	I-NP	-	33	PMOD	-	-
38	.	.	O	O	-	2	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	phorbol	phorbol	B-NP	B-NP	-	7	NMOD	-	-
6	ester	ester	I-NP	I-NP	-	7	NMOD	-	-
7	treatment	treatment	I-NP	I-NP	-	9	SUB	-	-
8	also	also	B-ADVP	B-ADVP	-	9	VMOD	-	-
9	abolishes	abolishes	B-VP	B-VP	-	4	SBAR	-	-
10	induction	induction	B-NP	B-NP	-	9	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	chloramphenicol	chloramphenicol	B-NP	B-NP	-	14	NMOD	-	-
13	acetyltransferase	acetyltransferase	I-NP	I-NP	-	14	NMOD	-	-
14	activity	activity	I-NP	I-NP	-	11	PMOD	-	-
15	in	in	B-PP	B-PP	-	10	NMOD	-	-
16	Ar-5	Ar-5	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	transfected	transfected	B-VP	B-VP	-	17	NMOD	-	-
19	with	with	B-PP	B-PP	-	18	VMOD	-	-
20	a	a	B-NP	B-NP	-	21	NMOD	-	-
21	plasmid	plasmid	I-NP	I-NP	-	19	PMOD	-	-
22	containing	containing	B-VP	B-VP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	IL-2	IL-2	I-NP	I-NP	-	25	NMOD	-	-
25	promoter	promoter	I-NP	I-NP	-	22	OBJ	-	-
26	linked	linked	B-VP	B-VP	-	25	NMOD	-	-
27	to	to	B-PP	B-PP	-	26	VMOD	-	-
28	this	this	B-NP	B-NP	-	30	NMOD	-	-
29	reporter	reporter	I-NP	I-NP	-	30	NMOD	-	-
30	gene	gene	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	IL-2	IL-2	I-NP	I-NP	-	3	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	4	SUB	-	-
4	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
5	binding	binding	I-VP	I-VP	-	6	NMOD	-	-
6	sites	sites	B-NP	B-NP	-	4	OBJ	-	-
7	for	for	B-PP	B-PP	-	6	NMOD	-	-
8	nuclear	nuclear	B-NP	B-NP	-	9	NMOD	-	-
9	factors	factors	I-NP	I-NP	-	7	PMOD	-	-
10	including	including	B-PP	B-PP	-	9	NMOD	-	-
11	NFAT-1	NFAT-1	B-NP	B-NP	-	19	NMOD	-	-
12	,	,	O	O	-	19	P	-	-
13	Oct	Oct	B-NP	B-NP	-	19	NMOD	-	-
14	,	,	O	O	-	19	P	-	-
15	NF-kappa	NF-kappa	B-NP	B-NP	-	16	NMOD	-	-
16	B	B	I-NP	I-NP	-	19	NMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	and	and	O	O	-	19	NMOD	-	-
19	AP-1	AP-1	B-NP	B-NP	-	10	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	which	which	B-NP	B-NP	-	19	NMOD	-	-
22	are	are	B-VP	B-VP	-	21	SBAR	-	-
23	all	all	B-ADVP	B-ADVP	-	22	VMOD	-	-
24	potentially	potentially	B-ADJP	B-ADJP	-	25	AMOD	-	-
25	sensitive	sensitive	I-ADJP	I-ADJP	-	22	PRD	-	-
26	to	to	B-PP	B-PP	-	25	AMOD	-	-
27	activation	activation	B-NP	B-NP	-	26	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	PKC	PKC	B-NP	B-NP	-	28	PMOD	-	-
30	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	23	DEP	-	-
4	induction	induction	B-NP	B-NP	-	14	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	trimer	trimer	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	13	NMOD	-	-
10	NFAT	NFAT	I-NP	I-NP	-	12	NMOD	-	-
11	and	and	I-NP	I-NP	-	12	NMOD	-	-
12	Oct	Oct	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	8	PMOD	-	-
14	is	is	B-VP	B-VP	-	3	SBAR	-	-
15	not	not	O	O	-	14	VMOD	-	-
16	sensitive	sensitive	B-ADJP	B-ADJP	-	14	PRD	-	-
17	to	to	B-PP	B-PP	-	16	AMOD	-	-
18	phorbol	phorbol	B-NP	B-NP	-	20	NMOD	-	-
19	ester	ester	I-NP	I-NP	-	20	NMOD	-	-
20	treatment	treatment	I-NP	I-NP	-	17	PMOD	-	-
21	,	,	O	O	-	23	P	-	-
22	and	and	O	O	-	23	DEP	-	-
23	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
24	mutations	mutations	B-NP	B-NP	-	30	SUB	-	-
25	in	in	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	NF-kappa	NF-kappa	I-NP	I-NP	-	29	NMOD	-	-
28	B	B	I-NP	I-NP	-	29	NMOD	-	-
29	site	site	I-NP	I-NP	-	25	PMOD	-	-
30	have	have	B-VP	B-VP	-	23	SBAR	-	-
31	no	no	B-NP	B-NP	-	32	NMOD	-	-
32	effect	effect	I-NP	I-NP	-	30	OBJ	-	-
33	on	on	B-PP	B-PP	-	30	VMOD	-	-
34	inducibility	inducibility	B-NP	B-NP	-	33	PMOD	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	the	the	B-NP	B-NP	-	38	NMOD	-	-
37	IL-2	IL-2	I-NP	I-NP	-	38	NMOD	-	-
38	promoter	promoter	I-NP	I-NP	-	35	PMOD	-	-
39	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	15	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	15	P	-	-
4	mutations	mutations	B-NP	B-NP	-	15	SUB	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	AP-1	AP-1	I-NP	I-NP	-	8	NMOD	-	-
8	site	site	I-NP	I-NP	-	5	PMOD	-	-
9	located	located	B-ADJP	B-ADJP	-	8	NMOD	-	-
10	at	at	B-PP	B-PP	-	9	AMOD	-	-
11	-150	-150	B-NP	B-NP	-	12	NMOD	-	-
12	bp	bp	I-NP	I-NP	-	10	PMOD	-	-
13	almost	almost	B-ADVP	B-ADVP	-	15	VMOD	-	-
14	completely	completely	I-ADVP	I-ADVP	-	13	AMOD	-	-
15	abrogate	abrogate	I-VP	I-VP	-	33	VMOD	-	-
16	induction	induction	B-NP	B-NP	-	23	NMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	IL-2	IL-2	I-NP	I-NP	-	20	NMOD	-	-
20	promoter	promoter	I-NP	I-NP	-	17	PMOD	-	-
21	,	,	O	O	-	23	P	-	-
22	and	and	O	O	-	23	NMOD	-	-
23	appearance	appearance	B-NP	B-NP	-	33	SUB	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	an	an	B-NP	B-NP	-	28	NMOD	-	-
26	inducible	inducible	I-NP	I-NP	-	28	NMOD	-	-
27	nuclear	nuclear	I-NP	I-NP	-	28	NMOD	-	-
28	factor	factor	I-NP	I-NP	-	24	PMOD	-	-
29	binding	binding	B-VP	B-VP	-	28	NMOD	-	-
30	to	to	B-PP	B-PP	-	29	VMOD	-	-
31	this	this	B-NP	B-NP	-	32	NMOD	-	-
32	site	site	I-NP	I-NP	-	30	PMOD	-	-
33	is	is	B-VP	B-VP	-	0	ROOT	-	-
34	sensitive	sensitive	B-ADJP	B-ADJP	-	33	PRD	-	-
35	to	to	B-PP	B-PP	-	34	AMOD	-	-
36	PKC	PKC	B-NP	B-NP	-	37	NMOD	-	-
37	depletion	depletion	I-NP	I-NP	-	35	PMOD	-	-
38	.	.	O	O	-	33	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	cotransfections	cotransfections	B-NP	B-NP	-	11	SUB	-	-
4	with	with	B-PP	B-PP	-	3	NMOD	-	-
5	c-fos	c-fos	B-NP	B-NP	-	7	NMOD	-	-
6	and	and	O	O	-	7	NMOD	-	-
7	c-jun	c-jun	B-NP	B-NP	-	9	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	9	NMOD	-	-
9	plasmids	plasmids	I-NP	I-NP	-	4	PMOD	-	-
10	markedly	markedly	B-ADVP	B-ADVP	-	11	VMOD	-	-
11	enhance	enhance	B-VP	B-VP	-	0	ROOT	-	-
12	induction	induction	B-NP	B-NP	-	11	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	IL-2	IL-2	I-NP	I-NP	-	16	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	13	PMOD	-	-
17	in	in	B-PP	B-PP	-	12	NMOD	-	-
18	minimally	minimally	B-NP	B-NP	-	19	AMOD	-	-
19	stimulated	stimulated	I-NP	I-NP	-	21	NMOD	-	-
20	T	T	I-NP	I-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	11	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	AP-1	AP-1	I-NP	I-NP	-	7	NMOD	-	-
7	site	site	I-NP	I-NP	-	11	SUB	-	-
8	at	at	B-PP	B-PP	-	7	NMOD	-	-
9	-150	-150	B-NP	B-NP	-	10	NMOD	-	-
10	bp	bp	I-NP	I-NP	-	8	PMOD	-	-
11	represents	represents	B-VP	B-VP	-	4	SBAR	-	-
12	a	a	B-NP	B-NP	-	13	NMOD	-	-
13	major	major	I-NP	I-NP	-	11	OBJ	-	-
14	,	,	O	O	-	11	P	-	-
15	if	if	B-CONJP	B-CONJP	-	20	NMOD	-	-
16	not	not	I-CONJP	I-CONJP	-	15	DEP	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	only	only	I-NP	I-NP	-	20	NMOD	-	-
19	,	,	I-NP	I-NP	-	20	P	-	-
20	site	site	I-NP	I-NP	-	11	OBJ	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	PKC	PKC	B-NP	B-NP	-	23	NMOD	-	-
23	responsiveness	responsiveness	I-NP	I-NP	-	21	PMOD	-	-
24	in	in	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	IL-2	IL-2	I-NP	I-NP	-	27	NMOD	-	-
27	promoter	promoter	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	jun	jun	B-NP	B-NP	-	9	NMOD	-	-
5	and	and	I-NP	I-NP	-	9	NMOD	-	-
6	fos	fos	I-NP	I-NP	-	9	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	9	NMOD	-	-
8	family	family	I-NP	I-NP	-	9	NMOD	-	-
9	members	members	I-NP	I-NP	-	3	PMOD	-	-
10	in	in	B-PP	B-PP	-	2	NMOD	-	-
11	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	B-NP	-	10	PMOD	-	-
12	induced	induced	I-NP	I-NP	-	14	NMOD	-	-
13	hemopoietic	hemopoietic	I-NP	I-NP	-	14	NMOD	-	-
14	differentiation	differentiation	I-NP	I-NP	-	10	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	Terminal	Terminal	B-NP	B-NP	-	2	NMOD	-	-
2	differentiation	differentiation	I-NP	I-NP	-	10	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	leukemic	leukemic	I-NP	I-NP	-	7	NMOD	-	-
6	cell	cell	I-NP	I-NP	-	7	NMOD	-	-
7	lines	lines	I-NP	I-NP	-	10	NMOD	-	-
8	U-937	U-937	B-NP	B-NP	-	10	NMOD	-	-
9	and	and	O	O	-	10	NMOD	-	-
10	HL-60	HL-60	B-NP	B-NP	-	13	SUB	-	-
11	by	by	B-PP	B-PP	-	10	NMOD	-	-
12	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	B-NP	-	11	PMOD	-	-
13	is	is	B-VP	B-VP	-	0	ROOT	-	-
14	accompanied	accompanied	I-VP	I-VP	-	13	VC	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	marked	marked	B-NP	B-NP	-	17	NMOD	-	-
17	changes	changes	I-NP	I-NP	-	15	PMOD	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	gene	gene	B-NP	B-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	13	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	17	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	jun	jun	B-NP	B-NP	-	16	NMOD	-	-
12	and	and	I-NP	I-NP	-	16	NMOD	-	-
13	fos	fos	I-NP	I-NP	-	16	NMOD	-	-
14	gene	gene	I-NP	I-NP	-	16	NMOD	-	-
15	family	family	I-NP	I-NP	-	16	NMOD	-	-
16	members	members	I-NP	I-NP	-	10	PMOD	-	-
17	is	is	B-VP	B-VP	-	7	SBAR	-	-
18	induced	induced	I-VP	I-VP	-	17	VC	-	-
19	with	with	B-PP	B-PP	-	18	VMOD	-	-
20	variable	variable	B-NP	B-NP	-	21	NMOD	-	-
21	kinetics	kinetics	I-NP	I-NP	-	19	PMOD	-	-
22	during	during	B-PP	B-PP	-	18	VMOD	-	-
23	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	B-NP	-	25	NMOD	-	-
24	induced	induced	I-NP	I-NP	-	25	VMOD	-	-
25	differentiation	differentiation	I-NP	I-NP	-	22	PMOD	-	-
26	,	,	O	O	-	18	P	-	-
27	with	with	B-PP	B-PP	-	18	VMOD	-	-
28	c-jun	c-jun	B-NP	B-NP	-	29	NMOD	-	-
29	expression	expression	I-NP	I-NP	-	27	PMOD	-	-
30	best	best	B-NP	B-NP	-	32	NMOD	-	-
31	paralleling	paralleling	I-NP	I-NP	-	32	NMOD	-	-
32	differentiation	differentiation	I-NP	I-NP	-	27	PMOD	-	-
33	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	generation	generation	I-NP	I-NP	-	15	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	AP-1	AP-1	B-NP	B-NP	-	5	NMOD	-	-
5	complexes	complexes	I-NP	I-NP	-	3	PMOD	-	-
6	,	,	O	O	-	5	P	-	-
7	as	as	B-SBAR	B-SBAR	-	5	NMOD	-	-
8	measured	measured	B-VP	B-VP	-	7	SBAR	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	DNA	DNA	B-NP	B-NP	-	12	NMOD	-	-
11	binding	binding	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	2	P	-	-
14	closely	closely	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	parallels	parallels	B-VP	B-VP	-	0	ROOT	-	-
16	morphological	morphological	B-NP	B-NP	-	17	NMOD	-	-
17	differentiation	differentiation	I-NP	I-NP	-	15	OBJ	-	-
18	.	.	O	O	-	15	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	12	VMOD	-	-
2	,	,	O	O	-	12	P	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	ability	ability	I-NP	I-NP	-	12	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	these	these	B-NP	B-NP	-	7	NMOD	-	-
7	complexes	complexes	I-NP	I-NP	-	5	PMOD	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	regulate	regulate	I-VP	I-VP	-	4	NMOD	-	-
10	gene	gene	B-NP	B-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	9	OBJ	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	demonstrated	demonstrated	I-VP	I-VP	-	12	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	increased	increased	B-NP	B-NP	-	16	NMOD	-	-
16	transcription	transcription	I-NP	I-NP	-	14	PMOD	-	-
17	from	from	B-PP	B-PP	-	16	NMOD	-	-
18	an	an	B-NP	B-NP	-	22	NMOD	-	-
19	AP-1	AP-1	I-NP	I-NP	-	22	NMOD	-	-
20	driven	driven	I-NP	I-NP	-	22	NMOD	-	-
21	reporter	reporter	I-NP	I-NP	-	22	NMOD	-	-
22	construct	construct	I-NP	I-NP	-	17	PMOD	-	-
23	and	and	O	O	-	25	NMOD	-	-
24	marked	marked	B-NP	B-NP	-	25	NMOD	-	-
25	increases	increases	I-NP	I-NP	-	17	PMOD	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	expression	expression	I-NP	I-NP	-	26	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	endogenous	endogenous	B-NP	B-NP	-	33	NMOD	-	-
31	AP-1	AP-1	I-NP	I-NP	-	33	NMOD	-	-
32	regulated	regulated	I-NP	I-NP	-	33	NMOD	-	-
33	genes	genes	I-NP	I-NP	-	29	PMOD	-	-
34	.	.	O	O	-	12	P	-	-

1	Differentiation	Differentiation	B-NP	B-NP	-	2	NMOD	-	-
2	assays	assays	I-NP	I-NP	-	8	SUB	-	-
3	using	using	B-VP	B-VP	-	2	NMOD	-	-
4	water	water	B-NP	B-NP	-	7	NMOD	-	-
5	soluble	soluble	I-NP	I-NP	-	7	NMOD	-	-
6	phorbol	phorbol	I-NP	I-NP	-	7	NMOD	-	-
7	esters	esters	I-NP	I-NP	-	3	OBJ	-	-
8	reveal	reveal	B-VP	B-VP	-	0	ROOT	-	-
9	that	that	B-SBAR	B-SBAR	-	8	VMOD	-	-
10	differentiation	differentiation	B-NP	B-NP	-	11	SUB	-	-
11	becomes	becomes	B-VP	B-VP	-	9	SBAR	-	-
12	irreversible	irreversible	B-ADJP	B-ADJP	-	11	PRD	-	-
13	soon	soon	B-ADVP	B-ADVP	-	11	VMOD	-	-
14	after	after	B-SBAR	B-SBAR	-	9	SBAR	-	-
15	AP-1	AP-1	B-NP	B-NP	-	16	SUB	-	-
16	appears	appears	B-VP	B-VP	-	14	SBAR	-	-
17	.	.	O	O	-	8	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	tight	tight	I-NP	I-NP	-	3	NMOD	-	-
3	correlation	correlation	I-NP	I-NP	-	9	NMOD	-	-
4	between	between	B-PP	B-PP	-	3	NMOD	-	-
5	c-jun	c-jun	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	9	NMOD	-	-
7	,	,	O	O	-	9	P	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	generation	generation	I-NP	I-NP	-	16	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	AP-1	AP-1	B-NP	B-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	16	P	-	-
14	and	and	O	O	-	16	VMOD	-	-
15	differentiation	differentiation	B-NP	B-NP	-	16	SUB	-	-
16	suggests	suggests	B-VP	B-VP	-	0	ROOT	-	-
17	a	a	B-NP	B-NP	-	19	NMOD	-	-
18	critical	critical	I-NP	I-NP	-	19	NMOD	-	-
19	role	role	I-NP	I-NP	-	16	OBJ	-	-
20	for	for	B-PP	B-PP	-	19	NMOD	-	-
21	this	this	B-NP	B-NP	-	22	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	25	NMOD	-	-
23	and	and	O	O	-	25	NMOD	-	-
24	transcriptional	transcriptional	B-NP	B-NP	-	25	NMOD	-	-
25	complex	complex	I-NP	I-NP	-	20	PMOD	-	-
26	during	during	B-PP	B-PP	-	19	NMOD	-	-
27	this	this	B-NP	B-NP	-	28	NMOD	-	-
28	process	process	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	16	P	-	-

1	Characterization	Characterization	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	a	a	B-NP	B-NP	-	4	NMOD	-	-
4	cofactor	cofactor	I-NP	I-NP	-	2	PMOD	-	-
5	that	that	B-NP	B-NP	-	4	NMOD	-	-
6	regulates	regulates	B-VP	B-VP	-	5	SBAR	-	-
7	dimerization	dimerization	B-NP	B-NP	-	6	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	a	a	B-NP	B-NP	-	12	NMOD	-	-
10	mammalian	mammalian	I-NP	I-NP	-	12	NMOD	-	-
11	homeodomain	homeodomain	I-NP	I-NP	-	12	NMOD	-	-
12	protein	protein	I-NP	I-NP	-	8	PMOD	-	-
13	.	.	O	O	-	1	P	-	-

1	Dimerization	Dimerization	B-NP	B-NP	-	5	SUB	-	-
2	among	among	B-PP	B-PP	-	1	NMOD	-	-
3	transcription	transcription	B-NP	B-NP	-	4	NMOD	-	-
4	factors	factors	I-NP	I-NP	-	2	PMOD	-	-
5	has	has	B-VP	B-VP	-	0	ROOT	-	-
6	become	become	I-VP	I-VP	-	5	VC	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	recurrent	recurrent	I-NP	I-NP	-	9	NMOD	-	-
9	theme	theme	I-NP	I-NP	-	6	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	regulation	regulation	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	eukaryotic	eukaryotic	B-NP	B-NP	-	16	NMOD	-	-
15	gene	gene	I-NP	I-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	5	P	-	-

1	Hepatocyte	Hepatocyte	B-NP	B-NP	-	4	NMOD	-	-
2	nuclear	nuclear	I-NP	I-NP	-	4	NMOD	-	-
3	factor-1	factor-1	I-NP	I-NP	-	4	NMOD	-	-
4	alpha	alpha	I-NP	I-NP	-	9	SUB	-	-
5	(	(	O	O	-	7	P	-	-
6	HNF-1	HNF-1	B-NP	B-NP	-	7	NMOD	-	-
7	alpha	alpha	I-NP	I-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	homeodomain-containing	homeodomain-containing	I-NP	I-NP	-	12	NMOD	-	-
12	protein	protein	I-NP	I-NP	-	9	PRD	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	functions	functions	B-VP	B-VP	-	13	SBAR	-	-
15	as	as	B-PP	B-PP	-	14	VMOD	-	-
16	a	a	B-NP	B-NP	-	17	NMOD	-	-
17	dimer	dimer	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	9	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	dimerization	dimerization	I-NP	I-NP	-	3	NMOD	-	-
3	cofactor	cofactor	I-NP	I-NP	-	10	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	HNF-1	HNF-1	B-NP	B-NP	-	6	NMOD	-	-
6	alpha	alpha	I-NP	I-NP	-	4	PMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	DCoH	DCoH	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	identified	identified	I-VP	I-VP	-	10	VC	-	-
12	that	that	B-NP	B-NP	-	11	VMOD	-	-
13	displayed	displayed	B-VP	B-VP	-	12	SBAR	-	-
14	a	a	B-NP	B-NP	-	17	NMOD	-	-
15	restricted	restricted	I-NP	I-NP	-	17	NMOD	-	-
16	tissue	tissue	I-NP	I-NP	-	17	NMOD	-	-
17	distribution	distribution	I-NP	I-NP	-	13	OBJ	-	-
18	and	and	O	O	-	13	VMOD	-	-
19	did	did	B-VP	B-VP	-	13	VMOD	-	-
20	not	not	I-VP	I-VP	-	19	VMOD	-	-
21	bind	bind	I-VP	I-VP	-	19	VC	-	-
22	to	to	B-PP	B-PP	-	21	VMOD	-	-
23	DNA	DNA	B-NP	B-NP	-	22	PMOD	-	-
24	,	,	O	O	-	30	P	-	-
25	but	but	O	O	-	30	VMOD	-	-
26	,	,	O	O	-	30	P	-	-
27	rather	rather	B-ADVP	B-ADVP	-	30	VMOD	-	-
28	,	,	O	O	-	30	P	-	-
29	selectively	selectively	B-VP	B-VP	-	30	VMOD	-	-
30	stabilized	stabilized	I-VP	I-VP	-	13	VMOD	-	-
31	HNF-1	HNF-1	B-NP	B-NP	-	33	NMOD	-	-
32	alpha	alpha	I-NP	I-NP	-	33	NMOD	-	-
33	dimers	dimers	I-NP	I-NP	-	30	OBJ	-	-
34	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	formation	formation	I-NP	I-NP	-	20	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	9	NMOD	-	-
5	stable	stable	I-NP	I-NP	-	9	NMOD	-	-
6	tetrameric	tetrameric	I-NP	I-NP	-	9	NMOD	-	-
7	DCoH-HNF-1	DCoH-HNF-1	I-NP	I-NP	-	9	NMOD	-	-
8	alpha	alpha	I-NP	I-NP	-	9	NMOD	-	-
9	complex	complex	I-NP	I-NP	-	3	PMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	which	which	B-NP	B-NP	-	9	NMOD	-	-
12	required	required	B-VP	B-VP	-	11	SBAR	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	dimerization	dimerization	I-NP	I-NP	-	15	NMOD	-	-
15	domain	domain	I-NP	I-NP	-	12	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	HNF-1	HNF-1	B-NP	B-NP	-	18	NMOD	-	-
18	alpha	alpha	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	2	P	-	-
20	did	did	B-VP	B-VP	-	0	ROOT	-	-
21	not	not	I-VP	I-VP	-	20	VMOD	-	-
22	change	change	I-VP	I-VP	-	20	VC	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	DNA	DNA	I-NP	I-NP	-	26	NMOD	-	-
25	binding	binding	I-NP	I-NP	-	26	NMOD	-	-
26	characteristics	characteristics	I-NP	I-NP	-	22	OBJ	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	HNF-1	HNF-1	B-NP	B-NP	-	29	NMOD	-	-
29	alpha	alpha	I-NP	I-NP	-	27	PMOD	-	-
30	,	,	O	O	-	20	P	-	-
31	but	but	O	O	-	20	VMOD	-	-
32	enhanced	enhanced	B-VP	B-VP	-	20	VMOD	-	-
33	its	its	B-NP	B-NP	-	35	NMOD	-	-
34	transcriptional	transcriptional	I-NP	I-NP	-	35	NMOD	-	-
35	activity	activity	I-NP	I-NP	-	32	OBJ	-	-
36	.	.	O	O	-	20	P	-	-

1	However	However	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	DCoH	DCoH	B-NP	B-NP	-	4	SUB	-	-
4	did	did	B-VP	B-VP	-	0	ROOT	-	-
5	not	not	I-VP	I-VP	-	4	VMOD	-	-
6	confer	confer	I-VP	I-VP	-	4	VC	-	-
7	transcriptional	transcriptional	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	6	OBJ	-	-
9	to	to	B-PP	B-PP	-	6	VMOD	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	GAL4	GAL4	I-NP	I-NP	-	14	NMOD	-	-
12	DNA	DNA	I-NP	I-NP	-	14	NMOD	-	-
13	binding	binding	I-NP	I-NP	-	14	NMOD	-	-
14	domain	domain	I-NP	I-NP	-	9	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	DCoH	DCoH	B-NP	B-NP	-	6	SUB	-	-
6	regulates	regulates	B-VP	B-VP	-	4	SBAR	-	-
7	formation	formation	B-NP	B-NP	-	6	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	transcriptionally	transcriptionally	B-NP	B-NP	-	10	AMOD	-	-
10	active	active	I-NP	I-NP	-	12	NMOD	-	-
11	tetrameric	tetrameric	I-NP	I-NP	-	12	NMOD	-	-
12	complexes	complexes	I-NP	I-NP	-	8	PMOD	-	-
13	and	and	O	O	-	6	VMOD	-	-
14	may	may	B-VP	B-VP	-	4	SBAR	-	-
15	contribute	contribute	I-VP	I-VP	-	14	VC	-	-
16	to	to	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	developmental	developmental	I-NP	I-NP	-	19	NMOD	-	-
19	specificity	specificity	I-NP	I-NP	-	16	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	complex	complex	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	4	NMOD	-	-
2	factor	factor	I-NP	I-NP	-	4	NMOD	-	-
3	kappa	kappa	I-NP	I-NP	-	4	NMOD	-	-
4	B	B	I-NP	I-NP	-	5	SUB	-	-
5	activates	activates	B-VP	B-VP	-	0	ROOT	-	-
6	proenkephalin	proenkephalin	B-NP	B-NP	-	7	NMOD	-	-
7	transcription	transcription	I-NP	I-NP	-	5	OBJ	-	-
8	in	in	B-PP	B-PP	-	5	VMOD	-	-
9	T	T	B-NP	B-NP	-	10	NMOD	-	-
10	lymphocytes	lymphocytes	I-NP	I-NP	-	8	PMOD	-	-
11	.	.	O	O	-	5	P	-	-

1	Upon	Upon	B-PP	B-PP	-	6	VMOD	-	-
2	activation	activation	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	T	T	B-NP	B-NP	-	5	NMOD	-	-
5	lymphocytes	lymphocytes	I-NP	I-NP	-	6	SUB	-	-
6	accumulate	accumulate	B-VP	B-VP	-	0	ROOT	-	-
7	high	high	B-NP	B-NP	-	8	NMOD	-	-
8	levels	levels	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	neuropeptide	neuropeptide	I-NP	I-NP	-	12	NMOD	-	-
12	enkephalin	enkephalin	I-NP	I-NP	-	9	PMOD	-	-
13	which	which	B-NP	B-NP	-	8	NMOD	-	-
14	correlate	correlate	B-VP	B-VP	-	13	SBAR	-	-
15	with	with	B-PP	B-PP	-	14	VMOD	-	-
16	high	high	B-NP	B-NP	-	17	NMOD	-	-
17	levels	levels	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	proenkephalin	proenkephalin	B-NP	B-NP	-	20	NMOD	-	-
20	mRNA	mRNA	I-NP	I-NP	-	18	PMOD	-	-
21	in	in	B-PP	B-PP	-	17	NMOD	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	6	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	investigated	investigated	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	transcriptional	transcriptional	I-NP	I-NP	-	6	NMOD	-	-
6	basis	basis	I-NP	I-NP	-	3	OBJ	-	-
7	for	for	B-PP	B-PP	-	6	NMOD	-	-
8	these	these	B-NP	B-NP	-	9	NMOD	-	-
9	changes	changes	I-NP	I-NP	-	7	PMOD	-	-
10	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	proenkephalin	proenkephalin	I-NP	I-NP	-	3	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	4	SUB	-	-
4	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	sequence	sequence	I-NP	I-NP	-	7	NMOD	-	-
7	GGGGACGTCCCC	GGGGACGTCCCC	I-NP	I-NP	-	4	OBJ	-	-
8	,	,	O	O	-	7	P	-	-
9	named	named	B-VP	B-VP	-	7	NMOD	-	-
10	B2	B2	B-NP	B-NP	-	9	VMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	which	which	B-NP	B-NP	-	10	NMOD	-	-
13	is	is	B-VP	B-VP	-	12	SBAR	-	-
14	similar	similar	B-ADJP	B-ADJP	-	13	PRD	-	-
15	to	to	B-PP	B-PP	-	14	AMOD	-	-
16	the	the	B-NP	B-NP	-	20	NMOD	-	-
17	kappa	kappa	I-NP	I-NP	-	20	NMOD	-	-
18	B	B	I-NP	I-NP	-	20	NMOD	-	-
19	sequence	sequence	I-NP	I-NP	-	20	NMOD	-	-
20	GGGGACTTTCC	GGGGACTTTCC	I-NP	I-NP	-	24	NMOD	-	-
21	,	,	O	O	-	24	P	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	binding	binding	I-NP	I-NP	-	24	NMOD	-	-
24	site	site	I-NP	I-NP	-	15	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	transcription	transcription	I-NP	I-NP	-	28	NMOD	-	-
28	factor	factor	I-NP	I-NP	-	35	NMOD	-	-
29	nuclear	nuclear	B-NP	B-NP	-	35	NMOD	-	-
30	factor	factor	I-NP	I-NP	-	35	NMOD	-	-
31	(	(	O	O	-	35	P	-	-
32	NF	NF	B-NP	B-NP	-	35	NMOD	-	-
33	)	)	O	O	-	35	P	-	-
34	-kappa	-kappa	B-NP	B-NP	-	35	NMOD	-	-
35	B	B	I-NP	I-NP	-	25	PMOD	-	-
36	.	.	O	O	-	4	P	-	-

1	Activation	Activation	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	4	NMOD	-	-
4	lymphocytes	lymphocytes	I-NP	I-NP	-	2	PMOD	-	-
5	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
6	an	an	B-NP	B-NP	-	10	NMOD	-	-
7	NF-kappa	NF-kappa	I-NP	I-NP	-	10	NMOD	-	-
8	B-like	B-like	I-NP	I-NP	-	7	AMOD	-	-
9	binding	binding	I-NP	I-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	5	OBJ	-	-
11	to	to	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	B2	B2	I-NP	I-NP	-	14	NMOD	-	-
14	site	site	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	concomitant	concomitant	B-ADJP	B-ADJP	-	14	NMOD	-	-
17	with	with	B-PP	B-PP	-	16	AMOD	-	-
18	activation	activation	B-NP	B-NP	-	17	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	proenkephalin	proenkephalin	I-NP	I-NP	-	22	NMOD	-	-
22	promoter	promoter	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	Mutations	Mutations	B-NP	B-NP	-	6	SUB	-	-
2	at	at	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	B2	B2	I-NP	I-NP	-	5	NMOD	-	-
5	site	site	I-NP	I-NP	-	2	PMOD	-	-
6	abolish	abolish	B-VP	B-VP	-	0	ROOT	-	-
7	this	this	B-NP	B-NP	-	9	NMOD	-	-
8	transcriptional	transcriptional	I-NP	I-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	6	OBJ	-	-
10	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	purified	purified	I-NP	I-NP	-	3	NMOD	-	-
3	homodimer	homodimer	I-NP	I-NP	-	15	SUB	-	-
4	(	(	O	O	-	6	P	-	-
5	two	two	B-NP	B-NP	-	6	NMOD	-	-
6	p50s	p50s	I-NP	I-NP	-	3	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	of	of	B-PP	B-PP	-	6	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	DNA-binding	DNA-binding	I-NP	I-NP	-	11	NMOD	-	-
11	subunit	subunit	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	NF-kappa	NF-kappa	B-NP	B-NP	-	14	NMOD	-	-
14	B	B	I-NP	I-NP	-	12	PMOD	-	-
15	binds	binds	B-VP	B-VP	-	0	ROOT	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	B2	B2	I-NP	I-NP	-	18	NMOD	-	-
18	site	site	I-NP	I-NP	-	15	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	proenkephalin	proenkephalin	B-NP	B-NP	-	19	PMOD	-	-
21	relatively	relatively	B-ADVP	B-ADVP	-	18	NMOD	-	-
22	better	better	I-ADVP	I-ADVP	-	21	AMOD	-	-
23	than	than	B-SBAR	B-SBAR	-	15	VMOD	-	-
24	does	does	O	O	-	23	SBAR	-	-
25	the	the	O	O	-	34	NMOD	-	-
26	heterotetramer	heterotetramer	B-NP	B-NP	-	34	NMOD	-	-
27	(	(	O	O	-	32	P	-	-
28	two	two	B-NP	B-NP	-	29	NMOD	-	-
29	p65s	p65s	I-NP	I-NP	-	32	NMOD	-	-
30	plus	plus	O	O	-	32	NMOD	-	-
31	two	two	B-NP	B-NP	-	32	NMOD	-	-
32	p50s	p50s	I-NP	I-NP	-	34	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	form	form	B-NP	B-NP	-	24	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	the	the	B-NP	B-NP	-	37	NMOD	-	-
37	factor	factor	I-NP	I-NP	-	35	PMOD	-	-
38	.	.	O	O	-	15	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	it	it	B-NP	B-NP	-	4	SUB	-	-
4	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	T-cell-specific	T-cell-specific	I-NP	I-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	13	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	proenkephalin	proenkephalin	I-NP	I-NP	-	12	NMOD	-	-
12	promoter	promoter	I-NP	I-NP	-	9	PMOD	-	-
13	is	is	B-VP	B-VP	-	5	SBAR	-	-
14	mediated	mediated	I-VP	I-VP	-	13	VC	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	17	NMOD	-	-
17	B	B	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	However	However	B-ADVP	B-ADVP	-	16	VMOD	-	-
2	,	,	O	O	-	16	P	-	-
3	as	as	B-SBAR	B-SBAR	-	16	VMOD	-	-
4	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
5	B	B	I-NP	I-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	3	SBAR	-	-
7	ubiquitous	ubiquitous	B-ADJP	B-ADJP	-	6	PRD	-	-
8	and	and	O	O	-	16	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	transcriptional	transcriptional	I-NP	I-NP	-	11	NMOD	-	-
11	activation	activation	I-NP	I-NP	-	16	SUB	-	-
12	through	through	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	B2	B2	I-NP	I-NP	-	15	NMOD	-	-
15	site	site	I-NP	I-NP	-	12	PMOD	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	T	T	B-NP	B-NP	-	18	NMOD	-	-
18	cell	cell	I-NP	I-NP	-	19	AMOD	-	-
19	specific	specific	B-ADJP	B-ADJP	-	16	PRD	-	-
20	,	,	O	O	-	24	P	-	-
21	yet	yet	B-NP	B-NP	-	24	NMOD	-	-
22	another	another	I-NP	I-NP	-	24	NMOD	-	-
23	T-cell-specific	T-cell-specific	I-NP	I-NP	-	24	NMOD	-	-
24	factor	factor	I-NP	I-NP	-	16	PRD	-	-
25	which	which	B-NP	B-NP	-	24	NMOD	-	-
26	synergizes	synergizes	B-VP	B-VP	-	25	SBAR	-	-
27	with	with	B-PP	B-PP	-	26	VMOD	-	-
28	NF-kappa	NF-kappa	B-NP	B-NP	-	29	NMOD	-	-
29	B	B	I-NP	I-NP	-	27	PMOD	-	-
30	should	should	B-VP	B-VP	-	27	SBAR	-	-
31	be	be	I-VP	I-VP	-	30	VC	-	-
32	considered	considered	I-VP	I-VP	-	31	VC	-	-
33	.	.	O	O	-	16	P	-	-

1	ETS1	ETS1	B-NP	B-NP	-	2	SUB	-	-
2	transactivates	transactivates	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	human	human	I-NP	I-NP	-	6	NMOD	-	-
5	GM-CSF	GM-CSF	I-NP	I-NP	-	6	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	2	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	Jurkat	Jurkat	B-NP	B-NP	-	10	NMOD	-	-
9	T	T	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
11	stimulated	stimulated	B-VP	B-VP	-	10	NMOD	-	-
12	with	with	B-PP	B-PP	-	11	VMOD	-	-
13	PMA	PMA	B-NP	B-NP	-	15	NMOD	-	-
14	and	and	I-NP	I-NP	-	15	NMOD	-	-
15	ionomycin	ionomycin	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	2	P	-	-

1	Activation	Activation	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	5	NMOD	-	-
4	helper	helper	I-NP	I-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
6	results	results	B-VP	B-VP	-	0	ROOT	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	coordinate	coordinate	B-NP	B-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	number	number	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	cytokines	cytokines	B-NP	B-NP	-	13	PMOD	-	-
15	involved	involved	B-VP	B-VP	-	14	NMOD	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	differentiation	differentiation	B-NP	B-NP	-	21	NMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	proliferation	proliferation	B-NP	B-NP	-	21	NMOD	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	activation	activation	B-NP	B-NP	-	16	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	haematopoietic	haematopoietic	I-NP	I-NP	-	25	NMOD	-	-
25	system	system	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	6	P	-	-

1	Granulocyte-macrophage	Granulocyte-macrophage	B-NP	B-NP	-	3	NMOD	-	-
2	colony-stimulating	colony-stimulating	I-NP	I-NP	-	3	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	GM-CSF	GM-CSF	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	one	one	B-NP	B-NP	-	10	NMOD	-	-
9	such	such	I-NP	I-NP	-	10	NMOD	-	-
10	cytokine	cytokine	I-NP	I-NP	-	7	PRD	-	-
11	whose	whose	B-NP	B-NP	-	10	NMOD	-	-
12	increased	increased	I-NP	I-NP	-	11	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	NMOD	-	-
14	results	results	B-VP	B-VP	-	11	SBAR	-	-
15	partly	partly	B-ADVP	B-ADVP	-	14	VMOD	-	-
16	from	from	B-PP	B-PP	-	14	VMOD	-	-
17	increases	increases	B-NP	B-NP	-	16	PMOD	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	transcription	transcription	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	7	P	-	-

1	Cis-acting	Cis-acting	B-NP	B-NP	-	2	NMOD	-	-
2	elements	elements	I-NP	I-NP	-	12	SUB	-	-
3	with	with	B-PP	B-PP	-	2	NMOD	-	-
4	NF	NF	B-NP	B-NP	-	6	NMOD	-	-
5	kappa	kappa	I-NP	I-NP	-	6	NMOD	-	-
6	B	B	I-NP	I-NP	-	11	NMOD	-	-
7	,	,	O	O	-	11	P	-	-
8	AP-1	AP-1	B-NP	B-NP	-	11	NMOD	-	-
9	and	and	O	O	-	11	NMOD	-	-
10	ETS-like	ETS-like	B-NP	B-NP	-	11	NMOD	-	-
11	motifs	motifs	I-NP	I-NP	-	3	PMOD	-	-
12	have	have	B-VP	B-VP	-	0	ROOT	-	-
13	been	been	I-VP	I-VP	-	12	VC	-	-
14	identified	identified	I-VP	I-VP	-	13	VC	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	18	NMOD	-	-
18	region	region	I-NP	I-NP	-	15	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	GM-CSF	GM-CSF	I-NP	I-NP	-	22	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	19	PMOD	-	-
23	,	,	O	O	-	18	P	-	-
24	which	which	B-NP	B-NP	-	18	NMOD	-	-
25	are	are	B-VP	B-VP	-	24	SBAR	-	-
26	important	important	B-ADJP	B-ADJP	-	25	PRD	-	-
27	for	for	B-PP	B-PP	-	26	AMOD	-	-
28	transcriptional	transcriptional	B-NP	B-NP	-	29	NMOD	-	-
29	activity	activity	I-NP	I-NP	-	27	PMOD	-	-
30	following	following	B-PP	B-PP	-	29	NMOD	-	-
31	PMA	PMA	B-NP	B-NP	-	34	NMOD	-	-
32	and	and	O	O	-	34	NMOD	-	-
33	ionomycin	ionomycin	B-NP	B-NP	-	34	NMOD	-	-
34	stimulation	stimulation	I-NP	I-NP	-	30	PMOD	-	-
35	.	.	O	O	-	12	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	number	number	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	ETS	ETS	I-NP	I-NP	-	6	NMOD	-	-
6	family	family	I-NP	I-NP	-	3	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	transcription	transcription	B-NP	B-NP	-	9	NMOD	-	-
9	factors	factors	I-NP	I-NP	-	7	PMOD	-	-
10	are	are	B-VP	B-VP	-	0	ROOT	-	-
11	expressed	expressed	I-VP	I-VP	-	10	VC	-	-
12	in	in	B-PP	B-PP	-	11	VMOD	-	-
13	T	T	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	including	including	B-PP	B-PP	-	14	NMOD	-	-
17	ETS1	ETS1	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	ELF1	ELF1	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	describe	describe	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	ability	ability	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	these	these	B-NP	B-NP	-	8	NMOD	-	-
8	factors	factors	I-NP	I-NP	-	6	PMOD	-	-
9	to	to	B-VP	B-VP	-	10	VMOD	-	-
10	interact	interact	I-VP	I-VP	-	5	NMOD	-	-
11	with	with	B-PP	B-PP	-	10	VMOD	-	-
12	a	a	B-NP	B-NP	-	13	NMOD	-	-
13	site	site	I-NP	I-NP	-	11	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	GM5	GM5	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	,	,	O	O	-	13	P	-	-
18	located	located	B-ADJP	B-ADJP	-	13	NMOD	-	-
19	within	within	B-PP	B-PP	-	18	AMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	CLE0	CLE0	I-NP	I-NP	-	22	NMOD	-	-
22	element	element	I-NP	I-NP	-	19	PMOD	-	-
23	,	,	O	O	-	26	P	-	-
24	-47	-47	B-NP	B-NP	-	26	NMOD	-	-
25	to	to	B-PP	B-PP	-	26	NMOD	-	-
26	-40	-40	B-NP	B-NP	-	22	NMOD	-	-
27	upstream	upstream	B-ADVP	B-ADVP	-	22	NMOD	-	-
28	of	of	B-PP	B-PP	-	27	AMOD	-	-
29	the	the	B-NP	B-NP	-	33	NMOD	-	-
30	GM-CSF	GM-CSF	I-NP	I-NP	-	33	NMOD	-	-
31	transcription	transcription	I-NP	I-NP	-	33	NMOD	-	-
32	initiation	initiation	I-NP	I-NP	-	33	NMOD	-	-
33	site	site	I-NP	I-NP	-	28	PMOD	-	-
34	.	.	O	O	-	3	P	-	-

1	Exogenous	Exogenous	B-NP	B-NP	-	2	NMOD	-	-
2	ETS1	ETS1	I-NP	I-NP	-	6	NMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	but	but	O	O	-	6	NMOD	-	-
5	not	not	O	O	-	4	DEP	-	-
6	ELF1	ELF1	B-NP	B-NP	-	8	SUB	-	-
7	,	,	O	O	-	6	P	-	-
8	can	can	B-VP	B-VP	-	0	ROOT	-	-
9	transactivate	transactivate	I-VP	I-VP	-	8	VC	-	-
10	GM-CSF	GM-CSF	B-NP	B-NP	-	9	OBJ	-	-
11	,	,	O	O	-	9	P	-	-
12	through	through	B-PP	B-PP	-	9	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	GM5	GM5	I-NP	I-NP	-	15	NMOD	-	-
15	site	site	I-NP	I-NP	-	12	PMOD	-	-
16	,	,	O	O	-	9	P	-	-
17	in	in	B-PP	B-PP	-	9	VMOD	-	-
18	a	a	B-NP	B-NP	-	21	NMOD	-	-
19	PMA/ionomycin	PMA/ionomycin	I-NP	I-NP	-	20	AMOD	-	-
20	dependent	dependent	I-NP	I-NP	-	21	NMOD	-	-
21	manner	manner	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	Other	Other	B-NP	B-NP	-	4	NMOD	-	-
2	unidentified	unidentified	I-NP	I-NP	-	4	NMOD	-	-
3	ETS-like	ETS-like	I-NP	I-NP	-	4	NMOD	-	-
4	factors	factors	I-NP	I-NP	-	9	SUB	-	-
5	present	present	B-ADJP	B-ADJP	-	4	NMOD	-	-
6	in	in	B-PP	B-PP	-	5	AMOD	-	-
7	Jurkat	Jurkat	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	are	are	B-VP	B-VP	-	0	ROOT	-	-
10	also	also	B-ADVP	B-ADVP	-	9	VMOD	-	-
11	capable	capable	B-ADJP	B-ADJP	-	9	PRD	-	-
12	of	of	B-PP	B-PP	-	11	AMOD	-	-
13	binding	binding	B-VP	B-VP	-	12	PMOD	-	-
14	GM5	GM5	B-NP	B-NP	-	13	OBJ	-	-
15	.	.	O	O	-	9	P	-	-

1	Mutation	Mutation	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	core	core	I-NP	I-NP	-	7	NMOD	-	-
5	ETS	ETS	I-NP	I-NP	-	7	NMOD	-	-
6	binding	binding	I-NP	I-NP	-	7	NMOD	-	-
7	site	site	I-NP	I-NP	-	2	PMOD	-	-
8	from	from	B-PP	B-PP	-	7	NMOD	-	-
9	-GGAA-	-GGAA-	B-NP	B-NP	-	8	PMOD	-	-
10	to	to	B-PP	B-PP	-	7	NMOD	-	-
11	-GGAT-	-GGAT-	B-NP	B-NP	-	10	PMOD	-	-
12	prevents	prevents	B-VP	B-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	binding	binding	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	ETS-like	ETS-like	B-NP	B-NP	-	17	NMOD	-	-
17	factors	factors	I-NP	I-NP	-	15	PMOD	-	-
18	with	with	B-PP	B-PP	-	14	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	exception	exception	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	ETS1	ETS1	B-NP	B-NP	-	21	PMOD	-	-
23	.	.	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	GM-CSF	GM-CSF	I-NP	I-NP	-	3	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	14	SUB	-	-
4	,	,	O	O	-	3	P	-	-
5	modified	modified	B-VP	B-VP	-	3	NMOD	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	this	this	B-NP	B-NP	-	8	NMOD	-	-
8	way	way	I-NP	I-NP	-	6	PMOD	-	-
9	to	to	B-VP	B-VP	-	10	VMOD	-	-
10	be	be	I-VP	I-VP	-	8	NMOD	-	-
11	ETS1	ETS1	B-NP	B-NP	-	12	AMOD	-	-
12	specific	specific	B-ADJP	B-ADJP	-	10	PRD	-	-
13	,	,	O	O	-	3	P	-	-
14	is	is	B-VP	B-VP	-	0	ROOT	-	-
15	fully	fully	B-ADJP	B-ADJP	-	16	AMOD	-	-
16	responsive	responsive	I-ADJP	I-ADJP	-	14	PRD	-	-
17	to	to	B-PP	B-PP	-	16	AMOD	-	-
18	PMA/ionomycin	PMA/ionomycin	B-NP	B-NP	-	19	NMOD	-	-
19	induction	induction	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	14	P	-	-
21	in	in	B-PP	B-PP	-	14	VMOD	-	-
22	addition	addition	B-NP	B-NP	-	21	PMOD	-	-
23	to	to	B-PP	B-PP	-	22	NMOD	-	-
24	ETS1	ETS1	B-NP	B-NP	-	25	NMOD	-	-
25	transactivation	transactivation	I-NP	I-NP	-	23	PMOD	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	I-PP	I-PP	-	28	NMOD	-	-
28	presence	presence	I-PP	I-PP	-	26	PMOD	-	-
29	of	of	I-PP	I-PP	-	25	NMOD	-	-
30	PMA	PMA	B-NP	B-NP	-	32	NMOD	-	-
31	and	and	I-NP	I-NP	-	32	NMOD	-	-
32	ionomycin	ionomycin	I-NP	I-NP	-	29	PMOD	-	-
33	.	.	O	O	-	14	P	-	-

1	Together	Together	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	these	these	B-NP	B-NP	-	3	NMOD	-	-
3	data	data	I-NP	I-NP	-	4	SUB	-	-
4	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	ETS1	ETS1	B-NP	B-NP	-	7	SUB	-	-
7	may	may	B-VP	B-VP	-	5	SBAR	-	-
8	be	be	I-VP	I-VP	-	7	VC	-	-
9	involved	involved	I-VP	I-VP	-	8	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	mediating	mediating	B-VP	B-VP	-	10	PMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	increased	increased	I-NP	I-NP	-	15	NMOD	-	-
14	GM-CSF	GM-CSF	I-NP	I-NP	-	15	NMOD	-	-
15	production	production	I-NP	I-NP	-	11	OBJ	-	-
16	associated	associated	B-VP	B-VP	-	15	NMOD	-	-
17	with	with	B-PP	B-PP	-	16	VMOD	-	-
18	T	T	B-NP	B-NP	-	20	NMOD	-	-
19	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
20	activation	activation	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	4	P	-	-

1	Tissue-specific	Tissue-specific	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	rabbit	rabbit	I-NP	I-NP	-	7	NMOD	-	-
6	15-lipoxygenase	15-lipoxygenase	I-NP	I-NP	-	7	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	3	PMOD	-	-
8	in	in	B-PP	B-PP	-	2	NMOD	-	-
9	erythroid	erythroid	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	by	by	B-PP	B-PP	-	2	NMOD	-	-
12	a	a	B-NP	B-NP	-	14	NMOD	-	-
13	transcriptional	transcriptional	I-NP	I-NP	-	14	NMOD	-	-
14	silencer	silencer	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	6	NMOD	-	-
2	15-lipoxygenase	15-lipoxygenase	I-NP	I-NP	-	6	NMOD	-	-
3	(	(	O	O	-	4	P	-	-
4	lox	lox	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	6	P	-	-
6	gene	gene	B-NP	B-NP	-	7	SUB	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	expressed	expressed	I-VP	I-VP	-	7	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	tissue-specific	tissue-specific	I-NP	I-NP	-	12	NMOD	-	-
12	manner	manner	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	8	P	-	-
14	predominantly	predominantly	B-ADVP	B-ADVP	-	15	PMOD	-	-
15	in	in	B-PP	B-PP	-	8	VMOD	-	-
16	erythroid	erythroid	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	but	but	B-CONJP	B-CONJP	-	15	PMOD	-	-
19	also	also	I-CONJP	I-CONJP	-	18	DEP	-	-
20	in	in	B-PP	B-PP	-	15	PMOD	-	-
21	airway	airway	B-NP	B-NP	-	23	NMOD	-	-
22	epithelial	epithelial	I-NP	I-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	25	NMOD	-	-
24	and	and	O	O	-	25	NMOD	-	-
25	eosinophils	eosinophils	B-NP	B-NP	-	20	PMOD	-	-
26	.	.	O	O	-	7	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	in	in	B-PP	B-PP	-	2	VMOD	-	-
4	this	this	B-NP	B-NP	-	5	NMOD	-	-
5	report	report	I-NP	I-NP	-	3	PMOD	-	-
6	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
7	the	the	B-NP	B-NP	-	11	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
9	'	'	I-NP	I-NP	-	11	NMOD	-	-
10	flanking	flanking	I-NP	I-NP	-	11	NMOD	-	-
11	DNA	DNA	I-NP	I-NP	-	16	SUB	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	15-lox	15-lox	I-NP	I-NP	-	15	NMOD	-	-
15	gene	gene	I-NP	I-NP	-	12	PMOD	-	-
16	contains	contains	B-VP	B-VP	-	6	SBAR	-	-
17	sequences	sequences	B-NP	B-NP	-	16	OBJ	-	-
18	which	which	B-NP	B-NP	-	17	NMOD	-	-
19	down-regulate	down-regulate	B-VP	B-VP	-	18	SBAR	-	-
20	its	its	B-NP	B-NP	-	21	NMOD	-	-
21	activity	activity	I-NP	I-NP	-	19	OBJ	-	-
22	in	in	B-PP	B-PP	-	21	NMOD	-	-
23	a	a	B-NP	B-NP	-	24	NMOD	-	-
24	variety	variety	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	non-erythroid	non-erythroid	B-NP	B-NP	-	28	NMOD	-	-
27	cell	cell	I-NP	I-NP	-	28	NMOD	-	-
28	lines	lines	I-NP	I-NP	-	25	PMOD	-	-
29	but	but	B-PP	B-PP	-	22	PMOD	-	-
30	not	not	B-PP	B-PP	-	31	PMOD	-	-
31	in	in	I-PP	I-PP	-	22	PMOD	-	-
32	two	two	B-NP	B-NP	-	31	PMOD	-	-
33	erythroid	erythroid	I-NP	I-NP	-	35	NMOD	-	-
34	cell	cell	I-NP	I-NP	-	35	NMOD	-	-
35	lines	lines	I-NP	I-NP	-	32	NMOD	-	-
36	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	element	element	I-NP	I-NP	-	3	SUB	-	-
3	has	has	B-VP	B-VP	-	0	ROOT	-	-
4	characteristics	characteristics	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	transcriptional	transcriptional	I-NP	I-NP	-	8	NMOD	-	-
8	'silencer	'silencer	I-NP	I-NP	-	5	PMOD	-	-
9	'	'	O	O	-	8	P	-	-
10	since	since	B-SBAR	B-SBAR	-	3	VMOD	-	-
11	it	it	B-NP	B-NP	-	12	SUB	-	-
12	functions	functions	B-VP	B-VP	-	10	SBAR	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	both	both	B-NP	B-NP	-	15	NMOD	-	-
15	orientations	orientations	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	main	main	I-NP	I-NP	-	3	NMOD	-	-
3	activity	activity	I-NP	I-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	silencer	silencer	I-NP	I-NP	-	4	PMOD	-	-
7	has	has	B-VP	B-VP	-	0	ROOT	-	-
8	been	been	I-VP	I-VP	-	7	VC	-	-
9	mapped	mapped	I-VP	I-VP	-	8	VC	-	-
10	to	to	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	first	first	I-NP	I-NP	-	14	NMOD	-	-
13	<num>	<num>	I-NP	I-NP	-	14	NMOD	-	-
14	bp	bp	I-NP	I-NP	-	10	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	<num>	<num>	B-NP	B-NP	-	19	NMOD	-	-
17	'	'	I-NP	I-NP	-	19	NMOD	-	-
18	flanking	flanking	I-NP	I-NP	-	19	NMOD	-	-
19	DNA	DNA	I-NP	I-NP	-	15	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	which	which	B-NP	B-NP	-	19	NMOD	-	-
22	contains	contains	B-VP	B-VP	-	21	SBAR	-	-
23	nine	nine	B-NP	B-NP	-	25	NMOD	-	-
24	binding	binding	I-NP	I-NP	-	25	NMOD	-	-
25	sites	sites	I-NP	I-NP	-	22	OBJ	-	-
26	for	for	B-PP	B-PP	-	25	NMOD	-	-
27	a	a	B-NP	B-NP	-	29	NMOD	-	-
28	nuclear	nuclear	I-NP	I-NP	-	29	NMOD	-	-
29	factor	factor	I-NP	I-NP	-	26	PMOD	-	-
30	present	present	B-ADJP	B-ADJP	-	29	NMOD	-	-
31	in	in	B-PP	B-PP	-	30	AMOD	-	-
32	non-erythroid	non-erythroid	B-NP	B-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	31	PMOD	-	-
34	but	but	B-PP	B-PP	-	31	PMOD	-	-
35	not	not	B-PP	B-PP	-	36	PMOD	-	-
36	in	in	I-PP	I-PP	-	31	PMOD	-	-
37	erythroid	erythroid	B-NP	B-NP	-	38	NMOD	-	-
38	cells	cells	I-NP	I-NP	-	36	PMOD	-	-
39	.	.	O	O	-	7	P	-	-

1	These	These	B-NP	B-NP	-	3	NMOD	-	-
2	binding	binding	I-NP	I-NP	-	3	NMOD	-	-
3	sites	sites	I-NP	I-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	14	VMOD	-	-
5	similar	similar	B-NP	B-NP	-	6	NMOD	-	-
6	sequences	sequences	I-NP	I-NP	-	9	NMOD	-	-
7	and	and	O	O	-	9	NMOD	-	-
8	multiple	multiple	B-NP	B-NP	-	9	NMOD	-	-
9	copies	copies	I-NP	I-NP	-	14	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	binding	binding	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	10	PMOD	-	-
14	confer	confer	B-VP	B-VP	-	0	ROOT	-	-
15	tissue-specific	tissue-specific	B-NP	B-NP	-	16	NMOD	-	-
16	down-regulation	down-regulation	I-NP	I-NP	-	14	OBJ	-	-
17	when	when	B-ADVP	B-ADVP	-	14	VMOD	-	-
18	attached	attached	B-VP	B-VP	-	17	SBAR	-	-
19	to	to	B-PP	B-PP	-	18	VMOD	-	-
20	a	a	B-NP	B-NP	-	24	NMOD	-	-
21	minimal	minimal	I-NP	I-NP	-	24	NMOD	-	-
22	lox	lox	I-NP	I-NP	-	24	NMOD	-	-
23	promoter	promoter	I-NP	I-NP	-	24	NMOD	-	-
24	fragment	fragment	I-NP	I-NP	-	19	PMOD	-	-
25	.	.	O	O	-	14	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	<num>	<num>	I-NP	I-NP	-	5	NMOD	-	-
3	'	'	I-NP	I-NP	-	5	NMOD	-	-
4	flanking	flanking	I-NP	I-NP	-	5	NMOD	-	-
5	DNA	DNA	I-NP	I-NP	-	7	SUB	-	-
6	also	also	B-ADVP	B-ADVP	-	7	VMOD	-	-
7	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
8	a	a	B-NP	B-NP	-	9	NMOD	-	-
9	cluster	cluster	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	three	three	B-NP	B-NP	-	13	NMOD	-	-
12	binding	binding	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	10	PMOD	-	-
14	for	for	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	GATA	GATA	I-NP	I-NP	-	17	NMOD	-	-
17	family	family	I-NP	I-NP	-	14	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	transcription	transcription	B-NP	B-NP	-	20	NMOD	-	-
20	factors	factors	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	7	P	-	-

1	Coexpression	Coexpression	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
4	B/Rel	B/Rel	I-NP	I-NP	-	6	NMOD	-	-
5	and	and	O	O	-	6	NMOD	-	-
6	Sp1	Sp1	B-NP	B-NP	-	8	NMOD	-	-
7	transcription	transcription	B-NP	B-NP	-	8	NMOD	-	-
8	factors	factors	I-NP	I-NP	-	2	PMOD	-	-
9	in	in	B-PP	B-PP	-	1	NMOD	-	-
10	human	human	B-NP	B-NP	-	12	NMOD	-	-
11	immunodeficiency	immunodeficiency	I-NP	I-NP	-	12	NMOD	-	-
12	virus	virus	I-NP	I-NP	-	17	NMOD	-	-
13	1-induced	1-induced	B-NP	B-NP	-	17	NMOD	-	-
14	,	,	I-NP	I-NP	-	17	P	-	-
15	dendritic	dendritic	I-NP	I-NP	-	17	NMOD	-	-
16	cell-T-cell	cell-T-cell	I-NP	I-NP	-	17	NMOD	-	-
17	syncytia	syncytia	I-NP	I-NP	-	9	PMOD	-	-
18	.	.	O	O	-	1	P	-	-

1	Productive	Productive	B-NP	B-NP	-	2	NMOD	-	-
2	infection	infection	I-NP	I-NP	-	15	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	T	T	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
6	with	with	B-PP	B-PP	-	2	NMOD	-	-
7	human	human	B-NP	B-NP	-	9	NMOD	-	-
8	immunodeficiency	immunodeficiency	I-NP	I-NP	-	9	NMOD	-	-
9	virus	virus	I-NP	I-NP	-	6	PMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	9	NMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	HIV-1	HIV-1	B-NP	B-NP	-	9	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	typically	typically	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	requires	requires	B-VP	B-VP	-	0	ROOT	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	T	T	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	20	SUB	-	-
20	be	be	B-VP	B-VP	-	16	SBAR	-	-
21	stimulated	stimulated	I-VP	I-VP	-	20	VC	-	-
22	with	with	B-PP	B-PP	-	21	VMOD	-	-
23	antigens	antigens	B-NP	B-NP	-	25	NMOD	-	-
24	or	or	I-NP	I-NP	-	25	NMOD	-	-
25	mitogens	mitogens	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	15	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	requirement	requirement	I-NP	I-NP	-	3	SUB	-	-
3	has	has	B-VP	B-VP	-	0	ROOT	-	-
4	been	been	I-VP	I-VP	-	3	VC	-	-
5	attributed	attributed	I-VP	I-VP	-	4	VC	-	-
6	to	to	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	transcription	transcription	I-NP	I-NP	-	14	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	14	NMOD	-	-
13	NF-kappa	NF-kappa	I-NP	I-NP	-	14	NMOD	-	-
14	B	B	I-NP	I-NP	-	9	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	which	which	B-NP	B-NP	-	14	NMOD	-	-
17	synergizes	synergizes	B-VP	B-VP	-	16	SBAR	-	-
18	with	with	B-PP	B-PP	-	17	VMOD	-	-
19	the	the	B-NP	B-NP	-	23	NMOD	-	-
20	constitutive	constitutive	I-NP	I-NP	-	22	NMOD	-	-
21	transcription	transcription	I-NP	I-NP	-	22	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	23	NMOD	-	-
23	Sp1	Sp1	I-NP	I-NP	-	18	PMOD	-	-
24	to	to	B-VP	B-VP	-	25	VMOD	-	-
25	drive	drive	I-VP	I-VP	-	17	VMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	HIV-1	HIV-1	I-NP	I-NP	-	28	NMOD	-	-
28	promoter	promoter	I-NP	I-NP	-	25	OBJ	-	-
29	.	.	O	O	-	3	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	found	found	I-VP	I-VP	-	4	VC	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	vigorous	vigorous	B-NP	B-NP	-	8	NMOD	-	-
8	replication	replication	I-NP	I-NP	-	11	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	HIV-1	HIV-1	B-NP	B-NP	-	9	PMOD	-	-
11	takes	takes	B-VP	B-VP	-	6	SBAR	-	-
12	place	place	B-NP	B-NP	-	11	OBJ	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	nonactivated	nonactivated	B-NP	B-NP	-	17	NMOD	-	-
15	memory	memory	I-NP	I-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
18	after	after	B-PP	B-PP	-	11	VMOD	-	-
19	syncytium	syncytium	B-NP	B-NP	-	20	NMOD	-	-
20	formation	formation	I-NP	I-NP	-	18	PMOD	-	-
21	with	with	B-PP	B-PP	-	20	NMOD	-	-
22	dendritic	dendritic	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
24	(	(	O	O	-	25	P	-	-
25	DCs	DCs	B-NP	B-NP	-	23	NMOD	-	-
26	)	)	O	O	-	25	P	-	-
27	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	3	NMOD	-	-
2	syncytia	syncytia	I-NP	I-NP	-	3	NMOD	-	-
3	lack	lack	I-NP	I-NP	-	0	ROOT	-	-
4	activated	activated	B-VP	B-VP	-	3	NMOD	-	-
5	cells	cells	B-NP	B-NP	-	4	OBJ	-	-
6	as	as	B-SBAR	B-SBAR	-	4	VMOD	-	-
7	determined	determined	B-VP	B-VP	-	6	SBAR	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	an	an	B-NP	B-NP	-	10	NMOD	-	-
10	absence	absence	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	staining	staining	B-NP	B-NP	-	11	PMOD	-	-
13	for	for	B-PP	B-PP	-	12	NMOD	-	-
14	Ki-67	Ki-67	B-NP	B-NP	-	17	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	17	NMOD	-	-
16	cycle	cycle	I-NP	I-NP	-	17	NMOD	-	-
17	antigen	antigen	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	4	NMOD	-	-
3	and	and	O	O	-	4	NMOD	-	-
4	activity	activity	B-NP	B-NP	-	10	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	7	NMOD	-	-
7	B	B	I-NP	I-NP	-	9	NMOD	-	-
8	and	and	O	O	-	9	NMOD	-	-
9	Sp1	Sp1	B-NP	B-NP	-	5	PMOD	-	-
10	were	were	B-VP	B-VP	-	0	ROOT	-	-
11	,	,	O	O	-	10	P	-	-
12	therefore	therefore	B-ADVP	B-ADVP	-	10	VMOD	-	-
13	,	,	O	O	-	10	P	-	-
14	analyzed	analyzed	B-VP	B-VP	-	10	VMOD	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	isolated	isolated	B-NP	B-NP	-	18	NMOD	-	-
17	T	T	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	20	NMOD	-	-
19	and	and	O	O	-	20	NMOD	-	-
20	DCs	DCs	B-NP	B-NP	-	15	PMOD	-	-
21	from	from	B-PP	B-PP	-	20	NMOD	-	-
22	humans	humans	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	mice	mice	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	used	used	I-VP	I-VP	-	2	VC	-	-
4	immunolabeling	immunolabeling	B-NP	B-NP	-	16	NMOD	-	-
5	,	,	O	O	-	16	P	-	-
6	Western	Western	B-NP	B-NP	-	8	NMOD	-	-
7	blot	blot	I-NP	I-NP	-	8	NMOD	-	-
8	analysis	analysis	I-NP	I-NP	-	16	NMOD	-	-
9	,	,	O	O	-	16	P	-	-
10	and	and	O	O	-	16	NMOD	-	-
11	electrophoretic	electrophoretic	B-NP	B-NP	-	13	NMOD	-	-
12	mobility	mobility	I-NP	I-NP	-	13	NMOD	-	-
13	shift	shift	I-NP	I-NP	-	16	NMOD	-	-
14	and	and	I-NP	I-NP	-	16	NMOD	-	-
15	supershift	supershift	I-NP	I-NP	-	16	NMOD	-	-
16	assays	assays	I-NP	I-NP	-	3	OBJ	-	-
17	.	.	O	O	-	2	P	-	-

1	T	T	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	3	SUB	-	-
3	lack	lack	B-VP	B-VP	-	0	ROOT	-	-
4	active	active	B-NP	B-NP	-	6	NMOD	-	-
5	NF-kappa	NF-kappa	I-NP	I-NP	-	6	NMOD	-	-
6	B	B	I-NP	I-NP	-	3	OBJ	-	-
7	but	but	O	O	-	3	VMOD	-	-
8	express	express	B-VP	B-VP	-	3	VMOD	-	-
9	Sp1	Sp1	B-NP	B-NP	-	8	OBJ	-	-
10	as	as	B-SBAR	B-SBAR	-	3	VMOD	-	-
11	expected	expected	B-VP	B-VP	-	10	SBAR	-	-
12	.	.	O	O	-	3	P	-	-

1	DCs	DCs	B-NP	B-NP	-	2	SUB	-	-
2	express	express	B-VP	B-VP	-	0	ROOT	-	-
3	high	high	B-NP	B-NP	-	4	NMOD	-	-
4	levels	levels	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	all	all	B-NP	B-NP	-	12	NMOD	-	-
7	known	known	I-NP	I-NP	-	12	NMOD	-	-
8	NF-kappa	NF-kappa	I-NP	I-NP	-	12	NMOD	-	-
9	B	B	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	I-NP	I-NP	-	12	NMOD	-	-
11	Rel	Rel	I-NP	I-NP	-	12	NMOD	-	-
12	proteins	proteins	I-NP	I-NP	-	5	PMOD	-	-
13	,	,	O	O	-	2	P	-	-
14	with	with	B-PP	B-PP	-	2	VMOD	-	-
15	activity	activity	B-NP	B-NP	-	14	PMOD	-	-
16	residing	residing	B-VP	B-VP	-	15	NMOD	-	-
17	primarily	primarily	B-ADVP	B-ADVP	-	16	VMOD	-	-
18	within	within	B-PP	B-PP	-	16	VMOD	-	-
19	RelB	RelB	B-NP	B-NP	-	24	NMOD	-	-
20	,	,	O	O	-	24	P	-	-
21	p50	p50	B-NP	B-NP	-	24	NMOD	-	-
22	,	,	O	O	-	24	P	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	p65	p65	B-NP	B-NP	-	18	PMOD	-	-
25	.	.	O	O	-	2	P	-	-

1	However	However	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	DCs	DCs	B-NP	B-NP	-	4	SUB	-	-
4	lack	lack	B-VP	B-VP	-	0	ROOT	-	-
5	Sp1	Sp1	B-NP	B-NP	-	4	OBJ	-	-
6	,	,	O	O	-	5	P	-	-
7	which	which	B-NP	B-NP	-	5	NMOD	-	-
8	may	may	B-VP	B-VP	-	7	SBAR	-	-
9	explain	explain	I-VP	I-VP	-	8	VC	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	failure	failure	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	HIV-1	HIV-1	B-NP	B-NP	-	12	PMOD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	replicate	replicate	I-VP	I-VP	-	11	NMOD	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	purified	purified	B-NP	B-NP	-	18	NMOD	-	-
18	DCs	DCs	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	4	P	-	-

1	Coexpression	Coexpression	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
4	B	B	I-NP	I-NP	-	6	NMOD	-	-
5	and	and	O	O	-	6	NMOD	-	-
6	Sp1	Sp1	B-NP	B-NP	-	2	PMOD	-	-
7	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	heterologous	heterologous	I-NP	I-NP	-	12	NMOD	-	-
11	DC-T-cell	DC-T-cell	I-NP	I-NP	-	12	NMOD	-	-
12	syncytia	syncytia	I-NP	I-NP	-	8	PMOD	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	are	are	B-VP	B-VP	-	13	SBAR	-	-
15	induced	induced	I-VP	I-VP	-	14	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	HIV-1	HIV-1	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	7	P	-	-

1	Therefore	Therefore	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	HIV-1-induced	HIV-1-induced	B-NP	B-NP	-	5	NMOD	-	-
4	cell	cell	I-NP	I-NP	-	5	NMOD	-	-
5	fusion	fusion	I-NP	I-NP	-	6	SUB	-	-
6	brings	brings	B-VP	B-VP	-	0	ROOT	-	-
7	together	together	B-ADVP	B-ADVP	-	6	VMOD	-	-
8	factors	factors	B-NP	B-NP	-	6	OBJ	-	-
9	that	that	B-NP	B-NP	-	8	NMOD	-	-
10	upregulate	upregulate	B-VP	B-VP	-	9	SBAR	-	-
11	virus	virus	B-NP	B-NP	-	12	NMOD	-	-
12	transcription	transcription	I-NP	I-NP	-	10	OBJ	-	-
13	.	.	O	O	-	6	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	17	VMOD	-	-
2	DCs	DCs	B-NP	B-NP	-	6	NMOD	-	-
3	and	and	O	O	-	6	NMOD	-	-
4	memory	memory	B-NP	B-NP	-	6	NMOD	-	-
5	T	T	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	8	SUB	-	-
7	frequently	frequently	B-ADVP	B-ADVP	-	8	VMOD	-	-
8	traffic	traffic	B-VP	B-VP	-	1	SBAR	-	-
9	together	together	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	in	in	B-ADVP	B-ADVP	-	8	VMOD	-	-
11	situ	situ	I-ADVP	I-ADVP	-	10	AMOD	-	-
12	,	,	O	O	-	17	P	-	-
13	these	these	B-NP	B-NP	-	16	NMOD	-	-
14	unusual	unusual	I-NP	I-NP	-	16	NMOD	-	-
15	heterologous	heterologous	I-NP	I-NP	-	16	NMOD	-	-
16	syncytia	syncytia	I-NP	I-NP	-	17	SUB	-	-
17	could	could	B-VP	B-VP	-	0	ROOT	-	-
18	develop	develop	I-VP	I-VP	-	17	VC	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	infected	infected	B-NP	B-NP	-	21	NMOD	-	-
21	individuals	individuals	I-NP	I-NP	-	19	PMOD	-	-
22	and	and	O	O	-	18	VMOD	-	-
23	lead	lead	B-VP	B-VP	-	18	VMOD	-	-
24	to	to	B-PP	B-PP	-	23	VMOD	-	-
25	chronic	chronic	B-NP	B-NP	-	27	NMOD	-	-
26	HIV-1	HIV-1	I-NP	I-NP	-	27	NMOD	-	-
27	replication	replication	I-NP	I-NP	-	24	PMOD	-	-
28	without	without	B-PP	B-PP	-	27	NMOD	-	-
29	ostensible	ostensible	B-NP	B-NP	-	31	NMOD	-	-
30	immune	immune	I-NP	I-NP	-	31	NMOD	-	-
31	stimulation	stimulation	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	17	P	-	-

1	Costimulation	Costimulation	B-NP	B-NP	-	2	NMOD	-	-
2	requirement	requirement	I-NP	I-NP	-	0	ROOT	-	-
3	for	for	B-PP	B-PP	-	2	NMOD	-	-
4	AP-1	AP-1	B-NP	B-NP	-	10	NMOD	-	-
5	and	and	O	O	-	10	NMOD	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	10	NMOD	-	-
7	B	B	I-NP	I-NP	-	10	NMOD	-	-
8	transcription	transcription	I-NP	I-NP	-	10	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	3	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	T	T	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	transcriptional	transcriptional	I-NP	I-NP	-	3	NMOD	-	-
3	activity	activity	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	IL-2	IL-2	I-NP	I-NP	-	7	NMOD	-	-
7	promoter	promoter	I-NP	I-NP	-	4	PMOD	-	-
8	requires	requires	B-VP	B-VP	-	0	ROOT	-	-
9	T-cell	T-cell	B-NP	B-NP	-	10	NMOD	-	-
10	costimulation	costimulation	I-NP	I-NP	-	8	OBJ	-	-
11	delivered	delivered	B-VP	B-VP	-	10	NMOD	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	TCR	TCR	I-NP	I-NP	-	19	NMOD	-	-
15	and	and	O	O	-	19	NMOD	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	auxiliary	auxiliary	I-NP	I-NP	-	19	NMOD	-	-
18	receptor	receptor	I-NP	I-NP	-	19	NMOD	-	-
19	CD28	CD28	I-NP	I-NP	-	12	PMOD	-	-
20	.	.	O	O	-	8	P	-	-

1	Several	Several	B-NP	B-NP	-	3	NMOD	-	-
2	transcription	transcription	I-NP	I-NP	-	3	NMOD	-	-
3	factors	factors	I-NP	I-NP	-	4	SUB	-	-
4	participate	participate	B-VP	B-VP	-	0	ROOT	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	IL-2	IL-2	B-NP	B-NP	-	7	NMOD	-	-
7	promoter	promoter	I-NP	I-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	5	PMOD	-	-
9	,	,	O	O	-	4	P	-	-
10	among	among	B-PP	B-PP	-	4	VMOD	-	-
11	which	which	B-NP	B-NP	-	10	PMOD	-	-
12	are	are	B-VP	B-VP	-	10	SBAR	-	-
13	AP-1-like	AP-1-like	B-NP	B-NP	-	14	NMOD	-	-
14	factors	factors	I-NP	I-NP	-	17	NMOD	-	-
15	and	and	O	O	-	17	NMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	17	NMOD	-	-
17	B	B	I-NP	I-NP	-	12	PRD	-	-
18	.	.	O	O	-	4	P	-	-

1	Protein	Protein	B-NP	B-NP	-	2	NMOD	-	-
2	phosphorylation	phosphorylation	I-NP	I-NP	-	3	SUB	-	-
3	has	has	B-VP	B-VP	-	34	VMOD	-	-
4	an	an	B-NP	B-NP	-	6	NMOD	-	-
5	important	important	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	in	in	B-PP	B-PP	-	3	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	regulation	regulation	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	these	these	B-NP	B-NP	-	13	NMOD	-	-
12	two	two	I-NP	I-NP	-	13	NMOD	-	-
13	factors	factors	I-NP	I-NP	-	10	PMOD	-	-
14	:	:	O	O	-	3	P	-	-
15	(	(	B-LST	B-LST	-	16	P	-	-
16	<num>	<num>	I-LST	I-LST	-	19	VMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	it	it	B-NP	B-NP	-	19	SUB	-	-
19	induces	induces	B-VP	B-VP	-	34	VMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	transactivating	transactivating	I-NP	I-NP	-	22	NMOD	-	-
22	capacity	capacity	I-NP	I-NP	-	19	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	27	NMOD	-	-
25	AP-1	AP-1	I-NP	I-NP	-	27	NMOD	-	-
26	protein	protein	I-NP	I-NP	-	27	NMOD	-	-
27	c-Jun	c-Jun	I-NP	I-NP	-	23	PMOD	-	-
28	;	;	O	O	-	34	P	-	-
29	and	and	O	O	-	34	VMOD	-	-
30	(	(	B-LST	B-LST	-	31	P	-	-
31	<num>	<num>	I-LST	I-LST	-	34	VMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	it	it	B-NP	B-NP	-	34	SUB	-	-
34	is	is	B-VP	B-VP	-	0	ROOT	-	-
35	involved	involved	I-VP	I-VP	-	34	VC	-	-
36	in	in	B-PP	B-PP	-	35	VMOD	-	-
37	the	the	B-NP	B-NP	-	38	NMOD	-	-
38	release	release	I-NP	I-NP	-	36	PMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	the	the	B-NP	B-NP	-	42	NMOD	-	-
41	cytoplasmic	cytoplasmic	I-NP	I-NP	-	42	NMOD	-	-
42	inhibitor	inhibitor	I-NP	I-NP	-	46	NMOD	-	-
43	,	,	O	O	-	46	P	-	-
44	I	I	B-NP	B-NP	-	46	NMOD	-	-
45	kappa	kappa	I-NP	I-NP	-	46	NMOD	-	-
46	B	B	I-NP	I-NP	-	39	PMOD	-	-
47	,	,	O	O	-	35	P	-	-
48	from	from	B-PP	B-PP	-	35	VMOD	-	-
49	NF-kappa	NF-kappa	B-NP	B-NP	-	50	NMOD	-	-
50	B	B	I-NP	I-NP	-	48	PMOD	-	-
51	,	,	O	O	-	34	P	-	-
52	allowing	allowing	B-VP	B-VP	-	34	VMOD	-	-
53	translocation	translocation	B-NP	B-NP	-	52	OBJ	-	-
54	of	of	B-PP	B-PP	-	53	NMOD	-	-
55	the	the	B-NP	B-NP	-	56	NMOD	-	-
56	latter	latter	I-NP	I-NP	-	54	PMOD	-	-
57	into	into	B-PP	B-PP	-	53	NMOD	-	-
58	the	the	B-NP	B-NP	-	59	NMOD	-	-
59	nucleus	nucleus	I-NP	I-NP	-	57	PMOD	-	-
60	.	.	O	O	-	34	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	recently	recently	I-VP	I-VP	-	2	VMOD	-	-
4	shown	shown	I-VP	I-VP	-	2	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	both	both	O	O	-	8	NMOD	-	-
7	phosphorylation	phosphorylation	B-NP	B-NP	-	8	NMOD	-	-
8	processes	processes	I-NP	I-NP	-	9	SUB	-	-
9	require	require	B-VP	B-VP	-	5	SBAR	-	-
10	T-cell	T-cell	B-NP	B-NP	-	11	NMOD	-	-
11	costimulation	costimulation	I-NP	I-NP	-	9	OBJ	-	-
12	.	.	O	O	-	2	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	15	VMOD	-	-
2	,	,	O	O	-	15	P	-	-
3	in	in	B-PP	B-PP	-	15	VMOD	-	-
4	activated	activated	B-NP	B-NP	-	6	NMOD	-	-
5	T	T	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
7	,	,	O	O	-	15	P	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	kinetics	kinetics	I-NP	I-NP	-	15	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	two	two	I-NP	I-NP	-	14	NMOD	-	-
13	phosphorylation	phosphorylation	I-NP	I-NP	-	14	NMOD	-	-
14	events	events	I-NP	I-NP	-	10	PMOD	-	-
15	are	are	B-VP	B-VP	-	0	ROOT	-	-
16	essentially	essentially	B-ADJP	B-ADJP	-	17	AMOD	-	-
17	similar	similar	I-ADJP	I-ADJP	-	15	PRD	-	-
18	.	.	O	O	-	15	P	-	-

1	According	According	B-PP	B-PP	-	15	VMOD	-	-
2	to	to	B-PP	B-PP	-	1	VMOD	-	-
3	our	our	B-NP	B-NP	-	4	NMOD	-	-
4	results	results	I-NP	I-NP	-	2	PMOD	-	-
5	,	,	O	O	-	15	P	-	-
6	however	however	B-ADVP	B-ADVP	-	15	VMOD	-	-
7	,	,	O	O	-	15	P	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	kinases	kinases	I-NP	I-NP	-	15	SUB	-	-
10	responsible	responsible	B-ADJP	B-ADJP	-	9	NMOD	-	-
11	for	for	B-PP	B-PP	-	10	AMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	two	two	I-NP	I-NP	-	14	NMOD	-	-
14	processes	processes	I-NP	I-NP	-	11	PMOD	-	-
15	are	are	B-VP	B-VP	-	0	ROOT	-	-
16	distinct	distinct	B-NP	B-NP	-	17	NMOD	-	-
17	entities	entities	I-NP	I-NP	-	15	PRD	-	-
18	.	.	O	O	-	15	P	-	-

1	Whereas	Whereas	B-SBAR	B-SBAR	-	20	VMOD	-	-
2	TPCK	TPCK	B-NP	B-NP	-	3	SUB	-	-
3	inhibits	inhibits	B-VP	B-VP	-	1	SBAR	-	-
4	phosphorylation	phosphorylation	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	I	I	B-NP	B-NP	-	8	NMOD	-	-
7	kappa	kappa	I-NP	I-NP	-	8	NMOD	-	-
8	B	B	I-NP	I-NP	-	5	PMOD	-	-
9	and	and	O	O	-	3	VMOD	-	-
10	,	,	O	O	-	3	P	-	-
11	consequently	consequently	B-ADVP	B-ADVP	-	20	VMOD	-	-
12	,	,	O	O	-	20	P	-	-
13	activation	activation	B-NP	B-NP	-	20	SUB	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	NF-kappa	NF-kappa	B-NP	B-NP	-	16	NMOD	-	-
16	B	B	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	20	P	-	-
18	it	it	B-NP	B-NP	-	20	SUB	-	-
19	markedly	markedly	B-ADVP	B-ADVP	-	20	VMOD	-	-
20	enhances	enhances	B-VP	B-VP	-	0	ROOT	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	activity	activity	I-NP	I-NP	-	20	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	JNK	JNK	B-NP	B-NP	-	29	NMOD	-	-
25	,	,	O	O	-	29	P	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	MAP	MAP	I-NP	I-NP	-	29	NMOD	-	-
28	kinase-related	kinase-related	I-NP	I-NP	-	29	NMOD	-	-
29	kinase	kinase	I-NP	I-NP	-	23	PMOD	-	-
30	that	that	B-NP	B-NP	-	29	NMOD	-	-
31	phosphorylates	phosphorylates	B-VP	B-VP	-	30	SBAR	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	transactivation	transactivation	I-NP	I-NP	-	34	NMOD	-	-
34	domain	domain	I-NP	I-NP	-	31	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	c-Jun	c-Jun	B-NP	B-NP	-	35	PMOD	-	-
37	.	.	O	O	-	20	P	-	-

1	We	We	B-NP	B-NP	-	5	SUB	-	-
2	,	,	O	O	-	5	P	-	-
3	therefore	therefore	B-ADVP	B-ADVP	-	5	VMOD	-	-
4	,	,	O	O	-	5	P	-	-
5	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	8	NMOD	-	-
8	scheme	scheme	I-NP	I-NP	-	5	OBJ	-	-
9	presented	presented	B-VP	B-VP	-	8	NMOD	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	FIGURE	FIGURE	B-NP	B-NP	-	10	PMOD	-	-
12	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
13	for	for	B-PP	B-PP	-	11	NMOD	-	-
14	T-cell	T-cell	B-NP	B-NP	-	15	NMOD	-	-
15	costimulation	costimulation	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	5	P	-	-

1	Costimulation	Costimulation	B-NP	B-NP	-	2	SUB	-	-
2	results	results	B-VP	B-VP	-	0	ROOT	-	-
3	in	in	B-PP	B-PP	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	activation	activation	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	signaling	signaling	I-NP	I-NP	-	9	NMOD	-	-
9	pathway	pathway	I-NP	I-NP	-	6	PMOD	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	leads	leads	B-VP	B-VP	-	10	SBAR	-	-
12	to	to	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	simultaneous	simultaneous	I-NP	I-NP	-	15	NMOD	-	-
15	induction	induction	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	two	two	I-NP	I-NP	-	20	NMOD	-	-
19	transcription	transcription	I-NP	I-NP	-	20	NMOD	-	-
20	factors	factors	I-NP	I-NP	-	16	PMOD	-	-
21	,	,	O	O	-	25	P	-	-
22	AP-1	AP-1	B-NP	B-NP	-	25	NMOD	-	-
23	and	and	O	O	-	25	NMOD	-	-
24	NF-kappa	NF-kappa	B-NP	B-NP	-	25	NMOD	-	-
25	B	B	I-NP	I-NP	-	16	PMOD	-	-
26	.	.	O	O	-	2	P	-	-

1	Integration	Integration	B-NP	B-NP	-	11	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	signals	signals	I-NP	I-NP	-	2	PMOD	-	-
5	generated	generated	B-VP	B-VP	-	4	NMOD	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	TCR	TCR	B-NP	B-NP	-	9	NMOD	-	-
8	and	and	I-NP	I-NP	-	9	NMOD	-	-
9	CD28	CD28	I-NP	I-NP	-	10	NMOD	-	-
10	engagement	engagement	I-NP	I-NP	-	6	PMOD	-	-
11	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
12	along	along	B-PP	B-PP	-	11	VMOD	-	-
13	this	this	B-NP	B-NP	-	14	NMOD	-	-
14	pathway	pathway	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	11	P	-	-
16	which	which	B-NP	B-NP	-	11	VMOD	-	-
17	then	then	B-ADVP	B-ADVP	-	18	VMOD	-	-
18	bifurcates	bifurcates	B-VP	B-VP	-	16	SBAR	-	-
19	to	to	I-VP	I-VP	-	20	VMOD	-	-
20	induce	induce	I-VP	I-VP	-	18	VMOD	-	-
21	I	I	B-NP	B-NP	-	24	NMOD	-	-
22	kappa	kappa	I-NP	I-NP	-	24	NMOD	-	-
23	B	B	I-NP	I-NP	-	24	NMOD	-	-
24	phosphorylation	phosphorylation	I-NP	I-NP	-	28	NMOD	-	-
25	and	and	O	O	-	28	NMOD	-	-
26	NF-kappa	NF-kappa	B-NP	B-NP	-	28	NMOD	-	-
27	B	B	I-NP	I-NP	-	28	NMOD	-	-
28	activation	activation	I-NP	I-NP	-	20	OBJ	-	-
29	on	on	B-PP	B-PP	-	28	NMOD	-	-
30	the	the	B-NP	B-NP	-	32	NMOD	-	-
31	one	one	I-NP	I-NP	-	32	NMOD	-	-
32	hand	hand	I-NP	I-NP	-	29	PMOD	-	-
33	,	,	O	O	-	39	P	-	-
34	and	and	O	O	-	39	NMOD	-	-
35	JNK	JNK	B-NP	B-NP	-	36	NMOD	-	-
36	activation	activation	B-NP	B-NP	-	39	NMOD	-	-
37	and	and	O	O	-	39	NMOD	-	-
38	c-Jun	c-Jun	B-NP	B-NP	-	39	NMOD	-	-
39	phosphorylation	phosphorylation	I-NP	I-NP	-	29	PMOD	-	-
40	on	on	B-PP	B-PP	-	29	PMOD	-	-
41	the	the	B-NP	B-NP	-	42	NMOD	-	-
42	other	other	I-NP	I-NP	-	40	PMOD	-	-
43	.	.	O	O	-	11	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	are	are	B-VP	B-VP	-	0	ROOT	-	-
3	currently	currently	I-VP	I-VP	-	2	VMOD	-	-
4	engaged	engaged	I-VP	I-VP	-	2	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	defining	defining	B-VP	B-VP	-	5	PMOD	-	-
7	where	where	B-ADVP	B-ADVP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	two	two	I-NP	I-NP	-	10	NMOD	-	-
10	signals	signals	I-NP	I-NP	-	11	SUB	-	-
11	integrate	integrate	B-VP	B-VP	-	7	SBAR	-	-
12	along	along	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	AP-1/NF-kappa	AP-1/NF-kappa	I-NP	I-NP	-	16	NMOD	-	-
15	B	B	I-NP	I-NP	-	16	NMOD	-	-
16	pathway	pathway	I-NP	I-NP	-	12	PMOD	-	-
17	.	.	O	O	-	2	P	-	-

1	Cupric	Cupric	B-NP	B-NP	-	2	NMOD	-	-
2	ion	ion	I-NP	I-NP	-	3	SUB	-	-
3	blocks	blocks	B-VP	B-VP	-	0	ROOT	-	-
4	NF	NF	B-NP	B-NP	-	6	NMOD	-	-
5	kappa	kappa	I-NP	I-NP	-	6	NMOD	-	-
6	B	B	I-NP	I-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	3	OBJ	-	-
8	through	through	B-PP	B-PP	-	3	VMOD	-	-
9	inhibiting	inhibiting	B-VP	B-VP	-	8	PMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	signal-induced	signal-induced	I-NP	I-NP	-	12	NMOD	-	-
12	phosphorylation	phosphorylation	I-NP	I-NP	-	9	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	I	I	B-NP	B-NP	-	17	NMOD	-	-
15	kappa	kappa	I-NP	I-NP	-	17	NMOD	-	-
16	B	B	I-NP	I-NP	-	17	NMOD	-	-
17	alpha	alpha	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	3	P	-	-

1	A	A	B-NP	B-NP	-	6	NMOD	-	-
2	transcription	transcription	I-NP	I-NP	-	6	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	6	NMOD	-	-
4	NF	NF	I-NP	I-NP	-	6	NMOD	-	-
5	kappa	kappa	I-NP	I-NP	-	6	NMOD	-	-
6	B	B	I-NP	I-NP	-	25	SUB	-	-
7	,	,	O	O	-	6	P	-	-
8	which	which	B-NP	B-NP	-	6	NMOD	-	-
9	regulates	regulates	B-VP	B-VP	-	8	SBAR	-	-
10	expression	expression	B-NP	B-NP	-	9	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	various	various	B-NP	B-NP	-	14	NMOD	-	-
13	cellular	cellular	I-NP	I-NP	-	14	NMOD	-	-
14	genes	genes	I-NP	I-NP	-	11	PMOD	-	-
15	involved	involved	B-VP	B-VP	-	14	NMOD	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	immune	immune	B-NP	B-NP	-	18	NMOD	-	-
18	responses	responses	I-NP	I-NP	-	21	NMOD	-	-
19	and	and	O	O	-	21	NMOD	-	-
20	viral	viral	B-NP	B-NP	-	21	NMOD	-	-
21	genes	genes	I-NP	I-NP	-	16	PMOD	-	-
22	including	including	B-PP	B-PP	-	21	NMOD	-	-
23	HIV	HIV	B-NP	B-NP	-	22	PMOD	-	-
24	,	,	O	O	-	6	P	-	-
25	is	is	B-VP	B-VP	-	0	ROOT	-	-
26	sequestered	sequestered	I-VP	I-VP	-	25	VC	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	cytoplasm	cytoplasm	I-NP	I-NP	-	27	PMOD	-	-
30	as	as	B-PP	B-PP	-	26	VMOD	-	-
31	a	a	B-NP	B-NP	-	32	NMOD	-	-
32	complex	complex	I-NP	I-NP	-	30	PMOD	-	-
33	with	with	B-PP	B-PP	-	32	NMOD	-	-
34	an	an	B-NP	B-NP	-	39	NMOD	-	-
35	inhibitory	inhibitory	I-NP	I-NP	-	39	NMOD	-	-
36	protein	protein	I-NP	I-NP	-	39	NMOD	-	-
37	I	I	I-NP	I-NP	-	39	NMOD	-	-
38	kappa	kappa	I-NP	I-NP	-	39	NMOD	-	-
39	B	B	I-NP	I-NP	-	33	PMOD	-	-
40	.	.	O	O	-	25	P	-	-

1	Various	Various	B-NP	B-NP	-	3	NMOD	-	-
2	extracellular	extracellular	I-NP	I-NP	-	3	NMOD	-	-
3	signals	signals	I-NP	I-NP	-	4	SUB	-	-
4	induce	induce	B-VP	B-VP	-	0	ROOT	-	-
5	phosphorylation	phosphorylation	B-NP	B-NP	-	8	NMOD	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	rapid	rapid	B-NP	B-NP	-	8	NMOD	-	-
8	degradation	degradation	I-NP	I-NP	-	4	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	I	I	B-NP	B-NP	-	13	NMOD	-	-
11	kappa	kappa	I-NP	I-NP	-	13	NMOD	-	-
12	B	B	I-NP	I-NP	-	13	NMOD	-	-
13	alpha	alpha	I-NP	I-NP	-	9	PMOD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	release	release	I-VP	I-VP	-	4	VMOD	-	-
16	NF	NF	B-NP	B-NP	-	18	NMOD	-	-
17	kappa	kappa	I-NP	I-NP	-	18	NMOD	-	-
18	B	B	I-NP	I-NP	-	15	OBJ	-	-
19	.	.	O	O	-	4	P	-	-

1	Cu2+	Cu2+	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	found	found	I-VP	I-VP	-	2	VC	-	-
4	to	to	I-VP	I-VP	-	5	VMOD	-	-
5	inhibit	inhibit	I-VP	I-VP	-	3	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	NF	NF	B-NP	B-NP	-	11	NMOD	-	-
10	kappa	kappa	I-NP	I-NP	-	11	NMOD	-	-
11	B	B	I-NP	I-NP	-	8	PMOD	-	-
12	induced	induced	B-VP	B-VP	-	11	NMOD	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	TNF-alpha	TNF-alpha	B-NP	B-NP	-	19	NMOD	-	-
15	,	,	O	O	-	19	P	-	-
16	TPA	TPA	B-NP	B-NP	-	19	NMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	or	or	O	O	-	19	NMOD	-	-
19	H2O2	H2O2	B-NP	B-NP	-	13	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	Deoxycholate	Deoxycholate	B-NP	B-NP	-	2	NMOD	-	-
2	treatment	treatment	I-NP	I-NP	-	18	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	cytoplasmic	cytoplasmic	I-NP	I-NP	-	6	NMOD	-	-
6	extract	extract	I-NP	I-NP	-	3	PMOD	-	-
7	prepared	prepared	B-VP	B-VP	-	6	NMOD	-	-
8	from	from	B-PP	B-PP	-	7	VMOD	-	-
9	cells	cells	B-NP	B-NP	-	8	PMOD	-	-
10	stimulated	stimulated	B-VP	B-VP	-	9	NMOD	-	-
11	by	by	B-PP	B-PP	-	10	VMOD	-	-
12	TNF-alpha	TNF-alpha	B-NP	B-NP	-	11	PMOD	-	-
13	in	in	B-PP	B-PP	-	10	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	presence	presence	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	Cu2+	Cu2+	B-NP	B-NP	-	16	PMOD	-	-
18	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	release	release	I-NP	I-NP	-	19	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	NF	NF	B-NP	B-NP	-	25	NMOD	-	-
24	kappa	kappa	I-NP	I-NP	-	25	NMOD	-	-
25	B	B	I-NP	I-NP	-	22	PMOD	-	-
26	from	from	B-PP	B-PP	-	21	NMOD	-	-
27	I	I	B-NP	B-NP	-	30	NMOD	-	-
28	kappa	kappa	I-NP	I-NP	-	30	NMOD	-	-
29	B	B	I-NP	I-NP	-	30	NMOD	-	-
30	alpha	alpha	I-NP	I-NP	-	26	PMOD	-	-
31	,	,	O	O	-	18	P	-	-
32	indicating	indicating	B-VP	B-VP	-	18	VMOD	-	-
33	that	that	B-SBAR	B-SBAR	-	32	VMOD	-	-
34	Cu2+	Cu2+	B-NP	B-NP	-	35	SUB	-	-
35	interferes	interferes	B-VP	B-VP	-	33	SBAR	-	-
36	with	with	B-PP	B-PP	-	35	VMOD	-	-
37	the	the	B-NP	B-NP	-	38	NMOD	-	-
38	dissociation	dissociation	I-NP	I-NP	-	36	PMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	the	the	B-NP	B-NP	-	46	NMOD	-	-
41	NF	NF	I-NP	I-NP	-	46	NMOD	-	-
42	kappa	kappa	I-NP	I-NP	-	46	NMOD	-	-
43	B-I	B-I	I-NP	I-NP	-	46	NMOD	-	-
44	kappa	kappa	I-NP	I-NP	-	46	NMOD	-	-
45	B	B	I-NP	I-NP	-	46	NMOD	-	-
46	complex	complex	I-NP	I-NP	-	39	PMOD	-	-
47	.	.	O	O	-	18	P	-	-

1	Neither	Neither	O	O	-	4	NMOD	-	-
2	phosphorylation	phosphorylation	B-NP	B-NP	-	4	NMOD	-	-
3	nor	nor	I-NP	I-NP	-	4	NMOD	-	-
4	degradation	degradation	I-NP	I-NP	-	10	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	I	I	B-NP	B-NP	-	9	NMOD	-	-
7	kappa	kappa	I-NP	I-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	5	PMOD	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	observed	observed	I-VP	I-VP	-	10	VC	-	-
12	upon	upon	B-PP	B-PP	-	11	VMOD	-	-
13	TNF-alpha	TNF-alpha	B-NP	B-NP	-	14	NMOD	-	-
14	stimulation	stimulation	I-NP	I-NP	-	12	PMOD	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	I-PP	I-PP	-	17	NMOD	-	-
17	presence	presence	I-PP	I-PP	-	15	PMOD	-	-
18	of	of	I-PP	I-PP	-	14	NMOD	-	-
19	Cu2+	Cu2+	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	Cu2+	Cu2+	B-NP	B-NP	-	6	SUB	-	-
6	inhibits	inhibits	B-VP	B-VP	-	4	SBAR	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	release	release	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF	NF	B-NP	B-NP	-	12	NMOD	-	-
11	kappa	kappa	I-NP	I-NP	-	12	NMOD	-	-
12	B	B	I-NP	I-NP	-	9	PMOD	-	-
13	by	by	B-PP	B-PP	-	8	NMOD	-	-
14	blockade	blockade	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	a	a	B-NP	B-NP	-	17	NMOD	-	-
17	signal	signal	I-NP	I-NP	-	15	PMOD	-	-
18	leading	leading	B-VP	B-VP	-	17	NMOD	-	-
19	to	to	B-PP	B-PP	-	18	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	phosphorylation	phosphorylation	I-NP	I-NP	-	19	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	I	I	B-NP	B-NP	-	26	NMOD	-	-
24	kappa	kappa	I-NP	I-NP	-	26	NMOD	-	-
25	B	B	I-NP	I-NP	-	26	NMOD	-	-
26	alpha	alpha	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	Salicylates	Salicylates	B-NP	B-NP	-	2	SUB	-	-
2	inhibit	inhibit	B-VP	B-VP	-	0	ROOT	-	-
3	lipopolysaccharide-induced	lipopolysaccharide-induced	B-NP	B-NP	-	5	NMOD	-	-
4	transcriptional	transcriptional	I-NP	I-NP	-	5	NMOD	-	-
5	activation	activation	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	tissue	tissue	I-NP	I-NP	-	10	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	6	PMOD	-	-
11	in	in	B-PP	B-PP	-	5	NMOD	-	-
12	human	human	B-NP	B-NP	-	14	NMOD	-	-
13	monocytic	monocytic	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	Binding	Binding	B-NP	B-NP	-	14	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	plasma	plasma	B-NP	B-NP	-	5	NMOD	-	-
4	Factor	Factor	I-NP	I-NP	-	5	NMOD	-	-
5	VII/VIIa	VII/VIIa	I-NP	I-NP	-	2	PMOD	-	-
6	to	to	B-PP	B-PP	-	1	NMOD	-	-
7	the	the	B-NP	B-NP	-	13	NMOD	-	-
8	tissue	tissue	I-NP	I-NP	-	13	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	13	NMOD	-	-
10	(	(	O	O	-	13	P	-	-
11	TF	TF	B-NP	B-NP	-	13	NMOD	-	-
12	)	)	O	O	-	13	P	-	-
13	receptor	receptor	B-NP	B-NP	-	6	PMOD	-	-
14	initiates	initiates	B-VP	B-VP	-	0	ROOT	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	coagulation	coagulation	I-NP	I-NP	-	18	NMOD	-	-
17	protease	protease	I-NP	I-NP	-	18	NMOD	-	-
18	cascades	cascades	I-NP	I-NP	-	14	OBJ	-	-
19	.	.	O	O	-	14	P	-	-

1	TF	TF	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	6	SUB	-	-
3	by	by	B-PP	B-PP	-	2	NMOD	-	-
4	circulating	circulating	B-VP	B-VP	-	3	PMOD	-	-
5	monocytes	monocytes	B-NP	B-NP	-	4	OBJ	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	associated	associated	I-VP	I-VP	-	6	VC	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	thrombotic	thrombotic	B-NP	B-NP	-	12	NMOD	-	-
10	and	and	I-NP	I-NP	-	12	NMOD	-	-
11	inflammatory	inflammatory	I-NP	I-NP	-	12	NMOD	-	-
12	complications	complications	I-NP	I-NP	-	8	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	a	a	B-NP	B-NP	-	15	NMOD	-	-
15	variety	variety	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	diseases	diseases	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	Transcriptional	Transcriptional	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	18	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	human	human	I-NP	I-NP	-	7	NMOD	-	-
6	TF	TF	I-NP	I-NP	-	7	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	3	PMOD	-	-
8	in	in	B-PP	B-PP	-	2	NMOD	-	-
9	monocytic	monocytic	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	exposed	exposed	B-VP	B-VP	-	10	NMOD	-	-
12	to	to	B-PP	B-PP	-	11	VMOD	-	-
13	bacterial	bacterial	B-NP	B-NP	-	12	PMOD	-	-
14	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	13	NMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	LPS	LPS	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	is	is	B-VP	B-VP	-	0	ROOT	-	-
19	mediated	mediated	I-VP	I-VP	-	18	VC	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	binding	binding	B-NP	B-NP	-	20	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	c-Rel/p65	c-Rel/p65	B-NP	B-NP	-	24	NMOD	-	-
24	heterodimers	heterodimers	I-NP	I-NP	-	22	PMOD	-	-
25	to	to	B-PP	B-PP	-	21	NMOD	-	-
26	a	a	B-NP	B-NP	-	29	NMOD	-	-
27	kappa	kappa	I-NP	I-NP	-	29	NMOD	-	-
28	B	B	I-NP	I-NP	-	29	NMOD	-	-
29	site	site	I-NP	I-NP	-	25	PMOD	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	TF	TF	I-NP	I-NP	-	33	NMOD	-	-
33	promoter	promoter	I-NP	I-NP	-	30	PMOD	-	-
34	.	.	O	O	-	18	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	report	report	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	family	family	I-NP	I-NP	-	17	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	anti-inflammatory	anti-inflammatory	B-NP	B-NP	-	10	NMOD	-	-
10	agents	agents	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	known	known	B-VP	B-VP	-	10	NMOD	-	-
13	as	as	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	salicylates	salicylates	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	10	P	-	-
17	inhibited	inhibited	B-VP	B-VP	-	5	SBAR	-	-
18	LPS	LPS	B-NP	B-NP	-	19	NMOD	-	-
19	induction	induction	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	TF	TF	B-NP	B-NP	-	22	NMOD	-	-
22	activity	activity	I-NP	I-NP	-	26	NMOD	-	-
23	and	and	I-NP	I-NP	-	26	NMOD	-	-
24	TF	TF	I-NP	I-NP	-	26	NMOD	-	-
25	gene	gene	I-NP	I-NP	-	26	NMOD	-	-
26	transcription	transcription	I-NP	I-NP	-	20	PMOD	-	-
27	in	in	B-PP	B-PP	-	19	NMOD	-	-
28	human	human	B-NP	B-NP	-	29	NMOD	-	-
29	monocytes	monocytes	I-NP	I-NP	-	33	NMOD	-	-
30	and	and	O	O	-	33	NMOD	-	-
31	monocytic	monocytic	B-NP	B-NP	-	33	NMOD	-	-
32	THP-1	THP-1	I-NP	I-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	27	PMOD	-	-
34	at	at	B-PP	B-PP	-	17	VMOD	-	-
35	clinically	clinically	B-NP	B-NP	-	36	AMOD	-	-
36	relevant	relevant	I-NP	I-NP	-	37	NMOD	-	-
37	doses	doses	I-NP	I-NP	-	34	PMOD	-	-
38	.	.	O	O	-	4	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	sodium	sodium	B-NP	B-NP	-	4	NMOD	-	-
4	salicylate	salicylate	I-NP	I-NP	-	5	SUB	-	-
5	blocked	blocked	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	LPS-induced	LPS-induced	I-NP	I-NP	-	9	NMOD	-	-
8	proteolytic	proteolytic	I-NP	I-NP	-	9	NMOD	-	-
9	degradation	degradation	I-NP	I-NP	-	5	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	I	I	B-NP	B-NP	-	14	NMOD	-	-
12	kappa	kappa	I-NP	I-NP	-	14	NMOD	-	-
13	B	B	I-NP	I-NP	-	14	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	which	which	B-NP	B-NP	-	14	NMOD	-	-
17	prevented	prevented	B-VP	B-VP	-	16	SBAR	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	nuclear	nuclear	I-NP	I-NP	-	20	NMOD	-	-
20	translocation	translocation	I-NP	I-NP	-	17	OBJ	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	c-Rel/p65	c-Rel/p65	B-NP	B-NP	-	23	NMOD	-	-
23	heterodimers	heterodimers	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	In	In	B-PP	B-PP	-	14	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	14	P	-	-
4	two	two	B-NP	B-NP	-	8	NMOD	-	-
5	other	other	I-NP	I-NP	-	8	NMOD	-	-
6	nonsteroidal	nonsteroidal	I-NP	I-NP	-	8	NMOD	-	-
7	anti-inflammatory	anti-inflammatory	I-NP	I-NP	-	8	NMOD	-	-
8	drugs	drugs	I-NP	I-NP	-	14	SUB	-	-
9	,	,	O	O	-	14	P	-	-
10	ibuprofen	ibuprofen	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	I-NP	I-NP	-	12	NMOD	-	-
12	indomethacin	indomethacin	I-NP	I-NP	-	14	SUB	-	-
13	,	,	O	O	-	14	P	-	-
14	did	did	B-VP	B-VP	-	0	ROOT	-	-
15	not	not	I-VP	I-VP	-	14	VMOD	-	-
16	inhibit	inhibit	I-VP	I-VP	-	14	VC	-	-
17	LPS	LPS	B-NP	B-NP	-	18	NMOD	-	-
18	induction	induction	I-NP	I-NP	-	16	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	TF	TF	I-NP	I-NP	-	22	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	14	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	salicylates	salicylates	B-NP	B-NP	-	6	SUB	-	-
6	inhibited	inhibited	B-VP	B-VP	-	4	SBAR	-	-
7	LPS	LPS	B-NP	B-NP	-	8	NMOD	-	-
8	induction	induction	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	TF	TF	B-NP	B-NP	-	12	NMOD	-	-
11	gene	gene	I-NP	I-NP	-	12	NMOD	-	-
12	transcription	transcription	I-NP	I-NP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	8	NMOD	-	-
14	monocytic	monocytic	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	by	by	B-PP	B-PP	-	6	VMOD	-	-
17	preventing	preventing	B-VP	B-VP	-	16	PMOD	-	-
18	nuclear	nuclear	B-NP	B-NP	-	19	NMOD	-	-
19	translocation	translocation	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	c-Rel/p65	c-Rel/p65	B-NP	B-NP	-	22	NMOD	-	-
22	heterodimers	heterodimers	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	clinical	clinical	I-NP	I-NP	-	3	NMOD	-	-
3	benefits	benefits	I-NP	I-NP	-	19	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	salicylates	salicylates	B-NP	B-NP	-	4	PMOD	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	treatment	treatment	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	several	several	B-NP	B-NP	-	11	NMOD	-	-
11	diseases	diseases	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	11	P	-	-
13	including	including	B-PP	B-PP	-	11	NMOD	-	-
14	atherosclerosis	atherosclerosis	B-NP	B-NP	-	17	NMOD	-	-
15	and	and	O	O	-	17	NMOD	-	-
16	rheumatoid	rheumatoid	B-NP	B-NP	-	17	NMOD	-	-
17	arthritis	arthritis	I-NP	I-NP	-	13	PMOD	-	-
18	,	,	O	O	-	11	P	-	-
19	may	may	B-VP	B-VP	-	0	ROOT	-	-
20	be	be	I-VP	I-VP	-	19	VC	-	-
21	related	related	I-VP	I-VP	-	20	PRD	-	-
22	to	to	B-PP	B-PP	-	21	AMOD	-	-
23	their	their	B-NP	B-NP	-	24	NMOD	-	-
24	ability	ability	I-NP	I-NP	-	22	PMOD	-	-
25	to	to	B-VP	B-VP	-	26	VMOD	-	-
26	reduce	reduce	I-VP	I-VP	-	24	NMOD	-	-
27	monocyte	monocyte	B-NP	B-NP	-	29	NMOD	-	-
28	gene	gene	I-NP	I-NP	-	29	NMOD	-	-
29	expression	expression	I-NP	I-NP	-	26	OBJ	-	-
30	.	.	O	O	-	19	P	-	-

1	CIITA	CIITA	B-NP	B-NP	-	2	SUB	-	-
2	activates	activates	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	expression	expression	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	MHC	MHC	B-NP	B-NP	-	9	NMOD	-	-
7	class	class	I-NP	I-NP	-	9	NMOD	-	-
8	II	II	B-NP	B-NP	-	9	NMOD	-	-
9	genes	genes	I-NP	I-NP	-	5	PMOD	-	-
10	in	in	B-PP	B-PP	-	4	NMOD	-	-
11	mouse	mouse	B-NP	B-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	has	has	B-VP	B-VP	-	0	ROOT	-	-
3	long	long	I-VP	I-VP	-	2	VMOD	-	-
4	been	been	I-VP	I-VP	-	2	VC	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	puzzle	puzzle	I-NP	I-NP	-	4	OBJ	-	-
7	that	that	B-NP	B-NP	-	6	NMOD	-	-
8	MHC	MHC	B-NP	B-NP	-	11	NMOD	-	-
9	class	class	I-NP	I-NP	-	11	NMOD	-	-
10	II	II	B-NP	B-NP	-	11	NMOD	-	-
11	molecules	molecules	I-NP	I-NP	-	12	SUB	-	-
12	are	are	B-VP	B-VP	-	7	SBAR	-	-
13	expressed	expressed	I-VP	I-VP	-	12	VC	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	human	human	B-NP	B-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	after	after	B-PP	B-PP	-	13	VMOD	-	-
19	activation	activation	B-NP	B-NP	-	18	PMOD	-	-
20	but	but	B-PP	B-PP	-	18	PMOD	-	-
21	not	not	B-PP	B-PP	-	22	PMOD	-	-
22	in	in	I-PP	I-PP	-	18	PMOD	-	-
23	mouse	mouse	B-NP	B-NP	-	25	NMOD	-	-
24	T	T	I-NP	I-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
26	;	;	O	O	-	12	P	-	-
27	this	this	B-NP	B-NP	-	28	NMOD	-	-
28	expression	expression	I-NP	I-NP	-	29	SUB	-	-
29	is	is	B-VP	B-VP	-	7	SBAR	-	-
30	believed	believed	I-VP	I-VP	-	29	VC	-	-
31	to	to	I-VP	I-VP	-	32	VMOD	-	-
32	play	play	I-VP	I-VP	-	30	VMOD	-	-
33	a	a	B-NP	B-NP	-	34	NMOD	-	-
34	role	role	I-NP	I-NP	-	32	OBJ	-	-
35	in	in	B-PP	B-PP	-	32	VMOD	-	-
36	the	the	B-NP	B-NP	-	40	NMOD	-	-
37	cell	cell	I-NP	I-NP	-	40	NMOD	-	-
38	mediated	mediated	I-NP	I-NP	-	40	NMOD	-	-
39	immune	immune	I-NP	I-NP	-	40	NMOD	-	-
40	response	response	I-NP	I-NP	-	35	PMOD	-	-
41	.	.	O	O	-	2	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	the	the	B-NP	B-NP	-	6	NMOD	-	-
3	MHC	MHC	I-NP	I-NP	-	6	NMOD	-	-
4	class	class	I-NP	I-NP	-	6	NMOD	-	-
5	II	II	I-NP	I-NP	-	6	NMOD	-	-
6	transactivator	transactivator	I-NP	I-NP	-	10	SUB	-	-
7	(	(	O	O	-	8	P	-	-
8	CIITA	CIITA	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	has	has	B-VP	B-VP	-	0	ROOT	-	-
11	been	been	I-VP	I-VP	-	10	VC	-	-
12	reported	reported	I-VP	I-VP	-	11	VC	-	-
13	to	to	I-VP	I-VP	-	14	VMOD	-	-
14	be	be	I-VP	I-VP	-	12	VMOD	-	-
15	a	a	B-NP	B-NP	-	18	NMOD	-	-
16	major	major	I-NP	I-NP	-	18	NMOD	-	-
17	regulatory	regulatory	I-NP	I-NP	-	18	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	14	PRD	-	-
19	for	for	B-PP	B-PP	-	18	NMOD	-	-
20	both	both	O	O	-	26	NMOD	-	-
21	the	the	B-NP	B-NP	-	26	NMOD	-	-
22	constitutive	constitutive	I-NP	I-NP	-	26	NMOD	-	-
23	and	and	I-NP	I-NP	-	26	NMOD	-	-
24	IFN	IFN	I-NP	I-NP	-	26	NMOD	-	-
25	inducible	inducible	I-NP	I-NP	-	26	NMOD	-	-
26	expression	expression	I-NP	I-NP	-	19	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	MHC	MHC	B-NP	B-NP	-	31	NMOD	-	-
29	class	class	I-NP	I-NP	-	31	NMOD	-	-
30	II	II	B-NP	B-NP	-	31	NMOD	-	-
31	genes	genes	I-NP	I-NP	-	27	PMOD	-	-
32	.	.	O	O	-	10	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	human	human	B-NP	B-NP	-	7	NMOD	-	-
6	T	T	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	12	SUB	-	-
8	expressing	expressing	B-VP	B-VP	-	7	NMOD	-	-
9	MHC	MHC	B-NP	B-NP	-	10	NMOD	-	-
10	class	class	I-NP	I-NP	-	8	OBJ	-	-
11	II	II	I-NP	I-NP	-	10	NMOD	-	-
12	have	have	B-VP	B-VP	-	4	SBAR	-	-
13	CIITA	CIITA	B-NP	B-NP	-	14	NMOD	-	-
14	transcripts	transcripts	I-NP	I-NP	-	12	OBJ	-	-
15	while	while	B-SBAR	B-SBAR	-	12	VMOD	-	-
16	MHC	MHC	B-NP	B-NP	-	21	NMOD	-	-
17	class	class	I-NP	I-NP	-	21	NMOD	-	-
18	II-negative	II-negative	I-NP	I-NP	-	21	NMOD	-	-
19	human	human	I-NP	I-NP	-	21	NMOD	-	-
20	T	T	I-NP	I-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	25	NMOD	-	-
22	and	and	O	O	-	25	NMOD	-	-
23	mouse	mouse	B-NP	B-NP	-	25	NMOD	-	-
24	T	T	I-NP	I-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	26	SUB	-	-
26	do	do	B-VP	B-VP	-	15	SBAR	-	-
27	not	not	O	O	-	26	VMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	MHC	MHC	B-NP	B-NP	-	7	NMOD	-	-
5	class	class	I-NP	I-NP	-	7	NMOD	-	-
6	II	II	B-NP	B-NP	-	7	NMOD	-	-
7	genes	genes	I-NP	I-NP	-	3	PMOD	-	-
8	in	in	B-PP	B-PP	-	2	NMOD	-	-
9	mouse	mouse	B-NP	B-NP	-	11	NMOD	-	-
10	T	T	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
12	can	can	B-VP	B-VP	-	0	ROOT	-	-
13	be	be	I-VP	I-VP	-	12	VC	-	-
14	reconstituted	reconstituted	I-VP	I-VP	-	13	VC	-	-
15	upon	upon	B-PP	B-PP	-	14	VMOD	-	-
16	transfection	transfection	B-NP	B-NP	-	15	PMOD	-	-
17	with	with	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	human	human	I-NP	I-NP	-	21	NMOD	-	-
20	CIITA	CIITA	I-NP	I-NP	-	21	NMOD	-	-
21	cDNA	cDNA	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	12	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	9	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	CIITA	CIITA	B-NP	B-NP	-	7	PMOD	-	-
9	explains	explains	B-VP	B-VP	-	4	SBAR	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	13	NMOD	-	-
12	or	or	I-NP	I-NP	-	13	NMOD	-	-
13	lack	lack	I-NP	I-NP	-	9	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	expression	expression	B-NP	B-NP	-	14	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	MHC	MHC	B-NP	B-NP	-	18	NMOD	-	-
18	class	class	I-NP	I-NP	-	16	PMOD	-	-
19	II	II	I-NP	I-NP	-	18	NMOD	-	-
20	in	in	B-PP	B-PP	-	15	NMOD	-	-
21	human	human	B-NP	B-NP	-	25	NMOD	-	-
22	and	and	I-NP	I-NP	-	25	NMOD	-	-
23	mouse	mouse	I-NP	I-NP	-	25	NMOD	-	-
24	T	T	I-NP	I-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
26	respectively	respectively	B-ADVP	B-ADVP	-	25	NMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	Identification	Identification	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	an	an	B-NP	B-NP	-	9	NMOD	-	-
4	I	I	I-NP	I-NP	-	9	NMOD	-	-
5	kappa	kappa	I-NP	I-NP	-	9	NMOD	-	-
6	B	B	I-NP	I-NP	-	9	NMOD	-	-
7	alpha-associated	alpha-associated	I-NP	I-NP	-	9	NMOD	-	-
8	protein	protein	I-NP	I-NP	-	9	NMOD	-	-
9	kinase	kinase	I-NP	I-NP	-	2	PMOD	-	-
10	in	in	B-PP	B-PP	-	1	NMOD	-	-
11	a	a	B-NP	B-NP	-	15	NMOD	-	-
12	human	human	I-NP	I-NP	-	15	NMOD	-	-
13	monocytic	monocytic	I-NP	I-NP	-	15	NMOD	-	-
14	cell	cell	I-NP	I-NP	-	15	NMOD	-	-
15	line	line	I-NP	I-NP	-	17	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	determination	determination	B-NP	B-NP	-	10	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	its	its	B-NP	B-NP	-	21	NMOD	-	-
20	phosphorylation	phosphorylation	I-NP	I-NP	-	21	NMOD	-	-
21	sites	sites	I-NP	I-NP	-	18	PMOD	-	-
22	on	on	B-PP	B-PP	-	21	NMOD	-	-
23	I	I	B-NP	B-NP	-	26	NMOD	-	-
24	kappa	kappa	I-NP	I-NP	-	26	NMOD	-	-
25	B	B	I-NP	I-NP	-	26	NMOD	-	-
26	alpha	alpha	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	1	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	4	NMOD	-	-
2	factor	factor	I-NP	I-NP	-	4	NMOD	-	-
3	kappa	kappa	I-NP	I-NP	-	4	NMOD	-	-
4	B	B	I-NP	I-NP	-	9	SUB	-	-
5	(	(	O	O	-	7	P	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	7	NMOD	-	-
7	B	B	I-NP	I-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	stored	stored	I-VP	I-VP	-	9	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	cytoplasm	cytoplasm	I-NP	I-NP	-	11	PMOD	-	-
14	as	as	B-PP	B-PP	-	10	VMOD	-	-
15	an	an	B-NP	B-NP	-	17	NMOD	-	-
16	inactive	inactive	I-NP	I-NP	-	17	NMOD	-	-
17	form	form	I-NP	I-NP	-	14	PMOD	-	-
18	through	through	B-PP	B-PP	-	10	VMOD	-	-
19	interaction	interaction	B-NP	B-NP	-	18	PMOD	-	-
20	with	with	B-PP	B-PP	-	19	NMOD	-	-
21	I	I	B-NP	B-NP	-	23	NMOD	-	-
22	kappa	kappa	I-NP	I-NP	-	23	NMOD	-	-
23	B	B	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	9	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	4	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	cells	cells	B-NP	B-NP	-	2	PMOD	-	-
4	leads	leads	B-VP	B-VP	-	0	ROOT	-	-
5	to	to	B-PP	B-PP	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	rapid	rapid	I-NP	I-NP	-	8	NMOD	-	-
8	phosphorylation	phosphorylation	I-NP	I-NP	-	5	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	I	I	B-NP	B-NP	-	13	NMOD	-	-
11	kappa	kappa	I-NP	I-NP	-	13	NMOD	-	-
12	B	B	I-NP	I-NP	-	13	NMOD	-	-
13	alpha	alpha	I-NP	I-NP	-	9	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	which	which	B-NP	B-NP	-	13	NMOD	-	-
16	is	is	B-VP	B-VP	-	15	SBAR	-	-
17	presumed	presumed	I-VP	I-VP	-	16	VC	-	-
18	to	to	I-VP	I-VP	-	19	VMOD	-	-
19	be	be	I-VP	I-VP	-	17	VMOD	-	-
20	important	important	B-ADJP	B-ADJP	-	19	PRD	-	-
21	for	for	B-PP	B-PP	-	20	AMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	subsequent	subsequent	I-NP	I-NP	-	24	NMOD	-	-
24	degradation	degradation	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	recently	recently	I-VP	I-VP	-	2	VMOD	-	-
4	reported	reported	I-VP	I-VP	-	2	VC	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	establishment	establishment	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	a	a	B-NP	B-NP	-	16	NMOD	-	-
9	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	16	NMOD	-	-
10	(	(	O	O	-	11	P	-	-
11	LPS	LPS	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	-dependent	-dependent	B-NP	B-NP	-	16	NMOD	-	-
14	cell-free	cell-free	I-NP	I-NP	-	16	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	16	NMOD	-	-
16	system	system	I-NP	I-NP	-	7	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	NF-kappa	NF-kappa	B-NP	B-NP	-	19	NMOD	-	-
19	B	B	I-NP	I-NP	-	17	PMOD	-	-
20	in	in	B-PP	B-PP	-	16	NMOD	-	-
21	association	association	B-NP	B-NP	-	20	PMOD	-	-
22	with	with	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	induction	induction	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	I	I	B-NP	B-NP	-	30	NMOD	-	-
27	kappa	kappa	I-NP	I-NP	-	30	NMOD	-	-
28	B	B	I-NP	I-NP	-	30	NMOD	-	-
29	alpha	alpha	I-NP	I-NP	-	30	NMOD	-	-
30	phosphorylation	phosphorylation	I-NP	I-NP	-	25	PMOD	-	-
31	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	have	have	B-VP	B-VP	-	0	ROOT	-	-
7	identified	identified	I-VP	I-VP	-	6	VC	-	-
8	a	a	B-NP	B-NP	-	9	NMOD	-	-
9	kinase	kinase	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	7	VMOD	-	-
11	cell	cell	B-NP	B-NP	-	12	NMOD	-	-
12	extracts	extracts	I-NP	I-NP	-	10	PMOD	-	-
13	from	from	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	19	NMOD	-	-
15	LPS-stimulated	LPS-stimulated	I-NP	I-NP	-	19	NMOD	-	-
16	human	human	I-NP	I-NP	-	19	NMOD	-	-
17	monocytic	monocytic	I-NP	I-NP	-	19	NMOD	-	-
18	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
19	line	line	I-NP	I-NP	-	21	NMOD	-	-
20	,	,	O	O	-	21	P	-	-
21	THP-1	THP-1	B-NP	B-NP	-	13	PMOD	-	-
22	,	,	O	O	-	21	P	-	-
23	that	that	B-NP	B-NP	-	21	NMOD	-	-
24	specifically	specifically	B-ADVP	B-ADVP	-	25	VMOD	-	-
25	binds	binds	B-VP	B-VP	-	23	SBAR	-	-
26	and	and	I-VP	I-VP	-	25	VMOD	-	-
27	phosphorylates	phosphorylates	I-VP	I-VP	-	25	VMOD	-	-
28	I	I	B-NP	B-NP	-	31	NMOD	-	-
29	kappa	kappa	I-NP	I-NP	-	31	NMOD	-	-
30	B	B	I-NP	I-NP	-	31	NMOD	-	-
31	alpha	alpha	I-NP	I-NP	-	27	OBJ	-	-
32	.	.	O	O	-	6	P	-	-

1	LPS	LPS	B-NP	B-NP	-	2	NMOD	-	-
2	stimulation	stimulation	I-NP	I-NP	-	4	SUB	-	-
3	transiently	transiently	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	11	NMOD	-	-
6	I	I	I-NP	I-NP	-	11	NMOD	-	-
7	kappa	kappa	I-NP	I-NP	-	11	NMOD	-	-
8	B	B	I-NP	I-NP	-	11	NMOD	-	-
9	alpha-bound	alpha-bound	I-NP	I-NP	-	11	NMOD	-	-
10	kinase	kinase	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	4	OBJ	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	THP-1	THP-1	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	Mutational	Mutational	B-NP	B-NP	-	2	NMOD	-	-
2	analyses	analyses	I-NP	I-NP	-	10	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	I	I	B-NP	B-NP	-	7	NMOD	-	-
5	kappa	kappa	I-NP	I-NP	-	7	NMOD	-	-
6	B	B	I-NP	I-NP	-	7	NMOD	-	-
7	alpha	alpha	I-NP	I-NP	-	3	PMOD	-	-
8	and	and	O	O	-	10	NMOD	-	-
9	competition	competition	B-NP	B-NP	-	10	NMOD	-	-
10	experiments	experiments	I-NP	I-NP	-	15	SUB	-	-
11	with	with	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	synthetic	synthetic	I-NP	I-NP	-	14	NMOD	-	-
14	peptides	peptides	I-NP	I-NP	-	11	PMOD	-	-
15	identified	identified	B-VP	B-VP	-	0	ROOT	-	-
16	major	major	B-NP	B-NP	-	18	NMOD	-	-
17	phosphorylation	phosphorylation	I-NP	I-NP	-	18	NMOD	-	-
18	sites	sites	I-NP	I-NP	-	15	OBJ	-	-
19	by	by	B-PP	B-PP	-	15	VMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	bound	bound	I-NP	I-NP	-	22	NMOD	-	-
22	kinase	kinase	I-NP	I-NP	-	19	PMOD	-	-
23	as	as	B-PP	B-PP	-	15	VMOD	-	-
24	Ser	Ser	B-NP	B-NP	-	27	NMOD	-	-
25	and	and	I-NP	I-NP	-	27	NMOD	-	-
26	Thr	Thr	I-NP	I-NP	-	27	NMOD	-	-
27	residues	residues	I-NP	I-NP	-	23	PMOD	-	-
28	in	in	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	32	NMOD	-	-
30	C-terminal	C-terminal	I-NP	I-NP	-	32	NMOD	-	-
31	acidic	acidic	I-NP	I-NP	-	32	NMOD	-	-
32	domain	domain	I-NP	I-NP	-	28	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	I	I	B-NP	B-NP	-	37	NMOD	-	-
35	kappa	kappa	I-NP	I-NP	-	37	NMOD	-	-
36	B	B	I-NP	I-NP	-	37	NMOD	-	-
37	alpha	alpha	I-NP	I-NP	-	33	PMOD	-	-
38	.	.	O	O	-	15	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	show	show	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	peptide	peptide	I-NP	I-NP	-	21	SUB	-	-
8	,	,	O	O	-	7	P	-	-
9	corresponding	corresponding	B-VP	B-VP	-	7	NMOD	-	-
10	to	to	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	C-terminal	C-terminal	I-NP	I-NP	-	14	NMOD	-	-
13	acidic	acidic	I-NP	I-NP	-	14	NMOD	-	-
14	domain	domain	I-NP	I-NP	-	10	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	I	I	B-NP	B-NP	-	19	NMOD	-	-
17	kappa	kappa	I-NP	I-NP	-	19	NMOD	-	-
18	B	B	I-NP	I-NP	-	19	NMOD	-	-
19	alpha	alpha	I-NP	I-NP	-	15	PMOD	-	-
20	,	,	O	O	-	7	P	-	-
21	blocked	blocked	B-VP	B-VP	-	5	SBAR	-	-
22	the	the	B-NP	B-NP	-	26	NMOD	-	-
23	LPS-induced	LPS-induced	I-NP	I-NP	-	26	NMOD	-	-
24	NF-kappa	NF-kappa	I-NP	I-NP	-	26	NMOD	-	-
25	B	B	I-NP	I-NP	-	26	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	31	NMOD	-	-
27	as	as	B-CONJP	B-CONJP	-	31	NMOD	-	-
28	well	well	I-CONJP	I-CONJP	-	27	DEP	-	-
29	as	as	I-CONJP	I-CONJP	-	27	DEP	-	-
30	inducible	inducible	B-NP	B-NP	-	31	NMOD	-	-
31	phosphorylation	phosphorylation	I-NP	I-NP	-	21	OBJ	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	endogenous	endogenous	B-NP	B-NP	-	37	NMOD	-	-
34	I	I	I-NP	I-NP	-	37	NMOD	-	-
35	kappa	kappa	I-NP	I-NP	-	37	NMOD	-	-
36	B	B	I-NP	I-NP	-	37	NMOD	-	-
37	alpha	alpha	I-NP	I-NP	-	32	PMOD	-	-
38	in	in	B-PP	B-PP	-	21	VMOD	-	-
39	a	a	B-NP	B-NP	-	41	NMOD	-	-
40	cell-free	cell-free	I-NP	I-NP	-	41	NMOD	-	-
41	system	system	I-NP	I-NP	-	38	PMOD	-	-
42	using	using	B-VP	B-VP	-	41	NMOD	-	-
43	THP-1	THP-1	B-NP	B-NP	-	44	NMOD	-	-
44	cells	cells	I-NP	I-NP	-	42	OBJ	-	-
45	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggested	suggested	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	bound	bound	I-NP	I-NP	-	7	NMOD	-	-
7	kinase	kinase	I-NP	I-NP	-	8	SUB	-	-
8	is	is	B-VP	B-VP	-	4	SBAR	-	-
9	involved	involved	I-VP	I-VP	-	8	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	13	NMOD	-	-
13	pathway	pathway	I-NP	I-NP	-	10	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	LPS	LPS	B-NP	B-NP	-	14	PMOD	-	-
16	by	by	B-PP	B-PP	-	9	VMOD	-	-
17	inducing	inducing	B-VP	B-VP	-	16	PMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	phosphorylation	phosphorylation	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	23	NMOD	-	-
22	C-terminal	C-terminal	I-NP	I-NP	-	23	NMOD	-	-
23	region	region	I-NP	I-NP	-	20	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	I	I	B-NP	B-NP	-	28	NMOD	-	-
26	kappa	kappa	I-NP	I-NP	-	28	NMOD	-	-
27	B	B	I-NP	I-NP	-	28	NMOD	-	-
28	alpha	alpha	I-NP	I-NP	-	24	PMOD	-	-
29	and	and	O	O	-	31	NMOD	-	-
30	subsequent	subsequent	B-NP	B-NP	-	31	NMOD	-	-
31	dissociation	dissociation	I-NP	I-NP	-	24	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	39	NMOD	-	-
34	NF-kappa	NF-kappa	I-NP	I-NP	-	39	NMOD	-	-
35	B.I	B.I	I-NP	I-NP	-	39	NMOD	-	-
36	kappa	kappa	I-NP	I-NP	-	39	NMOD	-	-
37	B	B	I-NP	I-NP	-	39	NMOD	-	-
38	alpha	alpha	I-NP	I-NP	-	39	NMOD	-	-
39	complex	complex	I-NP	I-NP	-	32	PMOD	-	-
40	.	.	O	O	-	3	P	-	-

1	Triggering	Triggering	B-NP	B-NP	-	16	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	human	human	I-NP	I-NP	-	6	NMOD	-	-
5	interleukin-6	interleukin-6	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	interferon-gamma	interferon-gamma	B-NP	B-NP	-	12	NMOD	-	-
9	and	and	O	O	-	12	NMOD	-	-
10	tumor	tumor	B-NP	B-NP	-	12	NMOD	-	-
11	necrosis	necrosis	I-NP	I-NP	-	12	NMOD	-	-
12	factor-alpha	factor-alpha	I-NP	I-NP	-	7	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	monocytic	monocytic	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	involves	involves	B-VP	B-VP	-	0	ROOT	-	-
17	cooperation	cooperation	B-NP	B-NP	-	16	OBJ	-	-
18	between	between	B-PP	B-PP	-	17	NMOD	-	-
19	interferon	interferon	B-NP	B-NP	-	21	NMOD	-	-
20	regulatory	regulatory	I-NP	I-NP	-	21	NMOD	-	-
21	factor-1	factor-1	I-NP	I-NP	-	30	NMOD	-	-
22	,	,	O	O	-	30	P	-	-
23	NF	NF	B-NP	B-NP	-	25	NMOD	-	-
24	kappa	kappa	I-NP	I-NP	-	25	NMOD	-	-
25	B	B	I-NP	I-NP	-	30	NMOD	-	-
26	,	,	O	O	-	30	P	-	-
27	and	and	O	O	-	30	NMOD	-	-
28	Sp1	Sp1	B-NP	B-NP	-	30	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	30	NMOD	-	-
30	factors	factors	I-NP	I-NP	-	18	PMOD	-	-
31	.	.	O	O	-	16	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	investigated	investigated	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	molecular	molecular	I-NP	I-NP	-	5	NMOD	-	-
5	basis	basis	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	synergistic	synergistic	I-NP	I-NP	-	9	NMOD	-	-
9	induction	induction	I-NP	I-NP	-	6	PMOD	-	-
10	by	by	B-PP	B-PP	-	9	NMOD	-	-
11	interferon-gamma	interferon-gamma	B-NP	B-NP	-	17	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	IFN-gamma	IFN-gamma	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	/tumor	/tumor	B-NP	B-NP	-	17	NMOD	-	-
16	necrosis	necrosis	I-NP	I-NP	-	17	NMOD	-	-
17	factor-alpha	factor-alpha	I-NP	I-NP	-	10	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	TNF-alpha	TNF-alpha	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	of	of	B-PP	B-PP	-	17	NMOD	-	-
22	human	human	B-NP	B-NP	-	27	NMOD	-	-
23	interleukin-6	interleukin-6	I-NP	I-NP	-	27	NMOD	-	-
24	(	(	O	O	-	25	P	-	-
25	IL-6	IL-6	B-NP	B-NP	-	23	NMOD	-	-
26	)	)	O	O	-	27	P	-	-
27	gene	gene	B-NP	B-NP	-	21	PMOD	-	-
28	in	in	B-PP	B-PP	-	9	NMOD	-	-
29	THP-1	THP-1	B-NP	B-NP	-	31	NMOD	-	-
30	monocytic	monocytic	I-NP	I-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	28	PMOD	-	-
32	,	,	O	O	-	2	P	-	-
33	and	and	O	O	-	2	VMOD	-	-
34	compared	compared	B-VP	B-VP	-	2	VMOD	-	-
35	it	it	B-NP	B-NP	-	34	OBJ	-	-
36	with	with	B-PP	B-PP	-	34	VMOD	-	-
37	the	the	B-NP	B-NP	-	38	NMOD	-	-
38	basis	basis	I-NP	I-NP	-	36	PMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	this	this	B-NP	B-NP	-	41	NMOD	-	-
41	induction	induction	I-NP	I-NP	-	39	PMOD	-	-
42	by	by	B-PP	B-PP	-	41	NMOD	-	-
43	lipopolysaccharide	lipopolysaccharide	B-NP	B-NP	-	42	PMOD	-	-
44	(	(	O	O	-	45	P	-	-
45	LPS	LPS	B-NP	B-NP	-	43	NMOD	-	-
46	)	)	O	O	-	45	P	-	-
47	.	.	O	O	-	2	P	-	-

1	Functional	Functional	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	6	SUB	-	-
3	with	with	B-PP	B-PP	-	2	NMOD	-	-
4	IL-6	IL-6	B-NP	B-NP	-	5	NMOD	-	-
5	promoter	promoter	I-NP	I-NP	-	3	PMOD	-	-
6	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	three	three	B-NP	B-NP	-	9	NMOD	-	-
9	regions	regions	I-NP	I-NP	-	10	SUB	-	-
10	are	are	B-VP	B-VP	-	7	SBAR	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	targets	targets	I-NP	I-NP	-	10	PRD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	IFN-gamma	IFN-gamma	I-NP	I-NP	-	17	NMOD	-	-
16	and/or	and/or	I-NP	I-NP	-	17	NMOD	-	-
17	TNF-alpha	TNF-alpha	I-NP	I-NP	-	18	NMOD	-	-
18	action	action	I-NP	I-NP	-	13	PMOD	-	-
19	,	,	O	O	-	10	P	-	-
20	whereas	whereas	O	O	-	10	VMOD	-	-
21	only	only	B-NP	B-NP	-	26	VMOD	-	-
22	one	one	I-NP	I-NP	-	21	AMOD	-	-
23	of	of	B-PP	B-PP	-	21	NMOD	-	-
24	these	these	B-NP	B-NP	-	25	NMOD	-	-
25	regions	regions	I-NP	I-NP	-	23	PMOD	-	-
26	seemed	seemed	B-VP	B-VP	-	20	VMOD	-	-
27	to	to	I-VP	I-VP	-	28	VMOD	-	-
28	be	be	I-VP	I-VP	-	26	VMOD	-	-
29	implicated	implicated	I-VP	I-VP	-	28	VC	-	-
30	in	in	B-PP	B-PP	-	29	VMOD	-	-
31	LPS	LPS	B-NP	B-NP	-	32	NMOD	-	-
32	activation	activation	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	three	three	I-NP	I-NP	-	3	NMOD	-	-
3	regions	regions	I-NP	I-NP	-	5	SUB	-	-
4	concerned	concerned	B-ADJP	B-ADJP	-	3	NMOD	-	-
5	are	are	B-VP	B-VP	-	0	ROOT	-	-
6	:	:	O	O	-	5	P	-	-
7	<num>	<num>	B-LST	B-LST	-	10	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	a	a	B-NP	B-NP	-	10	NMOD	-	-
10	region	region	I-NP	I-NP	-	5	PRD	-	-
11	between	between	B-NP	B-NP	-	10	NMOD	-	-
12	-73	-73	I-NP	I-NP	-	11	AMOD	-	-
13	and	and	I-NP	I-NP	-	11	PMOD	-	-
14	-36	-36	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	10	P	-	-
16	which	which	B-NP	B-NP	-	10	NMOD	-	-
17	is	is	B-VP	B-VP	-	16	SBAR	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	minimal	minimal	I-NP	I-NP	-	20	NMOD	-	-
20	element	element	I-NP	I-NP	-	17	PRD	-	-
21	inducible	inducible	B-ADJP	B-ADJP	-	20	NMOD	-	-
22	by	by	B-PP	B-PP	-	21	AMOD	-	-
23	LPS	LPS	B-NP	B-NP	-	25	NMOD	-	-
24	or	or	I-NP	I-NP	-	25	NMOD	-	-
25	TNF-alpha	TNF-alpha	I-NP	I-NP	-	22	PMOD	-	-
26	;	;	O	O	-	5	P	-	-
27	<num>	<num>	B-LST	B-LST	-	30	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	an	an	B-NP	B-NP	-	30	NMOD	-	-
30	element	element	I-NP	I-NP	-	5	PRD	-	-
31	located	located	B-ADJP	B-ADJP	-	30	NMOD	-	-
32	between	between	B-PP	B-PP	-	31	AMOD	-	-
33	-181	-181	B-NP	B-NP	-	35	NMOD	-	-
34	and	and	I-NP	I-NP	-	35	NMOD	-	-
35	-73	-73	I-NP	I-NP	-	32	PMOD	-	-
36	,	,	O	O	-	35	P	-	-
37	which	which	B-NP	B-NP	-	35	NMOD	-	-
38	appeared	appeared	B-VP	B-VP	-	37	SBAR	-	-
39	to	to	I-VP	I-VP	-	40	VMOD	-	-
40	regulate	regulate	I-VP	I-VP	-	38	VMOD	-	-
41	the	the	B-NP	B-NP	-	42	NMOD	-	-
42	response	response	I-NP	I-NP	-	40	OBJ	-	-
43	to	to	B-PP	B-PP	-	42	NMOD	-	-
44	IFN-gamma	IFN-gamma	B-NP	B-NP	-	46	NMOD	-	-
45	and	and	I-NP	I-NP	-	46	NMOD	-	-
46	TNF-alpha	TNF-alpha	I-NP	I-NP	-	43	PMOD	-	-
47	negatively	negatively	B-ADVP	B-ADVP	-	40	VMOD	-	-
48	;	;	O	O	-	38	VMOD	-	-
49	and	and	O	O	-	32	PMOD	-	-
50	<num>	<num>	B-LST	B-LST	-	5	VMOD	-	-
51	)	)	O	O	-	50	P	-	-
52	a	a	B-NP	B-NP	-	54	NMOD	-	-
53	distal	distal	I-NP	I-NP	-	54	NMOD	-	-
54	element	element	I-NP	I-NP	-	5	PRD	-	-
55	upstream	upstream	B-ADJP	B-ADJP	-	54	NMOD	-	-
56	of	of	B-PP	B-PP	-	55	AMOD	-	-
57	-224	-224	B-NP	B-NP	-	56	PMOD	-	-
58	,	,	O	O	-	54	P	-	-
59	which	which	B-NP	B-NP	-	54	NMOD	-	-
60	was	was	B-VP	B-VP	-	59	SBAR	-	-
61	inducible	inducible	B-ADJP	B-ADJP	-	60	PRD	-	-
62	by	by	B-PP	B-PP	-	61	AMOD	-	-
63	IFN-gamma	IFN-gamma	B-NP	B-NP	-	62	PMOD	-	-
64	alone	alone	B-ADVP	B-ADVP	-	63	NMOD	-	-
65	.	.	O	O	-	5	P	-	-

1	LPS	LPS	B-NP	B-NP	-	2	NMOD	-	-
2	signaling	signaling	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	found	found	I-VP	I-VP	-	3	VC	-	-
5	to	to	I-VP	I-VP	-	6	VMOD	-	-
6	involve	involve	I-VP	I-VP	-	4	VMOD	-	-
7	NF	NF	B-NP	B-NP	-	9	NMOD	-	-
8	kappa	kappa	I-NP	I-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	6	OBJ	-	-
11	by	by	B-PP	B-PP	-	6	VMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	p50/p65	p50/p65	I-NP	I-NP	-	14	NMOD	-	-
14	heterodimers	heterodimers	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	3	P	-	-

1	Synergistic	Synergistic	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	17	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	IL-6	IL-6	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	3	PMOD	-	-
7	by	by	B-PP	B-PP	-	2	NMOD	-	-
8	IFN-gamma	IFN-gamma	B-NP	B-NP	-	10	NMOD	-	-
9	and	and	I-NP	I-NP	-	10	NMOD	-	-
10	TNF-alpha	TNF-alpha	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	2	P	-	-
12	in	in	B-PP	B-PP	-	2	NMOD	-	-
13	monocytic	monocytic	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	2	P	-	-
16	involved	involved	B-NP	B-NP	-	17	NMOD	-	-
17	cooperation	cooperation	I-NP	I-NP	-	29	NMOD	-	-
18	between	between	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	26	NMOD	-	-
20	IRF-1	IRF-1	I-NP	I-NP	-	26	NMOD	-	-
21	and	and	I-NP	I-NP	-	26	NMOD	-	-
22	NF	NF	I-NP	I-NP	-	26	NMOD	-	-
23	kappa	kappa	I-NP	I-NP	-	26	NMOD	-	-
24	B	B	I-NP	I-NP	-	26	NMOD	-	-
25	p65	p65	I-NP	I-NP	-	26	NMOD	-	-
26	homodimers	homodimers	I-NP	I-NP	-	18	PMOD	-	-
27	with	with	B-PP	B-PP	-	17	NMOD	-	-
28	concomitant	concomitant	B-NP	B-NP	-	29	NMOD	-	-
29	removal	removal	I-NP	I-NP	-	0	ROOT	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	negative	negative	I-NP	I-NP	-	33	NMOD	-	-
33	effect	effect	I-NP	I-NP	-	30	PMOD	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	the	the	B-NP	B-NP	-	38	NMOD	-	-
36	retinoblastoma	retinoblastoma	I-NP	I-NP	-	38	NMOD	-	-
37	control	control	I-NP	I-NP	-	38	NMOD	-	-
38	element	element	I-NP	I-NP	-	34	PMOD	-	-
39	present	present	B-ADJP	B-ADJP	-	38	NMOD	-	-
40	in	in	B-PP	B-PP	-	39	AMOD	-	-
41	the	the	B-NP	B-NP	-	43	NMOD	-	-
42	IL-6	IL-6	I-NP	I-NP	-	43	NMOD	-	-
43	promoter	promoter	I-NP	I-NP	-	40	PMOD	-	-
44	.	.	O	O	-	29	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	removal	removal	I-NP	I-NP	-	3	SUB	-	-
3	occurred	occurred	B-VP	B-VP	-	0	ROOT	-	-
4	by	by	B-PP	B-PP	-	3	VMOD	-	-
5	activation	activation	B-NP	B-NP	-	4	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	constitutive	constitutive	I-NP	I-NP	-	10	NMOD	-	-
9	Sp1	Sp1	I-NP	I-NP	-	10	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	6	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	whose	whose	B-NP	B-NP	-	10	NMOD	-	-
13	increased	increased	B-VP	B-VP	-	12	SBAR	-	-
14	binding	binding	B-NP	B-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	17	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	phosphorylation	phosphorylation	B-NP	B-NP	-	12	NMOD	-	-
18	were	were	B-VP	B-VP	-	12	SBAR	-	-
19	mediated	mediated	I-VP	I-VP	-	18	VC	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	IFN-gamma	IFN-gamma	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	lymphotoxin	lymphotoxin	I-NP	I-NP	-	3	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	stimulated	stimulated	I-VP	I-VP	-	4	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	HTLV-I	HTLV-I	B-NP	B-NP	-	9	NMOD	-	-
8	tax	tax	I-NP	I-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
12	B	B	I-NP	I-NP	-	10	PMOD	-	-
13	in	in	B-PP	B-PP	-	9	NMOD	-	-
14	human	human	B-NP	B-NP	-	16	NMOD	-	-
15	T-cell	T-cell	I-NP	I-NP	-	16	NMOD	-	-
16	lines	lines	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	HTLV-I	HTLV-I	I-NP	I-NP	-	5	NMOD	-	-
3	transcriptional	transcriptional	I-NP	I-NP	-	5	NMOD	-	-
4	activator	activator	I-NP	I-NP	-	5	NMOD	-	-
5	tax	tax	I-NP	I-NP	-	6	SUB	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	used	used	I-VP	I-VP	-	6	VC	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	gain	gain	I-VP	I-VP	-	7	VMOD	-	-
10	insight	insight	B-NP	B-NP	-	9	OBJ	-	-
11	into	into	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	mechanism	mechanism	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	lymphotoxin	lymphotoxin	B-NP	B-NP	-	21	NMOD	-	-
16	(	(	O	O	-	19	P	-	-
17	LT	LT	B-NP	B-NP	-	19	NMOD	-	-
18	;	;	O	O	-	19	P	-	-
19	TNF-beta	TNF-beta	B-NP	B-NP	-	15	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	gene	gene	B-NP	B-NP	-	22	NMOD	-	-
22	induction	induction	I-NP	I-NP	-	14	PMOD	-	-
23	.	.	O	O	-	6	P	-	-

1	Tax-expressing	Tax-expressing	B-NP	B-NP	-	3	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	3	NMOD	-	-
3	lines	lines	I-NP	I-NP	-	4	SUB	-	-
4	produce	produce	B-VP	B-VP	-	0	ROOT	-	-
5	LT	LT	B-NP	B-NP	-	7	NMOD	-	-
6	biologic	biologic	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	4	OBJ	-	-
8	.	.	O	O	-	4	P	-	-

1	An	An	B-NP	B-NP	-	3	NMOD	-	-
2	LT	LT	I-NP	I-NP	-	3	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	8	NMOD	-	-
4	(	(	O	O	-	8	P	-	-
5	LT-293	LT-293	B-NP	B-NP	-	8	NMOD	-	-
6	)	)	O	O	-	8	P	-	-
7	CAT	CAT	B-NP	B-NP	-	8	NMOD	-	-
8	construct	construct	I-NP	I-NP	-	15	SUB	-	-
9	that	that	B-NP	B-NP	-	8	NMOD	-	-
10	contained	contained	B-VP	B-VP	-	9	SBAR	-	-
11	an	an	B-NP	B-NP	-	14	NMOD	-	-
12	NF-kappa	NF-kappa	I-NP	I-NP	-	14	NMOD	-	-
13	B	B	I-NP	I-NP	-	14	NMOD	-	-
14	site	site	I-NP	I-NP	-	10	OBJ	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	active	active	B-ADJP	B-ADJP	-	15	PRD	-	-
17	in	in	B-PP	B-PP	-	16	AMOD	-	-
18	the	the	B-NP	B-NP	-	22	NMOD	-	-
19	LT-producing	LT-producing	I-NP	I-NP	-	22	NMOD	-	-
20	C81-66-45	C81-66-45	I-NP	I-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	line	line	I-NP	I-NP	-	17	PMOD	-	-
23	,	,	O	O	-	22	P	-	-
24	which	which	B-NP	B-NP	-	22	NMOD	-	-
25	contains	contains	B-VP	B-VP	-	24	SBAR	-	-
26	defective	defective	B-NP	B-NP	-	27	NMOD	-	-
27	HTLV-I	HTLV-I	I-NP	I-NP	-	25	OBJ	-	-
28	but	but	O	O	-	25	VMOD	-	-
29	expresses	expresses	B-VP	B-VP	-	25	VMOD	-	-
30	tax	tax	B-NP	B-NP	-	29	OBJ	-	-
31	.	.	O	O	-	15	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	observation	observation	I-NP	I-NP	-	8	NMOD	-	-
3	that	that	B-SBAR	B-SBAR	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	8	NMOD	-	-
5	mutated	mutated	I-NP	I-NP	-	8	NMOD	-	-
6	LT-kappa	LT-kappa	I-NP	I-NP	-	8	NMOD	-	-
7	B	B	I-NP	I-NP	-	8	NMOD	-	-
8	construct	construct	I-NP	I-NP	-	12	SUB	-	-
9	(	(	O	O	-	10	P	-	-
10	M1-CAT	M1-CAT	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	was	was	B-VP	B-VP	-	0	ROOT	-	-
13	inactive	inactive	B-ADJP	B-ADJP	-	12	PRD	-	-
14	in	in	B-PP	B-PP	-	13	AMOD	-	-
15	C81-66-45	C81-66-45	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	12	P	-	-
17	confirmed	confirmed	B-VP	B-VP	-	12	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	importance	importance	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	NF-kappa	NF-kappa	B-NP	B-NP	-	22	NMOD	-	-
22	B	B	I-NP	I-NP	-	20	PMOD	-	-
23	in	in	B-PP	B-PP	-	19	NMOD	-	-
24	LT	LT	B-NP	B-NP	-	26	NMOD	-	-
25	gene	gene	I-NP	I-NP	-	26	NMOD	-	-
26	expression	expression	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	12	P	-	-

1	Tax	Tax	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	transfected	transfected	I-VP	I-VP	-	2	VC	-	-
4	into	into	B-PP	B-PP	-	3	VMOD	-	-
5	HTLV-I-negative	HTLV-I-negative	B-NP	B-NP	-	8	NMOD	-	-
6	human	human	I-NP	I-NP	-	8	NMOD	-	-
7	T-cell	T-cell	I-NP	I-NP	-	8	NMOD	-	-
8	lines	lines	I-NP	I-NP	-	4	PMOD	-	-
9	.	.	O	O	-	2	P	-	-

1	Jurkat	Jurkat	B-NP	B-NP	-	3	NMOD	-	-
2	T	T	I-NP	I-NP	-	3	NMOD	-	-
3	cells	cells	I-NP	I-NP	-	7	SUB	-	-
4	stably	stably	B-VP	B-VP	-	5	VMOD	-	-
5	expressing	expressing	I-VP	I-VP	-	3	NMOD	-	-
6	tax	tax	B-NP	B-NP	-	5	OBJ	-	-
7	contained	contained	B-VP	B-VP	-	0	ROOT	-	-
8	elevated	elevated	B-NP	B-NP	-	9	NMOD	-	-
9	levels	levels	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
12	B	B	I-NP	I-NP	-	10	PMOD	-	-
13	that	that	B-NP	B-NP	-	9	NMOD	-	-
14	directly	directly	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	bound	bound	B-VP	B-VP	-	13	SBAR	-	-
16	to	to	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	LT-kappa	LT-kappa	I-NP	I-NP	-	20	NMOD	-	-
19	B	B	I-NP	I-NP	-	20	NMOD	-	-
20	site	site	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	7	P	-	-

1	Tax	Tax	B-NP	B-NP	-	10	SUB	-	-
2	co-transfected	co-transfected	B-VP	B-VP	-	1	NMOD	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	reporter	reporter	B-NP	B-NP	-	5	NMOD	-	-
5	constructs	constructs	I-NP	I-NP	-	3	PMOD	-	-
6	into	into	B-PP	B-PP	-	2	VMOD	-	-
7	Jurkat	Jurkat	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	maximally	maximally	B-ADVP	B-ADVP	-	10	VMOD	-	-
10	activated	activated	B-VP	B-VP	-	0	ROOT	-	-
11	HTLV-I-LTR-CAT	HTLV-I-LTR-CAT	B-NP	B-NP	-	14	NMOD	-	-
12	and	and	I-NP	I-NP	-	14	NMOD	-	-
13	kappa	kappa	I-NP	I-NP	-	14	NMOD	-	-
14	B-fos-CAT	B-fos-CAT	I-NP	I-NP	-	10	OBJ	-	-
15	and	and	O	O	-	10	VMOD	-	-
16	also	also	B-ADVP	B-ADVP	-	10	VMOD	-	-
17	activated	activated	B-VP	B-VP	-	10	VMOD	-	-
18	LT-293	LT-293	B-NP	B-NP	-	17	OBJ	-	-
19	to	to	B-PP	B-PP	-	17	VMOD	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	lesser	lesser	I-NP	I-NP	-	22	NMOD	-	-
22	extent	extent	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	10	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	JM	JM	B-NP	B-NP	-	4	NMOD	-	-
3	T	T	I-NP	I-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	tax	tax	B-NP	B-NP	-	7	SUB	-	-
7	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
8	LT-293	LT-293	B-NP	B-NP	-	9	NMOD	-	-
9	activity	activity	I-NP	I-NP	-	7	OBJ	-	-
10	by	by	B-PP	B-PP	-	7	VMOD	-	-
11	two-	two-	B-NP	B-NP	-	10	PMOD	-	-
12	to	to	B-PP	B-PP	-	7	VMOD	-	-
13	four-fold	four-fold	B-NP	B-NP	-	12	PMOD	-	-
14	,	,	O	O	-	7	P	-	-
15	though	though	B-SBAR	B-SBAR	-	7	VMOD	-	-
16	there	there	B-NP	B-NP	-	17	SUB	-	-
17	was	was	B-VP	B-VP	-	15	SBAR	-	-
18	no	no	B-NP	B-NP	-	19	NMOD	-	-
19	induction	induction	I-NP	I-NP	-	17	PRD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	M1-CAT	M1-CAT	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	increase	increase	I-NP	I-NP	-	7	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	LT-293	LT-293	B-NP	B-NP	-	6	NMOD	-	-
5	CAT	CAT	I-NP	I-NP	-	6	NMOD	-	-
6	activity	activity	I-NP	I-NP	-	3	PMOD	-	-
7	mirrored	mirrored	B-VP	B-VP	-	0	ROOT	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	increase	increase	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	LT	LT	B-NP	B-NP	-	13	NMOD	-	-
12	biologic	biologic	I-NP	I-NP	-	13	NMOD	-	-
13	activity	activity	I-NP	I-NP	-	10	PMOD	-	-
14	seen	seen	B-VP	B-VP	-	13	NMOD	-	-
15	under	under	B-PP	B-PP	-	14	VMOD	-	-
16	these	these	B-NP	B-NP	-	17	NMOD	-	-
17	conditions	conditions	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	7	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	17	SUB	-	-
3	,	,	O	O	-	5	P	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	first	first	I-NP	I-NP	-	2	NMOD	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	demonstrate	demonstrate	I-VP	I-VP	-	5	NMOD	-	-
8	induction	induction	B-NP	B-NP	-	7	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	LT	LT	B-NP	B-NP	-	12	NMOD	-	-
11	promoter	promoter	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	9	PMOD	-	-
13	over	over	B-PP	B-PP	-	8	NMOD	-	-
14	basal	basal	B-NP	B-NP	-	15	NMOD	-	-
15	levels	levels	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	2	P	-	-
17	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	HTLV-I	HTLV-I	B-NP	B-NP	-	20	NMOD	-	-
20	tax	tax	I-NP	I-NP	-	21	SUB	-	-
21	causes	causes	B-VP	B-VP	-	18	SBAR	-	-
22	low-level	low-level	B-NP	B-NP	-	23	NMOD	-	-
23	activation	activation	I-NP	I-NP	-	21	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	both	both	O	O	-	31	NMOD	-	-
26	endogenous	endogenous	B-NP	B-NP	-	27	NMOD	-	-
27	LT	LT	I-NP	I-NP	-	31	NMOD	-	-
28	and	and	O	O	-	31	NMOD	-	-
29	the	the	B-NP	B-NP	-	31	NMOD	-	-
30	LT	LT	I-NP	I-NP	-	31	NMOD	-	-
31	promoter	promoter	I-NP	I-NP	-	24	PMOD	-	-
32	,	,	O	O	-	21	P	-	-
33	at	at	B-ADVP	B-ADVP	-	35	PMOD	-	-
34	least	least	I-ADVP	I-ADVP	-	33	AMOD	-	-
35	in	in	B-PP	B-PP	-	21	VMOD	-	-
36	part	part	B-NP	B-NP	-	35	PMOD	-	-
37	through	through	B-PP	B-PP	-	35	PMOD	-	-
38	activation	activation	B-NP	B-NP	-	37	PMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	NF-kappa	NF-kappa	B-NP	B-NP	-	41	NMOD	-	-
41	B	B	I-NP	I-NP	-	39	PMOD	-	-
42	.	.	O	O	-	17	P	-	-

1	Induction	Induction	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	tyrosine	tyrosine	B-NP	B-NP	-	4	NMOD	-	-
4	phosphorylation	phosphorylation	I-NP	I-NP	-	7	NMOD	-	-
5	and	and	O	O	-	7	NMOD	-	-
6	T-cell	T-cell	B-NP	B-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	2	PMOD	-	-
8	by	by	B-PP	B-PP	-	1	NMOD	-	-
9	vanadate	vanadate	B-NP	B-NP	-	10	NMOD	-	-
10	peroxide	peroxide	I-NP	I-NP	-	13	NMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	an	an	B-NP	B-NP	-	13	NMOD	-	-
13	inhibitor	inhibitor	I-NP	I-NP	-	8	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	protein	protein	B-NP	B-NP	-	17	NMOD	-	-
16	tyrosine	tyrosine	I-NP	I-NP	-	17	NMOD	-	-
17	phosphatases	phosphatases	I-NP	I-NP	-	14	PMOD	-	-
18	.	.	O	O	-	1	P	-	-

1	Rapid	Rapid	B-NP	B-NP	-	3	NMOD	-	-
2	tyrosine	tyrosine	I-NP	I-NP	-	3	NMOD	-	-
3	phosphorylation	phosphorylation	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	key	key	B-NP	B-NP	-	7	NMOD	-	-
6	cellular	cellular	I-NP	I-NP	-	7	NMOD	-	-
7	proteins	proteins	I-NP	I-NP	-	4	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	crucial	crucial	I-NP	I-NP	-	11	NMOD	-	-
11	event	event	I-NP	I-NP	-	8	PRD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	transduction	transduction	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	activation	activation	B-NP	B-NP	-	17	NMOD	-	-
17	signals	signals	I-NP	I-NP	-	15	PMOD	-	-
18	to	to	B-PP	B-PP	-	14	NMOD	-	-
19	T-lymphocytes	T-lymphocytes	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	8	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	regulatory	regulatory	I-NP	I-NP	-	3	NMOD	-	-
3	role	role	I-NP	I-NP	-	14	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	protein	protein	B-NP	B-NP	-	7	NMOD	-	-
6	tyrosine	tyrosine	I-NP	I-NP	-	7	NMOD	-	-
7	phosphatases	phosphatases	I-NP	I-NP	-	4	PMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	PTPases	PTPases	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	in	in	B-PP	B-PP	-	3	NMOD	-	-
12	this	this	B-NP	B-NP	-	13	NMOD	-	-
13	process	process	I-NP	I-NP	-	11	PMOD	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	explored	explored	I-VP	I-VP	-	14	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	studying	studying	B-VP	B-VP	-	16	PMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	effects	effects	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	a	a	B-NP	B-NP	-	24	NMOD	-	-
22	powerful	powerful	I-NP	I-NP	-	24	NMOD	-	-
23	PTPase	PTPase	I-NP	I-NP	-	24	NMOD	-	-
24	inhibitor	inhibitor	I-NP	I-NP	-	20	PMOD	-	-
25	,	,	O	O	-	29	P	-	-
26	vanadate	vanadate	B-NP	B-NP	-	27	NMOD	-	-
27	peroxide	peroxide	I-NP	I-NP	-	29	NMOD	-	-
28	(	(	O	O	-	29	P	-	-
29	pervanadate	pervanadate	B-NP	B-NP	-	24	NMOD	-	-
30	)	)	O	O	-	29	P	-	-
31	,	,	O	O	-	19	P	-	-
32	on	on	B-PP	B-PP	-	19	NMOD	-	-
33	the	the	B-NP	B-NP	-	35	NMOD	-	-
34	activation	activation	I-NP	I-NP	-	35	NMOD	-	-
35	cascade	cascade	I-NP	I-NP	-	32	PMOD	-	-
36	of	of	B-PP	B-PP	-	35	NMOD	-	-
37	Jurkat	Jurkat	B-NP	B-NP	-	40	NMOD	-	-
38	human	human	I-NP	I-NP	-	40	NMOD	-	-
39	leukaemic	leukaemic	I-NP	I-NP	-	40	NMOD	-	-
40	T-cells	T-cells	I-NP	I-NP	-	36	PMOD	-	-
41	.	.	O	O	-	14	P	-	-

1	Pervanadate	Pervanadate	B-NP	B-NP	-	2	SUB	-	-
2	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
3	activation	activation	B-NP	B-NP	-	2	OBJ	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	tyrosine	tyrosine	I-NP	I-NP	-	7	NMOD	-	-
7	kinases	kinases	I-NP	I-NP	-	4	PMOD	-	-
8	lck	lck	I-NP	I-NP	-	10	NMOD	-	-
9	and	and	I-NP	I-NP	-	10	NMOD	-	-
10	fyn	fyn	I-NP	I-NP	-	7	NMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	4-	4-	B-NP	B-NP	-	7	NMOD	-	-
13	and	and	O	O	-	15	AMOD	-	-
14	3-fold	3-fold	B-ADJP	B-ADJP	-	15	AMOD	-	-
15	respectively	respectively	I-ADJP	I-ADJP	-	12	NMOD	-	-
16	)	)	O	O	-	7	P	-	-
17	and	and	O	O	-	20	NMOD	-	-
18	a	a	B-NP	B-NP	-	20	NMOD	-	-
19	dramatic	dramatic	I-NP	I-NP	-	20	NMOD	-	-
20	increase	increase	I-NP	I-NP	-	2	OBJ	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	tyrosine	tyrosine	B-NP	B-NP	-	23	NMOD	-	-
23	phosphorylation	phosphorylation	I-NP	I-NP	-	21	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	cellular	cellular	B-NP	B-NP	-	26	NMOD	-	-
26	proteins	proteins	I-NP	I-NP	-	24	PMOD	-	-
27	,	,	O	O	-	31	P	-	-
28	notably	notably	B-NP	B-NP	-	31	NMOD	-	-
29	phospholipase	phospholipase	I-NP	I-NP	-	31	NMOD	-	-
30	C	C	I-NP	I-NP	-	31	NMOD	-	-
31	gamma	gamma	I-NP	I-NP	-	24	PMOD	-	-
32	<num>	<num>	I-NP	I-NP	-	31	NMOD	-	-
33	.	.	O	O	-	2	P	-	-

1	After	After	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	event	event	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	observed	observed	B-VP	B-VP	-	0	ROOT	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	rise	rise	I-NP	I-NP	-	6	OBJ	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	intracellular	intracellular	B-NP	B-NP	-	12	NMOD	-	-
11	Ca2+	Ca2+	I-NP	I-NP	-	12	NMOD	-	-
12	concentration	concentration	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	6	P	-	-
14	corresponding	corresponding	B-VP	B-VP	-	6	VMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	an	an	B-NP	B-NP	-	17	NMOD	-	-
17	influx	influx	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	3	SUB	-	-
3	required	required	B-VP	B-VP	-	0	ROOT	-	-
4	surface	surface	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	CD45	CD45	I-NP	I-NP	-	9	NMOD	-	-
9	PTPase	PTPase	I-NP	I-NP	-	6	PMOD	-	-
10	and	and	O	O	-	3	VMOD	-	-
11	was	was	B-VP	B-VP	-	3	VMOD	-	-
12	not	not	I-VP	I-VP	-	11	VMOD	-	-
13	observed	observed	I-VP	I-VP	-	11	VC	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	CD45-deficient	CD45-deficient	B-NP	B-NP	-	16	NMOD	-	-
16	variants	variants	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	Jurkat	Jurkat	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	13	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	CD45-negative	CD45-negative	I-NP	I-NP	-	4	NMOD	-	-
4	variant	variant	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	13	P	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	effect	effect	I-NP	I-NP	-	13	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	pervanadate	pervanadate	B-NP	B-NP	-	8	PMOD	-	-
10	on	on	B-PP	B-PP	-	7	NMOD	-	-
11	tyrosine	tyrosine	B-NP	B-NP	-	12	NMOD	-	-
12	phosphorylation	phosphorylation	I-NP	I-NP	-	10	PMOD	-	-
13	was	was	B-VP	B-VP	-	0	ROOT	-	-
14	globally	globally	I-VP	I-VP	-	13	VMOD	-	-
15	decreased	decreased	I-VP	I-VP	-	13	VC	-	-
16	and	and	O	O	-	20	VMOD	-	-
17	some	some	B-NP	B-NP	-	19	NMOD	-	-
18	phosphorylated	phosphorylated	I-NP	I-NP	-	19	NMOD	-	-
19	substrates	substrates	I-NP	I-NP	-	20	SUB	-	-
20	were	were	B-VP	B-VP	-	13	VMOD	-	-
21	specifically	specifically	B-ADJP	B-ADJP	-	22	AMOD	-	-
22	missing	missing	I-ADJP	I-ADJP	-	20	PRD	-	-
23	.	.	O	O	-	13	P	-	-

1	Pervanadate	Pervanadate	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	stimulated	stimulated	B-VP	B-VP	-	0	ROOT	-	-
4	transcription	transcription	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	c-fos	c-fos	I-NP	I-NP	-	8	NMOD	-	-
8	gene	gene	I-NP	I-NP	-	5	PMOD	-	-
9	and	and	O	O	-	10	NMOD	-	-
10	accumulation	accumulation	B-NP	B-NP	-	5	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	its	its	B-NP	B-NP	-	13	NMOD	-	-
13	mRNA	mRNA	I-NP	I-NP	-	11	PMOD	-	-
14	as	as	B-CONJP	B-CONJP	-	19	NMOD	-	-
15	well	well	I-CONJP	I-CONJP	-	14	DEP	-	-
16	as	as	I-CONJP	I-CONJP	-	14	DEP	-	-
17	several	several	B-NP	B-NP	-	19	NMOD	-	-
18	other	other	I-NP	I-NP	-	19	NMOD	-	-
19	hallmarks	hallmarks	I-NP	I-NP	-	5	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	T-lymphocyte	T-lymphocyte	B-NP	B-NP	-	22	NMOD	-	-
22	activation	activation	I-NP	I-NP	-	20	PMOD	-	-
23	such	such	B-PP	B-PP	-	24	PMOD	-	-
24	as	as	I-PP	I-PP	-	22	NMOD	-	-
25	surface	surface	B-NP	B-NP	-	26	NMOD	-	-
26	expression	expression	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	CD69	CD69	I-NP	I-NP	-	30	NMOD	-	-
30	antigen	antigen	I-NP	I-NP	-	27	PMOD	-	-
31	and	and	O	O	-	36	NMOD	-	-
32	the	the	B-NP	B-NP	-	36	NMOD	-	-
33	interleukin	interleukin	I-NP	I-NP	-	36	NMOD	-	-
34	<num>	<num>	I-NP	I-NP	-	36	NMOD	-	-
35	receptor	receptor	I-NP	I-NP	-	36	NMOD	-	-
36	alpha-chain	alpha-chain	I-NP	I-NP	-	27	PMOD	-	-
37	(	(	O	O	-	38	P	-	-
38	CD25	CD25	B-NP	B-NP	-	36	NMOD	-	-
39	)	)	O	O	-	38	P	-	-
40	.	.	O	O	-	3	P	-	-

1	Pervanadate	Pervanadate	B-NP	B-NP	-	2	SUB	-	-
2	synergized	synergized	B-VP	B-VP	-	0	ROOT	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	signals	signals	B-NP	B-NP	-	3	PMOD	-	-
5	delivered	delivered	B-VP	B-VP	-	4	NMOD	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	T-cell	T-cell	B-NP	B-NP	-	10	NMOD	-	-
8	antigen	antigen	I-NP	I-NP	-	10	NMOD	-	-
9	receptor	receptor	I-NP	I-NP	-	10	NMOD	-	-
10	engagement	engagement	I-NP	I-NP	-	6	PMOD	-	-
11	or	or	B-PP	B-PP	-	6	PMOD	-	-
12	by	by	B-PP	B-PP	-	6	PMOD	-	-
13	a	a	B-NP	B-NP	-	15	NMOD	-	-
14	phorbol	phorbol	I-NP	I-NP	-	15	NMOD	-	-
15	ester	ester	I-NP	I-NP	-	12	PMOD	-	-
16	to	to	B-VP	B-VP	-	17	VMOD	-	-
17	induce	induce	I-VP	I-VP	-	15	NMOD	-	-
18	interleukin	interleukin	B-NP	B-NP	-	20	NMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	20	NMOD	-	-
20	production	production	I-NP	I-NP	-	17	OBJ	-	-
21	.	.	O	O	-	2	P	-	-

1	Pervanadate	Pervanadate	B-NP	B-NP	-	2	SUB	-	-
2	activated	activated	B-VP	B-VP	-	0	ROOT	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
4	B	B	I-NP	I-NP	-	2	OBJ	-	-
5	,	,	O	O	-	2	P	-	-
6	as	as	B-SBAR	B-SBAR	-	2	VMOD	-	-
7	shown	shown	B-VP	B-VP	-	6	SBAR	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	an	an	B-NP	B-NP	-	10	NMOD	-	-
10	increase	increase	I-NP	I-NP	-	8	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	DNA-binding	DNA-binding	B-NP	B-NP	-	13	NMOD	-	-
13	activity	activity	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	this	this	B-NP	B-NP	-	17	NMOD	-	-
16	transcription	transcription	I-NP	I-NP	-	17	NMOD	-	-
17	factor	factor	I-NP	I-NP	-	14	PMOD	-	-
18	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	thus	thus	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	conclude	conclude	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	PTPases	PTPases	B-NP	B-NP	-	6	SUB	-	-
6	play	play	B-VP	B-VP	-	4	SBAR	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	crucial	crucial	I-NP	I-NP	-	9	NMOD	-	-
9	role	role	I-NP	I-NP	-	6	OBJ	-	-
10	in	in	B-PP	B-PP	-	6	VMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	negative	negative	I-NP	I-NP	-	13	NMOD	-	-
13	regulation	regulation	I-NP	I-NP	-	10	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	signal	signal	B-NP	B-NP	-	16	NMOD	-	-
16	transduction	transduction	I-NP	I-NP	-	14	PMOD	-	-
17	culminating	culminating	B-VP	B-VP	-	16	NMOD	-	-
18	in	in	B-PP	B-PP	-	17	VMOD	-	-
19	T-lymphocyte	T-lymphocyte	B-NP	B-NP	-	20	NMOD	-	-
20	activation	activation	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	induction	induction	B-NP	B-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	tyrosine	tyrosine	B-NP	B-NP	-	6	NMOD	-	-
6	phosphorylation	phosphorylation	I-NP	I-NP	-	4	PMOD	-	-
7	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
8	sufficient	sufficient	B-NP	B-NP	-	10	AMOD	-	-
9	per	per	I-NP	I-NP	-	10	NMOD	-	-
10	se	se	I-NP	I-NP	-	7	VMOD	-	-
11	to	to	B-VP	B-VP	-	12	VMOD	-	-
12	initiate	initiate	I-VP	I-VP	-	7	VMOD	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	complete	complete	I-NP	I-NP	-	16	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	16	NMOD	-	-
16	programme	programme	I-NP	I-NP	-	12	OBJ	-	-
17	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	7	NMOD	-	-
2	interleukin-8	interleukin-8	I-NP	I-NP	-	3	NMOD	-	-
3	AP-1	AP-1	I-NP	I-NP	-	7	NMOD	-	-
4	and	and	O	O	-	7	NMOD	-	-
5	kappa	kappa	B-NP	B-NP	-	7	NMOD	-	-
6	B-like	B-like	I-NP	I-NP	-	7	NMOD	-	-
7	sites	sites	I-NP	I-NP	-	8	SUB	-	-
8	are	are	B-VP	B-VP	-	0	ROOT	-	-
9	genetic	genetic	B-NP	B-NP	-	11	NMOD	-	-
10	end	end	I-NP	I-NP	-	11	NMOD	-	-
11	targets	targets	I-NP	I-NP	-	8	PRD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	FK506-sensitive	FK506-sensitive	B-NP	B-NP	-	14	NMOD	-	-
14	pathway	pathway	I-NP	I-NP	-	12	PMOD	-	-
15	accompanied	accompanied	B-VP	B-VP	-	14	NMOD	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	calcium	calcium	B-NP	B-NP	-	18	NMOD	-	-
18	mobilization	mobilization	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	8	P	-	-

1	FK506	FK506	B-NP	B-NP	-	4	NMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	an	an	B-NP	B-NP	-	4	NMOD	-	-
4	immunosuppressant	immunosuppressant	I-NP	I-NP	-	6	SUB	-	-
5	,	,	O	O	-	4	P	-	-
6	inhibits	inhibits	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	production	production	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	several	several	B-NP	B-NP	-	11	NMOD	-	-
11	cytokines	cytokines	I-NP	I-NP	-	9	PMOD	-	-
12	in	in	B-PP	B-PP	-	6	VMOD	-	-
13	T	T	B-NP	B-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	observed	observed	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	FK506	FK506	B-NP	B-NP	-	5	SUB	-	-
5	suppressed	suppressed	B-VP	B-VP	-	3	SBAR	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	transcription	transcription	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	chemotactic	chemotactic	I-NP	I-NP	-	11	NMOD	-	-
11	cytokine	cytokine	I-NP	I-NP	-	8	PMOD	-	-
12	,	,	O	O	-	15	P	-	-
13	interleukin-8	interleukin-8	B-NP	B-NP	-	15	NMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	IL-8	IL-8	B-NP	B-NP	-	11	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	in	in	B-PP	B-PP	-	11	NMOD	-	-
18	a	a	B-NP	B-NP	-	22	NMOD	-	-
19	human	human	I-NP	I-NP	-	22	NMOD	-	-
20	T	T	I-NP	I-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	line	line	I-NP	I-NP	-	25	NMOD	-	-
23	,	,	O	O	-	25	P	-	-
24	Jurkat	Jurkat	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
26	,	,	O	O	-	11	P	-	-
27	activated	activated	B-VP	B-VP	-	11	NMOD	-	-
28	by	by	B-PP	B-PP	-	27	VMOD	-	-
29	phorbol	phorbol	B-NP	B-NP	-	31	NMOD	-	-
30	12-myristate	12-myristate	I-NP	I-NP	-	31	NMOD	-	-
31	13-acetate	13-acetate	I-NP	I-NP	-	40	NMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	PMA	PMA	B-NP	B-NP	-	31	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	and	and	O	O	-	40	NMOD	-	-
36	calcium	calcium	B-NP	B-NP	-	40	NMOD	-	-
37	(	(	O	O	-	38	P	-	-
38	Ca2+	Ca2+	B-NP	B-NP	-	36	NMOD	-	-
39	)	)	O	O	-	38	P	-	-
40	ionophore	ionophore	B-NP	B-NP	-	28	PMOD	-	-
41	(	(	O	O	-	42	P	-	-
42	ionomycin	ionomycin	B-NP	B-NP	-	40	NMOD	-	-
43	)	)	O	O	-	42	P	-	-
44	.	.	O	O	-	2	P	-	-

1	By	By	B-PP	B-PP	-	17	VMOD	-	-
2	deleted	deleted	B-VP	B-VP	-	1	SBAR	-	-
3	and	and	O	O	-	2	VMOD	-	-
4	mutated	mutated	B-VP	B-VP	-	2	VMOD	-	-
5	analysis	analysis	B-NP	B-NP	-	4	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	IL-8	IL-8	I-NP	I-NP	-	9	NMOD	-	-
9	promoters	promoters	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	16	P	-	-
11	the	the	B-NP	B-NP	-	16	NMOD	-	-
12	AP-1	AP-1	I-NP	I-NP	-	16	NMOD	-	-
13	and	and	I-NP	I-NP	-	16	NMOD	-	-
14	kappa	kappa	I-NP	I-NP	-	16	NMOD	-	-
15	B-like	B-like	I-NP	I-NP	-	16	NMOD	-	-
16	sites	sites	I-NP	I-NP	-	6	PMOD	-	-
17	were	were	B-VP	B-VP	-	0	ROOT	-	-
18	identified	identified	I-VP	I-VP	-	17	VC	-	-
19	as	as	B-PP	B-PP	-	18	VMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	responsive	responsive	I-NP	I-NP	-	22	NMOD	-	-
22	elements	elements	I-NP	I-NP	-	19	PMOD	-	-
23	for	for	B-PP	B-PP	-	22	NMOD	-	-
24	PMA	PMA	B-NP	B-NP	-	26	NMOD	-	-
25	and	and	I-NP	I-NP	-	26	NMOD	-	-
26	ionomycin	ionomycin	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	17	P	-	-

1	FK506	FK506	B-NP	B-NP	-	2	SUB	-	-
2	suppressed	suppressed	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	transcriptions	transcriptions	I-NP	I-NP	-	2	OBJ	-	-
5	through	through	B-PP	B-PP	-	2	VMOD	-	-
6	the	the	B-NP	B-NP	-	11	NMOD	-	-
7	AP-1	AP-1	I-NP	I-NP	-	11	NMOD	-	-
8	or	or	I-NP	I-NP	-	11	NMOD	-	-
9	kappa	kappa	I-NP	I-NP	-	11	NMOD	-	-
10	B-like	B-like	I-NP	I-NP	-	11	NMOD	-	-
11	sites	sites	I-NP	I-NP	-	5	PMOD	-	-
12	induced	induced	B-VP	B-VP	-	11	NMOD	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	PMA	PMA	B-NP	B-NP	-	21	NMOD	-	-
15	plus	plus	O	O	-	21	NMOD	-	-
16	Ca	Ca	B-NP	B-NP	-	21	NMOD	-	-
17	(	(	O	O	-	18	P	-	-
18	2+	2+	B-ADJP	B-ADJP	-	16	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	-mobilizing	-mobilizing	B-NP	B-NP	-	21	NMOD	-	-
21	agents	agents	I-NP	I-NP	-	13	PMOD	-	-
22	,	,	O	O	-	13	P	-	-
23	but	but	B-CONJP	B-CONJP	-	13	PMOD	-	-
24	not	not	I-CONJP	I-CONJP	-	23	DEP	-	-
25	those	those	B-NP	B-NP	-	24	NMOD	-	-
26	induced	induced	B-VP	B-VP	-	25	NMOD	-	-
27	by	by	B-PP	B-PP	-	26	VMOD	-	-
28	Ca	Ca	B-NP	B-NP	-	33	NMOD	-	-
29	(	(	O	O	-	30	P	-	-
30	2+	2+	B-ADJP	B-ADJP	-	28	NMOD	-	-
31	)	)	O	O	-	30	P	-	-
32	-independent	-independent	B-NP	B-NP	-	33	NMOD	-	-
33	stimuli	stimuli	I-NP	I-NP	-	27	PMOD	-	-
34	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	gel	gel	B-NP	B-NP	-	4	NMOD	-	-
3	retardation	retardation	I-NP	I-NP	-	4	NMOD	-	-
4	analysis	analysis	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	FK506	FK506	B-NP	B-NP	-	7	SUB	-	-
7	had	had	B-VP	B-VP	-	0	ROOT	-	-
8	little	little	B-NP	B-NP	-	9	NMOD	-	-
9	effect	effect	I-NP	I-NP	-	7	OBJ	-	-
10	on	on	B-PP	B-PP	-	7	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	binding	binding	I-NP	I-NP	-	10	PMOD	-	-
13	to	to	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	AP-1	AP-1	I-NP	I-NP	-	16	NMOD	-	-
16	site	site	I-NP	I-NP	-	13	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	PMA/ionomycin-induced	PMA/ionomycin-induced	B-NP	B-NP	-	20	NMOD	-	-
19	nuclear	nuclear	I-NP	I-NP	-	20	NMOD	-	-
20	factors	factors	I-NP	I-NP	-	17	PMOD	-	-
21	,	,	O	O	-	20	P	-	-
22	which	which	B-NP	B-NP	-	20	NMOD	-	-
23	were	were	B-VP	B-VP	-	22	SBAR	-	-
24	recognized	recognized	I-VP	I-VP	-	23	VC	-	-
25	with	with	B-PP	B-PP	-	24	VMOD	-	-
26	anti-JunD	anti-JunD	B-NP	B-NP	-	29	NMOD	-	-
27	or	or	I-NP	I-NP	-	29	NMOD	-	-
28	c-Fos	c-Fos	I-NP	I-NP	-	29	NMOD	-	-
29	antibody	antibody	I-NP	I-NP	-	25	PMOD	-	-
30	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	12	P	-	-
4	FK506	FK506	B-NP	B-NP	-	6	NMOD	-	-
5	or	or	O	O	-	6	NMOD	-	-
6	EGTA	EGTA	B-NP	B-NP	-	12	SUB	-	-
7	(	(	O	O	-	9	P	-	-
8	Ca2+	Ca2+	B-NP	B-NP	-	9	NMOD	-	-
9	chelator	chelator	I-NP	I-NP	-	6	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	similarly	similarly	B-VP	B-VP	-	12	VMOD	-	-
12	affected	affected	I-VP	I-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	formation	formation	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	kappa	kappa	B-NP	B-NP	-	20	NMOD	-	-
17	B-like	B-like	I-NP	I-NP	-	20	NMOD	-	-
18	site	site	I-NP	I-NP	-	20	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	20	NMOD	-	-
20	complexes	complexes	I-NP	I-NP	-	15	PMOD	-	-
21	,	,	O	O	-	20	P	-	-
22	which	which	B-NP	B-NP	-	20	NMOD	-	-
23	were	were	B-VP	B-VP	-	22	SBAR	-	-
24	not	not	I-VP	I-VP	-	23	VMOD	-	-
25	recognized	recognized	I-VP	I-VP	-	23	VC	-	-
26	by	by	B-PP	B-PP	-	25	VMOD	-	-
27	any	any	B-NP	B-NP	-	28	NMOD	-	-
28	antibodies	antibodies	I-NP	I-NP	-	26	PMOD	-	-
29	against	against	B-PP	B-PP	-	28	NMOD	-	-
30	the	the	B-NP	B-NP	-	34	NMOD	-	-
31	human	human	I-NP	I-NP	-	34	NMOD	-	-
32	Rel	Rel	I-NP	I-NP	-	34	NMOD	-	-
33	family	family	I-NP	I-NP	-	34	NMOD	-	-
34	proteins	proteins	I-NP	I-NP	-	29	PMOD	-	-
35	(	(	O	O	-	43	P	-	-
36	c-Rel	c-Rel	B-NP	B-NP	-	43	NMOD	-	-
37	,	,	O	O	-	43	P	-	-
38	p65	p65	B-NP	B-NP	-	43	NMOD	-	-
39	,	,	O	O	-	43	P	-	-
40	p50	p50	B-NP	B-NP	-	43	NMOD	-	-
41	,	,	O	O	-	43	P	-	-
42	and	and	O	O	-	43	NMOD	-	-
43	p49	p49	B-NP	B-NP	-	34	NMOD	-	-
44	)	)	O	O	-	43	P	-	-
45	.	.	O	O	-	12	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	confirmed	confirmed	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	previous	previous	I-NP	I-NP	-	7	NMOD	-	-
7	report	report	I-NP	I-NP	-	4	OBJ	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	FK506	FK506	B-NP	B-NP	-	10	SUB	-	-
10	suppressed	suppressed	B-VP	B-VP	-	8	SBAR	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	PMA/ionomycin-induced	PMA/ionomycin-induced	I-NP	I-NP	-	13	NMOD	-	-
13	activation	activation	I-NP	I-NP	-	31	SUB	-	-
14	through	through	B-PP	B-PP	-	13	NMOD	-	-
15	authentic	authentic	B-NP	B-NP	-	18	NMOD	-	-
16	kappa	kappa	I-NP	I-NP	-	18	NMOD	-	-
17	B	B	I-NP	I-NP	-	18	NMOD	-	-
18	site	site	I-NP	I-NP	-	14	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	immunoglobulin	immunoglobulin	B-NP	B-NP	-	24	NMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	Ig	Ig	B-NP	B-NP	-	20	NMOD	-	-
23	)	)	O	O	-	24	P	-	-
24	gene	gene	B-NP	B-NP	-	19	PMOD	-	-
25	,	,	O	O	-	31	P	-	-
26	to	to	B-PP	B-PP	-	30	NMOD	-	-
27	which	which	B-NP	B-NP	-	26	PMOD	-	-
28	NF-kappa	NF-kappa	B-NP	B-NP	-	30	NMOD	-	-
29	B	B	I-NP	I-NP	-	30	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	31	SUB	-	-
31	was	was	B-VP	B-VP	-	8	SBAR	-	-
32	also	also	I-VP	I-VP	-	31	VMOD	-	-
33	decreased	decreased	I-VP	I-VP	-	31	VC	-	-
34	by	by	B-PP	B-PP	-	33	VMOD	-	-
35	FK506	FK506	B-NP	B-NP	-	34	PMOD	-	-
36	,	,	O	O	-	4	P	-	-
37	indicating	indicating	B-VP	B-VP	-	4	VMOD	-	-
38	that	that	B-SBAR	B-SBAR	-	37	VMOD	-	-
39	both	both	O	O	-	48	NMOD	-	-
40	IL-8	IL-8	B-NP	B-NP	-	43	NMOD	-	-
41	kappa	kappa	I-NP	I-NP	-	43	NMOD	-	-
42	B-like	B-like	I-NP	I-NP	-	43	NMOD	-	-
43	site	site	I-NP	I-NP	-	48	NMOD	-	-
44	and	and	I-NP	I-NP	-	48	NMOD	-	-
45	Ig	Ig	I-NP	I-NP	-	48	NMOD	-	-
46	kappa	kappa	I-NP	I-NP	-	48	NMOD	-	-
47	B	B	I-NP	I-NP	-	48	NMOD	-	-
48	site	site	I-NP	I-NP	-	49	SUB	-	-
49	are	are	B-VP	B-VP	-	38	SBAR	-	-
50	FK506-sensitive	FK506-sensitive	B-ADJP	B-ADJP	-	49	PRD	-	-
51	in	in	B-PP	B-PP	-	50	AMOD	-	-
52	spite	spite	B-NP	B-NP	-	51	PMOD	-	-
53	of	of	B-PP	B-PP	-	52	NMOD	-	-
54	the	the	B-NP	B-NP	-	55	NMOD	-	-
55	difference	difference	I-NP	I-NP	-	53	PMOD	-	-
56	of	of	B-PP	B-PP	-	55	NMOD	-	-
57	binding	binding	B-NP	B-NP	-	58	NMOD	-	-
58	factors	factors	I-NP	I-NP	-	56	PMOD	-	-
59	.	.	O	O	-	4	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	not	not	B-CONJP	B-CONJP	-	13	NMOD	-	-
6	only	only	I-CONJP	I-CONJP	-	5	DEP	-	-
7	the	the	B-NP	B-NP	-	13	NMOD	-	-
8	reported	reported	I-NP	I-NP	-	13	NMOD	-	-
9	IL-2	IL-2	I-NP	I-NP	-	13	NMOD	-	-
10	NF-AT	NF-AT	I-NP	I-NP	-	13	NMOD	-	-
11	and	and	I-NP	I-NP	-	13	NMOD	-	-
12	NFIL-2A	NFIL-2A	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	28	NMOD	-	-
14	and	and	O	O	-	18	NMOD	-	-
15	Ig	Ig	B-NP	B-NP	-	18	NMOD	-	-
16	kappa	kappa	I-NP	I-NP	-	18	NMOD	-	-
17	B	B	I-NP	I-NP	-	18	NMOD	-	-
18	site	site	I-NP	I-NP	-	28	NMOD	-	-
19	,	,	O	O	-	28	P	-	-
20	but	but	B-CONJP	B-CONJP	-	28	NMOD	-	-
21	also	also	I-CONJP	I-CONJP	-	20	DEP	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	IL-8	IL-8	I-NP	I-NP	-	24	NMOD	-	-
24	AP-1	AP-1	I-NP	I-NP	-	28	NMOD	-	-
25	and	and	O	O	-	28	NMOD	-	-
26	kappa	kappa	B-NP	B-NP	-	28	NMOD	-	-
27	B-like	B-like	I-NP	I-NP	-	28	NMOD	-	-
28	sites	sites	I-NP	I-NP	-	29	SUB	-	-
29	are	are	B-VP	B-VP	-	4	SBAR	-	-
30	terminals	terminals	B-NP	B-NP	-	29	PRD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	FK506-sensitive	FK506-sensitive	B-NP	B-NP	-	33	NMOD	-	-
33	pathway	pathway	I-NP	I-NP	-	31	PMOD	-	-
34	involving	involving	B-VP	B-VP	-	33	NMOD	-	-
35	Ca2+	Ca2+	B-NP	B-NP	-	36	NMOD	-	-
36	mobilization	mobilization	I-NP	I-NP	-	34	OBJ	-	-
37	.	.	O	O	-	3	P	-	-

1	Monocyte	Monocyte	B-NP	B-NP	-	2	NMOD	-	-
2	tethering	tethering	I-NP	I-NP	-	5	SUB	-	-
3	by	by	B-PP	B-PP	-	2	NMOD	-	-
4	P-selectin	P-selectin	B-NP	B-NP	-	3	PMOD	-	-
5	regulates	regulates	B-VP	B-VP	-	0	ROOT	-	-
6	monocyte	monocyte	B-NP	B-NP	-	8	NMOD	-	-
7	chemotactic	chemotactic	I-NP	I-NP	-	8	NMOD	-	-
8	protein-1	protein-1	I-NP	I-NP	-	13	NMOD	-	-
9	and	and	O	O	-	13	NMOD	-	-
10	tumor	tumor	B-NP	B-NP	-	13	NMOD	-	-
11	necrosis	necrosis	I-NP	I-NP	-	13	NMOD	-	-
12	factor-alpha	factor-alpha	I-NP	I-NP	-	13	NMOD	-	-
13	secretion	secretion	I-NP	I-NP	-	5	OBJ	-	-
14	.	.	O	O	-	5	P	-	-

1	Signal	Signal	B-NP	B-NP	-	2	NMOD	-	-
2	integration	integration	I-NP	I-NP	-	6	NMOD	-	-
3	and	and	O	O	-	6	NMOD	-	-
4	NF-kappa	NF-kappa	B-NP	B-NP	-	6	NMOD	-	-
5	B	B	I-NP	I-NP	-	6	NMOD	-	-
6	translocation	translocation	I-NP	I-NP	-	8	SUB	-	-
7	[	[	O	O	-	8	P	-	-
8	see	see	B-VP	B-VP	-	0	ROOT	-	-
9	comments	comments	B-NP	B-NP	-	8	OBJ	-	-
10	]	]	O	O	-	8	P	-	-

1	Adhesion	Adhesion	B-NP	B-NP	-	2	NMOD	-	-
2	molecules	molecules	I-NP	I-NP	-	6	NMOD	-	-
3	that	that	B-NP	B-NP	-	2	NMOD	-	-
4	tether	tether	B-VP	B-VP	-	3	SBAR	-	-
5	circulating	circulating	I-VP	I-VP	-	6	NMOD	-	-
6	leukocytes	leukocytes	B-NP	B-NP	-	10	SUB	-	-
7	to	to	B-PP	B-PP	-	6	NMOD	-	-
8	endothelial	endothelial	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	may	may	B-VP	B-VP	-	0	ROOT	-	-
11	also	also	I-VP	I-VP	-	10	VMOD	-	-
12	transduce	transduce	I-VP	I-VP	-	10	VC	-	-
13	or	or	I-VP	I-VP	-	12	VMOD	-	-
14	modulate	modulate	I-VP	I-VP	-	12	VMOD	-	-
15	outside-in	outside-in	B-NP	B-NP	-	16	NMOD	-	-
16	signals	signals	I-NP	I-NP	-	14	OBJ	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	cellular	cellular	B-NP	B-NP	-	19	NMOD	-	-
19	activation	activation	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	10	P	-	-
21	providing	providing	B-VP	B-VP	-	10	VMOD	-	-
22	an	an	B-NP	B-NP	-	25	NMOD	-	-
23	initial	initial	I-NP	I-NP	-	25	NMOD	-	-
24	regulatory	regulatory	I-NP	I-NP	-	25	NMOD	-	-
25	point	point	I-NP	I-NP	-	21	OBJ	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	inflammatory	inflammatory	I-NP	I-NP	-	29	NMOD	-	-
29	response	response	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	10	P	-	-

1	Adhesion	Adhesion	B-NP	B-NP	-	16	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	human	human	B-NP	B-NP	-	4	NMOD	-	-
4	monocytes	monocytes	I-NP	I-NP	-	2	PMOD	-	-
5	to	to	B-PP	B-PP	-	1	NMOD	-	-
6	P-selectin	P-selectin	B-NP	B-NP	-	5	PMOD	-	-
7	,	,	O	O	-	16	P	-	-
8	the	the	B-NP	B-NP	-	14	NMOD	-	-
9	most	most	I-NP	I-NP	-	10	AMOD	-	-
10	rapidly	rapidly	I-NP	I-NP	-	11	AMOD	-	-
11	expressed	expressed	I-NP	I-NP	-	14	NMOD	-	-
12	endothelial	endothelial	I-NP	I-NP	-	14	NMOD	-	-
13	tethering	tethering	I-NP	I-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	16	SUB	-	-
15	,	,	O	O	-	14	P	-	-
16	increased	increased	B-VP	B-VP	-	0	ROOT	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	secretion	secretion	I-NP	I-NP	-	16	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	monocyte	monocyte	B-NP	B-NP	-	22	NMOD	-	-
21	chemotactic	chemotactic	I-NP	I-NP	-	22	NMOD	-	-
22	protein-1	protein-1	I-NP	I-NP	-	29	NMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	MCP-1	MCP-1	B-NP	B-NP	-	22	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	and	and	O	O	-	29	NMOD	-	-
27	tumor	tumor	B-NP	B-NP	-	29	NMOD	-	-
28	necrosis	necrosis	I-NP	I-NP	-	29	NMOD	-	-
29	factor-alpha	factor-alpha	I-NP	I-NP	-	19	PMOD	-	-
30	(	(	O	O	-	31	P	-	-
31	TNF-alpha	TNF-alpha	B-NP	B-NP	-	29	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	by	by	B-PP	B-PP	-	16	VMOD	-	-
34	the	the	B-NP	B-NP	-	35	NMOD	-	-
35	leukocytes	leukocytes	I-NP	I-NP	-	33	PMOD	-	-
36	when	when	B-ADVP	B-ADVP	-	16	VMOD	-	-
37	they	they	B-NP	B-NP	-	38	SUB	-	-
38	were	were	B-VP	B-VP	-	36	SBAR	-	-
39	stimulated	stimulated	I-VP	I-VP	-	38	VC	-	-
40	with	with	B-PP	B-PP	-	39	VMOD	-	-
41	platelet-activating	platelet-activating	B-NP	B-NP	-	42	NMOD	-	-
42	factor	factor	I-NP	I-NP	-	40	PMOD	-	-
43	.	.	O	O	-	16	P	-	-

1	Increased	Increased	B-NP	B-NP	-	3	NMOD	-	-
2	cytokine	cytokine	I-NP	I-NP	-	3	NMOD	-	-
3	secretion	secretion	I-NP	I-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	specifically	specifically	I-VP	I-VP	-	4	VMOD	-	-
6	inhibited	inhibited	I-VP	I-VP	-	4	VC	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	G1	G1	B-NP	B-NP	-	7	PMOD	-	-
9	,	,	O	O	-	12	P	-	-
10	an	an	B-NP	B-NP	-	12	NMOD	-	-
11	anti-P-selectin	anti-P-selectin	I-NP	I-NP	-	12	NMOD	-	-
12	mAb	mAb	I-NP	I-NP	-	7	PMOD	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	prevents	prevents	B-VP	B-VP	-	13	SBAR	-	-
15	P-selectin	P-selectin	B-NP	B-NP	-	14	OBJ	-	-
16	from	from	B-PP	B-PP	-	14	VMOD	-	-
17	binding	binding	B-VP	B-VP	-	16	PMOD	-	-
18	to	to	B-PP	B-PP	-	17	VMOD	-	-
19	its	its	B-NP	B-NP	-	20	NMOD	-	-
20	ligand	ligand	I-NP	I-NP	-	18	PMOD	-	-
21	(	(	O	O	-	24	P	-	-
22	P-selectin	P-selectin	B-NP	B-NP	-	24	NMOD	-	-
23	glycoprotein	glycoprotein	I-NP	I-NP	-	24	NMOD	-	-
24	ligand-1	ligand-1	I-NP	I-NP	-	20	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	on	on	B-PP	B-PP	-	20	NMOD	-	-
27	myeloid	myeloid	B-NP	B-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	4	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	tethering	tethering	B-NP	B-NP	-	7	SUB	-	-
4	by	by	B-PP	B-PP	-	3	NMOD	-	-
5	P-selectin	P-selectin	B-NP	B-NP	-	4	PMOD	-	-
6	specifically	specifically	B-ADVP	B-ADVP	-	7	VMOD	-	-
7	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
8	nuclear	nuclear	B-NP	B-NP	-	9	NMOD	-	-
9	translocation	translocation	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	nuclear	nuclear	B-NP	B-NP	-	13	NMOD	-	-
12	factor-kappa	factor-kappa	I-NP	I-NP	-	13	NMOD	-	-
13	B	B	I-NP	I-NP	-	21	NMOD	-	-
14	(	(	O	O	-	16	P	-	-
15	NF-kappa	NF-kappa	B-NP	B-NP	-	16	NMOD	-	-
16	B	B	I-NP	I-NP	-	13	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	,	,	O	O	-	21	P	-	-
19	a	a	B-NP	B-NP	-	21	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	21	NMOD	-	-
21	factor	factor	I-NP	I-NP	-	10	PMOD	-	-
22	required	required	B-VP	B-VP	-	21	NMOD	-	-
23	for	for	B-PP	B-PP	-	22	VMOD	-	-
24	expression	expression	B-NP	B-NP	-	23	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	MCP-1	MCP-1	B-NP	B-NP	-	33	NMOD	-	-
27	,	,	O	O	-	33	P	-	-
28	TNF-alpha	TNF-alpha	B-NP	B-NP	-	33	NMOD	-	-
29	,	,	O	O	-	33	P	-	-
30	and	and	O	O	-	33	NMOD	-	-
31	other	other	B-NP	B-NP	-	33	NMOD	-	-
32	immediate-early	immediate-early	I-NP	I-NP	-	33	NMOD	-	-
33	genes	genes	I-NP	I-NP	-	25	PMOD	-	-
34	.	.	O	O	-	7	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	P-selectin	P-selectin	B-NP	B-NP	-	13	SUB	-	-
6	,	,	O	O	-	5	P	-	-
7	through	through	B-PP	B-PP	-	5	NMOD	-	-
8	its	its	B-NP	B-NP	-	9	NMOD	-	-
9	ligands	ligands	I-NP	I-NP	-	7	PMOD	-	-
10	on	on	B-PP	B-PP	-	9	NMOD	-	-
11	monocytes	monocytes	B-NP	B-NP	-	10	PMOD	-	-
12	,	,	O	O	-	5	P	-	-
13	may	may	B-VP	B-VP	-	4	SBAR	-	-
14	locally	locally	I-VP	I-VP	-	13	VMOD	-	-
15	regulate	regulate	I-VP	I-VP	-	13	VC	-	-
16	cytokine	cytokine	B-NP	B-NP	-	17	NMOD	-	-
17	secretion	secretion	I-NP	I-NP	-	15	OBJ	-	-
18	in	in	B-PP	B-PP	-	15	VMOD	-	-
19	inflamed	inflamed	B-NP	B-NP	-	20	NMOD	-	-
20	tissues	tissues	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	HMG-I	HMG-I	B-NP	B-NP	-	2	SUB	-	-
2	binds	binds	B-VP	B-VP	-	0	ROOT	-	-
3	to	to	B-PP	B-PP	-	2	VMOD	-	-
4	GATA	GATA	B-NP	B-NP	-	5	NMOD	-	-
5	motifs	motifs	I-NP	I-NP	-	3	PMOD	-	-
6	:	:	O	O	-	2	P	-	-
7	implications	implications	B-NP	B-NP	-	2	VMOD	-	-
8	for	for	B-PP	B-PP	-	7	NMOD	-	-
9	an	an	B-NP	B-NP	-	11	NMOD	-	-
10	HPFH	HPFH	I-NP	I-NP	-	11	NMOD	-	-
11	syndrome	syndrome	I-NP	I-NP	-	8	PMOD	-	-
12	.	.	O	O	-	7	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	examined	examined	I-VP	I-VP	-	2	VC	-	-
4	binding	binding	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	nuclear	nuclear	I-NP	I-NP	-	9	NMOD	-	-
8	protein	protein	I-NP	I-NP	-	9	NMOD	-	-
9	HMG-I	HMG-I	I-NP	I-NP	-	5	PMOD	-	-
10	to	to	B-PP	B-PP	-	4	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	human	human	I-NP	I-NP	-	14	NMOD	-	-
13	gamma-globin	gamma-globin	I-NP	I-NP	-	14	NMOD	-	-
14	promoter	promoter	I-NP	I-NP	-	10	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	find	find	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	HMG-I	HMG-I	B-NP	B-NP	-	5	SUB	-	-
5	binds	binds	B-VP	B-VP	-	3	SBAR	-	-
6	preferentially	preferentially	B-ADVP	B-ADVP	-	5	VMOD	-	-
7	to	to	B-PP	B-PP	-	5	VMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	more	more	I-NP	I-NP	-	10	AMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	7	PMOD	-	-
11	'	'	B-NP	B-NP	-	10	NMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	a	a	B-NP	B-NP	-	14	NMOD	-	-
14	pair	pair	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	GATA	GATA	B-NP	B-NP	-	17	NMOD	-	-
17	motifs	motifs	I-NP	I-NP	-	15	PMOD	-	-
18	in	in	B-PP	B-PP	-	14	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	gamma-globin	gamma-globin	I-NP	I-NP	-	21	NMOD	-	-
21	promoter	promoter	I-NP	I-NP	-	18	PMOD	-	-
22	;	;	O	O	-	5	P	-	-
23	this	this	B-NP	B-NP	-	25	NMOD	-	-
24	paired	paired	I-NP	I-NP	-	25	NMOD	-	-
25	motif	motif	I-NP	I-NP	-	26	SUB	-	-
26	is	is	B-VP	B-VP	-	3	SBAR	-	-
27	bound	bound	I-VP	I-VP	-	26	VC	-	-
28	by	by	B-PP	B-PP	-	27	VMOD	-	-
29	the	the	B-NP	B-NP	-	32	NMOD	-	-
30	erythroid	erythroid	I-NP	I-NP	-	32	NMOD	-	-
31	factor	factor	I-NP	I-NP	-	32	NMOD	-	-
32	GATA-1	GATA-1	I-NP	I-NP	-	28	PMOD	-	-
33	.	.	O	O	-	2	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	naturally	naturally	I-NP	I-NP	-	3	AMOD	-	-
3	occurring	occurring	I-NP	I-NP	-	4	NMOD	-	-
4	mutation	mutation	I-NP	I-NP	-	15	SUB	-	-
5	(	(	O	O	-	7	P	-	-
6	-175	-175	B-NP	B-NP	-	7	NMOD	-	-
7	T-C	T-C	I-NP	I-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	in	in	B-PP	B-PP	-	4	NMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	area	area	I-NP	I-NP	-	9	PMOD	-	-
12	bound	bound	B-VP	B-VP	-	11	NMOD	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	HMG-I	HMG-I	B-NP	B-NP	-	13	PMOD	-	-
15	results	results	B-VP	B-VP	-	41	VMOD	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	overexpression	overexpression	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	gamma-globin	gamma-globin	B-NP	B-NP	-	18	PMOD	-	-
20	in	in	B-PP	B-PP	-	17	NMOD	-	-
21	adult	adult	B-NP	B-NP	-	24	NMOD	-	-
22	red	red	I-NP	I-NP	-	24	NMOD	-	-
23	blood	blood	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	HPFH	HPFH	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	and	and	O	O	-	29	NMOD	-	-
29	up-regulation	up-regulation	B-NP	B-NP	-	20	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	gamma-globin	gamma-globin	I-NP	I-NP	-	33	NMOD	-	-
33	promoter	promoter	I-NP	I-NP	-	30	PMOD	-	-
34	in	in	B-PP	B-PP	-	29	NMOD	-	-
35	in	in	B-NP	B-NP	-	36	AMOD	-	-
36	vitro	vitro	I-NP	I-NP	-	38	NMOD	-	-
37	expression	expression	I-NP	I-NP	-	38	NMOD	-	-
38	assays	assays	I-NP	I-NP	-	34	PMOD	-	-
39	;	;	O	O	-	41	P	-	-
40	HMG-I	HMG-I	B-NP	B-NP	-	41	SUB	-	-
41	does	does	B-VP	B-VP	-	0	ROOT	-	-
42	not	not	I-VP	I-VP	-	41	VMOD	-	-
43	bind	bind	I-VP	I-VP	-	41	VC	-	-
44	to	to	B-PP	B-PP	-	43	VMOD	-	-
45	this	this	B-NP	B-NP	-	47	NMOD	-	-
46	mutant	mutant	I-NP	I-NP	-	47	NMOD	-	-
47	sequence	sequence	I-NP	I-NP	-	44	PMOD	-	-
48	.	.	O	O	-	41	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	survey	survey	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	GATA	GATA	B-NP	B-NP	-	5	NMOD	-	-
5	motifs	motifs	I-NP	I-NP	-	3	PMOD	-	-
6	from	from	B-PP	B-PP	-	5	NMOD	-	-
7	other	other	B-NP	B-NP	-	9	NMOD	-	-
8	globin	globin	I-NP	I-NP	-	9	NMOD	-	-
9	cis-elements	cis-elements	I-NP	I-NP	-	6	PMOD	-	-
10	demonstrates	demonstrates	B-VP	B-VP	-	0	ROOT	-	-
11	HMG-I	HMG-I	B-NP	B-NP	-	10	OBJ	-	-
12	binding	binding	B-VP	B-VP	-	11	NMOD	-	-
13	to	to	B-PP	B-PP	-	12	VMOD	-	-
14	most	most	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	them	them	B-NP	B-NP	-	15	PMOD	-	-
17	.	.	O	O	-	10	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	implicate	implicate	B-VP	B-VP	-	11	VMOD	-	-
4	HMG-I	HMG-I	B-NP	B-NP	-	3	OBJ	-	-
5	in	in	B-PP	B-PP	-	3	VMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	HPFH	HPFH	I-NP	I-NP	-	8	NMOD	-	-
8	phenotype	phenotype	I-NP	I-NP	-	5	PMOD	-	-
9	;	;	O	O	-	11	P	-	-
10	we	we	B-NP	B-NP	-	11	SUB	-	-
11	speculate	speculate	B-VP	B-VP	-	0	ROOT	-	-
12	that	that	B-SBAR	B-SBAR	-	11	VMOD	-	-
13	it	it	B-NP	B-NP	-	14	SUB	-	-
14	may	may	B-VP	B-VP	-	12	SBAR	-	-
15	participate	participate	I-VP	I-VP	-	14	VC	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	formation	formation	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	multiprotein	multiprotein	B-NP	B-NP	-	21	NMOD	-	-
21	complexes	complexes	I-NP	I-NP	-	19	PMOD	-	-
22	that	that	B-NP	B-NP	-	21	NMOD	-	-
23	regulate	regulate	B-VP	B-VP	-	22	SBAR	-	-
24	globin	globin	B-NP	B-NP	-	26	NMOD	-	-
25	gene	gene	I-NP	I-NP	-	26	NMOD	-	-
26	expression	expression	I-NP	I-NP	-	23	OBJ	-	-
27	.	.	O	O	-	11	P	-	-

1	Positive	Positive	B-NP	B-NP	-	4	NMOD	-	-
2	and	and	I-NP	I-NP	-	4	NMOD	-	-
3	negative	negative	I-NP	I-NP	-	4	NMOD	-	-
4	regulation	regulation	I-NP	I-NP	-	0	ROOT	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	granulocyte-macrophage	granulocyte-macrophage	B-NP	B-NP	-	10	NMOD	-	-
7	colony-stimulating	colony-stimulating	I-NP	I-NP	-	10	NMOD	-	-
8	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	5	PMOD	-	-
11	by	by	B-PP	B-PP	-	4	NMOD	-	-
12	AML1-related	AML1-related	B-NP	B-NP	-	14	NMOD	-	-
13	transcription	transcription	I-NP	I-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	16	NMOD	-	-
15	,	,	O	O	-	16	P	-	-
16	PEBP2	PEBP2	B-NP	B-NP	-	11	PMOD	-	-
17	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	9	NMOD	-	-
2	granulocyte-macrophage	granulocyte-macrophage	I-NP	I-NP	-	9	NMOD	-	-
3	colony-stimulating	colony-stimulating	I-NP	I-NP	-	9	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	9	NMOD	-	-
5	(	(	O	O	-	9	P	-	-
6	GM-CSF	GM-CSF	B-NP	B-NP	-	9	NMOD	-	-
7	)	)	O	O	-	9	P	-	-
8	gene	gene	B-NP	B-NP	-	9	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	10	SUB	-	-
10	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	consensus	consensus	I-NP	I-NP	-	13	NMOD	-	-
13	sequence	sequence	I-NP	I-NP	-	10	OBJ	-	-
14	for	for	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	24	NMOD	-	-
16	polyomavirus	polyomavirus	I-NP	I-NP	-	18	NMOD	-	-
17	enhancer	enhancer	I-NP	I-NP	-	18	NMOD	-	-
18	binding-protein	binding-protein	I-NP	I-NP	-	24	NMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	24	NMOD	-	-
20	(	(	O	O	-	24	P	-	-
21	PEBP2	PEBP2	B-NP	B-NP	-	24	NMOD	-	-
22	)	)	O	O	-	24	P	-	-
23	transcription	transcription	B-NP	B-NP	-	24	NMOD	-	-
24	factor	factor	I-NP	I-NP	-	14	PMOD	-	-
25	,	,	O	O	-	24	P	-	-
26	which	which	B-NP	B-NP	-	24	NMOD	-	-
27	consists	consists	B-VP	B-VP	-	26	SBAR	-	-
28	of	of	B-PP	B-PP	-	27	VMOD	-	-
29	alpha	alpha	B-NP	B-NP	-	31	NMOD	-	-
30	and	and	O	O	-	31	NMOD	-	-
31	beta	beta	B-NP	B-NP	-	32	NMOD	-	-
32	subunits	subunits	I-NP	I-NP	-	28	PMOD	-	-
33	.	.	O	O	-	10	P	-	-

1	There	There	B-NP	B-NP	-	2	SUB	-	-
2	are	are	B-VP	B-VP	-	0	ROOT	-	-
3	at	at	B-NP	B-NP	-	6	NMOD	-	-
4	least	least	I-NP	I-NP	-	3	AMOD	-	-
5	two	two	I-NP	I-NP	-	3	AMOD	-	-
6	genes	genes	I-NP	I-NP	-	12	NMOD	-	-
7	,	,	O	O	-	12	P	-	-
8	alpha	alpha	B-NP	B-NP	-	9	NMOD	-	-
9	A	A	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	I-NP	I-NP	-	12	NMOD	-	-
11	alpha	alpha	I-NP	I-NP	-	12	NMOD	-	-
12	B	B	I-NP	I-NP	-	2	PRD	-	-
13	,	,	O	O	-	2	P	-	-
14	encoding	encoding	B-VP	B-VP	-	2	VMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	alpha	alpha	I-NP	I-NP	-	17	NMOD	-	-
17	subunit	subunit	I-NP	I-NP	-	14	OBJ	-	-
18	.	.	O	O	-	2	P	-	-

1	alpha	alpha	B-NP	B-NP	-	2	NMOD	-	-
2	B	B	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	mouse	mouse	I-NP	I-NP	-	6	NMOD	-	-
6	homologue	homologue	I-NP	I-NP	-	3	PRD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	human	human	B-NP	B-NP	-	10	NMOD	-	-
9	AML1	AML1	I-NP	I-NP	-	10	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	7	PMOD	-	-
11	detected	detected	B-VP	B-VP	-	10	NMOD	-	-
12	at	at	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	breakpoints	breakpoints	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	t	t	B-NP	B-NP	-	23	NMOD	-	-
17	(	(	O	O	-	20	P	-	-
18	<num>	<num>	B-NP	B-NP	-	20	NMOD	-	-
19	;	;	O	O	-	20	P	-	-
20	<num>	<num>	B-NP	B-NP	-	16	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	and	and	O	O	-	23	NMOD	-	-
23	t	t	B-NP	B-NP	-	15	PMOD	-	-
24	(	(	O	O	-	27	P	-	-
25	<num>	<num>	B-NP	B-NP	-	27	NMOD	-	-
26	;	;	O	O	-	27	P	-	-
27	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	myeloid	myeloid	B-NP	B-NP	-	30	NMOD	-	-
30	leukemias	leukemias	I-NP	I-NP	-	15	PMOD	-	-
31	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
3	alpha	alpha	B-NP	B-NP	-	4	NMOD	-	-
4	A1	A1	I-NP	I-NP	-	2	OBJ	-	-
5	(	(	O	O	-	9	P	-	-
6	an	an	B-NP	B-NP	-	9	NMOD	-	-
7	alpha	alpha	I-NP	I-NP	-	9	NMOD	-	-
8	A-gene	A-gene	I-NP	I-NP	-	9	NMOD	-	-
9	product	product	I-NP	I-NP	-	16	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	and	and	O	O	-	16	NMOD	-	-
12	alpha	alpha	B-NP	B-NP	-	13	NMOD	-	-
13	B1	B1	I-NP	I-NP	-	16	NMOD	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	alpha	alpha	B-NP	B-NP	-	16	NMOD	-	-
16	B2	B2	I-NP	I-NP	-	21	NMOD	-	-
17	(	(	O	O	-	21	P	-	-
18	two	two	B-NP	B-NP	-	21	NMOD	-	-
19	alpha	alpha	I-NP	I-NP	-	21	NMOD	-	-
20	B-encoded	B-encoded	I-NP	I-NP	-	21	NMOD	-	-
21	isomers	isomers	I-NP	I-NP	-	4	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	for	for	B-PP	B-PP	-	21	NMOD	-	-
24	their	their	B-NP	B-NP	-	25	NMOD	-	-
25	effects	effects	I-NP	I-NP	-	23	PMOD	-	-
26	on	on	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	GM-CSF	GM-CSF	I-NP	I-NP	-	29	NMOD	-	-
29	promoter	promoter	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	2	P	-	-

1	PEBP2	PEBP2	B-NP	B-NP	-	11	NMOD	-	-
2	alpha	alpha	I-NP	I-NP	-	11	NMOD	-	-
3	A1	A1	I-NP	I-NP	-	11	NMOD	-	-
4	,	,	O	O	-	11	P	-	-
5	alpha	alpha	B-NP	B-NP	-	6	NMOD	-	-
6	B1	B1	I-NP	I-NP	-	11	NMOD	-	-
7	,	,	O	O	-	11	P	-	-
8	and	and	O	O	-	11	NMOD	-	-
9	alpha	alpha	B-NP	B-NP	-	11	NMOD	-	-
10	B2	B2	I-NP	I-NP	-	11	NMOD	-	-
11	proteins	proteins	I-NP	I-NP	-	12	SUB	-	-
12	bound	bound	B-VP	B-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	PEBP2	PEBP2	I-NP	I-NP	-	15	NMOD	-	-
15	site	site	I-NP	I-NP	-	12	OBJ	-	-
16	within	within	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	mouse	mouse	I-NP	I-NP	-	20	NMOD	-	-
19	GM-CSF	GM-CSF	I-NP	I-NP	-	20	NMOD	-	-
20	promoter	promoter	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	12	P	-	-

1	PEBP2	PEBP2	B-NP	B-NP	-	3	NMOD	-	-
2	alpha	alpha	I-NP	I-NP	-	3	NMOD	-	-
3	A1	A1	I-NP	I-NP	-	6	NMOD	-	-
4	and	and	O	O	-	6	NMOD	-	-
5	alpha	alpha	B-NP	B-NP	-	6	NMOD	-	-
6	B1	B1	I-NP	I-NP	-	7	SUB	-	-
7	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	GM-CSF	GM-CSF	I-NP	I-NP	-	15	NMOD	-	-
13	promoter-driven	promoter-driven	I-NP	I-NP	-	15	NMOD	-	-
14	reporter	reporter	I-NP	I-NP	-	15	NMOD	-	-
15	plasmid	plasmid	I-NP	I-NP	-	10	PMOD	-	-
16	in	in	B-PP	B-PP	-	9	NMOD	-	-
17	unstimulated	unstimulated	B-NP	B-NP	-	24	NMOD	-	-
18	and	and	I-NP	I-NP	-	24	NMOD	-	-
19	12-O-tetradecanoylphorbol	12-O-tetradecanoylphorbol	I-NP	I-NP	-	24	NMOD	-	-
20	13-acetate/phytohemagglutinin-stimulated	13-acetate/phytohemagglutinin-stimulated	I-NP	I-NP	-	24	NMOD	-	-
21	human	human	I-NP	I-NP	-	24	NMOD	-	-
22	Jurkat	Jurkat	I-NP	I-NP	-	24	NMOD	-	-
23	T	T	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
25	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	7	P	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	promoter	promoter	I-NP	I-NP	-	6	NMOD	-	-
6	activity	activity	I-NP	I-NP	-	7	SUB	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	suppressed	suppressed	I-VP	I-VP	-	7	VC	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	alpha	alpha	B-NP	B-NP	-	11	NMOD	-	-
11	B2	B2	I-NP	I-NP	-	9	PMOD	-	-
12	.	.	O	O	-	7	P	-	-

1	Coexpression	Coexpression	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	alpha	alpha	B-NP	B-NP	-	4	NMOD	-	-
4	B1	B1	I-NP	I-NP	-	7	NMOD	-	-
5	and	and	O	O	-	7	NMOD	-	-
6	alpha	alpha	B-NP	B-NP	-	7	NMOD	-	-
7	B2	B2	I-NP	I-NP	-	2	PMOD	-	-
8	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
9	that	that	B-SBAR	B-SBAR	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	promoter	promoter	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	13	SUB	-	-
13	could	could	B-VP	B-VP	-	9	SBAR	-	-
14	be	be	I-VP	I-VP	-	13	VC	-	-
15	determined	determined	I-VP	I-VP	-	14	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	alpha	alpha	I-NP	I-NP	-	21	NMOD	-	-
19	B1/alpha	B1/alpha	I-NP	I-NP	-	21	NMOD	-	-
20	B2	B2	I-NP	I-NP	-	21	NMOD	-	-
21	ratio	ratio	I-NP	I-NP	-	16	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	Jurkat	Jurkat	B-NP	B-NP	-	3	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	3	NMOD	-	-
3	extract	extract	I-NP	I-NP	-	4	SUB	-	-
4	contained	contained	B-VP	B-VP	-	0	ROOT	-	-
5	PEBP2	PEBP2	B-NP	B-NP	-	9	NMOD	-	-
6	site-binding	site-binding	I-NP	I-NP	-	9	NMOD	-	-
7	protein	protein	I-NP	I-NP	-	9	NMOD	-	-
8	(	(	I-NP	I-NP	-	9	P	-	-
9	s	s	I-NP	I-NP	-	4	OBJ	-	-
10	)	)	O	O	-	9	P	-	-
11	that	that	B-NP	B-NP	-	9	NMOD	-	-
12	cross-reacted	cross-reacted	B-VP	B-VP	-	11	SBAR	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	antimouse	antimouse	B-NP	B-NP	-	17	NMOD	-	-
15	alpha	alpha	I-NP	I-NP	-	17	NMOD	-	-
16	A1	A1	I-NP	I-NP	-	17	NMOD	-	-
17	antibodies	antibodies	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	Northern	Northern	B-NP	B-NP	-	3	NMOD	-	-
2	blot	blot	I-NP	I-NP	-	3	NMOD	-	-
3	analysis	analysis	I-NP	I-NP	-	4	SUB	-	-
4	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	human	human	B-NP	B-NP	-	11	NMOD	-	-
9	PEBP2	PEBP2	I-NP	I-NP	-	11	NMOD	-	-
10	alpha	alpha	I-NP	I-NP	-	11	NMOD	-	-
11	A	A	I-NP	I-NP	-	21	NMOD	-	-
12	,	,	O	O	-	21	P	-	-
13	alpha	alpha	B-NP	B-NP	-	14	NMOD	-	-
14	B	B	I-NP	I-NP	-	21	NMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	AML1	AML1	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	,	,	O	O	-	21	P	-	-
19	and	and	O	O	-	21	NMOD	-	-
20	beta	beta	B-NP	B-NP	-	21	NMOD	-	-
21	genes	genes	I-NP	I-NP	-	7	PMOD	-	-
22	in	in	B-PP	B-PP	-	6	NMOD	-	-
23	Jurkat	Jurkat	B-NP	B-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	4	P	-	-

1	Although	Although	B-SBAR	B-SBAR	-	22	VMOD	-	-
2	further	further	B-NP	B-NP	-	3	NMOD	-	-
3	studies	studies	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	1	SBAR	-	-
5	required	required	I-VP	I-VP	-	4	VC	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	determine	determine	I-VP	I-VP	-	5	VMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	precise	precise	I-NP	I-NP	-	10	NMOD	-	-
10	role	role	I-NP	I-NP	-	7	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	PEBP2	PEBP2	B-NP	B-NP	-	11	PMOD	-	-
13	in	in	B-PP	B-PP	-	10	NMOD	-	-
14	the	the	B-NP	B-NP	-	17	NMOD	-	-
15	GM-CSF	GM-CSF	I-NP	I-NP	-	17	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	17	NMOD	-	-
17	activity	activity	I-NP	I-NP	-	13	PMOD	-	-
18	,	,	O	O	-	22	P	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	present	present	I-NP	I-NP	-	21	NMOD	-	-
21	findings	findings	I-NP	I-NP	-	22	SUB	-	-
22	suggested	suggested	B-VP	B-VP	-	0	ROOT	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	importance	importance	I-NP	I-NP	-	22	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	relative	relative	I-NP	I-NP	-	28	NMOD	-	-
28	ratio	ratio	I-NP	I-NP	-	25	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	different	different	B-NP	B-NP	-	32	NMOD	-	-
31	PEBP2	PEBP2	I-NP	I-NP	-	32	NMOD	-	-
32	isoforms	isoforms	I-NP	I-NP	-	29	PMOD	-	-
33	in	in	B-PP	B-PP	-	28	NMOD	-	-
34	regulating	regulating	B-VP	B-VP	-	33	PMOD	-	-
35	the	the	B-NP	B-NP	-	36	NMOD	-	-
36	levels	levels	I-NP	I-NP	-	34	OBJ	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	the	the	B-NP	B-NP	-	40	NMOD	-	-
39	promoter	promoter	I-NP	I-NP	-	40	NMOD	-	-
40	activity	activity	I-NP	I-NP	-	37	PMOD	-	-
41	.	.	O	O	-	22	P	-	-

1	Differential	Differential	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	NF-AT	NF-AT	I-NP	I-NP	-	6	NMOD	-	-
6	complex	complex	I-NP	I-NP	-	3	PMOD	-	-
7	during	during	B-PP	B-PP	-	2	NMOD	-	-
8	restimulation	restimulation	B-NP	B-NP	-	11	NMOD	-	-
9	and	and	O	O	-	11	NMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	induction	induction	I-NP	I-NP	-	7	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	T-cell	T-cell	B-NP	B-NP	-	14	NMOD	-	-
14	anergy	anergy	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	20	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	human	human	B-NP	B-NP	-	6	NMOD	-	-
4	CD4+	CD4+	I-NP	I-NP	-	6	NMOD	-	-
5	T-cell	T-cell	I-NP	I-NP	-	6	NMOD	-	-
6	clones	clones	I-NP	I-NP	-	2	PMOD	-	-
7	through	through	B-PP	B-PP	-	1	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	T-cell	T-cell	I-NP	I-NP	-	10	NMOD	-	-
10	receptor	receptor	I-NP	I-NP	-	7	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	TcR	TcR	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	by	by	B-PP	B-PP	-	1	NMOD	-	-
15	high	high	B-NP	B-NP	-	16	NMOD	-	-
16	doses	doses	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	specific	specific	B-NP	B-NP	-	19	NMOD	-	-
19	peptide	peptide	I-NP	I-NP	-	17	PMOD	-	-
20	results	results	B-VP	B-VP	-	0	ROOT	-	-
21	in	in	B-PP	B-PP	-	20	VMOD	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	induction	induction	I-NP	I-NP	-	21	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	a	a	B-NP	B-NP	-	27	NMOD	-	-
26	long-lived	long-lived	I-NP	I-NP	-	27	NMOD	-	-
27	state	state	I-NP	I-NP	-	24	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	nonresponsiveness	nonresponsiveness	B-NP	B-NP	-	28	PMOD	-	-
30	that	that	B-NP	B-NP	-	27	NMOD	-	-
31	has	has	B-VP	B-VP	-	30	SBAR	-	-
32	been	been	I-VP	I-VP	-	31	VC	-	-
33	called	called	I-VP	I-VP	-	32	VC	-	-
34	anergy	anergy	B-NP	B-NP	-	33	VMOD	-	-
35	.	.	O	O	-	20	P	-	-

1	During	During	B-PP	B-PP	-	9	VMOD	-	-
2	the	the	B-NP	B-NP	-	3	NMOD	-	-
3	induction	induction	I-NP	I-NP	-	1	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	anergy	anergy	B-NP	B-NP	-	4	PMOD	-	-
6	,	,	O	O	-	9	P	-	-
7	T	T	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	9	SUB	-	-
9	are	are	B-VP	B-VP	-	0	ROOT	-	-
10	phenotypically	phenotypically	B-ADJP	B-ADJP	-	11	AMOD	-	-
11	similar	similar	I-ADJP	I-ADJP	-	9	PRD	-	-
12	to	to	B-PP	B-PP	-	11	AMOD	-	-
13	cells	cells	B-NP	B-NP	-	12	PMOD	-	-
14	responding	responding	B-VP	B-VP	-	13	NMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	an	an	B-NP	B-NP	-	18	NMOD	-	-
17	immunogenic	immunogenic	I-NP	I-NP	-	18	NMOD	-	-
18	stimulus	stimulus	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	amount	amount	I-NP	I-NP	-	9	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	TcR	TcR	B-NP	B-NP	-	3	PMOD	-	-
5	at	at	B-PP	B-PP	-	2	NMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	surface	surface	I-NP	I-NP	-	5	PMOD	-	-
9	is	is	B-VP	B-VP	-	12	VMOD	-	-
10	downmodulated	downmodulated	I-VP	I-VP	-	9	VC	-	-
11	,	,	O	O	-	12	P	-	-
12	whereas	whereas	O	O	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	17	NMOD	-	-
14	CD2	CD2	I-NP	I-NP	-	16	NMOD	-	-
15	and	and	I-NP	I-NP	-	16	NMOD	-	-
16	CD25	CD25	I-NP	I-NP	-	17	NMOD	-	-
17	receptors	receptors	I-NP	I-NP	-	18	SUB	-	-
18	are	are	B-VP	B-VP	-	12	SBAR	-	-
19	increased	increased	I-VP	I-VP	-	18	VC	-	-
20	.	.	O	O	-	12	P	-	-

1	When	When	B-ADVP	B-ADVP	-	9	VMOD	-	-
2	restimulated	restimulated	B-VP	B-VP	-	1	SBAR	-	-
3	,	,	O	O	-	2	P	-	-
4	however	however	B-ADVP	B-ADVP	-	2	VMOD	-	-
5	,	,	O	O	-	9	P	-	-
6	anergic	anergic	B-NP	B-NP	-	8	NMOD	-	-
7	T	T	I-NP	I-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	9	SUB	-	-
9	fail	fail	B-VP	B-VP	-	0	ROOT	-	-
10	to	to	I-VP	I-VP	-	11	VMOD	-	-
11	up-regulate	up-regulate	I-VP	I-VP	-	9	VMOD	-	-
12	transcription	transcription	B-NP	B-NP	-	11	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	IL-2	IL-2	I-NP	I-NP	-	16	NMOD	-	-
16	gene	gene	I-NP	I-NP	-	13	PMOD	-	-
17	and	and	B-PP	B-PP	-	13	PMOD	-	-
18	in	in	B-PP	B-PP	-	13	PMOD	-	-
19	consequence	consequence	B-NP	B-NP	-	18	PMOD	-	-
20	do	do	B-VP	B-VP	-	18	SBAR	-	-
21	not	not	I-VP	I-VP	-	20	VMOD	-	-
22	produce	produce	I-VP	I-VP	-	20	VC	-	-
23	IL-2	IL-2	B-NP	B-NP	-	22	OBJ	-	-
24	.	.	O	O	-	9	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	have	have	B-VP	B-VP	-	0	ROOT	-	-
7	compared	compared	I-VP	I-VP	-	6	VC	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	ability	ability	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	various	various	B-NP	B-NP	-	13	NMOD	-	-
12	transcription	transcription	I-NP	I-NP	-	13	NMOD	-	-
13	factors	factors	I-NP	I-NP	-	10	PMOD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	bind	bind	I-VP	I-VP	-	9	NMOD	-	-
16	to	to	B-PP	B-PP	-	15	VMOD	-	-
17	their	their	B-NP	B-NP	-	19	NMOD	-	-
18	appropriate	appropriate	I-NP	I-NP	-	19	NMOD	-	-
19	site	site	I-NP	I-NP	-	16	PMOD	-	-
20	on	on	B-PP	B-PP	-	19	NMOD	-	-
21	DNA	DNA	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	6	P	-	-

1	Factors	Factors	B-NP	B-NP	-	2	SUB	-	-
2	were	were	B-VP	B-VP	-	0	ROOT	-	-
3	isolated	isolated	I-VP	I-VP	-	2	VC	-	-
4	from	from	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	nuclei	nuclei	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	T	T	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	were	were	B-VP	B-VP	-	10	SBAR	-	-
12	in	in	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	induction	induction	I-NP	I-NP	-	15	NMOD	-	-
15	phase	phase	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	anergy	anergy	B-NP	B-NP	-	16	PMOD	-	-
18	or	or	O	O	-	11	VMOD	-	-
19	were	were	B-VP	B-VP	-	11	VMOD	-	-
20	undergoing	undergoing	I-VP	I-VP	-	19	VMOD	-	-
21	activation	activation	B-NP	B-NP	-	20	OBJ	-	-
22	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	pattern	pattern	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	binding	binding	B-NP	B-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	NMOD	-	-
7	restimulated	restimulated	B-NP	B-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	consistent	consistent	B-ADJP	B-ADJP	-	10	PRD	-	-
12	with	with	B-PP	B-PP	-	11	AMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	pattern	pattern	I-NP	I-NP	-	12	PMOD	-	-
15	that	that	B-NP	B-NP	-	14	NMOD	-	-
16	has	has	B-VP	B-VP	-	15	SBAR	-	-
17	previously	previously	I-VP	I-VP	-	16	VMOD	-	-
18	been	been	I-VP	I-VP	-	16	VC	-	-
19	shown	shown	I-VP	I-VP	-	18	VC	-	-
20	to	to	I-VP	I-VP	-	21	VMOD	-	-
21	regulate	regulate	I-VP	I-VP	-	19	VMOD	-	-
22	T-cell-specific	T-cell-specific	B-NP	B-NP	-	23	NMOD	-	-
23	expression	expression	I-NP	I-NP	-	21	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	30	NMOD	-	-
26	IL-2	IL-2	I-NP	I-NP	-	30	NMOD	-	-
27	and	and	O	O	-	30	NMOD	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	beta	beta	I-NP	I-NP	-	30	NMOD	-	-
30	chain	chain	I-NP	I-NP	-	24	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	TcR	TcR	I-NP	I-NP	-	34	NMOD	-	-
34	genes	genes	I-NP	I-NP	-	31	PMOD	-	-
35	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	measured	measured	I-NP	I-NP	-	3	NMOD	-	-
3	binding	binding	I-NP	I-NP	-	8	SUB	-	-
4	to	to	B-PP	B-PP	-	3	NMOD	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	TCF-1	TCF-1	I-NP	I-NP	-	7	NMOD	-	-
7	site	site	I-NP	I-NP	-	4	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	same	same	I-NP	I-NP	-	8	PRD	-	-
11	in	in	B-PP	B-PP	-	8	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	nuclei	nuclei	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	resting	resting	B-NP	B-NP	-	21	NMOD	-	-
16	,	,	O	O	-	21	P	-	-
17	activated	activated	B-VP	B-VP	-	21	NMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	and	and	O	O	-	21	NMOD	-	-
20	anergized	anergized	B-NP	B-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	inducible	inducible	I-NP	I-NP	-	3	NMOD	-	-
3	factors	factors	I-NP	I-NP	-	13	NMOD	-	-
4	NK-kappa	NK-kappa	I-NP	I-NP	-	5	NMOD	-	-
5	B	B	I-NP	I-NP	-	13	NMOD	-	-
6	,	,	O	O	-	13	P	-	-
7	beta	beta	B-NP	B-NP	-	8	NMOD	-	-
8	E2	E2	I-NP	I-NP	-	13	NMOD	-	-
9	,	,	O	O	-	13	P	-	-
10	CD28RC	CD28RC	B-NP	B-NP	-	13	NMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	AP-1	AP-1	B-NP	B-NP	-	14	SUB	-	-
14	are	are	B-VP	B-VP	-	0	ROOT	-	-
15	not	not	I-VP	I-VP	-	14	VMOD	-	-
16	expressed	expressed	I-VP	I-VP	-	14	VC	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	resting	resting	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	and	and	O	O	-	14	VMOD	-	-
21	are	are	B-VP	B-VP	-	14	VMOD	-	-
22	twofold	twofold	B-ADJP	B-ADJP	-	23	AMOD	-	-
23	lower	lower	I-ADJP	I-ADJP	-	21	PRD	-	-
24	in	in	B-PP	B-PP	-	21	VMOD	-	-
25	anergized	anergized	B-VP	B-VP	-	24	SBAR	-	-
26	as	as	B-SBAR	B-SBAR	-	25	VMOD	-	-
27	compared	compared	B-PP	B-PP	-	26	SBAR	-	-
28	with	with	B-PP	B-PP	-	27	VMOD	-	-
29	activated	activated	B-NP	B-NP	-	30	NMOD	-	-
30	cells	cells	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	14	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	7	P	-	-
4	anergic	anergic	B-NP	B-NP	-	6	NMOD	-	-
5	T	T	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	7	SUB	-	-
7	express	express	B-VP	B-VP	-	0	ROOT	-	-
8	approximately	approximately	B-NP	B-NP	-	9	NMOD	-	-
9	eightfold	eightfold	I-NP	I-NP	-	10	AMOD	-	-
10	lower	lower	I-NP	I-NP	-	11	NMOD	-	-
11	amounts	amounts	I-NP	I-NP	-	7	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	NF-AT	NF-AT	B-NP	B-NP	-	16	NMOD	-	-
14	,	,	O	O	-	16	P	-	-
15	a	a	B-NP	B-NP	-	16	NMOD	-	-
16	member	member	I-NP	I-NP	-	12	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	class	class	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	inducible	inducible	B-NP	B-NP	-	22	NMOD	-	-
22	factors	factors	I-NP	I-NP	-	20	PMOD	-	-
23	that	that	B-NP	B-NP	-	22	NMOD	-	-
24	regulates	regulates	B-VP	B-VP	-	23	SBAR	-	-
25	IL-2	IL-2	B-NP	B-NP	-	27	NMOD	-	-
26	gene	gene	I-NP	I-NP	-	27	NMOD	-	-
27	transcription	transcription	I-NP	I-NP	-	24	OBJ	-	-
28	.	.	O	O	-	7	P	-	-

1	(	(	O	O	-	2	P	-	-
2	ABSTRACT	ABSTRACT	B-NP	B-NP	-	0	ROOT	-	-
3	TRUNCATED	TRUNCATED	B-VP	B-VP	-	2	NMOD	-	-
4	AT	AT	B-PP	B-PP	-	3	VMOD	-	-
5	<num>	<num>	B-NP	B-NP	-	6	NMOD	-	-
6	WORDS	WORDS	I-NP	I-NP	-	4	PMOD	-	-
7	)	)	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	retinoblastoma	retinoblastoma	I-NP	I-NP	-	4	NMOD	-	-
3	gene	gene	I-NP	I-NP	-	4	NMOD	-	-
4	product	product	I-NP	I-NP	-	6	SUB	-	-
5	negatively	negatively	B-ADVP	B-ADVP	-	6	VMOD	-	-
6	regulates	regulates	B-VP	B-VP	-	0	ROOT	-	-
7	transcriptional	transcriptional	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	6	OBJ	-	-
9	mediated	mediated	B-VP	B-VP	-	8	NMOD	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	human	human	I-NP	I-NP	-	15	NMOD	-	-
13	cytomegalovirus	cytomegalovirus	I-NP	I-NP	-	15	NMOD	-	-
14	IE2	IE2	I-NP	I-NP	-	15	NMOD	-	-
15	protein	protein	I-NP	I-NP	-	10	PMOD	-	-
16	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	IE2	IE2	I-NP	I-NP	-	4	NMOD	-	-
3	gene	gene	I-NP	I-NP	-	4	NMOD	-	-
4	product	product	I-NP	I-NP	-	11	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	human	human	B-NP	B-NP	-	7	NMOD	-	-
7	cytomegalovirus	cytomegalovirus	I-NP	I-NP	-	5	PMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	HCMV	HCMV	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	is	is	B-VP	B-VP	-	0	ROOT	-	-
12	one	one	B-NP	B-NP	-	11	PRD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	a	a	B-NP	B-NP	-	18	NMOD	-	-
15	few	few	I-NP	I-NP	-	18	NMOD	-	-
16	viral	viral	I-NP	I-NP	-	18	NMOD	-	-
17	regulatory	regulatory	I-NP	I-NP	-	18	NMOD	-	-
18	proteins	proteins	I-NP	I-NP	-	13	PMOD	-	-
19	expressed	expressed	B-VP	B-VP	-	18	NMOD	-	-
20	immediately	immediately	B-ADVP	B-ADVP	-	19	VMOD	-	-
21	upon	upon	B-PP	B-PP	-	19	VMOD	-	-
22	infection	infection	B-NP	B-NP	-	21	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	host	host	I-NP	I-NP	-	26	NMOD	-	-
26	cell	cell	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	11	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	potent	potent	I-NP	I-NP	-	6	NMOD	-	-
5	transcriptional	transcriptional	I-NP	I-NP	-	6	NMOD	-	-
6	activator	activator	I-NP	I-NP	-	2	PRD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	many	many	B-NP	B-NP	-	7	PMOD	-	-
9	viral	viral	I-NP	I-NP	-	8	NMOD	-	-
10	and	and	I-NP	I-NP	-	8	NMOD	-	-
11	cellular	cellular	I-NP	I-NP	-	8	NMOD	-	-
12	promoters	promoters	I-NP	I-NP	-	8	NMOD	-	-
13	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	found	found	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	retinoblastoma	retinoblastoma	I-NP	I-NP	-	8	NMOD	-	-
6	susceptibility	susceptibility	I-NP	I-NP	-	8	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	NMOD	-	-
8	product	product	I-NP	I-NP	-	13	SUB	-	-
9	(	(	O	O	-	10	P	-	-
10	Rb	Rb	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	dramatically	dramatically	B-ADVP	B-ADVP	-	13	VMOD	-	-
13	suppressed	suppressed	B-VP	B-VP	-	3	SBAR	-	-
14	this	this	B-NP	B-NP	-	16	NMOD	-	-
15	IE2	IE2	I-NP	I-NP	-	16	NMOD	-	-
16	transactivation	transactivation	I-NP	I-NP	-	13	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	various	various	B-NP	B-NP	-	19	NMOD	-	-
19	promoters	promoters	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	However	However	B-ADVP	B-ADVP	-	12	VMOD	-	-
2	,	,	O	O	-	12	P	-	-
3	unlike	unlike	B-PP	B-PP	-	12	VMOD	-	-
4	another	another	B-NP	B-NP	-	7	NMOD	-	-
5	tumor	tumor	I-NP	I-NP	-	7	NMOD	-	-
6	suppressor	suppressor	I-NP	I-NP	-	7	NMOD	-	-
7	protein	protein	I-NP	I-NP	-	3	PMOD	-	-
8	,	,	O	O	-	12	P	-	-
9	p53	p53	B-NP	B-NP	-	11	NMOD	-	-
10	,	,	O	O	-	11	P	-	-
11	Rb	Rb	B-NP	B-NP	-	12	SUB	-	-
12	did	did	B-VP	B-VP	-	0	ROOT	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	have	have	I-VP	I-VP	-	12	VC	-	-
15	any	any	B-NP	B-NP	-	17	NMOD	-	-
16	significant	significant	I-NP	I-NP	-	17	NMOD	-	-
17	effect	effect	I-NP	I-NP	-	14	OBJ	-	-
18	on	on	B-PP	B-PP	-	14	VMOD	-	-
19	basal	basal	B-NP	B-NP	-	20	NMOD	-	-
20	levels	levels	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	transcription	transcription	B-NP	B-NP	-	21	PMOD	-	-
23	,	,	O	O	-	12	P	-	-
24	suggesting	suggesting	B-VP	B-VP	-	12	VMOD	-	-
25	that	that	B-SBAR	B-SBAR	-	24	VMOD	-	-
26	Rb	Rb	B-NP	B-NP	-	28	SUB	-	-
27	specifically	specifically	B-ADVP	B-ADVP	-	28	VMOD	-	-
28	interacts	interacts	B-VP	B-VP	-	25	SBAR	-	-
29	with	with	B-PP	B-PP	-	28	VMOD	-	-
30	IE2	IE2	B-NP	B-NP	-	29	PMOD	-	-
31	rather	rather	B-PP	B-PP	-	28	VMOD	-	-
32	than	than	I-PP	I-PP	-	31	DEP	-	-
33	other	other	B-NP	B-NP	-	32	PMOD	-	-
34	cellular	cellular	I-NP	I-NP	-	35	NMOD	-	-
35	factors	factors	I-NP	I-NP	-	33	NMOD	-	-
36	involved	involved	B-VP	B-VP	-	35	NMOD	-	-
37	in	in	B-PP	B-PP	-	36	VMOD	-	-
38	the	the	B-NP	B-NP	-	41	NMOD	-	-
39	general	general	I-NP	I-NP	-	41	NMOD	-	-
40	transcription	transcription	I-NP	I-NP	-	41	NMOD	-	-
41	machinery	machinery	I-NP	I-NP	-	37	PMOD	-	-
42	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	found	found	B-VP	B-VP	-	0	ROOT	-	-
3	by	by	B-PP	B-PP	-	2	VMOD	-	-
4	protein-affinity	protein-affinity	B-NP	B-NP	-	5	NMOD	-	-
5	chromatography	chromatography	I-NP	I-NP	-	3	PMOD	-	-
6	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
7	Rb	Rb	B-NP	B-NP	-	18	SUB	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	nuclear	nuclear	B-NP	B-NP	-	10	NMOD	-	-
10	extracts	extracts	I-NP	I-NP	-	8	PMOD	-	-
11	or	or	O	O	-	7	NMOD	-	-
12	produced	produced	B-VP	B-VP	-	7	NMOD	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	in	in	B-NP	B-NP	-	15	AMOD	-	-
15	vitro	vitro	I-NP	I-NP	-	16	NMOD	-	-
16	translation	translation	I-NP	I-NP	-	13	PMOD	-	-
17	directly	directly	B-ADVP	B-ADVP	-	18	VMOD	-	-
18	bound	bound	B-VP	B-VP	-	6	SBAR	-	-
19	to	to	B-PP	B-PP	-	18	VMOD	-	-
20	IE2	IE2	B-NP	B-NP	-	19	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	Rb	Rb	B-NP	B-NP	-	6	SUB	-	-
6	may	may	B-VP	B-VP	-	4	SBAR	-	-
7	regulate	regulate	I-VP	I-VP	-	6	VC	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	life	life	I-NP	I-NP	-	10	NMOD	-	-
10	cycle	cycle	I-NP	I-NP	-	7	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	HCMV	HCMV	B-NP	B-NP	-	11	PMOD	-	-
13	,	,	O	O	-	7	P	-	-
14	which	which	B-NP	B-NP	-	7	VMOD	-	-
15	is	is	B-VP	B-VP	-	14	SBAR	-	-
16	endemic	endemic	B-ADJP	B-ADJP	-	15	PRD	-	-
17	in	in	B-PP	B-PP	-	16	AMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	human	human	I-NP	I-NP	-	20	NMOD	-	-
20	population	population	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	data	data	I-NP	I-NP	-	5	SUB	-	-
5	may	may	B-VP	B-VP	-	0	ROOT	-	-
6	provide	provide	I-VP	I-VP	-	5	VC	-	-
7	new	new	B-NP	B-NP	-	8	NMOD	-	-
8	insights	insights	I-NP	I-NP	-	6	OBJ	-	-
9	into	into	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	slow	slow	I-NP	I-NP	-	12	NMOD	-	-
12	rate	rate	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	HCMV	HCMV	B-NP	B-NP	-	16	NMOD	-	-
15	DNA	DNA	I-NP	I-NP	-	16	NMOD	-	-
16	replication	replication	I-NP	I-NP	-	13	PMOD	-	-
17	in	in	B-PP	B-PP	-	16	NMOD	-	-
18	cells	cells	B-NP	B-NP	-	17	PMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	possible	possible	I-NP	I-NP	-	22	NMOD	-	-
22	involvement	involvement	I-NP	I-NP	-	17	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	HCMV	HCMV	B-NP	B-NP	-	23	PMOD	-	-
25	in	in	B-PP	B-PP	-	22	NMOD	-	-
26	tumorigenesis	tumorigenesis	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	5	P	-	-

1	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	5	NMOD	-	-
2	virus	virus	I-NP	I-NP	-	5	NMOD	-	-
3	replicative	replicative	I-NP	I-NP	-	5	NMOD	-	-
4	gene	gene	I-NP	I-NP	-	5	NMOD	-	-
5	transcription	transcription	I-NP	I-NP	-	16	NMOD	-	-
6	during	during	B-PP	B-PP	-	5	NMOD	-	-
7	de	de	B-NP	B-NP	-	8	AMOD	-	-
8	novo	novo	I-NP	I-NP	-	9	NMOD	-	-
9	infection	infection	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	human	human	B-NP	B-NP	-	12	NMOD	-	-
12	thymocytes	thymocytes	I-NP	I-NP	-	10	PMOD	-	-
13	:	:	O	O	-	5	P	-	-
14	simultaneous	simultaneous	B-NP	B-NP	-	16	NMOD	-	-
15	early	early	I-NP	I-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	0	ROOT	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	BZLF-1	BZLF-1	B-NP	B-NP	-	22	NMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	its	its	B-NP	B-NP	-	22	NMOD	-	-
21	repressor	repressor	I-NP	I-NP	-	22	NMOD	-	-
22	RAZ	RAZ	I-NP	I-NP	-	17	PMOD	-	-
23	.	.	O	O	-	16	P	-	-

1	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	2	NMOD	-	-
2	virus	virus	I-NP	I-NP	-	6	SUB	-	-
3	(	(	O	O	-	4	P	-	-
4	EBV	EBV	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	known	known	I-VP	I-VP	-	6	VC	-	-
8	to	to	I-VP	I-VP	-	9	VMOD	-	-
9	infect	infect	I-VP	I-VP	-	7	VMOD	-	-
10	B	B	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	14	NMOD	-	-
12	and	and	O	O	-	14	NMOD	-	-
13	epithelial	epithelial	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	9	OBJ	-	-
15	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	O	O	-	3	NMOD	-	-
3	others	others	B-NP	B-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	shown	shown	I-VP	I-VP	-	4	VC	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	EBV	EBV	B-NP	B-NP	-	8	SUB	-	-
8	can	can	B-VP	B-VP	-	6	SBAR	-	-
9	also	also	I-VP	I-VP	-	8	VMOD	-	-
10	infect	infect	I-VP	I-VP	-	8	VC	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	subset	subset	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	thymocytes	thymocytes	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	Infection	Infection	B-NP	B-NP	-	4	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	thymocytes	thymocytes	B-NP	B-NP	-	2	PMOD	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	accompanied	accompanied	I-VP	I-VP	-	4	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	appearance	appearance	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	linear	linear	B-NP	B-NP	-	12	NMOD	-	-
11	EBV	EBV	I-NP	I-NP	-	12	NMOD	-	-
12	genome	genome	I-NP	I-NP	-	9	PMOD	-	-
13	within	within	B-PP	B-PP	-	8	NMOD	-	-
14	<num>	<num>	B-NP	B-NP	-	15	NMOD	-	-
15	hr	hr	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	infection	infection	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	Circularization	Circularization	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	EBV	EBV	I-NP	I-NP	-	5	NMOD	-	-
5	genome	genome	I-NP	I-NP	-	2	PMOD	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	not	not	I-VP	I-VP	-	6	VMOD	-	-
8	detected	detected	I-VP	I-VP	-	6	VC	-	-
9	.	.	O	O	-	6	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	in	in	B-PP	B-PP	-	2	VMOD	-	-
4	contrast	contrast	B-NP	B-NP	-	3	PMOD	-	-
5	to	to	B-PP	B-PP	-	3	PMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	infection	infection	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	B	B	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	where	where	B-ADVP	B-ADVP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	genome	genome	I-NP	I-NP	-	14	SUB	-	-
14	can	can	B-VP	B-VP	-	11	SBAR	-	-
15	circularize	circularize	I-VP	I-VP	-	14	VC	-	-
16	within	within	B-PP	B-PP	-	15	VMOD	-	-
17	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
18	hr	hr	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	infection	infection	B-NP	B-NP	-	19	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	appearance	appearance	I-NP	I-NP	-	15	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	BamHI	BamHI	I-NP	I-NP	-	8	NMOD	-	-
6	ZLF-1	ZLF-1	I-NP	I-NP	-	8	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	NMOD	-	-
8	product	product	I-NP	I-NP	-	10	NMOD	-	-
9	,	,	O	O	-	10	P	-	-
10	ZEBRA	ZEBRA	B-NP	B-NP	-	3	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	by	by	B-PP	B-PP	-	2	NMOD	-	-
13	RT-PCR	RT-PCR	B-NP	B-NP	-	12	PMOD	-	-
14	,	,	O	O	-	2	P	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	observed	observed	I-VP	I-VP	-	15	VC	-	-
17	within	within	B-PP	B-PP	-	16	VMOD	-	-
18	<num>	<num>	B-NP	B-NP	-	19	NMOD	-	-
19	hr	hr	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	infection	infection	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	15	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	appearance	appearance	I-NP	I-NP	-	25	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	novel	novel	I-NP	I-NP	-	7	NMOD	-	-
6	fusion	fusion	I-NP	I-NP	-	7	NMOD	-	-
7	transcript	transcript	I-NP	I-NP	-	3	PMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	RAZ	RAZ	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	,	,	O	O	-	7	P	-	-
12	which	which	B-NP	B-NP	-	7	NMOD	-	-
13	comprised	comprised	B-VP	B-VP	-	12	SBAR	-	-
14	regions	regions	B-NP	B-NP	-	13	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	BZLF-1	BZLF-1	I-NP	I-NP	-	18	NMOD	-	-
18	locus	locus	I-NP	I-NP	-	23	NMOD	-	-
19	and	and	O	O	-	23	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	adjacent	adjacent	I-NP	I-NP	-	23	NMOD	-	-
22	BRLF-1	BRLF-1	I-NP	I-NP	-	23	NMOD	-	-
23	locus	locus	I-NP	I-NP	-	15	PMOD	-	-
24	,	,	O	O	-	2	P	-	-
25	was	was	B-VP	B-VP	-	0	ROOT	-	-
26	detected	detected	I-VP	I-VP	-	25	VC	-	-
27	by	by	B-PP	B-PP	-	26	VMOD	-	-
28	RT-PCR	RT-PCR	B-NP	B-NP	-	27	PMOD	-	-
29	.	.	O	O	-	25	P	-	-

1	ZEBRA	ZEBRA	B-NP	B-NP	-	2	NMOD	-	-
2	protein	protein	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	also	also	I-VP	I-VP	-	3	VMOD	-	-
5	identified	identified	I-VP	I-VP	-	3	VC	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	infected	infected	B-NP	B-NP	-	6	PMOD	-	-
8	thymocytes	thymocytes	I-NP	I-NP	-	7	NMOD	-	-
9	by	by	B-PP	B-PP	-	5	VMOD	-	-
10	immunoprecipitation	immunoprecipitation	B-NP	B-NP	-	9	PMOD	-	-
11	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	we	we	B-NP	B-NP	-	5	SUB	-	-
5	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	EBNA-1	EBNA-1	I-NP	I-NP	-	9	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	13	SUB	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	infected	infected	B-NP	B-NP	-	12	NMOD	-	-
12	thymocytes	thymocytes	I-NP	I-NP	-	10	PMOD	-	-
13	was	was	B-VP	B-VP	-	6	SBAR	-	-
14	transcribed	transcribed	I-VP	I-VP	-	13	VC	-	-
15	from	from	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	Fp	Fp	I-NP	I-NP	-	18	NMOD	-	-
18	promoter	promoter	I-NP	I-NP	-	15	PMOD	-	-
19	,	,	O	O	-	14	P	-	-
20	rather	rather	B-PP	B-PP	-	14	VMOD	-	-
21	than	than	I-PP	I-PP	-	20	DEP	-	-
22	from	from	B-PP	B-PP	-	21	PMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	Cp/Wp	Cp/Wp	I-NP	I-NP	-	25	NMOD	-	-
25	promoter	promoter	I-NP	I-NP	-	22	PMOD	-	-
26	which	which	B-NP	B-NP	-	25	NMOD	-	-
27	is	is	B-VP	B-VP	-	26	SBAR	-	-
28	used	used	I-VP	I-VP	-	27	VC	-	-
29	in	in	B-PP	B-PP	-	28	VMOD	-	-
30	latently	latently	B-NP	B-NP	-	31	AMOD	-	-
31	infected	infected	I-NP	I-NP	-	33	NMOD	-	-
32	B	B	I-NP	I-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	29	PMOD	-	-
34	.	.	O	O	-	5	P	-	-

1	Transcripts	Transcripts	B-NP	B-NP	-	12	SUB	-	-
2	encoding	encoding	B-VP	B-VP	-	1	NMOD	-	-
3	gp350/220	gp350/220	B-NP	B-NP	-	8	NMOD	-	-
4	,	,	O	O	-	8	P	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	major	major	I-NP	I-NP	-	8	NMOD	-	-
7	coat	coat	I-NP	I-NP	-	8	NMOD	-	-
8	protein	protein	I-NP	I-NP	-	2	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	EBV	EBV	B-NP	B-NP	-	9	PMOD	-	-
11	,	,	O	O	-	1	P	-	-
12	were	were	B-VP	B-VP	-	17	VMOD	-	-
13	identified	identified	I-VP	I-VP	-	12	VC	-	-
14	,	,	O	O	-	17	P	-	-
15	but	but	O	O	-	17	VMOD	-	-
16	we	we	B-NP	B-NP	-	17	SUB	-	-
17	did	did	B-VP	B-VP	-	0	ROOT	-	-
18	not	not	I-VP	I-VP	-	17	VMOD	-	-
19	find	find	I-VP	I-VP	-	17	VC	-	-
20	any	any	B-NP	B-NP	-	21	NMOD	-	-
21	evidence	evidence	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	transcription	transcription	B-NP	B-NP	-	22	PMOD	-	-
24	from	from	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	29	NMOD	-	-
26	LMP-2A	LMP-2A	I-NP	I-NP	-	29	NMOD	-	-
27	or	or	I-NP	I-NP	-	29	NMOD	-	-
28	EBER-1	EBER-1	I-NP	I-NP	-	29	NMOD	-	-
29	loci	loci	I-NP	I-NP	-	24	PMOD	-	-
30	in	in	B-PP	B-PP	-	23	NMOD	-	-
31	infected	infected	B-NP	B-NP	-	32	NMOD	-	-
32	thymocytes	thymocytes	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	17	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	observations	observations	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	de	de	B-NP	B-NP	-	6	AMOD	-	-
6	novo	novo	I-NP	I-NP	-	8	NMOD	-	-
7	EBV	EBV	I-NP	I-NP	-	8	NMOD	-	-
8	infection	infection	I-NP	I-NP	-	11	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	thymocytes	thymocytes	B-NP	B-NP	-	9	PMOD	-	-
11	differs	differs	B-VP	B-VP	-	4	SBAR	-	-
12	from	from	B-PP	B-PP	-	11	VMOD	-	-
13	infection	infection	B-NP	B-NP	-	12	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	B	B	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	main	main	I-NP	I-NP	-	3	NMOD	-	-
3	difference	difference	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	with	with	B-PP	B-PP	-	11	VMOD	-	-
7	thymocytes	thymocytes	B-NP	B-NP	-	6	PMOD	-	-
8	,	,	O	O	-	11	P	-	-
9	no	no	B-NP	B-NP	-	10	NMOD	-	-
10	evidence	evidence	I-NP	I-NP	-	11	SUB	-	-
11	could	could	B-VP	B-VP	-	5	SBAR	-	-
12	be	be	I-VP	I-VP	-	11	VC	-	-
13	found	found	I-VP	I-VP	-	12	VC	-	-
14	that	that	B-SBAR	B-SBAR	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	virus	virus	I-NP	I-NP	-	18	SUB	-	-
17	ever	ever	B-ADVP	B-ADVP	-	18	VMOD	-	-
18	circularizes	circularizes	B-VP	B-VP	-	14	SBAR	-	-
19	.	.	O	O	-	4	P	-	-

1	Rather	Rather	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	EBV	EBV	B-NP	B-NP	-	4	SUB	-	-
4	remains	remains	B-VP	B-VP	-	0	ROOT	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	linear	linear	I-NP	I-NP	-	8	NMOD	-	-
8	configuration	configuration	I-NP	I-NP	-	5	PMOD	-	-
9	from	from	B-PP	B-PP	-	8	NMOD	-	-
10	which	which	B-NP	B-NP	-	9	PMOD	-	-
11	replicative	replicative	B-NP	B-NP	-	12	NMOD	-	-
12	genes	genes	I-NP	I-NP	-	9	PMOD	-	-
13	are	are	B-VP	B-VP	-	9	SBAR	-	-
14	transcribed	transcribed	I-VP	I-VP	-	13	VC	-	-
15	.	.	O	O	-	4	P	-	-

1	Induction	Induction	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Sp1	Sp1	B-NP	B-NP	-	4	NMOD	-	-
4	phosphorylation	phosphorylation	I-NP	I-NP	-	2	PMOD	-	-
5	and	and	O	O	-	11	NMOD	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	11	NMOD	-	-
7	B-independent	B-independent	I-NP	I-NP	-	6	AMOD	-	-
8	HIV	HIV	I-NP	I-NP	-	11	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	11	NMOD	-	-
10	domain	domain	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	2	PMOD	-	-
12	in	in	B-PP	B-PP	-	1	NMOD	-	-
13	T	T	B-NP	B-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	12	PMOD	-	-
15	stimulated	stimulated	B-VP	B-VP	-	14	NMOD	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	okadaic	okadaic	B-NP	B-NP	-	18	NMOD	-	-
18	acid	acid	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	1	P	-	-

1	In	In	B-PP	B-PP	-	26	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	to	to	B-PP	B-PP	-	1	PMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	purely	purely	I-NP	I-NP	-	6	AMOD	-	-
6	enhancer-dependent	enhancer-dependent	I-NP	I-NP	-	7	NMOD	-	-
7	effect	effect	I-NP	I-NP	-	3	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	cytokines	cytokines	B-NP	B-NP	-	8	PMOD	-	-
10	such	such	B-PP	B-PP	-	11	PMOD	-	-
11	as	as	I-PP	I-PP	-	9	NMOD	-	-
12	TNF	TNF	B-NP	B-NP	-	11	PMOD	-	-
13	on	on	B-PP	B-PP	-	7	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	HIV	HIV	I-NP	I-NP	-	20	NMOD	-	-
19	regulatory	regulatory	I-NP	I-NP	-	20	NMOD	-	-
20	region	region	I-NP	I-NP	-	16	PMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	LTR	LTR	B-NP	B-NP	-	20	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	,	,	O	O	-	26	P	-	-
25	we	we	B-NP	B-NP	-	26	SUB	-	-
26	observed	observed	B-VP	B-VP	-	0	ROOT	-	-
27	that	that	B-SBAR	B-SBAR	-	26	VMOD	-	-
28	okadaic	okadaic	B-NP	B-NP	-	29	NMOD	-	-
29	acid	acid	I-NP	I-NP	-	33	SUB	-	-
30	(	(	O	O	-	31	P	-	-
31	OKA	OKA	B-NP	B-NP	-	29	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	activates	activates	B-VP	B-VP	-	27	SBAR	-	-
34	HIV	HIV	B-NP	B-NP	-	35	NMOD	-	-
35	transcription	transcription	I-NP	I-NP	-	33	OBJ	-	-
36	through	through	B-PP	B-PP	-	33	VMOD	-	-
37	both	both	O	O	-	39	NMOD	-	-
38	the	the	B-NP	B-NP	-	39	NMOD	-	-
39	enhancer	enhancer	I-NP	I-NP	-	36	PMOD	-	-
40	,	,	O	O	-	26	P	-	-
41	responding	responding	B-VP	B-VP	-	26	VMOD	-	-
42	to	to	B-PP	B-PP	-	41	VMOD	-	-
43	the	the	B-NP	B-NP	-	46	NMOD	-	-
44	factor	factor	I-NP	I-NP	-	46	NMOD	-	-
45	NF-kappa	NF-kappa	I-NP	I-NP	-	46	NMOD	-	-
46	B	B	I-NP	I-NP	-	51	NMOD	-	-
47	,	,	O	O	-	51	P	-	-
48	and	and	O	O	-	51	NMOD	-	-
49	the	the	B-NP	B-NP	-	51	NMOD	-	-
50	promoter	promoter	I-NP	I-NP	-	51	NMOD	-	-
51	domain	domain	I-NP	I-NP	-	42	PMOD	-	-
52	of	of	B-PP	B-PP	-	51	NMOD	-	-
53	the	the	B-NP	B-NP	-	54	NMOD	-	-
54	LTR	LTR	I-NP	I-NP	-	52	PMOD	-	-
55	.	.	O	O	-	26	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	inducibility	inducibility	I-NP	I-NP	-	15	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	HIV	HIV	B-NP	B-NP	-	8	NMOD	-	-
5	LTR-driven	LTR-driven	I-NP	I-NP	-	8	NMOD	-	-
6	luciferase	luciferase	I-NP	I-NP	-	8	NMOD	-	-
7	expression	expression	I-NP	I-NP	-	8	NMOD	-	-
8	constructs	constructs	I-NP	I-NP	-	3	PMOD	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	lymphoblastoid	lymphoblastoid	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
12	stimulated	stimulated	B-VP	B-VP	-	11	NMOD	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	OKA	OKA	B-NP	B-NP	-	13	PMOD	-	-
15	depended	depended	B-VP	B-VP	-	0	ROOT	-	-
16	on	on	B-PP	B-PP	-	15	VMOD	-	-
17	both	both	B-NP	B-NP	-	24	NMOD	-	-
18	functional	functional	I-NP	I-NP	-	21	NMOD	-	-
19	Sp1	Sp1	I-NP	I-NP	-	21	NMOD	-	-
20	binding	binding	I-NP	I-NP	-	21	NMOD	-	-
21	elements	elements	I-NP	I-NP	-	24	NMOD	-	-
22	and	and	O	O	-	24	NMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	ability	ability	I-NP	I-NP	-	16	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	TATA	TATA	I-NP	I-NP	-	28	NMOD	-	-
28	box	box	I-NP	I-NP	-	25	PMOD	-	-
29	to	to	B-VP	B-VP	-	30	VMOD	-	-
30	bind	bind	I-VP	I-VP	-	24	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	protein	protein	I-NP	I-NP	-	33	NMOD	-	-
33	TBP	TBP	I-NP	I-NP	-	30	OBJ	-	-
34	.	.	O	O	-	15	P	-	-

1	In	In	B-PP	B-PP	-	10	VMOD	-	-
2	both	both	O	O	-	3	AMOD	-	-
3	transformed	transformed	B-VP	B-VP	-	6	NMOD	-	-
4	and	and	O	O	-	6	NMOD	-	-
5	normal	normal	B-NP	B-NP	-	6	NMOD	-	-
6	lymphocytes	lymphocytes	I-NP	I-NP	-	1	PMOD	-	-
7	,	,	O	O	-	10	P	-	-
8	OKA	OKA	B-NP	B-NP	-	9	NMOD	-	-
9	stimulation	stimulation	I-NP	I-NP	-	10	SUB	-	-
10	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
11	intense	intense	B-NP	B-NP	-	12	NMOD	-	-
12	phosphorylation	phosphorylation	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	constitutively	constitutively	I-NP	I-NP	-	16	AMOD	-	-
16	expressed	expressed	I-NP	I-NP	-	18	NMOD	-	-
17	Sp1	Sp1	I-NP	I-NP	-	18	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	13	PMOD	-	-
19	in	in	B-PP	B-PP	-	12	NMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	nucleus	nucleus	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	10	P	-	-
23	a	a	B-NP	B-NP	-	24	NMOD	-	-
24	property	property	I-NP	I-NP	-	10	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	OKA	OKA	B-NP	B-NP	-	25	PMOD	-	-
27	not	not	B-VP	B-VP	-	28	VMOD	-	-
28	shared	shared	I-VP	I-VP	-	26	NMOD	-	-
29	by	by	B-PP	B-PP	-	28	VMOD	-	-
30	TNF	TNF	B-NP	B-NP	-	38	NMOD	-	-
31	,	,	O	O	-	38	P	-	-
32	phorbol	phorbol	B-NP	B-NP	-	33	NMOD	-	-
33	ester	ester	I-NP	I-NP	-	38	NMOD	-	-
34	,	,	O	O	-	38	P	-	-
35	or	or	O	O	-	38	NMOD	-	-
36	PHA	PHA	B-NP	B-NP	-	38	NMOD	-	-
37	and	and	O	O	-	38	NMOD	-	-
38	interleukin	interleukin	B-NP	B-NP	-	29	PMOD	-	-
39	<num>	<num>	I-NP	I-NP	-	38	NMOD	-	-
40	.	.	O	O	-	10	P	-	-

1	Responsiveness	Responsiveness	B-NP	B-NP	-	14	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	LTR	LTR	B-NP	B-NP	-	4	NMOD	-	-
4	constructs	constructs	I-NP	I-NP	-	2	PMOD	-	-
5	deleted	deleted	B-VP	B-VP	-	4	NMOD	-	-
6	of	of	B-PP	B-PP	-	5	VMOD	-	-
7	kappa	kappa	B-NP	B-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	elements	elements	I-NP	I-NP	-	6	PMOD	-	-
10	to	to	B-PP	B-PP	-	1	NMOD	-	-
11	HIV	HIV	B-NP	B-NP	-	13	NMOD	-	-
12	Tat	Tat	I-NP	I-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	10	PMOD	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	increased	increased	I-VP	I-VP	-	14	VC	-	-
16	upon	upon	B-PP	B-PP	-	15	VMOD	-	-
17	OKA	OKA	B-NP	B-NP	-	21	NMOD	-	-
18	but	but	B-NP	B-NP	-	21	NMOD	-	-
19	not	not	I-NP	I-NP	-	18	DEP	-	-
20	TNF	TNF	B-NP	B-NP	-	21	NMOD	-	-
21	stimulation	stimulation	I-NP	I-NP	-	16	PMOD	-	-
22	.	.	O	O	-	14	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	SP1	SP1	B-NP	B-NP	-	6	NMOD	-	-
6	phosphorylation	phosphorylation	I-NP	I-NP	-	13	NMOD	-	-
7	induced	induced	B-VP	B-VP	-	6	NMOD	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	OKA	OKA	B-NP	B-NP	-	13	NMOD	-	-
10	,	,	O	O	-	13	P	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	selective	selective	I-NP	I-NP	-	13	NMOD	-	-
13	inhibitor	inhibitor	I-NP	I-NP	-	20	SUB	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	serine-threonine	serine-threonine	I-NP	I-NP	-	18	NMOD	-	-
17	phosphatase	phosphatase	I-NP	I-NP	-	18	NMOD	-	-
18	PP2A	PP2A	I-NP	I-NP	-	14	PMOD	-	-
19	,	,	O	O	-	13	P	-	-
20	facilitates	facilitates	B-VP	B-VP	-	4	SBAR	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	formation	formation	I-NP	I-NP	-	20	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	a	a	B-NP	B-NP	-	26	NMOD	-	-
25	transcription	transcription	I-NP	I-NP	-	26	NMOD	-	-
26	complex	complex	I-NP	I-NP	-	23	PMOD	-	-
27	involving	involving	B-VP	B-VP	-	26	NMOD	-	-
28	general	general	B-NP	B-NP	-	30	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	30	NMOD	-	-
30	factors	factors	I-NP	I-NP	-	37	NMOD	-	-
31	,	,	O	O	-	37	P	-	-
32	HIV	HIV	B-NP	B-NP	-	33	NMOD	-	-
33	Tat	Tat	I-NP	I-NP	-	37	NMOD	-	-
34	,	,	O	O	-	37	P	-	-
35	and	and	O	O	-	37	NMOD	-	-
36	Sp1	Sp1	B-NP	B-NP	-	37	NMOD	-	-
37	proteins	proteins	I-NP	I-NP	-	27	OBJ	-	-
38	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	formation	formation	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	this	this	B-NP	B-NP	-	5	NMOD	-	-
5	complex	complex	I-NP	I-NP	-	3	PMOD	-	-
6	would	would	B-VP	B-VP	-	0	ROOT	-	-
7	increase	increase	I-VP	I-VP	-	6	VC	-	-
8	,	,	O	O	-	7	P	-	-
9	independently	independently	B-ADVP	B-ADVP	-	7	VMOD	-	-
10	of	of	B-PP	B-PP	-	7	VMOD	-	-
11	an	an	B-NP	B-NP	-	10	PMOD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	synergy	synergy	B-NP	B-NP	-	12	PMOD	-	-
14	with	with	B-PP	B-PP	-	13	NMOD	-	-
15	NF-kappa	NF-kappa	B-NP	B-NP	-	16	NMOD	-	-
16	B	B	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	7	P	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	low	low	I-NP	I-NP	-	21	NMOD	-	-
20	basal	basal	I-NP	I-NP	-	21	NMOD	-	-
21	activity	activity	I-NP	I-NP	-	26	SUB	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	HIV	HIV	I-NP	I-NP	-	25	NMOD	-	-
25	LTR	LTR	I-NP	I-NP	-	22	PMOD	-	-
26	observed	observed	B-VP	B-VP	-	7	VMOD	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	normal	normal	B-NP	B-NP	-	30	NMOD	-	-
29	T	T	I-NP	I-NP	-	30	NMOD	-	-
30	lymphocytes	lymphocytes	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	6	P	-	-

1	Human	Human	B-NP	B-NP	-	6	NMOD	-	-
2	MHC	MHC	I-NP	I-NP	-	5	NMOD	-	-
3	class	class	I-NP	I-NP	-	5	NMOD	-	-
4	II	II	I-NP	I-NP	-	5	NMOD	-	-
5	gene	gene	I-NP	I-NP	-	6	NMOD	-	-
6	transcription	transcription	I-NP	I-NP	-	0	ROOT	-	-
7	directed	directed	B-VP	B-VP	-	6	NMOD	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	carboxyl	carboxyl	I-NP	I-NP	-	11	NMOD	-	-
11	terminus	terminus	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	CIITA	CIITA	B-NP	B-NP	-	12	PMOD	-	-
14	,	,	O	O	-	15	P	-	-
15	one	one	B-NP	B-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	defective	defective	I-NP	I-NP	-	19	NMOD	-	-
19	genes	genes	I-NP	I-NP	-	16	PMOD	-	-
20	in	in	B-PP	B-PP	-	15	NMOD	-	-
21	type	type	B-NP	B-NP	-	26	NMOD	-	-
22	II	II	I-NP	I-NP	-	26	NMOD	-	-
23	MHC	MHC	I-NP	I-NP	-	26	NMOD	-	-
24	combined	combined	I-NP	I-NP	-	26	NMOD	-	-
25	immune	immune	I-NP	I-NP	-	26	NMOD	-	-
26	deficiency	deficiency	I-NP	I-NP	-	20	PMOD	-	-
27	.	.	O	O	-	15	P	-	-

1	Type	Type	B-NP	B-NP	-	5	NMOD	-	-
2	II	II	I-NP	I-NP	-	5	NMOD	-	-
3	major	major	I-NP	I-NP	-	5	NMOD	-	-
4	histocompatibility	histocompatibility	I-NP	I-NP	-	5	NMOD	-	-
5	complex	complex	I-NP	I-NP	-	8	NMOD	-	-
6	combined	combined	I-NP	I-NP	-	8	NMOD	-	-
7	immune	immune	I-NP	I-NP	-	8	NMOD	-	-
8	deficiency	deficiency	I-NP	I-NP	-	19	SUB	-	-
9	(	(	O	O	-	10	P	-	-
10	type	type	B-NP	B-NP	-	13	NMOD	-	-
11	II	II	I-NP	I-NP	-	13	NMOD	-	-
12	MHC	MHC	I-NP	I-NP	-	13	NMOD	-	-
13	CID	CID	I-NP	I-NP	-	17	NMOD	-	-
14	or	or	O	O	-	17	NMOD	-	-
15	bare	bare	B-NP	B-NP	-	17	NMOD	-	-
16	lymphocyte	lymphocyte	I-NP	I-NP	-	17	NMOD	-	-
17	syndrome	syndrome	I-NP	I-NP	-	8	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	is	is	B-VP	B-VP	-	0	ROOT	-	-
20	a	a	B-NP	B-NP	-	23	NMOD	-	-
21	congenital	congenital	I-NP	I-NP	-	23	NMOD	-	-
22	immunodeficiency	immunodeficiency	I-NP	I-NP	-	23	NMOD	-	-
23	disease	disease	I-NP	I-NP	-	19	PRD	-	-
24	characterized	characterized	B-VP	B-VP	-	23	NMOD	-	-
25	by	by	B-PP	B-PP	-	24	VMOD	-	-
26	absent	absent	B-NP	B-NP	-	30	NMOD	-	-
27	MHC	MHC	I-NP	I-NP	-	30	NMOD	-	-
28	class	class	I-NP	I-NP	-	30	NMOD	-	-
29	II	II	I-NP	I-NP	-	30	NMOD	-	-
30	expression	expression	I-NP	I-NP	-	25	PMOD	-	-
31	.	.	O	O	-	19	P	-	-

1	Four	Four	B-NP	B-NP	-	4	NMOD	-	-
2	distinct	distinct	I-NP	I-NP	-	4	NMOD	-	-
3	complementation	complementation	I-NP	I-NP	-	4	NMOD	-	-
4	groups	groups	I-NP	I-NP	-	5	SUB	-	-
5	have	have	B-VP	B-VP	-	0	ROOT	-	-
6	been	been	I-VP	I-VP	-	5	VC	-	-
7	identified	identified	I-VP	I-VP	-	6	VC	-	-
8	.	.	O	O	-	5	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	13	VMOD	-	-
2	,	,	O	O	-	13	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	defective	defective	I-NP	I-NP	-	5	NMOD	-	-
5	gene	gene	I-NP	I-NP	-	13	SUB	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	group	group	B-NP	B-NP	-	9	NMOD	-	-
8	II	II	I-NP	I-NP	-	9	NMOD	-	-
9	type	type	I-NP	I-NP	-	12	NMOD	-	-
10	II	II	I-NP	I-NP	-	12	NMOD	-	-
11	MHC	MHC	I-NP	I-NP	-	12	NMOD	-	-
12	CID	CID	I-NP	I-NP	-	6	PMOD	-	-
13	has	has	B-VP	B-VP	-	0	ROOT	-	-
14	been	been	I-VP	I-VP	-	13	VC	-	-
15	isolated	isolated	I-VP	I-VP	-	14	VC	-	-
16	and	and	O	O	-	15	VMOD	-	-
17	termed	termed	B-VP	B-VP	-	15	VMOD	-	-
18	CIITA	CIITA	B-NP	B-NP	-	17	VMOD	-	-
19	.	.	O	O	-	13	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	CIITA	CIITA	B-NP	B-NP	-	7	SUB	-	-
7	is	is	B-VP	B-VP	-	5	SBAR	-	-
8	an	an	B-NP	B-NP	-	14	NMOD	-	-
9	MHC	MHC	I-NP	I-NP	-	14	NMOD	-	-
10	class	class	I-NP	I-NP	-	14	NMOD	-	-
11	II	II	I-NP	I-NP	-	14	NMOD	-	-
12	gene-specific	gene-specific	I-NP	I-NP	-	14	NMOD	-	-
13	transcription	transcription	I-NP	I-NP	-	14	NMOD	-	-
14	activator	activator	I-NP	I-NP	-	7	PRD	-	-
15	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	transcription	transcription	I-NP	I-NP	-	4	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	4	NMOD	-	-
4	function	function	I-NP	I-NP	-	5	SUB	-	-
5	is	is	B-VP	B-VP	-	0	ROOT	-	-
6	provided	provided	I-VP	I-VP	-	5	VC	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	N-terminal	N-terminal	I-NP	I-NP	-	11	NMOD	-	-
10	acidic	acidic	I-NP	I-NP	-	11	NMOD	-	-
11	domain	domain	I-NP	I-NP	-	14	NMOD	-	-
12	(	(	O	O	-	14	P	-	-
13	amino	amino	B-NP	B-NP	-	14	NMOD	-	-
14	acids	acids	I-NP	I-NP	-	7	PMOD	-	-
15	26-137	26-137	B-NP	B-NP	-	14	NMOD	-	-
16	)	)	O	O	-	14	P	-	-
17	,	,	O	O	-	14	P	-	-
18	which	which	B-NP	B-NP	-	14	NMOD	-	-
19	is	is	B-VP	B-VP	-	18	SBAR	-	-
20	experimentally	experimentally	B-ADJP	B-ADJP	-	21	AMOD	-	-
21	exchangeable	exchangeable	I-ADJP	I-ADJP	-	19	PRD	-	-
22	with	with	B-PP	B-PP	-	21	AMOD	-	-
23	a	a	B-NP	B-NP	-	27	NMOD	-	-
24	heterologous	heterologous	I-NP	I-NP	-	27	NMOD	-	-
25	viral	viral	I-NP	I-NP	-	27	NMOD	-	-
26	transcription-activating	transcription-activating	I-NP	I-NP	-	27	NMOD	-	-
27	domain	domain	I-NP	I-NP	-	22	PMOD	-	-
28	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	specificity	specificity	I-NP	I-NP	-	19	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	CIITA	CIITA	B-NP	B-NP	-	3	PMOD	-	-
5	for	for	B-PP	B-PP	-	2	NMOD	-	-
6	three	three	B-NP	B-NP	-	11	NMOD	-	-
7	major	major	I-NP	I-NP	-	11	NMOD	-	-
8	MHC	MHC	I-NP	I-NP	-	11	NMOD	-	-
9	class	class	I-NP	I-NP	-	11	NMOD	-	-
10	II	II	B-NP	B-NP	-	11	NMOD	-	-
11	genes	genes	I-NP	I-NP	-	17	NMOD	-	-
12	,	,	O	O	-	17	P	-	-
13	DR	DR	B-NP	B-NP	-	17	NMOD	-	-
14	,	,	O	O	-	17	P	-	-
15	DQ	DQ	B-NP	B-NP	-	17	NMOD	-	-
16	and	and	I-NP	I-NP	-	17	NMOD	-	-
17	DP	DP	I-NP	I-NP	-	5	PMOD	-	-
18	,	,	O	O	-	2	P	-	-
19	is	is	B-VP	B-VP	-	0	ROOT	-	-
20	mediated	mediated	I-VP	I-VP	-	19	VC	-	-
21	by	by	B-PP	B-PP	-	20	VMOD	-	-
22	its	its	B-NP	B-NP	-	25	NMOD	-	-
23	remaining	remaining	I-NP	I-NP	-	25	NMOD	-	-
24	C-terminal	C-terminal	I-NP	I-NP	-	25	NMOD	-	-
25	residues	residues	I-NP	I-NP	-	28	NMOD	-	-
26	(	(	O	O	-	28	P	-	-
27	amino	amino	B-NP	B-NP	-	28	NMOD	-	-
28	acids	acids	I-NP	I-NP	-	21	PMOD	-	-
29	317-1130	317-1130	B-NP	B-NP	-	28	NMOD	-	-
30	)	)	O	O	-	28	P	-	-
31	.	.	O	O	-	19	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	transactivation	transactivation	I-NP	I-NP	-	18	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	multiple	multiple	B-NP	B-NP	-	6	NMOD	-	-
5	cis	cis	I-NP	I-NP	-	6	NMOD	-	-
6	elements	elements	I-NP	I-NP	-	3	PMOD	-	-
7	,	,	O	O	-	18	P	-	-
8	especially	especially	B-NP	B-NP	-	9	NMOD	-	-
9	S	S	I-NP	I-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	X2	X2	I-NP	I-NP	-	18	NMOD	-	-
12	,	,	O	O	-	11	P	-	-
13	of	of	B-PP	B-PP	-	11	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	DR	DR	I-NP	I-NP	-	18	NMOD	-	-
16	alpha	alpha	I-NP	I-NP	-	18	NMOD	-	-
17	proximal	proximal	I-NP	I-NP	-	18	NMOD	-	-
18	promoter	promoter	I-NP	I-NP	-	24	SUB	-	-
19	in	in	B-PP	B-PP	-	18	NMOD	-	-
20	group	group	B-NP	B-NP	-	23	NMOD	-	-
21	II	II	I-NP	I-NP	-	23	NMOD	-	-
22	CID	CID	I-NP	I-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
24	is	is	B-VP	B-VP	-	0	ROOT	-	-
25	CIITA	CIITA	B-NP	B-NP	-	24	PRD	-	-
26	dependent	dependent	B-ADJP	B-ADJP	-	25	AMOD	-	-
27	.	.	O	O	-	24	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	15	VMOD	-	-
2	CIITA	CIITA	B-NP	B-NP	-	3	NMOD	-	-
3	overexpression	overexpression	I-NP	I-NP	-	7	SUB	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	normal	normal	B-NP	B-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
7	did	did	B-VP	B-VP	-	1	SBAR	-	-
8	not	not	I-VP	I-VP	-	7	VMOD	-	-
9	increase	increase	I-VP	I-VP	-	7	VC	-	-
10	class	class	B-NP	B-NP	-	12	NMOD	-	-
11	II	II	I-NP	I-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	9	OBJ	-	-
13	,	,	O	O	-	15	P	-	-
14	we	we	B-NP	B-NP	-	15	SUB	-	-
15	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	initiation	initiation	B-NP	B-NP	-	21	SUB	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	CIITA	CIITA	B-NP	B-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	18	PMOD	-	-
21	serves	serves	B-VP	B-VP	-	16	SBAR	-	-
22	as	as	B-PP	B-PP	-	21	VMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	on-off	on-off	I-NP	I-NP	-	25	NMOD	-	-
25	switch	switch	I-NP	I-NP	-	22	PMOD	-	-
26	,	,	O	O	-	15	P	-	-
27	while	while	B-SBAR	B-SBAR	-	15	VMOD	-	-
28	availability	availability	B-NP	B-NP	-	35	SUB	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	downstream	downstream	B-NP	B-NP	-	33	NMOD	-	-
31	interactor	interactor	I-NP	I-NP	-	33	NMOD	-	-
32	(	(	I-NP	I-NP	-	33	P	-	-
33	s	s	I-NP	I-NP	-	29	PMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	limits	limits	B-VP	B-VP	-	27	SBAR	-	-
36	transcription	transcription	B-NP	B-NP	-	35	OBJ	-	-
37	.	.	O	O	-	15	P	-	-

1	Abnormal	Abnormal	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	IL-2	IL-2	I-NP	I-NP	-	6	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	3	PMOD	-	-
7	in	in	B-PP	B-PP	-	2	NMOD	-	-
8	lpr	lpr	B-NP	B-NP	-	11	NMOD	-	-
9	CD4-CD8-	CD4-CD8-	I-NP	I-NP	-	11	NMOD	-	-
10	T	T	I-NP	I-NP	-	11	NMOD	-	-
11	lymphocytes	lymphocytes	I-NP	I-NP	-	7	PMOD	-	-
12	results	results	B-VP	B-VP	-	0	ROOT	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	constitutive	constitutive	B-NP	B-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	a	a	B-NP	B-NP	-	20	NMOD	-	-
18	novel	novel	I-NP	I-NP	-	20	NMOD	-	-
19	nuclear	nuclear	I-NP	I-NP	-	20	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	16	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	activated	activated	B-NP	B-NP	-	25	NMOD	-	-
23	T	T	I-NP	I-NP	-	25	NMOD	-	-
24	cells-binding	cells-binding	I-NP	I-NP	-	25	NMOD	-	-
25	factor	factor	I-NP	I-NP	-	21	PMOD	-	-
26	.	.	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	inert	inert	I-NP	I-NP	-	3	NMOD	-	-
3	quality	quality	I-NP	I-NP	-	16	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	MRL-Ipr/Ipr	MRL-Ipr/Ipr	B-NP	B-NP	-	15	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	Ipr	Ipr	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	peripheral	peripheral	O	O	-	15	NMOD	-	-
10	CD4-CD8-	CD4-CD8-	O	O	-	15	NMOD	-	-
11	(	(	O	O	-	15	P	-	-
12	CD4-8-	CD4-8-	O	O	-	15	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	T	T	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
16	manifests	manifests	B-VP	B-VP	-	0	ROOT	-	-
17	primarily	primarily	B-ADVP	B-ADVP	-	16	VMOD	-	-
18	as	as	B-PP	B-PP	-	16	VMOD	-	-
19	an	an	B-NP	B-NP	-	20	NMOD	-	-
20	inability	inability	I-NP	I-NP	-	18	PMOD	-	-
21	to	to	B-VP	B-VP	-	22	VMOD	-	-
22	proliferate	proliferate	I-VP	I-VP	-	20	NMOD	-	-
23	or	or	I-VP	I-VP	-	22	VMOD	-	-
24	produce	produce	I-VP	I-VP	-	22	VMOD	-	-
25	IL-2	IL-2	B-NP	B-NP	-	24	OBJ	-	-
26	in	in	B-PP	B-PP	-	24	VMOD	-	-
27	response	response	B-NP	B-NP	-	26	PMOD	-	-
28	to	to	B-PP	B-PP	-	27	NMOD	-	-
29	TCR	TCR	B-NP	B-NP	-	32	NMOD	-	-
30	or	or	O	O	-	32	NMOD	-	-
31	mitogenic	mitogenic	B-NP	B-NP	-	32	NMOD	-	-
32	stimulation	stimulation	I-NP	I-NP	-	28	PMOD	-	-
33	.	.	O	O	-	16	P	-	-

1	Yet	Yet	B-NP	B-NP	-	4	NMOD	-	-
2	these	these	I-NP	I-NP	-	4	NMOD	-	-
3	same	same	I-NP	I-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	5	SUB	-	-
5	do	do	B-VP	B-VP	-	0	ROOT	-	-
6	initiate	initiate	I-VP	I-VP	-	5	VC	-	-
7	early	early	B-NP	B-NP	-	10	NMOD	-	-
8	TCR-mediated	TCR-mediated	I-NP	I-NP	-	10	NMOD	-	-
9	signaling	signaling	I-NP	I-NP	-	10	NMOD	-	-
10	events	events	I-NP	I-NP	-	6	OBJ	-	-
11	,	,	O	O	-	10	P	-	-
12	such	such	B-PP	B-PP	-	13	PMOD	-	-
13	as	as	I-PP	I-PP	-	10	NMOD	-	-
14	generation	generation	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	inositol	inositol	B-NP	B-NP	-	17	NMOD	-	-
17	phosphates	phosphates	I-NP	I-NP	-	15	PMOD	-	-
18	and	and	O	O	-	21	NMOD	-	-
19	increased	increased	B-NP	B-NP	-	21	NMOD	-	-
20	intracellular	intracellular	I-NP	I-NP	-	21	NMOD	-	-
21	calcium	calcium	I-NP	I-NP	-	13	PMOD	-	-
22	.	.	O	O	-	5	P	-	-

1	They	They	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	display	display	B-VP	B-VP	-	0	ROOT	-	-
4	constitutively	constitutively	B-NP	B-NP	-	5	AMOD	-	-
5	high	high	I-NP	I-NP	-	6	NMOD	-	-
6	levels	levels	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	p59fyn	p59fyn	B-NP	B-NP	-	13	NMOD	-	-
9	and	and	I-NP	I-NP	-	13	NMOD	-	-
10	CD3	CD3	I-NP	I-NP	-	13	NMOD	-	-
11	zeta	zeta	I-NP	I-NP	-	13	NMOD	-	-
12	tyrosine	tyrosine	I-NP	I-NP	-	13	NMOD	-	-
13	phosphorylation	phosphorylation	I-NP	I-NP	-	7	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	generation	generation	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	second	second	B-NP	B-NP	-	5	NMOD	-	-
5	messengers	messengers	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	NMOD	-	-
7	T	T	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	normally	normally	B-ADVP	B-ADVP	-	10	VMOD	-	-
10	leads	leads	B-VP	B-VP	-	0	ROOT	-	-
11	to	to	B-PP	B-PP	-	10	VMOD	-	-
12	downstream	downstream	B-NP	B-NP	-	13	NMOD	-	-
13	signaling	signaling	I-NP	I-NP	-	11	PMOD	-	-
14	that	that	B-NP	B-NP	-	13	NMOD	-	-
15	results	results	B-VP	B-VP	-	14	SBAR	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	transcriptional	transcriptional	B-NP	B-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	IL-2	IL-2	I-NP	I-NP	-	22	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	5	SUB	-	-
2	,	,	O	O	-	5	P	-	-
3	therefore	therefore	B-ADVP	B-ADVP	-	5	VMOD	-	-
4	,	,	O	O	-	5	P	-	-
5	compared	compared	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	8	NMOD	-	-
8	state	state	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	IL-2	IL-2	I-NP	I-NP	-	14	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	14	NMOD	-	-
13	promoter	promoter	I-NP	I-NP	-	14	NMOD	-	-
14	region	region	I-NP	I-NP	-	9	PMOD	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	freshly	freshly	B-NP	B-NP	-	19	AMOD	-	-
17	isolated	isolated	I-NP	I-NP	-	19	AMOD	-	-
18	and	and	I-NP	I-NP	-	19	AMOD	-	-
19	stimulated	stimulated	I-NP	I-NP	-	23	NMOD	-	-
20	Ipr	Ipr	I-NP	I-NP	-	23	NMOD	-	-
21	CD4-8-	CD4-8-	I-NP	I-NP	-	23	NMOD	-	-
22	T	T	I-NP	I-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
24	with	with	B-PP	B-PP	-	14	NMOD	-	-
25	that	that	B-NP	B-NP	-	24	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	normal	normal	B-NP	B-NP	-	29	NMOD	-	-
28	T	T	I-NP	I-NP	-	29	NMOD	-	-
29	lymphocytes	lymphocytes	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	5	P	-	-

1	Levels	Levels	B-NP	B-NP	-	17	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	octamer	octamer	I-NP	I-NP	-	2	PMOD	-	-
5	,	,	O	O	-	16	P	-	-
6	NF-kappa	NF-kappa	B-NP	B-NP	-	7	NMOD	-	-
7	B	B	I-NP	I-NP	-	16	NMOD	-	-
8	(	(	O	O	-	10	P	-	-
9	p50-p65	p50-p65	B-NP	B-NP	-	10	NMOD	-	-
10	heterodimer	heterodimer	I-NP	I-NP	-	7	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	,	,	O	O	-	16	P	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	AP-1	AP-1	B-NP	B-NP	-	16	NMOD	-	-
15	transcriptional	transcriptional	I-NP	I-NP	-	16	NMOD	-	-
16	factors	factors	I-NP	I-NP	-	2	PMOD	-	-
17	are	are	B-VP	B-VP	-	0	ROOT	-	-
18	constitutively	constitutively	I-VP	I-VP	-	17	VMOD	-	-
19	elevated	elevated	I-VP	I-VP	-	17	VC	-	-
20	in	in	B-PP	B-PP	-	19	VMOD	-	-
21	freshly	freshly	B-NP	B-NP	-	22	AMOD	-	-
22	isolated	isolated	I-NP	I-NP	-	26	NMOD	-	-
23	Ipr	Ipr	I-NP	I-NP	-	26	NMOD	-	-
24	CD4-8-	CD4-8-	I-NP	I-NP	-	26	NMOD	-	-
25	T	T	I-NP	I-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
27	,	,	O	O	-	26	P	-	-
28	consistent	consistent	B-ADJP	B-ADJP	-	26	NMOD	-	-
29	with	with	B-PP	B-PP	-	28	AMOD	-	-
30	the	the	B-NP	B-NP	-	32	NMOD	-	-
31	activated	activated	I-NP	I-NP	-	32	NMOD	-	-
32	phenotype	phenotype	I-NP	I-NP	-	29	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	these	these	B-NP	B-NP	-	35	NMOD	-	-
35	cells	cells	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	17	P	-	-

1	Upon	Upon	B-PP	B-PP	-	22	VMOD	-	-
2	stimulation	stimulation	B-NP	B-NP	-	1	PMOD	-	-
3	with	with	B-PP	B-PP	-	2	NMOD	-	-
4	mitogens	mitogens	B-NP	B-NP	-	3	PMOD	-	-
5	,	,	O	O	-	22	P	-	-
6	formation	formation	B-NP	B-NP	-	22	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	13	NMOD	-	-
9	transactivating	transactivating	I-NP	I-NP	-	10	NMOD	-	-
10	complex	complex	I-NP	I-NP	-	13	NMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	nuclear	nuclear	B-NP	B-NP	-	13	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	7	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	activated	activated	B-NP	B-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	NF-AT	NF-AT	B-NP	B-NP	-	13	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	6	P	-	-
22	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
23	with	with	B-PP	B-PP	-	22	VMOD	-	-
24	normal	normal	B-NP	B-NP	-	25	NMOD	-	-
25	kinetics	kinetics	I-NP	I-NP	-	23	PMOD	-	-
26	in	in	B-PP	B-PP	-	22	VMOD	-	-
27	Ipr	Ipr	B-NP	B-NP	-	30	NMOD	-	-
28	CD4-8-	CD4-8-	I-NP	I-NP	-	30	NMOD	-	-
29	T	T	I-NP	I-NP	-	30	NMOD	-	-
30	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
31	.	.	O	O	-	22	P	-	-

1	Yet	Yet	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	levels	levels	I-NP	I-NP	-	11	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	activating	activating	I-NP	I-NP	-	9	NMOD	-	-
8	NF-AT	NF-AT	I-NP	I-NP	-	9	NMOD	-	-
9	complex	complex	I-NP	I-NP	-	5	PMOD	-	-
10	never	never	B-ADVP	B-ADVP	-	11	VMOD	-	-
11	reach	reach	B-VP	B-VP	-	0	ROOT	-	-
12	those	those	B-NP	B-NP	-	11	OBJ	-	-
13	observed	observed	B-VP	B-VP	-	12	NMOD	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	similarly	similarly	B-NP	B-NP	-	16	AMOD	-	-
16	stimulated	stimulated	I-NP	I-NP	-	19	NMOD	-	-
17	normal	normal	I-NP	I-NP	-	19	NMOD	-	-
18	T	T	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
20	.	.	O	O	-	11	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	nuclear	nuclear	B-NP	B-NP	-	4	NMOD	-	-
4	extracts	extracts	I-NP	I-NP	-	10	SUB	-	-
5	from	from	B-PP	B-PP	-	4	NMOD	-	-
6	Ipr	Ipr	B-NP	B-NP	-	9	NMOD	-	-
7	CD4-8-	CD4-8-	I-NP	I-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
10	display	display	B-VP	B-VP	-	0	ROOT	-	-
11	high	high	B-NP	B-NP	-	12	NMOD	-	-
12	levels	levels	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	a	a	B-NP	B-NP	-	18	NMOD	-	-
15	novel	novel	I-NP	I-NP	-	16	AMOD	-	-
16	specific	specific	I-NP	I-NP	-	18	NMOD	-	-
17	binding	binding	I-NP	I-NP	-	18	NMOD	-	-
18	activity	activity	I-NP	I-NP	-	13	PMOD	-	-
19	at	at	B-PP	B-PP	-	12	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	NF-AT	NF-AT	I-NP	I-NP	-	22	NMOD	-	-
22	site	site	I-NP	I-NP	-	19	PMOD	-	-
23	,	,	O	O	-	22	P	-	-
24	which	which	B-NP	B-NP	-	22	NMOD	-	-
25	is	is	B-VP	B-VP	-	24	SBAR	-	-
26	present	present	B-ADJP	B-ADJP	-	25	PRD	-	-
27	at	at	B-PP	B-PP	-	26	AMOD	-	-
28	much	much	B-NP	B-NP	-	29	AMOD	-	-
29	lower	lower	I-NP	I-NP	-	30	NMOD	-	-
30	levels	levels	I-NP	I-NP	-	27	PMOD	-	-
31	in	in	B-PP	B-PP	-	30	NMOD	-	-
32	freshly	freshly	B-NP	B-NP	-	36	NMOD	-	-
33	isolated	isolated	I-NP	I-NP	-	36	NMOD	-	-
34	normal	normal	I-NP	I-NP	-	36	NMOD	-	-
35	T	T	I-NP	I-NP	-	36	NMOD	-	-
36	lymphocytes	lymphocytes	I-NP	I-NP	-	31	PMOD	-	-
37	.	.	O	O	-	10	P	-	-

1	Upon	Upon	B-PP	B-PP	-	13	VMOD	-	-
2	mitogenic	mitogenic	B-NP	B-NP	-	3	NMOD	-	-
3	stimulation	stimulation	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	13	P	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	binding	binding	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	13	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	novel	novel	I-NP	I-NP	-	12	NMOD	-	-
11	NF-AT-binding	NF-AT-binding	I-NP	I-NP	-	12	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	8	PMOD	-	-
13	is	is	B-VP	B-VP	-	0	ROOT	-	-
14	rapidly	rapidly	I-VP	I-VP	-	13	VMOD	-	-
15	down-regulated	down-regulated	I-VP	I-VP	-	13	VC	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	normal	normal	B-NP	B-NP	-	19	NMOD	-	-
18	T	T	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	13	P	-	-
21	but	but	O	O	-	13	VMOD	-	-
22	persists	persists	B-VP	B-VP	-	13	VMOD	-	-
23	at	at	B-PP	B-PP	-	22	VMOD	-	-
24	high	high	B-NP	B-NP	-	25	NMOD	-	-
25	levels	levels	I-NP	I-NP	-	23	PMOD	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	Ipr	Ipr	B-NP	B-NP	-	30	NMOD	-	-
28	CD4-8-	CD4-8-	I-NP	I-NP	-	30	NMOD	-	-
29	T	T	I-NP	I-NP	-	30	NMOD	-	-
30	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
31	.	.	O	O	-	13	P	-	-

1	These	These	B-NP	B-NP	-	3	NMOD	-	-
2	two	two	I-NP	I-NP	-	3	NMOD	-	-
3	abnormalities	abnormalities	I-NP	I-NP	-	8	SUB	-	-
4	at	at	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	NF-AT	NF-AT	I-NP	I-NP	-	7	NMOD	-	-
7	site	site	I-NP	I-NP	-	4	PMOD	-	-
8	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	potential	potential	I-NP	I-NP	-	11	NMOD	-	-
11	mechanism	mechanism	I-NP	I-NP	-	8	OBJ	-	-
12	to	to	B-VP	B-VP	-	13	VMOD	-	-
13	account	account	I-VP	I-VP	-	11	NMOD	-	-
14	for	for	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	defect	defect	I-NP	I-NP	-	14	PMOD	-	-
17	in	in	B-PP	B-PP	-	16	NMOD	-	-
18	IL-2	IL-2	B-NP	B-NP	-	19	NMOD	-	-
19	production	production	I-NP	I-NP	-	17	PMOD	-	-
20	from	from	B-PP	B-PP	-	19	NMOD	-	-
21	Ipr	Ipr	B-NP	B-NP	-	24	NMOD	-	-
22	CD4-8-	CD4-8-	I-NP	I-NP	-	24	NMOD	-	-
23	T	T	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
25	.	.	O	O	-	8	P	-	-

1	GM-CSF	GM-CSF	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	IL-2	IL-2	I-NP	I-NP	-	4	SUB	-	-
4	share	share	B-VP	B-VP	-	0	ROOT	-	-
5	common	common	B-NP	B-NP	-	7	NMOD	-	-
6	control	control	I-NP	I-NP	-	7	NMOD	-	-
7	mechanisms	mechanisms	I-NP	I-NP	-	4	OBJ	-	-
8	in	in	B-PP	B-PP	-	4	VMOD	-	-
9	response	response	B-NP	B-NP	-	8	PMOD	-	-
10	to	to	B-PP	B-PP	-	9	NMOD	-	-
11	costimulatory	costimulatory	B-NP	B-NP	-	12	NMOD	-	-
12	signals	signals	I-NP	I-NP	-	10	PMOD	-	-
13	in	in	B-PP	B-PP	-	4	VMOD	-	-
14	T	T	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	4	P	-	-

1	Antigen	Antigen	B-NP	B-NP	-	19	SUB	-	-
2	complexed	complexed	B-VP	B-VP	-	1	NMOD	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	major	major	B-NP	B-NP	-	11	NMOD	-	-
5	histocompatibility	histocompatibility	I-NP	I-NP	-	11	NMOD	-	-
6	complex	complex	I-NP	I-NP	-	11	NMOD	-	-
7	class	class	I-NP	I-NP	-	11	NMOD	-	-
8	I	I	B-NP	B-NP	-	11	NMOD	-	-
9	or	or	I-NP	I-NP	-	11	NMOD	-	-
10	II	II	I-NP	I-NP	-	11	NMOD	-	-
11	molecules	molecules	I-NP	I-NP	-	3	PMOD	-	-
12	on	on	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	surface	surface	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	antigen	antigen	B-NP	B-NP	-	18	NMOD	-	-
17	presenting	presenting	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
19	interacts	interacts	B-VP	B-VP	-	0	ROOT	-	-
20	with	with	B-PP	B-PP	-	19	VMOD	-	-
21	the	the	B-NP	B-NP	-	24	NMOD	-	-
22	T	T	I-NP	I-NP	-	24	NMOD	-	-
23	cell	cell	I-NP	I-NP	-	24	NMOD	-	-
24	receptor	receptor	I-NP	I-NP	-	20	PMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	TCR	TCR	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	on	on	B-PP	B-PP	-	24	NMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	surface	surface	I-NP	I-NP	-	28	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	T	T	B-NP	B-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	31	PMOD	-	-
34	and	and	O	O	-	19	VMOD	-	-
35	initiates	initiates	B-VP	B-VP	-	19	VMOD	-	-
36	an	an	B-NP	B-NP	-	38	NMOD	-	-
37	activation	activation	I-NP	I-NP	-	38	NMOD	-	-
38	cascade	cascade	I-NP	I-NP	-	35	OBJ	-	-
39	.	.	O	O	-	19	P	-	-

1	So	So	O	O	-	2	AMOD	-	-
2	called	called	B-VP	B-VP	-	4	NMOD	-	-
3	costimulatory	costimulatory	B-NP	B-NP	-	4	NMOD	-	-
4	signals	signals	I-NP	I-NP	-	21	SUB	-	-
5	,	,	O	O	-	4	P	-	-
6	mediated	mediated	B-VP	B-VP	-	4	NMOD	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	other	other	B-NP	B-NP	-	11	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
10	surface	surface	I-NP	I-NP	-	11	NMOD	-	-
11	interactions	interactions	I-NP	I-NP	-	14	NMOD	-	-
12	or	or	O	O	-	14	NMOD	-	-
13	soluble	soluble	B-NP	B-NP	-	14	NMOD	-	-
14	cytokines	cytokines	I-NP	I-NP	-	7	PMOD	-	-
15	produced	produced	B-VP	B-VP	-	14	NMOD	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	antigen	antigen	B-NP	B-NP	-	19	NMOD	-	-
18	presenting	presenting	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	4	P	-	-
21	are	are	B-VP	B-VP	-	0	ROOT	-	-
22	also	also	I-VP	I-VP	-	21	VMOD	-	-
23	required	required	I-VP	I-VP	-	21	VC	-	-
24	for	for	B-PP	B-PP	-	23	VMOD	-	-
25	complete	complete	B-NP	B-NP	-	28	NMOD	-	-
26	T	T	I-NP	I-NP	-	28	NMOD	-	-
27	cell	cell	I-NP	I-NP	-	28	NMOD	-	-
28	activation	activation	I-NP	I-NP	-	24	PMOD	-	-
29	.	.	O	O	-	21	P	-	-

1	High	High	B-NP	B-NP	-	2	NMOD	-	-
2	levels	levels	I-NP	I-NP	-	11	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	cytokine	cytokine	B-NP	B-NP	-	6	NMOD	-	-
5	gene	gene	I-NP	I-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	T	T	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	also	also	B-ADVP	B-ADVP	-	11	VMOD	-	-
11	required	required	B-VP	B-VP	-	0	ROOT	-	-
12	both	both	O	O	-	16	NMOD	-	-
13	TCR	TCR	B-NP	B-NP	-	16	NMOD	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	costimulatory	costimulatory	B-NP	B-NP	-	16	NMOD	-	-
16	signals	signals	I-NP	I-NP	-	11	OBJ	-	-
17	.	.	O	O	-	11	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	granulocyte-macrophage	granulocyte-macrophage	I-NP	I-NP	-	4	NMOD	-	-
3	colony-stimulating	colony-stimulating	I-NP	I-NP	-	4	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	5	SUB	-	-
5	requires	requires	B-VP	B-VP	-	0	ROOT	-	-
6	sequences	sequences	B-NP	B-NP	-	5	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	7	PMOD	-	-
10	as	as	B-CONJP	B-CONJP	-	7	PMOD	-	-
11	well	well	I-CONJP	I-CONJP	-	10	DEP	-	-
12	as	as	I-CONJP	I-CONJP	-	10	DEP	-	-
13	a	a	B-NP	B-NP	-	15	NMOD	-	-
14	powerful	powerful	I-NP	I-NP	-	15	NMOD	-	-
15	enhancer	enhancer	I-NP	I-NP	-	18	NMOD	-	-
16	located	located	I-NP	I-NP	-	18	AMOD	-	-
17	3kb	3kb	I-NP	I-NP	-	18	AMOD	-	-
18	upstream	upstream	I-NP	I-NP	-	7	PMOD	-	-
19	to	to	B-VP	B-VP	-	20	VMOD	-	-
20	respond	respond	I-VP	I-VP	-	18	AMOD	-	-
21	to	to	B-PP	B-PP	-	20	VMOD	-	-
22	TCR-like	TCR-like	B-NP	B-NP	-	23	NMOD	-	-
23	signals	signals	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	5	NMOD	-	-
2	promoter	promoter	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	enhancer	enhancer	I-NP	I-NP	-	5	NMOD	-	-
5	regions	regions	I-NP	I-NP	-	6	SUB	-	-
6	are	are	B-VP	B-VP	-	0	ROOT	-	-
7	mainly	mainly	I-VP	I-VP	-	6	VMOD	-	-
8	activated	activated	I-VP	I-VP	-	6	VC	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	transcription	transcription	I-NP	I-NP	-	12	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	14	NMOD	-	-
13	nuclear	nuclear	B-NP	B-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	9	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	activated	activated	B-NP	B-NP	-	18	NMOD	-	-
17	T	T	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	NFAT	NFAT	B-NP	B-NP	-	14	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NFAT	NFAT	B-NP	B-NP	-	3	PMOD	-	-
5	by	by	B-PP	B-PP	-	2	NMOD	-	-
6	TCR	TCR	B-NP	B-NP	-	7	NMOD	-	-
7	signals	signals	I-NP	I-NP	-	5	PMOD	-	-
8	has	has	B-VP	B-VP	-	0	ROOT	-	-
9	been	been	I-VP	I-VP	-	8	VC	-	-
10	well	well	I-VP	I-VP	-	9	VMOD	-	-
11	described	described	I-VP	I-VP	-	9	VC	-	-
12	for	for	B-PP	B-PP	-	11	VMOD	-	-
13	interleukin-2	interleukin-2	B-NP	B-NP	-	20	NMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	IL-2	IL-2	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	and	and	O	O	-	20	NMOD	-	-
18	IL-4	IL-4	B-NP	B-NP	-	19	NMOD	-	-
19	gene	gene	I-NP	I-NP	-	20	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	12	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	T	T	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	8	P	-	-

1	Costimulatory	Costimulatory	B-NP	B-NP	-	2	NMOD	-	-
2	signals	signals	I-NP	I-NP	-	17	SUB	-	-
3	,	,	O	O	-	2	P	-	-
4	such	such	B-PP	B-PP	-	5	PMOD	-	-
5	as	as	I-PP	I-PP	-	2	NMOD	-	-
6	activation	activation	B-NP	B-NP	-	5	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	12	NMOD	-	-
9	CD28	CD28	I-NP	I-NP	-	12	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	12	NMOD	-	-
11	surface	surface	I-NP	I-NP	-	12	NMOD	-	-
12	molecule	molecule	I-NP	I-NP	-	7	PMOD	-	-
13	on	on	B-PP	B-PP	-	6	NMOD	-	-
14	T	T	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	2	P	-	-
17	lead	lead	B-VP	B-VP	-	0	ROOT	-	-
18	to	to	B-PP	B-PP	-	17	VMOD	-	-
19	activation	activation	B-NP	B-NP	-	18	PMOD	-	-
20	through	through	B-PP	B-PP	-	19	NMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	distinct	distinct	I-NP	I-NP	-	23	NMOD	-	-
23	region	region	I-NP	I-NP	-	20	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	32	NMOD	-	-
26	granulocyte-macrophage	granulocyte-macrophage	I-NP	I-NP	-	32	NMOD	-	-
27	colony-stimulating	colony-stimulating	I-NP	I-NP	-	32	NMOD	-	-
28	factor	factor	I-NP	I-NP	-	32	NMOD	-	-
29	(	(	O	O	-	32	P	-	-
30	GM-CSF	GM-CSF	B-NP	B-NP	-	32	NMOD	-	-
31	)	)	O	O	-	32	P	-	-
32	promoter	promoter	B-NP	B-NP	-	24	PMOD	-	-
33	.	.	O	O	-	17	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	region	region	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	termed	termed	I-VP	I-VP	-	3	VC	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	CK-1	CK-1	I-NP	I-NP	-	8	NMOD	-	-
7	or	or	I-NP	I-NP	-	8	NMOD	-	-
8	CD28RE	CD28RE	I-NP	I-NP	-	4	VMOD	-	-
9	and	and	O	O	-	3	VMOD	-	-
10	appears	appears	B-VP	B-VP	-	3	VMOD	-	-
11	to	to	I-VP	I-VP	-	12	VMOD	-	-
12	bind	bind	I-VP	I-VP	-	10	VMOD	-	-
13	specific	specific	B-NP	B-NP	-	14	NMOD	-	-
14	members	members	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	NF-kappa	NF-kappa	I-NP	I-NP	-	19	NMOD	-	-
18	B	B	I-NP	I-NP	-	19	NMOD	-	-
19	family	family	I-NP	I-NP	-	15	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	transcription	transcription	B-NP	B-NP	-	22	NMOD	-	-
22	factors	factors	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	Human	Human	B-NP	B-NP	-	5	NMOD	-	-
2	T	T	I-NP	I-NP	-	5	NMOD	-	-
3	leukemia	leukemia	I-NP	I-NP	-	5	NMOD	-	-
4	virus	virus	I-NP	I-NP	-	5	NMOD	-	-
5	type	type	I-NP	I-NP	-	10	SUB	-	-
6	<num>	<num>	I-NP	I-NP	-	5	NMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	HTLV-1	HTLV-1	B-NP	B-NP	-	5	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	infects	infects	B-VP	B-VP	-	0	ROOT	-	-
11	T	T	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	OBJ	-	-
13	and	and	O	O	-	10	VMOD	-	-
14	can	can	B-VP	B-VP	-	10	VMOD	-	-
15	lead	lead	I-VP	I-VP	-	14	VC	-	-
16	to	to	I-VP	I-VP	-	17	VMOD	-	-
17	increase	increase	I-VP	I-VP	-	15	VMOD	-	-
18	GM-CSF	GM-CSF	B-NP	B-NP	-	19	NMOD	-	-
19	expression	expression	I-NP	I-NP	-	17	OBJ	-	-
20	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	found	found	I-VP	I-VP	-	2	VC	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	HTLV-1	HTLV-1	I-NP	I-NP	-	8	NMOD	-	-
7	transactivator	transactivator	I-NP	I-NP	-	8	NMOD	-	-
8	protein	protein	I-NP	I-NP	-	10	NMOD	-	-
9	,	,	O	O	-	10	P	-	-
10	tax	tax	B-NP	B-NP	-	12	SUB	-	-
11	,	,	O	O	-	10	P	-	-
12	acts	acts	B-VP	B-VP	-	4	SBAR	-	-
13	as	as	B-PP	B-PP	-	12	VMOD	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	costimulatory	costimulatory	I-NP	I-NP	-	16	NMOD	-	-
16	signal	signal	I-NP	I-NP	-	13	PMOD	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	GM-CSF	GM-CSF	B-NP	B-NP	-	22	NMOD	-	-
19	and	and	I-NP	I-NP	-	22	NMOD	-	-
20	IL-2	IL-2	I-NP	I-NP	-	22	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	22	NMOD	-	-
22	transcription	transcription	I-NP	I-NP	-	17	PMOD	-	-
23	,	,	O	O	-	12	P	-	-
24	in	in	B-SBAR	B-SBAR	-	12	VMOD	-	-
25	that	that	I-SBAR	I-SBAR	-	3	VMOD	-	-
26	it	it	B-NP	B-NP	-	27	SUB	-	-
27	can	can	B-VP	B-VP	-	25	SBAR	-	-
28	cooperate	cooperate	I-VP	I-VP	-	27	VC	-	-
29	with	with	B-PP	B-PP	-	28	VMOD	-	-
30	TCR	TCR	B-NP	B-NP	-	31	NMOD	-	-
31	signals	signals	I-NP	I-NP	-	29	PMOD	-	-
32	to	to	B-VP	B-VP	-	33	VMOD	-	-
33	mediate	mediate	I-VP	I-VP	-	31	NMOD	-	-
34	high	high	B-NP	B-NP	-	37	NMOD	-	-
35	level	level	I-NP	I-NP	-	37	NMOD	-	-
36	gene	gene	I-NP	I-NP	-	37	NMOD	-	-
37	expression	expression	I-NP	I-NP	-	33	OBJ	-	-
38	.	.	O	O	-	2	P	-	-

1	Tax	Tax	B-NP	B-NP	-	2	SUB	-	-
2	activates	activates	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	GM-CSF	GM-CSF	I-NP	I-NP	-	5	NMOD	-	-
5	promoter	promoter	I-NP	I-NP	-	2	OBJ	-	-
6	through	through	B-PP	B-PP	-	2	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	CK-1/CD28RE	CK-1/CD28RE	I-NP	I-NP	-	9	NMOD	-	-
9	region	region	I-NP	I-NP	-	6	PMOD	-	-
10	and	and	O	O	-	2	VMOD	-	-
11	also	also	B-VP	B-VP	-	2	VMOD	-	-
12	activates	activates	I-VP	I-VP	-	2	VMOD	-	-
13	nuclear	nuclear	B-NP	B-NP	-	15	NMOD	-	-
14	factor-kappa	factor-kappa	I-NP	I-NP	-	15	NMOD	-	-
15	B	B	I-NP	I-NP	-	12	OBJ	-	-
16	binding	binding	B-VP	B-VP	-	15	NMOD	-	-
17	to	to	B-PP	B-PP	-	16	VMOD	-	-
18	this	this	B-NP	B-NP	-	19	NMOD	-	-
19	region	region	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	However	However	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	other	other	B-NP	B-NP	-	7	NMOD	-	-
4	transcription	transcription	I-NP	I-NP	-	5	NMOD	-	-
5	factors	factors	I-NP	I-NP	-	3	NMOD	-	-
6	or	or	O	O	-	7	NMOD	-	-
7	coactivators	coactivators	B-NP	B-NP	-	11	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	NF-kappa	NF-kappa	B-NP	B-NP	-	10	NMOD	-	-
10	B	B	I-NP	I-NP	-	8	PMOD	-	-
11	are	are	B-VP	B-VP	-	18	VMOD	-	-
12	required	required	I-VP	I-VP	-	11	VC	-	-
13	for	for	B-PP	B-PP	-	12	VMOD	-	-
14	tax	tax	B-NP	B-NP	-	15	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	13	PMOD	-	-
16	but	but	O	O	-	18	VMOD	-	-
17	these	these	B-NP	B-NP	-	18	SUB	-	-
18	remain	remain	B-VP	B-VP	-	0	ROOT	-	-
19	to	to	I-VP	I-VP	-	20	VMOD	-	-
20	be	be	I-VP	I-VP	-	18	VMOD	-	-
21	identified	identified	I-VP	I-VP	-	20	VC	-	-
22	.	.	O	O	-	18	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	CK-1/CD28RE	CK-1/CD28RE	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	GM-CSF	GM-CSF	B-NP	B-NP	-	3	PMOD	-	-
5	shows	shows	B-VP	B-VP	-	0	ROOT	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	high	high	I-NP	I-NP	-	8	NMOD	-	-
8	degree	degree	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	similarity	similarity	B-NP	B-NP	-	9	PMOD	-	-
11	to	to	B-PP	B-PP	-	8	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	IL-2	IL-2	I-NP	I-NP	-	14	NMOD	-	-
14	CD28RE	CD28RE	I-NP	I-NP	-	18	NMOD	-	-
15	and	and	O	O	-	18	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	IL-3	IL-3	I-NP	I-NP	-	18	NMOD	-	-
18	gene	gene	I-NP	I-NP	-	11	PMOD	-	-
19	also	also	B-ADVP	B-ADVP	-	20	VMOD	-	-
20	contains	contains	B-VP	B-VP	-	5	VMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	related	related	I-NP	I-NP	-	23	NMOD	-	-
23	region	region	I-NP	I-NP	-	20	OBJ	-	-
24	.	.	O	O	-	5	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	observation	observation	I-NP	I-NP	-	7	NMOD	-	-
3	,	,	O	O	-	2	P	-	-
4	together	together	B-ADVP	B-ADVP	-	2	NMOD	-	-
5	with	with	B-PP	B-PP	-	2	NMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	fact	fact	I-NP	I-NP	-	12	NMOD	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	both	both	O	O	-	12	NMOD	-	-
10	GM-CSF	GM-CSF	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	IL-2	IL-2	B-NP	B-NP	-	13	SUB	-	-
13	respond	respond	B-VP	B-VP	-	0	ROOT	-	-
14	to	to	B-PP	B-PP	-	13	VMOD	-	-
15	TCR	TCR	B-NP	B-NP	-	16	NMOD	-	-
16	signals	signals	I-NP	I-NP	-	14	PMOD	-	-
17	via	via	B-PP	B-PP	-	13	VMOD	-	-
18	NFAT	NFAT	B-NP	B-NP	-	17	PMOD	-	-
19	,	,	O	O	-	13	P	-	-
20	implies	implies	B-VP	B-VP	-	13	VMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	high	high	I-NP	I-NP	-	23	NMOD	-	-
23	degree	degree	I-NP	I-NP	-	20	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	conservation	conservation	B-NP	B-NP	-	24	PMOD	-	-
26	in	in	B-PP	B-PP	-	23	NMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	regulation	regulation	I-NP	I-NP	-	26	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	cytokine	cytokine	B-NP	B-NP	-	32	NMOD	-	-
31	gene	gene	I-NP	I-NP	-	32	NMOD	-	-
32	expression	expression	I-NP	I-NP	-	29	PMOD	-	-
33	in	in	B-PP	B-PP	-	28	NMOD	-	-
34	T	T	B-NP	B-NP	-	35	NMOD	-	-
35	cells	cells	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	20	P	-	-

1	MIP1	MIP1	B-NP	B-NP	-	4	NMOD	-	-
2	alpha	alpha	I-NP	I-NP	-	4	NMOD	-	-
3	nuclear	nuclear	I-NP	I-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	12	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	MNP	MNP	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	,	,	O	O	-	12	P	-	-
9	a	a	B-NP	B-NP	-	12	NMOD	-	-
10	novel	novel	I-NP	I-NP	-	12	NMOD	-	-
11	transcription	transcription	I-NP	I-NP	-	12	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	0	ROOT	-	-
13	expressed	expressed	B-VP	B-VP	-	12	NMOD	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	hematopoietic	hematopoietic	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
17	that	that	B-NP	B-NP	-	12	NMOD	-	-
18	is	is	B-VP	B-VP	-	17	SBAR	-	-
19	crucial	crucial	B-ADJP	B-ADJP	-	18	PRD	-	-
20	for	for	B-PP	B-PP	-	19	AMOD	-	-
21	transcription	transcription	B-NP	B-NP	-	20	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	27	NMOD	-	-
24	human	human	I-NP	I-NP	-	27	NMOD	-	-
25	MIP-1	MIP-1	I-NP	I-NP	-	27	NMOD	-	-
26	alpha	alpha	I-NP	I-NP	-	27	NMOD	-	-
27	gene	gene	I-NP	I-NP	-	22	PMOD	-	-
28	.	.	O	O	-	12	P	-	-

1	Murine	Murine	B-NP	B-NP	-	6	NMOD	-	-
2	macrophage	macrophage	I-NP	I-NP	-	4	NMOD	-	-
3	inflammatory	inflammatory	I-NP	I-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	6	NMOD	-	-
5	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
6	alpha	alpha	I-NP	I-NP	-	14	NMOD	-	-
7	(	(	O	O	-	9	P	-	-
8	MIP-1	MIP-1	B-NP	B-NP	-	9	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	6	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	its	its	B-NP	B-NP	-	14	NMOD	-	-
13	human	human	I-NP	I-NP	-	14	NMOD	-	-
14	equivalent	equivalent	I-NP	I-NP	-	23	SUB	-	-
15	(	(	O	O	-	21	P	-	-
16	GOS19	GOS19	B-NP	B-NP	-	21	NMOD	-	-
17	,	,	O	O	-	21	P	-	-
18	LD78	LD78	B-NP	B-NP	-	21	NMOD	-	-
19	,	,	O	O	-	21	P	-	-
20	or	or	O	O	-	21	NMOD	-	-
21	AT464	AT464	B-NP	B-NP	-	14	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	are	are	B-VP	B-VP	-	0	ROOT	-	-
24	members	members	B-NP	B-NP	-	23	PRD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	-C-C	-C-C	I-NP	I-NP	-	28	NMOD	-	-
28	family	family	I-NP	I-NP	-	25	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	low-molecular-weight	low-molecular-weight	B-NP	B-NP	-	31	NMOD	-	-
31	chemokines	chemokines	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	23	P	-	-

1	Secreted	Secreted	B-VP	B-VP	-	13	VMOD	-	-
2	from	from	B-PP	B-PP	-	1	VMOD	-	-
3	activated	activated	B-NP	B-NP	-	5	NMOD	-	-
4	T	T	I-NP	I-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	7	NMOD	-	-
6	and	and	O	O	-	7	NMOD	-	-
7	macrophages	macrophages	B-NP	B-NP	-	2	PMOD	-	-
8	,	,	O	O	-	13	P	-	-
9	bone	bone	B-NP	B-NP	-	12	NMOD	-	-
10	marrow-derived	marrow-derived	I-NP	I-NP	-	12	NMOD	-	-
11	MIP-1	MIP-1	I-NP	I-NP	-	12	NMOD	-	-
12	alpha/GOS19	alpha/GOS19	I-NP	I-NP	-	13	SUB	-	-
13	inhibits	inhibits	B-VP	B-VP	-	0	ROOT	-	-
14	primitive	primitive	B-NP	B-NP	-	17	NMOD	-	-
15	hematopoietic	hematopoietic	I-NP	I-NP	-	17	NMOD	-	-
16	stem	stem	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	13	OBJ	-	-
18	and	and	O	O	-	13	VMOD	-	-
19	appears	appears	B-VP	B-VP	-	13	VMOD	-	-
20	to	to	I-VP	I-VP	-	21	VMOD	-	-
21	be	be	I-VP	I-VP	-	19	VMOD	-	-
22	involved	involved	I-VP	I-VP	-	21	VC	-	-
23	in	in	B-PP	B-PP	-	22	VMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	homeostatic	homeostatic	I-NP	I-NP	-	26	NMOD	-	-
26	control	control	I-NP	I-NP	-	23	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	stem	stem	B-NP	B-NP	-	30	NMOD	-	-
29	cell	cell	I-NP	I-NP	-	30	NMOD	-	-
30	proliferation	proliferation	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	13	P	-	-

1	It	It	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
4	chemotaxis	chemotaxis	B-NP	B-NP	-	7	NMOD	-	-
5	and	and	I-NP	I-NP	-	7	NMOD	-	-
6	inflammatory	inflammatory	I-NP	I-NP	-	7	NMOD	-	-
7	responses	responses	I-NP	I-NP	-	3	OBJ	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	mature	mature	B-NP	B-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	types	types	I-NP	I-NP	-	8	PMOD	-	-
12	.	.	O	O	-	3	P	-	-

1	Therefore	Therefore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	it	it	B-NP	B-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	important	important	B-ADJP	B-ADJP	-	4	PRD	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	understand	understand	I-VP	I-VP	-	5	AMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	mechanisms	mechanisms	I-NP	I-NP	-	7	OBJ	-	-
10	which	which	B-NP	B-NP	-	9	NMOD	-	-
11	control	control	B-VP	B-VP	-	10	SBAR	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	MIP-1	MIP-1	B-NP	B-NP	-	16	NMOD	-	-
16	alpha/GOS19	alpha/GOS19	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	4	P	-	-

1	Previous	Previous	B-NP	B-NP	-	2	NMOD	-	-
2	work	work	I-NP	I-NP	-	3	SUB	-	-
3	has	has	B-VP	B-VP	-	0	ROOT	-	-
4	shown	shown	I-VP	I-VP	-	3	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	in	in	B-PP	B-PP	-	23	VMOD	-	-
7	Jurkat	Jurkat	B-NP	B-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	23	P	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	set	set	I-NP	I-NP	-	23	SUB	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	widely	widely	B-NP	B-NP	-	15	AMOD	-	-
15	expressed	expressed	I-NP	I-NP	-	17	NMOD	-	-
16	transcription	transcription	I-NP	I-NP	-	17	NMOD	-	-
17	factors	factors	I-NP	I-NP	-	13	PMOD	-	-
18	(	(	O	O	-	21	P	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	ICK-1	ICK-1	I-NP	I-NP	-	21	NMOD	-	-
21	family	family	I-NP	I-NP	-	17	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	affect	affect	B-VP	B-VP	-	5	SBAR	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	GOS19	GOS19	I-NP	I-NP	-	26	NMOD	-	-
26	promoter	promoter	I-NP	I-NP	-	23	OBJ	-	-
27	.	.	O	O	-	3	P	-	-

1	One	One	B-NP	B-NP	-	2	NMOD	-	-
2	member	member	I-NP	I-NP	-	4	NMOD	-	-
3	,	,	O	O	-	4	P	-	-
4	ICK-1A	ICK-1A	B-NP	B-NP	-	6	SUB	-	-
5	,	,	O	O	-	4	P	-	-
6	behaves	behaves	B-VP	B-VP	-	0	ROOT	-	-
7	as	as	B-PP	B-PP	-	6	VMOD	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	strong	strong	I-NP	I-NP	-	11	NMOD	-	-
10	negative	negative	I-NP	I-NP	-	11	NMOD	-	-
11	regulator	regulator	I-NP	I-NP	-	7	PMOD	-	-
12	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	communication	communication	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
7	evidence	evidence	B-NP	B-NP	-	6	OBJ	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	pathway	pathway	I-NP	I-NP	-	19	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	induction	induction	B-NP	B-NP	-	11	PMOD	-	-
13	in	in	B-PP	B-PP	-	10	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	macrophage	macrophage	I-NP	I-NP	-	18	NMOD	-	-
16	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
17	line	line	I-NP	I-NP	-	18	NMOD	-	-
18	U937	U937	I-NP	I-NP	-	13	PMOD	-	-
19	is	is	B-VP	B-VP	-	8	SBAR	-	-
20	different	different	B-ADJP	B-ADJP	-	19	PRD	-	-
21	from	from	B-PP	B-PP	-	20	AMOD	-	-
22	that	that	B-NP	B-NP	-	21	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	Jurkat	Jurkat	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	6	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	show	show	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	ICK-1	ICK-1	I-NP	I-NP	-	9	NMOD	-	-
8	binding	binding	I-NP	I-NP	-	9	NMOD	-	-
9	site	site	I-NP	I-NP	-	10	SUB	-	-
10	does	does	B-VP	B-VP	-	5	SBAR	-	-
11	not	not	I-VP	I-VP	-	10	VMOD	-	-
12	confer	confer	I-VP	I-VP	-	10	VC	-	-
13	negative	negative	B-NP	B-NP	-	14	NMOD	-	-
14	regulation	regulation	I-NP	I-NP	-	12	OBJ	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	U937	U937	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
3	evidence	evidence	B-NP	B-NP	-	2	OBJ	-	-
4	for	for	B-PP	B-PP	-	3	NMOD	-	-
5	an	an	B-NP	B-NP	-	8	NMOD	-	-
6	additional	additional	I-NP	I-NP	-	8	NMOD	-	-
7	binding	binding	I-NP	I-NP	-	8	NMOD	-	-
8	site	site	I-NP	I-NP	-	18	NMOD	-	-
9	,	,	O	O	-	18	P	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	MIP-1	MIP-1	I-NP	I-NP	-	14	NMOD	-	-
12	alpha	alpha	I-NP	I-NP	-	14	NMOD	-	-
13	nuclear	nuclear	I-NP	I-NP	-	14	NMOD	-	-
14	protein	protein	I-NP	I-NP	-	18	NMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	MNP	MNP	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	18	P	-	-
18	site	site	B-NP	B-NP	-	4	PMOD	-	-
19	,	,	O	O	-	18	P	-	-
20	which	which	B-NP	B-NP	-	18	NMOD	-	-
21	overlaps	overlaps	B-VP	B-VP	-	20	SBAR	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	ICK-1	ICK-1	I-NP	I-NP	-	24	NMOD	-	-
24	site	site	I-NP	I-NP	-	21	OBJ	-	-
25	.	.	O	O	-	2	P	-	-

1	Interaction	Interaction	B-NP	B-NP	-	15	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	nuclear	nuclear	B-NP	B-NP	-	4	NMOD	-	-
4	extracts	extracts	I-NP	I-NP	-	2	PMOD	-	-
5	from	from	B-PP	B-PP	-	4	NMOD	-	-
6	various	various	B-NP	B-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	lines	lines	I-NP	I-NP	-	5	PMOD	-	-
9	and	and	O	O	-	10	NMOD	-	-
10	tissue	tissue	B-NP	B-NP	-	5	PMOD	-	-
11	with	with	B-PP	B-PP	-	1	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	MNP	MNP	I-NP	I-NP	-	14	NMOD	-	-
14	site	site	I-NP	I-NP	-	11	PMOD	-	-
15	leads	leads	B-VP	B-VP	-	0	ROOT	-	-
16	to	to	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	formation	formation	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	fast-migrating	fast-migrating	B-NP	B-NP	-	22	NMOD	-	-
21	protein-DNA	protein-DNA	I-NP	I-NP	-	22	NMOD	-	-
22	complexes	complexes	I-NP	I-NP	-	19	PMOD	-	-
23	with	with	B-PP	B-PP	-	18	NMOD	-	-
24	similar	similar	B-NP	B-NP	-	26	AMOD	-	-
25	but	but	I-NP	I-NP	-	26	AMOD	-	-
26	distinct	distinct	I-NP	I-NP	-	28	NMOD	-	-
27	electrophoretic	electrophoretic	I-NP	I-NP	-	28	NMOD	-	-
28	mobilities	mobilities	I-NP	I-NP	-	23	PMOD	-	-
29	.	.	O	O	-	15	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	mutation	mutation	I-NP	I-NP	-	13	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	MNP	MNP	I-NP	I-NP	-	6	NMOD	-	-
6	site	site	I-NP	I-NP	-	3	PMOD	-	-
7	which	which	B-NP	B-NP	-	2	NMOD	-	-
8	does	does	B-VP	B-VP	-	7	SBAR	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	abrogate	abrogate	I-VP	I-VP	-	8	VC	-	-
11	ICK-1	ICK-1	B-NP	B-NP	-	12	NMOD	-	-
12	binding	binding	I-NP	I-NP	-	10	OBJ	-	-
13	inactivates	inactivates	B-VP	B-VP	-	0	ROOT	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	GOS19.1	GOS19.1	I-NP	I-NP	-	16	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	13	OBJ	-	-
17	in	in	B-PP	B-PP	-	13	VMOD	-	-
18	U937	U937	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	and	and	O	O	-	13	VMOD	-	-
21	reduces	reduces	B-VP	B-VP	-	13	VMOD	-	-
22	its	its	B-NP	B-NP	-	23	NMOD	-	-
23	activity	activity	I-NP	I-NP	-	21	OBJ	-	-
24	by	by	B-PP	B-PP	-	21	VMOD	-	-
25	fourfold	fourfold	B-ADVP	B-ADVP	-	24	PMOD	-	-
26	in	in	B-PP	B-PP	-	21	VMOD	-	-
27	Jurkat	Jurkat	B-NP	B-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	13	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	MNP	MNP	I-NP	I-NP	-	8	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	8	NMOD	-	-
7	(	(	I-NP	I-NP	-	8	P	-	-
8	s	s	I-NP	I-NP	-	15	SUB	-	-
9	)	)	O	O	-	8	P	-	-
10	binding	binding	B-NP	B-NP	-	8	NMOD	-	-
11	at	at	B-PP	B-PP	-	8	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	MNP	MNP	I-NP	I-NP	-	14	NMOD	-	-
14	site	site	I-NP	I-NP	-	11	PMOD	-	-
15	constitutes	constitutes	B-VP	B-VP	-	3	SBAR	-	-
16	a	a	B-NP	B-NP	-	21	NMOD	-	-
17	novel	novel	I-NP	I-NP	-	21	NMOD	-	-
18	transcription	transcription	I-NP	I-NP	-	19	NMOD	-	-
19	factor	factor	I-NP	I-NP	-	21	NMOD	-	-
20	(	(	B-NP	B-NP	-	21	P	-	-
21	s	s	I-NP	I-NP	-	15	OBJ	-	-
22	)	)	O	O	-	21	P	-	-
23	expressed	expressed	B-VP	B-VP	-	21	NMOD	-	-
24	in	in	B-PP	B-PP	-	23	VMOD	-	-
25	hematopoietic	hematopoietic	B-NP	B-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	24	PMOD	-	-
27	.	.	O	O	-	2	P	-	-

1	Ligand-dependent	Ligand-dependent	B-NP	B-NP	-	2	NMOD	-	-
2	repression	repression	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	erythroid	erythroid	I-NP	I-NP	-	7	NMOD	-	-
6	transcription	transcription	I-NP	I-NP	-	7	NMOD	-	-
7	factor	factor	I-NP	I-NP	-	8	NMOD	-	-
8	GATA-1	GATA-1	I-NP	I-NP	-	3	PMOD	-	-
9	by	by	B-PP	B-PP	-	2	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	estrogen	estrogen	I-NP	I-NP	-	12	NMOD	-	-
12	receptor	receptor	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	2	P	-	-

1	High-dose	High-dose	B-NP	B-NP	-	3	NMOD	-	-
2	estrogen	estrogen	I-NP	I-NP	-	3	NMOD	-	-
3	administration	administration	I-NP	I-NP	-	4	SUB	-	-
4	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
5	anemia	anemia	B-NP	B-NP	-	4	OBJ	-	-
6	in	in	B-PP	B-PP	-	4	VMOD	-	-
7	mammals	mammals	B-NP	B-NP	-	6	PMOD	-	-
8	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	chickens	chickens	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	estrogens	estrogens	B-NP	B-NP	-	5	SUB	-	-
5	stimulate	stimulate	B-VP	B-VP	-	0	ROOT	-	-
6	outgrowth	outgrowth	B-NP	B-NP	-	5	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	bone	bone	B-NP	B-NP	-	12	NMOD	-	-
9	marrow-derived	marrow-derived	I-NP	I-NP	-	12	NMOD	-	-
10	erythroid	erythroid	I-NP	I-NP	-	12	NMOD	-	-
11	progenitor	progenitor	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
13	and	and	O	O	-	5	VMOD	-	-
14	delay	delay	B-VP	B-VP	-	5	VMOD	-	-
15	their	their	B-NP	B-NP	-	16	NMOD	-	-
16	maturation	maturation	I-NP	I-NP	-	14	OBJ	-	-
17	.	.	O	O	-	5	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	delay	delay	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	associated	associated	I-VP	I-VP	-	3	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	down-regulation	down-regulation	B-NP	B-NP	-	5	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	many	many	B-NP	B-NP	-	7	PMOD	-	-
9	erythroid	erythroid	I-NP	I-NP	-	11	NMOD	-	-
10	cell-specific	cell-specific	I-NP	I-NP	-	11	NMOD	-	-
11	genes	genes	I-NP	I-NP	-	8	NMOD	-	-
12	,	,	O	O	-	11	P	-	-
13	including	including	B-PP	B-PP	-	11	NMOD	-	-
14	alpha-	alpha-	B-NP	B-NP	-	16	NMOD	-	-
15	and	and	I-NP	I-NP	-	16	NMOD	-	-
16	beta-globin	beta-globin	I-NP	I-NP	-	13	PMOD	-	-
17	,	,	O	O	-	29	P	-	-
18	band	band	B-NP	B-NP	-	29	NMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	29	NMOD	-	-
20	,	,	O	O	-	29	P	-	-
21	band	band	B-NP	B-NP	-	29	NMOD	-	-
22	<num>	<num>	I-NP	I-NP	-	21	NMOD	-	-
23	,	,	O	O	-	29	P	-	-
24	and	and	O	O	-	29	NMOD	-	-
25	the	the	B-NP	B-NP	-	29	NMOD	-	-
26	erythroid	erythroid	I-NP	I-NP	-	29	NMOD	-	-
27	cell-specific	cell-specific	I-NP	I-NP	-	29	NMOD	-	-
28	histone	histone	I-NP	I-NP	-	29	NMOD	-	-
29	H5	H5	I-NP	I-NP	-	13	PMOD	-	-
30	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	estrogens	estrogens	B-NP	B-NP	-	7	SUB	-	-
6	also	also	B-ADVP	B-ADVP	-	7	VMOD	-	-
7	reduce	reduce	B-VP	B-VP	-	4	SBAR	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	number	number	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	erythroid	erythroid	B-NP	B-NP	-	13	NMOD	-	-
12	progenitor	progenitor	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
14	in	in	B-PP	B-PP	-	7	VMOD	-	-
15	primary	primary	B-NP	B-NP	-	19	NMOD	-	-
16	human	human	I-NP	I-NP	-	19	NMOD	-	-
17	bone	bone	I-NP	I-NP	-	19	NMOD	-	-
18	marrow	marrow	I-NP	I-NP	-	19	NMOD	-	-
19	cultures	cultures	I-NP	I-NP	-	14	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	address	address	I-VP	I-VP	-	12	VMOD	-	-
3	potential	potential	B-NP	B-NP	-	4	NMOD	-	-
4	mechanisms	mechanisms	I-NP	I-NP	-	2	OBJ	-	-
5	by	by	B-PP	B-PP	-	4	NMOD	-	-
6	which	which	B-NP	B-NP	-	5	PMOD	-	-
7	estrogens	estrogens	B-NP	B-NP	-	8	SUB	-	-
8	suppress	suppress	B-VP	B-VP	-	5	SBAR	-	-
9	erythropoiesis	erythropoiesis	B-NP	B-NP	-	8	OBJ	-	-
10	,	,	O	O	-	12	P	-	-
11	we	we	B-NP	B-NP	-	12	SUB	-	-
12	have	have	B-VP	B-VP	-	0	ROOT	-	-
13	examined	examined	I-VP	I-VP	-	12	VC	-	-
14	their	their	B-NP	B-NP	-	15	NMOD	-	-
15	effects	effects	I-NP	I-NP	-	13	OBJ	-	-
16	on	on	B-PP	B-PP	-	15	NMOD	-	-
17	GATA-1	GATA-1	B-NP	B-NP	-	22	NMOD	-	-
18	,	,	O	O	-	22	P	-	-
19	an	an	B-NP	B-NP	-	22	NMOD	-	-
20	erythroid	erythroid	I-NP	I-NP	-	22	NMOD	-	-
21	transcription	transcription	I-NP	I-NP	-	22	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	16	PMOD	-	-
23	that	that	B-NP	B-NP	-	22	NMOD	-	-
24	participates	participates	B-VP	B-VP	-	23	SBAR	-	-
25	in	in	B-PP	B-PP	-	24	VMOD	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	regulation	regulation	I-NP	I-NP	-	25	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	majority	majority	I-NP	I-NP	-	28	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	erythroid	erythroid	B-NP	B-NP	-	34	NMOD	-	-
33	cell-specific	cell-specific	I-NP	I-NP	-	34	NMOD	-	-
34	genes	genes	I-NP	I-NP	-	31	PMOD	-	-
35	and	and	O	O	-	24	VMOD	-	-
36	is	is	B-VP	B-VP	-	24	VMOD	-	-
37	necessary	necessary	B-ADJP	B-ADJP	-	36	PRD	-	-
38	for	for	B-PP	B-PP	-	37	AMOD	-	-
39	full	full	B-NP	B-NP	-	40	NMOD	-	-
40	maturation	maturation	I-NP	I-NP	-	38	PMOD	-	-
41	of	of	B-PP	B-PP	-	40	NMOD	-	-
42	erythrocytes	erythrocytes	B-NP	B-NP	-	41	PMOD	-	-
43	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	24	DEP	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	transcriptional	transcriptional	I-NP	I-NP	-	6	NMOD	-	-
6	activity	activity	I-NP	I-NP	-	9	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	GATA-1	GATA-1	B-NP	B-NP	-	7	PMOD	-	-
9	is	is	B-VP	B-VP	-	3	SBAR	-	-
10	strongly	strongly	I-VP	I-VP	-	9	VMOD	-	-
11	repressed	repressed	I-VP	I-VP	-	9	VC	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	estrogen	estrogen	I-NP	I-NP	-	15	NMOD	-	-
15	receptor	receptor	I-NP	I-NP	-	12	PMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	ER	ER	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	in	in	B-PP	B-PP	-	11	VMOD	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	ligand-dependent	ligand-dependent	I-NP	I-NP	-	22	NMOD	-	-
22	manner	manner	I-NP	I-NP	-	19	PMOD	-	-
23	and	and	O	O	-	24	DEP	-	-
24	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
25	this	this	B-NP	B-NP	-	26	NMOD	-	-
26	repression	repression	I-NP	I-NP	-	27	SUB	-	-
27	is	is	B-VP	B-VP	-	24	SBAR	-	-
28	reversible	reversible	B-ADJP	B-ADJP	-	27	PRD	-	-
29	in	in	B-PP	B-PP	-	28	AMOD	-	-
30	the	the	I-PP	I-PP	-	29	PMOD	-	-
31	presence	presence	I-PP	I-PP	-	29	PMOD	-	-
32	of	of	I-PP	I-PP	-	31	NMOD	-	-
33	4-hydroxytamoxifen	4-hydroxytamoxifen	B-NP	B-NP	-	32	PMOD	-	-
34	.	.	O	O	-	2	P	-	-

1	ER-mediated	ER-mediated	B-NP	B-NP	-	2	NMOD	-	-
2	repression	repression	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	GATA-1	GATA-1	B-NP	B-NP	-	5	NMOD	-	-
5	activity	activity	I-NP	I-NP	-	3	PMOD	-	-
6	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
7	on	on	B-PP	B-PP	-	6	VMOD	-	-
8	an	an	B-NP	B-NP	-	10	NMOD	-	-
9	artificial	artificial	I-NP	I-NP	-	10	NMOD	-	-
10	promoter	promoter	I-NP	I-NP	-	7	PMOD	-	-
11	containing	containing	B-VP	B-VP	-	10	NMOD	-	-
12	a	a	B-NP	B-NP	-	15	NMOD	-	-
13	single	single	I-NP	I-NP	-	15	NMOD	-	-
14	GATA-binding	GATA-binding	I-NP	I-NP	-	15	NMOD	-	-
15	site	site	I-NP	I-NP	-	11	OBJ	-	-
16	,	,	O	O	-	7	P	-	-
17	as	as	B-CONJP	B-CONJP	-	7	PMOD	-	-
18	well	well	I-CONJP	I-CONJP	-	17	DEP	-	-
19	as	as	I-CONJP	I-CONJP	-	17	DEP	-	-
20	in	in	B-PP	B-PP	-	7	PMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	context	context	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	an	an	B-NP	B-NP	-	26	NMOD	-	-
25	intact	intact	I-NP	I-NP	-	26	NMOD	-	-
26	promoter	promoter	I-NP	I-NP	-	23	PMOD	-	-
27	which	which	B-NP	B-NP	-	22	NMOD	-	-
28	is	is	B-VP	B-VP	-	27	SBAR	-	-
29	normally	normally	I-VP	I-VP	-	28	VMOD	-	-
30	regulated	regulated	I-VP	I-VP	-	28	VC	-	-
31	by	by	B-PP	B-PP	-	30	VMOD	-	-
32	GATA-1	GATA-1	B-NP	B-NP	-	31	PMOD	-	-
33	.	.	O	O	-	6	P	-	-

1	GATA-1	GATA-1	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	ER	ER	I-NP	I-NP	-	4	SUB	-	-
4	bind	bind	B-VP	B-VP	-	0	ROOT	-	-
5	to	to	B-PP	B-PP	-	4	VMOD	-	-
6	each	each	B-NP	B-NP	-	7	NMOD	-	-
7	other	other	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-ADVP	B-ADVP	-	4	VMOD	-	-
9	vitro	vitro	I-ADVP	I-ADVP	-	8	AMOD	-	-
10	in	in	B-PP	B-PP	-	4	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	absence	absence	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	DNA	DNA	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	coimmunoprecipitation	coimmunoprecipitation	B-NP	B-NP	-	3	NMOD	-	-
3	experiments	experiments	I-NP	I-NP	-	1	PMOD	-	-
4	using	using	B-VP	B-VP	-	3	NMOD	-	-
5	transfected	transfected	B-NP	B-NP	-	7	NMOD	-	-
6	COS	COS	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
8	,	,	O	O	-	12	P	-	-
9	GATA-1	GATA-1	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	ER	ER	I-NP	I-NP	-	12	SUB	-	-
12	associate	associate	B-VP	B-VP	-	0	ROOT	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	ligand-dependent	ligand-dependent	I-NP	I-NP	-	16	NMOD	-	-
16	manner	manner	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	12	P	-	-

1	Mapping	Mapping	B-NP	B-NP	-	2	NMOD	-	-
2	experiments	experiments	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	GATA-1	GATA-1	B-NP	B-NP	-	9	NMOD	-	-
6	and	and	O	O	-	9	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	ER	ER	I-NP	I-NP	-	9	NMOD	-	-
9	form	form	I-NP	I-NP	-	13	NMOD	-	-
10	at	at	B-NP	B-NP	-	13	NMOD	-	-
11	least	least	I-NP	I-NP	-	10	AMOD	-	-
12	two	two	I-NP	I-NP	-	10	AMOD	-	-
13	contacts	contacts	I-NP	I-NP	-	16	SUB	-	-
14	,	,	O	O	-	16	P	-	-
15	which	which	B-NP	B-NP	-	16	VMOD	-	-
16	involve	involve	B-VP	B-VP	-	4	SBAR	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	finger	finger	I-NP	I-NP	-	19	NMOD	-	-
19	region	region	I-NP	I-NP	-	24	NMOD	-	-
20	and	and	O	O	-	24	NMOD	-	-
21	the	the	B-NP	B-NP	-	24	NMOD	-	-
22	N-terminal	N-terminal	I-NP	I-NP	-	24	NMOD	-	-
23	activation	activation	I-NP	I-NP	-	24	NMOD	-	-
24	domain	domain	I-NP	I-NP	-	16	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	GATA-1	GATA-1	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	speculate	speculate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	estrogens	estrogens	B-NP	B-NP	-	5	SUB	-	-
5	exert	exert	B-VP	B-VP	-	3	SBAR	-	-
6	effects	effects	B-NP	B-NP	-	5	OBJ	-	-
7	on	on	B-PP	B-PP	-	6	NMOD	-	-
8	erythropoiesis	erythropoiesis	B-NP	B-NP	-	7	PMOD	-	-
9	by	by	B-PP	B-PP	-	5	VMOD	-	-
10	modulating	modulating	B-VP	B-VP	-	9	PMOD	-	-
11	GATA-1	GATA-1	B-NP	B-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	10	OBJ	-	-
13	through	through	B-PP	B-PP	-	10	VMOD	-	-
14	protein-protein	protein-protein	B-NP	B-NP	-	15	NMOD	-	-
15	interaction	interaction	I-NP	I-NP	-	13	PMOD	-	-
16	with	with	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	ER	ER	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	2	P	-	-

1	(	(	O	O	-	2	P	-	-
2	ABSTRACT	ABSTRACT	B-NP	B-NP	-	0	ROOT	-	-
3	TRUNCATED	TRUNCATED	B-VP	B-VP	-	2	NMOD	-	-
4	AT	AT	B-PP	B-PP	-	3	VMOD	-	-
5	<num>	<num>	B-NP	B-NP	-	6	NMOD	-	-
6	WORDS	WORDS	I-NP	I-NP	-	4	PMOD	-	-
7	)	)	O	O	-	2	P	-	-

1	Activation	Activation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	pp90rsk	pp90rsk	B-NP	B-NP	-	9	NMOD	-	-
4	and	and	O	O	-	9	NMOD	-	-
5	early	early	B-NP	B-NP	-	9	NMOD	-	-
6	growth	growth	I-NP	I-NP	-	9	NMOD	-	-
7	response-1	response-1	I-NP	I-NP	-	9	NMOD	-	-
8	gene	gene	I-NP	I-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
10	by	by	B-PP	B-PP	-	1	NMOD	-	-
11	pokeweed	pokeweed	B-NP	B-NP	-	12	NMOD	-	-
12	mitogen	mitogen	I-NP	I-NP	-	10	PMOD	-	-
13	in	in	B-PP	B-PP	-	1	NMOD	-	-
14	human	human	B-NP	B-NP	-	16	NMOD	-	-
15	B	B	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	present	present	I-NP	I-NP	-	3	NMOD	-	-
3	studies	studies	I-NP	I-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	examined	examined	I-VP	I-VP	-	4	VC	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	effects	effects	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	pokeweed	pokeweed	B-NP	B-NP	-	10	NMOD	-	-
10	mitogen	mitogen	I-NP	I-NP	-	8	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	PWM	PWM	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	on	on	B-PP	B-PP	-	7	NMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	induction	induction	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	early	early	B-NP	B-NP	-	21	NMOD	-	-
19	growth	growth	I-NP	I-NP	-	21	NMOD	-	-
20	response-1	response-1	I-NP	I-NP	-	21	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	17	PMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	EGR-1	EGR-1	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	in	in	B-PP	B-PP	-	16	NMOD	-	-
26	normal	normal	B-NP	B-NP	-	29	NMOD	-	-
27	human	human	I-NP	I-NP	-	29	NMOD	-	-
28	B	B	I-NP	I-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
30	.	.	O	O	-	4	P	-	-

1	PWM	PWM	B-NP	B-NP	-	2	SUB	-	-
2	regulates	regulates	B-VP	B-VP	-	0	ROOT	-	-
3	EGR-1	EGR-1	B-NP	B-NP	-	5	NMOD	-	-
4	gene	gene	I-NP	I-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	2	OBJ	-	-
6	by	by	B-PP	B-PP	-	5	NMOD	-	-
7	both	both	B-NP	B-NP	-	11	NMOD	-	-
8	transcriptional	transcriptional	I-NP	I-NP	-	11	NMOD	-	-
9	and	and	I-NP	I-NP	-	11	NMOD	-	-
10	post-transcriptional	post-transcriptional	I-NP	I-NP	-	11	NMOD	-	-
11	mechanisms	mechanisms	I-NP	I-NP	-	6	PMOD	-	-
12	.	.	O	O	-	2	P	-	-

1	Transient	Transient	B-NP	B-NP	-	3	NMOD	-	-
2	transfection	transfection	I-NP	I-NP	-	3	NMOD	-	-
3	assays	assays	I-NP	I-NP	-	17	SUB	-	-
4	with	with	B-PP	B-PP	-	3	NMOD	-	-
5	EGR-1	EGR-1	B-NP	B-NP	-	7	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	7	NMOD	-	-
7	fragments	fragments	I-NP	I-NP	-	4	PMOD	-	-
8	linked	linked	B-VP	B-VP	-	7	NMOD	-	-
9	to	to	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	16	NMOD	-	-
11	chloramphenicol	chloramphenicol	I-NP	I-NP	-	12	NMOD	-	-
12	acetyltransferase	acetyltransferase	I-NP	I-NP	-	16	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	CAT	CAT	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	gene	gene	B-NP	B-NP	-	9	PMOD	-	-
17	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	PWM	PWM	B-NP	B-NP	-	20	SUB	-	-
20	induced	induced	B-VP	B-VP	-	18	SBAR	-	-
21	EGR-1	EGR-1	B-NP	B-NP	-	22	NMOD	-	-
22	transcription	transcription	I-NP	I-NP	-	20	OBJ	-	-
23	is	is	B-VP	B-VP	-	18	SBAR	-	-
24	conferred	conferred	I-VP	I-VP	-	23	VC	-	-
25	by	by	B-PP	B-PP	-	24	VMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	CArG	CArG	I-NP	I-NP	-	28	NMOD	-	-
28	motif	motif	I-NP	I-NP	-	25	PMOD	-	-
29	(	(	O	O	-	35	P	-	-
30	C	C	B-NP	B-NP	-	31	NMOD	-	-
31	C	C	I-NP	I-NP	-	35	NMOD	-	-
32	[	[	O	O	-	33	P	-	-
33	AT	AT	B-NP	B-NP	-	31	NMOD	-	-
34	]	]	O	O	-	35	P	-	-
35	6GG	6GG	B-NP	B-NP	-	28	NMOD	-	-
36	)	)	O	O	-	35	P	-	-
37	in	in	B-PP	B-PP	-	28	NMOD	-	-
38	the	the	B-NP	B-NP	-	40	NMOD	-	-
39	EGR-1	EGR-1	I-NP	I-NP	-	40	NMOD	-	-
40	promoter	promoter	I-NP	I-NP	-	37	PMOD	-	-
41	.	.	O	O	-	17	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	4	SUB	-	-
3	further	further	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	S6	S6	B-NP	B-NP	-	9	NMOD	-	-
9	kinase	kinase	I-NP	I-NP	-	7	PMOD	-	-
10	(	(	O	O	-	11	P	-	-
11	pp90rsk	pp90rsk	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	,	,	O	O	-	6	P	-	-
14	evidenced	evidenced	B-VP	B-VP	-	6	NMOD	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	phosphorylation	phosphorylation	B-NP	B-NP	-	15	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	S6	S6	B-NP	B-NP	-	22	NMOD	-	-
19	and	and	I-NP	I-NP	-	22	NMOD	-	-
20	serum	serum	I-NP	I-NP	-	22	NMOD	-	-
21	response	response	I-NP	I-NP	-	22	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	26	NMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	SRF	SRF	B-NP	B-NP	-	22	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	peptides	peptides	B-NP	B-NP	-	17	PMOD	-	-
27	,	,	O	O	-	16	P	-	-
28	in	in	B-PP	B-PP	-	16	NMOD	-	-
29	PWM	PWM	B-NP	B-NP	-	32	NMOD	-	-
30	treated	treated	I-NP	I-NP	-	32	NMOD	-	-
31	B	B	I-NP	I-NP	-	32	NMOD	-	-
32	cells	cells	I-NP	I-NP	-	28	PMOD	-	-
33	.	.	O	O	-	4	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	findings	findings	I-NP	I-NP	-	6	SUB	-	-
6	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	PWM	PWM	B-NP	B-NP	-	9	SUB	-	-
9	is	is	B-VP	B-VP	-	7	SBAR	-	-
10	able	able	B-ADJP	B-ADJP	-	9	PRD	-	-
11	to	to	B-VP	B-VP	-	12	VMOD	-	-
12	initiate	initiate	I-VP	I-VP	-	10	AMOD	-	-
13	an	an	B-NP	B-NP	-	16	NMOD	-	-
14	intracytoplasmic	intracytoplasmic	I-NP	I-NP	-	16	NMOD	-	-
15	signalling	signalling	I-NP	I-NP	-	16	NMOD	-	-
16	cascade	cascade	I-NP	I-NP	-	19	NMOD	-	-
17	and	and	O	O	-	19	NMOD	-	-
18	EGR-1	EGR-1	B-NP	B-NP	-	19	NMOD	-	-
19	induction	induction	I-NP	I-NP	-	12	OBJ	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	normal	normal	B-NP	B-NP	-	24	NMOD	-	-
22	human	human	I-NP	I-NP	-	24	NMOD	-	-
23	B	B	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
25	.	.	O	O	-	6	P	-	-

1	NF-kappa	NF-kappa	B-NP	B-NP	-	2	NMOD	-	-
2	B	B	I-NP	I-NP	-	3	SUB	-	-
3	controls	controls	B-VP	B-VP	-	0	ROOT	-	-
4	expression	expression	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	inhibitor	inhibitor	B-NP	B-NP	-	10	NMOD	-	-
7	I	I	I-NP	I-NP	-	10	NMOD	-	-
8	kappa	kappa	I-NP	I-NP	-	10	NMOD	-	-
9	B	B	I-NP	I-NP	-	10	NMOD	-	-
10	alpha	alpha	I-NP	I-NP	-	5	PMOD	-	-
11	:	:	O	O	-	3	P	-	-
12	evidence	evidence	B-NP	B-NP	-	3	OBJ	-	-
13	for	for	B-PP	B-PP	-	12	NMOD	-	-
14	an	an	B-NP	B-NP	-	17	NMOD	-	-
15	inducible	inducible	I-NP	I-NP	-	17	NMOD	-	-
16	autoregulatory	autoregulatory	I-NP	I-NP	-	17	NMOD	-	-
17	pathway	pathway	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	eukaryotic	eukaryotic	I-NP	I-NP	-	4	NMOD	-	-
3	transcription	transcription	I-NP	I-NP	-	4	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	7	NMOD	-	-
5	nuclear	nuclear	I-NP	I-NP	-	7	NMOD	-	-
6	factor-kappa	factor-kappa	I-NP	I-NP	-	7	NMOD	-	-
7	B	B	I-NP	I-NP	-	12	SUB	-	-
8	(	(	O	O	-	10	P	-	-
9	NF-kappa	NF-kappa	B-NP	B-NP	-	10	NMOD	-	-
10	B	B	I-NP	I-NP	-	7	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	participates	participates	B-VP	B-VP	-	0	ROOT	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	many	many	B-NP	B-NP	-	15	NMOD	-	-
15	parts	parts	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	genetic	genetic	I-NP	I-NP	-	19	NMOD	-	-
19	program	program	I-NP	I-NP	-	16	PMOD	-	-
20	mediating	mediating	B-VP	B-VP	-	19	NMOD	-	-
21	T	T	B-NP	B-NP	-	23	NMOD	-	-
22	lymphocyte	lymphocyte	I-NP	I-NP	-	23	NMOD	-	-
23	activation	activation	I-NP	I-NP	-	25	NMOD	-	-
24	and	and	O	O	-	25	NMOD	-	-
25	growth	growth	B-NP	B-NP	-	20	OBJ	-	-
26	.	.	O	O	-	12	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
5	B	B	I-NP	I-NP	-	3	PMOD	-	-
6	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
7	after	after	B-PP	B-PP	-	6	VMOD	-	-
8	its	its	B-NP	B-NP	-	10	NMOD	-	-
9	induced	induced	I-NP	I-NP	-	10	NMOD	-	-
10	dissociation	dissociation	I-NP	I-NP	-	7	PMOD	-	-
11	from	from	B-PP	B-PP	-	10	NMOD	-	-
12	its	its	B-NP	B-NP	-	18	NMOD	-	-
13	cytoplasmic	cytoplasmic	I-NP	I-NP	-	18	NMOD	-	-
14	inhibitor	inhibitor	I-NP	I-NP	-	18	NMOD	-	-
15	I	I	I-NP	I-NP	-	18	NMOD	-	-
16	kappa	kappa	I-NP	I-NP	-	18	NMOD	-	-
17	B	B	I-NP	I-NP	-	18	NMOD	-	-
18	alpha	alpha	I-NP	I-NP	-	11	PMOD	-	-
19	.	.	O	O	-	6	P	-	-

1	Phorbol	Phorbol	B-NP	B-NP	-	2	NMOD	-	-
2	ester	ester	I-NP	I-NP	-	6	NMOD	-	-
3	and	and	O	O	-	6	NMOD	-	-
4	tumor	tumor	B-NP	B-NP	-	6	NMOD	-	-
5	necrosis	necrosis	I-NP	I-NP	-	6	NMOD	-	-
6	factor-alpha	factor-alpha	I-NP	I-NP	-	7	NMOD	-	-
7	induction	induction	I-NP	I-NP	-	12	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	nuclear	nuclear	B-NP	B-NP	-	11	NMOD	-	-
10	NF-kappa	NF-kappa	I-NP	I-NP	-	11	NMOD	-	-
11	B	B	I-NP	I-NP	-	8	PMOD	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	associated	associated	I-VP	I-VP	-	12	VC	-	-
14	with	with	B-PP	B-PP	-	13	VMOD	-	-
15	both	both	O	O	-	17	NMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	degradation	degradation	I-NP	I-NP	-	26	NMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	performed	performed	B-NP	B-NP	-	23	NMOD	-	-
20	I	I	I-NP	I-NP	-	23	NMOD	-	-
21	kappa	kappa	I-NP	I-NP	-	23	NMOD	-	-
22	B	B	I-NP	I-NP	-	23	NMOD	-	-
23	alpha	alpha	I-NP	I-NP	-	18	PMOD	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	14	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	I	I	B-NP	B-NP	-	33	NMOD	-	-
29	kappa	kappa	I-NP	I-NP	-	33	NMOD	-	-
30	B	B	I-NP	I-NP	-	33	NMOD	-	-
31	alpha	alpha	I-NP	I-NP	-	33	NMOD	-	-
32	gene	gene	I-NP	I-NP	-	33	NMOD	-	-
33	expression	expression	I-NP	I-NP	-	27	PMOD	-	-
34	.	.	O	O	-	12	P	-	-

1	Transfection	Transfection	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	10	NMOD	-	-
6	I	I	I-NP	I-NP	-	10	NMOD	-	-
7	kappa	kappa	I-NP	I-NP	-	10	NMOD	-	-
8	B	B	I-NP	I-NP	-	10	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	10	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	11	SUB	-	-
11	is	is	B-VP	B-VP	-	4	SBAR	-	-
12	specifically	specifically	I-VP	I-VP	-	11	VMOD	-	-
13	induced	induced	I-VP	I-VP	-	11	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	65-kilodalton	65-kilodalton	I-NP	I-NP	-	18	NMOD	-	-
17	transactivating	transactivating	I-NP	I-NP	-	18	NMOD	-	-
18	subunit	subunit	I-NP	I-NP	-	14	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	NF-kappa	NF-kappa	B-NP	B-NP	-	21	NMOD	-	-
21	B	B	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	3	P	-	-

1	Association	Association	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	9	NMOD	-	-
4	newly	newly	I-NP	I-NP	-	5	AMOD	-	-
5	synthesized	synthesized	I-NP	I-NP	-	9	NMOD	-	-
6	I	I	I-NP	I-NP	-	9	NMOD	-	-
7	kappa	kappa	I-NP	I-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	2	PMOD	-	-
10	with	with	B-PP	B-PP	-	1	NMOD	-	-
11	p65	p65	B-NP	B-NP	-	10	PMOD	-	-
12	restores	restores	B-VP	B-VP	-	0	ROOT	-	-
13	intracellular	intracellular	B-NP	B-NP	-	14	NMOD	-	-
14	inhibition	inhibition	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	20	NMOD	-	-
17	B	B	I-NP	I-NP	-	20	NMOD	-	-
18	DNA	DNA	I-NP	I-NP	-	20	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	15	PMOD	-	-
21	and	and	O	O	-	12	VMOD	-	-
22	prolongs	prolongs	B-VP	B-VP	-	12	VMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	survival	survival	I-NP	I-NP	-	22	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	this	this	B-NP	B-NP	-	28	NMOD	-	-
27	labile	labile	I-NP	I-NP	-	28	NMOD	-	-
28	inhibitor	inhibitor	I-NP	I-NP	-	25	PMOD	-	-
29	.	.	O	O	-	12	P	-	-

1	Together	Together	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	results	results	I-NP	I-NP	-	5	SUB	-	-
5	show	show	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	NF-kappa	NF-kappa	B-NP	B-NP	-	8	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	SUB	-	-
9	controls	controls	B-VP	B-VP	-	6	SBAR	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	I	I	B-NP	B-NP	-	16	NMOD	-	-
14	kappa	kappa	I-NP	I-NP	-	16	NMOD	-	-
15	B	B	I-NP	I-NP	-	16	NMOD	-	-
16	alpha	alpha	I-NP	I-NP	-	12	PMOD	-	-
17	by	by	B-PP	B-PP	-	9	VMOD	-	-
18	means	means	B-NP	B-NP	-	17	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	an	an	B-NP	B-NP	-	23	NMOD	-	-
21	inducible	inducible	I-NP	I-NP	-	23	NMOD	-	-
22	autoregulatory	autoregulatory	I-NP	I-NP	-	23	NMOD	-	-
23	pathway	pathway	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	Activation	Activation	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	primary	primary	B-NP	B-NP	-	5	NMOD	-	-
4	human	human	I-NP	I-NP	-	5	NMOD	-	-
5	T-lymphocytes	T-lymphocytes	I-NP	I-NP	-	2	PMOD	-	-
6	through	through	B-PP	B-PP	-	1	NMOD	-	-
7	CD2	CD2	B-NP	B-NP	-	9	NMOD	-	-
8	plus	plus	O	O	-	9	NMOD	-	-
9	CD28	CD28	B-NP	B-NP	-	11	NMOD	-	-
10	adhesion	adhesion	I-NP	I-NP	-	11	NMOD	-	-
11	molecules	molecules	I-NP	I-NP	-	6	PMOD	-	-
12	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
13	long-term	long-term	B-NP	B-NP	-	15	NMOD	-	-
14	nuclear	nuclear	I-NP	I-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	12	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	NF-kappa	NF-kappa	B-NP	B-NP	-	18	NMOD	-	-
18	B	B	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	12	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	13	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	highly	highly	B-NP	B-NP	-	4	AMOD	-	-
4	purified	purified	I-NP	I-NP	-	6	NMOD	-	-
5	human	human	I-NP	I-NP	-	6	NMOD	-	-
6	T-cells	T-cells	I-NP	I-NP	-	2	PMOD	-	-
7	via	via	B-PP	B-PP	-	1	NMOD	-	-
8	CD2	CD2	B-NP	B-NP	-	10	NMOD	-	-
9	and	and	I-NP	I-NP	-	10	NMOD	-	-
10	CD28	CD28	I-NP	I-NP	-	12	NMOD	-	-
11	adhesion	adhesion	I-NP	I-NP	-	12	NMOD	-	-
12	molecules	molecules	I-NP	I-NP	-	7	PMOD	-	-
13	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
14	and	and	I-VP	I-VP	-	13	VMOD	-	-
15	maintains	maintains	I-VP	I-VP	-	13	VMOD	-	-
16	proliferation	proliferation	B-NP	B-NP	-	15	OBJ	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	more	more	B-NP	B-NP	-	19	AMOD	-	-
19	than	than	I-NP	I-NP	-	21	NMOD	-	-
20	<num>	<num>	I-NP	I-NP	-	19	AMOD	-	-
21	weeks	weeks	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	13	P	-	-

1	This	This	B-NP	B-NP	-	9	NMOD	-	-
2	potent	potent	I-NP	I-NP	-	9	NMOD	-	-
3	interleukin	interleukin	I-NP	I-NP	-	6	NMOD	-	-
4	<num>	<num>	I-NP	I-NP	-	3	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	IL-2	IL-2	B-NP	B-NP	-	2	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	-dependent	-dependent	B-NP	B-NP	-	6	AMOD	-	-
9	activation	activation	I-NP	I-NP	-	10	SUB	-	-
10	does	does	B-VP	B-VP	-	0	ROOT	-	-
11	not	not	I-VP	I-VP	-	10	VMOD	-	-
12	require	require	I-VP	I-VP	-	10	VC	-	-
13	monocytes	monocytes	B-NP	B-NP	-	16	NMOD	-	-
14	or	or	O	O	-	16	NMOD	-	-
15	accessory	accessory	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	12	OBJ	-	-
17	.	.	O	O	-	10	P	-	-

1	Long-lasting	Long-lasting	B-NP	B-NP	-	3	NMOD	-	-
2	IL-2	IL-2	I-NP	I-NP	-	3	NMOD	-	-
3	receptivity	receptivity	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	associated	associated	I-VP	I-VP	-	4	VC	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	high-level	high-level	B-NP	B-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	20	NMOD	-	-
11	inducible	inducible	I-NP	I-NP	-	20	NMOD	-	-
12	IL-2	IL-2	I-NP	I-NP	-	15	NMOD	-	-
13	receptor	receptor	I-NP	I-NP	-	15	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	15	NMOD	-	-
15	chain	chain	I-NP	I-NP	-	20	NMOD	-	-
16	(	(	O	O	-	20	P	-	-
17	IL-2R	IL-2R	B-NP	B-NP	-	20	NMOD	-	-
18	alpha	alpha	I-NP	I-NP	-	20	NMOD	-	-
19	)	)	O	O	-	20	P	-	-
20	gene	gene	B-NP	B-NP	-	9	PMOD	-	-
21	that	that	B-NP	B-NP	-	20	NMOD	-	-
22	is	is	B-VP	B-VP	-	21	SBAR	-	-
23	regulated	regulated	I-VP	I-VP	-	22	VC	-	-
24	at	at	B-PP	B-PP	-	23	VMOD	-	-
25	both	both	B-NP	B-NP	-	28	AMOD	-	-
26	transcriptional	transcriptional	I-NP	I-NP	-	28	AMOD	-	-
27	and	and	I-NP	I-NP	-	28	AMOD	-	-
28	posttranscriptional	posttranscriptional	I-NP	I-NP	-	29	NMOD	-	-
29	levels	levels	I-NP	I-NP	-	24	PMOD	-	-
30	.	.	O	O	-	4	P	-	-

1	Increase	Increase	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	IL-2R	IL-2R	B-NP	B-NP	-	6	NMOD	-	-
4	alpha	alpha	I-NP	I-NP	-	6	NMOD	-	-
5	gene	gene	I-NP	I-NP	-	6	NMOD	-	-
6	transcription	transcription	I-NP	I-NP	-	2	PMOD	-	-
7	involves	involves	B-VP	B-VP	-	0	ROOT	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	enhanced	enhanced	I-NP	I-NP	-	10	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	7	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	16	NMOD	-	-
13	transcription	transcription	I-NP	I-NP	-	16	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	16	NMOD	-	-
15	NF-kappa	NF-kappa	I-NP	I-NP	-	16	NMOD	-	-
16	B	B	I-NP	I-NP	-	11	PMOD	-	-
17	to	to	B-PP	B-PP	-	10	NMOD	-	-
18	its	its	B-NP	B-NP	-	20	NMOD	-	-
19	consensus	consensus	I-NP	I-NP	-	20	NMOD	-	-
20	sequence	sequence	I-NP	I-NP	-	17	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	5'-regulatory	5'-regulatory	I-NP	I-NP	-	24	NMOD	-	-
24	region	region	I-NP	I-NP	-	21	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	IL-2R	IL-2R	I-NP	I-NP	-	29	NMOD	-	-
28	alpha	alpha	I-NP	I-NP	-	29	NMOD	-	-
29	gene	gene	I-NP	I-NP	-	25	PMOD	-	-
30	.	.	O	O	-	7	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	dissect	dissect	I-VP	I-VP	-	18	VMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	molecular	molecular	I-NP	I-NP	-	5	NMOD	-	-
5	basis	basis	I-NP	I-NP	-	2	OBJ	-	-
6	for	for	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	unusually	unusually	I-NP	I-NP	-	9	AMOD	-	-
9	persistent	persistent	I-NP	I-NP	-	10	NMOD	-	-
10	transcription	transcription	I-NP	I-NP	-	6	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	IL-2R	IL-2R	I-NP	I-NP	-	15	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	15	NMOD	-	-
15	gene	gene	I-NP	I-NP	-	11	PMOD	-	-
16	,	,	O	O	-	18	P	-	-
17	we	we	B-NP	B-NP	-	18	SUB	-	-
18	analyzed	analyzed	B-VP	B-VP	-	0	ROOT	-	-
19	nuclear	nuclear	B-NP	B-NP	-	21	NMOD	-	-
20	NF-kappa	NF-kappa	I-NP	I-NP	-	21	NMOD	-	-
21	B	B	I-NP	I-NP	-	18	OBJ	-	-
22	binding	binding	B-VP	B-VP	-	21	NMOD	-	-
23	to	to	B-PP	B-PP	-	22	VMOD	-	-
24	a	a	B-NP	B-NP	-	31	NMOD	-	-
25	radiolabeled	radiolabeled	I-NP	I-NP	-	31	NMOD	-	-
26	IL-2R	IL-2R	I-NP	I-NP	-	27	NMOD	-	-
27	alpha	alpha	I-NP	I-NP	-	31	NMOD	-	-
28	kappa	kappa	I-NP	I-NP	-	31	NMOD	-	-
29	B-specific	B-specific	I-NP	I-NP	-	31	NMOD	-	-
30	oligonucleotide	oligonucleotide	I-NP	I-NP	-	31	NMOD	-	-
31	probe	probe	I-NP	I-NP	-	23	PMOD	-	-
32	during	during	B-PP	B-PP	-	22	VMOD	-	-
33	the	the	B-NP	B-NP	-	35	NMOD	-	-
34	time	time	I-NP	I-NP	-	35	NMOD	-	-
35	course	course	I-NP	I-NP	-	32	PMOD	-	-
36	of	of	B-PP	B-PP	-	35	NMOD	-	-
37	CD2	CD2	B-NP	B-NP	-	39	NMOD	-	-
38	+	+	I-NP	I-NP	-	39	NMOD	-	-
39	CD28	CD28	I-NP	I-NP	-	40	NMOD	-	-
40	activation	activation	I-NP	I-NP	-	36	PMOD	-	-
41	.	.	O	O	-	18	P	-	-

1	Resting	Resting	B-NP	B-NP	-	4	NMOD	-	-
2	T-cell	T-cell	I-NP	I-NP	-	4	NMOD	-	-
3	nuclear	nuclear	I-NP	I-NP	-	4	NMOD	-	-
4	extracts	extracts	I-NP	I-NP	-	5	SUB	-	-
5	contained	contained	B-VP	B-VP	-	0	ROOT	-	-
6	KBF1/p50	KBF1/p50	B-NP	B-NP	-	7	NMOD	-	-
7	homodimer	homodimer	I-NP	I-NP	-	5	OBJ	-	-
8	.	.	O	O	-	5	P	-	-

1	After	After	B-PP	B-PP	-	9	VMOD	-	-
2	stimulation	stimulation	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	9	P	-	-
4	two	two	B-NP	B-NP	-	8	NMOD	-	-
5	new	new	I-NP	I-NP	-	8	NMOD	-	-
6	kappa	kappa	I-NP	I-NP	-	8	NMOD	-	-
7	B-specific	B-specific	I-NP	I-NP	-	8	NMOD	-	-
8	complexes	complexes	I-NP	I-NP	-	9	SUB	-	-
9	were	were	B-VP	B-VP	-	0	ROOT	-	-
10	identified	identified	I-VP	I-VP	-	9	VC	-	-
11	as	as	B-PP	B-PP	-	10	VMOD	-	-
12	NF-kappa	NF-kappa	B-NP	B-NP	-	15	NMOD	-	-
13	B	B	I-NP	I-NP	-	15	NMOD	-	-
14	p50-p65	p50-p65	I-NP	I-NP	-	15	NMOD	-	-
15	heterodimer	heterodimer	I-NP	I-NP	-	22	NMOD	-	-
16	and	and	O	O	-	22	NMOD	-	-
17	putative	putative	B-NP	B-NP	-	19	NMOD	-	-
18	c-Rel	c-Rel	I-NP	I-NP	-	19	NMOD	-	-
19	homodimer	homodimer	I-NP	I-NP	-	22	NMOD	-	-
20	or	or	O	O	-	22	NMOD	-	-
21	c-Rel-p65	c-Rel-p65	B-NP	B-NP	-	22	NMOD	-	-
22	heterodimer	heterodimer	I-NP	I-NP	-	11	PMOD	-	-
23	.	.	O	O	-	9	P	-	-

1	Both	Both	B-NP	B-NP	-	3	NMOD	-	-
2	inducible	inducible	I-NP	I-NP	-	3	NMOD	-	-
3	complexes	complexes	I-NP	I-NP	-	4	SUB	-	-
4	persisted	persisted	B-VP	B-VP	-	0	ROOT	-	-
5	for	for	B-PP	B-PP	-	4	VMOD	-	-
6	at	at	B-NP	B-NP	-	9	NMOD	-	-
7	least	least	I-NP	I-NP	-	6	AMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	6	AMOD	-	-
9	weeks	weeks	I-NP	I-NP	-	5	PMOD	-	-
10	.	.	O	O	-	4	P	-	-

1	Their	Their	B-NP	B-NP	-	3	NMOD	-	-
2	relative	relative	I-NP	I-NP	-	3	NMOD	-	-
3	levels	levels	I-NP	I-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	0	ROOT	-	-
5	very	very	B-ADJP	B-ADJP	-	6	AMOD	-	-
6	similar	similar	I-ADJP	I-ADJP	-	4	PRD	-	-
7	for	for	B-PP	B-PP	-	6	AMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	duration	duration	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	proliferation	proliferation	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	8	VMOD	-	-
2	parallel	parallel	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	8	P	-	-
4	CD2	CD2	B-NP	B-NP	-	7	NMOD	-	-
5	+	+	O	O	-	7	NMOD	-	-
6	CD28	CD28	B-NP	B-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	8	SUB	-	-
8	triggered	triggered	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	13	NMOD	-	-
10	significant	significant	I-NP	I-NP	-	13	NMOD	-	-
11	intracellular	intracellular	I-NP	I-NP	-	13	NMOD	-	-
12	thiol	thiol	I-NP	I-NP	-	13	NMOD	-	-
13	decrease	decrease	I-NP	I-NP	-	8	OBJ	-	-
14	,	,	O	O	-	8	P	-	-
15	suggesting	suggesting	B-VP	B-VP	-	8	VMOD	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	oxygen	oxygen	B-NP	B-NP	-	18	NMOD	-	-
18	radicals	radicals	I-NP	I-NP	-	19	SUB	-	-
19	are	are	B-VP	B-VP	-	16	SBAR	-	-
20	involved	involved	I-VP	I-VP	-	19	VC	-	-
21	in	in	B-PP	B-PP	-	20	VMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	signaling	signaling	I-NP	I-NP	-	24	NMOD	-	-
24	pathway	pathway	I-NP	I-NP	-	21	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	adhesion	adhesion	B-NP	B-NP	-	27	NMOD	-	-
27	molecules	molecules	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	8	P	-	-

1	Finally	Finally	B-ADVP	B-ADVP	-	15	VMOD	-	-
2	,	,	O	O	-	15	P	-	-
3	micromolar	micromolar	B-NP	B-NP	-	4	NMOD	-	-
4	amounts	amounts	I-NP	I-NP	-	15	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	pyrrolidine	pyrrolidine	B-NP	B-NP	-	7	NMOD	-	-
7	dithiocarbamate	dithiocarbamate	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	15	P	-	-
9	an	an	B-NP	B-NP	-	12	NMOD	-	-
10	oxygen	oxygen	I-NP	I-NP	-	12	NMOD	-	-
11	radical	radical	I-NP	I-NP	-	12	NMOD	-	-
12	scavenger	scavenger	I-NP	I-NP	-	15	SUB	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	efficiently	efficiently	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	blocked	blocked	B-VP	B-VP	-	0	ROOT	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	nuclear	nuclear	I-NP	I-NP	-	18	NMOD	-	-
18	appearance	appearance	I-NP	I-NP	-	15	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	NF-kappa	NF-kappa	B-NP	B-NP	-	21	NMOD	-	-
21	B	B	I-NP	I-NP	-	19	PMOD	-	-
22	in	in	B-PP	B-PP	-	15	VMOD	-	-
23	T-lymphocytes	T-lymphocytes	B-NP	B-NP	-	22	PMOD	-	-
24	,	,	O	O	-	15	P	-	-
25	also	also	B-ADVP	B-ADVP	-	26	VMOD	-	-
26	inhibited	inhibited	B-VP	B-VP	-	15	VMOD	-	-
27	IL-2	IL-2	B-NP	B-NP	-	28	NMOD	-	-
28	secretion	secretion	I-NP	I-NP	-	38	NMOD	-	-
29	,	,	O	O	-	38	P	-	-
30	IL-2R	IL-2R	B-NP	B-NP	-	34	NMOD	-	-
31	alpha	alpha	I-NP	I-NP	-	34	NMOD	-	-
32	cell	cell	I-NP	I-NP	-	34	NMOD	-	-
33	surface	surface	I-NP	I-NP	-	34	NMOD	-	-
34	expression	expression	I-NP	I-NP	-	38	NMOD	-	-
35	,	,	O	O	-	38	P	-	-
36	and	and	O	O	-	38	NMOD	-	-
37	T-cell	T-cell	B-NP	B-NP	-	38	NMOD	-	-
38	proliferation	proliferation	I-NP	I-NP	-	26	OBJ	-	-
39	.	.	O	O	-	15	P	-	-

1	Together	Together	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	results	results	I-NP	I-NP	-	5	SUB	-	-
5	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	NF-kappa	NF-kappa	B-NP	B-NP	-	8	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	SUB	-	-
9	plays	plays	B-VP	B-VP	-	6	SBAR	-	-
10	an	an	B-NP	B-NP	-	12	NMOD	-	-
11	important	important	I-NP	I-NP	-	12	NMOD	-	-
12	role	role	I-NP	I-NP	-	9	OBJ	-	-
13	in	in	B-PP	B-PP	-	9	VMOD	-	-
14	long-term	long-term	B-NP	B-NP	-	15	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	human	human	B-NP	B-NP	-	19	NMOD	-	-
18	primary	primary	I-NP	I-NP	-	19	NMOD	-	-
19	T-lymphocytes	T-lymphocytes	I-NP	I-NP	-	16	PMOD	-	-
20	via	via	B-PP	B-PP	-	9	VMOD	-	-
21	CD2	CD2	B-NP	B-NP	-	23	NMOD	-	-
22	+	+	I-NP	I-NP	-	23	NMOD	-	-
23	CD28	CD28	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	Synergism	Synergism	B-NP	B-NP	-	0	ROOT	-	-
2	between	between	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	CD3	CD3	I-NP	I-NP	-	5	NMOD	-	-
5	antigen-	antigen-	I-NP	I-NP	-	9	NMOD	-	-
6	and	and	O	O	-	9	NMOD	-	-
7	CD2	CD2	B-NP	B-NP	-	9	NMOD	-	-
8	antigen-derived	antigen-derived	I-NP	I-NP	-	9	NMOD	-	-
9	signals	signals	I-NP	I-NP	-	2	PMOD	-	-
10	.	.	O	O	-	1	P	-	-

1	Exploration	Exploration	B-NP	B-NP	-	11	NMOD	-	-
2	at	at	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	level	level	I-NP	I-NP	-	2	PMOD	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	induction	induction	B-NP	B-NP	-	11	NMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	DNA-binding	DNA-binding	B-NP	B-NP	-	9	NMOD	-	-
9	proteins	proteins	I-NP	I-NP	-	7	PMOD	-	-
10	and	and	O	O	-	11	NMOD	-	-
11	characterization	characterization	B-NP	B-NP	-	0	ROOT	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	inhibitory	inhibitory	I-NP	I-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	cyclosporine	cyclosporine	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	11	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	demonstrated	demonstrated	I-VP	I-VP	-	2	VC	-	-
4	earlier	earlier	B-ADVP	B-ADVP	-	3	VMOD	-	-
5	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	crosslinkage	crosslinkage	I-NP	I-NP	-	16	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	CD3/TCR	CD3/TCR	I-NP	I-NP	-	11	NMOD	-	-
11	complex	complex	I-NP	I-NP	-	8	PMOD	-	-
12	with	with	B-PP	B-PP	-	7	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	CD2	CD2	I-NP	I-NP	-	15	NMOD	-	-
15	antigen	antigen	I-NP	I-NP	-	12	PMOD	-	-
16	results	results	B-VP	B-VP	-	5	SBAR	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	proliferation	proliferation	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	normal	normal	B-NP	B-NP	-	24	NMOD	-	-
22	human	human	I-NP	I-NP	-	24	NMOD	-	-
23	T	T	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
25	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	this	this	B-NP	B-NP	-	5	NMOD	-	-
5	synergism	synergism	I-NP	I-NP	-	3	PMOD	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	perceptible	perceptible	B-ADJP	B-ADJP	-	6	PRD	-	-
8	at	at	B-PP	B-PP	-	6	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	level	level	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	induction	induction	B-NP	B-NP	-	11	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	IL-2	IL-2	I-NP	I-NP	-	16	NMOD	-	-
16	gene	gene	I-NP	I-NP	-	19	NMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	a	a	B-NP	B-NP	-	19	NMOD	-	-
19	process	process	I-NP	I-NP	-	13	PMOD	-	-
20	critical	critical	B-ADJP	B-ADJP	-	19	NMOD	-	-
21	for	for	B-PP	B-PP	-	20	AMOD	-	-
22	T	T	B-NP	B-NP	-	24	NMOD	-	-
23	cell	cell	I-NP	I-NP	-	24	NMOD	-	-
24	growth	growth	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	6	P	-	-

1	To	To	B-VP	B-VP	-	3	VMOD	-	-
2	further	further	I-VP	I-VP	-	3	VMOD	-	-
3	understand	understand	I-VP	I-VP	-	14	VMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	molecular	molecular	I-NP	I-NP	-	7	AMOD	-	-
6	and	and	I-NP	I-NP	-	7	AMOD	-	-
7	nuclear	nuclear	I-NP	I-NP	-	8	NMOD	-	-
8	basis	basis	I-NP	I-NP	-	3	OBJ	-	-
9	for	for	B-PP	B-PP	-	8	NMOD	-	-
10	this	this	B-NP	B-NP	-	11	NMOD	-	-
11	synergism	synergism	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	we	we	B-NP	B-NP	-	14	SUB	-	-
14	have	have	B-VP	B-VP	-	0	ROOT	-	-
15	explored	explored	I-VP	I-VP	-	14	VC	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	induction	induction	I-NP	I-NP	-	15	OBJ	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	DNA-binding	DNA-binding	B-NP	B-NP	-	20	NMOD	-	-
20	proteins	proteins	I-NP	I-NP	-	18	PMOD	-	-
21	in	in	B-PP	B-PP	-	17	NMOD	-	-
22	highly	highly	B-NP	B-NP	-	23	AMOD	-	-
23	purified	purified	I-NP	I-NP	-	27	NMOD	-	-
24	normal	normal	I-NP	I-NP	-	27	NMOD	-	-
25	human	human	I-NP	I-NP	-	27	NMOD	-	-
26	T	T	I-NP	I-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
28	signaled	signaled	B-VP	B-VP	-	27	NMOD	-	-
29	via	via	B-PP	B-PP	-	28	VMOD	-	-
30	the	the	B-NP	B-NP	-	34	NMOD	-	-
31	CD3	CD3	I-NP	I-NP	-	33	NMOD	-	-
32	and/or	and/or	I-NP	I-NP	-	33	NMOD	-	-
33	CD2	CD2	I-NP	I-NP	-	34	NMOD	-	-
34	proteins	proteins	I-NP	I-NP	-	29	PMOD	-	-
35	.	.	O	O	-	14	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	19	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	transmembrane	transmembrane	B-NP	B-NP	-	5	NMOD	-	-
5	signaling	signaling	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	T	T	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	with	with	B-PP	B-PP	-	5	NMOD	-	-
10	ionomycin	ionomycin	B-NP	B-NP	-	17	NMOD	-	-
11	,	,	O	O	-	17	P	-	-
12	and/or	and/or	O	O	-	13	NMOD	-	-
13	sn-1	sn-1	B-NP	B-NP	-	17	NMOD	-	-
14	,	,	O	O	-	17	P	-	-
15	<num>	<num>	B-NP	B-NP	-	17	NMOD	-	-
16	dioctanoyl	dioctanoyl	I-NP	I-NP	-	17	NMOD	-	-
17	glycerol	glycerol	I-NP	I-NP	-	9	PMOD	-	-
18	,	,	O	O	-	2	P	-	-
19	was	was	B-VP	B-VP	-	0	ROOT	-	-
20	also	also	I-VP	I-VP	-	19	VMOD	-	-
21	determined	determined	I-VP	I-VP	-	19	VC	-	-
22	.	.	O	O	-	19	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	emergence	emergence	I-NP	I-NP	-	7	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	nuclear	nuclear	B-NP	B-NP	-	6	NMOD	-	-
5	binding	binding	I-NP	I-NP	-	6	NMOD	-	-
6	proteins	proteins	I-NP	I-NP	-	3	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	investigated	investigated	I-VP	I-VP	-	7	VC	-	-
9	using	using	B-VP	B-VP	-	8	VMOD	-	-
10	interleukin-2	interleukin-2	B-NP	B-NP	-	14	NMOD	-	-
11	sequence	sequence	I-NP	I-NP	-	14	NMOD	-	-
12	specific	specific	I-NP	I-NP	-	14	NMOD	-	-
13	oligonucleotide	oligonucleotide	I-NP	I-NP	-	14	NMOD	-	-
14	probes	probes	I-NP	I-NP	-	9	OBJ	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	20	NMOD	-	-
17	electrophoretic	electrophoretic	I-NP	I-NP	-	20	NMOD	-	-
18	mobility	mobility	I-NP	I-NP	-	20	NMOD	-	-
19	shift	shift	I-NP	I-NP	-	20	NMOD	-	-
20	assay	assay	I-NP	I-NP	-	15	PMOD	-	-
21	.	.	O	O	-	7	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	for	for	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	first	first	I-NP	I-NP	-	7	NMOD	-	-
7	time	time	I-NP	I-NP	-	4	PMOD	-	-
8	that	that	B-ADVP	B-ADVP	-	3	VMOD	-	-
9	CD3	CD3	B-VP	B-VP	-	11	NMOD	-	-
10	antigen-derived	antigen-derived	B-NP	B-NP	-	11	NMOD	-	-
11	signals	signals	I-NP	I-NP	-	15	NMOD	-	-
12	and	and	O	O	-	15	NMOD	-	-
13	CD2	CD2	B-NP	B-NP	-	15	NMOD	-	-
14	antigen-derived	antigen-derived	I-NP	I-NP	-	15	NMOD	-	-
15	signals	signals	I-NP	I-NP	-	16	SUB	-	-
16	are	are	B-VP	B-VP	-	8	SBAR	-	-
17	synergistic	synergistic	B-ADJP	B-ADJP	-	16	PRD	-	-
18	in	in	B-PP	B-PP	-	17	AMOD	-	-
19	inducing	inducing	B-VP	B-VP	-	18	PMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	emergence	emergence	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	transcription	transcription	B-NP	B-NP	-	24	NMOD	-	-
24	factors	factors	I-NP	I-NP	-	22	PMOD	-	-
25	that	that	B-NP	B-NP	-	24	NMOD	-	-
26	bind	bind	B-VP	B-VP	-	25	SBAR	-	-
27	to	to	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	35	NMOD	-	-
29	NF-AT1	NF-AT1	I-NP	I-NP	-	35	NMOD	-	-
30	,	,	O	O	-	35	P	-	-
31	AP-1	AP-1	B-NP	B-NP	-	35	NMOD	-	-
32	,	,	O	O	-	35	P	-	-
33	and	and	O	O	-	35	NMOD	-	-
34	NF-kB	NF-kB	B-NP	B-NP	-	35	NMOD	-	-
35	sites	sites	I-NP	I-NP	-	27	PMOD	-	-
36	located	located	B-ADJP	B-ADJP	-	35	NMOD	-	-
37	in	in	B-PP	B-PP	-	36	AMOD	-	-
38	the	the	B-NP	B-NP	-	40	NMOD	-	-
39	promoter/enhancer	promoter/enhancer	I-NP	I-NP	-	40	NMOD	-	-
40	region	region	I-NP	I-NP	-	37	PMOD	-	-
41	of	of	B-PP	B-PP	-	40	NMOD	-	-
42	the	the	B-NP	B-NP	-	44	NMOD	-	-
43	IL-2	IL-2	I-NP	I-NP	-	44	NMOD	-	-
44	gene	gene	I-NP	I-NP	-	41	PMOD	-	-
45	.	.	O	O	-	3	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	13	VMOD	-	-
2	,	,	O	O	-	13	P	-	-
3	cyclosporine	cyclosporine	B-NP	B-NP	-	13	SUB	-	-
4	,	,	O	O	-	3	P	-	-
5	at	at	B-PP	B-PP	-	3	NMOD	-	-
6	concentrations	concentrations	B-NP	B-NP	-	5	PMOD	-	-
7	readily	readily	B-VP	B-VP	-	8	VMOD	-	-
8	accomplished	accomplished	I-VP	I-VP	-	6	NMOD	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	clinical	clinical	B-NP	B-NP	-	11	NMOD	-	-
11	practice	practice	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	3	P	-	-
13	was	was	B-VP	B-VP	-	0	ROOT	-	-
14	found	found	I-VP	I-VP	-	13	VC	-	-
15	to	to	I-VP	I-VP	-	16	VMOD	-	-
16	inhibit	inhibit	I-VP	I-VP	-	14	VMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	emergence	emergence	I-NP	I-NP	-	16	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	these	these	B-NP	B-NP	-	22	NMOD	-	-
21	DNA-binding	DNA-binding	I-NP	I-NP	-	22	NMOD	-	-
22	proteins	proteins	I-NP	I-NP	-	19	PMOD	-	-
23	in	in	B-PP	B-PP	-	18	NMOD	-	-
24	normal	normal	B-NP	B-NP	-	27	NMOD	-	-
25	human	human	I-NP	I-NP	-	27	NMOD	-	-
26	T	T	I-NP	I-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
28	signaled	signaled	B-VP	B-VP	-	27	NMOD	-	-
29	via	via	B-PP	B-PP	-	28	VMOD	-	-
30	cell	cell	B-NP	B-NP	-	32	NMOD	-	-
31	surface	surface	I-NP	I-NP	-	32	NMOD	-	-
32	proteins	proteins	I-NP	I-NP	-	29	PMOD	-	-
33	implicated	implicated	B-VP	B-VP	-	32	NMOD	-	-
34	in	in	B-PP	B-PP	-	33	VMOD	-	-
35	antigen-dependent	antigen-dependent	B-NP	B-NP	-	38	NMOD	-	-
36	T	T	I-NP	I-NP	-	38	NMOD	-	-
37	cell	cell	I-NP	I-NP	-	38	NMOD	-	-
38	activation	activation	I-NP	I-NP	-	34	PMOD	-	-
39	and	and	B-PP	B-PP	-	34	PMOD	-	-
40	in	in	B-PP	B-PP	-	34	PMOD	-	-
41	T	T	B-NP	B-NP	-	42	NMOD	-	-
42	cells	cells	I-NP	I-NP	-	40	PMOD	-	-
43	stimulated	stimulated	B-VP	B-VP	-	42	NMOD	-	-
44	by	by	B-PP	B-PP	-	43	VMOD	-	-
45	mobilization	mobilization	B-NP	B-NP	-	44	PMOD	-	-
46	of	of	B-PP	B-PP	-	45	NMOD	-	-
47	cellular	cellular	B-NP	B-NP	-	48	NMOD	-	-
48	calcium	calcium	I-NP	I-NP	-	50	NMOD	-	-
49	and	and	O	O	-	50	NMOD	-	-
50	activation	activation	B-NP	B-NP	-	46	PMOD	-	-
51	of	of	B-PP	B-PP	-	50	NMOD	-	-
52	protein	protein	B-NP	B-NP	-	54	NMOD	-	-
53	kinase	kinase	I-NP	I-NP	-	54	NMOD	-	-
54	C	C	I-NP	I-NP	-	51	PMOD	-	-
55	.	.	O	O	-	13	P	-	-

1	Antisense	Antisense	B-NP	B-NP	-	2	NMOD	-	-
2	oligonucleotides	oligonucleotides	I-NP	I-NP	-	10	SUB	-	-
3	to	to	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	p65	p65	I-NP	I-NP	-	6	NMOD	-	-
6	subunit	subunit	I-NP	I-NP	-	3	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappa	NF-kappa	B-NP	B-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	7	PMOD	-	-
10	block	block	B-VP	B-VP	-	0	ROOT	-	-
11	CD11b	CD11b	B-NP	B-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	10	OBJ	-	-
13	and	and	O	O	-	10	VMOD	-	-
14	alter	alter	B-VP	B-VP	-	10	VMOD	-	-
15	adhesion	adhesion	B-NP	B-NP	-	16	NMOD	-	-
16	properties	properties	I-NP	I-NP	-	14	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	differentiated	differentiated	B-NP	B-NP	-	20	NMOD	-	-
19	HL-60	HL-60	I-NP	I-NP	-	20	NMOD	-	-
20	granulocytes	granulocytes	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	10	P	-	-

1	NF-kappa	NF-kappa	B-NP	B-NP	-	2	NMOD	-	-
2	B	B	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	pleiotropic	pleiotropic	I-NP	I-NP	-	6	NMOD	-	-
6	regulator	regulator	I-NP	I-NP	-	3	PRD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	a	a	B-NP	B-NP	-	9	NMOD	-	-
9	variety	variety	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	genes	genes	B-NP	B-NP	-	10	PMOD	-	-
12	implicated	implicated	B-VP	B-VP	-	11	NMOD	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	cellular	cellular	I-NP	I-NP	-	16	NMOD	-	-
16	response	response	I-NP	I-NP	-	13	PMOD	-	-
17	to	to	B-PP	B-PP	-	16	NMOD	-	-
18	injury	injury	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	function	function	I-NP	I-NP	-	3	SUB	-	-
3	has	has	B-VP	B-VP	-	0	ROOT	-	-
4	been	been	I-VP	I-VP	-	3	VC	-	-
5	attributed	attributed	I-VP	I-VP	-	4	VC	-	-
6	to	to	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	coordinated	coordinated	I-NP	I-NP	-	9	NMOD	-	-
9	binding	binding	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	subunits	subunits	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	NF-kappa	NF-kappa	B-NP	B-NP	-	14	NMOD	-	-
14	B	B	I-NP	I-NP	-	12	PMOD	-	-
15	to	to	B-PP	B-PP	-	9	NMOD	-	-
16	distinct	distinct	B-NP	B-NP	-	17	NMOD	-	-
17	regions	regions	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	promoter	promoter	I-NP	I-NP	-	21	NMOD	-	-
21	elements	elements	I-NP	I-NP	-	18	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	numerous	numerous	B-NP	B-NP	-	24	NMOD	-	-
24	genes	genes	I-NP	I-NP	-	22	PMOD	-	-
25	,	,	O	O	-	24	P	-	-
26	including	including	B-PP	B-PP	-	24	NMOD	-	-
27	cytokines	cytokines	B-NP	B-NP	-	35	NMOD	-	-
28	,	,	O	O	-	35	P	-	-
29	growth	growth	B-NP	B-NP	-	31	NMOD	-	-
30	factor	factor	I-NP	I-NP	-	31	NMOD	-	-
31	receptors	receptors	I-NP	I-NP	-	35	NMOD	-	-
32	,	,	O	O	-	35	P	-	-
33	and	and	O	O	-	35	NMOD	-	-
34	adhesion	adhesion	B-NP	B-NP	-	35	NMOD	-	-
35	molecules	molecules	I-NP	I-NP	-	26	PMOD	-	-
36	.	.	O	O	-	3	P	-	-

1	Antisense	Antisense	B-NP	B-NP	-	3	NMOD	-	-
2	phosphorothioate	phosphorothioate	I-NP	I-NP	-	3	NMOD	-	-
3	oligonucleotides	oligonucleotides	I-NP	I-NP	-	15	SUB	-	-
4	to	to	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	9	NMOD	-	-
6	p50	p50	I-NP	I-NP	-	9	NMOD	-	-
7	and	and	I-NP	I-NP	-	9	NMOD	-	-
8	p65	p65	I-NP	I-NP	-	9	NMOD	-	-
9	subunits	subunits	I-NP	I-NP	-	4	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	NF-kappa	NF-kappa	I-NP	I-NP	-	14	NMOD	-	-
13	B	B	I-NP	I-NP	-	14	NMOD	-	-
14	complex	complex	I-NP	I-NP	-	10	PMOD	-	-
15	were	were	B-VP	B-VP	-	0	ROOT	-	-
16	used	used	I-VP	I-VP	-	15	VC	-	-
17	to	to	B-VP	B-VP	-	18	VMOD	-	-
18	define	define	I-VP	I-VP	-	16	VMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	physiologic	physiologic	I-NP	I-NP	-	21	NMOD	-	-
21	role	role	I-NP	I-NP	-	18	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	this	this	B-NP	B-NP	-	25	NMOD	-	-
24	transcription	transcription	I-NP	I-NP	-	25	NMOD	-	-
25	factor	factor	I-NP	I-NP	-	22	PMOD	-	-
26	in	in	B-PP	B-PP	-	21	NMOD	-	-
27	resting	resting	B-NP	B-NP	-	29	AMOD	-	-
28	and	and	I-NP	I-NP	-	29	AMOD	-	-
29	stimulated	stimulated	I-NP	I-NP	-	30	NMOD	-	-
30	granulocytes	granulocytes	I-NP	I-NP	-	26	PMOD	-	-
31	.	.	O	O	-	15	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	reduction	reduction	I-NP	I-NP	-	8	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	p65	p65	B-NP	B-NP	-	6	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	produced	produced	I-VP	I-VP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	treatment	treatment	B-NP	B-NP	-	10	PMOD	-	-
12	with	with	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	phosphorothioate	phosphorothioate	I-NP	I-NP	-	16	NMOD	-	-
15	antisense	antisense	I-NP	I-NP	-	16	NMOD	-	-
16	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	I-NP	-	12	PMOD	-	-
17	.	.	O	O	-	8	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	reduction	reduction	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	accompanied	accompanied	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	rapid	rapid	B-NP	B-NP	-	7	NMOD	-	-
7	changes	changes	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	cellular	cellular	I-NP	I-NP	-	11	NMOD	-	-
11	adhesion	adhesion	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	dimethyl	dimethyl	B-NP	B-NP	-	17	NMOD	-	-
14	sulfoxide-differentiated	sulfoxide-differentiated	I-NP	I-NP	-	17	NMOD	-	-
15	HL-60	HL-60	I-NP	I-NP	-	17	NMOD	-	-
16	leukemia	leukemia	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
18	stimulated	stimulated	B-VP	B-VP	-	17	NMOD	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	12-O-tetradecanoylphorbol	12-O-tetradecanoylphorbol	B-NP	B-NP	-	21	NMOD	-	-
21	13-acetate	13-acetate	I-NP	I-NP	-	19	PMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	TPA	TPA	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	.	.	O	O	-	3	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	effects	effects	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	characterized	characterized	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	marked	marked	I-NP	I-NP	-	8	NMOD	-	-
8	reduction	reduction	I-NP	I-NP	-	5	PMOD	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	CD11b	CD11b	B-NP	B-NP	-	12	NMOD	-	-
11	integrin	integrin	I-NP	I-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	9	PMOD	-	-
13	on	on	B-PP	B-PP	-	8	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	surface	surface	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	treated	treated	B-NP	B-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	p65	p65	I-NP	I-NP	-	6	NMOD	-	-
5	antisense	antisense	I-NP	I-NP	-	6	NMOD	-	-
6	oligomer	oligomer	I-NP	I-NP	-	8	SUB	-	-
7	effectively	effectively	B-VP	B-VP	-	8	VMOD	-	-
8	abolished	abolished	I-VP	I-VP	-	0	ROOT	-	-
9	an	an	B-NP	B-NP	-	10	NMOD	-	-
10	upregulation	upregulation	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	CD11b	CD11b	B-NP	B-NP	-	11	PMOD	-	-
13	that	that	B-NP	B-NP	-	10	NMOD	-	-
14	was	was	B-VP	B-VP	-	13	SBAR	-	-
15	produced	produced	I-VP	I-VP	-	14	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	formyl-met-leu-phe	formyl-met-leu-phe	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	TPA	TPA	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	8	P	-	-

1	However	However	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	p65	p65	I-NP	I-NP	-	7	NMOD	-	-
5	antisense	antisense	I-NP	I-NP	-	7	NMOD	-	-
6	phosphorothioate	phosphorothioate	I-NP	I-NP	-	7	NMOD	-	-
7	oligodeoxynucleotide	oligodeoxynucleotide	I-NP	I-NP	-	8	SUB	-	-
8	had	had	B-VP	B-VP	-	0	ROOT	-	-
9	no	no	B-NP	B-NP	-	11	NMOD	-	-
10	significant	significant	I-NP	I-NP	-	11	NMOD	-	-
11	effect	effect	I-NP	I-NP	-	8	OBJ	-	-
12	on	on	B-PP	B-PP	-	8	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	production	production	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	reactive	reactive	B-NP	B-NP	-	18	NMOD	-	-
17	oxygen	oxygen	I-NP	I-NP	-	18	NMOD	-	-
18	intermediates	intermediates	I-NP	I-NP	-	15	PMOD	-	-
19	or	or	B-PP	B-PP	-	15	PMOD	-	-
20	on	on	B-PP	B-PP	-	15	PMOD	-	-
21	phagocytosis	phagocytosis	B-NP	B-NP	-	20	PMOD	-	-
22	by	by	B-PP	B-PP	-	14	NMOD	-	-
23	these	these	B-NP	B-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	antisense	antisense	B-NP	B-NP	-	6	NMOD	-	-
6	oligomers	oligomers	I-NP	I-NP	-	9	SUB	-	-
7	to	to	B-PP	B-PP	-	6	NMOD	-	-
8	p65	p65	B-NP	B-NP	-	7	PMOD	-	-
9	can	can	B-VP	B-VP	-	4	SBAR	-	-
10	be	be	I-VP	I-VP	-	9	VC	-	-
11	used	used	I-VP	I-VP	-	10	VC	-	-
12	to	to	B-VP	B-VP	-	13	VMOD	-	-
13	define	define	I-VP	I-VP	-	11	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	role	role	I-NP	I-NP	-	13	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	NF-kappa	NF-kappa	B-NP	B-NP	-	18	NMOD	-	-
18	B	B	I-NP	I-NP	-	16	PMOD	-	-
19	in	in	B-PP	B-PP	-	15	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	22	NMOD	-	-
22	pathways	pathways	I-NP	I-NP	-	19	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	neutrophils	neutrophils	B-NP	B-NP	-	23	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Human	Human	B-NP	B-NP	-	6	NMOD	-	-
2	interferon	interferon	I-NP	I-NP	-	6	NMOD	-	-
3	regulatory	regulatory	I-NP	I-NP	-	6	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	6	NMOD	-	-
5	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	0	ROOT	-	-
7	.	.	O	O	-	6	P	-	-

1	Intron-exon	Intron-exon	B-NP	B-NP	-	2	NMOD	-	-
2	organization	organization	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	O	O	-	5	NMOD	-	-
4	functional	functional	B-NP	B-NP	-	5	NMOD	-	-
5	analysis	analysis	I-NP	I-NP	-	0	ROOT	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	5'-flanking	5'-flanking	B-NP	B-NP	-	8	NMOD	-	-
8	region	region	I-NP	I-NP	-	6	PMOD	-	-
9	.	.	O	O	-	5	P	-	-

1	Interferon	Interferon	B-NP	B-NP	-	3	NMOD	-	-
2	regulatory	regulatory	I-NP	I-NP	-	3	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	8	SUB	-	-
4	<num>	<num>	I-NP	I-NP	-	3	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	IRF-2	IRF-2	B-NP	B-NP	-	3	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	12	NMOD	-	-
10	transcriptional	transcriptional	I-NP	I-NP	-	12	NMOD	-	-
11	regulatory	regulatory	I-NP	I-NP	-	12	NMOD	-	-
12	protein	protein	I-NP	I-NP	-	8	PRD	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	terminates	terminates	B-VP	B-VP	-	13	SBAR	-	-
15	interferon	interferon	B-NP	B-NP	-	17	NMOD	-	-
16	beta	beta	I-NP	I-NP	-	17	NMOD	-	-
17	expression	expression	I-NP	I-NP	-	14	OBJ	-	-
18	initiated	initiated	B-VP	B-VP	-	17	NMOD	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	interferon	interferon	B-NP	B-NP	-	22	NMOD	-	-
21	regulatory	regulatory	I-NP	I-NP	-	22	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	19	PMOD	-	-
23	<num>	<num>	I-NP	I-NP	-	22	NMOD	-	-
24	.	.	O	O	-	8	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	isolated	isolated	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	genomic	genomic	I-NP	I-NP	-	9	NMOD	-	-
9	DNA	DNA	I-NP	I-NP	-	6	OBJ	-	-
10	for	for	B-PP	B-PP	-	9	NMOD	-	-
11	human	human	B-NP	B-NP	-	13	NMOD	-	-
12	IRF-2	IRF-2	I-NP	I-NP	-	13	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	6	P	-	-
15	determined	determined	B-VP	B-VP	-	6	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	intron-exon	intron-exon	I-NP	I-NP	-	18	NMOD	-	-
18	structure	structure	I-NP	I-NP	-	15	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	human	human	I-NP	I-NP	-	23	NMOD	-	-
22	IRF-2	IRF-2	I-NP	I-NP	-	23	NMOD	-	-
23	gene	gene	I-NP	I-NP	-	19	PMOD	-	-
24	,	,	O	O	-	6	P	-	-
25	mapped	mapped	B-VP	B-VP	-	6	VMOD	-	-
26	the	the	B-NP	B-NP	-	30	NMOD	-	-
27	major	major	I-NP	I-NP	-	30	NMOD	-	-
28	transcription	transcription	I-NP	I-NP	-	30	NMOD	-	-
29	initiation	initiation	I-NP	I-NP	-	30	NMOD	-	-
30	site	site	I-NP	I-NP	-	25	OBJ	-	-
31	,	,	O	O	-	6	P	-	-
32	identified	identified	B-VP	B-VP	-	6	VMOD	-	-
33	a	a	B-NP	B-NP	-	34	NMOD	-	-
34	number	number	I-NP	I-NP	-	32	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	potential	potential	B-NP	B-NP	-	38	NMOD	-	-
37	regulatory	regulatory	I-NP	I-NP	-	38	NMOD	-	-
38	elements	elements	I-NP	I-NP	-	35	PMOD	-	-
39	in	in	B-PP	B-PP	-	38	NMOD	-	-
40	the	the	B-NP	B-NP	-	42	NMOD	-	-
41	5'-flanking	5'-flanking	I-NP	I-NP	-	42	NMOD	-	-
42	region	region	I-NP	I-NP	-	39	PMOD	-	-
43	,	,	O	O	-	6	P	-	-
44	and	and	O	O	-	6	VMOD	-	-
45	localized	localized	B-VP	B-VP	-	6	VMOD	-	-
46	the	the	B-NP	B-NP	-	48	NMOD	-	-
47	IRF-2	IRF-2	I-NP	I-NP	-	48	NMOD	-	-
48	gene	gene	I-NP	I-NP	-	45	OBJ	-	-
49	on	on	B-PP	B-PP	-	45	VMOD	-	-
50	human	human	B-NP	B-NP	-	51	NMOD	-	-
51	chromosome	chromosome	I-NP	I-NP	-	49	PMOD	-	-
52	<num>	<num>	I-NP	I-NP	-	51	NMOD	-	-
53	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	IRF-2	IRF-2	I-NP	I-NP	-	4	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	4	NMOD	-	-
4	region	region	I-NP	I-NP	-	5	SUB	-	-
5	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	CpG	CpG	I-NP	I-NP	-	8	NMOD	-	-
8	island	island	I-NP	I-NP	-	5	OBJ	-	-
9	,	,	O	O	-	5	P	-	-
10	with	with	B-PP	B-PP	-	5	VMOD	-	-
11	several	several	B-NP	B-NP	-	13	NMOD	-	-
12	GC	GC	I-NP	I-NP	-	13	NMOD	-	-
13	boxes	boxes	I-NP	I-NP	-	29	NMOD	-	-
14	,	,	O	O	-	29	P	-	-
15	a	a	B-NP	B-NP	-	19	NMOD	-	-
16	putative	putative	I-NP	I-NP	-	19	NMOD	-	-
17	NF-kappa	NF-kappa	I-NP	I-NP	-	19	NMOD	-	-
18	B-binding	B-binding	I-NP	I-NP	-	19	NMOD	-	-
19	site	site	I-NP	I-NP	-	29	NMOD	-	-
20	,	,	O	O	-	29	P	-	-
21	and	and	O	O	-	24	NMOD	-	-
22	a	a	B-NP	B-NP	-	24	NMOD	-	-
23	CAAT	CAAT	I-NP	I-NP	-	24	NMOD	-	-
24	box	box	I-NP	I-NP	-	29	NMOD	-	-
25	,	,	O	O	-	29	P	-	-
26	but	but	O	O	-	29	NMOD	-	-
27	no	no	B-NP	B-NP	-	29	NMOD	-	-
28	TATA	TATA	I-NP	I-NP	-	29	NMOD	-	-
29	box	box	I-NP	I-NP	-	5	OBJ	-	-
30	.	.	O	O	-	5	P	-	-

1	When	When	B-ADVP	B-ADVP	-	14	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	promoter	promoter	I-NP	I-NP	-	4	NMOD	-	-
4	region	region	I-NP	I-NP	-	5	SUB	-	-
5	was	was	B-VP	B-VP	-	1	SBAR	-	-
6	linked	linked	I-VP	I-VP	-	5	VC	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	heterologous	heterologous	I-NP	I-NP	-	11	NMOD	-	-
10	reporter	reporter	I-NP	I-NP	-	11	NMOD	-	-
11	gene	gene	I-NP	I-NP	-	7	PMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	we	we	B-NP	B-NP	-	14	SUB	-	-
14	found	found	B-VP	B-VP	-	0	ROOT	-	-
15	that	that	B-SBAR	B-SBAR	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	18	NMOD	-	-
18	region	region	I-NP	I-NP	-	19	SUB	-	-
19	is	is	B-VP	B-VP	-	15	SBAR	-	-
20	inducible	inducible	B-ADJP	B-ADJP	-	19	PRD	-	-
21	by	by	B-PP	B-PP	-	20	AMOD	-	-
22	both	both	B-NP	B-NP	-	23	NMOD	-	-
23	interferons	interferons	I-NP	I-NP	-	21	PMOD	-	-
24	(	(	O	O	-	27	P	-	-
25	interferon-alpha	interferon-alpha	B-NP	B-NP	-	27	NMOD	-	-
26	and	and	O	O	-	27	NMOD	-	-
27	-gamma	-gamma	B-NP	B-NP	-	23	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	and	and	O	O	-	32	NMOD	-	-
30	interferon	interferon	B-NP	B-NP	-	32	NMOD	-	-
31	regulatory	regulatory	I-NP	I-NP	-	32	NMOD	-	-
32	factor	factor	I-NP	I-NP	-	23	NMOD	-	-
33	<num>	<num>	I-NP	I-NP	-	32	NMOD	-	-
34	.	.	O	O	-	14	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	region	region	I-NP	I-NP	-	7	SUB	-	-
3	which	which	B-NP	B-NP	-	2	NMOD	-	-
4	induced	induced	B-VP	B-VP	-	3	SBAR	-	-
5	these	these	B-NP	B-NP	-	6	NMOD	-	-
6	inductions	inductions	I-NP	I-NP	-	4	OBJ	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	identified	identified	I-VP	I-VP	-	7	VC	-	-
9	as	as	B-PP	B-PP	-	8	VMOD	-	-
10	being	being	B-VP	B-VP	-	9	PMOD	-	-
11	confined	confined	I-VP	I-VP	-	10	VC	-	-
12	to	to	B-PP	B-PP	-	11	VMOD	-	-
13	<num>	<num>	B-NP	B-NP	-	14	NMOD	-	-
14	nucleotides	nucleotides	I-NP	I-NP	-	12	PMOD	-	-
15	<num>	<num>	B-NP	B-NP	-	14	NMOD	-	-
16	'	'	B-NP	B-NP	-	17	PMOD	-	-
17	to	to	B-PP	B-PP	-	11	VMOD	-	-
18	the	the	B-NP	B-NP	-	22	NMOD	-	-
19	major	major	I-NP	I-NP	-	22	NMOD	-	-
20	transcriptional	transcriptional	I-NP	I-NP	-	22	NMOD	-	-
21	initiation	initiation	I-NP	I-NP	-	22	NMOD	-	-
22	site	site	I-NP	I-NP	-	17	PMOD	-	-
23	by	by	B-PP	B-PP	-	11	VMOD	-	-
24	testing	testing	B-VP	B-VP	-	23	PMOD	-	-
25	a	a	B-NP	B-NP	-	26	NMOD	-	-
26	series	series	I-NP	I-NP	-	24	OBJ	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	clones	clones	B-NP	B-NP	-	27	PMOD	-	-
29	with	with	B-PP	B-PP	-	28	NMOD	-	-
30	truncated	truncated	B-NP	B-NP	-	31	NMOD	-	-
31	promoter	promoter	I-NP	I-NP	-	29	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	IRF-2	IRF-2	B-NP	B-NP	-	32	PMOD	-	-
34	.	.	O	O	-	7	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	region	region	I-NP	I-NP	-	3	SUB	-	-
3	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
4	elements	elements	B-NP	B-NP	-	3	OBJ	-	-
5	which	which	B-NP	B-NP	-	4	NMOD	-	-
6	are	are	B-VP	B-VP	-	5	SBAR	-	-
7	shared	shared	I-VP	I-VP	-	6	VC	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	transcriptional	transcriptional	I-NP	I-NP	-	11	NMOD	-	-
11	enhancers	enhancers	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	other	other	B-NP	B-NP	-	14	NMOD	-	-
14	genes	genes	I-NP	I-NP	-	12	PMOD	-	-
15	including	including	B-PP	B-PP	-	14	NMOD	-	-
16	interferon	interferon	B-NP	B-NP	-	18	NMOD	-	-
17	regulatory	regulatory	I-NP	I-NP	-	18	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	26	NMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	18	NMOD	-	-
20	,	,	O	O	-	26	P	-	-
21	interferon	interferon	B-NP	B-NP	-	22	NMOD	-	-
22	beta	beta	I-NP	I-NP	-	26	NMOD	-	-
23	,	,	O	O	-	26	P	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	interferon-inducible	interferon-inducible	B-NP	B-NP	-	26	NMOD	-	-
26	genes	genes	I-NP	I-NP	-	15	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	interferon	interferon	B-NP	B-NP	-	7	NMOD	-	-
6	regulatory	regulatory	I-NP	I-NP	-	7	NMOD	-	-
7	factor	factor	I-NP	I-NP	-	9	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	7	NMOD	-	-
9	not	not	B-CONJP	B-CONJP	-	11	VMOD	-	-
10	only	only	I-CONJP	I-CONJP	-	9	DEP	-	-
11	triggers	triggers	B-VP	B-VP	-	4	SBAR	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	activation	activation	I-NP	I-NP	-	11	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	19	NMOD	-	-
16	interferon	interferon	I-NP	I-NP	-	19	NMOD	-	-
17	signal	signal	I-NP	I-NP	-	19	NMOD	-	-
18	transduction	transduction	I-NP	I-NP	-	19	NMOD	-	-
19	pathway	pathway	I-NP	I-NP	-	14	PMOD	-	-
20	,	,	O	O	-	23	P	-	-
21	but	but	O	O	-	23	VMOD	-	-
22	also	also	B-ADVP	B-ADVP	-	23	VMOD	-	-
23	may	may	B-VP	B-VP	-	4	SBAR	-	-
24	play	play	I-VP	I-VP	-	23	VC	-	-
25	a	a	B-NP	B-NP	-	26	NMOD	-	-
26	role	role	I-NP	I-NP	-	24	OBJ	-	-
27	in	in	B-PP	B-PP	-	24	VMOD	-	-
28	limiting	limiting	B-VP	B-VP	-	27	PMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	duration	duration	I-NP	I-NP	-	28	OBJ	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	this	this	B-NP	B-NP	-	33	NMOD	-	-
33	response	response	I-NP	I-NP	-	31	PMOD	-	-
34	by	by	B-PP	B-PP	-	28	VMOD	-	-
35	activating	activating	B-VP	B-VP	-	34	PMOD	-	-
36	the	the	B-NP	B-NP	-	37	NMOD	-	-
37	transcription	transcription	I-NP	I-NP	-	35	OBJ	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	IRF-2	IRF-2	B-NP	B-NP	-	38	PMOD	-	-
40	.	.	O	O	-	3	P	-	-

1	Overproduction	Overproduction	B-NP	B-NP	-	11	NMOD	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NFKB2	NFKB2	B-NP	B-NP	-	8	NMOD	-	-
4	(	(	O	O	-	5	P	-	-
5	lyt-10	lyt-10	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	and	and	O	O	-	8	NMOD	-	-
8	c-Rel	c-Rel	B-NP	B-NP	-	2	PMOD	-	-
9	:	:	O	O	-	1	P	-	-
10	a	a	B-NP	B-NP	-	11	NMOD	-	-
11	mechanism	mechanism	I-NP	I-NP	-	0	ROOT	-	-
12	for	for	B-PP	B-PP	-	11	NMOD	-	-
13	HTLV-I	HTLV-I	B-NP	B-NP	-	15	NMOD	-	-
14	Tax-mediated	Tax-mediated	I-NP	I-NP	-	15	NMOD	-	-
15	trans-activation	trans-activation	I-NP	I-NP	-	12	PMOD	-	-
16	via	via	B-PP	B-PP	-	11	NMOD	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	NF-kappa	NF-kappa	I-NP	I-NP	-	21	NMOD	-	-
19	B	B	I-NP	I-NP	-	21	NMOD	-	-
20	signalling	signalling	I-NP	I-NP	-	21	NMOD	-	-
21	pathway	pathway	I-NP	I-NP	-	16	PMOD	-	-
22	.	.	O	O	-	11	P	-	-

1	Molecular	Molecular	B-NP	B-NP	-	6	NMOD	-	-
2	,	,	I-NP	I-NP	-	6	P	-	-
3	biochemical	biochemical	I-NP	I-NP	-	6	NMOD	-	-
4	and	and	I-NP	I-NP	-	6	NMOD	-	-
5	epidemiological	epidemiological	I-NP	I-NP	-	6	NMOD	-	-
6	evidence	evidence	I-NP	I-NP	-	7	SUB	-	-
7	implicate	implicate	B-VP	B-VP	-	0	ROOT	-	-
8	HTLV-I	HTLV-I	B-NP	B-NP	-	7	OBJ	-	-
9	as	as	B-PP	B-PP	-	7	VMOD	-	-
10	an	an	B-NP	B-NP	-	12	NMOD	-	-
11	etiologic	etiologic	I-NP	I-NP	-	12	NMOD	-	-
12	agent	agent	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	adult	adult	B-NP	B-NP	-	17	NMOD	-	-
15	T	T	I-NP	I-NP	-	17	NMOD	-	-
16	cell	cell	I-NP	I-NP	-	17	NMOD	-	-
17	leukemia	leukemia	I-NP	I-NP	-	13	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	ATL	ATL	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	Tax	Tax	I-NP	I-NP	-	3	NMOD	-	-
3	protein	protein	I-NP	I-NP	-	16	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	HTLV-I	HTLV-I	B-NP	B-NP	-	4	PMOD	-	-
6	,	,	O	O	-	10	P	-	-
7	a	a	B-NP	B-NP	-	10	NMOD	-	-
8	positive	positive	I-NP	I-NP	-	10	NMOD	-	-
9	transcriptional	transcriptional	I-NP	I-NP	-	10	NMOD	-	-
10	activator	activator	I-NP	I-NP	-	4	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	HTLV-I	HTLV-I	B-NP	B-NP	-	14	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	3	P	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	a	a	B-NP	B-NP	-	19	NMOD	-	-
18	viral	viral	I-NP	I-NP	-	19	NMOD	-	-
19	oncogene	oncogene	I-NP	I-NP	-	16	PRD	-	-
20	that	that	B-NP	B-NP	-	19	NMOD	-	-
21	also	also	B-ADVP	B-ADVP	-	22	VMOD	-	-
22	increases	increases	B-VP	B-VP	-	20	SBAR	-	-
23	transcription	transcription	B-NP	B-NP	-	22	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	cellular	cellular	B-NP	B-NP	-	26	NMOD	-	-
26	genes	genes	I-NP	I-NP	-	24	PMOD	-	-
27	including	including	B-PP	B-PP	-	26	NMOD	-	-
28	GM-CSF	GM-CSF	B-NP	B-NP	-	33	NMOD	-	-
29	,	,	O	O	-	33	P	-	-
30	IL-2R	IL-2R	B-NP	B-NP	-	31	NMOD	-	-
31	alpha	alpha	I-NP	I-NP	-	33	NMOD	-	-
32	and	and	O	O	-	33	NMOD	-	-
33	IL-2	IL-2	B-NP	B-NP	-	27	PMOD	-	-
34	.	.	O	O	-	16	P	-	-

1	One	One	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	cellular	cellular	I-NP	I-NP	-	5	NMOD	-	-
5	targets	targets	I-NP	I-NP	-	2	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	trans-activating	trans-activating	I-NP	I-NP	-	9	NMOD	-	-
9	effects	effects	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	Tax	Tax	B-NP	B-NP	-	10	PMOD	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	NF-kappa	NF-kappa	I-NP	I-NP	-	16	NMOD	-	-
15	B/Rel	B/Rel	I-NP	I-NP	-	16	NMOD	-	-
16	family	family	I-NP	I-NP	-	12	PRD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	transcription	transcription	B-NP	B-NP	-	19	NMOD	-	-
19	factors	factors	I-NP	I-NP	-	22	NMOD	-	-
20	,	,	O	O	-	22	P	-	-
21	pleiotropic	pleiotropic	B-NP	B-NP	-	22	NMOD	-	-
22	regulators	regulators	I-NP	I-NP	-	17	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	immunoregulatory	immunoregulatory	B-NP	B-NP	-	30	NMOD	-	-
25	,	,	I-NP	I-NP	-	30	P	-	-
26	cytokine	cytokine	I-NP	I-NP	-	30	NMOD	-	-
27	and	and	I-NP	I-NP	-	30	NMOD	-	-
28	viral	viral	I-NP	I-NP	-	30	NMOD	-	-
29	gene	gene	I-NP	I-NP	-	30	NMOD	-	-
30	expression	expression	I-NP	I-NP	-	23	PMOD	-	-
31	.	.	O	O	-	12	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	report	report	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	NFKB2	NFKB2	B-NP	B-NP	-	13	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	lyt-10	lyt-10	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	c-Rel	c-Rel	B-NP	B-NP	-	14	SUB	-	-
14	are	are	B-VP	B-VP	-	7	SBAR	-	-
15	overexpressed	overexpressed	I-VP	I-VP	-	14	VC	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	HTLV-I	HTLV-I	B-NP	B-NP	-	21	NMOD	-	-
18	infected	infected	I-NP	I-NP	-	21	NMOD	-	-
19	and	and	I-NP	I-NP	-	21	NMOD	-	-
20	Tax-expressing	Tax-expressing	I-NP	I-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
22	and	and	O	O	-	14	VMOD	-	-
23	,	,	O	O	-	14	P	-	-
24	together	together	B-ADVP	B-ADVP	-	14	VMOD	-	-
25	,	,	O	O	-	14	P	-	-
26	account	account	B-VP	B-VP	-	7	SBAR	-	-
27	for	for	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	majority	majority	I-NP	I-NP	-	27	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	36	NMOD	-	-
32	constitutive	constitutive	I-NP	I-NP	-	36	NMOD	-	-
33	NF-kappa	NF-kappa	I-NP	I-NP	-	36	NMOD	-	-
34	B	B	I-NP	I-NP	-	36	NMOD	-	-
35	binding	binding	I-NP	I-NP	-	36	NMOD	-	-
36	activity	activity	I-NP	I-NP	-	30	PMOD	-	-
37	in	in	B-PP	B-PP	-	36	NMOD	-	-
38	these	these	B-NP	B-NP	-	39	NMOD	-	-
39	cells	cells	I-NP	I-NP	-	37	PMOD	-	-
40	before	before	B-PP	B-PP	-	29	NMOD	-	-
41	and	and	I-PP	I-PP	-	40	PMOD	-	-
42	after	after	I-PP	I-PP	-	40	PMOD	-	-
43	PMA	PMA	B-NP	B-NP	-	44	NMOD	-	-
44	stimulation	stimulation	I-NP	I-NP	-	40	PMOD	-	-
45	.	.	O	O	-	6	P	-	-

1	Most	Most	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	importantly	importantly	I-ADVP	I-ADVP	-	1	AMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	we	we	B-NP	B-NP	-	5	SUB	-	-
5	show	show	B-VP	B-VP	-	0	ROOT	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	Tax-dependent	Tax-dependent	I-NP	I-NP	-	8	NMOD	-	-
8	correlation	correlation	I-NP	I-NP	-	5	OBJ	-	-
9	between	between	B-PP	B-PP	-	8	NMOD	-	-
10	expression	expression	B-NP	B-NP	-	17	NMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	NFKB2	NFKB2	B-NP	B-NP	-	17	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	p100	p100	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	processing	processing	B-NP	B-NP	-	9	PMOD	-	-
18	to	to	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	DNA	DNA	I-NP	I-NP	-	22	NMOD	-	-
21	binding	binding	I-NP	I-NP	-	22	NMOD	-	-
22	NFKB2	NFKB2	I-NP	I-NP	-	26	NMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	p52	p52	B-NP	B-NP	-	22	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	form	form	B-NP	B-NP	-	18	PMOD	-	-
27	,	,	O	O	-	33	P	-	-
28	induction	induction	B-NP	B-NP	-	33	NMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	c-Rel	c-Rel	B-NP	B-NP	-	33	NMOD	-	-
31	,	,	O	O	-	33	P	-	-
32	and	and	O	O	-	33	NMOD	-	-
33	trans-activation	trans-activation	B-NP	B-NP	-	18	PMOD	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	NF-kappa	NF-kappa	B-NP	B-NP	-	38	NMOD	-	-
36	B-mediated	B-mediated	I-NP	I-NP	-	35	AMOD	-	-
37	gene	gene	I-NP	I-NP	-	38	NMOD	-	-
38	expression	expression	I-NP	I-NP	-	34	PMOD	-	-
39	.	.	O	O	-	5	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	NFKB2	NFKB2	I-NP	I-NP	-	5	NMOD	-	-
5	precursor	precursor	I-NP	I-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	physically	physically	I-VP	I-VP	-	6	VMOD	-	-
8	associated	associated	I-VP	I-VP	-	6	VC	-	-
9	with	with	B-PP	B-PP	-	8	VMOD	-	-
10	c-Rel	c-Rel	B-NP	B-NP	-	9	PMOD	-	-
11	and	and	B-PP	B-PP	-	9	PMOD	-	-
12	with	with	B-PP	B-PP	-	9	PMOD	-	-
13	Tax	Tax	B-NP	B-NP	-	12	PMOD	-	-
14	in	in	B-PP	B-PP	-	6	VMOD	-	-
15	HTLV-I	HTLV-I	B-NP	B-NP	-	17	NMOD	-	-
16	infected	infected	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	NFKB2	NFKB2	B-NP	B-NP	-	5	NMOD	-	-
5	synthesis	synthesis	I-NP	I-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	processing	processing	I-NP	I-NP	-	8	SUB	-	-
8	allows	allows	B-VP	B-VP	-	3	SBAR	-	-
9	continuous	continuous	B-NP	B-NP	-	11	NMOD	-	-
10	nuclear	nuclear	I-NP	I-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	8	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	an	an	B-NP	B-NP	-	16	NMOD	-	-
14	otherwise	otherwise	I-NP	I-NP	-	15	AMOD	-	-
15	cytoplasmic	cytoplasmic	I-NP	I-NP	-	16	NMOD	-	-
16	protein	protein	I-NP	I-NP	-	12	PMOD	-	-
17	and	and	O	O	-	8	VMOD	-	-
18	,	,	O	O	-	8	P	-	-
19	in	in	B-PP	B-PP	-	8	VMOD	-	-
20	conjunction	conjunction	B-NP	B-NP	-	19	PMOD	-	-
21	with	with	B-PP	B-PP	-	20	NMOD	-	-
22	overexpression	overexpression	B-NP	B-NP	-	21	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	c-Rel	c-Rel	B-NP	B-NP	-	23	PMOD	-	-
25	,	,	O	O	-	27	P	-	-
26	NFKB2	NFKB2	B-NP	B-NP	-	27	SUB	-	-
27	alters	alters	B-VP	B-VP	-	21	SBAR	-	-
28	the	the	B-NP	B-NP	-	32	NMOD	-	-
29	NF-kappa	NF-kappa	I-NP	I-NP	-	32	NMOD	-	-
30	B	B	I-NP	I-NP	-	32	NMOD	-	-
31	signalling	signalling	I-NP	I-NP	-	32	NMOD	-	-
32	pathway	pathway	I-NP	I-NP	-	27	OBJ	-	-
33	and	and	O	O	-	27	VMOD	-	-
34	contributes	contributes	B-VP	B-VP	-	27	VMOD	-	-
35	to	to	B-PP	B-PP	-	34	VMOD	-	-
36	leukemic	leukemic	B-NP	B-NP	-	37	NMOD	-	-
37	transformation	transformation	I-NP	I-NP	-	35	PMOD	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	T	T	B-NP	B-NP	-	40	NMOD	-	-
40	cells	cells	I-NP	I-NP	-	38	PMOD	-	-
41	by	by	B-PP	B-PP	-	37	NMOD	-	-
42	HTLV-I	HTLV-I	B-NP	B-NP	-	41	PMOD	-	-
43	.	.	O	O	-	2	P	-	-

1	Autoregulation	Autoregulation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	NF-kappa	NF-kappa	I-NP	I-NP	-	7	NMOD	-	-
5	B	B	I-NP	I-NP	-	7	NMOD	-	-
6	transactivator	transactivator	I-NP	I-NP	-	7	NMOD	-	-
7	RelA	RelA	I-NP	I-NP	-	2	PMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	p65	p65	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	by	by	B-PP	B-PP	-	1	NMOD	-	-
12	multiple	multiple	B-NP	B-NP	-	14	NMOD	-	-
13	cytoplasmic	cytoplasmic	I-NP	I-NP	-	14	NMOD	-	-
14	inhibitors	inhibitors	I-NP	I-NP	-	11	PMOD	-	-
15	containing	containing	B-VP	B-VP	-	14	NMOD	-	-
16	ankyrin	ankyrin	B-NP	B-NP	-	17	NMOD	-	-
17	motifs	motifs	I-NP	I-NP	-	15	OBJ	-	-
18	.	.	O	O	-	1	P	-	-

1	RelA	RelA	B-NP	B-NP	-	5	SUB	-	-
2	(	(	O	O	-	3	P	-	-
3	p65	p65	B-NP	B-NP	-	1	NMOD	-	-
4	)	)	O	O	-	3	P	-	-
5	functions	functions	B-VP	B-VP	-	0	ROOT	-	-
6	as	as	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	critical	critical	I-NP	I-NP	-	10	NMOD	-	-
9	transactivating	transactivating	I-NP	I-NP	-	10	NMOD	-	-
10	component	component	I-NP	I-NP	-	6	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	17	NMOD	-	-
13	heterodimeric	heterodimeric	I-NP	I-NP	-	17	NMOD	-	-
14	p50-p65	p50-p65	I-NP	I-NP	-	17	NMOD	-	-
15	NF-kappa	NF-kappa	I-NP	I-NP	-	17	NMOD	-	-
16	B	B	I-NP	I-NP	-	17	NMOD	-	-
17	complex	complex	I-NP	I-NP	-	11	PMOD	-	-
18	and	and	O	O	-	5	VMOD	-	-
19	contains	contains	B-VP	B-VP	-	5	VMOD	-	-
20	a	a	B-NP	B-NP	-	23	NMOD	-	-
21	high-affinity	high-affinity	I-NP	I-NP	-	23	NMOD	-	-
22	binding	binding	I-NP	I-NP	-	23	NMOD	-	-
23	site	site	I-NP	I-NP	-	19	OBJ	-	-
24	for	for	B-PP	B-PP	-	23	NMOD	-	-
25	its	its	B-NP	B-NP	-	27	NMOD	-	-
26	cytoplasmic	cytoplasmic	I-NP	I-NP	-	27	NMOD	-	-
27	inhibitor	inhibitor	I-NP	I-NP	-	32	NMOD	-	-
28	,	,	O	O	-	32	P	-	-
29	I	I	B-NP	B-NP	-	32	NMOD	-	-
30	kappa	kappa	I-NP	I-NP	-	32	NMOD	-	-
31	B	B	I-NP	I-NP	-	32	NMOD	-	-
32	alpha	alpha	I-NP	I-NP	-	24	PMOD	-	-
33	.	.	O	O	-	5	P	-	-

1	After	After	B-PP	B-PP	-	9	VMOD	-	-
2	cellular	cellular	B-NP	B-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	9	P	-	-
5	I	I	B-NP	B-NP	-	8	NMOD	-	-
6	kappa	kappa	I-NP	I-NP	-	8	NMOD	-	-
7	B	B	I-NP	I-NP	-	8	NMOD	-	-
8	alpha	alpha	I-NP	I-NP	-	9	SUB	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	rapidly	rapidly	I-VP	I-VP	-	11	VMOD	-	-
11	degraded	degraded	I-VP	I-VP	-	9	VC	-	-
12	in	in	B-PP	B-PP	-	11	VMOD	-	-
13	concert	concert	B-NP	B-NP	-	12	PMOD	-	-
14	with	with	B-PP	B-PP	-	11	VMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	induced	induced	I-NP	I-NP	-	18	NMOD	-	-
17	nuclear	nuclear	I-NP	I-NP	-	18	NMOD	-	-
18	translocation	translocation	I-NP	I-NP	-	14	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	NF-kappa	NF-kappa	B-NP	B-NP	-	21	NMOD	-	-
21	B	B	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	present	present	I-NP	I-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	4	SUB	-	-
4	demonstrates	demonstrates	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	tumor	tumor	B-NP	B-NP	-	10	NMOD	-	-
7	necrosis	necrosis	I-NP	I-NP	-	10	NMOD	-	-
8	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
9	alpha-induced	alpha-induced	I-NP	I-NP	-	10	NMOD	-	-
10	degradation	degradation	I-NP	I-NP	-	20	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	I	I	B-NP	B-NP	-	15	NMOD	-	-
13	kappa	kappa	I-NP	I-NP	-	15	NMOD	-	-
14	B	B	I-NP	I-NP	-	15	NMOD	-	-
15	alpha	alpha	I-NP	I-NP	-	11	PMOD	-	-
16	in	in	B-PP	B-PP	-	10	NMOD	-	-
17	human	human	B-NP	B-NP	-	19	NMOD	-	-
18	T	T	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	is	is	B-VP	B-VP	-	5	SBAR	-	-
21	preceded	preceded	I-VP	I-VP	-	20	VC	-	-
22	by	by	B-PP	B-PP	-	21	VMOD	-	-
23	its	its	B-NP	B-NP	-	25	NMOD	-	-
24	rapid	rapid	I-NP	I-NP	-	25	NMOD	-	-
25	phosphorylation	phosphorylation	I-NP	I-NP	-	22	PMOD	-	-
26	in	in	B-ADVP	B-ADVP	-	21	VMOD	-	-
27	vivo	vivo	I-ADVP	I-ADVP	-	26	AMOD	-	-
28	.	.	O	O	-	4	P	-	-

1	However	However	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	effects	effects	I-NP	I-NP	-	10	SUB	-	-
5	on	on	B-PP	B-PP	-	4	NMOD	-	-
6	I	I	B-NP	B-NP	-	9	NMOD	-	-
7	kappa	kappa	I-NP	I-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	5	PMOD	-	-
10	result	result	B-VP	B-VP	-	0	ROOT	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	nuclear	nuclear	B-NP	B-NP	-	13	NMOD	-	-
13	mobilization	mobilization	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	only	only	B-NP	B-NP	-	17	NMOD	-	-
16	a	a	I-NP	I-NP	-	17	NMOD	-	-
17	fraction	fraction	I-NP	I-NP	-	14	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	entire	entire	I-NP	I-NP	-	22	NMOD	-	-
21	cytoplasmic	cytoplasmic	I-NP	I-NP	-	22	NMOD	-	-
22	pool	pool	I-NP	I-NP	-	18	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	RelA	RelA	B-NP	B-NP	-	23	PMOD	-	-
25	.	.	O	O	-	10	P	-	-

1	Subsequent	Subsequent	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	have	have	B-VP	B-VP	-	0	ROOT	-	-
4	revealed	revealed	I-VP	I-VP	-	3	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	(	(	B-LST	B-LST	-	7	P	-	-
7	i	i	I-LST	I-LST	-	11	VMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	cytoplasmic	cytoplasmic	B-NP	B-NP	-	10	NMOD	-	-
10	RelA	RelA	I-NP	I-NP	-	11	SUB	-	-
11	is	is	B-VP	B-VP	-	5	SBAR	-	-
12	stably	stably	I-VP	I-VP	-	11	VMOD	-	-
13	associated	associated	I-VP	I-VP	-	11	VC	-	-
14	not	not	B-CONJP	B-CONJP	-	13	VMOD	-	-
15	only	only	I-CONJP	I-CONJP	-	14	DEP	-	-
16	with	with	B-PP	B-PP	-	14	PMOD	-	-
17	I	I	B-NP	B-NP	-	20	NMOD	-	-
18	kappa	kappa	I-NP	I-NP	-	20	NMOD	-	-
19	B	B	I-NP	I-NP	-	20	NMOD	-	-
20	alpha	alpha	I-NP	I-NP	-	16	PMOD	-	-
21	but	but	B-CONJP	B-CONJP	-	140	NMOD	-	-
22	also	also	I-CONJP	I-CONJP	-	21	DEP	-	-
23	with	with	B-PP	B-PP	-	21	PMOD	-	-
24	other	other	B-NP	B-NP	-	27	NMOD	-	-
25	ankyrin	ankyrin	I-NP	I-NP	-	27	NMOD	-	-
26	motif-rich	motif-rich	I-NP	I-NP	-	27	NMOD	-	-
27	proteins	proteins	I-NP	I-NP	-	23	PMOD	-	-
28	including	including	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	products	products	I-NP	I-NP	-	28	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	NF-kappa	NF-kappa	I-NP	I-NP	-	34	NMOD	-	-
34	B2	B2	I-NP	I-NP	-	40	NMOD	-	-
35	(	(	O	O	-	36	P	-	-
36	p100	p100	B-NP	B-NP	-	34	NMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	and	and	O	O	-	40	NMOD	-	-
39	NF-kappa	NF-kappa	B-NP	B-NP	-	40	NMOD	-	-
40	B1	B1	I-NP	I-NP	-	44	NMOD	-	-
41	(	(	O	O	-	42	P	-	-
42	p105	p105	B-NP	B-NP	-	40	NMOD	-	-
43	)	)	O	O	-	42	P	-	-
44	genes	genes	B-NP	B-NP	-	31	PMOD	-	-
45	;	;	O	O	-	60	P	-	-
46	(	(	B-LST	B-LST	-	47	P	-	-
47	ii	ii	I-LST	I-LST	-	60	VMOD	-	-
48	)	)	O	O	-	47	P	-	-
49	in	in	B-PP	B-PP	-	60	VMOD	-	-
50	contrast	contrast	B-NP	B-NP	-	49	PMOD	-	-
51	to	to	B-PP	B-PP	-	49	PMOD	-	-
52	RelA-I	RelA-I	B-NP	B-NP	-	55	NMOD	-	-
53	kappa	kappa	I-NP	I-NP	-	55	NMOD	-	-
54	B	B	I-NP	I-NP	-	55	NMOD	-	-
55	alpha	alpha	I-NP	I-NP	-	51	PMOD	-	-
56	,	,	O	O	-	60	P	-	-
57	RelA-p100	RelA-p100	B-NP	B-NP	-	59	NMOD	-	-
58	cytoplasmic	cytoplasmic	I-NP	I-NP	-	59	NMOD	-	-
59	complexes	complexes	I-NP	I-NP	-	60	SUB	-	-
60	are	are	B-VP	B-VP	-	94	VMOD	-	-
61	not	not	I-VP	I-VP	-	60	VMOD	-	-
62	dissociated	dissociated	I-VP	I-VP	-	60	VC	-	-
63	following	following	B-PP	B-PP	-	62	VMOD	-	-
64	tumor	tumor	B-NP	B-NP	-	68	NMOD	-	-
65	necrosis	necrosis	I-NP	I-NP	-	68	NMOD	-	-
66	factor	factor	I-NP	I-NP	-	68	NMOD	-	-
67	alpha	alpha	I-NP	I-NP	-	68	NMOD	-	-
68	activation	activation	I-NP	I-NP	-	63	PMOD	-	-
69	;	;	O	O	-	60	P	-	-
70	(	(	B-LST	B-LST	-	71	P	-	-
71	iii	iii	I-LST	I-LST	-	74	VMOD	-	-
72	)	)	O	O	-	71	P	-	-
73	p100	p100	B-NP	B-NP	-	74	SUB	-	-
74	functions	functions	B-VP	B-VP	-	94	VMOD	-	-
75	as	as	B-PP	B-PP	-	74	VMOD	-	-
76	a	a	B-NP	B-NP	-	78	NMOD	-	-
77	potent	potent	I-NP	I-NP	-	78	NMOD	-	-
78	inhibitor	inhibitor	I-NP	I-NP	-	75	PMOD	-	-
79	of	of	B-PP	B-PP	-	78	NMOD	-	-
80	RelA-mediated	RelA-mediated	B-NP	B-NP	-	81	NMOD	-	-
81	transcription	transcription	I-NP	I-NP	-	79	PMOD	-	-
82	in	in	B-ADVP	B-ADVP	-	74	VMOD	-	-
83	vivo	vivo	I-ADVP	I-ADVP	-	82	AMOD	-	-
84	;	;	O	O	-	94	P	-	-
85	(	(	B-LST	B-LST	-	86	P	-	-
86	iv	iv	I-LST	I-LST	-	94	VMOD	-	-
87	)	)	O	O	-	86	P	-	-
88	the	the	B-NP	B-NP	-	89	NMOD	-	-
89	interaction	interaction	I-NP	I-NP	-	94	SUB	-	-
90	of	of	B-PP	B-PP	-	89	NMOD	-	-
91	RelA	RelA	B-NP	B-NP	-	93	NMOD	-	-
92	and	and	I-NP	I-NP	-	93	NMOD	-	-
93	p100	p100	I-NP	I-NP	-	90	PMOD	-	-
94	involves	involves	B-VP	B-VP	-	99	NMOD	-	-
95	the	the	B-NP	B-NP	-	99	NMOD	-	-
96	conserved	conserved	I-NP	I-NP	-	99	NMOD	-	-
97	Rel	Rel	I-NP	I-NP	-	99	NMOD	-	-
98	homology	homology	I-NP	I-NP	-	99	NMOD	-	-
99	domain	domain	I-NP	I-NP	-	108	NMOD	-	-
100	of	of	B-PP	B-PP	-	99	NMOD	-	-
101	both	both	B-NP	B-NP	-	102	NMOD	-	-
102	proteins	proteins	B-NP	B-NP	-	100	PMOD	-	-
103	but	but	B-NP	B-NP	-	108	NMOD	-	-
104	not	not	I-NP	I-NP	-	103	DEP	-	-
105	the	the	B-NP	B-NP	-	108	NMOD	-	-
106	nuclear	nuclear	I-NP	I-NP	-	108	NMOD	-	-
107	localization	localization	I-NP	I-NP	-	108	NMOD	-	-
108	signal	signal	I-NP	I-NP	-	21	PMOD	-	-
109	of	of	B-PP	B-PP	-	108	NMOD	-	-
110	RelA	RelA	B-NP	B-NP	-	109	PMOD	-	-
111	,	,	O	O	-	110	P	-	-
112	which	which	B-NP	B-NP	-	110	NMOD	-	-
113	is	is	B-VP	B-VP	-	112	SBAR	-	-
114	required	required	I-VP	I-VP	-	113	VC	-	-
115	for	for	B-PP	B-PP	-	114	VMOD	-	-
116	I	I	B-NP	B-NP	-	120	NMOD	-	-
117	kappa	kappa	I-NP	I-NP	-	120	NMOD	-	-
118	B	B	I-NP	I-NP	-	120	NMOD	-	-
119	alpha	alpha	I-NP	I-NP	-	120	NMOD	-	-
120	binding	binding	I-NP	I-NP	-	21	PMOD	-	-
121	;	;	O	O	-	130	P	-	-
122	(	(	B-LST	B-LST	-	123	P	-	-
123	v	v	I-LST	I-LST	-	130	VMOD	-	-
124	)	)	O	O	-	123	P	-	-
125	p100	p100	B-NP	B-NP	-	126	NMOD	-	-
126	inhibition	inhibition	I-NP	I-NP	-	130	SUB	-	-
127	of	of	B-PP	B-PP	-	126	NMOD	-	-
128	RelA	RelA	B-NP	B-NP	-	129	NMOD	-	-
129	function	function	I-NP	I-NP	-	127	PMOD	-	-
130	requires	requires	B-VP	B-VP	-	135	NMOD	-	-
131	the	the	B-NP	B-NP	-	135	NMOD	-	-
132	C-terminal	C-terminal	I-NP	I-NP	-	135	NMOD	-	-
133	ankyrin	ankyrin	I-NP	I-NP	-	135	NMOD	-	-
134	motif	motif	I-NP	I-NP	-	135	NMOD	-	-
135	domain	domain	I-NP	I-NP	-	21	PMOD	-	-
136	,	,	O	O	-	135	P	-	-
137	which	which	B-NP	B-NP	-	135	NMOD	-	-
138	mediates	mediates	B-VP	B-VP	-	137	SBAR	-	-
139	cytoplasmic	cytoplasmic	B-NP	B-NP	-	140	NMOD	-	-
140	retention	retention	I-NP	I-NP	-	14	PMOD	-	-
141	of	of	B-PP	B-PP	-	140	NMOD	-	-
142	RelA	RelA	B-NP	B-NP	-	141	PMOD	-	-
143	;	;	O	O	-	140	P	-	-
144	and	and	O	O	-	14	PMOD	-	-
145	(	(	B-LST	B-LST	-	13	P	-	-
146	vi	vi	I-LST	I-LST	-	13	VMOD	-	-
147	)	)	O	O	-	146	P	-	-
148	as	as	B-SBAR	B-SBAR	-	146	VMOD	-	-
149	observed	observed	B-VP	B-VP	-	148	SBAR	-	-
150	with	with	B-PP	B-PP	-	149	VMOD	-	-
151	I	I	B-NP	B-NP	-	154	NMOD	-	-
152	kappa	kappa	I-NP	I-NP	-	154	NMOD	-	-
153	B	B	I-NP	I-NP	-	154	NMOD	-	-
154	alpha	alpha	I-NP	I-NP	-	150	PMOD	-	-
155	,	,	O	O	-	158	P	-	-
156	nuclear	nuclear	B-NP	B-NP	-	157	NMOD	-	-
157	RelA	RelA	I-NP	I-NP	-	158	SUB	-	-
158	stimulates	stimulates	B-VP	B-VP	-	148	SBAR	-	-
159	p100	p100	B-NP	B-NP	-	160	NMOD	-	-
160	mRNA	mRNA	I-NP	I-NP	-	163	NMOD	-	-
161	and	and	O	O	-	163	NMOD	-	-
162	protein	protein	B-NP	B-NP	-	163	NMOD	-	-
163	expression	expression	I-NP	I-NP	-	158	OBJ	-	-
164	.	.	O	O	-	3	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	4	SUB	-	-
3	thus	thus	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	reveal	reveal	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	presence	presence	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	a	a	B-NP	B-NP	-	13	NMOD	-	-
9	second	second	I-NP	I-NP	-	13	NMOD	-	-
10	inducible	inducible	I-NP	I-NP	-	13	NMOD	-	-
11	autoregulated	autoregulated	I-NP	I-NP	-	13	NMOD	-	-
12	inhibitory	inhibitory	I-NP	I-NP	-	13	NMOD	-	-
13	pathway	pathway	I-NP	I-NP	-	7	PMOD	-	-
14	that	that	B-NP	B-NP	-	13	NMOD	-	-
15	helps	helps	B-VP	B-VP	-	14	SBAR	-	-
16	ensure	ensure	I-VP	I-VP	-	15	VC	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	rapid	rapid	I-NP	I-NP	-	20	AMOD	-	-
19	but	but	I-NP	I-NP	-	20	AMOD	-	-
20	transient	transient	I-NP	I-NP	-	21	NMOD	-	-
21	action	action	I-NP	I-NP	-	16	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	nuclear	nuclear	B-NP	B-NP	-	25	NMOD	-	-
24	NF-kappa	NF-kappa	I-NP	I-NP	-	25	NMOD	-	-
25	B	B	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	4	P	-	-

1	Calcineurin	Calcineurin	B-NP	B-NP	-	2	SUB	-	-
2	acts	acts	B-VP	B-VP	-	0	ROOT	-	-
3	in	in	B-PP	B-PP	-	2	VMOD	-	-
4	synergy	synergy	B-NP	B-NP	-	3	PMOD	-	-
5	with	with	B-PP	B-PP	-	4	NMOD	-	-
6	PMA	PMA	B-NP	B-NP	-	3	PMOD	-	-
7	to	to	B-VP	B-VP	-	8	VMOD	-	-
8	inactivate	inactivate	I-VP	I-VP	-	2	VMOD	-	-
9	I	I	B-NP	B-NP	-	11	NMOD	-	-
10	kappa	kappa	I-NP	I-NP	-	11	NMOD	-	-
11	B/MAD3	B/MAD3	I-NP	I-NP	-	14	NMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	an	an	B-NP	B-NP	-	14	NMOD	-	-
14	inhibitor	inhibitor	I-NP	I-NP	-	8	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	17	NMOD	-	-
17	B	B	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	6	NMOD	-	-
2	interleukin-2	interleukin-2	I-NP	I-NP	-	6	NMOD	-	-
3	(	(	O	O	-	4	P	-	-
4	IL-2	IL-2	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	promoter	promoter	B-NP	B-NP	-	7	SUB	-	-
7	consists	consists	B-VP	B-VP	-	0	ROOT	-	-
8	of	of	B-PP	B-PP	-	7	VMOD	-	-
9	several	several	B-NP	B-NP	-	18	NMOD	-	-
10	independent	independent	I-NP	I-NP	-	13	NMOD	-	-
11	T	T	I-NP	I-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	receptor	receptor	I-NP	I-NP	-	18	NMOD	-	-
14	(	(	I-NP	I-NP	-	15	P	-	-
15	TcR	TcR	I-NP	I-NP	-	13	NMOD	-	-
16	)	)	I-NP	I-NP	-	15	P	-	-
17	responsive	responsive	I-NP	I-NP	-	18	NMOD	-	-
18	elements	elements	I-NP	I-NP	-	8	PMOD	-	-
19	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	9	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	promoters	promoters	B-NP	B-NP	-	3	PMOD	-	-
5	dependent	dependent	B-ADJP	B-ADJP	-	4	NMOD	-	-
6	on	on	B-PP	B-PP	-	5	AMOD	-	-
7	these	these	B-NP	B-NP	-	8	NMOD	-	-
8	elements	elements	I-NP	I-NP	-	6	PMOD	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	inhibitable	inhibitable	B-ADJP	B-ADJP	-	9	PRD	-	-
11	by	by	B-PP	B-PP	-	10	AMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	immunosuppressants	immunosuppressants	I-NP	I-NP	-	20	NMOD	-	-
14	cyclosporin	cyclosporin	I-NP	I-NP	-	15	NMOD	-	-
15	A	A	I-NP	I-NP	-	20	NMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	CsA	CsA	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	and	and	O	O	-	20	NMOD	-	-
20	tacrolimus	tacrolimus	B-NP	B-NP	-	11	PMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	FK-506	FK-506	B-NP	B-NP	-	20	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	.	.	O	O	-	9	P	-	-

1	Calcineurin	Calcineurin	B-NP	B-NP	-	6	NMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	Ca2+/calmodulin-dependent	Ca2+/calmodulin-dependent	I-NP	I-NP	-	6	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	6	NMOD	-	-
6	phosphatase	phosphatase	I-NP	I-NP	-	8	SUB	-	-
7	,	,	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	13	NMOD	-	-
10	FK-506-	FK-506-	I-NP	I-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	CsA-sensitive	CsA-sensitive	B-NP	B-NP	-	13	NMOD	-	-
13	enzyme	enzyme	I-NP	I-NP	-	8	PRD	-	-
14	required	required	B-VP	B-VP	-	13	NMOD	-	-
15	for	for	B-PP	B-PP	-	14	VMOD	-	-
16	TcR	TcR	B-NP	B-NP	-	18	NMOD	-	-
17	mediated	mediated	I-NP	I-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	15	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	IL-2	IL-2	I-NP	I-NP	-	22	NMOD	-	-
22	promoter	promoter	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	8	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	report	report	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	constitutively	constitutively	I-NP	I-NP	-	6	AMOD	-	-
6	active	active	I-NP	I-NP	-	7	NMOD	-	-
7	form	form	I-NP	I-NP	-	11	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	calcineurin	calcineurin	B-NP	B-NP	-	8	PMOD	-	-
10	partially	partially	B-ADVP	B-ADVP	-	11	VMOD	-	-
11	substitutes	substitutes	B-VP	B-VP	-	3	SBAR	-	-
12	for	for	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	Ca2+	Ca2+	I-NP	I-NP	-	15	NMOD	-	-
15	co-stimulus	co-stimulus	I-NP	I-NP	-	12	PMOD	-	-
16	required	required	B-VP	B-VP	-	15	NMOD	-	-
17	to	to	I-VP	I-VP	-	18	VMOD	-	-
18	activate	activate	I-VP	I-VP	-	16	VMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	IL-2	IL-2	I-NP	I-NP	-	22	NMOD	-	-
21	promoter	promoter	I-NP	I-NP	-	22	NMOD	-	-
22	elements	elements	I-NP	I-NP	-	23	NMOD	-	-
23	IL-2A	IL-2A	I-NP	I-NP	-	18	OBJ	-	-
24	(	(	O	O	-	25	P	-	-
25	which	which	B-NP	B-NP	-	23	NMOD	-	-
26	binds	binds	B-VP	B-VP	-	25	SBAR	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	factors	factors	I-NP	I-NP	-	26	OBJ	-	-
29	OAP	OAP	B-NP	B-NP	-	31	NMOD	-	-
30	and	and	O	O	-	31	NMOD	-	-
31	Oct-1	Oct-1	B-NP	B-NP	-	28	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	and	and	O	O	-	34	NMOD	-	-
34	IL-2E	IL-2E	B-NP	B-NP	-	28	NMOD	-	-
35	(	(	O	O	-	36	P	-	-
36	which	which	B-NP	B-NP	-	34	NMOD	-	-
37	binds	binds	B-VP	B-VP	-	36	SBAR	-	-
38	NF-AT	NF-AT	B-NP	B-NP	-	37	OBJ	-	-
39	)	)	O	O	-	38	P	-	-
40	,	,	O	O	-	34	P	-	-
41	and	and	O	O	-	26	VMOD	-	-
42	completely	completely	B-VP	B-VP	-	43	VMOD	-	-
43	substitutes	substitutes	I-VP	I-VP	-	26	VMOD	-	-
44	for	for	B-PP	B-PP	-	43	VMOD	-	-
45	the	the	B-NP	B-NP	-	47	NMOD	-	-
46	Ca2+	Ca2+	I-NP	I-NP	-	47	NMOD	-	-
47	co-stimulus	co-stimulus	I-NP	I-NP	-	44	PMOD	-	-
48	required	required	B-VP	B-VP	-	47	NMOD	-	-
49	to	to	B-VP	B-VP	-	50	VMOD	-	-
50	stimulate	stimulate	I-VP	I-VP	-	48	VMOD	-	-
51	an	an	B-NP	B-NP	-	54	NMOD	-	-
52	NF-kappa	NF-kappa	I-NP	I-NP	-	54	NMOD	-	-
53	B-dependent	B-dependent	I-NP	I-NP	-	54	NMOD	-	-
54	element	element	I-NP	I-NP	-	50	OBJ	-	-
55	.	.	O	O	-	2	P	-	-

1	Calcineurin	Calcineurin	B-NP	B-NP	-	2	SUB	-	-
2	stimulates	stimulates	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	NF-kappa	NF-kappa	I-NP	I-NP	-	6	NMOD	-	-
5	B	B	I-NP	I-NP	-	6	NMOD	-	-
6	element	element	I-NP	I-NP	-	2	OBJ	-	-
7	by	by	B-PP	B-PP	-	2	VMOD	-	-
8	enhancing	enhancing	B-VP	B-VP	-	7	PMOD	-	-
9	inactivation	inactivation	B-NP	B-NP	-	8	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	I	I	B-NP	B-NP	-	13	NMOD	-	-
12	kappa	kappa	I-NP	I-NP	-	13	NMOD	-	-
13	B/MAD3	B/MAD3	I-NP	I-NP	-	16	NMOD	-	-
14	,	,	O	O	-	16	P	-	-
15	an	an	B-NP	B-NP	-	16	NMOD	-	-
16	inhibitor	inhibitor	I-NP	I-NP	-	10	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	NF-kappa	NF-kappa	B-NP	B-NP	-	19	NMOD	-	-
19	B	B	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	2	P	-	-
21	thereby	thereby	B-ADVP	B-ADVP	-	22	VMOD	-	-
22	increasing	increasing	B-VP	B-VP	-	2	VMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	amount	amount	I-NP	I-NP	-	22	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	nuclear	nuclear	B-NP	B-NP	-	31	NMOD	-	-
27	NF-kappa	NF-kappa	I-NP	I-NP	-	31	NMOD	-	-
28	B	B	I-NP	I-NP	-	31	NMOD	-	-
29	DNA	DNA	I-NP	I-NP	-	31	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	31	NMOD	-	-
31	activity	activity	I-NP	I-NP	-	25	PMOD	-	-
32	.	.	O	O	-	2	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	first	first	I-NP	I-NP	-	6	NMOD	-	-
6	demonstration	demonstration	I-NP	I-NP	-	3	OBJ	-	-
7	in	in	B-ADVP	B-ADVP	-	3	VMOD	-	-
8	vivo	vivo	I-ADVP	I-ADVP	-	7	AMOD	-	-
9	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
10	activation	activation	B-NP	B-NP	-	15	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	a	a	B-NP	B-NP	-	14	NMOD	-	-
13	protein	protein	I-NP	I-NP	-	14	NMOD	-	-
14	phosphatase	phosphatase	I-NP	I-NP	-	11	PMOD	-	-
15	can	can	B-VP	B-VP	-	9	SBAR	-	-
16	inactivate	inactivate	I-VP	I-VP	-	15	VC	-	-
17	I	I	B-NP	B-NP	-	19	NMOD	-	-
18	kappa	kappa	I-NP	I-NP	-	19	NMOD	-	-
19	B	B	I-NP	I-NP	-	16	OBJ	-	-
20	,	,	O	O	-	3	P	-	-
21	and	and	O	O	-	3	VMOD	-	-
22	suggest	suggest	B-VP	B-VP	-	3	VMOD	-	-
23	one	one	B-NP	B-NP	-	25	NMOD	-	-
24	possible	possible	I-NP	I-NP	-	25	NMOD	-	-
25	explanation	explanation	I-NP	I-NP	-	22	OBJ	-	-
26	for	for	B-PP	B-PP	-	25	NMOD	-	-
27	mechanism-based	mechanism-based	B-NP	B-NP	-	28	NMOD	-	-
28	toxicities	toxicities	I-NP	I-NP	-	26	PMOD	-	-
29	associated	associated	B-VP	B-VP	-	28	NMOD	-	-
30	with	with	B-PP	B-PP	-	29	VMOD	-	-
31	FK-506	FK-506	B-NP	B-NP	-	33	NMOD	-	-
32	and	and	I-NP	I-NP	-	33	NMOD	-	-
33	CsA	CsA	I-NP	I-NP	-	30	PMOD	-	-
34	by	by	B-PP	B-PP	-	29	VMOD	-	-
35	demonstrating	demonstrating	B-VP	B-VP	-	34	PMOD	-	-
36	that	that	B-SBAR	B-SBAR	-	35	VMOD	-	-
37	these	these	B-NP	B-NP	-	38	NMOD	-	-
38	drugs	drugs	I-NP	I-NP	-	39	SUB	-	-
39	can	can	B-VP	B-VP	-	36	SBAR	-	-
40	inhibit	inhibit	I-VP	I-VP	-	39	VC	-	-
41	the	the	B-NP	B-NP	-	43	NMOD	-	-
42	calcineurin-dependent	calcineurin-dependent	I-NP	I-NP	-	43	NMOD	-	-
43	activation	activation	I-NP	I-NP	-	40	OBJ	-	-
44	of	of	B-PP	B-PP	-	43	NMOD	-	-
45	a	a	B-NP	B-NP	-	49	NMOD	-	-
46	virtually	virtually	I-NP	I-NP	-	47	AMOD	-	-
47	ubiquitous	ubiquitous	I-NP	I-NP	-	49	NMOD	-	-
48	transcription	transcription	I-NP	I-NP	-	49	NMOD	-	-
49	factor	factor	I-NP	I-NP	-	44	PMOD	-	-
50	.	.	O	O	-	3	P	-	-

1	Activation	Activation	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	interleukin	interleukin	I-NP	I-NP	-	6	NMOD	-	-
5	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	Mycobacterium	Mycobacterium	B-NP	B-NP	-	9	NMOD	-	-
9	tuberculosis	tuberculosis	I-NP	I-NP	-	11	NMOD	-	-
10	or	or	I-NP	I-NP	-	11	NMOD	-	-
11	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	7	PMOD	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	mediated	mediated	I-VP	I-VP	-	12	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	nuclear	nuclear	B-NP	B-NP	-	16	NMOD	-	-
16	factors	factors	I-NP	I-NP	-	14	PMOD	-	-
17	NF-IL6	NF-IL6	B-NP	B-NP	-	20	NMOD	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	NF-kappa	NF-kappa	B-NP	B-NP	-	20	NMOD	-	-
20	B	B	I-NP	I-NP	-	16	NMOD	-	-
21	[	[	O	O	-	24	P	-	-
22	published	published	B-NP	B-NP	-	23	NMOD	-	-
23	erratum	erratum	I-NP	I-NP	-	24	SUB	-	-
24	appears	appears	B-VP	B-VP	-	16	NMOD	-	-
25	in	in	B-PP	B-PP	-	24	VMOD	-	-
26	Proc	Proc	B-NP	B-NP	-	31	NMOD	-	-
27	Natl	Natl	I-NP	I-NP	-	31	NMOD	-	-
28	Acad	Acad	I-NP	I-NP	-	31	NMOD	-	-
29	Sci	Sci	I-NP	I-NP	-	31	NMOD	-	-
30	U	U	I-NP	I-NP	-	31	NMOD	-	-
31	S	S	I-NP	I-NP	-	32	NMOD	-	-
32	A	A	I-NP	I-NP	-	42	NMOD	-	-
33	<num>	<num>	I-NP	I-NP	-	32	NMOD	-	-
34	Apr	Apr	B-PP	B-PP	-	32	NMOD	-	-
35	<num>	<num>	B-NP	B-NP	-	34	AMOD	-	-
36	;	;	O	O	-	42	P	-	-
37	<num>	<num>	B-NP	B-NP	-	39	NMOD	-	-
38	(	(	O	O	-	39	P	-	-
39	<num>	<num>	B-NP	B-NP	-	42	NMOD	-	-
40	)	)	O	O	-	39	P	-	-
41	:	:	O	O	-	42	P	-	-
42	<num>	<num>	B-NP	B-NP	-	25	PMOD	-	-
43	]	]	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	host	host	I-NP	I-NP	-	3	NMOD	-	-
3	response	response	I-NP	I-NP	-	7	SUB	-	-
4	to	to	B-PP	B-PP	-	3	NMOD	-	-
5	Mycobacterium	Mycobacterium	B-NP	B-NP	-	6	NMOD	-	-
6	tuberculosis	tuberculosis	I-NP	I-NP	-	4	PMOD	-	-
7	includes	includes	B-VP	B-VP	-	0	ROOT	-	-
8	granuloma	granuloma	B-NP	B-NP	-	9	NMOD	-	-
9	formation	formation	I-NP	I-NP	-	7	OBJ	-	-
10	at	at	B-PP	B-PP	-	7	VMOD	-	-
11	sites	sites	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	infection	infection	B-NP	B-NP	-	16	NMOD	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	systemic	systemic	B-NP	B-NP	-	16	NMOD	-	-
16	symptoms	symptoms	I-NP	I-NP	-	12	PMOD	-	-
17	.	.	O	O	-	7	P	-	-

1	Cytokines	Cytokines	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	been	been	I-VP	I-VP	-	2	VC	-	-
4	identified	identified	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	immunohistochemistry	immunohistochemistry	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	granulomas	granulomas	B-NP	B-NP	-	7	PMOD	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	animal	animal	B-NP	B-NP	-	11	NMOD	-	-
11	models	models	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	bacillus	bacillus	B-NP	B-NP	-	14	NMOD	-	-
14	Calmette-Guerin	Calmette-Guerin	I-NP	I-NP	-	18	NMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	BCG	BCG	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	infection	infection	B-NP	B-NP	-	12	PMOD	-	-
19	and	and	O	O	-	2	VMOD	-	-
20	are	are	B-VP	B-VP	-	2	VMOD	-	-
21	released	released	I-VP	I-VP	-	20	VC	-	-
22	by	by	B-PP	B-PP	-	21	VMOD	-	-
23	mononuclear	mononuclear	B-NP	B-NP	-	24	NMOD	-	-
24	phagocytes	phagocytes	I-NP	I-NP	-	22	PMOD	-	-
25	upon	upon	B-PP	B-PP	-	21	VMOD	-	-
26	stimulation	stimulation	B-NP	B-NP	-	25	PMOD	-	-
27	by	by	B-PP	B-PP	-	26	NMOD	-	-
28	mycobacterial	mycobacterial	B-NP	B-NP	-	29	NMOD	-	-
29	proteins	proteins	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	regard	regard	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	12	P	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	cytokine	cytokine	I-NP	I-NP	-	12	SUB	-	-
7	interleukin	interleukin	I-NP	I-NP	-	10	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	7	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	IL-6	IL-6	B-NP	B-NP	-	6	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	may	may	B-VP	B-VP	-	0	ROOT	-	-
13	play	play	I-VP	I-VP	-	12	VC	-	-
14	a	a	B-NP	B-NP	-	15	NMOD	-	-
15	role	role	I-NP	I-NP	-	13	OBJ	-	-
16	in	in	B-PP	B-PP	-	13	VMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	clinical	clinical	I-NP	I-NP	-	19	NMOD	-	-
19	manifestations	manifestations	I-NP	I-NP	-	22	NMOD	-	-
20	and	and	O	O	-	22	NMOD	-	-
21	pathological	pathological	B-NP	B-NP	-	22	NMOD	-	-
22	events	events	I-NP	I-NP	-	16	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	tuberculosis	tuberculosis	B-NP	B-NP	-	25	NMOD	-	-
25	infection	infection	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	demonstrated	demonstrated	I-VP	I-VP	-	2	VC	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	lipoarabinomannan	lipoarabinomannan	B-NP	B-NP	-	25	SUB	-	-
6	(	(	O	O	-	7	P	-	-
7	LAM	LAM	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	from	from	B-PP	B-PP	-	5	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	mycobacterial	mycobacterial	I-NP	I-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	wall	wall	I-NP	I-NP	-	9	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	which	which	B-NP	B-NP	-	13	NMOD	-	-
16	was	was	B-VP	B-VP	-	15	SBAR	-	-
17	virtually	virtually	B-ADJP	B-ADJP	-	18	AMOD	-	-
18	devoid	devoid	I-ADJP	I-ADJP	-	16	PRD	-	-
19	of	of	B-PP	B-PP	-	18	AMOD	-	-
20	lipopolysaccharide	lipopolysaccharide	B-NP	B-NP	-	19	PMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	LPS	LPS	B-NP	B-NP	-	20	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	,	,	O	O	-	13	P	-	-
25	stimulated	stimulated	B-VP	B-VP	-	4	SBAR	-	-
26	mononuclear	mononuclear	B-NP	B-NP	-	27	NMOD	-	-
27	phagocytes	phagocytes	I-NP	I-NP	-	25	OBJ	-	-
28	to	to	B-VP	B-VP	-	29	VMOD	-	-
29	release	release	I-VP	I-VP	-	25	VMOD	-	-
30	IL-6	IL-6	B-NP	B-NP	-	29	OBJ	-	-
31	in	in	B-PP	B-PP	-	29	VMOD	-	-
32	a	a	B-NP	B-NP	-	34	NMOD	-	-
33	dose-response	dose-response	I-NP	I-NP	-	34	NMOD	-	-
34	manner	manner	I-NP	I-NP	-	31	PMOD	-	-
35	.	.	O	O	-	2	P	-	-

1	LAM	LAM	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	LPS	LPS	I-NP	I-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	0	ROOT	-	-
5	potent	potent	B-NP	B-NP	-	6	NMOD	-	-
6	inducers	inducers	I-NP	I-NP	-	4	PRD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	IL-6	IL-6	B-NP	B-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	7	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	peripheral	peripheral	B-NP	B-NP	-	14	NMOD	-	-
13	blood	blood	I-NP	I-NP	-	14	NMOD	-	-
14	monocytes	monocytes	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	Both	Both	O	O	-	7	NMOD	-	-
2	LAM-	LAM-	B-NP	B-NP	-	7	NMOD	-	-
3	and	and	O	O	-	7	NMOD	-	-
4	LPS-inducible	LPS-inducible	B-NP	B-NP	-	7	NMOD	-	-
5	IL-6	IL-6	I-NP	I-NP	-	7	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	8	SUB	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	localized	localized	B-ADJP	B-ADJP	-	8	PRD	-	-
10	to	to	B-PP	B-PP	-	9	AMOD	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	DNA	DNA	I-NP	I-NP	-	13	NMOD	-	-
13	fragment	fragment	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	15	P	-	-
15	positions	positions	B-NP	B-NP	-	13	NMOD	-	-
16	-158	-158	B-NP	B-NP	-	18	NMOD	-	-
17	to	to	B-PP	B-PP	-	18	NMOD	-	-
18	-49	-49	B-NP	B-NP	-	15	NMOD	-	-
19	,	,	O	O	-	8	P	-	-
20	by	by	B-PP	B-PP	-	8	VMOD	-	-
21	deletion	deletion	B-NP	B-NP	-	22	NMOD	-	-
22	analysis	analysis	I-NP	I-NP	-	26	NMOD	-	-
23	and	and	O	O	-	26	NMOD	-	-
24	chloramphenicol	chloramphenicol	B-NP	B-NP	-	26	NMOD	-	-
25	acetyltransferase	acetyltransferase	I-NP	I-NP	-	26	NMOD	-	-
26	assay	assay	I-NP	I-NP	-	20	PMOD	-	-
27	.	.	O	O	-	8	P	-	-

1	Two	Two	B-NP	B-NP	-	4	NMOD	-	-
2	nuclear	nuclear	I-NP	I-NP	-	4	NMOD	-	-
3	factor	factor	I-NP	I-NP	-	4	NMOD	-	-
4	NF-IL6	NF-IL6	I-NP	I-NP	-	22	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	positions	positions	B-NP	B-NP	-	4	NMOD	-	-
7	-153	-153	B-NP	B-NP	-	9	NMOD	-	-
8	to	to	B-PP	B-PP	-	9	NMOD	-	-
9	-145	-145	B-NP	B-NP	-	6	NMOD	-	-
10	and	and	O	O	-	22	NMOD	-	-
11	-83	-83	B-NP	B-NP	-	13	NMOD	-	-
12	to	to	B-PP	B-PP	-	13	NMOD	-	-
13	-75	-75	B-NP	B-NP	-	22	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	and	and	O	O	-	22	NMOD	-	-
16	one	one	B-NP	B-NP	-	22	NMOD	-	-
17	nuclear	nuclear	I-NP	I-NP	-	20	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	20	NMOD	-	-
19	NF-kappa	NF-kappa	I-NP	I-NP	-	20	NMOD	-	-
20	B	B	I-NP	I-NP	-	22	NMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	positions	positions	B-NP	B-NP	-	27	NMOD	-	-
23	-72	-72	B-NP	B-NP	-	25	NMOD	-	-
24	to	to	B-PP	B-PP	-	25	NMOD	-	-
25	-63	-63	B-NP	B-NP	-	22	NMOD	-	-
26	)	)	O	O	-	22	P	-	-
27	motifs	motifs	B-NP	B-NP	-	28	SUB	-	-
28	are	are	B-VP	B-VP	-	0	ROOT	-	-
29	present	present	B-ADJP	B-ADJP	-	28	PRD	-	-
30	within	within	B-PP	B-PP	-	29	AMOD	-	-
31	this	this	B-NP	B-NP	-	32	NMOD	-	-
32	fragment	fragment	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	28	P	-	-

1	Site-directed	Site-directed	B-NP	B-NP	-	2	NMOD	-	-
2	mutagenesis	mutagenesis	I-NP	I-NP	-	14	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	one	one	B-NP	B-NP	-	6	AMOD	-	-
5	or	or	I-NP	I-NP	-	4	AMOD	-	-
6	more	more	I-NP	I-NP	-	3	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	these	these	B-NP	B-NP	-	9	NMOD	-	-
9	motifs	motifs	I-NP	I-NP	-	7	PMOD	-	-
10	within	within	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	IL-6	IL-6	I-NP	I-NP	-	13	NMOD	-	-
13	promoter	promoter	I-NP	I-NP	-	10	PMOD	-	-
14	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
15	that	that	B-SBAR	B-SBAR	-	22	DEP	-	-
16	each	each	B-NP	B-NP	-	17	SUB	-	-
17	has	has	B-VP	B-VP	-	15	SBAR	-	-
18	positive	positive	B-NP	B-NP	-	20	NMOD	-	-
19	regulatory	regulatory	I-NP	I-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	17	OBJ	-	-
21	and	and	O	O	-	22	DEP	-	-
22	that	that	B-SBAR	B-SBAR	-	14	VMOD	-	-
23	they	they	B-NP	B-NP	-	24	SUB	-	-
24	could	could	B-VP	B-VP	-	22	SBAR	-	-
25	act	act	I-VP	I-VP	-	24	VC	-	-
26	in	in	B-PP	B-PP	-	25	VMOD	-	-
27	a	a	B-NP	B-NP	-	31	NMOD	-	-
28	function-	function-	I-NP	I-NP	-	30	AMOD	-	-
29	and	and	I-NP	I-NP	-	30	AMOD	-	-
30	orientation-independent	orientation-independent	I-NP	I-NP	-	31	NMOD	-	-
31	manner	manner	I-NP	I-NP	-	26	PMOD	-	-
32	.	.	O	O	-	14	P	-	-

1	Deletion	Deletion	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	all	all	B-NP	B-NP	-	5	NMOD	-	-
4	three	three	I-NP	I-NP	-	5	NMOD	-	-
5	elements	elements	I-NP	I-NP	-	2	PMOD	-	-
6	abolished	abolished	B-VP	B-VP	-	0	ROOT	-	-
7	inducibility	inducibility	B-NP	B-NP	-	6	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	IL-6	IL-6	B-NP	B-NP	-	11	NMOD	-	-
10	promoter	promoter	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	8	PMOD	-	-
12	by	by	B-PP	B-PP	-	7	NMOD	-	-
13	both	both	O	O	-	16	NMOD	-	-
14	LAM	LAM	B-NP	B-NP	-	16	NMOD	-	-
15	and	and	O	O	-	16	NMOD	-	-
16	LPS	LPS	B-NP	B-NP	-	12	PMOD	-	-
17	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	conclude	conclude	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	9	NMOD	-	-
5	NF-IL6	NF-IL6	I-NP	I-NP	-	9	NMOD	-	-
6	and	and	I-NP	I-NP	-	9	NMOD	-	-
7	NF-kappa	NF-kappa	I-NP	I-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	sites	sites	I-NP	I-NP	-	10	SUB	-	-
10	mediate	mediate	B-VP	B-VP	-	3	SBAR	-	-
11	IL-6	IL-6	B-NP	B-NP	-	12	NMOD	-	-
12	induction	induction	I-NP	I-NP	-	10	OBJ	-	-
13	in	in	B-PP	B-PP	-	10	VMOD	-	-
14	response	response	I-PP	I-PP	-	13	PMOD	-	-
15	to	to	I-PP	I-PP	-	13	PMOD	-	-
16	both	both	O	O	-	19	NMOD	-	-
17	LPS	LPS	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	LAM	LAM	I-NP	I-NP	-	13	PMOD	-	-
20	,	,	O	O	-	10	P	-	-
21	acting	acting	B-VP	B-VP	-	10	VMOD	-	-
22	as	as	B-PP	B-PP	-	21	VMOD	-	-
23	bacterial	bacterial	B-NP	B-NP	-	27	NMOD	-	-
24	or	or	I-NP	I-NP	-	27	NMOD	-	-
25	mycobacterial	mycobacterial	I-NP	I-NP	-	27	NMOD	-	-
26	response	response	I-NP	I-NP	-	27	NMOD	-	-
27	elements	elements	I-NP	I-NP	-	22	PMOD	-	-
28	.	.	O	O	-	2	P	-	-

1	Calcineurin	Calcineurin	B-NP	B-NP	-	2	SUB	-	-
2	activates	activates	B-VP	B-VP	-	0	ROOT	-	-
3	transcription	transcription	B-NP	B-NP	-	2	OBJ	-	-
4	from	from	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	GM-CSF	GM-CSF	I-NP	I-NP	-	7	NMOD	-	-
7	promoter	promoter	I-NP	I-NP	-	4	PMOD	-	-
8	in	in	B-PP	B-PP	-	3	NMOD	-	-
9	synergy	synergy	B-NP	B-NP	-	8	PMOD	-	-
10	with	with	B-PP	B-PP	-	9	NMOD	-	-
11	either	either	O	O	-	17	NMOD	-	-
12	protein	protein	B-NP	B-NP	-	14	NMOD	-	-
13	kinase	kinase	I-NP	I-NP	-	14	NMOD	-	-
14	C	C	I-NP	I-NP	-	17	NMOD	-	-
15	or	or	O	O	-	17	NMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	17	NMOD	-	-
17	B/AP-1	B/AP-1	I-NP	I-NP	-	10	PMOD	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	T	T	B-NP	B-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	Two	Two	B-NP	B-NP	-	3	NMOD	-	-
2	cis-acting	cis-acting	I-NP	I-NP	-	3	NMOD	-	-
3	elements	elements	I-NP	I-NP	-	7	NMOD	-	-
4	GM-kappa	GM-kappa	I-NP	I-NP	-	5	NMOD	-	-
5	B/GC-box	B/GC-box	I-NP	I-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	CLE0	CLE0	I-NP	I-NP	-	18	SUB	-	-
8	,	,	O	O	-	18	P	-	-
9	of	of	B-PP	B-PP	-	18	VMOD	-	-
10	the	the	B-NP	B-NP	-	17	NMOD	-	-
11	granulocyte-macrophage	granulocyte-macrophage	I-NP	I-NP	-	17	NMOD	-	-
12	colony-stimulating	colony-stimulating	I-NP	I-NP	-	17	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	17	NMOD	-	-
14	(	(	O	O	-	17	P	-	-
15	GM-CSF	GM-CSF	B-NP	B-NP	-	17	NMOD	-	-
16	)	)	O	O	-	17	P	-	-
17	gene	gene	B-NP	B-NP	-	9	PMOD	-	-
18	are	are	B-VP	B-VP	-	0	ROOT	-	-
19	required	required	I-VP	I-VP	-	18	VC	-	-
20	for	for	B-PP	B-PP	-	19	VMOD	-	-
21	maximal	maximal	B-NP	B-NP	-	22	NMOD	-	-
22	induction	induction	I-NP	I-NP	-	20	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	Jurkat	Jurkat	B-NP	B-NP	-	26	NMOD	-	-
25	T	T	I-NP	I-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
27	by	by	B-PP	B-PP	-	22	NMOD	-	-
28	costimulation	costimulation	B-NP	B-NP	-	27	PMOD	-	-
29	with	with	B-PP	B-PP	-	22	NMOD	-	-
30	phorbol-12-myristate	phorbol-12-myristate	B-NP	B-NP	-	31	NMOD	-	-
31	acetate	acetate	I-NP	I-NP	-	37	NMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	PMA	PMA	B-NP	B-NP	-	31	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	and	and	O	O	-	37	NMOD	-	-
36	Ca2+	Ca2+	B-NP	B-NP	-	37	NMOD	-	-
37	ionophore	ionophore	I-NP	I-NP	-	29	PMOD	-	-
38	(	(	O	O	-	39	P	-	-
39	A23187	A23187	B-NP	B-NP	-	37	NMOD	-	-
40	)	)	O	O	-	39	P	-	-
41	.	.	O	O	-	18	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	GM-kappa	GM-kappa	I-NP	I-NP	-	4	NMOD	-	-
3	B	B	I-NP	I-NP	-	4	NMOD	-	-
4	sequence	sequence	I-NP	I-NP	-	5	SUB	-	-
5	is	is	B-VP	B-VP	-	0	ROOT	-	-
6	recognized	recognized	I-VP	I-VP	-	5	VC	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	NF-kappa	NF-kappa	B-NP	B-NP	-	9	NMOD	-	-
9	B	B	I-NP	I-NP	-	7	PMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	which	which	B-NP	B-NP	-	9	NMOD	-	-
12	is	is	B-VP	B-VP	-	11	SBAR	-	-
13	mainly	mainly	I-VP	I-VP	-	12	VMOD	-	-
14	induced	induced	I-VP	I-VP	-	12	VC	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	PMA	PMA	B-NP	B-NP	-	15	PMOD	-	-
17	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	CLE0	CLE0	I-NP	I-NP	-	3	NMOD	-	-
3	sequence	sequence	I-NP	I-NP	-	4	SUB	-	-
4	interacts	interacts	B-VP	B-VP	-	0	ROOT	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	factors	factors	B-NP	B-NP	-	5	PMOD	-	-
7	,	,	O	O	-	6	P	-	-
8	related	related	B-ADJP	B-ADJP	-	6	NMOD	-	-
9	to	to	B-PP	B-PP	-	8	AMOD	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	PMA-induced	PMA-induced	I-NP	I-NP	-	12	NMOD	-	-
12	AP-1	AP-1	I-NP	I-NP	-	16	NMOD	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	PMA/A23187-induced	PMA/A23187-induced	I-NP	I-NP	-	16	NMOD	-	-
16	NF-AT	NF-AT	I-NP	I-NP	-	9	PMOD	-	-
17	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
3	whether	whether	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	signal	signal	B-NP	B-NP	-	6	NMOD	-	-
5	transducing	transducing	I-NP	I-NP	-	6	NMOD	-	-
6	components	components	I-NP	I-NP	-	10	SUB	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	T	T	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	can	can	B-VP	B-VP	-	3	SBAR	-	-
11	activate	activate	I-VP	I-VP	-	10	VC	-	-
12	transcription	transcription	B-NP	B-NP	-	11	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	GM-CSF	GM-CSF	I-NP	I-NP	-	16	NMOD	-	-
16	gene	gene	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	2	P	-	-

1	Cotransfection	Cotransfection	B-NP	B-NP	-	28	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-kappa	NF-kappa	B-NP	B-NP	-	4	NMOD	-	-
4	B	B	I-NP	I-NP	-	10	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	p50/p65	p50/p65	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	-	-	B-NP	B-NP	-	10	NMOD	-	-
9	or	or	O	O	-	10	NMOD	-	-
10	AP-1	AP-1	B-NP	B-NP	-	2	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	c-Jun/c-Fos	c-Jun/c-Fos	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	-	-	B-NP	B-NP	-	16	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	16	NMOD	-	-
16	vectors	vectors	I-NP	I-NP	-	2	PMOD	-	-
17	into	into	B-PP	B-PP	-	1	NMOD	-	-
18	Jurkat	Jurkat	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	with	with	B-PP	B-PP	-	1	NMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	luciferase	luciferase	I-NP	I-NP	-	23	NMOD	-	-
23	reporter	reporter	I-NP	I-NP	-	20	PMOD	-	-
24	containing	containing	B-VP	B-VP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	GM-CSF	GM-CSF	I-NP	I-NP	-	27	NMOD	-	-
27	promoter	promoter	I-NP	I-NP	-	24	OBJ	-	-
28	did	did	B-VP	B-VP	-	0	ROOT	-	-
29	not	not	I-VP	I-VP	-	28	VMOD	-	-
30	stimulate	stimulate	I-VP	I-VP	-	28	VC	-	-
31	transcription	transcription	B-NP	B-NP	-	30	OBJ	-	-
32	from	from	B-PP	B-PP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	35	NMOD	-	-
34	GM-CSF	GM-CSF	I-NP	I-NP	-	35	NMOD	-	-
35	promoter	promoter	I-NP	I-NP	-	32	PMOD	-	-
36	.	.	O	O	-	28	P	-	-

1	In	In	B-PP	B-PP	-	14	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	14	P	-	-
4	cotransfection	cotransfection	B-NP	B-NP	-	14	SUB	-	-
5	with	with	B-PP	B-PP	-	4	NMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	combination	combination	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	NF-kappa	NF-kappa	B-NP	B-NP	-	10	NMOD	-	-
10	B	B	I-NP	I-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	AP-1	AP-1	B-NP	B-NP	-	8	PMOD	-	-
13	significantly	significantly	B-ADVP	B-ADVP	-	14	VMOD	-	-
14	augmented	augmented	B-VP	B-VP	-	0	ROOT	-	-
15	transcription	transcription	B-NP	B-NP	-	14	OBJ	-	-
16	from	from	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	GM-CSF	GM-CSF	I-NP	I-NP	-	19	NMOD	-	-
19	promoter	promoter	I-NP	I-NP	-	16	PMOD	-	-
20	containing	containing	B-VP	B-VP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	23	NMOD	-	-
22	GM-kappa	GM-kappa	I-NP	I-NP	-	23	NMOD	-	-
23	B/GC-box	B/GC-box	I-NP	I-NP	-	26	NMOD	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	CLE0	CLE0	I-NP	I-NP	-	20	OBJ	-	-
27	(	(	O	O	-	28	P	-	-
28	AP-1/NF-AT	AP-1/NF-AT	B-NP	B-NP	-	26	NMOD	-	-
29	)	)	O	O	-	28	P	-	-
30	.	.	O	O	-	14	P	-	-

1	Expression	Expression	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	constitutively	constitutively	I-NP	I-NP	-	5	AMOD	-	-
5	active	active	I-NP	I-NP	-	6	NMOD	-	-
6	calcineurin	calcineurin	I-NP	I-NP	-	14	NMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	CN	CN	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	,	,	O	O	-	14	P	-	-
11	a	a	B-NP	B-NP	-	14	NMOD	-	-
12	Ca2+/calmodulin-dependent	Ca2+/calmodulin-dependent	I-NP	I-NP	-	14	NMOD	-	-
13	protein	protein	I-NP	I-NP	-	14	NMOD	-	-
14	phosphatase	phosphatase	I-NP	I-NP	-	2	PMOD	-	-
15	,	,	O	O	-	1	P	-	-
16	potentiated	potentiated	B-VP	B-VP	-	1	NMOD	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	two	two	B-NP	B-NP	-	22	NMOD	-	-
19	fold	fold	I-NP	I-NP	-	22	NMOD	-	-
20	the	the	I-NP	I-NP	-	22	NMOD	-	-
21	transcriptional	transcriptional	I-NP	I-NP	-	22	NMOD	-	-
22	activation	activation	I-NP	I-NP	-	17	PMOD	-	-
23	by	by	B-PP	B-PP	-	22	NMOD	-	-
24	NF-kappa	NF-kappa	B-NP	B-NP	-	25	NMOD	-	-
25	B/AP-1	B/AP-1	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	1	P	-	-

1	Both	Both	O	O	-	4	NMOD	-	-
2	constitutively	constitutively	B-NP	B-NP	-	3	AMOD	-	-
3	active	active	I-NP	I-NP	-	4	NMOD	-	-
4	forms	forms	I-NP	I-NP	-	15	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	CN	CN	B-NP	B-NP	-	10	NMOD	-	-
7	and	and	O	O	-	10	NMOD	-	-
8	protein	protein	B-NP	B-NP	-	10	NMOD	-	-
9	kinase	kinase	I-NP	I-NP	-	10	NMOD	-	-
10	C	C	I-NP	I-NP	-	5	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	PKC	PKC	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	synergistically	synergistically	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	activated	activated	B-VP	B-VP	-	0	ROOT	-	-
16	transcription	transcription	B-NP	B-NP	-	15	OBJ	-	-
17	from	from	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	GM-CSF	GM-CSF	I-NP	I-NP	-	20	NMOD	-	-
20	promoter	promoter	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	15	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	cooperation	cooperation	B-NP	B-NP	-	14	SUB	-	-
6	among	among	B-PP	B-PP	-	5	NMOD	-	-
7	NF-kappa	NF-kappa	B-NP	B-NP	-	8	NMOD	-	-
8	B-	B-	I-NP	I-NP	-	13	NMOD	-	-
9	,	,	O	O	-	13	P	-	-
10	AP-1-	AP-1-	B-NP	B-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	NF-AT-binding	NF-AT-binding	B-NP	B-NP	-	13	NMOD	-	-
13	sequences	sequences	I-NP	I-NP	-	6	PMOD	-	-
14	is	is	B-VP	B-VP	-	4	SBAR	-	-
15	required	required	I-VP	I-VP	-	14	VC	-	-
16	for	for	B-PP	B-PP	-	15	VMOD	-	-
17	induction	induction	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	GM-CSF	GM-CSF	I-NP	I-NP	-	21	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	18	PMOD	-	-
22	through	through	B-PP	B-PP	-	17	NMOD	-	-
23	PKC-	PKC-	B-NP	B-NP	-	27	NMOD	-	-
24	and	and	I-NP	I-NP	-	27	NMOD	-	-
25	Ca2+-	Ca2+-	I-NP	I-NP	-	27	NMOD	-	-
26	signaling	signaling	I-NP	I-NP	-	27	NMOD	-	-
27	pathways	pathways	I-NP	I-NP	-	22	PMOD	-	-
28	downstream	downstream	B-ADJP	B-ADJP	-	27	NMOD	-	-
29	of	of	B-PP	B-PP	-	28	AMOD	-	-
30	T	T	B-NP	B-NP	-	32	NMOD	-	-
31	cell	cell	I-NP	I-NP	-	32	NMOD	-	-
32	activation	activation	I-NP	I-NP	-	29	PMOD	-	-
33	.	.	O	O	-	3	P	-	-

1	Cell-specific	Cell-specific	B-NP	B-NP	-	3	NMOD	-	-
2	bifunctional	bifunctional	I-NP	I-NP	-	3	NMOD	-	-
3	role	role	I-NP	I-NP	-	0	ROOT	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	Jun	Jun	B-NP	B-NP	-	8	NMOD	-	-
6	oncogene	oncogene	I-NP	I-NP	-	8	NMOD	-	-
7	family	family	I-NP	I-NP	-	8	NMOD	-	-
8	members	members	I-NP	I-NP	-	4	PMOD	-	-
9	on	on	B-PP	B-PP	-	3	NMOD	-	-
10	glucocorticoid	glucocorticoid	B-NP	B-NP	-	12	NMOD	-	-
11	receptor-dependent	receptor-dependent	I-NP	I-NP	-	12	NMOD	-	-
12	transcription	transcription	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	3	P	-	-

1	Interaction	Interaction	B-NP	B-NP	-	18	SUB	-	-
2	between	between	B-PP	B-PP	-	1	NMOD	-	-
3	protein	protein	B-NP	B-NP	-	5	NMOD	-	-
4	kinase	kinase	I-NP	I-NP	-	5	NMOD	-	-
5	C	C	I-NP	I-NP	-	12	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	PKC	PKC	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	-	-	O	O	-	5	P	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	glucocorticoid	glucocorticoid	B-NP	B-NP	-	12	NMOD	-	-
12	receptor	receptor	I-NP	I-NP	-	17	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	GR	GR	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	-mediated	-mediated	B-NP	B-NP	-	17	NMOD	-	-
17	signaling	signaling	I-NP	I-NP	-	2	PMOD	-	-
18	is	is	B-VP	B-VP	-	0	ROOT	-	-
19	suggested	suggested	I-VP	I-VP	-	18	VC	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	ability	ability	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	PKC	PKC	I-NP	I-NP	-	23	PMOD	-	-
26	activating	activating	B-VP	B-VP	-	25	NMOD	-	-
27	phorbol	phorbol	B-NP	B-NP	-	29	NMOD	-	-
28	ester	ester	I-NP	I-NP	-	29	NMOD	-	-
29	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	I-NP	I-NP	-	26	OBJ	-	-
30	(	(	O	O	-	31	P	-	-
31	TPA	TPA	B-NP	B-NP	-	29	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	to	to	B-VP	B-VP	-	34	VMOD	-	-
34	inhibit	inhibit	I-VP	I-VP	-	22	NMOD	-	-
35	GR-dependent	GR-dependent	B-NP	B-NP	-	36	NMOD	-	-
36	transcription	transcription	I-NP	I-NP	-	34	OBJ	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	the	the	B-NP	B-NP	-	42	NMOD	-	-
39	mouse	mouse	I-NP	I-NP	-	42	NMOD	-	-
40	mammary	mammary	I-NP	I-NP	-	42	NMOD	-	-
41	tumor	tumor	I-NP	I-NP	-	42	NMOD	-	-
42	virus	virus	I-NP	I-NP	-	48	NMOD	-	-
43	(	(	O	O	-	44	P	-	-
44	MMTV	MMTV	B-NP	B-NP	-	42	NMOD	-	-
45	)	)	O	O	-	44	P	-	-
46	long	long	B-NP	B-NP	-	48	NMOD	-	-
47	terminal	terminal	I-NP	I-NP	-	48	NMOD	-	-
48	repeat	repeat	I-NP	I-NP	-	37	PMOD	-	-
49	(	(	O	O	-	50	P	-	-
50	LTR	LTR	B-NP	B-NP	-	48	NMOD	-	-
51	)	)	O	O	-	50	P	-	-
52	.	.	O	O	-	18	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	report	report	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	this	this	B-NP	B-NP	-	6	NMOD	-	-
6	interference	interference	I-NP	I-NP	-	7	SUB	-	-
7	is	is	B-VP	B-VP	-	4	SBAR	-	-
8	cell	cell	B-NP	B-NP	-	9	AMOD	-	-
9	specific	specific	I-NP	I-NP	-	7	PRD	-	-
10	,	,	O	O	-	7	P	-	-
11	as	as	B-SBAR	B-SBAR	-	3	VMOD	-	-
12	TPA	TPA	B-NP	B-NP	-	13	SUB	-	-
13	augmented	augmented	B-VP	B-VP	-	11	SBAR	-	-
14	dexamethasone-induced	dexamethasone-induced	B-NP	B-NP	-	16	NMOD	-	-
15	transcriptional	transcriptional	I-NP	I-NP	-	16	NMOD	-	-
16	activation	activation	I-NP	I-NP	-	13	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	MMTV	MMTV	I-NP	I-NP	-	20	NMOD	-	-
20	LTR	LTR	I-NP	I-NP	-	17	PMOD	-	-
21	in	in	B-PP	B-PP	-	16	NMOD	-	-
22	several	several	B-NP	B-NP	-	25	NMOD	-	-
23	T	T	I-NP	I-NP	-	25	NMOD	-	-
24	cell	cell	I-NP	I-NP	-	25	NMOD	-	-
25	lines	lines	I-NP	I-NP	-	21	PMOD	-	-
26	but	but	O	O	-	13	VMOD	-	-
27	was	was	B-VP	B-VP	-	13	VMOD	-	-
28	inhibitory	inhibitory	B-ADJP	B-ADJP	-	27	PRD	-	-
29	in	in	B-PP	B-PP	-	28	AMOD	-	-
30	NIH-3T3	NIH-3T3	B-NP	B-NP	-	31	NMOD	-	-
31	fibroblasts	fibroblasts	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	3	P	-	-

1	TPA-GR	TPA-GR	B-NP	B-NP	-	2	NMOD	-	-
2	synergism	synergism	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	determined	determined	I-VP	I-VP	-	3	VC	-	-
5	to	to	I-VP	I-VP	-	6	VMOD	-	-
6	have	have	I-VP	I-VP	-	4	VMOD	-	-
7	occurred	occurred	I-VP	I-VP	-	6	VC	-	-
8	at	at	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	15	NMOD	-	-
10	GR-responsive	GR-responsive	I-NP	I-NP	-	15	NMOD	-	-
11	element	element	I-NP	I-NP	-	15	NMOD	-	-
12	(	(	I-NP	I-NP	-	13	P	-	-
13	GRE	GRE	I-NP	I-NP	-	11	NMOD	-	-
14	)	)	I-NP	I-NP	-	13	P	-	-
15	level	level	I-NP	I-NP	-	8	PMOD	-	-
16	by	by	B-PP	B-PP	-	7	VMOD	-	-
17	functional	functional	B-NP	B-NP	-	18	NMOD	-	-
18	analysis	analysis	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	deletion	deletion	B-NP	B-NP	-	21	NMOD	-	-
21	mutants	mutants	I-NP	I-NP	-	25	NMOD	-	-
22	or	or	O	O	-	25	NMOD	-	-
23	synthetic	synthetic	B-NP	B-NP	-	25	NMOD	-	-
24	GRE	GRE	I-NP	I-NP	-	25	NMOD	-	-
25	oligonucleotides	oligonucleotides	I-NP	I-NP	-	19	PMOD	-	-
26	driving	driving	B-VP	B-VP	-	25	NMOD	-	-
27	chloramphenicol	chloramphenicol	B-NP	B-NP	-	29	NMOD	-	-
28	acetyl-transferase	acetyl-transferase	I-NP	I-NP	-	29	NMOD	-	-
29	expression	expression	I-NP	I-NP	-	26	OBJ	-	-
30	.	.	O	O	-	3	P	-	-

1	Synergism	Synergism	B-NP	B-NP	-	2	SUB	-	-
2	required	required	B-VP	B-VP	-	9	VMOD	-	-
3	an	an	B-NP	B-NP	-	7	NMOD	-	-
4	intact	intact	I-NP	I-NP	-	7	NMOD	-	-
5	GR	GR	I-NP	I-NP	-	7	NMOD	-	-
6	DNA-binding	DNA-binding	I-NP	I-NP	-	7	NMOD	-	-
7	domain	domain	I-NP	I-NP	-	2	OBJ	-	-
8	,	,	O	O	-	2	P	-	-
9	whereas	whereas	O	O	-	0	ROOT	-	-
10	amino-	amino-	B-NP	B-NP	-	13	NMOD	-	-
11	or	or	O	O	-	13	NMOD	-	-
12	carboxyl-terminal	carboxyl-terminal	B-NP	B-NP	-	13	NMOD	-	-
13	domains	domains	I-NP	I-NP	-	14	SUB	-	-
14	were	were	B-VP	B-VP	-	9	VMOD	-	-
15	dispensable	dispensable	B-ADJP	B-ADJP	-	14	PRD	-	-
16	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	abrogated	abrogated	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	PKC	PKC	I-NP	I-NP	-	9	NMOD	-	-
8	inhibitor	inhibitor	I-NP	I-NP	-	9	NMOD	-	-
9	staurosporine	staurosporine	I-NP	I-NP	-	5	PMOD	-	-
10	,	,	O	O	-	3	P	-	-
11	suggesting	suggesting	B-VP	B-VP	-	3	VMOD	-	-
12	a	a	B-NP	B-NP	-	13	NMOD	-	-
13	role	role	I-NP	I-NP	-	11	OBJ	-	-
14	for	for	B-PP	B-PP	-	13	NMOD	-	-
15	PKC	PKC	B-NP	B-NP	-	14	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	Increased	Increased	B-VP	B-VP	-	2	NMOD	-	-
2	c-jun	c-jun	B-NP	B-NP	-	8	NMOD	-	-
3	,	,	O	O	-	8	P	-	-
4	jun-B	jun-B	B-NP	B-NP	-	8	NMOD	-	-
5	,	,	O	O	-	8	P	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	jun-D	jun-D	B-NP	B-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	15	NMOD	-	-
9	above	above	B-PP	B-PP	-	8	NMOD	-	-
10	basal	basal	B-NP	B-NP	-	11	NMOD	-	-
11	levels	levels	I-NP	I-NP	-	15	NMOD	-	-
12	and	and	O	O	-	15	NMOD	-	-
13	increased	increased	B-NP	B-NP	-	15	NMOD	-	-
14	transcriptional	transcriptional	I-NP	I-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	25	SUB	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	AP-1/TPA	AP-1/TPA	B-NP	B-NP	-	19	NMOD	-	-
18	responsive	responsive	I-NP	I-NP	-	19	NMOD	-	-
19	elements	elements	I-NP	I-NP	-	16	PMOD	-	-
20	fused	fused	B-VP	B-VP	-	19	NMOD	-	-
21	to	to	B-PP	B-PP	-	20	VMOD	-	-
22	chloramphenicol	chloramphenicol	B-NP	B-NP	-	24	NMOD	-	-
23	acetyl-transferase	acetyl-transferase	I-NP	I-NP	-	24	NMOD	-	-
24	vectors	vectors	I-NP	I-NP	-	21	PMOD	-	-
25	were	were	B-VP	B-VP	-	0	ROOT	-	-
26	observed	observed	I-VP	I-VP	-	25	VC	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	T	T	B-NP	B-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	27	PMOD	-	-
30	treated	treated	B-VP	B-VP	-	29	NMOD	-	-
31	with	with	B-PP	B-PP	-	30	VMOD	-	-
32	TPA	TPA	B-NP	B-NP	-	31	PMOD	-	-
33	alone	alone	B-ADVP	B-ADVP	-	32	NMOD	-	-
34	or	or	O	O	-	27	PMOD	-	-
35	in	in	B-PP	B-PP	-	27	PMOD	-	-
36	combination	combination	B-NP	B-NP	-	35	PMOD	-	-
37	with	with	B-PP	B-PP	-	36	NMOD	-	-
38	dexamethasone	dexamethasone	B-NP	B-NP	-	37	PMOD	-	-
39	.	.	O	O	-	25	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	ability	ability	I-NP	I-NP	-	13	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	Jun	Jun	B-NP	B-NP	-	5	NMOD	-	-
5	proteins	proteins	I-NP	I-NP	-	3	PMOD	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	cooperate	cooperate	I-VP	I-VP	-	2	NMOD	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	GR	GR	B-NP	B-NP	-	8	PMOD	-	-
10	in	in	B-PP	B-PP	-	7	VMOD	-	-
11	T	T	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	has	has	B-VP	B-VP	-	0	ROOT	-	-
14	been	been	I-VP	I-VP	-	13	VC	-	-
15	investigated	investigated	I-VP	I-VP	-	14	VC	-	-
16	after	after	B-PP	B-PP	-	15	VMOD	-	-
17	transfection	transfection	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	c-jun	c-jun	B-NP	B-NP	-	26	NMOD	-	-
20	,	,	O	O	-	26	P	-	-
21	jun-B	jun-B	B-NP	B-NP	-	26	NMOD	-	-
22	,	,	O	O	-	26	P	-	-
23	or	or	O	O	-	26	NMOD	-	-
24	jun-D	jun-D	B-NP	B-NP	-	26	NMOD	-	-
25	expression	expression	I-NP	I-NP	-	26	NMOD	-	-
26	vectors	vectors	I-NP	I-NP	-	18	PMOD	-	-
27	,	,	O	O	-	26	P	-	-
28	which	which	B-NP	B-NP	-	26	NMOD	-	-
29	augmented	augmented	B-VP	B-VP	-	28	SBAR	-	-
30	GR-dependent	GR-dependent	B-NP	B-NP	-	31	NMOD	-	-
31	transcription	transcription	I-NP	I-NP	-	29	OBJ	-	-
32	from	from	B-PP	B-PP	-	31	NMOD	-	-
33	either	either	O	O	-	37	NMOD	-	-
34	MMTV	MMTV	B-NP	B-NP	-	35	NMOD	-	-
35	LTR	LTR	I-NP	I-NP	-	37	NMOD	-	-
36	or	or	I-NP	I-NP	-	37	NMOD	-	-
37	GRE	GRE	I-NP	I-NP	-	32	PMOD	-	-
38	.	.	O	O	-	13	P	-	-

1	Conversely	Conversely	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	c-jun	c-jun	B-NP	B-NP	-	6	NMOD	-	-
4	and	and	O	O	-	6	NMOD	-	-
5	jun-B	jun-B	B-NP	B-NP	-	6	NMOD	-	-
6	transfection	transfection	I-NP	I-NP	-	7	SUB	-	-
7	blunted	blunted	B-VP	B-VP	-	0	ROOT	-	-
8	GR-dependent	GR-dependent	B-NP	B-NP	-	9	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	HeLa	HeLa	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	presence	presence	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	c-fos	c-fos	B-NP	B-NP	-	3	PMOD	-	-
5	had	had	B-VP	B-VP	-	42	VMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	negative	negative	I-NP	I-NP	-	8	NMOD	-	-
8	influence	influence	I-NP	I-NP	-	5	OBJ	-	-
9	on	on	B-PP	B-PP	-	5	VMOD	-	-
10	GR	GR	B-NP	B-NP	-	11	NMOD	-	-
11	function	function	I-NP	I-NP	-	9	PMOD	-	-
12	and	and	O	O	-	5	VMOD	-	-
13	correlated	correlated	B-VP	B-VP	-	5	VMOD	-	-
14	with	with	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	cell-specific	cell-specific	I-NP	I-NP	-	19	AMOD	-	-
17	synergistic	synergistic	I-NP	I-NP	-	19	AMOD	-	-
18	or	or	I-NP	I-NP	-	19	AMOD	-	-
19	antagonistic	antagonistic	I-NP	I-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	14	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	Jun	Jun	B-NP	B-NP	-	21	PMOD	-	-
23	with	with	B-PP	B-PP	-	20	NMOD	-	-
24	respect	respect	B-NP	B-NP	-	23	PMOD	-	-
25	to	to	B-PP	B-PP	-	24	NMOD	-	-
26	GR	GR	B-NP	B-NP	-	25	PMOD	-	-
27	;	;	O	O	-	42	P	-	-
28	high	high	B-NP	B-NP	-	30	NMOD	-	-
29	basal	basal	I-NP	I-NP	-	30	NMOD	-	-
30	expression	expression	I-NP	I-NP	-	41	NMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	c-fos	c-fos	B-NP	B-NP	-	31	PMOD	-	-
33	as	as	B-CONJP	B-CONJP	-	41	NMOD	-	-
34	well	well	I-CONJP	I-CONJP	-	33	DEP	-	-
35	as	as	I-CONJP	I-CONJP	-	33	DEP	-	-
36	AP-1	AP-1	B-NP	B-NP	-	38	NMOD	-	-
37	DNA	DNA	I-NP	I-NP	-	38	NMOD	-	-
38	binding	binding	I-NP	I-NP	-	41	NMOD	-	-
39	and	and	O	O	-	41	NMOD	-	-
40	transcriptional	transcriptional	B-NP	B-NP	-	41	NMOD	-	-
41	activity	activity	I-NP	I-NP	-	42	SUB	-	-
42	were	were	B-VP	B-VP	-	0	ROOT	-	-
43	observed	observed	I-VP	I-VP	-	42	VC	-	-
44	in	in	B-PP	B-PP	-	43	VMOD	-	-
45	HeLa	HeLa	B-NP	B-NP	-	46	NMOD	-	-
46	cells	cells	I-NP	I-NP	-	44	PMOD	-	-
47	,	,	B-PP	B-PP	-	44	P	-	-
48	but	but	I-PP	I-PP	-	44	PMOD	-	-
49	not	not	B-PP	B-PP	-	50	PMOD	-	-
50	in	in	I-PP	I-PP	-	44	PMOD	-	-
51	T	T	B-NP	B-NP	-	52	NMOD	-	-
52	cells	cells	I-NP	I-NP	-	50	PMOD	-	-
53	.	.	O	O	-	42	P	-	-

1	Furthermore	Furthermore	B-NP	B-NP	-	2	NMOD	-	-
2	overexpression	overexpression	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	exogenous	exogenous	B-NP	B-NP	-	5	NMOD	-	-
5	c-fos	c-fos	I-NP	I-NP	-	3	PMOD	-	-
6	has	has	B-VP	B-VP	-	0	ROOT	-	-
7	an	an	B-NP	B-NP	-	9	NMOD	-	-
8	inhibitory	inhibitory	I-NP	I-NP	-	9	NMOD	-	-
9	effect	effect	I-NP	I-NP	-	6	OBJ	-	-
10	on	on	B-PP	B-PP	-	6	VMOD	-	-
11	GR-dependent	GR-dependent	B-NP	B-NP	-	12	NMOD	-	-
12	transcription	transcription	I-NP	I-NP	-	10	PMOD	-	-
13	from	from	B-PP	B-PP	-	12	NMOD	-	-
14	GRE	GRE	B-NP	B-NP	-	13	PMOD	-	-
15	in	in	B-PP	B-PP	-	12	NMOD	-	-
16	T	T	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	Jun	Jun	B-NP	B-NP	-	5	SUB	-	-
5	plays	plays	B-VP	B-VP	-	3	SBAR	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	bifunctional	bifunctional	I-NP	I-NP	-	8	NMOD	-	-
8	role	role	I-NP	I-NP	-	5	OBJ	-	-
9	on	on	B-PP	B-PP	-	5	VMOD	-	-
10	GR-dependent	GR-dependent	B-NP	B-NP	-	12	NMOD	-	-
11	transcriptional	transcriptional	I-NP	I-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	GRE	GRE	B-NP	B-NP	-	13	PMOD	-	-
15	,	,	O	O	-	2	P	-	-
16	selecting	selecting	B-VP	B-VP	-	2	VMOD	-	-
17	either	either	O	O	-	20	AMOD	-	-
18	synergistic	synergistic	B-NP	B-NP	-	20	AMOD	-	-
19	or	or	I-NP	I-NP	-	20	AMOD	-	-
20	antagonistic	antagonistic	I-NP	I-NP	-	21	NMOD	-	-
21	activity	activity	I-NP	I-NP	-	16	OBJ	-	-
22	depending	depending	B-PP	B-PP	-	21	NMOD	-	-
23	on	on	B-PP	B-PP	-	22	PMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	cell-specific	cell-specific	I-NP	I-NP	-	26	NMOD	-	-
26	microenvironment	microenvironment	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	9	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	regard	regard	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	9	P	-	-
5	intracellular	intracellular	B-NP	B-NP	-	6	NMOD	-	-
6	levels	levels	I-NP	I-NP	-	9	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	c-fos	c-fos	B-NP	B-NP	-	7	PMOD	-	-
9	appear	appear	B-VP	B-VP	-	0	ROOT	-	-
10	to	to	I-VP	I-VP	-	11	VMOD	-	-
11	be	be	I-VP	I-VP	-	9	VMOD	-	-
12	influential	influential	B-ADJP	B-ADJP	-	11	PRD	-	-
13	.	.	O	O	-	9	P	-	-

1	Defective	Defective	B-NP	B-NP	-	2	NMOD	-	-
2	translocation	translocation	I-NP	I-NP	-	11	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	protein	protein	B-NP	B-NP	-	6	NMOD	-	-
5	kinase	kinase	I-NP	I-NP	-	6	NMOD	-	-
6	C	C	I-NP	I-NP	-	3	PMOD	-	-
7	in	in	B-PP	B-PP	-	2	NMOD	-	-
8	multidrug-resistant	multidrug-resistant	B-NP	B-NP	-	10	NMOD	-	-
9	HL-60	HL-60	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
11	confers	confers	B-VP	B-VP	-	0	ROOT	-	-
12	a	a	B-NP	B-NP	-	14	NMOD	-	-
13	reversible	reversible	I-NP	I-NP	-	14	NMOD	-	-
14	loss	loss	I-NP	I-NP	-	11	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	phorbol	phorbol	B-NP	B-NP	-	19	NMOD	-	-
17	ester-induced	ester-induced	I-NP	I-NP	-	16	AMOD	-	-
18	monocytic	monocytic	I-NP	I-NP	-	19	NMOD	-	-
19	differentiation	differentiation	I-NP	I-NP	-	15	PMOD	-	-
20	.	.	O	O	-	11	P	-	-

1	Previous	Previous	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	have	have	B-VP	B-VP	-	0	ROOT	-	-
4	demonstrated	demonstrated	I-VP	I-VP	-	3	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	human	human	B-NP	B-NP	-	10	NMOD	-	-
7	HL-60	HL-60	I-NP	I-NP	-	10	NMOD	-	-
8	myeloid	myeloid	I-NP	I-NP	-	10	NMOD	-	-
9	leukemia	leukemia	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	11	SUB	-	-
11	differentiate	differentiate	B-VP	B-VP	-	5	SBAR	-	-
12	in	in	B-PP	B-PP	-	11	VMOD	-	-
13	response	response	B-NP	B-NP	-	12	PMOD	-	-
14	to	to	B-PP	B-PP	-	13	NMOD	-	-
15	phorbol	phorbol	B-NP	B-NP	-	16	NMOD	-	-
16	esters	esters	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	event	event	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	associated	associated	I-VP	I-VP	-	3	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	induction	induction	B-NP	B-NP	-	14	NMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	12	NMOD	-	-
9	c-jun	c-jun	I-NP	I-NP	-	12	NMOD	-	-
10	early	early	I-NP	I-NP	-	12	NMOD	-	-
11	response	response	I-NP	I-NP	-	12	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	7	PMOD	-	-
13	and	and	I-NP	I-NP	-	14	NMOD	-	-
14	appearance	appearance	I-NP	I-NP	-	5	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	a	a	B-NP	B-NP	-	18	NMOD	-	-
17	monocytic	monocytic	I-NP	I-NP	-	18	NMOD	-	-
18	phenotype	phenotype	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	present	present	I-NP	I-NP	-	3	NMOD	-	-
3	studies	studies	I-NP	I-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	examined	examined	I-VP	I-VP	-	4	VC	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	effects	effects	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	vincristine-selected	vincristine-selected	B-NP	B-NP	-	11	AMOD	-	-
10	,	,	I-NP	I-NP	-	11	P	-	-
11	multidrug	multidrug	I-NP	I-NP	-	12	NMOD	-	-
12	resistance	resistance	I-NP	I-NP	-	8	PMOD	-	-
13	on	on	B-PP	B-PP	-	7	NMOD	-	-
14	12-O-tetradecanoylphorbol-13-acetate	12-O-tetradecanoylphorbol-13-acetate	B-NP	B-NP	-	21	NMOD	-	-
15	(	(	I-NP	I-NP	-	16	P	-	-
16	TPA	TPA	I-NP	I-NP	-	14	NMOD	-	-
17	)	)	I-NP	I-NP	-	14	P	-	-
18	-induced	-induced	I-NP	I-NP	-	21	NMOD	-	-
19	HL-60	HL-60	I-NP	I-NP	-	21	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	21	NMOD	-	-
21	differentiation	differentiation	I-NP	I-NP	-	13	PMOD	-	-
22	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	multidrug-resistant	multidrug-resistant	B-NP	B-NP	-	7	NMOD	-	-
6	HL-60	HL-60	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	12	SUB	-	-
8	,	,	O	O	-	7	P	-	-
9	designated	designated	B-VP	B-VP	-	7	NMOD	-	-
10	HL-60/vinc	HL-60/vinc	B-NP	B-NP	-	9	VMOD	-	-
11	,	,	O	O	-	7	P	-	-
12	fail	fail	B-VP	B-VP	-	4	SBAR	-	-
13	to	to	I-VP	I-VP	-	14	VMOD	-	-
14	respond	respond	I-VP	I-VP	-	12	VMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	TPA	TPA	B-NP	B-NP	-	15	PMOD	-	-
17	with	with	B-PP	B-PP	-	16	NMOD	-	-
18	an	an	B-NP	B-NP	-	19	NMOD	-	-
19	increase	increase	I-NP	I-NP	-	17	PMOD	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	c-jun	c-jun	B-NP	B-NP	-	22	NMOD	-	-
22	transcripts	transcripts	I-NP	I-NP	-	26	NMOD	-	-
23	or	or	O	O	-	26	NMOD	-	-
24	other	other	B-NP	B-NP	-	26	NMOD	-	-
25	phenotypic	phenotypic	I-NP	I-NP	-	26	NMOD	-	-
26	characteristics	characteristics	I-NP	I-NP	-	20	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	monocytic	monocytic	B-NP	B-NP	-	29	NMOD	-	-
29	differentiation	differentiation	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	3	P	-	-

1	By	By	B-PP	B-PP	-	19	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	19	P	-	-
4	treatment	treatment	B-NP	B-NP	-	19	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	HL-60/vinc	HL-60/vinc	B-NP	B-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
8	with	with	B-PP	B-PP	-	4	NMOD	-	-
9	okadaic	okadaic	B-NP	B-NP	-	10	NMOD	-	-
10	acid	acid	I-NP	I-NP	-	13	NMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	an	an	B-NP	B-NP	-	13	NMOD	-	-
13	inhibitor	inhibitor	I-NP	I-NP	-	8	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	serine/threonine	serine/threonine	B-NP	B-NP	-	17	NMOD	-	-
16	protein	protein	I-NP	I-NP	-	17	NMOD	-	-
17	phosphatases	phosphatases	I-NP	I-NP	-	14	PMOD	-	-
18	,	,	O	O	-	13	P	-	-
19	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
20	c-jun	c-jun	B-NP	B-NP	-	21	NMOD	-	-
21	transcription	transcription	I-NP	I-NP	-	27	NMOD	-	-
22	,	,	O	O	-	27	P	-	-
23	growth	growth	B-NP	B-NP	-	24	NMOD	-	-
24	arrest	arrest	I-NP	I-NP	-	27	NMOD	-	-
25	,	,	O	O	-	27	P	-	-
26	and	and	O	O	-	27	NMOD	-	-
27	expression	expression	B-NP	B-NP	-	19	OBJ	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	31	NMOD	-	-
30	c-fms	c-fms	I-NP	I-NP	-	31	NMOD	-	-
31	gene	gene	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	19	P	-	-

1	Studies	Studies	B-NP	B-NP	-	2	SUB	-	-
2	were	were	B-VP	B-VP	-	0	ROOT	-	-
3	also	also	I-VP	I-VP	-	2	VMOD	-	-
4	performed	performed	I-VP	I-VP	-	2	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	an	an	B-NP	B-NP	-	8	NMOD	-	-
7	HL-60/vinc	HL-60/vinc	I-NP	I-NP	-	8	NMOD	-	-
8	revertant	revertant	I-NP	I-NP	-	12	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	HL-60/vinc/R	HL-60/vinc/R	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	line	line	B-NP	B-NP	-	5	PMOD	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	has	has	B-VP	B-VP	-	13	SBAR	-	-
15	regained	regained	I-VP	I-VP	-	14	VC	-	-
16	partial	partial	B-NP	B-NP	-	17	NMOD	-	-
17	sensitivity	sensitivity	I-NP	I-NP	-	15	OBJ	-	-
18	to	to	B-PP	B-PP	-	17	NMOD	-	-
19	vincristine	vincristine	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	finding	finding	I-NP	I-NP	-	21	SUB	-	-
3	that	that	B-SBAR	B-SBAR	-	2	NMOD	-	-
4	HL-60/vinc/R	HL-60/vinc/R	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	6	SUB	-	-
6	respond	respond	B-VP	B-VP	-	3	SBAR	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	TPA	TPA	B-NP	B-NP	-	7	PMOD	-	-
9	with	with	B-PP	B-PP	-	8	NMOD	-	-
10	induction	induction	B-NP	B-NP	-	9	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	a	a	B-NP	B-NP	-	14	NMOD	-	-
13	monocytic	monocytic	I-NP	I-NP	-	14	NMOD	-	-
14	phenotype	phenotype	I-NP	I-NP	-	19	NMOD	-	-
15	,	,	O	O	-	19	P	-	-
16	but	but	O	O	-	19	NMOD	-	-
17	not	not	O	O	-	16	DEP	-	-
18	c-jun	c-jun	B-NP	B-NP	-	19	NMOD	-	-
19	expression	expression	I-NP	I-NP	-	11	PMOD	-	-
20	,	,	O	O	-	6	P	-	-
21	suggests	suggests	B-VP	B-VP	-	0	ROOT	-	-
22	that	that	B-SBAR	B-SBAR	-	21	VMOD	-	-
23	c-jun	c-jun	B-NP	B-NP	-	24	NMOD	-	-
24	induction	induction	I-NP	I-NP	-	25	SUB	-	-
25	is	is	B-VP	B-VP	-	22	SBAR	-	-
26	not	not	O	O	-	25	VMOD	-	-
27	obligatory	obligatory	B-ADJP	B-ADJP	-	25	PRD	-	-
28	for	for	B-PP	B-PP	-	27	AMOD	-	-
29	monocytic	monocytic	B-NP	B-NP	-	30	NMOD	-	-
30	differentiation	differentiation	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	21	P	-	-

1	Other	Other	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	4	SUB	-	-
3	further	further	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	jun-B	jun-B	I-NP	I-NP	-	10	NMOD	-	-
8	and	and	I-NP	I-NP	-	10	NMOD	-	-
9	fra-1	fra-1	I-NP	I-NP	-	10	NMOD	-	-
10	genes	genes	I-NP	I-NP	-	11	SUB	-	-
11	are	are	B-VP	B-VP	-	5	SBAR	-	-
12	induced	induced	I-VP	I-VP	-	11	VC	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	TPA	TPA	B-NP	B-NP	-	13	PMOD	-	-
15	in	in	B-PP	B-PP	-	12	VMOD	-	-
16	both	both	O	O	-	20	NMOD	-	-
17	HL-60/vinc	HL-60/vinc	B-NP	B-NP	-	20	NMOD	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	HL-60/vinc/R	HL-60/vinc/R	B-NP	B-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
21	,	,	O	O	-	22	P	-	-
22	whereas	whereas	O	O	-	12	VMOD	-	-
23	c-fos	c-fos	B-NP	B-NP	-	24	NMOD	-	-
24	expression	expression	I-NP	I-NP	-	25	SUB	-	-
25	is	is	B-VP	B-VP	-	22	SBAR	-	-
26	attenuated	attenuated	I-VP	I-VP	-	25	VC	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	HL-60/vinc	HL-60/vinc	I-NP	I-NP	-	30	NMOD	-	-
30	line	line	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	4	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	12	VMOD	-	-
2	TPA	TPA	B-NP	B-NP	-	3	SUB	-	-
3	activates	activates	B-VP	B-VP	-	1	SBAR	-	-
4	protein	protein	B-NP	B-NP	-	6	NMOD	-	-
5	kinase	kinase	I-NP	I-NP	-	6	NMOD	-	-
6	C	C	I-NP	I-NP	-	3	OBJ	-	-
7	(	(	O	O	-	8	P	-	-
8	PKC	PKC	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	,	,	O	O	-	12	P	-	-
11	we	we	B-NP	B-NP	-	12	SUB	-	-
12	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
13	translocation	translocation	B-NP	B-NP	-	12	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	PKC	PKC	B-NP	B-NP	-	14	PMOD	-	-
16	from	from	B-PP	B-PP	-	13	NMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	cytosol	cytosol	I-NP	I-NP	-	16	PMOD	-	-
19	to	to	B-PP	B-PP	-	13	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	membrane	membrane	I-NP	I-NP	-	22	NMOD	-	-
22	fraction	fraction	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	12	P	-	-

1	Although	Although	B-SBAR	B-SBAR	-	15	VMOD	-	-
2	HL-60	HL-60	B-NP	B-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	HL-60/vinc/R	HL-60/vinc/R	I-NP	I-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	6	SUB	-	-
6	demonstrated	demonstrated	B-VP	B-VP	-	1	SBAR	-	-
7	translocation	translocation	B-NP	B-NP	-	6	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	PKC	PKC	B-NP	B-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	15	P	-	-
12	this	this	B-NP	B-NP	-	14	NMOD	-	-
13	subcellular	subcellular	I-NP	I-NP	-	14	NMOD	-	-
14	redistribution	redistribution	I-NP	I-NP	-	15	SUB	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	undetectable	undetectable	B-ADJP	B-ADJP	-	15	PRD	-	-
17	in	in	B-PP	B-PP	-	15	VMOD	-	-
18	HL-60/vinc	HL-60/vinc	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	15	P	-	-

1	Activity	Activity	B-NP	B-NP	-	14	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	mitogen-activated	mitogen-activated	I-NP	I-NP	-	7	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	7	NMOD	-	-
6	kinase	kinase	I-NP	I-NP	-	7	NMOD	-	-
7	family	family	I-NP	I-NP	-	2	PMOD	-	-
8	with	with	B-PP	B-PP	-	1	NMOD	-	-
9	associated	associated	B-NP	B-NP	-	10	NMOD	-	-
10	phosphorylation	phosphorylation	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	c-Jun	c-Jun	B-NP	B-NP	-	13	NMOD	-	-
13	Y-peptide	Y-peptide	I-NP	I-NP	-	11	PMOD	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	markedly	markedly	I-VP	I-VP	-	14	VMOD	-	-
16	diminished	diminished	I-VP	I-VP	-	14	VC	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	TPA-treated	TPA-treated	B-NP	B-NP	-	20	NMOD	-	-
19	HL-60/vinc	HL-60/vinc	I-NP	I-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
21	,	,	B-PP	B-PP	-	17	P	-	-
22	but	but	I-PP	I-PP	-	17	PMOD	-	-
23	not	not	B-PP	B-PP	-	24	PMOD	-	-
24	in	in	I-PP	I-PP	-	17	PMOD	-	-
25	response	response	B-NP	B-NP	-	24	PMOD	-	-
26	to	to	B-PP	B-PP	-	24	PMOD	-	-
27	okadaic	okadaic	B-NP	B-NP	-	28	NMOD	-	-
28	acid	acid	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	14	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	findings	findings	I-NP	I-NP	-	6	SUB	-	-
6	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	vincristine	vincristine	B-NP	B-NP	-	9	NMOD	-	-
9	resistance	resistance	I-NP	I-NP	-	10	SUB	-	-
10	confers	confers	B-VP	B-VP	-	7	SBAR	-	-
11	insensitivity	insensitivity	B-NP	B-NP	-	10	OBJ	-	-
12	to	to	B-PP	B-PP	-	11	NMOD	-	-
13	TPA-induced	TPA-induced	B-NP	B-NP	-	14	NMOD	-	-
14	differentiation	differentiation	I-NP	I-NP	-	12	PMOD	-	-
15	and	and	O	O	-	10	VMOD	-	-
16	can	can	B-VP	B-VP	-	10	VMOD	-	-
17	include	include	I-VP	I-VP	-	16	VC	-	-
18	defects	defects	B-NP	B-NP	-	17	OBJ	-	-
19	in	in	B-PP	B-PP	-	17	VMOD	-	-
20	PKC-mediated	PKC-mediated	B-NP	B-NP	-	22	NMOD	-	-
21	signaling	signaling	I-NP	I-NP	-	22	NMOD	-	-
22	events	events	I-NP	I-NP	-	19	PMOD	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	induction	induction	B-NP	B-NP	-	19	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	jun/fos	jun/fos	B-NP	B-NP	-	30	NMOD	-	-
27	early	early	I-NP	I-NP	-	30	NMOD	-	-
28	response	response	I-NP	I-NP	-	30	NMOD	-	-
29	gene	gene	I-NP	I-NP	-	30	NMOD	-	-
30	expression	expression	I-NP	I-NP	-	25	PMOD	-	-
31	.	.	O	O	-	6	P	-	-

1	Initiation	Initiation	B-NP	B-NP	-	3	NMOD	-	-
2	binding	binding	I-NP	I-NP	-	3	NMOD	-	-
3	repressor	repressor	I-NP	I-NP	-	6	NMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	factor	factor	I-NP	I-NP	-	20	SUB	-	-
7	that	that	B-NP	B-NP	-	6	NMOD	-	-
8	binds	binds	B-VP	B-VP	-	7	SBAR	-	-
9	to	to	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	transcription	transcription	I-NP	I-NP	-	13	NMOD	-	-
12	initiation	initiation	I-NP	I-NP	-	13	NMOD	-	-
13	site	site	I-NP	I-NP	-	9	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	histone	histone	I-NP	I-NP	-	18	NMOD	-	-
17	h5	h5	I-NP	I-NP	-	18	NMOD	-	-
18	gene	gene	I-NP	I-NP	-	14	PMOD	-	-
19	,	,	O	O	-	6	P	-	-
20	is	is	B-VP	B-VP	-	37	VMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	glycosylated	glycosylated	I-NP	I-NP	-	23	NMOD	-	-
23	member	member	I-NP	I-NP	-	20	PRD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	a	a	B-NP	B-NP	-	26	NMOD	-	-
26	family	family	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	cell	cell	B-NP	B-NP	-	30	NMOD	-	-
29	growth	growth	I-NP	I-NP	-	30	NMOD	-	-
30	regulators	regulators	I-NP	I-NP	-	27	PMOD	-	-
31	[	[	O	O	-	37	P	-	-
32	corrected	corrected	B-VP	B-VP	-	37	VMOD	-	-
33	]	]	O	O	-	32	P	-	-
34	[	[	O	O	-	37	P	-	-
35	published	published	B-NP	B-NP	-	36	NMOD	-	-
36	erratum	erratum	I-NP	I-NP	-	37	SUB	-	-
37	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
38	in	in	B-PP	B-PP	-	37	VMOD	-	-
39	Mol	Mol	B-NP	B-NP	-	41	NMOD	-	-
40	Cell	Cell	I-NP	I-NP	-	41	NMOD	-	-
41	Biol	Biol	I-NP	I-NP	-	50	NMOD	-	-
42	<num>	<num>	I-NP	I-NP	-	43	NMOD	-	-
43	Feb	Feb	I-NP	I-NP	-	50	NMOD	-	-
44	;	;	O	O	-	50	P	-	-
45	<num>	<num>	B-NP	B-NP	-	47	NMOD	-	-
46	(	(	O	O	-	47	P	-	-
47	<num>	<num>	B-NP	B-NP	-	50	NMOD	-	-
48	)	)	O	O	-	47	P	-	-
49	:	:	O	O	-	50	P	-	-
50	<num>	<num>	B-NP	B-NP	-	38	PMOD	-	-
51	]	]	O	O	-	37	P	-	-

1	Initiation	Initiation	B-NP	B-NP	-	3	NMOD	-	-
2	binding	binding	I-NP	I-NP	-	3	NMOD	-	-
3	repressor	repressor	I-NP	I-NP	-	10	SUB	-	-
4	[	[	O	O	-	5	P	-	-
5	corrected	corrected	B-VP	B-VP	-	3	NMOD	-	-
6	]	]	O	O	-	5	P	-	-
7	(	(	O	O	-	8	P	-	-
8	IBR	IBR	B-NP	B-NP	-	3	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	a	a	B-NP	B-NP	-	14	NMOD	-	-
12	chicken	chicken	I-NP	I-NP	-	14	NMOD	-	-
13	erythrocyte	erythrocyte	I-NP	I-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	10	PRD	-	-
15	(	(	O	O	-	23	P	-	-
16	apparent	apparent	B-NP	B-NP	-	18	NMOD	-	-
17	molecular	molecular	I-NP	I-NP	-	18	NMOD	-	-
18	mass	mass	I-NP	I-NP	-	23	NMOD	-	-
19	,	,	O	O	-	23	P	-	-
20	<num>	<num>	B-NP	B-NP	-	22	AMOD	-	-
21	to	to	I-NP	I-NP	-	22	AMOD	-	-
22	<num>	<num>	I-NP	I-NP	-	23	NMOD	-	-
23	kDa	kDa	I-NP	I-NP	-	14	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	that	that	B-NP	B-NP	-	14	NMOD	-	-
26	binds	binds	B-VP	B-VP	-	25	SBAR	-	-
27	to	to	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	sequences	sequences	I-NP	I-NP	-	27	PMOD	-	-
30	spanning	spanning	B-VP	B-VP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	34	NMOD	-	-
32	transcription	transcription	I-NP	I-NP	-	34	NMOD	-	-
33	initiation	initiation	I-NP	I-NP	-	34	NMOD	-	-
34	site	site	I-NP	I-NP	-	30	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	the	the	B-NP	B-NP	-	39	NMOD	-	-
37	histone	histone	I-NP	I-NP	-	39	NMOD	-	-
38	h5	h5	I-NP	I-NP	-	39	NMOD	-	-
39	gene	gene	I-NP	I-NP	-	35	PMOD	-	-
40	,	,	O	O	-	29	P	-	-
41	repressing	repressing	B-VP	B-VP	-	26	VMOD	-	-
42	its	its	B-NP	B-NP	-	43	NMOD	-	-
43	transcription	transcription	I-NP	I-NP	-	41	OBJ	-	-
44	.	.	O	O	-	10	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	variety	variety	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	other	other	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
6	,	,	O	O	-	5	P	-	-
7	including	including	B-PP	B-PP	-	5	NMOD	-	-
8	transformed	transformed	B-VP	B-VP	-	10	NMOD	-	-
9	erythroid	erythroid	B-NP	B-NP	-	10	NMOD	-	-
10	precursors	precursors	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	5	P	-	-
12	do	do	B-VP	B-VP	-	0	ROOT	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	have	have	I-VP	I-VP	-	12	VC	-	-
15	IBR	IBR	B-NP	B-NP	-	18	NMOD	-	-
16	but	but	O	O	-	18	NMOD	-	-
17	a	a	B-NP	B-NP	-	18	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	14	OBJ	-	-
19	referred	referred	B-VP	B-VP	-	18	NMOD	-	-
20	to	to	B-PP	B-PP	-	19	VMOD	-	-
21	as	as	B-PP	B-PP	-	19	VMOD	-	-
22	IBF	IBF	B-NP	B-NP	-	21	PMOD	-	-
23	(	(	O	O	-	27	P	-	-
24	<num>	<num>	B-NP	B-NP	-	26	AMOD	-	-
25	to	to	O	O	-	26	AMOD	-	-
26	<num>	<num>	B-NP	B-NP	-	27	NMOD	-	-
27	kDa	kDa	I-NP	I-NP	-	22	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	that	that	B-NP	B-NP	-	22	NMOD	-	-
30	recognizes	recognizes	B-VP	B-VP	-	29	SBAR	-	-
31	the	the	B-NP	B-NP	-	34	NMOD	-	-
32	same	same	I-NP	I-NP	-	34	NMOD	-	-
33	IBR	IBR	I-NP	I-NP	-	34	NMOD	-	-
34	sites	sites	I-NP	I-NP	-	30	OBJ	-	-
35	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	cloned	cloned	I-VP	I-VP	-	2	VC	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	IBR	IBR	I-NP	I-NP	-	6	NMOD	-	-
6	cDNA	cDNA	I-NP	I-NP	-	3	OBJ	-	-
7	and	and	O	O	-	3	VMOD	-	-
8	studied	studied	B-VP	B-VP	-	3	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	relationship	relationship	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	IBR	IBR	B-NP	B-NP	-	14	NMOD	-	-
13	and	and	I-NP	I-NP	-	14	NMOD	-	-
14	IBF	IBF	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	IBR	IBR	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	503-amino-acid-long	503-amino-acid-long	I-NP	I-NP	-	6	NMOD	-	-
5	acidic	acidic	I-NP	I-NP	-	6	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	2	PRD	-	-
7	which	which	B-NP	B-NP	-	6	NMOD	-	-
8	is	is	B-VP	B-VP	-	7	SBAR	-	-
9	<num>	<num>	B-NP	B-NP	-	10	NMOD	-	-
10	%	%	I-NP	I-NP	-	8	PRD	-	-
11	identical	identical	B-ADJP	B-ADJP	-	10	NMOD	-	-
12	to	to	B-PP	B-PP	-	11	AMOD	-	-
13	the	the	B-NP	B-NP	-	18	NMOD	-	-
14	recently	recently	I-NP	I-NP	-	15	AMOD	-	-
15	reported	reported	I-NP	I-NP	-	18	NMOD	-	-
16	human	human	I-NP	I-NP	-	18	NMOD	-	-
17	NRF-1/alpha-Pal	NRF-1/alpha-Pal	I-NP	I-NP	-	18	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	21	AMOD	-	-
19	and	and	O	O	-	21	AMOD	-	-
20	highly	highly	B-ADJP	B-ADJP	-	21	AMOD	-	-
21	related	related	I-ADJP	I-ADJP	-	8	PRD	-	-
22	to	to	B-PP	B-PP	-	21	AMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	invertebrate	invertebrate	I-NP	I-NP	-	26	NMOD	-	-
25	transcription	transcription	I-NP	I-NP	-	26	NMOD	-	-
26	factors	factors	I-NP	I-NP	-	22	PMOD	-	-
27	P3A2	P3A2	B-NP	B-NP	-	32	NMOD	-	-
28	and	and	O	O	-	32	NMOD	-	-
29	erected	erected	B-NP	B-NP	-	32	NMOD	-	-
30	wing	wing	I-NP	I-NP	-	32	NMOD	-	-
31	gene	gene	I-NP	I-NP	-	32	NMOD	-	-
32	product	product	I-NP	I-NP	-	22	PMOD	-	-
33	(	(	O	O	-	34	P	-	-
34	EWG	EWG	B-NP	B-NP	-	32	NMOD	-	-
35	)	)	O	O	-	34	P	-	-
36	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	present	present	B-VP	B-VP	-	0	ROOT	-	-
3	evidence	evidence	B-NP	B-NP	-	2	OBJ	-	-
4	that	that	B-SBAR	B-SBAR	-	3	NMOD	-	-
5	IBR	IBR	B-NP	B-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	IBF	IBF	I-NP	I-NP	-	8	SUB	-	-
8	are	are	B-VP	B-VP	-	4	SBAR	-	-
9	most	most	B-NP	B-NP	-	12	NMOD	-	-
10	likely	likely	I-NP	I-NP	-	12	NMOD	-	-
11	identical	identical	I-NP	I-NP	-	12	NMOD	-	-
12	proteins	proteins	I-NP	I-NP	-	8	PRD	-	-
13	,	,	O	O	-	2	P	-	-
14	differing	differing	B-VP	B-VP	-	2	VMOD	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	their	their	B-NP	B-NP	-	17	NMOD	-	-
17	degree	degree	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	glycosylation	glycosylation	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	analyzed	analyzed	I-VP	I-VP	-	2	VC	-	-
4	several	several	B-NP	B-NP	-	6	NMOD	-	-
5	molecular	molecular	I-NP	I-NP	-	6	NMOD	-	-
6	aspects	aspects	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	IBR/F	IBR/F	B-NP	B-NP	-	7	PMOD	-	-
9	and	and	O	O	-	19	DEP	-	-
10	shown	shown	B-VP	B-VP	-	11	DEP	-	-
11	that	that	B-SBAR	B-SBAR	-	19	DEP	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	14	SUB	-	-
14	associates	associates	B-VP	B-VP	-	11	SBAR	-	-
15	as	as	B-PP	B-PP	-	14	VMOD	-	-
16	stable	stable	B-NP	B-NP	-	17	NMOD	-	-
17	homodimers	homodimers	I-NP	I-NP	-	15	PMOD	-	-
18	and	and	O	O	-	19	DEP	-	-
19	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	dimer	dimer	I-NP	I-NP	-	22	SUB	-	-
22	is	is	B-VP	B-VP	-	19	SBAR	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	relevant	relevant	I-NP	I-NP	-	26	NMOD	-	-
25	DNA-binding	DNA-binding	I-NP	I-NP	-	26	NMOD	-	-
26	species	species	I-NP	I-NP	-	22	PRD	-	-
27	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	evolutionarily	evolutionarily	I-NP	I-NP	-	3	AMOD	-	-
3	conserved	conserved	I-NP	I-NP	-	5	NMOD	-	-
4	N-terminal	N-terminal	I-NP	I-NP	-	5	NMOD	-	-
5	half	half	I-NP	I-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	IBR/F	IBR/F	B-NP	B-NP	-	6	PMOD	-	-
8	harbors	harbors	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	DNA-binding/dimerization	DNA-binding/dimerization	I-NP	I-NP	-	11	NMOD	-	-
11	domain	domain	I-NP	I-NP	-	27	NMOD	-	-
12	(	(	O	O	-	14	P	-	-
13	outer	outer	B-NP	B-NP	-	14	NMOD	-	-
14	limits	limits	I-NP	I-NP	-	11	NMOD	-	-
15	,	,	O	O	-	27	P	-	-
16	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
17	to	to	B-PP	B-PP	-	18	NMOD	-	-
18	<num>	<num>	B-NP	B-NP	-	27	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	,	,	O	O	-	27	P	-	-
21	one	one	B-NP	B-NP	-	27	NMOD	-	-
22	or	or	O	O	-	27	NMOD	-	-
23	several	several	B-NP	B-NP	-	27	NMOD	-	-
24	casein	casein	I-NP	I-NP	-	27	NMOD	-	-
25	kinase	kinase	I-NP	I-NP	-	27	NMOD	-	-
26	II	II	B-NP	B-NP	-	27	NMOD	-	-
27	sites	sites	I-NP	I-NP	-	39	NMOD	-	-
28	(	(	O	O	-	31	P	-	-
29	<num>	<num>	B-NP	B-NP	-	31	NMOD	-	-
30	to	to	O	O	-	31	NMOD	-	-
31	<num>	<num>	B-NP	B-NP	-	27	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	,	,	O	O	-	39	P	-	-
34	and	and	O	O	-	39	NMOD	-	-
35	a	a	B-NP	B-NP	-	39	NMOD	-	-
36	bipartite	bipartite	I-NP	I-NP	-	39	NMOD	-	-
37	nuclear	nuclear	I-NP	I-NP	-	39	NMOD	-	-
38	localization	localization	I-NP	I-NP	-	39	NMOD	-	-
39	signal	signal	I-NP	I-NP	-	8	OBJ	-	-
40	(	(	O	O	-	43	P	-	-
41	<num>	<num>	B-NP	B-NP	-	43	NMOD	-	-
42	to	to	O	O	-	43	NMOD	-	-
43	<num>	<num>	O	O	-	39	NMOD	-	-
44	)	)	O	O	-	43	P	-	-
45	which	which	B-NP	B-NP	-	39	NMOD	-	-
46	appears	appears	B-VP	B-VP	-	45	SBAR	-	-
47	to	to	I-VP	I-VP	-	48	VMOD	-	-
48	be	be	I-VP	I-VP	-	46	VMOD	-	-
49	necessary	necessary	B-ADJP	B-ADJP	-	48	PRD	-	-
50	for	for	B-PP	B-PP	-	49	AMOD	-	-
51	nuclear	nuclear	B-NP	B-NP	-	52	NMOD	-	-
52	targeting	targeting	I-NP	I-NP	-	50	PMOD	-	-
53	.	.	O	O	-	8	P	-	-

1	Binding	Binding	B-NP	B-NP	-	3	NMOD	-	-
2	site	site	I-NP	I-NP	-	3	NMOD	-	-
3	selection	selection	I-NP	I-NP	-	4	SUB	-	-
4	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	16	DEP	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	alternating	alternating	I-NP	I-NP	-	9	NMOD	-	-
8	RCGCRYGCGY	RCGCRYGCGY	I-NP	I-NP	-	9	NMOD	-	-
9	consensus	consensus	I-NP	I-NP	-	10	SUB	-	-
10	constitutes	constitutes	B-VP	B-VP	-	5	SBAR	-	-
11	high-affinity	high-affinity	B-NP	B-NP	-	14	NMOD	-	-
12	IBR/F	IBR/F	I-NP	I-NP	-	14	NMOD	-	-
13	binding	binding	I-NP	I-NP	-	14	NMOD	-	-
14	sites	sites	I-NP	I-NP	-	10	OBJ	-	-
15	and	and	O	O	-	16	DEP	-	-
16	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	direct-repeat	direct-repeat	I-NP	I-NP	-	20	NMOD	-	-
19	palindrome	palindrome	I-NP	I-NP	-	20	NMOD	-	-
20	TGCGCATGCGCA	TGCGCATGCGCA	I-NP	I-NP	-	21	SUB	-	-
21	is	is	B-VP	B-VP	-	16	SBAR	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	optimal	optimal	I-NP	I-NP	-	24	NMOD	-	-
24	site	site	I-NP	I-NP	-	21	PRD	-	-
25	.	.	O	O	-	4	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	survey	survey	I-NP	I-NP	-	13	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	genes	genes	B-NP	B-NP	-	3	PMOD	-	-
5	potentially	potentially	B-VP	B-VP	-	6	VMOD	-	-
6	regulated	regulated	I-VP	I-VP	-	4	NMOD	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	this	this	B-NP	B-NP	-	9	NMOD	-	-
9	family	family	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	factors	factors	B-NP	B-NP	-	10	PMOD	-	-
12	primarily	primarily	B-ADVP	B-ADVP	-	13	VMOD	-	-
13	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
14	genes	genes	B-NP	B-NP	-	13	OBJ	-	-
15	involved	involved	B-VP	B-VP	-	14	NMOD	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	growth-related	growth-related	B-NP	B-NP	-	18	NMOD	-	-
18	metabolism	metabolism	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	13	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-AT	NF-AT	B-NP	B-NP	-	6	NMOD	-	-
4	signal	signal	I-NP	I-NP	-	6	NMOD	-	-
5	transduction	transduction	I-NP	I-NP	-	6	NMOD	-	-
6	events	events	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	dominant-negative	dominant-negative	I-NP	I-NP	-	10	NMOD	-	-
10	form	form	I-NP	I-NP	-	7	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	calcineurin	calcineurin	B-NP	B-NP	-	11	PMOD	-	-
13	.	.	O	O	-	1	P	-	-

1	An	An	B-NP	B-NP	-	2	NMOD	-	-
2	inhibitory	inhibitory	I-NP	I-NP	-	17	VMOD	-	-
3	,	,	O	O	-	17	P	-	-
4	"	"	O	O	-	5	P	-	-
5	dominant-negative	dominant-negative	B-ADJP	B-ADJP	-	17	VMOD	-	-
6	,	,	O	O	-	17	P	-	-
7	"	"	O	O	-	8	P	-	-
8	form	form	B-NP	B-NP	-	17	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	16	NMOD	-	-
11	calcineurin	calcineurin	I-NP	I-NP	-	16	NMOD	-	-
12	catalytic	catalytic	I-NP	I-NP	-	16	NMOD	-	-
13	(	(	O	O	-	16	P	-	-
14	A	A	B-NP	B-NP	-	16	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	subunit	subunit	B-NP	B-NP	-	9	PMOD	-	-
17	was	was	B-VP	B-VP	-	0	ROOT	-	-
18	prepared	prepared	I-VP	I-VP	-	17	VC	-	-
19	,	,	O	O	-	17	P	-	-
20	which	which	B-NP	B-NP	-	17	VMOD	-	-
21	lacks	lacks	B-VP	B-VP	-	20	SBAR	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	calmodulin-binding	calmodulin-binding	I-NP	I-NP	-	24	NMOD	-	-
24	domain	domain	I-NP	I-NP	-	27	NMOD	-	-
25	,	,	O	O	-	27	P	-	-
26	autoinhibitory	autoinhibitory	B-NP	B-NP	-	27	NMOD	-	-
27	domain	domain	I-NP	I-NP	-	21	OBJ	-	-
28	and	and	O	O	-	21	VMOD	-	-
29	most	most	B-NP	B-NP	-	21	OBJ	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	its	its	B-NP	B-NP	-	33	NMOD	-	-
32	catalytic	catalytic	I-NP	I-NP	-	33	NMOD	-	-
33	core	core	I-NP	I-NP	-	30	PMOD	-	-
34	but	but	O	O	-	21	VMOD	-	-
35	possesses	possesses	B-VP	B-VP	-	21	VMOD	-	-
36	the	the	B-NP	B-NP	-	43	NMOD	-	-
37	regulatory	regulatory	I-NP	I-NP	-	43	NMOD	-	-
38	(	(	O	O	-	39	P	-	-
39	B	B	B-NP	B-NP	-	37	NMOD	-	-
40	)	)	O	O	-	39	P	-	-
41	subunit	subunit	B-NP	B-NP	-	43	NMOD	-	-
42	binding	binding	I-NP	I-NP	-	43	NMOD	-	-
43	domain	domain	I-NP	I-NP	-	35	OBJ	-	-
44	.	.	O	O	-	17	P	-	-

1	When	When	B-ADVP	B-ADVP	-	25	VMOD	-	-
2	tested	tested	B-VP	B-VP	-	1	SBAR	-	-
3	for	for	B-PP	B-PP	-	2	VMOD	-	-
4	its	its	B-NP	B-NP	-	5	NMOD	-	-
5	ability	ability	I-NP	I-NP	-	3	PMOD	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	block	block	I-VP	I-VP	-	5	NMOD	-	-
8	calcineurin-dependent	calcineurin-dependent	B-NP	B-NP	-	9	NMOD	-	-
9	signaling	signaling	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	7	VMOD	-	-
11	Jurkat	Jurkat	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	25	P	-	-
14	expression	expression	B-NP	B-NP	-	25	SUB	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	this	this	B-NP	B-NP	-	24	NMOD	-	-
17	"	"	I-NP	I-NP	-	24	P	-	-
18	B-subunit	B-subunit	I-NP	I-NP	-	24	NMOD	-	-
19	knock-out	knock-out	I-NP	I-NP	-	24	NMOD	-	-
20	"	"	O	O	-	24	P	-	-
21	(	(	O	O	-	24	P	-	-
22	BKO	BKO	B-NP	B-NP	-	24	NMOD	-	-
23	)	)	O	O	-	24	P	-	-
24	construct	construct	B-NP	B-NP	-	15	PMOD	-	-
25	suppressed	suppressed	B-VP	B-VP	-	0	ROOT	-	-
26	reporter	reporter	B-NP	B-NP	-	28	NMOD	-	-
27	gene	gene	I-NP	I-NP	-	28	NMOD	-	-
28	activity	activity	I-NP	I-NP	-	25	OBJ	-	-
29	driven	driven	B-VP	B-VP	-	28	NMOD	-	-
30	by	by	B-PP	B-PP	-	29	VMOD	-	-
31	NF-AT	NF-AT	B-NP	B-NP	-	30	PMOD	-	-
32	,	,	O	O	-	36	P	-	-
33	the	the	B-NP	B-NP	-	36	NMOD	-	-
34	pivotal	pivotal	I-NP	I-NP	-	36	NMOD	-	-
35	promoter	promoter	I-NP	I-NP	-	36	NMOD	-	-
36	element	element	I-NP	I-NP	-	30	PMOD	-	-
37	for	for	B-PP	B-PP	-	36	NMOD	-	-
38	interleukin	interleukin	B-NP	B-NP	-	43	NMOD	-	-
39	(	(	O	O	-	40	P	-	-
40	IL	IL	B-NP	B-NP	-	38	NMOD	-	-
41	)	)	O	O	-	40	P	-	-
42	-2	-2	B-NP	B-NP	-	43	NMOD	-	-
43	gene	gene	I-NP	I-NP	-	44	NMOD	-	-
44	induction	induction	I-NP	I-NP	-	37	PMOD	-	-
45	.	.	O	O	-	25	P	-	-

1	Immunoprecipitation	Immunoprecipitation	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	epitope-labeled	epitope-labeled	B-NP	B-NP	-	4	NMOD	-	-
4	BKO	BKO	I-NP	I-NP	-	2	PMOD	-	-
5	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
6	for	for	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	formation	formation	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	tight	tight	I-NP	I-NP	-	12	NMOD	-	-
12	complex	complex	I-NP	I-NP	-	9	PMOD	-	-
13	with	with	B-PP	B-PP	-	8	NMOD	-	-
14	endogenous	endogenous	B-NP	B-NP	-	16	NMOD	-	-
15	B	B	I-NP	I-NP	-	16	NMOD	-	-
16	subunit	subunit	I-NP	I-NP	-	13	PMOD	-	-
17	in	in	B-PP	B-PP	-	8	NMOD	-	-
18	Jurkat	Jurkat	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	consistent	consistent	B-ADJP	B-ADJP	-	19	NMOD	-	-
22	with	with	B-PP	B-PP	-	21	AMOD	-	-
23	an	an	B-NP	B-NP	-	25	NMOD	-	-
24	inhibitory	inhibitory	I-NP	I-NP	-	25	NMOD	-	-
25	mechanism	mechanism	I-NP	I-NP	-	22	PMOD	-	-
26	that	that	B-NP	B-NP	-	25	NMOD	-	-
27	involves	involves	B-VP	B-VP	-	26	SBAR	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	sequestration	sequestration	I-NP	I-NP	-	27	OBJ	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	B	B	I-NP	I-NP	-	33	NMOD	-	-
33	subunit	subunit	I-NP	I-NP	-	30	PMOD	-	-
34	.	.	O	O	-	5	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	12	VMOD	-	-
2	,	,	O	O	-	12	P	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	sharply	sharply	I-NP	I-NP	-	5	AMOD	-	-
5	reduced	reduced	I-NP	I-NP	-	7	NMOD	-	-
6	NF-AT	NF-AT	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	12	SUB	-	-
8	produced	produced	B-VP	B-VP	-	7	NMOD	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	co-transfecting	co-transfecting	B-VP	B-VP	-	9	PMOD	-	-
11	BKO	BKO	B-NP	B-NP	-	10	OBJ	-	-
12	could	could	B-VP	B-VP	-	0	ROOT	-	-
13	be	be	I-VP	I-VP	-	12	VC	-	-
14	"	"	O	O	-	13	PRD	-	-
15	rescued	rescued	B-ADJP	B-ADJP	-	13	VC	-	-
16	"	"	O	O	-	15	P	-	-
17	by	by	B-PP	B-PP	-	15	VMOD	-	-
18	overexpression	overexpression	B-NP	B-NP	-	17	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	transfected	transfected	B-NP	B-NP	-	22	NMOD	-	-
21	B	B	I-NP	I-NP	-	22	NMOD	-	-
22	subunit	subunit	I-NP	I-NP	-	19	PMOD	-	-
23	,	,	O	O	-	12	P	-	-
24	suggesting	suggesting	B-VP	B-VP	-	12	VMOD	-	-
25	that	that	B-SBAR	B-SBAR	-	24	VMOD	-	-
26	depletion	depletion	B-NP	B-NP	-	30	SUB	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	this	this	B-NP	B-NP	-	29	NMOD	-	-
29	subunit	subunit	I-NP	I-NP	-	27	PMOD	-	-
30	was	was	B-VP	B-VP	-	25	SBAR	-	-
31	responsible	responsible	B-ADJP	B-ADJP	-	30	PRD	-	-
32	for	for	B-PP	B-PP	-	31	AMOD	-	-
33	the	the	B-NP	B-NP	-	34	NMOD	-	-
34	inhibition	inhibition	I-NP	I-NP	-	32	PMOD	-	-
35	.	.	O	O	-	12	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	potential	potential	I-NP	I-NP	-	6	NMOD	-	-
6	utility	utility	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	agents	agents	B-NP	B-NP	-	7	PMOD	-	-
9	that	that	B-NP	B-NP	-	8	NMOD	-	-
10	disrupt	disrupt	B-VP	B-VP	-	9	SBAR	-	-
11	calcineurin-mediated	calcineurin-mediated	B-NP	B-NP	-	14	NMOD	-	-
12	signal	signal	I-NP	I-NP	-	14	NMOD	-	-
13	transduction	transduction	I-NP	I-NP	-	14	NMOD	-	-
14	pathways	pathways	I-NP	I-NP	-	10	OBJ	-	-
15	by	by	B-PP	B-PP	-	10	VMOD	-	-
16	blocking	blocking	B-VP	B-VP	-	15	PMOD	-	-
17	formation	formation	B-NP	B-NP	-	16	OBJ	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	catalytically	catalytically	I-NP	I-NP	-	21	AMOD	-	-
21	active	active	I-NP	I-NP	-	22	NMOD	-	-
22	dimer	dimer	I-NP	I-NP	-	18	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	calcineurin	calcineurin	B-NP	B-NP	-	25	NMOD	-	-
25	A	A	I-NP	I-NP	-	28	NMOD	-	-
26	and	and	I-NP	I-NP	-	28	NMOD	-	-
27	B	B	I-NP	I-NP	-	28	NMOD	-	-
28	subunits	subunits	I-NP	I-NP	-	23	PMOD	-	-
29	.	.	O	O	-	3	P	-	-

1	Modulation	Modulation	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	endogenous	endogenous	B-NP	B-NP	-	5	NMOD	-	-
4	IL-1	IL-1	I-NP	I-NP	-	5	NMOD	-	-
5	beta	beta	I-NP	I-NP	-	9	NMOD	-	-
6	and	and	I-NP	I-NP	-	9	NMOD	-	-
7	IL-1	IL-1	I-NP	I-NP	-	9	NMOD	-	-
8	receptor	receptor	I-NP	I-NP	-	9	NMOD	-	-
9	antagonist	antagonist	I-NP	I-NP	-	2	PMOD	-	-
10	results	results	B-VP	B-VP	-	0	ROOT	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	opposing	opposing	B-VP	B-VP	-	13	NMOD	-	-
13	effects	effects	B-NP	B-NP	-	11	PMOD	-	-
14	on	on	B-PP	B-PP	-	13	NMOD	-	-
15	HIV	HIV	B-NP	B-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
17	in	in	B-PP	B-PP	-	16	NMOD	-	-
18	chronically	chronically	B-NP	B-NP	-	19	AMOD	-	-
19	infected	infected	I-NP	I-NP	-	21	NMOD	-	-
20	monocytic	monocytic	I-NP	I-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	10	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	proportion	proportion	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	HIV-infected	HIV-infected	B-NP	B-NP	-	5	NMOD	-	-
5	individuals	individuals	I-NP	I-NP	-	3	PMOD	-	-
6	experience	experience	B-VP	B-VP	-	0	ROOT	-	-
7	episodes	episodes	B-NP	B-NP	-	6	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	localized	localized	B-NP	B-NP	-	11	AMOD	-	-
10	or	or	I-NP	I-NP	-	11	AMOD	-	-
11	systemic	systemic	I-NP	I-NP	-	13	NMOD	-	-
12	bacterial	bacterial	I-NP	I-NP	-	13	NMOD	-	-
13	infections	infections	I-NP	I-NP	-	8	PMOD	-	-
14	caused	caused	B-VP	B-VP	-	13	NMOD	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	Gram-negative	Gram-negative	B-NP	B-NP	-	17	NMOD	-	-
17	bacteria	bacteria	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	Many	Many	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	clinical	clinical	I-NP	I-NP	-	6	NMOD	-	-
5	side	side	I-NP	I-NP	-	6	NMOD	-	-
6	effects	effects	I-NP	I-NP	-	2	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	these	these	B-NP	B-NP	-	9	NMOD	-	-
9	infections	infections	I-NP	I-NP	-	7	PMOD	-	-
10	are	are	B-VP	B-VP	-	0	ROOT	-	-
11	associated	associated	I-VP	I-VP	-	10	VC	-	-
12	with	with	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	production	production	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	proinflammatory	proinflammatory	B-NP	B-NP	-	17	NMOD	-	-
17	cytokines	cytokines	I-NP	I-NP	-	15	PMOD	-	-
18	,	,	O	O	-	17	P	-	-
19	which	which	B-NP	B-NP	-	17	NMOD	-	-
20	are	are	B-VP	B-VP	-	19	SBAR	-	-
21	induced	induced	I-VP	I-VP	-	20	VC	-	-
22	primarily	primarily	B-ADVP	B-ADVP	-	21	VMOD	-	-
23	by	by	B-PP	B-PP	-	21	VMOD	-	-
24	LPS	LPS	B-NP	B-NP	-	27	NMOD	-	-
25	,	,	O	O	-	27	P	-	-
26	a	a	B-NP	B-NP	-	27	NMOD	-	-
27	constituent	constituent	I-NP	I-NP	-	23	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	32	NMOD	-	-
30	bacterial	bacterial	I-NP	I-NP	-	32	NMOD	-	-
31	cell	cell	I-NP	I-NP	-	32	NMOD	-	-
32	wall	wall	I-NP	I-NP	-	28	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	Gram-negative	Gram-negative	B-NP	B-NP	-	35	NMOD	-	-
35	bacteria	bacteria	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	present	present	I-NP	I-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	4	SUB	-	-
4	examines	examines	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	mechanisms	mechanisms	I-NP	I-NP	-	4	OBJ	-	-
7	involved	involved	B-VP	B-VP	-	6	NMOD	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	LPS-mediated	LPS-mediated	B-NP	B-NP	-	10	NMOD	-	-
10	induction	induction	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	HIV	HIV	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	PMOD	-	-
14	in	in	B-PP	B-PP	-	10	NMOD	-	-
15	U1	U1	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	21	P	-	-
18	a	a	B-NP	B-NP	-	21	NMOD	-	-
19	promonocytic	promonocytic	I-NP	I-NP	-	21	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	21	NMOD	-	-
21	line	line	I-NP	I-NP	-	14	PMOD	-	-
22	chronically	chronically	B-ADJP	B-ADJP	-	23	VMOD	-	-
23	infected	infected	I-ADJP	I-ADJP	-	21	NMOD	-	-
24	with	with	B-PP	B-PP	-	23	VMOD	-	-
25	HIV	HIV	B-NP	B-NP	-	24	PMOD	-	-
26	.	.	O	O	-	4	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	U1	U1	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	by	by	B-PP	B-PP	-	1	NMOD	-	-
6	LPS	LPS	B-NP	B-NP	-	5	PMOD	-	-
7	alone	alone	B-ADVP	B-ADVP	-	6	NMOD	-	-
8	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
9	minimal	minimal	B-NP	B-NP	-	10	NMOD	-	-
10	levels	levels	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	HIV	HIV	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	10	P	-	-
15	which	which	B-NP	B-NP	-	10	NMOD	-	-
16	was	was	B-VP	B-VP	-	15	SBAR	-	-
17	significantly	significantly	I-VP	I-VP	-	16	VMOD	-	-
18	enhanced	enhanced	I-VP	I-VP	-	16	VC	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	granulocyte-macrophage	granulocyte-macrophage	B-NP	B-NP	-	22	NMOD	-	-
21	colony-stimulating	colony-stimulating	I-NP	I-NP	-	22	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	19	PMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	GM-CSF	GM-CSF	B-NP	B-NP	-	22	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	.	.	O	O	-	8	P	-	-

1	Costimulation	Costimulation	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	U1	U1	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	with	with	B-PP	B-PP	-	1	NMOD	-	-
6	LPS	LPS	B-NP	B-NP	-	8	NMOD	-	-
7	plus	plus	O	O	-	8	NMOD	-	-
8	GM-CSF	GM-CSF	B-NP	B-NP	-	5	PMOD	-	-
9	resulted	resulted	B-VP	B-VP	-	49	VMOD	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	accumulation	accumulation	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	steady-state	steady-state	B-NP	B-NP	-	15	NMOD	-	-
15	levels	levels	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	HIV	HIV	B-NP	B-NP	-	18	NMOD	-	-
18	RNA	RNA	I-NP	I-NP	-	16	PMOD	-	-
19	;	;	O	O	-	9	P	-	-
20	however	however	B-ADVP	B-ADVP	-	9	VMOD	-	-
21	,	,	O	O	-	49	P	-	-
22	only	only	B-NP	B-NP	-	25	NMOD	-	-
23	a	a	I-NP	I-NP	-	25	NMOD	-	-
24	weak	weak	I-NP	I-NP	-	25	NMOD	-	-
25	induction	induction	I-NP	I-NP	-	49	SUB	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	HIV	HIV	B-NP	B-NP	-	31	NMOD	-	-
28	long	long	I-NP	I-NP	-	31	NMOD	-	-
29	terminal	terminal	I-NP	I-NP	-	31	NMOD	-	-
30	repeat-driven	repeat-driven	I-NP	I-NP	-	31	NMOD	-	-
31	transcription	transcription	I-NP	I-NP	-	26	PMOD	-	-
32	,	,	O	O	-	25	P	-	-
33	which	which	B-NP	B-NP	-	25	NMOD	-	-
34	was	was	B-VP	B-VP	-	33	SBAR	-	-
35	not	not	I-VP	I-VP	-	34	VMOD	-	-
36	associated	associated	I-VP	I-VP	-	34	VC	-	-
37	with	with	B-PP	B-PP	-	36	VMOD	-	-
38	the	the	B-NP	B-NP	-	39	NMOD	-	-
39	activation	activation	I-NP	I-NP	-	37	PMOD	-	-
40	of	of	B-PP	B-PP	-	39	NMOD	-	-
41	the	the	B-NP	B-NP	-	47	NMOD	-	-
42	cellular	cellular	I-NP	I-NP	-	44	NMOD	-	-
43	transcription	transcription	I-NP	I-NP	-	44	NMOD	-	-
44	factor	factor	I-NP	I-NP	-	47	NMOD	-	-
45	nuclear	nuclear	I-NP	I-NP	-	47	NMOD	-	-
46	factor-kappa	factor-kappa	I-NP	I-NP	-	47	NMOD	-	-
47	B	B	I-NP	I-NP	-	40	PMOD	-	-
48	,	,	O	O	-	25	P	-	-
49	was	was	B-VP	B-VP	-	0	ROOT	-	-
50	noted	noted	I-VP	I-VP	-	49	VC	-	-
51	.	.	O	O	-	49	P	-	-

1	Costimulation	Costimulation	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	cells	cells	B-NP	B-NP	-	2	PMOD	-	-
4	with	with	B-PP	B-PP	-	1	NMOD	-	-
5	LPS	LPS	B-NP	B-NP	-	7	NMOD	-	-
6	plus	plus	O	O	-	7	NMOD	-	-
7	GM-CSF	GM-CSF	B-NP	B-NP	-	4	PMOD	-	-
8	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	production	production	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	proinflammatory	proinflammatory	B-NP	B-NP	-	13	NMOD	-	-
13	cytokines	cytokines	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	24	P	-	-
15	IL-8	IL-8	B-NP	B-NP	-	24	NMOD	-	-
16	,	,	O	O	-	24	P	-	-
17	IL-1	IL-1	B-NP	B-NP	-	18	NMOD	-	-
18	beta	beta	I-NP	I-NP	-	20	NMOD	-	-
19	and	and	I-NP	I-NP	-	20	NMOD	-	-
20	IL-6	IL-6	I-NP	I-NP	-	24	NMOD	-	-
21	,	,	B-NP	B-NP	-	24	P	-	-
22	but	but	I-NP	I-NP	-	24	NMOD	-	-
23	not	not	I-NP	I-NP	-	22	DEP	-	-
24	TNF-alpha	TNF-alpha	B-NP	B-NP	-	11	PMOD	-	-
25	.	.	O	O	-	8	P	-	-

1	IL-1	IL-1	B-NP	B-NP	-	3	NMOD	-	-
2	receptor	receptor	I-NP	I-NP	-	3	NMOD	-	-
3	antagonist	antagonist	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	ra	ra	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
8	LPS	LPS	B-NP	B-NP	-	9	NMOD	-	-
9	enhancement	enhancement	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	HIV	HIV	B-NP	B-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	10	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	GM-CSF-stimulated	GM-CSF-stimulated	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	7	P	-	-
17	suggesting	suggesting	B-VP	B-VP	-	7	VMOD	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	endogenous	endogenous	B-NP	B-NP	-	20	NMOD	-	-
20	IL-1	IL-1	I-NP	I-NP	-	21	SUB	-	-
21	was	was	B-VP	B-VP	-	18	SBAR	-	-
22	involved	involved	I-VP	I-VP	-	21	VC	-	-
23	in	in	B-PP	B-PP	-	22	VMOD	-	-
24	LPS-mediated	LPS-mediated	B-NP	B-NP	-	26	NMOD	-	-
25	viral	viral	I-NP	I-NP	-	26	NMOD	-	-
26	production	production	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	regard	regard	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	7	P	-	-
5	anti-inflammatory	anti-inflammatory	B-NP	B-NP	-	6	NMOD	-	-
6	cytokines	cytokines	I-NP	I-NP	-	7	SUB	-	-
7	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
8	LPS	LPS	B-NP	B-NP	-	12	NMOD	-	-
9	plus	plus	O	O	-	12	NMOD	-	-
10	GM-CSF-stimulated	GM-CSF-stimulated	B-NP	B-NP	-	12	NMOD	-	-
11	HIV	HIV	I-NP	I-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	7	OBJ	-	-
13	,	,	O	O	-	18	P	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	this	this	B-NP	B-NP	-	16	NMOD	-	-
16	effect	effect	I-NP	I-NP	-	18	SUB	-	-
17	closely	closely	B-ADVP	B-ADVP	-	18	VMOD	-	-
18	correlated	correlated	B-VP	B-VP	-	7	VMOD	-	-
19	with	with	B-PP	B-PP	-	18	VMOD	-	-
20	inhibition	inhibition	B-NP	B-NP	-	19	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	IL-1	IL-1	B-NP	B-NP	-	24	NMOD	-	-
23	beta	beta	I-NP	I-NP	-	24	NMOD	-	-
24	release	release	I-NP	I-NP	-	21	PMOD	-	-
25	and	and	O	O	-	18	VMOD	-	-
26	,	,	O	O	-	7	P	-	-
27	in	in	B-PP	B-PP	-	7	VMOD	-	-
28	particular	particular	B-ADJP	B-ADJP	-	27	PMOD	-	-
29	,	,	O	O	-	27	P	-	-
30	with	with	B-PP	B-PP	-	27	PMOD	-	-
31	up-regulation	up-regulation	B-NP	B-NP	-	30	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	endogenous	endogenous	B-NP	B-NP	-	35	NMOD	-	-
34	IL-1ra	IL-1ra	I-NP	I-NP	-	35	NMOD	-	-
35	production	production	I-NP	I-NP	-	32	PMOD	-	-
36	.	.	O	O	-	7	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	21	VMOD	-	-
2	,	,	O	O	-	21	P	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	balance	balance	I-NP	I-NP	-	21	SUB	-	-
5	between	between	B-PP	B-PP	-	4	NMOD	-	-
6	an	an	B-NP	B-NP	-	10	NMOD	-	-
7	endogenously	endogenously	I-NP	I-NP	-	8	AMOD	-	-
8	produced	produced	I-NP	I-NP	-	10	NMOD	-	-
9	viral	viral	I-NP	I-NP	-	10	NMOD	-	-
10	inducer	inducer	I-NP	I-NP	-	17	NMOD	-	-
11	(	(	O	O	-	13	P	-	-
12	IL-1	IL-1	B-NP	B-NP	-	13	NMOD	-	-
13	beta	beta	I-NP	I-NP	-	10	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	and	and	O	O	-	17	NMOD	-	-
16	an	an	B-NP	B-NP	-	17	NMOD	-	-
17	inhibitor	inhibitor	I-NP	I-NP	-	5	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	IL-1ra	IL-1ra	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	may	may	B-VP	B-VP	-	0	ROOT	-	-
22	represent	represent	I-VP	I-VP	-	21	VC	-	-
23	an	an	B-NP	B-NP	-	25	NMOD	-	-
24	important	important	I-NP	I-NP	-	25	NMOD	-	-
25	pathway	pathway	I-NP	I-NP	-	22	OBJ	-	-
26	leading	leading	B-VP	B-VP	-	25	NMOD	-	-
27	to	to	B-PP	B-PP	-	26	VMOD	-	-
28	modulation	modulation	B-NP	B-NP	-	27	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	HIV	HIV	B-NP	B-NP	-	31	NMOD	-	-
31	expression	expression	I-NP	I-NP	-	29	PMOD	-	-
32	from	from	B-PP	B-PP	-	31	NMOD	-	-
33	monocytic	monocytic	B-NP	B-NP	-	34	NMOD	-	-
34	cells	cells	I-NP	I-NP	-	32	PMOD	-	-
35	.	.	O	O	-	21	P	-	-

1	Transcriptional	Transcriptional	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	interleukin-2	interleukin-2	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	3	PMOD	-	-
7	in	in	B-PP	B-PP	-	2	NMOD	-	-
8	normal	normal	B-NP	B-NP	-	13	NMOD	-	-
9	human	human	I-NP	I-NP	-	13	NMOD	-	-
10	peripheral	peripheral	I-NP	I-NP	-	13	NMOD	-	-
11	blood	blood	I-NP	I-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	Convergence	Convergence	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	costimulatory	costimulatory	B-NP	B-NP	-	6	NMOD	-	-
4	signals	signals	I-NP	I-NP	-	6	NMOD	-	-
5	and	and	I-NP	I-NP	-	6	NMOD	-	-
6	differences	differences	I-NP	I-NP	-	2	PMOD	-	-
7	from	from	B-PP	B-PP	-	6	NMOD	-	-
8	transformed	transformed	B-NP	B-NP	-	10	NMOD	-	-
9	T	T	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
11	.	.	O	O	-	1	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	study	study	I-VP	I-VP	-	12	VMOD	-	-
3	transcriptional	transcriptional	B-NP	B-NP	-	4	NMOD	-	-
4	regulation	regulation	I-NP	I-NP	-	2	OBJ	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	normal	normal	B-NP	B-NP	-	9	NMOD	-	-
7	human	human	I-NP	I-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
10	,	,	O	O	-	12	P	-	-
11	we	we	B-NP	B-NP	-	12	SUB	-	-
12	have	have	B-VP	B-VP	-	0	ROOT	-	-
13	optimized	optimized	I-VP	I-VP	-	12	VC	-	-
14	conditions	conditions	B-NP	B-NP	-	13	OBJ	-	-
15	for	for	B-PP	B-PP	-	14	NMOD	-	-
16	transient	transient	B-NP	B-NP	-	17	NMOD	-	-
17	transfection	transfection	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	12	P	-	-

1	Interleukin-2	Interleukin-2	B-NP	B-NP	-	7	NMOD	-	-
2	(	(	I-NP	I-NP	-	3	P	-	-
3	IL-2	IL-2	I-NP	I-NP	-	1	NMOD	-	-
4	)	)	I-NP	I-NP	-	3	P	-	-
5	promoter-reporter	promoter-reporter	I-NP	I-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	behavior	behavior	I-NP	I-NP	-	9	SUB	-	-
8	closely	closely	B-ADVP	B-ADVP	-	9	VMOD	-	-
9	parallels	parallels	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	endogenous	endogenous	I-NP	I-NP	-	12	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	9	OBJ	-	-
13	in	in	B-PP	B-PP	-	9	VMOD	-	-
14	response	response	I-PP	I-PP	-	13	PMOD	-	-
15	to	to	I-PP	I-PP	-	13	PMOD	-	-
16	T	T	B-NP	B-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	receptor	receptor	I-NP	I-NP	-	21	NMOD	-	-
19	and	and	O	O	-	21	NMOD	-	-
20	costimulatory	costimulatory	B-NP	B-NP	-	21	NMOD	-	-
21	signals	signals	I-NP	I-NP	-	13	PMOD	-	-
22	.	.	O	O	-	9	P	-	-

1	As	As	B-SBAR	B-SBAR	-	17	VMOD	-	-
2	assessed	assessed	B-VP	B-VP	-	1	SBAR	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	mutagenized	mutagenized	B-NP	B-NP	-	5	NMOD	-	-
5	promoters	promoters	I-NP	I-NP	-	3	PMOD	-	-
6	,	,	O	O	-	12	P	-	-
7	the	the	B-NP	B-NP	-	12	NMOD	-	-
8	most	most	I-NP	I-NP	-	9	AMOD	-	-
9	important	important	I-NP	I-NP	-	12	NMOD	-	-
10	IL-2	IL-2	I-NP	I-NP	-	12	NMOD	-	-
11	cis-regulatory	cis-regulatory	I-NP	I-NP	-	12	NMOD	-	-
12	elements	elements	I-NP	I-NP	-	3	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	normal	normal	B-NP	B-NP	-	16	NMOD	-	-
15	T	T	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
17	are	are	B-VP	B-VP	-	0	ROOT	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	proximal	proximal	I-NP	I-NP	-	21	NMOD	-	-
20	AP-1	AP-1	I-NP	I-NP	-	21	NMOD	-	-
21	site	site	I-NP	I-NP	-	26	NMOD	-	-
22	and	and	O	O	-	26	NMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	NF-	NF-	I-NP	I-NP	-	26	NMOD	-	-
25	kappaB	kappaB	I-NP	I-NP	-	26	NMOD	-	-
26	site	site	I-NP	I-NP	-	17	PRD	-	-
27	.	.	O	O	-	17	P	-	-

1	Both	Both	O	O	-	13	NMOD	-	-
2	primary	primary	B-NP	B-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	13	NMOD	-	-
4	,	,	O	O	-	3	P	-	-
5	with	with	B-PP	B-PP	-	3	NMOD	-	-
6	phytohemagglutinin	phytohemagglutinin	B-NP	B-NP	-	8	NMOD	-	-
7	or	or	I-NP	I-NP	-	8	NMOD	-	-
8	antibodies	antibodies	I-NP	I-NP	-	5	PMOD	-	-
9	to	to	B-PP	B-PP	-	8	NMOD	-	-
10	CD3	CD3	B-NP	B-NP	-	9	PMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	costimulation	costimulation	B-NP	B-NP	-	17	NMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	provided	provided	B-PP	B-PP	-	13	NMOD	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	pairs	pairs	B-NP	B-NP	-	33	NMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	CD2	CD2	B-NP	B-NP	-	20	NMOD	-	-
20	antibodies	antibodies	I-NP	I-NP	-	33	NMOD	-	-
21	or	or	O	O	-	25	NMOD	-	-
22	B7-positive	B7-positive	B-NP	B-NP	-	25	NMOD	-	-
23	(	(	O	O	-	25	P	-	-
24	B	B	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	33	NMOD	-	-
26	)	)	O	O	-	33	P	-	-
27	or	or	O	O	-	33	NMOD	-	-
28	B7-negative	B7-negative	O	O	-	33	NMOD	-	-
29	(	(	O	O	-	33	P	-	-
30	endothelial	endothelial	B-ADJP	B-ADJP	-	33	NMOD	-	-
31	)	)	O	O	-	30	P	-	-
32	accessory	accessory	B-NP	B-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	35	SUB	-	-
34	,	,	O	O	-	33	P	-	-
35	are	are	B-VP	B-VP	-	0	ROOT	-	-
36	mediated	mediated	I-VP	I-VP	-	35	VC	-	-
37	through	through	B-PP	B-PP	-	36	VMOD	-	-
38	the	the	B-NP	B-NP	-	40	NMOD	-	-
39	same	same	I-NP	I-NP	-	40	NMOD	-	-
40	cis-elements	cis-elements	I-NP	I-NP	-	37	PMOD	-	-
41	.	.	O	O	-	35	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	nuclear	nuclear	I-NP	I-NP	-	5	NMOD	-	-
5	factor	factor	I-NP	I-NP	-	11	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	activated	activated	B-NP	B-NP	-	10	NMOD	-	-
8	T	T	I-NP	I-NP	-	10	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	10	NMOD	-	-
10	sites	sites	I-NP	I-NP	-	6	PMOD	-	-
11	are	are	B-VP	B-VP	-	0	ROOT	-	-
12	much	much	B-ADJP	B-ADJP	-	11	VMOD	-	-
13	less	less	I-ADJP	I-ADJP	-	14	AMOD	-	-
14	important	important	I-ADJP	I-ADJP	-	12	AMOD	-	-
15	in	in	B-PP	B-PP	-	12	AMOD	-	-
16	normal	normal	B-NP	B-NP	-	18	NMOD	-	-
17	T	T	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
19	than	than	B-PP	B-PP	-	12	AMOD	-	-
20	in	in	B-PP	B-PP	-	19	PMOD	-	-
21	Jurkat	Jurkat	B-NP	B-NP	-	23	NMOD	-	-
22	T	T	I-NP	I-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	11	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	conclude	conclude	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	18	DEP	-	-
4	IL-2	IL-2	B-NP	B-NP	-	6	NMOD	-	-
5	transcriptional	transcriptional	I-NP	I-NP	-	6	NMOD	-	-
6	regulation	regulation	I-NP	I-NP	-	7	SUB	-	-
7	differs	differs	B-VP	B-VP	-	3	SBAR	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	tumor	tumor	B-NP	B-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	lines	lines	I-NP	I-NP	-	8	PMOD	-	-
12	compared	compared	B-PP	B-PP	-	7	VMOD	-	-
13	with	with	B-PP	B-PP	-	12	PMOD	-	-
14	normal	normal	B-NP	B-NP	-	16	NMOD	-	-
15	T	T	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
17	and	and	O	O	-	18	DEP	-	-
18	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
19	different	different	B-NP	B-NP	-	21	NMOD	-	-
20	costimulatory	costimulatory	I-NP	I-NP	-	21	NMOD	-	-
21	signals	signals	I-NP	I-NP	-	22	SUB	-	-
22	converge	converge	B-VP	B-VP	-	18	SBAR	-	-
23	on	on	B-PP	B-PP	-	22	VMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	same	same	I-NP	I-NP	-	26	NMOD	-	-
26	cis-elements	cis-elements	I-NP	I-NP	-	23	PMOD	-	-
27	in	in	B-PP	B-PP	-	22	VMOD	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	IL-2	IL-2	I-NP	I-NP	-	30	NMOD	-	-
30	promoter	promoter	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	2	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	hydrophobic	hydrophobic	I-NP	I-NP	-	3	NMOD	-	-
3	domain	domain	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	Ca2+-modulating	Ca2+-modulating	B-NP	B-NP	-	7	NMOD	-	-
6	cyclophilin	cyclophilin	I-NP	I-NP	-	7	NMOD	-	-
7	ligand	ligand	I-NP	I-NP	-	4	PMOD	-	-
8	modulates	modulates	B-VP	B-VP	-	0	ROOT	-	-
9	calcium	calcium	B-NP	B-NP	-	11	NMOD	-	-
10	influx	influx	I-NP	I-NP	-	11	NMOD	-	-
11	signaling	signaling	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	T	T	B-NP	B-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	8	P	-	-

1	Ca2+-modulating	Ca2+-modulating	B-NP	B-NP	-	3	NMOD	-	-
2	cyclophilin	cyclophilin	I-NP	I-NP	-	3	NMOD	-	-
3	ligand	ligand	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	CAML	CAML	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	originally	originally	I-VP	I-VP	-	7	VMOD	-	-
9	described	described	I-VP	I-VP	-	7	VC	-	-
10	as	as	B-PP	B-PP	-	9	VMOD	-	-
11	a	a	B-NP	B-NP	-	14	NMOD	-	-
12	cyclophilin	cyclophilin	I-NP	I-NP	-	14	NMOD	-	-
13	B-binding	B-binding	I-NP	I-NP	-	14	NMOD	-	-
14	protein	protein	I-NP	I-NP	-	10	PMOD	-	-
15	whose	whose	B-NP	B-NP	-	14	NMOD	-	-
16	overexpression	overexpression	I-NP	I-NP	-	15	NMOD	-	-
17	in	in	B-PP	B-PP	-	16	NMOD	-	-
18	T	T	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	causes	causes	B-VP	B-VP	-	15	SBAR	-	-
21	a	a	B-NP	B-NP	-	22	NMOD	-	-
22	rise	rise	I-NP	I-NP	-	20	OBJ	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	intracellular	intracellular	B-NP	B-NP	-	25	NMOD	-	-
25	calcium	calcium	I-NP	I-NP	-	23	PMOD	-	-
26	,	,	O	O	-	20	P	-	-
27	thus	thus	B-ADVP	B-ADVP	-	28	VMOD	-	-
28	activating	activating	B-VP	B-VP	-	15	NMOD	-	-
29	transcription	transcription	B-NP	B-NP	-	30	NMOD	-	-
30	factors	factors	I-NP	I-NP	-	28	OBJ	-	-
31	responsible	responsible	B-ADJP	B-ADJP	-	30	NMOD	-	-
32	for	for	B-PP	B-PP	-	31	AMOD	-	-
33	the	the	B-NP	B-NP	-	36	NMOD	-	-
34	early	early	I-NP	I-NP	-	36	NMOD	-	-
35	immune	immune	I-NP	I-NP	-	36	NMOD	-	-
36	response	response	I-NP	I-NP	-	32	PMOD	-	-
37	.	.	O	O	-	7	P	-	-

1	As	As	B-SBAR	B-SBAR	-	15	VMOD	-	-
2	reported	reported	B-VP	B-VP	-	1	SBAR	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	,	,	O	O	-	15	P	-	-
5	structure-function	structure-function	B-NP	B-NP	-	6	NMOD	-	-
6	analysis	analysis	I-NP	I-NP	-	15	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	CAML	CAML	I-NP	I-NP	-	10	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	7	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	Jurkat	Jurkat	B-NP	B-NP	-	14	NMOD	-	-
13	T	T	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
15	indicates	indicates	B-VP	B-VP	-	0	ROOT	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	two	two	B-NP	B-NP	-	24	SUB	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	CAML	CAML	B-NP	B-NP	-	20	NMOD	-	-
20	's	's	B-NP	B-NP	-	23	NMOD	-	-
21	putative	putative	I-NP	I-NP	-	23	NMOD	-	-
22	membrane-spanning	membrane-spanning	I-NP	I-NP	-	23	NMOD	-	-
23	domains	domains	I-NP	I-NP	-	18	PMOD	-	-
24	are	are	B-VP	B-VP	-	16	SBAR	-	-
25	necessary	necessary	B-ADJP	B-ADJP	-	27	AMOD	-	-
26	and	and	I-ADJP	I-ADJP	-	27	AMOD	-	-
27	sufficient	sufficient	I-ADJP	I-ADJP	-	24	PRD	-	-
28	for	for	B-PP	B-PP	-	27	AMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	modulation	modulation	I-NP	I-NP	-	28	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	intracellular	intracellular	B-NP	B-NP	-	33	NMOD	-	-
33	calcium	calcium	I-NP	I-NP	-	31	PMOD	-	-
34	.	.	O	O	-	15	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	7	NMOD	-	-
5	hydrophobic	hydrophobic	I-NP	I-NP	-	7	NMOD	-	-
6	C-terminal	C-terminal	I-NP	I-NP	-	7	NMOD	-	-
7	tail	tail	I-NP	I-NP	-	10	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	CAML	CAML	B-NP	B-NP	-	8	PMOD	-	-
10	forms	forms	B-VP	B-VP	-	3	SBAR	-	-
11	its	its	B-NP	B-NP	-	13	NMOD	-	-
12	effector	effector	I-NP	I-NP	-	13	NMOD	-	-
13	domain	domain	I-NP	I-NP	-	10	OBJ	-	-
14	,	,	O	O	-	10	P	-	-
15	thus	thus	B-ADVP	B-ADVP	-	16	VMOD	-	-
16	implicating	implicating	B-VP	B-VP	-	10	VMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	N-terminal	N-terminal	I-NP	I-NP	-	20	NMOD	-	-
19	hydrophilic	hydrophilic	I-NP	I-NP	-	20	NMOD	-	-
20	domain	domain	I-NP	I-NP	-	16	OBJ	-	-
21	in	in	B-PP	B-PP	-	16	VMOD	-	-
22	a	a	B-NP	B-NP	-	24	NMOD	-	-
23	regulatory	regulatory	I-NP	I-NP	-	24	NMOD	-	-
24	role	role	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	2	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	define	define	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	novel	novel	I-NP	I-NP	-	7	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	7	NMOD	-	-
7	motif	motif	I-NP	I-NP	-	3	OBJ	-	-
8	that	that	B-NP	B-NP	-	7	NMOD	-	-
9	functions	functions	B-VP	B-VP	-	8	SBAR	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	intracellular	intracellular	B-NP	B-NP	-	13	NMOD	-	-
12	calcium	calcium	I-NP	I-NP	-	13	NMOD	-	-
13	signaling	signaling	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	Interactions	Interactions	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	transcriptional	transcriptional	I-NP	I-NP	-	5	NMOD	-	-
5	activator	activator	I-NP	I-NP	-	2	PMOD	-	-
6	in	in	B-PP	B-PP	-	1	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	env	env	I-NP	I-NP	-	9	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	mouse	mouse	I-NP	I-NP	-	15	NMOD	-	-
13	mammary	mammary	I-NP	I-NP	-	15	NMOD	-	-
14	tumor	tumor	I-NP	I-NP	-	15	NMOD	-	-
15	virus	virus	I-NP	I-NP	-	10	PMOD	-	-
16	with	with	B-PP	B-PP	-	9	NMOD	-	-
17	activation-dependent	activation-dependent	B-NP	B-NP	-	22	NMOD	-	-
18	,	,	I-NP	I-NP	-	22	P	-	-
19	T	T	I-NP	I-NP	-	22	NMOD	-	-
20	cell-specific	cell-specific	I-NP	I-NP	-	19	AMOD	-	-
21	transacting	transacting	I-NP	I-NP	-	22	NMOD	-	-
22	factors	factors	I-NP	I-NP	-	16	PMOD	-	-
23	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	7	NMOD	-	-
2	mouse	mouse	I-NP	I-NP	-	7	NMOD	-	-
3	mammary	mammary	I-NP	I-NP	-	7	NMOD	-	-
4	tumor	tumor	I-NP	I-NP	-	7	NMOD	-	-
5	virus	virus	I-NP	I-NP	-	7	NMOD	-	-
6	env	env	I-NP	I-NP	-	7	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	SUB	-	-
8	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	transcriptional	transcriptional	I-NP	I-NP	-	11	NMOD	-	-
11	activator	activator	I-NP	I-NP	-	8	OBJ	-	-
12	(	(	O	O	-	13	P	-	-
13	META	META	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	that	that	B-NP	B-NP	-	11	NMOD	-	-
16	can	can	B-VP	B-VP	-	15	SBAR	-	-
17	control	control	I-VP	I-VP	-	16	VC	-	-
18	transcription	transcription	B-NP	B-NP	-	17	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	25	NMOD	-	-
21	adjacent	adjacent	I-NP	I-NP	-	25	NMOD	-	-
22	long	long	I-NP	I-NP	-	25	NMOD	-	-
23	terminal	terminal	I-NP	I-NP	-	25	NMOD	-	-
24	repeat	repeat	I-NP	I-NP	-	25	NMOD	-	-
25	region	region	I-NP	I-NP	-	19	PMOD	-	-
26	.	.	O	O	-	8	P	-	-

1	Transcriptional	Transcriptional	B-NP	B-NP	-	2	NMOD	-	-
2	control	control	I-NP	I-NP	-	5	SUB	-	-
3	by	by	B-PP	B-PP	-	2	NMOD	-	-
4	META	META	B-NP	B-NP	-	3	PMOD	-	-
5	parallels	parallels	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-NP	B-NP	-	5	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	several	several	B-NP	B-NP	-	10	NMOD	-	-
9	lymphokine	lymphokine	I-NP	I-NP	-	10	NMOD	-	-
10	genes	genes	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	5	P	-	-
12	being	being	B-VP	B-VP	-	5	VMOD	-	-
13	specific	specific	B-ADJP	B-ADJP	-	12	PRD	-	-
14	to	to	B-PP	B-PP	-	13	AMOD	-	-
15	T	T	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	16	P	-	-
18	dependent	dependent	B-ADJP	B-ADJP	-	13	AMOD	-	-
19	on	on	B-PP	B-PP	-	18	AMOD	-	-
20	their	their	B-NP	B-NP	-	21	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	5	P	-	-
23	and	and	O	O	-	5	VMOD	-	-
24	inhibited	inhibited	B-VP	B-VP	-	5	VMOD	-	-
25	by	by	B-PP	B-PP	-	24	VMOD	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	immunosuppressive	immunosuppressive	I-NP	I-NP	-	29	NMOD	-	-
28	drug	drug	I-NP	I-NP	-	29	NMOD	-	-
29	cyclosporine	cyclosporine	I-NP	I-NP	-	25	PMOD	-	-
30	(	(	O	O	-	31	P	-	-
31	CsA	CsA	B-NP	B-NP	-	29	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	.	.	O	O	-	5	P	-	-

1	DNase	DNase	B-NP	B-NP	-	3	NMOD	-	-
2	I	I	I-NP	I-NP	-	3	NMOD	-	-
3	footprinting	footprinting	I-NP	I-NP	-	4	SUB	-	-
4	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	nuclear	nuclear	B-NP	B-NP	-	7	NMOD	-	-
7	factors	factors	I-NP	I-NP	-	12	SUB	-	-
8	from	from	B-PP	B-PP	-	7	NMOD	-	-
9	activated	activated	B-NP	B-NP	-	11	NMOD	-	-
10	T	T	I-NP	I-NP	-	11	NMOD	-	-
11	lymphocytes	lymphocytes	I-NP	I-NP	-	8	PMOD	-	-
12	bound	bound	B-VP	B-VP	-	5	SBAR	-	-
13	a	a	B-NP	B-NP	-	15	NMOD	-	-
14	promoter-proximal	promoter-proximal	I-NP	I-NP	-	15	NMOD	-	-
15	site	site	I-NP	I-NP	-	25	NMOD	-	-
16	,	,	O	O	-	25	P	-	-
17	META	META	B-NP	B-NP	-	25	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	P	P	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	25	P	-	-
22	and	and	O	O	-	25	NMOD	-	-
23	a	a	B-NP	B-NP	-	25	NMOD	-	-
24	promoter-distal	promoter-distal	I-NP	I-NP	-	25	NMOD	-	-
25	site	site	I-NP	I-NP	-	12	OBJ	-	-
26	,	,	O	O	-	29	P	-	-
27	META	META	B-NP	B-NP	-	29	NMOD	-	-
28	(	(	O	O	-	29	P	-	-
29	D+	D+	B-NP	B-NP	-	25	NMOD	-	-
30	)	)	O	O	-	29	P	-	-
31	,	,	O	O	-	12	P	-	-
32	within	within	B-PP	B-PP	-	12	VMOD	-	-
33	the	the	B-NP	B-NP	-	37	NMOD	-	-
34	400-base	400-base	I-NP	I-NP	-	37	NMOD	-	-
35	pair	pair	I-NP	I-NP	-	37	NMOD	-	-
36	META	META	I-NP	I-NP	-	37	NMOD	-	-
37	region	region	I-NP	I-NP	-	32	PMOD	-	-
38	.	.	O	O	-	4	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	2	NMOD	-	-
2	factors	factors	I-NP	I-NP	-	12	SUB	-	-
3	from	from	B-PP	B-PP	-	2	NMOD	-	-
4	unstimulated	unstimulated	B-NP	B-NP	-	3	PMOD	-	-
5	,	,	B-PP	B-PP	-	12	P	-	-
6	but	but	I-PP	I-PP	-	12	VMOD	-	-
7	not	not	I-PP	I-PP	-	8	PMOD	-	-
8	from	from	B-PP	B-PP	-	12	VMOD	-	-
9	activated	activated	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	12	P	-	-
12	bound	bound	B-VP	B-VP	-	0	ROOT	-	-
13	a	a	B-NP	B-NP	-	14	NMOD	-	-
14	site	site	I-NP	I-NP	-	12	OBJ	-	-
15	,	,	O	O	-	18	P	-	-
16	META	META	B-NP	B-NP	-	18	NMOD	-	-
17	(	(	O	O	-	18	P	-	-
18	D-	D-	B-NP	B-NP	-	14	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	,	,	O	O	-	14	P	-	-
21	adjacent	adjacent	B-ADJP	B-ADJP	-	14	NMOD	-	-
22	to	to	B-PP	B-PP	-	21	AMOD	-	-
23	META	META	B-NP	B-NP	-	22	PMOD	-	-
24	(	(	O	O	-	25	P	-	-
25	D+	D+	B-NP	B-NP	-	23	NMOD	-	-
26	)	)	O	O	-	25	P	-	-
27	.	.	O	O	-	12	P	-	-

1	META	META	B-NP	B-NP	-	6	NMOD	-	-
2	(	(	O	O	-	3	P	-	-
3	D+	D+	B-NP	B-NP	-	1	NMOD	-	-
4	)	)	O	O	-	3	P	-	-
5	directed	directed	B-VP	B-VP	-	6	NMOD	-	-
6	transcription	transcription	B-NP	B-NP	-	17	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	linked	linked	I-NP	I-NP	-	11	NMOD	-	-
10	luciferase	luciferase	I-NP	I-NP	-	11	NMOD	-	-
11	gene	gene	I-NP	I-NP	-	7	PMOD	-	-
12	,	,	O	O	-	17	P	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	gel	gel	B-NP	B-NP	-	16	NMOD	-	-
15	shift	shift	I-NP	I-NP	-	16	NMOD	-	-
16	analysis	analysis	I-NP	I-NP	-	17	SUB	-	-
17	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
18	binding	binding	B-NP	B-NP	-	17	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	inducible	inducible	B-NP	B-NP	-	25	NMOD	-	-
21	,	,	I-NP	I-NP	-	25	P	-	-
22	CsA-sensitive	CsA-sensitive	I-NP	I-NP	-	25	NMOD	-	-
23	T	T	I-NP	I-NP	-	25	NMOD	-	-
24	cell	cell	I-NP	I-NP	-	25	NMOD	-	-
25	factors	factors	I-NP	I-NP	-	19	PMOD	-	-
26	,	,	O	O	-	17	P	-	-
27	in	in	B-PP	B-PP	-	17	VMOD	-	-
28	parallel	parallel	B-NP	B-NP	-	27	PMOD	-	-
29	with	with	B-PP	B-PP	-	28	NMOD	-	-
30	transfection	transfection	B-NP	B-NP	-	31	NMOD	-	-
31	results	results	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	17	P	-	-

1	Authentic	Authentic	B-NP	B-NP	-	5	NMOD	-	-
2	NFAT	NFAT	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	NF-kappaB	NF-kappaB	I-NP	I-NP	-	5	NMOD	-	-
5	targets	targets	I-NP	I-NP	-	6	SUB	-	-
6	did	did	B-VP	B-VP	-	0	ROOT	-	-
7	not	not	I-VP	I-VP	-	6	VMOD	-	-
8	compete	compete	I-VP	I-VP	-	6	VC	-	-
9	for	for	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	18	NMOD	-	-
11	META	META	I-NP	I-NP	-	13	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	D+	D+	B-NP	B-NP	-	18	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	binding	binding	B-NP	B-NP	-	18	NMOD	-	-
16	factor	factor	I-NP	I-NP	-	18	NMOD	-	-
17	(	(	I-NP	I-NP	-	18	P	-	-
18	s	s	I-NP	I-NP	-	9	PMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	SV40	SV40	I-NP	I-NP	-	4	NMOD	-	-
3	core	core	I-NP	I-NP	-	4	NMOD	-	-
4	sequence	sequence	I-NP	I-NP	-	5	SUB	-	-
5	competed	competed	B-VP	B-VP	-	0	ROOT	-	-
6	for	for	B-PP	B-PP	-	5	VMOD	-	-
7	META	META	B-NP	B-NP	-	12	NMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	D+	D+	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	12	P	-	-
11	binding	binding	B-NP	B-NP	-	12	NMOD	-	-
12	factors	factors	I-NP	I-NP	-	6	PMOD	-	-
13	,	,	O	O	-	19	P	-	-
14	but	but	O	O	-	19	VMOD	-	-
15	META	META	B-NP	B-NP	-	19	SUB	-	-
16	(	(	O	O	-	17	P	-	-
17	D+	D+	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	failed	failed	B-VP	B-VP	-	5	VMOD	-	-
20	to	to	I-VP	I-VP	-	21	VMOD	-	-
21	compete	compete	I-VP	I-VP	-	19	VMOD	-	-
22	for	for	B-PP	B-PP	-	21	VMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	complexes	complexes	I-NP	I-NP	-	22	PMOD	-	-
25	obtained	obtained	B-VP	B-VP	-	24	NMOD	-	-
26	with	with	B-PP	B-PP	-	25	VMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	SV40	SV40	I-NP	I-NP	-	29	NMOD	-	-
29	probe	probe	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	5	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	7	SUB	-	-
3	,	,	O	O	-	2	P	-	-
4	taken	taken	B-VP	B-VP	-	2	NMOD	-	-
5	together	together	B-ADVP	B-ADVP	-	4	VMOD	-	-
6	,	,	O	O	-	4	P	-	-
7	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	META	META	B-NP	B-NP	-	13	SUB	-	-
10	(	(	O	O	-	11	P	-	-
11	D+	D+	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	is	is	B-VP	B-VP	-	8	SBAR	-	-
14	a	a	B-NP	B-NP	-	18	NMOD	-	-
15	novel	novel	I-NP	I-NP	-	18	NMOD	-	-
16	transcriptional	transcriptional	I-NP	I-NP	-	18	NMOD	-	-
17	enhancer	enhancer	I-NP	I-NP	-	18	NMOD	-	-
18	element	element	I-NP	I-NP	-	13	PRD	-	-
19	that	that	B-NP	B-NP	-	18	NMOD	-	-
20	is	is	B-VP	B-VP	-	19	SBAR	-	-
21	similar	similar	B-ADJP	B-ADJP	-	20	PRD	-	-
22	in	in	B-PP	B-PP	-	21	AMOD	-	-
23	its	its	B-NP	B-NP	-	25	NMOD	-	-
24	cell-type	cell-type	I-NP	I-NP	-	25	NMOD	-	-
25	specificity	specificity	I-NP	I-NP	-	22	PMOD	-	-
26	,	,	O	O	-	32	P	-	-
27	activation	activation	B-NP	B-NP	-	28	NMOD	-	-
28	dependence	dependence	I-NP	I-NP	-	32	NMOD	-	-
29	,	,	O	O	-	32	P	-	-
30	and	and	O	O	-	32	NMOD	-	-
31	CsA	CsA	B-NP	B-NP	-	32	NMOD	-	-
32	sensitivity	sensitivity	I-NP	I-NP	-	22	PMOD	-	-
33	to	to	B-PP	B-PP	-	32	NMOD	-	-
34	the	the	B-NP	B-NP	-	36	NMOD	-	-
35	NFAT	NFAT	I-NP	I-NP	-	36	NMOD	-	-
36	element	element	I-NP	I-NP	-	33	PMOD	-	-
37	.	.	O	O	-	7	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	may	may	B-VP	B-VP	-	0	ROOT	-	-
3	be	be	I-VP	I-VP	-	2	VC	-	-
4	relevant	relevant	B-ADJP	B-ADJP	-	3	PRD	-	-
5	to	to	B-PP	B-PP	-	4	AMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	role	role	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	MMTV	MMTV	B-NP	B-NP	-	8	PMOD	-	-
10	in	in	B-PP	B-PP	-	7	NMOD	-	-
11	expression	expression	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	Mls	Mls	B-NP	B-NP	-	14	NMOD	-	-
14	antigens	antigens	I-NP	I-NP	-	12	PMOD	-	-
15	or	or	O	O	-	17	NMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	induction	induction	I-NP	I-NP	-	14	NMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	T	T	B-NP	B-NP	-	21	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	21	NMOD	-	-
21	lymphomas	lymphomas	I-NP	I-NP	-	18	PMOD	-	-
22	.	.	O	O	-	2	P	-	-

1	Monocytic	Monocytic	B-NP	B-NP	-	5	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	5	NMOD	-	-
3	type-specific	type-specific	I-NP	I-NP	-	2	AMOD	-	-
4	transcriptional	transcriptional	I-NP	I-NP	-	5	NMOD	-	-
5	induction	induction	I-NP	I-NP	-	0	ROOT	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	collagenase	collagenase	B-NP	B-NP	-	6	PMOD	-	-
8	.	.	O	O	-	5	P	-	-

1	Interstitial	Interstitial	B-NP	B-NP	-	2	NMOD	-	-
2	collagenase	collagenase	I-NP	I-NP	-	8	NMOD	-	-
3	(	(	O	O	-	4	P	-	-
4	MMP-1	MMP-1	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	,	,	O	O	-	8	P	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	metalloproteinase	metalloproteinase	I-NP	I-NP	-	20	SUB	-	-
9	produced	produced	B-VP	B-VP	-	8	NMOD	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	resident	resident	B-NP	B-NP	-	14	NMOD	-	-
12	and	and	I-NP	I-NP	-	14	NMOD	-	-
13	inflammatory	inflammatory	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
15	during	during	B-PP	B-PP	-	9	VMOD	-	-
16	connective	connective	B-NP	B-NP	-	18	NMOD	-	-
17	tissue	tissue	I-NP	I-NP	-	18	NMOD	-	-
18	turnover	turnover	I-NP	I-NP	-	15	PMOD	-	-
19	,	,	O	O	-	8	P	-	-
20	cleaves	cleaves	B-VP	B-VP	-	0	ROOT	-	-
21	type	type	B-NP	B-NP	-	24	NMOD	-	-
22	I	I	I-NP	I-NP	-	24	NMOD	-	-
23	collagen	collagen	I-NP	I-NP	-	24	NMOD	-	-
24	fibrils	fibrils	I-NP	I-NP	-	20	OBJ	-	-
25	.	.	O	O	-	20	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	catalytic	catalytic	I-NP	I-NP	-	3	NMOD	-	-
3	event	event	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	rate	rate	B-NP	B-NP	-	4	PRD	-	-
6	limiting	limiting	B-VP	B-VP	-	5	NMOD	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	remodeling	remodeling	B-NP	B-NP	-	7	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	tissues	tissues	B-NP	B-NP	-	9	PMOD	-	-
11	rich	rich	B-ADJP	B-ADJP	-	10	NMOD	-	-
12	in	in	B-PP	B-PP	-	11	AMOD	-	-
13	fibrillar	fibrillar	B-NP	B-NP	-	14	NMOD	-	-
14	collagen	collagen	I-NP	I-NP	-	12	PMOD	-	-
15	such	such	B-PP	B-PP	-	16	PMOD	-	-
16	as	as	I-PP	I-PP	-	10	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	skin	skin	I-NP	I-NP	-	20	NMOD	-	-
19	and	and	I-NP	I-NP	-	20	NMOD	-	-
20	lungs	lungs	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	collagenase	collagenase	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
6	is	is	B-VP	B-VP	-	21	VMOD	-	-
7	cell-type	cell-type	B-ADJP	B-ADJP	-	8	AMOD	-	-
8	specific	specific	B-ADJP	B-ADJP	-	6	PRD	-	-
9	;	;	O	O	-	21	P	-	-
10	bacterial	bacterial	B-NP	B-NP	-	11	NMOD	-	-
11	LPS	LPS	I-NP	I-NP	-	13	NMOD	-	-
12	and	and	I-NP	I-NP	-	13	NMOD	-	-
13	zymosan	zymosan	I-NP	I-NP	-	21	SUB	-	-
14	,	,	O	O	-	21	P	-	-
15	a	a	B-NP	B-NP	-	19	NMOD	-	-
16	yeast	yeast	I-NP	I-NP	-	19	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
18	wall	wall	I-NP	I-NP	-	19	NMOD	-	-
19	derivative	derivative	I-NP	I-NP	-	21	SUB	-	-
20	,	,	O	O	-	19	P	-	-
21	are	are	B-VP	B-VP	-	0	ROOT	-	-
22	potent	potent	B-NP	B-NP	-	23	NMOD	-	-
23	inducers	inducers	I-NP	I-NP	-	21	PRD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	collagenase	collagenase	B-NP	B-NP	-	26	NMOD	-	-
26	expression	expression	I-NP	I-NP	-	24	PMOD	-	-
27	in	in	B-PP	B-PP	-	26	NMOD	-	-
28	macrophages	macrophages	B-NP	B-NP	-	27	PMOD	-	-
29	,	,	O	O	-	21	P	-	-
30	but	but	O	O	-	21	VMOD	-	-
31	do	do	B-VP	B-VP	-	21	VMOD	-	-
32	not	not	I-VP	I-VP	-	31	VMOD	-	-
33	alter	alter	I-VP	I-VP	-	31	VC	-	-
34	fibroblast	fibroblast	B-NP	B-NP	-	36	NMOD	-	-
35	collagenase	collagenase	I-NP	I-NP	-	36	NMOD	-	-
36	expression	expression	I-NP	I-NP	-	33	OBJ	-	-
37	.	.	O	O	-	21	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	17	VMOD	-	-
2	promoter	promoter	B-NP	B-NP	-	3	NMOD	-	-
3	elements	elements	I-NP	I-NP	-	10	SUB	-	-
4	controlling	controlling	B-VP	B-VP	-	3	NMOD	-	-
5	collagenase	collagenase	B-NP	B-NP	-	6	NMOD	-	-
6	transcription	transcription	I-NP	I-NP	-	4	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	monocytic	monocytic	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	have	have	B-VP	B-VP	-	1	SBAR	-	-
11	not	not	I-VP	I-VP	-	10	VMOD	-	-
12	been	been	I-VP	I-VP	-	10	VC	-	-
13	previously	previously	I-VP	I-VP	-	12	VMOD	-	-
14	defined	defined	I-VP	I-VP	-	12	VC	-	-
15	,	,	O	O	-	17	P	-	-
16	we	we	B-NP	B-NP	-	17	SUB	-	-
17	sought	sought	B-VP	B-VP	-	0	ROOT	-	-
18	to	to	I-VP	I-VP	-	19	VMOD	-	-
19	delineate	delineate	I-VP	I-VP	-	17	VMOD	-	-
20	responsive	responsive	B-NP	B-NP	-	22	NMOD	-	-
21	cis-acting	cis-acting	I-NP	I-NP	-	22	NMOD	-	-
22	elements	elements	I-NP	I-NP	-	19	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	collagenase	collagenase	I-NP	I-NP	-	26	NMOD	-	-
26	promoter	promoter	I-NP	I-NP	-	23	PMOD	-	-
27	in	in	B-PP	B-PP	-	22	NMOD	-	-
28	transiently	transiently	B-NP	B-NP	-	29	AMOD	-	-
29	transfected	transfected	I-NP	I-NP	-	35	AMOD	-	-
30	human	human	I-NP	I-NP	-	35	AMOD	-	-
31	(	(	O	O	-	32	P	-	-
32	U937	U937	B-NP	B-NP	-	30	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	and	and	O	O	-	35	AMOD	-	-
35	murine	murine	B-NP	B-NP	-	41	NMOD	-	-
36	(	(	O	O	-	41	P	-	-
37	J774	J774	B-NP	B-NP	-	41	NMOD	-	-
38	)	)	I-NP	I-NP	-	37	P	-	-
39	monocytic	monocytic	I-NP	I-NP	-	41	NMOD	-	-
40	cell	cell	I-NP	I-NP	-	41	NMOD	-	-
41	lines	lines	I-NP	I-NP	-	27	PMOD	-	-
42	.	.	O	O	-	17	P	-	-

1	Deletion	Deletion	B-NP	B-NP	-	2	NMOD	-	-
2	constructs	constructs	I-NP	I-NP	-	18	SUB	-	-
3	containing	containing	B-VP	B-VP	-	2	NMOD	-	-
4	as	as	B-NP	B-NP	-	5	AMOD	-	-
5	little	little	I-NP	I-NP	-	8	NMOD	-	-
6	as	as	I-NP	I-NP	-	8	NMOD	-	-
7	<num>	<num>	I-NP	I-NP	-	8	NMOD	-	-
8	bp	bp	I-NP	I-NP	-	3	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
11	'	'	I-NP	I-NP	-	13	NMOD	-	-
12	-flanking	-flanking	I-NP	I-NP	-	13	NMOD	-	-
13	sequence	sequence	I-NP	I-NP	-	9	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	collagenase	collagenase	I-NP	I-NP	-	17	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	14	PMOD	-	-
18	were	were	B-VP	B-VP	-	27	VMOD	-	-
19	sufficient	sufficient	B-ADJP	B-ADJP	-	18	PRD	-	-
20	for	for	B-PP	B-PP	-	19	AMOD	-	-
21	LPS-	LPS-	B-NP	B-NP	-	25	NMOD	-	-
22	or	or	O	O	-	25	NMOD	-	-
23	zymosan-mediated	zymosan-mediated	B-NP	B-NP	-	25	NMOD	-	-
24	transcriptional	transcriptional	I-NP	I-NP	-	25	NMOD	-	-
25	induction	induction	I-NP	I-NP	-	20	PMOD	-	-
26	,	,	O	O	-	27	P	-	-
27	whereas	whereas	O	O	-	0	ROOT	-	-
28	phorbol	phorbol	B-NP	B-NP	-	29	NMOD	-	-
29	inducibility	inducibility	I-NP	I-NP	-	30	SUB	-	-
30	exhibited	exhibited	B-VP	B-VP	-	27	VMOD	-	-
31	an	an	B-NP	B-NP	-	33	NMOD	-	-
32	absolute	absolute	I-NP	I-NP	-	33	NMOD	-	-
33	requirement	requirement	I-NP	I-NP	-	30	OBJ	-	-
34	for	for	B-PP	B-PP	-	33	NMOD	-	-
35	upstream	upstream	B-NP	B-NP	-	36	NMOD	-	-
36	elements	elements	I-NP	I-NP	-	34	PMOD	-	-
37	including	including	B-PP	B-PP	-	36	NMOD	-	-
38	the	the	B-NP	B-NP	-	43	NMOD	-	-
39	polyoma	polyoma	I-NP	I-NP	-	43	NMOD	-	-
40	enhancer	enhancer	I-NP	I-NP	-	43	NMOD	-	-
41	A-binding	A-binding	I-NP	I-NP	-	43	NMOD	-	-
42	protein-3	protein-3	I-NP	I-NP	-	43	NMOD	-	-
43	site	site	I-NP	I-NP	-	51	NMOD	-	-
44	(	(	O	O	-	47	P	-	-
45	-83	-83	B-NP	B-NP	-	47	NMOD	-	-
46	to	to	O	O	-	47	NMOD	-	-
47	-91	-91	B-NP	B-NP	-	43	NMOD	-	-
48	)	)	O	O	-	47	P	-	-
49	and	and	O	O	-	51	NMOD	-	-
50	TTCA	TTCA	B-NP	B-NP	-	51	NMOD	-	-
51	sequence	sequence	I-NP	I-NP	-	37	PMOD	-	-
52	(	(	O	O	-	55	P	-	-
53	-102	-102	B-NP	B-NP	-	55	NMOD	-	-
54	to	to	O	O	-	55	NMOD	-	-
55	-105	-105	B-NP	B-NP	-	51	NMOD	-	-
56	)	)	O	O	-	55	P	-	-
57	in	in	B-PP	B-PP	-	51	NMOD	-	-
58	both	both	B-NP	B-NP	-	62	NMOD	-	-
59	monocytic	monocytic	I-NP	I-NP	-	60	NMOD	-	-
60	cells	cells	I-NP	I-NP	-	62	NMOD	-	-
61	and	and	I-NP	I-NP	-	62	NMOD	-	-
62	fibroblasts	fibroblasts	I-NP	I-NP	-	57	PMOD	-	-
63	.	.	O	O	-	27	P	-	-

1	Mutagenesis	Mutagenesis	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	9	NMOD	-	-
4	activator	activator	I-NP	I-NP	-	9	NMOD	-	-
5	protein-1	protein-1	I-NP	I-NP	-	9	NMOD	-	-
6	[	[	O	O	-	7	P	-	-
7	AP-1	AP-1	B-NP	B-NP	-	5	NMOD	-	-
8	]	]	O	O	-	9	P	-	-
9	site	site	B-NP	B-NP	-	2	PMOD	-	-
10	at	at	B-PP	B-PP	-	1	NMOD	-	-
11	-72	-72	B-NP	B-NP	-	10	PMOD	-	-
12	abolished	abolished	B-VP	B-VP	-	0	ROOT	-	-
13	basal	basal	B-NP	B-NP	-	15	NMOD	-	-
14	promoter	promoter	I-NP	I-NP	-	15	NMOD	-	-
15	activity	activity	I-NP	I-NP	-	18	NMOD	-	-
16	and	and	O	O	-	18	NMOD	-	-
17	LPS/zymosan	LPS/zymosan	B-NP	B-NP	-	18	NMOD	-	-
18	inducibility	inducibility	I-NP	I-NP	-	12	OBJ	-	-
19	,	,	O	O	-	12	P	-	-
20	while	while	B-SBAR	B-SBAR	-	12	VMOD	-	-
21	mutagenesis	mutagenesis	B-NP	B-NP	-	30	SUB	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	an	an	B-NP	B-NP	-	25	NMOD	-	-
24	NF-kappaB-like	NF-kappaB-like	I-NP	I-NP	-	25	NMOD	-	-
25	site	site	I-NP	I-NP	-	22	PMOD	-	-
26	at	at	B-PP	B-PP	-	21	NMOD	-	-
27	-20	-20	B-NP	B-NP	-	29	NMOD	-	-
28	to	to	B-PP	B-PP	-	29	NMOD	-	-
29	-10	-10	B-NP	B-NP	-	26	PMOD	-	-
30	had	had	B-VP	B-VP	-	20	SBAR	-	-
31	no	no	B-NP	B-NP	-	32	NMOD	-	-
32	effect	effect	I-NP	I-NP	-	30	OBJ	-	-
33	.	.	O	O	-	12	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	2	NMOD	-	-
2	extracts	extracts	I-NP	I-NP	-	8	SUB	-	-
3	from	from	B-PP	B-PP	-	2	NMOD	-	-
4	LPS-	LPS-	B-NP	B-NP	-	7	NMOD	-	-
5	and	and	O	O	-	7	NMOD	-	-
6	zymosan-treated	zymosan-treated	B-NP	B-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
8	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
9	strong	strong	B-NP	B-NP	-	11	NMOD	-	-
10	AP-1	AP-1	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	8	OBJ	-	-
12	by	by	B-PP	B-PP	-	11	NMOD	-	-
13	gel-shift	gel-shift	B-NP	B-NP	-	14	NMOD	-	-
14	analysis	analysis	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	19	P	-	-
16	and	and	O	O	-	19	VMOD	-	-
17	supershift	supershift	B-NP	B-NP	-	18	NMOD	-	-
18	analysis	analysis	I-NP	I-NP	-	19	SUB	-	-
19	showed	showed	B-VP	B-VP	-	12	SBAR	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	AP-1	AP-1	I-NP	I-NP	-	22	NMOD	-	-
22	complexes	complexes	I-NP	I-NP	-	19	OBJ	-	-
23	contained	contained	B-VP	B-VP	-	19	VMOD	-	-
24	specific	specific	B-NP	B-NP	-	25	NMOD	-	-
25	members	members	I-NP	I-NP	-	23	OBJ	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	both	both	O	O	-	33	NMOD	-	-
28	the	the	O	O	-	33	NMOD	-	-
29	jun	jun	B-NP	B-NP	-	33	NMOD	-	-
30	and	and	I-NP	I-NP	-	33	NMOD	-	-
31	fos	fos	I-NP	I-NP	-	33	NMOD	-	-
32	gene	gene	I-NP	I-NP	-	33	NMOD	-	-
33	families	families	I-NP	I-NP	-	26	PMOD	-	-
34	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	,	,	O	O	-	4	P	-	-
6	in	in	B-PP	B-PP	-	20	VMOD	-	-
7	contrast	contrast	B-NP	B-NP	-	6	PMOD	-	-
8	to	to	B-PP	B-PP	-	6	PMOD	-	-
9	most	most	B-NP	B-NP	-	11	NMOD	-	-
10	LPS	LPS	I-NP	I-NP	-	11	NMOD	-	-
11	effects	effects	I-NP	I-NP	-	8	PMOD	-	-
12	,	,	O	O	-	20	P	-	-
13	AP-1	AP-1	B-NP	B-NP	-	18	NMOD	-	-
14	,	,	O	O	-	18	P	-	-
15	but	but	O	O	-	18	NMOD	-	-
16	not	not	O	O	-	15	DEP	-	-
17	nuclear	nuclear	B-NP	B-NP	-	18	NMOD	-	-
18	factor-kappaB	factor-kappaB	I-NP	I-NP	-	20	SUB	-	-
19	,	,	O	O	-	18	P	-	-
20	mediates	mediates	B-VP	B-VP	-	4	SBAR	-	-
21	LPS	LPS	B-NP	B-NP	-	22	NMOD	-	-
22	induction	induction	I-NP	I-NP	-	20	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	collagenase	collagenase	B-NP	B-NP	-	25	NMOD	-	-
25	transcription	transcription	I-NP	I-NP	-	23	PMOD	-	-
26	in	in	B-PP	B-PP	-	22	NMOD	-	-
27	macrophagelike	macrophagelike	B-NP	B-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	3	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	24	VMOD	-	-
2	,	,	O	O	-	24	P	-	-
3	as	as	B-SBAR	B-SBAR	-	24	VMOD	-	-
4	compared	compared	B-VP	B-VP	-	3	SBAR	-	-
5	to	to	B-PP	B-PP	-	4	VMOD	-	-
6	regulation	regulation	B-NP	B-NP	-	5	PMOD	-	-
7	by	by	B-PP	B-PP	-	6	NMOD	-	-
8	phorbol	phorbol	B-NP	B-NP	-	9	NMOD	-	-
9	ester	ester	I-NP	I-NP	-	12	NMOD	-	-
10	,	,	O	O	-	12	P	-	-
11	collagenase	collagenase	B-NP	B-NP	-	12	NMOD	-	-
12	induction	induction	I-NP	I-NP	-	7	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	monocytic	monocytic	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	by	by	B-PP	B-PP	-	12	NMOD	-	-
17	cell	cell	B-NP	B-NP	-	19	NMOD	-	-
18	wall	wall	I-NP	I-NP	-	19	NMOD	-	-
19	derivatives	derivatives	I-NP	I-NP	-	16	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	bacteria	bacteria	B-NP	B-NP	-	23	NMOD	-	-
22	or	or	I-NP	I-NP	-	23	NMOD	-	-
23	yeast	yeast	I-NP	I-NP	-	20	PMOD	-	-
24	is	is	B-VP	B-VP	-	0	ROOT	-	-
25	largely	largely	B-ADJP	B-ADJP	-	26	AMOD	-	-
26	independent	independent	I-ADJP	I-ADJP	-	24	PRD	-	-
27	of	of	B-PP	B-PP	-	26	AMOD	-	-
28	upstream	upstream	B-NP	B-NP	-	30	NMOD	-	-
29	promoter	promoter	I-NP	I-NP	-	30	NMOD	-	-
30	sequences	sequences	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	24	P	-	-

1	Inhibitory	Inhibitory	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	E3330	E3330	B-NP	B-NP	-	9	NMOD	-	-
5	,	,	O	O	-	9	P	-	-
6	a	a	B-NP	B-NP	-	9	NMOD	-	-
7	novel	novel	I-NP	I-NP	-	9	NMOD	-	-
8	quinone	quinone	I-NP	I-NP	-	9	NMOD	-	-
9	derivative	derivative	I-NP	I-NP	-	3	PMOD	-	-
10	able	able	B-ADJP	B-ADJP	-	9	NMOD	-	-
11	to	to	B-VP	B-VP	-	12	VMOD	-	-
12	suppress	suppress	I-VP	I-VP	-	10	AMOD	-	-
13	tumor	tumor	B-NP	B-NP	-	15	NMOD	-	-
14	necrosis	necrosis	I-NP	I-NP	-	15	NMOD	-	-
15	factor-alpha	factor-alpha	I-NP	I-NP	-	16	NMOD	-	-
16	generation	generation	I-NP	I-NP	-	12	OBJ	-	-
17	,	,	O	O	-	2	P	-	-
18	on	on	B-PP	B-PP	-	2	NMOD	-	-
19	activation	activation	B-NP	B-NP	-	18	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	nuclear	nuclear	B-NP	B-NP	-	23	NMOD	-	-
22	factor-kappa	factor-kappa	I-NP	I-NP	-	23	NMOD	-	-
23	B	B	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	2	P	-	-

1	(	(	O	O	-	12	P	-	-
2	2E	2E	B-NP	B-NP	-	4	NMOD	-	-
3	)	)	O	O	-	2	P	-	-
4	-3-	-3-	B-NP	B-NP	-	12	NMOD	-	-
5	[	[	O	O	-	12	P	-	-
6	5-	5-	B-NP	B-NP	-	12	NMOD	-	-
7	(	(	O	O	-	12	P	-	-
8	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
9	,	,	O	O	-	12	P	-	-
10	3-Dimethoxy-6-methyl-1	3-Dimethoxy-6-methyl-1	B-NP	B-NP	-	12	NMOD	-	-
11	,	,	O	O	-	12	P	-	-
12	4-benzoquinoyl	4-benzoquinoyl	B-NP	B-NP	-	22	SUB	-	-
13	)	)	O	O	-	12	P	-	-
14	]	]	O	O	-	17	NMOD	-	-
15	-2-nonyl-2-	-2-nonyl-2-	B-NP	B-NP	-	17	NMOD	-	-
16	propenoic	propenoic	I-NP	I-NP	-	17	NMOD	-	-
17	acid	acid	I-NP	I-NP	-	22	SUB	-	-
18	(	(	O	O	-	19	P	-	-
19	E3330	E3330	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	17	P	-	-
22	is	is	B-VP	B-VP	-	0	ROOT	-	-
23	a	a	B-NP	B-NP	-	25	NMOD	-	-
24	novel	novel	I-NP	I-NP	-	25	NMOD	-	-
25	agent	agent	I-NP	I-NP	-	22	PRD	-	-
26	with	with	B-PP	B-PP	-	25	NMOD	-	-
27	hepatoprotective	hepatoprotective	B-NP	B-NP	-	28	NMOD	-	-
28	activity	activity	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	22	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	report	report	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	effect	effect	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	E3330	E3330	B-NP	B-NP	-	5	PMOD	-	-
7	on	on	B-PP	B-PP	-	4	NMOD	-	-
8	transcriptional	transcriptional	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	tumor	tumor	B-NP	B-NP	-	18	NMOD	-	-
12	necrosis	necrosis	I-NP	I-NP	-	18	NMOD	-	-
13	factor	factor	I-NP	I-NP	-	18	NMOD	-	-
14	(	(	O	O	-	18	P	-	-
15	TNF	TNF	B-NP	B-NP	-	18	NMOD	-	-
16	)	)	O	O	-	18	P	-	-
17	-alpha	-alpha	B-NP	B-NP	-	18	NMOD	-	-
18	gene	gene	I-NP	I-NP	-	10	PMOD	-	-
19	and	and	B-PP	B-PP	-	7	PMOD	-	-
20	on	on	B-PP	B-PP	-	7	PMOD	-	-
21	nuclear	nuclear	B-NP	B-NP	-	27	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	27	NMOD	-	-
23	(	(	O	O	-	27	P	-	-
24	NF	NF	B-NP	B-NP	-	27	NMOD	-	-
25	)	)	O	O	-	27	P	-	-
26	-kappa	-kappa	B-NP	B-NP	-	27	NMOD	-	-
27	B	B	I-NP	I-NP	-	28	NMOD	-	-
28	activation	activation	I-NP	I-NP	-	20	PMOD	-	-
29	.	.	O	O	-	2	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	3	NMOD	-	-
2	run-on	run-on	I-NP	I-NP	-	3	NMOD	-	-
3	experiments	experiments	I-NP	I-NP	-	4	SUB	-	-
4	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	E3330	E3330	B-NP	B-NP	-	7	SUB	-	-
7	decreases	decreases	B-VP	B-VP	-	5	SBAR	-	-
8	transcriptional	transcriptional	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	TNF-alpha	TNF-alpha	B-NP	B-NP	-	12	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	10	PMOD	-	-
13	induced	induced	B-VP	B-VP	-	9	NMOD	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	lipopolysaccharide	lipopolysaccharide	B-NP	B-NP	-	19	NMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	LPS	LPS	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	stimulation	stimulation	B-NP	B-NP	-	14	PMOD	-	-
20	in	in	B-PP	B-PP	-	19	NMOD	-	-
21	human	human	B-NP	B-NP	-	23	NMOD	-	-
22	peripheral	peripheral	I-NP	I-NP	-	23	NMOD	-	-
23	monocytes	monocytes	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	4	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	investigate	investigate	I-VP	I-VP	-	8	VMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	inhibitory	inhibitory	I-NP	I-NP	-	5	NMOD	-	-
5	mechanisms	mechanisms	I-NP	I-NP	-	2	OBJ	-	-
6	,	,	O	O	-	8	P	-	-
7	we	we	B-NP	B-NP	-	8	SUB	-	-
8	constructed	constructed	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	13	NMOD	-	-
10	secreted-type	secreted-type	I-NP	I-NP	-	13	NMOD	-	-
11	placental	placental	I-NP	I-NP	-	13	NMOD	-	-
12	alkaline	alkaline	I-NP	I-NP	-	13	NMOD	-	-
13	phosphatase	phosphatase	I-NP	I-NP	-	18	NMOD	-	-
14	(	(	O	O	-	18	P	-	-
15	PLAP	PLAP	B-NP	B-NP	-	18	NMOD	-	-
16	)	)	O	O	-	18	P	-	-
17	reporter	reporter	B-NP	B-NP	-	18	NMOD	-	-
18	gene	gene	I-NP	I-NP	-	8	OBJ	-	-
19	whose	whose	B-NP	B-NP	-	18	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	19	NMOD	-	-
21	is	is	B-VP	B-VP	-	19	SBAR	-	-
22	controlled	controlled	I-VP	I-VP	-	21	VC	-	-
23	by	by	B-PP	B-PP	-	22	VMOD	-	-
24	a	a	B-NP	B-NP	-	28	NMOD	-	-
25	1.4-kb	1.4-kb	I-NP	I-NP	-	28	NMOD	-	-
26	human	human	I-NP	I-NP	-	28	NMOD	-	-
27	TNF-alpha	TNF-alpha	I-NP	I-NP	-	28	NMOD	-	-
28	promoter	promoter	I-NP	I-NP	-	23	PMOD	-	-
29	.	.	O	O	-	8	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	stable	stable	I-NP	I-NP	-	3	NMOD	-	-
3	transformant	transformant	I-NP	I-NP	-	15	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	PLAP	PLAP	I-NP	I-NP	-	8	NMOD	-	-
7	reporter	reporter	I-NP	I-NP	-	8	NMOD	-	-
8	gene	gene	I-NP	I-NP	-	4	PMOD	-	-
9	derived	derived	B-VP	B-VP	-	8	NMOD	-	-
10	from	from	B-PP	B-PP	-	9	VMOD	-	-
11	human	human	B-NP	B-NP	-	14	NMOD	-	-
12	monocytic	monocytic	I-NP	I-NP	-	14	NMOD	-	-
13	cell	cell	I-NP	I-NP	-	14	NMOD	-	-
14	line	line	I-NP	I-NP	-	10	PMOD	-	-
15	showed	showed	B-VP	B-VP	-	25	VMOD	-	-
16	very	very	B-NP	B-NP	-	17	AMOD	-	-
17	little	little	I-NP	I-NP	-	18	NMOD	-	-
18	activity	activity	I-NP	I-NP	-	15	OBJ	-	-
19	on	on	B-PP	B-PP	-	15	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	promoter	promoter	I-NP	I-NP	-	19	PMOD	-	-
22	before	before	B-PP	B-PP	-	15	VMOD	-	-
23	stimulation	stimulation	B-NP	B-NP	-	22	PMOD	-	-
24	,	,	O	O	-	15	P	-	-
25	whereas	whereas	O	O	-	0	ROOT	-	-
26	LPS	LPS	B-NP	B-NP	-	27	NMOD	-	-
27	stimulation	stimulation	I-NP	I-NP	-	28	SUB	-	-
28	led	led	B-VP	B-VP	-	25	VMOD	-	-
29	to	to	B-PP	B-PP	-	28	VMOD	-	-
30	a	a	B-NP	B-NP	-	32	NMOD	-	-
31	dramatic	dramatic	I-NP	I-NP	-	32	NMOD	-	-
32	increase	increase	I-NP	I-NP	-	29	PMOD	-	-
33	in	in	B-PP	B-PP	-	32	NMOD	-	-
34	PLAP	PLAP	B-NP	B-NP	-	35	NMOD	-	-
35	activity	activity	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	25	P	-	-

1	E3330	E3330	B-NP	B-NP	-	2	SUB	-	-
2	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
3	this	this	B-NP	B-NP	-	6	NMOD	-	-
4	induced	induced	I-NP	I-NP	-	6	NMOD	-	-
5	promoter	promoter	I-NP	I-NP	-	6	NMOD	-	-
6	activity	activity	I-NP	I-NP	-	2	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	dose-dependent	dose-dependent	I-NP	I-NP	-	10	NMOD	-	-
10	manner	manner	I-NP	I-NP	-	7	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	There	There	B-NP	B-NP	-	2	SUB	-	-
2	are	are	B-VP	B-VP	-	0	ROOT	-	-
3	four	four	B-NP	B-NP	-	2	PRD	-	-
4	putative	putative	I-NP	I-NP	-	8	NMOD	-	-
5	NF-kappa	NF-kappa	I-NP	I-NP	-	8	NMOD	-	-
6	B	B	I-NP	I-NP	-	8	NMOD	-	-
7	binding	binding	I-NP	I-NP	-	8	NMOD	-	-
8	sites	sites	I-NP	I-NP	-	3	NMOD	-	-
9	(	(	O	O	-	20	P	-	-
10	kappa	kappa	B-NP	B-NP	-	11	NMOD	-	-
11	B-1	B-1	I-NP	I-NP	-	20	NMOD	-	-
12	,	,	O	O	-	20	P	-	-
13	kappa	kappa	B-NP	B-NP	-	14	NMOD	-	-
14	B-2	B-2	I-NP	I-NP	-	20	NMOD	-	-
15	,	,	O	O	-	20	P	-	-
16	kappa	kappa	B-NP	B-NP	-	17	NMOD	-	-
17	B-3	B-3	I-NP	I-NP	-	20	NMOD	-	-
18	,	,	O	O	-	20	P	-	-
19	kappa	kappa	B-NP	B-NP	-	20	NMOD	-	-
20	B-4	B-4	I-NP	I-NP	-	8	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	in	in	B-PP	B-PP	-	8	NMOD	-	-
23	human	human	B-NP	B-NP	-	25	NMOD	-	-
24	TNF-alpha	TNF-alpha	I-NP	I-NP	-	25	NMOD	-	-
25	promoter	promoter	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	2	P	-	-

1	By	By	B-PP	B-PP	-	8	VMOD	-	-
2	using	using	B-VP	B-VP	-	1	PMOD	-	-
3	mutated	mutated	B-NP	B-NP	-	5	NMOD	-	-
4	promoter-PLAP	promoter-PLAP	I-NP	I-NP	-	5	NMOD	-	-
5	plasmids	plasmids	I-NP	I-NP	-	2	OBJ	-	-
6	,	,	O	O	-	8	P	-	-
7	we	we	B-NP	B-NP	-	8	SUB	-	-
8	established	established	B-VP	B-VP	-	0	ROOT	-	-
9	that	that	B-SBAR	B-SBAR	-	8	VMOD	-	-
10	these	these	B-NP	B-NP	-	13	NMOD	-	-
11	NF-kappa	NF-kappa	I-NP	I-NP	-	13	NMOD	-	-
12	B	B	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	14	SUB	-	-
14	were	were	B-VP	B-VP	-	9	SBAR	-	-
15	necessary	necessary	B-ADJP	B-ADJP	-	14	PRD	-	-
16	for	for	B-PP	B-PP	-	15	AMOD	-	-
17	induction	induction	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	TNF-alpha	TNF-alpha	B-NP	B-NP	-	20	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	18	PMOD	-	-
21	on	on	B-PP	B-PP	-	17	NMOD	-	-
22	stimulation	stimulation	B-NP	B-NP	-	21	PMOD	-	-
23	with	with	B-PP	B-PP	-	22	NMOD	-	-
24	LPS	LPS	B-NP	B-NP	-	23	PMOD	-	-
25	.	.	O	O	-	8	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	gel	gel	I-NP	I-NP	-	4	NMOD	-	-
3	retardation	retardation	I-NP	I-NP	-	4	NMOD	-	-
4	experiment	experiment	I-NP	I-NP	-	9	SUB	-	-
5	with	with	B-PP	B-PP	-	4	NMOD	-	-
6	synthetic	synthetic	B-NP	B-NP	-	8	NMOD	-	-
7	double-stranded	double-stranded	I-NP	I-NP	-	8	NMOD	-	-
8	oligonucleotides	oligonucleotides	I-NP	I-NP	-	5	PMOD	-	-
9	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
10	that	that	B-SBAR	B-SBAR	-	9	VMOD	-	-
11	activated	activated	B-NP	B-NP	-	13	NMOD	-	-
12	NF-kappa	NF-kappa	I-NP	I-NP	-	13	NMOD	-	-
13	B	B	I-NP	I-NP	-	18	SUB	-	-
14	consisting	consisting	B-VP	B-VP	-	13	NMOD	-	-
15	of	of	B-PP	B-PP	-	14	VMOD	-	-
16	p50/p65	p50/p65	B-NP	B-NP	-	17	NMOD	-	-
17	heterodimer	heterodimer	I-NP	I-NP	-	15	PMOD	-	-
18	bound	bound	B-VP	B-VP	-	10	SBAR	-	-
19	to	to	B-PP	B-PP	-	18	VMOD	-	-
20	all	all	B-NP	B-NP	-	21	NMOD	-	-
21	four	four	I-NP	I-NP	-	26	NMOD	-	-
22	putative	putative	I-NP	I-NP	-	26	NMOD	-	-
23	NF-kappa	NF-kappa	I-NP	I-NP	-	26	NMOD	-	-
24	B	B	I-NP	I-NP	-	26	NMOD	-	-
25	DNA	DNA	I-NP	I-NP	-	26	NMOD	-	-
26	probes	probes	I-NP	I-NP	-	19	PMOD	-	-
27	,	,	O	O	-	18	P	-	-
28	suggesting	suggesting	B-VP	B-VP	-	18	VMOD	-	-
29	that	that	B-SBAR	B-SBAR	-	28	VMOD	-	-
30	all	all	B-NP	B-NP	-	31	NMOD	-	-
31	four	four	I-NP	I-NP	-	36	NMOD	-	-
32	putative	putative	I-NP	I-NP	-	36	NMOD	-	-
33	NF-kappa	NF-kappa	I-NP	I-NP	-	36	NMOD	-	-
34	B	B	I-NP	I-NP	-	36	NMOD	-	-
35	recognition	recognition	I-NP	I-NP	-	36	NMOD	-	-
36	sites	sites	I-NP	I-NP	-	37	SUB	-	-
37	play	play	B-VP	B-VP	-	29	SBAR	-	-
38	an	an	B-NP	B-NP	-	40	NMOD	-	-
39	important	important	I-NP	I-NP	-	40	NMOD	-	-
40	role	role	I-NP	I-NP	-	37	OBJ	-	-
41	in	in	B-PP	B-PP	-	37	VMOD	-	-
42	inducible	inducible	B-NP	B-NP	-	44	NMOD	-	-
43	TNF-alpha	TNF-alpha	I-NP	I-NP	-	44	NMOD	-	-
44	expression	expression	I-NP	I-NP	-	41	PMOD	-	-
45	.	.	O	O	-	9	P	-	-

1	E3330	E3330	B-NP	B-NP	-	2	SUB	-	-
2	decreased	decreased	B-VP	B-VP	-	0	ROOT	-	-
3	activated	activated	I-VP	I-VP	-	2	VC	-	-
4	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
5	B	B	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	3	VMOD	-	-
7	nuclei	nuclei	B-NP	B-NP	-	6	PMOD	-	-
8	,	,	O	O	-	2	P	-	-
9	suggesting	suggesting	B-VP	B-VP	-	2	VMOD	-	-
10	that	that	B-SBAR	B-SBAR	-	9	VMOD	-	-
11	E3330	E3330	B-NP	B-NP	-	12	SUB	-	-
12	inhibits	inhibits	B-VP	B-VP	-	10	SBAR	-	-
13	NF-kappa	NF-kappa	B-NP	B-NP	-	15	NMOD	-	-
14	B	B	I-NP	I-NP	-	15	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	17	NMOD	-	-
16	and/or	and/or	O	O	-	17	NMOD	-	-
17	translocation	translocation	B-NP	B-NP	-	2	OBJ	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	nuclei	nuclei	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	Western	Western	B-NP	B-NP	-	3	NMOD	-	-
2	blotting	blotting	I-NP	I-NP	-	3	NMOD	-	-
3	analysis	analysis	I-NP	I-NP	-	9	SUB	-	-
4	with	with	B-PP	B-PP	-	3	NMOD	-	-
5	anti-I	anti-I	B-NP	B-NP	-	8	NMOD	-	-
6	kappa	kappa	I-NP	I-NP	-	8	NMOD	-	-
7	B-alpha	B-alpha	I-NP	I-NP	-	8	NMOD	-	-
8	antibody	antibody	I-NP	I-NP	-	4	PMOD	-	-
9	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
10	that	that	B-SBAR	B-SBAR	-	9	VMOD	-	-
11	E3330	E3330	B-NP	B-NP	-	12	SUB	-	-
12	inhibited	inhibited	B-VP	B-VP	-	10	SBAR	-	-
13	degradation	degradation	B-NP	B-NP	-	12	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	I	I	B-NP	B-NP	-	17	NMOD	-	-
16	kappa	kappa	I-NP	I-NP	-	17	NMOD	-	-
17	B-alpha	B-alpha	I-NP	I-NP	-	14	PMOD	-	-
18	,	,	O	O	-	17	P	-	-
19	which	which	B-NP	B-NP	-	17	NMOD	-	-
20	is	is	B-VP	B-VP	-	19	SBAR	-	-
21	an	an	B-NP	B-NP	-	23	NMOD	-	-
22	inhibitory	inhibitory	I-NP	I-NP	-	23	NMOD	-	-
23	protein	protein	I-NP	I-NP	-	20	PRD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	NF-kappa	NF-kappa	B-NP	B-NP	-	26	NMOD	-	-
26	B	B	I-NP	I-NP	-	24	PMOD	-	-
27	,	,	O	O	-	12	P	-	-
28	in	in	B-PP	B-PP	-	12	VMOD	-	-
29	LPS-stimulated	LPS-stimulated	B-NP	B-NP	-	30	NMOD	-	-
30	monocytes	monocytes	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	9	P	-	-

1	E3330	E3330	B-NP	B-NP	-	2	SUB	-	-
2	may	may	B-VP	B-VP	-	0	ROOT	-	-
3	suppress	suppress	I-VP	I-VP	-	2	VC	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	production	production	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	active	active	B-NP	B-NP	-	9	NMOD	-	-
8	oxygen	oxygen	I-NP	I-NP	-	9	NMOD	-	-
9	species	species	I-NP	I-NP	-	6	PMOD	-	-
10	serving	serving	B-VP	B-VP	-	9	NMOD	-	-
11	as	as	B-PP	B-PP	-	10	VMOD	-	-
12	common	common	B-NP	B-NP	-	13	NMOD	-	-
13	messengers	messengers	I-NP	I-NP	-	11	PMOD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	activate	activate	I-VP	I-VP	-	5	NMOD	-	-
16	NF-kappa	NF-kappa	B-NP	B-NP	-	17	NMOD	-	-
17	B	B	I-NP	I-NP	-	15	OBJ	-	-
18	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	p16	p16	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	E2F-dependent	E2F-dependent	I-NP	I-NP	-	10	NMOD	-	-
8	thymidine	thymidine	I-NP	I-NP	-	10	NMOD	-	-
9	kinase	kinase	I-NP	I-NP	-	10	NMOD	-	-
10	regulation	regulation	I-NP	I-NP	-	5	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	alterations	alterations	B-NP	B-NP	-	3	PMOD	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	MTS1	MTS1	I-NP	I-NP	-	10	NMOD	-	-
8	tumor	tumor	I-NP	I-NP	-	10	NMOD	-	-
9	suppressor	suppressor	I-NP	I-NP	-	10	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	5	PMOD	-	-
11	on	on	B-PP	B-PP	-	2	NMOD	-	-
12	chromosome	chromosome	B-NP	B-NP	-	13	NMOD	-	-
13	9p21	9p21	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	which	which	B-NP	B-NP	-	13	NMOD	-	-
16	encodes	encodes	B-VP	B-VP	-	15	SBAR	-	-
17	p16	p16	B-NP	B-NP	-	20	NMOD	-	-
18	,	,	O	O	-	20	P	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	inhibitor	inhibitor	I-NP	I-NP	-	16	OBJ	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	cyclin-dependent-kinase-4	cyclin-dependent-kinase-4	B-NP	B-NP	-	21	PMOD	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	<num>	<num>	B-NP	B-NP	-	22	NMOD	-	-
25	,	,	O	O	-	20	P	-	-
26	in	in	B-PP	B-PP	-	20	NMOD	-	-
27	tumorigenesis	tumorigenesis	B-NP	B-NP	-	26	PMOD	-	-
28	is	is	B-VP	B-VP	-	26	SBAR	-	-
29	not	not	O	O	-	28	VMOD	-	-
30	yet	yet	B-ADJP	B-ADJP	-	31	AMOD	-	-
31	clear	clear	I-ADJP	I-ADJP	-	28	PRD	-	-
32	.	.	O	O	-	2	P	-	-

1	Phosphorylation	Phosphorylation	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	retinoblastoma	retinoblastoma	I-NP	I-NP	-	5	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	2	PMOD	-	-
6	by	by	B-PP	B-PP	-	1	NMOD	-	-
7	cyclin-dependent	cyclin-dependent	B-NP	B-NP	-	8	NMOD	-	-
8	kinases	kinases	I-NP	I-NP	-	6	PMOD	-	-
9	<num>	<num>	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	<num>	<num>	I-NP	I-NP	-	8	NMOD	-	-
12	prevents	prevents	B-VP	B-VP	-	0	ROOT	-	-
13	its	its	B-NP	B-NP	-	14	NMOD	-	-
14	interaction	interaction	I-NP	I-NP	-	12	OBJ	-	-
15	with	with	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	transcription	transcription	I-NP	I-NP	-	19	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	19	NMOD	-	-
19	E2F	E2F	I-NP	I-NP	-	15	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	which	which	B-NP	B-NP	-	19	NMOD	-	-
22	subsequently	subsequently	B-ADVP	B-ADVP	-	23	VMOD	-	-
23	promotes	promotes	B-VP	B-VP	-	21	SBAR	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	expression	expression	I-NP	I-NP	-	23	OBJ	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	S	S	B-NP	B-NP	-	30	NMOD	-	-
28	phase	phase	I-NP	I-NP	-	30	NMOD	-	-
29	regulated	regulated	I-NP	I-NP	-	30	NMOD	-	-
30	genes	genes	I-NP	I-NP	-	26	PMOD	-	-
31	,	,	O	O	-	30	P	-	-
32	such	such	B-PP	B-PP	-	33	PMOD	-	-
33	as	as	I-PP	I-PP	-	30	NMOD	-	-
34	thymidine	thymidine	B-NP	B-NP	-	35	NMOD	-	-
35	kinase	kinase	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	12	P	-	-

1	Although	Although	B-SBAR	B-SBAR	-	14	VMOD	-	-
2	a	a	B-NP	B-NP	-	3	NMOD	-	-
3	role	role	I-NP	I-NP	-	9	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	p16	p16	B-NP	B-NP	-	4	PMOD	-	-
6	in	in	B-PP	B-PP	-	3	NMOD	-	-
7	this	this	B-NP	B-NP	-	8	NMOD	-	-
8	regulation	regulation	I-NP	I-NP	-	6	PMOD	-	-
9	has	has	B-VP	B-VP	-	1	SBAR	-	-
10	been	been	I-VP	I-VP	-	9	VC	-	-
11	presumed	presumed	I-VP	I-VP	-	10	VC	-	-
12	,	,	O	O	-	14	P	-	-
13	there	there	B-NP	B-NP	-	14	SUB	-	-
14	is	is	B-VP	B-VP	-	0	ROOT	-	-
15	no	no	B-NP	B-NP	-	16	NMOD	-	-
16	proof	proof	I-NP	I-NP	-	14	PRD	-	-
17	so	so	B-ADVP	B-ADVP	-	14	VMOD	-	-
18	far	far	I-ADVP	I-ADVP	-	17	AMOD	-	-
19	that	that	B-SBAR	B-SBAR	-	17	DEP	-	-
20	loss	loss	B-NP	B-NP	-	27	SUB	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	this	this	B-NP	B-NP	-	25	NMOD	-	-
23	tumor	tumor	I-NP	I-NP	-	25	NMOD	-	-
24	suppressor	suppressor	I-NP	I-NP	-	25	NMOD	-	-
25	gene	gene	I-NP	I-NP	-	21	PMOD	-	-
26	really	really	B-ADVP	B-ADVP	-	27	VMOD	-	-
27	affects	affects	B-VP	B-VP	-	19	SBAR	-	-
28	E2F-mediated	E2F-mediated	B-NP	B-NP	-	29	NMOD	-	-
29	regulations	regulations	I-NP	I-NP	-	27	OBJ	-	-
30	.	.	O	O	-	14	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	investigated	investigated	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	regulation	regulation	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	thymidine	thymidine	B-NP	B-NP	-	7	NMOD	-	-
7	kinase	kinase	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-PP	B-PP	-	4	NMOD	-	-
9	phytohemagglutinin-stimulated	phytohemagglutinin-stimulated	B-NP	B-NP	-	12	NMOD	-	-
10	normal	normal	I-NP	I-NP	-	12	NMOD	-	-
11	human	human	I-NP	I-NP	-	12	NMOD	-	-
12	lymphocytes	lymphocytes	I-NP	I-NP	-	8	PMOD	-	-
13	and	and	B-PP	B-PP	-	8	PMOD	-	-
14	in	in	B-PP	B-PP	-	8	PMOD	-	-
15	the	the	B-NP	B-NP	-	22	NMOD	-	-
16	p16-negative	p16-negative	I-NP	I-NP	-	22	NMOD	-	-
17	human	human	I-NP	I-NP	-	22	NMOD	-	-
18	acute	acute	I-NP	I-NP	-	22	NMOD	-	-
19	lymphoblastic	lymphoblastic	I-NP	I-NP	-	22	NMOD	-	-
20	leukemia	leukemia	I-NP	I-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	lines	lines	I-NP	I-NP	-	26	NMOD	-	-
23	,	,	O	O	-	26	P	-	-
24	MOLT-4	MOLT-4	B-NP	B-NP	-	26	NMOD	-	-
25	and	and	I-NP	I-NP	-	26	NMOD	-	-
26	CEM	CEM	I-NP	I-NP	-	14	PMOD	-	-
27	.	.	O	O	-	2	P	-	-

1	Compared	Compared	B-PP	B-PP	-	10	VMOD	-	-
2	to	to	B-PP	B-PP	-	1	VMOD	-	-
3	normal	normal	B-NP	B-NP	-	4	NMOD	-	-
4	lymphocytes	lymphocytes	I-NP	I-NP	-	2	PMOD	-	-
5	,	,	O	O	-	10	P	-	-
6	MOLT-4	MOLT-4	B-NP	B-NP	-	9	NMOD	-	-
7	and	and	I-NP	I-NP	-	9	NMOD	-	-
8	CEM	CEM	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	10	SUB	-	-
10	exhibited	exhibited	B-VP	B-VP	-	0	ROOT	-	-
11	an	an	B-NP	B-NP	-	15	NMOD	-	-
12	altered	altered	I-NP	I-NP	-	15	NMOD	-	-
13	cell	cell	I-NP	I-NP	-	15	NMOD	-	-
14	cycle	cycle	I-NP	I-NP	-	15	NMOD	-	-
15	regulation	regulation	I-NP	I-NP	-	10	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	thymidine	thymidine	B-NP	B-NP	-	18	NMOD	-	-
18	kinase	kinase	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	10	P	-	-
20	a	a	B-NP	B-NP	-	24	NMOD	-	-
21	much	much	I-NP	I-NP	-	22	AMOD	-	-
22	higher	higher	I-NP	I-NP	-	24	NMOD	-	-
23	intracellular	intracellular	I-NP	I-NP	-	24	NMOD	-	-
24	activity	activity	I-NP	I-NP	-	10	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	this	this	B-NP	B-NP	-	27	NMOD	-	-
27	enzyme	enzyme	I-NP	I-NP	-	34	NMOD	-	-
28	,	,	O	O	-	34	P	-	-
29	and	and	O	O	-	34	NMOD	-	-
30	higher	higher	B-NP	B-NP	-	34	NMOD	-	-
31	thymidine	thymidine	I-NP	I-NP	-	34	NMOD	-	-
32	kinase	kinase	I-NP	I-NP	-	34	NMOD	-	-
33	mRNA	mRNA	I-NP	I-NP	-	34	NMOD	-	-
34	expression	expression	I-NP	I-NP	-	25	PMOD	-	-
35	.	.	O	O	-	10	P	-	-

1	Transient	Transient	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	9	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	p16	p16	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	normal	normal	B-NP	B-NP	-	8	NMOD	-	-
7	human	human	I-NP	I-NP	-	8	NMOD	-	-
8	lymphocytes	lymphocytes	I-NP	I-NP	-	5	PMOD	-	-
9	caused	caused	B-VP	B-VP	-	0	ROOT	-	-
10	arrest	arrest	B-NP	B-NP	-	9	OBJ	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	G1	G1	B-NP	B-NP	-	11	PMOD	-	-
13	,	,	O	O	-	9	P	-	-
14	but	but	O	O	-	9	VMOD	-	-
15	was	was	B-VP	B-VP	-	9	VMOD	-	-
16	without	without	B-PP	B-PP	-	15	VMOD	-	-
17	effect	effect	B-NP	B-NP	-	16	PMOD	-	-
18	on	on	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	21	NMOD	-	-
21	growth	growth	I-NP	I-NP	-	18	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	MOLT-4	MOLT-4	B-NP	B-NP	-	26	NMOD	-	-
24	and	and	I-NP	I-NP	-	26	NMOD	-	-
25	CEM	CEM	I-NP	I-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
27	,	,	O	O	-	9	P	-	-
28	although	although	B-SBAR	B-SBAR	-	9	VMOD	-	-
29	all	all	B-NP	B-NP	-	32	SUB	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	them	them	B-NP	B-NP	-	30	PMOD	-	-
32	express	express	B-VP	B-VP	-	28	SBAR	-	-
33	functional	functional	B-NP	B-NP	-	35	NMOD	-	-
34	retinoblastoma	retinoblastoma	I-NP	I-NP	-	35	NMOD	-	-
35	protein	protein	I-NP	I-NP	-	32	OBJ	-	-
36	.	.	O	O	-	9	P	-	-

1	Nevertheless	Nevertheless	B-ADVP	B-ADVP	-	13	VMOD	-	-
2	,	,	O	O	-	13	P	-	-
3	in	in	B-PP	B-PP	-	13	VMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	two	two	I-NP	I-NP	-	8	NMOD	-	-
6	leukemia	leukemia	I-NP	I-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	lines	lines	I-NP	I-NP	-	3	PMOD	-	-
9	transient	transient	B-NP	B-NP	-	10	NMOD	-	-
10	overexpression	overexpression	I-NP	I-NP	-	13	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	p16	p16	B-NP	B-NP	-	11	PMOD	-	-
13	reestablished	reestablished	B-VP	B-VP	-	37	VMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	normal	normal	I-NP	I-NP	-	16	NMOD	-	-
16	regulation	regulation	I-NP	I-NP	-	13	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	thymidine	thymidine	B-NP	B-NP	-	19	NMOD	-	-
19	kinase	kinase	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	paralleled	paralleled	B-VP	B-VP	-	16	NMOD	-	-
22	by	by	B-PP	B-PP	-	21	VMOD	-	-
23	an	an	B-NP	B-NP	-	24	NMOD	-	-
24	increase	increase	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	underphosphorylated	underphosphorylated	I-NP	I-NP	-	28	NMOD	-	-
28	form	form	I-NP	I-NP	-	25	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	retinoblastoma	retinoblastoma	B-NP	B-NP	-	31	NMOD	-	-
31	protein	protein	I-NP	I-NP	-	29	PMOD	-	-
32	and	and	O	O	-	37	VMOD	-	-
33	decrease	decrease	B-NP	B-NP	-	37	SUB	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	free	free	B-NP	B-NP	-	36	NMOD	-	-
36	E2F	E2F	I-NP	I-NP	-	34	PMOD	-	-
37	bound	bound	B-VP	B-VP	-	0	ROOT	-	-
38	to	to	B-PP	B-PP	-	37	VMOD	-	-
39	its	its	B-NP	B-NP	-	40	NMOD	-	-
40	motif	motif	I-NP	I-NP	-	38	PMOD	-	-
41	in	in	B-PP	B-PP	-	40	NMOD	-	-
42	the	the	B-NP	B-NP	-	45	NMOD	-	-
43	thymidine	thymidine	I-NP	I-NP	-	45	NMOD	-	-
44	kinase	kinase	I-NP	I-NP	-	45	NMOD	-	-
45	promoter	promoter	I-NP	I-NP	-	41	PMOD	-	-
46	.	.	O	O	-	37	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	loss	loss	B-NP	B-NP	-	7	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	p16	p16	B-NP	B-NP	-	5	PMOD	-	-
7	causes	causes	B-VP	B-VP	-	3	SBAR	-	-
8	upregulation	upregulation	B-NP	B-NP	-	7	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	this	this	B-NP	B-NP	-	14	NMOD	-	-
11	DNA	DNA	I-NP	I-NP	-	14	NMOD	-	-
12	precursor	precursor	I-NP	I-NP	-	14	NMOD	-	-
13	pathway	pathway	I-NP	I-NP	-	14	NMOD	-	-
14	enzyme	enzyme	I-NP	I-NP	-	9	PMOD	-	-
15	via	via	B-PP	B-PP	-	8	NMOD	-	-
16	activation	activation	B-NP	B-NP	-	15	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	E2F	E2F	B-NP	B-NP	-	17	PMOD	-	-
19	by	by	B-PP	B-PP	-	16	NMOD	-	-
20	a	a	B-NP	B-NP	-	21	NMOD	-	-
21	mechanism	mechanism	I-NP	I-NP	-	19	PMOD	-	-
22	involving	involving	B-VP	B-VP	-	21	NMOD	-	-
23	retinoblastoma	retinoblastoma	B-NP	B-NP	-	24	NMOD	-	-
24	protein	protein	I-NP	I-NP	-	22	OBJ	-	-
25	.	.	O	O	-	2	P	-	-

1	Rel-deficient	Rel-deficient	B-NP	B-NP	-	3	NMOD	-	-
2	T	T	I-NP	I-NP	-	3	NMOD	-	-
3	cells	cells	I-NP	I-NP	-	4	SUB	-	-
4	exhibit	exhibit	B-VP	B-VP	-	0	ROOT	-	-
5	defects	defects	B-NP	B-NP	-	4	OBJ	-	-
6	in	in	B-PP	B-PP	-	4	VMOD	-	-
7	production	production	B-NP	B-NP	-	6	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	interleukin	interleukin	B-NP	B-NP	-	14	NMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	9	NMOD	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	granulocyte-macrophage	granulocyte-macrophage	B-NP	B-NP	-	14	NMOD	-	-
13	colony-stimulating	colony-stimulating	I-NP	I-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	8	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	c-rel	c-rel	I-NP	I-NP	-	3	NMOD	-	-
3	protooncogene	protooncogene	I-NP	I-NP	-	4	SUB	-	-
4	encodes	encodes	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	subunit	subunit	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	NF-kappa	NF-kappa	I-NP	I-NP	-	11	NMOD	-	-
10	B-like	B-like	I-NP	I-NP	-	9	AMOD	-	-
11	family	family	I-NP	I-NP	-	7	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	transcription	transcription	B-NP	B-NP	-	14	NMOD	-	-
14	factors	factors	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	Mice	Mice	B-NP	B-NP	-	4	SUB	-	-
2	lacking	lacking	B-VP	B-VP	-	1	NMOD	-	-
3	Rel	Rel	B-NP	B-NP	-	2	OBJ	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	defective	defective	B-ADJP	B-ADJP	-	4	PRD	-	-
6	in	in	B-PP	B-PP	-	5	AMOD	-	-
7	mitogenic	mitogenic	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	B	B	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	T	T	B-NP	B-NP	-	13	NMOD	-	-
13	lymphocytes	lymphocytes	B-NP	B-NP	-	9	PMOD	-	-
14	and	and	O	O	-	4	VMOD	-	-
15	display	display	B-VP	B-VP	-	4	VMOD	-	-
16	impaired	impaired	B-NP	B-NP	-	18	NMOD	-	-
17	humoral	humoral	I-NP	I-NP	-	18	NMOD	-	-
18	immunity	immunity	I-NP	I-NP	-	15	OBJ	-	-
19	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	24	VMOD	-	-
2	an	an	B-NP	B-NP	-	3	NMOD	-	-
3	attempt	attempt	I-NP	I-NP	-	1	PMOD	-	-
4	to	to	B-VP	B-VP	-	5	VMOD	-	-
5	identify	identify	I-VP	I-VP	-	3	NMOD	-	-
6	changes	changes	B-NP	B-NP	-	5	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	gene	gene	B-NP	B-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	7	PMOD	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	accompany	accompany	B-VP	B-VP	-	10	SBAR	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	T-cell	T-cell	I-NP	I-NP	-	15	NMOD	-	-
14	stimulation	stimulation	I-NP	I-NP	-	15	NMOD	-	-
15	defects	defects	I-NP	I-NP	-	11	OBJ	-	-
16	associated	associated	B-VP	B-VP	-	15	NMOD	-	-
17	with	with	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	loss	loss	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	Rel	Rel	B-NP	B-NP	-	20	PMOD	-	-
22	,	,	O	O	-	24	P	-	-
23	we	we	B-NP	B-NP	-	24	SUB	-	-
24	have	have	B-VP	B-VP	-	0	ROOT	-	-
25	examined	examined	I-VP	I-VP	-	24	VC	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	expression	expression	I-NP	I-NP	-	25	OBJ	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	cell	cell	B-NP	B-NP	-	32	NMOD	-	-
30	surface	surface	I-NP	I-NP	-	32	NMOD	-	-
31	activation	activation	I-NP	I-NP	-	32	NMOD	-	-
32	markers	markers	I-NP	I-NP	-	28	PMOD	-	-
33	and	and	O	O	-	35	NMOD	-	-
34	cytokine	cytokine	B-NP	B-NP	-	35	NMOD	-	-
35	production	production	I-NP	I-NP	-	28	PMOD	-	-
36	in	in	B-PP	B-PP	-	35	NMOD	-	-
37	mitogen-stimulated	mitogen-stimulated	B-NP	B-NP	-	40	NMOD	-	-
38	Rel-/-	Rel-/-	I-NP	I-NP	-	40	NMOD	-	-
39	T	T	I-NP	I-NP	-	40	NMOD	-	-
40	cells	cells	I-NP	I-NP	-	36	PMOD	-	-
41	.	.	O	O	-	24	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	28	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	cell	cell	B-NP	B-NP	-	6	NMOD	-	-
5	surface	surface	I-NP	I-NP	-	6	NMOD	-	-
6	markers	markers	I-NP	I-NP	-	3	PMOD	-	-
7	including	including	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	17	NMOD	-	-
9	interleukin	interleukin	I-NP	I-NP	-	12	NMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	12	NMOD	-	-
11	receptor	receptor	I-NP	I-NP	-	12	NMOD	-	-
12	alpha	alpha	I-NP	I-NP	-	17	NMOD	-	-
13	(	(	O	O	-	15	P	-	-
14	IL-2R	IL-2R	B-NP	B-NP	-	15	NMOD	-	-
15	alpha	alpha	I-NP	I-NP	-	12	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	chain	chain	B-NP	B-NP	-	24	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	CD25	CD25	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	24	P	-	-
22	CD69	CD69	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	L-selectin	L-selectin	B-NP	B-NP	-	7	PMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	CD62	CD62	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	is	is	B-VP	B-VP	-	39	VMOD	-	-
29	normal	normal	B-ADJP	B-ADJP	-	28	PRD	-	-
30	in	in	B-PP	B-PP	-	29	AMOD	-	-
31	mitogen-activated	mitogen-activated	B-NP	B-NP	-	34	NMOD	-	-
32	Rel-/-	Rel-/-	I-NP	I-NP	-	34	NMOD	-	-
33	T	T	I-NP	I-NP	-	34	NMOD	-	-
34	cells	cells	I-NP	I-NP	-	30	PMOD	-	-
35	,	,	O	O	-	39	P	-	-
36	but	but	O	O	-	39	VMOD	-	-
37	cytokine	cytokine	B-NP	B-NP	-	38	NMOD	-	-
38	production	production	I-NP	I-NP	-	39	SUB	-	-
39	is	is	B-VP	B-VP	-	0	ROOT	-	-
40	impaired	impaired	B-ADJP	B-ADJP	-	39	PRD	-	-
41	.	.	O	O	-	39	P	-	-

1	In	In	B-PP	B-PP	-	44	VMOD	-	-
2	Rel-/-	Rel-/-	B-NP	B-NP	-	6	NMOD	-	-
3	splenic	splenic	I-NP	I-NP	-	6	NMOD	-	-
4	T	T	I-NP	I-NP	-	6	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
6	cultures	cultures	I-NP	I-NP	-	1	PMOD	-	-
7	stimulated	stimulated	B-VP	B-VP	-	6	NMOD	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	phorbol	phorbol	B-NP	B-NP	-	11	NMOD	-	-
10	12-myristate	12-myristate	I-NP	I-NP	-	11	NMOD	-	-
11	13-acetate	13-acetate	I-NP	I-NP	-	13	NMOD	-	-
12	and	and	I-NP	I-NP	-	13	NMOD	-	-
13	ionomycin	ionomycin	I-NP	I-NP	-	8	PMOD	-	-
14	,	,	O	O	-	44	P	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	levels	levels	I-NP	I-NP	-	44	SUB	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	IL-3	IL-3	B-NP	B-NP	-	25	NMOD	-	-
19	,	,	O	O	-	25	P	-	-
20	IL-5	IL-5	B-NP	B-NP	-	25	NMOD	-	-
21	,	,	O	O	-	25	P	-	-
22	granulocyte-	granulocyte-	B-NP	B-NP	-	25	NMOD	-	-
23	macrophage	macrophage	B-NP	B-NP	-	25	NMOD	-	-
24	colony-stimulating	colony-stimulating	I-NP	I-NP	-	25	NMOD	-	-
25	factor	factor	I-NP	I-NP	-	33	NMOD	-	-
26	(	(	O	O	-	27	P	-	-
27	GM-CSF	GM-CSF	B-NP	B-NP	-	25	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	,	,	O	O	-	33	P	-	-
30	tumor	tumor	B-NP	B-NP	-	33	NMOD	-	-
31	necrosis	necrosis	I-NP	I-NP	-	33	NMOD	-	-
32	factor	factor	I-NP	I-NP	-	33	NMOD	-	-
33	alpha	alpha	I-NP	I-NP	-	40	NMOD	-	-
34	(	(	O	O	-	35	P	-	-
35	TNF-alpha	TNF-alpha	B-NP	B-NP	-	33	NMOD	-	-
36	)	)	O	O	-	35	P	-	-
37	,	,	O	O	-	40	P	-	-
38	and	and	O	O	-	40	NMOD	-	-
39	gamma	gamma	B-NP	B-NP	-	40	NMOD	-	-
40	interferon	interferon	I-NP	I-NP	-	17	PMOD	-	-
41	(	(	O	O	-	42	P	-	-
42	IFN-gamma	IFN-gamma	B-NP	B-NP	-	40	NMOD	-	-
43	)	)	O	O	-	42	P	-	-
44	were	were	B-VP	B-VP	-	0	ROOT	-	-
45	only	only	B-ADVP	B-ADVP	-	44	VMOD	-	-
46	2-	2-	B-NP	B-NP	-	45	AMOD	-	-
47	to	to	B-PP	B-PP	-	46	NMOD	-	-
48	3-fold	3-fold	B-NP	B-NP	-	49	AMOD	-	-
49	lower	lower	I-NP	I-NP	-	47	PMOD	-	-
50	compared	compared	B-PP	B-PP	-	44	VC	-	-
51	with	with	B-PP	B-PP	-	50	PMOD	-	-
52	normal	normal	B-NP	B-NP	-	54	NMOD	-	-
53	T	T	I-NP	I-NP	-	54	NMOD	-	-
54	cells	cells	I-NP	I-NP	-	51	PMOD	-	-
55	.	.	O	O	-	44	P	-	-

1	In	In	B-PP	B-PP	-	13	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	10	P	-	-
4	anti-CD3	anti-CD3	B-NP	B-NP	-	10	NMOD	-	-
5	and	and	I-NP	I-NP	-	10	NMOD	-	-
6	anti-CD28	anti-CD28	I-NP	I-NP	-	10	NMOD	-	-
7	stimulated	stimulated	I-NP	I-NP	-	10	NMOD	-	-
8	Rel-/-	Rel-/-	I-NP	I-NP	-	10	NMOD	-	-
9	T	T	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	which	which	B-NP	B-NP	-	10	NMOD	-	-
13	fail	fail	B-VP	B-VP	-	0	ROOT	-	-
14	to	to	I-VP	I-VP	-	15	VMOD	-	-
15	proliferate	proliferate	I-VP	I-VP	-	13	VMOD	-	-
16	,	,	O	O	-	15	P	-	-
17	make	make	B-VP	B-VP	-	15	VMOD	-	-
18	little	little	B-NP	B-NP	-	22	NMOD	-	-
19	or	or	I-NP	I-NP	-	22	NMOD	-	-
20	no	no	I-NP	I-NP	-	22	NMOD	-	-
21	detectable	detectable	I-NP	I-NP	-	22	NMOD	-	-
22	cytokines	cytokines	I-NP	I-NP	-	17	OBJ	-	-
23	.	.	O	O	-	17	P	-	-

1	Exogenous	Exogenous	B-NP	B-NP	-	2	NMOD	-	-
2	IL-2	IL-2	I-NP	I-NP	-	18	SUB	-	-
3	,	,	O	O	-	2	P	-	-
4	which	which	B-NP	B-NP	-	2	NMOD	-	-
5	restitutes	restitutes	B-VP	B-VP	-	4	SBAR	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	proliferative	proliferative	I-NP	I-NP	-	8	NMOD	-	-
8	response	response	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	16	NMOD	-	-
11	anti-CD3-	anti-CD3-	I-NP	I-NP	-	16	NMOD	-	-
12	and	and	I-NP	I-NP	-	16	NMOD	-	-
13	anti-CD28-treated	anti-CD28-treated	I-NP	I-NP	-	16	NMOD	-	-
14	Rel-/-	Rel-/-	I-NP	I-NP	-	16	NMOD	-	-
15	T	T	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
17	,	,	O	O	-	2	P	-	-
18	restores	restores	B-VP	B-VP	-	0	ROOT	-	-
19	production	production	B-NP	B-NP	-	33	NMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	IL-5	IL-5	B-NP	B-NP	-	30	NMOD	-	-
22	,	,	O	O	-	30	P	-	-
23	TNF-alpha	TNF-alpha	B-NP	B-NP	-	30	NMOD	-	-
24	,	,	O	O	-	30	P	-	-
25	and	and	O	O	-	26	NMOD	-	-
26	IFN-gamma	IFN-gamma	B-NP	B-NP	-	30	NMOD	-	-
27	,	,	O	O	-	30	P	-	-
28	but	but	O	O	-	30	NMOD	-	-
29	not	not	O	O	-	28	DEP	-	-
30	IL-3	IL-3	B-NP	B-NP	-	33	NMOD	-	-
31	and	and	O	O	-	33	NMOD	-	-
32	GM-CSF	GM-CSF	B-NP	B-NP	-	33	NMOD	-	-
33	expression	expression	I-NP	I-NP	-	18	OBJ	-	-
34	to	to	B-PP	B-PP	-	33	NMOD	-	-
35	approximately	approximately	B-NP	B-NP	-	36	AMOD	-	-
36	normal	normal	I-NP	I-NP	-	37	NMOD	-	-
37	levels	levels	I-NP	I-NP	-	34	PMOD	-	-
38	.	.	O	O	-	18	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	to	to	B-PP	B-PP	-	1	PMOD	-	-
4	mitogen-activated	mitogen-activated	B-NP	B-NP	-	7	NMOD	-	-
5	Rel-/-	Rel-/-	I-NP	I-NP	-	7	NMOD	-	-
6	T	T	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
8	,	,	O	O	-	12	P	-	-
9	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	B-NP	B-NP	-	11	NMOD	-	-
10	Rel-/-	Rel-/-	I-NP	I-NP	-	11	NMOD	-	-
11	macrophages	macrophages	I-NP	I-NP	-	12	SUB	-	-
12	produce	produce	B-VP	B-VP	-	0	ROOT	-	-
13	higher	higher	B-ADJP	B-ADJP	-	12	VMOD	-	-
14	than	than	B-PP	B-PP	-	13	NMOD	-	-
15	normal	normal	B-NP	B-NP	-	16	NMOD	-	-
16	levels	levels	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	GM-CSF	GM-CSF	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	12	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	establish	establish	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	Rel	Rel	B-NP	B-NP	-	6	SUB	-	-
6	can	can	B-VP	B-VP	-	4	SBAR	-	-
7	function	function	I-VP	I-VP	-	6	VC	-	-
8	as	as	B-PP	B-PP	-	7	VMOD	-	-
9	an	an	B-NP	B-NP	-	12	NMOD	-	-
10	activator	activator	I-NP	I-NP	-	12	NMOD	-	-
11	or	or	I-NP	I-NP	-	12	NMOD	-	-
12	repressor	repressor	I-NP	I-NP	-	8	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	gene	gene	B-NP	B-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	13	PMOD	-	-
16	and	and	O	O	-	7	VMOD	-	-
17	is	is	B-VP	B-VP	-	6	VMOD	-	-
18	required	required	I-VP	I-VP	-	17	VC	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	T	T	B-NP	B-NP	-	21	NMOD	-	-
21	lymphocytes	lymphocytes	I-NP	I-NP	-	19	PMOD	-	-
22	for	for	B-PP	B-PP	-	21	NMOD	-	-
23	production	production	B-NP	B-NP	-	22	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	IL-3	IL-3	B-NP	B-NP	-	27	NMOD	-	-
26	and	and	I-NP	I-NP	-	27	NMOD	-	-
27	GM-CSF	GM-CSF	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	Human	Human	B-NP	B-NP	-	5	NMOD	-	-
2	T	T	I-NP	I-NP	-	5	NMOD	-	-
3	lymphotropic	lymphotropic	I-NP	I-NP	-	5	NMOD	-	-
4	virus-I	virus-I	I-NP	I-NP	-	5	NMOD	-	-
5	infection	infection	I-NP	I-NP	-	10	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	human	human	B-NP	B-NP	-	9	NMOD	-	-
8	T	T	I-NP	I-NP	-	9	NMOD	-	-
9	lymphocytes	lymphocytes	I-NP	I-NP	-	6	PMOD	-	-
10	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
11	expression	expression	B-NP	B-NP	-	10	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	beta-galactoside-binding	beta-galactoside-binding	I-NP	I-NP	-	15	NMOD	-	-
15	lectin	lectin	I-NP	I-NP	-	17	NMOD	-	-
16	,	,	O	O	-	17	P	-	-
17	galectin-3	galectin-3	B-NP	B-NP	-	12	PMOD	-	-
18	.	.	O	O	-	10	P	-	-

1	Animal	Animal	B-NP	B-NP	-	2	NMOD	-	-
2	lectins	lectins	I-NP	I-NP	-	3	SUB	-	-
3	play	play	B-VP	B-VP	-	0	ROOT	-	-
4	important	important	B-NP	B-NP	-	5	NMOD	-	-
5	roles	roles	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	3	VMOD	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	variety	variety	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	biological	biological	B-NP	B-NP	-	11	NMOD	-	-
11	processes	processes	I-NP	I-NP	-	9	PMOD	-	-
12	via	via	B-PP	B-PP	-	3	VMOD	-	-
13	their	their	B-NP	B-NP	-	14	NMOD	-	-
14	recognition	recognition	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	glycoconjugates	glycoconjugates	B-NP	B-NP	-	15	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	Galectin-3	Galectin-3	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	28	VMOD	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	beta-galactoside-binding	beta-galactoside-binding	I-NP	I-NP	-	5	NMOD	-	-
5	lectin	lectin	I-NP	I-NP	-	2	PRD	-	-
6	previously	previously	B-VP	B-VP	-	7	VMOD	-	-
7	designated	designated	I-VP	I-VP	-	5	NMOD	-	-
8	as	as	B-PP	B-PP	-	7	VMOD	-	-
9	epsilon	epsilon	B-NP	B-NP	-	10	NMOD	-	-
10	BP	BP	I-NP	I-NP	-	8	PMOD	-	-
11	(	(	O	O	-	13	P	-	-
12	IgE-binding	IgE-binding	B-NP	B-NP	-	13	NMOD	-	-
13	protein	protein	I-NP	I-NP	-	10	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	,	,	O	O	-	23	P	-	-
16	CBP35	CBP35	B-NP	B-NP	-	23	NMOD	-	-
17	,	,	O	O	-	23	P	-	-
18	Mac-2	Mac-2	B-NP	B-NP	-	23	NMOD	-	-
19	,	,	O	O	-	23	P	-	-
20	L-29	L-29	B-NP	B-NP	-	23	NMOD	-	-
21	,	,	O	O	-	23	P	-	-
22	and	and	O	O	-	23	NMOD	-	-
23	L-34	L-34	B-NP	B-NP	-	8	PMOD	-	-
24	,	,	O	O	-	28	P	-	-
25	and	and	O	O	-	28	VMOD	-	-
26	its	its	B-NP	B-NP	-	27	NMOD	-	-
27	expression	expression	I-NP	I-NP	-	28	SUB	-	-
28	has	has	B-VP	B-VP	-	0	ROOT	-	-
29	been	been	I-VP	I-VP	-	28	VC	-	-
30	associated	associated	I-VP	I-VP	-	29	VC	-	-
31	with	with	B-PP	B-PP	-	30	VMOD	-	-
32	various	various	B-NP	B-NP	-	36	NMOD	-	-
33	physiological	physiological	I-NP	I-NP	-	36	NMOD	-	-
34	and	and	I-NP	I-NP	-	36	NMOD	-	-
35	pathological	pathological	I-NP	I-NP	-	36	NMOD	-	-
36	processes	processes	I-NP	I-NP	-	31	PMOD	-	-
37	,	,	O	O	-	36	P	-	-
38	including	including	B-PP	B-PP	-	36	NMOD	-	-
39	cell	cell	B-NP	B-NP	-	40	NMOD	-	-
40	growth	growth	I-NP	I-NP	-	46	NMOD	-	-
41	,	,	O	O	-	46	P	-	-
42	tumor	tumor	B-NP	B-NP	-	43	NMOD	-	-
43	transformation	transformation	I-NP	I-NP	-	46	NMOD	-	-
44	,	,	O	O	-	46	P	-	-
45	and	and	O	O	-	46	NMOD	-	-
46	metastasis	metastasis	B-NP	B-NP	-	38	PMOD	-	-
47	.	.	O	O	-	28	P	-	-

1	Galectin-3	Galectin-3	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	widely	widely	I-VP	I-VP	-	2	VMOD	-	-
4	distributed	distributed	I-VP	I-VP	-	2	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	various	various	B-NP	B-NP	-	7	NMOD	-	-
7	tissues	tissues	I-NP	I-NP	-	10	NMOD	-	-
8	and	and	O	O	-	10	NMOD	-	-
9	cell	cell	B-NP	B-NP	-	10	NMOD	-	-
10	types	types	I-NP	I-NP	-	5	PMOD	-	-
11	and	and	O	O	-	2	VMOD	-	-
12	is	is	B-VP	B-VP	-	2	VMOD	-	-
13	expressed	expressed	I-VP	I-VP	-	12	VC	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	many	many	B-NP	B-NP	-	16	NMOD	-	-
16	leukocytes	leukocytes	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	13	P	-	-
18	with	with	B-PP	B-PP	-	13	VMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	notable	notable	I-NP	I-NP	-	21	NMOD	-	-
21	exception	exception	I-NP	I-NP	-	18	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	B	B	B-NP	B-NP	-	25	NMOD	-	-
24	and	and	O	O	-	25	NMOD	-	-
25	T	T	B-NP	B-NP	-	26	NMOD	-	-
26	lymphocytes	lymphocytes	B-NP	B-NP	-	22	PMOD	-	-
27	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	now	now	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	report	report	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	galectin-3	galectin-3	B-NP	B-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	4	SBAR	-	-
7	abundantly	abundantly	I-VP	I-VP	-	6	VMOD	-	-
8	expressed	expressed	I-VP	I-VP	-	6	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	a	a	B-NP	B-NP	-	11	NMOD	-	-
11	number	number	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	human	human	B-NP	B-NP	-	16	NMOD	-	-
14	T	T	I-NP	I-NP	-	16	NMOD	-	-
15	lymphotropic	lymphotropic	I-NP	I-NP	-	16	NMOD	-	-
16	virus	virus	I-NP	I-NP	-	24	NMOD	-	-
17	(	(	O	O	-	18	P	-	-
18	HTLV	HTLV	B-NP	B-NP	-	16	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	-I-infected	-I-infected	B-NP	B-NP	-	24	NMOD	-	-
21	human	human	I-NP	I-NP	-	24	NMOD	-	-
22	T	T	I-NP	I-NP	-	24	NMOD	-	-
23	cell	cell	I-NP	I-NP	-	24	NMOD	-	-
24	lines	lines	I-NP	I-NP	-	12	PMOD	-	-
25	,	,	O	O	-	24	P	-	-
26	including	including	B-PP	B-PP	-	24	NMOD	-	-
27	F6T	F6T	B-NP	B-NP	-	37	NMOD	-	-
28	,	,	O	O	-	37	P	-	-
29	HUT	HUT	B-NP	B-NP	-	37	NMOD	-	-
30	<num>	<num>	I-NP	I-NP	-	29	NMOD	-	-
31	,	,	O	O	-	37	P	-	-
32	K3T	K3T	B-NP	B-NP	-	37	NMOD	-	-
33	,	,	O	O	-	37	P	-	-
34	MT-2	MT-2	B-NP	B-NP	-	37	NMOD	-	-
35	,	,	O	O	-	37	P	-	-
36	and	and	O	O	-	37	NMOD	-	-
37	SLB-I	SLB-I	B-NP	B-NP	-	26	PMOD	-	-
38	,	,	O	O	-	6	P	-	-
39	but	but	O	O	-	6	VMOD	-	-
40	is	is	B-VP	B-VP	-	4	SBAR	-	-
41	not	not	I-VP	I-VP	-	40	VMOD	-	-
42	expressed	expressed	I-VP	I-VP	-	40	VC	-	-
43	in	in	B-PP	B-PP	-	42	VMOD	-	-
44	non-HTLV-I-infected	non-HTLV-I-infected	B-NP	B-NP	-	47	NMOD	-	-
45	T	T	I-NP	I-NP	-	47	NMOD	-	-
46	cell	cell	I-NP	I-NP	-	47	NMOD	-	-
47	lines	lines	I-NP	I-NP	-	43	PMOD	-	-
48	such	such	B-PP	B-PP	-	49	PMOD	-	-
49	as	as	I-PP	I-PP	-	47	NMOD	-	-
50	Jurkat	Jurkat	B-NP	B-NP	-	55	NMOD	-	-
51	,	,	O	O	-	55	P	-	-
52	CEM	CEM	B-NP	B-NP	-	55	NMOD	-	-
53	,	,	O	O	-	55	P	-	-
54	and	and	O	O	-	55	NMOD	-	-
55	MOLT-4	MOLT-4	B-NP	B-NP	-	49	PMOD	-	-
56	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	7	P	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	galectin-3	galectin-3	I-NP	I-NP	-	6	NMOD	-	-
6	level	level	I-NP	I-NP	-	7	SUB	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	markedly	markedly	I-VP	I-VP	-	7	VMOD	-	-
9	increased	increased	I-VP	I-VP	-	7	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	human	human	B-NP	B-NP	-	12	NMOD	-	-
12	thymocytes	thymocytes	I-NP	I-NP	-	10	PMOD	-	-
13	after	after	B-PP	B-PP	-	9	VMOD	-	-
14	infection	infection	B-NP	B-NP	-	13	PMOD	-	-
15	with	with	B-PP	B-PP	-	14	NMOD	-	-
16	HTLV-I	HTLV-I	B-NP	B-NP	-	15	PMOD	-	-
17	as	as	B-PP	B-PP	-	9	VMOD	-	-
18	compared	compared	B-PP	B-PP	-	17	SBAR	-	-
19	with	with	B-PP	B-PP	-	18	VMOD	-	-
20	uninfected	uninfected	B-NP	B-NP	-	21	NMOD	-	-
21	thymocytes	thymocytes	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	up-regulation	up-regulation	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	galectin-3	galectin-3	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
6	appeared	appeared	B-VP	B-VP	-	0	ROOT	-	-
7	to	to	I-VP	I-VP	-	8	VMOD	-	-
8	correlate	correlate	I-VP	I-VP	-	6	VMOD	-	-
9	well	well	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	with	with	B-PP	B-PP	-	8	VMOD	-	-
11	HTLV-I	HTLV-I	B-NP	B-NP	-	13	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	8	P	-	-
15	as	as	B-SBAR	B-SBAR	-	8	VMOD	-	-
16	undetectable	undetectable	B-NP	B-NP	-	20	NMOD	-	-
17	or	or	I-NP	I-NP	-	20	NMOD	-	-
18	very	very	I-NP	I-NP	-	19	AMOD	-	-
19	low	low	I-NP	I-NP	-	20	NMOD	-	-
20	levels	levels	I-NP	I-NP	-	23	SUB	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	galectin-3	galectin-3	B-NP	B-NP	-	21	PMOD	-	-
23	were	were	B-VP	B-VP	-	15	SBAR	-	-
24	found	found	I-VP	I-VP	-	23	VC	-	-
25	in	in	B-PP	B-PP	-	24	VMOD	-	-
26	the	the	B-NP	B-NP	-	31	NMOD	-	-
27	S1T	S1T	I-NP	I-NP	-	31	NMOD	-	-
28	and	and	I-NP	I-NP	-	31	NMOD	-	-
29	ATL-1K	ATL-1K	I-NP	I-NP	-	31	NMOD	-	-
30	cell	cell	I-NP	I-NP	-	31	NMOD	-	-
31	lines	lines	I-NP	I-NP	-	25	PMOD	-	-
32	,	,	O	O	-	31	P	-	-
33	which	which	B-NP	B-NP	-	31	NMOD	-	-
34	are	are	B-VP	B-VP	-	33	SBAR	-	-
35	nonproductively	nonproductively	I-VP	I-VP	-	34	VMOD	-	-
36	infected	infected	I-VP	I-VP	-	34	VC	-	-
37	with	with	B-PP	B-PP	-	36	VMOD	-	-
38	HTLV-I	HTLV-I	B-NP	B-NP	-	37	PMOD	-	-
39	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	8	VMOD	-	-
2	co-transfection	co-transfection	B-NP	B-NP	-	3	NMOD	-	-
3	experiments	experiments	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	8	P	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	galectin-3	galectin-3	I-NP	I-NP	-	7	NMOD	-	-
7	promoter	promoter	I-NP	I-NP	-	8	SUB	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	significantly	significantly	I-VP	I-VP	-	8	VMOD	-	-
10	up-regulated	up-regulated	I-VP	I-VP	-	8	VC	-	-
11	by	by	B-PP	B-PP	-	10	VMOD	-	-
12	expression	expression	B-NP	B-NP	-	13	NMOD	-	-
13	vectors	vectors	I-NP	I-NP	-	11	PMOD	-	-
14	encoding	encoding	B-VP	B-VP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	40-kd	40-kd	I-NP	I-NP	-	18	NMOD	-	-
17	Tax	Tax	I-NP	I-NP	-	18	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	22	NMOD	-	-
19	,	,	O	O	-	22	P	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	potent	potent	I-NP	I-NP	-	22	NMOD	-	-
22	transactivator	transactivator	I-NP	I-NP	-	14	OBJ	-	-
23	in	in	B-PP	B-PP	-	14	VMOD	-	-
24	HTLV-I	HTLV-I	B-NP	B-NP	-	23	PMOD	-	-
25	.	.	O	O	-	8	P	-	-

1	Analysis	Analysis	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	various	various	B-NP	B-NP	-	5	NMOD	-	-
4	Tax	Tax	I-NP	I-NP	-	5	NMOD	-	-
5	mutants	mutants	I-NP	I-NP	-	2	PMOD	-	-
6	suggested	suggested	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	galectin-3	galectin-3	B-NP	B-NP	-	9	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	10	NMOD	-	-
10	induction	induction	I-NP	I-NP	-	11	SUB	-	-
11	is	is	B-VP	B-VP	-	7	SBAR	-	-
12	dependent	dependent	B-ADJP	B-ADJP	-	11	PRD	-	-
13	on	on	B-PP	B-PP	-	12	AMOD	-	-
14	activation	activation	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	23	NMOD	-	-
17	cyclic-AMP-responsive	cyclic-AMP-responsive	I-NP	I-NP	-	23	NMOD	-	-
18	element	element	I-NP	I-NP	-	23	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	23	NMOD	-	-
20	protein/activation	protein/activation	I-NP	I-NP	-	23	NMOD	-	-
21	transcription	transcription	I-NP	I-NP	-	23	NMOD	-	-
22	factor	factor	I-NP	I-NP	-	23	NMOD	-	-
23	family	family	I-NP	I-NP	-	15	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	transcription	transcription	B-NP	B-NP	-	26	NMOD	-	-
26	factors	factors	I-NP	I-NP	-	24	PMOD	-	-
27	and	and	O	O	-	11	VMOD	-	-
28	,	,	O	O	-	11	P	-	-
29	to	to	B-PP	B-PP	-	11	VMOD	-	-
30	a	a	B-NP	B-NP	-	32	NMOD	-	-
31	lesser	lesser	I-NP	I-NP	-	32	NMOD	-	-
32	extent	extent	I-NP	I-NP	-	29	PMOD	-	-
33	,	,	O	O	-	37	P	-	-
34	nuclear	nuclear	B-NP	B-NP	-	37	NMOD	-	-
35	factor-kappa	factor-kappa	I-NP	I-NP	-	37	NMOD	-	-
36	B/Rel	B/Rel	I-NP	I-NP	-	37	NMOD	-	-
37	induction	induction	I-NP	I-NP	-	29	PMOD	-	-
38	.	.	O	O	-	6	P	-	-

1	Transfection	Transfection	B-NP	B-NP	-	13	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	human	human	B-NP	B-NP	-	6	NMOD	-	-
4	promonocytic	promonocytic	I-NP	I-NP	-	6	NMOD	-	-
5	U-937	U-937	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
7	with	with	B-PP	B-PP	-	1	NMOD	-	-
8	an	an	B-NP	B-NP	-	12	NMOD	-	-
9	HTLV-I	HTLV-I	I-NP	I-NP	-	12	NMOD	-	-
10	Tax	Tax	I-NP	I-NP	-	12	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	12	NMOD	-	-
12	vector	vector	I-NP	I-NP	-	7	PMOD	-	-
13	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
14	galectin-3	galectin-3	B-NP	B-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	13	OBJ	-	-
16	in	in	B-PP	B-PP	-	13	VMOD	-	-
17	this	this	B-NP	B-NP	-	19	NMOD	-	-
18	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
19	line	line	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	13	P	-	-

1	Functionally	Functionally	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	galectin-3	galectin-3	B-NP	B-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	shown	shown	I-VP	I-VP	-	4	VC	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	activate	activate	I-VP	I-VP	-	5	VMOD	-	-
8	interleukin-2	interleukin-2	B-NP	B-NP	-	9	NMOD	-	-
9	production	production	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	7	VMOD	-	-
11	Jurkat	Jurkat	B-NP	B-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	4	P	-	-

1	Together	Together	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	findings	findings	I-NP	I-NP	-	5	SUB	-	-
5	raise	raise	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	possibility	possibility	I-NP	I-NP	-	5	OBJ	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	HTLV-I	HTLV-I	B-NP	B-NP	-	11	NMOD	-	-
10	Tax	Tax	I-NP	I-NP	-	11	NMOD	-	-
11	production	production	I-NP	I-NP	-	12	SUB	-	-
12	induces	induces	B-VP	B-VP	-	8	SBAR	-	-
13	the	the	B-NP	B-NP	-	17	NMOD	-	-
14	transcription	transcription	I-NP	I-NP	-	17	NMOD	-	-
15	and	and	I-NP	I-NP	-	17	NMOD	-	-
16	subsequent	subsequent	I-NP	I-NP	-	17	NMOD	-	-
17	synthesis	synthesis	I-NP	I-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	secretion	secretion	I-NP	I-NP	-	12	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	galectin-3	galectin-3	B-NP	B-NP	-	20	PMOD	-	-
22	,	,	O	O	-	21	P	-	-
23	which	which	B-NP	B-NP	-	21	NMOD	-	-
24	in	in	B-PP	B-PP	-	26	VMOD	-	-
25	turn	turn	B-NP	B-NP	-	24	PMOD	-	-
26	may	may	B-VP	B-VP	-	23	SBAR	-	-
27	further	further	I-VP	I-VP	-	26	VMOD	-	-
28	activate	activate	I-VP	I-VP	-	26	VC	-	-
29	these	these	B-NP	B-NP	-	31	NMOD	-	-
30	T	T	I-NP	I-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	28	OBJ	-	-
32	and	and	O	O	-	12	VMOD	-	-
33	contribute	contribute	B-VP	B-VP	-	12	VMOD	-	-
34	to	to	B-PP	B-PP	-	33	VMOD	-	-
35	the	the	B-NP	B-NP	-	37	NMOD	-	-
36	altered	altered	I-NP	I-NP	-	37	NMOD	-	-
37	properties	properties	I-NP	I-NP	-	34	PMOD	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	cell	cell	B-NP	B-NP	-	40	NMOD	-	-
40	growth	growth	I-NP	I-NP	-	38	PMOD	-	-
41	found	found	B-VP	B-VP	-	40	NMOD	-	-
42	in	in	B-PP	B-PP	-	41	VMOD	-	-
43	adult	adult	B-NP	B-NP	-	46	NMOD	-	-
44	T	T	I-NP	I-NP	-	46	NMOD	-	-
45	cell	cell	I-NP	I-NP	-	46	NMOD	-	-
46	leukemia	leukemia	I-NP	I-NP	-	42	PMOD	-	-
47	induced	induced	B-VP	B-VP	-	46	NMOD	-	-
48	by	by	B-PP	B-PP	-	47	VMOD	-	-
49	HTLV-I	HTLV-I	B-NP	B-NP	-	48	PMOD	-	-
50	.	.	O	O	-	5	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	2	NMOD	-	-
2	appearance	appearance	I-NP	I-NP	-	16	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	5	NMOD	-	-
5	factor	factor	I-NP	I-NP	-	3	PMOD	-	-
6	that	that	B-NP	B-NP	-	5	NMOD	-	-
7	binds	binds	B-VP	B-VP	-	6	SBAR	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	CD28	CD28	I-NP	I-NP	-	11	NMOD	-	-
10	response	response	I-NP	I-NP	-	11	NMOD	-	-
11	element	element	I-NP	I-NP	-	16	SUB	-	-
12	within	within	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	interleukin-2	interleukin-2	I-NP	I-NP	-	15	NMOD	-	-
15	enhancer	enhancer	I-NP	I-NP	-	12	PMOD	-	-
16	correlates	correlates	B-VP	B-VP	-	0	ROOT	-	-
17	with	with	B-PP	B-PP	-	16	VMOD	-	-
18	interleukin-2	interleukin-2	B-NP	B-NP	-	19	NMOD	-	-
19	production	production	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	16	P	-	-

1	Activation	Activation	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	4	NMOD	-	-
4	lymphocytes	lymphocytes	I-NP	I-NP	-	2	PMOD	-	-
5	requires	requires	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	combined	combined	I-NP	I-NP	-	8	NMOD	-	-
8	signaling	signaling	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	T	T	I-NP	I-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	receptor	receptor	I-NP	I-NP	-	9	PMOD	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	costimulatory	costimulatory	B-NP	B-NP	-	16	NMOD	-	-
16	molecules	molecules	I-NP	I-NP	-	9	PMOD	-	-
17	such	such	B-PP	B-PP	-	18	PMOD	-	-
18	as	as	I-PP	I-PP	-	16	NMOD	-	-
19	CD28	CD28	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	ability	ability	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	T	T	B-NP	B-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	produce	produce	I-VP	I-VP	-	2	NMOD	-	-
8	interleukin-2	interleukin-2	B-NP	B-NP	-	7	OBJ	-	-
9	(	(	O	O	-	10	P	-	-
10	IL-2	IL-2	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	critical	critical	I-NP	I-NP	-	16	NMOD	-	-
15	control	control	I-NP	I-NP	-	16	NMOD	-	-
16	point	point	I-NP	I-NP	-	12	PRD	-	-
17	in	in	B-PP	B-PP	-	16	NMOD	-	-
18	T	T	B-NP	B-NP	-	20	NMOD	-	-
19	lymphocyte	lymphocyte	I-NP	I-NP	-	20	NMOD	-	-
20	activation	activation	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	IL-2	IL-2	I-NP	I-NP	-	3	NMOD	-	-
3	enhancer	enhancer	I-NP	I-NP	-	4	SUB	-	-
4	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	functional	functional	I-NP	I-NP	-	7	NMOD	-	-
7	motif	motif	I-NP	I-NP	-	4	OBJ	-	-
8	named	named	B-VP	B-VP	-	7	NMOD	-	-
9	CD28	CD28	B-NP	B-NP	-	11	NMOD	-	-
10	response	response	I-NP	I-NP	-	11	NMOD	-	-
11	element	element	I-NP	I-NP	-	8	VMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	CD28RE	CD28RE	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	that	that	B-NP	B-NP	-	11	NMOD	-	-
16	serves	serves	B-VP	B-VP	-	15	SBAR	-	-
17	a	a	B-NP	B-NP	-	18	NMOD	-	-
18	role	role	I-NP	I-NP	-	16	OBJ	-	-
19	as	as	B-PP	B-PP	-	16	VMOD	-	-
20	a	a	B-NP	B-NP	-	21	NMOD	-	-
21	target	target	I-NP	I-NP	-	19	PMOD	-	-
22	for	for	B-PP	B-PP	-	21	NMOD	-	-
23	mitogenic	mitogenic	B-NP	B-NP	-	27	NMOD	-	-
24	T	T	I-NP	I-NP	-	27	NMOD	-	-
25	cell	cell	I-NP	I-NP	-	27	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	27	NMOD	-	-
27	signals	signals	I-NP	I-NP	-	22	PMOD	-	-
28	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	CD28RE	CD28RE	I-NP	I-NP	-	3	NMOD	-	-
3	sequence	sequence	I-NP	I-NP	-	4	SUB	-	-
4	reveals	reveals	B-VP	B-VP	-	0	ROOT	-	-
5	similarity	similarity	B-NP	B-NP	-	4	OBJ	-	-
6	to	to	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	11	NMOD	-	-
8	consensus	consensus	I-NP	I-NP	-	11	NMOD	-	-
9	kappaB	kappaB	I-NP	I-NP	-	11	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	11	NMOD	-	-
11	motif	motif	I-NP	I-NP	-	6	PMOD	-	-
12	.	.	O	O	-	4	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	CD28RE	CD28RE	B-NP	B-NP	-	6	SUB	-	-
6	binds	binds	B-VP	B-VP	-	4	SBAR	-	-
7	an	an	B-NP	B-NP	-	9	NMOD	-	-
8	inducible	inducible	I-NP	I-NP	-	9	NMOD	-	-
9	protein	protein	I-NP	I-NP	-	6	OBJ	-	-
10	with	with	B-PP	B-PP	-	9	NMOD	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	molecular	molecular	I-NP	I-NP	-	13	NMOD	-	-
13	mass	mass	I-NP	I-NP	-	10	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	approximately	approximately	B-NP	B-NP	-	17	NMOD	-	-
16	<num>	<num>	I-NP	I-NP	-	15	AMOD	-	-
17	kDa	kDa	I-NP	I-NP	-	14	PMOD	-	-
18	called	called	B-VP	B-VP	-	17	NMOD	-	-
19	nuclear	nuclear	B-NP	B-NP	-	20	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	14	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	mitogenic-activated	mitogenic-activated	B-NP	B-NP	-	24	NMOD	-	-
23	T	T	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	NF-MATp35	NF-MATp35	B-NP	B-NP	-	20	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	that	that	B-NP	B-NP	-	20	NMOD	-	-
29	is	is	B-VP	B-VP	-	28	SBAR	-	-
30	clearly	clearly	B-ADJP	B-ADJP	-	31	AMOD	-	-
31	different	different	I-ADJP	I-ADJP	-	29	PRD	-	-
32	from	from	B-PP	B-PP	-	31	AMOD	-	-
33	the	the	B-NP	B-NP	-	38	NMOD	-	-
34	known	known	I-NP	I-NP	-	38	NMOD	-	-
35	NF-	NF-	I-NP	I-NP	-	38	NMOD	-	-
36	kappaB/Rel	kappaB/Rel	I-NP	I-NP	-	38	NMOD	-	-
37	family	family	I-NP	I-NP	-	38	NMOD	-	-
38	members	members	I-NP	I-NP	-	32	PMOD	-	-
39	.	.	O	O	-	3	P	-	-

1	Induction	Induction	B-NP	B-NP	-	4	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NF-MATp35	NF-MATp35	B-NP	B-NP	-	2	PMOD	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	shown	shown	I-VP	I-VP	-	4	VC	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	depend	depend	I-VP	I-VP	-	5	VMOD	-	-
8	on	on	B-PP	B-PP	-	7	VMOD	-	-
9	de	de	B-NP	B-NP	-	10	AMOD	-	-
10	novo	novo	I-NP	I-NP	-	12	NMOD	-	-
11	protein	protein	I-NP	I-NP	-	12	NMOD	-	-
12	synthesis	synthesis	I-NP	I-NP	-	8	PMOD	-	-
13	and	and	O	O	-	4	VMOD	-	-
14	was	was	B-VP	B-VP	-	4	VMOD	-	-
15	restricted	restricted	B-ADJP	B-ADJP	-	14	PRD	-	-
16	to	to	B-PP	B-PP	-	15	AMOD	-	-
17	T	T	B-NP	B-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
19	that	that	B-NP	B-NP	-	18	NMOD	-	-
20	received	received	B-VP	B-VP	-	19	SBAR	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	mitogenic	mitogenic	I-NP	I-NP	-	23	NMOD	-	-
23	combination	combination	I-NP	I-NP	-	20	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	T	T	B-NP	B-NP	-	27	NMOD	-	-
26	cell	cell	I-NP	I-NP	-	27	NMOD	-	-
27	stimuli	stimuli	I-NP	I-NP	-	24	PMOD	-	-
28	,	,	O	O	-	14	P	-	-
29	not	not	B-VP	B-VP	-	14	VMOD	-	-
30	necessarily	necessarily	I-VP	I-VP	-	29	AMOD	-	-
31	including	including	I-VP	I-VP	-	29	NMOD	-	-
32	CD28	CD28	B-NP	B-NP	-	33	NMOD	-	-
33	signaling	signaling	I-NP	I-NP	-	31	PMOD	-	-
34	.	.	O	O	-	4	P	-	-

1	Nonmitogenic	Nonmitogenic	B-NP	B-NP	-	4	NMOD	-	-
2	T	T	I-NP	I-NP	-	4	NMOD	-	-
3	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
4	stimulation	stimulation	I-NP	I-NP	-	5	SUB	-	-
5	did	did	B-VP	B-VP	-	0	ROOT	-	-
6	not	not	I-VP	I-VP	-	5	VMOD	-	-
7	result	result	I-VP	I-VP	-	5	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	appearance	appearance	B-NP	B-NP	-	8	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-MATp35	NF-MATp35	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	mitogenic	mitogenic	B-NP	B-NP	-	6	NMOD	-	-
6	combinations	combinations	I-NP	I-NP	-	12	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	T	T	B-NP	B-NP	-	11	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	11	NMOD	-	-
11	signals	signals	I-NP	I-NP	-	7	PMOD	-	-
12	are	are	B-VP	B-VP	-	4	SBAR	-	-
13	integrated	integrated	I-VP	I-VP	-	12	VC	-	-
14	at	at	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	level	level	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	NF-MATp35	NF-MATp35	B-NP	B-NP	-	19	NMOD	-	-
19	induction	induction	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	Similar	Similar	B-ADJP	B-ADJP	-	11	VMOD	-	-
2	to	to	B-PP	B-PP	-	1	AMOD	-	-
3	its	its	B-NP	B-NP	-	4	NMOD	-	-
4	effect	effect	I-NP	I-NP	-	2	PMOD	-	-
5	on	on	B-PP	B-PP	-	4	NMOD	-	-
6	IL-2	IL-2	B-NP	B-NP	-	7	NMOD	-	-
7	production	production	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	11	P	-	-
9	cyclosporin	cyclosporin	B-NP	B-NP	-	10	NMOD	-	-
10	A	A	I-NP	I-NP	-	11	SUB	-	-
11	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	induction	induction	I-NP	I-NP	-	11	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	NF-MATp35	NF-MATp35	B-NP	B-NP	-	14	PMOD	-	-
16	.	.	O	O	-	11	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	data	data	I-NP	I-NP	-	6	SUB	-	-
6	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	nuclear	nuclear	I-NP	I-NP	-	10	NMOD	-	-
10	appearance	appearance	I-NP	I-NP	-	13	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	NF-MATp35	NF-MATp35	B-NP	B-NP	-	11	PMOD	-	-
13	shows	shows	B-VP	B-VP	-	7	SBAR	-	-
14	excellent	excellent	B-NP	B-NP	-	15	NMOD	-	-
15	correlation	correlation	I-NP	I-NP	-	13	OBJ	-	-
16	with	with	B-PP	B-PP	-	15	NMOD	-	-
17	IL-2	IL-2	B-NP	B-NP	-	18	NMOD	-	-
18	production	production	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	15	P	-	-
20	which	which	B-NP	B-NP	-	15	NMOD	-	-
21	is	is	B-VP	B-VP	-	20	SBAR	-	-
22	a	a	B-NP	B-NP	-	24	NMOD	-	-
23	unique	unique	I-NP	I-NP	-	24	NMOD	-	-
24	characteristic	characteristic	I-NP	I-NP	-	21	PRD	-	-
25	among	among	B-PP	B-PP	-	24	NMOD	-	-
26	nuclear	nuclear	B-NP	B-NP	-	27	NMOD	-	-
27	factors	factors	I-NP	I-NP	-	25	PMOD	-	-
28	implicated	implicated	B-VP	B-VP	-	27	NMOD	-	-
29	in	in	B-PP	B-PP	-	28	VMOD	-	-
30	the	the	B-NP	B-NP	-	31	NMOD	-	-
31	control	control	I-NP	I-NP	-	29	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	IL-2	IL-2	B-NP	B-NP	-	35	NMOD	-	-
34	gene	gene	I-NP	I-NP	-	35	NMOD	-	-
35	expression	expression	I-NP	I-NP	-	32	PMOD	-	-
36	.	.	O	O	-	6	P	-	-

1	Preassociation	Preassociation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	STAT1	STAT1	B-NP	B-NP	-	2	PMOD	-	-
4	with	with	B-PP	B-PP	-	1	NMOD	-	-
5	STAT2	STAT2	B-NP	B-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	STAT3	STAT3	I-NP	I-NP	-	4	PMOD	-	-
8	in	in	B-PP	B-PP	-	1	NMOD	-	-
9	separate	separate	B-NP	B-NP	-	11	NMOD	-	-
10	signalling	signalling	I-NP	I-NP	-	11	NMOD	-	-
11	complexes	complexes	I-NP	I-NP	-	8	PMOD	-	-
12	prior	prior	B-ADVP	B-ADVP	-	13	PMOD	-	-
13	to	to	B-PP	B-PP	-	1	NMOD	-	-
14	cytokine	cytokine	B-NP	B-NP	-	15	NMOD	-	-
15	stimulation	stimulation	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	1	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	variety	variety	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	cytokines	cytokines	B-NP	B-NP	-	7	NMOD	-	-
5	and	and	O	O	-	7	NMOD	-	-
6	growth	growth	B-NP	B-NP	-	7	NMOD	-	-
7	factors	factors	I-NP	I-NP	-	3	PMOD	-	-
8	act	act	B-VP	B-VP	-	0	ROOT	-	-
9	through	through	B-PP	B-PP	-	8	VMOD	-	-
10	an	an	B-NP	B-NP	-	11	NMOD	-	-
11	induction	induction	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	gene	gene	B-NP	B-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	12	PMOD	-	-
15	mediated	mediated	B-VP	B-VP	-	11	NMOD	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	a	a	B-NP	B-NP	-	18	NMOD	-	-
18	family	family	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	latent	latent	B-NP	B-NP	-	22	NMOD	-	-
21	transcription	transcription	I-NP	I-NP	-	22	NMOD	-	-
22	factors	factors	I-NP	I-NP	-	19	PMOD	-	-
23	called	called	B-VP	B-VP	-	22	NMOD	-	-
24	STAT	STAT	B-NP	B-NP	-	31	NMOD	-	-
25	(	(	O	O	-	31	P	-	-
26	signal	signal	B-NP	B-NP	-	31	NMOD	-	-
27	transducers	transducers	I-NP	I-NP	-	31	NMOD	-	-
28	and	and	O	O	-	31	NMOD	-	-
29	activators	activators	B-NP	B-NP	-	31	NMOD	-	-
30	of	of	B-PP	B-PP	-	31	NMOD	-	-
31	transcription	transcription	B-NP	B-NP	-	33	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	proteins	proteins	B-NP	B-NP	-	23	VMOD	-	-
34	.	.	O	O	-	8	P	-	-

1	Ligand-induced	Ligand-induced	B-NP	B-NP	-	3	NMOD	-	-
2	tyrosine	tyrosine	I-NP	I-NP	-	3	NMOD	-	-
3	phosphorylation	phosphorylation	I-NP	I-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	STATs	STATs	I-NP	I-NP	-	4	PMOD	-	-
7	promotes	promotes	B-VP	B-VP	-	0	ROOT	-	-
8	their	their	B-NP	B-NP	-	16	NMOD	-	-
9	homodimer	homodimer	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	I-NP	I-NP	-	12	NMOD	-	-
11	heterodimer	heterodimer	I-NP	I-NP	-	12	NMOD	-	-
12	formation	formation	I-NP	I-NP	-	16	NMOD	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	subsequent	subsequent	B-NP	B-NP	-	16	NMOD	-	-
15	nuclear	nuclear	I-NP	I-NP	-	16	NMOD	-	-
16	translocation	translocation	I-NP	I-NP	-	7	OBJ	-	-
17	.	.	O	O	-	7	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	STAT	STAT	B-NP	B-NP	-	7	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	7	NMOD	-	-
7	heterocomplexes	heterocomplexes	I-NP	I-NP	-	8	SUB	-	-
8	exist	exist	B-VP	B-VP	-	4	SBAR	-	-
9	prior	prior	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	to	to	B-PP	B-PP	-	8	VMOD	-	-
11	cytokine	cytokine	B-NP	B-NP	-	12	NMOD	-	-
12	treatment	treatment	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	2	P	-	-

1	When	When	B-ADVP	B-ADVP	-	25	VMOD	-	-
2	unstimulated	unstimulated	B-NP	B-NP	-	4	NMOD	-	-
3	HeLa	HeLa	I-NP	I-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	5	SUB	-	-
5	are	are	B-VP	B-VP	-	1	SBAR	-	-
6	ruptured	ruptured	I-VP	I-VP	-	5	VC	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	hypotonic	hypotonic	B-NP	B-NP	-	9	NMOD	-	-
9	buffer	buffer	I-NP	I-NP	-	7	PMOD	-	-
10	without	without	B-PP	B-PP	-	9	NMOD	-	-
11	salt	salt	B-NP	B-NP	-	13	NMOD	-	-
12	or	or	I-NP	I-NP	-	13	NMOD	-	-
13	detergent	detergent	I-NP	I-NP	-	10	PMOD	-	-
14	,	,	O	O	-	25	P	-	-
15	immunoadsorption	immunoadsorption	B-NP	B-NP	-	25	SUB	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	either	either	O	O	-	20	NMOD	-	-
18	STAT1	STAT1	B-NP	B-NP	-	20	NMOD	-	-
19	or	or	I-NP	I-NP	-	20	NMOD	-	-
20	STAT2	STAT2	I-NP	I-NP	-	16	PMOD	-	-
21	from	from	B-PP	B-PP	-	15	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	resulting	resulting	I-NP	I-NP	-	24	NMOD	-	-
24	cytosol	cytosol	I-NP	I-NP	-	21	PMOD	-	-
25	yields	yields	B-VP	B-VP	-	0	ROOT	-	-
26	coimmunoadsorption	coimmunoadsorption	B-NP	B-NP	-	25	OBJ	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	31	NMOD	-	-
29	other	other	I-NP	I-NP	-	31	NMOD	-	-
30	STAT	STAT	I-NP	I-NP	-	31	NMOD	-	-
31	protein	protein	I-NP	I-NP	-	27	PMOD	-	-
32	.	.	O	O	-	25	P	-	-

1	Similarly	Similarly	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	STAT1-STAT3	STAT1-STAT3	B-NP	B-NP	-	4	NMOD	-	-
4	heterocomplexes	heterocomplexes	I-NP	I-NP	-	5	SUB	-	-
5	are	are	B-VP	B-VP	-	0	ROOT	-	-
6	coimmunoadsorbed	coimmunoadsorbed	I-VP	I-VP	-	5	VC	-	-
7	from	from	B-PP	B-PP	-	6	VMOD	-	-
8	hypotonic	hypotonic	B-NP	B-NP	-	9	NMOD	-	-
9	cytosol	cytosol	I-NP	I-NP	-	7	PMOD	-	-
10	.	.	O	O	-	5	P	-	-

1	STAT1	STAT1	B-NP	B-NP	-	7	NMOD	-	-
2	and	and	I-NP	I-NP	-	7	NMOD	-	-
3	STAT2	STAT2	I-NP	I-NP	-	7	NMOD	-	-
4	or	or	I-NP	I-NP	-	7	NMOD	-	-
5	STAT1	STAT1	I-NP	I-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	STAT3	STAT3	I-NP	I-NP	-	13	SUB	-	-
8	translated	translated	B-VP	B-VP	-	7	NMOD	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	reticulocyte	reticulocyte	B-NP	B-NP	-	11	NMOD	-	-
11	lysate	lysate	I-NP	I-NP	-	9	PMOD	-	-
12	spontaneously	spontaneously	B-VP	B-VP	-	13	VMOD	-	-
13	form	form	I-VP	I-VP	-	0	ROOT	-	-
14	heterocomplexes	heterocomplexes	B-NP	B-NP	-	13	OBJ	-	-
15	when	when	B-ADVP	B-ADVP	-	13	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	translation	translation	I-NP	I-NP	-	18	NMOD	-	-
18	lysates	lysates	I-NP	I-NP	-	19	SUB	-	-
19	are	are	B-VP	B-VP	-	15	SBAR	-	-
20	mixed	mixed	I-VP	I-VP	-	19	VC	-	-
21	at	at	B-PP	B-PP	-	20	VMOD	-	-
22	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
23	degrees	degrees	I-NP	I-NP	-	21	PMOD	-	-
24	C	C	B-ADJP	B-ADJP	-	23	NMOD	-	-
25	.	.	O	O	-	19	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	interferon-alpha	interferon-alpha	B-NP	B-NP	-	8	NMOD	-	-
6	/beta-induced	/beta-induced	I-NP	I-NP	-	8	NMOD	-	-
7	tyrosine	tyrosine	I-NP	I-NP	-	8	NMOD	-	-
8	phosphorylation	phosphorylation	I-NP	I-NP	-	9	SUB	-	-
9	increases	increases	B-VP	B-VP	-	4	SBAR	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	stability	stability	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	a	a	B-NP	B-NP	-	20	NMOD	-	-
14	preexisting	preexisting	I-NP	I-NP	-	20	NMOD	-	-
15	,	,	I-NP	I-NP	-	20	P	-	-
16	latent	latent	I-NP	I-NP	-	20	NMOD	-	-
17	,	,	I-NP	I-NP	-	20	P	-	-
18	STAT1-STAT2	STAT1-STAT2	I-NP	I-NP	-	20	NMOD	-	-
19	signaling	signaling	I-NP	I-NP	-	20	NMOD	-	-
20	complex	complex	I-NP	I-NP	-	12	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	Newly	Newly	B-NP	B-NP	-	2	AMOD	-	-
2	translated	translated	I-NP	I-NP	-	3	NMOD	-	-
3	STAT1	STAT1	I-NP	I-NP	-	4	SUB	-	-
4	binds	binds	B-VP	B-VP	-	15	VMOD	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	equilibrium	equilibrium	B-NP	B-NP	-	7	NMOD	-	-
7	fashion	fashion	I-NP	I-NP	-	5	PMOD	-	-
8	to	to	B-PP	B-PP	-	4	VMOD	-	-
9	STAT2	STAT2	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	STAT3	STAT3	I-NP	I-NP	-	8	PMOD	-	-
12	,	,	O	O	-	15	P	-	-
13	but	but	O	O	-	15	VMOD	-	-
14	we	we	B-NP	B-NP	-	15	SUB	-	-
15	show	show	B-VP	B-VP	-	0	ROOT	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	STAT2	STAT2	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	STAT3	STAT3	I-NP	I-NP	-	20	SUB	-	-
20	exist	exist	B-VP	B-VP	-	16	SBAR	-	-
21	in	in	B-PP	B-PP	-	20	VMOD	-	-
22	separate	separate	B-NP	B-NP	-	23	NMOD	-	-
23	heterocomplexes	heterocomplexes	I-NP	I-NP	-	21	PMOD	-	-
24	with	with	B-PP	B-PP	-	20	VMOD	-	-
25	STAT1	STAT1	B-NP	B-NP	-	24	PMOD	-	-
26	,	,	O	O	-	20	P	-	-
27	consistent	consistent	B-ADJP	B-ADJP	-	20	VMOD	-	-
28	with	with	B-PP	B-PP	-	27	AMOD	-	-
29	a	a	B-NP	B-NP	-	30	NMOD	-	-
30	model	model	I-NP	I-NP	-	28	PMOD	-	-
31	in	in	B-PP	B-PP	-	30	NMOD	-	-
32	which	which	B-NP	B-NP	-	31	PMOD	-	-
33	STAT1	STAT1	B-NP	B-NP	-	31	PMOD	-	-
34	contains	contains	B-VP	B-VP	-	31	SBAR	-	-
35	a	a	B-NP	B-NP	-	38	NMOD	-	-
36	common	common	I-NP	I-NP	-	38	NMOD	-	-
37	binding	binding	I-NP	I-NP	-	38	NMOD	-	-
38	site	site	I-NP	I-NP	-	34	OBJ	-	-
39	for	for	B-PP	B-PP	-	38	NMOD	-	-
40	other	other	B-NP	B-NP	-	42	NMOD	-	-
41	STAT	STAT	I-NP	I-NP	-	42	NMOD	-	-
42	proteins	proteins	I-NP	I-NP	-	39	PMOD	-	-
43	.	.	O	O	-	15	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	p105	p105	B-NP	B-NP	-	4	NMOD	-	-
4	processing	processing	I-NP	I-NP	-	2	PMOD	-	-
5	by	by	B-PP	B-PP	-	1	NMOD	-	-
6	NF-kappaB	NF-kappaB	B-NP	B-NP	-	7	NMOD	-	-
7	proteins	proteins	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-PP	B-PP	-	1	NMOD	-	-
9	transiently	transiently	B-NP	B-NP	-	10	AMOD	-	-
10	transfected	transfected	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
12	.	.	O	O	-	1	P	-	-

1	Regulation	Regulation	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	transcription	transcription	I-NP	I-NP	-	6	NMOD	-	-
5	factor	factor	I-NP	I-NP	-	6	NMOD	-	-
6	NF-kappaB	NF-kappaB	I-NP	I-NP	-	2	PMOD	-	-
7	involves	involves	B-VP	B-VP	-	0	ROOT	-	-
8	proteasome-mediated	proteasome-mediated	B-NP	B-NP	-	9	NMOD	-	-
9	processing	processing	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	NF-kappaB1	NF-kappaB1	I-NP	I-NP	-	15	NMOD	-	-
13	p105	p105	I-NP	I-NP	-	15	NMOD	-	-
14	precursor	precursor	I-NP	I-NP	-	15	NMOD	-	-
15	protein	protein	I-NP	I-NP	-	10	PMOD	-	-
16	,	,	O	O	-	15	P	-	-
17	which	which	B-NP	B-NP	-	15	NMOD	-	-
18	generates	generates	B-VP	B-VP	-	17	SBAR	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	p50	p50	I-NP	I-NP	-	21	NMOD	-	-
21	subunit	subunit	I-NP	I-NP	-	18	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	NF-kappaB	NF-kappaB	B-NP	B-NP	-	22	PMOD	-	-
24	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	processing	processing	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	p105	p105	B-NP	B-NP	-	3	PMOD	-	-
5	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
6	constitutively	constitutively	B-ADVP	B-ADVP	-	5	VMOD	-	-
7	in	in	B-ADVP	B-ADVP	-	5	VMOD	-	-
8	vivo	vivo	I-ADVP	I-ADVP	-	7	AMOD	-	-
9	but	but	O	O	-	5	VMOD	-	-
10	can	can	B-VP	B-VP	-	5	VMOD	-	-
11	be	be	I-VP	I-VP	-	10	VC	-	-
12	markedly	markedly	I-VP	I-VP	-	11	VMOD	-	-
13	enhanced	enhanced	I-VP	I-VP	-	11	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	various	various	B-NP	B-NP	-	18	NMOD	-	-
16	cellular	cellular	I-NP	I-NP	-	18	NMOD	-	-
17	activation	activation	I-NP	I-NP	-	18	NMOD	-	-
18	agents	agents	I-NP	I-NP	-	14	PMOD	-	-
19	,	,	O	O	-	5	P	-	-
20	although	although	B-SBAR	B-SBAR	-	5	VMOD	-	-
21	the	the	B-NP	B-NP	-	24	NMOD	-	-
22	underlying	underlying	I-NP	I-NP	-	24	NMOD	-	-
23	regulatory	regulatory	I-NP	I-NP	-	24	NMOD	-	-
24	mechanism	mechanism	I-NP	I-NP	-	25	SUB	-	-
25	is	is	B-VP	B-VP	-	20	SBAR	-	-
26	not	not	O	O	-	25	VMOD	-	-
27	yet	yet	B-ADJP	B-ADJP	-	28	AMOD	-	-
28	clear	clear	I-ADJP	I-ADJP	-	25	PRD	-	-
29	.	.	O	O	-	5	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	present	present	I-NP	I-NP	-	4	NMOD	-	-
4	study	study	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	signal-mediated	signal-mediated	B-NP	B-NP	-	10	NMOD	-	-
10	induction	induction	I-NP	I-NP	-	18	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	p105	p105	B-NP	B-NP	-	13	NMOD	-	-
13	processing	processing	I-NP	I-NP	-	11	PMOD	-	-
14	in	in	B-PP	B-PP	-	10	NMOD	-	-
15	human	human	B-NP	B-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	is	is	B-VP	B-VP	-	8	SBAR	-	-
19	associated	associated	I-VP	I-VP	-	18	VC	-	-
20	with	with	B-PP	B-PP	-	19	VMOD	-	-
21	de	de	B-NP	B-NP	-	22	AMOD	-	-
22	novo	novo	I-NP	I-NP	-	23	NMOD	-	-
23	synthesis	synthesis	I-NP	I-NP	-	20	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	this	this	B-NP	B-NP	-	27	NMOD	-	-
26	precursor	precursor	I-NP	I-NP	-	27	NMOD	-	-
27	protein	protein	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	7	P	-	-

1	Transient	Transient	B-NP	B-NP	-	3	NMOD	-	-
2	transfection	transfection	I-NP	I-NP	-	3	NMOD	-	-
3	studies	studies	I-NP	I-NP	-	8	SUB	-	-
4	performed	performed	B-VP	B-VP	-	3	NMOD	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	COS7	COS7	B-NP	B-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
8	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
9	that	that	B-SBAR	B-SBAR	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	newly	newly	I-NP	I-NP	-	12	AMOD	-	-
12	synthesized	synthesized	I-NP	I-NP	-	14	NMOD	-	-
13	p105	p105	I-NP	I-NP	-	14	NMOD	-	-
14	protein	protein	I-NP	I-NP	-	15	SUB	-	-
15	appears	appears	B-VP	B-VP	-	9	SBAR	-	-
16	to	to	I-VP	I-VP	-	17	VMOD	-	-
17	be	be	I-VP	I-VP	-	15	VMOD	-	-
18	more	more	B-ADVP	B-ADVP	-	19	AMOD	-	-
19	rapidly	rapidly	I-ADVP	I-ADVP	-	20	VMOD	-	-
20	processed	processed	B-VP	B-VP	-	15	VMOD	-	-
21	compared	compared	I-VP	I-VP	-	20	VMOD	-	-
22	to	to	B-PP	B-PP	-	21	PMOD	-	-
23	its	its	B-NP	B-NP	-	25	NMOD	-	-
24	accumulated	accumulated	I-NP	I-NP	-	25	NMOD	-	-
25	form	form	I-NP	I-NP	-	22	PMOD	-	-
26	that	that	B-NP	B-NP	-	25	NMOD	-	-
27	is	is	B-VP	B-VP	-	26	SBAR	-	-
28	already	already	I-VP	I-VP	-	27	VMOD	-	-
29	associated	associated	I-VP	I-VP	-	27	VC	-	-
30	with	with	B-PP	B-PP	-	29	VMOD	-	-
31	the	the	B-NP	B-NP	-	34	NMOD	-	-
32	processed	processed	I-NP	I-NP	-	34	NMOD	-	-
33	product	product	I-NP	I-NP	-	34	NMOD	-	-
34	p50	p50	I-NP	I-NP	-	30	PMOD	-	-
35	.	.	O	O	-	8	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	processing	processing	I-NP	I-NP	-	5	NMOD	-	-
5	rate	rate	I-NP	I-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	p105	p105	B-NP	B-NP	-	6	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	markedly	markedly	I-VP	I-VP	-	8	VMOD	-	-
10	inhibited	inhibited	I-VP	I-VP	-	8	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	cells	cells	B-NP	B-NP	-	11	PMOD	-	-
13	co-transfected	co-transfected	B-VP	B-VP	-	12	NMOD	-	-
14	with	with	B-PP	B-PP	-	13	VMOD	-	-
15	p50	p50	B-NP	B-NP	-	19	NMOD	-	-
16	or	or	O	O	-	19	NMOD	-	-
17	other	other	B-NP	B-NP	-	19	NMOD	-	-
18	NF-kappaB	NF-kappaB	I-NP	I-NP	-	19	NMOD	-	-
19	subunits	subunits	I-NP	I-NP	-	14	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	including	including	B-PP	B-PP	-	19	NMOD	-	-
22	RelA	RelA	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	c-Rel	c-Rel	I-NP	I-NP	-	21	PMOD	-	-
25	,	,	O	O	-	24	P	-	-
26	that	that	B-NP	B-NP	-	24	NMOD	-	-
27	physically	physically	B-ADVP	B-ADVP	-	28	VMOD	-	-
28	interact	interact	B-VP	B-VP	-	26	SBAR	-	-
29	with	with	B-PP	B-PP	-	28	VMOD	-	-
30	p105	p105	B-NP	B-NP	-	29	PMOD	-	-
31	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	processing	processing	I-NP	I-NP	-	9	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	p105	p105	B-NP	B-NP	-	7	PMOD	-	-
9	is	is	B-VP	B-VP	-	4	SBAR	-	-
10	subject	subject	B-ADJP	B-ADJP	-	9	PRD	-	-
11	to	to	B-PP	B-PP	-	10	AMOD	-	-
12	negative	negative	B-NP	B-NP	-	13	NMOD	-	-
13	regulation	regulation	I-NP	I-NP	-	11	PMOD	-	-
14	by	by	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	various	various	I-NP	I-NP	-	18	NMOD	-	-
17	NF-kappaB	NF-kappaB	I-NP	I-NP	-	18	NMOD	-	-
18	subunits	subunits	I-NP	I-NP	-	14	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	further	further	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	p105	p105	B-NP	B-NP	-	6	SUB	-	-
6	undergoes	undergoes	B-VP	B-VP	-	4	SBAR	-	-
7	degradation	degradation	B-NP	B-NP	-	6	OBJ	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	lipopolysaccharide-stimulated	lipopolysaccharide-stimulated	B-NP	B-NP	-	12	NMOD	-	-
10	human	human	I-NP	I-NP	-	12	NMOD	-	-
11	monocytic	monocytic	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
13	.	.	O	O	-	3	P	-	-

1	However	However	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	inducible	inducible	I-NP	I-NP	-	5	NMOD	-	-
5	degradation	degradation	I-NP	I-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	p105	p105	B-NP	B-NP	-	6	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	coupled	coupled	I-VP	I-VP	-	8	VC	-	-
11	with	with	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	generation	generation	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	p50	p50	B-NP	B-NP	-	14	PMOD	-	-
16	.	.	O	O	-	8	P	-	-

1	Together	Together	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	studies	studies	I-NP	I-NP	-	5	SUB	-	-
5	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	11	NMOD	-	-
8	processing	processing	I-NP	I-NP	-	11	NMOD	-	-
9	and	and	I-NP	I-NP	-	11	NMOD	-	-
10	inducible	inducible	I-NP	I-NP	-	11	NMOD	-	-
11	degradation	degradation	I-NP	I-NP	-	14	SUB	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	p105	p105	B-NP	B-NP	-	12	PMOD	-	-
14	are	are	B-VP	B-VP	-	6	SBAR	-	-
15	differentially	differentially	I-VP	I-VP	-	14	VMOD	-	-
16	regulated	regulated	I-VP	I-VP	-	14	VC	-	-
17	.	.	O	O	-	5	P	-	-

1	Globin	Globin	B-NP	B-NP	-	3	NMOD	-	-
2	gene	gene	I-NP	I-NP	-	3	NMOD	-	-
3	switching	switching	I-NP	I-NP	-	0	ROOT	-	-
4	.	.	O	O	-	3	P	-	-

1	In	In	B-NP	B-NP	-	2	AMOD	-	-
2	vivo	vivo	I-NP	I-NP	-	4	NMOD	-	-
3	protein-DNA	protein-DNA	I-NP	I-NP	-	4	NMOD	-	-
4	interactions	interactions	I-NP	I-NP	-	0	ROOT	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	human	human	I-NP	I-NP	-	9	NMOD	-	-
8	beta-globin	beta-globin	I-NP	I-NP	-	9	NMOD	-	-
9	locus	locus	I-NP	I-NP	-	5	PMOD	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	erythroid	erythroid	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	expressing	expressing	B-VP	B-VP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	fetal	fetal	I-NP	I-NP	-	21	NMOD	-	-
16	or	or	O	O	-	21	NMOD	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	adult	adult	I-NP	I-NP	-	21	NMOD	-	-
19	globin	globin	I-NP	I-NP	-	21	NMOD	-	-
20	gene	gene	I-NP	I-NP	-	21	NMOD	-	-
21	program	program	I-NP	I-NP	-	13	OBJ	-	-
22	.	.	O	O	-	4	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	characterize	characterize	I-VP	I-VP	-	18	VMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	protein-DNA	protein-DNA	I-NP	I-NP	-	5	NMOD	-	-
5	interactions	interactions	I-NP	I-NP	-	2	OBJ	-	-
6	important	important	B-ADJP	B-ADJP	-	5	NMOD	-	-
7	for	for	B-PP	B-PP	-	6	AMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	developmental	developmental	I-NP	I-NP	-	10	NMOD	-	-
10	control	control	I-NP	I-NP	-	7	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	human	human	I-NP	I-NP	-	15	NMOD	-	-
14	beta-globin	beta-globin	I-NP	I-NP	-	15	NMOD	-	-
15	locus	locus	I-NP	I-NP	-	11	PMOD	-	-
16	,	,	O	O	-	18	P	-	-
17	we	we	B-NP	B-NP	-	18	SUB	-	-
18	analyzed	analyzed	B-VP	B-VP	-	0	ROOT	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	in	in	B-NP	B-NP	-	21	AMOD	-	-
21	vivo	vivo	I-NP	I-NP	-	26	NMOD	-	-
22	dimethyl	dimethyl	I-NP	I-NP	-	26	NMOD	-	-
23	sulfate	sulfate	I-NP	I-NP	-	26	NMOD	-	-
24	footprinting	footprinting	I-NP	I-NP	-	26	NMOD	-	-
25	erythroid	erythroid	I-NP	I-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
27	expressing	expressing	B-VP	B-VP	-	26	NMOD	-	-
28	either	either	O	O	-	36	NMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	fetal	fetal	I-NP	I-NP	-	28	PRD	-	-
31	or	or	O	O	-	36	NMOD	-	-
32	the	the	B-NP	B-NP	-	36	NMOD	-	-
33	adult	adult	I-NP	I-NP	-	36	NMOD	-	-
34	globin	globin	I-NP	I-NP	-	36	NMOD	-	-
35	developmental	developmental	I-NP	I-NP	-	36	NMOD	-	-
36	program	program	I-NP	I-NP	-	27	OBJ	-	-
37	.	.	O	O	-	18	P	-	-

1	In	In	B-PP	B-PP	-	26	VMOD	-	-
2	the	the	B-NP	B-NP	-	5	NMOD	-	-
3	locus	locus	I-NP	I-NP	-	5	NMOD	-	-
4	control	control	I-NP	I-NP	-	5	NMOD	-	-
5	region	region	I-NP	I-NP	-	1	PMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	LCR	LCR	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	of	of	B-PP	B-PP	-	5	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	beta-globin	beta-globin	I-NP	I-NP	-	12	NMOD	-	-
12	locus	locus	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	26	P	-	-
14	in	in	B-NP	B-NP	-	15	AMOD	-	-
15	vivo	vivo	I-NP	I-NP	-	16	NMOD	-	-
16	footprints	footprints	I-NP	I-NP	-	26	SUB	-	-
17	on	on	B-PP	B-PP	-	16	NMOD	-	-
18	NF-E2	NF-E2	B-NP	B-NP	-	25	NMOD	-	-
19	(	(	O	O	-	21	P	-	-
20	or	or	O	O	-	21	NMOD	-	-
21	AP-1	AP-1	B-NP	B-NP	-	18	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	and	and	O	O	-	25	NMOD	-	-
24	GATA-1	GATA-1	B-NP	B-NP	-	25	NMOD	-	-
25	motifs	motifs	I-NP	I-NP	-	17	PMOD	-	-
26	remained	remained	B-VP	B-VP	-	0	ROOT	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	same	same	I-NP	I-NP	-	26	PRD	-	-
29	regardless	regardless	B-ADVP	B-ADVP	-	26	VMOD	-	-
30	of	of	B-PP	B-PP	-	29	AMOD	-	-
31	whether	whether	B-SBAR	B-SBAR	-	30	PMOD	-	-
32	the	the	B-NP	B-NP	-	33	NMOD	-	-
33	fetal	fetal	I-NP	I-NP	-	38	NMOD	-	-
34	or	or	O	O	-	38	NMOD	-	-
35	the	the	B-NP	B-NP	-	38	NMOD	-	-
36	adult	adult	I-NP	I-NP	-	38	NMOD	-	-
37	globin	globin	I-NP	I-NP	-	38	NMOD	-	-
38	genes	genes	I-NP	I-NP	-	39	SUB	-	-
39	are	are	B-VP	B-VP	-	31	SBAR	-	-
40	expressed	expressed	I-VP	I-VP	-	39	VC	-	-
41	.	.	O	O	-	26	P	-	-

1	In	In	B-PP	B-PP	-	13	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	13	P	-	-
4	in	in	B-NP	B-NP	-	5	AMOD	-	-
5	vivo	vivo	I-NP	I-NP	-	6	NMOD	-	-
6	footprints	footprints	I-NP	I-NP	-	13	SUB	-	-
7	on	on	B-PP	B-PP	-	6	NMOD	-	-
8	GT	GT	B-NP	B-NP	-	12	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	CACCC	CACCC	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	motifs	motifs	B-NP	B-NP	-	7	PMOD	-	-
13	differed	differed	B-VP	B-VP	-	0	ROOT	-	-
14	between	between	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
17	expressing	expressing	B-VP	B-VP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	fetal	fetal	I-NP	I-NP	-	24	NMOD	-	-
20	or	or	O	O	-	24	NMOD	-	-
21	the	the	B-NP	B-NP	-	24	NMOD	-	-
22	adult	adult	I-NP	I-NP	-	24	NMOD	-	-
23	globin	globin	I-NP	I-NP	-	24	NMOD	-	-
24	program	program	I-NP	I-NP	-	17	OBJ	-	-
25	.	.	O	O	-	13	P	-	-

1	In	In	B-PP	B-PP	-	9	VMOD	-	-
2	promoter	promoter	B-NP	B-NP	-	3	NMOD	-	-
3	regions	regions	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	9	P	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	actively	actively	I-NP	I-NP	-	7	AMOD	-	-
7	transcribed	transcribed	I-NP	I-NP	-	8	NMOD	-	-
8	genes	genes	I-NP	I-NP	-	9	SUB	-	-
9	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
10	extensive	extensive	B-NP	B-NP	-	13	NMOD	-	-
11	and	and	I-NP	I-NP	-	13	NMOD	-	-
12	consistent	consistent	I-NP	I-NP	-	13	NMOD	-	-
13	footprints	footprints	I-NP	I-NP	-	9	OBJ	-	-
14	over	over	B-PP	B-PP	-	9	VMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	canonical	canonical	I-NP	I-NP	-	17	NMOD	-	-
17	elements	elements	I-NP	I-NP	-	14	PMOD	-	-
18	,	,	O	O	-	17	P	-	-
19	such	such	B-PP	B-PP	-	20	PMOD	-	-
20	as	as	I-PP	I-PP	-	17	NMOD	-	-
21	CACCC	CACCC	B-NP	B-NP	-	24	NMOD	-	-
22	and	and	I-NP	I-NP	-	24	NMOD	-	-
23	CCAAT	CCAAT	I-NP	I-NP	-	24	NMOD	-	-
24	motifs	motifs	I-NP	I-NP	-	20	PMOD	-	-
25	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	adult	adult	I-NP	I-NP	-	5	NMOD	-	-
3	globin	globin	I-NP	I-NP	-	5	NMOD	-	-
4	expressing	expressing	I-NP	I-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	6	SUB	-	-
6	displayed	displayed	B-VP	B-VP	-	0	ROOT	-	-
7	more	more	B-NP	B-NP	-	8	AMOD	-	-
8	extensive	extensive	I-NP	I-NP	-	9	NMOD	-	-
9	footprints	footprints	I-NP	I-NP	-	6	OBJ	-	-
10	than	than	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	fetal	fetal	I-NP	I-NP	-	15	NMOD	-	-
13	globin	globin	I-NP	I-NP	-	15	NMOD	-	-
14	expressing	expressing	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
16	in	in	B-PP	B-PP	-	6	VMOD	-	-
17	the	the	B-NP	B-NP	-	21	NMOD	-	-
18	<num>	<num>	I-NP	I-NP	-	20	AMOD	-	-
19	'	'	I-NP	I-NP	-	20	AMOD	-	-
20	regulatory	regulatory	I-NP	I-NP	-	21	NMOD	-	-
21	sequences	sequences	I-NP	I-NP	-	16	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	both	both	O	O	-	29	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	Agamma-	Agamma-	I-NP	I-NP	-	29	NMOD	-	-
26	and	and	O	O	-	29	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	beta-globin	beta-globin	I-NP	I-NP	-	29	NMOD	-	-
29	genes	genes	I-NP	I-NP	-	22	PMOD	-	-
30	,	,	O	O	-	6	P	-	-
31	suggesting	suggesting	B-VP	B-VP	-	6	VMOD	-	-
32	a	a	B-NP	B-NP	-	33	NMOD	-	-
33	role	role	I-NP	I-NP	-	31	OBJ	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	these	these	B-NP	B-NP	-	38	NMOD	-	-
36	<num>	<num>	I-NP	I-NP	-	38	NMOD	-	-
37	'	'	I-NP	I-NP	-	38	NMOD	-	-
38	elements	elements	I-NP	I-NP	-	34	PMOD	-	-
39	in	in	B-PP	B-PP	-	38	NMOD	-	-
40	beta-globin	beta-globin	B-NP	B-NP	-	42	NMOD	-	-
41	gene	gene	I-NP	I-NP	-	42	NMOD	-	-
42	expression	expression	I-NP	I-NP	-	39	PMOD	-	-
43	.	.	O	O	-	6	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	29	DEP	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	bulk	bulk	I-NP	I-NP	-	18	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	protein-DNA	protein-DNA	B-NP	B-NP	-	9	NMOD	-	-
9	interactions	interactions	I-NP	I-NP	-	7	PMOD	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	underlies	underlies	B-VP	B-VP	-	10	SBAR	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	developmental	developmental	I-NP	I-NP	-	14	NMOD	-	-
14	control	control	I-NP	I-NP	-	11	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	globin	globin	B-NP	B-NP	-	17	NMOD	-	-
17	genes	genes	I-NP	I-NP	-	15	PMOD	-	-
18	takes	takes	B-VP	B-VP	-	29	DEP	-	-
19	place	place	B-NP	B-NP	-	18	OBJ	-	-
20	in	in	B-PP	B-PP	-	18	VMOD	-	-
21	the	the	B-NP	B-NP	-	26	NMOD	-	-
22	gamma-	gamma-	I-NP	I-NP	-	26	NMOD	-	-
23	and	and	I-NP	I-NP	-	26	NMOD	-	-
24	beta-globin	beta-globin	I-NP	I-NP	-	26	NMOD	-	-
25	gene	gene	I-NP	I-NP	-	26	NMOD	-	-
26	promoters	promoters	I-NP	I-NP	-	20	PMOD	-	-
27	,	,	O	O	-	29	P	-	-
28	and	and	O	O	-	29	DEP	-	-
29	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
30	GT	GT	B-NP	B-NP	-	31	NMOD	-	-
31	motifs	motifs	I-NP	I-NP	-	37	SUB	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	36	NMOD	-	-
34	beta-globin	beta-globin	I-NP	I-NP	-	36	NMOD	-	-
35	locus	locus	I-NP	I-NP	-	36	NMOD	-	-
36	LCR	LCR	I-NP	I-NP	-	32	PMOD	-	-
37	may	may	B-VP	B-VP	-	29	SBAR	-	-
38	play	play	I-VP	I-VP	-	37	VC	-	-
39	a	a	B-NP	B-NP	-	40	NMOD	-	-
40	role	role	I-NP	I-NP	-	38	OBJ	-	-
41	in	in	B-PP	B-PP	-	38	VMOD	-	-
42	the	the	B-NP	B-NP	-	44	NMOD	-	-
43	developmental	developmental	I-NP	I-NP	-	44	NMOD	-	-
44	regulation	regulation	I-NP	I-NP	-	41	PMOD	-	-
45	of	of	B-PP	B-PP	-	44	NMOD	-	-
46	human	human	B-NP	B-NP	-	49	NMOD	-	-
47	beta-globin	beta-globin	I-NP	I-NP	-	49	NMOD	-	-
48	gene	gene	I-NP	I-NP	-	49	NMOD	-	-
49	expression	expression	I-NP	I-NP	-	45	PMOD	-	-
50	,	,	O	O	-	38	P	-	-
51	perhaps	perhaps	B-ADVP	B-ADVP	-	52	PMOD	-	-
52	by	by	B-PP	B-PP	-	38	VMOD	-	-
53	increasing	increasing	B-VP	B-VP	-	52	PMOD	-	-
54	the	the	B-NP	B-NP	-	55	NMOD	-	-
55	probability	probability	I-NP	I-NP	-	53	OBJ	-	-
56	of	of	B-PP	B-PP	-	55	NMOD	-	-
57	interaction	interaction	B-NP	B-NP	-	56	PMOD	-	-
58	of	of	B-PP	B-PP	-	57	NMOD	-	-
59	the	the	B-NP	B-NP	-	61	NMOD	-	-
60	LCR	LCR	I-NP	I-NP	-	61	NMOD	-	-
61	holocomplex	holocomplex	I-NP	I-NP	-	58	PMOD	-	-
62	with	with	B-PP	B-PP	-	57	NMOD	-	-
63	the	the	B-NP	B-NP	-	64	NMOD	-	-
64	fetal	fetal	I-NP	I-NP	-	69	NMOD	-	-
65	or	or	O	O	-	69	NMOD	-	-
66	the	the	B-NP	B-NP	-	69	NMOD	-	-
67	adult	adult	I-NP	I-NP	-	69	NMOD	-	-
68	globin	globin	I-NP	I-NP	-	69	NMOD	-	-
69	gene	gene	I-NP	I-NP	-	62	PMOD	-	-
70	.	.	O	O	-	3	P	-	-

1	Interleukin	Interleukin	B-NP	B-NP	-	3	SUB	-	-
2	<num>	<num>	I-NP	I-NP	-	1	NMOD	-	-
3	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
4	c-fos	c-fos	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	human	human	B-NP	B-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
10	by	by	B-PP	B-PP	-	3	VMOD	-	-
11	activation	activation	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	divergent	divergent	B-NP	B-NP	-	15	NMOD	-	-
14	protein	protein	I-NP	I-NP	-	15	NMOD	-	-
15	kinases	kinases	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	IL-10	IL-10	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	potent	potent	I-NP	I-NP	-	5	NMOD	-	-
5	mediator	mediator	I-NP	I-NP	-	14	NMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	human	human	B-NP	B-NP	-	10	NMOD	-	-
8	B	B	I-NP	I-NP	-	10	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	10	NMOD	-	-
10	growth	growth	I-NP	I-NP	-	14	NMOD	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	plasma	plasma	B-NP	B-NP	-	14	NMOD	-	-
13	cell	cell	I-NP	I-NP	-	14	NMOD	-	-
14	formation	formation	I-NP	I-NP	-	2	PRD	-	-
15	.	.	O	O	-	2	P	-	-

1	However	However	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	signal	signal	B-NP	B-NP	-	4	NMOD	-	-
4	transduction	transduction	I-NP	I-NP	-	10	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	IL-10	IL-10	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	4	NMOD	-	-
8	B	B	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	poorly	poorly	B-ADJP	B-ADJP	-	10	VMOD	-	-
12	understood	understood	I-ADJP	I-ADJP	-	10	VC	-	-
13	.	.	O	O	-	10	P	-	-

1	In	In	B-PP	B-PP	-	15	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	effect	effect	I-NP	I-NP	-	15	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	IL-10	IL-10	B-NP	B-NP	-	6	PMOD	-	-
8	on	on	B-PP	B-PP	-	5	NMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	protooncogene	protooncogene	I-NP	I-NP	-	14	NMOD	-	-
14	c-fos	c-fos	I-NP	I-NP	-	11	PMOD	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	investigated	investigated	I-VP	I-VP	-	15	VC	-	-
17	,	,	O	O	-	16	P	-	-
18	because	because	B-SBAR	B-SBAR	-	16	VMOD	-	-
19	Fos	Fos	B-NP	B-NP	-	20	SUB	-	-
20	plays	plays	B-VP	B-VP	-	18	SBAR	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	potential	potential	I-NP	I-NP	-	23	NMOD	-	-
23	role	role	I-NP	I-NP	-	20	OBJ	-	-
24	in	in	B-PP	B-PP	-	20	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	regulation	regulation	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	B	B	B-NP	B-NP	-	30	NMOD	-	-
29	cell	cell	I-NP	I-NP	-	30	NMOD	-	-
30	proliferation	proliferation	I-NP	I-NP	-	32	NMOD	-	-
31	and	and	O	O	-	32	NMOD	-	-
32	differentiation	differentiation	B-NP	B-NP	-	27	PMOD	-	-
33	.	.	O	O	-	15	P	-	-

1	B	B	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	purified	purified	I-VP	I-VP	-	3	VC	-	-
5	from	from	B-PP	B-PP	-	4	VMOD	-	-
6	buffy	buffy	B-NP	B-NP	-	8	NMOD	-	-
7	coat	coat	I-NP	I-NP	-	8	NMOD	-	-
8	preparations	preparations	I-NP	I-NP	-	5	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	healthy	healthy	B-NP	B-NP	-	12	NMOD	-	-
11	blood	blood	I-NP	I-NP	-	12	NMOD	-	-
12	donors	donors	I-NP	I-NP	-	9	PMOD	-	-
13	by	by	B-PP	B-PP	-	4	VMOD	-	-
14	positive	positive	B-NP	B-NP	-	15	NMOD	-	-
15	selection	selection	I-NP	I-NP	-	13	PMOD	-	-
16	using	using	B-VP	B-VP	-	15	NMOD	-	-
17	an	an	B-NP	B-NP	-	21	NMOD	-	-
18	anti	anti	I-NP	I-NP	-	21	NMOD	-	-
19	CD20	CD20	I-NP	I-NP	-	21	NMOD	-	-
20	monoclonal	monoclonal	I-NP	I-NP	-	21	NMOD	-	-
21	antibody	antibody	I-NP	I-NP	-	26	NMOD	-	-
22	and	and	O	O	-	26	NMOD	-	-
23	a	a	B-NP	B-NP	-	26	NMOD	-	-
24	MiniMACS	MiniMACS	I-NP	I-NP	-	26	NMOD	-	-
25	separation	separation	I-NP	I-NP	-	26	NMOD	-	-
26	unit	unit	I-NP	I-NP	-	16	OBJ	-	-
27	.	.	O	O	-	3	P	-	-

1	B	B	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	prestimulated	prestimulated	I-VP	I-VP	-	3	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	SAC	SAC	B-NP	B-NP	-	5	PMOD	-	-
7	for	for	B-PP	B-PP	-	4	VMOD	-	-
8	<num>	<num>	B-NP	B-NP	-	9	NMOD	-	-
9	hrs	hrs	I-NP	I-NP	-	7	PMOD	-	-
10	.	.	O	O	-	3	P	-	-

1	Then	Then	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	cells	cells	B-NP	B-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	0	ROOT	-	-
5	incubated	incubated	I-VP	I-VP	-	4	VC	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	medium	medium	B-NP	B-NP	-	9	NMOD	-	-
8	or	or	I-NP	I-NP	-	9	NMOD	-	-
9	IL-10	IL-10	I-NP	I-NP	-	6	PMOD	-	-
10	(	(	O	O	-	12	P	-	-
11	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
12	ng/ml	ng/ml	I-NP	I-NP	-	9	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	for	for	B-PP	B-PP	-	5	VMOD	-	-
15	<num>	<num>	B-NP	B-NP	-	17	AMOD	-	-
16	to	to	I-NP	I-NP	-	17	AMOD	-	-
17	<num>	<num>	I-NP	I-NP	-	18	NMOD	-	-
18	min	min	I-NP	I-NP	-	14	PMOD	-	-
19	.	.	O	O	-	4	P	-	-

1	RNA	RNA	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	9	VMOD	-	-
3	extracted	extracted	I-VP	I-VP	-	2	VC	-	-
4	by	by	B-PP	B-PP	-	3	VMOD	-	-
5	phenol/chloroform	phenol/chloroform	B-NP	B-NP	-	8	NMOD	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	c-fos	c-fos	B-NP	B-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	9	SUB	-	-
9	was	was	B-VP	B-VP	-	0	ROOT	-	-
10	analyzed	analyzed	I-VP	I-VP	-	9	VC	-	-
11	by	by	B-PP	B-PP	-	10	VMOD	-	-
12	PCR	PCR	B-NP	B-NP	-	11	PMOD	-	-
13	assisted	assisted	B-VP	B-VP	-	9	VMOD	-	-
14	mRNA	mRNA	B-NP	B-NP	-	15	NMOD	-	-
15	assay	assay	I-NP	I-NP	-	13	OBJ	-	-
16	.	.	O	O	-	9	P	-	-

1	A	A	B-NP	B-NP	-	5	NMOD	-	-
2	significant	significant	I-NP	I-NP	-	5	NMOD	-	-
3	2-4	2-4	I-NP	I-NP	-	5	NMOD	-	-
4	fold	fold	I-NP	I-NP	-	5	NMOD	-	-
5	increase	increase	I-NP	I-NP	-	9	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	c-fos	c-fos	B-NP	B-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	6	PMOD	-	-
9	was	was	B-VP	B-VP	-	0	ROOT	-	-
10	observed	observed	I-VP	I-VP	-	9	VC	-	-
11	within	within	B-PP	B-PP	-	10	VMOD	-	-
12	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
13	min	min	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	stimulation	stimulation	B-NP	B-NP	-	14	PMOD	-	-
16	with	with	B-PP	B-PP	-	15	NMOD	-	-
17	IL-10	IL-10	B-NP	B-NP	-	16	PMOD	-	-
18	(	(	O	O	-	21	P	-	-
19	p	p	B-NP	B-NP	-	21	SUB	-	-
20	<	<	O	O	-	21	VMOD	-	-
21	<num>	<num>	B-NP	B-NP	-	17	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	.	.	O	O	-	9	P	-	-

1	After	After	B-PP	B-PP	-	6	VMOD	-	-
2	<num>	<num>	B-NP	B-NP	-	3	NMOD	-	-
3	hrs	hrs	I-NP	I-NP	-	1	PMOD	-	-
4	c-fos	c-fos	I-NP	I-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	6	SUB	-	-
6	declined	declined	B-VP	B-VP	-	0	ROOT	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	basal	basal	B-NP	B-NP	-	9	NMOD	-	-
9	levels	levels	I-NP	I-NP	-	7	PMOD	-	-
10	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	IL-10	IL-10	B-NP	B-NP	-	3	PMOD	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	dose-dependent	dose-dependent	B-ADJP	B-ADJP	-	5	PRD	-	-
7	with	with	B-PP	B-PP	-	6	AMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	maximum	maximum	I-NP	I-NP	-	10	NMOD	-	-
10	stimulation	stimulation	I-NP	I-NP	-	7	PMOD	-	-
11	using	using	B-VP	B-VP	-	10	NMOD	-	-
12	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
13	ng/ml	ng/ml	I-NP	I-NP	-	11	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	IL-10	IL-10	B-NP	B-NP	-	14	PMOD	-	-
16	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	IL-10	IL-10	I-NP	I-NP	-	3	NMOD	-	-
3	effect	effect	I-NP	I-NP	-	7	SUB	-	-
4	on	on	B-PP	B-PP	-	3	NMOD	-	-
5	c-fos	c-fos	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	4	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	not	not	I-VP	I-VP	-	7	VMOD	-	-
9	blocked	blocked	I-VP	I-VP	-	7	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	polymyxin	polymyxin	B-NP	B-NP	-	12	NMOD	-	-
12	B	B	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	7	P	-	-

1	Using	Using	B-VP	B-VP	-	19	VMOD	-	-
2	the	the	B-NP	B-NP	-	6	NMOD	-	-
3	tyrosine	tyrosine	I-NP	I-NP	-	6	NMOD	-	-
4	kinase	kinase	I-NP	I-NP	-	6	NMOD	-	-
5	inhibitor	inhibitor	I-NP	I-NP	-	6	NMOD	-	-
6	genistein	genistein	I-NP	I-NP	-	13	NMOD	-	-
7	(	(	O	O	-	9	P	-	-
8	<num>	<num>	B-NP	B-NP	-	9	NMOD	-	-
9	microM	microM	I-NP	I-NP	-	6	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	complete	complete	I-NP	I-NP	-	13	NMOD	-	-
13	inhibition	inhibition	I-NP	I-NP	-	19	SUB	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	IL-10	IL-10	B-NP	B-NP	-	18	NMOD	-	-
16	induced	induced	I-NP	I-NP	-	18	NMOD	-	-
17	c-fos	c-fos	I-NP	I-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
19	was	was	B-VP	B-VP	-	0	ROOT	-	-
20	observed	observed	I-VP	I-VP	-	19	VC	-	-
21	.	.	O	O	-	19	P	-	-

1	In	In	B-PP	B-PP	-	18	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	12	P	-	-
4	H-7	H-7	B-NP	B-NP	-	12	NMOD	-	-
5	(	(	O	O	-	7	P	-	-
6	<num>	<num>	B-NP	B-NP	-	7	NMOD	-	-
7	microM	microM	I-NP	I-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	,	,	O	O	-	12	P	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	specific	specific	I-NP	I-NP	-	12	NMOD	-	-
12	inhibitor	inhibitor	I-NP	I-NP	-	1	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	serine/threonine	serine/threonine	B-NP	B-NP	-	15	NMOD	-	-
15	kinases	kinases	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	12	P	-	-
17	significantly	significantly	B-VP	B-VP	-	18	VMOD	-	-
18	blocked	blocked	I-VP	I-VP	-	0	ROOT	-	-
19	IL-10	IL-10	B-NP	B-NP	-	22	NMOD	-	-
20	mediated	mediated	I-NP	I-NP	-	22	NMOD	-	-
21	c-fos	c-fos	I-NP	I-NP	-	22	NMOD	-	-
22	expression	expression	I-NP	I-NP	-	18	OBJ	-	-
23	(	(	O	O	-	26	P	-	-
24	p	p	B-NP	B-NP	-	26	SUB	-	-
25	<	<	O	O	-	26	VMOD	-	-
26	<num>	<num>	B-NP	B-NP	-	22	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	.	.	O	O	-	18	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	conclusion	conclusion	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	data	data	I-NP	I-NP	-	6	SUB	-	-
6	show	show	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	IL-10	IL-10	B-NP	B-NP	-	9	SUB	-	-
9	induces	induces	B-VP	B-VP	-	7	SBAR	-	-
10	c-fos	c-fos	B-NP	B-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	9	OBJ	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	human	human	B-NP	B-NP	-	14	NMOD	-	-
14	B-cells	B-cells	I-NP	I-NP	-	12	PMOD	-	-
15	by	by	B-PP	B-PP	-	9	VMOD	-	-
16	activation	activation	B-NP	B-NP	-	15	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	tyrosine	tyrosine	B-NP	B-NP	-	21	NMOD	-	-
19	and	and	I-NP	I-NP	-	21	NMOD	-	-
20	serine/threonine	serine/threonine	I-NP	I-NP	-	21	NMOD	-	-
21	kinases	kinases	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	6	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	15	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	1	SBAR	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	first	first	I-NP	I-NP	-	6	NMOD	-	-
6	report	report	I-NP	I-NP	-	3	PRD	-	-
7	on	on	B-PP	B-PP	-	6	NMOD	-	-
8	IL-10	IL-10	B-NP	B-NP	-	7	PMOD	-	-
9	induced	induced	B-VP	B-VP	-	1	SBAR	-	-
10	signal	signal	B-NP	B-NP	-	11	NMOD	-	-
11	transduction	transduction	I-NP	I-NP	-	9	OBJ	-	-
12	,	,	O	O	-	15	P	-	-
13	these	these	B-NP	B-NP	-	14	NMOD	-	-
14	data	data	I-NP	I-NP	-	15	SUB	-	-
15	may	may	B-VP	B-VP	-	0	ROOT	-	-
16	help	help	I-VP	I-VP	-	15	VC	-	-
17	to	to	I-VP	I-VP	-	18	VMOD	-	-
18	identify	identify	I-VP	I-VP	-	16	VMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	intracellular	intracellular	I-NP	I-NP	-	21	NMOD	-	-
21	mechanisms	mechanisms	I-NP	I-NP	-	18	OBJ	-	-
22	by	by	B-PP	B-PP	-	21	NMOD	-	-
23	which	which	B-NP	B-NP	-	22	PMOD	-	-
24	IL-10	IL-10	B-NP	B-NP	-	25	SUB	-	-
25	stimulates	stimulates	B-VP	B-VP	-	22	SBAR	-	-
26	human	human	B-NP	B-NP	-	27	NMOD	-	-
27	B-cells	B-cells	I-NP	I-NP	-	25	OBJ	-	-
28	.	.	O	O	-	15	P	-	-

1	IL-10	IL-10	B-NP	B-NP	-	2	SUB	-	-
2	inhibits	inhibits	B-VP	B-VP	-	0	ROOT	-	-
3	nuclear	nuclear	B-NP	B-NP	-	7	NMOD	-	-
4	factor-kappa	factor-kappa	I-NP	I-NP	-	7	NMOD	-	-
5	B/Rel	B/Rel	I-NP	I-NP	-	7	NMOD	-	-
6	nuclear	nuclear	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	2	OBJ	-	-
8	in	in	B-PP	B-PP	-	7	NMOD	-	-
9	CD3-stimulated	CD3-stimulated	B-NP	B-NP	-	13	NMOD	-	-
10	human	human	I-NP	I-NP	-	13	NMOD	-	-
11	peripheral	peripheral	I-NP	I-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	lymphocytes	lymphocytes	I-NP	I-NP	-	8	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	IL-10	IL-10	B-NP	B-NP	-	3	SUB	-	-
2	markedly	markedly	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	reduces	reduces	B-VP	B-VP	-	0	ROOT	-	-
4	nuclear	nuclear	B-NP	B-NP	-	10	NMOD	-	-
5	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
6	(	(	O	O	-	10	P	-	-
7	NF	NF	B-NP	B-NP	-	10	NMOD	-	-
8	)	)	O	O	-	10	P	-	-
9	-kappa	-kappa	B-NP	B-NP	-	10	NMOD	-	-
10	B/Rel	B/Rel	I-NP	I-NP	-	12	NMOD	-	-
11	nuclear	nuclear	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	3	OBJ	-	-
13	induced	induced	B-VP	B-VP	-	12	NMOD	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	PBMC	PBMC	B-NP	B-NP	-	14	PMOD	-	-
16	by	by	B-PP	B-PP	-	13	VMOD	-	-
17	stimulation	stimulation	B-NP	B-NP	-	16	PMOD	-	-
18	with	with	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	anti-CD3	anti-CD3	I-NP	I-NP	-	22	NMOD	-	-
21	mAb	mAb	I-NP	I-NP	-	22	NMOD	-	-
22	OKT3	OKT3	I-NP	I-NP	-	18	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	inhibition	inhibition	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	exerted	exerted	I-VP	I-VP	-	3	VC	-	-
5	specifically	specifically	B-ADVP	B-ADVP	-	4	VMOD	-	-
6	on	on	B-PP	B-PP	-	4	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	NF-kappa	NF-kappa	I-NP	I-NP	-	10	NMOD	-	-
9	B/Rel	B/Rel	I-NP	I-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
11	induced	induced	B-VP	B-VP	-	10	NMOD	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	mAb	mAb	B-NP	B-NP	-	14	NMOD	-	-
14	OKT3	OKT3	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	B-NP	B-NP	-	18	P	-	-
16	and	and	I-NP	I-NP	-	18	NMOD	-	-
17	not	not	I-NP	I-NP	-	18	DEP	-	-
18	that	that	B-NP	B-NP	-	14	NMOD	-	-
19	produced	produced	B-VP	B-VP	-	18	NMOD	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	PMA	PMA	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	3	P	-	-

1	As	As	B-SBAR	B-SBAR	-	31	VMOD	-	-
2	judged	judged	B-VP	B-VP	-	1	SBAR	-	-
3	by	by	B-PP	B-PP	-	2	VMOD	-	-
4	supershifting	supershifting	B-VP	B-VP	-	3	PMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	DNA-protein	DNA-protein	I-NP	I-NP	-	7	NMOD	-	-
7	complexes	complexes	I-NP	I-NP	-	4	OBJ	-	-
8	with	with	B-PP	B-PP	-	7	NMOD	-	-
9	Abs	Abs	B-NP	B-NP	-	8	PMOD	-	-
10	recognizing	recognizing	B-VP	B-VP	-	9	NMOD	-	-
11	specific	specific	B-NP	B-NP	-	12	NMOD	-	-
12	components	components	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	NF-kappa	NF-kappa	I-NP	I-NP	-	18	NMOD	-	-
16	B/Rel	B/Rel	I-NP	I-NP	-	18	NMOD	-	-
17	protein	protein	I-NP	I-NP	-	18	NMOD	-	-
18	family	family	I-NP	I-NP	-	13	PMOD	-	-
19	,	,	O	O	-	31	P	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	p50/p65	p50/p65	I-NP	I-NP	-	27	NMOD	-	-
22	(	(	O	O	-	24	P	-	-
23	Rel	Rel	B-NP	B-NP	-	24	NMOD	-	-
24	A	A	I-NP	I-NP	-	21	NMOD	-	-
25	)	)	I-NP	I-NP	-	24	P	-	-
26	heterodimeric	heterodimeric	I-NP	I-NP	-	27	NMOD	-	-
27	form	form	I-NP	I-NP	-	31	SUB	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	NF-kappa	NF-kappa	B-NP	B-NP	-	30	NMOD	-	-
30	B	B	I-NP	I-NP	-	28	PMOD	-	-
31	is	is	B-VP	B-VP	-	0	ROOT	-	-
32	primarily	primarily	I-VP	I-VP	-	31	VMOD	-	-
33	affected	affected	I-VP	I-VP	-	31	VC	-	-
34	.	.	O	O	-	31	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	maximal	maximal	I-NP	I-NP	-	3	NMOD	-	-
3	effect	effect	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	observed	observed	I-VP	I-VP	-	4	VC	-	-
6	at	at	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	IL-10	IL-10	I-NP	I-NP	-	9	NMOD	-	-
9	concentration	concentration	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
12	U/ml	U/ml	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	4	P	-	-

1	IL-10	IL-10	B-NP	B-NP	-	3	NMOD	-	-
2	inhibitory	inhibitory	I-NP	I-NP	-	3	NMOD	-	-
3	activity	activity	I-NP	I-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	exerted	exerted	I-VP	I-VP	-	4	VC	-	-
6	on	on	B-PP	B-PP	-	5	VMOD	-	-
7	T	T	B-NP	B-NP	-	8	NMOD	-	-
8	lymphocytes	lymphocytes	I-NP	I-NP	-	6	PMOD	-	-
9	and	and	O	O	-	4	VMOD	-	-
10	is	is	B-VP	B-VP	-	4	VMOD	-	-
11	mediated	mediated	I-VP	I-VP	-	10	VC	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	monocytes	monocytes	B-NP	B-NP	-	12	PMOD	-	-
14	.	.	O	O	-	4	P	-	-

1	Indeed	Indeed	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	monocytes	monocytes	B-NP	B-NP	-	7	SUB	-	-
4	pretreated	pretreated	B-VP	B-VP	-	3	NMOD	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	IL-10	IL-10	B-NP	B-NP	-	5	PMOD	-	-
7	are	are	B-VP	B-VP	-	0	ROOT	-	-
8	able	able	B-ADJP	B-ADJP	-	7	PRD	-	-
9	so	so	B-VP	B-VP	-	10	VMOD	-	-
10	inhibit	inhibit	I-VP	I-VP	-	8	AMOD	-	-
11	NF-kappa	NF-kappa	B-NP	B-NP	-	14	NMOD	-	-
12	B	B	I-NP	I-NP	-	14	NMOD	-	-
13	nuclear	nuclear	I-NP	I-NP	-	14	NMOD	-	-
14	activity	activity	I-NP	I-NP	-	10	OBJ	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	purified	purified	B-NP	B-NP	-	18	NMOD	-	-
17	T	T	I-NP	I-NP	-	18	NMOD	-	-
18	lymphocytes	lymphocytes	I-NP	I-NP	-	15	PMOD	-	-
19	stimulated	stimulated	B-VP	B-VP	-	18	NMOD	-	-
20	with	with	B-PP	B-PP	-	19	VMOD	-	-
21	OKT3	OKT3	B-NP	B-NP	-	20	PMOD	-	-
22	.	.	O	O	-	7	P	-	-

1	Soluble	Soluble	B-NP	B-NP	-	2	NMOD	-	-
2	factors	factors	I-NP	I-NP	-	3	SUB	-	-
3	do	do	B-VP	B-VP	-	0	ROOT	-	-
4	not	not	I-VP	I-VP	-	3	VMOD	-	-
5	appear	appear	I-VP	I-VP	-	3	VC	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	be	be	I-VP	I-VP	-	5	VMOD	-	-
8	involved	involved	I-VP	I-VP	-	7	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	mechanism	mechanism	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	inhibition	inhibition	B-NP	B-NP	-	12	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	On	On	B-PP	B-PP	-	22	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	other	other	I-NP	I-NP	-	4	NMOD	-	-
4	hand	hand	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	22	P	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	up-regulation	up-regulation	I-NP	I-NP	-	22	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	CD80	CD80	B-NP	B-NP	-	10	NMOD	-	-
10	Ag	Ag	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	found	found	B-VP	B-VP	-	10	NMOD	-	-
13	on	on	B-PP	B-PP	-	12	VMOD	-	-
14	monocytes	monocytes	B-NP	B-NP	-	13	PMOD	-	-
15	obtained	obtained	B-VP	B-VP	-	14	NMOD	-	-
16	from	from	B-PP	B-PP	-	15	VMOD	-	-
17	PBMC	PBMC	B-NP	B-NP	-	16	PMOD	-	-
18	incubated	incubated	B-VP	B-VP	-	17	NMOD	-	-
19	with	with	B-PP	B-PP	-	18	VMOD	-	-
20	OKT3	OKT3	B-NP	B-NP	-	19	PMOD	-	-
21	,	,	O	O	-	10	P	-	-
22	is	is	B-VP	B-VP	-	35	VMOD	-	-
23	not	not	I-VP	I-VP	-	22	VMOD	-	-
24	detected	detected	I-VP	I-VP	-	22	VC	-	-
25	after	after	B-PP	B-PP	-	24	VMOD	-	-
26	addition	addition	B-NP	B-NP	-	25	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	IL-10	IL-10	B-NP	B-NP	-	27	PMOD	-	-
29	,	,	O	O	-	35	P	-	-
30	and	and	O	O	-	35	VMOD	-	-
31	the	the	B-NP	B-NP	-	34	NMOD	-	-
32	anti-CD28	anti-CD28	I-NP	I-NP	-	34	NMOD	-	-
33	mAb	mAb	I-NP	I-NP	-	34	NMOD	-	-
34	CLB-CD28/1	CLB-CD28/1	I-NP	I-NP	-	35	SUB	-	-
35	restores	restores	B-VP	B-VP	-	0	ROOT	-	-
36	the	the	B-NP	B-NP	-	40	NMOD	-	-
37	NF-kappa	NF-kappa	I-NP	I-NP	-	38	NMOD	-	-
38	B/Rel	B/Rel	I-NP	I-NP	-	40	NMOD	-	-
39	nuclear	nuclear	I-NP	I-NP	-	40	NMOD	-	-
40	activity	activity	I-NP	I-NP	-	35	OBJ	-	-
41	in	in	B-PP	B-PP	-	40	NMOD	-	-
42	IL-10-inhibited	IL-10-inhibited	B-NP	B-NP	-	43	NMOD	-	-
43	lymphocytes	lymphocytes	I-NP	I-NP	-	41	PMOD	-	-
44	.	.	O	O	-	35	P	-	-

1	Therefore	Therefore	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	NF-kappa	NF-kappa	I-NP	I-NP	-	6	NMOD	-	-
5	B/Rel	B/Rel	I-NP	I-NP	-	6	NMOD	-	-
6	inhibition	inhibition	I-NP	I-NP	-	7	SUB	-	-
7	might	might	B-VP	B-VP	-	0	ROOT	-	-
8	be	be	I-VP	I-VP	-	7	VC	-	-
9	ascribed	ascribed	I-VP	I-VP	-	8	VC	-	-
10	to	to	B-PP	B-PP	-	9	VMOD	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	lack	lack	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	cooperation	cooperation	B-NP	B-NP	-	13	PMOD	-	-
15	between	between	B-PP	B-PP	-	14	NMOD	-	-
16	accessory	accessory	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	20	NMOD	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	T	T	B-NP	B-NP	-	20	NMOD	-	-
20	lymphocytes	lymphocytes	I-NP	I-NP	-	15	PMOD	-	-
21	,	,	O	O	-	7	P	-	-
22	resulting	resulting	B-VP	B-VP	-	7	VMOD	-	-
23	from	from	B-PP	B-PP	-	22	VMOD	-	-
24	down-regulation	down-regulation	B-NP	B-NP	-	23	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	a	a	B-NP	B-NP	-	28	NMOD	-	-
27	costimulatory	costimulatory	I-NP	I-NP	-	28	NMOD	-	-
28	molecule	molecule	I-NP	I-NP	-	25	PMOD	-	-
29	,	,	O	O	-	28	P	-	-
30	such	such	B-PP	B-PP	-	31	PMOD	-	-
31	as	as	I-PP	I-PP	-	28	NMOD	-	-
32	CD80	CD80	B-NP	B-NP	-	31	PMOD	-	-
33	,	,	O	O	-	32	P	-	-
34	produced	produced	B-VP	B-VP	-	32	NMOD	-	-
35	by	by	B-PP	B-PP	-	34	VMOD	-	-
36	IL-10	IL-10	B-NP	B-NP	-	35	PMOD	-	-
37	on	on	B-PP	B-PP	-	36	NMOD	-	-
38	activated	activated	B-NP	B-NP	-	39	NMOD	-	-
39	monocytes	monocytes	I-NP	I-NP	-	37	PMOD	-	-
40	.	.	O	O	-	7	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	IL-10	IL-10	B-NP	B-NP	-	6	SUB	-	-
6	can	can	B-VP	B-VP	-	4	SBAR	-	-
7	inhibit	inhibit	I-VP	I-VP	-	6	VC	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	induction	induction	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
12	B/Rel	B/Rel	I-NP	I-NP	-	14	NMOD	-	-
13	nuclear	nuclear	I-NP	I-NP	-	14	NMOD	-	-
14	activity	activity	I-NP	I-NP	-	10	PMOD	-	-
15	in	in	B-PP	B-PP	-	9	NMOD	-	-
16	CD3-stimulated	CD3-stimulated	B-NP	B-NP	-	18	NMOD	-	-
17	T	T	I-NP	I-NP	-	18	NMOD	-	-
18	lymphocytes	lymphocytes	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	25	VMOD	-	-
2	inappropriate	inappropriate	B-NP	B-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	kappa	kappa	B-NP	B-NP	-	7	NMOD	-	-
6	B-driven	B-driven	I-NP	I-NP	-	7	NMOD	-	-
7	genes	genes	I-NP	I-NP	-	4	PMOD	-	-
8	has	has	B-VP	B-VP	-	1	SBAR	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	physiopathologic	physiopathologic	I-NP	I-NP	-	11	NMOD	-	-
11	role	role	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	8	VMOD	-	-
13	a	a	B-NP	B-NP	-	14	NMOD	-	-
14	number	number	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	diseases	diseases	B-NP	B-NP	-	15	PMOD	-	-
17	,	,	O	O	-	16	P	-	-
18	such	such	B-PP	B-PP	-	19	PMOD	-	-
19	as	as	I-PP	I-PP	-	16	NMOD	-	-
20	HIV	HIV	B-NP	B-NP	-	21	NMOD	-	-
21	infection	infection	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	25	P	-	-
23	our	our	B-NP	B-NP	-	24	NMOD	-	-
24	findings	findings	I-NP	I-NP	-	25	SUB	-	-
25	support	support	B-VP	B-VP	-	0	ROOT	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	possibility	possibility	I-NP	I-NP	-	25	OBJ	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	using	using	B-VP	B-VP	-	28	PMOD	-	-
30	this	this	B-NP	B-NP	-	31	NMOD	-	-
31	cytokine	cytokine	I-NP	I-NP	-	29	OBJ	-	-
32	to	to	B-VP	B-VP	-	33	VMOD	-	-
33	suppress	suppress	I-VP	I-VP	-	31	NMOD	-	-
34	an	an	B-NP	B-NP	-	36	NMOD	-	-
35	undesirable	undesirable	I-NP	I-NP	-	36	NMOD	-	-
36	activation	activation	I-NP	I-NP	-	33	OBJ	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	these	these	B-NP	B-NP	-	40	NMOD	-	-
39	transcription	transcription	I-NP	I-NP	-	40	NMOD	-	-
40	factors	factors	I-NP	I-NP	-	37	PMOD	-	-
41	.	.	O	O	-	25	P	-	-

1	Vitamin	Vitamin	B-NP	B-NP	-	2	NMOD	-	-
2	D3-	D3-	I-NP	I-NP	-	5	AMOD	-	-
3	and	and	O	O	-	5	AMOD	-	-
4	retinoic	retinoic	B-NP	B-NP	-	5	AMOD	-	-
5	acid-induced	acid-induced	I-NP	I-NP	-	9	NMOD	-	-
6	monocytic	monocytic	I-NP	I-NP	-	7	NMOD	-	-
7	differentiation	differentiation	I-NP	I-NP	-	5	NMOD	-	-
8	:	:	O	O	-	5	P	-	-
9	interactions	interactions	B-NP	B-NP	-	0	ROOT	-	-
10	between	between	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	endogenous	endogenous	I-NP	I-NP	-	15	NMOD	-	-
13	vitamin	vitamin	I-NP	I-NP	-	15	NMOD	-	-
14	D3	D3	I-NP	I-NP	-	15	NMOD	-	-
15	receptor	receptor	I-NP	I-NP	-	24	NMOD	-	-
16	,	,	O	O	-	24	P	-	-
17	retinoic	retinoic	B-NP	B-NP	-	19	NMOD	-	-
18	acid	acid	I-NP	I-NP	-	19	NMOD	-	-
19	receptors	receptors	I-NP	I-NP	-	24	NMOD	-	-
20	,	,	O	O	-	24	P	-	-
21	and	and	O	O	-	24	NMOD	-	-
22	retinoid	retinoid	B-NP	B-NP	-	24	NMOD	-	-
23	X	X	I-NP	I-NP	-	24	NMOD	-	-
24	receptors	receptors	I-NP	I-NP	-	10	PMOD	-	-
25	in	in	B-PP	B-PP	-	9	NMOD	-	-
26	U-937	U-937	B-NP	B-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	9	P	-	-

1	Retinoic	Retinoic	B-NP	B-NP	-	2	NMOD	-	-
2	acid	acid	I-NP	I-NP	-	7	NMOD	-	-
3	(	(	O	O	-	4	P	-	-
4	RA	RA	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	and	and	O	O	-	7	NMOD	-	-
7	<num>	<num>	B-NP	B-NP	-	14	SUB	-	-
8	,	,	O	O	-	14	P	-	-
9	<num>	<num>	B-NP	B-NP	-	10	NMOD	-	-
10	alpha-dihydroxycholecalciferol	alpha-dihydroxycholecalciferol	I-NP	I-NP	-	14	SUB	-	-
11	(	(	O	O	-	12	P	-	-
12	VitD3	VitD3	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	are	are	B-VP	B-VP	-	0	ROOT	-	-
15	potent	potent	B-NP	B-NP	-	16	NMOD	-	-
16	regulators	regulators	I-NP	I-NP	-	14	PRD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	hematopoletic	hematopoletic	B-NP	B-NP	-	19	NMOD	-	-
19	differentiation	differentiation	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	14	P	-	-

1	Yet	Yet	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	little	little	B-NP	B-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	known	known	I-VP	I-VP	-	4	VC	-	-
6	as	as	B-PP	B-PP	-	5	VMOD	-	-
7	to	to	B-PP	B-PP	-	6	PMOD	-	-
8	how	how	B-ADVP	B-ADVP	-	7	PMOD	-	-
9	the	the	B-NP	B-NP	-	14	NMOD	-	-
10	RA	RA	I-NP	I-NP	-	14	NMOD	-	-
11	and	and	I-NP	I-NP	-	14	NMOD	-	-
12	VitD3	VitD3	I-NP	I-NP	-	14	NMOD	-	-
13	receptor	receptor	I-NP	I-NP	-	14	NMOD	-	-
14	network	network	I-NP	I-NP	-	15	SUB	-	-
15	operates	operates	B-VP	B-VP	-	8	SBAR	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	hematopoietic	hematopoietic	B-NP	B-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	24	P	-	-
20	and	and	O	O	-	21	DEP	-	-
21	whether	whether	B-SBAR	B-SBAR	-	24	VMOD	-	-
22	receptor	receptor	B-NP	B-NP	-	23	NMOD	-	-
23	interactions	interactions	I-NP	I-NP	-	24	SUB	-	-
24	can	can	B-VP	B-VP	-	8	SBAR	-	-
25	explain	explain	I-VP	I-VP	-	24	VC	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	interplay	interplay	I-NP	I-NP	-	25	OBJ	-	-
28	between	between	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	33	NMOD	-	-
30	RA-	RA-	I-NP	I-NP	-	33	NMOD	-	-
31	and	and	O	O	-	33	NMOD	-	-
32	VitD3-signaling	VitD3-signaling	B-NP	B-NP	-	33	NMOD	-	-
33	pathways	pathways	I-NP	I-NP	-	28	PMOD	-	-
34	during	during	B-PP	B-PP	-	27	NMOD	-	-
35	differentiation	differentiation	B-NP	B-NP	-	34	PMOD	-	-
36	.	.	O	O	-	4	P	-	-

1	Therefore	Therefore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	analyzed	analyzed	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	13	NMOD	-	-
7	,	,	O	O	-	13	P	-	-
8	DNA	DNA	B-NP	B-NP	-	9	NMOD	-	-
9	binding	binding	I-NP	I-NP	-	13	NMOD	-	-
10	,	,	O	O	-	13	P	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	transcriptional	transcriptional	B-NP	B-NP	-	13	NMOD	-	-
13	activity	activity	I-NP	I-NP	-	4	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	endogenous	endogenous	I-NP	I-NP	-	20	NMOD	-	-
17	RA	RA	I-NP	I-NP	-	20	NMOD	-	-
18	and	and	I-NP	I-NP	-	20	NMOD	-	-
19	VitD3	VitD3	I-NP	I-NP	-	20	NMOD	-	-
20	receptors	receptors	I-NP	I-NP	-	24	NMOD	-	-
21	[	[	O	O	-	24	P	-	-
22	retinoic	retinoic	B-NP	B-NP	-	24	NMOD	-	-
23	acid	acid	I-NP	I-NP	-	24	NMOD	-	-
24	receptors	receptors	I-NP	I-NP	-	31	NMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	RARs	RARs	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	,	,	O	O	-	31	P	-	-
29	retinoid	retinoid	B-NP	B-NP	-	31	NMOD	-	-
30	X	X	I-NP	I-NP	-	31	NMOD	-	-
31	receptors	receptors	I-NP	I-NP	-	38	NMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	RXRs	RXRs	B-NP	B-NP	-	31	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	,	,	O	O	-	38	P	-	-
36	and	and	O	O	-	38	NMOD	-	-
37	VitD3	VitD3	B-NP	B-NP	-	38	NMOD	-	-
38	receptor	receptor	I-NP	I-NP	-	14	PMOD	-	-
39	(	(	O	O	-	40	P	-	-
40	VDR	VDR	B-NP	B-NP	-	38	NMOD	-	-
41	)	)	O	O	-	40	P	-	-
42	]	]	O	O	-	38	P	-	-
43	in	in	B-PP	B-PP	-	38	NMOD	-	-
44	the	the	B-NP	B-NP	-	47	NMOD	-	-
45	U-937	U-937	I-NP	I-NP	-	47	NMOD	-	-
46	cell	cell	I-NP	I-NP	-	47	NMOD	-	-
47	line	line	I-NP	I-NP	-	43	PMOD	-	-
48	,	,	O	O	-	47	P	-	-
49	in	in	B-PP	B-PP	-	47	NMOD	-	-
50	which	which	B-NP	B-NP	-	49	PMOD	-	-
51	RA	RA	B-NP	B-NP	-	53	NMOD	-	-
52	and	and	I-NP	I-NP	-	53	NMOD	-	-
53	VitD3	VitD3	I-NP	I-NP	-	54	SUB	-	-
54	induce	induce	B-VP	B-VP	-	49	SBAR	-	-
55	distinct	distinct	B-NP	B-NP	-	58	NMOD	-	-
56	monocytic	monocytic	I-NP	I-NP	-	58	NMOD	-	-
57	differentiation	differentiation	I-NP	I-NP	-	58	NMOD	-	-
58	pathways	pathways	I-NP	I-NP	-	54	OBJ	-	-
59	.	.	O	O	-	4	P	-	-

1	VitD3	VitD3	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	3	SUB	-	-
3	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
4	in	in	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	formation	formation	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	VDR/RXR	VDR/RXR	B-NP	B-NP	-	10	NMOD	-	-
9	DNA-binding	DNA-binding	I-NP	I-NP	-	10	NMOD	-	-
10	complexes	complexes	I-NP	I-NP	-	7	PMOD	-	-
11	on	on	B-PP	B-PP	-	6	NMOD	-	-
12	both	both	O	O	-	19	NMOD	-	-
13	VitD3	VitD3	B-NP	B-NP	-	15	NMOD	-	-
14	response	response	I-NP	I-NP	-	15	NMOD	-	-
15	elements	elements	I-NP	I-NP	-	19	NMOD	-	-
16	and	and	O	O	-	19	NMOD	-	-
17	RA	RA	B-NP	B-NP	-	19	NMOD	-	-
18	response	response	I-NP	I-NP	-	19	NMOD	-	-
19	elements	elements	I-NP	I-NP	-	11	PMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	RAREs	RAREs	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	.	.	O	O	-	3	P	-	-

1	However	However	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	transcriptional	transcriptional	B-NP	B-NP	-	4	NMOD	-	-
4	activation	activation	I-NP	I-NP	-	5	SUB	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	only	only	I-VP	I-VP	-	5	VMOD	-	-
7	observed	observed	I-VP	I-VP	-	5	VC	-	-
8	from	from	B-PP	B-PP	-	7	VMOD	-	-
9	a	a	B-NP	B-NP	-	14	NMOD	-	-
10	VitD3	VitD3	I-NP	I-NP	-	14	NMOD	-	-
11	response	response	I-NP	I-NP	-	14	NMOD	-	-
12	element-driven	element-driven	I-NP	I-NP	-	14	NMOD	-	-
13	reporter	reporter	I-NP	I-NP	-	14	NMOD	-	-
14	construct	construct	I-NP	I-NP	-	8	PMOD	-	-
15	.	.	O	O	-	5	P	-	-

1	Several	Several	B-NP	B-NP	-	3	NMOD	-	-
2	DNA-binding	DNA-binding	I-NP	I-NP	-	3	NMOD	-	-
3	complexes	complexes	I-NP	I-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	0	ROOT	-	-
5	detected	detected	I-VP	I-VP	-	4	VC	-	-
6	on	on	B-PP	B-PP	-	5	VMOD	-	-
7	RAREs	RAREs	B-NP	B-NP	-	6	PMOD	-	-
8	in	in	B-PP	B-PP	-	5	VMOD	-	-
9	undifferentiated	undifferentiated	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	.	.	O	O	-	4	P	-	-

1	Stimulation	Stimulation	B-NP	B-NP	-	4	SUB	-	-
2	by	by	B-PP	B-PP	-	1	NMOD	-	-
3	RA	RA	B-NP	B-NP	-	2	PMOD	-	-
4	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	increased	increased	B-NP	B-NP	-	10	NMOD	-	-
7	RAR	RAR	I-NP	I-NP	-	10	NMOD	-	-
8	beta/RXR	beta/RXR	I-NP	I-NP	-	10	NMOD	-	-
9	DNA	DNA	I-NP	I-NP	-	10	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	5	PMOD	-	-
11	,	,	O	O	-	4	P	-	-
12	activated	activated	B-VP	B-VP	-	14	NMOD	-	-
13	RARE-dependent	RARE-dependent	B-NP	B-NP	-	14	NMOD	-	-
14	transcription	transcription	I-NP	I-NP	-	18	NMOD	-	-
15	,	,	O	O	-	18	P	-	-
16	and	and	O	O	-	18	NMOD	-	-
17	increased	increased	B-NP	B-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	4	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	RAR-beta	RAR-beta	B-NP	B-NP	-	19	PMOD	-	-
21	.	.	O	O	-	4	P	-	-

1	Concomitant	Concomitant	B-NP	B-NP	-	2	NMOD	-	-
2	stimulation	stimulation	I-NP	I-NP	-	5	SUB	-	-
3	by	by	B-PP	B-PP	-	2	NMOD	-	-
4	VitD3	VitD3	B-NP	B-NP	-	3	PMOD	-	-
5	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	RA-stimulated	RA-stimulated	I-NP	I-NP	-	8	NMOD	-	-
8	formation	formation	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	RAR	RAR	B-NP	B-NP	-	12	NMOD	-	-
11	beta/RXR	beta/RXR	I-NP	I-NP	-	12	NMOD	-	-
12	heterodimers	heterodimers	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	5	P	-	-
14	favoring	favoring	B-VP	B-VP	-	5	VMOD	-	-
15	VDR/RXR	VDR/RXR	B-NP	B-NP	-	16	NMOD	-	-
16	binding	binding	I-NP	I-NP	-	14	OBJ	-	-
17	to	to	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	RARE	RARE	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	5	P	-	-

1	Also	Also	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	VitD3	VitD3	B-NP	B-NP	-	4	SUB	-	-
4	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	CD23	CD23	B-NP	B-NP	-	10	NMOD	-	-
9	and	and	I-NP	I-NP	-	10	NMOD	-	-
10	CD49f	CD49f	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	characteristic	characteristic	B-NP	B-NP	-	13	NMOD	-	-
13	markers	markers	I-NP	I-NP	-	7	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	retinoid-induced	retinoid-induced	B-NP	B-NP	-	18	NMOD	-	-
16	U-937	U-937	I-NP	I-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	differentiation	differentiation	I-NP	I-NP	-	14	PMOD	-	-
19	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	15	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	15	P	-	-
4	neither	neither	O	O	-	15	VMOD	-	-
5	the	the	B-NP	B-NP	-	9	NMOD	-	-
6	RA-stimulated	RA-stimulated	I-NP	I-NP	-	8	AMOD	-	-
7	,	,	I-NP	I-NP	-	8	P	-	-
8	RARE-mediated	RARE-mediated	I-NP	I-NP	-	9	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	14	NMOD	-	-
10	nor	nor	O	O	-	14	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	induced	induced	I-NP	I-NP	-	14	NMOD	-	-
13	RAR-beta	RAR-beta	I-NP	I-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	15	SUB	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	suppressed	suppressed	I-VP	I-VP	-	15	VC	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	VitD3	VitD3	B-NP	B-NP	-	17	PMOD	-	-
19	,	,	O	O	-	15	P	-	-
20	suggesting	suggesting	B-VP	B-VP	-	15	VMOD	-	-
21	that	that	B-SBAR	B-SBAR	-	20	VMOD	-	-
22	VitD3	VitD3	B-NP	B-NP	-	24	SUB	-	-
23	selectively	selectively	B-ADVP	B-ADVP	-	24	VMOD	-	-
24	inhibited	inhibited	B-VP	B-VP	-	21	SBAR	-	-
25	the	the	B-NP	B-NP	-	28	NMOD	-	-
26	retinoid-induced	retinoid-induced	I-NP	I-NP	-	28	NMOD	-	-
27	differentiation	differentiation	I-NP	I-NP	-	28	NMOD	-	-
28	program	program	I-NP	I-NP	-	33	NMOD	-	-
29	but	but	B-NP	B-NP	-	33	NMOD	-	-
30	not	not	I-NP	I-NP	-	29	DEP	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	RARE-mediated	RARE-mediated	I-NP	I-NP	-	33	NMOD	-	-
33	signal	signal	I-NP	I-NP	-	24	OBJ	-	-
34	.	.	O	O	-	15	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	complex	complex	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	for	for	B-PP	B-PP	-	6	NMOD	-	-
8	VitD3	VitD3	B-NP	B-NP	-	7	PMOD	-	-
9	in	in	B-PP	B-PP	-	6	NMOD	-	-
10	modifying	modifying	B-VP	B-VP	-	9	PMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	retinoid	retinoid	I-NP	I-NP	-	14	NMOD	-	-
13	differentiation	differentiation	I-NP	I-NP	-	14	NMOD	-	-
14	pathway	pathway	I-NP	I-NP	-	10	OBJ	-	-
15	and	and	O	O	-	3	VMOD	-	-
16	may	may	B-VP	B-VP	-	3	VMOD	-	-
17	have	have	I-VP	I-VP	-	16	VC	-	-
18	implications	implications	B-NP	B-NP	-	17	OBJ	-	-
19	for	for	B-PP	B-PP	-	18	NMOD	-	-
20	differentiation-inducing	differentiation-inducing	B-NP	B-NP	-	21	NMOD	-	-
21	therapy	therapy	I-NP	I-NP	-	19	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	hematopoietic	hematopoietic	B-NP	B-NP	-	24	NMOD	-	-
24	tumors	tumors	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Calcium-dependent	Calcium-dependent	B-NP	B-NP	-	4	NMOD	-	-
2	immediate-early	immediate-early	I-NP	I-NP	-	4	NMOD	-	-
3	gene	gene	I-NP	I-NP	-	4	NMOD	-	-
4	induction	induction	I-NP	I-NP	-	7	SUB	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	lymphocytes	lymphocytes	B-NP	B-NP	-	5	PMOD	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	negatively	negatively	I-VP	I-VP	-	7	VMOD	-	-
9	regulated	regulated	I-VP	I-VP	-	7	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	p21Ha-ras	p21Ha-ras	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	18	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	immediate-early	immediate-early	O	O	-	9	NMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	IE	IE	B-ADJP	B-ADJP	-	4	AMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	response	response	B-NP	B-NP	-	9	NMOD	-	-
9	genes	genes	I-NP	I-NP	-	18	NMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	such	such	B-PP	B-PP	-	12	PMOD	-	-
12	as	as	I-PP	I-PP	-	9	NMOD	-	-
13	egr-1	egr-1	B-NP	B-NP	-	18	NMOD	-	-
14	,	,	O	O	-	18	P	-	-
15	c-fos	c-fos	B-NP	B-NP	-	18	NMOD	-	-
16	,	,	O	O	-	18	P	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	c-jun	c-jun	B-NP	B-NP	-	20	SUB	-	-
19	,	,	O	O	-	18	P	-	-
20	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
21	rapidly	rapidly	B-ADVP	B-ADVP	-	20	VMOD	-	-
22	after	after	B-PP	B-PP	-	20	VMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	activation	activation	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	T	T	B-NP	B-NP	-	27	NMOD	-	-
27	lymphocytes	lymphocytes	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	20	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	process	process	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	activation	activation	B-NP	B-NP	-	3	PMOD	-	-
5	involves	involves	B-VP	B-VP	-	0	ROOT	-	-
6	calcium	calcium	B-NP	B-NP	-	7	NMOD	-	-
7	mobilization	mobilization	I-NP	I-NP	-	19	NMOD	-	-
8	,	,	O	O	-	19	P	-	-
9	activation	activation	B-NP	B-NP	-	19	NMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	protein	protein	B-NP	B-NP	-	13	NMOD	-	-
12	kinase	kinase	I-NP	I-NP	-	13	NMOD	-	-
13	C	C	I-NP	I-NP	-	10	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	PKC	PKC	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	,	,	O	O	-	19	P	-	-
18	and	and	O	O	-	19	NMOD	-	-
19	phosphorylation	phosphorylation	B-NP	B-NP	-	5	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	tyrosine	tyrosine	B-NP	B-NP	-	22	NMOD	-	-
22	kinases	kinases	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	p21	p21	B-NP	B-NP	-	10	NMOD	-	-
2	(	(	O	O	-	3	P	-	-
3	ras	ras	B-NP	B-NP	-	1	NMOD	-	-
4	)	)	O	O	-	3	P	-	-
5	,	,	O	O	-	10	P	-	-
6	a	a	B-NP	B-NP	-	10	NMOD	-	-
7	guanine	guanine	I-NP	I-NP	-	10	NMOD	-	-
8	nucleotide	nucleotide	I-NP	I-NP	-	10	NMOD	-	-
9	binding	binding	I-NP	I-NP	-	10	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	12	SUB	-	-
11	,	,	O	O	-	10	P	-	-
12	mediates	mediates	B-VP	B-VP	-	0	ROOT	-	-
13	T-cell	T-cell	B-NP	B-NP	-	15	NMOD	-	-
14	signal	signal	I-NP	I-NP	-	15	NMOD	-	-
15	transduction	transduction	I-NP	I-NP	-	12	OBJ	-	-
16	through	through	B-PP	B-PP	-	12	VMOD	-	-
17	PKC-dependent	PKC-dependent	B-NP	B-NP	-	20	NMOD	-	-
18	and	and	I-NP	I-NP	-	20	NMOD	-	-
19	PKC-independent	PKC-independent	I-NP	I-NP	-	20	NMOD	-	-
20	pathways	pathways	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	involvement	involvement	I-NP	I-NP	-	14	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	p21	p21	B-NP	B-NP	-	3	PMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	ras	ras	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	in	in	B-PP	B-PP	-	2	NMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	regulation	regulation	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	calcium-dependent	calcium-dependent	B-NP	B-NP	-	13	NMOD	-	-
13	signals	signals	I-NP	I-NP	-	11	PMOD	-	-
14	has	has	B-VP	B-VP	-	0	ROOT	-	-
15	been	been	I-VP	I-VP	-	14	VC	-	-
16	suggested	suggested	I-VP	I-VP	-	15	VC	-	-
17	through	through	B-PP	B-PP	-	16	VMOD	-	-
18	analysis	analysis	B-NP	B-NP	-	17	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	its	its	B-NP	B-NP	-	21	NMOD	-	-
21	role	role	I-NP	I-NP	-	19	PMOD	-	-
22	in	in	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	activation	activation	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	NF-AT	NF-AT	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	14	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	investigated	investigated	I-VP	I-VP	-	2	VC	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	inductions	inductions	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	IE	IE	I-NP	I-NP	-	9	NMOD	-	-
9	genes	genes	I-NP	I-NP	-	6	PMOD	-	-
10	in	in	B-PP	B-PP	-	5	NMOD	-	-
11	response	response	B-NP	B-NP	-	10	PMOD	-	-
12	to	to	B-PP	B-PP	-	11	NMOD	-	-
13	calcium	calcium	B-NP	B-NP	-	14	NMOD	-	-
14	signals	signals	I-NP	I-NP	-	12	PMOD	-	-
15	in	in	B-PP	B-PP	-	11	NMOD	-	-
16	Jurkat	Jurkat	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	in	in	B-PP	B-PP	-	15	PMOD	-	-
20	the	the	I-PP	I-PP	-	19	PMOD	-	-
21	presence	presence	I-PP	I-PP	-	19	PMOD	-	-
22	of	of	I-PP	I-PP	-	21	NMOD	-	-
23	activated	activated	B-NP	B-NP	-	32	NMOD	-	-
24	p21	p21	I-NP	I-NP	-	32	NMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	ras	ras	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	)	)	O	O	-	24	P	-	-
29	and	and	O	O	-	32	NMOD	-	-
30	their	their	B-NP	B-NP	-	32	NMOD	-	-
31	correlated	correlated	I-NP	I-NP	-	32	NMOD	-	-
32	consequences	consequences	I-NP	I-NP	-	19	PMOD	-	-
33	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	activated	activated	B-NP	B-NP	-	5	NMOD	-	-
5	p21	p21	I-NP	I-NP	-	3	PMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	ras	ras	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	negatively	negatively	B-ADVP	B-ADVP	-	10	VMOD	-	-
10	regulated	regulated	B-VP	B-VP	-	0	ROOT	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	induction	induction	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	IE	IE	B-NP	B-NP	-	15	NMOD	-	-
15	genes	genes	I-NP	I-NP	-	13	PMOD	-	-
16	by	by	B-PP	B-PP	-	12	NMOD	-	-
17	calcium	calcium	B-NP	B-NP	-	18	NMOD	-	-
18	ionophore	ionophore	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	10	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	inhibition	inhibition	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	calcium-activated	calcium-activated	B-NP	B-NP	-	7	NMOD	-	-
5	IE	IE	I-NP	I-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	induction	induction	I-NP	I-NP	-	3	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	reversed	reversed	I-VP	I-VP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	treatment	treatment	B-NP	B-NP	-	10	PMOD	-	-
12	with	with	B-PP	B-PP	-	11	NMOD	-	-
13	cyclosporin	cyclosporin	B-NP	B-NP	-	14	NMOD	-	-
14	A	A	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	8	P	-	-
16	suggesting	suggesting	B-VP	B-VP	-	8	VMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	involvement	involvement	I-NP	I-NP	-	16	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	calcineurin	calcineurin	B-NP	B-NP	-	19	PMOD	-	-
21	in	in	B-PP	B-PP	-	18	NMOD	-	-
22	this	this	B-NP	B-NP	-	23	NMOD	-	-
23	regulation	regulation	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	8	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	later	later	I-NP	I-NP	-	3	NMOD	-	-
3	result	result	I-NP	I-NP	-	15	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	inhibition	inhibition	B-NP	B-NP	-	4	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	this	this	B-NP	B-NP	-	9	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	9	NMOD	-	-
9	pathway	pathway	I-NP	I-NP	-	6	PMOD	-	-
10	by	by	B-PP	B-PP	-	5	NMOD	-	-
11	p21	p21	B-NP	B-NP	-	10	PMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	ras	ras	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	was	was	B-VP	B-VP	-	0	ROOT	-	-
16	down-regulation	down-regulation	B-NP	B-NP	-	15	PRD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	activity	activity	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	24	NMOD	-	-
22	transcription	transcription	I-NP	I-NP	-	24	NMOD	-	-
23	factor	factor	I-NP	I-NP	-	24	NMOD	-	-
24	AP-1	AP-1	I-NP	I-NP	-	20	PMOD	-	-
25	and	and	O	O	-	28	NMOD	-	-
26	subsequent	subsequent	B-NP	B-NP	-	28	NMOD	-	-
27	coordinate	coordinate	I-NP	I-NP	-	28	NMOD	-	-
28	reductions	reductions	I-NP	I-NP	-	20	PMOD	-	-
29	in	in	B-PP	B-PP	-	28	NMOD	-	-
30	IL-2	IL-2	B-NP	B-NP	-	32	NMOD	-	-
31	gene	gene	I-NP	I-NP	-	32	NMOD	-	-
32	expression	expression	I-NP	I-NP	-	35	NMOD	-	-
33	and	and	O	O	-	35	NMOD	-	-
34	protein	protein	B-NP	B-NP	-	35	NMOD	-	-
35	production	production	I-NP	I-NP	-	29	PMOD	-	-
36	.	.	O	O	-	15	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	p2l	p2l	B-NP	B-NP	-	9	SUB	-	-
6	(	(	O	O	-	7	P	-	-
7	ras	ras	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	is	is	B-VP	B-VP	-	4	SBAR	-	-
10	an	an	B-NP	B-NP	-	12	NMOD	-	-
11	essential	essential	I-NP	I-NP	-	12	NMOD	-	-
12	mediator	mediator	I-NP	I-NP	-	9	PRD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	generating	generating	B-VP	B-VP	-	13	PMOD	-	-
15	not	not	B-CONJP	B-CONJP	-	22	NMOD	-	-
16	only	only	I-CONJP	I-CONJP	-	15	DEP	-	-
17	positive	positive	B-ADJP	B-ADJP	-	22	NMOD	-	-
18	but	but	B-CONJP	B-CONJP	-	22	NMOD	-	-
19	also	also	I-CONJP	I-CONJP	-	18	DEP	-	-
20	negative	negative	B-NP	B-NP	-	22	NMOD	-	-
21	modulatory	modulatory	I-NP	I-NP	-	22	NMOD	-	-
22	mechanisms	mechanisms	I-NP	I-NP	-	9	PRD	-	-
23	controlling	controlling	B-VP	B-VP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	competence	competence	I-NP	I-NP	-	23	OBJ	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	T	T	B-NP	B-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
29	in	in	B-PP	B-PP	-	25	NMOD	-	-
30	response	response	B-NP	B-NP	-	29	PMOD	-	-
31	to	to	B-PP	B-PP	-	30	NMOD	-	-
32	inductive	inductive	B-NP	B-NP	-	33	NMOD	-	-
33	stimulations	stimulations	I-NP	I-NP	-	31	PMOD	-	-
34	.	.	O	O	-	3	P	-	-

1	Apoptosis	Apoptosis	B-NP	B-NP	-	3	NMOD	-	-
2	signaling	signaling	I-NP	I-NP	-	3	NMOD	-	-
3	pathways	pathways	I-NP	I-NP	-	10	NMOD	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	normal	normal	B-NP	B-NP	-	7	NMOD	-	-
6	T	T	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
8	:	:	O	O	-	3	P	-	-
9	differential	differential	B-NP	B-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	0	ROOT	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	Bcl-2	Bcl-2	B-NP	B-NP	-	18	NMOD	-	-
13	and	and	I-NP	I-NP	-	18	NMOD	-	-
14	IL-1beta-converting	IL-1beta-converting	I-NP	I-NP	-	18	NMOD	-	-
15	enzyme	enzyme	I-NP	I-NP	-	18	NMOD	-	-
16	family	family	I-NP	I-NP	-	18	NMOD	-	-
17	protease	protease	I-NP	I-NP	-	18	NMOD	-	-
18	inhibitors	inhibitors	I-NP	I-NP	-	11	PMOD	-	-
19	on	on	B-PP	B-PP	-	18	NMOD	-	-
20	glucocorticoid-	glucocorticoid-	B-NP	B-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	Fas-mediated	Fas-mediated	B-NP	B-NP	-	23	NMOD	-	-
23	cytotoxicity	cytotoxicity	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	10	P	-	-

1	Fas-mediated	Fas-mediated	B-NP	B-NP	-	2	NMOD	-	-
2	apoptosis	apoptosis	I-NP	I-NP	-	3	SUB	-	-
3	plays	plays	B-VP	B-VP	-	0	ROOT	-	-
4	an	an	B-NP	B-NP	-	6	NMOD	-	-
5	important	important	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	in	in	B-PP	B-PP	-	3	VMOD	-	-
8	regulating	regulating	B-VP	B-VP	-	7	PMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	immune	immune	I-NP	I-NP	-	11	NMOD	-	-
11	response	response	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	peripheral	peripheral	B-NP	B-NP	-	15	NMOD	-	-
14	T	T	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	Restimulation	Restimulation	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	5	NMOD	-	-
4	cell	cell	I-NP	I-NP	-	5	NMOD	-	-
5	blasts	blasts	I-NP	I-NP	-	2	PMOD	-	-
6	up-regulates	up-regulates	B-VP	B-VP	-	0	ROOT	-	-
7	Fas	Fas	B-NP	B-NP	-	11	NMOD	-	-
8	and	and	I-NP	I-NP	-	11	NMOD	-	-
9	Fas	Fas	I-NP	I-NP	-	11	NMOD	-	-
10	ligand	ligand	I-NP	I-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	6	OBJ	-	-
12	,	,	O	O	-	6	P	-	-
13	with	with	B-PP	B-PP	-	6	VMOD	-	-
14	subsequent	subsequent	B-NP	B-NP	-	15	NMOD	-	-
15	interaction	interaction	I-NP	I-NP	-	13	PMOD	-	-
16	leading	leading	B-VP	B-VP	-	15	NMOD	-	-
17	to	to	B-PP	B-PP	-	16	VMOD	-	-
18	cell	cell	B-NP	B-NP	-	19	NMOD	-	-
19	death	death	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	6	P	-	-

1	Overexpression	Overexpression	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Bcl-2	Bcl-2	B-NP	B-NP	-	2	PMOD	-	-
4	in	in	B-PP	B-PP	-	1	NMOD	-	-
5	tumor	tumor	B-NP	B-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
7	blocks	blocks	B-VP	B-VP	-	19	VMOD	-	-
8	apoptosis	apoptosis	B-NP	B-NP	-	7	OBJ	-	-
9	induced	induced	B-VP	B-VP	-	8	NMOD	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	many	many	B-NP	B-NP	-	12	NMOD	-	-
12	stimuli	stimuli	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	19	P	-	-
14	but	but	O	O	-	19	VMOD	-	-
15	inhibition	inhibition	B-NP	B-NP	-	19	SUB	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	Fas-mediated	Fas-mediated	B-NP	B-NP	-	18	NMOD	-	-
18	killing	killing	I-NP	I-NP	-	16	PMOD	-	-
19	has	has	B-VP	B-VP	-	0	ROOT	-	-
20	not	not	I-VP	I-VP	-	19	VMOD	-	-
21	been	been	I-VP	I-VP	-	19	VC	-	-
22	consistently	consistently	I-VP	I-VP	-	21	VMOD	-	-
23	observed	observed	I-VP	I-VP	-	21	VC	-	-
24	.	.	O	O	-	19	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	examine	examine	I-VP	I-VP	-	14	VMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	behavior	behavior	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	Bcl-2	Bcl-2	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	4	NMOD	-	-
8	normal	normal	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	,	,	O	O	-	14	P	-	-
11	T	T	B-NP	B-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	blasts	blasts	I-NP	I-NP	-	14	SUB	-	-
14	were	were	B-VP	B-VP	-	0	ROOT	-	-
15	transiently	transiently	I-VP	I-VP	-	14	VMOD	-	-
16	transfected	transfected	I-VP	I-VP	-	14	VC	-	-
17	with	with	B-PP	B-PP	-	16	VMOD	-	-
18	Bcl-2	Bcl-2	B-NP	B-NP	-	22	NMOD	-	-
19	and	and	I-NP	I-NP	-	22	NMOD	-	-
20	related	related	I-NP	I-NP	-	22	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	22	NMOD	-	-
22	products	products	I-NP	I-NP	-	17	PMOD	-	-
23	to	to	B-VP	B-VP	-	24	VMOD	-	-
24	determine	determine	I-VP	I-VP	-	14	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	effect	effect	I-NP	I-NP	-	24	OBJ	-	-
27	on	on	B-PP	B-PP	-	26	NMOD	-	-
28	apoptotic	apoptotic	B-NP	B-NP	-	29	NMOD	-	-
29	signaling	signaling	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	14	P	-	-

1	Transient	Transient	B-NP	B-NP	-	2	NMOD	-	-
2	overexpression	overexpression	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	Bcl-2	Bcl-2	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	mouse	mouse	B-NP	B-NP	-	11	NMOD	-	-
7	and	and	O	O	-	11	NMOD	-	-
8	human	human	B-NP	B-NP	-	11	NMOD	-	-
9	T	T	B-NP	B-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	blasts	blasts	I-NP	I-NP	-	5	PMOD	-	-
12	did	did	B-VP	B-VP	-	18	VMOD	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	block	block	I-VP	I-VP	-	12	VC	-	-
15	Fas-mediated	Fas-mediated	B-NP	B-NP	-	16	NMOD	-	-
16	apoptosis	apoptosis	I-NP	I-NP	-	14	OBJ	-	-
17	,	,	O	O	-	12	P	-	-
18	whereas	whereas	O	O	-	0	ROOT	-	-
19	etoposide-	etoposide-	B-NP	B-NP	-	22	NMOD	-	-
20	and	and	O	O	-	22	NMOD	-	-
21	glucocorticoid-induced	glucocorticoid-induced	B-NP	B-NP	-	22	NMOD	-	-
22	cytotoxicity	cytotoxicity	I-NP	I-NP	-	23	SUB	-	-
23	was	was	B-VP	B-VP	-	18	SBAR	-	-
24	potently	potently	I-VP	I-VP	-	23	VMOD	-	-
25	inhibited	inhibited	I-VP	I-VP	-	23	VC	-	-
26	.	.	O	O	-	18	P	-	-

1	Expression	Expression	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Bcl-xL	Bcl-xL	B-NP	B-NP	-	7	NMOD	-	-
4	and	and	I-NP	I-NP	-	7	NMOD	-	-
5	adenovirus	adenovirus	I-NP	I-NP	-	7	NMOD	-	-
6	E1B	E1B	I-NP	I-NP	-	7	NMOD	-	-
7	19K	19K	I-NP	I-NP	-	2	PMOD	-	-
8	did	did	B-VP	B-VP	-	0	ROOT	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	interfere	interfere	I-VP	I-VP	-	8	VC	-	-
11	with	with	B-PP	B-PP	-	10	VMOD	-	-
12	anti-Fas	anti-Fas	B-NP	B-NP	-	13	NMOD	-	-
13	killing	killing	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	8	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	12	P	-	-
4	interleukin-1beta-converting	interleukin-1beta-converting	B-NP	B-NP	-	8	NMOD	-	-
5	enzyme	enzyme	I-NP	I-NP	-	8	NMOD	-	-
6	family	family	I-NP	I-NP	-	8	NMOD	-	-
7	protease	protease	I-NP	I-NP	-	8	NMOD	-	-
8	inhibitors	inhibitors	I-NP	I-NP	-	11	NMOD	-	-
9	Ac-DEVD-CHO	Ac-DEVD-CHO	I-NP	I-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	CrmA	CrmA	I-NP	I-NP	-	12	SUB	-	-
12	blocked	blocked	B-VP	B-VP	-	0	ROOT	-	-
13	Fas-mediated	Fas-mediated	B-NP	B-NP	-	14	NMOD	-	-
14	apoptosis	apoptosis	I-NP	I-NP	-	12	OBJ	-	-
15	.	.	O	O	-	12	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	peripheral	peripheral	B-NP	B-NP	-	7	NMOD	-	-
6	T	T	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	8	SUB	-	-
8	use	use	B-VP	B-VP	-	4	SBAR	-	-
9	distinct	distinct	B-NP	B-NP	-	12	NMOD	-	-
10	apoptosis	apoptosis	I-NP	I-NP	-	12	NMOD	-	-
11	signaling	signaling	I-NP	I-NP	-	12	NMOD	-	-
12	pathways	pathways	I-NP	I-NP	-	8	OBJ	-	-
13	with	with	B-PP	B-PP	-	12	NMOD	-	-
14	differential	differential	B-NP	B-NP	-	15	NMOD	-	-
15	sensitivity	sensitivity	I-NP	I-NP	-	13	PMOD	-	-
16	to	to	B-PP	B-PP	-	15	NMOD	-	-
17	Bcl-2	Bcl-2	B-NP	B-NP	-	16	PMOD	-	-
18	and	and	O	O	-	23	NMOD	-	-
19	interleukin-1beta-converting	interleukin-1beta-converting	B-NP	B-NP	-	23	NMOD	-	-
20	enzyme	enzyme	I-NP	I-NP	-	23	NMOD	-	-
21	family	family	I-NP	I-NP	-	23	NMOD	-	-
22	protease	protease	I-NP	I-NP	-	23	NMOD	-	-
23	inhibitors	inhibitors	I-NP	I-NP	-	13	PMOD	-	-
24	.	.	O	O	-	3	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	18	VMOD	-	-
2	T	T	B-NP	B-NP	-	3	NMOD	-	-
3	cells	cells	I-NP	I-NP	-	5	SUB	-	-
4	normally	normally	B-ADVP	B-ADVP	-	5	VMOD	-	-
5	express	express	B-VP	B-VP	-	1	SBAR	-	-
6	Bcl-2	Bcl-2	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	I-NP	I-NP	-	8	NMOD	-	-
8	Bcl-xL	Bcl-xL	I-NP	I-NP	-	5	OBJ	-	-
9	following	following	B-PP	B-PP	-	5	VMOD	-	-
10	activation	activation	B-NP	B-NP	-	13	NMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	their	their	B-NP	B-NP	-	13	NMOD	-	-
13	inability	inability	I-NP	I-NP	-	9	PMOD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	block	block	I-VP	I-VP	-	13	NMOD	-	-
16	Fas-mediated	Fas-mediated	B-NP	B-NP	-	17	NMOD	-	-
17	apoptosis	apoptosis	I-NP	I-NP	-	15	OBJ	-	-
18	may	may	B-VP	B-VP	-	0	ROOT	-	-
19	allow	allow	I-VP	I-VP	-	18	VC	-	-
20	for	for	B-PP	B-PP	-	19	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	elimination	elimination	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	self-reactive	self-reactive	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
26	and	and	O	O	-	29	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	appropriate	appropriate	I-NP	I-NP	-	29	NMOD	-	-
29	regulation	regulation	I-NP	I-NP	-	23	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	immune	immune	B-NP	B-NP	-	32	NMOD	-	-
32	responses	responses	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	18	P	-	-

1	Interferons	Interferons	B-NP	B-NP	-	2	SUB	-	-
2	induce	induce	B-VP	B-VP	-	0	ROOT	-	-
3	normal	normal	B-NP	B-NP	-	7	NMOD	-	-
4	and	and	I-NP	I-NP	-	7	NMOD	-	-
5	aberrant	aberrant	I-NP	I-NP	-	7	NMOD	-	-
6	retinoic-acid	retinoic-acid	I-NP	I-NP	-	7	NMOD	-	-
7	receptors	receptors	I-NP	I-NP	-	9	NMOD	-	-
8	type	type	I-NP	I-NP	-	9	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	2	OBJ	-	-
10	in	in	B-PP	B-PP	-	2	VMOD	-	-
11	acute	acute	B-NP	B-NP	-	14	NMOD	-	-
12	promyelocytic	promyelocytic	I-NP	I-NP	-	14	NMOD	-	-
13	leukemia	leukemia	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
15	:	:	O	O	-	2	P	-	-
16	potentiation	potentiation	B-NP	B-NP	-	2	VMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	induction	induction	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	retinoid-dependent	retinoid-dependent	B-NP	B-NP	-	23	NMOD	-	-
22	differentiation	differentiation	I-NP	I-NP	-	23	NMOD	-	-
23	markers	markers	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	2	P	-	-

1	Treatment	Treatment	B-NP	B-NP	-	32	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	11	NMOD	-	-
4	acute	acute	I-NP	I-NP	-	11	NMOD	-	-
5	promyelocytic	promyelocytic	I-NP	I-NP	-	11	NMOD	-	-
6	(	(	O	O	-	11	P	-	-
7	APL	APL	B-NP	B-NP	-	11	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	cell	cell	B-NP	B-NP	-	11	NMOD	-	-
10	line	line	I-NP	I-NP	-	11	NMOD	-	-
11	NB4	NB4	I-NP	I-NP	-	2	PMOD	-	-
12	with	with	B-PP	B-PP	-	1	NMOD	-	-
13	interferon	interferon	B-NP	B-NP	-	14	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	30	NMOD	-	-
15	(	(	O	O	-	30	P	-	-
16	IFN	IFN	B-NP	B-NP	-	30	NMOD	-	-
17	(	(	O	O	-	30	P	-	-
18	alpha	alpha	B-NP	B-NP	-	30	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	)	)	O	O	-	18	P	-	-
21	,	,	O	O	-	30	P	-	-
22	as	as	B-CONJP	B-CONJP	-	30	NMOD	-	-
23	well	well	I-CONJP	I-CONJP	-	22	DEP	-	-
24	as	as	I-CONJP	I-CONJP	-	22	DEP	-	-
25	IFN	IFN	B-NP	B-NP	-	30	NMOD	-	-
26	(	(	O	O	-	30	P	-	-
27	beta	beta	B-NP	B-NP	-	30	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	and	and	O	O	-	30	NMOD	-	-
30	gamma	gamma	B-NP	B-NP	-	12	PMOD	-	-
31	,	,	O	O	-	1	P	-	-
32	results	results	B-VP	B-VP	-	0	ROOT	-	-
33	in	in	B-PP	B-PP	-	32	VMOD	-	-
34	an	an	B-NP	B-NP	-	36	NMOD	-	-
35	increased	increased	I-NP	I-NP	-	36	NMOD	-	-
36	expression	expression	I-NP	I-NP	-	33	PMOD	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	the	the	B-NP	B-NP	-	39	NMOD	-	-
39	transcripts	transcripts	I-NP	I-NP	-	37	PMOD	-	-
40	coding	coding	B-VP	B-VP	-	39	NMOD	-	-
41	for	for	B-PP	B-PP	-	40	VMOD	-	-
42	retinoic-acid	retinoic-acid	B-NP	B-NP	-	45	NMOD	-	-
43	receptor	receptor	I-NP	I-NP	-	45	NMOD	-	-
44	type	type	I-NP	I-NP	-	45	NMOD	-	-
45	alpha	alpha	I-NP	I-NP	-	41	PMOD	-	-
46	(	(	O	O	-	49	P	-	-
47	RAR	RAR	B-NP	B-NP	-	49	NMOD	-	-
48	(	(	O	O	-	49	P	-	-
49	alpha	alpha	B-NP	B-NP	-	45	NMOD	-	-
50	)	)	O	O	-	49	P	-	-
51	)	)	O	O	-	49	P	-	-
52	and	and	O	O	-	58	NMOD	-	-
53	the	the	B-NP	B-NP	-	58	NMOD	-	-
54	leukemia-specific	leukemia-specific	I-NP	I-NP	-	58	NMOD	-	-
55	retinoic	retinoic	I-NP	I-NP	-	58	NMOD	-	-
56	acid	acid	I-NP	I-NP	-	58	NMOD	-	-
57	receptor	receptor	I-NP	I-NP	-	58	NMOD	-	-
58	PML-RAR	PML-RAR	I-NP	I-NP	-	41	PMOD	-	-
59	.	.	O	O	-	32	P	-	-

1	Transcriptional	Transcriptional	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	11	NMOD	-	-
5	RAR	RAR	I-NP	I-NP	-	11	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	alpha	alpha	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	and	and	O	O	-	11	NMOD	-	-
10	PML-RAR	PML-RAR	B-NP	B-NP	-	11	NMOD	-	-
11	mRNAs	mRNAs	I-NP	I-NP	-	3	PMOD	-	-
12	is	is	B-VP	B-VP	-	16	VMOD	-	-
13	rapid	rapid	B-ADJP	B-ADJP	-	12	PRD	-	-
14	and	and	O	O	-	16	VMOD	-	-
15	it	it	B-NP	B-NP	-	16	SUB	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	parallelled	parallelled	I-VP	I-VP	-	16	VC	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	an	an	B-NP	B-NP	-	20	NMOD	-	-
20	increase	increase	I-NP	I-NP	-	18	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	corresponding	corresponding	I-NP	I-NP	-	24	NMOD	-	-
24	proteins	proteins	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	16	P	-	-

1	Up-regulation	Up-regulation	B-NP	B-NP	-	16	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	RAR	RAR	B-NP	B-NP	-	10	NMOD	-	-
4	(	(	O	O	-	5	P	-	-
5	alpha	alpha	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	and	and	O	O	-	10	NMOD	-	-
8	PML-RAR	PML-RAR	B-NP	B-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
11	by	by	B-PP	B-PP	-	1	NMOD	-	-
12	IFN	IFN	B-NP	B-NP	-	11	PMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	alpha	alpha	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	accompanied	accompanied	I-VP	I-VP	-	16	VC	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	a	a	B-NP	B-NP	-	21	NMOD	-	-
20	strong	strong	I-NP	I-NP	-	21	NMOD	-	-
21	potentiation	potentiation	I-NP	I-NP	-	18	PMOD	-	-
22	in	in	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	induction	induction	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	<num>	<num>	B-NP	B-NP	-	29	NMOD	-	-
27	retinoid-dependent	retinoid-dependent	I-NP	I-NP	-	29	NMOD	-	-
28	granulocytic	granulocytic	I-NP	I-NP	-	29	NMOD	-	-
29	markers	markers	I-NP	I-NP	-	25	PMOD	-	-
30	,	,	O	O	-	40	P	-	-
31	i.e.	i.e.	B-NP	B-NP	-	40	NMOD	-	-
32	,	,	O	O	-	40	P	-	-
33	granulocyte-colony-stimulating	granulocyte-colony-stimulating	B-NP	B-NP	-	36	NMOD	-	-
34	factor	factor	I-NP	I-NP	-	36	NMOD	-	-
35	receptor	receptor	I-NP	I-NP	-	36	NMOD	-	-
36	mRNA	mRNA	I-NP	I-NP	-	40	NMOD	-	-
37	and	and	O	O	-	40	NMOD	-	-
38	leukocyte	leukocyte	B-NP	B-NP	-	40	NMOD	-	-
39	alkaline	alkaline	I-NP	I-NP	-	40	NMOD	-	-
40	phosphatase	phosphatase	I-NP	I-NP	-	25	PMOD	-	-
41	.	.	O	O	-	16	P	-	-

1	However	However	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	IFN	IFN	B-NP	B-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	alpha	alpha	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	does	does	B-VP	B-VP	-	0	ROOT	-	-
8	not	not	I-VP	I-VP	-	7	VMOD	-	-
9	have	have	I-VP	I-VP	-	7	VC	-	-
10	any	any	B-NP	B-NP	-	11	NMOD	-	-
11	effects	effects	I-NP	I-NP	-	9	OBJ	-	-
12	on	on	B-PP	B-PP	-	9	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	retinoid-dependent	retinoid-dependent	I-NP	I-NP	-	15	NMOD	-	-
15	regulation	regulation	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	myeloid	myeloid	I-NP	I-NP	-	20	NMOD	-	-
19	surface	surface	I-NP	I-NP	-	20	NMOD	-	-
20	markers	markers	I-NP	I-NP	-	16	PMOD	-	-
21	CD11b	CD11b	I-NP	I-NP	-	23	NMOD	-	-
22	and	and	I-NP	I-NP	-	23	NMOD	-	-
23	CD33	CD33	I-NP	I-NP	-	20	NMOD	-	-
24	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	IFN-dependent	IFN-dependent	I-NP	I-NP	-	3	NMOD	-	-
3	increase	increase	I-NP	I-NP	-	13	NMOD	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	RAR	RAR	B-NP	B-NP	-	9	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	alpha	alpha	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	levels	levels	B-NP	B-NP	-	13	NMOD	-	-
10	and	and	O	O	-	13	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	enhancing	enhancing	I-NP	I-NP	-	13	NMOD	-	-
13	effect	effect	I-NP	I-NP	-	22	SUB	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	cytokine	cytokine	I-NP	I-NP	-	14	PMOD	-	-
17	on	on	B-PP	B-PP	-	13	NMOD	-	-
18	retinoid-dependent	retinoid-dependent	B-NP	B-NP	-	20	NMOD	-	-
19	granulocytic	granulocytic	I-NP	I-NP	-	20	NMOD	-	-
20	markers	markers	I-NP	I-NP	-	21	NMOD	-	-
21	expression	expression	I-NP	I-NP	-	17	PMOD	-	-
22	may	may	B-VP	B-VP	-	0	ROOT	-	-
23	be	be	I-VP	I-VP	-	22	VC	-	-
24	a	a	B-NP	B-NP	-	25	NMOD	-	-
25	characteristic	characteristic	I-NP	I-NP	-	23	PRD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	PML-RAR	PML-RAR	B-NP	B-NP	-	29	NMOD	-	-
28	positive	positive	I-NP	I-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
30	,	,	O	O	-	22	P	-	-
31	since	since	B-SBAR	B-SBAR	-	22	VMOD	-	-
32	the	the	B-NP	B-NP	-	33	NMOD	-	-
33	phenomena	phenomena	I-NP	I-NP	-	34	SUB	-	-
34	are	are	B-VP	B-VP	-	31	SBAR	-	-
35	not	not	I-VP	I-VP	-	34	VMOD	-	-
36	observed	observed	I-VP	I-VP	-	34	VC	-	-
37	in	in	B-PP	B-PP	-	36	VMOD	-	-
38	HL-60	HL-60	B-NP	B-NP	-	39	NMOD	-	-
39	promyelocytes	promyelocytes	I-NP	I-NP	-	37	PMOD	-	-
40	.	.	O	O	-	22	P	-	-

1	Interferons	Interferons	B-NP	B-NP	-	5	NMOD	-	-
2	as	as	B-CONJP	B-CONJP	-	5	NMOD	-	-
3	well	well	I-CONJP	I-CONJP	-	2	DEP	-	-
4	as	as	I-CONJP	I-CONJP	-	2	DEP	-	-
5	retinoids	retinoids	B-NP	B-NP	-	6	SUB	-	-
6	inhibit	inhibit	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	growth	growth	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NB4	NB4	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	6	P	-	-
13	although	although	B-SBAR	B-SBAR	-	6	VMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	<num>	<num>	I-NP	I-NP	-	16	NMOD	-	-
16	classes	classes	I-NP	I-NP	-	19	SUB	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	compounds	compounds	B-NP	B-NP	-	17	PMOD	-	-
19	do	do	B-VP	B-VP	-	13	SBAR	-	-
20	not	not	I-VP	I-VP	-	19	VMOD	-	-
21	significantly	significantly	I-VP	I-VP	-	19	VMOD	-	-
22	interact	interact	I-VP	I-VP	-	19	VC	-	-
23	in	in	B-PP	B-PP	-	22	VMOD	-	-
24	terms	terms	B-NP	B-NP	-	23	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	anti-proliferative	anti-proliferative	B-NP	B-NP	-	27	NMOD	-	-
27	activity	activity	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	6	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	possible	possible	I-NP	I-NP	-	6	NMOD	-	-
6	use	use	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	combinations	combinations	B-NP	B-NP	-	7	PMOD	-	-
9	between	between	B-PP	B-PP	-	8	NMOD	-	-
10	IFNs	IFNs	B-NP	B-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	retinoic	retinoic	B-NP	B-NP	-	13	NMOD	-	-
13	acid	acid	I-NP	I-NP	-	9	PMOD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	cyto-differentiating	cyto-differentiating	I-NP	I-NP	-	17	NMOD	-	-
17	treatment	treatment	I-NP	I-NP	-	14	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	APL	APL	B-NP	B-NP	-	20	NMOD	-	-
20	patients	patients	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	An	An	B-NP	B-NP	-	4	NMOD	-	-
2	IL-2	IL-2	I-NP	I-NP	-	4	NMOD	-	-
3	response	response	I-NP	I-NP	-	4	NMOD	-	-
4	element	element	I-NP	I-NP	-	13	SUB	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	12	NMOD	-	-
7	human	human	I-NP	I-NP	-	12	NMOD	-	-
8	IL-2	IL-2	I-NP	I-NP	-	12	NMOD	-	-
9	receptor	receptor	I-NP	I-NP	-	12	NMOD	-	-
10	alpha	alpha	I-NP	I-NP	-	12	NMOD	-	-
11	chain	chain	I-NP	I-NP	-	12	NMOD	-	-
12	promoter	promoter	I-NP	I-NP	-	5	PMOD	-	-
13	is	is	B-VP	B-VP	-	0	ROOT	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	composite	composite	I-NP	I-NP	-	16	NMOD	-	-
16	element	element	I-NP	I-NP	-	13	PRD	-	-
17	that	that	B-NP	B-NP	-	16	NMOD	-	-
18	binds	binds	B-VP	B-VP	-	17	SBAR	-	-
19	Stat5	Stat5	B-NP	B-NP	-	18	OBJ	-	-
20	,	,	O	O	-	31	P	-	-
21	Elf-1	Elf-1	B-NP	B-NP	-	31	NMOD	-	-
22	,	,	O	O	-	31	P	-	-
23	HMG-I	HMG-I	B-NP	B-NP	-	31	NMOD	-	-
24	(	(	O	O	-	25	P	-	-
25	Y	Y	B-NP	B-NP	-	23	NMOD	-	-
26	)	)	O	O	-	25	P	-	-
27	and	and	O	O	-	31	NMOD	-	-
28	a	a	B-NP	B-NP	-	31	NMOD	-	-
29	GATA	GATA	I-NP	I-NP	-	31	NMOD	-	-
30	family	family	I-NP	I-NP	-	31	NMOD	-	-
31	protein	protein	I-NP	I-NP	-	18	OBJ	-	-
32	.	.	O	O	-	13	P	-	-

1	Expression	Expression	B-NP	B-NP	-	13	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	12	NMOD	-	-
4	human	human	I-NP	I-NP	-	12	NMOD	-	-
5	interleukin-2	interleukin-2	I-NP	I-NP	-	12	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	IL-2	IL-2	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	12	P	-	-
9	receptor	receptor	B-NP	B-NP	-	12	NMOD	-	-
10	alpha	alpha	I-NP	I-NP	-	12	NMOD	-	-
11	chain	chain	I-NP	I-NP	-	12	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	2	PMOD	-	-
13	is	is	B-VP	B-VP	-	0	ROOT	-	-
14	potently	potently	I-VP	I-VP	-	13	VMOD	-	-
15	upregulated	upregulated	I-VP	I-VP	-	13	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	its	its	B-NP	B-NP	-	19	NMOD	-	-
18	own	own	I-NP	I-NP	-	19	NMOD	-	-
19	ligand	ligand	I-NP	I-NP	-	21	NMOD	-	-
20	,	,	O	O	-	21	P	-	-
21	IL-2	IL-2	B-NP	B-NP	-	16	PMOD	-	-
22	.	.	O	O	-	13	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	characterize	characterize	B-VP	B-VP	-	0	ROOT	-	-
7	an	an	B-NP	B-NP	-	12	NMOD	-	-
8	essential	essential	I-NP	I-NP	-	12	NMOD	-	-
9	upstream	upstream	I-NP	I-NP	-	12	NMOD	-	-
10	IL-2	IL-2	I-NP	I-NP	-	12	NMOD	-	-
11	response	response	I-NP	I-NP	-	12	NMOD	-	-
12	element	element	I-NP	I-NP	-	6	OBJ	-	-
13	that	that	B-NP	B-NP	-	12	NMOD	-	-
14	contains	contains	B-VP	B-VP	-	13	SBAR	-	-
15	both	both	O	O	-	26	NMOD	-	-
16	consensus	consensus	B-NP	B-NP	-	26	NMOD	-	-
17	and	and	O	O	-	26	NMOD	-	-
18	non-consensus	non-consensus	B-NP	B-NP	-	20	NMOD	-	-
19	GAS	GAS	I-NP	I-NP	-	20	NMOD	-	-
20	motifs	motifs	I-NP	I-NP	-	26	NMOD	-	-
21	,	,	O	O	-	26	P	-	-
22	two	two	B-NP	B-NP	-	26	NMOD	-	-
23	putative	putative	I-NP	I-NP	-	26	NMOD	-	-
24	Ets	Ets	I-NP	I-NP	-	26	NMOD	-	-
25	binding	binding	I-NP	I-NP	-	26	NMOD	-	-
26	sites	sites	I-NP	I-NP	-	38	NMOD	-	-
27	(	(	O	O	-	28	P	-	-
28	EBS	EBS	B-NP	B-NP	-	26	NMOD	-	-
29	)	)	O	O	-	28	P	-	-
30	,	,	O	O	-	26	P	-	-
31	one	one	B-NP	B-NP	-	32	NMOD	-	-
32	of	of	B-PP	B-PP	-	26	NMOD	-	-
33	which	which	B-NP	B-NP	-	32	PMOD	-	-
34	overlaps	overlaps	B-VP	B-VP	-	33	SBAR	-	-
35	the	the	B-NP	B-NP	-	38	NMOD	-	-
36	consensus	consensus	I-NP	I-NP	-	38	NMOD	-	-
37	GAS	GAS	I-NP	I-NP	-	38	NMOD	-	-
38	motif	motif	I-NP	I-NP	-	43	NMOD	-	-
39	,	,	O	O	-	43	P	-	-
40	and	and	O	O	-	43	NMOD	-	-
41	a	a	B-NP	B-NP	-	43	NMOD	-	-
42	GATA	GATA	I-NP	I-NP	-	43	NMOD	-	-
43	motif	motif	I-NP	I-NP	-	14	OBJ	-	-
44	,	,	O	O	-	43	P	-	-
45	which	which	B-NP	B-NP	-	43	NMOD	-	-
46	overlaps	overlaps	B-VP	B-VP	-	45	SBAR	-	-
47	the	the	B-NP	B-NP	-	50	NMOD	-	-
48	non-consensus	non-consensus	I-NP	I-NP	-	50	NMOD	-	-
49	GAS	GAS	I-NP	I-NP	-	50	NMOD	-	-
50	motif	motif	I-NP	I-NP	-	46	OBJ	-	-
51	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	although	although	B-SBAR	B-SBAR	-	19	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	individual	individual	I-NP	I-NP	-	7	NMOD	-	-
7	components	components	I-NP	I-NP	-	11	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	this	this	B-NP	B-NP	-	10	NMOD	-	-
10	element	element	I-NP	I-NP	-	8	PMOD	-	-
11	do	do	B-VP	B-VP	-	4	SBAR	-	-
12	not	not	I-VP	I-VP	-	11	VMOD	-	-
13	respond	respond	I-VP	I-VP	-	11	VC	-	-
14	to	to	B-PP	B-PP	-	13	VMOD	-	-
15	IL-2	IL-2	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	19	P	-	-
17	together	together	B-ADVP	B-ADVP	-	19	VMOD	-	-
18	they	they	B-NP	B-NP	-	19	SUB	-	-
19	form	form	B-VP	B-VP	-	3	SBAR	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	composite	composite	I-NP	I-NP	-	22	NMOD	-	-
22	element	element	I-NP	I-NP	-	19	OBJ	-	-
23	capable	capable	B-ADJP	B-ADJP	-	22	NMOD	-	-
24	of	of	B-PP	B-PP	-	23	AMOD	-	-
25	conferring	conferring	B-VP	B-VP	-	24	PMOD	-	-
26	IL-2	IL-2	B-NP	B-NP	-	27	NMOD	-	-
27	responsiveness	responsiveness	I-NP	I-NP	-	25	OBJ	-	-
28	to	to	B-PP	B-PP	-	27	NMOD	-	-
29	a	a	B-NP	B-NP	-	31	NMOD	-	-
30	heterologous	heterologous	I-NP	I-NP	-	31	NMOD	-	-
31	promoter	promoter	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	2	P	-	-

1	Multiple	Multiple	B-NP	B-NP	-	2	NMOD	-	-
2	factors	factors	I-NP	I-NP	-	16	SUB	-	-
3	including	including	B-PP	B-PP	-	2	NMOD	-	-
4	Stat5	Stat5	B-NP	B-NP	-	3	PMOD	-	-
5	,	,	O	O	-	16	P	-	-
6	Elf-1	Elf-1	B-NP	B-NP	-	15	NMOD	-	-
7	,	,	O	O	-	15	P	-	-
8	HMG-I	HMG-I	B-NP	B-NP	-	15	NMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	Y	Y	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	and	and	O	O	-	15	NMOD	-	-
13	GATA	GATA	B-NP	B-NP	-	15	NMOD	-	-
14	family	family	I-NP	I-NP	-	15	NMOD	-	-
15	proteins	proteins	I-NP	I-NP	-	16	SUB	-	-
16	bind	bind	B-VP	B-VP	-	0	ROOT	-	-
17	to	to	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	IL-2	IL-2	I-NP	I-NP	-	21	NMOD	-	-
20	response	response	I-NP	I-NP	-	21	NMOD	-	-
21	element	element	I-NP	I-NP	-	23	NMOD	-	-
22	and	and	I-NP	I-NP	-	23	NMOD	-	-
23	mutation	mutation	I-NP	I-NP	-	17	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	any	any	B-NP	B-NP	-	26	NMOD	-	-
26	one	one	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	these	these	B-NP	B-NP	-	30	NMOD	-	-
29	binding	binding	I-NP	I-NP	-	30	NMOD	-	-
30	sites	sites	I-NP	I-NP	-	27	PMOD	-	-
31	diminishes	diminishes	B-VP	B-VP	-	16	VMOD	-	-
32	the	the	B-NP	B-NP	-	33	NMOD	-	-
33	activity	activity	I-NP	I-NP	-	31	OBJ	-	-
34	of	of	B-PP	B-PP	-	33	NMOD	-	-
35	this	this	B-NP	B-NP	-	36	NMOD	-	-
36	element	element	I-NP	I-NP	-	34	PMOD	-	-
37	.	.	O	O	-	16	P	-	-

1	An	An	B-NP	B-NP	-	5	NMOD	-	-
2	unidentified	unidentified	I-NP	I-NP	-	5	NMOD	-	-
3	Ets	Ets	I-NP	I-NP	-	5	NMOD	-	-
4	family	family	I-NP	I-NP	-	5	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	6	SUB	-	-
6	binds	binds	B-VP	B-VP	-	0	ROOT	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	EBS	EBS	I-NP	I-NP	-	7	PMOD	-	-
10	overlapping	overlapping	B-VP	B-VP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	consensus	consensus	I-NP	I-NP	-	14	NMOD	-	-
13	GAS	GAS	I-NP	I-NP	-	14	NMOD	-	-
14	motif	motif	I-NP	I-NP	-	10	OBJ	-	-
15	and	and	O	O	-	6	VMOD	-	-
16	appears	appears	B-VP	B-VP	-	6	VMOD	-	-
17	to	to	I-VP	I-VP	-	19	VMOD	-	-
18	negatively	negatively	I-VP	I-VP	-	19	VMOD	-	-
19	regulate	regulate	I-VP	I-VP	-	16	VMOD	-	-
20	the	the	B-NP	B-NP	-	24	NMOD	-	-
21	human	human	I-NP	I-NP	-	24	NMOD	-	-
22	IL-2R	IL-2R	I-NP	I-NP	-	24	NMOD	-	-
23	alpha	alpha	I-NP	I-NP	-	24	NMOD	-	-
24	promoter	promoter	I-NP	I-NP	-	19	OBJ	-	-
25	.	.	O	O	-	6	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	IL-2-induced	IL-2-induced	B-NP	B-NP	-	7	NMOD	-	-
4	IL-2R	IL-2R	I-NP	I-NP	-	7	NMOD	-	-
5	alpha	alpha	I-NP	I-NP	-	7	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	8	SUB	-	-
8	requires	requires	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	12	NMOD	-	-
10	complex	complex	I-NP	I-NP	-	12	NMOD	-	-
11	upstream	upstream	I-NP	I-NP	-	12	NMOD	-	-
12	element	element	I-NP	I-NP	-	8	OBJ	-	-
13	,	,	O	O	-	12	P	-	-
14	which	which	B-NP	B-NP	-	12	NMOD	-	-
15	appears	appears	B-VP	B-VP	-	14	SBAR	-	-
16	to	to	I-VP	I-VP	-	17	VMOD	-	-
17	contain	contain	I-VP	I-VP	-	15	VMOD	-	-
18	binding	binding	B-NP	B-NP	-	19	NMOD	-	-
19	sites	sites	I-NP	I-NP	-	17	OBJ	-	-
20	for	for	B-PP	B-PP	-	19	NMOD	-	-
21	both	both	B-NP	B-NP	-	24	AMOD	-	-
22	positive	positive	I-NP	I-NP	-	24	AMOD	-	-
23	and	and	I-NP	I-NP	-	24	AMOD	-	-
24	negative	negative	I-NP	I-NP	-	26	NMOD	-	-
25	regulatory	regulatory	I-NP	I-NP	-	26	NMOD	-	-
26	factors	factors	I-NP	I-NP	-	20	PMOD	-	-
27	.	.	O	O	-	8	P	-	-

1	Active	Active	B-NP	B-NP	-	2	NMOD	-	-
2	suppression	suppression	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	9	NMOD	-	-
5	class	class	I-NP	I-NP	-	9	NMOD	-	-
6	II	II	I-NP	I-NP	-	9	NMOD	-	-
7	transactivator-encoding	transactivator-encoding	I-NP	I-NP	-	9	NMOD	-	-
8	AIR-1	AIR-1	I-NP	I-NP	-	9	NMOD	-	-
9	locus	locus	I-NP	I-NP	-	3	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	responsible	responsible	B-ADJP	B-ADJP	-	10	PRD	-	-
12	for	for	B-PP	B-PP	-	11	AMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	lack	lack	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	major	major	B-NP	B-NP	-	22	NMOD	-	-
17	histocompatibility	histocompatibility	I-NP	I-NP	-	22	NMOD	-	-
18	complex	complex	I-NP	I-NP	-	22	NMOD	-	-
19	class	class	I-NP	I-NP	-	22	NMOD	-	-
20	II	II	I-NP	I-NP	-	22	NMOD	-	-
21	gene	gene	I-NP	I-NP	-	22	NMOD	-	-
22	expression	expression	I-NP	I-NP	-	15	PMOD	-	-
23	observed	observed	B-VP	B-VP	-	22	NMOD	-	-
24	during	during	B-PP	B-PP	-	23	VMOD	-	-
25	differentiation	differentiation	B-NP	B-NP	-	24	PMOD	-	-
26	from	from	B-PP	B-PP	-	25	NMOD	-	-
27	B	B	B-NP	B-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
29	to	to	B-PP	B-PP	-	25	NMOD	-	-
30	plasma	plasma	B-NP	B-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	10	P	-	-

1	In	In	B-PP	B-PP	-	27	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	genetic	genetic	I-NP	I-NP	-	6	NMOD	-	-
6	control	control	I-NP	I-NP	-	1	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	major	major	B-NP	B-NP	-	17	NMOD	-	-
9	histocompatibility	histocompatibility	I-NP	I-NP	-	17	NMOD	-	-
10	complex	complex	I-NP	I-NP	-	17	NMOD	-	-
11	(	(	O	O	-	16	P	-	-
12	MHC	MHC	B-NP	B-NP	-	16	NMOD	-	-
13	)	)	O	O	-	16	P	-	-
14	class	class	B-NP	B-NP	-	16	NMOD	-	-
15	II	II	I-NP	I-NP	-	16	NMOD	-	-
16	gene	gene	I-NP	I-NP	-	17	NMOD	-	-
17	expression	expression	I-NP	I-NP	-	7	PMOD	-	-
18	during	during	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	transition	transition	I-NP	I-NP	-	18	PMOD	-	-
21	from	from	B-PP	B-PP	-	20	NMOD	-	-
22	B	B	B-NP	B-NP	-	23	NMOD	-	-
23	cell	cell	I-NP	I-NP	-	21	PMOD	-	-
24	to	to	B-PP	B-PP	-	20	NMOD	-	-
25	plasma	plasma	B-NP	B-NP	-	26	NMOD	-	-
26	cell	cell	I-NP	I-NP	-	24	PMOD	-	-
27	has	has	B-VP	B-VP	-	0	ROOT	-	-
28	been	been	I-VP	I-VP	-	27	VC	-	-
29	analyzed	analyzed	I-VP	I-VP	-	28	VC	-	-
30	.	.	O	O	-	27	P	-	-

1	Class	Class	B-NP	B-NP	-	3	NMOD	-	-
2	II	II	B-NP	B-NP	-	3	NMOD	-	-
3	molecules	molecules	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	not	not	I-VP	I-VP	-	4	VMOD	-	-
6	expressed	expressed	I-VP	I-VP	-	4	VC	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	plasma	plasma	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	because	because	B-PP	B-PP	-	6	VMOD	-	-
11	of	of	I-PP	I-PP	-	10	PMOD	-	-
12	an	an	B-NP	B-NP	-	14	NMOD	-	-
13	active	active	I-NP	I-NP	-	14	NMOD	-	-
14	suppression	suppression	I-NP	I-NP	-	10	PMOD	-	-
15	resulting	resulting	B-VP	B-VP	-	14	NMOD	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	abrogation	abrogation	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	class	class	B-NP	B-NP	-	22	NMOD	-	-
21	II	II	I-NP	I-NP	-	22	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	23	NMOD	-	-
23	transcription	transcription	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	the	the	B-NP	B-NP	-	9	NMOD	-	-
6	plasma	plasma	I-NP	I-NP	-	9	NMOD	-	-
7	cell-specific	cell-specific	I-NP	I-NP	-	6	AMOD	-	-
8	repressor	repressor	I-NP	I-NP	-	9	NMOD	-	-
9	function	function	I-NP	I-NP	-	14	NMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	designated	designated	B-VP	B-VP	-	9	NMOD	-	-
12	SIR	SIR	B-NP	B-NP	-	11	VMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	suppressor	suppressor	B-NP	B-NP	-	21	SUB	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	immune	immune	B-NP	B-NP	-	18	NMOD	-	-
17	response	response	I-NP	I-NP	-	18	NMOD	-	-
18	genes	genes	I-NP	I-NP	-	15	PMOD	-	-
19	)	)	O	O	-	14	P	-	-
20	,	,	O	O	-	14	P	-	-
21	does	does	B-VP	B-VP	-	4	SBAR	-	-
22	not	not	I-VP	I-VP	-	21	VMOD	-	-
23	act	act	I-VP	I-VP	-	21	VC	-	-
24	directly	directly	B-ADVP	B-ADVP	-	23	VMOD	-	-
25	on	on	B-PP	B-PP	-	23	VMOD	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	transcription	transcription	I-NP	I-NP	-	25	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	class	class	B-NP	B-NP	-	31	NMOD	-	-
30	II	II	I-NP	I-NP	-	31	NMOD	-	-
31	genes	genes	I-NP	I-NP	-	28	PMOD	-	-
32	,	,	O	O	-	23	P	-	-
33	but	but	O	O	-	23	VMOD	-	-
34	instead	instead	B-ADVP	B-ADVP	-	35	PMOD	-	-
35	on	on	B-PP	B-PP	-	23	VMOD	-	-
36	the	the	B-NP	B-NP	-	37	NMOD	-	-
37	transcription	transcription	I-NP	I-NP	-	35	PMOD	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	the	the	B-NP	B-NP	-	41	NMOD	-	-
40	AIR-1	AIR-1	I-NP	I-NP	-	41	NMOD	-	-
41	gene	gene	I-NP	I-NP	-	38	PMOD	-	-
42	,	,	O	O	-	41	P	-	-
43	whose	whose	B-NP	B-NP	-	41	NMOD	-	-
44	product	product	I-NP	I-NP	-	43	NMOD	-	-
45	,	,	O	O	-	23	P	-	-
46	the	the	B-NP	B-NP	-	49	NMOD	-	-
47	class	class	I-NP	I-NP	-	49	NMOD	-	-
48	II	II	I-NP	I-NP	-	49	NMOD	-	-
49	transactivator	transactivator	I-NP	I-NP	-	54	SUB	-	-
50	(	(	O	O	-	51	P	-	-
51	CIITA	CIITA	B-NP	B-NP	-	49	NMOD	-	-
52	)	)	O	O	-	51	P	-	-
53	,	,	O	O	-	49	P	-	-
54	is	is	B-VP	B-VP	-	4	SBAR	-	-
55	fundamental	fundamental	B-ADJP	B-ADJP	-	54	PRD	-	-
56	for	for	B-PP	B-PP	-	55	AMOD	-	-
57	the	the	B-NP	B-NP	-	58	NMOD	-	-
58	regulation	regulation	I-NP	I-NP	-	56	PMOD	-	-
59	of	of	B-PP	B-PP	-	58	NMOD	-	-
60	the	the	B-NP	B-NP	-	64	NMOD	-	-
61	constitutive	constitutive	I-NP	I-NP	-	63	AMOD	-	-
62	and	and	I-NP	I-NP	-	63	AMOD	-	-
63	inducible	inducible	I-NP	I-NP	-	64	NMOD	-	-
64	expression	expression	I-NP	I-NP	-	59	PMOD	-	-
65	of	of	B-PP	B-PP	-	64	NMOD	-	-
66	MHC	MHC	B-NP	B-NP	-	69	NMOD	-	-
67	class	class	I-NP	I-NP	-	69	NMOD	-	-
68	II	II	B-NP	B-NP	-	69	NMOD	-	-
69	genes	genes	I-NP	I-NP	-	65	PMOD	-	-
70	.	.	O	O	-	2	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	unambiguously	unambiguously	I-VP	I-VP	-	2	VMOD	-	-
4	demonstrated	demonstrated	I-VP	I-VP	-	2	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	fact	fact	I-NP	I-NP	-	5	PMOD	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	plasmacytoma	plasmacytoma	B-NP	B-NP	-	13	NMOD	-	-
10	x	x	I-NP	I-NP	-	13	NMOD	-	-
11	B	B	I-NP	I-NP	-	13	NMOD	-	-
12	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
13	hybrids	hybrids	I-NP	I-NP	-	22	SUB	-	-
14	carrying	carrying	B-VP	B-VP	-	13	NMOD	-	-
15	an	an	B-NP	B-NP	-	17	NMOD	-	-
16	AIR-1	AIR-1	I-NP	I-NP	-	17	NMOD	-	-
17	locus	locus	I-NP	I-NP	-	14	PMOD	-	-
18	derived	derived	B-VP	B-VP	-	17	NMOD	-	-
19	from	from	B-PP	B-PP	-	18	VMOD	-	-
20	CIITA-expressing	CIITA-expressing	B-NP	B-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
22	do	do	B-VP	B-VP	-	8	SBAR	-	-
23	not	not	I-VP	I-VP	-	22	VMOD	-	-
24	express	express	I-VP	I-VP	-	22	VC	-	-
25	CIITA-specific	CIITA-specific	B-NP	B-NP	-	26	NMOD	-	-
26	transcripts	transcripts	I-NP	I-NP	-	24	OBJ	-	-
27	.	.	O	O	-	2	P	-	-

1	Transfection	Transfection	B-NP	B-NP	-	18	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	a	a	B-NP	B-NP	-	4	NMOD	-	-
4	cDNA	cDNA	I-NP	I-NP	-	2	PMOD	-	-
5	containing	containing	B-VP	B-VP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	human	human	I-NP	I-NP	-	10	NMOD	-	-
8	CIITA	CIITA	I-NP	I-NP	-	10	NMOD	-	-
9	coding	coding	I-NP	I-NP	-	10	NMOD	-	-
10	sequence	sequence	I-NP	I-NP	-	5	OBJ	-	-
11	under	under	B-PP	B-PP	-	5	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	control	control	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	an	an	B-NP	B-NP	-	17	NMOD	-	-
16	heterologous	heterologous	I-NP	I-NP	-	17	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	14	PMOD	-	-
18	restores	restores	B-VP	B-VP	-	0	ROOT	-	-
19	expression	expression	B-NP	B-NP	-	18	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	human	human	B-NP	B-NP	-	25	NMOD	-	-
22	MHC	MHC	I-NP	I-NP	-	25	NMOD	-	-
23	class	class	I-NP	I-NP	-	25	NMOD	-	-
24	II	II	B-NP	B-NP	-	25	NMOD	-	-
25	genes	genes	I-NP	I-NP	-	20	PMOD	-	-
26	in	in	B-PP	B-PP	-	19	NMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	hybrids	hybrids	I-NP	I-NP	-	26	PMOD	-	-
29	and	and	O	O	-	18	VMOD	-	-
30	is	is	B-VP	B-VP	-	18	VMOD	-	-
31	responsible	responsible	B-ADJP	B-ADJP	-	30	PRD	-	-
32	for	for	B-PP	B-PP	-	31	AMOD	-	-
33	de	de	B-NP	B-NP	-	34	AMOD	-	-
34	novo	novo	I-NP	I-NP	-	35	NMOD	-	-
35	expression	expression	I-NP	I-NP	-	32	PMOD	-	-
36	of	of	B-PP	B-PP	-	35	NMOD	-	-
37	mouse	mouse	B-NP	B-NP	-	41	NMOD	-	-
38	MHC	MHC	I-NP	I-NP	-	41	NMOD	-	-
39	class	class	I-NP	I-NP	-	41	NMOD	-	-
40	II	II	B-NP	B-NP	-	41	NMOD	-	-
41	genes	genes	I-NP	I-NP	-	36	PMOD	-	-
42	in	in	B-PP	B-PP	-	35	NMOD	-	-
43	both	both	O	O	-	51	NMOD	-	-
44	the	the	B-NP	B-NP	-	48	NMOD	-	-
45	mouse	mouse	I-NP	I-NP	-	48	NMOD	-	-
46	plasmacytoma	plasmacytoma	I-NP	I-NP	-	48	NMOD	-	-
47	cell	cell	I-NP	I-NP	-	48	NMOD	-	-
48	line	line	I-NP	I-NP	-	51	NMOD	-	-
49	and	and	O	O	-	51	NMOD	-	-
50	the	the	B-NP	B-NP	-	51	NMOD	-	-
51	hybrids	hybrids	I-NP	I-NP	-	42	PMOD	-	-
52	.	.	O	O	-	18	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	confirm	confirm	B-VP	B-VP	-	0	ROOT	-	-
4	and	and	I-VP	I-VP	-	3	VMOD	-	-
5	extend	extend	I-VP	I-VP	-	3	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	notion	notion	I-NP	I-NP	-	5	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	functional	functional	I-NP	I-NP	-	11	NMOD	-	-
11	conservation	conservation	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	AIR-1	AIR-1	I-NP	I-NP	-	16	NMOD	-	-
15	gene	gene	I-NP	I-NP	-	16	NMOD	-	-
16	product	product	I-NP	I-NP	-	12	PMOD	-	-
17	across	across	B-PP	B-PP	-	16	NMOD	-	-
18	species	species	B-NP	B-NP	-	19	NMOD	-	-
19	barriers	barriers	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	16	VMOD	-	-
2	,	,	O	O	-	16	P	-	-
3	in	in	B-PP	B-PP	-	16	VMOD	-	-
4	CIITA-transfected	CIITA-transfected	B-NP	B-NP	-	6	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
6	hybrids	hybrids	I-NP	I-NP	-	3	PMOD	-	-
7	,	,	O	O	-	16	P	-	-
8	cell	cell	B-NP	B-NP	-	10	NMOD	-	-
9	surface	surface	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	16	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	human	human	I-NP	I-NP	-	15	NMOD	-	-
14	HLA-DQ	HLA-DQ	I-NP	I-NP	-	15	NMOD	-	-
15	heterodimer	heterodimer	I-NP	I-NP	-	11	PMOD	-	-
16	was	was	B-VP	B-VP	-	0	ROOT	-	-
17	not	not	I-VP	I-VP	-	16	VMOD	-	-
18	observed	observed	I-VP	I-VP	-	16	VC	-	-
19	.	.	O	O	-	16	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	result	result	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	not	not	O	O	-	3	VMOD	-	-
5	attributable	attributable	B-ADJP	B-ADJP	-	3	PRD	-	-
6	to	to	B-PP	B-PP	-	5	AMOD	-	-
7	lack	lack	B-NP	B-NP	-	6	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	HLA-DQ	HLA-DQ	B-NP	B-NP	-	10	NMOD	-	-
10	alpha	alpha	I-NP	I-NP	-	14	NMOD	-	-
11	or	or	O	O	-	14	NMOD	-	-
12	-DQ	-DQ	B-NP	B-NP	-	14	NMOD	-	-
13	beta	beta	I-NP	I-NP	-	14	NMOD	-	-
14	transcription	transcription	I-NP	I-NP	-	8	PMOD	-	-
15	,	,	O	O	-	3	P	-	-
16	because	because	B-SBAR	B-SBAR	-	3	VMOD	-	-
17	both	both	B-NP	B-NP	-	18	NMOD	-	-
18	transcripts	transcripts	I-NP	I-NP	-	19	SUB	-	-
19	were	were	B-VP	B-VP	-	16	SBAR	-	-
20	present	present	B-ADJP	B-ADJP	-	19	PRD	-	-
21	in	in	B-PP	B-PP	-	20	AMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	CIITA-transfected	CIITA-transfected	I-NP	I-NP	-	24	NMOD	-	-
24	hybrids	hybrids	I-NP	I-NP	-	21	PMOD	-	-
25	,	,	O	O	-	3	P	-	-
26	although	although	B-SBAR	B-SBAR	-	3	VMOD	-	-
27	at	at	B-PP	B-PP	-	26	DEP	-	-
28	reduced	reduced	B-NP	B-NP	-	29	NMOD	-	-
29	levels	levels	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	3	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	4	SUB	-	-
3	further	further	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	support	support	B-VP	B-VP	-	0	ROOT	-	-
5	our	our	B-NP	B-NP	-	7	NMOD	-	-
6	previous	previous	I-NP	I-NP	-	7	NMOD	-	-
7	observations	observations	I-NP	I-NP	-	4	OBJ	-	-
8	on	on	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	distinct	distinct	I-NP	I-NP	-	11	NMOD	-	-
11	regulation	regulation	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	expression	expression	B-NP	B-NP	-	12	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	human	human	I-NP	I-NP	-	20	NMOD	-	-
17	HLA-DQ	HLA-DQ	I-NP	I-NP	-	20	NMOD	-	-
18	class	class	I-NP	I-NP	-	20	NMOD	-	-
19	II	II	I-NP	I-NP	-	20	NMOD	-	-
20	subset	subset	I-NP	I-NP	-	14	PMOD	-	-
21	,	,	O	O	-	20	P	-	-
22	which	which	B-NP	B-NP	-	20	NMOD	-	-
23	may	may	B-VP	B-VP	-	22	SBAR	-	-
24	be	be	I-VP	I-VP	-	23	VC	-	-
25	thus	thus	I-VP	I-VP	-	24	VMOD	-	-
26	controlled	controlled	I-VP	I-VP	-	24	VC	-	-
27	at	at	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	posttranscriptional	posttranscriptional	I-NP	I-NP	-	30	NMOD	-	-
30	level	level	I-NP	I-NP	-	27	PMOD	-	-
31	by	by	B-PP	B-PP	-	26	VMOD	-	-
32	a	a	B-NP	B-NP	-	34	NMOD	-	-
33	CIITA-independent	CIITA-independent	I-NP	I-NP	-	34	NMOD	-	-
34	mechanism	mechanism	I-NP	I-NP	-	31	PMOD	-	-
35	.	.	O	O	-	4	P	-	-

1	Silencing	Silencing	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	human	human	B-NP	B-NP	-	6	NMOD	-	-
4	fetal	fetal	I-NP	I-NP	-	6	NMOD	-	-
5	globin	globin	I-NP	I-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	impaired	impaired	B-ADJP	B-ADJP	-	7	PRD	-	-
9	in	in	B-PP	B-PP	-	8	AMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	absence	absence	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	19	NMOD	-	-
14	adult	adult	I-NP	I-NP	-	19	NMOD	-	-
15	beta-globin	beta-globin	I-NP	I-NP	-	19	NMOD	-	-
16	gene	gene	I-NP	I-NP	-	19	NMOD	-	-
17	activator	activator	I-NP	I-NP	-	19	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	19	NMOD	-	-
19	EKLF	EKLF	I-NP	I-NP	-	12	PMOD	-	-
20	.	.	O	O	-	7	P	-	-

1	Globin	Globin	B-NP	B-NP	-	2	NMOD	-	-
2	genes	genes	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	subject	subject	B-ADJP	B-ADJP	-	3	PRD	-	-
5	to	to	B-PP	B-PP	-	4	AMOD	-	-
6	tissue-specific	tissue-specific	B-NP	B-NP	-	10	NMOD	-	-
7	and	and	I-NP	I-NP	-	10	NMOD	-	-
8	developmental	developmental	I-NP	I-NP	-	10	NMOD	-	-
9	stage-specific	stage-specific	I-NP	I-NP	-	10	NMOD	-	-
10	regulation	regulation	I-NP	I-NP	-	5	PMOD	-	-
11	.	.	O	O	-	3	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	switch	switch	I-NP	I-NP	-	16	SUB	-	-
3	from	from	B-PP	B-PP	-	2	NMOD	-	-
4	human	human	B-NP	B-NP	-	15	NMOD	-	-
5	fetal	fetal	I-NP	I-NP	-	7	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	gamma	gamma	B-NP	B-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	-to	-to	B-PP	B-PP	-	4	NMOD	-	-
10	adult	adult	B-ADJP	B-ADJP	-	15	NMOD	-	-
11	(	(	O	O	-	15	P	-	-
12	beta	beta	B-NP	B-NP	-	15	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	-globin	-globin	B-NP	B-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
16	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
17	within	within	B-PP	B-PP	-	16	VMOD	-	-
18	erythroid	erythroid	B-NP	B-NP	-	20	NMOD	-	-
19	precursor	precursor	I-NP	I-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	adult	adult	I-NP	I-NP	-	24	NMOD	-	-
24	lineage	lineage	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	16	P	-	-

1	Previously	Previously	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	we	we	B-NP	B-NP	-	4	NMOD	-	-
3	and	and	O	O	-	4	NMOD	-	-
4	others	others	B-NP	B-NP	-	5	SUB	-	-
5	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	targeted	targeted	B-NP	B-NP	-	9	NMOD	-	-
8	gene	gene	I-NP	I-NP	-	9	NMOD	-	-
9	disruption	disruption	I-NP	I-NP	-	6	PMOD	-	-
10	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	zinc	zinc	I-NP	I-NP	-	14	NMOD	-	-
13	finger	finger	I-NP	I-NP	-	14	NMOD	-	-
14	gene	gene	I-NP	I-NP	-	18	NMOD	-	-
15	,	,	O	O	-	18	P	-	-
16	erythroid	erythroid	B-NP	B-NP	-	18	NMOD	-	-
17	Kruppel-like	Kruppel-like	I-NP	I-NP	-	18	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	23	SUB	-	-
19	(	(	O	O	-	20	P	-	-
20	EKLF	EKLF	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	,	,	O	O	-	18	P	-	-
23	is	is	B-VP	B-VP	-	10	SBAR	-	-
24	required	required	I-VP	I-VP	-	23	VC	-	-
25	for	for	B-PP	B-PP	-	24	VMOD	-	-
26	expression	expression	B-NP	B-NP	-	25	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	beta-globin	beta-globin	I-NP	I-NP	-	30	NMOD	-	-
30	gene	gene	I-NP	I-NP	-	27	PMOD	-	-
31	in	in	B-PP	B-PP	-	26	NMOD	-	-
32	mice	mice	B-NP	B-NP	-	31	PMOD	-	-
33	,	,	O	O	-	24	P	-	-
34	presumably	presumably	B-ADVP	B-ADVP	-	35	PMOD	-	-
35	through	through	B-PP	B-PP	-	24	VMOD	-	-
36	interaction	interaction	B-NP	B-NP	-	35	PMOD	-	-
37	with	with	B-PP	B-PP	-	36	NMOD	-	-
38	a	a	B-NP	B-NP	-	41	NMOD	-	-
39	high-affinity	high-affinity	I-NP	I-NP	-	41	NMOD	-	-
40	binding	binding	I-NP	I-NP	-	41	NMOD	-	-
41	site	site	I-NP	I-NP	-	37	PMOD	-	-
42	in	in	B-PP	B-PP	-	36	NMOD	-	-
43	the	the	B-NP	B-NP	-	45	NMOD	-	-
44	proximal	proximal	I-NP	I-NP	-	45	NMOD	-	-
45	promoter	promoter	I-NP	I-NP	-	42	PMOD	-	-
46	.	.	O	O	-	5	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	examine	examine	I-VP	I-VP	-	17	VMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	role	role	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	EKLF	EKLF	B-NP	B-NP	-	5	PMOD	-	-
7	in	in	B-PP	B-PP	-	4	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	developmental	developmental	I-NP	I-NP	-	10	NMOD	-	-
10	regulation	regulation	I-NP	I-NP	-	7	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	human	human	I-NP	I-NP	-	15	NMOD	-	-
14	gamma-globin	gamma-globin	I-NP	I-NP	-	15	NMOD	-	-
15	gene	gene	I-NP	I-NP	-	11	PMOD	-	-
16	we	we	B-NP	B-NP	-	17	SUB	-	-
17	interbred	interbred	B-VP	B-VP	-	0	ROOT	-	-
18	EKLF	EKLF	B-NP	B-NP	-	19	NMOD	-	-
19	heterozygotes	heterozygotes	I-NP	I-NP	-	17	OBJ	-	-
20	(	(	O	O	-	21	P	-	-
21	+/-	+/-	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	with	with	B-PP	B-PP	-	17	VMOD	-	-
24	mice	mice	B-NP	B-NP	-	23	PMOD	-	-
25	harboring	harboring	B-VP	B-VP	-	24	NMOD	-	-
26	a	a	B-NP	B-NP	-	32	NMOD	-	-
27	human	human	I-NP	I-NP	-	32	NMOD	-	-
28	beta-globin	beta-globin	I-NP	I-NP	-	32	NMOD	-	-
29	yeast	yeast	I-NP	I-NP	-	32	NMOD	-	-
30	artificial	artificial	I-NP	I-NP	-	32	NMOD	-	-
31	chromosome	chromosome	I-NP	I-NP	-	32	NMOD	-	-
32	transgene	transgene	I-NP	I-NP	-	25	OBJ	-	-
33	.	.	O	O	-	17	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	find	find	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	in	in	B-PP	B-PP	-	2	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	absence	absence	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	EKLF	EKLF	B-NP	B-NP	-	7	PMOD	-	-
9	,	,	O	O	-	2	P	-	-
10	while	while	B-SBAR	B-SBAR	-	2	VMOD	-	-
11	human	human	B-NP	B-NP	-	13	NMOD	-	-
12	beta-globin	beta-globin	I-NP	I-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	14	SUB	-	-
14	is	is	B-VP	B-VP	-	10	SBAR	-	-
15	dramatically	dramatically	I-VP	I-VP	-	14	VMOD	-	-
16	reduced	reduced	I-VP	I-VP	-	14	VC	-	-
17	,	,	O	O	-	20	P	-	-
18	gamma-globin	gamma-globin	B-NP	B-NP	-	19	NMOD	-	-
19	transcripts	transcripts	I-NP	I-NP	-	20	SUB	-	-
20	are	are	B-VP	B-VP	-	10	SBAR	-	-
21	elevated	elevated	I-VP	I-VP	-	20	VC	-	-
22	approximately	approximately	B-ADVP	B-ADVP	-	21	VMOD	-	-
23	5-fold	5-fold	I-ADVP	I-ADVP	-	22	AMOD	-	-
24	.	.	O	O	-	2	P	-	-

1	Impaired	Impaired	B-NP	B-NP	-	2	NMOD	-	-
2	silencing	silencing	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	gamma-globin	gamma-globin	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	PMOD	-	-
6	identifies	identifies	B-VP	B-VP	-	0	ROOT	-	-
7	EKLF	EKLF	B-NP	B-NP	-	6	OBJ	-	-
8	as	as	B-PP	B-PP	-	6	VMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	first	first	I-NP	I-NP	-	12	NMOD	-	-
11	transcription	transcription	I-NP	I-NP	-	12	NMOD	-	-
12	factor	factor	I-NP	I-NP	-	8	PMOD	-	-
13	participating	participating	B-VP	B-VP	-	12	NMOD	-	-
14	quantitatively	quantitatively	B-ADVP	B-ADVP	-	13	VMOD	-	-
15	in	in	B-PP	B-PP	-	13	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	gamma-globin	gamma-globin	I-NP	I-NP	-	15	PMOD	-	-
18	to	to	B-PP	B-PP	-	17	NMOD	-	-
19	beta-globin	beta-globin	B-NP	B-NP	-	20	NMOD	-	-
20	switch	switch	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	compatible	compatible	B-ADJP	B-ADJP	-	3	PRD	-	-
5	with	with	B-PP	B-PP	-	4	AMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	competitive	competitive	I-NP	I-NP	-	8	NMOD	-	-
8	model	model	I-NP	I-NP	-	5	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	switching	switching	B-NP	B-NP	-	9	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	which	which	B-NP	B-NP	-	11	PMOD	-	-
13	EKLF	EKLF	B-NP	B-NP	-	14	SUB	-	-
14	mediates	mediates	B-VP	B-VP	-	11	SBAR	-	-
15	an	an	B-NP	B-NP	-	18	NMOD	-	-
16	adult	adult	I-NP	I-NP	-	18	NMOD	-	-
17	stage-specific	stage-specific	I-NP	I-NP	-	18	NMOD	-	-
18	interaction	interaction	I-NP	I-NP	-	14	OBJ	-	-
19	between	between	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	beta-globin	beta-globin	I-NP	I-NP	-	23	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	23	NMOD	-	-
23	promoter	promoter	I-NP	I-NP	-	19	PMOD	-	-
24	and	and	O	O	-	28	NMOD	-	-
25	the	the	B-NP	B-NP	-	28	NMOD	-	-
26	locus	locus	I-NP	I-NP	-	28	NMOD	-	-
27	control	control	I-NP	I-NP	-	28	NMOD	-	-
28	region	region	I-NP	I-NP	-	19	PMOD	-	-
29	that	that	B-NP	B-NP	-	28	NMOD	-	-
30	excludes	excludes	B-VP	B-VP	-	29	SBAR	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	gamma-globin	gamma-globin	I-NP	I-NP	-	33	NMOD	-	-
33	gene	gene	I-NP	I-NP	-	30	OBJ	-	-
34	.	.	O	O	-	3	P	-	-

1	Nasal	Nasal	B-NP	B-NP	-	5	NMOD	-	-
2	NK-	NK-	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	T-cell	T-cell	I-NP	I-NP	-	5	NMOD	-	-
5	lymphomas	lymphomas	I-NP	I-NP	-	6	SUB	-	-
6	share	share	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	same	same	I-NP	I-NP	-	9	NMOD	-	-
9	type	type	I-NP	I-NP	-	6	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	13	NMOD	-	-
12	virus	virus	I-NP	I-NP	-	13	NMOD	-	-
13	latency	latency	I-NP	I-NP	-	10	PMOD	-	-
14	as	as	B-PP	B-PP	-	6	VMOD	-	-
15	nasopharyngeal	nasopharyngeal	B-NP	B-NP	-	16	NMOD	-	-
16	carcinoma	carcinoma	I-NP	I-NP	-	18	NMOD	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	Hodgkin	Hodgkin	B-NP	B-NP	-	19	NMOD	-	-
19	's	's	B-NP	B-NP	-	20	NMOD	-	-
20	disease	disease	I-NP	I-NP	-	14	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	Nasal	Nasal	B-NP	B-NP	-	3	NMOD	-	-
2	T/NK-cell	T/NK-cell	I-NP	I-NP	-	3	NMOD	-	-
3	lymphomas	lymphomas	I-NP	I-NP	-	4	SUB	-	-
4	can	can	B-VP	B-VP	-	0	ROOT	-	-
5	be	be	I-VP	I-VP	-	4	VC	-	-
6	further	further	B-ADJP	B-ADJP	-	5	VMOD	-	-
7	separated	separated	I-ADJP	I-ADJP	-	5	VC	-	-
8	into	into	B-PP	B-PP	-	7	VMOD	-	-
9	those	those	B-NP	B-NP	-	8	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	natural	natural	B-NP	B-NP	-	12	NMOD	-	-
12	killer	killer	I-NP	I-NP	-	17	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	NK	NK	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	cell	cell	B-NP	B-NP	-	17	NMOD	-	-
17	lineage	lineage	I-NP	I-NP	-	10	PMOD	-	-
18	or	or	B-PP	B-PP	-	10	PMOD	-	-
19	of	of	B-PP	B-PP	-	10	PMOD	-	-
20	T-cell	T-cell	B-NP	B-NP	-	21	NMOD	-	-
21	lineage	lineage	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	7	P	-	-
23	with	with	B-PP	B-PP	-	7	VMOD	-	-
24	differences	differences	B-NP	B-NP	-	23	PMOD	-	-
25	in	in	B-PP	B-PP	-	24	NMOD	-	-
26	cellular	cellular	B-NP	B-NP	-	27	NMOD	-	-
27	phenotype	phenotype	I-NP	I-NP	-	39	NMOD	-	-
28	,	,	O	O	-	39	P	-	-
29	T-cell	T-cell	B-NP	B-NP	-	30	NMOD	-	-
30	receptor	receptor	I-NP	I-NP	-	35	NMOD	-	-
31	(	(	O	O	-	32	P	-	-
32	TcR	TcR	B-NP	B-NP	-	30	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	gene	gene	B-NP	B-NP	-	35	NMOD	-	-
35	rearrangement	rearrangement	I-NP	I-NP	-	39	NMOD	-	-
36	and	and	O	O	-	39	NMOD	-	-
37	TcR	TcR	B-NP	B-NP	-	39	NMOD	-	-
38	transcript	transcript	I-NP	I-NP	-	39	NMOD	-	-
39	expression	expression	I-NP	I-NP	-	25	PMOD	-	-
40	.	.	O	O	-	4	P	-	-

1	Both	Both	O	O	-	5	NMOD	-	-
2	NK-	NK-	B-NP	B-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	T-cell	T-cell	I-NP	I-NP	-	5	NMOD	-	-
5	subtypes	subtypes	I-NP	I-NP	-	6	SUB	-	-
6	are	are	B-VP	B-VP	-	0	ROOT	-	-
7	closely	closely	I-VP	I-VP	-	6	VMOD	-	-
8	associated	associated	I-VP	I-VP	-	6	VC	-	-
9	with	with	B-PP	B-PP	-	8	VMOD	-	-
10	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	11	NMOD	-	-
11	virus	virus	I-NP	I-NP	-	9	PMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	EBV	EBV	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	8	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	8	P	-	-
5	EBV	EBV	B-NP	B-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	expression	expression	I-NP	I-NP	-	8	SUB	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	determined	determined	I-VP	I-VP	-	8	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
12	cases	cases	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	nasal	nasal	B-NP	B-NP	-	15	NMOD	-	-
15	lymphoma	lymphoma	I-NP	I-NP	-	13	PMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	NL	NL	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	by	by	B-PP	B-PP	-	9	VMOD	-	-
20	in	in	B-NP	B-NP	-	21	AMOD	-	-
21	situ	situ	I-NP	I-NP	-	22	NMOD	-	-
22	hybridisation	hybridisation	I-NP	I-NP	-	19	PMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	ISH	ISH	B-NP	B-NP	-	22	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	,	,	O	O	-	35	P	-	-
27	reverse	reverse	B-NP	B-NP	-	30	NMOD	-	-
28	transcriptase-polymerase	transcriptase-polymerase	I-NP	I-NP	-	30	NMOD	-	-
29	chain	chain	I-NP	I-NP	-	30	NMOD	-	-
30	reaction	reaction	I-NP	I-NP	-	35	NMOD	-	-
31	(	(	O	O	-	32	P	-	-
32	RT-PCR	RT-PCR	B-NP	B-NP	-	30	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	and	and	O	O	-	35	NMOD	-	-
35	immunohistochemistry	immunohistochemistry	B-NP	B-NP	-	19	PMOD	-	-
36	(	(	O	O	-	37	P	-	-
37	IH	IH	B-NP	B-NP	-	35	NMOD	-	-
38	)	)	O	O	-	37	P	-	-
39	.	.	O	O	-	8	P	-	-

1	Of	Of	B-PP	B-PP	-	7	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	<num>	<num>	I-NP	I-NP	-	4	NMOD	-	-
4	cases	cases	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	<num>	<num>	B-NP	B-NP	-	7	SUB	-	-
7	were	were	B-VP	B-VP	-	0	ROOT	-	-
8	classified	classified	I-VP	I-VP	-	7	VC	-	-
9	as	as	B-PP	B-PP	-	8	VMOD	-	-
10	NK-cell	NK-cell	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	<num>	<num>	B-NP	B-NP	-	9	PMOD	-	-
13	as	as	B-SBAR	B-SBAR	-	8	VMOD	-	-
14	T-cell	T-cell	B-NP	B-NP	-	15	NMOD	-	-
15	tumours	tumours	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	7	P	-	-

1	ISH	ISH	B-NP	B-NP	-	7	SUB	-	-
2	for	for	B-PP	B-PP	-	1	NMOD	-	-
3	EBV-encoded	EBV-encoded	B-NP	B-NP	-	6	NMOD	-	-
4	small	small	I-NP	I-NP	-	6	NMOD	-	-
5	non-polyadenylated	non-polyadenylated	I-NP	I-NP	-	6	NMOD	-	-
6	RNAs	RNAs	I-NP	I-NP	-	2	PMOD	-	-
7	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	all	all	B-NP	B-NP	-	10	NMOD	-	-
10	cases	cases	I-NP	I-NP	-	17	SUB	-	-
11	,	,	O	O	-	17	P	-	-
12	whether	whether	B-SBAR	B-SBAR	-	17	VMOD	-	-
13	NK	NK	B-NP	B-NP	-	15	NMOD	-	-
14	or	or	I-NP	I-NP	-	15	NMOD	-	-
15	T	T	I-NP	I-NP	-	17	SUB	-	-
16	,	,	O	O	-	15	P	-	-
17	harboured	harboured	B-VP	B-VP	-	8	SBAR	-	-
18	EBV	EBV	B-NP	B-NP	-	17	OBJ	-	-
19	in	in	B-PP	B-PP	-	18	NMOD	-	-
20	virtually	virtually	B-NP	B-NP	-	23	NMOD	-	-
21	all	all	I-NP	I-NP	-	23	NMOD	-	-
22	tumour	tumour	I-NP	I-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	7	P	-	-

1	RT-PCR	RT-PCR	B-NP	B-NP	-	2	SUB	-	-
2	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	NL	NL	B-NP	B-NP	-	8	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	both	both	B-NP	B-NP	-	7	NMOD	-	-
7	subtypes	subtypes	I-NP	I-NP	-	5	PMOD	-	-
8	expressed	expressed	B-VP	B-VP	-	3	SBAR	-	-
9	EBNAI	EBNAI	B-NP	B-NP	-	8	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	QUK	QUK	I-NP	I-NP	-	14	NMOD	-	-
13	splice	splice	I-NP	I-NP	-	14	NMOD	-	-
14	pattern	pattern	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	29	P	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	latent	latent	I-NP	I-NP	-	19	NMOD	-	-
18	membrane	membrane	I-NP	I-NP	-	19	NMOD	-	-
19	proteins	proteins	I-NP	I-NP	-	29	NMOD	-	-
20	,	,	O	O	-	29	P	-	-
21	LMP1	LMP1	B-NP	B-NP	-	23	NMOD	-	-
22	and	and	O	O	-	23	NMOD	-	-
23	<num>	<num>	B-NP	B-NP	-	29	NMOD	-	-
24	and	and	O	O	-	29	NMOD	-	-
25	the	the	B-NP	B-NP	-	29	NMOD	-	-
26	BamHI	BamHI	I-NP	I-NP	-	29	NMOD	-	-
27	A	A	I-NP	I-NP	-	29	NMOD	-	-
28	rightward	rightward	I-NP	I-NP	-	29	NMOD	-	-
29	transcripts	transcripts	I-NP	I-NP	-	10	PMOD	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	32	NMOD	-	-
32	absence	absence	I-NP	I-NP	-	30	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	EBNA2	EBNA2	B-NP	B-NP	-	35	NMOD	-	-
35	mRNAs	mRNAs	I-NP	I-NP	-	33	PMOD	-	-
36	,	,	O	O	-	29	P	-	-
37	compatible	compatible	B-ADJP	B-ADJP	-	29	NMOD	-	-
38	with	with	B-PP	B-PP	-	37	AMOD	-	-
39	the	the	B-NP	B-NP	-	43	NMOD	-	-
40	latency	latency	I-NP	I-NP	-	43	NMOD	-	-
41	type	type	I-NP	I-NP	-	43	NMOD	-	-
42	II	II	I-NP	I-NP	-	43	NMOD	-	-
43	pattern	pattern	I-NP	I-NP	-	38	PMOD	-	-
44	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	11	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	11	P	-	-
4	analysis	analysis	B-NP	B-NP	-	11	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	EBV	EBV	B-NP	B-NP	-	8	NMOD	-	-
7	protein	protein	I-NP	I-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	5	PMOD	-	-
9	by	by	B-PP	B-PP	-	4	NMOD	-	-
10	IH	IH	B-NP	B-NP	-	9	PMOD	-	-
11	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
12	a	a	B-NP	B-NP	-	14	NMOD	-	-
13	heterogeneous	heterogeneous	I-NP	I-NP	-	14	NMOD	-	-
14	pattern	pattern	I-NP	I-NP	-	11	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	EBV	EBV	B-NP	B-NP	-	18	NMOD	-	-
17	gene	gene	I-NP	I-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	15	PMOD	-	-
19	at	at	B-PP	B-PP	-	14	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	single-cell	single-cell	I-NP	I-NP	-	22	NMOD	-	-
22	level	level	I-NP	I-NP	-	19	PMOD	-	-
23	consisting	consisting	B-VP	B-VP	-	22	NMOD	-	-
24	of	of	B-PP	B-PP	-	23	VMOD	-	-
25	both	both	O	O	-	30	NMOD	-	-
26	LMP1+	LMP1+	B-NP	B-NP	-	30	NMOD	-	-
27	and	and	I-NP	I-NP	-	30	NMOD	-	-
28	LMP1-	LMP1-	I-NP	I-NP	-	30	NMOD	-	-
29	tumour	tumour	I-NP	I-NP	-	30	NMOD	-	-
30	cells	cells	I-NP	I-NP	-	24	PMOD	-	-
31	,	,	O	O	-	11	P	-	-
32	suggesting	suggesting	B-VP	B-VP	-	11	VMOD	-	-
33	a	a	B-NP	B-NP	-	34	NMOD	-	-
34	mixture	mixture	I-NP	I-NP	-	32	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	latency	latency	B-NP	B-NP	-	35	PMOD	-	-
37	I	I	I-NP	I-NP	-	36	NMOD	-	-
38	and	and	I-NP	I-NP	-	36	NMOD	-	-
39	II	II	I-NP	I-NP	-	36	NMOD	-	-
40	.	.	O	O	-	11	P	-	-

1	Although	Although	B-SBAR	B-SBAR	-	30	VMOD	-	-
2	<num>	<num>	B-NP	B-NP	-	5	NMOD	-	-
3	early	early	I-NP	I-NP	-	5	NMOD	-	-
4	lytic	lytic	I-NP	I-NP	-	5	NMOD	-	-
5	transcripts	transcripts	I-NP	I-NP	-	9	NMOD	-	-
6	,	,	O	O	-	9	P	-	-
7	BZLF1	BZLF1	B-NP	B-NP	-	9	NMOD	-	-
8	and	and	O	O	-	9	NMOD	-	-
9	BHRF1	BHRF1	B-NP	B-NP	-	11	SUB	-	-
10	,	,	O	O	-	9	P	-	-
11	were	were	B-VP	B-VP	-	1	SBAR	-	-
12	also	also	I-VP	I-VP	-	11	VMOD	-	-
13	detected	detected	I-VP	I-VP	-	11	VC	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
16	and	and	I-NP	I-NP	-	18	NMOD	-	-
17	<num>	<num>	I-NP	I-NP	-	18	NMOD	-	-
18	cases	cases	I-NP	I-NP	-	14	PMOD	-	-
19	,	,	O	O	-	13	P	-	-
20	respectively	respectively	B-ADVP	B-ADVP	-	1	PMOD	-	-
21	,	,	O	O	-	30	P	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	lack	lack	I-NP	I-NP	-	30	SUB	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	ZEBRA	ZEBRA	B-NP	B-NP	-	26	NMOD	-	-
26	staining	staining	I-NP	I-NP	-	24	PMOD	-	-
27	in	in	B-PP	B-PP	-	23	NMOD	-	-
28	any	any	B-NP	B-NP	-	29	NMOD	-	-
29	case	case	I-NP	I-NP	-	27	PMOD	-	-
30	indicates	indicates	B-VP	B-VP	-	0	ROOT	-	-
31	that	that	B-SBAR	B-SBAR	-	30	VMOD	-	-
32	these	these	B-NP	B-NP	-	34	NMOD	-	-
33	lytic	lytic	I-NP	I-NP	-	34	NMOD	-	-
34	transcripts	transcripts	I-NP	I-NP	-	35	SUB	-	-
35	are	are	B-VP	B-VP	-	31	SBAR	-	-
36	most	most	I-VP	I-VP	-	35	PRD	-	-
37	likely	likely	I-VP	I-VP	-	38	VMOD	-	-
38	expressed	expressed	I-VP	I-VP	-	36	VC	-	-
39	by	by	B-PP	B-PP	-	38	VMOD	-	-
40	rare	rare	B-NP	B-NP	-	41	NMOD	-	-
41	cells	cells	I-NP	I-NP	-	39	PMOD	-	-
42	in	in	B-PP	B-PP	-	38	VMOD	-	-
43	the	the	B-NP	B-NP	-	44	NMOD	-	-
44	biopsies	biopsies	I-NP	I-NP	-	42	PMOD	-	-
45	entering	entering	B-VP	B-VP	-	44	NMOD	-	-
46	lytic	lytic	B-NP	B-NP	-	47	NMOD	-	-
47	cycle	cycle	I-NP	I-NP	-	45	OBJ	-	-
48	.	.	O	O	-	30	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	viral	viral	I-NP	I-NP	-	4	NMOD	-	-
3	transcriptional	transcriptional	I-NP	I-NP	-	4	NMOD	-	-
4	pattern	pattern	I-NP	I-NP	-	15	SUB	-	-
5	similar	similar	B-ADJP	B-ADJP	-	4	NMOD	-	-
6	to	to	B-PP	B-PP	-	5	AMOD	-	-
7	that	that	B-NP	B-NP	-	6	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	nasopharyngeal	nasopharyngeal	B-NP	B-NP	-	10	NMOD	-	-
10	carcinoma	carcinoma	I-NP	I-NP	-	8	PMOD	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	Hodgkin	Hodgkin	B-NP	B-NP	-	13	NMOD	-	-
13	's	's	B-NP	B-NP	-	14	NMOD	-	-
14	disease	disease	I-NP	I-NP	-	8	PMOD	-	-
15	suggests	suggests	B-VP	B-VP	-	0	ROOT	-	-
16	that	that	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	EBV	EBV	B-NP	B-NP	-	18	SUB	-	-
18	can	can	B-VP	B-VP	-	16	SBAR	-	-
19	exploit	exploit	I-VP	I-VP	-	18	VC	-	-
20	common	common	B-NP	B-NP	-	22	NMOD	-	-
21	regulatory	regulatory	I-NP	I-NP	-	22	NMOD	-	-
22	mechanisms	mechanisms	I-NP	I-NP	-	19	OBJ	-	-
23	for	for	B-PP	B-PP	-	22	NMOD	-	-
24	gene	gene	B-NP	B-NP	-	25	NMOD	-	-
25	transcription	transcription	I-NP	I-NP	-	23	PMOD	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	diverse	diverse	B-NP	B-NP	-	30	NMOD	-	-
28	host	host	I-NP	I-NP	-	30	NMOD	-	-
29	cell	cell	I-NP	I-NP	-	30	NMOD	-	-
30	types	types	I-NP	I-NP	-	26	PMOD	-	-
31	.	.	O	O	-	15	P	-	-

1	Down-regulation	Down-regulation	B-NP	B-NP	-	11	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	immunogenic	immunogenic	B-NP	B-NP	-	4	NMOD	-	-
4	proteins	proteins	I-NP	I-NP	-	2	PMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	EBNA2-EBNA6	EBNA2-EBNA6	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	in	in	B-PP	B-PP	-	1	NMOD	-	-
9	nasal	nasal	B-NP	B-NP	-	10	NMOD	-	-
10	lymphoma	lymphoma	I-NP	I-NP	-	8	PMOD	-	-
11	may	may	B-VP	B-VP	-	0	ROOT	-	-
12	enable	enable	I-VP	I-VP	-	11	VC	-	-
13	tumour	tumour	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	12	OBJ	-	-
15	to	to	B-VP	B-VP	-	16	VMOD	-	-
16	evade	evade	I-VP	I-VP	-	12	VMOD	-	-
17	host	host	B-NP	B-NP	-	20	NMOD	-	-
18	cytotoxic	cytotoxic	I-NP	I-NP	-	20	NMOD	-	-
19	T-cell	T-cell	I-NP	I-NP	-	20	NMOD	-	-
20	surveillance	surveillance	I-NP	I-NP	-	16	OBJ	-	-
21	.	.	O	O	-	11	P	-	-

1	Identification	Identification	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	characterization	characterization	I-NP	I-NP	-	0	ROOT	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	leukocyte-specific	leukocyte-specific	I-NP	I-NP	-	7	NMOD	-	-
7	component	component	I-NP	I-NP	-	4	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	nuclear	nuclear	I-NP	I-NP	-	11	NMOD	-	-
11	body	body	I-NP	I-NP	-	8	PMOD	-	-
12	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	nuclear	nuclear	I-NP	I-NP	-	3	NMOD	-	-
3	body	body	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	NB	NB	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	cellular	cellular	I-NP	I-NP	-	10	NMOD	-	-
10	organelle	organelle	I-NP	I-NP	-	7	PRD	-	-
11	that	that	B-NP	B-NP	-	10	NMOD	-	-
12	is	is	B-VP	B-VP	-	11	SBAR	-	-
13	involved	involved	I-VP	I-VP	-	12	VC	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	pathogenesis	pathogenesis	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	acute	acute	B-NP	B-NP	-	20	NMOD	-	-
19	promyelocytic	promyelocytic	I-NP	I-NP	-	20	NMOD	-	-
20	leukemia	leukemia	I-NP	I-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	viral	viral	B-NP	B-NP	-	23	NMOD	-	-
23	infection	infection	I-NP	I-NP	-	17	PMOD	-	-
24	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	NB	NB	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	target	target	I-NP	I-NP	-	3	PRD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	antibodies	antibodies	B-NP	B-NP	-	7	PMOD	-	-
9	in	in	B-PP	B-PP	-	6	NMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	serum	serum	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	patients	patients	B-NP	B-NP	-	12	PMOD	-	-
14	with	with	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	autoimmune	autoimmune	I-NP	I-NP	-	20	NMOD	-	-
17	disease	disease	I-NP	I-NP	-	20	NMOD	-	-
18	primary	primary	B-NP	B-NP	-	20	NMOD	-	-
19	biliary	biliary	I-NP	I-NP	-	20	NMOD	-	-
20	cirrhosis	cirrhosis	I-NP	I-NP	-	14	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	13	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	13	P	-	-
5	serum	serum	B-NP	B-NP	-	13	SUB	-	-
6	from	from	B-PP	B-PP	-	5	NMOD	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	patient	patient	I-NP	I-NP	-	6	PMOD	-	-
9	with	with	B-PP	B-PP	-	5	NMOD	-	-
10	primary	primary	B-NP	B-NP	-	12	NMOD	-	-
11	biliary	biliary	I-NP	I-NP	-	12	NMOD	-	-
12	cirrhosis	cirrhosis	I-NP	I-NP	-	9	PMOD	-	-
13	was	was	B-VP	B-VP	-	0	ROOT	-	-
14	used	used	I-VP	I-VP	-	13	VC	-	-
15	to	to	B-VP	B-VP	-	16	VMOD	-	-
16	identify	identify	I-VP	I-VP	-	14	VMOD	-	-
17	a	a	B-NP	B-NP	-	18	NMOD	-	-
18	cDNA	cDNA	I-NP	I-NP	-	16	OBJ	-	-
19	encoding	encoding	B-VP	B-VP	-	18	NMOD	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	novel	novel	I-NP	I-NP	-	22	NMOD	-	-
22	component	component	I-NP	I-NP	-	19	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	NB	NB	I-NP	I-NP	-	23	PMOD	-	-
26	,	,	O	O	-	29	P	-	-
27	a	a	B-NP	B-NP	-	29	NMOD	-	-
28	140-kDa	140-kDa	I-NP	I-NP	-	29	NMOD	-	-
29	protein	protein	I-NP	I-NP	-	23	PMOD	-	-
30	designated	designated	B-VP	B-VP	-	29	NMOD	-	-
31	Sp140	Sp140	B-NP	B-NP	-	30	VMOD	-	-
32	.	.	O	O	-	13	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	predicted	predicted	I-NP	I-NP	-	5	NMOD	-	-
3	amino	amino	I-NP	I-NP	-	5	NMOD	-	-
4	acid	acid	I-NP	I-NP	-	5	NMOD	-	-
5	sequence	sequence	I-NP	I-NP	-	12	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	amino-terminal	amino-terminal	I-NP	I-NP	-	9	NMOD	-	-
9	portion	portion	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	Sp140	Sp140	B-NP	B-NP	-	10	PMOD	-	-
12	was	was	B-VP	B-VP	-	0	ROOT	-	-
13	similar	similar	B-ADJP	B-ADJP	-	12	PRD	-	-
14	to	to	B-PP	B-PP	-	13	AMOD	-	-
15	Sp100	Sp100	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	21	P	-	-
17	a	a	B-NP	B-NP	-	21	NMOD	-	-
18	previously	previously	I-NP	I-NP	-	19	AMOD	-	-
19	identified	identified	I-NP	I-NP	-	21	NMOD	-	-
20	NB	NB	I-NP	I-NP	-	21	NMOD	-	-
21	protein	protein	I-NP	I-NP	-	14	PMOD	-	-
22	.	.	O	O	-	12	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	carboxyl	carboxyl	I-NP	I-NP	-	3	NMOD	-	-
3	portion	portion	I-NP	I-NP	-	6	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	Sp140	Sp140	B-NP	B-NP	-	4	PMOD	-	-
6	contained	contained	B-VP	B-VP	-	0	ROOT	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	zinc-finger	zinc-finger	I-NP	I-NP	-	9	NMOD	-	-
9	domain	domain	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	bromodomain	bromodomain	I-NP	I-NP	-	14	NMOD	-	-
13	,	,	O	O	-	14	P	-	-
14	motifs	motifs	B-NP	B-NP	-	6	OBJ	-	-
15	that	that	B-NP	B-NP	-	14	NMOD	-	-
16	are	are	B-VP	B-VP	-	15	SBAR	-	-
17	present	present	B-ADJP	B-ADJP	-	16	PRD	-	-
18	in	in	B-PP	B-PP	-	17	AMOD	-	-
19	proteins	proteins	B-NP	B-NP	-	18	PMOD	-	-
20	regulating	regulating	B-VP	B-VP	-	19	NMOD	-	-
21	gene	gene	B-NP	B-NP	-	22	NMOD	-	-
22	transcription	transcription	I-NP	I-NP	-	20	OBJ	-	-
23	.	.	O	O	-	6	P	-	-

1	High	High	B-NP	B-NP	-	2	NMOD	-	-
2	levels	levels	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	Sp140	Sp140	B-NP	B-NP	-	5	NMOD	-	-
5	mRNA	mRNA	I-NP	I-NP	-	3	PMOD	-	-
6	were	were	B-VP	B-VP	-	0	ROOT	-	-
7	detected	detected	I-VP	I-VP	-	6	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	human	human	B-NP	B-NP	-	10	NMOD	-	-
10	spleen	spleen	I-NP	I-NP	-	14	NMOD	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	peripheral	peripheral	B-NP	B-NP	-	14	NMOD	-	-
13	blood	blood	I-NP	I-NP	-	14	NMOD	-	-
14	leukocytes	leukocytes	I-NP	I-NP	-	20	NMOD	-	-
15	,	,	O	O	-	20	P	-	-
16	but	but	O	O	-	20	NMOD	-	-
17	not	not	O	O	-	16	DEP	-	-
18	other	other	B-NP	B-NP	-	20	NMOD	-	-
19	human	human	I-NP	I-NP	-	20	NMOD	-	-
20	tissues	tissues	I-NP	I-NP	-	8	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	level	level	I-NP	I-NP	-	15	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	SP140	SP140	B-NP	B-NP	-	5	NMOD	-	-
5	mRNA	mRNA	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	NMOD	-	-
7	myeloid	myeloid	B-NP	B-NP	-	10	NMOD	-	-
8	precursor	precursor	I-NP	I-NP	-	10	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	10	NMOD	-	-
10	lines	lines	I-NP	I-NP	-	13	NMOD	-	-
11	HL60	HL60	B-NP	B-NP	-	13	NMOD	-	-
12	and	and	I-NP	I-NP	-	13	NMOD	-	-
13	NB4	NB4	I-NP	I-NP	-	6	PMOD	-	-
14	markedly	markedly	B-ADVP	B-ADVP	-	15	VMOD	-	-
15	increased	increased	B-VP	B-VP	-	0	ROOT	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	response	response	B-NP	B-NP	-	16	PMOD	-	-
18	to	to	B-PP	B-PP	-	16	PMOD	-	-
19	chemically	chemically	B-NP	B-NP	-	20	AMOD	-	-
20	induced	induced	I-NP	I-NP	-	22	NMOD	-	-
21	cellular	cellular	I-NP	I-NP	-	22	NMOD	-	-
22	differentiation	differentiation	I-NP	I-NP	-	18	PMOD	-	-
23	.	.	O	O	-	15	P	-	-

1	Immunohistochemical	Immunohistochemical	B-NP	B-NP	-	2	NMOD	-	-
2	techniques	techniques	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	used	used	I-VP	I-VP	-	3	VC	-	-
5	to	to	B-VP	B-VP	-	6	VMOD	-	-
6	demonstrate	demonstrate	I-VP	I-VP	-	4	VMOD	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	SP140	SP140	B-NP	B-NP	-	9	SUB	-	-
9	localized	localized	B-VP	B-VP	-	7	SBAR	-	-
10	to	to	B-PP	B-PP	-	9	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	NB	NB	I-NP	I-NP	-	10	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	differentiated	differentiated	B-NP	B-NP	-	18	NMOD	-	-
15	HL60	HL60	I-NP	I-NP	-	18	NMOD	-	-
16	and	and	I-NP	I-NP	-	18	NMOD	-	-
17	NB4	NB4	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	location	location	I-NP	I-NP	-	21	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	Sp140	Sp140	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	NB	NB	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	21	P	-	-
9	and	and	O	O	-	10	NMOD	-	-
10	expression	expression	B-NP	B-NP	-	21	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	this	this	B-NP	B-NP	-	13	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	11	PMOD	-	-
14	in	in	B-PP	B-PP	-	10	NMOD	-	-
15	cells	cells	B-NP	B-NP	-	14	PMOD	-	-
16	involved	involved	B-VP	B-VP	-	15	NMOD	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	host	host	B-NP	B-NP	-	19	NMOD	-	-
19	defense	defense	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	10	P	-	-
21	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
22	that	that	B-SBAR	B-SBAR	-	21	VMOD	-	-
23	Sp140	Sp140	B-NP	B-NP	-	24	SUB	-	-
24	may	may	B-VP	B-VP	-	22	SBAR	-	-
25	be	be	I-VP	I-VP	-	24	VC	-	-
26	involved	involved	I-VP	I-VP	-	25	VC	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	pathogenesis	pathogenesis	I-NP	I-NP	-	27	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	acute	acute	B-NP	B-NP	-	33	NMOD	-	-
32	promyelocytic	promyelocytic	I-NP	I-NP	-	33	NMOD	-	-
33	leukemia	leukemia	I-NP	I-NP	-	36	NMOD	-	-
34	and	and	O	O	-	36	NMOD	-	-
35	viral	viral	B-NP	B-NP	-	36	NMOD	-	-
36	infection	infection	I-NP	I-NP	-	30	PMOD	-	-
37	.	.	O	O	-	21	P	-	-

1	Potent	Potent	B-NP	B-NP	-	6	NMOD	-	-
2	gene	gene	I-NP	I-NP	-	6	NMOD	-	-
3	regulatory	regulatory	I-NP	I-NP	-	6	NMOD	-	-
4	and	and	I-NP	I-NP	-	6	NMOD	-	-
5	antiproliferative	antiproliferative	I-NP	I-NP	-	6	NMOD	-	-
6	activities	activities	I-NP	I-NP	-	15	NMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	20-methyl	20-methyl	B-NP	B-NP	-	9	NMOD	-	-
9	analogues	analogues	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	15	NMOD	-	-
12	,	,	I-NP	I-NP	-	15	P	-	-
13	<num>	<num>	I-NP	I-NP	-	15	NMOD	-	-
14	dihydroxyvitamin	dihydroxyvitamin	I-NP	I-NP	-	15	NMOD	-	-
15	D3	D3	I-NP	I-NP	-	0	ROOT	-	-
16	.	.	O	O	-	15	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	biological	biological	I-NP	I-NP	-	4	NMOD	-	-
3	active	active	I-NP	I-NP	-	4	NMOD	-	-
4	form	form	I-NP	I-NP	-	17	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	vitamin	vitamin	B-NP	B-NP	-	7	NMOD	-	-
7	D3	D3	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	17	P	-	-
9	<num>	<num>	B-NP	B-NP	-	17	SUB	-	-
10	,	,	O	O	-	17	P	-	-
11	25-dihydroxyvitamin	25-dihydroxyvitamin	B-NP	B-NP	-	12	NMOD	-	-
12	D3	D3	I-NP	I-NP	-	17	SUB	-	-
13	(	(	O	O	-	14	P	-	-
14	VD	VD	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	,	,	O	O	-	12	P	-	-
17	regulates	regulates	B-VP	B-VP	-	0	ROOT	-	-
18	cellular	cellular	B-NP	B-NP	-	21	NMOD	-	-
19	growth	growth	B-NP	B-NP	-	21	NMOD	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	differentiation	differentiation	B-NP	B-NP	-	17	OBJ	-	-
22	.	.	O	O	-	17	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	provides	provides	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	hormone	hormone	I-NP	I-NP	-	2	OBJ	-	-
5	with	with	B-PP	B-PP	-	4	NMOD	-	-
6	an	an	B-NP	B-NP	-	9	NMOD	-	-
7	interesting	interesting	I-NP	I-NP	-	9	NMOD	-	-
8	therapeutic	therapeutic	I-NP	I-NP	-	9	NMOD	-	-
9	potential	potential	I-NP	I-NP	-	5	PMOD	-	-
10	.	.	O	O	-	2	P	-	-

1	However	However	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	hypercalcemia	hypercalcemia	B-NP	B-NP	-	4	SUB	-	-
4	is	is	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	side	side	I-NP	I-NP	-	7	NMOD	-	-
7	effect	effect	I-NP	I-NP	-	4	PRD	-	-
8	,	,	O	O	-	7	P	-	-
9	which	which	B-NP	B-NP	-	7	NMOD	-	-
10	is	is	B-VP	B-VP	-	9	SBAR	-	-
11	caused	caused	I-VP	I-VP	-	10	VC	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	VD	VD	B-NP	B-NP	-	14	NMOD	-	-
14	's	's	B-NP	B-NP	-	16	NMOD	-	-
15	classical	classical	I-NP	I-NP	-	16	NMOD	-	-
16	action	action	I-NP	I-NP	-	19	NMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	regulation	regulation	I-NP	I-NP	-	12	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	calcium	calcium	B-NP	B-NP	-	22	NMOD	-	-
22	homeostasis	homeostasis	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	4	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	made	made	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	need	need	I-NP	I-NP	-	2	OBJ	-	-
5	for	for	B-PP	B-PP	-	4	NMOD	-	-
6	VD	VD	B-NP	B-NP	-	7	NMOD	-	-
7	analogues	analogues	I-NP	I-NP	-	5	PMOD	-	-
8	with	with	B-PP	B-PP	-	7	NMOD	-	-
9	selectively	selectively	B-NP	B-NP	-	10	AMOD	-	-
10	increased	increased	I-NP	I-NP	-	13	NMOD	-	-
11	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
12	regulatory	regulatory	I-NP	I-NP	-	13	NMOD	-	-
13	properties	properties	I-NP	I-NP	-	8	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	Studies	Studies	B-NP	B-NP	-	5	SUB	-	-
2	with	with	B-PP	B-PP	-	1	NMOD	-	-
3	20-epi	20-epi	B-NP	B-NP	-	4	NMOD	-	-
4	analogues	analogues	I-NP	I-NP	-	2	PMOD	-	-
5	pointed	pointed	B-VP	B-VP	-	0	ROOT	-	-
6	out	out	B-PRT	B-PRT	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	importance	importance	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	carbon-20	carbon-20	I-NP	I-NP	-	12	NMOD	-	-
12	position	position	I-NP	I-NP	-	9	PMOD	-	-
13	and	and	O	O	-	5	VMOD	-	-
14	led	led	B-VP	B-VP	-	5	VMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	development	development	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	20-methyl	20-methyl	B-NP	B-NP	-	20	NMOD	-	-
20	derivatives	derivatives	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	VD	VD	B-NP	B-NP	-	21	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	In	In	B-PP	B-PP	-	22	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	report	report	I-NP	I-NP	-	1	PMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	biological	biological	I-NP	I-NP	-	6	NMOD	-	-
6	properties	properties	I-NP	I-NP	-	1	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	12	NMOD	-	-
9	compounds	compounds	I-NP	I-NP	-	12	NMOD	-	-
10	ZK161422	ZK161422	I-NP	I-NP	-	12	NMOD	-	-
11	and	and	I-NP	I-NP	-	12	NMOD	-	-
12	ZK157202	ZK157202	I-NP	I-NP	-	18	NMOD	-	-
13	,	,	O	O	-	12	P	-	-
14	which	which	B-NP	B-NP	-	12	NMOD	-	-
15	are	are	B-VP	B-VP	-	14	SBAR	-	-
16	20-methyl-	20-methyl-	B-ADJP	B-ADJP	-	18	NMOD	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	20-methyl-23-eneanalogues	20-methyl-23-eneanalogues	B-NP	B-NP	-	22	SUB	-	-
19	,	,	O	O	-	22	P	-	-
20	respectively	respectively	B-ADVP	B-ADVP	-	22	VMOD	-	-
21	,	,	O	O	-	22	P	-	-
22	have	have	B-VP	B-VP	-	0	ROOT	-	-
23	been	been	I-VP	I-VP	-	22	VC	-	-
24	analyzed	analyzed	I-VP	I-VP	-	23	VC	-	-
25	in	in	B-PP	B-PP	-	24	VMOD	-	-
26	comparison	comparison	B-NP	B-NP	-	25	PMOD	-	-
27	with	with	B-PP	B-PP	-	26	NMOD	-	-
28	VD	VD	B-NP	B-NP	-	27	PMOD	-	-
29	.	.	O	O	-	22	P	-	-

1	Both	Both	B-NP	B-NP	-	2	NMOD	-	-
2	compounds	compounds	I-NP	I-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	about	about	B-PP	B-PP	-	3	VMOD	-	-
5	2-fold	2-fold	B-NP	B-NP	-	6	AMOD	-	-
6	lower	lower	I-NP	I-NP	-	7	NMOD	-	-
7	affinity	affinity	I-NP	I-NP	-	4	PMOD	-	-
8	to	to	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	VD	VD	I-NP	I-NP	-	11	NMOD	-	-
11	receptor	receptor	I-NP	I-NP	-	8	PMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	VDR	VDR	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	than	than	B-PP	B-PP	-	11	NMOD	-	-
16	VD	VD	B-NP	B-NP	-	15	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	However	However	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	compared	compared	B-PP	B-PP	-	10	VMOD	-	-
4	to	to	B-PP	B-PP	-	3	PMOD	-	-
5	VD	VD	B-NP	B-NP	-	4	PMOD	-	-
6	,	,	O	O	-	10	P	-	-
7	their	their	B-NP	B-NP	-	9	NMOD	-	-
8	antiproliferative	antiproliferative	I-NP	I-NP	-	9	NMOD	-	-
9	effect	effect	I-NP	I-NP	-	10	SUB	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	up	up	B-PP	B-PP	-	10	VMOD	-	-
12	to	to	B-PP	B-PP	-	11	AMOD	-	-
13	30-fold	30-fold	B-NP	B-NP	-	14	AMOD	-	-
14	higher	higher	I-NP	I-NP	-	12	PMOD	-	-
15	on	on	B-PP	B-PP	-	11	PMOD	-	-
16	human	human	B-NP	B-NP	-	20	NMOD	-	-
17	peripheral	peripheral	I-NP	I-NP	-	20	NMOD	-	-
18	blood	blood	I-NP	I-NP	-	20	NMOD	-	-
19	mononuclear	mononuclear	I-NP	I-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
21	and	and	O	O	-	11	PMOD	-	-
22	even	even	B-ADVP	B-ADVP	-	23	AMOD	-	-
23	up	up	I-ADVP	I-ADVP	-	11	AMOD	-	-
24	to	to	B-PP	B-PP	-	23	AMOD	-	-
25	300-fold	300-fold	B-NP	B-NP	-	26	AMOD	-	-
26	higher	higher	I-NP	I-NP	-	24	PMOD	-	-
27	on	on	B-PP	B-PP	-	11	PMOD	-	-
28	human	human	B-NP	B-NP	-	32	NMOD	-	-
29	breast	breast	I-NP	I-NP	-	32	NMOD	-	-
30	cancer	cancer	I-NP	I-NP	-	32	NMOD	-	-
31	MCF-7	MCF-7	I-NP	I-NP	-	32	NMOD	-	-
32	cells	cells	I-NP	I-NP	-	27	PMOD	-	-
33	.	.	O	O	-	10	P	-	-

1	Whereas	Whereas	B-PP	B-PP	-	13	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	hypercalcemic	hypercalcemic	I-NP	I-NP	-	4	NMOD	-	-
4	effect	effect	I-NP	I-NP	-	7	SUB	-	-
5	for	for	B-PP	B-PP	-	4	NMOD	-	-
6	ZK157202	ZK157202	B-NP	B-NP	-	5	PMOD	-	-
7	is	is	B-VP	B-VP	-	1	SBAR	-	-
8	also	also	I-VP	I-VP	-	7	VMOD	-	-
9	increased	increased	I-VP	I-VP	-	7	VC	-	-
10	10-fold	10-fold	B-ADVP	B-ADVP	-	9	VMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	ZK161422	ZK161422	B-NP	B-NP	-	13	SUB	-	-
13	has	has	B-VP	B-VP	-	0	ROOT	-	-
14	the	the	B-NP	B-NP	-	17	NMOD	-	-
15	same	same	I-NP	I-NP	-	17	NMOD	-	-
16	calcium-mobilizing	calcium-mobilizing	I-NP	I-NP	-	17	NMOD	-	-
17	potency	potency	I-NP	I-NP	-	13	OBJ	-	-
18	as	as	B-PP	B-PP	-	13	VMOD	-	-
19	VD	VD	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	13	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	9	VMOD	-	-
2	,	,	O	O	-	9	P	-	-
3	ZK161422	ZK161422	B-NP	B-NP	-	9	SUB	-	-
4	,	,	O	O	-	9	P	-	-
5	but	but	O	O	-	9	VMOD	-	-
6	not	not	O	O	-	5	DEP	-	-
7	ZK157202	ZK157202	B-NP	B-NP	-	9	SUB	-	-
8	,	,	O	O	-	7	P	-	-
9	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
10	preference	preference	B-NP	B-NP	-	9	OBJ	-	-
11	for	for	B-PP	B-PP	-	10	NMOD	-	-
12	gene	gene	B-NP	B-NP	-	13	NMOD	-	-
13	activation	activation	I-NP	I-NP	-	11	PMOD	-	-
14	from	from	B-PP	B-PP	-	13	NMOD	-	-
15	a	a	B-NP	B-NP	-	16	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	14	PMOD	-	-
17	carrying	carrying	B-VP	B-VP	-	16	NMOD	-	-
18	a	a	B-NP	B-NP	-	21	NMOD	-	-
19	VD	VD	I-NP	I-NP	-	21	NMOD	-	-
20	response	response	I-NP	I-NP	-	21	NMOD	-	-
21	element	element	I-NP	I-NP	-	17	OBJ	-	-
22	with	with	B-PP	B-PP	-	17	VMOD	-	-
23	a	a	B-NP	B-NP	-	25	NMOD	-	-
24	palindromic	palindromic	I-NP	I-NP	-	25	NMOD	-	-
25	arrangement	arrangement	I-NP	I-NP	-	22	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	two	two	B-NP	B-NP	-	31	NMOD	-	-
28	hexameric	hexameric	I-NP	I-NP	-	31	NMOD	-	-
29	receptor	receptor	I-NP	I-NP	-	31	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	31	NMOD	-	-
31	sites	sites	I-NP	I-NP	-	26	PMOD	-	-
32	spaced	spaced	B-VP	B-VP	-	31	NMOD	-	-
33	by	by	B-PP	B-PP	-	32	VMOD	-	-
34	<num>	<num>	B-NP	B-NP	-	35	NMOD	-	-
35	nucleotides	nucleotides	B-NP	B-NP	-	33	PMOD	-	-
36	(	(	O	O	-	37	P	-	-
37	IP9	IP9	B-NP	B-NP	-	35	NMOD	-	-
38	)	)	O	O	-	37	P	-	-
39	rather	rather	B-PP	B-PP	-	33	PMOD	-	-
40	than	than	I-PP	I-PP	-	39	DEP	-	-
41	for	for	B-PP	B-PP	-	39	DEP	-	-
42	activation	activation	B-NP	B-NP	-	41	PMOD	-	-
43	from	from	B-PP	B-PP	-	42	NMOD	-	-
44	a	a	B-NP	B-NP	-	46	NMOD	-	-
45	response	response	I-NP	I-NP	-	46	NMOD	-	-
46	element	element	I-NP	I-NP	-	43	PMOD	-	-
47	formed	formed	B-VP	B-VP	-	46	NMOD	-	-
48	by	by	B-PP	B-PP	-	47	VMOD	-	-
49	a	a	B-NP	B-NP	-	51	NMOD	-	-
50	direct	direct	I-NP	I-NP	-	51	NMOD	-	-
51	repeat	repeat	I-NP	I-NP	-	48	PMOD	-	-
52	spaced	spaced	B-VP	B-VP	-	51	NMOD	-	-
53	by	by	B-PP	B-PP	-	52	VMOD	-	-
54	<num>	<num>	B-NP	B-NP	-	55	NMOD	-	-
55	nucleotides	nucleotides	B-NP	B-NP	-	53	PMOD	-	-
56	(	(	O	O	-	57	P	-	-
57	DR3	DR3	B-NP	B-NP	-	55	NMOD	-	-
58	)	)	O	O	-	57	P	-	-
59	.	.	O	O	-	9	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	observation	observation	I-NP	I-NP	-	3	SUB	-	-
3	supports	supports	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	5	NMOD	-	-
5	model	model	I-NP	I-NP	-	3	OBJ	-	-
6	,	,	O	O	-	3	P	-	-
7	in	in	B-PP	B-PP	-	3	VMOD	-	-
8	which	which	B-NP	B-NP	-	7	PMOD	-	-
9	promoter	promoter	B-NP	B-NP	-	10	NMOD	-	-
10	selectivity	selectivity	I-NP	I-NP	-	11	SUB	-	-
11	reflects	reflects	B-VP	B-VP	-	7	SBAR	-	-
12	the	the	B-NP	B-NP	-	16	NMOD	-	-
13	selectively	selectively	I-NP	I-NP	-	14	AMOD	-	-
14	increased	increased	I-NP	I-NP	-	16	NMOD	-	-
15	antiproliferative	antiproliferative	I-NP	I-NP	-	16	NMOD	-	-
16	effect	effect	I-NP	I-NP	-	11	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	VD	VD	B-NP	B-NP	-	19	NMOD	-	-
19	analogues	analogues	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	Second	Second	B-NP	B-NP	-	3	NMOD	-	-
2	messenger	messenger	I-NP	I-NP	-	3	NMOD	-	-
3	up-regulation	up-regulation	I-NP	I-NP	-	9	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	androgen	androgen	B-NP	B-NP	-	8	NMOD	-	-
6	receptor	receptor	I-NP	I-NP	-	8	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	NMOD	-	-
8	transcription	transcription	I-NP	I-NP	-	4	PMOD	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	absent	absent	B-ADJP	B-ADJP	-	9	PRD	-	-
11	in	in	B-PP	B-PP	-	10	AMOD	-	-
12	androgen	androgen	B-NP	B-NP	-	18	NMOD	-	-
13	insensitive	insensitive	I-NP	I-NP	-	18	NMOD	-	-
14	human	human	I-NP	I-NP	-	18	NMOD	-	-
15	prostatic	prostatic	I-NP	I-NP	-	18	NMOD	-	-
16	carcinoma	carcinoma	I-NP	I-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	lines	lines	I-NP	I-NP	-	22	NMOD	-	-
19	,	,	O	O	-	22	P	-	-
20	PC-3	PC-3	B-NP	B-NP	-	22	NMOD	-	-
21	and	and	I-NP	I-NP	-	22	NMOD	-	-
22	DU-145	DU-145	I-NP	I-NP	-	11	PMOD	-	-
23	.	.	O	O	-	9	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	theoretical	theoretical	I-NP	I-NP	-	3	NMOD	-	-
3	pathway	pathway	I-NP	I-NP	-	15	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	transcriptional	transcriptional	B-NP	B-NP	-	6	NMOD	-	-
6	regulation	regulation	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	14	NMOD	-	-
9	androgen	androgen	I-NP	I-NP	-	14	NMOD	-	-
10	receptor	receptor	I-NP	I-NP	-	14	NMOD	-	-
11	(	(	O	O	-	14	P	-	-
12	AR	AR	B-NP	B-NP	-	14	NMOD	-	-
13	)	)	O	O	-	14	P	-	-
14	gene	gene	B-NP	B-NP	-	7	PMOD	-	-
15	is	is	B-VP	B-VP	-	0	ROOT	-	-
16	via	via	B-PP	B-PP	-	15	PRD	-	-
17	a	a	B-NP	B-NP	-	20	NMOD	-	-
18	cAMP	cAMP	I-NP	I-NP	-	20	NMOD	-	-
19	response	response	I-NP	I-NP	-	20	NMOD	-	-
20	element	element	I-NP	I-NP	-	16	PMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	CRE	CRE	B-NP	B-NP	-	20	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	present	present	B-ADJP	B-ADJP	-	20	NMOD	-	-
25	in	in	B-PP	B-PP	-	24	AMOD	-	-
26	its	its	B-NP	B-NP	-	28	NMOD	-	-
27	promoter	promoter	I-NP	I-NP	-	28	NMOD	-	-
28	region	region	I-NP	I-NP	-	25	PMOD	-	-
29	(	(	O	O	-	32	P	-	-
30	-508	-508	B-NP	B-NP	-	32	NMOD	-	-
31	to	to	O	O	-	32	NMOD	-	-
32	-501	-501	B-NP	B-NP	-	28	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	.	.	O	O	-	15	P	-	-

1	After	After	B-PP	B-PP	-	11	VMOD	-	-
2	<num>	<num>	B-NP	B-NP	-	3	NMOD	-	-
3	h	h	I-NP	I-NP	-	1	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	stimulation	stimulation	B-NP	B-NP	-	4	PMOD	-	-
6	with	with	B-PP	B-PP	-	5	NMOD	-	-
7	8-bromo-cAMP	8-bromo-cAMP	B-NP	B-NP	-	6	PMOD	-	-
8	,	,	O	O	-	11	P	-	-
9	AR	AR	B-NP	B-NP	-	10	NMOD	-	-
10	mRNA	mRNA	I-NP	I-NP	-	11	SUB	-	-
11	was	was	B-VP	B-VP	-	0	ROOT	-	-
12	upregulated	upregulated	I-VP	I-VP	-	11	VC	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	LNCaP	LNCaP	B-NP	B-NP	-	13	PMOD	-	-
15	but	but	B-PP	B-PP	-	13	PMOD	-	-
16	not	not	B-PP	B-PP	-	17	PMOD	-	-
17	in	in	I-PP	I-PP	-	13	PMOD	-	-
18	either	either	O	O	-	23	NMOD	-	-
19	PC-3	PC-3	B-NP	B-NP	-	23	NMOD	-	-
20	or	or	O	O	-	23	NMOD	-	-
21	DU-145	DU-145	B-NP	B-NP	-	23	NMOD	-	-
22	cell	cell	I-NP	I-NP	-	23	NMOD	-	-
23	lines	lines	I-NP	I-NP	-	17	PMOD	-	-
24	.	.	O	O	-	11	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	demonstrated	demonstrated	I-VP	I-VP	-	2	VC	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	level	level	I-NP	I-NP	-	14	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	CRE	CRE	B-NP	B-NP	-	10	NMOD	-	-
9	binding	binding	I-NP	I-NP	-	10	NMOD	-	-
10	protein	protein	I-NP	I-NP	-	7	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	CREB	CREB	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	was	was	B-VP	B-VP	-	4	SBAR	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	same	same	I-NP	I-NP	-	14	PRD	-	-
17	in	in	B-PP	B-PP	-	14	VMOD	-	-
18	all	all	B-NP	B-NP	-	20	NMOD	-	-
19	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
20	lines	lines	I-NP	I-NP	-	17	PMOD	-	-
21	and	and	O	O	-	22	DEP	-	-
22	that	that	B-SBAR	B-SBAR	-	17	PMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	putative	putative	I-NP	I-NP	-	26	NMOD	-	-
25	AR-CRE	AR-CRE	I-NP	I-NP	-	26	NMOD	-	-
26	forms	forms	I-NP	I-NP	-	31	NMOD	-	-
27	specific	specific	B-NP	B-NP	-	31	NMOD	-	-
28	and	and	I-NP	I-NP	-	31	NMOD	-	-
29	compatible	compatible	I-NP	I-NP	-	31	NMOD	-	-
30	protein	protein	I-NP	I-NP	-	31	NMOD	-	-
31	interactions	interactions	I-NP	I-NP	-	17	PMOD	-	-
32	with	with	B-PP	B-PP	-	31	NMOD	-	-
33	CREB	CREB	B-NP	B-NP	-	32	PMOD	-	-
34	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	ability	ability	I-NP	I-NP	-	13	SUB	-	-
3	to	to	B-VP	B-VP	-	4	VMOD	-	-
4	regulate	regulate	I-VP	I-VP	-	2	NMOD	-	-
5	AR	AR	B-NP	B-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	transcription	transcription	I-NP	I-NP	-	4	OBJ	-	-
8	via	via	B-PP	B-PP	-	4	VMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	second	second	I-NP	I-NP	-	12	NMOD	-	-
11	messenger	messenger	I-NP	I-NP	-	12	NMOD	-	-
12	pathway	pathway	I-NP	I-NP	-	8	PMOD	-	-
13	is	is	B-VP	B-VP	-	0	ROOT	-	-
14	lost	lost	I-VP	I-VP	-	13	VC	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	21	NMOD	-	-
17	PC-3	PC-3	I-NP	I-NP	-	21	NMOD	-	-
18	and	and	I-NP	I-NP	-	21	NMOD	-	-
19	DU-145	DU-145	I-NP	I-NP	-	21	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	21	NMOD	-	-
21	lines	lines	I-NP	I-NP	-	15	PMOD	-	-
22	.	.	O	O	-	13	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	may	may	B-VP	B-VP	-	0	ROOT	-	-
3	be	be	I-VP	I-VP	-	2	VC	-	-
4	an	an	B-NP	B-NP	-	7	NMOD	-	-
5	important	important	I-NP	I-NP	-	7	NMOD	-	-
6	primary	primary	I-NP	I-NP	-	7	NMOD	-	-
7	mechanism	mechanism	I-NP	I-NP	-	3	PRD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	androgen	androgen	B-NP	B-NP	-	10	NMOD	-	-
10	insensitivity	insensitivity	I-NP	I-NP	-	8	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	prostate	prostate	B-NP	B-NP	-	13	NMOD	-	-
13	cancer	cancer	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	Activation	Activation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	NF-kappaB	NF-kappaB	I-NP	I-NP	-	6	NMOD	-	-
5	transcription	transcription	I-NP	I-NP	-	6	NMOD	-	-
6	factor	factor	I-NP	I-NP	-	2	PMOD	-	-
7	in	in	B-PP	B-PP	-	1	NMOD	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	T-lymphocytic	T-lymphocytic	I-NP	I-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	line	line	I-NP	I-NP	-	7	PMOD	-	-
12	by	by	B-PP	B-PP	-	1	NMOD	-	-
13	hypochlorous	hypochlorous	B-NP	B-NP	-	14	NMOD	-	-
14	acid	acid	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	1	P	-	-

1	Reactive	Reactive	B-NP	B-NP	-	3	NMOD	-	-
2	oxygen	oxygen	I-NP	I-NP	-	3	NMOD	-	-
3	species	species	I-NP	I-NP	-	11	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	ROS	ROS	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	such	such	B-PP	B-PP	-	8	PMOD	-	-
8	as	as	I-PP	I-PP	-	3	NMOD	-	-
9	hydrogen	hydrogen	B-NP	B-NP	-	10	NMOD	-	-
10	peroxide	peroxide	I-NP	I-NP	-	8	PMOD	-	-
11	serve	serve	B-VP	B-VP	-	0	ROOT	-	-
12	as	as	B-PP	B-PP	-	11	VMOD	-	-
13	second	second	B-NP	B-NP	-	14	NMOD	-	-
14	messengers	messengers	I-NP	I-NP	-	12	PMOD	-	-
15	in	in	B-PP	B-PP	-	11	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	induction	induction	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	22	NMOD	-	-
21	factor	factor	I-NP	I-NP	-	22	NMOD	-	-
22	NF-kappaB	NF-kappaB	I-NP	I-NP	-	18	PMOD	-	-
23	,	,	O	O	-	11	P	-	-
24	and	and	O	O	-	11	VMOD	-	-
25	hence	hence	B-ADVP	B-ADVP	-	26	PMOD	-	-
26	in	in	B-PP	B-PP	-	11	VMOD	-	-
27	the	the	B-NP	B-NP	-	30	NMOD	-	-
28	activation	activation	I-NP	I-NP	-	30	NMOD	-	-
29	and	and	O	O	-	30	NMOD	-	-
30	replication	replication	B-NP	B-NP	-	26	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	human	human	B-NP	B-NP	-	35	NMOD	-	-
33	immunodeficiency	immunodeficiency	I-NP	I-NP	-	35	NMOD	-	-
34	virus	virus	I-NP	I-NP	-	35	NMOD	-	-
35	type	type	I-NP	I-NP	-	31	PMOD	-	-
36	<num>	<num>	I-NP	I-NP	-	35	NMOD	-	-
37	(	(	O	O	-	38	P	-	-
38	HIV-1	HIV-1	B-NP	B-NP	-	35	NMOD	-	-
39	)	)	O	O	-	38	P	-	-
40	in	in	B-PP	B-PP	-	30	NMOD	-	-
41	human	human	B-NP	B-NP	-	42	NMOD	-	-
42	cells	cells	I-NP	I-NP	-	40	PMOD	-	-
43	.	.	O	O	-	11	P	-	-

1	During	During	B-PP	B-PP	-	8	VMOD	-	-
2	inflammatory	inflammatory	B-NP	B-NP	-	3	NMOD	-	-
3	reactions	reactions	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	8	P	-	-
5	many	many	B-NP	B-NP	-	7	NMOD	-	-
6	oxidative	oxidative	I-NP	I-NP	-	7	NMOD	-	-
7	species	species	I-NP	I-NP	-	8	SUB	-	-
8	are	are	B-VP	B-VP	-	0	ROOT	-	-
9	produced	produced	I-VP	I-VP	-	8	VC	-	-
10	,	,	O	O	-	9	P	-	-
11	one	one	B-NP	B-NP	-	12	NMOD	-	-
12	of	of	B-PP	B-PP	-	9	NMOD	-	-
13	which	which	B-NP	B-NP	-	12	PMOD	-	-
14	is	is	B-VP	B-VP	-	12	SBAR	-	-
15	hypochlorous	hypochlorous	B-NP	B-NP	-	16	NMOD	-	-
16	acid	acid	I-NP	I-NP	-	14	PRD	-	-
17	(	(	O	O	-	18	P	-	-
18	HOCl	HOCl	B-NP	B-NP	-	16	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	,	,	O	O	-	16	P	-	-
21	which	which	B-NP	B-NP	-	16	NMOD	-	-
22	is	is	B-VP	B-VP	-	21	SBAR	-	-
23	responsible	responsible	B-ADJP	B-ADJP	-	22	PRD	-	-
24	for	for	B-PP	B-PP	-	23	AMOD	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	microbicidal	microbicidal	I-NP	I-NP	-	27	NMOD	-	-
27	effects	effects	I-NP	I-NP	-	24	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	activated	activated	B-NP	B-NP	-	32	NMOD	-	-
30	human	human	I-NP	I-NP	-	32	NMOD	-	-
31	polymorphonuclear	polymorphonuclear	I-NP	I-NP	-	32	NMOD	-	-
32	leukocytes	leukocytes	I-NP	I-NP	-	28	PMOD	-	-
33	.	.	O	O	-	8	P	-	-

1	Treatment	Treatment	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	T-lymphocytic	T-lymphocytic	I-NP	I-NP	-	6	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
6	line	line	I-NP	I-NP	-	2	PMOD	-	-
7	with	with	B-PP	B-PP	-	1	NMOD	-	-
8	micromolar	micromolar	B-NP	B-NP	-	9	NMOD	-	-
9	concentrations	concentrations	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	HOCl	HOCl	B-NP	B-NP	-	10	PMOD	-	-
12	promoted	promoted	B-VP	B-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	appearance	appearance	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	transcription	transcription	B-NP	B-NP	-	18	NMOD	-	-
17	factor	factor	I-NP	I-NP	-	18	NMOD	-	-
18	NF-kappaB	NF-kappaB	I-NP	I-NP	-	15	PMOD	-	-
19	(	(	O	O	-	22	P	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	heterodimer	heterodimer	I-NP	I-NP	-	22	NMOD	-	-
22	p50/p65	p50/p65	I-NP	I-NP	-	18	NMOD	-	-
23	)	)	O	O	-	22	P	-	-
24	in	in	B-PP	B-PP	-	14	NMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	nucleus	nucleus	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	27	PMOD	-	-
30	,	,	O	O	-	14	P	-	-
31	even	even	B-ADVP	B-ADVP	-	32	PMOD	-	-
32	in	in	B-PP	B-PP	-	14	NMOD	-	-
33	the	the	B-NP	B-NP	-	34	NMOD	-	-
34	absence	absence	I-NP	I-NP	-	32	PMOD	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	de	de	B-NP	B-NP	-	37	AMOD	-	-
37	novo	novo	I-NP	I-NP	-	39	NMOD	-	-
38	protein	protein	I-NP	I-NP	-	39	NMOD	-	-
39	synthesis	synthesis	I-NP	I-NP	-	35	PMOD	-	-
40	.	.	O	O	-	12	P	-	-

1	Western	Western	B-NP	B-NP	-	3	NMOD	-	-
2	blot	blot	I-NP	I-NP	-	3	NMOD	-	-
3	analysis	analysis	I-NP	I-NP	-	12	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	NF-kappaB	NF-kappaB	I-NP	I-NP	-	8	NMOD	-	-
7	inhibitory	inhibitory	I-NP	I-NP	-	8	NMOD	-	-
8	subunits	subunits	I-NP	I-NP	-	4	PMOD	-	-
9	(	(	O	O	-	10	P	-	-
10	IkappaB	IkappaB	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
13	that	that	B-SBAR	B-SBAR	-	12	VMOD	-	-
14	both	both	O	O	-	19	NMOD	-	-
15	IkappaB-alpha	IkappaB-alpha	B-NP	B-NP	-	16	NMOD	-	-
16	proteolysis	proteolysis	I-NP	I-NP	-	19	NMOD	-	-
17	and	and	O	O	-	19	NMOD	-	-
18	p105	p105	B-NP	B-NP	-	19	NMOD	-	-
19	processing	processing	I-NP	I-NP	-	20	SUB	-	-
20	were	were	B-VP	B-VP	-	13	SBAR	-	-
21	induced	induced	I-VP	I-VP	-	20	VC	-	-
22	by	by	B-PP	B-PP	-	21	VMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	treatment	treatment	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	12	P	-	-

1	NF-kappaB	NF-kappaB	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	very	very	B-ADJP	B-ADJP	-	5	AMOD	-	-
5	effective	effective	I-ADJP	I-ADJP	-	3	PRD	-	-
6	when	when	B-ADVP	B-ADVP	-	3	VMOD	-	-
7	cells	cells	B-NP	B-NP	-	8	SUB	-	-
8	were	were	B-VP	B-VP	-	6	SBAR	-	-
9	subjected	subjected	I-VP	I-VP	-	8	VC	-	-
10	to	to	B-PP	B-PP	-	9	VMOD	-	-
11	hyperthermia	hyperthermia	B-NP	B-NP	-	10	PMOD	-	-
12	before	before	B-PP	B-PP	-	9	VMOD	-	-
13	being	being	B-VP	B-VP	-	12	PMOD	-	-
14	treated	treated	I-VP	I-VP	-	13	VC	-	-
15	with	with	B-PP	B-PP	-	14	VMOD	-	-
16	HOCl	HOCl	B-NP	B-NP	-	15	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	Various	Various	B-NP	B-NP	-	2	NMOD	-	-
2	antioxidants	antioxidants	I-NP	I-NP	-	13	SUB	-	-
3	,	,	O	O	-	2	P	-	-
4	such	such	B-PP	B-PP	-	5	PMOD	-	-
5	as	as	I-PP	I-PP	-	2	NMOD	-	-
6	pyrrolidine	pyrrolidine	B-NP	B-NP	-	7	NMOD	-	-
7	dithiocarbamate	dithiocarbamate	I-NP	I-NP	-	12	NMOD	-	-
8	,	,	O	O	-	12	P	-	-
9	p-bromophenacyl-bromide	p-bromophenacyl-bromide	B-NP	B-NP	-	12	NMOD	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	nordihydroguaiaretic	nordihydroguaiaretic	B-NP	B-NP	-	12	NMOD	-	-
12	acid	acid	I-NP	I-NP	-	5	PMOD	-	-
13	could	could	B-VP	B-VP	-	0	ROOT	-	-
14	strongly	strongly	I-VP	I-VP	-	13	VMOD	-	-
15	reduce	reduce	I-VP	I-VP	-	13	VC	-	-
16	NF-kappaB	NF-kappaB	B-NP	B-NP	-	17	NMOD	-	-
17	translocation	translocation	I-NP	I-NP	-	15	OBJ	-	-
18	,	,	O	O	-	15	P	-	-
19	demonstrating	demonstrating	B-VP	B-VP	-	15	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	importance	importance	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	oxidative	oxidative	B-NP	B-NP	-	24	NMOD	-	-
24	species	species	I-NP	I-NP	-	22	PMOD	-	-
25	in	in	B-PP	B-PP	-	21	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	transduction	transduction	I-NP	I-NP	-	28	NMOD	-	-
28	mechanism	mechanism	I-NP	I-NP	-	25	PMOD	-	-
29	.	.	O	O	-	13	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	ACH-2	ACH-2	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	10	SUB	-	-
5	treated	treated	B-VP	B-VP	-	4	NMOD	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	HOCl	HOCl	B-NP	B-NP	-	9	NMOD	-	-
8	or	or	I-NP	I-NP	-	9	NMOD	-	-
9	H2O2	H2O2	I-NP	I-NP	-	6	PMOD	-	-
10	released	released	B-VP	B-VP	-	0	ROOT	-	-
11	tumour	tumour	B-NP	B-NP	-	13	NMOD	-	-
12	necrosis	necrosis	I-NP	I-NP	-	13	NMOD	-	-
13	factor-alpha	factor-alpha	I-NP	I-NP	-	10	OBJ	-	-
14	(	(	O	O	-	15	P	-	-
15	TNF-alpha	TNF-alpha	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	in	in	B-PP	B-PP	-	10	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	supernatants	supernatants	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	importance	importance	I-NP	I-NP	-	13	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	TNF-alpha	TNF-alpha	B-NP	B-NP	-	5	NMOD	-	-
5	release	release	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	NF-kappaB	NF-kappaB	B-NP	B-NP	-	8	NMOD	-	-
8	induction	induction	I-NP	I-NP	-	6	PMOD	-	-
9	by	by	B-PP	B-PP	-	5	NMOD	-	-
10	HOCl	HOCl	B-NP	B-NP	-	12	NMOD	-	-
11	or	or	I-NP	I-NP	-	12	NMOD	-	-
12	H2O2	H2O2	I-NP	I-NP	-	9	PMOD	-	-
13	was	was	B-VP	B-VP	-	43	VMOD	-	-
14	demonstrated	demonstrated	I-VP	I-VP	-	13	VC	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	fact	fact	I-NP	I-NP	-	15	PMOD	-	-
18	that	that	B-SBAR	B-SBAR	-	17	NMOD	-	-
19	:	:	O	O	-	18	P	-	-
20	(	(	B-LST	B-LST	-	21	P	-	-
21	<num>	<num>	I-LST	I-LST	-	28	VMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	nuclear	nuclear	I-NP	I-NP	-	25	NMOD	-	-
25	appearance	appearance	I-NP	I-NP	-	28	SUB	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	NF-kappaB	NF-kappaB	B-NP	B-NP	-	26	PMOD	-	-
28	was	was	B-VP	B-VP	-	18	SBAR	-	-
29	promoted	promoted	I-VP	I-VP	-	28	VC	-	-
30	in	in	B-PP	B-PP	-	29	VMOD	-	-
31	untreated	untreated	B-NP	B-NP	-	32	NMOD	-	-
32	cells	cells	I-NP	I-NP	-	30	PMOD	-	-
33	;	;	O	O	-	13	P	-	-
34	and	and	O	O	-	43	VMOD	-	-
35	(	(	B-LST	B-LST	-	36	P	-	-
36	<num>	<num>	I-LST	I-LST	-	43	VMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	synergism	synergism	B-NP	B-NP	-	43	SUB	-	-
39	between	between	B-PP	B-PP	-	38	NMOD	-	-
40	TNF-alpha	TNF-alpha	B-NP	B-NP	-	42	NMOD	-	-
41	and	and	I-NP	I-NP	-	42	NMOD	-	-
42	HOCl	HOCl	I-NP	I-NP	-	39	PMOD	-	-
43	was	was	B-VP	B-VP	-	0	ROOT	-	-
44	detected	detected	I-VP	I-VP	-	43	VC	-	-
45	.	.	O	O	-	43	P	-	-

1	Collectively	Collectively	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	results	results	I-NP	I-NP	-	5	SUB	-	-
5	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	HOCl	HOCl	B-NP	B-NP	-	8	SUB	-	-
8	should	should	B-VP	B-VP	-	6	SBAR	-	-
9	be	be	I-VP	I-VP	-	8	VC	-	-
10	considered	considered	I-VP	I-VP	-	9	VC	-	-
11	as	as	B-PP	B-PP	-	10	VMOD	-	-
12	an	an	B-NP	B-NP	-	14	NMOD	-	-
13	oxidative	oxidative	I-NP	I-NP	-	14	NMOD	-	-
14	species	species	I-NP	I-NP	-	11	PMOD	-	-
15	capable	capable	B-ADJP	B-ADJP	-	14	NMOD	-	-
16	of	of	B-PP	B-PP	-	15	AMOD	-	-
17	inducing	inducing	B-VP	B-VP	-	16	PMOD	-	-
18	NF-kappaB	NF-kappaB	B-NP	B-NP	-	17	OBJ	-	-
19	in	in	B-PP	B-PP	-	17	VMOD	-	-
20	a	a	B-NP	B-NP	-	23	NMOD	-	-
21	T-lymphocytic	T-lymphocytic	I-NP	I-NP	-	23	NMOD	-	-
22	cell	cell	I-NP	I-NP	-	23	NMOD	-	-
23	line	line	I-NP	I-NP	-	19	PMOD	-	-
24	through	through	B-PP	B-PP	-	17	VMOD	-	-
25	a	a	B-NP	B-NP	-	27	NMOD	-	-
26	transduction	transduction	I-NP	I-NP	-	27	NMOD	-	-
27	mechanism	mechanism	I-NP	I-NP	-	24	PMOD	-	-
28	involving	involving	B-VP	B-VP	-	27	NMOD	-	-
29	ROS	ROS	B-NP	B-NP	-	28	OBJ	-	-
30	,	,	O	O	-	14	P	-	-
31	and	and	O	O	-	14	NMOD	-	-
32	having	having	B-VP	B-VP	-	14	NMOD	-	-
33	a	a	B-NP	B-NP	-	35	NMOD	-	-
34	long-distance	long-distance	I-NP	I-NP	-	35	NMOD	-	-
35	effect	effect	I-NP	I-NP	-	32	OBJ	-	-
36	through	through	B-PP	B-PP	-	32	VMOD	-	-
37	subsequent	subsequent	B-NP	B-NP	-	39	NMOD	-	-
38	TNF-alpha	TNF-alpha	I-NP	I-NP	-	39	NMOD	-	-
39	release	release	I-NP	I-NP	-	36	PMOD	-	-
40	.	.	O	O	-	5	P	-	-

1	Thymocytes	Thymocytes	B-NP	B-NP	-	2	SUB	-	-
2	control	control	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	CD4	CD4	I-NP	I-NP	-	5	NMOD	-	-
5	gene	gene	I-NP	I-NP	-	2	OBJ	-	-
6	differently	differently	B-ADVP	B-ADVP	-	2	VMOD	-	-
7	from	from	B-PP	B-PP	-	6	AMOD	-	-
8	mature	mature	B-NP	B-NP	-	10	NMOD	-	-
9	T	T	I-NP	I-NP	-	10	NMOD	-	-
10	lymphocytes	lymphocytes	I-NP	I-NP	-	7	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	analyzed	analyzed	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	activity	activity	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	enhancer	enhancer	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	2	P	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	promoter	promoter	I-NP	I-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	silencer	silencer	I-NP	I-NP	-	2	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	human	human	I-NP	I-NP	-	18	NMOD	-	-
17	CD4	CD4	I-NP	I-NP	-	18	NMOD	-	-
18	gene	gene	I-NP	I-NP	-	14	PMOD	-	-
19	during	during	B-PP	B-PP	-	13	NMOD	-	-
20	T	T	B-NP	B-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	development	development	I-NP	I-NP	-	19	PMOD	-	-
23	using	using	B-VP	B-VP	-	22	NMOD	-	-
24	transgenic	transgenic	B-NP	B-NP	-	25	NMOD	-	-
25	mice	mice	I-NP	I-NP	-	23	OBJ	-	-
26	.	.	O	O	-	2	P	-	-

1	Immunofluorescence	Immunofluorescence	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	18	SUB	-	-
3	on	on	B-PP	B-PP	-	2	NMOD	-	-
4	thymic	thymic	B-NP	B-NP	-	5	NMOD	-	-
5	populations	populations	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	mice	mice	B-NP	B-NP	-	6	PMOD	-	-
8	carrying	carrying	B-VP	B-VP	-	7	NMOD	-	-
9	transgenes	transgenes	B-NP	B-NP	-	8	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	various	various	B-NP	B-NP	-	12	NMOD	-	-
12	combinations	combinations	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	these	these	B-NP	B-NP	-	17	NMOD	-	-
15	regulatory	regulatory	I-NP	I-NP	-	17	NMOD	-	-
16	DNA	DNA	I-NP	I-NP	-	17	NMOD	-	-
17	elements	elements	I-NP	I-NP	-	13	PMOD	-	-
18	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
19	that	that	B-SBAR	B-SBAR	-	18	VMOD	-	-
20	thymocytes	thymocytes	B-NP	B-NP	-	21	SUB	-	-
21	control	control	B-VP	B-VP	-	19	SBAR	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	CD4	CD4	I-NP	I-NP	-	24	NMOD	-	-
24	gene	gene	I-NP	I-NP	-	21	OBJ	-	-
25	in	in	B-PP	B-PP	-	21	VMOD	-	-
26	a	a	B-NP	B-NP	-	28	NMOD	-	-
27	different	different	I-NP	I-NP	-	28	NMOD	-	-
28	manner	manner	I-NP	I-NP	-	25	PMOD	-	-
29	than	than	B-PP	B-PP	-	21	VMOD	-	-
30	mature	mature	B-NP	B-NP	-	33	NMOD	-	-
31	peripheral	peripheral	I-NP	I-NP	-	33	NMOD	-	-
32	T	T	I-NP	I-NP	-	33	NMOD	-	-
33	lymphocytes	lymphocytes	I-NP	I-NP	-	29	PMOD	-	-
34	.	.	O	O	-	18	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	5'-positive	5'-positive	I-NP	I-NP	-	4	NMOD	-	-
3	regulatory	regulatory	I-NP	I-NP	-	4	NMOD	-	-
4	unit	unit	I-NP	I-NP	-	16	SUB	-	-
5	,	,	O	O	-	4	P	-	-
6	consisting	consisting	B-VP	B-VP	-	4	NMOD	-	-
7	of	of	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	14	NMOD	-	-
10	and	and	O	O	-	14	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	<num>	<num>	I-NP	I-NP	-	14	NMOD	-	-
13	'	'	I-NP	I-NP	-	14	NMOD	-	-
14	enhancer	enhancer	I-NP	I-NP	-	7	PMOD	-	-
15	,	,	O	O	-	4	P	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	already	already	B-ADVP	B-ADVP	-	16	VMOD	-	-
18	active	active	B-ADJP	B-ADJP	-	16	PRD	-	-
19	at	at	B-PP	B-PP	-	18	AMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	CD4-CD8-double-negative	CD4-CD8-double-negative	I-NP	I-NP	-	25	NMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	DN	DN	B-ADJP	B-ADJP	-	21	AMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	stage	stage	B-NP	B-NP	-	19	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	development	development	B-NP	B-NP	-	26	PMOD	-	-
28	.	.	O	O	-	16	P	-	-

1	However	However	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	its	its	B-NP	B-NP	-	4	NMOD	-	-
4	activity	activity	I-NP	I-NP	-	5	SUB	-	-
5	becomes	becomes	B-VP	B-VP	-	0	ROOT	-	-
6	lower	lower	B-ADJP	B-ADJP	-	5	VMOD	-	-
7	in	in	B-PP	B-PP	-	6	AMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	double-positive	double-positive	I-NP	I-NP	-	7	PMOD	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	fraction	fraction	I-NP	I-NP	-	7	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	CD4+	CD4+	I-NP	I-NP	-	18	NMOD	-	-
16	CD8int/-	CD8int/-	I-NP	I-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	population	population	I-NP	I-NP	-	13	PMOD	-	-
19	,	,	O	O	-	5	P	-	-
20	indicating	indicating	B-VP	B-VP	-	5	VMOD	-	-
21	that	that	B-SBAR	B-SBAR	-	20	VMOD	-	-
22	an	an	B-NP	B-NP	-	24	NMOD	-	-
23	additional	additional	I-NP	I-NP	-	24	NMOD	-	-
24	enhancer	enhancer	I-NP	I-NP	-	34	NMOD	-	-
25	,	,	O	O	-	24	P	-	-
26	located	located	B-ADJP	B-ADJP	-	24	NMOD	-	-
27	in	in	B-PP	B-PP	-	26	AMOD	-	-
28	either	either	O	O	-	34	NMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	first	first	I-NP	I-NP	-	34	NMOD	-	-
31	or	or	O	O	-	34	NMOD	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	third	third	I-NP	I-NP	-	34	NMOD	-	-
34	intron	intron	I-NP	I-NP	-	40	SUB	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	the	the	B-NP	B-NP	-	38	NMOD	-	-
37	CD4	CD4	I-NP	I-NP	-	38	NMOD	-	-
38	gene	gene	I-NP	I-NP	-	35	PMOD	-	-
39	,	,	O	O	-	34	P	-	-
40	is	is	B-VP	B-VP	-	21	SBAR	-	-
41	required	required	I-VP	I-VP	-	40	VC	-	-
42	for	for	B-PP	B-PP	-	41	VMOD	-	-
43	CD4	CD4	B-NP	B-NP	-	45	NMOD	-	-
44	gene	gene	I-NP	I-NP	-	45	NMOD	-	-
45	expression	expression	I-NP	I-NP	-	42	PMOD	-	-
46	in	in	B-PP	B-PP	-	45	NMOD	-	-
47	this	this	B-NP	B-NP	-	48	NMOD	-	-
48	population	population	I-NP	I-NP	-	46	PMOD	-	-
49	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	other	other	I-NP	I-NP	-	5	NMOD	-	-
3	studied	studied	I-NP	I-NP	-	5	NMOD	-	-
4	regulatory	regulatory	I-NP	I-NP	-	5	NMOD	-	-
5	element	element	I-NP	I-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	minimal	minimal	I-NP	I-NP	-	10	NMOD	-	-
9	CD4	CD4	I-NP	I-NP	-	10	NMOD	-	-
10	silencer	silencer	I-NP	I-NP	-	6	PRD	-	-
11	which	which	B-NP	B-NP	-	10	NMOD	-	-
12	inhibits	inhibits	B-VP	B-VP	-	11	SBAR	-	-
13	CD4	CD4	B-NP	B-NP	-	15	NMOD	-	-
14	gene	gene	I-NP	I-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	12	OBJ	-	-
16	in	in	B-PP	B-PP	-	15	NMOD	-	-
17	peripheral	peripheral	B-NP	B-NP	-	20	NMOD	-	-
18	CD8	CD8	I-NP	I-NP	-	20	NMOD	-	-
19	T	T	I-NP	I-NP	-	20	NMOD	-	-
20	lymphocytes	lymphocytes	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	silencer	silencer	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	inactive	inactive	B-ADJP	B-ADJP	-	3	PRD	-	-
5	in	in	B-PP	B-PP	-	4	AMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	most	most	I-NP	I-NP	-	10	NMOD	-	-
8	immature	immature	I-NP	I-NP	-	10	NMOD	-	-
9	DN	DN	I-NP	I-NP	-	10	NMOD	-	-
10	thymocytes	thymocytes	I-NP	I-NP	-	5	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	which	which	B-NP	B-NP	-	10	NMOD	-	-
13	probably	probably	B-ADVP	B-ADVP	-	14	VMOD	-	-
14	use	use	B-VP	B-VP	-	12	SBAR	-	-
15	a	a	B-NP	B-NP	-	18	NMOD	-	-
16	distinct	distinct	I-NP	I-NP	-	18	NMOD	-	-
17	silencer	silencer	I-NP	I-NP	-	18	NMOD	-	-
18	mechanism	mechanism	I-NP	I-NP	-	20	SUB	-	-
19	to	to	B-VP	B-VP	-	20	VMOD	-	-
20	down-regulate	down-regulate	I-VP	I-VP	-	14	VMOD	-	-
21	CD4	CD4	B-NP	B-NP	-	23	NMOD	-	-
22	gene	gene	I-NP	I-NP	-	23	NMOD	-	-
23	expression	expression	I-NP	I-NP	-	20	OBJ	-	-
24	.	.	O	O	-	3	P	-	-

1	Unexpectedly	Unexpectedly	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	CD4	CD4	I-NP	I-NP	-	5	NMOD	-	-
5	silencer	silencer	I-NP	I-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	also	also	B-ADVP	B-ADVP	-	6	VMOD	-	-
8	active	active	B-ADJP	B-ADJP	-	6	PRD	-	-
9	in	in	B-PP	B-PP	-	8	AMOD	-	-
10	CD4+	CD4+	B-NP	B-NP	-	12	NMOD	-	-
11	CD8int/-	CD8int/-	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	thymus	thymus	I-NP	I-NP	-	13	PMOD	-	-
16	,	,	O	O	-	6	P	-	-
17	implying	implying	B-VP	B-VP	-	6	VMOD	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	an	an	B-NP	B-NP	-	20	NMOD	-	-
20	anti-silencer	anti-silencer	I-NP	I-NP	-	21	SUB	-	-
21	may	may	B-VP	B-VP	-	18	SBAR	-	-
22	be	be	I-VP	I-VP	-	21	VC	-	-
23	required	required	I-VP	I-VP	-	22	VC	-	-
24	to	to	I-VP	I-VP	-	25	VMOD	-	-
25	resume	resume	I-VP	I-VP	-	23	VMOD	-	-
26	CD4	CD4	B-NP	B-NP	-	27	NMOD	-	-
27	expression	expression	I-NP	I-NP	-	25	OBJ	-	-
28	in	in	B-PP	B-PP	-	27	NMOD	-	-
29	this	this	B-NP	B-NP	-	31	NMOD	-	-
30	cell	cell	I-NP	I-NP	-	31	NMOD	-	-
31	population	population	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	6	P	-	-

1	Altogether	Altogether	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	CD4	CD4	I-NP	I-NP	-	5	NMOD	-	-
5	gene	gene	I-NP	I-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	regulated	regulated	I-VP	I-VP	-	6	VC	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	several	several	B-NP	B-NP	-	14	NMOD	-	-
10	positive	positive	I-NP	I-NP	-	14	NMOD	-	-
11	and	and	I-NP	I-NP	-	14	NMOD	-	-
12	negative	negative	I-NP	I-NP	-	14	NMOD	-	-
13	regulatory	regulatory	I-NP	I-NP	-	14	NMOD	-	-
14	mechanisms	mechanisms	I-NP	I-NP	-	8	PMOD	-	-
15	which	which	B-NP	B-NP	-	14	NMOD	-	-
16	come	come	B-VP	B-VP	-	15	SBAR	-	-
17	into	into	B-PP	B-PP	-	16	VMOD	-	-
18	play	play	B-NP	B-NP	-	17	PMOD	-	-
19	in	in	B-PP	B-PP	-	18	NMOD	-	-
20	a	a	B-NP	B-NP	-	23	NMOD	-	-
21	developmentally	developmentally	I-NP	I-NP	-	22	AMOD	-	-
22	coordinated	coordinated	I-NP	I-NP	-	23	NMOD	-	-
23	manner	manner	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	6	P	-	-

1	Triggering	Triggering	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	HLA-DR	HLA-DR	B-NP	B-NP	-	4	NMOD	-	-
4	antigens	antigens	I-NP	I-NP	-	2	PMOD	-	-
5	differentially	differentially	B-ADVP	B-ADVP	-	6	VMOD	-	-
6	modulates	modulates	B-VP	B-VP	-	0	ROOT	-	-
7	tumor	tumor	B-NP	B-NP	-	11	NMOD	-	-
8	necrosis	necrosis	I-NP	I-NP	-	11	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	11	NMOD	-	-
10	alpha	alpha	I-NP	I-NP	-	11	NMOD	-	-
11	release	release	I-NP	I-NP	-	6	OBJ	-	-
12	by	by	B-PP	B-PP	-	11	NMOD	-	-
13	B	B	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
15	at	at	B-PP	B-PP	-	11	NMOD	-	-
16	distinct	distinct	B-NP	B-NP	-	17	NMOD	-	-
17	stage	stage	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	maturation	maturation	B-NP	B-NP	-	18	PMOD	-	-
20	.	.	O	O	-	6	P	-	-

1	Triggering	Triggering	B-NP	B-NP	-	24	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	HLA	HLA	B-NP	B-NP	-	6	NMOD	-	-
4	class	class	I-NP	I-NP	-	6	NMOD	-	-
5	II	II	B-NP	B-NP	-	6	NMOD	-	-
6	antigens	antigens	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	anti-HLA-DR	anti-HLA-DR	I-NP	I-NP	-	11	NMOD	-	-
10	monoclonal	monoclonal	I-NP	I-NP	-	11	NMOD	-	-
11	antibody	antibody	I-NP	I-NP	-	7	PMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	mAb	mAb	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	L243	L243	B-NP	B-NP	-	11	NMOD	-	-
16	significantly	significantly	B-ADVP	B-ADVP	-	11	NMOD	-	-
17	(	(	O	O	-	18	P	-	-
18	P	P	B-NP	B-NP	-	11	NMOD	-	-
19	<	<	O	O	-	18	NMOD	-	-
20	<num>	<num>	B-NP	B-NP	-	19	AMOD	-	-
21	)	)	O	O	-	18	P	-	-
22	and	and	O	O	-	11	NMOD	-	-
23	differentially	differentially	B-VP	B-VP	-	24	VMOD	-	-
24	enhanced	enhanced	I-VP	I-VP	-	68	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	release	release	I-NP	I-NP	-	24	OBJ	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	tumor	tumor	B-NP	B-NP	-	31	NMOD	-	-
29	necrosis	necrosis	I-NP	I-NP	-	31	NMOD	-	-
30	factor	factor	I-NP	I-NP	-	31	NMOD	-	-
31	alpha	alpha	I-NP	I-NP	-	27	PMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	TNF-alpha	TNF-alpha	B-NP	B-NP	-	31	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	by	by	B-PP	B-PP	-	26	NMOD	-	-
36	the	the	B-NP	B-NP	-	40	NMOD	-	-
37	non-Hodgkin	non-Hodgkin	I-NP	I-NP	-	40	NMOD	-	-
38	's	's	B-NP	B-NP	-	40	NMOD	-	-
39	lymphoma	lymphoma	I-NP	I-NP	-	40	NMOD	-	-
40	cells	cells	I-NP	I-NP	-	46	NMOD	-	-
41	Ri-I	Ri-I	I-NP	I-NP	-	46	NMOD	-	-
42	,	,	O	O	-	46	P	-	-
43	Ci-I	Ci-I	B-NP	B-NP	-	46	NMOD	-	-
44	,	,	O	O	-	46	P	-	-
45	and	and	O	O	-	46	NMOD	-	-
46	Sc-I	Sc-I	B-NP	B-NP	-	35	PMOD	-	-
47	,	,	O	O	-	46	P	-	-
48	which	which	B-NP	B-NP	-	46	NMOD	-	-
49	are	are	B-VP	B-VP	-	48	SBAR	-	-
50	at	at	B-PP	B-PP	-	49	PRD	-	-
51	a	a	B-NP	B-NP	-	53	NMOD	-	-
52	distinct	distinct	I-NP	I-NP	-	53	NMOD	-	-
53	stage	stage	I-NP	I-NP	-	50	PMOD	-	-
54	of	of	B-PP	B-PP	-	53	NMOD	-	-
55	B-cell	B-cell	B-NP	B-NP	-	56	NMOD	-	-
56	differentiation	differentiation	I-NP	I-NP	-	54	PMOD	-	-
57	,	,	O	O	-	49	P	-	-
58	and	and	O	O	-	49	VMOD	-	-
59	by	by	B-PP	B-PP	-	49	VMOD	-	-
60	the	the	B-NP	B-NP	-	66	NMOD	-	-
61	more	more	I-NP	I-NP	-	62	AMOD	-	-
62	mature	mature	I-NP	I-NP	-	66	NMOD	-	-
63	Burkitt	Burkitt	I-NP	I-NP	-	66	NMOD	-	-
64	lymphoma	lymphoma	I-NP	I-NP	-	66	NMOD	-	-
65	cell	cell	I-NP	I-NP	-	66	NMOD	-	-
66	Raji	Raji	I-NP	I-NP	-	59	PMOD	-	-
67	;	;	O	O	-	24	P	-	-
68	in	in	B-PP	B-PP	-	72	VMOD	-	-
69	contrast	contrast	B-NP	B-NP	-	68	PMOD	-	-
70	,	,	O	O	-	72	P	-	-
71	it	it	B-NP	B-NP	-	72	SUB	-	-
72	did	did	B-VP	B-VP	-	0	ROOT	-	-
73	not	not	I-VP	I-VP	-	72	VMOD	-	-
74	induce	induce	I-VP	I-VP	-	72	VC	-	-
75	TNF-alpha	TNF-alpha	B-NP	B-NP	-	76	NMOD	-	-
76	release	release	I-NP	I-NP	-	74	OBJ	-	-
77	by	by	B-PP	B-PP	-	74	VMOD	-	-
78	the	the	B-NP	B-NP	-	81	NMOD	-	-
79	pre-B	pre-B	I-NP	I-NP	-	81	NMOD	-	-
80	leukemia	leukemia	I-NP	I-NP	-	81	NMOD	-	-
81	cells	cells	I-NP	I-NP	-	77	PMOD	-	-
82	Nalm-6	Nalm-6	I-NP	I-NP	-	84	NMOD	-	-
83	and	and	I-NP	I-NP	-	84	NMOD	-	-
84	BV173	BV173	I-NP	I-NP	-	81	NMOD	-	-
85	.	.	O	O	-	72	P	-	-

1	TNF-alpha	TNF-alpha	B-NP	B-NP	-	2	NMOD	-	-
2	release	release	I-NP	I-NP	-	3	SUB	-	-
3	peaked	peaked	B-VP	B-VP	-	0	ROOT	-	-
4	at	at	B-PP	B-PP	-	3	VMOD	-	-
5	<num>	<num>	B-NP	B-NP	-	6	NMOD	-	-
6	h	h	I-NP	I-NP	-	4	PMOD	-	-
7	and	and	O	O	-	3	VMOD	-	-
8	decreased	decreased	B-VP	B-VP	-	3	VMOD	-	-
9	thereafter	thereafter	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	,	,	O	O	-	13	P	-	-
11	and	and	O	O	-	13	VMOD	-	-
12	it	it	B-NP	B-NP	-	13	SUB	-	-
13	was	was	B-VP	B-VP	-	8	VMOD	-	-
14	dose	dose	B-ADJP	B-ADJP	-	13	PRD	-	-
15	dependent	dependent	I-ADJP	I-ADJP	-	14	AMOD	-	-
16	and	and	O	O	-	3	VMOD	-	-
17	preceded	preceded	B-VP	B-VP	-	3	VMOD	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	an	an	B-NP	B-NP	-	20	NMOD	-	-
20	increase	increase	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	TNF-alpha	TNF-alpha	B-NP	B-NP	-	23	NMOD	-	-
23	mRNA	mRNA	I-NP	I-NP	-	21	PMOD	-	-
24	detectable	detectable	B-ADJP	B-ADJP	-	20	NMOD	-	-
25	after	after	B-PP	B-PP	-	24	AMOD	-	-
26	<num>	<num>	B-NP	B-NP	-	27	NMOD	-	-
27	h	h	I-NP	I-NP	-	25	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	stimulation	stimulation	B-NP	B-NP	-	28	PMOD	-	-
30	with	with	B-PP	B-PP	-	29	NMOD	-	-
31	mAb	mAb	B-NP	B-NP	-	32	NMOD	-	-
32	L243	L243	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	3	P	-	-

1	Secreted	Secreted	B-NP	B-NP	-	2	NMOD	-	-
2	TNF-alpha	TNF-alpha	I-NP	I-NP	-	3	SUB	-	-
3	mediated	mediated	B-VP	B-VP	-	39	VMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	enhancement	enhancement	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	nuclear	nuclear	B-NP	B-NP	-	10	NMOD	-	-
8	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
9	kappa	kappa	I-NP	I-NP	-	10	NMOD	-	-
10	B	B	I-NP	I-NP	-	17	NMOD	-	-
11	(	(	O	O	-	13	P	-	-
12	NF-kappa	NF-kappa	B-NP	B-NP	-	13	NMOD	-	-
13	B	B	I-NP	I-NP	-	10	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	and	and	O	O	-	17	NMOD	-	-
16	activator	activator	B-NP	B-NP	-	17	NMOD	-	-
17	protein-1	protein-1	I-NP	I-NP	-	22	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	AP-1	AP-1	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	binding	binding	B-NP	B-NP	-	22	NMOD	-	-
22	activity	activity	I-NP	I-NP	-	6	PMOD	-	-
23	;	;	O	O	-	3	P	-	-
24	in	in	B-PP	B-PP	-	39	VMOD	-	-
25	fact	fact	B-NP	B-NP	-	24	PMOD	-	-
26	,	,	O	O	-	39	P	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	triggering	triggering	I-NP	I-NP	-	39	SUB	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	HLA-DR	HLA-DR	B-NP	B-NP	-	31	NMOD	-	-
31	antigens	antigens	I-NP	I-NP	-	29	PMOD	-	-
32	in	in	B-PP	B-PP	-	28	NMOD	-	-
33	the	the	B-NP	B-NP	-	34	NMOD	-	-
34	presence	presence	I-NP	I-NP	-	32	PMOD	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	antihuman	antihuman	B-NP	B-NP	-	38	NMOD	-	-
37	TNF-alpha-neutralizing	TNF-alpha-neutralizing	I-NP	I-NP	-	38	NMOD	-	-
38	antibodies	antibodies	I-NP	I-NP	-	35	PMOD	-	-
39	did	did	B-VP	B-VP	-	0	ROOT	-	-
40	not	not	I-VP	I-VP	-	39	VMOD	-	-
41	upregulate	upregulate	I-VP	I-VP	-	39	VC	-	-
42	NF-kappa	NF-kappa	B-NP	B-NP	-	43	NMOD	-	-
43	B	B	I-NP	I-NP	-	45	NMOD	-	-
44	and	and	O	O	-	45	NMOD	-	-
45	AP-1	AP-1	B-NP	B-NP	-	41	OBJ	-	-
46	.	.	O	O	-	39	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	released	released	B-NP	B-NP	-	5	NMOD	-	-
5	TNF-alpha	TNF-alpha	I-NP	I-NP	-	6	SUB	-	-
6	was	was	B-VP	B-VP	-	30	VMOD	-	-
7	not	not	O	O	-	6	VMOD	-	-
8	responsible	responsible	B-ADJP	B-ADJP	-	6	PRD	-	-
9	for	for	B-PP	B-PP	-	8	AMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	homotypic	homotypic	I-NP	I-NP	-	12	NMOD	-	-
12	aggregation	aggregation	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	Ri-I	Ri-I	B-NP	B-NP	-	22	NMOD	-	-
15	,	,	O	O	-	22	P	-	-
16	Ci-I	Ci-I	B-NP	B-NP	-	22	NMOD	-	-
17	,	,	O	O	-	22	P	-	-
18	Sc-I	Sc-I	B-NP	B-NP	-	22	NMOD	-	-
19	,	,	O	O	-	22	P	-	-
20	and	and	O	O	-	22	NMOD	-	-
21	Raji	Raji	B-NP	B-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
23	induced	induced	B-VP	B-VP	-	22	NMOD	-	-
24	by	by	B-PP	B-PP	-	23	VMOD	-	-
25	mAb	mAb	B-NP	B-NP	-	26	NMOD	-	-
26	L243	L243	I-NP	I-NP	-	24	PMOD	-	-
27	,	,	O	O	-	30	P	-	-
28	and	and	O	O	-	30	VMOD	-	-
29	it	it	B-NP	B-NP	-	30	SUB	-	-
30	did	did	B-VP	B-VP	-	0	ROOT	-	-
31	not	not	I-VP	I-VP	-	30	VMOD	-	-
32	affect	affect	I-VP	I-VP	-	30	VC	-	-
33	the	the	B-NP	B-NP	-	34	NMOD	-	-
34	proliferation	proliferation	I-NP	I-NP	-	32	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	B	B	B-NP	B-NP	-	37	NMOD	-	-
37	cells	cells	I-NP	I-NP	-	35	PMOD	-	-
38	investigated	investigated	B-VP	B-VP	-	37	NMOD	-	-
39	.	.	O	O	-	30	P	-	-

1	Altogether	Altogether	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	our	our	B-NP	B-NP	-	4	NMOD	-	-
4	data	data	I-NP	I-NP	-	5	SUB	-	-
5	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	:	:	O	O	-	6	P	-	-
8	(	(	B-LST	B-LST	-	9	P	-	-
9	a	a	I-LST	I-LST	-	12	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	ability	ability	I-NP	I-NP	-	24	SUB	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	B	B	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	to	to	B-VP	B-VP	-	17	VMOD	-	-
17	release	release	I-VP	I-VP	-	12	NMOD	-	-
18	TNF-alpha	TNF-alpha	B-NP	B-NP	-	17	OBJ	-	-
19	after	after	B-PP	B-PP	-	17	VMOD	-	-
20	triggering	triggering	B-NP	B-NP	-	19	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	HLA-DR	HLA-DR	B-NP	B-NP	-	23	NMOD	-	-
23	antigens	antigens	I-NP	I-NP	-	21	PMOD	-	-
24	depends	depends	B-VP	B-VP	-	92	VMOD	-	-
25	on	on	B-PP	B-PP	-	24	VMOD	-	-
26	their	their	B-NP	B-NP	-	27	NMOD	-	-
27	stage	stage	I-NP	I-NP	-	25	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	differentiation	differentiation	B-NP	B-NP	-	28	PMOD	-	-
30	;	;	O	O	-	38	P	-	-
31	(	(	B-LST	B-LST	-	32	P	-	-
32	b	b	I-LST	I-LST	-	34	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	levels	levels	B-NP	B-NP	-	38	SUB	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	released	released	B-NP	B-NP	-	37	NMOD	-	-
37	TNF-alpha	TNF-alpha	I-NP	I-NP	-	35	PMOD	-	-
38	seem	seem	B-VP	B-VP	-	65	VMOD	-	-
39	to	to	I-VP	I-VP	-	40	VMOD	-	-
40	correlate	correlate	I-VP	I-VP	-	38	VMOD	-	-
41	with	with	B-PP	B-PP	-	40	VMOD	-	-
42	the	the	B-NP	B-NP	-	43	NMOD	-	-
43	stage	stage	I-NP	I-NP	-	41	PMOD	-	-
44	of	of	B-PP	B-PP	-	43	NMOD	-	-
45	B-cell	B-cell	B-NP	B-NP	-	46	NMOD	-	-
46	maturation	maturation	I-NP	I-NP	-	44	PMOD	-	-
47	but	but	O	O	-	38	VMOD	-	-
48	do	do	B-VP	B-VP	-	38	VMOD	-	-
49	not	not	I-VP	I-VP	-	48	VMOD	-	-
50	correlate	correlate	I-VP	I-VP	-	48	VC	-	-
51	with	with	B-PP	B-PP	-	50	VMOD	-	-
52	the	the	B-NP	B-NP	-	53	NMOD	-	-
53	amounts	amounts	I-NP	I-NP	-	51	PMOD	-	-
54	of	of	B-PP	B-PP	-	53	NMOD	-	-
55	cell	cell	B-NP	B-NP	-	58	NMOD	-	-
56	surface	surface	I-NP	I-NP	-	58	NMOD	-	-
57	HLA-DR	HLA-DR	I-NP	I-NP	-	58	NMOD	-	-
58	antigens	antigens	I-NP	I-NP	-	54	PMOD	-	-
59	;	;	O	O	-	65	P	-	-
60	(	(	B-LST	B-LST	-	61	P	-	-
61	c	c	I-LST	I-LST	-	65	VMOD	-	-
62	)	)	O	O	-	61	P	-	-
63	secreted	secreted	B-NP	B-NP	-	64	NMOD	-	-
64	TNF-alpha	TNF-alpha	I-NP	I-NP	-	65	SUB	-	-
65	regulates	regulates	B-VP	B-VP	-	92	VMOD	-	-
66	the	the	B-NP	B-NP	-	67	NMOD	-	-
67	levels	levels	I-NP	I-NP	-	65	OBJ	-	-
68	of	of	B-PP	B-PP	-	67	NMOD	-	-
69	expression	expression	B-NP	B-NP	-	68	PMOD	-	-
70	of	of	B-PP	B-PP	-	69	NMOD	-	-
71	NF-kappa	NF-kappa	B-NP	B-NP	-	72	NMOD	-	-
72	B	B	I-NP	I-NP	-	74	NMOD	-	-
73	and	and	O	O	-	74	NMOD	-	-
74	AP-1	AP-1	B-NP	B-NP	-	68	PMOD	-	-
75	by	by	B-PP	B-PP	-	65	VMOD	-	-
76	an	an	B-NP	B-NP	-	78	NMOD	-	-
77	autocrine	autocrine	I-NP	I-NP	-	78	NMOD	-	-
78	loop	loop	I-NP	I-NP	-	75	PMOD	-	-
79	;	;	O	O	-	92	P	-	-
80	and	and	O	O	-	92	VMOD	-	-
81	(	(	B-LST	B-LST	-	82	P	-	-
82	d	d	I-LST	I-LST	-	92	VMOD	-	-
83	)	)	O	O	-	82	P	-	-
84	intracellular	intracellular	B-NP	B-NP	-	85	NMOD	-	-
85	signals	signals	I-NP	I-NP	-	92	SUB	-	-
86	mediating	mediating	B-VP	B-VP	-	85	NMOD	-	-
87	TNF-alpha	TNF-alpha	B-NP	B-NP	-	88	NMOD	-	-
88	release	release	I-NP	I-NP	-	86	OBJ	-	-
89	by	by	B-PP	B-PP	-	88	NMOD	-	-
90	B	B	B-NP	B-NP	-	91	NMOD	-	-
91	cells	cells	I-NP	I-NP	-	89	PMOD	-	-
92	are	are	B-VP	B-VP	-	101	VMOD	-	-
93	distinct	distinct	B-ADJP	B-ADJP	-	92	PRD	-	-
94	from	from	B-PP	B-PP	-	93	AMOD	-	-
95	those	those	B-NP	B-NP	-	100	NMOD	-	-
96	regulating	regulating	I-NP	I-NP	-	95	NMOD	-	-
97	homotypic	homotypic	I-NP	I-NP	-	98	NMOD	-	-
98	aggregation	aggregation	I-NP	I-NP	-	100	NMOD	-	-
99	and	and	I-NP	I-NP	-	100	NMOD	-	-
100	proliferation	proliferation	I-NP	I-NP	-	94	PMOD	-	-
101	.	.	O	O	-	5	P	-	-

1	Cytomegalovirus	Cytomegalovirus	B-NP	B-NP	-	4	NMOD	-	-
2	immediate	immediate	I-NP	I-NP	-	4	NMOD	-	-
3	early	early	I-NP	I-NP	-	4	NMOD	-	-
4	genes	genes	I-NP	I-NP	-	5	SUB	-	-
5	upregulate	upregulate	B-VP	B-VP	-	0	ROOT	-	-
6	interleukin-6	interleukin-6	B-NP	B-NP	-	8	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	5	OBJ	-	-
9	.	.	O	O	-	5	P	-	-

1	BACKGROUND	BACKGROUND	B-NP	B-NP	-	6	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	The	The	B-NP	B-NP	-	6	NMOD	-	-
4	immediate	immediate	I-NP	I-NP	-	6	NMOD	-	-
5	early	early	I-NP	I-NP	-	6	NMOD	-	-
6	genes	genes	I-NP	I-NP	-	16	SUB	-	-
7	(	(	O	O	-	8	P	-	-
8	IE	IE	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	of	of	B-PP	B-PP	-	6	NMOD	-	-
11	human	human	B-NP	B-NP	-	12	NMOD	-	-
12	cytomegalovirus	cytomegalovirus	I-NP	I-NP	-	10	PMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	CMV	CMV	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	can	can	B-VP	B-VP	-	0	ROOT	-	-
17	be	be	I-VP	I-VP	-	16	VC	-	-
18	expressed	expressed	I-VP	I-VP	-	17	VC	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	monocytic	monocytic	B-NP	B-NP	-	21	NMOD	-	-
21	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
22	and	and	O	O	-	17	VMOD	-	-
23	are	are	B-VP	B-VP	-	16	VMOD	-	-
24	known	known	I-VP	I-VP	-	23	VC	-	-
25	to	to	I-VP	I-VP	-	26	VMOD	-	-
26	regulate	regulate	I-VP	I-VP	-	24	VMOD	-	-
27	viral	viral	B-NP	B-NP	-	30	NMOD	-	-
28	and	and	I-NP	I-NP	-	30	NMOD	-	-
29	cellular	cellular	I-NP	I-NP	-	30	NMOD	-	-
30	genes	genes	I-NP	I-NP	-	26	OBJ	-	-
31	.	.	O	O	-	16	P	-	-

1	Interleukin-6	Interleukin-6	B-NP	B-NP	-	5	SUB	-	-
2	(	(	O	O	-	3	P	-	-
3	IL-6	IL-6	B-NP	B-NP	-	1	NMOD	-	-
4	)	)	O	O	-	3	P	-	-
5	plays	plays	B-VP	B-VP	-	0	ROOT	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	central	central	I-NP	I-NP	-	8	NMOD	-	-
8	role	role	I-NP	I-NP	-	5	OBJ	-	-
9	in	in	B-PP	B-PP	-	5	VMOD	-	-
10	numerous	numerous	B-NP	B-NP	-	14	NMOD	-	-
11	inflammatory	inflammatory	I-NP	I-NP	-	14	NMOD	-	-
12	and	and	I-NP	I-NP	-	14	NMOD	-	-
13	immune	immune	I-NP	I-NP	-	14	NMOD	-	-
14	processes	processes	I-NP	I-NP	-	9	PMOD	-	-
15	.	.	O	O	-	5	P	-	-

1	Interleukin-6	Interleukin-6	B-NP	B-NP	-	2	NMOD	-	-
2	levels	levels	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	increased	increased	I-VP	I-VP	-	3	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	lung	lung	B-NP	B-NP	-	8	NMOD	-	-
7	transplant	transplant	I-NP	I-NP	-	8	NMOD	-	-
8	patients	patients	I-NP	I-NP	-	5	PMOD	-	-
9	clinically	clinically	B-VP	B-VP	-	10	VMOD	-	-
10	diagnosed	diagnosed	I-VP	I-VP	-	8	NMOD	-	-
11	with	with	B-PP	B-PP	-	10	VMOD	-	-
12	CMV	CMV	B-NP	B-NP	-	13	NMOD	-	-
13	pneumonitis	pneumonitis	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	IL-6	IL-6	B-NP	B-NP	-	3	PMOD	-	-
5	is	is	B-VP	B-VP	-	0	ROOT	-	-
6	dependent	dependent	B-ADJP	B-ADJP	-	5	PRD	-	-
7	on	on	B-PP	B-PP	-	6	AMOD	-	-
8	various	various	B-NP	B-NP	-	9	NMOD	-	-
9	stimuli	stimuli	I-NP	I-NP	-	7	PMOD	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	include	include	B-VP	B-VP	-	10	SBAR	-	-
12	lipopolysaccharide	lipopolysaccharide	B-NP	B-NP	-	21	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	LPS	LPS	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	,	,	O	O	-	21	P	-	-
17	viruses	viruses	B-NP	B-NP	-	21	NMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	and	and	O	O	-	21	NMOD	-	-
20	other	other	B-NP	B-NP	-	21	NMOD	-	-
21	cytokines	cytokines	I-NP	I-NP	-	11	OBJ	-	-
22	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	ability	ability	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	CMV	CMV	B-NP	B-NP	-	10	NMOD	-	-
8	IE	IE	I-NP	I-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	products	products	I-NP	I-NP	-	6	PMOD	-	-
11	to	to	B-VP	B-VP	-	12	VMOD	-	-
12	modulate	modulate	I-VP	I-VP	-	5	NMOD	-	-
13	IL-6	IL-6	B-NP	B-NP	-	14	NMOD	-	-
14	production	production	I-NP	I-NP	-	12	OBJ	-	-
15	.	.	O	O	-	3	P	-	-

1	METHODS	METHODS	B-NP	B-NP	-	4	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	THP-1	THP-1	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	9	NMOD	-	-
5	,	,	O	O	-	9	P	-	-
6	a	a	B-NP	B-NP	-	9	NMOD	-	-
7	monocytic	monocytic	I-NP	I-NP	-	9	NMOD	-	-
8	cell	cell	I-NP	I-NP	-	9	NMOD	-	-
9	line	line	I-NP	I-NP	-	11	SUB	-	-
10	,	,	O	O	-	9	P	-	-
11	were	were	B-VP	B-VP	-	0	ROOT	-	-
12	transfected	transfected	I-VP	I-VP	-	11	VC	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	17	NMOD	-	-
15	CMV	CMV	I-NP	I-NP	-	17	NMOD	-	-
16	IE	IE	I-NP	I-NP	-	17	NMOD	-	-
17	genes	genes	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	11	P	-	-

1	Interleukin-6	Interleukin-6	B-NP	B-NP	-	2	NMOD	-	-
2	protein	protein	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	O	O	-	5	NMOD	-	-
4	IL-6	IL-6	B-NP	B-NP	-	5	NMOD	-	-
5	mRNA	mRNA	I-NP	I-NP	-	6	SUB	-	-
6	were	were	B-VP	B-VP	-	0	ROOT	-	-
7	measured	measured	I-VP	I-VP	-	6	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	control	control	B-NP	B-NP	-	15	NMOD	-	-
10	and	and	O	O	-	15	NMOD	-	-
11	CMV	CMV	B-NP	B-NP	-	15	NMOD	-	-
12	immediate	immediate	I-NP	I-NP	-	15	NMOD	-	-
13	early	early	I-NP	I-NP	-	15	NMOD	-	-
14	transfected	transfected	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
16	.	.	O	O	-	6	P	-	-

1	Cotransfection	Cotransfection	B-NP	B-NP	-	18	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	CMV	CMV	B-NP	B-NP	-	5	NMOD	-	-
4	IE	IE	I-NP	I-NP	-	5	NMOD	-	-
5	genes	genes	I-NP	I-NP	-	2	PMOD	-	-
6	and	and	O	O	-	17	NMOD	-	-
7	IL-6	IL-6	B-NP	B-NP	-	8	NMOD	-	-
8	chloramphenicol	chloramphenicol	I-NP	I-NP	-	17	NMOD	-	-
9	acetyl	acetyl	I-NP	I-NP	-	17	NMOD	-	-
10	transferase	transferase	I-NP	I-NP	-	17	NMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	CAT	CAT	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	or	or	O	O	-	17	NMOD	-	-
15	IL-6	IL-6	B-NP	B-NP	-	17	NMOD	-	-
16	luciferase	luciferase	I-NP	I-NP	-	17	NMOD	-	-
17	constructs	constructs	I-NP	I-NP	-	18	SUB	-	-
18	were	were	B-VP	B-VP	-	0	ROOT	-	-
19	used	used	I-VP	I-VP	-	18	VC	-	-
20	to	to	B-VP	B-VP	-	21	VMOD	-	-
21	study	study	I-VP	I-VP	-	19	VMOD	-	-
22	IL-6	IL-6	B-NP	B-NP	-	24	NMOD	-	-
23	promoter	promoter	I-NP	I-NP	-	24	NMOD	-	-
24	activity	activity	I-NP	I-NP	-	21	OBJ	-	-
25	.	.	O	O	-	18	P	-	-

1	RESULTS	RESULTS	B-NP	B-NP	-	4	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	Interleukin-6	Interleukin-6	B-NP	B-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	7	NMOD	-	-
5	and	and	O	O	-	7	NMOD	-	-
6	mRNA	mRNA	B-NP	B-NP	-	7	NMOD	-	-
7	production	production	I-NP	I-NP	-	8	SUB	-	-
8	were	were	B-VP	B-VP	-	0	ROOT	-	-
9	significantly	significantly	I-VP	I-VP	-	8	VMOD	-	-
10	increased	increased	I-VP	I-VP	-	8	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	cells	cells	B-NP	B-NP	-	11	PMOD	-	-
13	transfected	transfected	B-VP	B-VP	-	12	NMOD	-	-
14	with	with	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	CMV	CMV	I-NP	I-NP	-	18	NMOD	-	-
17	IE	IE	I-NP	I-NP	-	18	NMOD	-	-
18	genes	genes	I-NP	I-NP	-	14	PMOD	-	-
19	and	and	O	O	-	13	VMOD	-	-
20	stimulated	stimulated	B-VP	B-VP	-	10	VMOD	-	-
21	with	with	B-PP	B-PP	-	20	VMOD	-	-
22	LPS	LPS	B-NP	B-NP	-	21	PMOD	-	-
23	compared	compared	B-VP	B-VP	-	22	NMOD	-	-
24	to	to	B-PP	B-PP	-	23	PMOD	-	-
25	LPS-stimulated	LPS-stimulated	B-NP	B-NP	-	27	NMOD	-	-
26	control	control	I-NP	I-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	8	P	-	-

1	Cytomegalovirus	Cytomegalovirus	B-NP	B-NP	-	4	NMOD	-	-
2	IE	IE	I-NP	I-NP	-	4	NMOD	-	-
3	gene	gene	I-NP	I-NP	-	4	NMOD	-	-
4	products	products	I-NP	I-NP	-	6	SUB	-	-
5	significantly	significantly	B-ADVP	B-ADVP	-	6	VMOD	-	-
6	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
7	LPS	LPS	B-NP	B-NP	-	8	NMOD	-	-
8	stimulation	stimulation	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	IL-6	IL-6	B-NP	B-NP	-	12	NMOD	-	-
11	promoter	promoter	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	8	NMOD	-	-
14	both	both	O	O	-	20	NMOD	-	-
15	IL-6	IL-6	B-NP	B-NP	-	16	NMOD	-	-
16	CAT	CAT	I-NP	I-NP	-	20	NMOD	-	-
17	and	and	O	O	-	20	NMOD	-	-
18	IL-6	IL-6	B-NP	B-NP	-	20	NMOD	-	-
19	luciferase	luciferase	I-NP	I-NP	-	20	NMOD	-	-
20	assays	assays	I-NP	I-NP	-	13	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	deletion	deletion	I-NP	I-NP	-	3	NMOD	-	-
3	construct	construct	I-NP	I-NP	-	17	SUB	-	-
4	that	that	B-NP	B-NP	-	3	NMOD	-	-
5	contains	contains	B-VP	B-VP	-	4	SBAR	-	-
6	a	a	B-NP	B-NP	-	9	NMOD	-	-
7	NF-kappa	NF-kappa	I-NP	I-NP	-	9	NMOD	-	-
8	B	B	I-NP	I-NP	-	9	NMOD	-	-
9	site	site	I-NP	I-NP	-	5	OBJ	-	-
10	but	but	O	O	-	5	VMOD	-	-
11	is	is	B-VP	B-VP	-	5	VMOD	-	-
12	missing	missing	I-VP	I-VP	-	11	VC	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	multiple	multiple	I-NP	I-NP	-	16	NMOD	-	-
15	response	response	I-NP	I-NP	-	16	NMOD	-	-
16	region	region	I-NP	I-NP	-	12	OBJ	-	-
17	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
18	a	a	B-NP	B-NP	-	20	NMOD	-	-
19	continued	continued	I-NP	I-NP	-	20	NMOD	-	-
20	increase	increase	I-NP	I-NP	-	17	OBJ	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	IL-6	IL-6	B-NP	B-NP	-	24	NMOD	-	-
23	luciferase	luciferase	I-NP	I-NP	-	24	NMOD	-	-
24	activity	activity	I-NP	I-NP	-	21	PMOD	-	-
25	in	in	B-PP	B-PP	-	24	NMOD	-	-
26	LPS-stimulated	LPS-stimulated	B-NP	B-NP	-	29	NMOD	-	-
27	CMV	CMV	I-NP	I-NP	-	29	NMOD	-	-
28	transfected	transfected	I-NP	I-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
30	.	.	O	O	-	17	P	-	-

1	CONCLUSION	CONCLUSION	B-NP	B-NP	-	7	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	Cytomegalovirus	Cytomegalovirus	B-NP	B-NP	-	7	NMOD	-	-
4	immediate	immediate	I-NP	I-NP	-	7	NMOD	-	-
5	early	early	I-NP	I-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	products	products	I-NP	I-NP	-	9	SUB	-	-
8	significantly	significantly	B-ADVP	B-ADVP	-	9	VMOD	-	-
9	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
10	expression	expression	B-NP	B-NP	-	9	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	IL-6	IL-6	B-NP	B-NP	-	11	PMOD	-	-
13	in	in	B-PP	B-PP	-	10	NMOD	-	-
14	LPS-stimulated	LPS-stimulated	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	9	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	increase	increase	I-NP	I-NP	-	7	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	IL-6	IL-6	B-NP	B-NP	-	6	NMOD	-	-
5	luciferase	luciferase	I-NP	I-NP	-	6	NMOD	-	-
6	activity	activity	I-NP	I-NP	-	3	PMOD	-	-
7	occurs	occurs	B-VP	B-VP	-	0	ROOT	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	absence	absence	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	multiple	multiple	I-NP	I-NP	-	15	NMOD	-	-
14	response	response	I-NP	I-NP	-	15	NMOD	-	-
15	region	region	I-NP	I-NP	-	11	PMOD	-	-
16	,	,	O	O	-	7	P	-	-
17	the	the	B-NP	B-NP	-	18	NMOD	-	-
18	area	area	I-NP	I-NP	-	36	NMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	IL-6	IL-6	I-NP	I-NP	-	22	NMOD	-	-
22	promoter	promoter	I-NP	I-NP	-	19	PMOD	-	-
23	responsive	responsive	B-ADJP	B-ADJP	-	22	NMOD	-	-
24	to	to	B-PP	B-PP	-	23	AMOD	-	-
25	IL-1	IL-1	B-NP	B-NP	-	24	PMOD	-	-
26	,	,	O	O	-	36	P	-	-
27	TNF	TNF	B-NP	B-NP	-	28	NMOD	-	-
28	alpha	alpha	I-NP	I-NP	-	36	NMOD	-	-
29	,	,	O	O	-	36	P	-	-
30	cyclic	cyclic	B-NP	B-NP	-	31	NMOD	-	-
31	amp	amp	I-NP	I-NP	-	36	NMOD	-	-
32	,	,	O	O	-	36	P	-	-
33	and	and	O	O	-	36	NMOD	-	-
34	phorbol	phorbol	B-NP	B-NP	-	36	NMOD	-	-
35	12-myristate	12-myristate	I-NP	I-NP	-	36	NMOD	-	-
36	13-acetate	13-acetate	I-NP	I-NP	-	7	OBJ	-	-
37	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	ability	ability	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	CMV	CMV	B-NP	B-NP	-	7	NMOD	-	-
5	IE	IE	I-NP	I-NP	-	7	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	7	NMOD	-	-
7	products	products	I-NP	I-NP	-	3	PMOD	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	enhance	enhance	I-VP	I-VP	-	2	NMOD	-	-
10	IL-6	IL-6	B-NP	B-NP	-	11	NMOD	-	-
11	production	production	I-NP	I-NP	-	9	OBJ	-	-
12	may	may	B-VP	B-VP	-	0	ROOT	-	-
13	play	play	I-VP	I-VP	-	12	VC	-	-
14	an	an	B-NP	B-NP	-	16	NMOD	-	-
15	important	important	I-NP	I-NP	-	16	NMOD	-	-
16	role	role	I-NP	I-NP	-	13	OBJ	-	-
17	in	in	B-PP	B-PP	-	13	VMOD	-	-
18	immune	immune	B-NP	B-NP	-	20	NMOD	-	-
19	inflammatory	inflammatory	I-NP	I-NP	-	20	NMOD	-	-
20	states	states	I-NP	I-NP	-	17	PMOD	-	-
21	associated	associated	B-VP	B-VP	-	20	NMOD	-	-
22	with	with	B-PP	B-PP	-	21	VMOD	-	-
23	CMV	CMV	B-NP	B-NP	-	24	NMOD	-	-
24	infection	infection	I-NP	I-NP	-	22	PMOD	-	-
25	.	.	O	O	-	12	P	-	-

1	Homodimerization	Homodimerization	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	9	NMOD	-	-
4	human	human	I-NP	I-NP	-	9	NMOD	-	-
5	interleukin	interleukin	I-NP	I-NP	-	9	NMOD	-	-
6	<num>	<num>	I-NP	I-NP	-	9	NMOD	-	-
7	receptor	receptor	I-NP	I-NP	-	9	NMOD	-	-
8	alpha	alpha	I-NP	I-NP	-	9	NMOD	-	-
9	chain	chain	I-NP	I-NP	-	2	PMOD	-	-
10	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
11	Cepsilon	Cepsilon	B-NP	B-NP	-	13	NMOD	-	-
12	germline	germline	I-NP	I-NP	-	13	NMOD	-	-
13	transcripts	transcripts	I-NP	I-NP	-	10	OBJ	-	-
14	in	in	B-PP	B-PP	-	10	VMOD	-	-
15	B	B	B-NP	B-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
17	in	in	B-PP	B-PP	-	10	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	absence	absence	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	the	the	B-NP	B-NP	-	26	NMOD	-	-
22	interleukin	interleukin	I-NP	I-NP	-	26	NMOD	-	-
23	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
24	receptor	receptor	I-NP	I-NP	-	26	NMOD	-	-
25	gamma	gamma	I-NP	I-NP	-	26	NMOD	-	-
26	chain	chain	I-NP	I-NP	-	20	PMOD	-	-
27	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	cytokines	cytokines	I-NP	I-NP	-	9	NMOD	-	-
3	interleukin	interleukin	I-NP	I-NP	-	5	NMOD	-	-
4	(	(	O	O	-	5	P	-	-
5	IL	IL	B-NP	B-NP	-	2	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	-4	-4	B-NP	B-NP	-	5	NMOD	-	-
8	and	and	O	O	-	9	NMOD	-	-
9	IL-13	IL-13	B-NP	B-NP	-	10	SUB	-	-
10	play	play	B-VP	B-VP	-	0	ROOT	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	critical	critical	I-NP	I-NP	-	13	NMOD	-	-
13	role	role	I-NP	I-NP	-	10	OBJ	-	-
14	in	in	B-PP	B-PP	-	10	VMOD	-	-
15	inducing	inducing	B-VP	B-VP	-	14	PMOD	-	-
16	Cepsilon	Cepsilon	B-NP	B-NP	-	18	NMOD	-	-
17	germline	germline	I-NP	I-NP	-	18	NMOD	-	-
18	transcripts	transcripts	I-NP	I-NP	-	22	NMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	IgE	IgE	B-NP	B-NP	-	22	NMOD	-	-
21	isotype	isotype	I-NP	I-NP	-	22	NMOD	-	-
22	switching	switching	I-NP	I-NP	-	15	OBJ	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	human	human	B-NP	B-NP	-	26	NMOD	-	-
25	B	B	I-NP	I-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	IL-4	IL-4	I-NP	I-NP	-	3	NMOD	-	-
3	receptor	receptor	I-NP	I-NP	-	10	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	IL-4R	IL-4R	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	in	in	B-PP	B-PP	-	3	NMOD	-	-
8	B	B	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	composed	composed	I-VP	I-VP	-	10	VC	-	-
12	of	of	B-PP	B-PP	-	11	VMOD	-	-
13	two	two	B-NP	B-NP	-	14	NMOD	-	-
14	chains	chains	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	19	P	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	IL-4-binding	IL-4-binding	I-NP	I-NP	-	19	NMOD	-	-
18	IL-4Ralpha	IL-4Ralpha	I-NP	I-NP	-	19	NMOD	-	-
19	chain	chain	I-NP	I-NP	-	12	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	which	which	B-NP	B-NP	-	19	NMOD	-	-
22	is	is	B-VP	B-VP	-	21	SBAR	-	-
23	shared	shared	I-VP	I-VP	-	22	VC	-	-
24	with	with	B-PP	B-PP	-	23	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	IL-13R	IL-13R	I-NP	I-NP	-	34	NMOD	-	-
27	,	,	O	O	-	34	P	-	-
28	and	and	O	O	-	34	NMOD	-	-
29	the	the	B-NP	B-NP	-	34	NMOD	-	-
30	IL-2Rgamma	IL-2Rgamma	I-NP	I-NP	-	34	NMOD	-	-
31	(	(	O	O	-	34	P	-	-
32	gammac	gammac	B-NP	B-NP	-	34	NMOD	-	-
33	)	)	O	O	-	34	P	-	-
34	chain	chain	B-NP	B-NP	-	24	PMOD	-	-
35	,	,	O	O	-	34	P	-	-
36	which	which	B-NP	B-NP	-	34	NMOD	-	-
37	is	is	B-VP	B-VP	-	36	SBAR	-	-
38	shared	shared	I-VP	I-VP	-	37	VC	-	-
39	with	with	B-PP	B-PP	-	38	VMOD	-	-
40	IL-7R	IL-7R	B-NP	B-NP	-	45	NMOD	-	-
41	,	,	O	O	-	45	P	-	-
42	IL-9R	IL-9R	B-NP	B-NP	-	45	NMOD	-	-
43	,	,	O	O	-	45	P	-	-
44	and	and	O	O	-	45	NMOD	-	-
45	IL-15R	IL-15R	B-NP	B-NP	-	39	PMOD	-	-
46	.	.	O	O	-	10	P	-	-

1	IL-4	IL-4	B-NP	B-NP	-	2	SUB	-	-
2	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
3	Cepsilon	Cepsilon	B-NP	B-NP	-	5	NMOD	-	-
4	germline	germline	I-NP	I-NP	-	5	NMOD	-	-
5	transcripts	transcripts	I-NP	I-NP	-	9	NMOD	-	-
6	and	and	O	O	-	9	NMOD	-	-
7	IgE	IgE	B-NP	B-NP	-	9	NMOD	-	-
8	isotype	isotype	I-NP	I-NP	-	9	NMOD	-	-
9	switching	switching	I-NP	I-NP	-	2	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	B	B	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	from	from	B-PP	B-PP	-	12	NMOD	-	-
14	patients	patients	B-NP	B-NP	-	13	PMOD	-	-
15	with	with	B-PP	B-PP	-	14	NMOD	-	-
16	gammac	gammac	B-NP	B-NP	-	18	NMOD	-	-
17	chain	chain	I-NP	I-NP	-	18	NMOD	-	-
18	deficiency	deficiency	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	2	P	-	-

1	Induction	Induction	B-NP	B-NP	-	16	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Cepsilon	Cepsilon	B-NP	B-NP	-	5	NMOD	-	-
4	germline	germline	I-NP	I-NP	-	5	NMOD	-	-
5	transcripts	transcripts	I-NP	I-NP	-	2	PMOD	-	-
6	by	by	B-PP	B-PP	-	1	NMOD	-	-
7	IL-4	IL-4	B-NP	B-NP	-	6	PMOD	-	-
8	in	in	B-PP	B-PP	-	1	NMOD	-	-
9	B	B	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	that	that	B-NP	B-NP	-	10	NMOD	-	-
12	lack	lack	B-VP	B-VP	-	11	SBAR	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	gammac	gammac	I-NP	I-NP	-	15	NMOD	-	-
15	chain	chain	I-NP	I-NP	-	12	OBJ	-	-
16	may	may	B-VP	B-VP	-	0	ROOT	-	-
17	involve	involve	I-VP	I-VP	-	16	VC	-	-
18	signaling	signaling	B-NP	B-NP	-	17	OBJ	-	-
19	via	via	B-PP	B-PP	-	17	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	IL-13R	IL-13R	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	16	P	-	-

1	Alternatively	Alternatively	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	IL-4Ralpha	IL-4Ralpha	I-NP	I-NP	-	5	NMOD	-	-
5	chain	chain	I-NP	I-NP	-	6	SUB	-	-
6	may	may	B-VP	B-VP	-	0	ROOT	-	-
7	transduce	transduce	I-VP	I-VP	-	6	VC	-	-
8	intracellular	intracellular	B-NP	B-NP	-	9	NMOD	-	-
9	signals	signals	I-NP	I-NP	-	7	OBJ	-	-
10	that	that	B-NP	B-NP	-	9	NMOD	-	-
11	lead	lead	B-VP	B-VP	-	10	SBAR	-	-
12	to	to	B-PP	B-PP	-	11	VMOD	-	-
13	Cepsilon	Cepsilon	B-NP	B-NP	-	15	NMOD	-	-
14	gene	gene	I-NP	I-NP	-	15	NMOD	-	-
15	transcription	transcription	I-NP	I-NP	-	12	PMOD	-	-
16	independently	independently	B-ADVP	B-ADVP	-	11	VMOD	-	-
17	of	of	B-PP	B-PP	-	16	AMOD	-	-
18	its	its	B-NP	B-NP	-	19	NMOD	-	-
19	association	association	I-NP	I-NP	-	17	PMOD	-	-
20	with	with	B-PP	B-PP	-	19	NMOD	-	-
21	other	other	B-NP	B-NP	-	22	NMOD	-	-
22	chains	chains	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	ligand-induced	ligand-induced	B-NP	B-NP	-	5	NMOD	-	-
5	homodimerization	homodimerization	I-NP	I-NP	-	28	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	chimeric	chimeric	B-NP	B-NP	-	9	NMOD	-	-
8	surface	surface	I-NP	I-NP	-	9	NMOD	-	-
9	receptors	receptors	I-NP	I-NP	-	6	PMOD	-	-
10	consisting	consisting	B-VP	B-VP	-	9	NMOD	-	-
11	of	of	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	16	NMOD	-	-
13	extracellular	extracellular	I-NP	I-NP	-	15	AMOD	-	-
14	and	and	I-NP	I-NP	-	15	AMOD	-	-
15	transmembrane	transmembrane	I-NP	I-NP	-	16	NMOD	-	-
16	domains	domains	I-NP	I-NP	-	11	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	erythropoietin	erythropoietin	I-NP	I-NP	-	20	NMOD	-	-
20	receptor	receptor	I-NP	I-NP	-	17	PMOD	-	-
21	and	and	B-PP	B-PP	-	17	PMOD	-	-
22	of	of	B-PP	B-PP	-	11	PMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	intracellular	intracellular	I-NP	I-NP	-	25	NMOD	-	-
25	domain	domain	I-NP	I-NP	-	22	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	IL-4Ralpha	IL-4Ralpha	B-NP	B-NP	-	26	PMOD	-	-
28	induces	induces	B-VP	B-VP	-	3	SBAR	-	-
29	Janus	Janus	B-NP	B-NP	-	30	NMOD	-	-
30	kinase	kinase	I-NP	I-NP	-	35	NMOD	-	-
31	<num>	<num>	I-NP	I-NP	-	30	NMOD	-	-
32	(	(	O	O	-	33	P	-	-
33	Jak1	Jak1	B-NP	B-NP	-	30	NMOD	-	-
34	)	)	O	O	-	33	P	-	-
35	activation	activation	B-NP	B-NP	-	28	OBJ	-	-
36	,	,	O	O	-	43	P	-	-
37	STAT6	STAT6	B-NP	B-NP	-	38	NMOD	-	-
38	activation	activation	I-NP	I-NP	-	43	NMOD	-	-
39	,	,	O	O	-	43	P	-	-
40	and	and	O	O	-	43	NMOD	-	-
41	Cepsilon	Cepsilon	B-NP	B-NP	-	43	NMOD	-	-
42	germline	germline	I-NP	I-NP	-	43	NMOD	-	-
43	transcripts	transcripts	I-NP	I-NP	-	35	NMOD	-	-
44	in	in	B-PP	B-PP	-	35	NMOD	-	-
45	human	human	B-NP	B-NP	-	49	NMOD	-	-
46	B	B	I-NP	I-NP	-	49	NMOD	-	-
47	cell	cell	I-NP	I-NP	-	49	NMOD	-	-
48	line	line	I-NP	I-NP	-	49	NMOD	-	-
49	BJAB	BJAB	I-NP	I-NP	-	44	PMOD	-	-
50	.	.	O	O	-	2	P	-	-

1	Disruption	Disruption	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	Jak1-binding	Jak1-binding	I-NP	I-NP	-	7	NMOD	-	-
5	proline-rich	proline-rich	I-NP	I-NP	-	7	NMOD	-	-
6	Box1	Box1	I-NP	I-NP	-	7	NMOD	-	-
7	region	region	I-NP	I-NP	-	2	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	IL-4Ralpha	IL-4Ralpha	B-NP	B-NP	-	8	PMOD	-	-
10	abolished	abolished	B-VP	B-VP	-	0	ROOT	-	-
11	signaling	signaling	B-NP	B-NP	-	10	OBJ	-	-
12	by	by	B-PP	B-PP	-	10	VMOD	-	-
13	this	this	B-NP	B-NP	-	15	NMOD	-	-
14	chimeric	chimeric	I-NP	I-NP	-	15	NMOD	-	-
15	receptor	receptor	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	10	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	24	VMOD	-	-
2	,	,	O	O	-	24	P	-	-
3	B	B	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	24	SUB	-	-
5	transfected	transfected	B-VP	B-VP	-	4	NMOD	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	10	NMOD	-	-
8	chimeric	chimeric	I-NP	I-NP	-	10	NMOD	-	-
9	CD8alpha/IL-4Ralpha	CD8alpha/IL-4Ralpha	I-NP	I-NP	-	10	NMOD	-	-
10	receptor	receptor	I-NP	I-NP	-	6	PMOD	-	-
11	,	,	O	O	-	10	P	-	-
12	which	which	B-NP	B-NP	-	10	NMOD	-	-
13	is	is	B-VP	B-VP	-	12	SBAR	-	-
14	expressed	expressed	I-VP	I-VP	-	13	VC	-	-
15	on	on	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	surface	surface	I-NP	I-NP	-	15	PMOD	-	-
19	as	as	B-PP	B-PP	-	14	VMOD	-	-
20	a	a	B-NP	B-NP	-	21	NMOD	-	-
21	homodimer	homodimer	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	10	P	-	-
23	constitutively	constitutively	B-ADVP	B-ADVP	-	24	VMOD	-	-
24	expressed	expressed	B-VP	B-VP	-	0	ROOT	-	-
25	Cepsilon	Cepsilon	B-NP	B-NP	-	27	NMOD	-	-
26	germline	germline	I-NP	I-NP	-	27	NMOD	-	-
27	transcripts	transcripts	I-NP	I-NP	-	24	OBJ	-	-
28	.	.	O	O	-	24	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	homodimerization	homodimerization	B-NP	B-NP	-	10	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	IL-4Ralpha	IL-4Ralpha	I-NP	I-NP	-	9	NMOD	-	-
9	chain	chain	I-NP	I-NP	-	6	PMOD	-	-
10	is	is	B-VP	B-VP	-	4	SBAR	-	-
11	sufficient	sufficient	B-ADJP	B-ADJP	-	10	PRD	-	-
12	to	to	B-VP	B-VP	-	13	VMOD	-	-
13	transduce	transduce	I-VP	I-VP	-	11	AMOD	-	-
14	Jak1-dependent	Jak1-dependent	B-NP	B-NP	-	16	NMOD	-	-
15	intracellular	intracellular	I-NP	I-NP	-	16	NMOD	-	-
16	signals	signals	I-NP	I-NP	-	13	OBJ	-	-
17	that	that	B-NP	B-NP	-	16	NMOD	-	-
18	lead	lead	B-VP	B-VP	-	17	SBAR	-	-
19	to	to	B-PP	B-PP	-	18	VMOD	-	-
20	IgE	IgE	B-NP	B-NP	-	22	NMOD	-	-
21	isotype	isotype	I-NP	I-NP	-	22	NMOD	-	-
22	switching	switching	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	Characterization	Characterization	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	peripheral	peripheral	B-NP	B-NP	-	5	NMOD	-	-
4	blood	blood	I-NP	I-NP	-	5	NMOD	-	-
5	T-lymphocytes	T-lymphocytes	I-NP	I-NP	-	2	PMOD	-	-
6	transduced	transduced	B-VP	B-VP	-	5	NMOD	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	HTLV-I	HTLV-I	B-NP	B-NP	-	10	NMOD	-	-
9	Tax	Tax	I-NP	I-NP	-	10	NMOD	-	-
10	mutants	mutants	I-NP	I-NP	-	7	PMOD	-	-
11	with	with	B-PP	B-PP	-	10	NMOD	-	-
12	different	different	B-NP	B-NP	-	14	NMOD	-	-
13	trans-activating	trans-activating	I-NP	I-NP	-	14	NMOD	-	-
14	phenotypes	phenotypes	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	1	P	-	-

1	Tax1	Tax1	B-NP	B-NP	-	5	NMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	transcriptional	transcriptional	I-NP	I-NP	-	5	NMOD	-	-
5	trans-activator	trans-activator	I-NP	I-NP	-	18	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	12	NMOD	-	-
8	Human	Human	I-NP	I-NP	-	12	NMOD	-	-
9	T-cell	T-cell	I-NP	I-NP	-	12	NMOD	-	-
10	leukemia	leukemia	I-NP	I-NP	-	12	NMOD	-	-
11	virus	virus	I-NP	I-NP	-	12	NMOD	-	-
12	type	type	I-NP	I-NP	-	6	PMOD	-	-
13	I	I	I-NP	I-NP	-	12	NMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	HTLV-I	HTLV-I	B-NP	B-NP	-	12	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	,	,	O	O	-	5	P	-	-
18	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	18	OBJ	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	many	many	B-NP	B-NP	-	21	PMOD	-	-
23	cellular	cellular	I-NP	I-NP	-	24	NMOD	-	-
24	genes	genes	I-NP	I-NP	-	22	NMOD	-	-
25	through	through	B-PP	B-PP	-	18	VMOD	-	-
26	interaction	interaction	B-NP	B-NP	-	25	PMOD	-	-
27	with	with	B-PP	B-PP	-	26	NMOD	-	-
28	at	at	B-NP	B-NP	-	34	NMOD	-	-
29	least	least	I-NP	I-NP	-	28	AMOD	-	-
30	three	three	I-NP	I-NP	-	28	AMOD	-	-
31	distinct	distinct	I-NP	I-NP	-	34	NMOD	-	-
32	cellular	cellular	I-NP	I-NP	-	34	NMOD	-	-
33	transcription	transcription	I-NP	I-NP	-	34	NMOD	-	-
34	factors	factors	I-NP	I-NP	-	41	NMOD	-	-
35	;	;	O	O	-	41	P	-	-
36	CREB/ATF	CREB/ATF	B-NP	B-NP	-	41	NMOD	-	-
37	,	,	O	O	-	41	P	-	-
38	NF-kappaB	NF-kappaB	B-NP	B-NP	-	41	NMOD	-	-
39	,	,	O	O	-	41	P	-	-
40	and	and	O	O	-	41	NMOD	-	-
41	SRF	SRF	B-NP	B-NP	-	27	PMOD	-	-
42	.	.	O	O	-	18	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	Tax1-induced	Tax1-induced	I-NP	I-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	cellular	cellular	B-NP	B-NP	-	6	NMOD	-	-
6	genes	genes	I-NP	I-NP	-	4	PMOD	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	considered	considered	I-VP	I-VP	-	7	VC	-	-
9	to	to	I-VP	I-VP	-	10	VMOD	-	-
10	be	be	I-VP	I-VP	-	8	VMOD	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	critical	critical	I-NP	I-NP	-	13	NMOD	-	-
13	event	event	I-NP	I-NP	-	10	PRD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	T-cell	T-cell	B-NP	B-NP	-	16	NMOD	-	-
16	transformation	transformation	I-NP	I-NP	-	14	PMOD	-	-
17	by	by	B-PP	B-PP	-	13	NMOD	-	-
18	HTLV-I	HTLV-I	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	7	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	elucidate	elucidate	I-VP	I-VP	-	15	VMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	role	role	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	each	each	B-NP	B-NP	-	9	NMOD	-	-
7	Tax1-inducible	Tax1-inducible	I-NP	I-NP	-	9	NMOD	-	-
8	transcriptional	transcriptional	I-NP	I-NP	-	9	NMOD	-	-
9	pathway	pathway	I-NP	I-NP	-	5	PMOD	-	-
10	in	in	B-PP	B-PP	-	4	NMOD	-	-
11	T-cell	T-cell	B-NP	B-NP	-	12	NMOD	-	-
12	transformation	transformation	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	15	P	-	-
14	we	we	B-NP	B-NP	-	15	SUB	-	-
15	introduced	introduced	B-VP	B-VP	-	0	ROOT	-	-
16	Tax1	Tax1	B-NP	B-NP	-	17	NMOD	-	-
17	mutants	mutants	I-NP	I-NP	-	15	OBJ	-	-
18	with	with	B-PP	B-PP	-	17	NMOD	-	-
19	different	different	B-NP	B-NP	-	21	NMOD	-	-
20	trans-activating	trans-activating	I-NP	I-NP	-	21	NMOD	-	-
21	phenotypes	phenotypes	I-NP	I-NP	-	18	PMOD	-	-
22	into	into	B-PP	B-PP	-	21	NMOD	-	-
23	peripheral	peripheral	B-NP	B-NP	-	25	NMOD	-	-
24	blood	blood	I-NP	I-NP	-	25	NMOD	-	-
25	lymphocytes	lymphocytes	I-NP	I-NP	-	22	PMOD	-	-
26	(	(	O	O	-	27	P	-	-
27	PBL	PBL	B-NP	B-NP	-	25	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	by	by	B-PP	B-PP	-	15	VMOD	-	-
30	retroviral	retroviral	B-NP	B-NP	-	31	NMOD	-	-
31	vectors	vectors	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	15	P	-	-

1	Analysis	Analysis	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	these	these	B-NP	B-NP	-	4	NMOD	-	-
4	PBLs	PBLs	I-NP	I-NP	-	2	PMOD	-	-
5	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	activation	activation	B-NP	B-NP	-	12	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	NF-kappaB	NF-kappaB	I-NP	I-NP	-	11	NMOD	-	-
11	pathway	pathway	I-NP	I-NP	-	8	PMOD	-	-
12	is	is	B-VP	B-VP	-	6	SBAR	-	-
13	sufficient	sufficient	B-ADJP	B-ADJP	-	12	PRD	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	promote	promote	I-VP	I-VP	-	13	AMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	growth	growth	I-NP	I-NP	-	18	NMOD	-	-
18	response	response	I-NP	I-NP	-	15	OBJ	-	-
19	to	to	B-PP	B-PP	-	18	NMOD	-	-
20	IL-2	IL-2	B-NP	B-NP	-	19	PMOD	-	-
21	.	.	O	O	-	5	P	-	-

1	However	However	B-ADVP	B-ADVP	-	27	VMOD	-	-
2	,	,	O	O	-	27	P	-	-
3	for	for	B-PP	B-PP	-	27	VMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	clonal	clonal	I-NP	I-NP	-	6	NMOD	-	-
6	expansion	expansion	I-NP	I-NP	-	3	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	CD4+	CD4+	B-NP	B-NP	-	9	NMOD	-	-
9	T-cells	T-cells	I-NP	I-NP	-	7	PMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	which	which	B-NP	B-NP	-	6	NMOD	-	-
12	is	is	B-VP	B-VP	-	11	SBAR	-	-
13	a	a	B-NP	B-NP	-	15	NMOD	-	-
14	characteristic	characteristic	I-NP	I-NP	-	15	NMOD	-	-
15	result	result	I-NP	I-NP	-	12	PRD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	HTLV-I	HTLV-I	B-NP	B-NP	-	18	NMOD	-	-
18	infection	infection	I-NP	I-NP	-	16	PMOD	-	-
19	,	,	O	O	-	27	P	-	-
20	activation	activation	B-NP	B-NP	-	27	SUB	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	26	NMOD	-	-
23	CREB/ATF	CREB/ATF	I-NP	I-NP	-	25	NMOD	-	-
24	and	and	I-NP	I-NP	-	25	NMOD	-	-
25	SRF	SRF	I-NP	I-NP	-	26	NMOD	-	-
26	pathways	pathways	I-NP	I-NP	-	21	PMOD	-	-
27	is	is	B-VP	B-VP	-	0	ROOT	-	-
28	also	also	I-VP	I-VP	-	27	VMOD	-	-
29	required	required	I-VP	I-VP	-	27	VC	-	-
30	.	.	O	O	-	27	P	-	-

1	Involvement	Involvement	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	N-terminal	N-terminal	I-NP	I-NP	-	5	NMOD	-	-
5	region	region	I-NP	I-NP	-	2	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	12	NMOD	-	-
8	human	human	I-NP	I-NP	-	12	NMOD	-	-
9	mineralocorticoid	mineralocorticoid	I-NP	I-NP	-	12	NMOD	-	-
10	receptor	receptor	I-NP	I-NP	-	12	NMOD	-	-
11	hormone-binding	hormone-binding	I-NP	I-NP	-	12	NMOD	-	-
12	domain	domain	I-NP	I-NP	-	6	PMOD	-	-
13	in	in	B-PP	B-PP	-	1	NMOD	-	-
14	agonist	agonist	B-NP	B-NP	-	17	NMOD	-	-
15	and	and	I-NP	I-NP	-	17	NMOD	-	-
16	antagonist	antagonist	I-NP	I-NP	-	17	NMOD	-	-
17	binding	binding	I-NP	I-NP	-	13	PMOD	-	-
18	as	as	B-SBAR	B-SBAR	-	1	NMOD	-	-
19	revealed	revealed	B-VP	B-VP	-	18	SBAR	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	a	a	B-NP	B-NP	-	24	NMOD	-	-
22	new	new	I-NP	I-NP	-	24	NMOD	-	-
23	monoclonal	monoclonal	I-NP	I-NP	-	24	NMOD	-	-
24	antibody	antibody	I-NP	I-NP	-	20	PMOD	-	-
25	.	.	O	O	-	1	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	gain	gain	I-VP	I-VP	-	21	VMOD	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	better	better	I-NP	I-NP	-	5	NMOD	-	-
5	understanding	understanding	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	mechanism	mechanism	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	binding	binding	B-VP	B-VP	-	9	PMOD	-	-
11	to	to	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	human	human	I-NP	I-NP	-	15	NMOD	-	-
14	mineralocorticoid	mineralocorticoid	I-NP	I-NP	-	15	NMOD	-	-
15	receptor	receptor	I-NP	I-NP	-	11	PMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	hMR	hMR	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	,	,	O	O	-	21	P	-	-
20	we	we	B-NP	B-NP	-	21	SUB	-	-
21	developed	developed	B-VP	B-VP	-	0	ROOT	-	-
22	a	a	B-NP	B-NP	-	25	NMOD	-	-
23	new	new	I-NP	I-NP	-	25	NMOD	-	-
24	monoclonal	monoclonal	I-NP	I-NP	-	25	NMOD	-	-
25	antibody	antibody	I-NP	I-NP	-	21	OBJ	-	-
26	(	(	O	O	-	27	P	-	-
27	mAb	mAb	B-NP	B-NP	-	25	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	raised	raised	B-VP	B-VP	-	25	NMOD	-	-
30	against	against	B-PP	B-PP	-	29	VMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	hormone-binding	hormone-binding	I-NP	I-NP	-	33	NMOD	-	-
33	domain	domain	I-NP	I-NP	-	30	PMOD	-	-
34	(	(	O	O	-	35	P	-	-
35	HBD	HBD	B-NP	B-NP	-	33	NMOD	-	-
36	)	)	O	O	-	35	P	-	-
37	.	.	O	O	-	21	P	-	-

1	For	For	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	purpose	purpose	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	mice	mice	B-NP	B-NP	-	6	SUB	-	-
6	were	were	B-VP	B-VP	-	0	ROOT	-	-
7	immunized	immunized	I-VP	I-VP	-	6	VC	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	fusion	fusion	I-NP	I-NP	-	11	NMOD	-	-
11	protein	protein	I-NP	I-NP	-	8	PMOD	-	-
12	including	including	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	sequence	sequence	I-NP	I-NP	-	15	NMOD	-	-
15	Thr729-Lys984	Thr729-Lys984	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	hMR	hMR	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	After	After	B-PP	B-PP	-	7	VMOD	-	-
2	ELISA	ELISA	B-NP	B-NP	-	3	NMOD	-	-
3	screening	screening	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	7	P	-	-
5	mAb	mAb	B-NP	B-NP	-	6	NMOD	-	-
6	18C7	18C7	I-NP	I-NP	-	7	SUB	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	selected	selected	I-VP	I-VP	-	7	VC	-	-
9	for	for	B-PP	B-PP	-	8	VMOD	-	-
10	its	its	B-NP	B-NP	-	11	NMOD	-	-
11	specificity	specificity	I-NP	I-NP	-	9	PMOD	-	-
12	towards	towards	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	HBD	HBD	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	7	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	antibody	antibody	I-NP	I-NP	-	3	SUB	-	-
3	recognized	recognized	B-VP	B-VP	-	0	ROOT	-	-
4	both	both	O	O	-	10	NMOD	-	-
5	the	the	B-NP	B-NP	-	10	NMOD	-	-
6	denatured	denatured	I-NP	I-NP	-	10	NMOD	-	-
7	and	and	I-NP	I-NP	-	10	NMOD	-	-
8	native	native	I-NP	I-NP	-	10	NMOD	-	-
9	MR	MR	I-NP	I-NP	-	10	NMOD	-	-
10	forms	forms	I-NP	I-NP	-	23	NMOD	-	-
11	,	,	O	O	-	23	P	-	-
12	as	as	B-CONJP	B-CONJP	-	23	NMOD	-	-
13	well	well	I-CONJP	I-CONJP	-	12	DEP	-	-
14	as	as	I-CONJP	I-CONJP	-	12	DEP	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	hetero-oligomeric	hetero-oligomeric	I-NP	I-NP	-	18	NMOD	-	-
17	MR	MR	I-NP	I-NP	-	18	NMOD	-	-
18	form	form	I-NP	I-NP	-	23	NMOD	-	-
19	and	and	O	O	-	23	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	transformed	transformed	I-NP	I-NP	-	23	NMOD	-	-
22	MR	MR	I-NP	I-NP	-	23	NMOD	-	-
23	state	state	I-NP	I-NP	-	3	OBJ	-	-
24	.	.	O	O	-	3	P	-	-

1	By	By	B-PP	B-PP	-	11	VMOD	-	-
2	using	using	B-VP	B-VP	-	1	PMOD	-	-
3	several	several	B-NP	B-NP	-	5	NMOD	-	-
4	HBD	HBD	I-NP	I-NP	-	5	NMOD	-	-
5	subfragments	subfragments	I-NP	I-NP	-	2	OBJ	-	-
6	,	,	O	O	-	11	P	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	mAb	mAb	I-NP	I-NP	-	10	NMOD	-	-
9	18C7	18C7	I-NP	I-NP	-	10	NMOD	-	-
10	epitope	epitope	I-NP	I-NP	-	11	SUB	-	-
11	was	was	B-VP	B-VP	-	0	ROOT	-	-
12	located	located	I-VP	I-VP	-	11	PRD	-	-
13	in	in	B-PP	B-PP	-	12	AMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	N-terminal	N-terminal	I-NP	I-NP	-	16	NMOD	-	-
16	region	region	I-NP	I-NP	-	13	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	HBD	HBD	I-NP	I-NP	-	17	PMOD	-	-
20	from	from	B-PP	B-PP	-	19	NMOD	-	-
21	Thr729	Thr729	B-NP	B-NP	-	20	PMOD	-	-
22	to	to	B-PP	B-PP	-	20	PMOD	-	-
23	Leu765	Leu765	B-NP	B-NP	-	22	PMOD	-	-
24	.	.	O	O	-	11	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	then	then	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	studied	studied	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	effect	effect	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	antibody	antibody	I-NP	I-NP	-	6	PMOD	-	-
9	on	on	B-PP	B-PP	-	5	NMOD	-	-
10	aldosterone	aldosterone	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	progesterone	progesterone	B-NP	B-NP	-	13	NMOD	-	-
13	binding	binding	B-NP	B-NP	-	9	PMOD	-	-
14	to	to	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	hMR	hMR	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	When	When	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	18C7	18C7	B-NP	B-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	1	SBAR	-	-
4	incubated	incubated	I-VP	I-VP	-	3	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	liganded	liganded	B-NP	B-NP	-	7	NMOD	-	-
7	MR	MR	I-NP	I-NP	-	5	PMOD	-	-
8	,	,	O	O	-	10	P	-	-
9	it	it	B-NP	B-NP	-	10	SUB	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	able	able	B-ADJP	B-ADJP	-	10	PRD	-	-
12	to	to	B-VP	B-VP	-	14	VMOD	-	-
13	partly	partly	I-VP	I-VP	-	14	VMOD	-	-
14	displace	displace	I-VP	I-VP	-	11	AMOD	-	-
15	(	(	O	O	-	17	P	-	-
16	<num>	<num>	B-NP	B-NP	-	17	NMOD	-	-
17	%	%	I-NP	I-NP	-	20	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	hormone	hormone	I-NP	I-NP	-	14	OBJ	-	-
21	from	from	B-PP	B-PP	-	20	NMOD	-	-
22	its	its	B-NP	B-NP	-	24	NMOD	-	-
23	binding	binding	I-NP	I-NP	-	24	NMOD	-	-
24	site	site	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	10	P	-	-

1	When	When	B-ADVP	B-ADVP	-	14	VMOD	-	-
2	18C7	18C7	B-NP	B-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	1	SBAR	-	-
4	incubated	incubated	I-VP	I-VP	-	3	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	MR	MR	B-NP	B-NP	-	5	PMOD	-	-
7	before	before	B-PP	B-PP	-	4	VMOD	-	-
8	aldosterone	aldosterone	B-NP	B-NP	-	10	NMOD	-	-
9	or	or	I-NP	I-NP	-	10	NMOD	-	-
10	progesterone	progesterone	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	14	P	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	antibody	antibody	I-NP	I-NP	-	14	SUB	-	-
14	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
15	75-80	75-80	B-NP	B-NP	-	16	NMOD	-	-
16	%	%	I-NP	I-NP	-	14	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	binding	binding	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	14	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	18C7	18C7	B-NP	B-NP	-	3	PMOD	-	-
5	on	on	B-PP	B-PP	-	2	NMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	binding	binding	I-NP	I-NP	-	5	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	similar	similar	B-ADJP	B-ADJP	-	8	PRD	-	-
10	with	with	B-PP	B-PP	-	9	AMOD	-	-
11	both	both	B-NP	B-NP	-	12	NMOD	-	-
12	hormones	hormones	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	8	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	sucrose	sucrose	I-NP	I-NP	-	4	NMOD	-	-
3	gradient	gradient	I-NP	I-NP	-	4	NMOD	-	-
4	analysis	analysis	I-NP	I-NP	-	5	SUB	-	-
5	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	simultaneous	simultaneous	I-NP	I-NP	-	8	NMOD	-	-
8	presence	presence	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	two	two	B-NP	B-NP	-	11	NMOD	-	-
11	kinds	kinds	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	receptor	receptor	B-NP	B-NP	-	14	NMOD	-	-
14	complexes	complexes	I-NP	I-NP	-	12	PMOD	-	-
15	:	:	O	O	-	22	P	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	steroid-MR	steroid-MR	I-NP	I-NP	-	18	NMOD	-	-
18	complex	complex	I-NP	I-NP	-	22	NMOD	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	antibody-MR	antibody-MR	I-NP	I-NP	-	22	NMOD	-	-
22	complex	complex	I-NP	I-NP	-	12	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	After	After	B-PP	B-PP	-	12	VMOD	-	-
2	its	its	B-NP	B-NP	-	4	NMOD	-	-
3	associated	associated	I-NP	I-NP	-	4	NMOD	-	-
4	proteins	proteins	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	12	P	-	-
6	especially	especially	B-ADVP	B-ADVP	-	12	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	heat-shock	heat-shock	I-NP	I-NP	-	10	NMOD	-	-
9	protein	protein	I-NP	I-NP	-	10	NMOD	-	-
10	hsp90	hsp90	I-NP	I-NP	-	12	SUB	-	-
11	,	,	O	O	-	10	P	-	-
12	had	had	B-VP	B-VP	-	0	ROOT	-	-
13	been	been	I-VP	I-VP	-	12	VC	-	-
14	cross-linked	cross-linked	B-ADJP	B-ADJP	-	13	PRD	-	-
15	with	with	B-PP	B-PP	-	14	AMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	hMR	hMR	I-NP	I-NP	-	15	PMOD	-	-
18	by	by	B-PP	B-PP	-	14	NMOD	-	-
19	dimethylpimelimidate	dimethylpimelimidate	B-NP	B-NP	-	18	PMOD	-	-
20	,	,	O	O	-	22	P	-	-
21	18C7	18C7	B-NP	B-NP	-	22	SUB	-	-
22	was	was	B-VP	B-VP	-	18	SBAR	-	-
23	still	still	B-ADVP	B-ADVP	-	22	VMOD	-	-
24	able	able	B-ADJP	B-ADJP	-	22	PRD	-	-
25	to	to	B-VP	B-VP	-	26	VMOD	-	-
26	react	react	I-VP	I-VP	-	24	AMOD	-	-
27	with	with	B-PP	B-PP	-	26	VMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	receptor	receptor	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	12	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	epitope	epitope	I-NP	I-NP	-	10	SUB	-	-
7	recognized	recognized	B-VP	B-VP	-	6	NMOD	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	18C7	18C7	B-NP	B-NP	-	8	PMOD	-	-
10	was	was	B-VP	B-VP	-	4	SBAR	-	-
11	directly	directly	I-VP	I-VP	-	10	VMOD	-	-
12	implicated	implicated	I-VP	I-VP	-	10	VC	-	-
13	in	in	B-PP	B-PP	-	12	VMOD	-	-
14	hormone	hormone	B-NP	B-NP	-	15	NMOD	-	-
15	binding	binding	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	lack	lack	I-NP	I-NP	-	30	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	steroid	steroid	B-NP	B-NP	-	5	NMOD	-	-
5	binding	binding	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	HBD	HBD	B-NP	B-NP	-	8	NMOD	-	-
8	mutants	mutants	I-NP	I-NP	-	6	PMOD	-	-
9	with	with	B-PP	B-PP	-	5	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	Thr729-Leu765	Thr729-Leu765	I-NP	I-NP	-	12	NMOD	-	-
12	sequence	sequence	I-NP	I-NP	-	9	PMOD	-	-
13	deleted	deleted	B-VP	B-VP	-	12	NMOD	-	-
14	[	[	O	O	-	28	P	-	-
15	Jalaguier	Jalaguier	B-NP	B-NP	-	26	NMOD	-	-
16	,	,	O	O	-	21	P	-	-
17	Mesnier	Mesnier	B-NP	B-NP	-	21	NMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	Leger	Leger	B-NP	B-NP	-	21	NMOD	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	Auzou	Auzou	B-NP	B-NP	-	26	NMOD	-	-
22	(	(	O	O	-	26	P	-	-
23	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	J.Steroid	J.Steroid	B-NP	B-NP	-	26	NMOD	-	-
26	Biochem.Mol.Biol.57	Biochem.Mol.Biol.57	I-NP	I-NP	-	28	NMOD	-	-
27	,	,	O	O	-	28	P	-	-
28	43-50	43-50	B-NP	B-NP	-	2	NMOD	-	-
29	]	]	O	O	-	28	P	-	-
30	supports	supports	B-VP	B-VP	-	0	ROOT	-	-
31	this	this	B-NP	B-NP	-	32	NMOD	-	-
32	hypothesis	hypothesis	I-NP	I-NP	-	30	OBJ	-	-
33	.	.	O	O	-	30	P	-	-

1	Because	Because	B-PP	B-PP	-	12	VMOD	-	-
2	of	of	I-PP	I-PP	-	1	PMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	similar	similar	I-NP	I-NP	-	5	NMOD	-	-
5	behaviours	behaviours	I-NP	I-NP	-	2	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	aldosterone	aldosterone	B-NP	B-NP	-	9	NMOD	-	-
8	and	and	I-NP	I-NP	-	9	NMOD	-	-
9	progesterone	progesterone	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	12	P	-	-
11	we	we	B-NP	B-NP	-	12	SUB	-	-
12	conclude	conclude	B-VP	B-VP	-	0	ROOT	-	-
13	that	that	B-SBAR	B-SBAR	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	17	NMOD	-	-
15	N-terminal	N-terminal	I-NP	I-NP	-	17	NMOD	-	-
16	Thr729-Leu765	Thr729-Leu765	I-NP	I-NP	-	17	NMOD	-	-
17	region	region	I-NP	I-NP	-	21	SUB	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	HBD	HBD	I-NP	I-NP	-	18	PMOD	-	-
21	is	is	B-VP	B-VP	-	13	SBAR	-	-
22	similarly	similarly	I-VP	I-VP	-	21	VMOD	-	-
23	involved	involved	I-VP	I-VP	-	21	VC	-	-
24	in	in	B-PP	B-PP	-	23	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	binding	binding	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	both	both	B-NP	B-NP	-	29	NMOD	-	-
29	hormones	hormones	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	12	P	-	-

1	Abnormal	Abnormal	B-NP	B-NP	-	4	NMOD	-	-
2	T	T	I-NP	I-NP	-	4	NMOD	-	-
3	lymphocyte	lymphocyte	I-NP	I-NP	-	4	NMOD	-	-
4	development	development	I-NP	I-NP	-	0	ROOT	-	-
5	induced	induced	B-VP	B-VP	-	4	NMOD	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	targeted	targeted	B-NP	B-NP	-	8	NMOD	-	-
8	overexpression	overexpression	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	IkappaB	IkappaB	B-NP	B-NP	-	11	NMOD	-	-
11	alpha	alpha	I-NP	I-NP	-	9	PMOD	-	-
12	.	.	O	O	-	4	P	-	-

1	A	A	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	12	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	thymic	thymic	B-NP	B-NP	-	5	NMOD	-	-
5	maturation	maturation	I-NP	I-NP	-	3	PMOD	-	-
6	for	for	B-PP	B-PP	-	2	NMOD	-	-
7	factors	factors	B-NP	B-NP	-	6	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	NF-kappaB	NF-kappaB	I-NP	I-NP	-	11	NMOD	-	-
11	family	family	I-NP	I-NP	-	8	PMOD	-	-
12	has	has	B-VP	B-VP	-	0	ROOT	-	-
13	long	long	I-VP	I-VP	-	12	VMOD	-	-
14	been	been	I-VP	I-VP	-	12	VC	-	-
15	suspected	suspected	I-VP	I-VP	-	14	VC	-	-
16	,	,	O	O	-	12	P	-	-
17	but	but	O	O	-	12	VMOD	-	-
18	not	not	B-VP	B-VP	-	17	DEP	-	-
19	yet	yet	I-VP	I-VP	-	18	AMOD	-	-
20	proven	proven	I-VP	I-VP	-	18	DEP	-	-
21	.	.	O	O	-	17	P	-	-

1	Transgenic	Transgenic	B-NP	B-NP	-	2	NMOD	-	-
2	mice	mice	I-NP	I-NP	-	10	SUB	-	-
3	with	with	B-PP	B-PP	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	lymphocyte-specific	lymphocyte-specific	I-NP	I-NP	-	6	NMOD	-	-
6	defect	defect	I-NP	I-NP	-	3	PMOD	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappaB	NF-kappaB	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	7	PMOD	-	-
10	were	were	B-VP	B-VP	-	0	ROOT	-	-
11	produced	produced	I-VP	I-VP	-	10	VC	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	targeted	targeted	B-NP	B-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	human	human	B-NP	B-NP	-	18	NMOD	-	-
17	IkappaB	IkappaB	I-NP	I-NP	-	18	NMOD	-	-
18	alpha	alpha	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	thymic	thymic	I-NP	I-NP	-	3	NMOD	-	-
3	cellularity	cellularity	I-NP	I-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	these	these	B-NP	B-NP	-	6	NMOD	-	-
6	mice	mice	I-NP	I-NP	-	4	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	significantly	significantly	I-VP	I-VP	-	7	VMOD	-	-
9	decreased	decreased	I-VP	I-VP	-	7	VC	-	-
10	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	proportion	proportion	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	mature	mature	B-NP	B-NP	-	7	NMOD	-	-
5	,	,	I-NP	I-NP	-	7	P	-	-
6	TCRhigh	TCRhigh	I-NP	I-NP	-	7	NMOD	-	-
7	thymocytes	thymocytes	I-NP	I-NP	-	3	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	alphabeta	alphabeta	I-NP	I-NP	-	11	NMOD	-	-
11	lineage	lineage	I-NP	I-NP	-	8	PMOD	-	-
12	was	was	B-VP	B-VP	-	0	ROOT	-	-
13	reduced	reduced	I-VP	I-VP	-	12	VC	-	-
14	,	,	O	O	-	20	P	-	-
15	and	and	O	O	-	20	VMOD	-	-
16	the	the	B-NP	B-NP	-	19	NMOD	-	-
17	remaining	remaining	I-NP	I-NP	-	19	NMOD	-	-
18	TCRhigh	TCRhigh	I-NP	I-NP	-	19	NMOD	-	-
19	population	population	I-NP	I-NP	-	20	SUB	-	-
20	contained	contained	B-VP	B-VP	-	13	VMOD	-	-
21	an	an	B-NP	B-NP	-	24	NMOD	-	-
22	unusually	unusually	I-NP	I-NP	-	23	AMOD	-	-
23	high	high	I-NP	I-NP	-	24	NMOD	-	-
24	proportion	proportion	I-NP	I-NP	-	20	OBJ	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	double-positive	double-positive	B-NP	B-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	12	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	defect	defect	I-NP	I-NP	-	5	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	maturation	maturation	B-NP	B-NP	-	3	PMOD	-	-
5	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	10	NMOD	-	-
8	transgene	transgene	I-NP	I-NP	-	10	NMOD	-	-
9	dose-dependent	dose-dependent	I-NP	I-NP	-	10	NMOD	-	-
10	reduction	reduction	I-NP	I-NP	-	6	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	peripheral	peripheral	B-NP	B-NP	-	14	NMOD	-	-
13	T	T	I-NP	I-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	5	P	-	-
16	with	with	B-PP	B-PP	-	5	VMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	CD8	CD8	I-NP	I-NP	-	19	NMOD	-	-
19	lineage	lineage	I-NP	I-NP	-	16	PMOD	-	-
20	being	being	B-VP	B-VP	-	16	PMOD	-	-
21	more	more	I-VP	I-VP	-	20	VMOD	-	-
22	severely	severely	I-VP	I-VP	-	23	AMOD	-	-
23	affected	affected	I-VP	I-VP	-	21	NMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
4	direct	direct	B-NP	B-NP	-	5	NMOD	-	-
5	evidence	evidence	I-NP	I-NP	-	3	OBJ	-	-
6	for	for	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	involvement	involvement	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappaB/Rel	NF-kappaB/Rel	B-NP	B-NP	-	12	NMOD	-	-
11	family	family	I-NP	I-NP	-	12	NMOD	-	-
12	proteins	proteins	I-NP	I-NP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	8	NMOD	-	-
14	late	late	B-NP	B-NP	-	15	NMOD	-	-
15	stages	stages	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	T	T	B-NP	B-NP	-	19	NMOD	-	-
18	lymphocyte	lymphocyte	I-NP	I-NP	-	19	NMOD	-	-
19	development	development	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	26	P	-	-
21	coincident	coincident	B-ADJP	B-ADJP	-	26	NMOD	-	-
22	with	with	B-PP	B-PP	-	21	AMOD	-	-
23	positive	positive	B-NP	B-NP	-	26	NMOD	-	-
24	and	and	I-NP	I-NP	-	26	NMOD	-	-
25	negative	negative	I-NP	I-NP	-	26	NMOD	-	-
26	selection	selection	I-NP	I-NP	-	16	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	Sequential	Sequential	B-NP	B-NP	-	2	NMOD	-	-
2	development	development	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	structural	structural	B-NP	B-NP	-	7	NMOD	-	-
5	and	and	I-NP	I-NP	-	7	NMOD	-	-
6	functional	functional	I-NP	I-NP	-	7	NMOD	-	-
7	alterations	alterations	I-NP	I-NP	-	3	PMOD	-	-
8	in	in	B-PP	B-PP	-	2	NMOD	-	-
9	T	T	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	from	from	B-PP	B-PP	-	10	NMOD	-	-
12	tumor-bearing	tumor-bearing	B-NP	B-NP	-	13	NMOD	-	-
13	mice	mice	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	TCR	TCR	I-NP	I-NP	-	4	NMOD	-	-
3	alpha	alpha	I-NP	I-NP	-	4	NMOD	-	-
4	beta	beta	I-NP	I-NP	-	8	NMOD	-	-
5	or	or	O	O	-	8	NMOD	-	-
6	-gamma	-gamma	B-NP	B-NP	-	8	NMOD	-	-
7	delta	delta	I-NP	I-NP	-	8	NMOD	-	-
8	chains	chains	I-NP	I-NP	-	9	SUB	-	-
9	bind	bind	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	peptide	peptide	I-NP	I-NP	-	12	NMOD	-	-
12	ligand	ligand	I-NP	I-NP	-	9	OBJ	-	-
13	,	,	O	O	-	14	P	-	-
14	whereas	whereas	O	O	-	9	VMOD	-	-
15	the	the	B-NP	B-NP	-	20	NMOD	-	-
16	associated	associated	I-NP	I-NP	-	20	NMOD	-	-
17	CD3	CD3	I-NP	I-NP	-	20	NMOD	-	-
18	delta	delta	I-NP	I-NP	-	20	NMOD	-	-
19	epsilon	epsilon	I-NP	I-NP	-	20	NMOD	-	-
20	gamma	gamma	I-NP	I-NP	-	24	NMOD	-	-
21	and	and	O	O	-	24	NMOD	-	-
22	TCR	TCR	B-NP	B-NP	-	24	NMOD	-	-
23	zeta	zeta	I-NP	I-NP	-	24	NMOD	-	-
24	subunits	subunits	I-NP	I-NP	-	25	SUB	-	-
25	couple	couple	B-VP	B-VP	-	14	SBAR	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	TCR	TCR	I-NP	I-NP	-	25	OBJ	-	-
28	to	to	B-PP	B-PP	-	25	VMOD	-	-
29	intracellular	intracellular	B-NP	B-NP	-	32	NMOD	-	-
30	signal	signal	I-NP	I-NP	-	32	NMOD	-	-
31	transduction	transduction	I-NP	I-NP	-	32	NMOD	-	-
32	components	components	I-NP	I-NP	-	28	PMOD	-	-
33	.	.	O	O	-	14	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	5	VMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	several	several	B-NP	B-NP	-	4	NMOD	-	-
4	groups	groups	I-NP	I-NP	-	5	SUB	-	-
5	have	have	B-VP	B-VP	-	0	ROOT	-	-
6	described	described	I-VP	I-VP	-	5	VC	-	-
7	marked	marked	B-NP	B-NP	-	8	NMOD	-	-
8	alterations	alterations	I-NP	I-NP	-	6	OBJ	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	signal	signal	B-NP	B-NP	-	12	NMOD	-	-
11	transduction	transduction	I-NP	I-NP	-	12	NMOD	-	-
12	elements	elements	I-NP	I-NP	-	9	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	T	T	B-NP	B-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	13	PMOD	-	-
16	from	from	B-PP	B-PP	-	15	NMOD	-	-
17	cancer	cancer	B-NP	B-NP	-	18	NMOD	-	-
18	patients	patients	I-NP	I-NP	-	16	PMOD	-	-
19	or	or	B-PP	B-PP	-	13	PMOD	-	-
20	in	in	B-PP	B-PP	-	13	PMOD	-	-
21	mice	mice	B-NP	B-NP	-	20	PMOD	-	-
22	bearing	bearing	B-VP	B-VP	-	21	NMOD	-	-
23	tumor	tumor	B-NP	B-NP	-	22	OBJ	-	-
24	for	for	B-PP	B-PP	-	23	NMOD	-	-
25	a	a	B-NP	B-NP	-	27	NMOD	-	-
26	few	few	I-NP	I-NP	-	27	NMOD	-	-
27	weeks	weeks	I-NP	I-NP	-	24	PMOD	-	-
28	(	(	O	O	-	29	P	-	-
29	>	>	B-NP	B-NP	-	31	NMOD	-	-
30	<num>	<num>	B-NP	B-NP	-	31	NMOD	-	-
31	days	days	I-NP	I-NP	-	27	NMOD	-	-
32	)	)	O	O	-	31	P	-	-
33	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	sequence	sequence	I-NP	I-NP	-	7	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	which	which	B-NP	B-NP	-	3	PMOD	-	-
5	these	these	B-NP	B-NP	-	6	NMOD	-	-
6	alterations	alterations	I-NP	I-NP	-	7	SUB	-	-
7	develop	develop	B-VP	B-VP	-	0	ROOT	-	-
8	is	is	B-VP	B-VP	-	7	VMOD	-	-
9	unknown	unknown	B-ADJP	B-ADJP	-	8	PRD	-	-
10	.	.	O	O	-	7	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	aim	aim	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	this	this	B-NP	B-NP	-	5	NMOD	-	-
5	study	study	I-NP	I-NP	-	3	PMOD	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	to	to	B-VP	B-VP	-	8	VMOD	-	-
8	explore	explore	I-VP	I-VP	-	6	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	kinetics	kinetics	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	development	development	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	alterations	alterations	B-NP	B-NP	-	14	PMOD	-	-
16	in	in	B-PP	B-PP	-	15	NMOD	-	-
17	signal	signal	B-NP	B-NP	-	19	NMOD	-	-
18	transduction	transduction	I-NP	I-NP	-	19	NMOD	-	-
19	molecules	molecules	I-NP	I-NP	-	28	NMOD	-	-
20	(	(	O	O	-	28	P	-	-
21	TCR	TCR	B-NP	B-NP	-	23	NMOD	-	-
22	zeta	zeta	I-NP	I-NP	-	23	NMOD	-	-
23	chain	chain	I-NP	I-NP	-	28	NMOD	-	-
24	,	,	O	O	-	28	P	-	-
25	NF	NF	B-NP	B-NP	-	28	NMOD	-	-
26	kappaB	kappaB	I-NP	I-NP	-	28	NMOD	-	-
27	family	family	I-NP	I-NP	-	28	NMOD	-	-
28	proteins	proteins	I-NP	I-NP	-	35	NMOD	-	-
29	,	,	O	O	-	35	P	-	-
30	and	and	O	O	-	33	NMOD	-	-
31	tyrosine	tyrosine	B-NP	B-NP	-	33	NMOD	-	-
32	kinase	kinase	I-NP	I-NP	-	33	NMOD	-	-
33	p56	p56	I-NP	I-NP	-	35	NMOD	-	-
34	(	(	O	O	-	35	P	-	-
35	lck	lck	B-NP	B-NP	-	13	NMOD	-	-
36	)	)	O	O	-	35	P	-	-
37	)	)	O	O	-	35	P	-	-
38	in	in	B-PP	B-PP	-	13	NMOD	-	-
39	mice	mice	B-NP	B-NP	-	38	PMOD	-	-
40	bearing	bearing	B-VP	B-VP	-	39	NMOD	-	-
41	MC38	MC38	B-NP	B-NP	-	43	NMOD	-	-
42	colon	colon	I-NP	I-NP	-	43	NMOD	-	-
43	adenocarcinoma	adenocarcinoma	I-NP	I-NP	-	40	OBJ	-	-
44	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	alterations	alterations	B-NP	B-NP	-	14	NMOD	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	NF	NF	B-NP	B-NP	-	10	NMOD	-	-
8	kappaB	kappaB	I-NP	I-NP	-	10	NMOD	-	-
9	family	family	I-NP	I-NP	-	10	NMOD	-	-
10	proteins	proteins	I-NP	I-NP	-	6	PMOD	-	-
11	,	,	O	O	-	5	P	-	-
12	specifically	specifically	B-ADVP	B-ADVP	-	14	NMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	failure	failure	I-NP	I-NP	-	22	SUB	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	p65	p65	B-NP	B-NP	-	17	NMOD	-	-
17	translocation	translocation	I-NP	I-NP	-	15	PMOD	-	-
18	to	to	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	nucleus	nucleus	I-NP	I-NP	-	18	PMOD	-	-
21	,	,	O	O	-	14	P	-	-
22	occur	occur	B-VP	B-VP	-	4	SBAR	-	-
23	earlier	earlier	B-ADVP	B-ADVP	-	22	VMOD	-	-
24	and	and	B-ADVP	B-ADVP	-	22	VMOD	-	-
25	more	more	B-ADVP	B-ADVP	-	26	AMOD	-	-
26	frequently	frequently	I-ADVP	I-ADVP	-	22	VMOD	-	-
27	than	than	B-PP	B-PP	-	26	AMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	decrease	decrease	I-NP	I-NP	-	27	PMOD	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	zeta-chain	zeta-chain	B-NP	B-NP	-	30	PMOD	-	-
32	.	.	O	O	-	3	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	defects	defects	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	paralleled	paralleled	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	an	an	B-NP	B-NP	-	8	NMOD	-	-
7	impaired	impaired	I-NP	I-NP	-	8	NMOD	-	-
8	ability	ability	I-NP	I-NP	-	5	PMOD	-	-
9	to	to	B-VP	B-VP	-	10	VMOD	-	-
10	produce	produce	I-VP	I-VP	-	8	NMOD	-	-
11	Th1	Th1	B-NP	B-NP	-	12	NMOD	-	-
12	cytokines	cytokines	I-NP	I-NP	-	10	OBJ	-	-
13	(	(	O	O	-	16	P	-	-
14	IL-2	IL-2	B-NP	B-NP	-	16	NMOD	-	-
15	and	and	O	O	-	16	NMOD	-	-
16	IFN-gamma	IFN-gamma	B-NP	B-NP	-	12	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	.	.	O	O	-	3	P	-	-

1	These	These	B-NP	B-NP	-	3	NMOD	-	-
2	initial	initial	I-NP	I-NP	-	3	NMOD	-	-
3	changes	changes	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	followed	followed	I-VP	I-VP	-	4	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	eventual	eventual	I-NP	I-NP	-	9	NMOD	-	-
9	loss	loss	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	TCR	TCR	B-NP	B-NP	-	13	NMOD	-	-
12	zeta	zeta	I-NP	I-NP	-	13	NMOD	-	-
13	chain	chain	I-NP	I-NP	-	15	NMOD	-	-
14	and	and	O	O	-	15	NMOD	-	-
15	p56	p56	B-NP	B-NP	-	22	NMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	lck	lck	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	and	and	O	O	-	22	NMOD	-	-
20	a	a	B-NP	B-NP	-	22	NMOD	-	-
21	marked	marked	I-NP	I-NP	-	22	NMOD	-	-
22	decrease	decrease	I-NP	I-NP	-	10	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	cytotoxic	cytotoxic	B-NP	B-NP	-	25	NMOD	-	-
25	function	function	I-NP	I-NP	-	23	PMOD	-	-
26	.	.	O	O	-	4	P	-	-

1	An	An	B-NP	B-NP	-	3	NMOD	-	-
2	increased	increased	I-NP	I-NP	-	3	NMOD	-	-
3	rate	rate	I-NP	I-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	lysosomal	lysosomal	B-NP	B-NP	-	6	NMOD	-	-
6	degradation	degradation	I-NP	I-NP	-	4	PMOD	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	one	one	B-NP	B-NP	-	7	PRD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	mechanisms	mechanisms	I-NP	I-NP	-	9	PMOD	-	-
12	responsible	responsible	B-ADJP	B-ADJP	-	11	NMOD	-	-
13	for	for	B-PP	B-PP	-	12	AMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	loss	loss	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	zeta-chain	zeta-chain	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	7	P	-	-

1	An	An	B-NP	B-NP	-	3	NMOD	-	-
2	isotype-specific	isotype-specific	I-NP	I-NP	-	3	NMOD	-	-
3	activator	activator	I-NP	I-NP	-	0	ROOT	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	major	major	B-NP	B-NP	-	13	NMOD	-	-
6	histocompatibility	histocompatibility	I-NP	I-NP	-	13	NMOD	-	-
7	complex	complex	I-NP	I-NP	-	13	NMOD	-	-
8	(	(	O	O	-	13	P	-	-
9	MHC	MHC	B-NP	B-NP	-	13	NMOD	-	-
10	)	)	O	O	-	13	P	-	-
11	class	class	B-NP	B-NP	-	13	NMOD	-	-
12	II	II	I-NP	I-NP	-	13	NMOD	-	-
13	genes	genes	I-NP	I-NP	-	4	PMOD	-	-
14	that	that	B-NP	B-NP	-	3	NMOD	-	-
15	is	is	B-VP	B-VP	-	14	SBAR	-	-
16	independent	independent	B-ADJP	B-ADJP	-	15	PRD	-	-
17	of	of	B-PP	B-PP	-	16	AMOD	-	-
18	class	class	B-NP	B-NP	-	20	NMOD	-	-
19	II	II	I-NP	I-NP	-	20	NMOD	-	-
20	transactivator	transactivator	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	Patients	Patients	B-NP	B-NP	-	13	SUB	-	-
2	with	with	B-PP	B-PP	-	1	NMOD	-	-
3	one	one	B-NP	B-NP	-	4	NMOD	-	-
4	type	type	I-NP	I-NP	-	12	NMOD	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	major	major	B-NP	B-NP	-	9	NMOD	-	-
7	histocompatibility	histocompatibility	I-NP	I-NP	-	9	NMOD	-	-
8	complex	complex	I-NP	I-NP	-	9	NMOD	-	-
9	class	class	I-NP	I-NP	-	12	NMOD	-	-
10	II	II	I-NP	I-NP	-	12	NMOD	-	-
11	combined	combined	I-NP	I-NP	-	12	NMOD	-	-
12	immunodeficiency	immunodeficiency	I-NP	I-NP	-	2	PMOD	-	-
13	have	have	B-VP	B-VP	-	0	ROOT	-	-
14	mutations	mutations	B-NP	B-NP	-	13	OBJ	-	-
15	in	in	B-PP	B-PP	-	13	VMOD	-	-
16	a	a	B-NP	B-NP	-	17	NMOD	-	-
17	gene	gene	I-NP	I-NP	-	15	PMOD	-	-
18	termed	termed	B-VP	B-VP	-	17	NMOD	-	-
19	class	class	B-NP	B-NP	-	21	NMOD	-	-
20	II	II	I-NP	I-NP	-	21	NMOD	-	-
21	transactivator	transactivator	I-NP	I-NP	-	18	VMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	CIITA	CIITA	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	,	,	O	O	-	21	P	-	-
26	which	which	B-NP	B-NP	-	21	NMOD	-	-
27	coordinately	coordinately	B-ADVP	B-ADVP	-	28	VMOD	-	-
28	controls	controls	B-VP	B-VP	-	26	SBAR	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	transcription	transcription	I-NP	I-NP	-	28	OBJ	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	the	the	B-NP	B-NP	-	38	NMOD	-	-
33	three	three	I-NP	I-NP	-	38	NMOD	-	-
34	major	major	I-NP	I-NP	-	38	NMOD	-	-
35	human	human	I-NP	I-NP	-	38	NMOD	-	-
36	class	class	I-NP	I-NP	-	38	NMOD	-	-
37	II	II	B-NP	B-NP	-	38	NMOD	-	-
38	genes	genes	I-NP	I-NP	-	45	NMOD	-	-
39	,	,	O	O	-	45	P	-	-
40	HLA-DR	HLA-DR	B-NP	B-NP	-	45	NMOD	-	-
41	,	,	O	O	-	45	P	-	-
42	-DQ	-DQ	B-NP	B-NP	-	45	NMOD	-	-
43	,	,	O	O	-	45	P	-	-
44	and	and	O	O	-	45	NMOD	-	-
45	-DP	-DP	B-NP	B-NP	-	31	PMOD	-	-
46	.	.	O	O	-	13	P	-	-

1	However	However	B-ADVP	B-ADVP	-	13	VMOD	-	-
2	,	,	O	O	-	13	P	-	-
3	the	the	B-NP	B-NP	-	8	NMOD	-	-
4	experimentally	experimentally	I-NP	I-NP	-	5	AMOD	-	-
5	derived	derived	I-NP	I-NP	-	8	NMOD	-	-
6	B-lymphoblastoid	B-lymphoblastoid	I-NP	I-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	line	line	I-NP	I-NP	-	10	NMOD	-	-
9	,	,	O	O	-	10	P	-	-
10	clone	clone	B-NP	B-NP	-	13	SUB	-	-
11	<num>	<num>	I-NP	I-NP	-	10	NMOD	-	-
12	,	,	O	O	-	10	P	-	-
13	expresses	expresses	B-VP	B-VP	-	0	ROOT	-	-
14	high	high	B-NP	B-NP	-	15	NMOD	-	-
15	levels	levels	I-NP	I-NP	-	13	OBJ	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	HLADQ	HLADQ	B-NP	B-NP	-	16	PMOD	-	-
18	in	in	B-PP	B-PP	-	15	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	absence	absence	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	HLA-DR	HLA-DR	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	HLA-DP	HLA-DP	I-NP	I-NP	-	21	PMOD	-	-
25	,	,	O	O	-	13	P	-	-
26	despite	despite	B-PP	B-PP	-	13	VMOD	-	-
27	its	its	B-NP	B-NP	-	28	NMOD	-	-
28	mapping	mapping	I-NP	I-NP	-	26	PMOD	-	-
29	by	by	B-PP	B-PP	-	28	NMOD	-	-
30	complementation	complementation	B-NP	B-NP	-	31	NMOD	-	-
31	analysis	analysis	I-NP	I-NP	-	29	PMOD	-	-
32	to	to	B-PP	B-PP	-	31	NMOD	-	-
33	this	this	B-NP	B-NP	-	34	NMOD	-	-
34	group	group	I-NP	I-NP	-	32	PMOD	-	-
35	.	.	O	O	-	13	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	possible	possible	B-ADJP	B-ADJP	-	2	PRD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	one	one	B-NP	B-NP	-	12	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	11	NMOD	-	-
8	clone	clone	I-NP	I-NP	-	11	NMOD	-	-
9	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
10	CIITA	CIITA	I-NP	I-NP	-	11	NMOD	-	-
11	alleles	alleles	I-NP	I-NP	-	6	PMOD	-	-
12	bore	bore	B-VP	B-VP	-	4	SBAR	-	-
13	a	a	B-NP	B-NP	-	14	NMOD	-	-
14	mutation	mutation	I-NP	I-NP	-	12	OBJ	-	-
15	that	that	B-NP	B-NP	-	14	NMOD	-	-
16	allowed	allowed	B-VP	B-VP	-	15	SBAR	-	-
17	HLA-DQ	HLA-DQ	B-NP	B-NP	-	24	NMOD	-	-
18	,	,	O	O	-	24	P	-	-
19	but	but	O	O	-	24	NMOD	-	-
20	not	not	O	O	-	19	DEP	-	-
21	HLA-DR	HLA-DR	B-NP	B-NP	-	24	NMOD	-	-
22	or	or	O	O	-	24	NMOD	-	-
23	-DP	-DP	B-NP	B-NP	-	24	NMOD	-	-
24	transcription	transcription	I-NP	I-NP	-	16	OBJ	-	-
25	.	.	O	O	-	2	P	-	-

1	Alternatively	Alternatively	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	another	another	B-NP	B-NP	-	4	NMOD	-	-
4	factor	factor	I-NP	I-NP	-	10	SUB	-	-
5	,	,	O	O	-	4	P	-	-
6	distinct	distinct	B-ADJP	B-ADJP	-	4	NMOD	-	-
7	from	from	B-PP	B-PP	-	6	AMOD	-	-
8	CIITA	CIITA	B-NP	B-NP	-	7	PMOD	-	-
9	,	,	O	O	-	4	P	-	-
10	might	might	B-VP	B-VP	-	0	ROOT	-	-
11	control	control	I-VP	I-VP	-	10	VC	-	-
12	HLA-DQ	HLA-DQ	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	11	OBJ	-	-
14	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	report	report	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	ectopic	ectopic	B-NP	B-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	20	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	CIITA	CIITA	B-NP	B-NP	-	9	NMOD	-	-
9	cDNAs	cDNAs	I-NP	I-NP	-	7	PMOD	-	-
10	derived	derived	B-VP	B-VP	-	9	NMOD	-	-
11	by	by	B-PP	B-PP	-	10	VMOD	-	-
12	reverse	reverse	B-NP	B-NP	-	16	NMOD	-	-
13	transcriptase	transcriptase	I-NP	I-NP	-	16	NMOD	-	-
14	polymerase	polymerase	I-NP	I-NP	-	16	NMOD	-	-
15	chain	chain	I-NP	I-NP	-	16	NMOD	-	-
16	reaction	reaction	I-NP	I-NP	-	11	PMOD	-	-
17	from	from	B-PP	B-PP	-	16	NMOD	-	-
18	clone	clone	B-NP	B-NP	-	17	PMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	18	NMOD	-	-
20	do	do	B-VP	B-VP	-	4	SBAR	-	-
21	not	not	I-VP	I-VP	-	20	VMOD	-	-
22	restore	restore	I-VP	I-VP	-	20	VC	-	-
23	expression	expression	B-NP	B-NP	-	22	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	HLA-DQ	HLA-DQ	B-NP	B-NP	-	24	PMOD	-	-
26	in	in	B-PP	B-PP	-	23	NMOD	-	-
27	another	another	B-NP	B-NP	-	30	NMOD	-	-
28	CIITA-deficient	CIITA-deficient	I-NP	I-NP	-	30	NMOD	-	-
29	cell	cell	I-NP	I-NP	-	30	NMOD	-	-
30	line	line	I-NP	I-NP	-	32	NMOD	-	-
31	,	,	O	O	-	32	P	-	-
32	RJ2.2.5	RJ2.2.5	B-NP	B-NP	-	26	PMOD	-	-
33	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	7	P	-	-
4	no	no	B-NP	B-NP	-	6	NMOD	-	-
5	CIITA	CIITA	I-NP	I-NP	-	6	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	7	SUB	-	-
7	is	is	B-VP	B-VP	-	0	ROOT	-	-
8	detectable	detectable	B-ADJP	B-ADJP	-	7	PRD	-	-
9	in	in	B-PP	B-PP	-	8	AMOD	-	-
10	clone	clone	B-NP	B-NP	-	13	NMOD	-	-
11	<num>	<num>	I-NP	I-NP	-	13	NMOD	-	-
12	nuclear	nuclear	I-NP	I-NP	-	13	NMOD	-	-
13	extracts	extracts	I-NP	I-NP	-	9	PMOD	-	-
14	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	12	P	-	-
4	somatic	somatic	B-NP	B-NP	-	6	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
6	fusion	fusion	I-NP	I-NP	-	11	NMOD	-	-
7	between	between	B-PP	B-PP	-	6	NMOD	-	-
8	clone	clone	B-NP	B-NP	-	11	NMOD	-	-
9	<num>	<num>	I-NP	I-NP	-	8	NMOD	-	-
10	and	and	O	O	-	11	NMOD	-	-
11	RJ2.2.5	RJ2.2.5	B-NP	B-NP	-	12	SUB	-	-
12	restored	restored	B-VP	B-VP	-	0	ROOT	-	-
13	expression	expression	B-NP	B-NP	-	12	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	HLA-DQ	HLA-DQ	I-NP	I-NP	-	17	NMOD	-	-
17	haplotype	haplotype	I-NP	I-NP	-	14	PMOD	-	-
18	encoded	encoded	B-VP	B-VP	-	17	NMOD	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	RJ2.2.5	RJ2.2.5	I-NP	I-NP	-	23	NMOD	-	-
22	DQB	DQB	I-NP	I-NP	-	23	NMOD	-	-
23	gene	gene	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	12	P	-	-

1	Taken	Taken	B-VP	B-VP	-	6	VMOD	-	-
2	together	together	B-ADVP	B-ADVP	-	1	VMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	data	data	I-NP	I-NP	-	6	SUB	-	-
6	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	existence	existence	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	an	an	B-NP	B-NP	-	14	NMOD	-	-
11	HLA-DQ	HLA-DQ	I-NP	I-NP	-	14	NMOD	-	-
12	isotype-specific	isotype-specific	I-NP	I-NP	-	14	NMOD	-	-
13	trans-acting	trans-acting	I-NP	I-NP	-	14	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	9	PMOD	-	-
15	,	,	O	O	-	14	P	-	-
16	which	which	B-NP	B-NP	-	14	NMOD	-	-
17	functions	functions	B-VP	B-VP	-	16	SBAR	-	-
18	independently	independently	B-ADVP	B-ADVP	-	17	VMOD	-	-
19	of	of	B-PP	B-PP	-	17	VMOD	-	-
20	CIITA	CIITA	B-NP	B-NP	-	19	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	Induction	Induction	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	cytokine	cytokine	B-NP	B-NP	-	4	NMOD	-	-
4	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
5	in	in	B-PP	B-PP	-	1	NMOD	-	-
6	leukocytes	leukocytes	B-NP	B-NP	-	5	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	binding	binding	B-NP	B-NP	-	7	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	thrombin-stimulated	thrombin-stimulated	B-NP	B-NP	-	11	NMOD	-	-
11	platelets	platelets	I-NP	I-NP	-	9	PMOD	-	-
12	.	.	O	O	-	1	P	-	-

1	BACKGROUND	BACKGROUND	B-NP	B-NP	-	4	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	Activated	Activated	B-NP	B-NP	-	4	NMOD	-	-
4	platelets	platelets	I-NP	I-NP	-	5	SUB	-	-
5	tether	tether	B-VP	B-VP	-	0	ROOT	-	-
6	and	and	I-VP	I-VP	-	5	VMOD	-	-
7	activate	activate	I-VP	I-VP	-	5	VMOD	-	-
8	myeloid	myeloid	B-NP	B-NP	-	9	NMOD	-	-
9	leukocytes	leukocytes	I-NP	I-NP	-	7	OBJ	-	-
10	.	.	O	O	-	5	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	investigate	investigate	I-VP	I-VP	-	18	VMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	potential	potential	I-NP	I-NP	-	5	NMOD	-	-
5	relevance	relevance	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	this	this	B-NP	B-NP	-	8	NMOD	-	-
8	mechanism	mechanism	I-NP	I-NP	-	6	PMOD	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	acute	acute	B-NP	B-NP	-	12	NMOD	-	-
11	myocardial	myocardial	I-NP	I-NP	-	12	NMOD	-	-
12	infarction	infarction	I-NP	I-NP	-	9	PMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	AMI	AMI	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	,	,	O	O	-	18	P	-	-
17	we	we	B-NP	B-NP	-	18	SUB	-	-
18	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
19	cytokine	cytokine	B-NP	B-NP	-	20	NMOD	-	-
20	induction	induction	I-NP	I-NP	-	18	OBJ	-	-
21	by	by	B-PP	B-PP	-	20	NMOD	-	-
22	leukocyte-platelet	leukocyte-platelet	B-NP	B-NP	-	23	NMOD	-	-
23	adhesion	adhesion	I-NP	I-NP	-	26	NMOD	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	occurrence	occurrence	I-NP	I-NP	-	21	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	leukocyte-platelet	leukocyte-platelet	B-NP	B-NP	-	29	NMOD	-	-
29	conjugates	conjugates	I-NP	I-NP	-	27	PMOD	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	patients	patients	B-NP	B-NP	-	30	PMOD	-	-
32	with	with	B-PP	B-PP	-	31	NMOD	-	-
33	AMI	AMI	B-NP	B-NP	-	32	PMOD	-	-
34	.	.	O	O	-	18	P	-	-

1	METHODS	METHODS	B-NP	B-NP	-	3	NMOD	-	-
2	AND	AND	I-NP	I-NP	-	3	NMOD	-	-
3	RESULTS	RESULTS	I-NP	I-NP	-	6	SUB	-	-
4	:	:	O	O	-	6	P	-	-
5	We	We	B-NP	B-NP	-	6	SUB	-	-
6	obtained	obtained	B-VP	B-VP	-	0	ROOT	-	-
7	peripheral	peripheral	B-NP	B-NP	-	10	NMOD	-	-
8	venous	venous	I-NP	I-NP	-	10	NMOD	-	-
9	blood	blood	I-NP	I-NP	-	10	NMOD	-	-
10	samples	samples	I-NP	I-NP	-	6	OBJ	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
13	patients	patients	I-NP	I-NP	-	11	PMOD	-	-
14	with	with	B-PP	B-PP	-	13	NMOD	-	-
15	AMI	AMI	B-NP	B-NP	-	14	PMOD	-	-
16	before	before	B-PP	B-PP	-	6	VMOD	-	-
17	and	and	O	O	-	16	PMOD	-	-
18	daily	daily	B-ADVP	B-ADVP	-	16	PMOD	-	-
19	for	for	B-PP	B-PP	-	18	AMOD	-	-
20	<num>	<num>	B-NP	B-NP	-	21	NMOD	-	-
21	days	days	I-NP	I-NP	-	19	PMOD	-	-
22	after	after	B-PP	B-PP	-	21	NMOD	-	-
23	direct	direct	B-NP	B-NP	-	24	AMOD	-	-
24	percutaneous	percutaneous	I-NP	I-NP	-	27	NMOD	-	-
25	transluminal	transluminal	I-NP	I-NP	-	27	NMOD	-	-
26	coronary	coronary	I-NP	I-NP	-	27	NMOD	-	-
27	angioplasty	angioplasty	I-NP	I-NP	-	22	PMOD	-	-
28	(	(	O	O	-	29	P	-	-
29	PTCA	PTCA	B-NP	B-NP	-	27	NMOD	-	-
30	)	)	O	O	-	29	P	-	-
31	and	and	O	O	-	19	PMOD	-	-
32	in	in	B-PP	B-PP	-	16	PMOD	-	-
33	<num>	<num>	B-NP	B-NP	-	34	NMOD	-	-
34	patients	patients	I-NP	I-NP	-	32	PMOD	-	-
35	undergoing	undergoing	B-VP	B-VP	-	34	NMOD	-	-
36	elective	elective	B-NP	B-NP	-	37	NMOD	-	-
37	PTCA	PTCA	I-NP	I-NP	-	35	OBJ	-	-
38	.	.	O	O	-	6	P	-	-

1	Throughout	Throughout	B-PP	B-PP	-	14	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	study	study	I-NP	I-NP	-	4	NMOD	-	-
4	period	period	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	14	P	-	-
6	CD41	CD41	B-NP	B-NP	-	7	NMOD	-	-
7	immunofluorescence	immunofluorescence	I-NP	I-NP	-	14	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	leukocytes	leukocytes	B-NP	B-NP	-	8	PMOD	-	-
10	(	(	O	O	-	12	P	-	-
11	flow	flow	B-NP	B-NP	-	12	NMOD	-	-
12	cytometry	cytometry	I-NP	I-NP	-	9	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
15	increased	increased	B-NP	B-NP	-	17	NMOD	-	-
16	leukocyte-platelet	leukocyte-platelet	I-NP	I-NP	-	17	NMOD	-	-
17	adhesion	adhesion	I-NP	I-NP	-	14	OBJ	-	-
18	in	in	B-PP	B-PP	-	14	VMOD	-	-
19	patients	patients	B-NP	B-NP	-	18	PMOD	-	-
20	with	with	B-PP	B-PP	-	19	NMOD	-	-
21	AMI	AMI	B-NP	B-NP	-	20	PMOD	-	-
22	compared	compared	B-PP	B-PP	-	14	VMOD	-	-
23	with	with	B-PP	B-PP	-	22	PMOD	-	-
24	control	control	B-NP	B-NP	-	25	NMOD	-	-
25	patients	patients	I-NP	I-NP	-	29	NMOD	-	-
26	(	(	O	O	-	29	P	-	-
27	mean	mean	B-NP	B-NP	-	29	NMOD	-	-
28	+/-	+/-	O	O	-	29	NMOD	-	-
29	SE	SE	B-NP	B-NP	-	23	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	fluorescence	fluorescence	B-NP	B-NP	-	30	PMOD	-	-
32	[	[	O	O	-	33	P	-	-
33	channels	channels	B-NP	B-NP	-	31	NMOD	-	-
34	]	]	O	O	-	29	P	-	-
35	before	before	B-PP	B-PP	-	29	NMOD	-	-
36	PTCA	PTCA	B-NP	B-NP	-	35	PMOD	-	-
37	:	:	O	O	-	14	P	-	-
38	<num>	<num>	B-NP	B-NP	-	44	NMOD	-	-
39	+/-	+/-	I-NP	I-NP	-	44	NMOD	-	-
40	<num>	<num>	I-NP	I-NP	-	44	NMOD	-	-
41	versus	versus	I-NP	I-NP	-	44	NMOD	-	-
42	<num>	<num>	I-NP	I-NP	-	44	NMOD	-	-
43	+/-	+/-	I-NP	I-NP	-	44	NMOD	-	-
44	<num>	<num>	I-NP	I-NP	-	14	VMOD	-	-
45	;	;	O	O	-	14	P	-	-
46	P	P	B-NP	B-NP	-	45	P	-	-
47	=	=	B-VP	B-VP	-	46	NMOD	-	-
48	.003	.003	B-NP	B-NP	-	47	AMOD	-	-
49	)	)	O	O	-	46	P	-	-
50	.	.	O	O	-	14	P	-	-

1	In	In	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	vitro	vitro	I-ADVP	I-ADVP	-	1	AMOD	-	-
3	,	,	O	O	-	7	P	-	-
4	thrombin-stimulated	thrombin-stimulated	B-NP	B-NP	-	6	NMOD	-	-
5	fixed	fixed	I-NP	I-NP	-	6	NMOD	-	-
6	platelets	platelets	I-NP	I-NP	-	7	SUB	-	-
7	bound	bound	B-VP	B-VP	-	0	ROOT	-	-
8	to	to	B-PP	B-PP	-	7	VMOD	-	-
9	neutrophils	neutrophils	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	monocytes	monocytes	I-NP	I-NP	-	8	PMOD	-	-
12	.	.	O	O	-	7	P	-	-

1	Within	Within	B-PP	B-PP	-	6	VMOD	-	-
2	<num>	<num>	B-NP	B-NP	-	3	NMOD	-	-
3	hours	hours	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	this	this	B-NP	B-NP	-	6	SUB	-	-
6	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	increased	increased	B-NP	B-NP	-	9	NMOD	-	-
9	mRNA	mRNA	I-NP	I-NP	-	7	PMOD	-	-
10	for	for	B-PP	B-PP	-	9	NMOD	-	-
11	interleukin	interleukin	B-NP	B-NP	-	13	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	IL	IL	B-NP	B-NP	-	9	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	,	,	O	O	-	24	P	-	-
16	<num>	<num>	B-NP	B-NP	-	24	NMOD	-	-
17	beta	beta	B-NP	B-NP	-	24	NMOD	-	-
18	,	,	O	O	-	24	P	-	-
19	IL-8	IL-8	B-NP	B-NP	-	24	NMOD	-	-
20	,	,	O	O	-	24	P	-	-
21	and	and	O	O	-	24	NMOD	-	-
22	monocyte	monocyte	B-NP	B-NP	-	24	NMOD	-	-
23	chemoattractant	chemoattractant	I-NP	I-NP	-	24	NMOD	-	-
24	protein	protein	I-NP	I-NP	-	28	NMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	MCP	MCP	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	-1	-1	B-NP	B-NP	-	9	NMOD	-	-
29	in	in	B-PP	B-PP	-	9	NMOD	-	-
30	unfractionated	unfractionated	B-NP	B-NP	-	31	NMOD	-	-
31	leukocytes	leukocytes	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	6	P	-	-

1	After	After	B-PP	B-PP	-	14	VMOD	-	-
2	<num>	<num>	B-NP	B-NP	-	3	NMOD	-	-
3	hours	hours	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	14	P	-	-
5	IL-1	IL-1	B-NP	B-NP	-	6	NMOD	-	-
6	beta	beta	I-NP	I-NP	-	9	NMOD	-	-
7	and	and	I-NP	I-NP	-	9	NMOD	-	-
8	IL-8	IL-8	I-NP	I-NP	-	9	NMOD	-	-
9	concentration	concentration	I-NP	I-NP	-	14	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	cell-free	cell-free	I-NP	I-NP	-	13	NMOD	-	-
13	supernatant	supernatant	I-NP	I-NP	-	10	PMOD	-	-
14	had	had	B-VP	B-VP	-	33	VMOD	-	-
15	increased	increased	I-VP	I-VP	-	14	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	<num>	<num>	B-NP	B-NP	-	19	AMOD	-	-
18	+/-	+/-	I-NP	I-NP	-	19	AMOD	-	-
19	<num>	<num>	I-NP	I-NP	-	20	NMOD	-	-
20	%	%	I-NP	I-NP	-	25	NMOD	-	-
21	and	and	I-NP	I-NP	-	25	NMOD	-	-
22	<num>	<num>	I-NP	I-NP	-	24	AMOD	-	-
23	+/-	+/-	I-NP	I-NP	-	24	AMOD	-	-
24	<num>	<num>	I-NP	I-NP	-	25	NMOD	-	-
25	%	%	I-NP	I-NP	-	16	PMOD	-	-
26	,	,	O	O	-	33	P	-	-
27	respectively	respectively	B-ADVP	B-ADVP	-	33	VMOD	-	-
28	,	,	O	O	-	33	P	-	-
29	and	and	O	O	-	33	VMOD	-	-
30	cellular	cellular	B-NP	B-NP	-	32	NMOD	-	-
31	MCP-1	MCP-1	I-NP	I-NP	-	32	NMOD	-	-
32	content	content	I-NP	I-NP	-	33	SUB	-	-
33	had	had	B-VP	B-VP	-	0	ROOT	-	-
34	increased	increased	I-VP	I-VP	-	33	VC	-	-
35	by	by	B-PP	B-PP	-	34	VMOD	-	-
36	<num>	<num>	B-NP	B-NP	-	38	AMOD	-	-
37	+/-	+/-	I-NP	I-NP	-	38	AMOD	-	-
38	<num>	<num>	I-NP	I-NP	-	39	NMOD	-	-
39	%	%	I-NP	I-NP	-	35	PMOD	-	-
40	.	.	O	O	-	33	P	-	-

1	Addition	Addition	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	activated	activated	B-NP	B-NP	-	4	NMOD	-	-
4	platelets	platelets	I-NP	I-NP	-	2	PMOD	-	-
5	to	to	B-PP	B-PP	-	1	NMOD	-	-
6	adherent	adherent	B-NP	B-NP	-	7	NMOD	-	-
7	monocytes	monocytes	I-NP	I-NP	-	5	PMOD	-	-
8	had	had	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	similar	similar	I-NP	I-NP	-	11	NMOD	-	-
11	effect	effect	I-NP	I-NP	-	8	OBJ	-	-
12	and	and	O	O	-	8	VMOD	-	-
13	was	was	B-VP	B-VP	-	8	VMOD	-	-
14	associated	associated	I-VP	I-VP	-	13	VC	-	-
15	with	with	B-PP	B-PP	-	14	VMOD	-	-
16	nuclear	nuclear	B-NP	B-NP	-	19	NMOD	-	-
17	factor-kappa	factor-kappa	I-NP	I-NP	-	19	NMOD	-	-
18	B	B	I-NP	I-NP	-	19	NMOD	-	-
19	activation	activation	I-NP	I-NP	-	15	PMOD	-	-
20	.	.	O	O	-	8	P	-	-

1	Inhibition	Inhibition	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	binding	binding	B-NP	B-NP	-	2	PMOD	-	-
4	by	by	B-PP	B-PP	-	1	NMOD	-	-
5	anti-P	anti-P	B-NP	B-NP	-	7	NMOD	-	-
6	selectin	selectin	I-NP	I-NP	-	7	NMOD	-	-
7	antibodies	antibodies	I-NP	I-NP	-	4	PMOD	-	-
8	reduced	reduced	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	effect	effect	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	activated	activated	B-NP	B-NP	-	13	NMOD	-	-
13	platelets	platelets	I-NP	I-NP	-	11	PMOD	-	-
14	on	on	B-PP	B-PP	-	10	NMOD	-	-
15	cytokine	cytokine	B-NP	B-NP	-	16	NMOD	-	-
16	production	production	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	8	P	-	-

1	CONCLUSIONS	CONCLUSIONS	B-NP	B-NP	-	0	ROOT	-	-
2	:	:	O	O	-	1	P	-	-
3	In	In	B-PP	B-PP	-	1	NMOD	-	-
4	patients	patients	B-NP	B-NP	-	3	PMOD	-	-
5	with	with	B-PP	B-PP	-	4	NMOD	-	-
6	AMI	AMI	B-NP	B-NP	-	5	PMOD	-	-
7	,	,	O	O	-	10	P	-	-
8	leukocyte-platelet	leukocyte-platelet	B-NP	B-NP	-	9	NMOD	-	-
9	adhesion	adhesion	I-NP	I-NP	-	10	SUB	-	-
10	is	is	B-VP	B-VP	-	5	SBAR	-	-
11	increased	increased	I-VP	I-VP	-	10	VC	-	-
12	.	.	O	O	-	1	P	-	-

1	Binding	Binding	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	activated	activated	B-NP	B-NP	-	4	NMOD	-	-
4	platelets	platelets	I-NP	I-NP	-	2	PMOD	-	-
5	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
6	IL-1	IL-1	B-NP	B-NP	-	7	NMOD	-	-
7	beta	beta	I-NP	I-NP	-	12	NMOD	-	-
8	,	,	O	O	-	12	P	-	-
9	IL-8	IL-8	B-NP	B-NP	-	12	NMOD	-	-
10	,	,	O	O	-	12	P	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	MCP-1	MCP-1	B-NP	B-NP	-	5	OBJ	-	-
13	in	in	B-PP	B-PP	-	5	VMOD	-	-
14	leukocytes	leukocytes	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	5	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	findings	findings	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	leukocyte-platelet	leukocyte-platelet	B-NP	B-NP	-	6	NMOD	-	-
6	adhesion	adhesion	I-NP	I-NP	-	7	SUB	-	-
7	contributes	contributes	B-VP	B-VP	-	4	SBAR	-	-
8	to	to	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	regulation	regulation	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	inflammatory	inflammatory	B-NP	B-NP	-	13	NMOD	-	-
13	responses	responses	I-NP	I-NP	-	11	PMOD	-	-
14	in	in	B-PP	B-PP	-	10	NMOD	-	-
15	AMI	AMI	B-NP	B-NP	-	14	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	class	class	I-NP	I-NP	-	4	NMOD	-	-
3	II	II	I-NP	I-NP	-	4	NMOD	-	-
4	trans-activator	trans-activator	I-NP	I-NP	-	5	NMOD	-	-
5	CIITA	CIITA	I-NP	I-NP	-	6	SUB	-	-
6	interacts	interacts	B-VP	B-VP	-	0	ROOT	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	TBP-associated	TBP-associated	I-NP	I-NP	-	11	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	11	NMOD	-	-
11	TAFII32	TAFII32	I-NP	I-NP	-	7	PMOD	-	-
12	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	class	class	I-NP	I-NP	-	5	NMOD	-	-
3	II	II	I-NP	I-NP	-	5	NMOD	-	-
4	trans-	trans-	I-NP	I-NP	-	5	NMOD	-	-
5	activator	activator	I-NP	I-NP	-	9	SUB	-	-
6	(	(	O	O	-	7	P	-	-
7	CIITA	CIITA	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	main	main	I-NP	I-NP	-	13	NMOD	-	-
12	transcriptional	transcriptional	I-NP	I-NP	-	13	NMOD	-	-
13	co-activator	co-activator	I-NP	I-NP	-	9	PRD	-	-
14	for	for	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	MHC	MHC	B-NP	B-NP	-	21	NMOD	-	-
19	class	class	I-NP	I-NP	-	21	NMOD	-	-
20	II	II	B-NP	B-NP	-	21	NMOD	-	-
21	proteins	proteins	I-NP	I-NP	-	17	PMOD	-	-
22	.	.	O	O	-	9	P	-	-

1	Its	Its	B-NP	B-NP	-	5	NMOD	-	-
2	N-terminal	N-terminal	I-NP	I-NP	-	5	NMOD	-	-
3	<num>	<num>	I-NP	I-NP	-	5	NMOD	-	-
4	amino	amino	I-NP	I-NP	-	5	NMOD	-	-
5	acids	acids	I-NP	I-NP	-	6	SUB	-	-
6	function	function	B-VP	B-VP	-	0	ROOT	-	-
7	as	as	B-PP	B-PP	-	6	VMOD	-	-
8	an	an	B-NP	B-NP	-	12	NMOD	-	-
9	independent	independent	I-NP	I-NP	-	12	NMOD	-	-
10	transcriptional	transcriptional	I-NP	I-NP	-	12	NMOD	-	-
11	activation	activation	I-NP	I-NP	-	12	NMOD	-	-
12	domain	domain	I-NP	I-NP	-	7	PMOD	-	-
13	.	.	O	O	-	6	P	-	-

1	Analyses	Analyses	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	7	NMOD	-	-
4	primary	primary	I-NP	I-NP	-	7	NMOD	-	-
5	amino	amino	I-NP	I-NP	-	7	NMOD	-	-
6	acid	acid	I-NP	I-NP	-	7	NMOD	-	-
7	sequence	sequence	I-NP	I-NP	-	2	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	11	NMOD	-	-
11	domain	domain	I-NP	I-NP	-	8	PMOD	-	-
12	predict	predict	B-VP	B-VP	-	0	ROOT	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	presence	presence	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	three	three	B-NP	B-NP	-	17	NMOD	-	-
17	alpha-helices	alpha-helices	I-NP	I-NP	-	15	PMOD	-	-
18	,	,	O	O	-	12	P	-	-
19	each	each	B-NP	B-NP	-	12	VMOD	-	-
20	with	with	B-PP	B-PP	-	19	NMOD	-	-
21	a	a	B-NP	B-NP	-	23	NMOD	-	-
22	high	high	I-NP	I-NP	-	23	NMOD	-	-
23	proportion	proportion	I-NP	I-NP	-	20	PMOD	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	acidic	acidic	B-NP	B-NP	-	26	NMOD	-	-
26	residues	residues	I-NP	I-NP	-	24	PMOD	-	-
27	.	.	O	O	-	12	P	-	-

1	Using	Using	B-VP	B-VP	-	6	VMOD	-	-
2	site-directed	site-directed	B-NP	B-NP	-	3	NMOD	-	-
3	mutagenesis	mutagenesis	I-NP	I-NP	-	1	OBJ	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	found	found	B-VP	B-VP	-	0	ROOT	-	-
7	that	that	B-SBAR	B-SBAR	-	6	VMOD	-	-
8	two	two	B-NP	B-NP	-	13	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	these	these	B-NP	B-NP	-	12	NMOD	-	-
11	predicted	predicted	I-NP	I-NP	-	12	NMOD	-	-
12	alpha-helices	alpha-helices	I-NP	I-NP	-	9	PMOD	-	-
13	are	are	B-VP	B-VP	-	7	SBAR	-	-
14	required	required	I-VP	I-VP	-	13	VC	-	-
15	for	for	B-PP	B-PP	-	14	VMOD	-	-
16	full	full	B-NP	B-NP	-	18	NMOD	-	-
17	transcriptional	transcriptional	I-NP	I-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	15	PMOD	-	-
19	by	by	B-PP	B-PP	-	18	NMOD	-	-
20	CIITA	CIITA	B-NP	B-NP	-	19	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	CIITA	CIITA	I-NP	I-NP	-	5	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	10	NMOD	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	which	which	B-NP	B-NP	-	6	PMOD	-	-
8	both	both	O	O	-	10	NMOD	-	-
9	functional	functional	B-NP	B-NP	-	10	NMOD	-	-
10	alpha-helices	alpha-helices	I-NP	I-NP	-	11	SUB	-	-
11	have	have	B-VP	B-VP	-	0	ROOT	-	-
12	been	been	I-VP	I-VP	-	11	VC	-	-
13	deleted	deleted	I-VP	I-VP	-	12	VC	-	-
14	displays	displays	B-VP	B-VP	-	11	VMOD	-	-
15	a	a	B-NP	B-NP	-	18	NMOD	-	-
16	dominant	dominant	I-NP	I-NP	-	18	NMOD	-	-
17	negative	negative	I-NP	I-NP	-	18	NMOD	-	-
18	phenotype	phenotype	I-NP	I-NP	-	14	OBJ	-	-
19	.	.	O	O	-	11	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	3	NMOD	-	-
3	domain	domain	I-NP	I-NP	-	6	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	CIITA	CIITA	B-NP	B-NP	-	4	PMOD	-	-
6	interacts	interacts	B-VP	B-VP	-	0	ROOT	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	<num>	<num>	I-NP	I-NP	-	10	AMOD	-	-
10	kDa	kDa	I-NP	I-NP	-	11	NMOD	-	-
11	subunit	subunit	I-NP	I-NP	-	7	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	17	NMOD	-	-
14	general	general	I-NP	I-NP	-	17	NMOD	-	-
15	transcription	transcription	I-NP	I-NP	-	17	NMOD	-	-
16	complex	complex	I-NP	I-NP	-	17	NMOD	-	-
17	TFIID	TFIID	I-NP	I-NP	-	19	NMOD	-	-
18	,	,	O	O	-	19	P	-	-
19	TAFII32	TAFII32	B-NP	B-NP	-	12	PMOD	-	-
20	.	.	O	O	-	6	P	-	-

1	Decreased	Decreased	B-NP	B-NP	-	3	NMOD	-	-
2	transcriptional	transcriptional	I-NP	I-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	9	SUB	-	-
4	by	by	B-PP	B-PP	-	3	NMOD	-	-
5	N-terminal	N-terminal	B-NP	B-NP	-	6	NMOD	-	-
6	deletions	deletions	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	CIITA	CIITA	B-NP	B-NP	-	7	PMOD	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	correlated	correlated	I-VP	I-VP	-	9	VC	-	-
11	directly	directly	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	with	with	B-PP	B-PP	-	10	VMOD	-	-
13	their	their	B-NP	B-NP	-	15	NMOD	-	-
14	reduced	reduced	I-NP	I-NP	-	15	NMOD	-	-
15	binding	binding	I-NP	I-NP	-	12	PMOD	-	-
16	to	to	B-PP	B-PP	-	15	NMOD	-	-
17	TAFII32	TAFII32	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	9	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	conclude	conclude	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	interactions	interactions	B-NP	B-NP	-	9	SUB	-	-
5	between	between	B-PP	B-PP	-	4	NMOD	-	-
6	TAFII32	TAFII32	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	I-NP	I-NP	-	8	NMOD	-	-
8	CIITA	CIITA	I-NP	I-NP	-	5	PMOD	-	-
9	are	are	B-VP	B-VP	-	3	SBAR	-	-
10	responsible	responsible	B-ADJP	B-ADJP	-	9	PRD	-	-
11	for	for	B-PP	B-PP	-	10	AMOD	-	-
12	activation	activation	B-NP	B-NP	-	11	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	class	class	B-NP	B-NP	-	16	NMOD	-	-
15	II	II	B-NP	B-NP	-	16	NMOD	-	-
16	genes	genes	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	2	P	-	-

1	Lipopolysaccharide	Lipopolysaccharide	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	tumor	tumor	I-NP	I-NP	-	8	NMOD	-	-
6	necrosis	necrosis	I-NP	I-NP	-	8	NMOD	-	-
7	factor-alpha	factor-alpha	I-NP	I-NP	-	8	NMOD	-	-
8	promoter	promoter	I-NP	I-NP	-	3	PMOD	-	-
9	in	in	B-PP	B-PP	-	2	NMOD	-	-
10	human	human	B-NP	B-NP	-	12	NMOD	-	-
11	monocytic	monocytic	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	2	P	-	-

1	Regulation	Regulation	B-NP	B-NP	-	0	ROOT	-	-
2	by	by	B-PP	B-PP	-	1	NMOD	-	-
3	Egr-1	Egr-1	B-NP	B-NP	-	10	NMOD	-	-
4	,	,	O	O	-	10	P	-	-
5	c-Jun	c-Jun	B-NP	B-NP	-	10	NMOD	-	-
6	,	,	O	O	-	10	P	-	-
7	and	and	O	O	-	10	NMOD	-	-
8	NF-kappaB	NF-kappaB	B-NP	B-NP	-	10	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	10	NMOD	-	-
10	factors	factors	I-NP	I-NP	-	2	PMOD	-	-
11	.	.	O	O	-	1	P	-	-

1	Biosynthesis	Biosynthesis	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	tumor	tumor	B-NP	B-NP	-	5	NMOD	-	-
4	necrosis	necrosis	I-NP	I-NP	-	5	NMOD	-	-
5	factor-alpha	factor-alpha	I-NP	I-NP	-	2	PMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	TNF-alpha	TNF-alpha	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	is	is	B-VP	B-VP	-	0	ROOT	-	-
10	predominantly	predominantly	B-ADVP	B-ADVP	-	9	VMOD	-	-
11	by	by	B-PP	B-PP	-	9	VMOD	-	-
12	cells	cells	B-NP	B-NP	-	11	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	monocytic	monocytic	I-NP	I-NP	-	16	NMOD	-	-
16	lineage	lineage	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	9	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	study	study	I-NP	I-NP	-	3	SUB	-	-
3	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	role	role	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	various	various	B-NP	B-NP	-	10	NMOD	-	-
8	cis-acting	cis-acting	I-NP	I-NP	-	10	NMOD	-	-
9	regulatory	regulatory	I-NP	I-NP	-	10	NMOD	-	-
10	elements	elements	I-NP	I-NP	-	6	PMOD	-	-
11	in	in	B-PP	B-PP	-	5	NMOD	-	-
12	the	the	B-NP	B-NP	-	17	NMOD	-	-
13	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	17	NMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	LPS	LPS	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	induction	induction	B-NP	B-NP	-	11	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	human	human	I-NP	I-NP	-	22	NMOD	-	-
21	TNF-alpha	TNF-alpha	I-NP	I-NP	-	22	NMOD	-	-
22	promoter	promoter	I-NP	I-NP	-	18	PMOD	-	-
23	in	in	B-PP	B-PP	-	17	NMOD	-	-
24	cells	cells	B-NP	B-NP	-	23	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	monocytic	monocytic	B-NP	B-NP	-	27	NMOD	-	-
27	lineage	lineage	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	Functional	Functional	B-NP	B-NP	-	2	NMOD	-	-
2	analysis	analysis	I-NP	I-NP	-	16	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	monocytic	monocytic	B-NP	B-NP	-	6	NMOD	-	-
5	THP-1	THP-1	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
7	transfected	transfected	B-VP	B-VP	-	6	NMOD	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	plasmids	plasmids	B-NP	B-NP	-	8	PMOD	-	-
10	containing	containing	B-VP	B-VP	-	9	NMOD	-	-
11	various	various	B-NP	B-NP	-	12	NMOD	-	-
12	lengths	lengths	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	TNF-alpha	TNF-alpha	B-NP	B-NP	-	15	NMOD	-	-
15	promoter	promoter	I-NP	I-NP	-	13	PMOD	-	-
16	localized	localized	B-VP	B-VP	-	0	ROOT	-	-
17	enhancer	enhancer	B-NP	B-NP	-	18	NMOD	-	-
18	elements	elements	I-NP	I-NP	-	16	OBJ	-	-
19	in	in	B-PP	B-PP	-	16	VMOD	-	-
20	a	a	B-NP	B-NP	-	21	NMOD	-	-
21	region	region	I-NP	I-NP	-	19	PMOD	-	-
22	(	(	O	O	-	29	P	-	-
23	-182	-182	B-NP	B-NP	-	25	NMOD	-	-
24	to	to	I-NP	I-NP	-	25	NMOD	-	-
25	-37	-37	I-NP	I-NP	-	27	NMOD	-	-
26	base	base	I-NP	I-NP	-	27	NMOD	-	-
27	pairs	pairs	I-NP	I-NP	-	29	NMOD	-	-
28	(	(	O	O	-	29	P	-	-
29	bp	bp	B-NP	B-NP	-	21	NMOD	-	-
30	)	)	O	O	-	29	P	-	-
31	)	)	O	O	-	29	P	-	-
32	that	that	B-NP	B-NP	-	21	NMOD	-	-
33	were	were	B-VP	B-VP	-	32	SBAR	-	-
34	required	required	I-VP	I-VP	-	33	VC	-	-
35	for	for	B-PP	B-PP	-	34	VMOD	-	-
36	optimal	optimal	B-NP	B-NP	-	37	NMOD	-	-
37	transcription	transcription	I-NP	I-NP	-	35	PMOD	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	the	the	B-NP	B-NP	-	41	NMOD	-	-
40	TNF-alpha	TNF-alpha	I-NP	I-NP	-	41	NMOD	-	-
41	gene	gene	I-NP	I-NP	-	38	PMOD	-	-
42	in	in	B-PP	B-PP	-	37	NMOD	-	-
43	response	response	I-PP	I-PP	-	42	PMOD	-	-
44	to	to	I-PP	I-PP	-	42	PMOD	-	-
45	LPS	LPS	B-NP	B-NP	-	44	PMOD	-	-
46	.	.	O	O	-	16	P	-	-

1	Two	Two	B-NP	B-NP	-	2	NMOD	-	-
2	regions	regions	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	identified	identified	I-VP	I-VP	-	3	VC	-	-
5	:	:	O	O	-	3	P	-	-
6	region	region	B-NP	B-NP	-	14	SUB	-	-
7	I	I	I-NP	I-NP	-	6	NMOD	-	-
8	(	(	O	O	-	12	P	-	-
9	-182	-182	B-NP	B-NP	-	11	NMOD	-	-
10	to	to	O	O	-	11	NMOD	-	-
11	-162	-162	B-NP	B-NP	-	12	NMOD	-	-
12	bp	bp	I-NP	I-NP	-	6	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	contained	contained	B-VP	B-VP	-	3	VMOD	-	-
15	an	an	B-NP	B-NP	-	18	NMOD	-	-
16	overlapping	overlapping	I-NP	I-NP	-	18	NMOD	-	-
17	Sp1/Egr-1	Sp1/Egr-1	I-NP	I-NP	-	18	NMOD	-	-
18	site	site	I-NP	I-NP	-	14	OBJ	-	-
19	,	,	O	O	-	28	P	-	-
20	and	and	O	O	-	28	VMOD	-	-
21	region	region	B-NP	B-NP	-	28	SUB	-	-
22	II	II	I-NP	I-NP	-	21	NMOD	-	-
23	(	(	O	O	-	26	P	-	-
24	-119	-119	B-NP	B-NP	-	26	NMOD	-	-
25	to	to	O	O	-	26	NMOD	-	-
26	-88	-88	B-NP	B-NP	-	21	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	contained	contained	B-VP	B-VP	-	14	VMOD	-	-
29	CRE	CRE	B-NP	B-NP	-	31	NMOD	-	-
30	and	and	I-NP	I-NP	-	31	NMOD	-	-
31	NF-kappaB	NF-kappaB	I-NP	I-NP	-	36	NMOD	-	-
32	(	(	O	O	-	36	P	-	-
33	designated	designated	B-NP	B-NP	-	36	NMOD	-	-
34	kappaB3	kappaB3	I-NP	I-NP	-	33	NMOD	-	-
35	)	)	I-NP	I-NP	-	33	P	-	-
36	sites	sites	I-NP	I-NP	-	28	OBJ	-	-
37	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	16	VMOD	-	-
2	unstimulated	unstimulated	B-NP	B-NP	-	3	NMOD	-	-
3	THP-1	THP-1	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	16	P	-	-
5	CRE-binding	CRE-binding	B-NP	B-NP	-	6	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	4	NMOD	-	-
7	and	and	O	O	-	16	VMOD	-	-
8	,	,	O	O	-	16	P	-	-
9	to	to	B-PP	B-PP	-	16	VMOD	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	lesser	lesser	I-NP	I-NP	-	12	NMOD	-	-
12	extent	extent	I-NP	I-NP	-	9	PMOD	-	-
13	,	,	O	O	-	16	P	-	-
14	c-Jun	c-Jun	B-NP	B-NP	-	15	NMOD	-	-
15	complexes	complexes	I-NP	I-NP	-	16	SUB	-	-
16	were	were	B-VP	B-VP	-	0	ROOT	-	-
17	found	found	I-VP	I-VP	-	16	VC	-	-
18	to	to	I-VP	I-VP	-	19	VMOD	-	-
19	bind	bind	I-VP	I-VP	-	17	VMOD	-	-
20	to	to	B-PP	B-PP	-	19	VMOD	-	-
21	the	the	B-NP	B-NP	-	23	NMOD	-	-
22	CRE	CRE	I-NP	I-NP	-	23	NMOD	-	-
23	site	site	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	16	P	-	-

1	LPS	LPS	B-NP	B-NP	-	2	NMOD	-	-
2	stimulation	stimulation	I-NP	I-NP	-	3	SUB	-	-
3	increased	increased	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	binding	binding	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	c-Jun-containing	c-Jun-containing	B-NP	B-NP	-	8	NMOD	-	-
8	complexes	complexes	I-NP	I-NP	-	6	PMOD	-	-
9	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	LPS	LPS	B-NP	B-NP	-	5	NMOD	-	-
5	stimulation	stimulation	I-NP	I-NP	-	6	SUB	-	-
6	induced	induced	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	binding	binding	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	cognate	cognate	B-NP	B-NP	-	12	NMOD	-	-
11	nuclear	nuclear	I-NP	I-NP	-	12	NMOD	-	-
12	factors	factors	I-NP	I-NP	-	9	PMOD	-	-
13	to	to	B-PP	B-PP	-	8	NMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	Egr-1	Egr-1	I-NP	I-NP	-	18	NMOD	-	-
16	and	and	I-NP	I-NP	-	18	NMOD	-	-
17	kappaB3	kappaB3	I-NP	I-NP	-	18	NMOD	-	-
18	sites	sites	I-NP	I-NP	-	13	PMOD	-	-
19	,	,	O	O	-	18	P	-	-
20	which	which	B-NP	B-NP	-	18	NMOD	-	-
21	were	were	B-VP	B-VP	-	20	SBAR	-	-
22	identified	identified	I-VP	I-VP	-	21	VC	-	-
23	as	as	B-PP	B-PP	-	22	VMOD	-	-
24	Egr-1	Egr-1	B-NP	B-NP	-	26	NMOD	-	-
25	and	and	I-NP	I-NP	-	26	NMOD	-	-
26	p50/p65	p50/p65	I-NP	I-NP	-	23	PMOD	-	-
27	,	,	O	O	-	6	P	-	-
28	respectively	respectively	B-ADVP	B-ADVP	-	6	VMOD	-	-
29	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	CRE	CRE	I-NP	I-NP	-	5	NMOD	-	-
3	and	and	I-NP	I-NP	-	5	NMOD	-	-
4	kappaB3	kappaB3	I-NP	I-NP	-	5	NMOD	-	-
5	sites	sites	I-NP	I-NP	-	10	SUB	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	region	region	B-NP	B-NP	-	6	PMOD	-	-
8	II	II	I-NP	I-NP	-	7	NMOD	-	-
9	together	together	B-ADVP	B-ADVP	-	10	VMOD	-	-
10	conferred	conferred	B-VP	B-VP	-	0	ROOT	-	-
11	strong	strong	B-NP	B-NP	-	13	NMOD	-	-
12	LPS	LPS	I-NP	I-NP	-	13	NMOD	-	-
13	responsiveness	responsiveness	I-NP	I-NP	-	10	OBJ	-	-
14	to	to	B-PP	B-PP	-	13	NMOD	-	-
15	a	a	B-NP	B-NP	-	17	NMOD	-	-
16	heterologous	heterologous	I-NP	I-NP	-	17	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	14	PMOD	-	-
18	,	,	O	O	-	10	P	-	-
19	whereas	whereas	O	O	-	10	VMOD	-	-
20	individually	individually	B-ADVP	B-ADVP	-	22	VMOD	-	-
21	they	they	B-NP	B-NP	-	22	SUB	-	-
22	failed	failed	B-VP	B-VP	-	19	VMOD	-	-
23	to	to	I-VP	I-VP	-	24	VMOD	-	-
24	provide	provide	I-VP	I-VP	-	22	VMOD	-	-
25	transcriptional	transcriptional	B-NP	B-NP	-	26	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	24	OBJ	-	-
27	.	.	O	O	-	10	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	14	VMOD	-	-
2	,	,	O	O	-	14	P	-	-
3	increasing	increasing	B-VP	B-VP	-	14	VMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	spacing	spacing	I-NP	I-NP	-	3	OBJ	-	-
6	between	between	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	CRE	CRE	I-NP	I-NP	-	12	NMOD	-	-
9	and	and	O	O	-	12	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	kappaB3	kappaB3	I-NP	I-NP	-	12	NMOD	-	-
12	sites	sites	I-NP	I-NP	-	6	PMOD	-	-
13	completely	completely	B-ADVP	B-ADVP	-	14	VMOD	-	-
14	abolished	abolished	B-VP	B-VP	-	0	ROOT	-	-
15	LPS	LPS	B-NP	B-NP	-	16	NMOD	-	-
16	induction	induction	I-NP	I-NP	-	14	OBJ	-	-
17	,	,	O	O	-	14	P	-	-
18	suggesting	suggesting	B-VP	B-VP	-	14	VMOD	-	-
19	a	a	B-NP	B-NP	-	21	NMOD	-	-
20	cooperative	cooperative	I-NP	I-NP	-	21	NMOD	-	-
21	interaction	interaction	I-NP	I-NP	-	18	OBJ	-	-
22	between	between	B-PP	B-PP	-	21	NMOD	-	-
23	c-Jun	c-Jun	B-NP	B-NP	-	24	NMOD	-	-
24	complexes	complexes	I-NP	I-NP	-	26	NMOD	-	-
25	and	and	O	O	-	26	NMOD	-	-
26	p50/p65	p50/p65	B-NP	B-NP	-	22	PMOD	-	-
27	.	.	O	O	-	14	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	maximal	maximal	B-NP	B-NP	-	7	NMOD	-	-
6	LPS	LPS	I-NP	I-NP	-	7	NMOD	-	-
7	induction	induction	I-NP	I-NP	-	12	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	TNF-alpha	TNF-alpha	I-NP	I-NP	-	11	NMOD	-	-
11	promoter	promoter	I-NP	I-NP	-	8	PMOD	-	-
12	is	is	B-VP	B-VP	-	4	SBAR	-	-
13	mediated	mediated	I-VP	I-VP	-	12	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	concerted	concerted	B-NP	B-NP	-	16	NMOD	-	-
16	participation	participation	I-NP	I-NP	-	14	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	at	at	B-NP	B-NP	-	24	NMOD	-	-
19	least	least	I-NP	I-NP	-	18	AMOD	-	-
20	two	two	I-NP	I-NP	-	18	AMOD	-	-
21	separate	separate	I-NP	I-NP	-	24	NMOD	-	-
22	cis-acting	cis-acting	I-NP	I-NP	-	24	NMOD	-	-
23	regulatory	regulatory	I-NP	I-NP	-	24	NMOD	-	-
24	elements	elements	I-NP	I-NP	-	17	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Involvement	Involvement	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Rel	Rel	B-NP	B-NP	-	9	NMOD	-	-
4	,	,	O	O	-	9	P	-	-
5	Fos	Fos	B-NP	B-NP	-	9	NMOD	-	-
6	,	,	O	O	-	9	P	-	-
7	and	and	O	O	-	9	NMOD	-	-
8	Jun	Jun	B-NP	B-NP	-	9	NMOD	-	-
9	proteins	proteins	I-NP	I-NP	-	2	PMOD	-	-
10	in	in	B-PP	B-PP	-	1	NMOD	-	-
11	binding	binding	B-NP	B-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	10	PMOD	-	-
13	to	to	B-PP	B-PP	-	1	NMOD	-	-
14	the	the	B-NP	B-NP	-	20	NMOD	-	-
15	IL-2	IL-2	I-NP	I-NP	-	20	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	20	NMOD	-	-
17	CD28	CD28	I-NP	I-NP	-	20	NMOD	-	-
18	response	response	I-NP	I-NP	-	20	NMOD	-	-
19	element/AP-1	element/AP-1	I-NP	I-NP	-	20	NMOD	-	-
20	sequence	sequence	I-NP	I-NP	-	13	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	human	human	B-NP	B-NP	-	24	NMOD	-	-
23	T	T	I-NP	I-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	1	P	-	-

1	CD28	CD28	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	an	an	B-NP	B-NP	-	6	NMOD	-	-
4	important	important	I-NP	I-NP	-	6	NMOD	-	-
5	costimulatory	costimulatory	I-NP	I-NP	-	6	NMOD	-	-
6	molecule	molecule	I-NP	I-NP	-	2	PRD	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	human	human	B-NP	B-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	Costimulation	Costimulation	B-NP	B-NP	-	12	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	T	T	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	through	through	B-PP	B-PP	-	1	NMOD	-	-
6	both	both	O	O	-	11	NMOD	-	-
7	the	the	B-NP	B-NP	-	11	NMOD	-	-
8	Ag	Ag	I-NP	I-NP	-	9	NMOD	-	-
9	receptor	receptor	I-NP	I-NP	-	11	NMOD	-	-
10	and	and	I-NP	I-NP	-	11	NMOD	-	-
11	CD28	CD28	I-NP	I-NP	-	5	PMOD	-	-
12	leads	leads	B-VP	B-VP	-	0	ROOT	-	-
13	to	to	B-PP	B-PP	-	12	VMOD	-	-
14	high	high	B-NP	B-NP	-	17	NMOD	-	-
15	level	level	I-NP	I-NP	-	17	NMOD	-	-
16	IL-2	IL-2	I-NP	I-NP	-	17	NMOD	-	-
17	production	production	I-NP	I-NP	-	13	PMOD	-	-
18	,	,	O	O	-	17	P	-	-
19	which	which	B-NP	B-NP	-	17	NMOD	-	-
20	is	is	B-VP	B-VP	-	19	SBAR	-	-
21	vital	vital	B-ADJP	B-ADJP	-	20	PRD	-	-
22	to	to	B-PP	B-PP	-	21	AMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	development	development	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	an	an	B-NP	B-NP	-	28	NMOD	-	-
27	immune	immune	I-NP	I-NP	-	28	NMOD	-	-
28	response	response	I-NP	I-NP	-	25	PMOD	-	-
29	in	in	B-ADVP	B-ADVP	-	28	NMOD	-	-
30	vivo	vivo	I-ADVP	I-ADVP	-	29	AMOD	-	-
31	.	.	O	O	-	12	P	-	-

1	Previous	Previous	B-NP	B-NP	-	2	NMOD	-	-
2	reports	reports	I-NP	I-NP	-	3	SUB	-	-
3	have	have	B-VP	B-VP	-	0	ROOT	-	-
4	suggested	suggested	I-VP	I-VP	-	3	VC	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	CD28	CD28	I-NP	I-NP	-	7	NMOD	-	-
7	stimulation	stimulation	I-NP	I-NP	-	8	SUB	-	-
8	contributes	contributes	B-VP	B-VP	-	3	VMOD	-	-
9	to	to	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	activation	activation	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	IL-2	IL-2	I-NP	I-NP	-	15	NMOD	-	-
15	promoter	promoter	I-NP	I-NP	-	12	PMOD	-	-
16	by	by	B-PP	B-PP	-	8	VMOD	-	-
17	up-regulating	up-regulating	B-VP	B-VP	-	16	PMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	activity	activity	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	several	several	B-NP	B-NP	-	23	NMOD	-	-
22	transcription	transcription	I-NP	I-NP	-	23	NMOD	-	-
23	factors	factors	I-NP	I-NP	-	20	PMOD	-	-
24	,	,	O	O	-	23	P	-	-
25	including	including	B-PP	B-PP	-	23	NMOD	-	-
26	AP-1	AP-1	B-NP	B-NP	-	29	NMOD	-	-
27	and	and	O	O	-	29	NMOD	-	-
28	nuclear	nuclear	B-NP	B-NP	-	29	NMOD	-	-
29	factor-kappaB	factor-kappaB	I-NP	I-NP	-	35	NMOD	-	-
30	(	(	O	O	-	35	P	-	-
31	NF-kappaB	NF-kappaB	B-NP	B-NP	-	35	NMOD	-	-
32	)	)	O	O	-	35	P	-	-
33	/Rel	/Rel	B-NP	B-NP	-	35	NMOD	-	-
34	family	family	I-NP	I-NP	-	35	NMOD	-	-
35	members	members	I-NP	I-NP	-	42	NMOD	-	-
36	as	as	B-CONJP	B-CONJP	-	42	NMOD	-	-
37	well	well	I-CONJP	I-CONJP	-	36	DEP	-	-
38	as	as	I-CONJP	I-CONJP	-	36	DEP	-	-
39	an	an	B-NP	B-NP	-	42	NMOD	-	-
40	uncharacterized	uncharacterized	I-NP	I-NP	-	42	NMOD	-	-
41	transcription	transcription	I-NP	I-NP	-	42	NMOD	-	-
42	factor	factor	I-NP	I-NP	-	25	PMOD	-	-
43	called	called	B-VP	B-VP	-	42	NMOD	-	-
44	CD28	CD28	B-NP	B-NP	-	46	NMOD	-	-
45	response	response	I-NP	I-NP	-	46	NMOD	-	-
46	complex	complex	I-NP	I-NP	-	43	VMOD	-	-
47	.	.	O	O	-	3	P	-	-

1	While	While	B-SBAR	B-SBAR	-	23	VMOD	-	-
2	several	several	B-NP	B-NP	-	3	NMOD	-	-
3	lines	lines	I-NP	I-NP	-	6	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	investigation	investigation	B-NP	B-NP	-	4	PMOD	-	-
6	have	have	B-VP	B-VP	-	1	SBAR	-	-
7	suggested	suggested	I-VP	I-VP	-	6	VC	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	NF-kappaB/Rel	NF-kappaB/Rel	B-NP	B-NP	-	11	NMOD	-	-
10	family	family	I-NP	I-NP	-	11	NMOD	-	-
11	members	members	I-NP	I-NP	-	12	SUB	-	-
12	make	make	B-VP	B-VP	-	8	SBAR	-	-
13	up	up	B-PRT	B-PRT	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	19	NMOD	-	-
15	CD28	CD28	I-NP	I-NP	-	19	NMOD	-	-
16	response	response	I-NP	I-NP	-	19	NMOD	-	-
17	complex	complex	I-NP	I-NP	-	19	NMOD	-	-
18	transcription	transcription	I-NP	I-NP	-	19	NMOD	-	-
19	factor	factor	I-NP	I-NP	-	22	NMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	other	other	B-NP	B-NP	-	22	NMOD	-	-
22	work	work	I-NP	I-NP	-	23	SUB	-	-
23	has	has	B-VP	B-VP	-	0	ROOT	-	-
24	not	not	I-VP	I-VP	-	23	VMOD	-	-
25	supported	supported	I-VP	I-VP	-	23	VC	-	-
26	this	this	B-NP	B-NP	-	27	NMOD	-	-
27	conclusion	conclusion	I-NP	I-NP	-	25	OBJ	-	-
28	.	.	O	O	-	23	P	-	-

1	Recent	Recent	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	8	NMOD	-	-
6	CD28	CD28	I-NP	I-NP	-	8	NMOD	-	-
7	response	response	I-NP	I-NP	-	8	NMOD	-	-
8	element	element	I-NP	I-NP	-	12	SUB	-	-
9	(	(	O	O	-	10	P	-	-
10	CD28RE	CD28RE	B-NP	B-NP	-	8	NMOD	-	-
11	)	)	O	O	-	10	P	-	-
12	does	does	B-VP	B-VP	-	4	SBAR	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	function	function	I-VP	I-VP	-	12	VC	-	-
15	independently	independently	B-ADVP	B-ADVP	-	14	VMOD	-	-
16	but	but	O	O	-	12	VMOD	-	-
17	works	works	B-VP	B-VP	-	12	VMOD	-	-
18	instead	instead	B-ADVP	B-ADVP	-	17	VMOD	-	-
19	in	in	B-PP	B-PP	-	17	VMOD	-	-
20	conjunction	conjunction	B-NP	B-NP	-	19	PMOD	-	-
21	with	with	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	27	NMOD	-	-
23	adjacent	adjacent	I-NP	I-NP	-	27	NMOD	-	-
24	promoter	promoter	I-NP	I-NP	-	27	NMOD	-	-
25	proximal	proximal	I-NP	I-NP	-	27	NMOD	-	-
26	AP-1-binding	AP-1-binding	I-NP	I-NP	-	27	NMOD	-	-
27	site	site	I-NP	I-NP	-	21	PMOD	-	-
28	and	and	O	O	-	31	VMOD	-	-
29	this	this	B-NP	B-NP	-	30	NMOD	-	-
30	hypothesis	hypothesis	I-NP	I-NP	-	31	SUB	-	-
31	is	is	B-VP	B-VP	-	19	SBAR	-	-
32	confirmed	confirmed	I-VP	I-VP	-	31	VC	-	-
33	here	here	B-ADVP	B-ADVP	-	32	VMOD	-	-
34	.	.	O	O	-	3	P	-	-

1	Also	Also	B-ADVP	B-ADVP	-	2	PMOD	-	-
2	in	in	B-PP	B-PP	-	17	VMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	current	current	I-NP	I-NP	-	5	NMOD	-	-
5	study	study	I-NP	I-NP	-	2	PMOD	-	-
6	,	,	O	O	-	17	P	-	-
7	binding	binding	B-NP	B-NP	-	8	NMOD	-	-
8	activity	activity	I-NP	I-NP	-	17	SUB	-	-
9	to	to	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	CD28RE/AP-1	CD28RE/AP-1	I-NP	I-NP	-	12	NMOD	-	-
12	sequence	sequence	I-NP	I-NP	-	9	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	IL-2	IL-2	I-NP	I-NP	-	16	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	13	PMOD	-	-
17	is	is	B-VP	B-VP	-	0	ROOT	-	-
18	evaluated	evaluated	I-VP	I-VP	-	17	VC	-	-
19	.	.	O	O	-	17	P	-	-

1	Although	Although	B-SBAR	B-SBAR	-	18	VMOD	-	-
2	four	four	B-NP	B-NP	-	4	NMOD	-	-
3	specific	specific	I-NP	I-NP	-	4	NMOD	-	-
4	complexes	complexes	I-NP	I-NP	-	5	SUB	-	-
5	can	can	B-VP	B-VP	-	1	SBAR	-	-
6	be	be	I-VP	I-VP	-	5	VC	-	-
7	detected	detected	I-VP	I-VP	-	6	VC	-	-
8	binding	binding	B-VP	B-VP	-	7	VMOD	-	-
9	to	to	B-PP	B-PP	-	8	VMOD	-	-
10	this	this	B-NP	B-NP	-	11	NMOD	-	-
11	sequence	sequence	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	18	P	-	-
13	only	only	B-NP	B-NP	-	14	NMOD	-	-
14	one	one	I-NP	I-NP	-	18	SUB	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	these	these	B-NP	B-NP	-	17	NMOD	-	-
17	complexes	complexes	I-NP	I-NP	-	15	PMOD	-	-
18	is	is	B-VP	B-VP	-	0	ROOT	-	-
19	specific	specific	B-ADJP	B-ADJP	-	18	PRD	-	-
20	for	for	B-PP	B-PP	-	19	AMOD	-	-
21	both	both	O	O	-	28	NMOD	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	CD28RE	CD28RE	I-NP	I-NP	-	28	NMOD	-	-
24	and	and	O	O	-	28	NMOD	-	-
25	the	the	B-NP	B-NP	-	28	NMOD	-	-
26	adjacent	adjacent	I-NP	I-NP	-	28	NMOD	-	-
27	AP-1	AP-1	I-NP	I-NP	-	28	NMOD	-	-
28	site	site	I-NP	I-NP	-	20	PMOD	-	-
29	.	.	O	O	-	18	P	-	-

1	Of	Of	B-PP	B-PP	-	11	VMOD	-	-
2	the	the	B-NP	B-NP	-	5	NMOD	-	-
3	NF-kappaB/Rel	NF-kappaB/Rel	I-NP	I-NP	-	5	NMOD	-	-
4	family	family	I-NP	I-NP	-	5	NMOD	-	-
5	members	members	I-NP	I-NP	-	1	PMOD	-	-
6	tested	tested	B-VP	B-VP	-	5	NMOD	-	-
7	,	,	O	O	-	11	P	-	-
8	this	this	B-NP	B-NP	-	10	NMOD	-	-
9	CD28RE/AP-1-specific	CD28RE/AP-1-specific	I-NP	I-NP	-	10	NMOD	-	-
10	complex	complex	I-NP	I-NP	-	11	SUB	-	-
11	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
12	predominantly	predominantly	B-NP	B-NP	-	13	NMOD	-	-
13	c-Rel	c-Rel	I-NP	I-NP	-	11	OBJ	-	-
14	,	,	O	O	-	11	P	-	-
15	despite	despite	B-PP	B-PP	-	11	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	fact	fact	I-NP	I-NP	-	15	PMOD	-	-
18	that	that	B-SBAR	B-SBAR	-	17	NMOD	-	-
19	both	both	O	O	-	22	NMOD	-	-
20	p50	p50	B-NP	B-NP	-	22	NMOD	-	-
21	and	and	I-NP	I-NP	-	22	NMOD	-	-
22	RelA	RelA	I-NP	I-NP	-	23	SUB	-	-
23	can	can	B-VP	B-VP	-	18	SBAR	-	-
24	efficiently	efficiently	I-VP	I-VP	-	23	VMOD	-	-
25	bind	bind	I-VP	I-VP	-	23	VC	-	-
26	to	to	B-PP	B-PP	-	25	VMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	CD28RE	CD28RE	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	11	P	-	-

1	c-Fos	c-Fos	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	c-Jun	c-Jun	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	also	also	I-VP	I-VP	-	4	VMOD	-	-
6	found	found	I-VP	I-VP	-	4	VC	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	this	this	B-NP	B-NP	-	10	NMOD	-	-
9	CD28RE/AP-1-specific	CD28RE/AP-1-specific	I-NP	I-NP	-	10	NMOD	-	-
10	complex	complex	I-NP	I-NP	-	7	PMOD	-	-
11	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	functional	functional	B-NP	B-NP	-	6	NMOD	-	-
6	complexes	complexes	I-NP	I-NP	-	15	SUB	-	-
7	encompassing	encompassing	B-VP	B-VP	-	6	NMOD	-	-
8	both	both	O	O	-	14	NMOD	-	-
9	the	the	B-NP	B-NP	-	14	NMOD	-	-
10	CD28RE	CD28RE	I-NP	I-NP	-	14	NMOD	-	-
11	and	and	O	O	-	14	NMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	AP-1-binding	AP-1-binding	I-NP	I-NP	-	14	NMOD	-	-
14	sites	sites	I-NP	I-NP	-	7	OBJ	-	-
15	influence	influence	B-VP	B-VP	-	4	SBAR	-	-
16	IL-2	IL-2	B-NP	B-NP	-	18	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	18	NMOD	-	-
18	activity	activity	I-NP	I-NP	-	15	OBJ	-	-
19	in	in	B-PP	B-PP	-	18	NMOD	-	-
20	CD28-costimulated	CD28-costimulated	B-NP	B-NP	-	22	NMOD	-	-
21	T	T	I-NP	I-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	c-Myb	c-Myb	B-NP	B-NP	-	4	NMOD	-	-
2	and	and	I-NP	I-NP	-	4	NMOD	-	-
3	Ets	Ets	I-NP	I-NP	-	4	NMOD	-	-
4	proteins	proteins	I-NP	I-NP	-	5	SUB	-	-
5	synergize	synergize	B-VP	B-VP	-	0	ROOT	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	overcome	overcome	I-VP	I-VP	-	5	VMOD	-	-
8	transcriptional	transcriptional	B-NP	B-NP	-	9	NMOD	-	-
9	repression	repression	I-NP	I-NP	-	7	OBJ	-	-
10	by	by	B-PP	B-PP	-	7	VMOD	-	-
11	ZEB	ZEB	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	Zfh	Zfh	I-NP	I-NP	-	3	NMOD	-	-
3	family	family	I-NP	I-NP	-	8	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	zinc	zinc	B-NP	B-NP	-	7	NMOD	-	-
6	finger/homeodomain	finger/homeodomain	I-NP	I-NP	-	7	NMOD	-	-
7	proteins	proteins	I-NP	I-NP	-	4	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	first	first	I-VP	I-VP	-	8	VMOD	-	-
10	identified	identified	I-VP	I-VP	-	8	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	Drosophila	Drosophila	B-NP	B-NP	-	11	PMOD	-	-
13	where	where	B-ADVP	B-ADVP	-	11	PMOD	-	-
14	it	it	B-NP	B-NP	-	15	SUB	-	-
15	is	is	B-VP	B-VP	-	13	SBAR	-	-
16	required	required	I-VP	I-VP	-	15	VC	-	-
17	for	for	B-PP	B-PP	-	16	VMOD	-	-
18	differentiation	differentiation	B-NP	B-NP	-	17	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	tissues	tissues	B-NP	B-NP	-	19	PMOD	-	-
21	such	such	B-PP	B-PP	-	22	PMOD	-	-
22	as	as	I-PP	I-PP	-	20	NMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	central	central	I-NP	I-NP	-	26	NMOD	-	-
25	nervous	nervous	I-NP	I-NP	-	26	NMOD	-	-
26	system	system	I-NP	I-NP	-	28	NMOD	-	-
27	and	and	I-NP	I-NP	-	28	NMOD	-	-
28	muscle	muscle	I-NP	I-NP	-	22	PMOD	-	-
29	.	.	O	O	-	8	P	-	-

1	ZEB	ZEB	B-NP	B-NP	-	5	NMOD	-	-
2	,	,	O	O	-	5	P	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	vertebrate	vertebrate	I-NP	I-NP	-	5	NMOD	-	-
5	homolog	homolog	I-NP	I-NP	-	9	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	Zfh-1	Zfh-1	B-NP	B-NP	-	6	PMOD	-	-
8	,	,	O	O	-	5	P	-	-
9	binds	binds	B-VP	B-VP	-	0	ROOT	-	-
10	a	a	B-NP	B-NP	-	11	NMOD	-	-
11	subset	subset	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	E	E	B-NP	B-NP	-	14	NMOD	-	-
14	boxes	boxes	I-NP	I-NP	-	12	PMOD	-	-
15	and	and	O	O	-	9	VMOD	-	-
16	blocks	blocks	B-VP	B-VP	-	9	VMOD	-	-
17	myogenesis	myogenesis	B-NP	B-NP	-	16	OBJ	-	-
18	through	through	B-PP	B-PP	-	16	VMOD	-	-
19	transcriptional	transcriptional	B-NP	B-NP	-	20	NMOD	-	-
20	repression	repression	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	muscle	muscle	B-NP	B-NP	-	23	NMOD	-	-
23	genes	genes	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	9	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	present	present	B-VP	B-VP	-	0	ROOT	-	-
3	evidence	evidence	B-NP	B-NP	-	2	OBJ	-	-
4	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
5	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
6	ZEB	ZEB	B-NP	B-NP	-	8	SUB	-	-
7	also	also	B-ADVP	B-ADVP	-	8	VMOD	-	-
8	has	has	B-VP	B-VP	-	5	SBAR	-	-
9	an	an	B-NP	B-NP	-	11	NMOD	-	-
10	important	important	I-NP	I-NP	-	11	NMOD	-	-
11	role	role	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	8	VMOD	-	-
13	controlling	controlling	B-VP	B-VP	-	12	PMOD	-	-
14	hematopoietic	hematopoietic	B-NP	B-NP	-	16	NMOD	-	-
15	gene	gene	I-NP	I-NP	-	16	NMOD	-	-
16	transcription	transcription	I-NP	I-NP	-	13	OBJ	-	-
17	.	.	O	O	-	2	P	-	-

1	Two	Two	B-NP	B-NP	-	2	NMOD	-	-
2	families	families	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	transcription	transcription	B-NP	B-NP	-	5	NMOD	-	-
5	factors	factors	I-NP	I-NP	-	3	PMOD	-	-
6	that	that	B-NP	B-NP	-	5	NMOD	-	-
7	are	are	B-VP	B-VP	-	6	SBAR	-	-
8	required	required	I-VP	I-VP	-	7	VC	-	-
9	for	for	B-PP	B-PP	-	8	VMOD	-	-
10	normal	normal	B-NP	B-NP	-	11	NMOD	-	-
11	hematopoiesis	hematopoiesis	I-NP	I-NP	-	9	PMOD	-	-
12	are	are	B-VP	B-VP	-	0	ROOT	-	-
13	c-Myb	c-Myb	B-NP	B-NP	-	15	NMOD	-	-
14	and	and	I-NP	I-NP	-	15	NMOD	-	-
15	Ets	Ets	I-NP	I-NP	-	12	PRD	-	-
16	.	.	O	O	-	12	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	factors	factors	I-NP	I-NP	-	3	SUB	-	-
3	act	act	B-VP	B-VP	-	12	VMOD	-	-
4	synergistically	synergistically	B-ADVP	B-ADVP	-	3	VMOD	-	-
5	to	to	B-VP	B-VP	-	6	VMOD	-	-
6	activate	activate	I-VP	I-VP	-	3	VMOD	-	-
7	transcription	transcription	B-NP	B-NP	-	6	OBJ	-	-
8	,	,	O	O	-	12	P	-	-
9	and	and	O	O	-	12	VMOD	-	-
10	this	this	B-NP	B-NP	-	11	NMOD	-	-
11	synergy	synergy	I-NP	I-NP	-	12	SUB	-	-
12	is	is	B-VP	B-VP	-	0	ROOT	-	-
13	required	required	I-VP	I-VP	-	12	VC	-	-
14	for	for	B-PP	B-PP	-	13	VMOD	-	-
15	transcription	transcription	B-NP	B-NP	-	14	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	at	at	B-ADVP	B-ADVP	-	14	PMOD	-	-
18	least	least	I-ADVP	I-ADVP	-	17	AMOD	-	-
19	several	several	B-NP	B-NP	-	17	AMOD	-	-
20	important	important	I-NP	I-NP	-	22	NMOD	-	-
21	hematopoietic	hematopoietic	I-NP	I-NP	-	22	NMOD	-	-
22	genes	genes	I-NP	I-NP	-	19	NMOD	-	-
23	.	.	O	O	-	12	P	-	-

1	ZEB	ZEB	B-NP	B-NP	-	2	SUB	-	-
2	blocks	blocks	B-VP	B-VP	-	15	VMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	activity	activity	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	c-Myb	c-Myb	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	I-NP	I-NP	-	8	NMOD	-	-
8	Ets	Ets	I-NP	I-NP	-	5	PMOD	-	-
9	individually	individually	B-ADVP	B-ADVP	-	2	VMOD	-	-
10	,	,	O	O	-	15	P	-	-
11	but	but	O	O	-	15	VMOD	-	-
12	together	together	B-ADVP	B-ADVP	-	15	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	factors	factors	I-NP	I-NP	-	15	SUB	-	-
15	synergize	synergize	B-VP	B-VP	-	0	ROOT	-	-
16	to	to	I-VP	I-VP	-	17	VMOD	-	-
17	resist	resist	I-VP	I-VP	-	15	VMOD	-	-
18	this	this	B-NP	B-NP	-	19	NMOD	-	-
19	repression	repression	I-NP	I-NP	-	17	OBJ	-	-
20	.	.	O	O	-	15	P	-	-

1	Such	Such	B-NP	B-NP	-	2	NMOD	-	-
2	repression	repression	I-NP	I-NP	-	3	SUB	-	-
3	imposes	imposes	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	5	NMOD	-	-
5	requirement	requirement	I-NP	I-NP	-	3	OBJ	-	-
6	for	for	B-PP	B-PP	-	5	NMOD	-	-
7	both	both	O	O	-	10	NMOD	-	-
8	c-Myb	c-Myb	B-NP	B-NP	-	10	NMOD	-	-
9	and	and	O	O	-	10	NMOD	-	-
10	Ets	Ets	B-NP	B-NP	-	6	PMOD	-	-
11	for	for	B-PP	B-PP	-	5	NMOD	-	-
12	transcriptional	transcriptional	B-NP	B-NP	-	13	NMOD	-	-
13	activity	activity	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	3	P	-	-
15	providing	providing	B-VP	B-VP	-	3	VMOD	-	-
16	one	one	B-NP	B-NP	-	17	NMOD	-	-
17	explanation	explanation	I-NP	I-NP	-	15	OBJ	-	-
18	for	for	B-PP	B-PP	-	17	NMOD	-	-
19	why	why	B-ADVP	B-ADVP	-	18	PMOD	-	-
20	synergy	synergy	B-NP	B-NP	-	24	SUB	-	-
21	between	between	B-PP	B-PP	-	20	NMOD	-	-
22	these	these	B-NP	B-NP	-	23	NMOD	-	-
23	factors	factors	I-NP	I-NP	-	21	PMOD	-	-
24	is	is	B-VP	B-VP	-	19	SBAR	-	-
25	important	important	B-ADJP	B-ADJP	-	24	PRD	-	-
26	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	balance	balance	I-NP	I-NP	-	12	SUB	-	-
3	between	between	B-PP	B-PP	-	2	NMOD	-	-
4	repression	repression	B-NP	B-NP	-	3	PMOD	-	-
5	by	by	B-PP	B-PP	-	4	NMOD	-	-
6	ZEB	ZEB	B-NP	B-NP	-	9	NMOD	-	-
7	and	and	O	O	-	9	NMOD	-	-
8	transcriptional	transcriptional	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	5	PMOD	-	-
10	by	by	B-PP	B-PP	-	4	NMOD	-	-
11	c-Myb/Ets	c-Myb/Ets	B-NP	B-NP	-	10	PMOD	-	-
12	provides	provides	B-VP	B-VP	-	0	ROOT	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	flexible	flexible	I-NP	I-NP	-	16	NMOD	-	-
15	regulatory	regulatory	I-NP	I-NP	-	16	NMOD	-	-
16	mechanism	mechanism	I-NP	I-NP	-	12	OBJ	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	controlling	controlling	B-VP	B-VP	-	17	PMOD	-	-
19	gene	gene	B-NP	B-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	18	OBJ	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	hematopoietic	hematopoietic	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	one	one	B-NP	B-NP	-	5	NMOD	-	-
5	target	target	I-NP	I-NP	-	12	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	this	this	B-NP	B-NP	-	9	NMOD	-	-
8	positive/negative	positive/negative	I-NP	I-NP	-	9	NMOD	-	-
9	regulation	regulation	I-NP	I-NP	-	6	PMOD	-	-
10	in	in	B-ADVP	B-ADVP	-	5	NMOD	-	-
11	vivo	vivo	I-ADVP	I-ADVP	-	10	AMOD	-	-
12	is	is	B-VP	B-VP	-	3	SBAR	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	alpha4	alpha4	I-NP	I-NP	-	15	NMOD	-	-
15	integrin	integrin	I-NP	I-NP	-	12	PRD	-	-
16	,	,	O	O	-	15	P	-	-
17	which	which	B-NP	B-NP	-	15	NMOD	-	-
18	play	play	B-VP	B-VP	-	17	SBAR	-	-
19	a	a	B-NP	B-NP	-	21	NMOD	-	-
20	key	key	I-NP	I-NP	-	21	NMOD	-	-
21	role	role	I-NP	I-NP	-	18	OBJ	-	-
22	in	in	B-PP	B-PP	-	18	VMOD	-	-
23	normal	normal	B-NP	B-NP	-	24	NMOD	-	-
24	hematopoiesis	hematopoiesis	I-NP	I-NP	-	26	NMOD	-	-
25	and	and	I-NP	I-NP	-	26	NMOD	-	-
26	function	function	I-NP	I-NP	-	22	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	mature	mature	B-NP	B-NP	-	29	NMOD	-	-
29	leukocytes	leukocytes	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	2	P	-	-

1	GABP	GABP	B-NP	B-NP	-	2	NMOD	-	-
2	factors	factors	I-NP	I-NP	-	3	SUB	-	-
3	bind	bind	B-VP	B-VP	-	0	ROOT	-	-
4	to	to	B-PP	B-PP	-	3	VMOD	-	-
5	a	a	B-NP	B-NP	-	12	NMOD	-	-
6	distal	distal	I-NP	I-NP	-	12	NMOD	-	-
7	interleukin	interleukin	I-NP	I-NP	-	12	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	12	NMOD	-	-
9	(	(	O	O	-	12	P	-	-
10	IL-2	IL-2	B-NP	B-NP	-	12	NMOD	-	-
11	)	)	O	O	-	12	P	-	-
12	enhancer	enhancer	B-NP	B-NP	-	4	PMOD	-	-
13	and	and	O	O	-	3	VMOD	-	-
14	contribute	contribute	B-VP	B-VP	-	3	VMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	c-Raf-mediated	c-Raf-mediated	B-NP	B-NP	-	17	NMOD	-	-
17	increase	increase	I-NP	I-NP	-	15	PMOD	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	IL-2	IL-2	B-NP	B-NP	-	20	NMOD	-	-
20	induction	induction	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	3	P	-	-

1	Triggering	Triggering	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	T-cell	T-cell	I-NP	I-NP	-	6	NMOD	-	-
5	receptor-CD3	receptor-CD3	I-NP	I-NP	-	6	NMOD	-	-
6	complex	complex	I-NP	I-NP	-	2	PMOD	-	-
7	activates	activates	B-VP	B-VP	-	0	ROOT	-	-
8	two	two	B-NP	B-NP	-	11	NMOD	-	-
9	major	major	I-NP	I-NP	-	11	NMOD	-	-
10	signal	signal	I-NP	I-NP	-	11	NMOD	-	-
11	cascades	cascades	I-NP	I-NP	-	7	OBJ	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	T	T	B-NP	B-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	12	PMOD	-	-
15	,	,	O	O	-	28	P	-	-
16	(	(	B-LST	B-LST	-	17	P	-	-
17	i	i	I-LST	I-LST	-	21	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	Ca2+-dependent	Ca2+-dependent	B-NP	B-NP	-	21	NMOD	-	-
20	signal	signal	I-NP	I-NP	-	21	NMOD	-	-
21	cascades	cascades	I-NP	I-NP	-	28	NMOD	-	-
22	and	and	O	O	-	28	NMOD	-	-
23	(	(	B-LST	B-LST	-	24	P	-	-
24	ii	ii	I-LST	I-LST	-	28	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	protein	protein	B-NP	B-NP	-	28	NMOD	-	-
27	kinase	kinase	I-NP	I-NP	-	28	NMOD	-	-
28	cascades	cascades	I-NP	I-NP	-	12	PMOD	-	-
29	.	.	O	O	-	7	P	-	-

1	Both	Both	B-NP	B-NP	-	3	NMOD	-	-
2	signal	signal	I-NP	I-NP	-	3	NMOD	-	-
3	cascades	cascades	I-NP	I-NP	-	4	SUB	-	-
4	contribute	contribute	B-VP	B-VP	-	0	ROOT	-	-
5	to	to	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	induction	induction	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	15	NMOD	-	-
10	interleukin	interleukin	I-NP	I-NP	-	15	NMOD	-	-
11	<num>	<num>	I-NP	I-NP	-	10	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	IL-2	IL-2	B-NP	B-NP	-	10	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	gene	gene	B-NP	B-NP	-	8	PMOD	-	-
16	during	during	B-PP	B-PP	-	7	NMOD	-	-
17	T-cell	T-cell	B-NP	B-NP	-	18	NMOD	-	-
18	activation	activation	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	4	P	-	-

1	Prominent	Prominent	B-NP	B-NP	-	4	NMOD	-	-
2	protein	protein	I-NP	I-NP	-	4	NMOD	-	-
3	kinase	kinase	I-NP	I-NP	-	4	NMOD	-	-
4	cascades	cascades	I-NP	I-NP	-	5	SUB	-	-
5	are	are	B-VP	B-VP	-	0	ROOT	-	-
6	those	those	B-NP	B-NP	-	5	PRD	-	-
7	that	that	B-NP	B-NP	-	6	NMOD	-	-
8	activate	activate	B-VP	B-VP	-	7	SBAR	-	-
9	mitogen-activated	mitogen-activated	B-NP	B-NP	-	14	NMOD	-	-
10	protein	protein	I-NP	I-NP	-	14	NMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	MAP	MAP	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	kinases	kinases	B-NP	B-NP	-	8	OBJ	-	-
15	.	.	O	O	-	5	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
5	c-Raf	c-Raf	B-NP	B-NP	-	18	SUB	-	-
6	,	,	O	O	-	5	P	-	-
7	which	which	B-NP	B-NP	-	5	NMOD	-	-
8	is	is	B-VP	B-VP	-	7	SBAR	-	-
9	at	at	B-PP	B-PP	-	8	PRD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	helm	helm	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	classic	classic	I-NP	I-NP	-	16	NMOD	-	-
15	MAP-Erk	MAP-Erk	I-NP	I-NP	-	16	NMOD	-	-
16	cascade	cascade	I-NP	I-NP	-	12	PMOD	-	-
17	,	,	O	O	-	5	P	-	-
18	contributes	contributes	B-VP	B-VP	-	4	SBAR	-	-
19	to	to	B-PP	B-PP	-	18	VMOD	-	-
20	IL-2	IL-2	B-NP	B-NP	-	21	NMOD	-	-
21	induction	induction	I-NP	I-NP	-	19	PMOD	-	-
22	through	through	B-PP	B-PP	-	18	VMOD	-	-
23	a	a	B-NP	B-NP	-	26	NMOD	-	-
24	distal	distal	I-NP	I-NP	-	26	NMOD	-	-
25	enhancer	enhancer	I-NP	I-NP	-	26	NMOD	-	-
26	element	element	I-NP	I-NP	-	22	PMOD	-	-
27	spanning	spanning	B-VP	B-VP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	nucleotides	nucleotides	I-NP	I-NP	-	27	OBJ	-	-
30	from	from	B-PP	B-PP	-	29	NMOD	-	-
31	positions	positions	B-NP	B-NP	-	34	NMOD	-	-
32	-502	-502	B-NP	B-NP	-	34	NMOD	-	-
33	to	to	B-PP	B-PP	-	34	NMOD	-	-
34	-413	-413	B-NP	B-NP	-	30	PMOD	-	-
35	in	in	B-PP	B-PP	-	29	NMOD	-	-
36	front	front	B-NP	B-NP	-	35	PMOD	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	the	the	B-NP	B-NP	-	41	NMOD	-	-
39	transcriptional	transcriptional	I-NP	I-NP	-	41	NMOD	-	-
40	start	start	I-NP	I-NP	-	41	NMOD	-	-
41	site	site	I-NP	I-NP	-	37	PMOD	-	-
42	of	of	B-PP	B-PP	-	41	NMOD	-	-
43	the	the	B-NP	B-NP	-	45	NMOD	-	-
44	IL-2	IL-2	I-NP	I-NP	-	45	NMOD	-	-
45	gene	gene	I-NP	I-NP	-	42	PMOD	-	-
46	.	.	O	O	-	2	P	-	-

1	Induction	Induction	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	this	this	B-NP	B-NP	-	6	NMOD	-	-
4	distal	distal	I-NP	I-NP	-	6	NMOD	-	-
5	IL-2	IL-2	I-NP	I-NP	-	6	NMOD	-	-
6	enhancer	enhancer	I-NP	I-NP	-	2	PMOD	-	-
7	differs	differs	B-VP	B-VP	-	0	ROOT	-	-
8	from	from	B-PP	B-PP	-	7	VMOD	-	-
9	induction	induction	B-NP	B-NP	-	8	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	proximal	proximal	I-NP	I-NP	-	14	NMOD	-	-
13	IL-2	IL-2	I-NP	I-NP	-	14	NMOD	-	-
14	promoter-enhancer	promoter-enhancer	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	7	P	-	-
16	since	since	B-SBAR	B-SBAR	-	7	VMOD	-	-
17	it	it	B-NP	B-NP	-	18	SUB	-	-
18	is	is	B-VP	B-VP	-	16	SBAR	-	-
19	induced	induced	I-VP	I-VP	-	18	VC	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	phorbol	phorbol	B-NP	B-NP	-	22	NMOD	-	-
22	esters	esters	I-NP	I-NP	-	20	PMOD	-	-
23	alone	alone	B-ADVP	B-ADVP	-	22	NMOD	-	-
24	and	and	O	O	-	23	DEP	-	-
25	independent	independent	B-ADJP	B-ADJP	-	23	AMOD	-	-
26	from	from	B-PP	B-PP	-	25	AMOD	-	-
27	Ca2+	Ca2+	B-NP	B-NP	-	28	NMOD	-	-
28	signals	signals	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	DNA-protein	DNA-protein	B-NP	B-NP	-	4	NMOD	-	-
3	binding	binding	I-NP	I-NP	-	4	NMOD	-	-
4	studies	studies	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	detected	detected	B-VP	B-VP	-	0	ROOT	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	binding	binding	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	transcription	transcription	B-NP	B-NP	-	12	NMOD	-	-
12	factors	factors	I-NP	I-NP	-	16	NMOD	-	-
13	GABP	GABP	B-NP	B-NP	-	14	NMOD	-	-
14	alpha	alpha	I-NP	I-NP	-	16	NMOD	-	-
15	and	and	O	O	-	16	NMOD	-	-
16	-beta	-beta	B-NP	B-NP	-	10	PMOD	-	-
17	to	to	B-PP	B-PP	-	9	NMOD	-	-
18	a	a	B-NP	B-NP	-	21	NMOD	-	-
19	dyad	dyad	I-NP	I-NP	-	21	NMOD	-	-
20	symmetry	symmetry	I-NP	I-NP	-	21	NMOD	-	-
21	element	element	I-NP	I-NP	-	17	PMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	DSE	DSE	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	of	of	B-PP	B-PP	-	21	NMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	distal	distal	I-NP	I-NP	-	28	NMOD	-	-
28	enhancer	enhancer	I-NP	I-NP	-	25	PMOD	-	-
29	,	,	O	O	-	21	P	-	-
30	which	which	B-NP	B-NP	-	21	NMOD	-	-
31	is	is	B-VP	B-VP	-	30	SBAR	-	-
32	formed	formed	I-VP	I-VP	-	31	VC	-	-
33	by	by	B-PP	B-PP	-	32	VMOD	-	-
34	palindromic	palindromic	B-NP	B-NP	-	36	NMOD	-	-
35	binding	binding	I-NP	I-NP	-	36	NMOD	-	-
36	sites	sites	I-NP	I-NP	-	33	PMOD	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	Ets-like	Ets-like	B-NP	B-NP	-	39	NMOD	-	-
39	factors	factors	I-NP	I-NP	-	37	PMOD	-	-
40	.	.	O	O	-	7	P	-	-

1	Introduction	Introduction	B-NP	B-NP	-	11	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	point	point	B-NP	B-NP	-	4	NMOD	-	-
4	mutations	mutations	I-NP	I-NP	-	2	PMOD	-	-
5	suppressing	suppressing	B-VP	B-VP	-	4	NMOD	-	-
6	GABP	GABP	B-NP	B-NP	-	7	NMOD	-	-
7	binding	binding	I-NP	I-NP	-	5	OBJ	-	-
8	to	to	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	DSE	DSE	I-NP	I-NP	-	8	PMOD	-	-
11	interfered	interfered	B-VP	B-VP	-	0	ROOT	-	-
12	with	with	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	induction	induction	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	distal	distal	I-NP	I-NP	-	18	NMOD	-	-
18	enhancer	enhancer	I-NP	I-NP	-	15	PMOD	-	-
19	and	and	O	O	-	23	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	entire	entire	I-NP	I-NP	-	23	NMOD	-	-
22	IL-2	IL-2	I-NP	I-NP	-	23	NMOD	-	-
23	promoter-enhancer	promoter-enhancer	I-NP	I-NP	-	15	PMOD	-	-
24	,	,	O	O	-	11	P	-	-
25	while	while	B-SBAR	B-SBAR	-	11	VMOD	-	-
26	overexpression	overexpression	B-NP	B-NP	-	31	SUB	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	both	both	B-NP	B-NP	-	30	NMOD	-	-
29	GABP	GABP	I-NP	I-NP	-	30	NMOD	-	-
30	factors	factors	I-NP	I-NP	-	27	PMOD	-	-
31	enhanced	enhanced	B-VP	B-VP	-	25	SBAR	-	-
32	the	the	B-NP	B-NP	-	35	NMOD	-	-
33	IL-2	IL-2	I-NP	I-NP	-	35	NMOD	-	-
34	promoter-enhancer	promoter-enhancer	I-NP	I-NP	-	35	NMOD	-	-
35	induction	induction	I-NP	I-NP	-	31	OBJ	-	-
36	.	.	O	O	-	11	P	-	-

1	Overexpression	Overexpression	B-NP	B-NP	-	21	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	BXB	BXB	B-NP	B-NP	-	2	PMOD	-	-
4	,	,	O	O	-	21	P	-	-
5	a	a	B-NP	B-NP	-	8	NMOD	-	-
6	constitutive	constitutive	I-NP	I-NP	-	8	NMOD	-	-
7	active	active	I-NP	I-NP	-	8	NMOD	-	-
8	version	version	I-NP	I-NP	-	21	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	c-Raf	c-Raf	B-NP	B-NP	-	9	PMOD	-	-
11	,	,	B-PP	B-PP	-	21	P	-	-
12	and	and	I-PP	I-PP	-	21	VMOD	-	-
13	of	of	B-PP	B-PP	-	12	PMOD	-	-
14	further	further	B-NP	B-NP	-	15	NMOD	-	-
15	members	members	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	Ras-Raf-Erk	Ras-Raf-Erk	I-NP	I-NP	-	20	NMOD	-	-
19	signal	signal	I-NP	I-NP	-	20	NMOD	-	-
20	cascade	cascade	I-NP	I-NP	-	16	PMOD	-	-
21	exerted	exerted	B-VP	B-VP	-	0	ROOT	-	-
22	an	an	B-NP	B-NP	-	23	NMOD	-	-
23	increase	increase	I-NP	I-NP	-	21	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	GABP-mediated	GABP-mediated	B-NP	B-NP	-	27	NMOD	-	-
26	promoter-enhancer	promoter-enhancer	I-NP	I-NP	-	27	NMOD	-	-
27	induction	induction	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	21	P	-	-

1	In	In	B-PP	B-PP	-	16	VMOD	-	-
2	conjunction	conjunction	B-NP	B-NP	-	1	PMOD	-	-
3	with	with	B-PP	B-PP	-	2	NMOD	-	-
4	previously	previously	B-NP	B-NP	-	5	AMOD	-	-
5	published	published	I-NP	I-NP	-	6	NMOD	-	-
6	data	data	I-NP	I-NP	-	3	PMOD	-	-
7	on	on	B-PP	B-PP	-	2	NMOD	-	-
8	c-Raf-induced	c-Raf-induced	B-NP	B-NP	-	9	NMOD	-	-
9	phosphorylation	phosphorylation	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	GABP	GABP	B-NP	B-NP	-	12	NMOD	-	-
12	factors	factors	I-NP	I-NP	-	10	PMOD	-	-
13	(	(	O	O	-	16	P	-	-
14	E.Flory	E.Flory	B-NP	B-NP	-	16	NMOD	-	-
15	,	,	O	O	-	16	P	-	-
16	A	A	B-NP	B-NP	-	0	ROOT	-	-
17	.	.	O	O	-	16	P	-	-

1	Hoffmeyer	Hoffmeyer	B-NP	B-NP	-	8	NMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	U.Smola	U.Smola	B-NP	B-NP	-	8	NMOD	-	-
4	,	,	O	O	-	8	P	-	-
5	U.R.Rapp	U.R.Rapp	B-NP	B-NP	-	8	NMOD	-	-
6	,	,	O	O	-	8	P	-	-
7	and	and	O	O	-	8	NMOD	-	-
8	J.T.Bruder	J.T.Bruder	B-NP	B-NP	-	15	NMOD	-	-
9	,	,	O	O	-	15	P	-	-
10	J.Virol.70	J.Virol.70	B-NP	B-NP	-	15	NMOD	-	-
11	:	:	O	O	-	15	P	-	-
12	2260-	2260-	B-NP	B-NP	-	15	NMOD	-	-
13	<num>	<num>	I-NP	I-NP	-	15	NMOD	-	-
14	,	,	I-NP	I-NP	-	15	P	-	-
15	<num>	<num>	I-NP	I-NP	-	20	SUB	-	-
16	)	)	O	O	-	15	P	-	-
17	,	,	O	O	-	20	P	-	-
18	these	these	B-NP	B-NP	-	19	NMOD	-	-
19	results	results	I-NP	I-NP	-	20	SUB	-	-
20	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
21	a	a	B-NP	B-NP	-	22	NMOD	-	-
22	contribution	contribution	I-NP	I-NP	-	20	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	GABP	GABP	B-NP	B-NP	-	25	NMOD	-	-
25	factors	factors	I-NP	I-NP	-	23	PMOD	-	-
26	to	to	B-PP	B-PP	-	22	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	Raf-mediated	Raf-mediated	I-NP	I-NP	-	29	NMOD	-	-
29	enhancement	enhancement	I-NP	I-NP	-	26	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	IL-2	IL-2	B-NP	B-NP	-	32	NMOD	-	-
32	induction	induction	I-NP	I-NP	-	30	PMOD	-	-
33	during	during	B-PP	B-PP	-	29	NMOD	-	-
34	T-cell	T-cell	B-NP	B-NP	-	35	NMOD	-	-
35	activation	activation	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	20	P	-	-

1	Genomic	Genomic	B-NP	B-NP	-	2	NMOD	-	-
2	organization	organization	I-NP	I-NP	-	8	NMOD	-	-
3	,	,	O	O	-	8	P	-	-
4	sequence	sequence	B-NP	B-NP	-	8	NMOD	-	-
5	,	,	O	O	-	8	P	-	-
6	and	and	O	O	-	8	NMOD	-	-
7	transcriptional	transcriptional	B-NP	B-NP	-	8	NMOD	-	-
8	regulation	regulation	I-NP	I-NP	-	0	ROOT	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	human	human	I-NP	I-NP	-	13	NMOD	-	-
12	eotaxin	eotaxin	I-NP	I-NP	-	13	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	9	PMOD	-	-
14	.	.	O	O	-	8	P	-	-

1	Eotaxin	Eotaxin	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	an	an	B-NP	B-NP	-	6	NMOD	-	-
4	eosinophil	eosinophil	I-NP	I-NP	-	6	NMOD	-	-
5	specific	specific	I-NP	I-NP	-	6	NMOD	-	-
6	beta-chemokine	beta-chemokine	I-NP	I-NP	-	2	PRD	-	-
7	assumed	assumed	B-VP	B-VP	-	6	NMOD	-	-
8	to	to	I-VP	I-VP	-	9	VMOD	-	-
9	be	be	I-VP	I-VP	-	7	VMOD	-	-
10	involved	involved	I-VP	I-VP	-	9	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	eosinophilic	eosinophilic	B-NP	B-NP	-	14	NMOD	-	-
13	inflammatory	inflammatory	I-NP	I-NP	-	14	NMOD	-	-
14	diseases	diseases	I-NP	I-NP	-	11	PMOD	-	-
15	such	such	B-PP	B-PP	-	16	PMOD	-	-
16	as	as	I-PP	I-PP	-	14	NMOD	-	-
17	atopic	atopic	B-NP	B-NP	-	18	NMOD	-	-
18	dermatitis	dermatitis	I-NP	I-NP	-	26	NMOD	-	-
19	,	,	O	O	-	26	P	-	-
20	allergic	allergic	B-NP	B-NP	-	21	NMOD	-	-
21	rhinitis	rhinitis	I-NP	I-NP	-	26	NMOD	-	-
22	,	,	O	O	-	26	P	-	-
23	asthma	asthma	B-NP	B-NP	-	26	NMOD	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	parasitic	parasitic	B-NP	B-NP	-	26	NMOD	-	-
26	infections	infections	I-NP	I-NP	-	16	PMOD	-	-
27	.	.	O	O	-	2	P	-	-

1	Its	Its	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	stimulus-	stimulus-	B-NP	B-NP	-	3	PRD	-	-
5	and	and	O	O	-	6	AMOD	-	-
6	cell-specific	cell-specific	B-ADJP	B-ADJP	-	3	PRD	-	-
7	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	here	here	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	describe	describe	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	genomic	genomic	I-NP	I-NP	-	6	NMOD	-	-
6	organisation	organisation	I-NP	I-NP	-	9	NMOD	-	-
7	(	(	O	O	-	9	P	-	-
8	<num>	<num>	B-NP	B-NP	-	9	NMOD	-	-
9	exons	exons	I-NP	I-NP	-	3	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	16	NMOD	-	-
12	,	,	I-NP	I-NP	-	16	P	-	-
13	<num>	<num>	I-NP	I-NP	-	16	NMOD	-	-
14	and	and	I-NP	I-NP	-	16	NMOD	-	-
15	<num>	<num>	I-NP	I-NP	-	16	NMOD	-	-
16	bp	bp	I-NP	I-NP	-	19	NMOD	-	-
17	and	and	O	O	-	19	NMOD	-	-
18	<num>	<num>	B-NP	B-NP	-	19	NMOD	-	-
19	introns	introns	I-NP	I-NP	-	10	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	<num>	<num>	B-NP	B-NP	-	23	AMOD	-	-
22	and	and	I-NP	I-NP	-	23	AMOD	-	-
23	<num>	<num>	I-NP	I-NP	-	24	NMOD	-	-
24	bp	bp	I-NP	I-NP	-	20	PMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	and	and	O	O	-	27	NMOD	-	-
27	sequence	sequence	B-NP	B-NP	-	20	PMOD	-	-
28	including	including	B-PP	B-PP	-	27	NMOD	-	-
29	<num>	<num>	B-NP	B-NP	-	30	NMOD	-	-
30	kb	kb	I-NP	I-NP	-	20	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	DNA	DNA	B-NP	B-NP	-	31	PMOD	-	-
33	from	from	B-PP	B-PP	-	30	NMOD	-	-
34	the	the	B-NP	B-NP	-	39	NMOD	-	-
35	immediate	immediate	I-NP	I-NP	-	38	AMOD	-	-
36	<num>	<num>	I-NP	I-NP	-	38	AMOD	-	-
37	'	'	I-NP	I-NP	-	38	AMOD	-	-
38	upstream	upstream	I-NP	I-NP	-	39	NMOD	-	-
39	region	region	I-NP	I-NP	-	33	PMOD	-	-
40	of	of	B-PP	B-PP	-	39	NMOD	-	-
41	the	the	B-NP	B-NP	-	44	NMOD	-	-
42	human	human	I-NP	I-NP	-	44	NMOD	-	-
43	eotaxin	eotaxin	I-NP	I-NP	-	44	NMOD	-	-
44	gene	gene	I-NP	I-NP	-	40	PMOD	-	-
45	.	.	O	O	-	3	P	-	-

1	Among	Among	B-PP	B-PP	-	19	VMOD	-	-
2	the	the	B-NP	B-NP	-	5	NMOD	-	-
3	regulatory	regulatory	I-NP	I-NP	-	5	NMOD	-	-
4	promoter	promoter	I-NP	I-NP	-	5	NMOD	-	-
5	elements	elements	I-NP	I-NP	-	1	PMOD	-	-
6	potentially	potentially	B-VP	B-VP	-	7	VMOD	-	-
7	regulating	regulating	I-VP	I-VP	-	5	NMOD	-	-
8	eotaxin	eotaxin	B-NP	B-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	7	OBJ	-	-
11	and/or	and/or	O	O	-	7	VMOD	-	-
12	mediating	mediating	B-VP	B-VP	-	7	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	effects	effects	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	anti-inflammatory	anti-inflammatory	B-NP	B-NP	-	17	NMOD	-	-
17	drugs	drugs	I-NP	I-NP	-	15	PMOD	-	-
18	we	we	B-NP	B-NP	-	19	SUB	-	-
19	identified	identified	B-VP	B-VP	-	0	ROOT	-	-
20	consensus	consensus	B-NP	B-NP	-	21	NMOD	-	-
21	sequences	sequences	I-NP	I-NP	-	19	OBJ	-	-
22	known	known	B-VP	B-VP	-	21	NMOD	-	-
23	to	to	B-VP	B-VP	-	24	VMOD	-	-
24	interact	interact	I-VP	I-VP	-	22	VMOD	-	-
25	with	with	B-PP	B-PP	-	24	VMOD	-	-
26	nuclear	nuclear	B-NP	B-NP	-	27	NMOD	-	-
27	factors	factors	I-NP	I-NP	-	25	PMOD	-	-
28	like	like	B-PP	B-PP	-	24	VMOD	-	-
29	NF-IL6	NF-IL6	B-NP	B-NP	-	34	NMOD	-	-
30	,	,	O	O	-	34	P	-	-
31	AP-1	AP-1	B-NP	B-NP	-	34	NMOD	-	-
32	,	,	O	O	-	34	P	-	-
33	a	a	B-NP	B-NP	-	34	NMOD	-	-
34	NF-kappa-B	NF-kappa-B	I-NP	I-NP	-	28	PMOD	-	-
35	like	like	B-PP	B-PP	-	34	NMOD	-	-
36	consensus	consensus	B-NP	B-NP	-	37	NMOD	-	-
37	sequence	sequence	I-NP	I-NP	-	39	NMOD	-	-
38	and	and	I-NP	I-NP	-	39	NMOD	-	-
39	gamma-interferon-	gamma-interferon-	I-NP	I-NP	-	35	PMOD	-	-
40	as	as	B-CONJP	B-CONJP	-	45	NMOD	-	-
41	well	well	I-CONJP	I-CONJP	-	40	DEP	-	-
42	as	as	I-CONJP	I-CONJP	-	40	DEP	-	-
43	glucocorticoid	glucocorticoid	B-NP	B-NP	-	45	NMOD	-	-
44	response	response	I-NP	I-NP	-	45	NMOD	-	-
45	elements	elements	I-NP	I-NP	-	35	PMOD	-	-
46	.	.	O	O	-	19	P	-	-

1	Dysregulation	Dysregulation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	monocytic	monocytic	B-NP	B-NP	-	6	NMOD	-	-
4	nuclear	nuclear	I-NP	I-NP	-	6	NMOD	-	-
5	factor-kappa	factor-kappa	I-NP	I-NP	-	6	NMOD	-	-
6	B	B	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	oxidized	oxidized	B-NP	B-NP	-	10	NMOD	-	-
9	low-density	low-density	I-NP	I-NP	-	10	NMOD	-	-
10	lipoprotein	lipoprotein	I-NP	I-NP	-	7	PMOD	-	-
11	.	.	O	O	-	1	P	-	-

1	Nuclear	Nuclear	B-NP	B-NP	-	3	NMOD	-	-
2	factor-kappa	factor-kappa	I-NP	I-NP	-	3	NMOD	-	-
3	B	B	I-NP	I-NP	-	10	NMOD	-	-
4	(	(	O	O	-	6	P	-	-
5	NF-kappa	NF-kappa	B-NP	B-NP	-	6	NMOD	-	-
6	B	B	I-NP	I-NP	-	3	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	/Rel	/Rel	B-NP	B-NP	-	10	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	10	NMOD	-	-
10	factors	factors	I-NP	I-NP	-	11	SUB	-	-
11	may	may	B-VP	B-VP	-	0	ROOT	-	-
12	be	be	I-VP	I-VP	-	11	VC	-	-
13	involved	involved	I-VP	I-VP	-	12	VC	-	-
14	in	in	B-PP	B-PP	-	13	VMOD	-	-
15	atherosclerosis	atherosclerosis	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	11	P	-	-
17	as	as	B-SBAR	B-SBAR	-	11	VMOD	-	-
18	is	is	B-VP	B-VP	-	17	SBAR	-	-
19	suggested	suggested	I-VP	I-VP	-	18	VC	-	-
20	by	by	B-PP	B-PP	-	19	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	presence	presence	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	activated	activated	B-NP	B-NP	-	26	NMOD	-	-
25	NF-kappa	NF-kappa	I-NP	I-NP	-	26	NMOD	-	-
26	B	B	I-NP	I-NP	-	23	PMOD	-	-
27	in	in	B-PP	B-PP	-	22	NMOD	-	-
28	human	human	B-NP	B-NP	-	30	NMOD	-	-
29	atherosclerotic	atherosclerotic	I-NP	I-NP	-	30	NMOD	-	-
30	lesions	lesions	I-NP	I-NP	-	27	PMOD	-	-
31	.	.	O	O	-	11	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	aim	aim	I-NP	I-NP	-	7	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	present	present	I-NP	I-NP	-	6	NMOD	-	-
6	study	study	I-NP	I-NP	-	3	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	investigate	investigate	I-VP	I-VP	-	7	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	effects	effects	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	oxidized	oxidized	B-NP	B-NP	-	14	NMOD	-	-
14	LDL	LDL	I-NP	I-NP	-	12	PMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	oxLDL	oxLDL	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	on	on	B-PP	B-PP	-	11	NMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	NF-kappa	NF-kappa	I-NP	I-NP	-	22	NMOD	-	-
21	B	B	I-NP	I-NP	-	22	NMOD	-	-
22	system	system	I-NP	I-NP	-	18	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	human	human	B-NP	B-NP	-	27	NMOD	-	-
25	THP-1	THP-1	I-NP	I-NP	-	27	NMOD	-	-
26	monocytic	monocytic	I-NP	I-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
28	as	as	B-CONJP	B-CONJP	-	32	NMOD	-	-
29	well	well	I-CONJP	I-CONJP	-	28	DEP	-	-
30	as	as	I-CONJP	I-CONJP	-	28	DEP	-	-
31	adherent	adherent	B-NP	B-NP	-	32	NMOD	-	-
32	monocytes	monocytes	I-NP	I-NP	-	23	PMOD	-	-
33	.	.	O	O	-	7	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	short-term	short-term	B-NP	B-NP	-	6	NMOD	-	-
6	incubation	incubation	I-NP	I-NP	-	12	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	these	these	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	with	with	B-PP	B-PP	-	6	NMOD	-	-
11	oxLDL	oxLDL	B-NP	B-NP	-	10	PMOD	-	-
12	activated	activated	B-VP	B-VP	-	4	SBAR	-	-
13	p50/p65	p50/p65	B-NP	B-NP	-	12	OBJ	-	-
14	containing	containing	B-VP	B-VP	-	13	NMOD	-	-
15	NF-kappa	NF-kappa	B-NP	B-NP	-	17	NMOD	-	-
16	B	B	I-NP	I-NP	-	17	NMOD	-	-
17	dimers	dimers	I-NP	I-NP	-	14	OBJ	-	-
18	and	and	O	O	-	12	VMOD	-	-
19	induced	induced	B-VP	B-VP	-	12	VMOD	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	expression	expression	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	target	target	I-NP	I-NP	-	26	NMOD	-	-
25	gene	gene	I-NP	I-NP	-	26	NMOD	-	-
26	IL-8	IL-8	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NF-kappa	NF-kappa	B-NP	B-NP	-	5	NMOD	-	-
5	B	B	I-NP	I-NP	-	3	PMOD	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	inhibited	inhibited	I-VP	I-VP	-	6	VC	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	15	NMOD	-	-
10	antioxidant	antioxidant	I-NP	I-NP	-	15	NMOD	-	-
11	and	and	I-NP	I-NP	-	15	NMOD	-	-
12	H2O2	H2O2	I-NP	I-NP	-	15	NMOD	-	-
13	scavenger	scavenger	I-NP	I-NP	-	15	NMOD	-	-
14	pyrrolidine	pyrrolidine	I-NP	I-NP	-	15	NMOD	-	-
15	dithiocarbamate	dithiocarbamate	I-NP	I-NP	-	20	NMOD	-	-
16	and	and	O	O	-	20	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	proteasome	proteasome	I-NP	I-NP	-	20	NMOD	-	-
19	inhibitor	inhibitor	I-NP	I-NP	-	20	NMOD	-	-
20	PSI	PSI	I-NP	I-NP	-	8	PMOD	-	-
21	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	5	NMOD	-	-
2	oxLDL-induced	oxLDL-induced	I-NP	I-NP	-	5	NMOD	-	-
3	NF-kappa	NF-kappa	I-NP	I-NP	-	5	NMOD	-	-
4	B	B	I-NP	I-NP	-	5	NMOD	-	-
5	activation	activation	I-NP	I-NP	-	6	SUB	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	accompanied	accompanied	I-VP	I-VP	-	6	VC	-	-
8	by	by	B-PP	B-PP	-	7	VMOD	-	-
9	an	an	B-NP	B-NP	-	11	NMOD	-	-
10	initial	initial	I-NP	I-NP	-	11	NMOD	-	-
11	depletion	depletion	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	I	I	B-NP	B-NP	-	15	NMOD	-	-
14	kappa	kappa	I-NP	I-NP	-	15	NMOD	-	-
15	B-alpha	B-alpha	I-NP	I-NP	-	12	PMOD	-	-
16	followed	followed	B-VP	B-VP	-	15	NMOD	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	a	a	B-NP	B-NP	-	21	NMOD	-	-
19	slight	slight	I-NP	I-NP	-	21	NMOD	-	-
20	transient	transient	I-NP	I-NP	-	21	NMOD	-	-
21	increase	increase	I-NP	I-NP	-	17	PMOD	-	-
22	in	in	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	24	NMOD	-	-
24	level	level	I-NP	I-NP	-	22	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	this	this	B-NP	B-NP	-	28	NMOD	-	-
27	inhibitor	inhibitor	I-NP	I-NP	-	28	NMOD	-	-
28	protein	protein	I-NP	I-NP	-	25	PMOD	-	-
29	.	.	O	O	-	6	P	-	-

1	In	In	B-PP	B-PP	-	8	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	8	P	-	-
4	long-term	long-term	B-NP	B-NP	-	5	NMOD	-	-
5	treatment	treatment	I-NP	I-NP	-	8	SUB	-	-
6	with	with	B-PP	B-PP	-	5	NMOD	-	-
7	oxLDL	oxLDL	B-NP	B-NP	-	6	PMOD	-	-
8	prevented	prevented	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	lipopolysaccharide-induced	lipopolysaccharide-induced	I-NP	I-NP	-	11	NMOD	-	-
11	depletion	depletion	I-NP	I-NP	-	8	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	I	I	B-NP	B-NP	-	15	NMOD	-	-
14	kappa	kappa	I-NP	I-NP	-	15	NMOD	-	-
15	B-alpha	B-alpha	I-NP	I-NP	-	12	PMOD	-	-
16	,	,	O	O	-	11	P	-	-
17	accompanied	accompanied	B-VP	B-VP	-	11	NMOD	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	an	an	B-NP	B-NP	-	20	NMOD	-	-
20	inhibition	inhibition	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	both	both	O	O	-	28	NMOD	-	-
23	NF-kappa	NF-kappa	B-NP	B-NP	-	25	NMOD	-	-
24	B	B	I-NP	I-NP	-	25	NMOD	-	-
25	activation	activation	I-NP	I-NP	-	28	NMOD	-	-
26	and	and	O	O	-	28	NMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	expression	expression	I-NP	I-NP	-	21	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	tumor	tumor	B-NP	B-NP	-	32	NMOD	-	-
31	necrosis	necrosis	I-NP	I-NP	-	32	NMOD	-	-
32	factor-alpha	factor-alpha	I-NP	I-NP	-	36	NMOD	-	-
33	and	and	O	O	-	36	NMOD	-	-
34	interleukin-1	interleukin-1	B-NP	B-NP	-	36	NMOD	-	-
35	beta	beta	I-NP	I-NP	-	36	NMOD	-	-
36	genes	genes	I-NP	I-NP	-	29	PMOD	-	-
37	.	.	O	O	-	8	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	observations	observations	I-NP	I-NP	-	3	SUB	-	-
3	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
4	additional	additional	B-NP	B-NP	-	5	NMOD	-	-
5	evidence	evidence	I-NP	I-NP	-	3	OBJ	-	-
6	that	that	B-SBAR	B-SBAR	-	5	NMOD	-	-
7	oxLDL	oxLDL	B-NP	B-NP	-	8	SUB	-	-
8	is	is	B-VP	B-VP	-	6	SBAR	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	potent	potent	I-NP	I-NP	-	11	NMOD	-	-
11	modulator	modulator	I-NP	I-NP	-	8	PRD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	gene	gene	B-NP	B-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	12	PMOD	-	-
15	and	and	O	O	-	3	VMOD	-	-
16	suggest	suggest	B-VP	B-VP	-	3	VMOD	-	-
17	that	that	B-SBAR	B-SBAR	-	16	VMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	dys	dys	B-NP	B-NP	-	21	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	regulation	regulation	B-NP	B-NP	-	25	SUB	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	NF-kappa	NF-kappa	B-NP	B-NP	-	24	NMOD	-	-
24	B/Rel	B/Rel	I-NP	I-NP	-	22	PMOD	-	-
25	is	is	B-VP	B-VP	-	17	SBAR	-	-
26	likely	likely	B-ADJP	B-ADJP	-	25	PRD	-	-
27	to	to	B-VP	B-VP	-	28	VMOD	-	-
28	play	play	I-VP	I-VP	-	26	AMOD	-	-
29	an	an	B-NP	B-NP	-	31	NMOD	-	-
30	important	important	I-NP	I-NP	-	31	NMOD	-	-
31	role	role	I-NP	I-NP	-	28	OBJ	-	-
32	in	in	B-PP	B-PP	-	28	VMOD	-	-
33	atherogenesis	atherogenesis	B-NP	B-NP	-	32	PMOD	-	-
34	.	.	O	O	-	3	P	-	-

1	Suppression	Suppression	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	MHC	MHC	B-NP	B-NP	-	6	NMOD	-	-
4	class	class	I-NP	I-NP	-	6	NMOD	-	-
5	II	II	I-NP	I-NP	-	6	NMOD	-	-
6	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	human	human	B-NP	B-NP	-	12	NMOD	-	-
9	class	class	I-NP	I-NP	-	12	NMOD	-	-
10	II	II	I-NP	I-NP	-	12	NMOD	-	-
11	trans-activator	trans-activator	I-NP	I-NP	-	12	NMOD	-	-
12	constructs	constructs	I-NP	I-NP	-	7	PMOD	-	-
13	lacking	lacking	B-VP	B-VP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	N-terminal	N-terminal	I-NP	I-NP	-	16	NMOD	-	-
16	domain	domain	I-NP	I-NP	-	13	OBJ	-	-
17	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	class	class	I-NP	I-NP	-	4	NMOD	-	-
3	II	II	I-NP	I-NP	-	4	NMOD	-	-
4	trans-activator	trans-activator	I-NP	I-NP	-	8	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	CIITA	CIITA	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	14	NMOD	-	-
10	bi-	bi-	I-NP	I-NP	-	12	AMOD	-	-
11	or	or	I-NP	I-NP	-	12	AMOD	-	-
12	multi-functional	multi-functional	I-NP	I-NP	-	14	NMOD	-	-
13	domain	domain	I-NP	I-NP	-	14	NMOD	-	-
14	protein	protein	I-NP	I-NP	-	8	PRD	-	-
15	which	which	B-NP	B-NP	-	14	NMOD	-	-
16	plays	plays	B-VP	B-VP	-	15	SBAR	-	-
17	a	a	B-NP	B-NP	-	19	NMOD	-	-
18	critical	critical	I-NP	I-NP	-	19	NMOD	-	-
19	role	role	I-NP	I-NP	-	16	OBJ	-	-
20	in	in	B-PP	B-PP	-	16	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	expression	expression	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	MHC	MHC	B-NP	B-NP	-	27	NMOD	-	-
25	class	class	I-NP	I-NP	-	27	NMOD	-	-
26	II	II	B-NP	B-NP	-	27	NMOD	-	-
27	genes	genes	I-NP	I-NP	-	23	PMOD	-	-
28	.	.	O	O	-	8	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	report	report	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	removal	removal	B-NP	B-NP	-	25	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	N-terminal	N-terminal	I-NP	I-NP	-	10	NMOD	-	-
8	<num>	<num>	I-NP	I-NP	-	10	NMOD	-	-
9	amino	amino	I-NP	I-NP	-	10	NMOD	-	-
10	acids	acids	I-NP	I-NP	-	5	PMOD	-	-
11	,	,	O	O	-	4	P	-	-
12	encompassing	encompassing	B-VP	B-VP	-	4	NMOD	-	-
13	all	all	B-NP	B-NP	-	12	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	acidic	acidic	I-NP	I-NP	-	17	NMOD	-	-
17	domain	domain	I-NP	I-NP	-	14	PMOD	-	-
18	but	but	O	O	-	12	VMOD	-	-
19	leaving	leaving	B-VP	B-VP	-	4	NMOD	-	-
20	intact	intact	B-ADJP	B-ADJP	-	23	NMOD	-	-
21	the	the	B-NP	B-NP	-	23	NMOD	-	-
22	proline/serine/threonine-rich	proline/serine/threonine-rich	I-NP	I-NP	-	23	NMOD	-	-
23	domain	domain	I-NP	I-NP	-	19	OBJ	-	-
24	,	,	O	O	-	4	P	-	-
25	results	results	B-VP	B-VP	-	3	SBAR	-	-
26	in	in	B-PP	B-PP	-	25	VMOD	-	-
27	a	a	B-NP	B-NP	-	29	NMOD	-	-
28	mutant	mutant	I-NP	I-NP	-	29	NMOD	-	-
29	protein	protein	I-NP	I-NP	-	26	PMOD	-	-
30	with	with	B-PP	B-PP	-	29	NMOD	-	-
31	potent	potent	B-NP	B-NP	-	33	NMOD	-	-
32	suppressive	suppressive	I-NP	I-NP	-	33	NMOD	-	-
33	properties	properties	I-NP	I-NP	-	30	PMOD	-	-
34	for	for	B-PP	B-PP	-	33	NMOD	-	-
35	MHC	MHC	B-NP	B-NP	-	38	NMOD	-	-
36	class	class	I-NP	I-NP	-	38	NMOD	-	-
37	II	II	I-NP	I-NP	-	38	NMOD	-	-
38	expression	expression	I-NP	I-NP	-	34	PMOD	-	-
39	.	.	O	O	-	2	P	-	-

1	HeLa	HeLa	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	11	SUB	-	-
3	stably	stably	B-VP	B-VP	-	2	NMOD	-	-
4	or	or	I-VP	I-VP	-	3	AMOD	-	-
5	transiently	transiently	I-VP	I-VP	-	3	AMOD	-	-
6	transfected	transfected	I-VP	I-VP	-	2	NMOD	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	mutant	mutant	B-NP	B-NP	-	10	NMOD	-	-
9	CIITA	CIITA	I-NP	I-NP	-	10	NMOD	-	-
10	constructs	constructs	I-NP	I-NP	-	7	PMOD	-	-
11	showed	showed	B-VP	B-VP	-	0	ROOT	-	-
12	up	up	B-NP	B-NP	-	16	NMOD	-	-
13	to	to	I-NP	I-NP	-	12	AMOD	-	-
14	<num>	<num>	I-NP	I-NP	-	12	AMOD	-	-
15	%	%	I-NP	I-NP	-	16	NMOD	-	-
16	suppression	suppression	I-NP	I-NP	-	11	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	MHC	MHC	B-NP	B-NP	-	21	NMOD	-	-
19	class	class	I-NP	I-NP	-	21	NMOD	-	-
20	II	II	I-NP	I-NP	-	21	NMOD	-	-
21	antigen	antigen	I-NP	I-NP	-	22	NMOD	-	-
22	induction	induction	I-NP	I-NP	-	17	PMOD	-	-
23	by	by	B-PP	B-PP	-	22	NMOD	-	-
24	IFN-gamma	IFN-gamma	B-NP	B-NP	-	27	NMOD	-	-
25	and	and	O	O	-	27	NMOD	-	-
26	marked	marked	B-NP	B-NP	-	27	NMOD	-	-
27	suppression	suppression	I-NP	I-NP	-	23	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	HLA-DRA	HLA-DRA	B-NP	B-NP	-	31	NMOD	-	-
30	mRNA	mRNA	I-NP	I-NP	-	31	NMOD	-	-
31	expression	expression	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	11	P	-	-

1	Transient	Transient	B-NP	B-NP	-	2	NMOD	-	-
2	transfection	transfection	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	B	B	I-NP	I-NP	-	7	NMOD	-	-
6	lymphoma	lymphoma	I-NP	I-NP	-	7	NMOD	-	-
7	line	line	I-NP	I-NP	-	3	PMOD	-	-
8	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	up	up	B-NP	B-NP	-	14	NMOD	-	-
11	to	to	I-NP	I-NP	-	10	AMOD	-	-
12	<num>	<num>	I-NP	I-NP	-	10	AMOD	-	-
13	%	%	I-NP	I-NP	-	14	NMOD	-	-
14	reduction	reduction	I-NP	I-NP	-	9	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	constitutive	constitutive	B-NP	B-NP	-	20	NMOD	-	-
17	MHC	MHC	I-NP	I-NP	-	20	NMOD	-	-
18	class	class	I-NP	I-NP	-	20	NMOD	-	-
19	II	II	I-NP	I-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	15	PMOD	-	-
21	within	within	B-PP	B-PP	-	20	NMOD	-	-
22	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
23	days	days	I-NP	I-NP	-	25	NMOD	-	-
24	and	and	I-NP	I-NP	-	25	NMOD	-	-
25	suppression	suppression	I-NP	I-NP	-	21	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	HLA-DRA	HLA-DRA	B-NP	B-NP	-	29	NMOD	-	-
28	mRNA	mRNA	I-NP	I-NP	-	29	NMOD	-	-
29	synthesis	synthesis	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	8	P	-	-

1	CD30-dependent	CD30-dependent	B-NP	B-NP	-	2	NMOD	-	-
2	degradation	degradation	I-NP	I-NP	-	6	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	TRAF2	TRAF2	B-NP	B-NP	-	3	PMOD	-	-
5	:	:	O	O	-	2	P	-	-
6	implications	implications	B-NP	B-NP	-	0	ROOT	-	-
7	for	for	B-PP	B-PP	-	6	NMOD	-	-
8	negative	negative	B-NP	B-NP	-	9	NMOD	-	-
9	regulation	regulation	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	TRAF	TRAF	B-NP	B-NP	-	12	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	10	PMOD	-	-
13	and	and	O	O	-	15	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	control	control	I-NP	I-NP	-	10	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	cell	cell	B-NP	B-NP	-	18	NMOD	-	-
18	survival	survival	I-NP	I-NP	-	16	PMOD	-	-
19	.	.	O	O	-	6	P	-	-

1	CD30	CD30	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	a	a	B-NP	B-NP	-	5	NMOD	-	-
4	cell-surface	cell-surface	I-NP	I-NP	-	5	NMOD	-	-
5	receptor	receptor	I-NP	I-NP	-	2	PRD	-	-
6	that	that	B-NP	B-NP	-	5	NMOD	-	-
7	can	can	B-VP	B-VP	-	6	SBAR	-	-
8	augment	augment	I-VP	I-VP	-	7	VC	-	-
9	lymphocyte	lymphocyte	B-NP	B-NP	-	10	NMOD	-	-
10	activation	activation	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	survival	survival	B-NP	B-NP	-	8	OBJ	-	-
13	through	through	B-PP	B-PP	-	8	VMOD	-	-
14	its	its	B-NP	B-NP	-	15	NMOD	-	-
15	ability	ability	I-NP	I-NP	-	13	PMOD	-	-
16	to	to	B-VP	B-VP	-	17	VMOD	-	-
17	induce	induce	I-VP	I-VP	-	15	NMOD	-	-
18	the	the	B-NP	B-NP	-	21	NMOD	-	-
19	transcription	transcription	I-NP	I-NP	-	21	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	21	NMOD	-	-
21	NF-kappaB	NF-kappaB	I-NP	I-NP	-	17	OBJ	-	-
22	.	.	O	O	-	2	P	-	-

1	CD30	CD30	B-NP	B-NP	-	5	SUB	-	-
2	,	,	O	O	-	1	P	-	-
3	however	however	B-ADVP	B-ADVP	-	5	VMOD	-	-
4	,	,	O	O	-	5	P	-	-
5	has	has	B-VP	B-VP	-	0	ROOT	-	-
6	also	also	I-VP	I-VP	-	5	VMOD	-	-
7	been	been	I-VP	I-VP	-	5	VC	-	-
8	implicated	implicated	I-VP	I-VP	-	7	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	induction	induction	I-NP	I-NP	-	9	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	apoptotic	apoptotic	B-NP	B-NP	-	15	NMOD	-	-
14	cell	cell	I-NP	I-NP	-	15	NMOD	-	-
15	death	death	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	lymphocytes	lymphocytes	B-NP	B-NP	-	16	PMOD	-	-
18	.	.	O	O	-	5	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	one	one	B-NP	B-NP	-	13	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	effects	effects	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	CD30	CD30	B-NP	B-NP	-	12	NMOD	-	-
11	signal	signal	I-NP	I-NP	-	12	NMOD	-	-
12	transduction	transduction	I-NP	I-NP	-	9	PMOD	-	-
13	is	is	B-VP	B-VP	-	4	SBAR	-	-
14	to	to	B-VP	B-VP	-	15	VMOD	-	-
15	render	render	I-VP	I-VP	-	13	VMOD	-	-
16	cells	cells	B-NP	B-NP	-	15	OBJ	-	-
17	sensitive	sensitive	B-ADJP	B-ADJP	-	16	NMOD	-	-
18	to	to	B-PP	B-PP	-	17	AMOD	-	-
19	apoptosis	apoptosis	B-NP	B-NP	-	18	PMOD	-	-
20	induced	induced	B-VP	B-VP	-	19	NMOD	-	-
21	by	by	B-PP	B-PP	-	20	VMOD	-	-
22	the	the	B-NP	B-NP	-	28	NMOD	-	-
23	type	type	I-NP	I-NP	-	28	NMOD	-	-
24	<num>	<num>	I-NP	I-NP	-	28	NMOD	-	-
25	tumor	tumor	I-NP	I-NP	-	28	NMOD	-	-
26	necrosis	necrosis	I-NP	I-NP	-	28	NMOD	-	-
27	factor	factor	I-NP	I-NP	-	28	NMOD	-	-
28	receptor	receptor	I-NP	I-NP	-	21	PMOD	-	-
29	(	(	O	O	-	30	P	-	-
30	TNFR1	TNFR1	B-NP	B-NP	-	28	NMOD	-	-
31	)	)	O	O	-	30	P	-	-
32	.	.	O	O	-	3	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	sensitization	sensitization	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	dependent	dependent	B-ADJP	B-ADJP	-	3	PRD	-	-
5	on	on	B-PP	B-PP	-	4	AMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	TRAF-binding	TRAF-binding	I-NP	I-NP	-	8	NMOD	-	-
8	sites	sites	I-NP	I-NP	-	5	PMOD	-	-
9	within	within	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	CD30	CD30	I-NP	I-NP	-	13	NMOD	-	-
12	cytoplasmic	cytoplasmic	I-NP	I-NP	-	13	NMOD	-	-
13	domain	domain	I-NP	I-NP	-	9	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	One	One	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	proteins	proteins	I-NP	I-NP	-	2	PMOD	-	-
5	that	that	B-NP	B-NP	-	4	NMOD	-	-
6	binds	binds	B-VP	B-VP	-	5	SBAR	-	-
7	to	to	B-PP	B-PP	-	6	VMOD	-	-
8	these	these	B-NP	B-NP	-	9	NMOD	-	-
9	sites	sites	I-NP	I-NP	-	7	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	TRAF2	TRAF2	B-NP	B-NP	-	16	NMOD	-	-
12	,	,	O	O	-	16	P	-	-
13	a	a	B-NP	B-NP	-	16	NMOD	-	-
14	signal	signal	I-NP	I-NP	-	16	NMOD	-	-
15	transduction	transduction	I-NP	I-NP	-	16	NMOD	-	-
16	molecule	molecule	I-NP	I-NP	-	10	PRD	-	-
17	that	that	B-NP	B-NP	-	16	NMOD	-	-
18	is	is	B-VP	B-VP	-	17	SBAR	-	-
19	also	also	I-VP	I-VP	-	18	VMOD	-	-
20	utilized	utilized	I-VP	I-VP	-	18	VC	-	-
21	by	by	B-PP	B-PP	-	20	VMOD	-	-
22	TNFR1	TNFR1	B-NP	B-NP	-	21	PMOD	-	-
23	to	to	B-VP	B-VP	-	24	VMOD	-	-
24	mediate	mediate	I-VP	I-VP	-	18	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	24	OBJ	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	several	several	B-NP	B-NP	-	30	NMOD	-	-
29	downstream	downstream	I-NP	I-NP	-	30	NMOD	-	-
30	kinases	kinases	I-NP	I-NP	-	27	PMOD	-	-
31	and	and	O	O	-	33	NMOD	-	-
32	transcription	transcription	B-NP	B-NP	-	33	NMOD	-	-
33	factors	factors	I-NP	I-NP	-	27	PMOD	-	-
34	.	.	O	O	-	10	P	-	-

1	During	During	B-PP	B-PP	-	7	VMOD	-	-
2	CD30	CD30	B-NP	B-NP	-	4	NMOD	-	-
3	signal	signal	I-NP	I-NP	-	4	NMOD	-	-
4	transduction	transduction	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	found	found	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	binding	binding	B-NP	B-NP	-	18	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	TRAF2	TRAF2	B-NP	B-NP	-	10	PMOD	-	-
12	to	to	B-PP	B-PP	-	9	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	cytoplasmic	cytoplasmic	I-NP	I-NP	-	15	NMOD	-	-
15	domain	domain	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	CD30	CD30	B-NP	B-NP	-	16	PMOD	-	-
18	results	results	B-VP	B-VP	-	8	SBAR	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	rapid	rapid	I-NP	I-NP	-	22	NMOD	-	-
22	depletion	depletion	I-NP	I-NP	-	19	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	TRAF2	TRAF2	B-NP	B-NP	-	23	PMOD	-	-
25	and	and	O	O	-	29	NMOD	-	-
26	the	the	B-NP	B-NP	-	29	NMOD	-	-
27	associated	associated	I-NP	I-NP	-	29	NMOD	-	-
28	protein	protein	I-NP	I-NP	-	29	NMOD	-	-
29	TRAF1	TRAF1	I-NP	I-NP	-	23	PMOD	-	-
30	by	by	B-PP	B-PP	-	22	NMOD	-	-
31	proteolysis	proteolysis	B-NP	B-NP	-	30	PMOD	-	-
32	.	.	O	O	-	7	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	5	NMOD	-	-
5	model	model	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	which	which	B-NP	B-NP	-	6	PMOD	-	-
8	CD30	CD30	B-NP	B-NP	-	9	SUB	-	-
9	limits	limits	B-VP	B-VP	-	6	SBAR	-	-
10	its	its	B-NP	B-NP	-	12	NMOD	-	-
11	own	own	I-NP	I-NP	-	12	NMOD	-	-
12	ability	ability	I-NP	I-NP	-	9	OBJ	-	-
13	to	to	B-VP	B-VP	-	14	VMOD	-	-
14	transduce	transduce	I-VP	I-VP	-	12	NMOD	-	-
15	cell	cell	B-NP	B-NP	-	17	NMOD	-	-
16	survival	survival	I-NP	I-NP	-	17	NMOD	-	-
17	signals	signals	I-NP	I-NP	-	14	OBJ	-	-
18	through	through	B-PP	B-PP	-	14	VMOD	-	-
19	signal-coupled	signal-coupled	B-NP	B-NP	-	20	NMOD	-	-
20	depletion	depletion	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	TRAF2	TRAF2	B-NP	B-NP	-	21	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	Depletion	Depletion	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	intracellular	intracellular	B-NP	B-NP	-	4	NMOD	-	-
4	TRAF2	TRAF2	I-NP	I-NP	-	8	NMOD	-	-
5	and	and	O	O	-	8	NMOD	-	-
6	its	its	B-NP	B-NP	-	8	NMOD	-	-
7	coassociated	coassociated	I-NP	I-NP	-	8	NMOD	-	-
8	proteins	proteins	I-NP	I-NP	-	2	PMOD	-	-
9	also	also	B-ADVP	B-ADVP	-	10	VMOD	-	-
10	increased	increased	B-VP	B-VP	-	0	ROOT	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	sensitivity	sensitivity	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	13	PMOD	-	-
16	to	to	B-PP	B-PP	-	10	VMOD	-	-
17	undergoing	undergoing	B-VP	B-VP	-	16	PMOD	-	-
18	apoptosis	apoptosis	B-NP	B-NP	-	17	OBJ	-	-
19	during	during	B-PP	B-PP	-	18	NMOD	-	-
20	activation	activation	B-NP	B-NP	-	19	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	death-inducing	death-inducing	B-NP	B-NP	-	23	NMOD	-	-
23	receptors	receptors	I-NP	I-NP	-	21	PMOD	-	-
24	such	such	B-PP	B-PP	-	25	PMOD	-	-
25	as	as	I-PP	I-PP	-	23	NMOD	-	-
26	TNFR1	TNFR1	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	10	P	-	-

1	Consistent	Consistent	B-ADJP	B-ADJP	-	13	VMOD	-	-
2	with	with	B-PP	B-PP	-	1	AMOD	-	-
3	this	this	B-NP	B-NP	-	4	NMOD	-	-
4	hypothesis	hypothesis	I-NP	I-NP	-	2	PMOD	-	-
5	,	,	O	O	-	13	P	-	-
6	expression	expression	B-NP	B-NP	-	13	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	dominant-negative	dominant-negative	I-NP	I-NP	-	10	NMOD	-	-
10	form	form	I-NP	I-NP	-	7	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	TRAF2	TRAF2	B-NP	B-NP	-	11	PMOD	-	-
13	was	was	B-VP	B-VP	-	0	ROOT	-	-
14	found	found	I-VP	I-VP	-	13	VC	-	-
15	to	to	I-VP	I-VP	-	16	VMOD	-	-
16	potentiate	potentiate	I-VP	I-VP	-	14	VMOD	-	-
17	TNFR1-mediated	TNFR1-mediated	B-NP	B-NP	-	18	NMOD	-	-
18	death	death	I-NP	I-NP	-	16	OBJ	-	-
19	.	.	O	O	-	13	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	provide	provide	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	potential	potential	I-NP	I-NP	-	6	NMOD	-	-
6	mechanism	mechanism	I-NP	I-NP	-	16	NMOD	-	-
7	through	through	B-PP	B-PP	-	6	NMOD	-	-
8	which	which	B-NP	B-NP	-	7	PMOD	-	-
9	CD30	CD30	B-NP	B-NP	-	16	NMOD	-	-
10	,	,	O	O	-	16	P	-	-
11	as	as	B-CONJP	B-CONJP	-	16	NMOD	-	-
12	well	well	I-CONJP	I-CONJP	-	11	DEP	-	-
13	as	as	I-CONJP	I-CONJP	-	11	DEP	-	-
14	other	other	B-NP	B-NP	-	16	NMOD	-	-
15	TRAF-binding	TRAF-binding	I-NP	I-NP	-	16	NMOD	-	-
16	members	members	I-NP	I-NP	-	3	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	TNFR	TNFR	I-NP	I-NP	-	20	NMOD	-	-
20	superfamily	superfamily	I-NP	I-NP	-	17	PMOD	-	-
21	,	,	O	O	-	3	P	-	-
22	can	can	B-VP	B-VP	-	3	VMOD	-	-
23	negatively	negatively	I-VP	I-VP	-	22	VMOD	-	-
24	regulate	regulate	I-VP	I-VP	-	22	VC	-	-
25	cell	cell	B-NP	B-NP	-	26	NMOD	-	-
26	survival	survival	I-NP	I-NP	-	24	OBJ	-	-
27	.	.	O	O	-	3	P	-	-

1	TNFalpha	TNFalpha	B-NP	B-NP	-	2	SUB	-	-
2	cooperates	cooperates	B-VP	B-VP	-	0	ROOT	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	8	NMOD	-	-
6	kinase	kinase	I-NP	I-NP	-	8	NMOD	-	-
7	A	A	I-NP	I-NP	-	8	NMOD	-	-
8	pathway	pathway	I-NP	I-NP	-	3	PMOD	-	-
9	to	to	B-VP	B-VP	-	11	VMOD	-	-
10	synergistically	synergistically	I-VP	I-VP	-	11	VMOD	-	-
11	increase	increase	I-VP	I-VP	-	2	VMOD	-	-
12	HIV-1	HIV-1	B-NP	B-NP	-	14	NMOD	-	-
13	LTR	LTR	I-NP	I-NP	-	14	NMOD	-	-
14	transcription	transcription	I-NP	I-NP	-	11	OBJ	-	-
15	via	via	B-PP	B-PP	-	11	VMOD	-	-
16	downstream	downstream	B-NP	B-NP	-	20	NMOD	-	-
17	TRE-like	TRE-like	I-NP	I-NP	-	20	NMOD	-	-
18	cAMP	cAMP	I-NP	I-NP	-	20	NMOD	-	-
19	response	response	I-NP	I-NP	-	20	NMOD	-	-
20	elements	elements	I-NP	I-NP	-	15	PMOD	-	-
21	.	.	O	O	-	2	P	-	-

1	Activating	Activating	B-VP	B-VP	-	2	NMOD	-	-
2	protein-1	protein-1	B-NP	B-NP	-	9	NMOD	-	-
3	(	(	O	O	-	4	P	-	-
4	AP-1	AP-1	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	binding	binding	B-NP	B-NP	-	9	NMOD	-	-
7	TPA	TPA	I-NP	I-NP	-	9	NMOD	-	-
8	responsive	responsive	I-NP	I-NP	-	9	NMOD	-	-
9	elements	elements	I-NP	I-NP	-	13	SUB	-	-
10	(	(	O	O	-	11	P	-	-
11	TRE	TRE	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	are	are	B-VP	B-VP	-	0	ROOT	-	-
14	located	located	B-ADJP	B-ADJP	-	13	PRD	-	-
15	downstream	downstream	B-PP	B-PP	-	14	AMOD	-	-
16	of	of	B-PP	B-PP	-	15	AMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	transcription	transcription	I-NP	I-NP	-	20	NMOD	-	-
19	initiation	initiation	I-NP	I-NP	-	20	NMOD	-	-
20	site	site	I-NP	I-NP	-	16	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	U5	U5	I-NP	I-NP	-	24	NMOD	-	-
24	region	region	I-NP	I-NP	-	21	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	the	the	B-NP	B-NP	-	30	NMOD	-	-
27	HIV-1	HIV-1	I-NP	I-NP	-	30	NMOD	-	-
28	long	long	I-NP	I-NP	-	30	NMOD	-	-
29	terminal	terminal	I-NP	I-NP	-	30	NMOD	-	-
30	repeat	repeat	I-NP	I-NP	-	25	PMOD	-	-
31	(	(	O	O	-	32	P	-	-
32	LTR	LTR	B-NP	B-NP	-	30	NMOD	-	-
33	)	)	O	O	-	32	P	-	-
34	.	.	O	O	-	13	P	-	-

1	These	These	B-NP	B-NP	-	4	NMOD	-	-
2	downstream	downstream	I-NP	I-NP	-	4	NMOD	-	-
3	sequence	sequence	I-NP	I-NP	-	4	NMOD	-	-
4	elements	elements	I-NP	I-NP	-	9	SUB	-	-
5	,	,	O	O	-	4	P	-	-
6	termed	termed	B-NP	B-NP	-	4	NMOD	-	-
7	DSE	DSE	I-NP	I-NP	-	6	VMOD	-	-
8	,	,	O	O	-	4	P	-	-
9	can	can	B-VP	B-VP	-	0	ROOT	-	-
10	bind	bind	I-VP	I-VP	-	9	VC	-	-
11	both	both	O	O	-	16	NMOD	-	-
12	AP-1	AP-1	B-NP	B-NP	-	16	NMOD	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	CREB/ATF	CREB/ATF	B-NP	B-NP	-	16	NMOD	-	-
15	transcription	transcription	I-NP	I-NP	-	16	NMOD	-	-
16	factors	factors	I-NP	I-NP	-	10	OBJ	-	-
17	.	.	O	O	-	9	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	DSE	DSE	I-NP	I-NP	-	8	SUB	-	-
8	are	are	B-VP	B-VP	-	5	SBAR	-	-
9	also	also	B-ADVP	B-ADVP	-	8	VMOD	-	-
10	cAMP-responsive	cAMP-responsive	B-NP	B-NP	-	11	NMOD	-	-
11	elements	elements	I-NP	I-NP	-	8	PRD	-	-
12	(	(	O	O	-	13	P	-	-
13	CRE	CRE	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	,	,	O	O	-	8	P	-	-
16	since	since	B-SBAR	B-SBAR	-	8	VMOD	-	-
17	they	they	B-NP	B-NP	-	18	SUB	-	-
18	mediated	mediated	B-VP	B-VP	-	16	SBAR	-	-
19	activation	activation	B-NP	B-NP	-	20	NMOD	-	-
20	signals	signals	I-NP	I-NP	-	18	OBJ	-	-
21	elicited	elicited	B-VP	B-VP	-	20	NMOD	-	-
22	by	by	B-PP	B-PP	-	21	VMOD	-	-
23	cholera	cholera	B-NP	B-NP	-	24	NMOD	-	-
24	toxin	toxin	I-NP	I-NP	-	31	NMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	Ctx	Ctx	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	,	,	O	O	-	31	P	-	-
29	a	a	B-NP	B-NP	-	31	NMOD	-	-
30	potent	potent	I-NP	I-NP	-	31	NMOD	-	-
31	activator	activator	I-NP	I-NP	-	22	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	43	NMOD	-	-
34	cAMP-dependent	cAMP-dependent	I-NP	I-NP	-	43	NMOD	-	-
35	protein	protein	I-NP	I-NP	-	37	NMOD	-	-
36	kinase	kinase	I-NP	I-NP	-	37	NMOD	-	-
37	A	A	I-NP	I-NP	-	43	NMOD	-	-
38	(	(	O	O	-	39	P	-	-
39	PKA	PKA	B-NP	B-NP	-	37	NMOD	-	-
40	)	)	O	O	-	39	P	-	-
41	signal	signal	B-NP	B-NP	-	43	NMOD	-	-
42	transduction	transduction	I-NP	I-NP	-	43	NMOD	-	-
43	pathway	pathway	I-NP	I-NP	-	32	PMOD	-	-
44	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	present	present	I-NP	I-NP	-	4	NMOD	-	-
4	study	study	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	HIV-1	HIV-1	I-NP	I-NP	-	11	NMOD	-	-
11	DSE	DSE	I-NP	I-NP	-	12	SUB	-	-
12	can	can	B-VP	B-VP	-	8	SBAR	-	-
13	mediate	mediate	I-VP	I-VP	-	12	VC	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	transcriptional	transcriptional	I-NP	I-NP	-	16	NMOD	-	-
16	synergy	synergy	I-NP	I-NP	-	13	OBJ	-	-
17	elicited	elicited	B-VP	B-VP	-	16	NMOD	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	combination	combination	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	Ctx	Ctx	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	TNFalpha	TNFalpha	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	7	P	-	-

1	Ctx	Ctx	B-NP	B-NP	-	0	ROOT	-	-
2	combined	combined	B-VP	B-VP	-	1	NMOD	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	TNFalpha	TNFalpha	B-NP	B-NP	-	6	NMOD	-	-
5	or	or	I-NP	I-NP	-	6	NMOD	-	-
6	IL-1beta	IL-1beta	I-NP	I-NP	-	3	PMOD	-	-
7	to	to	B-VP	B-VP	-	8	VMOD	-	-
8	produce	produce	I-VP	I-VP	-	6	NMOD	-	-
9	a	a	B-NP	B-NP	-	11	NMOD	-	-
10	synergistic	synergistic	I-NP	I-NP	-	11	NMOD	-	-
11	increase	increase	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	p24	p24	B-NP	B-NP	-	15	NMOD	-	-
14	antigen	antigen	I-NP	I-NP	-	15	NMOD	-	-
15	production	production	I-NP	I-NP	-	12	PMOD	-	-
16	in	in	B-PP	B-PP	-	15	NMOD	-	-
17	U1	U1	B-NP	B-NP	-	19	NMOD	-	-
18	promonocytic	promonocytic	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	1	P	-	-

1	Transfection	Transfection	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	7	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	LTR	LTR	B-NP	B-NP	-	6	NMOD	-	-
5	reporter	reporter	I-NP	I-NP	-	6	NMOD	-	-
6	constructs	constructs	I-NP	I-NP	-	3	PMOD	-	-
7	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	mutation	mutation	B-NP	B-NP	-	14	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	DSE	DSE	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	10	PMOD	-	-
14	abrogated	abrogated	B-VP	B-VP	-	8	SBAR	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	LTR-mediated	LTR-mediated	I-NP	I-NP	-	17	NMOD	-	-
17	synergy	synergy	I-NP	I-NP	-	14	OBJ	-	-
18	induced	induced	B-VP	B-VP	-	17	NMOD	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	Ctx	Ctx	B-NP	B-NP	-	22	NMOD	-	-
21	and	and	I-NP	I-NP	-	22	NMOD	-	-
22	TNFalpha	TNFalpha	I-NP	I-NP	-	19	PMOD	-	-
23	,	,	O	O	-	14	P	-	-
24	whereas	whereas	O	O	-	14	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	synergy	synergy	I-NP	I-NP	-	32	SUB	-	-
27	induced	induced	B-VP	B-VP	-	26	NMOD	-	-
28	by	by	B-PP	B-PP	-	27	VMOD	-	-
29	Ctx	Ctx	B-NP	B-NP	-	31	NMOD	-	-
30	and	and	I-NP	I-NP	-	31	NMOD	-	-
31	IL-1beta	IL-1beta	I-NP	I-NP	-	28	PMOD	-	-
32	was	was	B-VP	B-VP	-	24	VMOD	-	-
33	unaffected	unaffected	B-ADJP	B-ADJP	-	32	PRD	-	-
34	,	,	O	O	-	14	P	-	-
35	suggesting	suggesting	B-VP	B-VP	-	14	VMOD	-	-
36	TNFalpha	TNFalpha	B-NP	B-NP	-	38	NMOD	-	-
37	and	and	I-NP	I-NP	-	38	NMOD	-	-
38	IL-1beta	IL-1beta	I-NP	I-NP	-	35	OBJ	-	-
39	cooperate	cooperate	B-VP	B-VP	-	35	VMOD	-	-
40	differently	differently	B-ADVP	B-ADVP	-	39	VMOD	-	-
41	with	with	B-PP	B-PP	-	39	VMOD	-	-
42	the	the	B-NP	B-NP	-	45	NMOD	-	-
43	cAMP/PKA	cAMP/PKA	I-NP	I-NP	-	45	NMOD	-	-
44	activation	activation	I-NP	I-NP	-	45	NMOD	-	-
45	pathway	pathway	I-NP	I-NP	-	41	PMOD	-	-
46	to	to	B-VP	B-VP	-	47	VMOD	-	-
47	induce	induce	I-VP	I-VP	-	39	VMOD	-	-
48	HIV-1	HIV-1	B-NP	B-NP	-	49	NMOD	-	-
49	expression	expression	I-NP	I-NP	-	47	OBJ	-	-
50	in	in	B-PP	B-PP	-	47	VMOD	-	-
51	U1	U1	B-NP	B-NP	-	52	NMOD	-	-
52	cells	cells	I-NP	I-NP	-	50	PMOD	-	-
53	.	.	O	O	-	7	P	-	-

1	Because	Because	B-SBAR	B-SBAR	-	10	VMOD	-	-
2	the	the	B-NP	B-NP	-	3	NMOD	-	-
3	DSE	DSE	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	1	SBAR	-	-
5	also	also	B-ADVP	B-ADVP	-	4	VMOD	-	-
6	TRE	TRE	B-NP	B-NP	-	7	NMOD	-	-
7	sites	sites	I-NP	I-NP	-	4	PRD	-	-
8	,	,	O	O	-	10	P	-	-
9	we	we	B-NP	B-NP	-	10	SUB	-	-
10	assessed	assessed	B-VP	B-VP	-	0	ROOT	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	effect	effect	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	agonist	agonist	I-NP	I-NP	-	16	NMOD	-	-
16	combinations	combinations	I-NP	I-NP	-	13	PMOD	-	-
17	on	on	B-PP	B-PP	-	12	NMOD	-	-
18	AP-1-dependent	AP-1-dependent	B-NP	B-NP	-	19	NMOD	-	-
19	transcription	transcription	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	TNFalpha	TNFalpha	B-NP	B-NP	-	5	NMOD	-	-
2	as	as	B-CONJP	B-CONJP	-	5	NMOD	-	-
3	well	well	I-CONJP	I-CONJP	-	2	DEP	-	-
4	as	as	I-CONJP	I-CONJP	-	2	DEP	-	-
5	IL-1beta	IL-1beta	B-NP	B-NP	-	6	SUB	-	-
6	cooperated	cooperated	B-VP	B-VP	-	0	ROOT	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	Ctx	Ctx	B-NP	B-NP	-	7	PMOD	-	-
9	to	to	B-VP	B-VP	-	10	VMOD	-	-
10	produce	produce	I-VP	I-VP	-	6	VMOD	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	synergistic	synergistic	I-NP	I-NP	-	13	NMOD	-	-
13	activation	activation	I-NP	I-NP	-	10	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	AP-1-mediated	AP-1-mediated	B-NP	B-NP	-	16	NMOD	-	-
16	transcription	transcription	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	6	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	9	NMOD	-	-
6	TRE-like	TRE-like	I-NP	I-NP	-	9	NMOD	-	-
7	cAMP-responsive	cAMP-responsive	I-NP	I-NP	-	9	NMOD	-	-
8	DSE	DSE	I-NP	I-NP	-	9	NMOD	-	-
9	sites	sites	I-NP	I-NP	-	14	SUB	-	-
10	within	within	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	5'-untranslated	5'-untranslated	I-NP	I-NP	-	13	NMOD	-	-
13	leader	leader	I-NP	I-NP	-	10	PMOD	-	-
14	can	can	B-VP	B-VP	-	4	SBAR	-	-
15	mediate	mediate	I-VP	I-VP	-	14	VC	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	transcriptional	transcriptional	I-NP	I-NP	-	18	NMOD	-	-
18	cooperativity	cooperativity	I-NP	I-NP	-	15	OBJ	-	-
19	between	between	B-PP	B-PP	-	18	NMOD	-	-
20	TNFalpha	TNFalpha	B-NP	B-NP	-	24	NMOD	-	-
21	and	and	O	O	-	24	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	cAMP/PKA	cAMP/PKA	I-NP	I-NP	-	24	NMOD	-	-
24	pathway	pathway	I-NP	I-NP	-	19	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	Since	Since	B-SBAR	B-SBAR	-	14	VMOD	-	-
2	the	the	B-NP	B-NP	-	6	NMOD	-	-
3	DSE	DSE	I-NP	I-NP	-	6	NMOD	-	-
4	and	and	I-NP	I-NP	-	6	NMOD	-	-
5	TRE	TRE	I-NP	I-NP	-	6	NMOD	-	-
6	sites	sites	I-NP	I-NP	-	7	SUB	-	-
7	can	can	B-VP	B-VP	-	1	SBAR	-	-
8	not	not	I-VP	I-VP	-	7	VMOD	-	-
9	bind	bind	I-VP	I-VP	-	7	VC	-	-
10	CREB/ATF	CREB/ATF	B-NP	B-NP	-	11	NMOD	-	-
11	homodimers	homodimers	I-NP	I-NP	-	9	OBJ	-	-
12	,	,	O	O	-	14	P	-	-
13	we	we	B-NP	B-NP	-	14	SUB	-	-
14	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
15	a	a	B-NP	B-NP	-	16	NMOD	-	-
16	mechanism	mechanism	I-NP	I-NP	-	14	OBJ	-	-
17	in	in	B-PP	B-PP	-	16	NMOD	-	-
18	which	which	B-NP	B-NP	-	17	PMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	HIV-1	HIV-1	I-NP	I-NP	-	21	NMOD	-	-
21	DSE	DSE	I-NP	I-NP	-	17	PMOD	-	-
22	bind	bind	B-VP	B-VP	-	14	VMOD	-	-
23	heterodimers	heterodimers	B-NP	B-NP	-	22	OBJ	-	-
24	composed	composed	B-VP	B-VP	-	23	NMOD	-	-
25	of	of	B-PP	B-PP	-	24	VMOD	-	-
26	both	both	O	O	-	30	NMOD	-	-
27	AP-1	AP-1	B-NP	B-NP	-	30	NMOD	-	-
28	and	and	I-NP	I-NP	-	30	NMOD	-	-
29	CREB/ATF	CREB/ATF	I-NP	I-NP	-	30	NMOD	-	-
30	proteins	proteins	I-NP	I-NP	-	25	PMOD	-	-
31	.	.	O	O	-	14	P	-	-

1	Copyright	Copyright	B-NP	B-NP	-	0	ROOT	-	-
2	<num>	<num>	I-NP	I-NP	-	4	NMOD	-	-
3	Academic	Academic	I-NP	I-NP	-	4	NMOD	-	-
4	Press	Press	I-NP	I-NP	-	1	NMOD	-	-
5	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	8	NMOD	-	-
2	Epstein-Barr	Epstein-Barr	I-NP	I-NP	-	8	NMOD	-	-
3	virus	virus	I-NP	I-NP	-	8	NMOD	-	-
4	oncogene	oncogene	I-NP	I-NP	-	8	NMOD	-	-
5	product	product	I-NP	I-NP	-	8	NMOD	-	-
6	latent	latent	I-NP	I-NP	-	8	NMOD	-	-
7	membrane	membrane	I-NP	I-NP	-	8	NMOD	-	-
8	protein	protein	I-NP	I-NP	-	10	SUB	-	-
9	<num>	<num>	I-NP	I-NP	-	8	NMOD	-	-
10	engages	engages	B-VP	B-VP	-	0	ROOT	-	-
11	the	the	B-NP	B-NP	-	18	NMOD	-	-
12	tumor	tumor	I-NP	I-NP	-	18	NMOD	-	-
13	necrosis	necrosis	I-NP	I-NP	-	18	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	18	NMOD	-	-
15	receptor-associated	receptor-associated	I-NP	I-NP	-	18	NMOD	-	-
16	death	death	I-NP	I-NP	-	18	NMOD	-	-
17	domain	domain	I-NP	I-NP	-	18	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	10	OBJ	-	-
19	to	to	B-VP	B-VP	-	20	VMOD	-	-
20	mediate	mediate	I-VP	I-VP	-	10	VMOD	-	-
21	B	B	B-NP	B-NP	-	24	NMOD	-	-
22	lymphocyte	lymphocyte	I-NP	I-NP	-	24	NMOD	-	-
23	growth	growth	I-NP	I-NP	-	24	NMOD	-	-
24	transformation	transformation	I-NP	I-NP	-	20	OBJ	-	-
25	and	and	O	O	-	10	VMOD	-	-
26	activate	activate	B-VP	B-VP	-	10	VMOD	-	-
27	NF-kappaB	NF-kappaB	B-NP	B-NP	-	26	OBJ	-	-
28	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	6	NMOD	-	-
2	Epstein-Barr	Epstein-Barr	I-NP	I-NP	-	6	NMOD	-	-
3	virus	virus	I-NP	I-NP	-	6	NMOD	-	-
4	latent	latent	I-NP	I-NP	-	6	NMOD	-	-
5	membrane	membrane	I-NP	I-NP	-	6	NMOD	-	-
6	protein	protein	I-NP	I-NP	-	11	SUB	-	-
7	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	LMP1	LMP1	B-NP	B-NP	-	6	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	is	is	B-VP	B-VP	-	0	ROOT	-	-
12	essential	essential	B-ADJP	B-ADJP	-	11	PRD	-	-
13	for	for	B-PP	B-PP	-	12	AMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	transformation	transformation	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	B	B	B-NP	B-NP	-	18	NMOD	-	-
18	lymphocytes	lymphocytes	I-NP	I-NP	-	16	PMOD	-	-
19	into	into	B-PP	B-PP	-	15	NMOD	-	-
20	lymphoblastoid	lymphoblastoid	B-NP	B-NP	-	22	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
22	lines	lines	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	11	P	-	-

1	Previous	Previous	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	are	are	B-VP	B-VP	-	0	ROOT	-	-
4	consistent	consistent	B-ADJP	B-ADJP	-	3	PRD	-	-
5	with	with	B-PP	B-PP	-	4	AMOD	-	-
6	a	a	B-NP	B-NP	-	7	NMOD	-	-
7	model	model	I-NP	I-NP	-	5	PMOD	-	-
8	that	that	B-SBAR	B-SBAR	-	7	NMOD	-	-
9	LMP1	LMP1	B-NP	B-NP	-	10	SUB	-	-
10	is	is	B-VP	B-VP	-	8	SBAR	-	-
11	a	a	B-NP	B-NP	-	14	NMOD	-	-
12	constitutively	constitutively	I-NP	I-NP	-	13	AMOD	-	-
13	activated	activated	I-NP	I-NP	-	14	NMOD	-	-
14	receptor	receptor	I-NP	I-NP	-	10	PRD	-	-
15	that	that	B-NP	B-NP	-	14	NMOD	-	-
16	transduces	transduces	B-VP	B-VP	-	15	SBAR	-	-
17	signals	signals	B-NP	B-NP	-	16	OBJ	-	-
18	for	for	B-PP	B-PP	-	17	NMOD	-	-
19	transformation	transformation	B-NP	B-NP	-	18	PMOD	-	-
20	through	through	B-PP	B-PP	-	16	VMOD	-	-
21	its	its	B-NP	B-NP	-	24	NMOD	-	-
22	carboxyl-terminal	carboxyl-terminal	I-NP	I-NP	-	24	NMOD	-	-
23	cytoplasmic	cytoplasmic	I-NP	I-NP	-	24	NMOD	-	-
24	tail	tail	I-NP	I-NP	-	20	PMOD	-	-
25	.	.	O	O	-	3	P	-	-

1	One	One	B-NP	B-NP	-	4	NMOD	-	-
2	transformation	transformation	I-NP	I-NP	-	4	NMOD	-	-
3	effector	effector	I-NP	I-NP	-	4	NMOD	-	-
4	site	site	I-NP	I-NP	-	22	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	TES1	TES1	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	,	,	O	O	-	4	P	-	-
9	located	located	B-ADJP	B-ADJP	-	4	NMOD	-	-
10	within	within	B-PP	B-PP	-	9	AMOD	-	-
11	the	the	B-NP	B-NP	-	15	NMOD	-	-
12	membrane	membrane	I-NP	I-NP	-	15	NMOD	-	-
13	proximal	proximal	I-NP	I-NP	-	15	NMOD	-	-
14	<num>	<num>	I-NP	I-NP	-	15	NMOD	-	-
15	residues	residues	I-NP	I-NP	-	10	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	cytoplasmic	cytoplasmic	I-NP	I-NP	-	19	NMOD	-	-
19	tail	tail	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	4	P	-	-
21	constitutively	constitutively	B-VP	B-VP	-	22	VMOD	-	-
22	engages	engages	I-VP	I-VP	-	0	ROOT	-	-
23	tumor	tumor	B-NP	B-NP	-	27	NMOD	-	-
24	necrosis	necrosis	I-NP	I-NP	-	27	NMOD	-	-
25	factor	factor	I-NP	I-NP	-	27	NMOD	-	-
26	receptor-associated	receptor-associated	I-NP	I-NP	-	27	NMOD	-	-
27	factors	factors	I-NP	I-NP	-	22	OBJ	-	-
28	.	.	O	O	-	22	P	-	-

1	Signals	Signals	B-NP	B-NP	-	4	SUB	-	-
2	from	from	B-PP	B-PP	-	1	NMOD	-	-
3	TES1	TES1	B-NP	B-NP	-	2	PMOD	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	sufficient	sufficient	B-ADJP	B-ADJP	-	4	PRD	-	-
6	to	to	B-VP	B-VP	-	7	VMOD	-	-
7	drive	drive	I-VP	I-VP	-	5	AMOD	-	-
8	initial	initial	B-NP	B-NP	-	9	NMOD	-	-
9	proliferation	proliferation	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	infected	infected	B-NP	B-NP	-	14	NMOD	-	-
12	resting	resting	I-NP	I-NP	-	14	NMOD	-	-
13	B	B	I-NP	I-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	19	P	-	-
16	but	but	O	O	-	19	NMOD	-	-
17	most	most	B-NP	B-NP	-	19	NMOD	-	-
18	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
20	infected	infected	B-VP	B-VP	-	19	NMOD	-	-
21	with	with	B-PP	B-PP	-	20	VMOD	-	-
22	a	a	B-NP	B-NP	-	23	NMOD	-	-
23	virus	virus	I-NP	I-NP	-	21	PMOD	-	-
24	that	that	B-NP	B-NP	-	23	NMOD	-	-
25	does	does	B-VP	B-VP	-	24	SBAR	-	-
26	not	not	I-VP	I-VP	-	25	VMOD	-	-
27	express	express	I-VP	I-VP	-	25	VC	-	-
28	the	the	B-NP	B-NP	-	30	NMOD	-	-
29	<num>	<num>	I-NP	I-NP	-	30	NMOD	-	-
30	residues	residues	I-NP	I-NP	-	27	OBJ	-	-
31	beyond	beyond	B-PP	B-PP	-	27	VMOD	-	-
32	TES1	TES1	B-NP	B-NP	-	31	PMOD	-	-
33	fail	fail	B-VP	B-VP	-	27	VMOD	-	-
34	to	to	I-VP	I-VP	-	35	VMOD	-	-
35	grow	grow	I-VP	I-VP	-	33	VMOD	-	-
36	as	as	B-PP	B-PP	-	35	VMOD	-	-
37	long-term	long-term	B-NP	B-NP	-	39	NMOD	-	-
38	cell	cell	I-NP	I-NP	-	39	NMOD	-	-
39	lines	lines	I-NP	I-NP	-	36	PMOD	-	-
40	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	now	now	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	find	find	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	mutating	mutating	B-VP	B-VP	-	4	SBAR	-	-
6	two	two	B-NP	B-NP	-	7	NMOD	-	-
7	tyrosines	tyrosines	I-NP	I-NP	-	5	OBJ	-	-
8	to	to	B-PP	B-PP	-	5	VMOD	-	-
9	an	an	B-NP	B-NP	-	10	NMOD	-	-
10	isoleucine	isoleucine	I-NP	I-NP	-	8	PMOD	-	-
11	at	at	B-PP	B-PP	-	5	VMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	carboxyl	carboxyl	I-NP	I-NP	-	14	NMOD	-	-
14	end	end	I-NP	I-NP	-	11	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	cytoplasmic	cytoplasmic	I-NP	I-NP	-	18	NMOD	-	-
18	tail	tail	I-NP	I-NP	-	15	PMOD	-	-
19	cripples	cripples	B-VP	B-VP	-	4	SBAR	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	ability	ability	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	EBV	EBV	B-NP	B-NP	-	22	PMOD	-	-
24	to	to	B-VP	B-VP	-	25	VMOD	-	-
25	cause	cause	I-VP	I-VP	-	21	NMOD	-	-
26	lymphoblastoid	lymphoblastoid	B-NP	B-NP	-	28	NMOD	-	-
27	cell	cell	I-NP	I-NP	-	28	NMOD	-	-
28	outgrowth	outgrowth	I-NP	I-NP	-	25	OBJ	-	-
29	,	,	O	O	-	19	P	-	-
30	thereby	thereby	B-VP	B-VP	-	31	VMOD	-	-
31	marking	marking	I-VP	I-VP	-	19	VMOD	-	-
32	a	a	B-NP	B-NP	-	36	NMOD	-	-
33	second	second	I-NP	I-NP	-	36	NMOD	-	-
34	transformation	transformation	I-NP	I-NP	-	36	NMOD	-	-
35	effector	effector	I-NP	I-NP	-	36	NMOD	-	-
36	site	site	I-NP	I-NP	-	38	NMOD	-	-
37	,	,	O	O	-	38	P	-	-
38	TES2	TES2	B-NP	B-NP	-	31	OBJ	-	-
39	.	.	O	O	-	3	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	yeast	yeast	I-NP	I-NP	-	4	NMOD	-	-
3	two-hybrid	two-hybrid	I-NP	I-NP	-	4	NMOD	-	-
4	screen	screen	I-NP	I-NP	-	5	SUB	-	-
5	identified	identified	B-VP	B-VP	-	0	ROOT	-	-
6	TES2	TES2	B-NP	B-NP	-	8	NMOD	-	-
7	interacting	interacting	I-NP	I-NP	-	8	NMOD	-	-
8	proteins	proteins	I-NP	I-NP	-	5	OBJ	-	-
9	,	,	O	O	-	8	P	-	-
10	including	including	B-PP	B-PP	-	8	NMOD	-	-
11	the	the	B-NP	B-NP	-	18	NMOD	-	-
12	tumor	tumor	I-NP	I-NP	-	18	NMOD	-	-
13	necrosis	necrosis	I-NP	I-NP	-	18	NMOD	-	-
14	factor	factor	I-NP	I-NP	-	18	NMOD	-	-
15	receptor-associated	receptor-associated	I-NP	I-NP	-	18	NMOD	-	-
16	death	death	I-NP	I-NP	-	18	NMOD	-	-
17	domain	domain	I-NP	I-NP	-	18	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	10	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	TRADD	TRADD	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	.	.	O	O	-	5	P	-	-

1	TRADD	TRADD	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	only	only	I-NP	I-NP	-	5	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	2	PRD	-	-
6	that	that	B-NP	B-NP	-	5	NMOD	-	-
7	interacted	interacted	B-VP	B-VP	-	6	SBAR	-	-
8	with	with	B-PP	B-PP	-	7	VMOD	-	-
9	wild-type	wild-type	B-NP	B-NP	-	10	NMOD	-	-
10	TES2	TES2	I-NP	I-NP	-	8	PMOD	-	-
11	and	and	B-PP	B-PP	-	8	PMOD	-	-
12	not	not	B-PP	B-PP	-	13	PMOD	-	-
13	with	with	I-PP	I-PP	-	8	PMOD	-	-
14	isoleucine-mutated	isoleucine-mutated	B-NP	B-NP	-	15	NMOD	-	-
15	TES2	TES2	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	2	P	-	-

1	TRADD	TRADD	B-NP	B-NP	-	16	NMOD	-	-
2	associated	associated	B-VP	B-VP	-	1	NMOD	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	wild-type	wild-type	B-NP	B-NP	-	5	NMOD	-	-
5	LMP1	LMP1	I-NP	I-NP	-	3	PMOD	-	-
6	but	but	B-PP	B-PP	-	3	PMOD	-	-
7	not	not	B-PP	B-PP	-	8	PMOD	-	-
8	with	with	I-PP	I-PP	-	3	PMOD	-	-
9	isoleucine-mutated	isoleucine-mutated	B-NP	B-NP	-	10	NMOD	-	-
10	LMP1	LMP1	I-NP	I-NP	-	16	NMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	mammalian	mammalian	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	16	P	-	-
15	and	and	O	O	-	16	NMOD	-	-
16	TRADD	TRADD	B-NP	B-NP	-	0	ROOT	-	-
17	constitutively	constitutively	B-VP	B-VP	-	18	VMOD	-	-
18	associated	associated	I-VP	I-VP	-	16	NMOD	-	-
19	with	with	B-PP	B-PP	-	18	VMOD	-	-
20	LMP1	LMP1	B-NP	B-NP	-	19	PMOD	-	-
21	in	in	B-PP	B-PP	-	18	VMOD	-	-
22	EBV-transformed	EBV-transformed	B-NP	B-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	16	P	-	-

1	In	In	B-PP	B-PP	-	9	VMOD	-	-
2	transfection	transfection	B-NP	B-NP	-	3	NMOD	-	-
3	assays	assays	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	9	P	-	-
5	TRADD	TRADD	B-NP	B-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	TES2	TES2	I-NP	I-NP	-	9	SUB	-	-
8	synergistically	synergistically	B-ADVP	B-ADVP	-	9	VMOD	-	-
9	mediated	mediated	B-VP	B-VP	-	0	ROOT	-	-
10	high-level	high-level	B-NP	B-NP	-	12	NMOD	-	-
11	NF-kappaB	NF-kappaB	I-NP	I-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	9	OBJ	-	-
13	.	.	O	O	-	9	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	LMP1	LMP1	B-NP	B-NP	-	6	SUB	-	-
6	appropriates	appropriates	B-VP	B-VP	-	4	SBAR	-	-
7	TRADD	TRADD	B-NP	B-NP	-	6	OBJ	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	enable	enable	I-VP	I-VP	-	6	VMOD	-	-
10	efficient	efficient	B-NP	B-NP	-	14	NMOD	-	-
11	long-term	long-term	I-NP	I-NP	-	14	NMOD	-	-
12	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	14	NMOD	-	-
13	cell	cell	I-NP	I-NP	-	14	NMOD	-	-
14	outgrowth	outgrowth	I-NP	I-NP	-	9	OBJ	-	-
15	.	.	O	O	-	3	P	-	-

1	High-level	High-level	B-NP	B-NP	-	3	NMOD	-	-
2	NF-kappaB	NF-kappaB	I-NP	I-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	5	SUB	-	-
4	also	also	B-ADVP	B-ADVP	-	5	VMOD	-	-
5	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
6	to	to	I-VP	I-VP	-	7	VMOD	-	-
7	be	be	I-VP	I-VP	-	5	VMOD	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	critical	critical	I-NP	I-NP	-	10	NMOD	-	-
10	component	component	I-NP	I-NP	-	7	PRD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	long-term	long-term	B-NP	B-NP	-	13	NMOD	-	-
13	outgrowth	outgrowth	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	5	P	-	-

1	Transcription	Transcription	B-NP	B-NP	-	3	NMOD	-	-
2	factor	factor	I-NP	I-NP	-	3	NMOD	-	-
3	NF-kappaB	NF-kappaB	I-NP	I-NP	-	4	SUB	-	-
4	regulates	regulates	B-VP	B-VP	-	0	ROOT	-	-
5	inducible	inducible	B-NP	B-NP	-	8	NMOD	-	-
6	Oct-2	Oct-2	I-NP	I-NP	-	8	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	4	OBJ	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	precursor	precursor	B-NP	B-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	lymphocytes	lymphocytes	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	POU	POU	I-NP	I-NP	-	4	NMOD	-	-
3	transcription	transcription	I-NP	I-NP	-	4	NMOD	-	-
4	factors	factors	I-NP	I-NP	-	7	NMOD	-	-
5	Oct-1	Oct-1	B-NP	B-NP	-	7	NMOD	-	-
6	and	and	I-NP	I-NP	-	7	NMOD	-	-
7	Oct-2	Oct-2	I-NP	I-NP	-	8	SUB	-	-
8	regulate	regulate	B-VP	B-VP	-	0	ROOT	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	activity	activity	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	octamer-dependent	octamer-dependent	B-NP	B-NP	-	13	NMOD	-	-
13	promoters	promoters	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	including	including	B-PP	B-PP	-	13	NMOD	-	-
16	those	those	B-NP	B-NP	-	15	PMOD	-	-
17	that	that	B-NP	B-NP	-	16	NMOD	-	-
18	direct	direct	B-VP	B-VP	-	17	SBAR	-	-
19	transcription	transcription	B-NP	B-NP	-	18	OBJ	-	-
20	from	from	B-PP	B-PP	-	19	NMOD	-	-
21	rearranged	rearranged	B-NP	B-NP	-	23	NMOD	-	-
22	immunoglobulin	immunoglobulin	I-NP	I-NP	-	23	NMOD	-	-
23	genes	genes	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	8	P	-	-

1	Unlike	Unlike	B-PP	B-PP	-	15	VMOD	-	-
2	Oct-1	Oct-1	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	2	P	-	-
4	which	which	B-NP	B-NP	-	2	NMOD	-	-
5	is	is	B-VP	B-VP	-	4	SBAR	-	-
6	constitutively	constitutively	I-VP	I-VP	-	5	VMOD	-	-
7	expressed	expressed	I-VP	I-VP	-	5	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	many	many	B-NP	B-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	types	types	I-NP	I-NP	-	8	PMOD	-	-
12	,	,	O	O	-	15	P	-	-
13	Oct-2	Oct-2	B-NP	B-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	15	SUB	-	-
15	is	is	B-VP	B-VP	-	0	ROOT	-	-
16	restricted	restricted	I-VP	I-VP	-	15	VC	-	-
17	primarily	primarily	B-ADVP	B-ADVP	-	16	VMOD	-	-
18	to	to	B-PP	B-PP	-	16	VMOD	-	-
19	B	B	B-NP	B-NP	-	20	NMOD	-	-
20	lymphocytes	lymphocytes	I-NP	I-NP	-	18	PMOD	-	-
21	and	and	O	O	-	15	VMOD	-	-
22	can	can	B-VP	B-VP	-	15	VMOD	-	-
23	be	be	I-VP	I-VP	-	22	VC	-	-
24	induced	induced	I-VP	I-VP	-	23	VC	-	-
25	in	in	B-PP	B-PP	-	24	VMOD	-	-
26	precursor	precursor	B-NP	B-NP	-	28	NMOD	-	-
27	B	B	I-NP	I-NP	-	28	NMOD	-	-
28	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
29	by	by	B-PP	B-PP	-	24	VMOD	-	-
30	stimulation	stimulation	B-NP	B-NP	-	29	PMOD	-	-
31	with	with	B-PP	B-PP	-	30	NMOD	-	-
32	bacterial	bacterial	B-NP	B-NP	-	33	NMOD	-	-
33	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	31	PMOD	-	-
34	(	(	O	O	-	35	P	-	-
35	LPS	LPS	B-NP	B-NP	-	33	NMOD	-	-
36	)	)	O	O	-	35	P	-	-
37	.	.	O	O	-	15	P	-	-

1	However	However	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	precise	precise	I-NP	I-NP	-	5	NMOD	-	-
5	factors	factors	I-NP	I-NP	-	11	SUB	-	-
6	that	that	B-NP	B-NP	-	5	NMOD	-	-
7	mediate	mediate	B-VP	B-VP	-	6	SBAR	-	-
8	this	this	B-NP	B-NP	-	10	NMOD	-	-
9	induction	induction	I-NP	I-NP	-	10	NMOD	-	-
10	mechanism	mechanism	I-NP	I-NP	-	7	OBJ	-	-
11	remain	remain	B-VP	B-VP	-	0	ROOT	-	-
12	unknown	unknown	B-ADJP	B-ADJP	-	11	PRD	-	-
13	.	.	O	O	-	11	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	present	present	I-NP	I-NP	-	4	NMOD	-	-
4	study	study	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	monitored	monitored	B-VP	B-VP	-	0	ROOT	-	-
8	Oct-2	Oct-2	B-NP	B-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	cells	cells	B-NP	B-NP	-	10	PMOD	-	-
12	arrested	arrested	B-VP	B-VP	-	11	NMOD	-	-
13	for	for	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	NF-kappaB	NF-kappaB	B-NP	B-NP	-	21	NMOD	-	-
18	,	,	O	O	-	21	P	-	-
19	an	an	B-NP	B-NP	-	21	NMOD	-	-
20	LPS-responsive	LPS-responsive	I-NP	I-NP	-	21	NMOD	-	-
21	member	member	I-NP	I-NP	-	16	PMOD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	the	the	B-NP	B-NP	-	27	NMOD	-	-
24	Rel	Rel	I-NP	I-NP	-	27	NMOD	-	-
25	transcription	transcription	I-NP	I-NP	-	27	NMOD	-	-
26	factor	factor	I-NP	I-NP	-	27	NMOD	-	-
27	family	family	I-NP	I-NP	-	22	PMOD	-	-
28	.	.	O	O	-	7	P	-	-

1	Despite	Despite	B-PP	B-PP	-	16	VMOD	-	-
2	stimulation	stimulation	B-NP	B-NP	-	1	PMOD	-	-
3	with	with	B-PP	B-PP	-	2	NMOD	-	-
4	LPS	LPS	B-NP	B-NP	-	3	PMOD	-	-
5	,	,	O	O	-	16	P	-	-
6	disruption	disruption	B-NP	B-NP	-	16	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	NF-kappaB	NF-kappaB	I-NP	I-NP	-	11	NMOD	-	-
10	signaling	signaling	I-NP	I-NP	-	11	NMOD	-	-
11	pathway	pathway	I-NP	I-NP	-	7	PMOD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	precursor	precursor	B-NP	B-NP	-	15	NMOD	-	-
14	B	B	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
16	led	led	B-VP	B-VP	-	0	ROOT	-	-
17	to	to	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	loss	loss	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	inducible	inducible	B-NP	B-NP	-	25	NMOD	-	-
22	Oct-2	Oct-2	I-NP	I-NP	-	25	NMOD	-	-
23	DNA	DNA	I-NP	I-NP	-	25	NMOD	-	-
24	binding	binding	I-NP	I-NP	-	25	NMOD	-	-
25	activity	activity	I-NP	I-NP	-	20	PMOD	-	-
26	in	in	B-ADVP	B-ADVP	-	25	NMOD	-	-
27	vitro	vitro	I-ADVP	I-ADVP	-	26	AMOD	-	-
28	and	and	O	O	-	30	NMOD	-	-
29	the	the	B-NP	B-NP	-	30	NMOD	-	-
30	suppression	suppression	I-NP	I-NP	-	20	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	Oct-2-directed	Oct-2-directed	B-NP	B-NP	-	33	NMOD	-	-
33	transcription	transcription	I-NP	I-NP	-	31	PMOD	-	-
34	in	in	B-ADVP	B-ADVP	-	30	NMOD	-	-
35	vivo	vivo	I-ADVP	I-ADVP	-	34	AMOD	-	-
36	.	.	O	O	-	16	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	biochemical	biochemical	I-NP	I-NP	-	3	NMOD	-	-
3	defect	defect	I-NP	I-NP	-	4	SUB	-	-
4	correlated	correlated	B-VP	B-VP	-	19	VMOD	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	a	a	B-NP	B-NP	-	8	NMOD	-	-
7	specific	specific	I-NP	I-NP	-	8	NMOD	-	-
8	block	block	I-NP	I-NP	-	5	PMOD	-	-
9	to	to	B-PP	B-PP	-	8	NMOD	-	-
10	Oct-2	Oct-2	B-NP	B-NP	-	12	NMOD	-	-
11	gene	gene	I-NP	I-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	9	PMOD	-	-
13	at	at	B-PP	B-PP	-	4	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	level	level	I-NP	I-NP	-	13	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	transcription	transcription	B-NP	B-NP	-	16	PMOD	-	-
18	,	,	O	O	-	19	P	-	-
19	whereas	whereas	O	O	-	0	ROOT	-	-
20	the	the	B-NP	B-NP	-	21	NMOD	-	-
21	expression	expression	I-NP	I-NP	-	24	SUB	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	Oct-1	Oct-1	B-NP	B-NP	-	22	PMOD	-	-
24	was	was	B-VP	B-VP	-	19	VMOD	-	-
25	unaffected	unaffected	B-ADJP	B-ADJP	-	24	PRD	-	-
26	.	.	O	O	-	19	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	finding	finding	I-NP	I-NP	-	9	SUB	-	-
3	that	that	B-SBAR	B-SBAR	-	2	NMOD	-	-
4	Oct-2	Oct-2	B-NP	B-NP	-	5	SUB	-	-
5	is	is	B-VP	B-VP	-	3	SBAR	-	-
6	under	under	B-PP	B-PP	-	5	PRD	-	-
7	NF-kappaB	NF-kappaB	B-NP	B-NP	-	8	NMOD	-	-
8	control	control	I-NP	I-NP	-	6	PMOD	-	-
9	highlights	highlights	B-VP	B-VP	-	0	ROOT	-	-
10	an	an	B-NP	B-NP	-	13	NMOD	-	-
11	important	important	I-NP	I-NP	-	13	NMOD	-	-
12	cross-talk	cross-talk	I-NP	I-NP	-	13	NMOD	-	-
13	mechanism	mechanism	I-NP	I-NP	-	9	OBJ	-	-
14	involving	involving	B-VP	B-VP	-	13	NMOD	-	-
15	two	two	B-NP	B-NP	-	19	NMOD	-	-
16	distinct	distinct	I-NP	I-NP	-	19	NMOD	-	-
17	transcription	transcription	I-NP	I-NP	-	19	NMOD	-	-
18	factor	factor	I-NP	I-NP	-	19	NMOD	-	-
19	families	families	I-NP	I-NP	-	14	OBJ	-	-
20	that	that	B-NP	B-NP	-	19	NMOD	-	-
21	regulate	regulate	B-VP	B-VP	-	20	SBAR	-	-
22	B	B	B-NP	B-NP	-	24	NMOD	-	-
23	lymphocyte	lymphocyte	I-NP	I-NP	-	24	NMOD	-	-
24	function	function	I-NP	I-NP	-	21	OBJ	-	-
25	.	.	O	O	-	9	P	-	-

1	Paternal	Paternal	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	WT1	WT1	B-NP	B-NP	-	3	PMOD	-	-
5	in	in	B-PP	B-PP	-	2	NMOD	-	-
6	human	human	B-NP	B-NP	-	9	NMOD	-	-
7	fibroblasts	fibroblasts	I-NP	I-NP	-	9	NMOD	-	-
8	and	and	I-NP	I-NP	-	9	NMOD	-	-
9	lymphocytes	lymphocytes	I-NP	I-NP	-	5	PMOD	-	-
10	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	6	NMOD	-	-
2	Wilms	Wilms	I-NP	I-NP	-	6	NMOD	-	-
3	'	'	B-NP	B-NP	-	6	NMOD	-	-
4	tumor	tumor	I-NP	I-NP	-	6	NMOD	-	-
5	suppressor	suppressor	I-NP	I-NP	-	6	NMOD	-	-
6	gene	gene	I-NP	I-NP	-	10	SUB	-	-
7	(	(	O	O	-	8	P	-	-
8	WT1	WT1	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	was	was	B-VP	B-VP	-	0	ROOT	-	-
11	previously	previously	I-VP	I-VP	-	10	VMOD	-	-
12	identified	identified	I-VP	I-VP	-	10	VC	-	-
13	as	as	B-PP	B-PP	-	12	VMOD	-	-
14	being	being	B-VP	B-VP	-	13	PMOD	-	-
15	imprinted	imprinted	I-VP	I-VP	-	14	VC	-	-
16	,	,	O	O	-	15	P	-	-
17	with	with	B-PP	B-PP	-	15	VMOD	-	-
18	frequent	frequent	B-NP	B-NP	-	20	NMOD	-	-
19	maternal	maternal	I-NP	I-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	17	PMOD	-	-
21	in	in	B-PP	B-PP	-	20	NMOD	-	-
22	human	human	B-NP	B-NP	-	23	NMOD	-	-
23	placentae	placentae	I-NP	I-NP	-	26	NMOD	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	fetal	fetal	B-NP	B-NP	-	26	NMOD	-	-
26	brains	brains	I-NP	I-NP	-	21	PMOD	-	-
27	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	allele-specific	allele-specific	I-NP	I-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	WT1	WT1	B-NP	B-NP	-	6	PMOD	-	-
8	in	in	B-PP	B-PP	-	5	NMOD	-	-
9	cultured	cultured	B-NP	B-NP	-	11	NMOD	-	-
10	human	human	I-NP	I-NP	-	11	NMOD	-	-
11	fibroblasts	fibroblasts	I-NP	I-NP	-	8	PMOD	-	-
12	from	from	B-PP	B-PP	-	11	NMOD	-	-
13	<num>	<num>	B-NP	B-NP	-	14	NMOD	-	-
14	individuals	individuals	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	2	P	-	-

1	Seven	Seven	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	<num>	<num>	B-NP	B-NP	-	5	NMOD	-	-
4	fibroblast	fibroblast	I-NP	I-NP	-	5	NMOD	-	-
5	lines	lines	I-NP	I-NP	-	2	PMOD	-	-
6	were	were	B-VP	B-VP	-	16	VMOD	-	-
7	heterozygous	heterozygous	B-ADJP	B-ADJP	-	6	PRD	-	-
8	for	for	B-PP	B-PP	-	7	AMOD	-	-
9	polymorphic	polymorphic	B-NP	B-NP	-	10	NMOD	-	-
10	alleles	alleles	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	16	P	-	-
12	and	and	O	O	-	16	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	15	NMOD	-	-
15	patterns	patterns	I-NP	I-NP	-	16	SUB	-	-
16	were	were	B-VP	B-VP	-	0	ROOT	-	-
17	variable	variable	B-ADJP	B-ADJP	-	16	PRD	-	-
18	,	,	O	O	-	27	P	-	-
19	i.e.	i.e.	O	O	-	27	NMOD	-	-
20	,	,	O	O	-	27	P	-	-
21	equal	equal	B-NP	B-NP	-	25	AMOD	-	-
22	,	,	I-NP	I-NP	-	25	P	-	-
23	unequal	unequal	I-NP	I-NP	-	25	AMOD	-	-
24	or	or	I-NP	I-NP	-	25	AMOD	-	-
25	monoallelic	monoallelic	I-NP	I-NP	-	27	NMOD	-	-
26	paternal	paternal	I-NP	I-NP	-	27	NMOD	-	-
27	expression	expression	I-NP	I-NP	-	16	OBJ	-	-
28	in	in	B-PP	B-PP	-	27	NMOD	-	-
29	three	three	B-NP	B-NP	-	34	NMOD	-	-
30	,	,	I-NP	I-NP	-	34	P	-	-
31	two	two	I-NP	I-NP	-	34	NMOD	-	-
32	and	and	I-NP	I-NP	-	34	NMOD	-	-
33	two	two	I-NP	I-NP	-	34	NMOD	-	-
34	cases	cases	I-NP	I-NP	-	28	PMOD	-	-
35	,	,	O	O	-	16	P	-	-
36	respectively	respectively	B-ADVP	B-ADVP	-	16	VMOD	-	-
37	.	.	O	O	-	16	P	-	-

1	Exclusive	Exclusive	B-NP	B-NP	-	3	NMOD	-	-
2	paternal	paternal	I-NP	I-NP	-	3	NMOD	-	-
3	expression	expression	I-NP	I-NP	-	6	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	WT1	WT1	B-NP	B-NP	-	4	PMOD	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	also	also	I-VP	I-VP	-	6	VMOD	-	-
8	shown	shown	I-VP	I-VP	-	6	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	non-cultured	non-cultured	B-NP	B-NP	-	12	NMOD	-	-
11	peripheral	peripheral	I-NP	I-NP	-	12	NMOD	-	-
12	lymphocytes	lymphocytes	I-NP	I-NP	-	9	PMOD	-	-
13	from	from	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	17	NMOD	-	-
15	latter	latter	I-NP	I-NP	-	17	NMOD	-	-
16	two	two	I-NP	I-NP	-	17	NMOD	-	-
17	individuals	individuals	I-NP	I-NP	-	13	PMOD	-	-
18	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	allele-specific	allele-specific	I-NP	I-NP	-	4	NMOD	-	-
3	expression	expression	I-NP	I-NP	-	4	NMOD	-	-
4	profiles	profiles	I-NP	I-NP	-	18	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	other	other	B-NP	B-NP	-	8	NMOD	-	-
7	imprinted	imprinted	I-NP	I-NP	-	8	NMOD	-	-
8	genes	genes	I-NP	I-NP	-	12	NMOD	-	-
9	,	,	O	O	-	12	P	-	-
10	IGF2	IGF2	B-NP	B-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	H19	H19	B-NP	B-NP	-	5	PMOD	-	-
13	,	,	O	O	-	12	P	-	-
14	on	on	B-PP	B-PP	-	4	NMOD	-	-
15	human	human	B-NP	B-NP	-	16	NMOD	-	-
16	chromosome	chromosome	I-NP	I-NP	-	14	PMOD	-	-
17	<num>	<num>	I-NP	I-NP	-	16	NMOD	-	-
18	were	were	B-VP	B-VP	-	0	ROOT	-	-
19	constant	constant	B-ADJP	B-ADJP	-	21	AMOD	-	-
20	and	and	I-ADJP	I-ADJP	-	21	AMOD	-	-
21	consistent	consistent	I-ADJP	I-ADJP	-	18	PRD	-	-
22	with	with	B-PP	B-PP	-	21	AMOD	-	-
23	those	those	B-NP	B-NP	-	22	PMOD	-	-
24	in	in	B-PP	B-PP	-	23	NMOD	-	-
25	other	other	B-NP	B-NP	-	26	NMOD	-	-
26	tissues	tissues	I-NP	I-NP	-	24	PMOD	-	-
27	.	.	O	O	-	18	P	-	-

1	Our	Our	B-NP	B-NP	-	3	NMOD	-	-
2	unexpected	unexpected	I-NP	I-NP	-	3	NMOD	-	-
3	observations	observations	I-NP	I-NP	-	31	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	paternal	paternal	B-NP	B-NP	-	7	AMOD	-	-
6	or	or	I-NP	I-NP	-	7	AMOD	-	-
7	biallelic	biallelic	I-NP	I-NP	-	8	NMOD	-	-
8	expression	expression	I-NP	I-NP	-	4	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	WT1	WT1	B-NP	B-NP	-	9	PMOD	-	-
11	in	in	B-PP	B-PP	-	8	NMOD	-	-
12	fibroblasts	fibroblasts	B-NP	B-NP	-	14	NMOD	-	-
13	and	and	I-NP	I-NP	-	14	NMOD	-	-
14	lymphocytes	lymphocytes	I-NP	I-NP	-	11	PMOD	-	-
15	,	,	O	O	-	31	P	-	-
16	together	together	B-ADVP	B-ADVP	-	17	PMOD	-	-
17	with	with	B-PP	B-PP	-	31	VMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	previous	previous	I-NP	I-NP	-	20	NMOD	-	-
20	findings	findings	I-NP	I-NP	-	17	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	maternal	maternal	B-NP	B-NP	-	24	AMOD	-	-
23	or	or	I-NP	I-NP	-	24	AMOD	-	-
24	biallelic	biallelic	I-NP	I-NP	-	25	NMOD	-	-
25	expression	expression	I-NP	I-NP	-	21	PMOD	-	-
26	in	in	B-PP	B-PP	-	25	NMOD	-	-
27	placentae	placentae	B-NP	B-NP	-	29	NMOD	-	-
28	and	and	I-NP	I-NP	-	29	NMOD	-	-
29	brains	brains	I-NP	I-NP	-	26	PMOD	-	-
30	,	,	O	O	-	20	P	-	-
31	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
32	that	that	B-SBAR	B-SBAR	-	31	VMOD	-	-
33	the	the	B-NP	B-NP	-	36	NMOD	-	-
34	allele-specific	allele-specific	I-NP	I-NP	-	36	NMOD	-	-
35	regulatory	regulatory	I-NP	I-NP	-	36	NMOD	-	-
36	system	system	I-NP	I-NP	-	39	SUB	-	-
37	of	of	B-PP	B-PP	-	36	NMOD	-	-
38	WT1	WT1	B-NP	B-NP	-	37	PMOD	-	-
39	is	is	B-VP	B-VP	-	32	SBAR	-	-
40	unique	unique	B-ADJP	B-ADJP	-	39	PRD	-	-
41	and	and	O	O	-	39	VMOD	-	-
42	may	may	B-VP	B-VP	-	39	VMOD	-	-
43	be	be	I-VP	I-VP	-	42	VC	-	-
44	controlled	controlled	I-VP	I-VP	-	43	VC	-	-
45	by	by	B-PP	B-PP	-	44	VMOD	-	-
46	a	a	B-NP	B-NP	-	48	NMOD	-	-
47	putative	putative	I-NP	I-NP	-	48	NMOD	-	-
48	tissue-	tissue-	I-NP	I-NP	-	51	NMOD	-	-
49	and	and	O	O	-	51	NMOD	-	-
50	individual-specific	individual-specific	B-NP	B-NP	-	51	NMOD	-	-
51	modifier	modifier	I-NP	I-NP	-	45	PMOD	-	-
52	.	.	O	O	-	31	P	-	-

1	Extinction	Extinction	B-NP	B-NP	-	14	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	immunoglobulin	immunoglobulin	B-NP	B-NP	-	5	NMOD	-	-
4	gene	gene	I-NP	I-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	2	PMOD	-	-
6	in	in	B-PP	B-PP	-	1	NMOD	-	-
7	B	B	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	upon	upon	B-PP	B-PP	-	1	NMOD	-	-
10	fusion	fusion	B-NP	B-NP	-	9	PMOD	-	-
11	with	with	B-PP	B-PP	-	10	NMOD	-	-
12	HeLa	HeLa	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	is	is	B-VP	B-VP	-	0	ROOT	-	-
15	preceded	preceded	I-VP	I-VP	-	14	VC	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	rapid	rapid	B-NP	B-NP	-	19	NMOD	-	-
18	nuclear	nuclear	I-NP	I-NP	-	19	NMOD	-	-
19	depletion	depletion	I-NP	I-NP	-	16	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	essential	essential	B-NP	B-NP	-	23	NMOD	-	-
22	transcription	transcription	I-NP	I-NP	-	23	NMOD	-	-
23	factors	factors	I-NP	I-NP	-	20	PMOD	-	-
24	and	and	O	O	-	14	VMOD	-	-
25	is	is	B-VP	B-VP	-	14	VMOD	-	-
26	accompanied	accompanied	I-VP	I-VP	-	25	VC	-	-
27	by	by	B-PP	B-PP	-	26	VMOD	-	-
28	widespread	widespread	B-NP	B-NP	-	29	NMOD	-	-
29	inactivation	inactivation	I-NP	I-NP	-	27	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	genes	genes	B-NP	B-NP	-	30	PMOD	-	-
32	expressed	expressed	B-VP	B-VP	-	31	NMOD	-	-
33	in	in	B-PP	B-PP	-	32	VMOD	-	-
34	a	a	B-NP	B-NP	-	37	NMOD	-	-
35	B	B	I-NP	I-NP	-	37	NMOD	-	-
36	cell-specific	cell-specific	I-NP	I-NP	-	35	AMOD	-	-
37	manner	manner	I-NP	I-NP	-	33	PMOD	-	-
38	.	.	O	O	-	14	P	-	-

1	When	When	B-ADVP	B-ADVP	-	17	VMOD	-	-
2	immunoglobulin	immunoglobulin	B-NP	B-NP	-	8	NMOD	-	-
3	(	(	O	O	-	4	P	-	-
4	Ig	Ig	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	expressing	expressing	B-VP	B-VP	-	8	NMOD	-	-
7	B	B	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	9	SUB	-	-
9	are	are	B-VP	B-VP	-	1	SBAR	-	-
10	fused	fused	I-VP	I-VP	-	9	VC	-	-
11	with	with	B-PP	B-PP	-	10	VMOD	-	-
12	non-B	non-B	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	17	P	-	-
15	Ig	Ig	B-NP	B-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	17	SUB	-	-
17	is	is	B-VP	B-VP	-	0	ROOT	-	-
18	rapidly	rapidly	I-VP	I-VP	-	17	VMOD	-	-
19	suppressed	suppressed	I-VP	I-VP	-	17	VC	-	-
20	at	at	B-PP	B-PP	-	19	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	level	level	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	transcription	transcription	B-NP	B-NP	-	23	PMOD	-	-
25	,	,	O	O	-	29	P	-	-
26	a	a	B-NP	B-NP	-	29	NMOD	-	-
27	phenomenon	phenomenon	I-NP	I-NP	-	29	NMOD	-	-
28	termed	termed	I-NP	I-NP	-	29	NMOD	-	-
29	extinction	extinction	I-NP	I-NP	-	23	PMOD	-	-
30	.	.	O	O	-	17	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	fusion	fusion	B-NP	B-NP	-	19	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	HeLa	HeLa	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	with	with	B-PP	B-PP	-	5	NMOD	-	-
10	either	either	B-NP	B-NP	-	15	NMOD	-	-
11	diploid	diploid	I-NP	I-NP	-	15	NMOD	-	-
12	or	or	I-NP	I-NP	-	15	NMOD	-	-
13	tetraploid	tetraploid	I-NP	I-NP	-	15	NMOD	-	-
14	B	B	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	Daudi	Daudi	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	results	results	B-VP	B-VP	-	4	SBAR	-	-
20	in	in	B-PP	B-PP	-	19	VMOD	-	-
21	widespread	widespread	B-NP	B-NP	-	22	NMOD	-	-
22	extinction	extinction	I-NP	I-NP	-	20	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	several	several	B-NP	B-NP	-	28	NMOD	-	-
25	other	other	I-NP	I-NP	-	28	NMOD	-	-
26	B	B	I-NP	I-NP	-	28	NMOD	-	-
27	cell-encoded	cell-encoded	I-NP	I-NP	-	28	NMOD	-	-
28	genes	genes	I-NP	I-NP	-	23	PMOD	-	-
29	that	that	B-NP	B-NP	-	28	NMOD	-	-
30	are	are	B-VP	B-VP	-	29	SBAR	-	-
31	expressed	expressed	I-VP	I-VP	-	30	VC	-	-
32	in	in	B-PP	B-PP	-	31	VMOD	-	-
33	a	a	B-NP	B-NP	-	36	NMOD	-	-
34	B	B	I-NP	I-NP	-	36	NMOD	-	-
35	cell-specific	cell-specific	I-NP	I-NP	-	34	AMOD	-	-
36	manner	manner	I-NP	I-NP	-	32	PMOD	-	-
37	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	16	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	16	P	-	-
4	expression	expression	B-NP	B-NP	-	16	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	B	B	B-NP	B-NP	-	8	NMOD	-	-
7	cell-expressed	cell-expressed	I-NP	I-NP	-	8	NMOD	-	-
8	genes	genes	I-NP	I-NP	-	5	PMOD	-	-
9	that	that	B-NP	B-NP	-	8	NMOD	-	-
10	are	are	B-VP	B-VP	-	9	SBAR	-	-
11	not	not	O	O	-	10	VMOD	-	-
12	dependent	dependent	B-ADJP	B-ADJP	-	10	PRD	-	-
13	on	on	B-PP	B-PP	-	12	AMOD	-	-
14	cell-specific	cell-specific	B-NP	B-NP	-	15	NMOD	-	-
15	controls	controls	I-NP	I-NP	-	13	PMOD	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	unaffected	unaffected	B-ADJP	B-ADJP	-	16	PRD	-	-
18	.	.	O	O	-	16	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	show	show	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	8	NMOD	-	-
5	molecular	molecular	I-NP	I-NP	-	8	NMOD	-	-
6	mechanism	mechanism	I-NP	I-NP	-	8	NMOD	-	-
7	(	(	I-NP	I-NP	-	8	P	-	-
8	s	s	I-NP	I-NP	-	14	SUB	-	-
9	)	)	O	O	-	8	P	-	-
10	underlying	underlying	B-VP	B-VP	-	8	NMOD	-	-
11	Ig	Ig	B-NP	B-NP	-	13	NMOD	-	-
12	gene	gene	I-NP	I-NP	-	13	NMOD	-	-
13	extinction	extinction	I-NP	I-NP	-	10	OBJ	-	-
14	can	can	B-VP	B-VP	-	3	SBAR	-	-
15	be	be	I-VP	I-VP	-	14	VC	-	-
16	explained	explained	I-VP	I-VP	-	15	VC	-	-
17	,	,	O	O	-	16	P	-	-
18	at	at	B-ADVP	B-ADVP	-	20	PMOD	-	-
19	least	least	I-ADVP	I-ADVP	-	18	AMOD	-	-
20	in	in	B-PP	B-PP	-	16	VMOD	-	-
21	part	part	B-NP	B-NP	-	20	PMOD	-	-
22	,	,	O	O	-	16	P	-	-
23	by	by	B-PP	B-PP	-	16	VMOD	-	-
24	a	a	B-NP	B-NP	-	25	NMOD	-	-
25	lack	lack	I-NP	I-NP	-	23	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	transcription	transcription	B-NP	B-NP	-	28	NMOD	-	-
28	factors	factors	I-NP	I-NP	-	26	PMOD	-	-
29	that	that	B-NP	B-NP	-	28	NMOD	-	-
30	are	are	B-VP	B-VP	-	29	SBAR	-	-
31	essential	essential	B-ADJP	B-ADJP	-	30	PRD	-	-
32	for	for	B-PP	B-PP	-	31	AMOD	-	-
33	Ig	Ig	B-NP	B-NP	-	35	NMOD	-	-
34	gene	gene	I-NP	I-NP	-	35	NMOD	-	-
35	transcription	transcription	I-NP	I-NP	-	32	PMOD	-	-
36	.	.	O	O	-	2	P	-	-

1	These	These	B-NP	B-NP	-	3	NMOD	-	-
2	transcription	transcription	I-NP	I-NP	-	3	NMOD	-	-
3	factors	factors	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	either	either	O	O	-	4	VMOD	-	-
6	not	not	O	O	-	4	VMOD	-	-
7	produced	produced	B-VP	B-VP	-	4	VC	-	-
8	due	due	B-ADJP	B-ADJP	-	4	PRD	-	-
9	to	to	B-PP	B-PP	-	8	AMOD	-	-
10	block	block	B-NP	B-NP	-	9	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	transcription	transcription	B-NP	B-NP	-	11	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	their	their	B-NP	B-NP	-	16	NMOD	-	-
15	respective	respective	I-NP	I-NP	-	16	NMOD	-	-
16	genes	genes	I-NP	I-NP	-	13	PMOD	-	-
17	(	(	O	O	-	34	P	-	-
18	Oct-2	Oct-2	B-NP	B-NP	-	34	NMOD	-	-
19	,	,	O	O	-	34	P	-	-
20	OBF-1	OBF-1	B-NP	B-NP	-	34	NMOD	-	-
21	,	,	O	O	-	34	P	-	-
22	PU.1	PU.1	B-NP	B-NP	-	34	P	-	-
23	)	)	O	O	-	22	P	-	-
24	,	,	O	O	-	34	P	-	-
25	or	or	O	O	-	34	NMOD	-	-
26	are	are	B-VP	B-VP	-	34	VMOD	-	-
27	rendered	rendered	I-VP	I-VP	-	26	VC	-	-
28	inactive	inactive	O	O	-	26	PRD	-	-
29	posttranslationally	posttranslationally	O	O	-	26	VMOD	-	-
30	(	(	O	O	-	34	P	-	-
31	NF-kappa	NF-kappa	B-NP	B-NP	-	32	NMOD	-	-
32	B	B	I-NP	I-NP	-	34	NMOD	-	-
33	,	,	O	O	-	34	P	-	-
34	E47	E47	B-NP	B-NP	-	13	PMOD	-	-
35	)	)	O	O	-	34	P	-	-
36	.	.	O	O	-	4	P	-	-

1	By	By	B-PP	B-PP	-	14	VMOD	-	-
2	isolating	isolating	B-VP	B-VP	-	1	PMOD	-	-
3	Daudi	Daudi	B-NP	B-NP	-	6	NMOD	-	-
4	x	x	B-NP	B-NP	-	6	NMOD	-	-
5	HeLa	HeLa	I-NP	I-NP	-	6	NMOD	-	-
6	heterokaryons	heterokaryons	I-NP	I-NP	-	2	OBJ	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	few	few	I-NP	I-NP	-	9	NMOD	-	-
9	hours	hours	I-NP	I-NP	-	2	OBJ	-	-
10	after	after	B-PP	B-PP	-	2	VMOD	-	-
11	fusion	fusion	B-NP	B-NP	-	10	PMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	we	we	B-NP	B-NP	-	14	SUB	-	-
14	have	have	B-VP	B-VP	-	0	ROOT	-	-
15	studied	studied	I-VP	I-VP	-	14	VC	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	initial	initial	I-NP	I-NP	-	18	NMOD	-	-
18	fate	fate	I-NP	I-NP	-	15	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	two	two	B-NP	B-NP	-	24	NMOD	-	-
21	B	B	I-NP	I-NP	-	24	NMOD	-	-
22	cell-specific	cell-specific	I-NP	I-NP	-	21	AMOD	-	-
23	transcription	transcription	I-NP	I-NP	-	24	NMOD	-	-
24	factors	factors	I-NP	I-NP	-	19	PMOD	-	-
25	involved	involved	B-VP	B-VP	-	24	NMOD	-	-
26	in	in	B-PP	B-PP	-	25	VMOD	-	-
27	Ig	Ig	B-NP	B-NP	-	29	NMOD	-	-
28	gene	gene	I-NP	I-NP	-	29	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	34	NMOD	-	-
30	,	,	O	O	-	34	P	-	-
31	Oct-2	Oct-2	B-NP	B-NP	-	34	NMOD	-	-
32	and	and	O	O	-	34	NMOD	-	-
33	NF-kappa	NF-kappa	B-NP	B-NP	-	34	NMOD	-	-
34	B	B	I-NP	I-NP	-	26	PMOD	-	-
35	.	.	O	O	-	14	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	report	report	I-NP	I-NP	-	3	SUB	-	-
3	provides	provides	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	first	first	I-NP	I-NP	-	6	NMOD	-	-
6	demonstration	demonstration	I-NP	I-NP	-	3	OBJ	-	-
7	that	that	B-NP	B-NP	-	6	NMOD	-	-
8	upon	upon	B-PP	B-PP	-	22	VMOD	-	-
9	fusion	fusion	B-NP	B-NP	-	8	PMOD	-	-
10	with	with	B-PP	B-PP	-	9	NMOD	-	-
11	HeLa	HeLa	B-NP	B-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	22	P	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	nuclear	nuclear	I-NP	I-NP	-	16	NMOD	-	-
16	contents	contents	I-NP	I-NP	-	22	SUB	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	B	B	B-NP	B-NP	-	21	NMOD	-	-
19	cell-expressed	cell-expressed	I-NP	I-NP	-	21	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	21	NMOD	-	-
21	factors	factors	I-NP	I-NP	-	17	PMOD	-	-
22	are	are	B-VP	B-VP	-	7	SBAR	-	-
23	depleted	depleted	I-VP	I-VP	-	22	VC	-	-
24	within	within	B-PP	B-PP	-	23	VMOD	-	-
25	a	a	B-NP	B-NP	-	27	NMOD	-	-
26	few	few	I-NP	I-NP	-	27	NMOD	-	-
27	hours	hours	I-NP	I-NP	-	24	PMOD	-	-
28	with	with	B-PP	B-PP	-	27	NMOD	-	-
29	kinetics	kinetics	B-NP	B-NP	-	28	PMOD	-	-
30	that	that	B-NP	B-NP	-	29	NMOD	-	-
31	are	are	B-VP	B-VP	-	30	SBAR	-	-
32	as	as	B-PP	B-PP	-	31	PRD	-	-
33	fast	fast	B-ADJP	B-ADJP	-	35	AMOD	-	-
34	or	or	I-ADJP	I-ADJP	-	35	AMOD	-	-
35	faster	faster	I-ADJP	I-ADJP	-	31	PRD	-	-
36	than	than	B-PP	B-PP	-	35	AMOD	-	-
37	that	that	B-NP	B-NP	-	36	PMOD	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	Ig	Ig	B-NP	B-NP	-	41	NMOD	-	-
40	gene	gene	I-NP	I-NP	-	41	NMOD	-	-
41	extinction	extinction	I-NP	I-NP	-	38	PMOD	-	-
42	.	.	O	O	-	3	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	extinguishing	extinguishing	I-NP	I-NP	-	5	NMOD	-	-
5	mechanism	mechanism	I-NP	I-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	effective	effective	B-ADJP	B-ADJP	-	6	PRD	-	-
8	very	very	B-ADVP	B-ADVP	-	6	VMOD	-	-
9	early	early	I-ADVP	I-ADVP	-	8	AMOD	-	-
10	after	after	B-PP	B-PP	-	6	VMOD	-	-
11	fusion	fusion	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	6	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	extinction	extinction	B-NP	B-NP	-	8	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	Ig	Ig	B-NP	B-NP	-	7	NMOD	-	-
7	genes	genes	I-NP	I-NP	-	5	PMOD	-	-
8	is	is	B-VP	B-VP	-	3	SBAR	-	-
9	part	part	B-NP	B-NP	-	8	PRD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	a	a	B-NP	B-NP	-	13	NMOD	-	-
12	global	global	I-NP	I-NP	-	13	NMOD	-	-
13	mechanism	mechanism	I-NP	I-NP	-	10	PMOD	-	-
14	that	that	B-NP	B-NP	-	13	NMOD	-	-
15	suppresses	suppresses	B-VP	B-VP	-	14	SBAR	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	differentiation	differentiation	I-NP	I-NP	-	18	NMOD	-	-
18	program	program	I-NP	I-NP	-	15	OBJ	-	-
19	foreign	foreign	B-ADJP	B-ADJP	-	18	NMOD	-	-
20	to	to	B-PP	B-PP	-	19	AMOD	-	-
21	the	the	B-NP	B-NP	-	23	NMOD	-	-
22	HeLa	HeLa	I-NP	I-NP	-	23	NMOD	-	-
23	phenotype	phenotype	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	2	P	-	-

1	Regulation	Regulation	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	Id3	Id3	B-NP	B-NP	-	6	NMOD	-	-
4	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
5	cycle	cycle	I-NP	I-NP	-	6	NMOD	-	-
6	function	function	I-NP	I-NP	-	2	PMOD	-	-
7	by	by	B-PP	B-PP	-	1	NMOD	-	-
8	Cdk-2-dependent	Cdk-2-dependent	B-NP	B-NP	-	9	NMOD	-	-
9	phosphorylation	phosphorylation	I-NP	I-NP	-	7	PMOD	-	-
10	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	functions	functions	I-NP	I-NP	-	23	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	basic	basic	B-NP	B-NP	-	10	NMOD	-	-
5	helix-loop-helix	helix-loop-helix	I-NP	I-NP	-	10	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	bHLH	bHLH	B-ADJP	B-ADJP	-	5	AMOD	-	-
8	)	)	O	O	-	10	P	-	-
9	transcription	transcription	B-NP	B-NP	-	10	NMOD	-	-
10	factors	factors	I-NP	I-NP	-	3	PMOD	-	-
11	in	in	B-PP	B-PP	-	2	NMOD	-	-
12	activating	activating	B-VP	B-VP	-	11	PMOD	-	-
13	differentiation-linked	differentiation-linked	B-NP	B-NP	-	15	NMOD	-	-
14	gene	gene	I-NP	I-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	12	OBJ	-	-
16	and	and	B-PP	B-PP	-	11	PMOD	-	-
17	in	in	B-PP	B-PP	-	11	PMOD	-	-
18	inducing	inducing	B-VP	B-VP	-	17	PMOD	-	-
19	G1	G1	B-NP	B-NP	-	22	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	22	NMOD	-	-
21	cycle	cycle	I-NP	I-NP	-	22	NMOD	-	-
22	arrest	arrest	I-NP	I-NP	-	18	OBJ	-	-
23	are	are	B-VP	B-VP	-	0	ROOT	-	-
24	negatively	negatively	I-VP	I-VP	-	23	VMOD	-	-
25	regulated	regulated	I-VP	I-VP	-	23	VC	-	-
26	by	by	B-PP	B-PP	-	25	VMOD	-	-
27	members	members	B-NP	B-NP	-	26	PMOD	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	the	the	B-NP	B-NP	-	31	NMOD	-	-
30	Id	Id	I-NP	I-NP	-	31	NMOD	-	-
31	family	family	I-NP	I-NP	-	28	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	HLH	HLH	B-NP	B-NP	-	34	NMOD	-	-
34	proteins	proteins	I-NP	I-NP	-	32	PMOD	-	-
35	.	.	O	O	-	23	P	-	-

1	These	These	B-NP	B-NP	-	3	NMOD	-	-
2	bHLH	bHLH	I-NP	I-NP	-	3	NMOD	-	-
3	antagonists	antagonists	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	14	VMOD	-	-
5	induced	induced	I-VP	I-VP	-	4	VC	-	-
6	during	during	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	10	NMOD	-	-
8	mitogenic	mitogenic	I-NP	I-NP	-	10	NMOD	-	-
9	signalling	signalling	I-NP	I-NP	-	10	NMOD	-	-
10	response	response	I-NP	I-NP	-	6	PMOD	-	-
11	,	,	O	O	-	14	P	-	-
12	and	and	O	O	-	14	VMOD	-	-
13	they	they	B-NP	B-NP	-	14	SUB	-	-
14	function	function	B-VP	B-VP	-	0	ROOT	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	sequestering	sequestering	B-VP	B-VP	-	15	PMOD	-	-
17	their	their	B-NP	B-NP	-	19	NMOD	-	-
18	bHLH	bHLH	I-NP	I-NP	-	19	NMOD	-	-
19	targets	targets	I-NP	I-NP	-	16	OBJ	-	-
20	in	in	B-PP	B-PP	-	16	VMOD	-	-
21	inactive	inactive	B-NP	B-NP	-	22	NMOD	-	-
22	heterodimers	heterodimers	I-NP	I-NP	-	20	PMOD	-	-
23	that	that	B-NP	B-NP	-	22	NMOD	-	-
24	are	are	B-VP	B-VP	-	23	SBAR	-	-
25	unable	unable	B-ADJP	B-ADJP	-	24	PRD	-	-
26	to	to	B-VP	B-VP	-	27	VMOD	-	-
27	bind	bind	I-VP	I-VP	-	25	AMOD	-	-
28	to	to	B-PP	B-PP	-	27	VMOD	-	-
29	specific	specific	B-NP	B-NP	-	36	NMOD	-	-
30	gene	gene	I-NP	I-NP	-	36	NMOD	-	-
31	regulatory	regulatory	I-NP	I-NP	-	36	NMOD	-	-
32	(	(	O	O	-	34	P	-	-
33	E	E	B-NP	B-NP	-	34	NMOD	-	-
34	box	box	I-NP	I-NP	-	31	NMOD	-	-
35	)	)	O	O	-	34	P	-	-
36	sequences	sequences	B-NP	B-NP	-	28	PMOD	-	-
37	.	.	O	O	-	14	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	20	VMOD	-	-
2	,	,	O	O	-	20	P	-	-
3	cyclin	cyclin	B-NP	B-NP	-	4	NMOD	-	-
4	E-Cdk2-	E-Cdk2-	I-NP	I-NP	-	8	NMOD	-	-
5	and	and	O	O	-	8	NMOD	-	-
6	cyclin	cyclin	B-NP	B-NP	-	8	NMOD	-	-
7	A-Cdk2-dependent	A-Cdk2-dependent	I-NP	I-NP	-	8	NMOD	-	-
8	phosphorylation	phosphorylation	I-NP	I-NP	-	20	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	a	a	B-NP	B-NP	-	14	NMOD	-	-
11	single	single	I-NP	I-NP	-	14	NMOD	-	-
12	conserved	conserved	I-NP	I-NP	-	14	NMOD	-	-
13	serine	serine	I-NP	I-NP	-	14	NMOD	-	-
14	residue	residue	I-NP	I-NP	-	9	PMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	Ser5	Ser5	B-NP	B-NP	-	14	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	in	in	B-PP	B-PP	-	14	NMOD	-	-
19	Id2	Id2	B-NP	B-NP	-	18	PMOD	-	-
20	has	has	B-VP	B-VP	-	0	ROOT	-	-
21	been	been	I-VP	I-VP	-	20	VC	-	-
22	shown	shown	I-VP	I-VP	-	21	VC	-	-
23	to	to	I-VP	I-VP	-	24	VMOD	-	-
24	occur	occur	I-VP	I-VP	-	22	VMOD	-	-
25	during	during	B-PP	B-PP	-	24	VMOD	-	-
26	late	late	B-NP	B-NP	-	29	NMOD	-	-
27	G1-to-S	G1-to-S	I-NP	I-NP	-	29	NMOD	-	-
28	phase	phase	I-NP	I-NP	-	29	NMOD	-	-
29	transition	transition	I-NP	I-NP	-	25	PMOD	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	cell	cell	I-NP	I-NP	-	33	NMOD	-	-
33	cycle	cycle	I-NP	I-NP	-	30	PMOD	-	-
34	,	,	O	O	-	37	P	-	-
35	and	and	O	O	-	37	VMOD	-	-
36	this	this	B-NP	B-NP	-	37	SUB	-	-
37	neutralizes	neutralizes	B-VP	B-VP	-	20	VMOD	-	-
38	the	the	B-NP	B-NP	-	39	NMOD	-	-
39	function	function	I-NP	I-NP	-	37	OBJ	-	-
40	of	of	B-PP	B-PP	-	39	NMOD	-	-
41	Id2	Id2	B-NP	B-NP	-	40	PMOD	-	-
42	in	in	B-PP	B-PP	-	37	VMOD	-	-
43	abrogating	abrogating	B-VP	B-VP	-	42	PMOD	-	-
44	E-box-dependent	E-box-dependent	B-NP	B-NP	-	45	AMOD	-	-
45	bHLH	bHLH	I-NP	I-NP	-	50	NMOD	-	-
46	homo-	homo-	I-NP	I-NP	-	50	NMOD	-	-
47	or	or	I-NP	I-NP	-	50	NMOD	-	-
48	heterodimer	heterodimer	I-NP	I-NP	-	50	NMOD	-	-
49	complex	complex	I-NP	I-NP	-	50	NMOD	-	-
50	formation	formation	I-NP	I-NP	-	43	OBJ	-	-
51	in	in	B-ADVP	B-ADVP	-	43	VMOD	-	-
52	vitro	vitro	I-ADVP	I-ADVP	-	51	AMOD	-	-
53	(	(	O	O	-	66	P	-	-
54	E.Hara	E.Hara	B-NP	B-NP	-	59	NMOD	-	-
55	,	,	O	O	-	59	P	-	-
56	M.Hall	M.Hall	B-NP	B-NP	-	59	NMOD	-	-
57	,	,	O	O	-	59	P	-	-
58	and	and	O	O	-	59	NMOD	-	-
59	G.Peters	G.Peters	B-NP	B-NP	-	66	NMOD	-	-
60	,	,	O	O	-	66	P	-	-
61	EMBO	EMBO	B-NP	B-NP	-	62	NMOD	-	-
62	J.16	J.16	I-NP	I-NP	-	66	NMOD	-	-
63	:	:	O	O	-	66	P	-	-
64	332-342	332-342	B-NP	B-NP	-	66	NMOD	-	-
65	,	,	I-NP	I-NP	-	66	P	-	-
66	<num>	<num>	I-NP	I-NP	-	43	OBJ	-	-
67	)	)	O	O	-	66	P	-	-
68	.	.	O	O	-	20	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	now	now	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	an	an	B-NP	B-NP	-	8	NMOD	-	-
6	analogous	analogous	I-NP	I-NP	-	8	NMOD	-	-
7	cell-cycle-regulated	cell-cycle-regulated	I-NP	I-NP	-	8	NMOD	-	-
8	phosphorylation	phosphorylation	I-NP	I-NP	-	11	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	Id3	Id3	B-NP	B-NP	-	9	PMOD	-	-
11	alters	alters	B-VP	B-VP	-	4	SBAR	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	specificity	specificity	I-NP	I-NP	-	11	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	Id3	Id3	B-NP	B-NP	-	14	PMOD	-	-
16	for	for	B-PP	B-PP	-	13	NMOD	-	-
17	abrogating	abrogating	B-VP	B-VP	-	16	PMOD	-	-
18	both	both	O	O	-	25	NMOD	-	-
19	E-box-dependent	E-box-dependent	B-NP	B-NP	-	21	NMOD	-	-
20	bHLH	bHLH	I-NP	I-NP	-	21	NMOD	-	-
21	homo-	homo-	I-NP	I-NP	-	25	NMOD	-	-
22	or	or	I-NP	I-NP	-	25	NMOD	-	-
23	heterodimer	heterodimer	I-NP	I-NP	-	25	NMOD	-	-
24	complex	complex	I-NP	I-NP	-	25	NMOD	-	-
25	formation	formation	I-NP	I-NP	-	17	OBJ	-	-
26	in	in	B-ADVP	B-ADVP	-	17	VMOD	-	-
27	vitro	vitro	I-ADVP	I-ADVP	-	26	AMOD	-	-
28	and	and	O	O	-	32	NMOD	-	-
29	E-box-dependent	E-box-dependent	B-NP	B-NP	-	32	NMOD	-	-
30	reporter	reporter	I-NP	I-NP	-	32	NMOD	-	-
31	gene	gene	I-NP	I-NP	-	32	NMOD	-	-
32	function	function	I-NP	I-NP	-	17	OBJ	-	-
33	in	in	B-ADVP	B-ADVP	-	32	NMOD	-	-
34	vivo	vivo	I-ADVP	I-ADVP	-	33	AMOD	-	-
35	.	.	O	O	-	3	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	16	VMOD	-	-
2	,	,	O	O	-	16	P	-	-
3	compared	compared	B-PP	B-PP	-	16	VMOD	-	-
4	with	with	B-PP	B-PP	-	3	PMOD	-	-
5	wild-type	wild-type	B-NP	B-NP	-	6	NMOD	-	-
6	Id3	Id3	I-NP	I-NP	-	4	PMOD	-	-
7	,	,	O	O	-	16	P	-	-
8	an	an	B-NP	B-NP	-	11	NMOD	-	-
9	Id3	Id3	I-NP	I-NP	-	11	NMOD	-	-
10	Asp5	Asp5	I-NP	I-NP	-	11	NMOD	-	-
11	mutant	mutant	I-NP	I-NP	-	16	SUB	-	-
12	(	(	O	O	-	14	P	-	-
13	mimicking	mimicking	B-VP	B-VP	-	14	NMOD	-	-
14	phosphorylation	phosphorylation	B-NP	B-NP	-	11	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	is	is	B-VP	B-VP	-	0	ROOT	-	-
17	unable	unable	B-ADJP	B-ADJP	-	16	PRD	-	-
18	to	to	B-VP	B-VP	-	19	VMOD	-	-
19	promote	promote	I-VP	I-VP	-	17	AMOD	-	-
20	cell	cell	B-NP	B-NP	-	24	NMOD	-	-
21	cycle	cycle	I-NP	I-NP	-	24	NMOD	-	-
22	S	S	I-NP	I-NP	-	24	NMOD	-	-
23	phase	phase	I-NP	I-NP	-	24	NMOD	-	-
24	entry	entry	I-NP	I-NP	-	19	OBJ	-	-
25	in	in	B-PP	B-PP	-	24	NMOD	-	-
26	transfected	transfected	B-NP	B-NP	-	27	NMOD	-	-
27	fibroblasts	fibroblasts	I-NP	I-NP	-	25	PMOD	-	-
28	,	,	O	O	-	29	P	-	-
29	whereas	whereas	O	O	-	16	VMOD	-	-
30	an	an	B-NP	B-NP	-	33	NMOD	-	-
31	Id3	Id3	I-NP	I-NP	-	33	NMOD	-	-
32	Ala5	Ala5	I-NP	I-NP	-	33	NMOD	-	-
33	mutant	mutant	I-NP	I-NP	-	38	SUB	-	-
34	(	(	O	O	-	36	P	-	-
35	ablating	ablating	B-VP	B-VP	-	36	NMOD	-	-
36	phosphorylation	phosphorylation	B-NP	B-NP	-	33	NMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	displays	displays	B-VP	B-VP	-	29	SBAR	-	-
39	an	an	B-NP	B-NP	-	40	NMOD	-	-
40	activity	activity	I-NP	I-NP	-	38	OBJ	-	-
41	significantly	significantly	B-ADJP	B-ADJP	-	42	AMOD	-	-
42	greater	greater	I-ADJP	I-ADJP	-	40	NMOD	-	-
43	than	than	B-PP	B-PP	-	42	AMOD	-	-
44	that	that	B-NP	B-NP	-	43	PMOD	-	-
45	of	of	B-PP	B-PP	-	44	NMOD	-	-
46	wild-type	wild-type	B-NP	B-NP	-	48	NMOD	-	-
47	Id3	Id3	I-NP	I-NP	-	48	NMOD	-	-
48	protein	protein	I-NP	I-NP	-	45	PMOD	-	-
49	.	.	O	O	-	16	P	-	-

1	Cdk2-dependent	Cdk2-dependent	B-NP	B-NP	-	2	NMOD	-	-
2	phosphorylation	phosphorylation	I-NP	I-NP	-	4	SUB	-	-
3	therefore	therefore	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	provides	provides	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	6	NMOD	-	-
6	switch	switch	I-NP	I-NP	-	4	OBJ	-	-
7	during	during	B-PP	B-PP	-	4	VMOD	-	-
8	late	late	B-NP	B-NP	-	10	NMOD	-	-
9	G1-to-S	G1-to-S	I-NP	I-NP	-	10	NMOD	-	-
10	phase	phase	I-NP	I-NP	-	7	PMOD	-	-
11	that	that	B-NP	B-NP	-	10	NMOD	-	-
12	both	both	O	O	-	11	SBAR	-	-
13	nullifies	nullifies	B-VP	B-VP	-	11	SBAR	-	-
14	an	an	B-NP	B-NP	-	20	NMOD	-	-
15	early	early	I-NP	I-NP	-	20	NMOD	-	-
16	G1	G1	I-NP	I-NP	-	20	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
18	cycle	cycle	I-NP	I-NP	-	20	NMOD	-	-
19	regulatory	regulatory	I-NP	I-NP	-	20	NMOD	-	-
20	function	function	I-NP	I-NP	-	13	OBJ	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	Id3	Id3	B-NP	B-NP	-	21	PMOD	-	-
23	and	and	O	O	-	13	VMOD	-	-
24	modulates	modulates	B-VP	B-VP	-	13	VMOD	-	-
25	its	its	B-NP	B-NP	-	28	NMOD	-	-
26	target	target	I-NP	I-NP	-	28	NMOD	-	-
27	bHLH	bHLH	I-NP	I-NP	-	28	NMOD	-	-
28	specificity	specificity	I-NP	I-NP	-	24	OBJ	-	-
29	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	4	SUB	-	-
3	also	also	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	ability	ability	I-NP	I-NP	-	17	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	Id3	Id3	B-NP	B-NP	-	8	PMOD	-	-
10	to	to	B-VP	B-VP	-	11	VMOD	-	-
11	promote	promote	I-VP	I-VP	-	7	NMOD	-	-
12	cell	cell	B-NP	B-NP	-	16	NMOD	-	-
13	cycle	cycle	I-NP	I-NP	-	16	NMOD	-	-
14	S	S	I-NP	I-NP	-	16	NMOD	-	-
15	phase	phase	I-NP	I-NP	-	16	NMOD	-	-
16	entry	entry	I-NP	I-NP	-	11	OBJ	-	-
17	is	is	B-VP	B-VP	-	5	SBAR	-	-
18	not	not	O	O	-	17	VMOD	-	-
19	simply	simply	B-ADVP	B-ADVP	-	17	VMOD	-	-
20	a	a	B-NP	B-NP	-	21	NMOD	-	-
21	function	function	I-NP	I-NP	-	17	PRD	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	its	its	B-NP	B-NP	-	24	NMOD	-	-
24	ability	ability	I-NP	I-NP	-	22	PMOD	-	-
25	to	to	B-VP	B-VP	-	26	VMOD	-	-
26	modulate	modulate	I-VP	I-VP	-	24	NMOD	-	-
27	bHLH	bHLH	B-NP	B-NP	-	30	NMOD	-	-
28	heterodimer-dependent	heterodimer-dependent	I-NP	I-NP	-	30	NMOD	-	-
29	gene	gene	I-NP	I-NP	-	30	NMOD	-	-
30	expression	expression	I-NP	I-NP	-	26	OBJ	-	-
31	and	and	O	O	-	26	VMOD	-	-
32	establish	establish	B-VP	B-VP	-	26	VMOD	-	-
33	a	a	B-NP	B-NP	-	36	NMOD	-	-
34	biologically	biologically	I-NP	I-NP	-	35	AMOD	-	-
35	important	important	I-NP	I-NP	-	36	NMOD	-	-
36	mechanism	mechanism	I-NP	I-NP	-	32	OBJ	-	-
37	through	through	B-PP	B-PP	-	36	NMOD	-	-
38	which	which	B-NP	B-NP	-	37	PMOD	-	-
39	Cdk2	Cdk2	B-NP	B-NP	-	42	NMOD	-	-
40	and	and	I-NP	I-NP	-	42	NMOD	-	-
41	Id-bHLH	Id-bHLH	I-NP	I-NP	-	42	NMOD	-	-
42	functions	functions	I-NP	I-NP	-	37	PMOD	-	-
43	are	are	B-VP	B-VP	-	37	SBAR	-	-
44	integrated	integrated	I-VP	I-VP	-	43	VC	-	-
45	in	in	B-PP	B-PP	-	44	VMOD	-	-
46	the	the	B-NP	B-NP	-	47	NMOD	-	-
47	coordination	coordination	I-NP	I-NP	-	45	PMOD	-	-
48	of	of	B-PP	B-PP	-	47	NMOD	-	-
49	cell	cell	B-NP	B-NP	-	48	PMOD	-	-
50	proliferation	proliferation	I-NP	I-NP	-	52	NMOD	-	-
51	and	and	O	O	-	52	NMOD	-	-
52	differentiation	differentiation	B-NP	B-NP	-	49	NMOD	-	-
53	.	.	O	O	-	4	P	-	-

1	Cytokine	Cytokine	B-NP	B-NP	-	2	NMOD	-	-
2	rescue	rescue	I-NP	I-NP	-	10	SUB	-	-
3	from	from	B-PP	B-PP	-	2	NMOD	-	-
4	glucocorticoid	glucocorticoid	B-NP	B-NP	-	3	PMOD	-	-
5	induced	induced	B-VP	B-VP	-	10	VMOD	-	-
6	apoptosis	apoptosis	B-NP	B-NP	-	5	OBJ	-	-
7	in	in	B-PP	B-PP	-	6	NMOD	-	-
8	T	T	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	mediated	mediated	I-VP	I-VP	-	10	VC	-	-
12	through	through	B-PP	B-PP	-	11	VMOD	-	-
13	inhibition	inhibition	B-NP	B-NP	-	12	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	14	PMOD	-	-
16	.	.	O	O	-	10	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	previously	previously	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	reported	reported	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	23	DEP	-	-
5	dexamethasone	dexamethasone	B-NP	B-NP	-	12	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	DEX	DEX	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	,	,	O	O	-	12	P	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	synthetic	synthetic	I-NP	I-NP	-	12	NMOD	-	-
12	glucocorticoid	glucocorticoid	I-NP	I-NP	-	14	SUB	-	-
13	,	,	O	O	-	12	P	-	-
14	causes	causes	B-VP	B-VP	-	4	SBAR	-	-
15	apoptosis	apoptosis	B-NP	B-NP	-	14	OBJ	-	-
16	in	in	B-PP	B-PP	-	15	NMOD	-	-
17	mature	mature	B-NP	B-NP	-	20	NMOD	-	-
18	Th	Th	I-NP	I-NP	-	20	NMOD	-	-
19	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
20	lines	lines	I-NP	I-NP	-	16	PMOD	-	-
21	,	,	O	O	-	23	P	-	-
22	and	and	O	O	-	23	DEP	-	-
23	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
24	this	this	B-NP	B-NP	-	25	NMOD	-	-
25	induction	induction	I-NP	I-NP	-	29	SUB	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	cell	cell	B-NP	B-NP	-	28	NMOD	-	-
28	death	death	I-NP	I-NP	-	26	PMOD	-	-
29	is	is	B-VP	B-VP	-	23	SBAR	-	-
30	prevented	prevented	I-VP	I-VP	-	29	VC	-	-
31	by	by	B-PP	B-PP	-	30	VMOD	-	-
32	specific	specific	B-NP	B-NP	-	33	NMOD	-	-
33	cytokines	cytokines	I-NP	I-NP	-	31	PMOD	-	-
34	,	,	O	O	-	30	P	-	-
35	namely	namely	B-ADVP	B-ADVP	-	30	VMOD	-	-
36	,	,	O	O	-	30	P	-	-
37	by	by	B-PP	B-PP	-	30	VMOD	-	-
38	IL-2	IL-2	B-NP	B-NP	-	37	PMOD	-	-
39	in	in	B-PP	B-PP	-	38	NMOD	-	-
40	Th1	Th1	B-NP	B-NP	-	41	NMOD	-	-
41	cells	cells	I-NP	I-NP	-	39	PMOD	-	-
42	and	and	B-PP	B-PP	-	37	PMOD	-	-
43	by	by	B-PP	B-PP	-	37	PMOD	-	-
44	IL-4	IL-4	B-NP	B-NP	-	43	PMOD	-	-
45	in	in	B-PP	B-PP	-	44	NMOD	-	-
46	Th2	Th2	B-NP	B-NP	-	47	NMOD	-	-
47	cells	cells	I-NP	I-NP	-	45	PMOD	-	-
48	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	now	now	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	this	this	B-NP	B-NP	-	7	NMOD	-	-
6	differential	differential	I-NP	I-NP	-	7	NMOD	-	-
7	rescue	rescue	I-NP	I-NP	-	14	SUB	-	-
8	by	by	B-PP	B-PP	-	7	NMOD	-	-
9	specific	specific	B-NP	B-NP	-	10	NMOD	-	-
10	cytokines	cytokines	I-NP	I-NP	-	8	PMOD	-	-
11	in	in	B-PP	B-PP	-	7	NMOD	-	-
12	Th	Th	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	correlates	correlates	B-VP	B-VP	-	4	SBAR	-	-
15	with	with	B-PP	B-PP	-	14	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	level	level	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	18	PMOD	-	-
20	that	that	B-NP	B-NP	-	17	NMOD	-	-
21	is	is	B-VP	B-VP	-	20	SBAR	-	-
22	regulated	regulated	I-VP	I-VP	-	21	VC	-	-
23	by	by	B-PP	B-PP	-	22	VMOD	-	-
24	DEX	DEX	B-NP	B-NP	-	26	NMOD	-	-
25	and	and	I-NP	I-NP	-	26	NMOD	-	-
26	cytokines	cytokines	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	13	VMOD	-	-
2	both	both	B-NP	B-NP	-	4	NMOD	-	-
3	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
4	types	types	I-NP	I-NP	-	1	PMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	cellular	cellular	I-NP	I-NP	-	7	NMOD	-	-
7	levels	levels	I-NP	I-NP	-	13	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	10	NMOD	-	-
10	mRNA	mRNA	I-NP	I-NP	-	12	NMOD	-	-
11	and	and	I-NP	I-NP	-	12	NMOD	-	-
12	protein	protein	I-NP	I-NP	-	8	PMOD	-	-
13	were	were	B-VP	B-VP	-	0	ROOT	-	-
14	evaluated	evaluated	I-VP	I-VP	-	13	VC	-	-
15	by	by	B-PP	B-PP	-	14	VMOD	-	-
16	DEX	DEX	B-NP	B-NP	-	17	NMOD	-	-
17	treatment	treatment	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	13	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	DEX-mediated	DEX-mediated	I-NP	I-NP	-	6	NMOD	-	-
5	IkappaBalpha	IkappaBalpha	I-NP	I-NP	-	6	NMOD	-	-
6	induction	induction	I-NP	I-NP	-	7	SUB	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	completely	completely	I-VP	I-VP	-	7	VMOD	-	-
9	inhibited	inhibited	I-VP	I-VP	-	7	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	IL-2	IL-2	B-NP	B-NP	-	15	NMOD	-	-
12	,	,	O	O	-	15	P	-	-
13	but	but	O	O	-	15	NMOD	-	-
14	not	not	O	O	-	13	DEP	-	-
15	IL-4	IL-4	B-NP	B-NP	-	10	PMOD	-	-
16	,	,	O	O	-	9	P	-	-
17	in	in	B-PP	B-PP	-	9	VMOD	-	-
18	Th1	Th1	B-NP	B-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	9	P	-	-
21	while	while	B-SBAR	B-SBAR	-	7	VMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	reverse	reverse	I-NP	I-NP	-	24	NMOD	-	-
24	profile	profile	I-NP	I-NP	-	25	SUB	-	-
25	was	was	B-VP	B-VP	-	21	SBAR	-	-
26	seen	seen	I-VP	I-VP	-	25	VC	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	Th2	Th2	B-NP	B-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	18	VMOD	-	-
2	both	both	B-NP	B-NP	-	4	NMOD	-	-
3	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
4	types	types	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	18	P	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	cytokine	cytokine	I-NP	I-NP	-	18	SUB	-	-
8	that	that	B-NP	B-NP	-	7	NMOD	-	-
9	inhibits	inhibits	B-VP	B-VP	-	8	SBAR	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	induction	induction	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	12	PMOD	-	-
14	by	by	B-PP	B-PP	-	11	NMOD	-	-
15	DEX	DEX	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	7	P	-	-
17	also	also	B-ADVP	B-ADVP	-	18	VMOD	-	-
18	rescues	rescues	B-VP	B-VP	-	0	ROOT	-	-
19	these	these	B-NP	B-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	18	OBJ	-	-
21	from	from	B-PP	B-PP	-	18	VMOD	-	-
22	DEX-induced	DEX-induced	B-NP	B-NP	-	23	NMOD	-	-
23	apoptosis	apoptosis	I-NP	I-NP	-	21	PMOD	-	-
24	,	,	O	O	-	18	P	-	-
25	although	although	B-SBAR	B-SBAR	-	18	VMOD	-	-
26	the	the	B-NP	B-NP	-	28	NMOD	-	-
27	rescue	rescue	I-NP	I-NP	-	28	NMOD	-	-
28	cytokine	cytokine	I-NP	I-NP	-	29	SUB	-	-
29	is	is	B-VP	B-VP	-	25	SBAR	-	-
30	different	different	B-ADJP	B-ADJP	-	29	PRD	-	-
31	in	in	B-PP	B-PP	-	30	AMOD	-	-
32	Th1	Th1	B-NP	B-NP	-	35	NMOD	-	-
33	and	and	O	O	-	35	NMOD	-	-
34	Th2	Th2	B-NP	B-NP	-	35	NMOD	-	-
35	cells	cells	I-NP	I-NP	-	31	PMOD	-	-
36	.	.	O	O	-	18	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	imply	imply	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	T	T	B-NP	B-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	7	SUB	-	-
7	need	need	B-VP	B-VP	-	4	SBAR	-	-
8	to	to	I-VP	I-VP	-	9	VMOD	-	-
9	maintain	maintain	I-VP	I-VP	-	7	VMOD	-	-
10	a	a	B-NP	B-NP	-	12	NMOD	-	-
11	certain	certain	I-NP	I-NP	-	12	NMOD	-	-
12	level	level	I-NP	I-NP	-	9	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	NF-kappaB	NF-kappaB	B-NP	B-NP	-	16	NMOD	-	-
15	transcriptional	transcriptional	I-NP	I-NP	-	16	NMOD	-	-
16	activity	activity	I-NP	I-NP	-	13	PMOD	-	-
17	in	in	B-SBAR	B-SBAR	-	12	NMOD	-	-
18	order	order	O	O	-	17	DEP	-	-
19	to	to	B-VP	B-VP	-	20	VMOD	-	-
20	survive	survive	I-VP	I-VP	-	17	SBAR	-	-
21	;	;	O	O	-	38	P	-	-
22	up-	up-	B-NP	B-NP	-	24	NMOD	-	-
23	or	or	I-NP	I-NP	-	24	NMOD	-	-
24	down-regulation	down-regulation	I-NP	I-NP	-	38	SUB	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	nuclear	nuclear	B-NP	B-NP	-	28	NMOD	-	-
27	NF	NF	I-NP	I-NP	-	28	NMOD	-	-
28	kappaB	kappaB	I-NP	I-NP	-	25	PMOD	-	-
29	through	through	B-PP	B-PP	-	24	NMOD	-	-
30	modulation	modulation	B-NP	B-NP	-	29	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	33	NMOD	-	-
33	expression	expression	I-NP	I-NP	-	31	PMOD	-	-
34	by	by	B-PP	B-PP	-	30	NMOD	-	-
35	cytokines	cytokines	B-NP	B-NP	-	37	NMOD	-	-
36	or	or	O	O	-	37	NMOD	-	-
37	DEX	DEX	B-NP	B-NP	-	34	PMOD	-	-
38	may	may	B-VP	B-VP	-	17	SBAR	-	-
39	lead	lead	I-VP	I-VP	-	38	VC	-	-
40	to	to	B-PP	B-PP	-	39	VMOD	-	-
41	cell	cell	B-NP	B-NP	-	42	NMOD	-	-
42	survival	survival	I-NP	I-NP	-	45	NMOD	-	-
43	or	or	O	O	-	45	NMOD	-	-
44	cell	cell	B-NP	B-NP	-	45	NMOD	-	-
45	death	death	I-NP	I-NP	-	40	PMOD	-	-
46	,	,	O	O	-	9	P	-	-
47	respectively	respectively	B-ADVP	B-ADVP	-	9	VMOD	-	-
48	.	.	O	O	-	3	P	-	-

1	Xenogeneic	Xenogeneic	B-NP	B-NP	-	3	NMOD	-	-
2	human	human	I-NP	I-NP	-	3	NMOD	-	-
3	serum	serum	I-NP	I-NP	-	4	SUB	-	-
4	promotes	promotes	B-VP	B-VP	-	0	ROOT	-	-
5	leukocyte	leukocyte	B-NP	B-NP	-	6	NMOD	-	-
6	adhesion	adhesion	I-NP	I-NP	-	4	OBJ	-	-
7	to	to	B-PP	B-PP	-	6	NMOD	-	-
8	porcine	porcine	B-NP	B-NP	-	9	NMOD	-	-
9	endothelium	endothelium	I-NP	I-NP	-	7	PMOD	-	-
10	under	under	B-PP	B-PP	-	9	NMOD	-	-
11	flow	flow	B-NP	B-NP	-	12	NMOD	-	-
12	conditions	conditions	I-NP	I-NP	-	10	PMOD	-	-
13	,	,	O	O	-	6	P	-	-
14	possibly	possibly	B-ADVP	B-ADVP	-	15	PMOD	-	-
15	through	through	B-PP	B-PP	-	4	VMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	activation	activation	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	23	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	23	NMOD	-	-
21	factor	factor	I-NP	I-NP	-	23	NMOD	-	-
22	NF-kappa	NF-kappa	I-NP	I-NP	-	23	NMOD	-	-
23	B	B	I-NP	I-NP	-	18	PMOD	-	-
24	.	.	O	O	-	4	P	-	-

1	Endothelial	Endothelial	B-NP	B-NP	-	3	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	6	NMOD	-	-
4	and	and	O	O	-	6	NMOD	-	-
5	leukocyte	leukocyte	B-NP	B-NP	-	6	NMOD	-	-
6	infiltration	infiltration	I-NP	I-NP	-	7	SUB	-	-
7	are	are	B-VP	B-VP	-	0	ROOT	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	consistent	consistent	I-NP	I-NP	-	10	NMOD	-	-
10	feature	feature	I-NP	I-NP	-	7	PRD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	discordant	discordant	B-NP	B-NP	-	14	NMOD	-	-
13	xenograft	xenograft	I-NP	I-NP	-	14	NMOD	-	-
14	rejection	rejection	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	7	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	3	VMOD	-	-
2	we	we	B-NP	B-NP	-	3	SUB	-	-
3	evaluated	evaluated	B-VP	B-VP	-	0	ROOT	-	-
4	whether	whether	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	xenogeneic	xenogeneic	B-NP	B-NP	-	6	NMOD	-	-
6	serum	serum	I-NP	I-NP	-	18	SUB	-	-
7	,	,	O	O	-	18	P	-	-
8	as	as	B-PP	B-PP	-	18	VMOD	-	-
9	a	a	B-NP	B-NP	-	10	NMOD	-	-
10	source	source	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	xenoreactive	xenoreactive	B-NP	B-NP	-	14	NMOD	-	-
13	natural	natural	I-NP	I-NP	-	14	NMOD	-	-
14	antibodies	antibodies	I-NP	I-NP	-	11	PMOD	-	-
15	and	and	O	O	-	16	NMOD	-	-
16	complement	complement	B-NP	B-NP	-	11	PMOD	-	-
17	,	,	O	O	-	16	P	-	-
18	induced	induced	B-VP	B-VP	-	4	SBAR	-	-
19	endothelial	endothelial	B-NP	B-NP	-	21	NMOD	-	-
20	cell	cell	I-NP	I-NP	-	21	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	18	OBJ	-	-
22	with	with	B-PP	B-PP	-	21	NMOD	-	-
23	consequent	consequent	B-NP	B-NP	-	25	NMOD	-	-
24	leukocyte	leukocyte	I-NP	I-NP	-	25	NMOD	-	-
25	adhesion	adhesion	I-NP	I-NP	-	22	PMOD	-	-
26	under	under	B-PP	B-PP	-	21	NMOD	-	-
27	flow	flow	B-NP	B-NP	-	28	NMOD	-	-
28	conditions	conditions	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	3	P	-	-

1	Porcine	Porcine	B-NP	B-NP	-	4	NMOD	-	-
2	aortic	aortic	I-NP	I-NP	-	4	NMOD	-	-
3	endothelial	endothelial	I-NP	I-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	8	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	PAEC	PAEC	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	were	were	B-VP	B-VP	-	0	ROOT	-	-
9	incubated	incubated	I-VP	I-VP	-	8	VC	-	-
10	for	for	B-PP	B-PP	-	9	VMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
12	hr	hr	I-NP	I-NP	-	14	NMOD	-	-
13	<num>	<num>	B-NP	B-NP	-	14	NMOD	-	-
14	min	min	I-NP	I-NP	-	17	NMOD	-	-
15	or	or	O	O	-	17	NMOD	-	-
16	<num>	<num>	B-NP	B-NP	-	17	NMOD	-	-
17	hr	hr	I-NP	I-NP	-	10	PMOD	-	-
18	with	with	B-PP	B-PP	-	9	VMOD	-	-
19	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
20	%	%	I-NP	I-NP	-	23	NMOD	-	-
21	homologous	homologous	I-NP	I-NP	-	23	NMOD	-	-
22	porcine	porcine	I-NP	I-NP	-	23	NMOD	-	-
23	serum	serum	I-NP	I-NP	-	32	NMOD	-	-
24	(	(	O	O	-	25	P	-	-
25	control	control	B-NP	B-NP	-	23	NMOD	-	-
26	)	)	O	O	-	25	P	-	-
27	or	or	O	O	-	32	NMOD	-	-
28	<num>	<num>	B-NP	B-NP	-	32	NMOD	-	-
29	%	%	I-NP	I-NP	-	32	NMOD	-	-
30	xenogeneic	xenogeneic	I-NP	I-NP	-	32	NMOD	-	-
31	human	human	I-NP	I-NP	-	32	NMOD	-	-
32	serum	serum	I-NP	I-NP	-	18	PMOD	-	-
33	and	and	O	O	-	9	VMOD	-	-
34	then	then	B-VP	B-VP	-	35	VMOD	-	-
35	perfused	perfused	I-VP	I-VP	-	9	VMOD	-	-
36	with	with	B-PP	B-PP	-	35	VMOD	-	-
37	total	total	B-NP	B-NP	-	39	NMOD	-	-
38	human	human	I-NP	I-NP	-	39	NMOD	-	-
39	leukocytes	leukocytes	I-NP	I-NP	-	36	PMOD	-	-
40	in	in	B-PP	B-PP	-	39	NMOD	-	-
41	a	a	B-NP	B-NP	-	45	NMOD	-	-
42	parallel	parallel	I-NP	I-NP	-	45	NMOD	-	-
43	plate	plate	I-NP	I-NP	-	45	NMOD	-	-
44	flow	flow	I-NP	I-NP	-	45	NMOD	-	-
45	chamber	chamber	I-NP	I-NP	-	40	PMOD	-	-
46	under	under	B-PP	B-PP	-	45	NMOD	-	-
47	laminar	laminar	B-NP	B-NP	-	48	NMOD	-	-
48	flow	flow	I-NP	I-NP	-	46	PMOD	-	-
49	(	(	O	O	-	51	P	-	-
50	<num>	<num>	B-NP	B-NP	-	51	NMOD	-	-
51	dynes/cm2	dynes/cm2	I-NP	I-NP	-	48	NMOD	-	-
52	)	)	O	O	-	51	P	-	-
53	.	.	O	O	-	8	P	-	-

1	Adherent	Adherent	B-NP	B-NP	-	2	NMOD	-	-
2	cells	cells	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	counted	counted	I-VP	I-VP	-	3	VC	-	-
5	by	by	B-PP	B-PP	-	4	VMOD	-	-
6	digital	digital	B-NP	B-NP	-	8	NMOD	-	-
7	image	image	I-NP	I-NP	-	8	NMOD	-	-
8	analysis	analysis	I-NP	I-NP	-	5	PMOD	-	-
9	.	.	O	O	-	3	P	-	-

1	Xenogeneic	Xenogeneic	B-NP	B-NP	-	3	NMOD	-	-
2	human	human	I-NP	I-NP	-	3	NMOD	-	-
3	serum	serum	I-NP	I-NP	-	10	SUB	-	-
4	significantly	significantly	B-ADVP	B-ADVP	-	10	VMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	P	P	B-NP	B-NP	-	10	SUB	-	-
7	<	<	O	O	-	6	NMOD	-	-
8	<num>	<num>	B-NP	B-NP	-	7	AMOD	-	-
9	)	)	O	O	-	6	P	-	-
10	increased	increased	B-VP	B-VP	-	0	ROOT	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	number	number	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	adherent	adherent	B-NP	B-NP	-	15	NMOD	-	-
15	leukocytes	leukocytes	I-NP	I-NP	-	13	PMOD	-	-
16	as	as	B-PP	B-PP	-	10	VMOD	-	-
17	compared	compared	B-PP	B-PP	-	16	SBAR	-	-
18	with	with	B-PP	B-PP	-	17	VMOD	-	-
19	porcine	porcine	B-NP	B-NP	-	20	NMOD	-	-
20	serum	serum	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	10	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	similar	similar	I-NP	I-NP	-	4	NMOD	-	-
3	adhesive	adhesive	I-NP	I-NP	-	4	NMOD	-	-
4	response	response	I-NP	I-NP	-	5	SUB	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	elicited	elicited	I-VP	I-VP	-	5	VC	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	TNF	TNF	B-NP	B-NP	-	9	NMOD	-	-
9	alpha	alpha	I-NP	I-NP	-	7	PMOD	-	-
10	(	(	O	O	-	12	P	-	-
11	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
12	U/ml	U/ml	I-NP	I-NP	-	9	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	,	,	O	O	-	15	P	-	-
15	one	one	B-NP	B-NP	-	7	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	20	NMOD	-	-
18	most	most	I-NP	I-NP	-	19	AMOD	-	-
19	potent	potent	I-NP	I-NP	-	20	NMOD	-	-
20	inducers	inducers	I-NP	I-NP	-	16	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	endothelial	endothelial	B-NP	B-NP	-	25	NMOD	-	-
23	cell	cell	I-NP	I-NP	-	25	NMOD	-	-
24	adhesive	adhesive	I-NP	I-NP	-	25	NMOD	-	-
25	properties	properties	I-NP	I-NP	-	21	PMOD	-	-
26	,	,	O	O	-	20	P	-	-
27	here	here	B-ADVP	B-ADVP	-	28	VMOD	-	-
28	used	used	B-VP	B-VP	-	20	NMOD	-	-
29	as	as	B-PP	B-PP	-	28	VMOD	-	-
30	positive	positive	B-NP	B-NP	-	31	NMOD	-	-
31	control	control	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	5	P	-	-

1	In	In	B-SBAR	B-SBAR	-	16	VMOD	-	-
2	order	order	O	O	-	1	DEP	-	-
3	to	to	B-VP	B-VP	-	4	VMOD	-	-
4	elucidate	elucidate	I-VP	I-VP	-	1	SBAR	-	-
5	possible	possible	B-NP	B-NP	-	6	NMOD	-	-
6	mechanisms	mechanisms	I-NP	I-NP	-	4	OBJ	-	-
7	underlying	underlying	B-VP	B-VP	-	6	NMOD	-	-
8	endothelial	endothelial	B-NP	B-NP	-	10	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	7	OBJ	-	-
11	by	by	B-PP	B-PP	-	10	NMOD	-	-
12	xenogeneic	xenogeneic	B-NP	B-NP	-	13	NMOD	-	-
13	serum	serum	I-NP	I-NP	-	11	PMOD	-	-
14	,	,	O	O	-	16	P	-	-
15	we	we	B-NP	B-NP	-	16	SUB	-	-
16	focussed	focussed	B-VP	B-VP	-	0	ROOT	-	-
17	on	on	B-PP	B-PP	-	16	VMOD	-	-
18	transcription	transcription	B-NP	B-NP	-	21	NMOD	-	-
19	factor	factor	I-NP	I-NP	-	21	NMOD	-	-
20	NF-kappa	NF-kappa	I-NP	I-NP	-	21	NMOD	-	-
21	B	B	I-NP	I-NP	-	25	NMOD	-	-
22	,	,	O	O	-	25	P	-	-
23	a	a	B-NP	B-NP	-	25	NMOD	-	-
24	central	central	I-NP	I-NP	-	25	NMOD	-	-
25	regulator	regulator	I-NP	I-NP	-	17	PMOD	-	-
26	for	for	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	B-NP	B-NP	-	28	NMOD	-	-
28	induction	induction	I-NP	I-NP	-	26	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	different	different	B-NP	B-NP	-	31	NMOD	-	-
31	genes	genes	I-NP	I-NP	-	29	PMOD	-	-
32	,	,	O	O	-	31	P	-	-
33	including	including	B-PP	B-PP	-	31	NMOD	-	-
34	adhesive	adhesive	B-NP	B-NP	-	35	NMOD	-	-
35	molecules	molecules	I-NP	I-NP	-	37	NMOD	-	-
36	and	and	I-NP	I-NP	-	37	NMOD	-	-
37	chemoattractants	chemoattractants	I-NP	I-NP	-	33	PMOD	-	-
38	.	.	O	O	-	16	P	-	-

1	By	By	B-PP	B-PP	-	7	VMOD	-	-
2	confocal	confocal	B-NP	B-NP	-	4	NMOD	-	-
3	fluorescence	fluorescence	I-NP	I-NP	-	4	NMOD	-	-
4	microscopy	microscopy	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	observed	observed	B-VP	B-VP	-	0	ROOT	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	positive	positive	I-NP	I-NP	-	10	NMOD	-	-
10	staining	staining	I-NP	I-NP	-	7	OBJ	-	-
11	for	for	B-PP	B-PP	-	10	NMOD	-	-
12	NF-kappa	NF-kappa	B-NP	B-NP	-	13	NMOD	-	-
13	B	B	I-NP	I-NP	-	11	PMOD	-	-
14	(	(	O	O	-	16	P	-	-
15	p65	p65	B-NP	B-NP	-	16	NMOD	-	-
16	subunit	subunit	I-NP	I-NP	-	13	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	in	in	B-PP	B-PP	-	10	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	nuclei	nuclei	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	PAEC	PAEC	B-NP	B-NP	-	21	PMOD	-	-
23	exposed	exposed	B-VP	B-VP	-	22	NMOD	-	-
24	for	for	B-PP	B-PP	-	23	VMOD	-	-
25	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
26	hr	hr	I-NP	I-NP	-	24	PMOD	-	-
27	<num>	<num>	B-NP	B-NP	-	28	NMOD	-	-
28	min	min	I-NP	I-NP	-	24	PMOD	-	-
29	to	to	B-PP	B-PP	-	28	NMOD	-	-
30	human	human	B-NP	B-NP	-	31	NMOD	-	-
31	serum	serum	I-NP	I-NP	-	29	PMOD	-	-
32	,	,	O	O	-	28	P	-	-
33	which	which	B-NP	B-NP	-	28	NMOD	-	-
34	indicated	indicated	B-VP	B-VP	-	33	SBAR	-	-
35	NF-kappa	NF-kappa	B-NP	B-NP	-	37	NMOD	-	-
36	B	B	I-NP	I-NP	-	37	NMOD	-	-
37	activation	activation	I-NP	I-NP	-	34	OBJ	-	-
38	in	in	B-PP	B-PP	-	37	NMOD	-	-
39	this	this	B-NP	B-NP	-	40	NMOD	-	-
40	setting	setting	I-NP	I-NP	-	38	PMOD	-	-
41	.	.	O	O	-	7	P	-	-

1	At	At	B-PP	B-PP	-	14	VMOD	-	-
2	variance	variance	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	14	P	-	-
4	in	in	B-PP	B-PP	-	14	VMOD	-	-
5	PAEC	PAEC	B-NP	B-NP	-	4	PMOD	-	-
6	incubated	incubated	B-VP	B-VP	-	5	NMOD	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	homologous	homologous	I-NP	I-NP	-	10	NMOD	-	-
10	serum	serum	I-NP	I-NP	-	7	PMOD	-	-
11	,	,	O	O	-	14	P	-	-
12	NF-kappa	NF-kappa	B-NP	B-NP	-	13	NMOD	-	-
13	B	B	I-NP	I-NP	-	14	SUB	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	strictly	strictly	I-VP	I-VP	-	14	VMOD	-	-
16	localized	localized	I-VP	I-VP	-	14	VC	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	20	NMOD	-	-
19	cell	cell	I-NP	I-NP	-	20	NMOD	-	-
20	cytoplasm	cytoplasm	I-NP	I-NP	-	17	PMOD	-	-
21	.	.	O	O	-	14	P	-	-

1	Treatment	Treatment	B-NP	B-NP	-	34	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	PAEC	PAEC	B-NP	B-NP	-	2	PMOD	-	-
4	exposed	exposed	B-VP	B-VP	-	3	NMOD	-	-
5	to	to	B-PP	B-PP	-	4	VMOD	-	-
6	xenogeneic	xenogeneic	B-NP	B-NP	-	7	NMOD	-	-
7	serum	serum	I-NP	I-NP	-	5	PMOD	-	-
8	with	with	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	NF-kappa	NF-kappa	I-NP	I-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	inhibitors	inhibitors	I-NP	I-NP	-	21	NMOD	-	-
13	pyrrolidinedithiocarbamate	pyrrolidinedithiocarbamate	B-NP	B-NP	-	18	NMOD	-	-
14	(	(	O	O	-	18	P	-	-
15	PDTC	PDTC	B-NP	B-NP	-	18	NMOD	-	-
16	,	,	O	O	-	18	P	-	-
17	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
18	microM	microM	I-NP	I-NP	-	12	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	tosyl-phechloromethylketone	tosyl-phechloromethylketone	B-NP	B-NP	-	8	PMOD	-	-
22	(	(	O	O	-	26	P	-	-
23	TPCK	TPCK	B-NP	B-NP	-	26	NMOD	-	-
24	,	,	O	O	-	26	P	-	-
25	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
26	microM	microM	I-NP	I-NP	-	21	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	significantly	significantly	B-ADVP	B-ADVP	-	34	VMOD	-	-
29	(	(	O	O	-	34	P	-	-
30	P	P	B-NP	B-NP	-	34	SUB	-	-
31	<	<	O	O	-	30	NMOD	-	-
32	<num>	<num>	B-NP	B-NP	-	31	AMOD	-	-
33	)	)	O	O	-	30	P	-	-
34	reduced	reduced	B-VP	B-VP	-	0	ROOT	-	-
35	leukocyte	leukocyte	B-NP	B-NP	-	36	NMOD	-	-
36	adhesion	adhesion	I-NP	I-NP	-	34	OBJ	-	-
37	in	in	B-PP	B-PP	-	36	NMOD	-	-
38	respect	respect	B-NP	B-NP	-	37	PMOD	-	-
39	to	to	B-PP	B-PP	-	34	VMOD	-	-
40	PAEC	PAEC	B-NP	B-NP	-	39	PMOD	-	-
41	treated	treated	B-VP	B-VP	-	40	NMOD	-	-
42	with	with	B-PP	B-PP	-	41	VMOD	-	-
43	human	human	B-NP	B-NP	-	44	NMOD	-	-
44	serum	serum	I-NP	I-NP	-	42	PMOD	-	-
45	alone	alone	B-ADVP	B-ADVP	-	44	NMOD	-	-
46	.	.	O	O	-	34	P	-	-

1	Findings	Findings	B-NP	B-NP	-	13	SUB	-	-
2	that	that	B-SBAR	B-SBAR	-	1	NMOD	-	-
3	xenogeneic	xenogeneic	B-NP	B-NP	-	4	NMOD	-	-
4	serum	serum	I-NP	I-NP	-	5	SUB	-	-
5	promotes	promotes	B-VP	B-VP	-	2	SBAR	-	-
6	leukocyte-endothelium	leukocyte-endothelium	B-NP	B-NP	-	7	NMOD	-	-
7	interaction	interaction	I-NP	I-NP	-	5	OBJ	-	-
8	possibly	possibly	B-ADVP	B-ADVP	-	5	VMOD	-	-
9	through	through	B-PP	B-PP	-	5	VMOD	-	-
10	NF-kappa	NF-kappa	B-NP	B-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	9	PMOD	-	-
13	might	might	B-VP	B-VP	-	0	ROOT	-	-
14	be	be	I-VP	I-VP	-	13	VC	-	-
15	relevant	relevant	B-ADJP	B-ADJP	-	14	PRD	-	-
16	for	for	B-PP	B-PP	-	15	AMOD	-	-
17	designing	designing	B-VP	B-VP	-	16	PMOD	-	-
18	future	future	B-NP	B-NP	-	20	NMOD	-	-
19	therapeutic	therapeutic	I-NP	I-NP	-	20	NMOD	-	-
20	strategies	strategies	I-NP	I-NP	-	17	OBJ	-	-
21	aimed	aimed	B-VP	B-VP	-	20	NMOD	-	-
22	at	at	B-PP	B-PP	-	21	VMOD	-	-
23	prolonging	prolonging	B-VP	B-VP	-	22	PMOD	-	-
24	xenograft	xenograft	B-NP	B-NP	-	25	NMOD	-	-
25	survival	survival	I-NP	I-NP	-	23	OBJ	-	-
26	.	.	O	O	-	13	P	-	-

1	IL-2-induced	IL-2-induced	B-NP	B-NP	-	2	NMOD	-	-
2	growth	growth	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	CD8+	CD8+	B-NP	B-NP	-	9	NMOD	-	-
5	T	T	I-NP	I-NP	-	9	NMOD	-	-
6	cell	cell	I-NP	I-NP	-	9	NMOD	-	-
7	prolymphocytic	prolymphocytic	I-NP	I-NP	-	9	NMOD	-	-
8	leukemia	leukemia	I-NP	I-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
10	mediated	mediated	B-VP	B-VP	-	9	NMOD	-	-
11	by	by	B-PP	B-PP	-	10	VMOD	-	-
12	NF-kappaB	NF-kappaB	B-NP	B-NP	-	13	NMOD	-	-
13	induction	induction	I-NP	I-NP	-	11	PMOD	-	-
14	and	and	O	O	-	18	NMOD	-	-
15	IL-2	IL-2	B-NP	B-NP	-	18	NMOD	-	-
16	receptor	receptor	I-NP	I-NP	-	18	NMOD	-	-
17	alpha	alpha	I-NP	I-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	11	PMOD	-	-
19	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	binding	binding	I-NP	I-NP	-	15	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	interleukin-2	interleukin-2	B-NP	B-NP	-	3	PMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	IL-2	IL-2	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	to	to	B-PP	B-PP	-	2	NMOD	-	-
9	its	its	B-NP	B-NP	-	10	NMOD	-	-
10	receptor	receptor	I-NP	I-NP	-	8	PMOD	-	-
11	on	on	B-PP	B-PP	-	10	NMOD	-	-
12	normal	normal	B-NP	B-NP	-	14	NMOD	-	-
13	T	T	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
15	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
16	nuclear	nuclear	B-NP	B-NP	-	17	NMOD	-	-
17	expression	expression	I-NP	I-NP	-	15	OBJ	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	nuclear	nuclear	B-NP	B-NP	-	21	NMOD	-	-
20	factor	factor	I-NP	I-NP	-	21	NMOD	-	-
21	kappaB	kappaB	I-NP	I-NP	-	26	NMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	NF-kappaB	NF-kappaB	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	,	,	O	O	-	26	P	-	-
26	activation	activation	B-NP	B-NP	-	18	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	the	the	B-NP	B-NP	-	36	NMOD	-	-
29	IL-2	IL-2	I-NP	I-NP	-	30	NMOD	-	-
30	receptor	receptor	I-NP	I-NP	-	36	NMOD	-	-
31	(	(	O	O	-	36	P	-	-
32	IL-2R	IL-2R	B-NP	B-NP	-	36	NMOD	-	-
33	)	)	O	O	-	36	P	-	-
34	alpha	alpha	B-NP	B-NP	-	36	NMOD	-	-
35	chain	chain	I-NP	I-NP	-	36	NMOD	-	-
36	gene	gene	I-NP	I-NP	-	40	NMOD	-	-
37	,	,	O	O	-	40	P	-	-
38	and	and	O	O	-	40	NMOD	-	-
39	cell	cell	B-NP	B-NP	-	40	NMOD	-	-
40	proliferation	proliferation	I-NP	I-NP	-	27	PMOD	-	-
41	.	.	O	O	-	15	P	-	-

1	In	In	B-PP	B-PP	-	24	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	present	present	I-NP	I-NP	-	4	NMOD	-	-
4	study	study	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	24	P	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	role	role	I-NP	I-NP	-	24	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	IL-2R	IL-2R	B-NP	B-NP	-	10	NMOD	-	-
10	signaling	signaling	I-NP	I-NP	-	8	PMOD	-	-
11	in	in	B-PP	B-PP	-	7	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	growth	growth	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	CD8+	CD8+	B-NP	B-NP	-	19	NMOD	-	-
16	T	T	I-NP	I-NP	-	19	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	19	NMOD	-	-
18	prolymphocytic	prolymphocytic	I-NP	I-NP	-	19	NMOD	-	-
19	leukemia	leukemia	I-NP	I-NP	-	23	NMOD	-	-
20	(	(	I-NP	I-NP	-	21	P	-	-
21	T-PLL	T-PLL	I-NP	I-NP	-	19	NMOD	-	-
22	)	)	I-NP	I-NP	-	21	P	-	-
23	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
24	has	has	B-VP	B-VP	-	0	ROOT	-	-
25	been	been	I-VP	I-VP	-	24	VC	-	-
26	investigated	investigated	I-VP	I-VP	-	25	VC	-	-
27	.	.	O	O	-	24	P	-	-

1	Flow	Flow	B-NP	B-NP	-	2	NMOD	-	-
2	cytometry	cytometry	I-NP	I-NP	-	3	SUB	-	-
3	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	primary	primary	B-NP	B-NP	-	7	NMOD	-	-
6	leukemia	leukemia	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	14	SUB	-	-
8	from	from	B-PP	B-PP	-	7	NMOD	-	-
9	a	a	B-NP	B-NP	-	10	NMOD	-	-
10	patient	patient	I-NP	I-NP	-	8	PMOD	-	-
11	with	with	B-PP	B-PP	-	10	NMOD	-	-
12	CD8+	CD8+	B-NP	B-NP	-	13	NMOD	-	-
13	T-PLL	T-PLL	I-NP	I-NP	-	11	PMOD	-	-
14	expressed	expressed	B-VP	B-VP	-	4	SBAR	-	-
15	IL-2Ralpha	IL-2Ralpha	B-NP	B-NP	-	17	NMOD	-	-
16	and	and	I-NP	I-NP	-	17	NMOD	-	-
17	beta	beta	I-NP	I-NP	-	18	NMOD	-	-
18	chains	chains	I-NP	I-NP	-	14	OBJ	-	-
19	,	,	O	O	-	23	P	-	-
20	and	and	O	O	-	23	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	23	SUB	-	-
23	showed	showed	B-VP	B-VP	-	4	SBAR	-	-
24	a	a	B-NP	B-NP	-	26	NMOD	-	-
25	proliferative	proliferative	I-NP	I-NP	-	26	NMOD	-	-
26	response	response	I-NP	I-NP	-	29	NMOD	-	-
27	and	and	O	O	-	29	NMOD	-	-
28	an	an	B-NP	B-NP	-	29	NMOD	-	-
29	increase	increase	I-NP	I-NP	-	23	OBJ	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	IL-2Ralpha	IL-2Ralpha	B-NP	B-NP	-	32	NMOD	-	-
32	expression	expression	I-NP	I-NP	-	30	PMOD	-	-
33	on	on	B-PP	B-PP	-	29	NMOD	-	-
34	culture	culture	B-NP	B-NP	-	33	PMOD	-	-
35	with	with	B-PP	B-PP	-	34	NMOD	-	-
36	exogeneous	exogeneous	B-NP	B-NP	-	37	NMOD	-	-
37	IL-2	IL-2	I-NP	I-NP	-	35	PMOD	-	-
38	.	.	O	O	-	3	P	-	-

1	Northern	Northern	B-NP	B-NP	-	3	NMOD	-	-
2	blot	blot	I-NP	I-NP	-	3	NMOD	-	-
3	analysis	analysis	I-NP	I-NP	-	4	SUB	-	-
4	failed	failed	B-VP	B-VP	-	0	ROOT	-	-
5	to	to	I-VP	I-VP	-	6	VMOD	-	-
6	detect	detect	I-VP	I-VP	-	4	VMOD	-	-
7	IL-2	IL-2	B-NP	B-NP	-	8	NMOD	-	-
8	mRNA	mRNA	I-NP	I-NP	-	6	OBJ	-	-
9	,	,	O	O	-	4	P	-	-
10	suggesting	suggesting	B-VP	B-VP	-	4	VMOD	-	-
11	that	that	B-SBAR	B-SBAR	-	10	VMOD	-	-
12	IL-2	IL-2	B-NP	B-NP	-	13	SUB	-	-
13	may	may	B-VP	B-VP	-	11	SBAR	-	-
14	act	act	I-VP	I-VP	-	13	VC	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	a	a	B-NP	B-NP	-	18	NMOD	-	-
17	paracrine	paracrine	I-NP	I-NP	-	18	NMOD	-	-
18	manner	manner	I-NP	I-NP	-	15	PMOD	-	-
19	in	in	B-ADVP	B-ADVP	-	14	VMOD	-	-
20	vivo	vivo	I-ADVP	I-ADVP	-	19	AMOD	-	-
21	.	.	O	O	-	4	P	-	-

1	Electrophoretic	Electrophoretic	B-NP	B-NP	-	3	NMOD	-	-
2	mobility-shift	mobility-shift	I-NP	I-NP	-	3	NMOD	-	-
3	assays	assays	I-NP	I-NP	-	4	SUB	-	-
4	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	recombinant	recombinant	B-NP	B-NP	-	7	NMOD	-	-
7	IL-2	IL-2	I-NP	I-NP	-	8	SUB	-	-
8	increased	increased	B-VP	B-VP	-	24	VMOD	-	-
9	NF-kappaB	NF-kappaB	B-NP	B-NP	-	11	NMOD	-	-
10	binding	binding	I-NP	I-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	8	OBJ	-	-
12	in	in	B-PP	B-PP	-	8	VMOD	-	-
13	nuclear	nuclear	B-NP	B-NP	-	14	NMOD	-	-
14	extracts	extracts	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	leukemia	leukemia	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
19	,	,	O	O	-	24	P	-	-
20	and	and	O	O	-	23	NMOD	-	-
21	Northern	Northern	B-NP	B-NP	-	23	NMOD	-	-
22	blot	blot	I-NP	I-NP	-	23	NMOD	-	-
23	analysis	analysis	I-NP	I-NP	-	24	SUB	-	-
24	showed	showed	B-VP	B-VP	-	5	SBAR	-	-
25	that	that	B-SBAR	B-SBAR	-	24	VMOD	-	-
26	IL-2	IL-2	B-NP	B-NP	-	27	SUB	-	-
27	increased	increased	B-VP	B-VP	-	25	SBAR	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	abundance	abundance	I-NP	I-NP	-	27	OBJ	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	mRNAs	mRNAs	B-NP	B-NP	-	30	PMOD	-	-
32	encoding	encoding	B-VP	B-VP	-	31	NMOD	-	-
33	the	the	B-NP	B-NP	-	35	NMOD	-	-
34	NF-kappaB	NF-kappaB	I-NP	I-NP	-	35	NMOD	-	-
35	components	components	I-NP	I-NP	-	38	NMOD	-	-
36	c-Rel	c-Rel	I-NP	I-NP	-	38	NMOD	-	-
37	and	and	I-NP	I-NP	-	38	NMOD	-	-
38	KBF1	KBF1	I-NP	I-NP	-	32	OBJ	-	-
39	in	in	B-PP	B-PP	-	27	VMOD	-	-
40	these	these	B-NP	B-NP	-	41	NMOD	-	-
41	cells	cells	I-NP	I-NP	-	39	PMOD	-	-
42	.	.	O	O	-	4	P	-	-

1	IL-2	IL-2	B-NP	B-NP	-	3	NMOD	-	-
2	binding	binding	I-NP	I-NP	-	3	NMOD	-	-
3	analysis	analysis	I-NP	I-NP	-	4	SUB	-	-
4	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	IL-2	IL-2	B-NP	B-NP	-	8	SUB	-	-
7	markedly	markedly	B-ADVP	B-ADVP	-	8	VMOD	-	-
8	increased	increased	B-VP	B-VP	-	5	SBAR	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	number	number	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	low	low	B-NP	B-NP	-	14	NMOD	-	-
13	affinity	affinity	I-NP	I-NP	-	14	NMOD	-	-
14	IL-2Rs	IL-2Rs	I-NP	I-NP	-	11	PMOD	-	-
15	on	on	B-PP	B-PP	-	8	VMOD	-	-
16	the	the	B-NP	B-NP	-	18	NMOD	-	-
17	leukemia	leukemia	I-NP	I-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
19	,	,	O	O	-	8	P	-	-
20	without	without	B-PP	B-PP	-	8	VMOD	-	-
21	an	an	B-NP	B-NP	-	22	NMOD	-	-
22	effect	effect	I-NP	I-NP	-	20	PMOD	-	-
23	on	on	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	number	number	I-NP	I-NP	-	23	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	high-affinity	high-affinity	B-NP	B-NP	-	28	NMOD	-	-
28	IL-2Rs	IL-2Rs	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	4	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	22	DEP	-	-
5	IL-2	IL-2	B-NP	B-NP	-	6	SUB	-	-
6	is	is	B-VP	B-VP	-	4	SBAR	-	-
7	capable	capable	B-ADJP	B-ADJP	-	6	PRD	-	-
8	of	of	B-PP	B-PP	-	7	AMOD	-	-
9	inducing	inducing	B-VP	B-VP	-	8	PMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	nuclear	nuclear	I-NP	I-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	9	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	NF-kappaB	NF-kappaB	B-NP	B-NP	-	13	PMOD	-	-
15	in	in	B-PP	B-PP	-	12	NMOD	-	-
16	primary	primary	B-NP	B-NP	-	19	NMOD	-	-
17	CD8+	CD8+	I-NP	I-NP	-	19	NMOD	-	-
18	T-PLL	T-PLL	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
20	,	,	O	O	-	22	P	-	-
21	and	and	O	O	-	22	DEP	-	-
22	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
23	this	this	B-NP	B-NP	-	24	NMOD	-	-
24	effect	effect	I-NP	I-NP	-	25	SUB	-	-
25	is	is	B-VP	B-VP	-	22	SBAR	-	-
26	mediated	mediated	I-VP	I-VP	-	25	VC	-	-
27	,	,	O	O	-	26	P	-	-
28	at	at	B-ADVP	B-ADVP	-	30	PMOD	-	-
29	least	least	I-ADVP	I-ADVP	-	28	AMOD	-	-
30	in	in	B-PP	B-PP	-	26	VMOD	-	-
31	part	part	B-NP	B-NP	-	30	PMOD	-	-
32	,	,	O	O	-	26	P	-	-
33	at	at	B-PP	B-PP	-	26	VMOD	-	-
34	a	a	B-NP	B-NP	-	36	NMOD	-	-
35	pretranslational	pretranslational	I-NP	I-NP	-	36	NMOD	-	-
36	level	level	I-NP	I-NP	-	33	PMOD	-	-
37	.	.	O	O	-	3	P	-	-

1	Molecular	Molecular	B-NP	B-NP	-	4	NMOD	-	-
2	and	and	I-NP	I-NP	-	4	NMOD	-	-
3	cellular	cellular	I-NP	I-NP	-	4	NMOD	-	-
4	analysis	analysis	I-NP	I-NP	-	0	ROOT	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	human	human	B-NP	B-NP	-	9	NMOD	-	-
7	immunodeficiency	immunodeficiency	I-NP	I-NP	-	9	NMOD	-	-
8	virus-induced	virus-induced	I-NP	I-NP	-	9	NMOD	-	-
9	apoptosis	apoptosis	I-NP	I-NP	-	5	PMOD	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	lymphoblastoid	lymphoblastoid	B-NP	B-NP	-	17	NMOD	-	-
12	T-cell-line-expressing	T-cell-line-expressing	I-NP	I-NP	-	17	NMOD	-	-
13	wild-type	wild-type	I-NP	I-NP	-	17	NMOD	-	-
14	and	and	I-NP	I-NP	-	17	NMOD	-	-
15	mutated	mutated	I-NP	I-NP	-	17	NMOD	-	-
16	CD4	CD4	I-NP	I-NP	-	17	NMOD	-	-
17	receptors	receptors	I-NP	I-NP	-	10	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	previously	previously	I-VP	I-VP	-	2	VMOD	-	-
4	shown	shown	I-VP	I-VP	-	2	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	presence	presence	I-NP	I-NP	-	13	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	CD4	CD4	I-NP	I-NP	-	12	NMOD	-	-
11	cytoplasmic	cytoplasmic	I-NP	I-NP	-	12	NMOD	-	-
12	tail	tail	I-NP	I-NP	-	8	PMOD	-	-
13	is	is	B-VP	B-VP	-	5	SBAR	-	-
14	critical	critical	B-ADJP	B-ADJP	-	13	PRD	-	-
15	for	for	B-PP	B-PP	-	14	AMOD	-	-
16	human	human	B-NP	B-NP	-	18	NMOD	-	-
17	immunodeficiency	immunodeficiency	I-NP	I-NP	-	18	NMOD	-	-
18	virus	virus	I-NP	I-NP	-	23	NMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	HIV	HIV	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	-induced	-induced	B-NP	B-NP	-	23	NMOD	-	-
23	apoptosis	apoptosis	I-NP	I-NP	-	15	PMOD	-	-
24	(	(	O	O	-	36	P	-	-
25	J.Corbeil	J.Corbeil	B-NP	B-NP	-	30	NMOD	-	-
26	,	,	O	O	-	30	P	-	-
27	M.Tremblay	M.Tremblay	B-NP	B-NP	-	30	NMOD	-	-
28	,	,	O	O	-	30	P	-	-
29	and	and	O	O	-	30	NMOD	-	-
30	D.D.Richman	D.D.Richman	B-NP	B-NP	-	36	NMOD	-	-
31	,	,	O	O	-	36	P	-	-
32	J.Exp.Med.183	J.Exp.Med.183	B-NP	B-NP	-	36	NMOD	-	-
33	:	:	O	O	-	36	P	-	-
34	39-48	39-48	B-NP	B-NP	-	36	NMOD	-	-
35	,	,	I-NP	I-NP	-	36	P	-	-
36	<num>	<num>	I-NP	I-NP	-	23	NMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	pursued	pursued	I-VP	I-VP	-	2	VC	-	-
4	our	our	B-NP	B-NP	-	5	NMOD	-	-
5	investigation	investigation	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	role	role	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	CD4	CD4	I-NP	I-NP	-	13	NMOD	-	-
12	transduction	transduction	I-NP	I-NP	-	13	NMOD	-	-
13	pathway	pathway	I-NP	I-NP	-	9	PMOD	-	-
14	in	in	B-PP	B-PP	-	8	NMOD	-	-
15	HIV-induced	HIV-induced	B-NP	B-NP	-	16	NMOD	-	-
16	apoptosis	apoptosis	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	2	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	do	do	I-VP	I-VP	-	14	VMOD	-	-
3	this	this	B-NP	B-NP	-	2	OBJ	-	-
4	,	,	O	O	-	14	P	-	-
5	wild-type	wild-type	B-NP	B-NP	-	8	NMOD	-	-
6	and	and	I-NP	I-NP	-	8	NMOD	-	-
7	mutant	mutant	I-NP	I-NP	-	8	NMOD	-	-
8	forms	forms	I-NP	I-NP	-	14	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	CD4	CD4	I-NP	I-NP	-	13	NMOD	-	-
12	cytoplasmic	cytoplasmic	I-NP	I-NP	-	13	NMOD	-	-
13	tail	tail	I-NP	I-NP	-	9	PMOD	-	-
14	were	were	B-VP	B-VP	-	0	ROOT	-	-
15	stably	stably	I-VP	I-VP	-	14	VMOD	-	-
16	expressed	expressed	I-VP	I-VP	-	14	VC	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	the	the	B-NP	B-NP	-	22	NMOD	-	-
19	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	22	NMOD	-	-
20	T-cell	T-cell	I-NP	I-NP	-	22	NMOD	-	-
21	line	line	I-NP	I-NP	-	22	NMOD	-	-
22	A2.01	A2.01	I-NP	I-NP	-	17	PMOD	-	-
23	.	.	O	O	-	14	P	-	-

1	Apoptosis	Apoptosis	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	prevented	prevented	I-VP	I-VP	-	2	VC	-	-
4	when	when	B-ADVP	B-ADVP	-	2	VMOD	-	-
5	CD4	CD4	B-NP	B-NP	-	10	SUB	-	-
6	truncated	truncated	B-VP	B-VP	-	5	NMOD	-	-
7	at	at	B-PP	B-PP	-	6	VMOD	-	-
8	residue	residue	B-NP	B-NP	-	7	PMOD	-	-
9	<num>	<num>	I-NP	I-NP	-	8	NMOD	-	-
10	was	was	B-VP	B-VP	-	4	SBAR	-	-
11	expressed	expressed	I-VP	I-VP	-	10	VC	-	-
12	;	;	O	O	-	2	P	-	-
13	however	however	B-ADVP	B-ADVP	-	2	VMOD	-	-
14	,	,	O	O	-	2	P	-	-
15	cells	cells	B-NP	B-NP	-	2	PRD	-	-
16	expressing	expressing	B-VP	B-VP	-	15	NMOD	-	-
17	mutated	mutated	B-NP	B-NP	-	18	NMOD	-	-
18	receptors	receptors	I-NP	I-NP	-	16	OBJ	-	-
19	that	that	B-NP	B-NP	-	18	NMOD	-	-
20	do	do	B-VP	B-VP	-	19	SBAR	-	-
21	not	not	I-VP	I-VP	-	20	VMOD	-	-
22	associate	associate	I-VP	I-VP	-	20	VC	-	-
23	with	with	B-PP	B-PP	-	22	VMOD	-	-
24	p56	p56	B-NP	B-NP	-	23	PMOD	-	-
25	(	(	O	O	-	26	P	-	-
26	lck	lck	B-NP	B-NP	-	24	NMOD	-	-
27	)	)	O	O	-	26	P	-	-
28	(	(	O	O	-	24	P	-	-
29	mutated	mutated	B-VP	B-VP	-	20	VC	-	-
30	at	at	B-PP	B-PP	-	29	VMOD	-	-
31	the	the	B-NP	B-NP	-	33	NMOD	-	-
32	dicysteine	dicysteine	I-NP	I-NP	-	33	NMOD	-	-
33	motif	motif	I-NP	I-NP	-	30	PMOD	-	-
34	and	and	O	O	-	33	DEP	-	-
35	truncated	truncated	B-VP	B-VP	-	33	NMOD	-	-
36	at	at	B-PP	B-PP	-	35	VMOD	-	-
37	residue	residue	B-NP	B-NP	-	36	PMOD	-	-
38	<num>	<num>	I-NP	I-NP	-	37	NMOD	-	-
39	)	)	O	O	-	33	P	-	-
40	but	but	O	O	-	33	NMOD	-	-
41	which	which	B-NP	B-NP	-	33	NMOD	-	-
42	conserved	conserved	B-VP	B-VP	-	41	SBAR	-	-
43	proximal	proximal	B-NP	B-NP	-	44	NMOD	-	-
44	domains	domains	I-NP	I-NP	-	42	OBJ	-	-
45	of	of	B-PP	B-PP	-	44	NMOD	-	-
46	the	the	B-NP	B-NP	-	48	NMOD	-	-
47	cytoplasmic	cytoplasmic	I-NP	I-NP	-	48	NMOD	-	-
48	tail	tail	I-NP	I-NP	-	45	PMOD	-	-
49	underwent	underwent	B-VP	B-VP	-	42	VMOD	-	-
50	apoptosis	apoptosis	B-NP	B-NP	-	49	OBJ	-	-
51	like	like	B-PP	B-PP	-	49	VMOD	-	-
52	wild-	wild-	B-NP	B-NP	-	54	NMOD	-	-
53	type	type	I-NP	I-NP	-	54	NMOD	-	-
54	CD4	CD4	I-NP	I-NP	-	51	PMOD	-	-
55	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	differences	differences	I-NP	I-NP	-	13	SUB	-	-
3	between	between	B-PP	B-PP	-	2	NMOD	-	-
4	wild-type	wild-type	B-NP	B-NP	-	7	NMOD	-	-
5	and	and	I-NP	I-NP	-	7	NMOD	-	-
6	mutated	mutated	I-NP	I-NP	-	7	NMOD	-	-
7	receptors	receptors	I-NP	I-NP	-	3	PMOD	-	-
8	in	in	B-PP	B-PP	-	2	NMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	induction	induction	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	apoptosis	apoptosis	B-NP	B-NP	-	11	PMOD	-	-
13	were	were	B-VP	B-VP	-	0	ROOT	-	-
14	not	not	O	O	-	13	VMOD	-	-
15	related	related	B-ADJP	B-ADJP	-	13	PRD	-	-
16	to	to	B-PP	B-PP	-	15	AMOD	-	-
17	levels	levels	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	p56	p56	B-NP	B-NP	-	26	NMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	lck	lck	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	or	or	O	O	-	26	NMOD	-	-
24	NF-	NF-	B-NP	B-NP	-	26	NMOD	-	-
25	kappaB	kappaB	I-NP	I-NP	-	26	NMOD	-	-
26	activation	activation	I-NP	I-NP	-	18	PMOD	-	-
27	.	.	O	O	-	13	P	-	-

1	Initial	Initial	B-NP	B-NP	-	2	NMOD	-	-
2	signaling	signaling	I-NP	I-NP	-	7	SUB	-	-
3	through	through	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	CD4	CD4	I-NP	I-NP	-	6	NMOD	-	-
6	receptor	receptor	I-NP	I-NP	-	3	PMOD	-	-
7	played	played	B-VP	B-VP	-	0	ROOT	-	-
8	a	a	B-NP	B-NP	-	10	NMOD	-	-
9	major	major	I-NP	I-NP	-	10	NMOD	-	-
10	role	role	I-NP	I-NP	-	7	OBJ	-	-
11	in	in	B-PP	B-PP	-	7	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	sensitization	sensitization	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	HIV-infected	HIV-infected	B-NP	B-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	to	to	B-VP	B-VP	-	19	VMOD	-	-
19	undergo	undergo	I-VP	I-VP	-	13	NMOD	-	-
20	apoptosis	apoptosis	B-NP	B-NP	-	19	OBJ	-	-
21	.	.	O	O	-	7	P	-	-

1	Incubation	Incubation	B-NP	B-NP	-	27	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	HIV-infected	HIV-infected	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	with	with	B-PP	B-PP	-	1	NMOD	-	-
6	monoclonal	monoclonal	B-NP	B-NP	-	7	NMOD	-	-
7	antibody	antibody	I-NP	I-NP	-	5	PMOD	-	-
8	(	(	O	O	-	9	P	-	-
9	MAb	MAb	B-NP	B-NP	-	7	NMOD	-	-
10	)	)	O	O	-	9	P	-	-
11	13B8-2	13B8-2	B-NP	B-NP	-	7	NMOD	-	-
12	,	,	O	O	-	7	P	-	-
13	which	which	B-NP	B-NP	-	7	NMOD	-	-
14	binds	binds	B-VP	B-VP	-	13	SBAR	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	CD4	CD4	B-NP	B-NP	-	15	PMOD	-	-
17	in	in	B-PP	B-PP	-	14	VMOD	-	-
18	a	a	B-NP	B-NP	-	19	NMOD	-	-
19	region	region	I-NP	I-NP	-	17	PMOD	-	-
20	critical	critical	B-ADJP	B-ADJP	-	19	NMOD	-	-
21	for	for	B-PP	B-PP	-	20	AMOD	-	-
22	dimerization	dimerization	B-NP	B-NP	-	21	PMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	the	the	B-NP	B-NP	-	25	NMOD	-	-
25	receptor	receptor	I-NP	I-NP	-	23	PMOD	-	-
26	,	,	O	O	-	7	P	-	-
27	prevented	prevented	B-VP	B-VP	-	0	ROOT	-	-
28	apoptosis	apoptosis	B-NP	B-NP	-	27	OBJ	-	-
29	without	without	B-PP	B-PP	-	27	VMOD	-	-
30	inhibiting	inhibiting	B-VP	B-VP	-	29	PMOD	-	-
31	HIV	HIV	B-NP	B-NP	-	32	NMOD	-	-
32	replication	replication	I-NP	I-NP	-	30	OBJ	-	-
33	.	.	O	O	-	27	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	6	VMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	apoptotic	apoptotic	I-NP	I-NP	-	5	NMOD	-	-
5	process	process	I-NP	I-NP	-	6	SUB	-	-
6	was	was	B-VP	B-VP	-	23	VMOD	-	-
7	not	not	O	O	-	6	VMOD	-	-
8	related	related	B-ADJP	B-ADJP	-	6	PRD	-	-
9	to	to	B-PP	B-PP	-	8	AMOD	-	-
10	Fas-Fas	Fas-Fas	B-NP	B-NP	-	12	NMOD	-	-
11	ligand	ligand	I-NP	I-NP	-	12	NMOD	-	-
12	interaction	interaction	I-NP	I-NP	-	9	PMOD	-	-
13	;	;	O	O	-	6	P	-	-
14	however	however	B-ADVP	B-ADVP	-	23	VMOD	-	-
15	,	,	O	O	-	23	P	-	-
16	an	an	B-NP	B-NP	-	19	NMOD	-	-
17	antagonistic	antagonistic	I-NP	I-NP	-	19	NMOD	-	-
18	anti-Fas	anti-Fas	I-NP	I-NP	-	19	NMOD	-	-
19	MAb	MAb	I-NP	I-NP	-	23	SUB	-	-
20	(	(	O	O	-	21	P	-	-
21	ZB-4	ZB-4	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	enhanced	enhanced	B-VP	B-VP	-	0	ROOT	-	-
24	apoptosis	apoptosis	B-NP	B-NP	-	23	OBJ	-	-
25	in	in	B-PP	B-PP	-	24	NMOD	-	-
26	HIV-infected	HIV-infected	B-NP	B-NP	-	27	NMOD	-	-
27	cells	cells	I-NP	I-NP	-	25	PMOD	-	-
28	without	without	B-PP	B-PP	-	23	VMOD	-	-
29	inducing	inducing	B-VP	B-VP	-	28	PMOD	-	-
30	apoptosis	apoptosis	B-NP	B-NP	-	29	OBJ	-	-
31	in	in	B-PP	B-PP	-	29	VMOD	-	-
32	uninfected	uninfected	B-NP	B-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	31	PMOD	-	-
34	.	.	O	O	-	23	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	observations	observations	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	CD4	CD4	B-NP	B-NP	-	6	NMOD	-	-
6	signaling	signaling	I-NP	I-NP	-	7	SUB	-	-
7	mediates	mediates	B-VP	B-VP	-	4	SBAR	-	-
8	HIV-induced	HIV-induced	B-NP	B-NP	-	9	NMOD	-	-
9	apoptosis	apoptosis	I-NP	I-NP	-	7	OBJ	-	-
10	by	by	B-PP	B-PP	-	7	VMOD	-	-
11	a	a	B-NP	B-NP	-	12	NMOD	-	-
12	mechanism	mechanism	I-NP	I-NP	-	10	PMOD	-	-
13	independent	independent	B-ADJP	B-ADJP	-	12	NMOD	-	-
14	of	of	B-PP	B-PP	-	13	AMOD	-	-
15	Fas-Fas	Fas-Fas	B-NP	B-NP	-	17	NMOD	-	-
16	ligand	ligand	I-NP	I-NP	-	17	NMOD	-	-
17	interaction	interaction	I-NP	I-NP	-	14	PMOD	-	-
18	,	,	O	O	-	7	P	-	-
19	does	does	B-VP	B-VP	-	7	VMOD	-	-
20	not	not	I-VP	I-VP	-	19	VMOD	-	-
21	require	require	I-VP	I-VP	-	19	VC	-	-
22	p56	p56	B-NP	B-NP	-	26	NMOD	-	-
23	(	(	O	O	-	24	P	-	-
24	lck	lck	B-NP	B-NP	-	22	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	signaling	signaling	B-NP	B-NP	-	21	OBJ	-	-
27	,	,	O	O	-	19	P	-	-
28	and	and	O	O	-	7	VMOD	-	-
29	may	may	B-VP	B-VP	-	7	VMOD	-	-
30	involve	involve	I-VP	I-VP	-	29	VC	-	-
31	a	a	B-NP	B-NP	-	33	NMOD	-	-
32	critical	critical	I-NP	I-NP	-	33	NMOD	-	-
33	region	region	I-NP	I-NP	-	30	OBJ	-	-
34	for	for	B-PP	B-PP	-	33	NMOD	-	-
35	CD4	CD4	B-NP	B-NP	-	36	NMOD	-	-
36	dimerization	dimerization	I-NP	I-NP	-	34	PMOD	-	-
37	.	.	O	O	-	3	P	-	-

1	NF-kappaB	NF-kappaB	B-NP	B-NP	-	4	SUB	-	-
2	only	only	B-ADVP	B-ADVP	-	4	VMOD	-	-
3	partially	partially	B-VP	B-VP	-	2	AMOD	-	-
4	mediates	mediates	I-VP	I-VP	-	0	ROOT	-	-
5	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	9	NMOD	-	-
6	virus	virus	I-NP	I-NP	-	9	NMOD	-	-
7	latent	latent	I-NP	I-NP	-	9	NMOD	-	-
8	membrane	membrane	I-NP	I-NP	-	9	NMOD	-	-
9	protein	protein	I-NP	I-NP	-	11	NMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
11	activation	activation	I-NP	I-NP	-	4	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	B	B	B-NP	B-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	latent	latent	I-NP	I-NP	-	4	NMOD	-	-
3	membrane	membrane	I-NP	I-NP	-	4	NMOD	-	-
4	protein	protein	I-NP	I-NP	-	15	SUB	-	-
5	<num>	<num>	I-NP	I-NP	-	4	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	LMP1	LMP1	B-NP	B-NP	-	4	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	of	of	B-PP	B-PP	-	4	NMOD	-	-
10	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	11	NMOD	-	-
11	virus	virus	I-NP	I-NP	-	9	PMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	EBV	EBV	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	is	is	B-VP	B-VP	-	0	ROOT	-	-
16	required	required	I-VP	I-VP	-	15	VC	-	-
17	for	for	B-PP	B-PP	-	16	VMOD	-	-
18	EBV-induced	EBV-induced	B-NP	B-NP	-	19	NMOD	-	-
19	immortalization	immortalization	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	human	human	B-NP	B-NP	-	23	NMOD	-	-
22	B	B	I-NP	I-NP	-	23	NMOD	-	-
23	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
24	and	and	O	O	-	15	VMOD	-	-
25	causes	causes	B-VP	B-VP	-	15	VMOD	-	-
26	tumorigenic	tumorigenic	B-NP	B-NP	-	27	NMOD	-	-
27	transformation	transformation	I-NP	I-NP	-	25	OBJ	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	cell	cell	B-NP	B-NP	-	30	NMOD	-	-
30	lines	lines	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	15	P	-	-

1	LMP1	LMP1	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	3	SUB	-	-
3	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
4	phenotypic	phenotypic	B-NP	B-NP	-	5	NMOD	-	-
5	changes	changes	I-NP	I-NP	-	3	OBJ	-	-
6	resembling	resembling	B-VP	B-VP	-	5	NMOD	-	-
7	B	B	B-NP	B-NP	-	9	NMOD	-	-
8	cell	cell	I-NP	I-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	6	OBJ	-	-
10	,	,	O	O	-	9	P	-	-
11	such	such	B-PP	B-PP	-	12	PMOD	-	-
12	as	as	I-PP	I-PP	-	9	NMOD	-	-
13	cell	cell	B-NP	B-NP	-	15	NMOD	-	-
14	size	size	I-NP	I-NP	-	15	NMOD	-	-
15	increase	increase	I-NP	I-NP	-	17	NMOD	-	-
16	and	and	I-NP	I-NP	-	17	NMOD	-	-
17	up-regulation	up-regulation	I-NP	I-NP	-	12	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	cell	cell	B-NP	B-NP	-	22	NMOD	-	-
20	surface	surface	I-NP	I-NP	-	22	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	22	NMOD	-	-
22	markers	markers	I-NP	I-NP	-	18	PMOD	-	-
23	.	.	O	O	-	3	P	-	-

1	LMP1	LMP1	B-NP	B-NP	-	2	SUB	-	-
2	contains	contains	B-VP	B-VP	-	0	ROOT	-	-
3	two	two	B-NP	B-NP	-	4	NMOD	-	-
4	domains	domains	I-NP	I-NP	-	2	OBJ	-	-
5	that	that	B-NP	B-NP	-	4	NMOD	-	-
6	activate	activate	B-VP	B-VP	-	5	SBAR	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	transcription	transcription	I-NP	I-NP	-	10	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
10	NF-kappaB	NF-kappaB	I-NP	I-NP	-	12	NMOD	-	-
11	,	,	O	O	-	12	P	-	-
12	one	one	B-NP	B-NP	-	13	NMOD	-	-
13	through	through	B-PP	B-PP	-	6	VMOD	-	-
14	interactions	interactions	B-NP	B-NP	-	13	PMOD	-	-
15	with	with	B-PP	B-PP	-	14	NMOD	-	-
16	TRAF	TRAF	B-NP	B-NP	-	17	NMOD	-	-
17	proteins	proteins	I-NP	I-NP	-	20	NMOD	-	-
18	and	and	O	O	-	20	NMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	other	other	I-NP	I-NP	-	14	NMOD	-	-
21	with	with	B-PP	B-PP	-	20	AMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	TRADD	TRADD	I-NP	I-NP	-	24	NMOD	-	-
24	protein	protein	I-NP	I-NP	-	21	PMOD	-	-
25	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	purpose	purpose	I-NP	I-NP	-	7	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	6	NMOD	-	-
5	present	present	I-NP	I-NP	-	6	NMOD	-	-
6	study	study	I-NP	I-NP	-	3	PMOD	-	-
7	was	was	B-VP	B-VP	-	0	ROOT	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	investigate	investigate	I-VP	I-VP	-	7	VMOD	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	importance	importance	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	NF-kappaB	NF-kappaB	B-NP	B-NP	-	14	NMOD	-	-
14	induction	induction	I-NP	I-NP	-	12	PMOD	-	-
15	in	in	B-PP	B-PP	-	11	NMOD	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	up-regulation	up-regulation	I-NP	I-NP	-	15	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	23	NMOD	-	-
20	B	B	I-NP	I-NP	-	23	NMOD	-	-
21	cell	cell	I-NP	I-NP	-	23	NMOD	-	-
22	activation	activation	I-NP	I-NP	-	23	NMOD	-	-
23	markers	markers	I-NP	I-NP	-	26	NMOD	-	-
24	ICAM-1	ICAM-1	I-NP	I-NP	-	26	NMOD	-	-
25	and	and	I-NP	I-NP	-	26	NMOD	-	-
26	CD71	CD71	I-NP	I-NP	-	18	PMOD	-	-
27	by	by	B-PP	B-PP	-	17	NMOD	-	-
28	LMP1	LMP1	B-NP	B-NP	-	27	PMOD	-	-
29	.	.	O	O	-	7	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	study	study	I-NP	I-NP	-	3	SUB	-	-
3	shows	shows	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	18	DEP	-	-
5	expression	expression	B-NP	B-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	LMP1	LMP1	B-NP	B-NP	-	6	PMOD	-	-
8	activates	activates	B-VP	B-VP	-	4	SBAR	-	-
9	transcription	transcription	B-NP	B-NP	-	8	OBJ	-	-
10	from	from	B-PP	B-PP	-	9	NMOD	-	-
11	p50/p65-	p50/p65-	B-NP	B-NP	-	15	NMOD	-	-
12	and	and	I-NP	I-NP	-	15	NMOD	-	-
13	c-Rel-	c-Rel-	I-NP	I-NP	-	15	NMOD	-	-
14	responsive	responsive	I-NP	I-NP	-	15	NMOD	-	-
15	promoters	promoters	I-NP	I-NP	-	10	PMOD	-	-
16	,	,	O	O	-	18	P	-	-
17	and	and	O	O	-	18	DEP	-	-
18	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
19	this	this	B-NP	B-NP	-	20	NMOD	-	-
20	activity	activity	I-NP	I-NP	-	21	SUB	-	-
21	can	can	B-VP	B-VP	-	18	SBAR	-	-
22	be	be	I-VP	I-VP	-	21	VC	-	-
23	completely	completely	I-VP	I-VP	-	22	VMOD	-	-
24	inhibited	inhibited	I-VP	I-VP	-	22	VC	-	-
25	by	by	B-PP	B-PP	-	24	VMOD	-	-
26	expression	expression	B-NP	B-NP	-	25	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	a	a	B-NP	B-NP	-	32	NMOD	-	-
29	dominant	dominant	I-NP	I-NP	-	32	NMOD	-	-
30	inhibitory	inhibitory	I-NP	I-NP	-	32	NMOD	-	-
31	IkappaB	IkappaB	I-NP	I-NP	-	32	NMOD	-	-
32	mutant	mutant	I-NP	I-NP	-	27	PMOD	-	-
33	.	.	O	O	-	3	P	-	-

1	ICAM-1	ICAM-1	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	CD71	CD71	I-NP	I-NP	-	4	SUB	-	-
4	are	are	B-VP	B-VP	-	0	ROOT	-	-
5	nevertheless	nevertheless	I-VP	I-VP	-	4	VMOD	-	-
6	up-regulated	up-regulated	I-VP	I-VP	-	4	VC	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	LMP1	LMP1	B-NP	B-NP	-	7	PMOD	-	-
9	in	in	B-PP	B-PP	-	6	VMOD	-	-
10	primary	primary	B-NP	B-NP	-	12	NMOD	-	-
11	B	B	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	15	NMOD	-	-
13	and	and	O	O	-	15	NMOD	-	-
14	cell	cell	B-NP	B-NP	-	15	NMOD	-	-
15	lines	lines	I-NP	I-NP	-	9	PMOD	-	-
16	expressing	expressing	B-VP	B-VP	-	15	NMOD	-	-
17	the	the	B-NP	B-NP	-	19	NMOD	-	-
18	dominant	dominant	I-NP	I-NP	-	19	NMOD	-	-
19	IkappaB	IkappaB	I-NP	I-NP	-	16	OBJ	-	-
20	.	.	O	O	-	4	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	11	VMOD	-	-
2	,	,	O	O	-	11	P	-	-
3	LMP1-induced	LMP1-induced	B-NP	B-NP	-	6	NMOD	-	-
4	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
5	size	size	I-NP	I-NP	-	6	NMOD	-	-
6	increase	increase	I-NP	I-NP	-	11	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	primary	primary	B-NP	B-NP	-	10	NMOD	-	-
9	B	B	I-NP	I-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
11	was	was	B-VP	B-VP	-	0	ROOT	-	-
12	unaffected	unaffected	B-ADJP	B-ADJP	-	11	VC	-	-
13	by	by	B-PP	B-PP	-	12	VMOD	-	-
14	IkappaB	IkappaB	B-NP	B-NP	-	15	NMOD	-	-
15	expression	expression	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	11	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	concluded	concluded	I-VP	I-VP	-	2	VC	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	even	even	B-ADVP	B-ADVP	-	6	AMOD	-	-
6	when	when	I-ADVP	I-ADVP	-	3	VMOD	-	-
7	LMP1	LMP1	B-NP	B-NP	-	8	SUB	-	-
8	is	is	B-VP	B-VP	-	6	SBAR	-	-
9	unable	unable	B-ADJP	B-ADJP	-	8	PRD	-	-
10	to	to	B-VP	B-VP	-	11	VMOD	-	-
11	activate	activate	I-VP	I-VP	-	9	AMOD	-	-
12	NF-kappaB	NF-kappaB	B-NP	B-NP	-	11	OBJ	-	-
13	,	,	O	O	-	15	P	-	-
14	it	it	B-NP	B-NP	-	15	SUB	-	-
15	is	is	B-VP	B-VP	-	6	SBAR	-	-
16	still	still	B-ADVP	B-ADVP	-	15	VMOD	-	-
17	capable	capable	B-ADJP	B-ADJP	-	15	PRD	-	-
18	of	of	B-PP	B-PP	-	17	AMOD	-	-
19	inducing	inducing	B-VP	B-VP	-	18	PMOD	-	-
20	certain	certain	B-NP	B-NP	-	21	NMOD	-	-
21	characteristics	characteristics	I-NP	I-NP	-	19	OBJ	-	-
22	of	of	B-PP	B-PP	-	21	NMOD	-	-
23	activated	activated	B-NP	B-NP	-	25	NMOD	-	-
24	B	B	I-NP	I-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
26	,	,	O	O	-	15	P	-	-
27	strongly	strongly	B-VP	B-VP	-	28	VMOD	-	-
28	suggesting	suggesting	I-VP	I-VP	-	15	VMOD	-	-
29	that	that	B-SBAR	B-SBAR	-	28	VMOD	-	-
30	LMP1	LMP1	B-NP	B-NP	-	31	SUB	-	-
31	can	can	B-VP	B-VP	-	29	SBAR	-	-
32	also	also	I-VP	I-VP	-	31	VMOD	-	-
33	activate	activate	I-VP	I-VP	-	31	VC	-	-
34	cells	cells	B-NP	B-NP	-	33	OBJ	-	-
35	independently	independently	B-ADVP	B-ADVP	-	33	VMOD	-	-
36	of	of	B-PP	B-PP	-	35	AMOD	-	-
37	NF-kappaB	NF-kappaB	B-NP	B-NP	-	36	PMOD	-	-
38	.	.	O	O	-	2	P	-	-

1	Relationship	Relationship	B-NP	B-NP	-	0	ROOT	-	-
2	between	between	B-PP	B-PP	-	1	NMOD	-	-
3	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	5	NMOD	-	-
4	constitutive	constitutive	I-NP	I-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	11	NMOD	-	-
6	,	,	O	O	-	11	P	-	-
7	TNFalpha	TNFalpha	B-NP	B-NP	-	8	NMOD	-	-
8	synthesis	synthesis	I-NP	I-NP	-	11	NMOD	-	-
9	,	,	O	O	-	11	P	-	-
10	and	and	O	O	-	11	NMOD	-	-
11	apoptosis	apoptosis	B-NP	B-NP	-	2	PMOD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	EBV-infected	EBV-infected	B-NP	B-NP	-	15	NMOD	-	-
14	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	15	NMOD	-	-
15	cells	cells	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	1	P	-	-

1	In	In	B-SBAR	B-SBAR	-	13	VMOD	-	-
2	order	order	O	O	-	1	DEP	-	-
3	to	to	B-VP	B-VP	-	4	VMOD	-	-
4	understand	understand	I-VP	I-VP	-	1	SBAR	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappaB	NF-kappaB	B-NP	B-NP	-	7	PMOD	-	-
9	in	in	B-PP	B-PP	-	6	NMOD	-	-
10	EBV	EBV	B-NP	B-NP	-	11	NMOD	-	-
11	transformation	transformation	I-NP	I-NP	-	9	PMOD	-	-
12	we	we	B-NP	B-NP	-	13	SUB	-	-
13	have	have	B-VP	B-VP	-	0	ROOT	-	-
14	established	established	I-VP	I-VP	-	13	VC	-	-
15	stably	stably	B-NP	B-NP	-	16	AMOD	-	-
16	transfected	transfected	I-NP	I-NP	-	17	NMOD	-	-
17	IkappaBalpha	IkappaBalpha	I-NP	I-NP	-	14	OBJ	-	-
18	into	into	B-PP	B-PP	-	14	VMOD	-	-
19	lymphoblastoid	lymphoblastoid	B-NP	B-NP	-	20	NMOD	-	-
20	cells	cells	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	13	P	-	-

1	Two	Two	B-NP	B-NP	-	2	NMOD	-	-
2	clones	clones	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	obtained	obtained	I-VP	I-VP	-	3	VC	-	-
5	in	in	B-PP	B-PP	-	4	VMOD	-	-
6	which	which	B-NP	B-NP	-	5	PMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	loss	loss	I-NP	I-NP	-	13	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	NF-kappaB	NF-kappaB	B-NP	B-NP	-	12	NMOD	-	-
11	binding	binding	I-NP	I-NP	-	12	NMOD	-	-
12	activity	activity	I-NP	I-NP	-	9	PMOD	-	-
13	correlated	correlated	B-VP	B-VP	-	3	VMOD	-	-
14	with	with	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	constitutive	constitutive	I-NP	I-NP	-	17	NMOD	-	-
17	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	transgenic	transgenic	I-NP	I-NP	-	21	NMOD	-	-
21	IkappaBalpha	IkappaBalpha	I-NP	I-NP	-	18	PMOD	-	-
22	.	.	O	O	-	3	P	-	-

1	Protein	Protein	B-NP	B-NP	-	3	NMOD	-	-
2	latency	latency	I-NP	I-NP	-	3	NMOD	-	-
3	expression	expression	I-NP	I-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	determined	determined	I-VP	I-VP	-	4	VC	-	-
6	by	by	B-PP	B-PP	-	5	VMOD	-	-
7	immunocytochemistry	immunocytochemistry	B-NP	B-NP	-	6	PMOD	-	-
8	.	.	O	O	-	4	P	-	-

1	Expression	Expression	B-NP	B-NP	-	22	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	surface	surface	B-NP	B-NP	-	4	NMOD	-	-
4	markers	markers	I-NP	I-NP	-	2	PMOD	-	-
5	,	,	O	O	-	22	P	-	-
6	intracytoplasmic	intracytoplasmic	B-NP	B-NP	-	7	NMOD	-	-
7	content	content	I-NP	I-NP	-	18	NMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	cytokines	cytokines	B-NP	B-NP	-	12	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	12	NMOD	-	-
11	cycle	cycle	I-NP	I-NP	-	12	NMOD	-	-
12	analysis	analysis	I-NP	I-NP	-	18	NMOD	-	-
13	after	after	B-PP	B-PP	-	12	NMOD	-	-
14	BrdU	BrdU	B-NP	B-NP	-	15	NMOD	-	-
15	incorporation	incorporation	I-NP	I-NP	-	18	NMOD	-	-
16	and	and	O	O	-	18	NMOD	-	-
17	DNA	DNA	B-NP	B-NP	-	18	NMOD	-	-
18	staining	staining	I-NP	I-NP	-	22	SUB	-	-
19	with	with	B-PP	B-PP	-	18	NMOD	-	-
20	propidium	propidium	B-NP	B-NP	-	21	NMOD	-	-
21	iodide	iodide	I-NP	I-NP	-	19	PMOD	-	-
22	were	were	B-VP	B-VP	-	0	ROOT	-	-
23	studied	studied	I-VP	I-VP	-	22	VC	-	-
24	by	by	B-PP	B-PP	-	23	VMOD	-	-
25	flow	flow	B-NP	B-NP	-	26	NMOD	-	-
26	cytometry	cytometry	I-NP	I-NP	-	24	PMOD	-	-
27	.	.	O	O	-	22	P	-	-

1	Percentage	Percentage	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	apoptotic	apoptotic	B-NP	B-NP	-	4	NMOD	-	-
4	cells	cells	I-NP	I-NP	-	2	PMOD	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	determined	determined	I-VP	I-VP	-	5	VC	-	-
7	by	by	B-PP	B-PP	-	6	VMOD	-	-
8	in-situ	in-situ	B-NP	B-NP	-	9	NMOD	-	-
9	labelling	labelling	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	DNA	DNA	B-NP	B-NP	-	13	NMOD	-	-
12	strand	strand	I-NP	I-NP	-	13	NMOD	-	-
13	breaks	breaks	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	5	P	-	-

1	No	No	B-NP	B-NP	-	3	NMOD	-	-
2	significative	significative	I-NP	I-NP	-	3	NMOD	-	-
3	changes	changes	I-NP	I-NP	-	13	SUB	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	EBV	EBV	B-NP	B-NP	-	6	NMOD	-	-
6	latency	latency	I-NP	I-NP	-	4	PMOD	-	-
7	nor	nor	B-PP	B-PP	-	4	PMOD	-	-
8	in	in	B-PP	B-PP	-	4	PMOD	-	-
9	cell	cell	B-NP	B-NP	-	12	NMOD	-	-
10	surface	surface	I-NP	I-NP	-	12	NMOD	-	-
11	marker	marker	I-NP	I-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	8	PMOD	-	-
13	was	was	B-VP	B-VP	-	0	ROOT	-	-
14	found	found	I-VP	I-VP	-	13	VC	-	-
15	.	.	O	O	-	13	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	7	P	-	-
4	intracytoplasmic	intracytoplasmic	B-NP	B-NP	-	6	NMOD	-	-
5	TNFalpha	TNFalpha	I-NP	I-NP	-	6	NMOD	-	-
6	levels	levels	I-NP	I-NP	-	7	SUB	-	-
7	were	were	B-VP	B-VP	-	0	ROOT	-	-
8	strongly	strongly	I-VP	I-VP	-	7	VMOD	-	-
9	reduced	reduced	I-VP	I-VP	-	7	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	transfected	transfected	B-NP	B-NP	-	12	NMOD	-	-
12	clones	clones	I-NP	I-NP	-	10	PMOD	-	-
13	.	.	O	O	-	7	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	9	VMOD	-	-
2	,	,	O	O	-	9	P	-	-
3	<num>	<num>	B-NP	B-NP	-	4	NMOD	-	-
4	%	%	I-NP	I-NP	-	9	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	8	NMOD	-	-
7	transfected	transfected	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
9	were	were	B-VP	B-VP	-	0	ROOT	-	-
10	apoptotic	apoptotic	B-ADJP	B-ADJP	-	9	PRD	-	-
11	after	after	B-PP	B-PP	-	9	VMOD	-	-
12	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
13	h	h	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	TNFalpha	TNFalpha	B-NP	B-NP	-	16	NMOD	-	-
16	treatment	treatment	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	9	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	correlated	correlated	B-VP	B-VP	-	0	ROOT	-	-
3	with	with	B-PP	B-PP	-	2	VMOD	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	strong	strong	I-NP	I-NP	-	6	NMOD	-	-
6	reduction	reduction	I-NP	I-NP	-	3	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	BrdU	BrdU	B-NP	B-NP	-	9	NMOD	-	-
9	incorporation	incorporation	I-NP	I-NP	-	7	PMOD	-	-
10	after	after	B-PP	B-PP	-	6	NMOD	-	-
11	<num>	<num>	B-NP	B-NP	-	12	NMOD	-	-
12	h	h	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	TNFalpha	TNFalpha	B-NP	B-NP	-	15	NMOD	-	-
15	treatment	treatment	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	2	P	-	-

1	No	No	B-NP	B-NP	-	2	NMOD	-	-
2	effect	effect	I-NP	I-NP	-	3	SUB	-	-
3	was	was	B-VP	B-VP	-	0	ROOT	-	-
4	seen	seen	I-VP	I-VP	-	3	VC	-	-
5	with	with	B-PP	B-PP	-	4	VMOD	-	-
6	non	non	B-NP	B-NP	-	8	NMOD	-	-
7	transfected	transfected	I-NP	I-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	5	PMOD	-	-
9	or	or	B-PP	B-PP	-	5	PMOD	-	-
10	with	with	B-PP	B-PP	-	5	PMOD	-	-
11	cells	cells	B-NP	B-NP	-	10	PMOD	-	-
12	transfected	transfected	B-VP	B-VP	-	11	NMOD	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	control	control	I-NP	I-NP	-	16	NMOD	-	-
16	plasmid	plasmid	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	21	DEP	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	TNFalpha	TNFalpha	I-NP	I-NP	-	7	NMOD	-	-
7	gene	gene	I-NP	I-NP	-	8	SUB	-	-
8	could	could	B-VP	B-VP	-	4	SBAR	-	-
9	be	be	I-VP	I-VP	-	8	VC	-	-
10	one	one	B-NP	B-NP	-	9	PRD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	targets	targets	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	NF-kappaB	NF-kappaB	B-NP	B-NP	-	14	PMOD	-	-
16	in	in	B-PP	B-PP	-	13	NMOD	-	-
17	EBV	EBV	B-NP	B-NP	-	19	NMOD	-	-
18	infected	infected	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	and	and	O	O	-	21	DEP	-	-
21	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
22	NF-kappaB	NF-kappaB	B-NP	B-NP	-	23	SUB	-	-
23	protects	protects	B-VP	B-VP	-	21	SBAR	-	-
24	EBV-infected	EBV-infected	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	23	OBJ	-	-
26	from	from	B-PP	B-PP	-	23	VMOD	-	-
27	apoptosis	apoptosis	B-NP	B-NP	-	26	PMOD	-	-
28	induced	induced	B-VP	B-VP	-	27	NMOD	-	-
29	by	by	B-PP	B-PP	-	28	VMOD	-	-
30	TNFalpha	TNFalpha	B-NP	B-NP	-	29	PMOD	-	-
31	,	,	O	O	-	30	P	-	-
32	which	which	B-NP	B-NP	-	30	NMOD	-	-
33	may	may	B-VP	B-VP	-	32	SBAR	-	-
34	favour	favour	I-VP	I-VP	-	33	VC	-	-
35	the	the	B-NP	B-NP	-	37	NMOD	-	-
36	proliferative	proliferative	I-NP	I-NP	-	37	NMOD	-	-
37	effect	effect	I-NP	I-NP	-	34	OBJ	-	-
38	of	of	B-PP	B-PP	-	37	NMOD	-	-
39	this	this	B-NP	B-NP	-	40	NMOD	-	-
40	cytokine	cytokine	I-NP	I-NP	-	38	PMOD	-	-
41	.	.	O	O	-	3	P	-	-

1	Uncoupling	Uncoupling	B-VP	B-VP	-	4	NMOD	-	-
2	activation-dependent	activation-dependent	B-NP	B-NP	-	4	NMOD	-	-
3	HS1	HS1	I-NP	I-NP	-	4	NMOD	-	-
4	phosphorylation	phosphorylation	I-NP	I-NP	-	13	NMOD	-	-
5	from	from	B-PP	B-PP	-	4	NMOD	-	-
6	nuclear	nuclear	B-NP	B-NP	-	7	NMOD	-	-
7	factor	factor	I-NP	I-NP	-	13	NMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	activated	activated	B-NP	B-NP	-	11	NMOD	-	-
10	T	T	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
12	transcriptional	transcriptional	B-NP	B-NP	-	13	NMOD	-	-
13	activation	activation	I-NP	I-NP	-	20	NMOD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	Jurkat	Jurkat	B-NP	B-NP	-	17	NMOD	-	-
16	T	T	I-NP	I-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	14	PMOD	-	-
18	:	:	O	O	-	13	P	-	-
19	differential	differential	B-NP	B-NP	-	20	NMOD	-	-
20	signaling	signaling	I-NP	I-NP	-	0	ROOT	-	-
21	through	through	B-PP	B-PP	-	20	NMOD	-	-
22	CD3	CD3	B-NP	B-NP	-	26	NMOD	-	-
23	and	and	O	O	-	26	NMOD	-	-
24	the	the	B-NP	B-NP	-	26	NMOD	-	-
25	costimulatory	costimulatory	I-NP	I-NP	-	26	NMOD	-	-
26	receptors	receptors	I-NP	I-NP	-	21	PMOD	-	-
27	CD2	CD2	I-NP	I-NP	-	29	NMOD	-	-
28	and	and	I-NP	I-NP	-	29	NMOD	-	-
29	CD28	CD28	I-NP	I-NP	-	26	NMOD	-	-
30	.	.	O	O	-	20	P	-	-

1	CD3	CD3	B-NP	B-NP	-	6	NMOD	-	-
2	,	,	O	O	-	6	P	-	-
3	CD2	CD2	B-NP	B-NP	-	6	NMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	and	and	O	O	-	6	NMOD	-	-
6	CD28	CD28	B-NP	B-NP	-	7	SUB	-	-
7	are	are	B-VP	B-VP	-	0	ROOT	-	-
8	functionally	functionally	B-NP	B-NP	-	9	AMOD	-	-
9	distinct	distinct	I-NP	I-NP	-	10	NMOD	-	-
10	receptors	receptors	I-NP	I-NP	-	7	PRD	-	-
11	on	on	B-PP	B-PP	-	7	VMOD	-	-
12	T	T	B-NP	B-NP	-	13	NMOD	-	-
13	lymphocytes	lymphocytes	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	7	P	-	-

1	Engagement	Engagement	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	any	any	B-NP	B-NP	-	2	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	these	these	B-NP	B-NP	-	6	NMOD	-	-
6	receptors	receptors	I-NP	I-NP	-	4	PMOD	-	-
7	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	rapid	rapid	I-NP	I-NP	-	11	NMOD	-	-
10	tyrosine	tyrosine	I-NP	I-NP	-	11	NMOD	-	-
11	phosphorylation	phosphorylation	I-NP	I-NP	-	7	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	a	a	B-NP	B-NP	-	15	NMOD	-	-
14	shared	shared	I-NP	I-NP	-	15	NMOD	-	-
15	group	group	I-NP	I-NP	-	12	PMOD	-	-
16	of	of	B-PP	B-PP	-	15	NMOD	-	-
17	intracellular	intracellular	B-NP	B-NP	-	19	NMOD	-	-
18	signaling	signaling	I-NP	I-NP	-	19	NMOD	-	-
19	proteins	proteins	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	19	P	-	-
21	including	including	B-PP	B-PP	-	19	NMOD	-	-
22	Vav	Vav	B-NP	B-NP	-	34	NMOD	-	-
23	,	,	O	O	-	34	P	-	-
24	Cbl	Cbl	B-NP	B-NP	-	34	NMOD	-	-
25	,	,	O	O	-	34	P	-	-
26	p85	p85	B-NP	B-NP	-	28	NMOD	-	-
27	phosphoinositide	phosphoinositide	I-NP	I-NP	-	28	NMOD	-	-
28	3-kinase	3-kinase	I-NP	I-NP	-	34	NMOD	-	-
29	,	,	O	O	-	34	P	-	-
30	and	and	O	O	-	34	NMOD	-	-
31	the	the	B-NP	B-NP	-	34	NMOD	-	-
32	Src	Src	I-NP	I-NP	-	34	NMOD	-	-
33	family	family	I-NP	I-NP	-	34	NMOD	-	-
34	kinases	kinases	I-NP	I-NP	-	21	PMOD	-	-
35	Lck	Lck	I-NP	I-NP	-	37	NMOD	-	-
36	and	and	I-NP	I-NP	-	37	NMOD	-	-
37	Fyn	Fyn	I-NP	I-NP	-	34	NMOD	-	-
38	.	.	O	O	-	7	P	-	-

1	Ligation	Ligation	B-NP	B-NP	-	5	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	CD3	CD3	B-NP	B-NP	-	2	PMOD	-	-
4	also	also	B-ADVP	B-ADVP	-	5	VMOD	-	-
5	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	tyrosine	tyrosine	I-NP	I-NP	-	8	NMOD	-	-
8	phosphorylation	phosphorylation	I-NP	I-NP	-	5	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	HS1	HS1	B-NP	B-NP	-	18	NMOD	-	-
11	,	,	O	O	-	18	P	-	-
12	a	a	B-NP	B-NP	-	18	NMOD	-	-
13	75-kDa	75-kDa	I-NP	I-NP	-	18	NMOD	-	-
14	hematopoietic	hematopoietic	I-NP	I-NP	-	18	NMOD	-	-
15	cell-specific	cell-specific	I-NP	I-NP	-	18	NMOD	-	-
16	intracellular	intracellular	I-NP	I-NP	-	18	NMOD	-	-
17	signaling	signaling	I-NP	I-NP	-	18	NMOD	-	-
18	protein	protein	I-NP	I-NP	-	9	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	unknown	unknown	B-NP	B-NP	-	21	NMOD	-	-
21	function	function	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	5	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	examined	examined	I-VP	I-VP	-	2	VC	-	-
4	changes	changes	B-NP	B-NP	-	3	OBJ	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	HS1	HS1	B-NP	B-NP	-	7	NMOD	-	-
7	phosphorylation	phosphorylation	I-NP	I-NP	-	5	PMOD	-	-
8	after	after	B-PP	B-PP	-	4	NMOD	-	-
9	differential	differential	B-NP	B-NP	-	10	NMOD	-	-
10	stimulation	stimulation	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	CD3	CD3	B-NP	B-NP	-	17	NMOD	-	-
13	,	,	O	O	-	17	P	-	-
14	CD2	CD2	B-NP	B-NP	-	17	NMOD	-	-
15	,	,	O	O	-	17	P	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	CD28	CD28	B-NP	B-NP	-	11	PMOD	-	-
18	to	to	B-VP	B-VP	-	19	VMOD	-	-
19	elucidate	elucidate	I-VP	I-VP	-	17	NMOD	-	-
20	its	its	B-NP	B-NP	-	21	NMOD	-	-
21	role	role	I-NP	I-NP	-	19	OBJ	-	-
22	in	in	B-PP	B-PP	-	21	NMOD	-	-
23	T	T	B-NP	B-NP	-	24	NMOD	-	-
24	cells	cells	I-NP	I-NP	-	22	PMOD	-	-
25	and	and	O	O	-	19	VMOD	-	-
26	to	to	B-VP	B-VP	-	28	VMOD	-	-
27	further	further	I-VP	I-VP	-	28	VMOD	-	-
28	delineate	delineate	I-VP	I-VP	-	19	VMOD	-	-
29	the	the	B-NP	B-NP	-	31	NMOD	-	-
30	signaling	signaling	I-NP	I-NP	-	31	NMOD	-	-
31	pathways	pathways	I-NP	I-NP	-	28	OBJ	-	-
32	recruited	recruited	B-VP	B-VP	-	31	NMOD	-	-
33	by	by	B-PP	B-PP	-	32	VMOD	-	-
34	these	these	B-NP	B-NP	-	35	NMOD	-	-
35	receptors	receptors	I-NP	I-NP	-	33	PMOD	-	-
36	.	.	O	O	-	2	P	-	-

1	Unlike	Unlike	B-PP	B-PP	-	20	VMOD	-	-
2	ligation	ligation	B-NP	B-NP	-	1	PMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	CD3	CD3	B-NP	B-NP	-	3	PMOD	-	-
5	,	,	O	O	-	20	P	-	-
6	stimulation	stimulation	B-NP	B-NP	-	20	SUB	-	-
7	with	with	B-PP	B-PP	-	6	NMOD	-	-
8	anti-CD28	anti-CD28	B-NP	B-NP	-	12	NMOD	-	-
9	mAb	mAb	I-NP	I-NP	-	12	NMOD	-	-
10	or	or	I-NP	I-NP	-	12	NMOD	-	-
11	CHO	CHO	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	7	PMOD	-	-
13	expressing	expressing	B-VP	B-VP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	CD28	CD28	I-NP	I-NP	-	16	NMOD	-	-
16	ligands	ligands	I-NP	I-NP	-	20	SUB	-	-
17	CD80	CD80	I-NP	I-NP	-	19	NMOD	-	-
18	or	or	I-NP	I-NP	-	19	NMOD	-	-
19	CD86	CD86	I-NP	I-NP	-	16	NMOD	-	-
20	did	did	B-VP	B-VP	-	0	ROOT	-	-
21	not	not	I-VP	I-VP	-	20	VMOD	-	-
22	lead	lead	I-VP	I-VP	-	20	VC	-	-
23	to	to	B-PP	B-PP	-	22	VMOD	-	-
24	tyrosine	tyrosine	B-NP	B-NP	-	25	NMOD	-	-
25	phosphorylation	phosphorylation	I-NP	I-NP	-	23	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	HS1	HS1	B-NP	B-NP	-	26	PMOD	-	-
28	in	in	B-PP	B-PP	-	25	NMOD	-	-
29	Jurkat	Jurkat	B-NP	B-NP	-	31	NMOD	-	-
30	T	T	I-NP	I-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	28	PMOD	-	-
32	.	.	O	O	-	20	P	-	-

1	Additionally	Additionally	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	no	no	B-NP	B-NP	-	5	NMOD	-	-
4	tyrosine	tyrosine	I-NP	I-NP	-	5	NMOD	-	-
5	phosphorylation	phosphorylation	I-NP	I-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	HS1	HS1	B-NP	B-NP	-	6	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	induced	induced	I-VP	I-VP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	mitogenic	mitogenic	B-NP	B-NP	-	12	NMOD	-	-
12	pairs	pairs	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	anti-CD2	anti-CD2	B-NP	B-NP	-	15	NMOD	-	-
15	mAbs	mAbs	I-NP	I-NP	-	13	PMOD	-	-
16	capable	capable	B-ADJP	B-ADJP	-	15	NMOD	-	-
17	of	of	B-PP	B-PP	-	16	AMOD	-	-
18	activating	activating	B-VP	B-VP	-	17	PMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	22	NMOD	-	-
21	factor	factor	I-NP	I-NP	-	22	NMOD	-	-
22	NFAT	NFAT	I-NP	I-NP	-	18	OBJ	-	-
23	(	(	O	O	-	25	P	-	-
24	nuclear	nuclear	B-NP	B-NP	-	25	NMOD	-	-
25	factor	factor	I-NP	I-NP	-	22	NMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	activated	activated	B-NP	B-NP	-	29	NMOD	-	-
28	T	T	I-NP	I-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	26	PMOD	-	-
30	)	)	O	O	-	25	P	-	-
31	.	.	O	O	-	8	P	-	-

1	Costimulation	Costimulation	B-NP	B-NP	-	6	SUB	-	-
2	through	through	B-PP	B-PP	-	1	NMOD	-	-
3	CD28	CD28	B-NP	B-NP	-	5	NMOD	-	-
4	and/or	and/or	O	O	-	5	NMOD	-	-
5	CD2	CD2	B-NP	B-NP	-	2	PMOD	-	-
6	did	did	B-VP	B-VP	-	0	ROOT	-	-
7	not	not	I-VP	I-VP	-	6	VMOD	-	-
8	modulate	modulate	I-VP	I-VP	-	6	VC	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	CD3-dependent	CD3-dependent	I-NP	I-NP	-	11	NMOD	-	-
11	phosphorylation	phosphorylation	I-NP	I-NP	-	8	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	HS1	HS1	B-NP	B-NP	-	12	PMOD	-	-
14	.	.	O	O	-	6	P	-	-

1	In	In	B-NP	B-NP	-	2	AMOD	-	-
2	vivo	vivo	I-NP	I-NP	-	3	NMOD	-	-
3	studies	studies	I-NP	I-NP	-	4	SUB	-	-
4	indicated	indicated	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	CD3-induced	CD3-induced	B-NP	B-NP	-	8	NMOD	-	-
7	HSI	HSI	I-NP	I-NP	-	8	NMOD	-	-
8	phosphorylation	phosphorylation	I-NP	I-NP	-	9	SUB	-	-
9	was	was	B-VP	B-VP	-	5	SBAR	-	-
10	dependent	dependent	B-ADJP	B-ADJP	-	9	PRD	-	-
11	upon	upon	B-PP	B-PP	-	10	AMOD	-	-
12	both	both	O	O	-	23	NMOD	-	-
13	the	the	B-NP	B-NP	-	18	NMOD	-	-
14	Src	Src	I-NP	I-NP	-	18	NMOD	-	-
15	family	family	I-NP	I-NP	-	18	NMOD	-	-
16	tyrosine	tyrosine	I-NP	I-NP	-	18	NMOD	-	-
17	kinase	kinase	I-NP	I-NP	-	18	NMOD	-	-
18	Lck	Lck	I-NP	I-NP	-	23	NMOD	-	-
19	and	and	O	O	-	23	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	tyrosine	tyrosine	I-NP	I-NP	-	23	NMOD	-	-
22	phosphatase	phosphatase	I-NP	I-NP	-	23	NMOD	-	-
23	CD45	CD45	I-NP	I-NP	-	11	PMOD	-	-
24	,	,	O	O	-	9	P	-	-
25	did	did	B-VP	B-VP	-	9	VMOD	-	-
26	not	not	I-VP	I-VP	-	25	VMOD	-	-
27	require	require	I-VP	I-VP	-	25	VC	-	-
28	MEK1	MEK1	B-NP	B-NP	-	30	NMOD	-	-
29	kinase	kinase	I-NP	I-NP	-	30	NMOD	-	-
30	activity	activity	I-NP	I-NP	-	27	OBJ	-	-
31	,	,	O	O	-	9	P	-	-
32	and	and	O	O	-	9	VMOD	-	-
33	was	was	B-VP	B-VP	-	9	VMOD	-	-
34	regulated	regulated	I-VP	I-VP	-	33	VC	-	-
35	by	by	B-PP	B-PP	-	34	VMOD	-	-
36	protein	protein	B-NP	B-NP	-	39	NMOD	-	-
37	kinase	kinase	I-NP	I-NP	-	39	NMOD	-	-
38	C	C	I-NP	I-NP	-	39	NMOD	-	-
39	activation	activation	I-NP	I-NP	-	35	PMOD	-	-
40	.	.	O	O	-	4	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	19	VMOD	-	-
2	,	,	O	O	-	19	P	-	-
3	although	although	B-SBAR	B-SBAR	-	19	VMOD	-	-
4	CD3	CD3	B-NP	B-NP	-	9	NMOD	-	-
5	,	,	O	O	-	9	P	-	-
6	CD28	CD28	B-NP	B-NP	-	9	NMOD	-	-
7	,	,	O	O	-	9	P	-	-
8	and	and	O	O	-	9	NMOD	-	-
9	CD2	CD2	B-NP	B-NP	-	10	SUB	-	-
10	activate	activate	B-VP	B-VP	-	3	SBAR	-	-
11	many	many	B-NP	B-NP	-	10	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	the	the	B-NP	B-NP	-	16	NMOD	-	-
14	same	same	I-NP	I-NP	-	16	NMOD	-	-
15	signaling	signaling	I-NP	I-NP	-	16	NMOD	-	-
16	molecules	molecules	I-NP	I-NP	-	12	PMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	they	they	B-NP	B-NP	-	19	SUB	-	-
19	differed	differed	B-VP	B-VP	-	0	ROOT	-	-
20	in	in	B-PP	B-PP	-	19	VMOD	-	-
21	their	their	B-NP	B-NP	-	22	NMOD	-	-
22	capacity	capacity	I-NP	I-NP	-	20	PMOD	-	-
23	to	to	B-VP	B-VP	-	24	VMOD	-	-
24	induce	induce	I-VP	I-VP	-	22	NMOD	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	tyrosine	tyrosine	I-NP	I-NP	-	27	NMOD	-	-
27	phosphorylation	phosphorylation	I-NP	I-NP	-	24	OBJ	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	HSI	HSI	B-NP	B-NP	-	28	PMOD	-	-
30	.	.	O	O	-	19	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	8	VMOD	-	-
2	,	,	O	O	-	8	P	-	-
3	activation-dependent	activation-dependent	B-NP	B-NP	-	5	NMOD	-	-
4	tyrosine	tyrosine	I-NP	I-NP	-	5	NMOD	-	-
5	phosphorylation	phosphorylation	I-NP	I-NP	-	8	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	HS1	HS1	B-NP	B-NP	-	6	PMOD	-	-
8	was	was	B-VP	B-VP	-	0	ROOT	-	-
9	not	not	I-VP	I-VP	-	8	VMOD	-	-
10	required	required	I-VP	I-VP	-	8	VC	-	-
11	for	for	B-PP	B-PP	-	10	VMOD	-	-
12	NFAT	NFAT	B-NP	B-NP	-	14	NMOD	-	-
13	transcriptional	transcriptional	I-NP	I-NP	-	14	NMOD	-	-
14	activation	activation	I-NP	I-NP	-	11	PMOD	-	-
15	.	.	O	O	-	8	P	-	-

1	IL-7	IL-7	B-NP	B-NP	-	2	SUB	-	-
2	reconstitutes	reconstitutes	B-VP	B-VP	-	0	ROOT	-	-
3	multiple	multiple	B-NP	B-NP	-	4	NMOD	-	-
4	aspects	aspects	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	v-Abl-mediated	v-Abl-mediated	B-NP	B-NP	-	7	NMOD	-	-
7	signaling	signaling	I-NP	I-NP	-	5	PMOD	-	-
8	.	.	O	O	-	2	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	mechanism	mechanism	I-NP	I-NP	-	8	SUB	-	-
3	by	by	B-PP	B-PP	-	2	NMOD	-	-
4	which	which	B-NP	B-NP	-	3	PMOD	-	-
5	early	early	B-NP	B-NP	-	7	NMOD	-	-
6	lymphoid	lymphoid	I-NP	I-NP	-	7	NMOD	-	-
7	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
8	are	are	B-VP	B-VP	-	0	ROOT	-	-
9	selectively	selectively	I-VP	I-VP	-	8	VMOD	-	-
10	transformed	transformed	I-VP	I-VP	-	8	VC	-	-
11	by	by	B-PP	B-PP	-	10	VMOD	-	-
12	v-Abl	v-Abl	B-NP	B-NP	-	11	PMOD	-	-
13	is	is	B-VP	B-VP	-	8	VMOD	-	-
14	currently	currently	B-ADJP	B-ADJP	-	15	AMOD	-	-
15	unknown	unknown	I-ADJP	I-ADJP	-	13	PRD	-	-
16	.	.	O	O	-	8	P	-	-

1	Previous	Previous	B-NP	B-NP	-	2	NMOD	-	-
2	studies	studies	I-NP	I-NP	-	3	SUB	-	-
3	have	have	B-VP	B-VP	-	0	ROOT	-	-
4	shown	shown	I-VP	I-VP	-	3	VC	-	-
5	constitutive	constitutive	B-NP	B-NP	-	6	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	IL-4	IL-4	B-NP	B-NP	-	12	NMOD	-	-
9	and	and	I-NP	I-NP	-	12	NMOD	-	-
10	IL-7	IL-7	I-NP	I-NP	-	12	NMOD	-	-
11	signaling	signaling	I-NP	I-NP	-	12	NMOD	-	-
12	pathways	pathways	I-NP	I-NP	-	7	PMOD	-	-
13	,	,	O	O	-	4	P	-	-
14	as	as	B-SBAR	B-SBAR	-	4	VMOD	-	-
15	measured	measured	B-VP	B-VP	-	14	SBAR	-	-
16	by	by	B-PP	B-PP	-	15	VMOD	-	-
17	activation	activation	B-NP	B-NP	-	16	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	Janus	Janus	B-NP	B-NP	-	21	NMOD	-	-
20	protein	protein	I-NP	I-NP	-	21	NMOD	-	-
21	kinase	kinase	I-NP	I-NP	-	18	PMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	JAK	JAK	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	<num>	<num>	B-NP	B-NP	-	32	NMOD	-	-
26	,	,	O	O	-	32	P	-	-
27	JAK3	JAK3	B-NP	B-NP	-	32	NMOD	-	-
28	,	,	O	O	-	32	P	-	-
29	STAT5	STAT5	B-NP	B-NP	-	32	NMOD	-	-
30	,	,	O	O	-	32	P	-	-
31	and	and	O	O	-	32	NMOD	-	-
32	STAT6	STAT6	B-NP	B-NP	-	18	PMOD	-	-
33	,	,	O	O	-	32	P	-	-
34	in	in	B-PP	B-PP	-	17	NMOD	-	-
35	pre-B	pre-B	B-NP	B-NP	-	36	NMOD	-	-
36	cells	cells	I-NP	I-NP	-	34	PMOD	-	-
37	transformed	transformed	B-VP	B-VP	-	36	NMOD	-	-
38	by	by	B-PP	B-PP	-	37	VMOD	-	-
39	v-Abl	v-Abl	B-NP	B-NP	-	38	PMOD	-	-
40	.	.	O	O	-	3	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	determine	determine	I-VP	I-VP	-	41	VMOD	-	-
3	whether	whether	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	activation	activation	B-NP	B-NP	-	12	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	these	these	B-NP	B-NP	-	9	NMOD	-	-
7	cytokine	cytokine	I-NP	I-NP	-	9	NMOD	-	-
8	signaling	signaling	I-NP	I-NP	-	9	NMOD	-	-
9	pathways	pathways	I-NP	I-NP	-	5	PMOD	-	-
10	by	by	B-PP	B-PP	-	4	NMOD	-	-
11	v-Abl	v-Abl	B-NP	B-NP	-	10	PMOD	-	-
12	is	is	B-VP	B-VP	-	3	SBAR	-	-
13	important	important	B-ADJP	B-ADJP	-	12	PRD	-	-
14	in	in	B-PP	B-PP	-	13	AMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	cellular	cellular	I-NP	I-NP	-	17	NMOD	-	-
17	events	events	I-NP	I-NP	-	14	PMOD	-	-
18	induced	induced	B-VP	B-VP	-	17	NMOD	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	the	the	B-NP	B-NP	-	24	NMOD	-	-
21	Abelson	Abelson	I-NP	I-NP	-	24	NMOD	-	-
22	murine	murine	I-NP	I-NP	-	24	NMOD	-	-
23	leukemia	leukemia	I-NP	I-NP	-	24	NMOD	-	-
24	virus	virus	I-NP	I-NP	-	19	PMOD	-	-
25	,	,	O	O	-	41	P	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	effects	effects	I-NP	I-NP	-	41	SUB	-	-
28	of	of	B-PP	B-PP	-	27	NMOD	-	-
29	IL-4	IL-4	B-NP	B-NP	-	31	NMOD	-	-
30	and	and	I-NP	I-NP	-	31	NMOD	-	-
31	IL-7	IL-7	I-NP	I-NP	-	28	PMOD	-	-
32	on	on	B-PP	B-PP	-	27	NMOD	-	-
33	pre-B	pre-B	B-NP	B-NP	-	34	NMOD	-	-
34	cells	cells	I-NP	I-NP	-	32	PMOD	-	-
35	transformed	transformed	B-VP	B-VP	-	34	NMOD	-	-
36	with	with	B-PP	B-PP	-	35	VMOD	-	-
37	a	a	B-NP	B-NP	-	40	NMOD	-	-
38	temperature-sensitive	temperature-sensitive	I-NP	I-NP	-	40	NMOD	-	-
39	v-Abl	v-Abl	I-NP	I-NP	-	40	NMOD	-	-
40	mutant	mutant	I-NP	I-NP	-	36	PMOD	-	-
41	were	were	B-VP	B-VP	-	0	ROOT	-	-
42	examined	examined	I-VP	I-VP	-	41	VC	-	-
43	.	.	O	O	-	41	P	-	-

1	Whereas	Whereas	B-SBAR	B-SBAR	-	10	VMOD	-	-
2	IL-4	IL-4	B-NP	B-NP	-	3	SUB	-	-
3	had	had	B-VP	B-VP	-	1	SBAR	-	-
4	little	little	B-NP	B-NP	-	7	NMOD	-	-
5	or	or	I-NP	I-NP	-	7	NMOD	-	-
6	no	no	I-NP	I-NP	-	7	NMOD	-	-
7	effect	effect	I-NP	I-NP	-	3	OBJ	-	-
8	,	,	O	O	-	10	P	-	-
9	IL-7	IL-7	B-NP	B-NP	-	10	SUB	-	-
10	delayed	delayed	B-VP	B-VP	-	0	ROOT	-	-
11	both	both	O	O	-	17	NMOD	-	-
12	the	the	B-NP	B-NP	-	17	NMOD	-	-
13	apoptosis	apoptosis	I-NP	I-NP	-	17	NMOD	-	-
14	and	and	I-NP	I-NP	-	17	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	17	NMOD	-	-
16	cycle	cycle	I-NP	I-NP	-	17	NMOD	-	-
17	arrest	arrest	I-NP	I-NP	-	10	OBJ	-	-
18	that	that	B-NP	B-NP	-	17	NMOD	-	-
19	occur	occur	B-VP	B-VP	-	18	SBAR	-	-
20	upon	upon	B-PP	B-PP	-	19	VMOD	-	-
21	v-Abl	v-Abl	B-NP	B-NP	-	23	NMOD	-	-
22	kinase	kinase	I-NP	I-NP	-	23	NMOD	-	-
23	inactivation	inactivation	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	10	P	-	-

1	IL-7	IL-7	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	delayed	delayed	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	decreases	decreases	I-NP	I-NP	-	3	OBJ	-	-
6	in	in	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	levels	levels	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	c-Myc	c-Myc	B-NP	B-NP	-	15	NMOD	-	-
11	,	,	O	O	-	15	P	-	-
12	Bcl-2	Bcl-2	B-NP	B-NP	-	15	NMOD	-	-
13	,	,	O	O	-	15	P	-	-
14	and	and	O	O	-	15	NMOD	-	-
15	Bcl-xL	Bcl-xL	B-NP	B-NP	-	9	PMOD	-	-
16	that	that	B-NP	B-NP	-	8	NMOD	-	-
17	occur	occur	B-VP	B-VP	-	16	SBAR	-	-
18	upon	upon	B-PP	B-PP	-	17	VMOD	-	-
19	loss	loss	B-NP	B-NP	-	18	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	v-Abl	v-Abl	B-NP	B-NP	-	23	NMOD	-	-
22	kinase	kinase	I-NP	I-NP	-	23	NMOD	-	-
23	activity	activity	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	3	P	-	-

1	IL-7	IL-7	B-NP	B-NP	-	2	SUB	-	-
2	did	did	B-VP	B-VP	-	21	VMOD	-	-
3	not	not	I-VP	I-VP	-	2	VMOD	-	-
4	maintain	maintain	I-VP	I-VP	-	2	VC	-	-
5	v-Abl-mediated	v-Abl-mediated	B-NP	B-NP	-	7	NMOD	-	-
6	differentiation	differentiation	I-NP	I-NP	-	7	NMOD	-	-
7	arrest	arrest	I-NP	I-NP	-	4	OBJ	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	11	NMOD	-	-
10	pre-B	pre-B	I-NP	I-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
12	,	,	O	O	-	4	P	-	-
13	as	as	B-PP	B-PP	-	4	VMOD	-	-
14	activation	activation	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	NF-kappaB	NF-kappaB	B-NP	B-NP	-	20	NMOD	-	-
17	and	and	I-NP	I-NP	-	20	NMOD	-	-
18	RAG	RAG	I-NP	I-NP	-	20	NMOD	-	-
19	gene	gene	I-NP	I-NP	-	20	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	15	PMOD	-	-
21	was	was	B-VP	B-VP	-	0	ROOT	-	-
22	unaffected	unaffected	B-ADJP	B-ADJP	-	21	VC	-	-
23	by	by	B-PP	B-PP	-	22	VMOD	-	-
24	IL-7	IL-7	B-NP	B-NP	-	23	PMOD	-	-
25	.	.	O	O	-	21	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	identify	identify	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	potential	potential	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	for	for	B-PP	B-PP	-	6	NMOD	-	-
8	IL-7	IL-7	B-NP	B-NP	-	10	NMOD	-	-
9	signaling	signaling	I-NP	I-NP	-	10	NMOD	-	-
10	pathways	pathways	I-NP	I-NP	-	7	PMOD	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	transformation	transformation	B-NP	B-NP	-	11	PMOD	-	-
13	by	by	B-PP	B-PP	-	6	NMOD	-	-
14	v-Abl	v-Abl	B-NP	B-NP	-	13	PMOD	-	-
15	while	while	B-SBAR	B-SBAR	-	3	VMOD	-	-
16	demonstrating	demonstrating	B-VP	B-VP	-	15	SBAR	-	-
17	that	that	B-SBAR	B-SBAR	-	16	VMOD	-	-
18	a	a	B-NP	B-NP	-	19	NMOD	-	-
19	combination	combination	I-NP	I-NP	-	25	SUB	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	IL-4	IL-4	B-NP	B-NP	-	24	NMOD	-	-
22	and	and	I-NP	I-NP	-	24	NMOD	-	-
23	IL-7	IL-7	I-NP	I-NP	-	24	NMOD	-	-
24	signaling	signaling	I-NP	I-NP	-	20	PMOD	-	-
25	can	can	B-VP	B-VP	-	17	SBAR	-	-
26	not	not	I-VP	I-VP	-	25	VMOD	-	-
27	substitute	substitute	I-VP	I-VP	-	25	VC	-	-
28	for	for	B-PP	B-PP	-	27	VMOD	-	-
29	an	an	B-NP	B-NP	-	32	NMOD	-	-
30	active	active	I-NP	I-NP	-	32	NMOD	-	-
31	v-Abl	v-Abl	I-NP	I-NP	-	32	NMOD	-	-
32	kinase	kinase	I-NP	I-NP	-	28	PMOD	-	-
33	in	in	B-PP	B-PP	-	32	NMOD	-	-
34	transformed	transformed	B-NP	B-NP	-	36	NMOD	-	-
35	pre-B	pre-B	I-NP	I-NP	-	36	NMOD	-	-
36	cells	cells	I-NP	I-NP	-	33	PMOD	-	-
37	.	.	O	O	-	3	P	-	-

1	p21ras	p21ras	B-NP	B-NP	-	2	SUB	-	-
2	initiates	initiates	B-VP	B-VP	-	0	ROOT	-	-
3	Rac-1	Rac-1	B-NP	B-NP	-	7	NMOD	-	-
4	but	but	B-NP	B-NP	-	7	NMOD	-	-
5	not	not	I-NP	I-NP	-	4	DEP	-	-
6	phosphatidyl	phosphatidyl	B-NP	B-NP	-	7	NMOD	-	-
7	inositol	inositol	I-NP	I-NP	-	9	NMOD	-	-
8	<num>	<num>	B-NP	B-NP	-	9	NMOD	-	-
9	kinase/PKB	kinase/PKB	I-NP	I-NP	-	13	NMOD	-	-
10	,	,	O	O	-	9	P	-	-
11	mediated	mediated	B-NP	B-NP	-	13	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	13	NMOD	-	-
13	pathways	pathways	I-NP	I-NP	-	2	OBJ	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	T	T	B-NP	B-NP	-	16	NMOD	-	-
16	lymphocytes	lymphocytes	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	2	P	-	-

1	p21ras	p21ras	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	activated	activated	I-VP	I-VP	-	2	VC	-	-
4	by	by	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	9	NMOD	-	-
6	T	T	I-NP	I-NP	-	9	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	9	NMOD	-	-
8	antigen	antigen	I-NP	I-NP	-	9	NMOD	-	-
9	receptor	receptor	I-NP	I-NP	-	4	PMOD	-	-
10	(	(	O	O	-	11	P	-	-
11	TCR	TCR	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	and	and	O	O	-	2	VMOD	-	-
14	then	then	B-VP	B-VP	-	15	VMOD	-	-
15	co-ordinates	co-ordinates	I-VP	I-VP	-	2	VMOD	-	-
16	important	important	B-NP	B-NP	-	18	NMOD	-	-
17	signaling	signaling	I-NP	I-NP	-	18	NMOD	-	-
18	pathways	pathways	I-NP	I-NP	-	15	OBJ	-	-
19	for	for	B-PP	B-PP	-	18	NMOD	-	-
20	T	T	B-NP	B-NP	-	22	NMOD	-	-
21	lymphocyte	lymphocyte	I-NP	I-NP	-	22	NMOD	-	-
22	activation	activation	I-NP	I-NP	-	19	PMOD	-	-
23	.	.	O	O	-	2	P	-	-

1	Effector	Effector	B-NP	B-NP	-	2	NMOD	-	-
2	pathways	pathways	I-NP	I-NP	-	12	SUB	-	-
3	for	for	B-PP	B-PP	-	2	NMOD	-	-
4	this	this	B-NP	B-NP	-	8	NMOD	-	-
5	guanine	guanine	I-NP	I-NP	-	8	NMOD	-	-
6	nucleotide	nucleotide	I-NP	I-NP	-	8	NMOD	-	-
7	binding	binding	I-NP	I-NP	-	8	NMOD	-	-
8	protein	protein	I-NP	I-NP	-	3	PMOD	-	-
9	in	in	B-PP	B-PP	-	2	NMOD	-	-
10	T	T	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
12	are	are	B-VP	B-VP	-	0	ROOT	-	-
13	mediated	mediated	I-VP	I-VP	-	12	VC	-	-
14	by	by	B-PP	B-PP	-	13	VMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	serine/threonine	serine/threonine	I-NP	I-NP	-	18	NMOD	-	-
17	kinase	kinase	I-NP	I-NP	-	18	NMOD	-	-
18	Raf-1	Raf-1	I-NP	I-NP	-	23	NMOD	-	-
19	and	and	O	O	-	23	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	Ras-related	Ras-related	I-NP	I-NP	-	23	NMOD	-	-
22	GTPase	GTPase	I-NP	I-NP	-	23	NMOD	-	-
23	Rac-1	Rac-1	I-NP	I-NP	-	14	PMOD	-	-
24	.	.	O	O	-	12	P	-	-

1	In	In	B-PP	B-PP	-	11	VMOD	-	-
2	fibroblasts	fibroblasts	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	11	P	-	-
4	an	an	B-NP	B-NP	-	6	NMOD	-	-
5	important	important	I-NP	I-NP	-	6	NMOD	-	-
6	effector	effector	I-NP	I-NP	-	11	SUB	-	-
7	for	for	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	Ras	Ras	I-NP	I-NP	-	10	NMOD	-	-
10	oncogene	oncogene	I-NP	I-NP	-	7	PMOD	-	-
11	is	is	B-VP	B-VP	-	0	ROOT	-	-
12	Phosphatidylinositol	Phosphatidylinositol	B-NP	B-NP	-	13	NMOD	-	-
13	3-kinase	3-kinase	I-NP	I-NP	-	11	PRD	-	-
14	(	(	O	O	-	16	P	-	-
15	PtdIns	PtdIns	B-NP	B-NP	-	16	NMOD	-	-
16	3-kinase	3-kinase	I-NP	I-NP	-	13	NMOD	-	-
17	)	)	O	O	-	16	P	-	-
18	.	.	O	O	-	11	P	-	-

1	Activation	Activation	B-NP	B-NP	-	6	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	this	this	B-NP	B-NP	-	5	NMOD	-	-
4	lipid	lipid	I-NP	I-NP	-	5	NMOD	-	-
5	kinase	kinase	I-NP	I-NP	-	2	PMOD	-	-
6	is	is	B-VP	B-VP	-	0	ROOT	-	-
7	able	able	B-ADJP	B-ADJP	-	6	PRD	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	induce	induce	I-VP	I-VP	-	7	AMOD	-	-
10	critical	critical	B-NP	B-NP	-	13	NMOD	-	-
11	Rac-1	Rac-1	I-NP	I-NP	-	13	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	13	NMOD	-	-
13	pathways	pathways	I-NP	I-NP	-	9	OBJ	-	-
14	and	and	O	O	-	6	VMOD	-	-
15	can	can	B-VP	B-VP	-	6	VMOD	-	-
16	couple	couple	I-VP	I-VP	-	15	VC	-	-
17	p21ras	p21ras	B-NP	B-NP	-	16	OBJ	-	-
18	to	to	B-PP	B-PP	-	16	VMOD	-	-
19	cell	cell	B-NP	B-NP	-	21	NMOD	-	-
20	survival	survival	I-NP	I-NP	-	21	NMOD	-	-
21	mechanisms	mechanisms	I-NP	I-NP	-	18	PMOD	-	-
22	via	via	B-PP	B-PP	-	16	VMOD	-	-
23	the	the	B-NP	B-NP	-	26	NMOD	-	-
24	serine/threonine	serine/threonine	I-NP	I-NP	-	26	NMOD	-	-
25	kinase	kinase	I-NP	I-NP	-	26	NMOD	-	-
26	Akt/PKB	Akt/PKB	I-NP	I-NP	-	22	PMOD	-	-
27	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	12	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	PtdIns	PtdIns	B-NP	B-NP	-	5	NMOD	-	-
5	3-kinase	3-kinase	I-NP	I-NP	-	3	PMOD	-	-
6	in	in	B-PP	B-PP	-	2	NMOD	-	-
7	Ras	Ras	B-NP	B-NP	-	8	NMOD	-	-
8	signaling	signaling	I-NP	I-NP	-	6	PMOD	-	-
9	in	in	B-PP	B-PP	-	8	NMOD	-	-
10	T	T	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
12	has	has	B-VP	B-VP	-	0	ROOT	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	been	been	I-VP	I-VP	-	12	VC	-	-
15	explored	explored	I-VP	I-VP	-	14	VC	-	-
16	.	.	O	O	-	12	P	-	-

1	In	In	B-PP	B-PP	-	7	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	present	present	I-NP	I-NP	-	4	NMOD	-	-
4	study	study	I-NP	I-NP	-	1	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	we	we	B-NP	B-NP	-	7	SUB	-	-
7	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	ability	ability	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	PtdIns	PtdIns	B-NP	B-NP	-	12	NMOD	-	-
12	3-kinase	3-kinase	I-NP	I-NP	-	10	PMOD	-	-
13	to	to	B-VP	B-VP	-	14	VMOD	-	-
14	initiate	initiate	I-VP	I-VP	-	9	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	Rac-1	Rac-1	I-NP	I-NP	-	18	NMOD	-	-
17	signaling	signaling	I-NP	I-NP	-	18	NMOD	-	-
18	pathways	pathways	I-NP	I-NP	-	14	OBJ	-	-
19	important	important	B-ADJP	B-ADJP	-	18	NMOD	-	-
20	for	for	B-PP	B-PP	-	19	AMOD	-	-
21	T	T	B-NP	B-NP	-	23	NMOD	-	-
22	cell	cell	I-NP	I-NP	-	23	NMOD	-	-
23	activation	activation	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	7	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	also	also	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	examined	examined	B-VP	B-VP	-	0	ROOT	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	possibility	possibility	I-NP	I-NP	-	3	OBJ	-	-
6	that	that	B-SBAR	B-SBAR	-	5	NMOD	-	-
7	Akt/PKB	Akt/PKB	B-NP	B-NP	-	8	SUB	-	-
8	is	is	B-VP	B-VP	-	6	SBAR	-	-
9	regulated	regulated	I-VP	I-VP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	Ras	Ras	B-NP	B-NP	-	13	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	13	NMOD	-	-
13	pathways	pathways	I-NP	I-NP	-	10	PMOD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	T	T	B-NP	B-NP	-	16	NMOD	-	-
16	lymphocytes	lymphocytes	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	Ras	Ras	B-NP	B-NP	-	6	SUB	-	-
6	can	can	B-VP	B-VP	-	4	SBAR	-	-
7	initiate	initiate	I-VP	I-VP	-	6	VC	-	-
8	a	a	B-NP	B-NP	-	11	NMOD	-	-
9	Rac-1	Rac-1	I-NP	I-NP	-	11	NMOD	-	-
10	mediated	mediated	I-NP	I-NP	-	11	NMOD	-	-
11	pathway	pathway	I-NP	I-NP	-	7	OBJ	-	-
12	that	that	B-NP	B-NP	-	11	NMOD	-	-
13	regulates	regulates	B-VP	B-VP	-	12	SBAR	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	transcriptional	transcriptional	I-NP	I-NP	-	16	NMOD	-	-
16	function	function	I-NP	I-NP	-	13	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	AP-1	AP-1	B-NP	B-NP	-	19	NMOD	-	-
19	complexes	complexes	I-NP	I-NP	-	17	PMOD	-	-
20	.	.	O	O	-	3	P	-	-

1	PtdIns	PtdIns	B-NP	B-NP	-	3	NMOD	-	-
2	3-kinase	3-kinase	I-NP	I-NP	-	3	NMOD	-	-
3	signals	signals	I-NP	I-NP	-	4	SUB	-	-
4	can	can	B-VP	B-VP	-	0	ROOT	-	-
5	not	not	I-VP	I-VP	-	4	VMOD	-	-
6	mimic	mimic	I-VP	I-VP	-	4	VC	-	-
7	p21ras	p21ras	B-NP	B-NP	-	6	OBJ	-	-
8	and	and	O	O	-	6	VMOD	-	-
9	induce	induce	B-VP	B-VP	-	6	VMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	Rac	Rac	I-NP	I-NP	-	13	NMOD	-	-
12	mediated	mediated	B-VP	B-VP	-	13	NMOD	-	-
13	responses	responses	B-NP	B-NP	-	6	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	AP-1	AP-1	B-NP	B-NP	-	17	NMOD	-	-
16	transcriptional	transcriptional	I-NP	I-NP	-	17	NMOD	-	-
17	activation	activation	I-NP	I-NP	-	14	PMOD	-	-
18	.	.	O	O	-	4	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	10	VMOD	-	-
2	,	,	O	O	-	10	P	-	-
3	neither	neither	O	O	-	7	NMOD	-	-
4	TCR	TCR	B-NP	B-NP	-	7	NMOD	-	-
5	or	or	I-NP	I-NP	-	7	NMOD	-	-
6	Ras	Ras	I-NP	I-NP	-	7	NMOD	-	-
7	activation	activation	I-NP	I-NP	-	10	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	AP-1	AP-1	B-NP	B-NP	-	8	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	dependent	dependent	B-ADJP	B-ADJP	-	10	PRD	-	-
12	on	on	B-PP	B-PP	-	11	AMOD	-	-
13	PtdIns	PtdIns	B-NP	B-NP	-	14	NMOD	-	-
14	3-kinase	3-kinase	I-NP	I-NP	-	12	PMOD	-	-
15	.	.	O	O	-	10	P	-	-

1	PKB	PKB	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	18	VMOD	-	-
3	activated	activated	I-VP	I-VP	-	2	VC	-	-
4	in	in	B-PP	B-PP	-	3	VMOD	-	-
5	response	response	I-PP	I-PP	-	4	PMOD	-	-
6	to	to	I-PP	I-PP	-	4	PMOD	-	-
7	triggering	triggering	B-NP	B-NP	-	4	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	the	the	B-NP	B-NP	-	13	NMOD	-	-
10	T	T	I-NP	I-NP	-	13	NMOD	-	-
11	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
12	antigen	antigen	I-NP	I-NP	-	13	NMOD	-	-
13	receptor	receptor	I-NP	I-NP	-	8	PMOD	-	-
14	;	;	O	O	-	2	P	-	-
15	PtdIns	PtdIns	B-NP	B-NP	-	17	NMOD	-	-
16	3-kinase	3-kinase	I-NP	I-NP	-	17	NMOD	-	-
17	activity	activity	I-NP	I-NP	-	18	SUB	-	-
18	is	is	B-VP	B-VP	-	0	ROOT	-	-
19	both	both	I-VP	I-VP	-	18	VMOD	-	-
20	required	required	I-VP	I-VP	-	18	VC	-	-
21	and	and	O	O	-	18	VMOD	-	-
22	sufficient	sufficient	B-ADJP	B-ADJP	-	18	PRD	-	-
23	for	for	B-PP	B-PP	-	22	AMOD	-	-
24	this	this	B-NP	B-NP	-	26	NMOD	-	-
25	TCR	TCR	I-NP	I-NP	-	26	NMOD	-	-
26	response	response	I-NP	I-NP	-	23	PMOD	-	-
27	.	.	O	O	-	18	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	6	P	-	-
4	p21ras	p21ras	B-NP	B-NP	-	5	NMOD	-	-
5	signals	signals	I-NP	I-NP	-	6	SUB	-	-
6	are	are	B-VP	B-VP	-	0	ROOT	-	-
7	unable	unable	B-ADJP	B-ADJP	-	6	PRD	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	induce	induce	I-VP	I-VP	-	7	AMOD	-	-
10	Akt/PKB	Akt/PKB	B-NP	B-NP	-	11	NMOD	-	-
11	activity	activity	I-NP	I-NP	-	9	OBJ	-	-
12	in	in	B-PP	B-PP	-	9	VMOD	-	-
13	T	T	B-NP	B-NP	-	14	NMOD	-	-
14	cell	cell	I-NP	I-NP	-	12	PMOD	-	-
15	nor	nor	O	O	-	6	VMOD	-	-
16	is	is	B-VP	B-VP	-	6	VMOD	-	-
17	Ras	Ras	B-NP	B-NP	-	18	NMOD	-	-
18	function	function	I-NP	I-NP	-	16	PRD	-	-
19	required	required	B-VP	B-VP	-	18	NMOD	-	-
20	for	for	B-PP	B-PP	-	19	VMOD	-	-
21	Akt/PKB	Akt/PKB	B-NP	B-NP	-	22	NMOD	-	-
22	activation	activation	I-NP	I-NP	-	20	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	response	response	B-NP	B-NP	-	23	PMOD	-	-
25	to	to	B-PP	B-PP	-	23	PMOD	-	-
26	the	the	B-NP	B-NP	-	27	NMOD	-	-
27	TCR	TCR	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	present	present	I-NP	I-NP	-	3	NMOD	-	-
3	data	data	I-NP	I-NP	-	5	SUB	-	-
4	thus	thus	B-ADVP	B-ADVP	-	5	VMOD	-	-
5	highlight	highlight	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	PtdIns	PtdIns	B-NP	B-NP	-	8	NMOD	-	-
8	3-kinase	3-kinase	I-NP	I-NP	-	10	NMOD	-	-
9	and	and	I-NP	I-NP	-	10	NMOD	-	-
10	Akt/PKB	Akt/PKB	I-NP	I-NP	-	11	SUB	-	-
11	are	are	B-VP	B-VP	-	6	SBAR	-	-
12	not	not	O	O	-	11	VMOD	-	-
13	universal	universal	B-NP	B-NP	-	16	NMOD	-	-
14	Ras	Ras	I-NP	I-NP	-	16	NMOD	-	-
15	effector	effector	I-NP	I-NP	-	16	NMOD	-	-
16	molecules	molecules	I-NP	I-NP	-	11	PRD	-	-
17	.	.	O	O	-	5	P	-	-

1	Ras	Ras	B-NP	B-NP	-	2	SUB	-	-
2	can	can	B-VP	B-VP	-	0	ROOT	-	-
3	initiate	initiate	I-VP	I-VP	-	2	VC	-	-
4	Rac-1	Rac-1	B-NP	B-NP	-	7	NMOD	-	-
5	regulated	regulated	I-NP	I-NP	-	7	NMOD	-	-
6	signaling	signaling	I-NP	I-NP	-	7	NMOD	-	-
7	pathways	pathways	I-NP	I-NP	-	3	OBJ	-	-
8	in	in	B-PP	B-PP	-	3	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	context	context	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	T	T	B-NP	B-NP	-	15	NMOD	-	-
13	cell	cell	I-NP	I-NP	-	15	NMOD	-	-
14	antigen	antigen	I-NP	I-NP	-	15	NMOD	-	-
15	receptor	receptor	I-NP	I-NP	-	16	NMOD	-	-
16	function	function	I-NP	I-NP	-	11	PMOD	-	-
17	independently	independently	B-ADVP	B-ADVP	-	18	PMOD	-	-
18	of	of	B-PP	B-PP	-	16	NMOD	-	-
19	PtdIns	PtdIns	B-NP	B-NP	-	21	NMOD	-	-
20	3-kinase	3-kinase	I-NP	I-NP	-	21	NMOD	-	-
21	activity	activity	I-NP	I-NP	-	18	PMOD	-	-
22	.	.	O	O	-	2	P	-	-

1	Signal	Signal	B-NP	B-NP	-	3	NMOD	-	-
2	transduction	transduction	I-NP	I-NP	-	3	NMOD	-	-
3	abnormalities	abnormalities	I-NP	I-NP	-	17	NMOD	-	-
4	in	in	B-PP	B-PP	-	3	NMOD	-	-
5	T	T	B-NP	B-NP	-	6	NMOD	-	-
6	lymphocytes	lymphocytes	I-NP	I-NP	-	4	PMOD	-	-
7	from	from	B-PP	B-PP	-	6	NMOD	-	-
8	patients	patients	B-NP	B-NP	-	7	PMOD	-	-
9	with	with	B-PP	B-PP	-	8	NMOD	-	-
10	advanced	advanced	B-NP	B-NP	-	12	NMOD	-	-
11	renal	renal	I-NP	I-NP	-	12	NMOD	-	-
12	carcinoma	carcinoma	I-NP	I-NP	-	9	PMOD	-	-
13	:	:	O	O	-	3	P	-	-
14	clinical	clinical	B-NP	B-NP	-	15	NMOD	-	-
15	relevance	relevance	I-NP	I-NP	-	17	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	effects	effects	B-NP	B-NP	-	0	ROOT	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	cytokine	cytokine	B-NP	B-NP	-	20	NMOD	-	-
20	therapy	therapy	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	17	P	-	-

1	Studies	Studies	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	demonstrated	demonstrated	I-VP	I-VP	-	2	VC	-	-
4	abnormalities	abnormalities	B-NP	B-NP	-	3	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	CD3/T-cell	CD3/T-cell	I-NP	I-NP	-	9	NMOD	-	-
8	antigen	antigen	I-NP	I-NP	-	9	NMOD	-	-
9	receptor	receptor	I-NP	I-NP	-	14	NMOD	-	-
10	(	(	O	O	-	11	P	-	-
11	TCR	TCR	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	and	and	O	O	-	14	NMOD	-	-
14	pathways	pathways	B-NP	B-NP	-	5	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	signal	signal	B-NP	B-NP	-	17	NMOD	-	-
17	transduction	transduction	I-NP	I-NP	-	15	PMOD	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	T	T	B-NP	B-NP	-	20	NMOD	-	-
20	lymphocytes	lymphocytes	I-NP	I-NP	-	18	PMOD	-	-
21	from	from	B-PP	B-PP	-	20	NMOD	-	-
22	animals	animals	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	O	O	-	24	NMOD	-	-
24	patients	patients	B-NP	B-NP	-	21	PMOD	-	-
25	with	with	B-PP	B-PP	-	24	NMOD	-	-
26	advanced	advanced	B-NP	B-NP	-	27	NMOD	-	-
27	malignancy	malignancy	I-NP	I-NP	-	25	PMOD	-	-
28	.	.	O	O	-	2	P	-	-

1	Diminished	Diminished	B-NP	B-NP	-	2	NMOD	-	-
2	expression	expression	I-NP	I-NP	-	19	NMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	TCRzeta	TCRzeta	B-NP	B-NP	-	6	NMOD	-	-
5	and	and	O	O	-	6	NMOD	-	-
6	p56	p56	B-NP	B-NP	-	3	PMOD	-	-
7	(	(	O	O	-	8	P	-	-
8	lck	lck	B-NP	B-NP	-	6	NMOD	-	-
9	)	)	O	O	-	8	P	-	-
10	that	that	B-NP	B-NP	-	2	NMOD	-	-
11	are	are	B-VP	B-VP	-	10	SBAR	-	-
12	associated	associated	I-VP	I-VP	-	11	VC	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	the	the	B-NP	B-NP	-	15	NMOD	-	-
15	TCR	TCR	I-NP	I-NP	-	19	NMOD	-	-
16	and	and	O	O	-	19	NMOD	-	-
17	reduced	reduced	B-NP	B-NP	-	19	NMOD	-	-
18	nuclear	nuclear	I-NP	I-NP	-	19	NMOD	-	-
19	localization	localization	I-NP	I-NP	-	30	SUB	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	RelA	RelA	B-NP	B-NP	-	20	PMOD	-	-
22	containing	containing	B-VP	B-VP	-	21	NMOD	-	-
23	nuclear	nuclear	B-NP	B-NP	-	25	NMOD	-	-
24	factor	factor	I-NP	I-NP	-	25	NMOD	-	-
25	kappaB	kappaB	I-NP	I-NP	-	29	NMOD	-	-
26	(	(	O	O	-	27	P	-	-
27	NFkappaB	NFkappaB	B-NP	B-NP	-	25	NMOD	-	-
28	)	)	O	O	-	27	P	-	-
29	complexes	complexes	B-NP	B-NP	-	20	PMOD	-	-
30	have	have	B-VP	B-VP	-	0	ROOT	-	-
31	been	been	I-VP	I-VP	-	30	VC	-	-
32	noted	noted	I-VP	I-VP	-	31	VC	-	-
33	.	.	O	O	-	30	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	defects	defects	I-NP	I-NP	-	3	SUB	-	-
3	have	have	B-VP	B-VP	-	0	ROOT	-	-
4	been	been	I-VP	I-VP	-	3	VC	-	-
5	described	described	I-VP	I-VP	-	4	VC	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	T	T	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	PMOD	-	-
9	from	from	B-PP	B-PP	-	8	NMOD	-	-
10	patients	patients	B-NP	B-NP	-	9	PMOD	-	-
11	with	with	B-PP	B-PP	-	10	NMOD	-	-
12	malignant	malignant	B-NP	B-NP	-	13	NMOD	-	-
13	melanoma	melanoma	I-NP	I-NP	-	27	NMOD	-	-
14	,	,	O	O	-	27	P	-	-
15	renal	renal	B-NP	B-NP	-	17	NMOD	-	-
16	cell	cell	I-NP	I-NP	-	17	NMOD	-	-
17	carcinoma	carcinoma	I-NP	I-NP	-	27	NMOD	-	-
18	(	(	O	O	-	19	P	-	-
19	RCC	RCC	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	27	P	-	-
22	ovarian	ovarian	B-NP	B-NP	-	23	NMOD	-	-
23	cancer	cancer	I-NP	I-NP	-	27	NMOD	-	-
24	,	,	O	O	-	27	P	-	-
25	and	and	O	O	-	27	NMOD	-	-
26	colorectal	colorectal	B-NP	B-NP	-	27	NMOD	-	-
27	cancer	cancer	I-NP	I-NP	-	11	PMOD	-	-
28	.	.	O	O	-	3	P	-	-

1	Preliminary	Preliminary	B-NP	B-NP	-	2	NMOD	-	-
2	observations	observations	I-NP	I-NP	-	4	SUB	-	-
3	also	also	B-ADVP	B-ADVP	-	4	VMOD	-	-
4	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
5	possible	possible	B-NP	B-NP	-	6	NMOD	-	-
6	correlation	correlation	I-NP	I-NP	-	4	OBJ	-	-
7	with	with	B-PP	B-PP	-	6	NMOD	-	-
8	clinical	clinical	B-NP	B-NP	-	9	NMOD	-	-
9	variables	variables	I-NP	I-NP	-	7	PMOD	-	-
10	such	such	B-PP	B-PP	-	11	PMOD	-	-
11	as	as	I-PP	I-PP	-	9	NMOD	-	-
12	stage	stage	B-NP	B-NP	-	11	PMOD	-	-
13	in	in	B-PP	B-PP	-	12	NMOD	-	-
14	selected	selected	B-NP	B-NP	-	15	NMOD	-	-
15	instances	instances	I-NP	I-NP	-	13	PMOD	-	-
16	.	.	O	O	-	4	P	-	-

1	To	To	B-VP	B-VP	-	3	VMOD	-	-
2	further	further	I-VP	I-VP	-	3	VMOD	-	-
3	characterize	characterize	I-VP	I-VP	-	22	VMOD	-	-
4	altered	altered	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	3	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	TCRzeta	TCRzeta	B-NP	B-NP	-	16	NMOD	-	-
8	,	,	O	O	-	16	P	-	-
9	p56	p56	B-NP	B-NP	-	16	NMOD	-	-
10	(	(	O	O	-	11	P	-	-
11	lck	lck	B-NP	B-NP	-	9	NMOD	-	-
12	)	)	O	O	-	11	P	-	-
13	,	,	O	O	-	16	P	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	impaired	impaired	B-NP	B-NP	-	16	NMOD	-	-
16	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	NFkappaB	NFkappaB	B-NP	B-NP	-	17	PMOD	-	-
19	,	,	O	O	-	22	P	-	-
20	T	T	B-NP	B-NP	-	21	NMOD	-	-
21	lymphocytes	lymphocytes	I-NP	I-NP	-	22	SUB	-	-
22	were	were	B-VP	B-VP	-	0	ROOT	-	-
23	obtained	obtained	I-VP	I-VP	-	22	VC	-	-
24	from	from	B-PP	B-PP	-	23	VMOD	-	-
25	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
26	patients	patients	I-NP	I-NP	-	24	PMOD	-	-
27	with	with	B-PP	B-PP	-	26	NMOD	-	-
28	RCC	RCC	B-NP	B-NP	-	31	NMOD	-	-
29	,	,	O	O	-	31	P	-	-
30	the	the	B-NP	B-NP	-	31	NMOD	-	-
31	majority	majority	I-NP	I-NP	-	27	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	whom	whom	B-NP	B-NP	-	32	PMOD	-	-
34	were	were	B-VP	B-VP	-	32	SBAR	-	-
35	receiving	receiving	I-VP	I-VP	-	34	VMOD	-	-
36	combination	combination	B-NP	B-NP	-	38	NMOD	-	-
37	cytokine	cytokine	I-NP	I-NP	-	38	NMOD	-	-
38	therapy	therapy	I-NP	I-NP	-	53	NMOD	-	-
39	[	[	O	O	-	42	P	-	-
40	interleukin	interleukin	B-NP	B-NP	-	42	NMOD	-	-
41	(	(	O	O	-	42	P	-	-
42	IL	IL	B-NP	B-NP	-	38	NMOD	-	-
43	)	)	O	O	-	42	P	-	-
44	-2	-2	B-NP	B-NP	-	42	NMOD	-	-
45	,	,	O	O	-	48	P	-	-
46	IFN	IFN	B-NP	B-NP	-	48	NMOD	-	-
47	alpha-containing	alpha-containing	I-NP	I-NP	-	48	NMOD	-	-
48	regimens	regimens	I-NP	I-NP	-	38	NMOD	-	-
49	]	]	O	O	-	38	P	-	-
50	and	and	O	O	-	53	NMOD	-	-
51	<num>	<num>	B-NP	B-NP	-	53	NMOD	-	-
52	control	control	I-NP	I-NP	-	53	NMOD	-	-
53	individuals	individuals	I-NP	I-NP	-	32	PMOD	-	-
54	.	.	O	O	-	22	P	-	-

1	In	In	B-PP	B-PP	-	15	VMOD	-	-
2	<num>	<num>	B-NP	B-NP	-	1	PMOD	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	these	these	B-NP	B-NP	-	5	NMOD	-	-
5	patients	patients	I-NP	I-NP	-	3	PMOD	-	-
6	,	,	O	O	-	15	P	-	-
7	levels	levels	B-NP	B-NP	-	15	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	TCRzeta	TCRzeta	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	O	O	-	11	NMOD	-	-
11	p56	p56	B-NP	B-NP	-	8	PMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	lck	lck	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	were	were	B-VP	B-VP	-	0	ROOT	-	-
16	determined	determined	I-VP	I-VP	-	15	VC	-	-
17	by	by	B-PP	B-PP	-	16	VMOD	-	-
18	Western	Western	B-NP	B-NP	-	19	NMOD	-	-
19	blots	blots	I-NP	I-NP	-	17	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	T-cell	T-cell	B-NP	B-NP	-	22	NMOD	-	-
22	lysates	lysates	I-NP	I-NP	-	20	PMOD	-	-
23	and	and	O	O	-	16	VMOD	-	-
24	semiquantitated	semiquantitated	B-VP	B-VP	-	16	VMOD	-	-
25	using	using	B-VP	B-VP	-	24	VMOD	-	-
26	densitometry	densitometry	B-NP	B-NP	-	25	OBJ	-	-
27	.	.	O	O	-	15	P	-	-

1	Relative	Relative	B-NP	B-NP	-	2	NMOD	-	-
2	levels	levels	I-NP	I-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	0	ROOT	-	-
4	then	then	I-VP	I-VP	-	3	VMOD	-	-
5	correlated	correlated	I-VP	I-VP	-	3	VC	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	a	a	B-NP	B-NP	-	8	NMOD	-	-
8	series	series	I-NP	I-NP	-	6	PMOD	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	clinical	clinical	B-NP	B-NP	-	11	NMOD	-	-
11	variables	variables	I-NP	I-NP	-	9	PMOD	-	-
12	including	including	B-PP	B-PP	-	11	NMOD	-	-
13	response	response	B-NP	B-NP	-	12	PMOD	-	-
14	to	to	B-PP	B-PP	-	13	NMOD	-	-
15	therapy	therapy	B-NP	B-NP	-	14	PMOD	-	-
16	,	,	O	O	-	28	P	-	-
17	performance	performance	B-NP	B-NP	-	18	NMOD	-	-
18	status	status	I-NP	I-NP	-	28	NMOD	-	-
19	,	,	O	O	-	28	P	-	-
20	survival	survival	B-NP	B-NP	-	28	NMOD	-	-
21	,	,	O	O	-	28	P	-	-
22	disease	disease	B-NP	B-NP	-	23	NMOD	-	-
23	sites	sites	I-NP	I-NP	-	28	NMOD	-	-
24	,	,	O	O	-	28	P	-	-
25	age	age	B-NP	B-NP	-	28	NMOD	-	-
26	,	,	O	O	-	28	P	-	-
27	and	and	O	O	-	28	NMOD	-	-
28	others	others	B-NP	B-NP	-	14	PMOD	-	-
29	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	22	VMOD	-	-
2	another	another	B-NP	B-NP	-	3	NMOD	-	-
3	group	group	I-NP	I-NP	-	1	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	<num>	<num>	B-NP	B-NP	-	6	NMOD	-	-
6	patients	patients	I-NP	I-NP	-	4	PMOD	-	-
7	(	(	O	O	-	22	P	-	-
8	three	three	B-NP	B-NP	-	9	NMOD	-	-
9	individuals	individuals	I-NP	I-NP	-	22	SUB	-	-
10	from	from	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	first	first	I-NP	I-NP	-	13	NMOD	-	-
13	group	group	I-NP	I-NP	-	10	PMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	,	,	O	O	-	22	P	-	-
16	the	the	B-NP	B-NP	-	17	NMOD	-	-
17	frequency	frequency	I-NP	I-NP	-	22	SUB	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	abnormal	abnormal	B-NP	B-NP	-	21	NMOD	-	-
20	NFkappaB	NFkappaB	I-NP	I-NP	-	21	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	18	PMOD	-	-
22	was	was	B-VP	B-VP	-	0	ROOT	-	-
23	studied	studied	I-VP	I-VP	-	22	VC	-	-
24	using	using	B-VP	B-VP	-	23	VMOD	-	-
25	electrophoretic	electrophoretic	B-NP	B-NP	-	28	NMOD	-	-
26	mobility	mobility	I-NP	I-NP	-	28	NMOD	-	-
27	shift	shift	I-NP	I-NP	-	28	NMOD	-	-
28	assays	assays	I-NP	I-NP	-	24	OBJ	-	-
29	after	after	B-PP	B-PP	-	24	VMOD	-	-
30	activation	activation	B-NP	B-NP	-	29	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	T	T	B-NP	B-NP	-	33	NMOD	-	-
33	cells	cells	I-NP	I-NP	-	31	PMOD	-	-
34	with	with	B-PP	B-PP	-	30	NMOD	-	-
35	phorbol	phorbol	B-NP	B-NP	-	37	NMOD	-	-
36	myristate	myristate	I-NP	I-NP	-	37	NMOD	-	-
37	acetate/ionomycin	acetate/ionomycin	I-NP	I-NP	-	41	NMOD	-	-
38	or	or	O	O	-	41	NMOD	-	-
39	anti-CD3	anti-CD3	B-NP	B-NP	-	41	NMOD	-	-
40	monoclonal	monoclonal	I-NP	I-NP	-	41	NMOD	-	-
41	antibody	antibody	I-NP	I-NP	-	34	PMOD	-	-
42	.	.	O	O	-	22	P	-	-

1	Changes	Changes	B-NP	B-NP	-	9	SUB	-	-
2	in	in	B-PP	B-PP	-	1	NMOD	-	-
3	these	these	B-NP	B-NP	-	5	NMOD	-	-
4	signaling	signaling	I-NP	I-NP	-	5	NMOD	-	-
5	molecules	molecules	I-NP	I-NP	-	2	PMOD	-	-
6	during	during	B-PP	B-PP	-	1	NMOD	-	-
7	cytokine	cytokine	B-NP	B-NP	-	8	NMOD	-	-
8	treatment	treatment	I-NP	I-NP	-	6	PMOD	-	-
9	were	were	B-VP	B-VP	-	0	ROOT	-	-
10	also	also	I-VP	I-VP	-	9	VMOD	-	-
11	investigated	investigated	I-VP	I-VP	-	9	VC	-	-
12	.	.	O	O	-	9	P	-	-

1	TCRzeta	TCRzeta	B-NP	B-NP	-	3	NMOD	-	-
2	and	and	I-NP	I-NP	-	3	NMOD	-	-
3	p56	p56	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	lck	lck	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	were	were	B-VP	B-VP	-	26	VMOD	-	-
8	detected	detected	I-VP	I-VP	-	7	VC	-	-
9	in	in	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	14	NMOD	-	-
11	peripheral	peripheral	I-NP	I-NP	-	14	NMOD	-	-
12	blood	blood	I-NP	I-NP	-	14	NMOD	-	-
13	T	T	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
15	in	in	B-PP	B-PP	-	8	VMOD	-	-
16	<num>	<num>	B-NP	B-NP	-	15	PMOD	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	<num>	<num>	B-NP	B-NP	-	19	NMOD	-	-
19	patients	patients	I-NP	I-NP	-	17	PMOD	-	-
20	,	,	O	O	-	26	P	-	-
21	and	and	O	O	-	26	VMOD	-	-
22	overall	overall	B-ADVP	B-ADVP	-	26	VMOD	-	-
23	,	,	O	O	-	26	P	-	-
24	reduced	reduced	B-NP	B-NP	-	25	NMOD	-	-
25	levels	levels	I-NP	I-NP	-	26	SUB	-	-
26	were	were	B-VP	B-VP	-	0	ROOT	-	-
27	noted	noted	I-VP	I-VP	-	26	VC	-	-
28	visually	visually	B-ADVP	B-ADVP	-	27	VMOD	-	-
29	in	in	B-PP	B-PP	-	27	VMOD	-	-
30	<num>	<num>	B-NP	B-NP	-	29	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	<num>	<num>	B-NP	B-NP	-	45	NMOD	-	-
33	(	(	O	O	-	35	P	-	-
34	<num>	<num>	B-NP	B-NP	-	35	NMOD	-	-
35	%	%	I-NP	I-NP	-	32	NMOD	-	-
36	)	)	O	O	-	35	P	-	-
37	and	and	O	O	-	38	NMOD	-	-
38	<num>	<num>	B-NP	B-NP	-	40	NMOD	-	-
39	of	of	B-PP	B-PP	-	38	NMOD	-	-
40	<num>	<num>	B-NP	B-NP	-	45	NMOD	-	-
41	(	(	O	O	-	43	P	-	-
42	<num>	<num>	B-NP	B-NP	-	43	NMOD	-	-
43	%	%	I-NP	I-NP	-	40	NMOD	-	-
44	)	)	O	O	-	43	P	-	-
45	individuals	individuals	B-NP	B-NP	-	31	PMOD	-	-
46	,	,	O	O	-	27	P	-	-
47	respectively	respectively	B-ADVP	B-ADVP	-	27	VMOD	-	-
48	.	.	O	O	-	26	P	-	-

1	When	When	B-ADVP	B-ADVP	-	41	VMOD	-	-
2	levels	levels	B-NP	B-NP	-	3	SUB	-	-
3	were	were	B-VP	B-VP	-	1	SBAR	-	-
4	semiquantitated	semiquantitated	I-VP	I-VP	-	3	VC	-	-
5	using	using	B-VP	B-VP	-	4	VMOD	-	-
6	densitometry	densitometry	B-NP	B-NP	-	9	NMOD	-	-
7	,	,	O	O	-	9	P	-	-
8	significant	significant	B-NP	B-NP	-	9	NMOD	-	-
9	decreases	decreases	I-NP	I-NP	-	5	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	TCRzeta	TCRzeta	B-NP	B-NP	-	18	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	P	P	B-NP	B-NP	-	18	NMOD	-	-
14	=	=	B-VP	B-VP	-	13	NMOD	-	-
15	<num>	<num>	B-NP	B-NP	-	14	AMOD	-	-
16	)	)	O	O	-	13	P	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	p56	p56	B-NP	B-NP	-	10	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	lck	lck	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	(	(	O	O	-	23	P	-	-
23	P	P	B-NP	B-NP	-	18	NMOD	-	-
24	=	=	B-VP	B-VP	-	23	NMOD	-	-
25	<num>	<num>	B-NP	B-NP	-	24	AMOD	-	-
26	)	)	O	O	-	23	P	-	-
27	but	but	B-NP	B-NP	-	29	NMOD	-	-
28	not	not	I-NP	I-NP	-	27	DEP	-	-
29	CD3epsilon	CD3epsilon	B-NP	B-NP	-	10	PMOD	-	-
30	(	(	O	O	-	31	P	-	-
31	P	P	B-NP	B-NP	-	29	NMOD	-	-
32	=	=	B-VP	B-VP	-	31	NMOD	-	-
33	<num>	<num>	B-NP	B-NP	-	32	AMOD	-	-
34	)	)	O	O	-	31	P	-	-
35	,	,	O	O	-	9	P	-	-
36	compared	compared	B-PP	B-PP	-	9	NMOD	-	-
37	with	with	B-PP	B-PP	-	36	PMOD	-	-
38	control	control	B-NP	B-NP	-	39	NMOD	-	-
39	levels	levels	I-NP	I-NP	-	37	PMOD	-	-
40	,	,	O	O	-	3	P	-	-
41	were	were	B-VP	B-VP	-	0	ROOT	-	-
42	found	found	I-VP	I-VP	-	41	VC	-	-
43	.	.	O	O	-	41	P	-	-

1	In	In	B-PP	B-PP	-	13	VMOD	-	-
2	patients	patients	B-NP	B-NP	-	1	PMOD	-	-
3	treated	treated	B-VP	B-VP	-	2	NMOD	-	-
4	with	with	B-PP	B-PP	-	3	VMOD	-	-
5	IL-2/IFN	IL-2/IFN	B-NP	B-NP	-	7	NMOD	-	-
6	alpha-based	alpha-based	I-NP	I-NP	-	7	NMOD	-	-
7	therapy	therapy	I-NP	I-NP	-	4	PMOD	-	-
8	,	,	O	O	-	13	P	-	-
9	relative	relative	B-NP	B-NP	-	10	NMOD	-	-
10	levels	levels	I-NP	I-NP	-	13	SUB	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	TCRzeta	TCRzeta	B-NP	B-NP	-	11	PMOD	-	-
13	increased	increased	B-VP	B-VP	-	0	ROOT	-	-
14	significantly	significantly	B-ADVP	B-ADVP	-	13	VMOD	-	-
15	(	(	O	O	-	16	P	-	-
16	P	P	B-NP	B-NP	-	13	VMOD	-	-
17	=	=	B-VP	B-VP	-	16	NMOD	-	-
18	<num>	<num>	B-NP	B-NP	-	17	AMOD	-	-
19	)	)	O	O	-	16	P	-	-
20	on	on	B-PP	B-PP	-	13	VMOD	-	-
21	day	day	B-NP	B-NP	-	20	PMOD	-	-
22	<num>	<num>	I-NP	I-NP	-	21	NMOD	-	-
23	of	of	B-PP	B-PP	-	21	NMOD	-	-
24	cycle	cycle	B-NP	B-NP	-	23	PMOD	-	-
25	one	one	I-NP	I-NP	-	24	NMOD	-	-
26	compared	compared	B-PP	B-PP	-	13	VMOD	-	-
27	with	with	B-PP	B-PP	-	26	PMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	baseline	baseline	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	13	P	-	-

1	Correlations	Correlations	B-NP	B-NP	-	33	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	TCRzeta	TCRzeta	B-NP	B-NP	-	9	NMOD	-	-
4	or	or	O	O	-	9	NMOD	-	-
5	p56	p56	B-NP	B-NP	-	9	NMOD	-	-
6	(	(	O	O	-	7	P	-	-
7	lck	lck	B-NP	B-NP	-	5	NMOD	-	-
8	)	)	O	O	-	7	P	-	-
9	levels	levels	B-NP	B-NP	-	2	PMOD	-	-
10	with	with	B-PP	B-PP	-	9	NMOD	-	-
11	response	response	B-NP	B-NP	-	14	NMOD	-	-
12	or	or	I-NP	I-NP	-	14	NMOD	-	-
13	disease	disease	I-NP	I-NP	-	14	NMOD	-	-
14	variables	variables	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	9	P	-	-
16	except	except	B-PP	B-PP	-	33	VMOD	-	-
17	for	for	B-PP	B-PP	-	16	PMOD	-	-
18	lower	lower	B-NP	B-NP	-	20	NMOD	-	-
19	TCRzeta	TCRzeta	I-NP	I-NP	-	20	NMOD	-	-
20	levels	levels	I-NP	I-NP	-	17	PMOD	-	-
21	(	(	O	O	-	22	P	-	-
22	P	P	B-NP	B-NP	-	20	NMOD	-	-
23	<	<	O	O	-	22	NMOD	-	-
24	<num>	<num>	B-NP	B-NP	-	23	AMOD	-	-
25	)	)	O	O	-	22	P	-	-
26	in	in	B-PP	B-PP	-	20	NMOD	-	-
27	the	the	I-PP	I-PP	-	26	PMOD	-	-
28	presence	presence	I-PP	I-PP	-	26	PMOD	-	-
29	of	of	I-PP	I-PP	-	26	PMOD	-	-
30	bone	bone	B-NP	B-NP	-	31	NMOD	-	-
31	metastases	metastases	I-NP	I-NP	-	26	PMOD	-	-
32	,	,	O	O	-	20	P	-	-
33	were	were	B-VP	B-VP	-	0	ROOT	-	-
34	not	not	I-VP	I-VP	-	33	VMOD	-	-
35	found	found	I-VP	I-VP	-	33	VC	-	-
36	.	.	O	O	-	33	P	-	-

1	Abnormal	Abnormal	B-NP	B-NP	-	3	NMOD	-	-
2	NFkappaB	NFkappaB	I-NP	I-NP	-	3	NMOD	-	-
3	activation	activation	I-NP	I-NP	-	14	SUB	-	-
4	after	after	B-PP	B-PP	-	3	NMOD	-	-
5	stimulation	stimulation	B-NP	B-NP	-	4	PMOD	-	-
6	with	with	B-PP	B-PP	-	3	NMOD	-	-
7	phorbol	phorbol	B-NP	B-NP	-	9	NMOD	-	-
8	myristate	myristate	I-NP	I-NP	-	9	NMOD	-	-
9	acetate/ionomycin	acetate/ionomycin	I-NP	I-NP	-	13	NMOD	-	-
10	and/or	and/or	O	O	-	13	NMOD	-	-
11	anti-CD3	anti-CD3	B-NP	B-NP	-	13	NMOD	-	-
12	monoclonal	monoclonal	I-NP	I-NP	-	13	NMOD	-	-
13	antibody	antibody	I-NP	I-NP	-	6	PMOD	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	found	found	I-VP	I-VP	-	14	VC	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
18	%	%	I-NP	I-NP	-	16	PMOD	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	patients	patients	B-NP	B-NP	-	19	PMOD	-	-
21	(	(	O	O	-	24	P	-	-
22	<num>	<num>	B-NP	B-NP	-	24	NMOD	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	<num>	<num>	B-NP	B-NP	-	20	NMOD	-	-
25	)	)	O	O	-	24	P	-	-
26	and	and	O	O	-	14	VMOD	-	-
27	was	was	B-VP	B-VP	-	14	VMOD	-	-
28	not	not	I-VP	I-VP	-	27	VMOD	-	-
29	accounted	accounted	I-VP	I-VP	-	27	VC	-	-
30	for	for	B-PP	B-PP	-	29	VMOD	-	-
31	by	by	B-PP	B-PP	-	30	PMOD	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	advanced	advanced	I-NP	I-NP	-	34	NMOD	-	-
34	age	age	I-NP	I-NP	-	31	PMOD	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	the	the	B-NP	B-NP	-	38	NMOD	-	-
37	study	study	I-NP	I-NP	-	38	NMOD	-	-
38	cohort	cohort	I-NP	I-NP	-	35	PMOD	-	-
39	.	.	O	O	-	14	P	-	-

1	Activation	Activation	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	NFkappaB	NFkappaB	B-NP	B-NP	-	2	PMOD	-	-
4	in	in	B-PP	B-PP	-	1	NMOD	-	-
5	peripheral	peripheral	B-NP	B-NP	-	8	NMOD	-	-
6	blood	blood	I-NP	I-NP	-	8	NMOD	-	-
7	T	T	I-NP	I-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
9	was	was	B-VP	B-VP	-	0	ROOT	-	-
10	inducible	inducible	B-ADJP	B-ADJP	-	9	PRD	-	-
11	during	during	B-PP	B-PP	-	10	AMOD	-	-
12	cytokine	cytokine	B-NP	B-NP	-	13	NMOD	-	-
13	therapy	therapy	I-NP	I-NP	-	11	PMOD	-	-
14	in	in	B-PP	B-PP	-	13	NMOD	-	-
15	four	four	B-NP	B-NP	-	14	PMOD	-	-
16	of	of	I-NP	I-NP	-	15	NMOD	-	-
17	six	six	I-NP	I-NP	-	18	NMOD	-	-
18	individuals	individuals	I-NP	I-NP	-	16	PMOD	-	-
19	who	who	B-NP	B-NP	-	15	NMOD	-	-
20	displayed	displayed	B-VP	B-VP	-	19	VMOD	-	-
21	impaired	impaired	B-NP	B-NP	-	23	NMOD	-	-
22	NFkappaB	NFkappaB	I-NP	I-NP	-	23	NMOD	-	-
23	activity	activity	I-NP	I-NP	-	20	OBJ	-	-
24	prior	prior	B-ADVP	B-ADVP	-	25	PMOD	-	-
25	to	to	B-PP	B-PP	-	20	VMOD	-	-
26	therapy	therapy	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	9	P	-	-

1	Moreover	Moreover	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	impaired	impaired	B-NP	B-NP	-	4	NMOD	-	-
4	activation	activation	I-NP	I-NP	-	7	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	NFkappaB	NFkappaB	B-NP	B-NP	-	5	PMOD	-	-
7	does	does	B-VP	B-VP	-	0	ROOT	-	-
8	not	not	I-VP	I-VP	-	7	VMOD	-	-
9	appear	appear	I-VP	I-VP	-	7	VC	-	-
10	linked	linked	I-VP	I-VP	-	9	VC	-	-
11	to	to	B-PP	B-PP	-	10	VMOD	-	-
12	a	a	B-NP	B-NP	-	13	NMOD	-	-
13	reduction	reduction	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	TCRzeta	TCRzeta	B-NP	B-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	7	P	-	-
18	because	because	B-SBAR	B-SBAR	-	7	VMOD	-	-
19	in	in	B-PP	B-PP	-	26	VMOD	-	-
20	five	five	B-NP	B-NP	-	21	NMOD	-	-
21	patients	patients	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	26	P	-	-
23	normal	normal	B-NP	B-NP	-	25	NMOD	-	-
24	TCRzeta	TCRzeta	I-NP	I-NP	-	25	NMOD	-	-
25	levels	levels	I-NP	I-NP	-	26	SUB	-	-
26	were	were	B-VP	B-VP	-	18	SBAR	-	-
27	present	present	B-ADJP	B-ADJP	-	26	PRD	-	-
28	although	although	B-SBAR	B-SBAR	-	27	AMOD	-	-
29	kappaB	kappaB	B-NP	B-NP	-	30	NMOD	-	-
30	binding	binding	I-NP	I-NP	-	31	SUB	-	-
31	was	was	B-VP	B-VP	-	28	SBAR	-	-
32	not	not	O	O	-	31	VMOD	-	-
33	inducible	inducible	B-ADJP	B-ADJP	-	31	PRD	-	-
34	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	27	VMOD	-	-
2	the	the	B-NP	B-NP	-	3	NMOD	-	-
3	majority	majority	I-NP	I-NP	-	1	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	patients	patients	B-NP	B-NP	-	4	PMOD	-	-
6	with	with	B-PP	B-PP	-	5	NMOD	-	-
7	advanced	advanced	B-NP	B-NP	-	8	NMOD	-	-
8	RCC	RCC	I-NP	I-NP	-	6	PMOD	-	-
9	,	,	O	O	-	27	P	-	-
10	peripheral	peripheral	B-NP	B-NP	-	13	NMOD	-	-
11	blood	blood	I-NP	I-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	14	SUB	-	-
14	express	express	B-VP	B-VP	-	27	VMOD	-	-
15	TCRzeta	TCRzeta	B-NP	B-NP	-	17	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	p56	p56	B-NP	B-NP	-	14	OBJ	-	-
18	(	(	O	O	-	19	P	-	-
19	lck	lck	B-NP	B-NP	-	17	NMOD	-	-
20	)	)	O	O	-	19	P	-	-
21	,	,	O	O	-	27	P	-	-
22	and	and	O	O	-	27	VMOD	-	-
23	in	in	B-PP	B-PP	-	27	VMOD	-	-
24	a	a	B-NP	B-NP	-	25	NMOD	-	-
25	subset	subset	I-NP	I-NP	-	23	PMOD	-	-
26	,	,	O	O	-	27	P	-	-
27	reduced	reduced	B-VP	B-VP	-	0	ROOT	-	-
28	levels	levels	B-NP	B-NP	-	27	OBJ	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	these	these	B-NP	B-NP	-	33	NMOD	-	-
31	TCRzeta	TCRzeta	I-NP	I-NP	-	33	NMOD	-	-
32	associated	associated	I-NP	I-NP	-	33	NMOD	-	-
33	molecules	molecules	I-NP	I-NP	-	29	PMOD	-	-
34	are	are	B-VP	B-VP	-	27	VMOD	-	-
35	seen	seen	I-VP	I-VP	-	34	VC	-	-
36	that	that	B-NP	B-NP	-	35	VMOD	-	-
37	may	may	B-VP	B-VP	-	36	SBAR	-	-
38	increase	increase	I-VP	I-VP	-	37	VC	-	-
39	during	during	B-PP	B-PP	-	38	VMOD	-	-
40	cytokine-based	cytokine-based	B-NP	B-NP	-	41	NMOD	-	-
41	therapy	therapy	I-NP	I-NP	-	39	PMOD	-	-
42	.	.	O	O	-	27	P	-	-

1	Abnormal	Abnormal	B-NP	B-NP	-	2	NMOD	-	-
2	activation	activation	I-NP	I-NP	-	5	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NFkappaB	NFkappaB	B-NP	B-NP	-	3	PMOD	-	-
5	is	is	B-VP	B-VP	-	0	ROOT	-	-
6	also	also	B-ADVP	B-ADVP	-	5	VMOD	-	-
7	present	present	B-ADJP	B-ADJP	-	5	PRD	-	-
8	in	in	B-PP	B-PP	-	7	AMOD	-	-
9	>	>	B-NP	B-NP	-	11	NMOD	-	-
10	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
11	%	%	I-NP	I-NP	-	8	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	patients	patients	B-NP	B-NP	-	12	PMOD	-	-
14	and	and	O	O	-	5	VMOD	-	-
15	may	may	B-VP	B-VP	-	5	VMOD	-	-
16	also	also	I-VP	I-VP	-	15	VMOD	-	-
17	revert	revert	I-VP	I-VP	-	15	VC	-	-
18	to	to	B-PP	B-PP	-	17	VMOD	-	-
19	normal	normal	B-ADJP	B-ADJP	-	18	PMOD	-	-
20	during	during	B-PP	B-PP	-	19	AMOD	-	-
21	IL-2/IFN	IL-2/IFN	B-NP	B-NP	-	23	NMOD	-	-
22	alpha-based	alpha-based	I-NP	I-NP	-	23	NMOD	-	-
23	treatment	treatment	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	5	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	alteration	alteration	I-NP	I-NP	-	6	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	NFkappaB	NFkappaB	B-NP	B-NP	-	5	NMOD	-	-
5	activation	activation	I-NP	I-NP	-	3	PMOD	-	-
6	occurred	occurred	B-VP	B-VP	-	0	ROOT	-	-
7	in	in	B-PP	B-PP	-	6	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	presence	presence	I-NP	I-NP	-	7	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	normal	normal	B-NP	B-NP	-	12	NMOD	-	-
12	expression	expression	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	TCRzeta-associated	TCRzeta-associated	B-NP	B-NP	-	16	NMOD	-	-
15	signaling	signaling	I-NP	I-NP	-	16	NMOD	-	-
16	elements	elements	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	clinical	clinical	I-NP	I-NP	-	3	NMOD	-	-
3	significance	significance	I-NP	I-NP	-	7	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	these	these	B-NP	B-NP	-	6	NMOD	-	-
6	findings	findings	I-NP	I-NP	-	4	PMOD	-	-
7	remains	remains	B-VP	B-VP	-	0	ROOT	-	-
8	unclear	unclear	B-ADJP	B-ADJP	-	7	PRD	-	-
9	.	.	O	O	-	7	P	-	-

1	Transcriptional	Transcriptional	B-NP	B-NP	-	2	NMOD	-	-
2	regulation	regulation	I-NP	I-NP	-	10	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	lysosomal	lysosomal	B-NP	B-NP	-	6	NMOD	-	-
5	acid	acid	I-NP	I-NP	-	6	NMOD	-	-
6	lipase	lipase	I-NP	I-NP	-	3	PMOD	-	-
7	in	in	B-PP	B-PP	-	2	NMOD	-	-
8	differentiating	differentiating	B-VP	B-VP	-	9	NMOD	-	-
9	monocytes	monocytes	B-NP	B-NP	-	7	PMOD	-	-
10	is	is	B-VP	B-VP	-	0	ROOT	-	-
11	mediated	mediated	I-VP	I-VP	-	10	VC	-	-
12	by	by	B-PP	B-PP	-	11	VMOD	-	-
13	transcription	transcription	B-NP	B-NP	-	14	NMOD	-	-
14	factors	factors	I-NP	I-NP	-	12	PMOD	-	-
15	Sp1	Sp1	B-NP	B-NP	-	17	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	AP-2	AP-2	B-NP	B-NP	-	14	NMOD	-	-
18	.	.	O	O	-	10	P	-	-

1	Human	Human	B-NP	B-NP	-	4	NMOD	-	-
2	lysosomal	lysosomal	I-NP	I-NP	-	4	NMOD	-	-
3	acid	acid	I-NP	I-NP	-	4	NMOD	-	-
4	lipase	lipase	I-NP	I-NP	-	8	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	LAL	LAL	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	10	NMOD	-	-
10	hydrolase	hydrolase	I-NP	I-NP	-	8	PRD	-	-
11	required	required	B-VP	B-VP	-	8	VC	-	-
12	for	for	B-PP	B-PP	-	11	VMOD	-	-
13	the	the	B-NP	B-NP	-	14	NMOD	-	-
14	cleavage	cleavage	I-NP	I-NP	-	12	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	cholesteryl	cholesteryl	B-NP	B-NP	-	17	NMOD	-	-
17	esters	esters	I-NP	I-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	triglycerides	triglycerides	I-NP	I-NP	-	15	PMOD	-	-
20	derived	derived	B-VP	B-VP	-	19	NMOD	-	-
21	from	from	B-PP	B-PP	-	20	VMOD	-	-
22	plasma	plasma	B-NP	B-NP	-	23	NMOD	-	-
23	lipoproteins	lipoproteins	I-NP	I-NP	-	21	PMOD	-	-
24	.	.	O	O	-	8	P	-	-

1	It	It	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	shown	shown	I-VP	I-VP	-	2	VC	-	-
4	here	here	B-ADVP	B-ADVP	-	3	VMOD	-	-
5	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
6	during	during	B-PP	B-PP	-	16	VMOD	-	-
7	monocyte	monocyte	B-NP	B-NP	-	6	PMOD	-	-
8	to	to	B-PP	B-PP	-	7	NMOD	-	-
9	macrophage	macrophage	B-NP	B-NP	-	10	NMOD	-	-
10	differentiation	differentiation	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	16	P	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	expression	expression	I-NP	I-NP	-	16	SUB	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	LAL-mRNA	LAL-mRNA	B-NP	B-NP	-	14	PMOD	-	-
16	is	is	B-VP	B-VP	-	5	SBAR	-	-
17	induced	induced	I-VP	I-VP	-	16	VC	-	-
18	.	.	O	O	-	2	P	-	-

1	This	This	B-NP	B-NP	-	2	NMOD	-	-
2	induction	induction	I-NP	I-NP	-	3	SUB	-	-
3	is	is	B-VP	B-VP	-	0	ROOT	-	-
4	dependent	dependent	B-ADJP	B-ADJP	-	3	PRD	-	-
5	on	on	B-PP	B-PP	-	4	AMOD	-	-
6	protein	protein	B-NP	B-NP	-	9	NMOD	-	-
7	kinase	kinase	I-NP	I-NP	-	9	NMOD	-	-
8	C	C	I-NP	I-NP	-	9	NMOD	-	-
9	activity	activity	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	protein	protein	B-NP	B-NP	-	12	NMOD	-	-
12	synthesis	synthesis	I-NP	I-NP	-	5	PMOD	-	-
13	.	.	O	O	-	3	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
3	type-specific	type-specific	I-NP	I-NP	-	2	AMOD	-	-
4	increase	increase	I-NP	I-NP	-	8	SUB	-	-
5	in	in	B-PP	B-PP	-	4	NMOD	-	-
6	LAL	LAL	B-NP	B-NP	-	7	NMOD	-	-
7	expression	expression	I-NP	I-NP	-	5	PMOD	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	further	further	B-ADJP	B-ADJP	-	10	VMOD	-	-
10	investigated	investigated	I-ADJP	I-ADJP	-	8	VC	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	15	NMOD	-	-
13	THP-1	THP-1	I-NP	I-NP	-	15	NMOD	-	-
14	cell	cell	I-NP	I-NP	-	15	NMOD	-	-
15	line	line	I-NP	I-NP	-	11	PMOD	-	-
16	with	with	B-PP	B-PP	-	15	NMOD	-	-
17	respect	respect	B-NP	B-NP	-	16	PMOD	-	-
18	to	to	B-PP	B-PP	-	17	NMOD	-	-
19	transcriptional	transcriptional	B-NP	B-NP	-	20	NMOD	-	-
20	regulation	regulation	I-NP	I-NP	-	18	PMOD	-	-
21	.	.	O	O	-	8	P	-	-

1	The	The	B-NP	B-NP	-	7	NMOD	-	-
2	human	human	I-NP	I-NP	-	7	NMOD	-	-
3	monocytic	monocytic	I-NP	I-NP	-	7	NMOD	-	-
4	leukemia	leukemia	I-NP	I-NP	-	7	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	7	NMOD	-	-
6	line	line	I-NP	I-NP	-	7	NMOD	-	-
7	THP-1	THP-1	I-NP	I-NP	-	8	SUB	-	-
8	differentiates	differentiates	B-VP	B-VP	-	0	ROOT	-	-
9	into	into	B-PP	B-PP	-	8	VMOD	-	-
10	macrophage-like	macrophage-like	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
12	when	when	B-ADVP	B-ADVP	-	8	VMOD	-	-
13	treated	treated	B-VP	B-VP	-	12	SBAR	-	-
14	with	with	B-PP	B-PP	-	13	VMOD	-	-
15	phorbol	phorbol	B-NP	B-NP	-	16	NMOD	-	-
16	esters	esters	I-NP	I-NP	-	14	PMOD	-	-
17	.	.	O	O	-	8	P	-	-

1	In	In	B-SBAR	B-SBAR	-	24	VMOD	-	-
2	order	order	O	O	-	1	DEP	-	-
3	to	to	B-VP	B-VP	-	4	VMOD	-	-
4	determine	determine	I-VP	I-VP	-	1	SBAR	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	cis-acting	cis-acting	I-NP	I-NP	-	7	NMOD	-	-
7	elements	elements	I-NP	I-NP	-	4	OBJ	-	-
8	necessary	necessary	B-ADJP	B-ADJP	-	7	NMOD	-	-
9	for	for	B-PP	B-PP	-	8	AMOD	-	-
10	both	both	O	O	-	15	NMOD	-	-
11	basal	basal	B-NP	B-NP	-	15	NMOD	-	-
12	and	and	O	O	-	15	NMOD	-	-
13	phorbol	phorbol	B-NP	B-NP	-	15	NMOD	-	-
14	12-myristate-13	12-myristate-13	I-NP	I-NP	-	15	NMOD	-	-
15	acetate	acetate	I-NP	I-NP	-	21	NMOD	-	-
16	(	(	O	O	-	17	P	-	-
17	PMA	PMA	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	-enhanced	-enhanced	B-NP	B-NP	-	21	NMOD	-	-
20	promoter	promoter	I-NP	I-NP	-	21	NMOD	-	-
21	activity	activity	I-NP	I-NP	-	9	PMOD	-	-
22	,	,	O	O	-	24	P	-	-
23	we	we	B-NP	B-NP	-	24	SUB	-	-
24	performed	performed	B-VP	B-VP	-	0	ROOT	-	-
25	deletion	deletion	B-NP	B-NP	-	26	NMOD	-	-
26	analysis	analysis	I-NP	I-NP	-	30	NMOD	-	-
27	and	and	I-NP	I-NP	-	30	NMOD	-	-
28	reporter	reporter	I-NP	I-NP	-	30	NMOD	-	-
29	gene	gene	I-NP	I-NP	-	30	NMOD	-	-
30	assays	assays	I-NP	I-NP	-	24	OBJ	-	-
31	.	.	O	O	-	24	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	PMA	PMA	I-NP	I-NP	-	4	NMOD	-	-
3	responsive	responsive	I-NP	I-NP	-	4	NMOD	-	-
4	element	element	I-NP	I-NP	-	5	SUB	-	-
5	has	has	B-VP	B-VP	-	0	ROOT	-	-
6	been	been	I-VP	I-VP	-	5	VC	-	-
7	identified	identified	I-VP	I-VP	-	6	VC	-	-
8	between	between	B-PP	B-PP	-	7	VMOD	-	-
9	-182	-182	B-NP	B-NP	-	10	NMOD	-	-
10	bp	bp	I-NP	I-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	-107	-107	B-NP	B-NP	-	13	NMOD	-	-
13	bp	bp	I-NP	I-NP	-	8	PMOD	-	-
14	upstream	upstream	B-ADVP	B-ADVP	-	13	NMOD	-	-
15	of	of	B-PP	B-PP	-	13	NMOD	-	-
16	the	the	B-NP	B-NP	-	20	NMOD	-	-
17	major	major	I-NP	I-NP	-	20	NMOD	-	-
18	transcription	transcription	I-NP	I-NP	-	20	NMOD	-	-
19	start	start	I-NP	I-NP	-	20	NMOD	-	-
20	site	site	I-NP	I-NP	-	15	PMOD	-	-
21	.	.	O	O	-	5	P	-	-

1	Gel	Gel	B-NP	B-NP	-	4	NMOD	-	-
2	mobility	mobility	I-NP	I-NP	-	4	NMOD	-	-
3	shift	shift	I-NP	I-NP	-	4	NMOD	-	-
4	assays	assays	I-NP	I-NP	-	5	SUB	-	-
5	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	binding	binding	B-NP	B-NP	-	16	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	Sp1	Sp1	B-NP	B-NP	-	11	NMOD	-	-
10	and	and	O	O	-	11	NMOD	-	-
11	AP-2	AP-2	B-NP	B-NP	-	8	PMOD	-	-
12	to	to	B-PP	B-PP	-	7	NMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	LAL	LAL	I-NP	I-NP	-	15	NMOD	-	-
15	promoter	promoter	I-NP	I-NP	-	12	PMOD	-	-
16	is	is	B-VP	B-VP	-	6	SBAR	-	-
17	increased	increased	I-VP	I-VP	-	16	VC	-	-
18	by	by	B-PP	B-PP	-	17	VMOD	-	-
19	PMA	PMA	B-NP	B-NP	-	18	PMOD	-	-
20	in	in	B-PP	B-PP	-	17	VMOD	-	-
21	THP-1	THP-1	B-NP	B-NP	-	22	NMOD	-	-
22	cells	cells	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	5	P	-	-

1	Co-transfections	Co-transfections	B-NP	B-NP	-	10	SUB	-	-
2	with	with	B-PP	B-PP	-	1	NMOD	-	-
3	expression	expression	B-NP	B-NP	-	4	NMOD	-	-
4	plasmids	plasmids	I-NP	I-NP	-	2	PMOD	-	-
5	for	for	B-PP	B-PP	-	4	NMOD	-	-
6	Sp1	Sp1	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	O	O	-	8	NMOD	-	-
8	AP-2	AP-2	B-NP	B-NP	-	5	PMOD	-	-
9	further	further	B-ADVP	B-ADVP	-	10	VMOD	-	-
10	emphasized	emphasized	B-VP	B-VP	-	0	ROOT	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	important	important	I-NP	I-NP	-	13	NMOD	-	-
13	role	role	I-NP	I-NP	-	10	OBJ	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	these	these	B-NP	B-NP	-	17	NMOD	-	-
16	transcription	transcription	I-NP	I-NP	-	17	NMOD	-	-
17	factors	factors	I-NP	I-NP	-	14	PMOD	-	-
18	in	in	B-PP	B-PP	-	13	NMOD	-	-
19	both	both	B-NP	B-NP	-	22	AMOD	-	-
20	basal	basal	I-NP	I-NP	-	22	AMOD	-	-
21	and	and	I-NP	I-NP	-	22	AMOD	-	-
22	PMA-enhanced	PMA-enhanced	I-NP	I-NP	-	24	NMOD	-	-
23	LAL	LAL	I-NP	I-NP	-	24	NMOD	-	-
24	expression	expression	I-NP	I-NP	-	18	PMOD	-	-
25	.	.	O	O	-	10	P	-	-

1	Our	Our	B-NP	B-NP	-	2	NMOD	-	-
2	data	data	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	differentiation	differentiation	B-NP	B-NP	-	7	NMOD	-	-
6	dependent	dependent	I-NP	I-NP	-	7	NMOD	-	-
7	increase	increase	I-NP	I-NP	-	19	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	lysosomal	lysosomal	B-NP	B-NP	-	11	NMOD	-	-
10	acid	acid	I-NP	I-NP	-	11	NMOD	-	-
11	lipase	lipase	I-NP	I-NP	-	15	NMOD	-	-
12	(	(	O	O	-	13	P	-	-
13	LAL	LAL	B-NP	B-NP	-	11	NMOD	-	-
14	)	)	O	O	-	13	P	-	-
15	expression	expression	B-NP	B-NP	-	8	PMOD	-	-
16	in	in	B-PP	B-PP	-	15	NMOD	-	-
17	THP-1	THP-1	B-NP	B-NP	-	18	NMOD	-	-
18	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
19	is	is	B-VP	B-VP	-	4	SBAR	-	-
20	mediated	mediated	I-VP	I-VP	-	19	VC	-	-
21	by	by	B-PP	B-PP	-	20	VMOD	-	-
22	a	a	B-NP	B-NP	-	24	NMOD	-	-
23	concerted	concerted	I-NP	I-NP	-	24	NMOD	-	-
24	action	action	I-NP	I-NP	-	21	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	Sp1	Sp1	B-NP	B-NP	-	28	NMOD	-	-
27	and	and	I-NP	I-NP	-	28	NMOD	-	-
28	AP-2	AP-2	I-NP	I-NP	-	25	PMOD	-	-
29	.	.	O	O	-	3	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	nongenomic	nongenomic	I-NP	I-NP	-	3	NMOD	-	-
3	mechanism	mechanism	I-NP	I-NP	-	8	NMOD	-	-
4	for	for	B-PP	B-PP	-	3	NMOD	-	-
5	progesterone-mediated	progesterone-mediated	B-NP	B-NP	-	6	NMOD	-	-
6	immunosuppression	immunosuppression	I-NP	I-NP	-	4	PMOD	-	-
7	:	:	O	O	-	3	P	-	-
8	inhibition	inhibition	B-NP	B-NP	-	0	ROOT	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	K+	K+	B-NP	B-NP	-	11	NMOD	-	-
11	channels	channels	I-NP	I-NP	-	9	PMOD	-	-
12	,	,	O	O	-	18	P	-	-
13	Ca2+	Ca2+	B-NP	B-NP	-	14	NMOD	-	-
14	signaling	signaling	I-NP	I-NP	-	18	NMOD	-	-
15	,	,	O	O	-	18	P	-	-
16	and	and	O	O	-	18	NMOD	-	-
17	gene	gene	B-NP	B-NP	-	18	NMOD	-	-
18	expression	expression	I-NP	I-NP	-	9	PMOD	-	-
19	in	in	B-PP	B-PP	-	8	NMOD	-	-
20	T	T	B-NP	B-NP	-	21	NMOD	-	-
21	lymphocytes	lymphocytes	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	8	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	mechanism	mechanism	I-NP	I-NP	-	15	SUB	-	-
3	by	by	B-PP	B-PP	-	2	NMOD	-	-
4	which	which	B-NP	B-NP	-	3	PMOD	-	-
5	progesterone	progesterone	B-NP	B-NP	-	6	SUB	-	-
6	causes	causes	B-VP	B-VP	-	3	SBAR	-	-
7	localized	localized	B-NP	B-NP	-	8	NMOD	-	-
8	suppression	suppression	I-NP	I-NP	-	15	SUB	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	immune	immune	I-NP	I-NP	-	12	NMOD	-	-
12	response	response	I-NP	I-NP	-	9	PMOD	-	-
13	during	during	B-PP	B-PP	-	8	NMOD	-	-
14	pregnancy	pregnancy	B-NP	B-NP	-	13	PMOD	-	-
15	has	has	B-VP	B-VP	-	0	ROOT	-	-
16	remained	remained	I-VP	I-VP	-	15	VC	-	-
17	elusive	elusive	B-ADJP	B-ADJP	-	16	PRD	-	-
18	.	.	O	O	-	15	P	-	-

1	Using	Using	B-VP	B-VP	-	11	VMOD	-	-
2	human	human	B-NP	B-NP	-	4	NMOD	-	-
3	T	T	I-NP	I-NP	-	4	NMOD	-	-
4	lymphocytes	lymphocytes	I-NP	I-NP	-	8	NMOD	-	-
5	and	and	O	O	-	8	NMOD	-	-
6	T	T	B-NP	B-NP	-	8	NMOD	-	-
7	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
8	lines	lines	I-NP	I-NP	-	1	OBJ	-	-
9	,	,	O	O	-	11	P	-	-
10	we	we	B-NP	B-NP	-	11	SUB	-	-
11	show	show	B-VP	B-VP	-	0	ROOT	-	-
12	that	that	B-SBAR	B-SBAR	-	11	VMOD	-	-
13	progesterone	progesterone	B-NP	B-NP	-	25	SUB	-	-
14	,	,	O	O	-	13	P	-	-
15	at	at	B-PP	B-PP	-	13	NMOD	-	-
16	concentrations	concentrations	B-NP	B-NP	-	15	PMOD	-	-
17	found	found	B-VP	B-VP	-	16	NMOD	-	-
18	in	in	B-PP	B-PP	-	17	VMOD	-	-
19	the	the	B-NP	B-NP	-	20	NMOD	-	-
20	placenta	placenta	I-NP	I-NP	-	18	PMOD	-	-
21	,	,	O	O	-	13	P	-	-
22	rapidly	rapidly	B-ADVP	B-ADVP	-	25	VMOD	-	-
23	and	and	I-ADVP	I-ADVP	-	22	AMOD	-	-
24	reversibly	reversibly	B-VP	B-VP	-	22	AMOD	-	-
25	blocks	blocks	I-VP	I-VP	-	12	SBAR	-	-
26	voltage-gated	voltage-gated	B-NP	B-NP	-	28	AMOD	-	-
27	and	and	I-NP	I-NP	-	28	AMOD	-	-
28	calcium-activated	calcium-activated	I-NP	I-NP	-	30	NMOD	-	-
29	K+	K+	I-NP	I-NP	-	30	NMOD	-	-
30	channels	channels	I-NP	I-NP	-	34	NMOD	-	-
31	(	(	O	O	-	34	P	-	-
32	KV	KV	B-NP	B-NP	-	34	NMOD	-	-
33	and	and	I-NP	I-NP	-	34	NMOD	-	-
34	KCa	KCa	I-NP	I-NP	-	25	OBJ	-	-
35	,	,	O	O	-	25	P	-	-
36	respectively	respectively	B-ADVP	B-ADVP	-	25	VMOD	-	-
37	)	)	O	O	-	36	P	-	-
38	,	,	O	O	-	25	P	-	-
39	resulting	resulting	B-VP	B-VP	-	25	VMOD	-	-
40	in	in	B-PP	B-PP	-	39	VMOD	-	-
41	depolarization	depolarization	B-NP	B-NP	-	40	PMOD	-	-
42	of	of	B-PP	B-PP	-	41	NMOD	-	-
43	the	the	B-NP	B-NP	-	45	NMOD	-	-
44	membrane	membrane	I-NP	I-NP	-	45	NMOD	-	-
45	potential	potential	I-NP	I-NP	-	42	PMOD	-	-
46	.	.	O	O	-	11	P	-	-

1	As	As	B-PP	B-PP	-	20	VMOD	-	-
2	a	a	B-NP	B-NP	-	3	NMOD	-	-
3	result	result	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	20	P	-	-
5	Ca2+	Ca2+	B-NP	B-NP	-	6	NMOD	-	-
6	signaling	signaling	I-NP	I-NP	-	9	NMOD	-	-
7	and	and	O	O	-	9	NMOD	-	-
8	nuclear	nuclear	B-NP	B-NP	-	9	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	19	NMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	activated	activated	B-NP	B-NP	-	13	NMOD	-	-
12	T	T	I-NP	I-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	NF-AT	NF-AT	B-NP	B-NP	-	9	NMOD	-	-
16	)	)	I-NP	I-NP	-	15	P	-	-
17	-driven	-driven	I-NP	I-NP	-	19	NMOD	-	-
18	gene	gene	I-NP	I-NP	-	19	NMOD	-	-
19	expression	expression	I-NP	I-NP	-	20	SUB	-	-
20	are	are	B-VP	B-VP	-	0	ROOT	-	-
21	inhibited	inhibited	I-VP	I-VP	-	20	VC	-	-
22	.	.	O	O	-	20	P	-	-

1	Progesterone	Progesterone	B-NP	B-NP	-	2	SUB	-	-
2	acts	acts	B-VP	B-VP	-	0	ROOT	-	-
3	distally	distally	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	to	to	B-PP	B-PP	-	2	VMOD	-	-
5	the	the	B-NP	B-NP	-	7	NMOD	-	-
6	initial	initial	I-NP	I-NP	-	7	NMOD	-	-
7	steps	steps	I-NP	I-NP	-	4	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	T	T	B-NP	B-NP	-	11	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
11	receptor	receptor	I-NP	I-NP	-	17	NMOD	-	-
12	(	(	I-NP	I-NP	-	13	P	-	-
13	TCR	TCR	I-NP	I-NP	-	11	NMOD	-	-
14	)	)	I-NP	I-NP	-	13	P	-	-
15	-mediated	-mediated	I-NP	I-NP	-	17	NMOD	-	-
16	signal	signal	I-NP	I-NP	-	17	NMOD	-	-
17	transduction	transduction	I-NP	I-NP	-	8	PMOD	-	-
18	,	,	O	O	-	2	P	-	-
19	since	since	B-SBAR	B-SBAR	-	2	VMOD	-	-
20	it	it	B-NP	B-NP	-	21	SUB	-	-
21	blocks	blocks	B-VP	B-VP	-	19	SBAR	-	-
22	sustained	sustained	B-NP	B-NP	-	24	NMOD	-	-
23	Ca2+	Ca2+	I-NP	I-NP	-	24	NMOD	-	-
24	signals	signals	I-NP	I-NP	-	21	OBJ	-	-
25	after	after	B-PP	B-PP	-	21	VMOD	-	-
26	thapsigargin	thapsigargin	B-NP	B-NP	-	27	NMOD	-	-
27	stimulation	stimulation	I-NP	I-NP	-	25	PMOD	-	-
28	,	,	O	O	-	34	P	-	-
29	as	as	B-CONJP	B-CONJP	-	34	NMOD	-	-
30	well	well	I-CONJP	I-CONJP	-	29	DEP	-	-
31	as	as	I-CONJP	I-CONJP	-	29	DEP	-	-
32	oscillatory	oscillatory	B-NP	B-NP	-	34	NMOD	-	-
33	Ca2+	Ca2+	I-NP	I-NP	-	34	NMOD	-	-
34	signals	signals	I-NP	I-NP	-	25	PMOD	-	-
35	,	,	O	O	-	2	P	-	-
36	but	but	O	O	-	2	VMOD	-	-
37	not	not	O	O	-	36	DEP	-	-
38	the	the	B-NP	B-NP	-	39	NMOD	-	-
39	Ca2+	Ca2+	I-NP	I-NP	-	37	NMOD	-	-
40	transient	transient	B-ADJP	B-ADJP	-	39	NMOD	-	-
41	after	after	B-PP	B-PP	-	40	AMOD	-	-
42	TCR	TCR	B-NP	B-NP	-	43	NMOD	-	-
43	stimulation	stimulation	I-NP	I-NP	-	41	PMOD	-	-
44	.	.	O	O	-	2	P	-	-

1	K+	K+	B-NP	B-NP	-	3	NMOD	-	-
2	channel	channel	I-NP	I-NP	-	3	NMOD	-	-
3	blockade	blockade	I-NP	I-NP	-	6	SUB	-	-
4	by	by	B-PP	B-PP	-	3	NMOD	-	-
5	progesterone	progesterone	B-NP	B-NP	-	4	PMOD	-	-
6	is	is	B-VP	B-VP	-	12	VMOD	-	-
7	specific	specific	B-ADJP	B-ADJP	-	6	PRD	-	-
8	;	;	O	O	-	12	P	-	-
9	other	other	B-NP	B-NP	-	11	NMOD	-	-
10	steroid	steroid	I-NP	I-NP	-	11	NMOD	-	-
11	hormones	hormones	I-NP	I-NP	-	12	SUB	-	-
12	had	had	B-VP	B-VP	-	0	ROOT	-	-
13	little	little	B-NP	B-NP	-	16	NMOD	-	-
14	or	or	I-NP	I-NP	-	16	NMOD	-	-
15	no	no	I-NP	I-NP	-	16	NMOD	-	-
16	effect	effect	I-NP	I-NP	-	12	OBJ	-	-
17	,	,	O	O	-	12	P	-	-
18	although	although	B-SBAR	B-SBAR	-	12	VMOD	-	-
19	the	the	B-NP	B-NP	-	22	NMOD	-	-
20	progesterone	progesterone	I-NP	I-NP	-	22	NMOD	-	-
21	antagonist	antagonist	I-NP	I-NP	-	22	NMOD	-	-
22	RU	RU	I-NP	I-NP	-	25	SUB	-	-
23	<num>	<num>	I-NP	I-NP	-	22	NMOD	-	-
24	also	also	B-ADVP	B-ADVP	-	25	VMOD	-	-
25	blocked	blocked	B-VP	B-VP	-	18	SBAR	-	-
26	KV	KV	B-NP	B-NP	-	29	NMOD	-	-
27	and	and	I-NP	I-NP	-	29	NMOD	-	-
28	KCa	KCa	I-NP	I-NP	-	29	NMOD	-	-
29	channels	channels	I-NP	I-NP	-	25	OBJ	-	-
30	.	.	O	O	-	12	P	-	-

1	Progesterone	Progesterone	B-NP	B-NP	-	3	SUB	-	-
2	effectively	effectively	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	blocked	blocked	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	broad	broad	I-NP	I-NP	-	6	NMOD	-	-
6	spectrum	spectrum	I-NP	I-NP	-	3	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	K+	K+	B-NP	B-NP	-	9	NMOD	-	-
9	channels	channels	I-NP	I-NP	-	7	PMOD	-	-
10	,	,	O	O	-	3	P	-	-
11	reducing	reducing	B-VP	B-VP	-	3	VMOD	-	-
12	both	both	O	O	-	16	NMOD	-	-
13	Kv1.3	Kv1.3	B-NP	B-NP	-	16	NMOD	-	-
14	and	and	O	O	-	16	NMOD	-	-
15	charybdotoxin-resistant	charybdotoxin-resistant	B-NP	B-NP	-	16	NMOD	-	-
16	components	components	I-NP	I-NP	-	11	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	KV	KV	B-NP	B-NP	-	19	NMOD	-	-
19	current	current	I-NP	I-NP	-	22	NMOD	-	-
20	and	and	I-NP	I-NP	-	22	NMOD	-	-
21	KCa	KCa	I-NP	I-NP	-	22	NMOD	-	-
22	current	current	I-NP	I-NP	-	17	PMOD	-	-
23	in	in	B-PP	B-PP	-	22	NMOD	-	-
24	T	T	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
26	,	,	O	O	-	3	P	-	-
27	as	as	B-CONJP	B-CONJP	-	34	NMOD	-	-
28	well	well	I-CONJP	I-CONJP	-	27	DEP	-	-
29	as	as	I-CONJP	I-CONJP	-	27	DEP	-	-
30	blocking	blocking	B-VP	B-VP	-	29	PMOD	-	-
31	several	several	B-NP	B-NP	-	34	NMOD	-	-
32	cloned	cloned	I-NP	I-NP	-	34	NMOD	-	-
33	KV	KV	I-NP	I-NP	-	34	NMOD	-	-
34	channels	channels	I-NP	I-NP	-	3	OBJ	-	-
35	expressed	expressed	B-VP	B-VP	-	34	NMOD	-	-
36	in	in	B-PP	B-PP	-	35	VMOD	-	-
37	cell	cell	B-NP	B-NP	-	38	NMOD	-	-
38	lines	lines	I-NP	I-NP	-	36	PMOD	-	-
39	.	.	O	O	-	3	P	-	-

1	Progesterone	Progesterone	B-NP	B-NP	-	2	SUB	-	-
2	had	had	B-VP	B-VP	-	0	ROOT	-	-
3	little	little	B-NP	B-NP	-	6	NMOD	-	-
4	or	or	I-NP	I-NP	-	6	NMOD	-	-
5	no	no	I-NP	I-NP	-	6	NMOD	-	-
6	effect	effect	I-NP	I-NP	-	2	OBJ	-	-
7	on	on	B-PP	B-PP	-	2	VMOD	-	-
8	a	a	B-NP	B-NP	-	12	NMOD	-	-
9	cloned	cloned	I-NP	I-NP	-	12	NMOD	-	-
10	voltage-gated	voltage-gated	I-NP	I-NP	-	12	NMOD	-	-
11	Na+	Na+	I-NP	I-NP	-	12	NMOD	-	-
12	channel	channel	I-NP	I-NP	-	7	PMOD	-	-
13	,	,	O	O	-	18	P	-	-
14	an	an	B-NP	B-NP	-	18	NMOD	-	-
15	inward	inward	I-NP	I-NP	-	18	NMOD	-	-
16	rectifier	rectifier	I-NP	I-NP	-	18	NMOD	-	-
17	K+	K+	I-NP	I-NP	-	18	NMOD	-	-
18	channel	channel	I-NP	I-NP	-	7	PMOD	-	-
19	,	,	B-PP	B-PP	-	7	P	-	-
20	or	or	I-PP	I-PP	-	7	PMOD	-	-
21	on	on	B-PP	B-PP	-	7	PMOD	-	-
22	lymphocyte	lymphocyte	B-NP	B-NP	-	26	NMOD	-	-
23	Ca2+	Ca2+	I-NP	I-NP	-	26	NMOD	-	-
24	and	and	I-NP	I-NP	-	26	NMOD	-	-
25	Cl-	Cl-	I-NP	I-NP	-	26	NMOD	-	-
26	channels	channels	I-NP	I-NP	-	21	PMOD	-	-
27	.	.	O	O	-	2	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
3	that	that	B-SBAR	B-SBAR	-	2	VMOD	-	-
4	direct	direct	B-NP	B-NP	-	5	NMOD	-	-
5	inhibition	inhibition	I-NP	I-NP	-	14	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	K+	K+	B-NP	B-NP	-	8	NMOD	-	-
8	channels	channels	I-NP	I-NP	-	6	PMOD	-	-
9	in	in	B-PP	B-PP	-	5	NMOD	-	-
10	T	T	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
12	by	by	B-PP	B-PP	-	5	NMOD	-	-
13	progesterone	progesterone	B-NP	B-NP	-	12	PMOD	-	-
14	contributes	contributes	B-VP	B-VP	-	3	SBAR	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	progesterone-induced	progesterone-induced	B-NP	B-NP	-	17	NMOD	-	-
17	immunosuppression	immunosuppression	I-NP	I-NP	-	15	PMOD	-	-
18	.	.	O	O	-	2	P	-	-

1	Role	Role	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	IKK1	IKK1	B-NP	B-NP	-	5	NMOD	-	-
4	and	and	I-NP	I-NP	-	5	NMOD	-	-
5	IKK2	IKK2	I-NP	I-NP	-	2	PMOD	-	-
6	in	in	B-PP	B-PP	-	1	NMOD	-	-
7	lipopolysaccharide	lipopolysaccharide	B-NP	B-NP	-	8	NMOD	-	-
8	signaling	signaling	I-NP	I-NP	-	6	PMOD	-	-
9	in	in	B-PP	B-PP	-	1	NMOD	-	-
10	human	human	B-NP	B-NP	-	12	NMOD	-	-
11	monocytic	monocytic	I-NP	I-NP	-	12	NMOD	-	-
12	cells	cells	I-NP	I-NP	-	9	PMOD	-	-
13	.	.	O	O	-	1	P	-	-

1	Mononuclear	Mononuclear	B-NP	B-NP	-	2	NMOD	-	-
2	phagocytes	phagocytes	I-NP	I-NP	-	3	SUB	-	-
3	play	play	B-VP	B-VP	-	0	ROOT	-	-
4	a	a	B-NP	B-NP	-	6	NMOD	-	-
5	major	major	I-NP	I-NP	-	6	NMOD	-	-
6	role	role	I-NP	I-NP	-	3	OBJ	-	-
7	in	in	B-PP	B-PP	-	3	VMOD	-	-
8	immune	immune	B-NP	B-NP	-	10	AMOD	-	-
9	and	and	I-NP	I-NP	-	10	AMOD	-	-
10	inflammatory	inflammatory	I-NP	I-NP	-	11	NMOD	-	-
11	responses	responses	I-NP	I-NP	-	7	PMOD	-	-
12	.	.	O	O	-	3	P	-	-

1	Bacterial	Bacterial	B-NP	B-NP	-	2	NMOD	-	-
2	lipopolysaccharide	lipopolysaccharide	I-NP	I-NP	-	6	SUB	-	-
3	(	(	O	O	-	4	P	-	-
4	LPS	LPS	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	induces	induces	B-VP	B-VP	-	0	ROOT	-	-
7	monocytes	monocytes	B-NP	B-NP	-	6	OBJ	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	express	express	I-VP	I-VP	-	6	VMOD	-	-
10	a	a	B-NP	B-NP	-	11	NMOD	-	-
11	variety	variety	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	genes	genes	B-NP	B-NP	-	12	PMOD	-	-
14	by	by	B-PP	B-PP	-	6	VMOD	-	-
15	activating	activating	B-VP	B-VP	-	14	PMOD	-	-
16	the	the	B-NP	B-NP	-	20	NMOD	-	-
17	NF-kappaB/Rel	NF-kappaB/Rel	I-NP	I-NP	-	20	NMOD	-	-
18	transcription	transcription	I-NP	I-NP	-	20	NMOD	-	-
19	factor	factor	I-NP	I-NP	-	20	NMOD	-	-
20	family	family	I-NP	I-NP	-	15	OBJ	-	-
21	.	.	O	O	-	6	P	-	-

1	Recently	Recently	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	have	have	B-VP	B-VP	-	0	ROOT	-	-
5	reported	reported	I-VP	I-VP	-	4	VC	-	-
6	that	that	B-SBAR	B-SBAR	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	10	NMOD	-	-
8	tumor	tumor	I-NP	I-NP	-	10	NMOD	-	-
9	necrosis	necrosis	I-NP	I-NP	-	10	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	12	NMOD	-	-
11	and	and	O	O	-	12	NMOD	-	-
12	interleukin	interleukin	B-NP	B-NP	-	15	NMOD	-	-
13	<num>	<num>	I-NP	I-NP	-	15	NMOD	-	-
14	signaling	signaling	I-NP	I-NP	-	15	NMOD	-	-
15	pathways	pathways	I-NP	I-NP	-	16	SUB	-	-
16	activate	activate	B-VP	B-VP	-	6	SBAR	-	-
17	two	two	B-NP	B-NP	-	18	NMOD	-	-
18	kinases	kinases	I-NP	I-NP	-	22	NMOD	-	-
19	,	,	O	O	-	22	P	-	-
20	IKK1	IKK1	B-NP	B-NP	-	22	NMOD	-	-
21	and	and	I-NP	I-NP	-	22	NMOD	-	-
22	IKK2	IKK2	I-NP	I-NP	-	16	OBJ	-	-
23	.	.	O	O	-	4	P	-	-

1	Phosphorylation	Phosphorylation	B-NP	B-NP	-	18	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	IkappaB	IkappaB	I-NP	I-NP	-	6	NMOD	-	-
5	cytoplasmic	cytoplasmic	I-NP	I-NP	-	6	NMOD	-	-
6	inhibitors	inhibitors	I-NP	I-NP	-	13	NMOD	-	-
7	,	,	O	O	-	13	P	-	-
8	IkappaBalpha	IkappaBalpha	B-NP	B-NP	-	13	NMOD	-	-
9	,	,	O	O	-	13	P	-	-
10	IkappaBbeta	IkappaBbeta	B-NP	B-NP	-	13	NMOD	-	-
11	,	,	O	O	-	13	P	-	-
12	and	and	O	O	-	13	NMOD	-	-
13	IkappaBepsilon	IkappaBepsilon	B-NP	B-NP	-	2	PMOD	-	-
14	,	,	O	O	-	13	P	-	-
15	by	by	B-PP	B-PP	-	1	NMOD	-	-
16	these	these	B-NP	B-NP	-	17	NMOD	-	-
17	kinases	kinases	I-NP	I-NP	-	15	PMOD	-	-
18	triggers	triggers	B-VP	B-VP	-	0	ROOT	-	-
19	proteolytic	proteolytic	B-NP	B-NP	-	20	NMOD	-	-
20	degradation	degradation	I-NP	I-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	release	release	I-NP	I-NP	-	18	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	NF-kappaB/Rel	NF-kappaB/Rel	B-NP	B-NP	-	26	NMOD	-	-
26	proteins	proteins	I-NP	I-NP	-	24	PMOD	-	-
27	into	into	B-PP	B-PP	-	23	NMOD	-	-
28	the	the	B-NP	B-NP	-	29	NMOD	-	-
29	nucleus	nucleus	I-NP	I-NP	-	27	PMOD	-	-
30	.	.	O	O	-	18	P	-	-

1	At	At	B-PP	B-PP	-	12	VMOD	-	-
2	present	present	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	12	P	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	role	role	I-NP	I-NP	-	12	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	IKKs	IKKs	I-NP	I-NP	-	6	PMOD	-	-
9	in	in	B-PP	B-PP	-	5	NMOD	-	-
10	LPS	LPS	B-NP	B-NP	-	11	NMOD	-	-
11	signaling	signaling	I-NP	I-NP	-	9	PMOD	-	-
12	has	has	B-VP	B-VP	-	0	ROOT	-	-
13	not	not	I-VP	I-VP	-	12	VMOD	-	-
14	been	been	I-VP	I-VP	-	12	VC	-	-
15	investigated	investigated	I-VP	I-VP	-	14	VC	-	-
16	.	.	O	O	-	12	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	report	report	B-VP	B-VP	-	0	ROOT	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	LPS	LPS	B-NP	B-NP	-	7	SUB	-	-
7	induces	induces	B-VP	B-VP	-	5	SBAR	-	-
8	IKK	IKK	B-NP	B-NP	-	9	NMOD	-	-
9	activity	activity	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	human	human	B-NP	B-NP	-	12	NMOD	-	-
12	monocytes	monocytes	I-NP	I-NP	-	16	NMOD	-	-
13	and	and	O	O	-	16	NMOD	-	-
14	THP-1	THP-1	B-NP	B-NP	-	16	NMOD	-	-
15	monocytic	monocytic	I-NP	I-NP	-	16	NMOD	-	-
16	cells	cells	I-NP	I-NP	-	10	PMOD	-	-
17	.	.	O	O	-	4	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	kinetics	kinetics	I-NP	I-NP	-	11	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	activation	activation	B-NP	B-NP	-	3	PMOD	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	kinase	kinase	B-NP	B-NP	-	7	NMOD	-	-
7	activity	activity	I-NP	I-NP	-	5	PMOD	-	-
8	in	in	B-PP	B-PP	-	4	NMOD	-	-
9	monocytic	monocytic	B-NP	B-NP	-	10	NMOD	-	-
10	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
11	are	are	B-VP	B-VP	-	0	ROOT	-	-
12	relatively	relatively	B-ADJP	B-ADJP	-	13	AMOD	-	-
13	slow	slow	I-ADJP	I-ADJP	-	11	PRD	-	-
14	with	with	B-PP	B-PP	-	13	AMOD	-	-
15	maximal	maximal	B-NP	B-NP	-	16	NMOD	-	-
16	activity	activity	I-NP	I-NP	-	14	PMOD	-	-
17	observed	observed	B-VP	B-VP	-	16	NMOD	-	-
18	at	at	B-PP	B-PP	-	17	VMOD	-	-
19	<num>	<num>	B-NP	B-NP	-	20	NMOD	-	-
20	min	min	I-NP	I-NP	-	18	PMOD	-	-
21	,	,	O	O	-	16	P	-	-
22	which	which	B-NP	B-NP	-	16	NMOD	-	-
23	coincides	coincides	B-VP	B-VP	-	22	SBAR	-	-
24	with	with	B-PP	B-PP	-	23	VMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	degradation	degradation	I-NP	I-NP	-	32	NMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	IkappaBs	IkappaBs	B-NP	B-NP	-	32	NMOD	-	-
29	and	and	O	O	-	32	NMOD	-	-
30	the	the	B-NP	B-NP	-	32	NMOD	-	-
31	nuclear	nuclear	I-NP	I-NP	-	32	NMOD	-	-
32	translocation	translocation	I-NP	I-NP	-	24	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	NF-kappaB	NF-kappaB	B-NP	B-NP	-	33	PMOD	-	-
35	.	.	O	O	-	11	P	-	-

1	In	In	B-PP	B-PP	-	24	VMOD	-	-
2	transfection	transfection	B-NP	B-NP	-	3	NMOD	-	-
3	experiments	experiments	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	24	P	-	-
5	overexpression	overexpression	B-NP	B-NP	-	24	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	wild	wild	B-NP	B-NP	-	9	NMOD	-	-
8	type	type	I-NP	I-NP	-	9	NMOD	-	-
9	IKK1	IKK1	I-NP	I-NP	-	6	PMOD	-	-
10	,	,	O	O	-	24	P	-	-
11	a	a	B-NP	B-NP	-	15	NMOD	-	-
12	dominant	dominant	I-NP	I-NP	-	15	NMOD	-	-
13	negative	negative	I-NP	I-NP	-	15	NMOD	-	-
14	mutant	mutant	I-NP	I-NP	-	15	NMOD	-	-
15	IKK1	IKK1	I-NP	I-NP	-	24	SUB	-	-
16	(	(	O	O	-	17	P	-	-
17	K44M	K44M	B-NP	B-NP	-	15	NMOD	-	-
18	)	)	O	O	-	17	P	-	-
19	,	,	O	O	-	24	P	-	-
20	or	or	O	O	-	24	VMOD	-	-
21	wild	wild	B-NP	B-NP	-	23	NMOD	-	-
22	type	type	I-NP	I-NP	-	23	NMOD	-	-
23	IKK2	IKK2	I-NP	I-NP	-	24	SUB	-	-
24	did	did	B-VP	B-VP	-	0	ROOT	-	-
25	not	not	I-VP	I-VP	-	24	VMOD	-	-
26	affect	affect	I-VP	I-VP	-	24	VC	-	-
27	LPS-induced	LPS-induced	B-NP	B-NP	-	29	NMOD	-	-
28	kappaB-dependent	kappaB-dependent	I-NP	I-NP	-	29	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	26	OBJ	-	-
30	in	in	B-PP	B-PP	-	29	NMOD	-	-
31	monocytic	monocytic	B-NP	B-NP	-	32	NMOD	-	-
32	cells	cells	I-NP	I-NP	-	30	PMOD	-	-
33	.	.	O	O	-	24	P	-	-

1	In	In	B-PP	B-PP	-	10	VMOD	-	-
2	contrast	contrast	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	10	P	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	dominant	dominant	I-NP	I-NP	-	7	NMOD	-	-
6	negative	negative	I-NP	I-NP	-	7	NMOD	-	-
7	mutant	mutant	I-NP	I-NP	-	10	SUB	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	IKK2	IKK2	B-NP	B-NP	-	8	PMOD	-	-
10	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
11	LPS	LPS	B-NP	B-NP	-	12	NMOD	-	-
12	induction	induction	I-NP	I-NP	-	10	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	kappaB-dependent	kappaB-dependent	B-NP	B-NP	-	15	NMOD	-	-
15	transcription	transcription	I-NP	I-NP	-	13	PMOD	-	-
16	in	in	B-PP	B-PP	-	12	NMOD	-	-
17	a	a	B-NP	B-NP	-	19	NMOD	-	-
18	dose-dependent	dose-dependent	I-NP	I-NP	-	19	NMOD	-	-
19	manner	manner	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	10	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	indicate	indicate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	LPS	LPS	B-NP	B-NP	-	6	NMOD	-	-
6	induction	induction	I-NP	I-NP	-	15	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	kappaB-dependent	kappaB-dependent	B-NP	B-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	7	PMOD	-	-
11	in	in	B-PP	B-PP	-	6	NMOD	-	-
12	human	human	B-NP	B-NP	-	14	NMOD	-	-
13	monocytic	monocytic	I-NP	I-NP	-	14	NMOD	-	-
14	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
15	requires	requires	B-VP	B-VP	-	4	SBAR	-	-
16	activation	activation	B-NP	B-NP	-	15	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	IKK2	IKK2	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	3	P	-	-

1	Effects	Effects	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	overexpression	overexpression	B-NP	B-NP	-	2	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	IL-1	IL-1	B-NP	B-NP	-	7	NMOD	-	-
6	receptor-associated	receptor-associated	I-NP	I-NP	-	7	NMOD	-	-
7	kinase	kinase	I-NP	I-NP	-	4	PMOD	-	-
8	on	on	B-PP	B-PP	-	3	NMOD	-	-
9	NFkappaB	NFkappaB	B-NP	B-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	8	PMOD	-	-
11	,	,	O	O	-	17	P	-	-
12	IL-2	IL-2	B-NP	B-NP	-	13	NMOD	-	-
13	production	production	I-NP	I-NP	-	17	NMOD	-	-
14	and	and	O	O	-	17	NMOD	-	-
15	stress-activated	stress-activated	B-NP	B-NP	-	17	NMOD	-	-
16	protein	protein	I-NP	I-NP	-	17	NMOD	-	-
17	kinases	kinases	I-NP	I-NP	-	8	PMOD	-	-
18	in	in	B-PP	B-PP	-	3	NMOD	-	-
19	the	the	B-NP	B-NP	-	24	NMOD	-	-
20	murine	murine	I-NP	I-NP	-	24	NMOD	-	-
21	T	T	I-NP	I-NP	-	24	NMOD	-	-
22	cell	cell	I-NP	I-NP	-	24	NMOD	-	-
23	line	line	I-NP	I-NP	-	24	NMOD	-	-
24	EL4	EL4	I-NP	I-NP	-	18	PMOD	-	-
25	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	4	NMOD	-	-
2	association	association	I-NP	I-NP	-	4	NMOD	-	-
3	and	and	I-NP	I-NP	-	4	NMOD	-	-
4	activation	activation	I-NP	I-NP	-	19	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	10	NMOD	-	-
7	IL-1	IL-1	I-NP	I-NP	-	10	NMOD	-	-
8	receptor-associated	receptor-associated	I-NP	I-NP	-	10	NMOD	-	-
9	protein	protein	I-NP	I-NP	-	10	NMOD	-	-
10	kinase	kinase	I-NP	I-NP	-	5	PMOD	-	-
11	(	(	O	O	-	12	P	-	-
12	IRAK	IRAK	B-NP	B-NP	-	10	NMOD	-	-
13	)	)	O	O	-	12	P	-	-
14	to	to	B-PP	B-PP	-	4	NMOD	-	-
15	the	the	B-NP	B-NP	-	18	NMOD	-	-
16	IL-1	IL-1	I-NP	I-NP	-	18	NMOD	-	-
17	receptor	receptor	I-NP	I-NP	-	18	NMOD	-	-
18	complex	complex	I-NP	I-NP	-	14	PMOD	-	-
19	is	is	B-VP	B-VP	-	0	ROOT	-	-
20	one	one	B-NP	B-NP	-	19	PRD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	the	the	B-NP	B-NP	-	24	NMOD	-	-
23	earliest	earliest	I-NP	I-NP	-	24	NMOD	-	-
24	events	events	I-NP	I-NP	-	21	PMOD	-	-
25	detectable	detectable	B-ADJP	B-ADJP	-	24	NMOD	-	-
26	in	in	B-PP	B-PP	-	25	AMOD	-	-
27	IL-1	IL-1	B-NP	B-NP	-	29	NMOD	-	-
28	signal	signal	I-NP	I-NP	-	29	NMOD	-	-
29	transduction	transduction	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	19	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	generated	generated	B-VP	B-VP	-	0	ROOT	-	-
3	permanent	permanent	B-NP	B-NP	-	4	NMOD	-	-
4	clones	clones	I-NP	I-NP	-	2	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	11	NMOD	-	-
7	murine	murine	I-NP	I-NP	-	11	NMOD	-	-
8	T	T	I-NP	I-NP	-	11	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
10	line	line	I-NP	I-NP	-	11	NMOD	-	-
11	EL4	EL4	I-NP	I-NP	-	5	PMOD	-	-
12	<num>	<num>	I-NP	I-NP	-	11	NMOD	-	-
13	overexpressing	overexpressing	B-VP	B-VP	-	2	VMOD	-	-
14	human	human	O	O	-	18	NMOD	-	-
15	(	(	O	O	-	18	P	-	-
16	h	h	B-NP	B-NP	-	18	NMOD	-	-
17	)	)	O	O	-	18	P	-	-
18	IRAK	IRAK	B-NP	B-NP	-	13	OBJ	-	-
19	to	to	B-VP	B-VP	-	20	VMOD	-	-
20	evaluate	evaluate	I-VP	I-VP	-	2	VMOD	-	-
21	the	the	B-NP	B-NP	-	22	NMOD	-	-
22	role	role	I-NP	I-NP	-	20	OBJ	-	-
23	of	of	B-PP	B-PP	-	22	NMOD	-	-
24	this	this	B-NP	B-NP	-	25	NMOD	-	-
25	kinase	kinase	I-NP	I-NP	-	23	PMOD	-	-
26	in	in	B-PP	B-PP	-	22	NMOD	-	-
27	IL-1	IL-1	B-NP	B-NP	-	28	NMOD	-	-
28	signaling	signaling	I-NP	I-NP	-	26	PMOD	-	-
29	.	.	O	O	-	2	P	-	-

1	Overexpression	Overexpression	B-NP	B-NP	-	4	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	hIRAK	hIRAK	B-NP	B-NP	-	2	PMOD	-	-
4	enhanced	enhanced	B-VP	B-VP	-	13	VMOD	-	-
5	IL-1-stimulated	IL-1-stimulated	B-NP	B-NP	-	6	NMOD	-	-
6	activation	activation	I-NP	I-NP	-	4	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	11	NMOD	-	-
9	transcription	transcription	I-NP	I-NP	-	11	NMOD	-	-
10	factor	factor	I-NP	I-NP	-	11	NMOD	-	-
11	NFkappaB	NFkappaB	I-NP	I-NP	-	7	PMOD	-	-
12	,	,	O	O	-	4	P	-	-
13	whereas	whereas	O	O	-	0	ROOT	-	-
14	a	a	B-NP	B-NP	-	16	NMOD	-	-
15	truncated	truncated	I-NP	I-NP	-	16	NMOD	-	-
16	form	form	I-NP	I-NP	-	21	SUB	-	-
17	(	(	O	O	-	18	P	-	-
18	N-IRAK	N-IRAK	B-NP	B-NP	-	16	NMOD	-	-
19	)	)	O	O	-	18	P	-	-
20	specifically	specifically	B-ADVP	B-ADVP	-	21	VMOD	-	-
21	inhibited	inhibited	B-VP	B-VP	-	13	SBAR	-	-
22	IL-1-dependent	IL-1-dependent	B-NP	B-NP	-	24	NMOD	-	-
23	NFkappaB	NFkappaB	I-NP	I-NP	-	24	NMOD	-	-
24	activity	activity	I-NP	I-NP	-	21	OBJ	-	-
25	.	.	O	O	-	13	P	-	-

1	In	In	B-PP	B-PP	-	12	VMOD	-	-
2	clones	clones	B-NP	B-NP	-	1	PMOD	-	-
3	stably	stably	B-VP	B-VP	-	4	VMOD	-	-
4	overexpressing	overexpressing	I-VP	I-VP	-	2	NMOD	-	-
5	hIRAK	hIRAK	B-NP	B-NP	-	9	NMOD	-	-
6	a	a	B-NP	B-NP	-	9	NMOD	-	-
7	weak	weak	I-NP	I-NP	-	9	NMOD	-	-
8	constitutive	constitutive	I-NP	I-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	4	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NFkappaB	NFkappaB	B-NP	B-NP	-	10	PMOD	-	-
12	correlated	correlated	B-VP	B-VP	-	0	ROOT	-	-
13	with	with	B-PP	B-PP	-	12	VMOD	-	-
14	a	a	B-NP	B-NP	-	18	NMOD	-	-
15	low	low	I-NP	I-NP	-	18	NMOD	-	-
16	basal	basal	I-NP	I-NP	-	18	NMOD	-	-
17	IL-2	IL-2	I-NP	I-NP	-	18	NMOD	-	-
18	production	production	I-NP	I-NP	-	13	PMOD	-	-
19	which	which	B-NP	B-NP	-	18	NMOD	-	-
20	was	was	B-VP	B-VP	-	19	SBAR	-	-
21	enhanced	enhanced	I-VP	I-VP	-	20	VC	-	-
22	in	in	B-PP	B-PP	-	21	VMOD	-	-
23	an	an	B-NP	B-NP	-	25	NMOD	-	-
24	IL-1-dependent	IL-1-dependent	I-NP	I-NP	-	25	NMOD	-	-
25	manner	manner	I-NP	I-NP	-	22	PMOD	-	-
26	.	.	O	O	-	12	P	-	-

1	Compared	Compared	B-PP	B-PP	-	9	NMOD	-	-
2	to	to	B-PP	B-PP	-	1	VMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	parental	parental	I-NP	I-NP	-	6	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	6	NMOD	-	-
6	line	line	I-NP	I-NP	-	9	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	dose-response	dose-response	I-NP	I-NP	-	9	NMOD	-	-
9	curve	curve	I-NP	I-NP	-	14	SUB	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	IL-1-induced	IL-1-induced	B-NP	B-NP	-	13	NMOD	-	-
12	IL-2	IL-2	I-NP	I-NP	-	13	NMOD	-	-
13	production	production	I-NP	I-NP	-	10	PMOD	-	-
14	was	was	B-VP	B-VP	-	0	ROOT	-	-
15	shifted	shifted	I-VP	I-VP	-	14	VC	-	-
16	in	in	B-PP	B-PP	-	15	VMOD	-	-
17	both	both	O	O	-	20	NMOD	-	-
18	potency	potency	B-NP	B-NP	-	20	NMOD	-	-
19	and	and	I-NP	I-NP	-	20	NMOD	-	-
20	efficacy	efficacy	I-NP	I-NP	-	16	PMOD	-	-
21	.	.	O	O	-	14	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	IRAK	IRAK	B-NP	B-NP	-	7	SUB	-	-
6	directly	directly	B-ADVP	B-ADVP	-	7	VMOD	-	-
7	triggers	triggers	B-VP	B-VP	-	4	SBAR	-	-
8	NFkappaB-mediated	NFkappaB-mediated	B-NP	B-NP	-	10	NMOD	-	-
9	gene	gene	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	7	OBJ	-	-
11	in	in	B-PP	B-PP	-	10	NMOD	-	-
12	EL4	EL4	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	11	PMOD	-	-
14	.	.	O	O	-	3	P	-	-

1	Qualitatively	Qualitatively	B-NP	B-NP	-	2	AMOD	-	-
2	different	different	I-NP	I-NP	-	3	NMOD	-	-
3	effects	effects	I-NP	I-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	22	VMOD	-	-
5	observed	observed	I-VP	I-VP	-	4	VC	-	-
6	for	for	B-PP	B-PP	-	5	VMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	IL-1-induced	IL-1-induced	I-NP	I-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	stress-activated	stress-activated	B-NP	B-NP	-	16	NMOD	-	-
12	protein	protein	I-NP	I-NP	-	16	NMOD	-	-
13	(	(	O	O	-	14	P	-	-
14	SAP	SAP	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	kinases	kinases	B-NP	B-NP	-	10	PMOD	-	-
17	:	:	O	O	-	4	P	-	-
18	permanent	permanent	B-NP	B-NP	-	19	NMOD	-	-
19	overexpression	overexpression	I-NP	I-NP	-	22	SUB	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	IRAK	IRAK	B-NP	B-NP	-	20	PMOD	-	-
22	did	did	B-VP	B-VP	-	0	ROOT	-	-
23	not	not	I-VP	I-VP	-	22	VMOD	-	-
24	affect	affect	I-VP	I-VP	-	22	VC	-	-
25	the	the	B-NP	B-NP	-	27	NMOD	-	-
26	dose	dose	I-NP	I-NP	-	27	NMOD	-	-
27	dependence	dependence	I-NP	I-NP	-	24	OBJ	-	-
28	but	but	O	O	-	22	VMOD	-	-
29	prolonged	prolonged	B-VP	B-VP	-	22	VMOD	-	-
30	the	the	B-NP	B-NP	-	31	NMOD	-	-
31	kinetics	kinetics	I-NP	I-NP	-	29	OBJ	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	IL-1-induced	IL-1-induced	B-NP	B-NP	-	34	NMOD	-	-
34	activation	activation	I-NP	I-NP	-	32	PMOD	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	SAP	SAP	B-NP	B-NP	-	37	NMOD	-	-
37	kinases	kinases	I-NP	I-NP	-	35	PMOD	-	-
38	,	,	O	O	-	22	P	-	-
39	suggesting	suggesting	B-VP	B-VP	-	22	VMOD	-	-
40	that	that	B-SBAR	B-SBAR	-	39	VMOD	-	-
41	this	this	B-NP	B-NP	-	43	NMOD	-	-
42	signaling	signaling	I-NP	I-NP	-	43	NMOD	-	-
43	branch	branch	I-NP	I-NP	-	44	SUB	-	-
44	may	may	B-VP	B-VP	-	40	SBAR	-	-
45	be	be	I-VP	I-VP	-	44	VC	-	-
46	regulated	regulated	I-VP	I-VP	-	45	VC	-	-
47	by	by	B-PP	B-PP	-	46	VMOD	-	-
48	distinct	distinct	B-NP	B-NP	-	49	NMOD	-	-
49	mechanisms	mechanisms	I-NP	I-NP	-	47	PMOD	-	-
50	.	.	O	O	-	22	P	-	-

1	Decreased	Decreased	B-NP	B-NP	-	3	NMOD	-	-
2	IL-12	IL-12	I-NP	I-NP	-	3	NMOD	-	-
3	production	production	I-NP	I-NP	-	7	NMOD	-	-
4	and	and	I-NP	I-NP	-	7	NMOD	-	-
5	Th1	Th1	I-NP	I-NP	-	7	NMOD	-	-
6	cell	cell	I-NP	I-NP	-	7	NMOD	-	-
7	development	development	I-NP	I-NP	-	0	ROOT	-	-
8	by	by	B-PP	B-PP	-	7	NMOD	-	-
9	acetyl	acetyl	B-NP	B-NP	-	12	NMOD	-	-
10	salicylic	salicylic	I-NP	I-NP	-	12	NMOD	-	-
11	acid-mediated	acid-mediated	I-NP	I-NP	-	12	NMOD	-	-
12	inhibition	inhibition	I-NP	I-NP	-	8	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	NF-kappaB	NF-kappaB	B-NP	B-NP	-	13	PMOD	-	-
15	.	.	O	O	-	7	P	-	-

1	IL-12	IL-12	B-NP	B-NP	-	2	SUB	-	-
2	is	is	B-VP	B-VP	-	0	ROOT	-	-
3	a	a	B-NP	B-NP	-	6	NMOD	-	-
4	75-kDa	75-kDa	I-NP	I-NP	-	6	NMOD	-	-
5	heterodimeric	heterodimeric	I-NP	I-NP	-	6	NMOD	-	-
6	cytokine	cytokine	I-NP	I-NP	-	2	PRD	-	-
7	composed	composed	B-VP	B-VP	-	6	NMOD	-	-
8	of	of	B-PP	B-PP	-	7	VMOD	-	-
9	two	two	B-NP	B-NP	-	11	AMOD	-	-
10	covalently	covalently	I-NP	I-NP	-	11	AMOD	-	-
11	linked	linked	I-NP	I-NP	-	15	NMOD	-	-
12	p35	p35	I-NP	I-NP	-	14	NMOD	-	-
13	and	and	I-NP	I-NP	-	14	NMOD	-	-
14	p40	p40	I-NP	I-NP	-	15	NMOD	-	-
15	chains	chains	I-NP	I-NP	-	8	PMOD	-	-
16	.	.	O	O	-	2	P	-	-

1	This	This	B-NP	B-NP	-	3	NMOD	-	-
2	pro-inflammatory	pro-inflammatory	I-NP	I-NP	-	3	NMOD	-	-
3	cytokine	cytokine	I-NP	I-NP	-	4	SUB	-	-
4	plays	plays	B-VP	B-VP	-	0	ROOT	-	-
5	a	a	B-NP	B-NP	-	7	NMOD	-	-
6	prominent	prominent	I-NP	I-NP	-	7	NMOD	-	-
7	role	role	I-NP	I-NP	-	4	OBJ	-	-
8	in	in	B-PP	B-PP	-	4	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	development	development	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	Th1	Th1	B-NP	B-NP	-	15	NMOD	-	-
13	cell-mediated	cell-mediated	I-NP	I-NP	-	15	NMOD	-	-
14	immune	immune	I-NP	I-NP	-	15	NMOD	-	-
15	responses	responses	I-NP	I-NP	-	11	PMOD	-	-
16	.	.	O	O	-	4	P	-	-

1	Th1	Th1	B-NP	B-NP	-	4	NMOD	-	-
2	cell-mediated	cell-mediated	I-NP	I-NP	-	4	NMOD	-	-
3	immune	immune	I-NP	I-NP	-	4	NMOD	-	-
4	responses	responses	I-NP	I-NP	-	5	SUB	-	-
5	have	have	B-VP	B-VP	-	0	ROOT	-	-
6	been	been	I-VP	I-VP	-	5	VC	-	-
7	implicated	implicated	I-VP	I-VP	-	6	VC	-	-
8	in	in	B-PP	B-PP	-	7	VMOD	-	-
9	the	the	B-NP	B-NP	-	10	NMOD	-	-
10	pathogenesis	pathogenesis	I-NP	I-NP	-	8	PMOD	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	chronic	chronic	B-NP	B-NP	-	15	NMOD	-	-
13	inflammatory	inflammatory	I-NP	I-NP	-	15	NMOD	-	-
14	autoimmune	autoimmune	I-NP	I-NP	-	15	NMOD	-	-
15	diseases	diseases	I-NP	I-NP	-	11	PMOD	-	-
16	.	.	O	O	-	5	P	-	-

1	Thus	Thus	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	IL-12	IL-12	B-NP	B-NP	-	4	SUB	-	-
4	appears	appears	B-VP	B-VP	-	0	ROOT	-	-
5	to	to	I-VP	I-VP	-	6	VMOD	-	-
6	be	be	I-VP	I-VP	-	4	VMOD	-	-
7	a	a	B-NP	B-NP	-	9	NMOD	-	-
8	critical	critical	I-NP	I-NP	-	9	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	6	PRD	-	-
10	in	in	B-PP	B-PP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	14	NMOD	-	-
12	generation	generation	I-NP	I-NP	-	14	NMOD	-	-
13	and	and	I-NP	I-NP	-	14	NMOD	-	-
14	maintenance	maintenance	I-NP	I-NP	-	10	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	chronic	chronic	B-NP	B-NP	-	18	NMOD	-	-
17	inflammatory	inflammatory	I-NP	I-NP	-	18	NMOD	-	-
18	conditions	conditions	I-NP	I-NP	-	15	PMOD	-	-
19	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	investigated	investigated	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	8	NMOD	-	-
8	effects	effects	I-NP	I-NP	-	6	OBJ	-	-
9	of	of	B-PP	B-PP	-	8	NMOD	-	-
10	a	a	B-NP	B-NP	-	14	NMOD	-	-
11	commonly	commonly	I-NP	I-NP	-	12	AMOD	-	-
12	prescribed	prescribed	I-NP	I-NP	-	14	NMOD	-	-
13	anti-inflammatory	anti-inflammatory	I-NP	I-NP	-	14	NMOD	-	-
14	drug	drug	I-NP	I-NP	-	18	NMOD	-	-
15	,	,	O	O	-	18	P	-	-
16	acetyl	acetyl	B-NP	B-NP	-	18	NMOD	-	-
17	salicylic	salicylic	I-NP	I-NP	-	18	NMOD	-	-
18	acid	acid	I-NP	I-NP	-	9	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	ASA	ASA	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	,	,	O	O	-	6	P	-	-
23	on	on	B-PP	B-PP	-	6	VMOD	-	-
24	IL-12	IL-12	B-NP	B-NP	-	25	NMOD	-	-
25	production	production	I-NP	I-NP	-	29	NMOD	-	-
26	and	and	O	O	-	29	NMOD	-	-
27	Th1	Th1	B-NP	B-NP	-	29	NMOD	-	-
28	cell	cell	I-NP	I-NP	-	29	NMOD	-	-
29	development	development	I-NP	I-NP	-	23	PMOD	-	-
30	.	.	O	O	-	6	P	-	-

1	ASA	ASA	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	found	found	I-VP	I-VP	-	2	VC	-	-
4	to	to	I-VP	I-VP	-	5	VMOD	-	-
5	inhibit	inhibit	I-VP	I-VP	-	3	VMOD	-	-
6	secretion	secretion	B-NP	B-NP	-	5	OBJ	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	the	the	B-NP	B-NP	-	10	NMOD	-	-
9	IL-12	IL-12	I-NP	I-NP	-	10	NMOD	-	-
10	heterodimer	heterodimer	I-NP	I-NP	-	15	NMOD	-	-
11	as	as	B-CONJP	B-CONJP	-	15	NMOD	-	-
12	well	well	I-CONJP	I-CONJP	-	11	DEP	-	-
13	as	as	I-CONJP	I-CONJP	-	11	DEP	-	-
14	p40	p40	B-NP	B-NP	-	15	NMOD	-	-
15	monomer	monomer	I-NP	I-NP	-	7	PMOD	-	-
16	by	by	B-PP	B-PP	-	15	NMOD	-	-
17	human	human	B-NP	B-NP	-	19	NMOD	-	-
18	monocytic	monocytic	I-NP	I-NP	-	19	NMOD	-	-
19	cells	cells	I-NP	I-NP	-	16	PMOD	-	-
20	.	.	O	O	-	2	P	-	-

1	This	This	B-NP	B-NP	-	2	SUB	-	-
2	was	was	B-VP	B-VP	-	0	ROOT	-	-
3	associated	associated	I-VP	I-VP	-	2	VC	-	-
4	with	with	B-PP	B-PP	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	down-regulation	down-regulation	I-NP	I-NP	-	4	PMOD	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	IL-12p40	IL-12p40	B-NP	B-NP	-	10	NMOD	-	-
9	mRNA	mRNA	I-NP	I-NP	-	10	NMOD	-	-
10	expression	expression	I-NP	I-NP	-	7	PMOD	-	-
11	.	.	O	O	-	2	P	-	-

1	Analysis	Analysis	B-NP	B-NP	-	10	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	4	NMOD	-	-
4	regulation	regulation	I-NP	I-NP	-	2	PMOD	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	the	the	B-NP	B-NP	-	9	NMOD	-	-
7	p40	p40	I-NP	I-NP	-	9	NMOD	-	-
8	gene	gene	I-NP	I-NP	-	9	NMOD	-	-
9	promoter	promoter	I-NP	I-NP	-	5	PMOD	-	-
10	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
11	that	that	B-SBAR	B-SBAR	-	10	VMOD	-	-
12	ASA	ASA	B-NP	B-NP	-	13	SUB	-	-
13	inhibited	inhibited	B-VP	B-VP	-	11	SBAR	-	-
14	NF-kappaB	NF-kappaB	B-NP	B-NP	-	15	NMOD	-	-
15	activation	activation	I-NP	I-NP	-	17	NMOD	-	-
16	and	and	O	O	-	17	NMOD	-	-
17	binding	binding	B-NP	B-NP	-	13	OBJ	-	-
18	to	to	B-PP	B-PP	-	17	NMOD	-	-
19	the	the	B-NP	B-NP	-	21	NMOD	-	-
20	p40-kappaB	p40-kappaB	I-NP	I-NP	-	21	NMOD	-	-
21	site	site	I-NP	I-NP	-	18	PMOD	-	-
22	in	in	B-PP	B-PP	-	13	VMOD	-	-
23	the	the	B-NP	B-NP	-	25	NMOD	-	-
24	p40	p40	I-NP	I-NP	-	25	NMOD	-	-
25	promoter	promoter	I-NP	I-NP	-	22	PMOD	-	-
26	,	,	O	O	-	13	P	-	-
27	leading	leading	B-VP	B-VP	-	13	VMOD	-	-
28	to	to	B-PP	B-PP	-	27	VMOD	-	-
29	transcriptional	transcriptional	B-NP	B-NP	-	30	NMOD	-	-
30	repression	repression	I-NP	I-NP	-	28	PMOD	-	-
31	of	of	B-PP	B-PP	-	30	NMOD	-	-
32	the	the	B-NP	B-NP	-	34	NMOD	-	-
33	p40	p40	I-NP	I-NP	-	34	NMOD	-	-
34	gene	gene	I-NP	I-NP	-	31	PMOD	-	-
35	.	.	O	O	-	10	P	-	-

1	Addition	Addition	B-NP	B-NP	-	25	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	ASA	ASA	B-NP	B-NP	-	2	PMOD	-	-
4	to	to	B-PP	B-PP	-	1	NMOD	-	-
5	an	an	B-NP	B-NP	-	12	NMOD	-	-
6	in	in	I-NP	I-NP	-	7	AMOD	-	-
7	vitro	vitro	I-NP	I-NP	-	12	NMOD	-	-
8	T	T	I-NP	I-NP	-	12	NMOD	-	-
9	helper	helper	I-NP	I-NP	-	12	NMOD	-	-
10	cell	cell	I-NP	I-NP	-	12	NMOD	-	-
11	differentiation	differentiation	I-NP	I-NP	-	12	NMOD	-	-
12	system	system	I-NP	I-NP	-	4	PMOD	-	-
13	,	,	O	O	-	12	P	-	-
14	at	at	B-PP	B-PP	-	12	NMOD	-	-
15	concentrations	concentrations	B-NP	B-NP	-	14	PMOD	-	-
16	compatible	compatible	B-ADJP	B-ADJP	-	15	NMOD	-	-
17	with	with	B-PP	B-PP	-	16	AMOD	-	-
18	plasma	plasma	B-NP	B-NP	-	19	NMOD	-	-
19	levels	levels	I-NP	I-NP	-	17	PMOD	-	-
20	reached	reached	B-VP	B-VP	-	19	NMOD	-	-
21	during	during	B-PP	B-PP	-	20	VMOD	-	-
22	anti-inflammatory	anti-inflammatory	B-NP	B-NP	-	23	NMOD	-	-
23	therapy	therapy	I-NP	I-NP	-	21	PMOD	-	-
24	,	,	O	O	-	12	P	-	-
25	resulted	resulted	B-VP	B-VP	-	0	ROOT	-	-
26	in	in	B-PP	B-PP	-	25	VMOD	-	-
27	reduced	reduced	B-NP	B-NP	-	28	NMOD	-	-
28	development	development	I-NP	I-NP	-	26	PMOD	-	-
29	of	of	B-PP	B-PP	-	28	NMOD	-	-
30	Th1	Th1	B-NP	B-NP	-	31	NMOD	-	-
31	cells	cells	I-NP	I-NP	-	29	PMOD	-	-
32	.	.	O	O	-	25	P	-	-

1	These	These	B-NP	B-NP	-	2	NMOD	-	-
2	results	results	I-NP	I-NP	-	3	SUB	-	-
3	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	the	the	B-NP	B-NP	-	6	NMOD	-	-
6	inhibition	inhibition	I-NP	I-NP	-	12	SUB	-	-
7	of	of	B-PP	B-PP	-	6	NMOD	-	-
8	NF-kappaB	NF-kappaB	B-NP	B-NP	-	9	NMOD	-	-
9	activation	activation	I-NP	I-NP	-	7	PMOD	-	-
10	by	by	B-PP	B-PP	-	6	NMOD	-	-
11	ASA	ASA	B-NP	B-NP	-	10	PMOD	-	-
12	leads	leads	B-VP	B-VP	-	4	SBAR	-	-
13	to	to	B-PP	B-PP	-	12	VMOD	-	-
14	down-regulation	down-regulation	B-NP	B-NP	-	13	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	IL-12	IL-12	B-NP	B-NP	-	17	NMOD	-	-
17	production	production	I-NP	I-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	inhibition	inhibition	I-NP	I-NP	-	15	PMOD	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	Th1	Th1	B-NP	B-NP	-	23	NMOD	-	-
22	cell	cell	I-NP	I-NP	-	23	NMOD	-	-
23	development	development	I-NP	I-NP	-	20	PMOD	-	-
24	.	.	O	O	-	3	P	-	-

1	Membrane-associated	Membrane-associated	B-NP	B-NP	-	2	NMOD	-	-
2	lymphotoxin	lymphotoxin	I-NP	I-NP	-	7	SUB	-	-
3	on	on	B-PP	B-PP	-	2	NMOD	-	-
4	natural	natural	B-NP	B-NP	-	6	NMOD	-	-
5	killer	killer	I-NP	I-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	3	PMOD	-	-
7	activates	activates	B-VP	B-VP	-	0	ROOT	-	-
8	endothelial	endothelial	B-NP	B-NP	-	9	NMOD	-	-
9	cells	cells	I-NP	I-NP	-	7	OBJ	-	-
10	via	via	B-PP	B-PP	-	7	VMOD	-	-
11	an	an	B-NP	B-NP	-	13	NMOD	-	-
12	NF-kappaB-dependent	NF-kappaB-dependent	I-NP	I-NP	-	13	NMOD	-	-
13	pathway	pathway	I-NP	I-NP	-	10	PMOD	-	-
14	.	.	O	O	-	7	P	-	-

1	BACKGROUND	BACKGROUND	B-NP	B-NP	-	3	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	Inhibition	Inhibition	B-NP	B-NP	-	12	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	complement	complement	B-NP	B-NP	-	4	PMOD	-	-
6	in	in	B-PP	B-PP	-	3	NMOD	-	-
7	small	small	B-NP	B-NP	-	9	NMOD	-	-
8	animal	animal	I-NP	I-NP	-	9	NMOD	-	-
9	models	models	I-NP	I-NP	-	6	PMOD	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	xenotransplantation	xenotransplantation	B-NP	B-NP	-	10	PMOD	-	-
12	has	has	B-VP	B-VP	-	0	ROOT	-	-
13	demonstrated	demonstrated	I-VP	I-VP	-	12	VC	-	-
14	graft	graft	B-NP	B-NP	-	15	NMOD	-	-
15	infiltration	infiltration	I-NP	I-NP	-	13	OBJ	-	-
16	with	with	B-PP	B-PP	-	15	NMOD	-	-
17	natural	natural	B-NP	B-NP	-	18	NMOD	-	-
18	killer	killer	I-NP	I-NP	-	22	NMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	NK	NK	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	cells	cells	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	monocytes	monocytes	I-NP	I-NP	-	16	PMOD	-	-
25	associated	associated	B-VP	B-VP	-	24	NMOD	-	-
26	with	with	B-PP	B-PP	-	25	VMOD	-	-
27	endothelial	endothelial	B-NP	B-NP	-	28	NMOD	-	-
28	cell	cell	I-NP	I-NP	-	32	NMOD	-	-
29	(	(	O	O	-	30	P	-	-
30	EC	EC	B-NP	B-NP	-	28	NMOD	-	-
31	)	)	O	O	-	30	P	-	-
32	activation	activation	B-NP	B-NP	-	26	PMOD	-	-
33	.	.	O	O	-	12	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	have	have	B-VP	B-VP	-	0	ROOT	-	-
3	previously	previously	I-VP	I-VP	-	2	VMOD	-	-
4	demonstrated	demonstrated	I-VP	I-VP	-	2	VC	-	-
5	that	that	B-SBAR	B-SBAR	-	4	VMOD	-	-
6	human	human	B-NP	B-NP	-	8	NMOD	-	-
7	NK	NK	I-NP	I-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	9	SUB	-	-
9	activate	activate	B-VP	B-VP	-	5	SBAR	-	-
10	porcine	porcine	B-NP	B-NP	-	11	NMOD	-	-
11	EC	EC	I-NP	I-NP	-	9	OBJ	-	-
12	in	in	B-ADVP	B-ADVP	-	9	VMOD	-	-
13	vitro	vitro	I-ADVP	I-ADVP	-	12	AMOD	-	-
14	,	,	O	O	-	2	P	-	-
15	which	which	B-NP	B-NP	-	2	VMOD	-	-
16	results	results	B-VP	B-VP	-	15	SBAR	-	-
17	in	in	B-PP	B-PP	-	16	VMOD	-	-
18	adhesion	adhesion	B-NP	B-NP	-	20	NMOD	-	-
19	molecule	molecule	I-NP	I-NP	-	20	NMOD	-	-
20	expression	expression	I-NP	I-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	cytokine	cytokine	B-NP	B-NP	-	23	NMOD	-	-
23	secretion	secretion	I-NP	I-NP	-	17	PMOD	-	-
24	.	.	O	O	-	2	P	-	-

1	In	In	B-PP	B-PP	-	6	VMOD	-	-
2	this	this	B-NP	B-NP	-	3	NMOD	-	-
3	study	study	I-NP	I-NP	-	1	PMOD	-	-
4	,	,	O	O	-	6	P	-	-
5	we	we	B-NP	B-NP	-	6	SUB	-	-
6	used	used	B-VP	B-VP	-	0	ROOT	-	-
7	the	the	B-NP	B-NP	-	11	NMOD	-	-
8	NK	NK	I-NP	I-NP	-	11	NMOD	-	-
9	cell	cell	I-NP	I-NP	-	11	NMOD	-	-
10	line	line	I-NP	I-NP	-	11	NMOD	-	-
11	NK92	NK92	I-NP	I-NP	-	6	OBJ	-	-
12	to	to	B-VP	B-VP	-	13	VMOD	-	-
13	define	define	I-VP	I-VP	-	6	VMOD	-	-
14	the	the	B-NP	B-NP	-	18	NMOD	-	-
15	molecular	molecular	I-NP	I-NP	-	17	AMOD	-	-
16	and	and	I-NP	I-NP	-	17	AMOD	-	-
17	cellular	cellular	I-NP	I-NP	-	18	NMOD	-	-
18	basis	basis	I-NP	I-NP	-	13	OBJ	-	-
19	of	of	B-PP	B-PP	-	18	NMOD	-	-
20	NK	NK	B-NP	B-NP	-	23	NMOD	-	-
21	cell-mediated	cell-mediated	I-NP	I-NP	-	23	NMOD	-	-
22	EC	EC	I-NP	I-NP	-	23	NMOD	-	-
23	activation	activation	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	6	P	-	-

1	METHODS	METHODS	B-NP	B-NP	-	3	NMOD	-	-
2	:	:	O	O	-	1	P	-	-
3	EC	EC	B-NP	B-NP	-	4	SUB	-	-
4	were	were	B-VP	B-VP	-	0	ROOT	-	-
5	transfected	transfected	I-VP	I-VP	-	4	VC	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	either	either	O	O	-	9	NMOD	-	-
8	reporter	reporter	B-NP	B-NP	-	9	NMOD	-	-
9	constructs	constructs	I-NP	I-NP	-	6	PMOD	-	-
10	containing	containing	B-VP	B-VP	-	9	NMOD	-	-
11	the	the	B-NP	B-NP	-	13	NMOD	-	-
12	luciferase	luciferase	I-NP	I-NP	-	13	NMOD	-	-
13	gene	gene	I-NP	I-NP	-	10	OBJ	-	-
14	driven	driven	B-VP	B-VP	-	13	NMOD	-	-
15	either	either	B-PP	B-PP	-	14	VMOD	-	-
16	by	by	I-PP	I-PP	-	6	PMOD	-	-
17	E-selectin	E-selectin	B-NP	B-NP	-	29	NMOD	-	-
18	or	or	O	O	-	29	NMOD	-	-
19	interleukin	interleukin	B-NP	B-NP	-	24	NMOD	-	-
20	(	(	O	O	-	21	P	-	-
21	IL	IL	B-NP	B-NP	-	19	NMOD	-	-
22	)	)	O	O	-	21	P	-	-
23	-8	-8	B-NP	B-NP	-	24	NMOD	-	-
24	promoters	promoters	I-NP	I-NP	-	29	NMOD	-	-
25	or	or	O	O	-	29	NMOD	-	-
26	a	a	B-NP	B-NP	-	29	NMOD	-	-
27	synthetic	synthetic	I-NP	I-NP	-	29	NMOD	-	-
28	NF-kappaB-dependent	NF-kappaB-dependent	I-NP	I-NP	-	29	NMOD	-	-
29	promoter	promoter	I-NP	I-NP	-	16	PMOD	-	-
30	.	.	O	O	-	4	P	-	-

1	In	In	B-PP	B-PP	-	17	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	17	P	-	-
4	a	a	B-NP	B-NP	-	10	NMOD	-	-
5	dominant-negative	dominant-negative	I-NP	I-NP	-	10	NMOD	-	-
6	mutant	mutant	I-NP	I-NP	-	10	NMOD	-	-
7	tumor	tumor	I-NP	I-NP	-	10	NMOD	-	-
8	necrosis	necrosis	I-NP	I-NP	-	10	NMOD	-	-
9	factor	factor	I-NP	I-NP	-	10	NMOD	-	-
10	receptor	receptor	I-NP	I-NP	-	16	NMOD	-	-
11	I	I	I-NP	I-NP	-	16	NMOD	-	-
12	(	(	O	O	-	16	P	-	-
13	TNFRI	TNFRI	B-NP	B-NP	-	16	NMOD	-	-
14	)	)	O	O	-	16	P	-	-
15	expression	expression	B-NP	B-NP	-	16	NMOD	-	-
16	vector	vector	I-NP	I-NP	-	17	SUB	-	-
17	was	was	B-VP	B-VP	-	0	ROOT	-	-
18	co-transfected	co-transfected	I-VP	I-VP	-	17	VC	-	-
19	in	in	B-PP	B-PP	-	18	VMOD	-	-
20	inhibition	inhibition	B-NP	B-NP	-	21	NMOD	-	-
21	studies	studies	I-NP	I-NP	-	19	PMOD	-	-
22	.	.	O	O	-	17	P	-	-

1	Forty-eight	Forty-eight	B-NP	B-NP	-	2	NMOD	-	-
2	hours	hours	I-NP	I-NP	-	7	SUB	-	-
3	after	after	B-PP	B-PP	-	2	NMOD	-	-
4	transfection	transfection	B-NP	B-NP	-	3	PMOD	-	-
5	,	,	O	O	-	7	P	-	-
6	EC	EC	B-NP	B-NP	-	7	SUB	-	-
7	were	were	B-VP	B-VP	-	22	VMOD	-	-
8	stimulated	stimulated	I-VP	I-VP	-	7	VC	-	-
9	with	with	B-PP	B-PP	-	8	VMOD	-	-
10	NK	NK	B-NP	B-NP	-	11	NMOD	-	-
11	cells	cells	I-NP	I-NP	-	16	NMOD	-	-
12	or	or	O	O	-	16	NMOD	-	-
13	NK	NK	B-NP	B-NP	-	16	NMOD	-	-
14	cell	cell	I-NP	I-NP	-	16	NMOD	-	-
15	membrane	membrane	I-NP	I-NP	-	16	NMOD	-	-
16	extracts	extracts	I-NP	I-NP	-	9	PMOD	-	-
17	for	for	B-PP	B-PP	-	16	NMOD	-	-
18	<num>	<num>	B-NP	B-NP	-	19	NMOD	-	-
19	hr	hr	I-NP	I-NP	-	21	NMOD	-	-
20	and	and	I-NP	I-NP	-	21	NMOD	-	-
21	activation	activation	I-NP	I-NP	-	17	PMOD	-	-
22	was	was	B-VP	B-VP	-	0	ROOT	-	-
23	measured	measured	I-VP	I-VP	-	22	VC	-	-
24	by	by	B-PP	B-PP	-	23	VMOD	-	-
25	a	a	B-NP	B-NP	-	27	NMOD	-	-
26	luciferase	luciferase	I-NP	I-NP	-	27	NMOD	-	-
27	assay	assay	I-NP	I-NP	-	24	PMOD	-	-
28	.	.	O	O	-	22	P	-	-

1	RESULTS	RESULTS	B-NP	B-NP	-	0	ROOT	-	-
2	:	:	O	O	-	1	P	-	-
3	Co-culture	Co-culture	B-NP	B-NP	-	10	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	NK	NK	B-NP	B-NP	-	6	NMOD	-	-
6	cells	cells	I-NP	I-NP	-	4	PMOD	-	-
7	with	with	B-PP	B-PP	-	3	NMOD	-	-
8	transfected	transfected	B-NP	B-NP	-	9	NMOD	-	-
9	EC	EC	I-NP	I-NP	-	7	PMOD	-	-
10	enhanced	enhanced	B-VP	B-VP	-	1	NMOD	-	-
11	E-selectin	E-selectin	B-NP	B-NP	-	18	NMOD	-	-
12	,	,	O	O	-	18	P	-	-
13	IL-8	IL-8	B-NP	B-NP	-	18	NMOD	-	-
14	,	,	O	O	-	18	P	-	-
15	and	and	O	O	-	18	NMOD	-	-
16	NF-kappaB-dependent	NF-kappaB-dependent	B-NP	B-NP	-	18	NMOD	-	-
17	promoter	promoter	I-NP	I-NP	-	18	NMOD	-	-
18	activity	activity	I-NP	I-NP	-	10	OBJ	-	-
19	.	.	O	O	-	1	P	-	-

1	NK	NK	B-NP	B-NP	-	4	NMOD	-	-
2	cell	cell	I-NP	I-NP	-	4	NMOD	-	-
3	membrane	membrane	I-NP	I-NP	-	4	NMOD	-	-
4	extracts	extracts	I-NP	I-NP	-	5	SUB	-	-
5	retained	retained	B-VP	B-VP	-	0	ROOT	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	capacity	capacity	I-NP	I-NP	-	5	OBJ	-	-
8	to	to	B-VP	B-VP	-	9	VMOD	-	-
9	activate	activate	I-VP	I-VP	-	7	NMOD	-	-
10	EC	EC	B-NP	B-NP	-	9	OBJ	-	-
11	and	and	O	O	-	5	VMOD	-	-
12	induced	induced	B-VP	B-VP	-	5	VMOD	-	-
13	nuclear	nuclear	B-NP	B-NP	-	14	NMOD	-	-
14	translocation	translocation	I-NP	I-NP	-	12	OBJ	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	NF-kappaB	NF-kappaB	B-NP	B-NP	-	15	PMOD	-	-
17	(	(	O	O	-	20	P	-	-
18	p50	p50	B-NP	B-NP	-	20	NMOD	-	-
19	and	and	O	O	-	20	NMOD	-	-
20	p65	p65	B-NP	B-NP	-	16	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	.	.	O	O	-	5	P	-	-

1	Western	Western	B-NP	B-NP	-	2	NMOD	-	-
2	blotting	blotting	I-NP	I-NP	-	9	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NK	NK	B-NP	B-NP	-	5	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
6	and	and	I-NP	I-NP	-	8	NMOD	-	-
7	membrane	membrane	I-NP	I-NP	-	8	NMOD	-	-
8	extracts	extracts	I-NP	I-NP	-	3	PMOD	-	-
9	detected	detected	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	11	NMOD	-	-
11	presence	presence	I-NP	I-NP	-	9	OBJ	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	Lymphotoxin-alpha	Lymphotoxin-alpha	B-NP	B-NP	-	21	NMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	LTalpha	LTalpha	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	but	but	B-NP	B-NP	-	21	NMOD	-	-
18	not	not	I-NP	I-NP	-	17	DEP	-	-
19	tumor	tumor	B-NP	B-NP	-	21	NMOD	-	-
20	necrosis	necrosis	I-NP	I-NP	-	21	NMOD	-	-
21	factor-alpha	factor-alpha	I-NP	I-NP	-	12	PMOD	-	-
22	.	.	O	O	-	9	P	-	-

1	Furthermore	Furthermore	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	LTalpha	LTalpha	B-NP	B-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	secreted	secreted	I-VP	I-VP	-	4	VC	-	-
6	in	in	B-PP	B-PP	-	5	VMOD	-	-
7	NK	NK	B-NP	B-NP	-	10	NMOD	-	-
8	:	:	O	O	-	10	P	-	-
9	EC	EC	B-NP	B-NP	-	10	NMOD	-	-
10	co-cultures	co-cultures	I-NP	I-NP	-	6	PMOD	-	-
11	.	.	O	O	-	4	P	-	-

1	Co-transfection	Co-transfection	B-NP	B-NP	-	6	SUB	-	-
2	with	with	B-PP	B-PP	-	1	NMOD	-	-
3	dominant-negative	dominant-negative	B-NP	B-NP	-	5	NMOD	-	-
4	mutant	mutant	I-NP	I-NP	-	5	NMOD	-	-
5	TNFRI	TNFRI	I-NP	I-NP	-	2	PMOD	-	-
6	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
7	EC	EC	B-NP	B-NP	-	8	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	6	OBJ	-	-
9	by	by	B-PP	B-PP	-	6	VMOD	-	-
10	NK	NK	B-NP	B-NP	-	13	NMOD	-	-
11	cell	cell	I-NP	I-NP	-	13	NMOD	-	-
12	membrane	membrane	I-NP	I-NP	-	13	NMOD	-	-
13	extracts	extracts	I-NP	I-NP	-	9	PMOD	-	-
14	and	and	B-PP	B-PP	-	9	PMOD	-	-
15	by	by	B-PP	B-PP	-	9	PMOD	-	-
16	NK	NK	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	by	by	B-PP	B-PP	-	6	VMOD	-	-
19	<num>	<num>	B-NP	B-NP	-	20	NMOD	-	-
20	%	%	I-NP	I-NP	-	23	NMOD	-	-
21	and	and	O	O	-	23	NMOD	-	-
22	<num>	<num>	B-NP	B-NP	-	23	NMOD	-	-
23	%	%	I-NP	I-NP	-	18	PMOD	-	-
24	,	,	O	O	-	6	P	-	-
25	respectively	respectively	B-ADVP	B-ADVP	-	6	VMOD	-	-
26	.	.	O	O	-	6	P	-	-

1	The	The	B-NP	B-NP	-	3	NMOD	-	-
2	same	same	I-NP	I-NP	-	3	NMOD	-	-
3	pattern	pattern	I-NP	I-NP	-	6	SUB	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	inhibition	inhibition	B-NP	B-NP	-	4	PMOD	-	-
6	was	was	B-VP	B-VP	-	0	ROOT	-	-
7	observed	observed	I-VP	I-VP	-	6	VC	-	-
8	using	using	B-VP	B-VP	-	7	VMOD	-	-
9	anti-human	anti-human	B-NP	B-NP	-	11	NMOD	-	-
10	LT	LT	I-NP	I-NP	-	11	NMOD	-	-
11	sera	sera	I-NP	I-NP	-	8	OBJ	-	-
12	.	.	O	O	-	6	P	-	-

1	CONCLUSIONS	CONCLUSIONS	B-NP	B-NP	-	0	ROOT	-	-
2	:	:	O	O	-	1	P	-	-
3	Human	Human	B-NP	B-NP	-	8	NMOD	-	-
4	NK	NK	I-NP	I-NP	-	8	NMOD	-	-
5	cell	cell	I-NP	I-NP	-	8	NMOD	-	-
6	membrane-bound	membrane-bound	I-NP	I-NP	-	8	NMOD	-	-
7	LT	LT	I-NP	I-NP	-	8	NMOD	-	-
8	signals	signals	I-NP	I-NP	-	1	NMOD	-	-
9	across	across	B-PP	B-PP	-	8	NMOD	-	-
10	species	species	B-NP	B-NP	-	9	PMOD	-	-
11	via	via	B-PP	B-PP	-	10	NMOD	-	-
12	TNFRI	TNFRI	B-NP	B-NP	-	11	PMOD	-	-
13	,	,	O	O	-	1	P	-	-
14	leading	leading	B-VP	B-VP	-	1	NMOD	-	-
15	to	to	B-PP	B-PP	-	14	VMOD	-	-
16	NF-kappaB	NF-kappaB	B-NP	B-NP	-	18	NMOD	-	-
17	nuclear	nuclear	I-NP	I-NP	-	18	NMOD	-	-
18	translocation	translocation	I-NP	I-NP	-	20	NMOD	-	-
19	and	and	I-NP	I-NP	-	20	NMOD	-	-
20	transcription	transcription	I-NP	I-NP	-	15	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	E-selectin	E-selectin	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	IL-8	IL-8	I-NP	I-NP	-	21	PMOD	-	-
25	,	,	O	O	-	24	P	-	-
26	which	which	B-NP	B-NP	-	24	NMOD	-	-
27	results	results	B-VP	B-VP	-	26	SBAR	-	-
28	in	in	B-PP	B-PP	-	27	VMOD	-	-
29	EC	EC	B-NP	B-NP	-	30	NMOD	-	-
30	activation	activation	I-NP	I-NP	-	28	PMOD	-	-
31	.	.	O	O	-	1	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	discrepancy	discrepancy	I-NP	I-NP	-	17	SUB	-	-
3	in	in	B-PP	B-PP	-	2	NMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	degree	degree	I-NP	I-NP	-	3	PMOD	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	inhibition	inhibition	B-NP	B-NP	-	6	PMOD	-	-
8	by	by	B-PP	B-PP	-	7	NMOD	-	-
9	membrane	membrane	B-NP	B-NP	-	10	NMOD	-	-
10	extracts	extracts	I-NP	I-NP	-	8	PMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	NK	NK	B-NP	B-NP	-	13	NMOD	-	-
13	cells	cells	I-NP	I-NP	-	8	PMOD	-	-
14	with	with	B-PP	B-PP	-	7	NMOD	-	-
15	mutant	mutant	B-NP	B-NP	-	16	NMOD	-	-
16	TNFRI	TNFRI	I-NP	I-NP	-	14	PMOD	-	-
17	suggests	suggests	B-VP	B-VP	-	0	ROOT	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	additional	additional	B-NP	B-NP	-	20	NMOD	-	-
20	pathways	pathways	I-NP	I-NP	-	21	SUB	-	-
21	are	are	B-VP	B-VP	-	18	SBAR	-	-
22	utilized	utilized	I-VP	I-VP	-	21	VC	-	-
23	by	by	B-PP	B-PP	-	22	VMOD	-	-
24	NK	NK	B-NP	B-NP	-	25	NMOD	-	-
25	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
26	to	to	B-VP	B-VP	-	27	VMOD	-	-
27	activate	activate	I-VP	I-VP	-	22	VMOD	-	-
28	EC	EC	B-NP	B-NP	-	27	OBJ	-	-
29	.	.	O	O	-	17	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	involvement	involvement	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	multiple	multiple	B-NP	B-NP	-	8	NMOD	-	-
5	tumor	tumor	I-NP	I-NP	-	8	NMOD	-	-
6	necrosis	necrosis	I-NP	I-NP	-	8	NMOD	-	-
7	factor	factor	I-NP	I-NP	-	8	NMOD	-	-
8	receptor	receptor	I-NP	I-NP	-	13	NMOD	-	-
9	(	(	I-NP	I-NP	-	13	P	-	-
10	TNFR	TNFR	I-NP	I-NP	-	13	NMOD	-	-
11	)	)	I-NP	I-NP	-	13	P	-	-
12	-associated	-associated	I-NP	I-NP	-	13	NMOD	-	-
13	factors	factors	I-NP	I-NP	-	3	PMOD	-	-
14	in	in	B-PP	B-PP	-	2	NMOD	-	-
15	the	the	B-NP	B-NP	-	17	NMOD	-	-
16	signaling	signaling	I-NP	I-NP	-	17	NMOD	-	-
17	mechanisms	mechanisms	I-NP	I-NP	-	14	PMOD	-	-
18	of	of	B-PP	B-PP	-	17	NMOD	-	-
19	receptor	receptor	B-NP	B-NP	-	20	NMOD	-	-
20	activator	activator	I-NP	I-NP	-	18	PMOD	-	-
21	of	of	B-PP	B-PP	-	20	NMOD	-	-
22	NF-kappaB	NF-kappaB	B-NP	B-NP	-	25	NMOD	-	-
23	,	,	O	O	-	25	P	-	-
24	a	a	B-NP	B-NP	-	25	NMOD	-	-
25	member	member	I-NP	I-NP	-	21	PMOD	-	-
26	of	of	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	TNFR	TNFR	I-NP	I-NP	-	29	NMOD	-	-
29	superfamily	superfamily	I-NP	I-NP	-	26	PMOD	-	-
30	.	.	O	O	-	2	P	-	-

1	Receptor	Receptor	B-NP	B-NP	-	2	NMOD	-	-
2	activator	activator	I-NP	I-NP	-	8	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	NF-kappaB	NF-kappaB	B-NP	B-NP	-	3	PMOD	-	-
5	(	(	O	O	-	6	P	-	-
6	RANK	RANK	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	is	is	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	12	NMOD	-	-
10	recently	recently	I-NP	I-NP	-	11	AMOD	-	-
11	identified	identified	I-NP	I-NP	-	12	NMOD	-	-
12	member	member	I-NP	I-NP	-	8	PRD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	19	NMOD	-	-
15	tumor	tumor	I-NP	I-NP	-	19	NMOD	-	-
16	necrosis	necrosis	I-NP	I-NP	-	19	NMOD	-	-
17	factor	factor	I-NP	I-NP	-	19	NMOD	-	-
18	receptor	receptor	I-NP	I-NP	-	19	NMOD	-	-
19	superfamily	superfamily	I-NP	I-NP	-	13	PMOD	-	-
20	and	and	O	O	-	8	VMOD	-	-
21	is	is	B-VP	B-VP	-	8	VMOD	-	-
22	expressed	expressed	I-VP	I-VP	-	21	VC	-	-
23	on	on	B-PP	B-PP	-	22	VMOD	-	-
24	activated	activated	B-NP	B-NP	-	26	NMOD	-	-
25	T	T	I-NP	I-NP	-	26	NMOD	-	-
26	cells	cells	I-NP	I-NP	-	29	NMOD	-	-
27	and	and	O	O	-	29	NMOD	-	-
28	dendritic	dendritic	B-NP	B-NP	-	29	NMOD	-	-
29	cells	cells	I-NP	I-NP	-	23	PMOD	-	-
30	.	.	O	O	-	8	P	-	-

1	Its	Its	B-NP	B-NP	-	3	NMOD	-	-
2	cognate	cognate	I-NP	I-NP	-	3	NMOD	-	-
3	ligand	ligand	I-NP	I-NP	-	7	SUB	-	-
4	(	(	O	O	-	5	P	-	-
5	RANKL	RANKL	B-NP	B-NP	-	3	NMOD	-	-
6	)	)	O	O	-	5	P	-	-
7	plays	plays	B-VP	B-VP	-	0	ROOT	-	-
8	significant	significant	B-NP	B-NP	-	9	NMOD	-	-
9	roles	roles	I-NP	I-NP	-	7	OBJ	-	-
10	in	in	B-PP	B-PP	-	7	VMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	activation	activation	I-NP	I-NP	-	10	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	dendritic	dendritic	B-NP	B-NP	-	16	NMOD	-	-
15	cell	cell	I-NP	I-NP	-	16	NMOD	-	-
16	function	function	I-NP	I-NP	-	19	NMOD	-	-
17	and	and	O	O	-	19	NMOD	-	-
18	osteoclast	osteoclast	B-NP	B-NP	-	19	NMOD	-	-
19	differentiation	differentiation	I-NP	I-NP	-	13	PMOD	-	-
20	.	.	O	O	-	7	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
3	here	here	B-ADVP	B-ADVP	-	2	VMOD	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	interaction	interaction	I-NP	I-NP	-	2	OBJ	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	RANK	RANK	B-NP	B-NP	-	6	PMOD	-	-
8	with	with	B-PP	B-PP	-	5	NMOD	-	-
9	tumor	tumor	B-NP	B-NP	-	13	NMOD	-	-
10	necrosis	necrosis	I-NP	I-NP	-	13	NMOD	-	-
11	factor	factor	I-NP	I-NP	-	13	NMOD	-	-
12	receptor-associated	receptor-associated	I-NP	I-NP	-	13	NMOD	-	-
13	factors	factors	I-NP	I-NP	-	8	PMOD	-	-
14	(	(	O	O	-	15	P	-	-
15	TRAFs	TRAFs	B-NP	B-NP	-	13	NMOD	-	-
16	)	)	O	O	-	15	P	-	-
17	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
18	,	,	I-NP	I-NP	-	26	P	-	-
19	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
20	,	,	I-NP	I-NP	-	26	P	-	-
21	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
22	,	,	I-NP	I-NP	-	26	P	-	-
23	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
24	,	,	O	O	-	26	P	-	-
25	and	and	O	O	-	26	NMOD	-	-
26	<num>	<num>	B-NP	B-NP	-	13	NMOD	-	-
27	both	both	O	O	-	28	AMOD	-	-
28	in	in	B-ADVP	B-ADVP	-	26	NMOD	-	-
29	vitro	vitro	I-ADVP	I-ADVP	-	28	AMOD	-	-
30	and	and	O	O	-	28	AMOD	-	-
31	in	in	B-PP	B-PP	-	26	NMOD	-	-
32	cells	cells	B-NP	B-NP	-	31	PMOD	-	-
33	.	.	O	O	-	2	P	-	-

1	Mapping	Mapping	B-NP	B-NP	-	9	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	5	NMOD	-	-
4	structural	structural	I-NP	I-NP	-	5	NMOD	-	-
5	requirements	requirements	I-NP	I-NP	-	2	PMOD	-	-
6	for	for	B-PP	B-PP	-	5	NMOD	-	-
7	TRAF/RANK	TRAF/RANK	B-NP	B-NP	-	8	NMOD	-	-
8	interaction	interaction	I-NP	I-NP	-	6	PMOD	-	-
9	revealed	revealed	B-VP	B-VP	-	0	ROOT	-	-
10	multiple	multiple	B-NP	B-NP	-	13	NMOD	-	-
11	TRAF	TRAF	I-NP	I-NP	-	13	NMOD	-	-
12	binding	binding	I-NP	I-NP	-	13	NMOD	-	-
13	sites	sites	I-NP	I-NP	-	9	OBJ	-	-
14	clustered	clustered	B-VP	B-VP	-	13	NMOD	-	-
15	in	in	B-PP	B-PP	-	14	VMOD	-	-
16	two	two	B-NP	B-NP	-	18	NMOD	-	-
17	distinct	distinct	I-NP	I-NP	-	18	NMOD	-	-
18	domains	domains	I-NP	I-NP	-	15	PMOD	-	-
19	in	in	B-PP	B-PP	-	18	NMOD	-	-
20	the	the	B-NP	B-NP	-	23	NMOD	-	-
21	RANK	RANK	I-NP	I-NP	-	23	NMOD	-	-
22	cytoplasmic	cytoplasmic	I-NP	I-NP	-	23	NMOD	-	-
23	tail	tail	I-NP	I-NP	-	19	PMOD	-	-
24	.	.	O	O	-	9	P	-	-

1	These	These	B-NP	B-NP	-	4	NMOD	-	-
2	TRAF	TRAF	I-NP	I-NP	-	4	NMOD	-	-
3	binding	binding	I-NP	I-NP	-	4	NMOD	-	-
4	domains	domains	I-NP	I-NP	-	5	SUB	-	-
5	were	were	B-VP	B-VP	-	0	ROOT	-	-
6	shown	shown	I-VP	I-VP	-	5	VC	-	-
7	to	to	I-VP	I-VP	-	8	VMOD	-	-
8	be	be	I-VP	I-VP	-	6	VMOD	-	-
9	functionally	functionally	B-ADJP	B-ADJP	-	10	AMOD	-	-
10	important	important	I-ADJP	I-ADJP	-	8	PRD	-	-
11	for	for	B-PP	B-PP	-	10	AMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	RANK-dependent	RANK-dependent	I-NP	I-NP	-	14	NMOD	-	-
14	induction	induction	I-NP	I-NP	-	11	PMOD	-	-
15	of	of	B-PP	B-PP	-	14	NMOD	-	-
16	NF-kappaB	NF-kappaB	B-NP	B-NP	-	18	NMOD	-	-
17	and	and	O	O	-	18	NMOD	-	-
18	c-Jun	c-Jun	B-NP	B-NP	-	21	NMOD	-	-
19	NH2-terminal	NH2-terminal	I-NP	I-NP	-	21	NMOD	-	-
20	kinase	kinase	I-NP	I-NP	-	21	NMOD	-	-
21	activities	activities	I-NP	I-NP	-	15	PMOD	-	-
22	.	.	O	O	-	5	P	-	-

1	Site-directed	Site-directed	B-NP	B-NP	-	2	NMOD	-	-
2	mutagenesis	mutagenesis	I-NP	I-NP	-	3	SUB	-	-
3	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	these	these	B-NP	B-NP	-	8	NMOD	-	-
6	TRAF	TRAF	I-NP	I-NP	-	8	NMOD	-	-
7	binding	binding	I-NP	I-NP	-	8	NMOD	-	-
8	sites	sites	I-NP	I-NP	-	9	SUB	-	-
9	exhibited	exhibited	B-VP	B-VP	-	4	SBAR	-	-
10	selective	selective	B-NP	B-NP	-	11	NMOD	-	-
11	binding	binding	I-NP	I-NP	-	9	OBJ	-	-
12	for	for	B-PP	B-PP	-	11	NMOD	-	-
13	different	different	B-NP	B-NP	-	15	NMOD	-	-
14	TRAF	TRAF	I-NP	I-NP	-	15	NMOD	-	-
15	proteins	proteins	I-NP	I-NP	-	12	PMOD	-	-
16	.	.	O	O	-	3	P	-	-

1	In	In	B-PP	B-PP	-	5	VMOD	-	-
2	particular	particular	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	5	P	-	-
4	TRAF6	TRAF6	B-NP	B-NP	-	5	SUB	-	-
5	interacted	interacted	B-VP	B-VP	-	0	ROOT	-	-
6	with	with	B-PP	B-PP	-	5	VMOD	-	-
7	membrane-proximal	membrane-proximal	B-NP	B-NP	-	8	NMOD	-	-
8	determinants	determinants	I-NP	I-NP	-	6	PMOD	-	-
9	distinct	distinct	B-ADJP	B-ADJP	-	8	NMOD	-	-
10	from	from	B-PP	B-PP	-	9	AMOD	-	-
11	those	those	B-NP	B-NP	-	13	NMOD	-	-
12	binding	binding	I-NP	I-NP	-	11	NMOD	-	-
13	TRAFs	TRAFs	I-NP	I-NP	-	21	NMOD	-	-
14	<num>	<num>	I-NP	I-NP	-	21	NMOD	-	-
15	,	,	I-NP	I-NP	-	21	P	-	-
16	<num>	<num>	I-NP	I-NP	-	21	NMOD	-	-
17	,	,	I-NP	I-NP	-	21	P	-	-
18	<num>	<num>	I-NP	I-NP	-	21	NMOD	-	-
19	,	,	O	O	-	21	P	-	-
20	and	and	O	O	-	21	NMOD	-	-
21	<num>	<num>	B-NP	B-NP	-	8	NMOD	-	-
22	.	.	O	O	-	5	P	-	-

1	When	When	B-ADVP	B-ADVP	-	13	VMOD	-	-
2	this	this	B-NP	B-NP	-	6	NMOD	-	-
3	membrane-proximal	membrane-proximal	I-NP	I-NP	-	6	NMOD	-	-
4	TRAF6	TRAF6	I-NP	I-NP	-	6	NMOD	-	-
5	interaction	interaction	I-NP	I-NP	-	6	NMOD	-	-
6	domain	domain	I-NP	I-NP	-	7	SUB	-	-
7	was	was	B-VP	B-VP	-	1	SBAR	-	-
8	deleted	deleted	I-VP	I-VP	-	7	VC	-	-
9	,	,	O	O	-	13	P	-	-
10	RANK-mediated	RANK-mediated	B-NP	B-NP	-	12	NMOD	-	-
11	NF-kappaB	NF-kappaB	I-NP	I-NP	-	12	NMOD	-	-
12	signaling	signaling	I-NP	I-NP	-	13	SUB	-	-
13	was	was	B-VP	B-VP	-	0	ROOT	-	-
14	completely	completely	I-VP	I-VP	-	13	VMOD	-	-
15	inhibited	inhibited	I-VP	I-VP	-	13	VC	-	-
16	while	while	B-SBAR	B-SBAR	-	15	VMOD	-	-
17	c-Jun	c-Jun	B-NP	B-NP	-	20	NMOD	-	-
18	NH2-terminal	NH2-terminal	I-NP	I-NP	-	20	NMOD	-	-
19	kinase	kinase	I-NP	I-NP	-	20	NMOD	-	-
20	activation	activation	I-NP	I-NP	-	21	SUB	-	-
21	was	was	B-VP	B-VP	-	16	SBAR	-	-
22	partially	partially	I-VP	I-VP	-	21	VMOD	-	-
23	inhibited	inhibited	I-VP	I-VP	-	21	VC	-	-
24	.	.	O	O	-	13	P	-	-

1	An	An	B-NP	B-NP	-	4	NMOD	-	-
2	NH2-terminal	NH2-terminal	I-NP	I-NP	-	4	NMOD	-	-
3	truncation	truncation	I-NP	I-NP	-	4	NMOD	-	-
4	mutant	mutant	I-NP	I-NP	-	7	SUB	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	TRAF6	TRAF6	B-NP	B-NP	-	5	PMOD	-	-
7	inhibited	inhibited	B-VP	B-VP	-	0	ROOT	-	-
8	RANKL-mediated	RANKL-mediated	B-NP	B-NP	-	10	NMOD	-	-
9	NF-kappaB	NF-kappaB	I-NP	I-NP	-	10	NMOD	-	-
10	activation	activation	I-NP	I-NP	-	7	OBJ	-	-
11	,	,	O	O	-	7	P	-	-
12	but	but	O	O	-	7	VMOD	-	-
13	failed	failed	B-VP	B-VP	-	7	VMOD	-	-
14	to	to	I-VP	I-VP	-	15	VMOD	-	-
15	affect	affect	I-VP	I-VP	-	13	VMOD	-	-
16	constitutive	constitutive	B-NP	B-NP	-	17	NMOD	-	-
17	signaling	signaling	I-NP	I-NP	-	15	OBJ	-	-
18	induced	induced	B-VP	B-VP	-	17	NMOD	-	-
19	by	by	B-PP	B-PP	-	18	VMOD	-	-
20	receptor	receptor	B-NP	B-NP	-	21	NMOD	-	-
21	overexpression	overexpression	I-NP	I-NP	-	19	PMOD	-	-
22	,	,	O	O	-	7	P	-	-
23	revealing	revealing	B-VP	B-VP	-	7	VMOD	-	-
24	a	a	B-NP	B-NP	-	26	NMOD	-	-
25	selective	selective	I-NP	I-NP	-	26	NMOD	-	-
26	role	role	I-NP	I-NP	-	23	OBJ	-	-
27	for	for	B-PP	B-PP	-	26	NMOD	-	-
28	TRAF6	TRAF6	B-NP	B-NP	-	27	PMOD	-	-
29	in	in	B-PP	B-PP	-	26	NMOD	-	-
30	ligand-induced	ligand-induced	B-NP	B-NP	-	32	NMOD	-	-
31	activation	activation	I-NP	I-NP	-	32	NMOD	-	-
32	events	events	I-NP	I-NP	-	29	PMOD	-	-
33	.	.	O	O	-	7	P	-	-

1	Regulation	Regulation	B-NP	B-NP	-	8	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	interleukin-1beta	interleukin-1beta	B-NP	B-NP	-	4	NMOD	-	-
4	transcription	transcription	I-NP	I-NP	-	2	PMOD	-	-
5	by	by	B-PP	B-PP	-	1	NMOD	-	-
6	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	7	NMOD	-	-
7	virus	virus	I-NP	I-NP	-	5	PMOD	-	-
8	involves	involves	B-VP	B-VP	-	0	ROOT	-	-
9	a	a	B-NP	B-NP	-	10	NMOD	-	-
10	number	number	I-NP	I-NP	-	8	OBJ	-	-
11	of	of	B-PP	B-PP	-	10	NMOD	-	-
12	latent	latent	B-NP	B-NP	-	13	NMOD	-	-
13	proteins	proteins	I-NP	I-NP	-	11	PMOD	-	-
14	via	via	B-PP	B-PP	-	8	VMOD	-	-
15	their	their	B-NP	B-NP	-	16	NMOD	-	-
16	interaction	interaction	I-NP	I-NP	-	14	PMOD	-	-
17	with	with	B-PP	B-PP	-	16	NMOD	-	-
18	RBP	RBP	B-NP	B-NP	-	17	PMOD	-	-
19	.	.	O	O	-	8	P	-	-

1	Epstein-Barr	Epstein-Barr	B-NP	B-NP	-	2	NMOD	-	-
2	virus	virus	I-NP	I-NP	-	6	SUB	-	-
3	(	(	O	O	-	4	P	-	-
4	EBV	EBV	B-NP	B-NP	-	2	NMOD	-	-
5	)	)	O	O	-	4	P	-	-
6	infects	infects	B-VP	B-VP	-	0	ROOT	-	-
7	B	B	B-NP	B-NP	-	8	NMOD	-	-
8	cells	cells	I-NP	I-NP	-	6	OBJ	-	-
9	,	,	O	O	-	6	P	-	-
10	resulting	resulting	B-VP	B-VP	-	6	VMOD	-	-
11	in	in	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	13	NMOD	-	-
13	outgrowth	outgrowth	I-NP	I-NP	-	11	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	immortalised	immortalised	B-NP	B-NP	-	18	NMOD	-	-
16	lymphoblastoid	lymphoblastoid	I-NP	I-NP	-	18	NMOD	-	-
17	cell	cell	I-NP	I-NP	-	18	NMOD	-	-
18	lines	lines	I-NP	I-NP	-	14	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	LCLs	LCLs	B-NP	B-NP	-	18	NMOD	-	-
21	)	)	O	O	-	20	P	-	-
22	.	.	O	O	-	6	P	-	-

1	Here	Here	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	we	we	B-NP	B-NP	-	4	SUB	-	-
4	demonstrate	demonstrate	B-VP	B-VP	-	0	ROOT	-	-
5	through	through	B-PP	B-PP	-	4	VMOD	-	-
6	the	the	B-NP	B-NP	-	7	NMOD	-	-
7	use	use	I-NP	I-NP	-	5	PMOD	-	-
8	of	of	B-PP	B-PP	-	7	NMOD	-	-
9	intracellular	intracellular	B-NP	B-NP	-	10	NMOD	-	-
10	staining	staining	I-NP	I-NP	-	8	PMOD	-	-
11	that	that	B-NP	B-NP	-	10	NMOD	-	-
12	interleukin-1beta	interleukin-1beta	B-NP	B-NP	-	16	SUB	-	-
13	(	(	O	O	-	14	P	-	-
14	IL-1beta	IL-1beta	B-NP	B-NP	-	12	NMOD	-	-
15	)	)	O	O	-	14	P	-	-
16	is	is	B-VP	B-VP	-	11	SBAR	-	-
17	expressed	expressed	I-VP	I-VP	-	16	VC	-	-
18	in	in	B-PP	B-PP	-	17	VMOD	-	-
19	LCLs	LCLs	B-NP	B-NP	-	18	PMOD	-	-
20	and	and	O	O	-	16	VMOD	-	-
21	investigate	investigate	B-VP	B-VP	-	4	VMOD	-	-
22	the	the	B-NP	B-NP	-	23	NMOD	-	-
23	influence	influence	I-NP	I-NP	-	21	OBJ	-	-
24	of	of	B-PP	B-PP	-	23	NMOD	-	-
25	the	the	B-NP	B-NP	-	28	NMOD	-	-
26	individual	individual	I-NP	I-NP	-	28	NMOD	-	-
27	latent	latent	I-NP	I-NP	-	28	NMOD	-	-
28	proteins	proteins	I-NP	I-NP	-	24	PMOD	-	-
29	on	on	B-PP	B-PP	-	23	NMOD	-	-
30	the	the	B-NP	B-NP	-	31	NMOD	-	-
31	expression	expression	I-NP	I-NP	-	29	PMOD	-	-
32	of	of	B-PP	B-PP	-	31	NMOD	-	-
33	IL-1beta	IL-1beta	B-NP	B-NP	-	32	PMOD	-	-
34	.	.	O	O	-	4	P	-	-

1	Using	Using	B-VP	B-VP	-	5	VMOD	-	-
2	RT-PCR	RT-PCR	B-NP	B-NP	-	1	OBJ	-	-
3	,	,	O	O	-	5	P	-	-
4	IL-1beta	IL-1beta	B-NP	B-NP	-	5	SUB	-	-
5	was	was	B-VP	B-VP	-	0	ROOT	-	-
6	shown	shown	I-VP	I-VP	-	5	VC	-	-
7	to	to	I-VP	I-VP	-	8	VMOD	-	-
8	be	be	I-VP	I-VP	-	6	VMOD	-	-
9	up-regulated	up-regulated	I-VP	I-VP	-	8	VC	-	-
10	in	in	B-PP	B-PP	-	9	VMOD	-	-
11	EBV-transformed	EBV-transformed	B-NP	B-NP	-	12	NMOD	-	-
12	LCLs	LCLs	I-NP	I-NP	-	10	PMOD	-	-
13	as	as	B-CONJP	B-CONJP	-	10	PMOD	-	-
14	well	well	I-CONJP	I-CONJP	-	13	DEP	-	-
15	as	as	I-CONJP	I-CONJP	-	13	DEP	-	-
16	in	in	B-PP	B-PP	-	10	PMOD	-	-
17	group	group	B-NP	B-NP	-	21	NMOD	-	-
18	III	III	B-NP	B-NP	-	21	NMOD	-	-
19	Burkitt	Burkitt	I-NP	I-NP	-	21	NMOD	-	-
20	's	's	B-NP	B-NP	-	21	NMOD	-	-
21	lymphoma	lymphoma	I-NP	I-NP	-	26	NMOD	-	-
22	(	(	O	O	-	23	P	-	-
23	BL	BL	B-NP	B-NP	-	21	NMOD	-	-
24	)	)	O	O	-	23	P	-	-
25	cell	cell	B-NP	B-NP	-	26	NMOD	-	-
26	lines	lines	I-NP	I-NP	-	16	PMOD	-	-
27	,	,	O	O	-	9	P	-	-
28	compared	compared	B-PP	B-PP	-	9	VMOD	-	-
29	with	with	B-PP	B-PP	-	28	PMOD	-	-
30	group	group	B-NP	B-NP	-	34	NMOD	-	-
31	I	I	I-NP	I-NP	-	34	NMOD	-	-
32	BL	BL	I-NP	I-NP	-	34	NMOD	-	-
33	cell	cell	I-NP	I-NP	-	34	NMOD	-	-
34	lines	lines	I-NP	I-NP	-	29	PMOD	-	-
35	.	.	O	O	-	5	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	up-regulation	up-regulation	I-NP	I-NP	-	6	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	IL-1beta	IL-1beta	B-NP	B-NP	-	5	NMOD	-	-
5	message	message	I-NP	I-NP	-	3	PMOD	-	-
6	could	could	B-VP	B-VP	-	0	ROOT	-	-
7	be	be	I-VP	I-VP	-	6	VC	-	-
8	mediated	mediated	I-VP	I-VP	-	7	VC	-	-
9	by	by	B-PP	B-PP	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	latent	latent	I-NP	I-NP	-	13	NMOD	-	-
12	membrane	membrane	I-NP	I-NP	-	13	NMOD	-	-
13	protein-1	protein-1	I-NP	I-NP	-	26	NMOD	-	-
14	,	,	O	O	-	26	P	-	-
15	EBV	EBV	B-NP	B-NP	-	17	NMOD	-	-
16	nuclear	nuclear	I-NP	I-NP	-	17	NMOD	-	-
17	proteins	proteins	I-NP	I-NP	-	26	NMOD	-	-
18	<num>	<num>	I-NP	I-NP	-	17	NMOD	-	-
19	,	,	I-NP	I-NP	-	26	P	-	-
20	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
21	,	,	I-NP	I-NP	-	26	P	-	-
22	<num>	<num>	I-NP	I-NP	-	26	NMOD	-	-
23	,	,	O	O	-	26	P	-	-
24	and	and	O	O	-	26	NMOD	-	-
25	<num>	<num>	B-NP	B-NP	-	26	NMOD	-	-
26	genes	genes	I-NP	I-NP	-	9	PMOD	-	-
27	.	.	O	O	-	6	P	-	-

1	Electrophoretic	Electrophoretic	B-NP	B-NP	-	4	NMOD	-	-
2	mobility	mobility	I-NP	I-NP	-	4	NMOD	-	-
3	shift	shift	I-NP	I-NP	-	4	NMOD	-	-
4	assays	assays	I-NP	I-NP	-	8	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	EMSAs	EMSAs	B-NP	B-NP	-	4	NMOD	-	-
7	)	)	O	O	-	6	P	-	-
8	demonstrated	demonstrated	B-VP	B-VP	-	0	ROOT	-	-
9	that	that	B-SBAR	B-SBAR	-	8	VMOD	-	-
10	the	the	B-NP	B-NP	-	12	NMOD	-	-
11	-300	-300	I-NP	I-NP	-	12	NMOD	-	-
12	region	region	I-NP	I-NP	-	29	SUB	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	the	the	B-NP	B-NP	-	16	NMOD	-	-
15	IL-1beta	IL-1beta	I-NP	I-NP	-	16	NMOD	-	-
16	promoter	promoter	I-NP	I-NP	-	13	PMOD	-	-
17	,	,	O	O	-	12	P	-	-
18	which	which	B-NP	B-NP	-	12	NMOD	-	-
19	contains	contains	B-VP	B-VP	-	18	SBAR	-	-
20	a	a	B-NP	B-NP	-	27	NMOD	-	-
21	nuclear	nuclear	I-NP	I-NP	-	27	NMOD	-	-
22	factor-kappaB	factor-kappaB	I-NP	I-NP	-	27	NMOD	-	-
23	(	(	O	O	-	27	P	-	-
24	NF-kappaB	NF-kappaB	B-NP	B-NP	-	27	NMOD	-	-
25	)	)	O	O	-	27	P	-	-
26	binding	binding	B-NP	B-NP	-	27	NMOD	-	-
27	site	site	I-NP	I-NP	-	19	OBJ	-	-
28	,	,	O	O	-	12	P	-	-
29	contained	contained	B-VP	B-VP	-	9	SBAR	-	-
30	a	a	B-NP	B-NP	-	34	NMOD	-	-
31	functional	functional	I-NP	I-NP	-	34	NMOD	-	-
32	RBP	RBP	I-NP	I-NP	-	34	NMOD	-	-
33	binding	binding	I-NP	I-NP	-	34	NMOD	-	-
34	site	site	I-NP	I-NP	-	29	OBJ	-	-
35	.	.	O	O	-	8	P	-	-

1	Binding	Binding	B-NP	B-NP	-	7	SUB	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	RBP	RBP	B-NP	B-NP	-	2	PMOD	-	-
4	to	to	B-PP	B-PP	-	1	NMOD	-	-
5	this	this	B-NP	B-NP	-	6	NMOD	-	-
6	site	site	I-NP	I-NP	-	4	PMOD	-	-
7	could	could	B-VP	B-VP	-	0	ROOT	-	-
8	be	be	I-VP	I-VP	-	7	VC	-	-
9	inhibited	inhibited	I-VP	I-VP	-	8	VC	-	-
10	by	by	B-PP	B-PP	-	9	VMOD	-	-
11	addition	addition	B-NP	B-NP	-	10	PMOD	-	-
12	of	of	B-PP	B-PP	-	11	NMOD	-	-
13	EBV	EBV	B-NP	B-NP	-	15	NMOD	-	-
14	nuclear	nuclear	I-NP	I-NP	-	15	NMOD	-	-
15	proteins	proteins	I-NP	I-NP	-	12	PMOD	-	-
16	<num>	<num>	B-NP	B-NP	-	18	NMOD	-	-
17	and	and	I-NP	I-NP	-	18	NMOD	-	-
18	<num>	<num>	I-NP	I-NP	-	15	NMOD	-	-
19	,	,	O	O	-	7	P	-	-
20	suggesting	suggesting	B-VP	B-VP	-	7	VMOD	-	-
21	that	that	B-SBAR	B-SBAR	-	20	VMOD	-	-
22	these	these	B-NP	B-NP	-	23	NMOD	-	-
23	proteins	proteins	I-NP	I-NP	-	24	SUB	-	-
24	displace	displace	B-VP	B-VP	-	21	SBAR	-	-
25	RBP	RBP	B-NP	B-NP	-	24	OBJ	-	-
26	from	from	B-PP	B-PP	-	24	VMOD	-	-
27	its	its	B-NP	B-NP	-	29	NMOD	-	-
28	recognition	recognition	I-NP	I-NP	-	29	NMOD	-	-
29	sequence	sequence	I-NP	I-NP	-	26	PMOD	-	-
30	,	,	O	O	-	24	P	-	-
31	removing	removing	B-VP	B-VP	-	24	VMOD	-	-
32	transcriptional	transcriptional	B-NP	B-NP	-	33	NMOD	-	-
33	repression	repression	I-NP	I-NP	-	31	OBJ	-	-
34	and	and	O	O	-	24	VMOD	-	-
35	allowing	allowing	B-VP	B-VP	-	24	VMOD	-	-
36	gene	gene	B-NP	B-NP	-	37	NMOD	-	-
37	transcription	transcription	I-NP	I-NP	-	35	OBJ	-	-
38	to	to	B-VP	B-VP	-	39	VMOD	-	-
39	occur	occur	I-VP	I-VP	-	37	NMOD	-	-
40	.	.	O	O	-	7	P	-	-

1	In	In	B-PP	B-PP	-	16	VMOD	-	-
2	group	group	B-NP	B-NP	-	5	NMOD	-	-
3	I	I	I-NP	I-NP	-	5	NMOD	-	-
4	BL	BL	I-NP	I-NP	-	5	NMOD	-	-
5	cells	cells	I-NP	I-NP	-	1	PMOD	-	-
6	,	,	O	O	-	5	P	-	-
7	containing	containing	B-VP	B-VP	-	5	NMOD	-	-
8	low	low	B-NP	B-NP	-	9	NMOD	-	-
9	levels	levels	I-NP	I-NP	-	7	OBJ	-	-
10	of	of	B-PP	B-PP	-	9	NMOD	-	-
11	NF-kappaB	NF-kappaB	B-NP	B-NP	-	10	PMOD	-	-
12	,	,	O	O	-	16	P	-	-
13	only	only	B-NP	B-NP	-	15	NMOD	-	-
14	RBP	RBP	I-NP	I-NP	-	15	NMOD	-	-
15	binding	binding	I-NP	I-NP	-	16	SUB	-	-
16	was	was	B-VP	B-VP	-	24	VMOD	-	-
17	observed	observed	I-VP	I-VP	-	16	VC	-	-
18	in	in	B-PP	B-PP	-	17	VMOD	-	-
19	EMSAs	EMSAs	B-NP	B-NP	-	18	PMOD	-	-
20	,	,	O	O	-	21	P	-	-
21	whereas	whereas	O	O	-	16	VMOD	-	-
22	NF-kappaB	NF-kappaB	B-NP	B-NP	-	23	NMOD	-	-
23	binding	binding	I-NP	I-NP	-	24	SUB	-	-
24	could	could	B-VP	B-VP	-	0	ROOT	-	-
25	be	be	I-VP	I-VP	-	24	VC	-	-
26	demonstrated	demonstrated	I-VP	I-VP	-	25	VC	-	-
27	in	in	B-PP	B-PP	-	26	VMOD	-	-
28	EBV-transformed	EBV-transformed	B-NP	B-NP	-	31	NMOD	-	-
29	B	B	I-NP	I-NP	-	31	NMOD	-	-
30	cell	cell	I-NP	I-NP	-	31	NMOD	-	-
31	lines	lines	I-NP	I-NP	-	27	PMOD	-	-
32	containing	containing	B-VP	B-VP	-	31	NMOD	-	-
33	high	high	B-NP	B-NP	-	34	NMOD	-	-
34	levels	levels	I-NP	I-NP	-	32	OBJ	-	-
35	of	of	B-PP	B-PP	-	34	NMOD	-	-
36	activated	activated	B-NP	B-NP	-	37	NMOD	-	-
37	NF-kappaB	NF-kappaB	I-NP	I-NP	-	35	PMOD	-	-
38	.	.	O	O	-	24	P	-	-

1	In	In	B-PP	B-PP	-	10	VMOD	-	-
2	addition	addition	B-NP	B-NP	-	1	PMOD	-	-
3	,	,	O	O	-	10	P	-	-
4	the	the	B-NP	B-NP	-	5	NMOD	-	-
5	expression	expression	I-NP	I-NP	-	10	SUB	-	-
6	of	of	B-PP	B-PP	-	5	NMOD	-	-
7	latent	latent	B-NP	B-NP	-	9	NMOD	-	-
8	membrane	membrane	I-NP	I-NP	-	9	NMOD	-	-
9	protein-1	protein-1	I-NP	I-NP	-	6	PMOD	-	-
10	led	led	B-VP	B-VP	-	0	ROOT	-	-
11	to	to	B-PP	B-PP	-	10	VMOD	-	-
12	activation	activation	B-NP	B-NP	-	11	PMOD	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	NF-kappaB	NF-kappaB	B-NP	B-NP	-	13	PMOD	-	-
15	that	that	B-NP	B-NP	-	12	NMOD	-	-
16	was	was	B-VP	B-VP	-	15	SBAR	-	-
17	capable	capable	B-ADJP	B-ADJP	-	16	PRD	-	-
18	of	of	B-PP	B-PP	-	17	AMOD	-	-
19	binding	binding	B-VP	B-VP	-	18	PMOD	-	-
20	the	the	B-NP	B-NP	-	22	NMOD	-	-
21	IL-1beta	IL-1beta	I-NP	I-NP	-	22	NMOD	-	-
22	promoter	promoter	I-NP	I-NP	-	19	OBJ	-	-
23	.	.	O	O	-	10	P	-	-

1	The	The	B-NP	B-NP	-	2	NMOD	-	-
2	study	study	I-NP	I-NP	-	3	SUB	-	-
3	demonstrates	demonstrates	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	EBV	EBV	B-NP	B-NP	-	6	SUB	-	-
6	can	can	B-VP	B-VP	-	4	SBAR	-	-
7	up-regulate	up-regulate	I-VP	I-VP	-	6	VC	-	-
8	IL-1beta	IL-1beta	B-NP	B-NP	-	9	NMOD	-	-
9	expression	expression	I-NP	I-NP	-	7	OBJ	-	-
10	,	,	O	O	-	7	P	-	-
11	possibly	possibly	B-ADVP	B-ADVP	-	12	PMOD	-	-
12	by	by	B-PP	B-PP	-	7	VMOD	-	-
13	using	using	B-VP	B-VP	-	12	PMOD	-	-
14	RBP	RBP	B-NP	B-NP	-	16	NMOD	-	-
15	,	,	O	O	-	16	P	-	-
16	NF-kappaB	NF-kappaB	B-NP	B-NP	-	19	NMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	or	or	O	O	-	19	NMOD	-	-
19	both	both	B-NP	B-NP	-	13	OBJ	-	-
20	.	.	O	O	-	3	P	-	-

1	Copyright	Copyright	B-NP	B-NP	-	0	ROOT	-	-
2	<num>	<num>	I-NP	I-NP	-	4	NMOD	-	-
3	Academic	Academic	I-NP	I-NP	-	4	NMOD	-	-
4	Press	Press	I-NP	I-NP	-	1	NMOD	-	-
5	.	.	O	O	-	4	P	-	-

1	Characterization	Characterization	B-NP	B-NP	-	0	ROOT	-	-
2	of	of	B-PP	B-PP	-	1	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	human	human	I-NP	I-NP	-	6	NMOD	-	-
5	elk-1	elk-1	I-NP	I-NP	-	6	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	2	PMOD	-	-
7	.	.	O	O	-	1	P	-	-

1	Potential	Potential	B-NP	B-NP	-	2	NMOD	-	-
2	role	role	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	a	a	B-NP	B-NP	-	7	NMOD	-	-
5	downstream	downstream	I-NP	I-NP	-	7	NMOD	-	-
6	intronic	intronic	I-NP	I-NP	-	7	NMOD	-	-
7	sequence	sequence	I-NP	I-NP	-	3	PMOD	-	-
8	for	for	B-PP	B-PP	-	2	NMOD	-	-
9	elk-1	elk-1	B-NP	B-NP	-	11	NMOD	-	-
10	gene	gene	I-NP	I-NP	-	11	NMOD	-	-
11	expression	expression	I-NP	I-NP	-	8	PMOD	-	-
12	in	in	B-PP	B-PP	-	11	NMOD	-	-
13	monocytes	monocytes	B-NP	B-NP	-	12	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	To	To	B-VP	B-VP	-	2	VMOD	-	-
2	characterize	characterize	I-VP	I-VP	-	9	VMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	human	human	I-NP	I-NP	-	6	NMOD	-	-
5	elk-1	elk-1	I-NP	I-NP	-	6	NMOD	-	-
6	promoter	promoter	I-NP	I-NP	-	2	OBJ	-	-
7	,	,	O	O	-	9	P	-	-
8	we	we	B-NP	B-NP	-	9	SUB	-	-
9	mapped	mapped	B-VP	B-VP	-	0	ROOT	-	-
10	the	the	B-NP	B-NP	-	13	NMOD	-	-
11	transcriptional	transcriptional	I-NP	I-NP	-	13	NMOD	-	-
12	start	start	I-NP	I-NP	-	13	NMOD	-	-
13	site	site	I-NP	I-NP	-	19	NMOD	-	-
14	and	and	O	O	-	19	NMOD	-	-
15	isolated	isolated	B-VP	B-VP	-	19	NMOD	-	-
16	elk-1-specific	elk-1-specific	B-NP	B-NP	-	19	NMOD	-	-
17	genomic	genomic	I-NP	I-NP	-	19	NMOD	-	-
18	phage	phage	I-NP	I-NP	-	19	NMOD	-	-
19	clones	clones	I-NP	I-NP	-	9	OBJ	-	-
20	that	that	B-NP	B-NP	-	19	NMOD	-	-
21	contained	contained	B-VP	B-VP	-	20	SBAR	-	-
22	extensive	extensive	B-NP	B-NP	-	26	NMOD	-	-
23	upstream	upstream	I-NP	I-NP	-	26	NMOD	-	-
24	and	and	I-NP	I-NP	-	26	NMOD	-	-
25	downstream	downstream	I-NP	I-NP	-	26	NMOD	-	-
26	sequences	sequences	I-NP	I-NP	-	21	OBJ	-	-
27	.	.	O	O	-	9	P	-	-

1	A	A	B-NP	B-NP	-	3	NMOD	-	-
2	TATA-like	TATA-like	I-NP	I-NP	-	3	NMOD	-	-
3	motif	motif	I-NP	I-NP	-	4	SUB	-	-
4	was	was	B-VP	B-VP	-	0	ROOT	-	-
5	identified	identified	I-VP	I-VP	-	4	VC	-	-
6	immediately	immediately	B-ADVP	B-ADVP	-	5	VMOD	-	-
7	upstream	upstream	B-ADVP	B-ADVP	-	6	AMOD	-	-
8	of	of	B-PP	B-PP	-	7	AMOD	-	-
9	the	the	B-NP	B-NP	-	12	NMOD	-	-
10	transcriptional	transcriptional	I-NP	I-NP	-	12	NMOD	-	-
11	start	start	I-NP	I-NP	-	12	NMOD	-	-
12	site	site	I-NP	I-NP	-	8	PMOD	-	-
13	.	.	O	O	-	4	P	-	-

1	Functional	Functional	B-NP	B-NP	-	2	NMOD	-	-
2	analyses	analyses	I-NP	I-NP	-	30	SUB	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	DNA	DNA	B-NP	B-NP	-	5	NMOD	-	-
5	fragments	fragments	I-NP	I-NP	-	3	PMOD	-	-
6	containing	containing	B-VP	B-VP	-	5	NMOD	-	-
7	the	the	B-NP	B-NP	-	9	NMOD	-	-
8	TATA	TATA	I-NP	I-NP	-	9	NMOD	-	-
9	element	element	I-NP	I-NP	-	12	NMOD	-	-
10	and	and	O	O	-	12	NMOD	-	-
11	the	the	B-NP	B-NP	-	12	NMOD	-	-
12	identification	identification	I-NP	I-NP	-	6	OBJ	-	-
13	of	of	B-PP	B-PP	-	12	NMOD	-	-
14	a	a	B-NP	B-NP	-	18	NMOD	-	-
15	DNase	DNase	I-NP	I-NP	-	18	NMOD	-	-
16	I-hypersensitive	I-hypersensitive	I-NP	I-NP	-	18	NMOD	-	-
17	chromatin	chromatin	I-NP	I-NP	-	18	NMOD	-	-
18	site	site	I-NP	I-NP	-	13	PMOD	-	-
19	(	(	O	O	-	20	P	-	-
20	HS	HS	B-NP	B-NP	-	18	NMOD	-	-
21	<num>	<num>	I-NP	I-NP	-	20	NMOD	-	-
22	)	)	O	O	-	20	P	-	-
23	in	in	B-PP	B-PP	-	18	NMOD	-	-
24	close	close	B-NP	B-NP	-	25	NMOD	-	-
25	proximity	proximity	I-NP	I-NP	-	23	PMOD	-	-
26	to	to	B-PP	B-PP	-	25	NMOD	-	-
27	the	the	B-NP	B-NP	-	29	NMOD	-	-
28	TATA	TATA	I-NP	I-NP	-	29	NMOD	-	-
29	box	box	I-NP	I-NP	-	26	PMOD	-	-
30	suggest	suggest	B-VP	B-VP	-	0	ROOT	-	-
31	that	that	B-SBAR	B-SBAR	-	30	VMOD	-	-
32	the	the	B-NP	B-NP	-	35	NMOD	-	-
33	identified	identified	I-NP	I-NP	-	35	NMOD	-	-
34	TATA	TATA	I-NP	I-NP	-	35	NMOD	-	-
35	motif	motif	I-NP	I-NP	-	36	SUB	-	-
36	is	is	B-VP	B-VP	-	31	SBAR	-	-
37	important	important	B-ADJP	B-ADJP	-	36	PRD	-	-
38	for	for	B-PP	B-PP	-	37	AMOD	-	-
39	elk-1	elk-1	B-NP	B-NP	-	40	NMOD	-	-
40	transcription	transcription	I-NP	I-NP	-	38	PMOD	-	-
41	in	in	B-ADVP	B-ADVP	-	36	VMOD	-	-
42	vivo	vivo	I-ADVP	I-ADVP	-	41	AMOD	-	-
43	.	.	O	O	-	30	P	-	-

1	Sequences	Sequences	B-NP	B-NP	-	9	SUB	-	-
2	upstream	upstream	B-ADVP	B-ADVP	-	1	NMOD	-	-
3	and	and	I-ADVP	I-ADVP	-	2	AMOD	-	-
4	downstream	downstream	I-ADVP	I-ADVP	-	2	AMOD	-	-
5	from	from	B-PP	B-PP	-	2	AMOD	-	-
6	the	the	B-NP	B-NP	-	8	NMOD	-	-
7	TATA	TATA	I-NP	I-NP	-	8	NMOD	-	-
8	box	box	I-NP	I-NP	-	5	PMOD	-	-
9	were	were	B-VP	B-VP	-	0	ROOT	-	-
10	found	found	I-VP	I-VP	-	9	VC	-	-
11	to	to	I-VP	I-VP	-	12	VMOD	-	-
12	contribute	contribute	I-VP	I-VP	-	10	VMOD	-	-
13	to	to	B-PP	B-PP	-	12	VMOD	-	-
14	elk-1	elk-1	B-NP	B-NP	-	16	NMOD	-	-
15	promoter	promoter	I-NP	I-NP	-	16	NMOD	-	-
16	activity	activity	I-NP	I-NP	-	13	PMOD	-	-
17	.	.	O	O	-	9	P	-	-

1	A	A	B-NP	B-NP	-	4	NMOD	-	-
2	second	second	I-NP	I-NP	-	4	NMOD	-	-
3	hypersensitive	hypersensitive	I-NP	I-NP	-	4	NMOD	-	-
4	site	site	I-NP	I-NP	-	9	SUB	-	-
5	(	(	O	O	-	6	P	-	-
6	HS	HS	B-NP	B-NP	-	4	NMOD	-	-
7	<num>	<num>	I-NP	I-NP	-	6	NMOD	-	-
8	)	)	O	O	-	6	P	-	-
9	was	was	B-VP	B-VP	-	0	ROOT	-	-
10	identified	identified	I-VP	I-VP	-	9	VC	-	-
11	within	within	B-PP	B-PP	-	10	VMOD	-	-
12	the	the	B-NP	B-NP	-	14	NMOD	-	-
13	first	first	I-NP	I-NP	-	14	NMOD	-	-
14	intron	intron	I-NP	I-NP	-	11	PMOD	-	-
15	in	in	B-PP	B-PP	-	14	NMOD	-	-
16	pre-monocytic	pre-monocytic	B-NP	B-NP	-	17	NMOD	-	-
17	cells	cells	I-NP	I-NP	-	15	PMOD	-	-
18	,	,	O	O	-	17	P	-	-
19	which	which	B-NP	B-NP	-	17	NMOD	-	-
20	express	express	B-VP	B-VP	-	19	SBAR	-	-
21	Elk-1	Elk-1	B-NP	B-NP	-	20	OBJ	-	-
22	only	only	B-ADVP	B-ADVP	-	20	VMOD	-	-
23	when	when	B-ADVP	B-ADVP	-	20	VMOD	-	-
24	differentiating	differentiating	B-VP	B-VP	-	23	DEP	-	-
25	to	to	B-PP	B-PP	-	24	VMOD	-	-
26	monocytes	monocytes	B-NP	B-NP	-	25	PMOD	-	-
27	.	.	O	O	-	9	P	-	-

1	In	In	B-PP	B-PP	-	18	VMOD	-	-
2	a	a	B-NP	B-NP	-	3	NMOD	-	-
3	variety	variety	I-NP	I-NP	-	1	PMOD	-	-
4	of	of	B-PP	B-PP	-	3	NMOD	-	-
5	other	other	B-NP	B-NP	-	7	NMOD	-	-
6	cell	cell	I-NP	I-NP	-	7	NMOD	-	-
7	types	types	I-NP	I-NP	-	4	PMOD	-	-
8	,	,	O	O	-	7	P	-	-
9	which	which	B-NP	B-NP	-	7	NMOD	-	-
10	display	display	B-VP	B-VP	-	9	SBAR	-	-
11	a	a	B-NP	B-NP	-	14	NMOD	-	-
12	constitutive	constitutive	I-NP	I-NP	-	14	NMOD	-	-
13	Elk-1	Elk-1	I-NP	I-NP	-	14	NMOD	-	-
14	expression	expression	I-NP	I-NP	-	10	OBJ	-	-
15	,	,	O	O	-	18	P	-	-
16	HS	HS	B-NP	B-NP	-	18	SUB	-	-
17	<num>	<num>	I-NP	I-NP	-	16	NMOD	-	-
18	did	did	B-VP	B-VP	-	0	ROOT	-	-
19	not	not	I-VP	I-VP	-	18	VMOD	-	-
20	exist	exist	I-VP	I-VP	-	18	VC	-	-
21	,	,	O	O	-	18	P	-	-
22	suggesting	suggesting	B-VP	B-VP	-	18	VMOD	-	-
23	that	that	B-SBAR	B-SBAR	-	22	VMOD	-	-
24	inducibility	inducibility	B-NP	B-NP	-	28	SUB	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	elk-1	elk-1	B-NP	B-NP	-	27	NMOD	-	-
27	expression	expression	I-NP	I-NP	-	25	PMOD	-	-
28	is	is	B-VP	B-VP	-	23	SBAR	-	-
29	associated	associated	I-VP	I-VP	-	28	VC	-	-
30	with	with	B-PP	B-PP	-	29	VMOD	-	-
31	the	the	B-NP	B-NP	-	32	NMOD	-	-
32	presence	presence	I-NP	I-NP	-	30	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	HS	HS	B-NP	B-NP	-	33	PMOD	-	-
35	<num>	<num>	I-NP	I-NP	-	34	NMOD	-	-
36	.	.	O	O	-	18	P	-	-

1	Egr-1	Egr-1	B-NP	B-NP	-	6	NMOD	-	-
2	and	and	O	O	-	6	NMOD	-	-
3	the	the	B-NP	B-NP	-	6	NMOD	-	-
4	serum	serum	I-NP	I-NP	-	6	NMOD	-	-
5	response	response	I-NP	I-NP	-	6	NMOD	-	-
6	factor	factor	I-NP	I-NP	-	7	SUB	-	-
7	were	were	B-VP	B-VP	-	0	ROOT	-	-
8	found	found	I-VP	I-VP	-	7	VC	-	-
9	to	to	I-VP	I-VP	-	10	VMOD	-	-
10	interact	interact	I-VP	I-VP	-	8	VMOD	-	-
11	specifically	specifically	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	with	with	B-PP	B-PP	-	10	VMOD	-	-
13	the	the	B-NP	B-NP	-	15	NMOD	-	-
14	intronic	intronic	I-NP	I-NP	-	15	NMOD	-	-
15	sequence	sequence	I-NP	I-NP	-	12	PMOD	-	-
16	at	at	B-PP	B-PP	-	10	VMOD	-	-
17	+265	+265	B-NP	B-NP	-	19	NMOD	-	-
18	and	and	I-NP	I-NP	-	19	NMOD	-	-
19	+448	+448	I-NP	I-NP	-	16	PMOD	-	-
20	,	,	O	O	-	10	P	-	-
21	respectively	respectively	B-ADVP	B-ADVP	-	10	VMOD	-	-
22	.	.	O	O	-	7	P	-	-

1	Because	Because	B-SBAR	B-SBAR	-	19	VMOD	-	-
2	Egr-1	Egr-1	B-NP	B-NP	-	3	NMOD	-	-
3	mRNA	mRNA	I-NP	I-NP	-	5	NMOD	-	-
4	and	and	I-NP	I-NP	-	5	NMOD	-	-
5	protein	protein	I-NP	I-NP	-	6	NMOD	-	-
6	levels	levels	I-NP	I-NP	-	7	SUB	-	-
7	were	were	B-VP	B-VP	-	1	SBAR	-	-
8	observed	observed	I-VP	I-VP	-	7	VC	-	-
9	to	to	I-VP	I-VP	-	10	VMOD	-	-
10	increase	increase	I-VP	I-VP	-	8	VMOD	-	-
11	significantly	significantly	B-ADVP	B-ADVP	-	10	VMOD	-	-
12	before	before	B-PP	B-PP	-	10	VMOD	-	-
13	induction	induction	B-NP	B-NP	-	12	PMOD	-	-
14	of	of	B-PP	B-PP	-	13	NMOD	-	-
15	elk-1	elk-1	B-NP	B-NP	-	16	NMOD	-	-
16	expression	expression	I-NP	I-NP	-	14	PMOD	-	-
17	,	,	O	O	-	19	P	-	-
18	we	we	B-NP	B-NP	-	19	SUB	-	-
19	propose	propose	B-VP	B-VP	-	0	ROOT	-	-
20	that	that	B-SBAR	B-SBAR	-	19	VMOD	-	-
21	Egr-1	Egr-1	B-NP	B-NP	-	22	SUB	-	-
22	is	is	B-VP	B-VP	-	20	SBAR	-	-
23	important	important	B-ADJP	B-ADJP	-	22	PRD	-	-
24	for	for	B-PP	B-PP	-	23	AMOD	-	-
25	the	the	B-NP	B-NP	-	26	NMOD	-	-
26	regulation	regulation	I-NP	I-NP	-	24	PMOD	-	-
27	of	of	B-PP	B-PP	-	26	NMOD	-	-
28	elk-1	elk-1	B-NP	B-NP	-	29	NMOD	-	-
29	transcription	transcription	I-NP	I-NP	-	27	PMOD	-	-
30	in	in	B-PP	B-PP	-	26	NMOD	-	-
31	differentiating	differentiating	B-VP	B-VP	-	32	NMOD	-	-
32	monocytes	monocytes	B-NP	B-NP	-	30	PMOD	-	-
33	.	.	O	O	-	19	P	-	-

1	Functional	Functional	B-NP	B-NP	-	2	NMOD	-	-
2	association	association	I-NP	I-NP	-	0	ROOT	-	-
3	of	of	B-PP	B-PP	-	2	NMOD	-	-
4	Nmi	Nmi	B-NP	B-NP	-	3	PMOD	-	-
5	with	with	B-PP	B-PP	-	2	NMOD	-	-
6	Stat5	Stat5	B-NP	B-NP	-	8	NMOD	-	-
7	and	and	I-NP	I-NP	-	8	NMOD	-	-
8	Stat1	Stat1	I-NP	I-NP	-	5	PMOD	-	-
9	in	in	B-PP	B-PP	-	2	NMOD	-	-
10	IL-2-	IL-2-	B-NP	B-NP	-	13	NMOD	-	-
11	and	and	O	O	-	13	NMOD	-	-
12	IFNgamma-mediated	IFNgamma-mediated	B-NP	B-NP	-	13	NMOD	-	-
13	signaling	signaling	I-NP	I-NP	-	9	PMOD	-	-
14	.	.	O	O	-	2	P	-	-

1	Using	Using	B-VP	B-VP	-	17	VMOD	-	-
2	the	the	B-NP	B-NP	-	4	NMOD	-	-
3	coiled-coil	coiled-coil	I-NP	I-NP	-	4	NMOD	-	-
4	region	region	I-NP	I-NP	-	1	OBJ	-	-
5	of	of	B-PP	B-PP	-	4	NMOD	-	-
6	Stat5b	Stat5b	B-NP	B-NP	-	5	PMOD	-	-
7	as	as	B-PP	B-PP	-	1	VMOD	-	-
8	the	the	B-NP	B-NP	-	9	NMOD	-	-
9	bait	bait	I-NP	I-NP	-	7	PMOD	-	-
10	in	in	B-PP	B-PP	-	1	VMOD	-	-
11	a	a	B-NP	B-NP	-	14	NMOD	-	-
12	yeast	yeast	I-NP	I-NP	-	14	NMOD	-	-
13	two-hybrid	two-hybrid	I-NP	I-NP	-	14	NMOD	-	-
14	screen	screen	I-NP	I-NP	-	10	PMOD	-	-
15	,	,	O	O	-	17	P	-	-
16	we	we	B-NP	B-NP	-	17	SUB	-	-
17	identified	identified	B-VP	B-VP	-	0	ROOT	-	-
18	the	the	B-NP	B-NP	-	19	NMOD	-	-
19	association	association	I-NP	I-NP	-	17	OBJ	-	-
20	of	of	B-PP	B-PP	-	19	NMOD	-	-
21	Nmi	Nmi	B-NP	B-NP	-	24	NMOD	-	-
22	,	,	O	O	-	24	P	-	-
23	a	a	B-NP	B-NP	-	24	NMOD	-	-
24	protein	protein	I-NP	I-NP	-	20	PMOD	-	-
25	of	of	B-PP	B-PP	-	24	NMOD	-	-
26	unknown	unknown	B-NP	B-NP	-	27	NMOD	-	-
27	function	function	I-NP	I-NP	-	25	PMOD	-	-
28	previously	previously	B-VP	B-VP	-	29	VMOD	-	-
29	reported	reported	I-VP	I-VP	-	27	NMOD	-	-
30	as	as	B-PP	B-PP	-	29	VMOD	-	-
31	an	an	B-NP	B-NP	-	33	NMOD	-	-
32	N-Myc	N-Myc	I-NP	I-NP	-	33	NMOD	-	-
33	interactor	interactor	I-NP	I-NP	-	30	PMOD	-	-
34	.	.	O	O	-	17	P	-	-

1	We	We	B-NP	B-NP	-	3	SUB	-	-
2	further	further	B-ADVP	B-ADVP	-	3	VMOD	-	-
3	show	show	B-VP	B-VP	-	0	ROOT	-	-
4	that	that	B-SBAR	B-SBAR	-	3	VMOD	-	-
5	Nmi	Nmi	B-NP	B-NP	-	6	SUB	-	-
6	interacts	interacts	B-VP	B-VP	-	4	SBAR	-	-
7	with	with	B-PP	B-PP	-	6	VMOD	-	-
8	all	all	B-NP	B-NP	-	9	NMOD	-	-
9	STATs	STATs	I-NP	I-NP	-	7	PMOD	-	-
10	except	except	B-PP	B-PP	-	6	VMOD	-	-
11	Stat2	Stat2	B-NP	B-NP	-	10	PMOD	-	-
12	.	.	O	O	-	3	P	-	-

1	We	We	B-NP	B-NP	-	2	SUB	-	-
2	evaluated	evaluated	B-VP	B-VP	-	0	ROOT	-	-
3	two	two	B-NP	B-NP	-	5	NMOD	-	-
4	cytokine	cytokine	I-NP	I-NP	-	5	NMOD	-	-
5	systems	systems	I-NP	I-NP	-	9	NMOD	-	-
6	,	,	O	O	-	9	P	-	-
7	IL-2	IL-2	B-NP	B-NP	-	9	NMOD	-	-
8	and	and	O	O	-	9	NMOD	-	-
9	IFNgamma	IFNgamma	B-NP	B-NP	-	2	OBJ	-	-
10	,	,	O	O	-	2	P	-	-
11	and	and	O	O	-	2	VMOD	-	-
12	demonstrate	demonstrate	B-VP	B-VP	-	2	VMOD	-	-
13	that	that	B-SBAR	B-SBAR	-	12	VMOD	-	-
14	Nmi	Nmi	B-NP	B-NP	-	15	SUB	-	-
15	augments	augments	B-VP	B-VP	-	13	SBAR	-	-
16	STAT-mediated	STAT-mediated	B-NP	B-NP	-	17	NMOD	-	-
17	transcription	transcription	I-NP	I-NP	-	15	OBJ	-	-
18	in	in	B-PP	B-PP	-	17	NMOD	-	-
19	response	response	B-NP	B-NP	-	18	PMOD	-	-
20	to	to	B-PP	B-PP	-	18	PMOD	-	-
21	these	these	B-NP	B-NP	-	22	NMOD	-	-
22	cytokines	cytokines	I-NP	I-NP	-	20	PMOD	-	-
23	.	.	O	O	-	2	P	-	-

1	Interestingly	Interestingly	B-ADVP	B-ADVP	-	4	VMOD	-	-
2	,	,	O	O	-	4	P	-	-
3	Nmi	Nmi	B-NP	B-NP	-	4	SUB	-	-
4	lacks	lacks	B-VP	B-VP	-	30	VMOD	-	-
5	an	an	B-NP	B-NP	-	9	NMOD	-	-
6	intrinsic	intrinsic	I-NP	I-NP	-	9	NMOD	-	-
7	transcriptional	transcriptional	I-NP	I-NP	-	9	NMOD	-	-
8	activation	activation	I-NP	I-NP	-	9	NMOD	-	-
9	domain	domain	I-NP	I-NP	-	4	OBJ	-	-
10	;	;	O	O	-	4	P	-	-
11	instead	instead	B-ADVP	B-ADVP	-	14	VMOD	-	-
12	,	,	O	O	-	14	P	-	-
13	Nmi	Nmi	B-NP	B-NP	-	14	SUB	-	-
14	enhances	enhances	B-VP	B-VP	-	30	VMOD	-	-
15	the	the	B-NP	B-NP	-	16	NMOD	-	-
16	association	association	I-NP	I-NP	-	14	OBJ	-	-
17	of	of	B-PP	B-PP	-	16	NMOD	-	-
18	CBP/p300	CBP/p300	B-NP	B-NP	-	20	NMOD	-	-
19	coactivator	coactivator	I-NP	I-NP	-	20	NMOD	-	-
20	proteins	proteins	I-NP	I-NP	-	17	PMOD	-	-
21	with	with	B-PP	B-PP	-	16	NMOD	-	-
22	Stat1	Stat1	B-NP	B-NP	-	24	NMOD	-	-
23	and	and	I-NP	I-NP	-	24	NMOD	-	-
24	Stat5	Stat5	I-NP	I-NP	-	21	PMOD	-	-
25	,	,	O	O	-	30	P	-	-
26	and	and	O	O	-	30	VMOD	-	-
27	together	together	B-ADVP	B-ADVP	-	28	PMOD	-	-
28	with	with	B-PP	B-PP	-	30	VMOD	-	-
29	CBP/p300	CBP/p300	B-NP	B-NP	-	28	PMOD	-	-
30	can	can	B-VP	B-VP	-	0	ROOT	-	-
31	augment	augment	I-VP	I-VP	-	30	VC	-	-
32	IL-2-	IL-2-	B-NP	B-NP	-	35	NMOD	-	-
33	and	and	O	O	-	35	NMOD	-	-
34	IFNgamma-dependent	IFNgamma-dependent	B-NP	B-NP	-	35	NMOD	-	-
35	transcription	transcription	I-NP	I-NP	-	31	OBJ	-	-
36	.	.	O	O	-	30	P	-	-

1	Therefore	Therefore	B-ADVP	B-ADVP	-	7	VMOD	-	-
2	,	,	O	O	-	7	P	-	-
3	our	our	B-NP	B-NP	-	4	NMOD	-	-
4	data	data	I-NP	I-NP	-	7	SUB	-	-
5	not	not	B-CONJP	B-CONJP	-	7	VMOD	-	-
6	only	only	I-CONJP	I-CONJP	-	5	DEP	-	-
7	reveal	reveal	B-VP	B-VP	-	0	ROOT	-	-
8	that	that	B-SBAR	B-SBAR	-	7	VMOD	-	-
9	Nmi	Nmi	B-NP	B-NP	-	10	SUB	-	-
10	can	can	B-VP	B-VP	-	8	SBAR	-	-
11	potentiate	potentiate	I-VP	I-VP	-	10	VC	-	-
12	STAT-dependent	STAT-dependent	B-NP	B-NP	-	13	NMOD	-	-
13	transcription	transcription	I-NP	I-NP	-	11	OBJ	-	-
14	,	,	O	O	-	17	P	-	-
15	but	but	B-CONJP	B-CONJP	-	17	VMOD	-	-
16	also	also	I-CONJP	I-CONJP	-	15	DEP	-	-
17	suggest	suggest	B-VP	B-VP	-	11	VMOD	-	-
18	that	that	B-SBAR	B-SBAR	-	17	VMOD	-	-
19	it	it	B-NP	B-NP	-	20	SUB	-	-
20	can	can	B-VP	B-VP	-	18	SBAR	-	-
21	augment	augment	I-VP	I-VP	-	20	VC	-	-
22	coactivator	coactivator	B-NP	B-NP	-	24	NMOD	-	-
23	protein	protein	I-NP	I-NP	-	24	NMOD	-	-
24	recruitment	recruitment	I-NP	I-NP	-	21	OBJ	-	-
25	to	to	B-PP	B-PP	-	21	VMOD	-	-
26	at	at	B-ADVP	B-ADVP	-	21	VMOD	-	-
27	least	least	I-ADVP	I-ADVP	-	26	AMOD	-	-
28	some	some	B-NP	B-NP	-	26	AMOD	-	-
29	members	members	I-NP	I-NP	-	21	OBJ	-	-
30	of	of	B-PP	B-PP	-	29	NMOD	-	-
31	a	a	B-NP	B-NP	-	32	NMOD	-	-
32	group	group	I-NP	I-NP	-	30	PMOD	-	-
33	of	of	B-PP	B-PP	-	32	NMOD	-	-
34	sequence-specific	sequence-specific	B-NP	B-NP	-	36	NMOD	-	-
35	transcription	transcription	I-NP	I-NP	-	36	NMOD	-	-
36	factors	factors	I-NP	I-NP	-	33	PMOD	-	-
37	.	.	O	O	-	7	P	-	-

